0001193125-23-192729.txt : 20230725 0001193125-23-192729.hdr.sgml : 20230725 20230725070230 ACCESSION NUMBER: 0001193125-23-192729 CONFORMED SUBMISSION TYPE: 20-F PUBLIC DOCUMENT COUNT: 168 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230725 DATE AS OF CHANGE: 20230725 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Boqii Holding Ltd CENTRAL INDEX KEY: 0001815021 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-RETAIL STORES, NEC [5990] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 20-F SEC ACT: 1934 Act SEC FILE NUMBER: 001-39547 FILM NUMBER: 231106432 BUSINESS ADDRESS: STREET 1: FLOOR 6, BUILDING 1, NO. 399 STREET 2: SHENGXIA ROAD CITY: PUDONG NEW DISTRICT, SHANGHAI STATE: F4 ZIP: 201203 BUSINESS PHONE: 86-21-6109-6226 MAIL ADDRESS: STREET 1: FLOOR 6, BUILDING 1, NO. 399 STREET 2: SHENGXIA ROAD CITY: PUDONG NEW DISTRICT, SHANGHAI STATE: F4 ZIP: 201203 20-F 1 d290954d20f.htm FORM 20-F Form 20-F
Table of Contents
falseFYBoqii Holding Ltd0001815021true 0001815021 2020-04-01 2021-03-31 0001815021 2021-04-01 2022-03-31 0001815021 2022-04-01 2023-03-31 0001815021 2022-03-31 0001815021 2023-03-31 0001815021 2021-03-31 0001815021 2021-04-01 0001815021 2022-04-01 0001815021 2020-03-31 2020-03-31 0001815021 2018-07-25 2018-07-25 0001815021 2020-10-01 2020-10-31 0001815021 2020-10-31 0001815021 2022-01-01 2022-12-31 0001815021 2022-08-01 2022-08-31 0001815021 2021-01-01 2021-12-31 0001815021 2023-01-01 2023-12-31 0001815021 2022-05-31 0001815021 2020-03-31 0001815021 us-gaap:CommonClassAMember 2022-03-31 0001815021 us-gaap:CommonClassBMember 2022-03-31 0001815021 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:NonrecourseMember 2022-03-31 0001815021 bq:ShanghaiGuangchengInformationMember 2022-03-31 0001815021 bq:WuhanChunzhijinMember 2022-03-31 0001815021 bq:MerchantTycoonLimitedMember 2022-03-31 0001815021 bq:YingzhilisaTangMember 2022-03-31 0001815021 bq:LijunZhouMember 2022-03-31 0001815021 bq:YanJiangMember 2022-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2022-03-31 0001815021 bq:FeiWangMember 2022-03-31 0001815021 bq:ProductSalesMember 2022-03-31 0001815021 bq:OnlineMarketingAndInformationServicesAndOtherRevenueMember 2022-03-31 0001815021 bq:SuperbOriginInternationalLimitedMember 2022-03-31 0001815021 bq:WeishiNetworkMember 2022-03-31 0001815021 bq:SoftwareMember 2022-03-31 0001815021 us-gaap:LeaseholdImprovementsMember 2022-03-31 0001815021 us-gaap:VehiclesMember 2022-03-31 0001815021 us-gaap:FurnitureAndFixturesMember 2022-03-31 0001815021 bq:WarehouseEquipmentMember 2022-03-31 0001815021 us-gaap:DistributionRightsMember 2022-03-31 0001815021 us-gaap:LicenseMember 2022-03-31 0001815021 us-gaap:TrademarksMember 2022-03-31 0001815021 currency:CNY us-gaap:CashMember 2022-03-31 0001815021 currency:CNY us-gaap:CashEquivalentsMember 2022-03-31 0001815021 currency:HKD us-gaap:CashMember 2022-03-31 0001815021 us-gaap:CashEquivalentsMember currency:HKD 2022-03-31 0001815021 us-gaap:CashMember currency:USD 2022-03-31 0001815021 us-gaap:CashEquivalentsMember currency:USD 2022-03-31 0001815021 us-gaap:CashMember currency:EUR 2022-03-31 0001815021 currency:EUR us-gaap:CashEquivalentsMember 2022-03-31 0001815021 us-gaap:CashMember currency:NZD 2022-03-31 0001815021 us-gaap:CashEquivalentsMember currency:NZD 2022-03-31 0001815021 us-gaap:CashEquivalentsMember 2022-03-31 0001815021 us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001815021 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2022-03-31 0001815021 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2022-03-31 0001815021 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2022-03-31 0001815021 bq:WeightedAverageCostOfCapitalMember us-gaap:AvailableforsaleSecuritiesMember srt:MinimumMember 2022-03-31 0001815021 bq:WeightedAverageCostOfCapitalMember us-gaap:AvailableforsaleSecuritiesMember srt:MedianMember 2022-03-31 0001815021 srt:MaximumMember us-gaap:AvailableforsaleSecuritiesMember bq:WeightedAverageCostOfCapitalMember 2022-03-31 0001815021 us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember us-gaap:AvailableforsaleSecuritiesMember srt:MinimumMember 2022-03-31 0001815021 us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember us-gaap:AvailableforsaleSecuritiesMember srt:MedianMember 2022-03-31 0001815021 us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember us-gaap:AvailableforsaleSecuritiesMember srt:MaximumMember 2022-03-31 0001815021 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:AvailableforsaleSecuritiesMember srt:MinimumMember 2022-03-31 0001815021 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:AvailableforsaleSecuritiesMember bq:MinimumOneMember 2022-03-31 0001815021 bq:MinimumTwoMember us-gaap:AvailableforsaleSecuritiesMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-03-31 0001815021 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:AvailableforsaleSecuritiesMember srt:MaximumMember 2022-03-31 0001815021 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:AvailableforsaleSecuritiesMember srt:MinimumMember 2022-03-31 0001815021 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:AvailableforsaleSecuritiesMember bq:MinimumOneMember 2022-03-31 0001815021 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:AvailableforsaleSecuritiesMember bq:MinimumTwoMember 2022-03-31 0001815021 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:AvailableforsaleSecuritiesMember srt:MaximumMember 2022-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember bq:ProbabilityLiquidationScenarioMember 2022-03-31 0001815021 bq:ProbabilityRedemptionScenarioMember us-gaap:AvailableforsaleSecuritiesMember 2022-03-31 0001815021 bq:ProbabilityIpoScenarioMember us-gaap:AvailableforsaleSecuritiesMember 2022-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember srt:MinimumMember 2022-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember srt:MaximumMember 2022-03-31 0001815021 bq:AvailableForSaleDebtInvestmentsMember bq:QingdaoShuanganMember 2022-03-31 0001815021 bq:QingdaoShuanganBiotechnologyCoLtdMember 2022-03-31 0001815021 bq:BeijingPetdogTechnologyDevelopmentCoLtdMember 2022-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2022-03-31 0001815021 currency:CNY 2022-03-31 0001815021 us-gaap:ShortTermInvestmentsMember 2022-03-31 0001815021 us-gaap:ShortTermInvestmentsMember bq:ShortTermBankLoanMember 2022-03-31 0001815021 bq:ShortTermBankLoanMember 2022-03-31 0001815021 bq:LongTermLoanFromCmbMember 2022-03-31 0001815021 bq:LoanFromChongLiMember 2022-03-31 0001815021 bq:LoanForYokenSeriesAOneWarrantMember 2022-03-31 0001815021 bq:ConversionFeatureOfYokenSeriesAOneWarrantMember 2022-03-31 0001815021 bq:LoanForYokenSeriesAOneWarrantMember bq:YokenSeriesAOneWarrantMember 2022-03-31 0001815021 bq:YokenSeriesAOneWarrantMember 2022-03-31 0001815021 bq:ChongLiMember 2022-03-31 0001815021 bq:LongTermLoanFromCmbMember bq:CMBMember 2022-03-31 0001815021 us-gaap:EmployeeStockOptionMember srt:MaximumMember 2022-03-31 0001815021 us-gaap:EmployeeStockOptionMember srt:MinimumMember 2022-03-31 0001815021 us-gaap:CurrencySwapMember bq:NewForeignExchangeSwapContractThreeMember bq:NewForeignExchangeSwapContractMember 2022-03-31 0001815021 bq:NewForeignExchangeSwapContractMember bq:NewForeignExchangeSwapContractTwoMember us-gaap:CurrencySwapMember 2022-03-31 0001815021 bq:NewForeignExchangeSwapContractMember us-gaap:CurrencySwapMember bq:NewForeignExchangeSwapContractOneMember 2022-03-31 0001815021 bq:NewForeignExchangeSwapContractMember us-gaap:CurrencySwapMember 2022-03-31 0001815021 us-gaap:CommonClassAMember 2023-03-31 0001815021 us-gaap:CommonClassBMember 2023-03-31 0001815021 us-gaap:NonrecourseMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2023-03-31 0001815021 bq:ShanghaiGuangchengInformationMember 2023-03-31 0001815021 bq:WuhanChunzhijinMember 2023-03-31 0001815021 bq:MerchantTycoonLimitedMember 2023-03-31 0001815021 bq:YingzhilisaTangMember 2023-03-31 0001815021 bq:LijunZhouMember 2023-03-31 0001815021 bq:YanJiangMember 2023-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2023-03-31 0001815021 bq:FeiWangMember 2023-03-31 0001815021 bq:ProductSalesMember 2023-03-31 0001815021 bq:OnlineMarketingAndInformationServicesAndOtherRevenueMember 2023-03-31 0001815021 bq:SuperbOriginInternationalLimitedMember 2023-03-31 0001815021 bq:WeishiNetworkMember 2023-03-31 0001815021 bq:SoftwareMember 2023-03-31 0001815021 us-gaap:LeaseholdImprovementsMember 2023-03-31 0001815021 us-gaap:VehiclesMember 2023-03-31 0001815021 us-gaap:FurnitureAndFixturesMember 2023-03-31 0001815021 bq:WarehouseEquipmentMember 2023-03-31 0001815021 us-gaap:DistributionRightsMember 2023-03-31 0001815021 us-gaap:LicenseMember 2023-03-31 0001815021 us-gaap:TrademarksMember 2023-03-31 0001815021 us-gaap:CashMember currency:CNY 2023-03-31 0001815021 currency:CNY us-gaap:CashEquivalentsMember 2023-03-31 0001815021 us-gaap:CashMember currency:HKD 2023-03-31 0001815021 us-gaap:CashEquivalentsMember currency:HKD 2023-03-31 0001815021 currency:USD us-gaap:CashMember 2023-03-31 0001815021 currency:USD us-gaap:CashEquivalentsMember 2023-03-31 0001815021 us-gaap:CashMember currency:EUR 2023-03-31 0001815021 us-gaap:CashEquivalentsMember currency:EUR 2023-03-31 0001815021 us-gaap:CashMember currency:NZD 2023-03-31 0001815021 us-gaap:CashEquivalentsMember currency:NZD 2023-03-31 0001815021 us-gaap:CashEquivalentsMember 2023-03-31 0001815021 us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001815021 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2023-03-31 0001815021 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001815021 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001815021 bq:BoqiiCorporationLimitedMember 2023-03-31 0001815021 bq:BoqiiInternationalLimitedMember 2023-03-31 0001815021 bq:XingmuInternationalLimitedMember 2023-03-31 0001815021 bq:XingmuHkLimitedMember 2023-03-31 0001815021 bq:NanjingXinmuInformationTechnologyCoLtdMember 2023-03-31 0001815021 bq:XinchengshanghaiInformationTechnologyCoLtdMember 2023-03-31 0001815021 bq:ShanghaiYiqinPetsProductsCoLtdMember 2023-03-31 0001815021 bq:ShanghaiEverySupplyChainCoLtdMember 2023-03-31 0001815021 bq:ImpliedPriceToSalesAfterDiscountForLackOfMarketabilityMember us-gaap:AvailableforsaleSecuritiesMember 2023-03-31 0001815021 us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember us-gaap:AvailableforsaleSecuritiesMember 2023-03-31 0001815021 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:AvailableforsaleSecuritiesMember srt:MinimumMember 2023-03-31 0001815021 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:AvailableforsaleSecuritiesMember srt:MedianMember 2023-03-31 0001815021 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:AvailableforsaleSecuritiesMember srt:MaximumMember 2023-03-31 0001815021 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:AvailableforsaleSecuritiesMember srt:MinimumMember 2023-03-31 0001815021 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:AvailableforsaleSecuritiesMember srt:MedianMember 2023-03-31 0001815021 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:AvailableforsaleSecuritiesMember srt:MaximumMember 2023-03-31 0001815021 srt:MinimumMember us-gaap:AvailableforsaleSecuritiesMember bq:ProbabilityLiquidationScenarioMember 2023-03-31 0001815021 bq:ProbabilityLiquidationScenarioMember us-gaap:AvailableforsaleSecuritiesMember srt:MaximumMember 2023-03-31 0001815021 bq:ProbabilityRedemptionScenarioMember us-gaap:AvailableforsaleSecuritiesMember srt:MinimumMember 2023-03-31 0001815021 bq:ProbabilityRedemptionScenarioMember us-gaap:AvailableforsaleSecuritiesMember srt:MaximumMember 2023-03-31 0001815021 bq:ProbabilityIpoScenarioMember us-gaap:AvailableforsaleSecuritiesMember srt:MinimumMember 2023-03-31 0001815021 bq:ProbabilityIpoScenarioMember us-gaap:AvailableforsaleSecuritiesMember srt:MaximumMember 2023-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2023-03-31 0001815021 bq:QingdaoShuanganBiotechnologyCoLtdMember bq:AvailableForSaleDebtInvestmentsMember 2023-03-31 0001815021 bq:WuhanChunzhijinInformationTechnologyCoLtdMember bq:EquityMethodInvestmentMember 2023-03-31 0001815021 bq:WuhanChunzhijinInformationTechnologyCoLtdMember srt:MaximumMember bq:EquityMethodInvestmentMember 2023-03-31 0001815021 bq:QingdaoShuanganBiotechnologyCoLtdMember 2023-03-31 0001815021 bq:BeijingPetdogTechnologyDevelopmentCoLtdMember 2023-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2023-03-31 0001815021 bq:ContractualArrangementsMember 2023-03-31 0001815021 bq:RepaymentOfLoanMember bq:LoanAgreementsMember 2023-03-31 0001815021 bq:EquityInterestPledgeAgreementsMember 2023-03-31 0001815021 currency:CNY 2023-03-31 0001815021 us-gaap:ShortTermInvestmentsMember 2023-03-31 0001815021 bq:ShortTermBankLoanMember us-gaap:ShortTermInvestmentsMember 2023-03-31 0001815021 bq:ShortTermBankLoanMember 2023-03-31 0001815021 bq:LongTermBankLoanMember us-gaap:ShortTermInvestmentsMember 2023-03-31 0001815021 us-gaap:CommonStockMember 2023-03-31 0001815021 dei:AdrMember 2023-03-31 0001815021 bq:LoanFromChongLiMember 2023-03-31 0001815021 bq:LoanForYokenSeriesAOneWarrantMember 2023-03-31 0001815021 bq:ConversionFeatureOfYokenSeriesAOneWarrantMember 2023-03-31 0001815021 us-gaap:SwapMember 2023-03-31 0001815021 bq:LoanForYokenSeriesAOneWarrantMember bq:YokenSeriesAOneWarrantMember 2023-03-31 0001815021 bq:YokenSeriesAOneWarrantMember 2023-03-31 0001815021 bq:ChongLiMember 2023-03-31 0001815021 bq:CMBMember bq:LongTermLoanFromCmbMember 2023-03-31 0001815021 country:CN 2023-03-31 0001815021 bq:FromOctoberTwoThousandAndTwentyThreeToMarchTwoThousandAndTwentyFourMember bq:LoansReceivablePeriodRangingFromTwelveToTwentyFourMonthsMember 2023-03-31 0001815021 bq:NewForeignExchangeSwapContractMember us-gaap:CurrencySwapMember 2023-03-31 0001815021 bq:LoanReceivableForThePeriodTwentyFourToThirtySixMonthsMember 2023-03-31 0001815021 bq:ProductSalesMember 2020-04-01 2021-03-31 0001815021 bq:OnlineMarketingAndInformationServicesAndOtherRevenueMember 2020-04-01 2021-03-31 0001815021 bq:BeijingPetdogMember 2020-04-01 2021-03-31 0001815021 bq:WeishiNetworkMember 2020-04-01 2021-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2020-04-01 2021-03-31 0001815021 us-gaap:ReceivablesFromStockholderMember 2020-04-01 2021-03-31 0001815021 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2021-03-31 0001815021 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2021-03-31 0001815021 bq:StatutoryReservesMember 2020-04-01 2021-03-31 0001815021 us-gaap:RetainedEarningsMember 2020-04-01 2021-03-31 0001815021 us-gaap:NoncontrollingInterestMember 2020-04-01 2021-03-31 0001815021 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2020-04-01 2021-03-31 0001815021 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2020-04-01 2021-03-31 0001815021 us-gaap:CommonStockMember 2020-04-01 2021-03-31 0001815021 us-gaap:EmployeeStockOptionMember 2020-04-01 2021-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2020-04-01 2021-03-31 0001815021 currency:CNY 2020-04-01 2021-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember 2020-04-01 2021-03-31 0001815021 us-gaap:SupplierConcentrationRiskMember us-gaap:SalesRevenueNetMember bq:RoyalCaninChinaCoLtdMember 2020-04-01 2021-03-31 0001815021 bq:ThirdPartyMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:NonrecourseMember 2020-04-01 2021-03-31 0001815021 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:NonrecourseMember 2020-04-01 2021-03-31 0001815021 bq:InterCompanyMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:NonrecourseMember 2020-04-01 2021-03-31 0001815021 bq:QingdaoShuanganBiotechnologyCoLtdMember 2020-04-01 2021-03-31 0001815021 bq:BeijingPetdogTechnologyDevelopmentCoLtdMember 2020-04-01 2021-03-31 0001815021 bq:RoyalCaninChinaCoLtdMember us-gaap:SupplierConcentrationRiskMember bq:PurchasesMember 2020-04-01 2021-03-31 0001815021 us-gaap:SalesRevenueNetMember 2020-04-01 2021-03-31 0001815021 bq:ProductSalesMember 2021-04-01 2022-03-31 0001815021 bq:OnlineMarketingAndInformationServicesAndOtherRevenueMember 2021-04-01 2022-03-31 0001815021 bq:BeijingPetdogMember 2021-04-01 2022-03-31 0001815021 bq:WeishiNetworkMember 2021-04-01 2022-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2021-04-01 2022-03-31 0001815021 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2022-03-31 0001815021 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2022-03-31 0001815021 bq:StatutoryReservesMember 2021-04-01 2022-03-31 0001815021 us-gaap:RetainedEarningsMember 2021-04-01 2022-03-31 0001815021 us-gaap:ReceivablesFromStockholderMember 2021-04-01 2022-03-31 0001815021 us-gaap:NoncontrollingInterestMember 2021-04-01 2022-03-31 0001815021 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-04-01 2022-03-31 0001815021 us-gaap:EmployeeStockOptionMember 2021-04-01 2022-03-31 0001815021 currency:CNY 2021-04-01 2022-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2021-04-01 2022-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember 2021-04-01 2022-03-31 0001815021 bq:ThirdPartyMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:NonrecourseMember 2021-04-01 2022-03-31 0001815021 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:NonrecourseMember 2021-04-01 2022-03-31 0001815021 bq:InterCompanyMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:NonrecourseMember 2021-04-01 2022-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember srt:MinimumMember 2021-04-01 2022-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember srt:MaximumMember 2021-04-01 2022-03-31 0001815021 bq:QingdaoShuanganBiotechnologyCoLtdMember 2021-04-01 2022-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2021-04-01 2022-03-31 0001815021 bq:BeijingPetdogTechnologyDevelopmentCoLtdMember 2021-04-01 2022-03-31 0001815021 us-gaap:EmployeeStockOptionMember 2021-04-01 2022-03-31 0001815021 bq:EmployeesAndNonEmployeesMember 2021-04-01 2022-03-31 0001815021 us-gaap:CurrencySwapMember bq:NewForeignExchangeSwapContractMember 2021-04-01 2022-03-31 0001815021 bq:ExtensionOfLoanAgreementMember bq:CMBMember bq:LongTermLoanFromCmbMember 2021-04-01 2022-03-31 0001815021 bq:NewForeignExchangeSwapContractMember 2021-04-01 2022-03-31 0001815021 bq:ShanghaiGuangchengInformationMember 2021-04-01 2022-03-31 0001815021 bq:RoyalCaninChinaCoLtdMember us-gaap:SupplierConcentrationRiskMember bq:PurchasesMember 2021-04-01 2022-03-31 0001815021 bq:ChongLiMember 2021-04-01 2022-03-31 0001815021 bq:ProductSalesMember 2022-04-01 2023-03-31 0001815021 bq:OnlineMarketingAndInformationServicesAndOtherRevenueMember 2022-04-01 2023-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2022-04-01 2023-03-31 0001815021 bq:WuhanChunzhijinMember 2022-04-01 2023-03-31 0001815021 bq:WeishiNetworkMember 2022-04-01 2023-03-31 0001815021 bq:BeijingPetdogMember 2022-04-01 2023-03-31 0001815021 bq:ShanghaiGuangchengInformationTechnologyLimitedPartnershipshanghaiGuangchengInformationMember 2022-04-01 2023-03-31 0001815021 bq:MerchantTycoonLimitedMember 2022-04-01 2023-03-31 0001815021 bq:SuperbOriginInternationalLimitedMember 2022-04-01 2023-03-31 0001815021 bq:YingzhilisaTangMember 2022-04-01 2023-03-31 0001815021 bq:YanJiangMember 2022-04-01 2023-03-31 0001815021 bq:DijackieChenMember 2022-04-01 2023-03-31 0001815021 bq:YingchristinaZhangMember 2022-04-01 2023-03-31 0001815021 bq:FeiWangMember 2022-04-01 2023-03-31 0001815021 bq:LijunZhouMember 2022-04-01 2023-03-31 0001815021 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2023-03-31 0001815021 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2023-03-31 0001815021 bq:StatutoryReservesMember 2022-04-01 2023-03-31 0001815021 us-gaap:RetainedEarningsMember 2022-04-01 2023-03-31 0001815021 us-gaap:ReceivablesFromStockholderMember 2022-04-01 2023-03-31 0001815021 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-04-01 2023-03-31 0001815021 us-gaap:EmployeeStockOptionMember 2022-04-01 2023-03-31 0001815021 bq:ShanghaiEverySupplyChainCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:ShanghaiYiqinPetsProductsCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:XinchengshanghaiInformationTechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:NanjingXinmuInformationTechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:XingmuHkLimitedMember 2022-04-01 2023-03-31 0001815021 bq:XingmuInternationalLimitedMember 2022-04-01 2023-03-31 0001815021 bq:BoqiiInternationalLimitedMember 2022-04-01 2023-03-31 0001815021 bq:BoqiiCorporationLimitedMember 2022-04-01 2023-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember 2022-04-01 2023-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2022-04-01 2023-03-31 0001815021 bq:NanjingXingmuBiotechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:SuzhouXingyunYuemingSupplyChainCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:BoqiiShanghaiInformationTechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:TianjingGuangchengInformationTechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:NanjingCuidaBiotechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:TaizhouXingmuBiotechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:GuangchengShanghaiInformationTechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:SuzhouTaichengSupplyChainCoLtdSuzhouTaichengMember 2022-04-01 2023-03-31 0001815021 bq:ThirdPartyMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:NonrecourseMember 2022-04-01 2023-03-31 0001815021 us-gaap:NonrecourseMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2022-04-01 2023-03-31 0001815021 bq:InterCompanyMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:NonrecourseMember 2022-04-01 2023-03-31 0001815021 bq:QingdaoShuanganBiotechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2022-04-01 2023-03-31 0001815021 bq:BeijingPetdogTechnologyDevelopmentCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:WarehouseEquipmentMember srt:MinimumMember 2022-04-01 2023-03-31 0001815021 srt:MaximumMember bq:WarehouseEquipmentMember 2022-04-01 2023-03-31 0001815021 us-gaap:FurnitureAndFixturesMember srt:MinimumMember 2022-04-01 2023-03-31 0001815021 us-gaap:FurnitureAndFixturesMember srt:MaximumMember 2022-04-01 2023-03-31 0001815021 us-gaap:VehiclesMember 2022-04-01 2023-03-31 0001815021 bq:SoftwareMember 2022-04-01 2023-03-31 0001815021 us-gaap:LeaseholdImprovementsMember 2022-04-01 2023-03-31 0001815021 us-gaap:TrademarksMember 2022-04-01 2023-03-31 0001815021 us-gaap:DistributionRightsMember 2022-04-01 2023-03-31 0001815021 us-gaap:LicenseMember 2022-04-01 2023-03-31 0001815021 bq:EmployeesAndNonEmployeesMember 2022-04-01 2023-03-31 0001815021 srt:MinimumMember country:HK 2022-04-01 2023-03-31 0001815021 country:HK srt:MaximumMember 2022-04-01 2023-03-31 0001815021 country:CN 2022-04-01 2023-03-31 0001815021 dei:BusinessContactMember 2022-04-01 2023-03-31 0001815021 dei:AdrMember 2022-04-01 2023-03-31 0001815021 us-gaap:CommonClassAMember 2022-04-01 2023-03-31 0001815021 bq:ChongniNetworkTechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 us-gaap:CommonClassBMember 2022-04-01 2023-03-31 0001815021 bq:SeriesCRedeemableConvertiblePreferredSharesMember 2022-04-01 2023-03-31 0001815021 us-gaap:CurrencySwapMember bq:NewForeignExchangeSwapContractMember 2022-04-01 2023-03-31 0001815021 us-gaap:TaxYear2018Member 2022-04-01 2023-03-31 0001815021 us-gaap:NoncontrollingInterestMember 2022-04-01 2023-03-31 0001815021 bq:LongTermLoanFromCmbMember bq:CMBMember bq:ExtensionOfLoanAgreementMember 2022-04-01 2023-03-31 0001815021 bq:NewForeignExchangeSwapContractMember 2022-04-01 2023-03-31 0001815021 bq:RoyalCaninChinaCoLtdMember us-gaap:SupplierConcentrationRiskMember bq:PurchasesMember 2022-04-01 2023-03-31 0001815021 srt:MaximumMember bq:FromOctoberTwoThousandAndTwentyThreeToMarchTwoThousandAndTwentyFourMember bq:LoansReceivablePeriodRangingFromTwelveToTwentyFourMonthsMember 2022-04-01 2023-03-31 0001815021 bq:LoansReceivablePeriodRangingFromTwelveToTwentyFourMonthsMember bq:FromOctoberTwoThousandAndTwentyThreeToMarchTwoThousandAndTwentyFourMember srt:MinimumMember 2022-04-01 2023-03-31 0001815021 bq:LoansReceivablePeriodRangingFromTwelveToTwentyFourMonthsMember srt:MinimumMember 2022-04-01 2023-03-31 0001815021 bq:LoansReceivablePeriodRangingFromTwelveToTwentyFourMonthsMember srt:MaximumMember 2022-04-01 2023-03-31 0001815021 bq:FromMayTwoThousandAndTwentyOneToMayTwoThousandAndTwentyTwoMember bq:LoanReceivableForThePeriodTwentyFourToThirtySixMonthsMember srt:MinimumMember 2022-04-01 2023-03-31 0001815021 bq:FromMayTwoThousandAndTwentyOneToMayTwoThousandAndTwentyTwoMember bq:LoanReceivableForThePeriodTwentyFourToThirtySixMonthsMember srt:MaximumMember 2022-04-01 2023-03-31 0001815021 bq:ChongLiMember 2022-04-01 2023-03-31 0001815021 country:CN bq:DomesticEnterpriseMember bq:StatutorySurplusReserveMember 2022-04-01 2023-03-31 0001815021 country:CN 2022-04-01 2023-03-31 0001815021 bq:QingdaoShuanganMember 2022-04-01 2023-03-31 0001815021 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2022-04-01 2023-03-31 0001815021 bq:IntellectualPropertyLicenseAgreementsMember 2023-03-31 2023-03-31 0001815021 bq:LoanAgreementMember bq:ShanghaiGuangchengInformationMember 2021-04-01 0001815021 bq:ShanghaiGuangchengInformationMember 2021-04-01 0001815021 bq:ChongniNetworkTechnologyCoLtdMember 2018-10-31 0001815021 bq:ChongniNetworkTechnologyCoLtdMember 2021-06-30 2021-06-30 0001815021 bq:BetterChoiceCompanyIncMember 2021-06-30 2021-06-30 0001815021 bq:ChongniNetworkTechnologyCoLtdMember 2021-06-30 0001815021 bq:XingmuGroupMember 2021-06-30 0001815021 bq:NanjingCuidaBiotechnologyCoLtdMember 2021-06-30 2022-03-31 0001815021 bq:JiangsuNanjingAgriculturalUniversityAnimalPharmaceuticalCoLtdMember 2019-04-01 2019-04-30 0001815021 bq:BeijingPetdogTechnologyDevelopmentCoLtdMember 2019-10-01 2019-10-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2021-07-31 2021-07-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2021-07-31 0001815021 bq:NanjingAnimalPharmaceuticalMember bq:AccruedLiabilitiesAndOtherCurrentLiabilitiesMember 2021-07-31 0001815021 bq:WuhanChunzhijinMember 2021-03-31 0001815021 bq:MerchantTycoonLimitedMember 2021-03-31 0001815021 bq:YingzhilisaTangMember 2021-03-31 0001815021 bq:LijunZhouMember 2021-03-31 0001815021 bq:YanJiangMember 2021-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2021-03-31 0001815021 bq:FeiWangMember 2021-03-31 0001815021 bq:ShanghaiGuangchengInformationMember 2021-03-31 0001815021 bq:SuperbOriginInternationalLimitedMember 2021-03-31 0001815021 bq:AdsMember us-gaap:IPOMember 2020-10-01 2020-10-31 0001815021 bq:AdsMember us-gaap:OverAllotmentOptionMember 2020-10-01 2020-10-31 0001815021 us-gaap:CommonClassAMember 2020-10-01 2020-10-31 0001815021 us-gaap:IPOMember bq:SeriesARedeemableConvertiblePreferredSharesMember 2020-10-01 2020-10-31 0001815021 us-gaap:IPOMember bq:SeriesBRedeemableConvertiblePreferredSharesMember 2020-10-01 2020-10-31 0001815021 us-gaap:IPOMember bq:SeriesCPlusRedeemableConvertiblePreferredSharesMember 2020-10-01 2020-10-31 0001815021 us-gaap:IPOMember us-gaap:CommonClassBMember 2020-10-01 2020-10-31 0001815021 bq:AdsMember 2020-10-31 0001815021 us-gaap:IPOMember us-gaap:CommonClassAMember 2020-10-31 0001815021 us-gaap:CommonClassBMember 2020-10-31 0001815021 bq:SeriesARedeemableConvertiblePreferredSharesMember us-gaap:IPOMember 2020-10-31 0001815021 us-gaap:IPOMember bq:SeriesBRedeemableConvertiblePreferredSharesMember 2020-10-31 0001815021 us-gaap:IPOMember bq:SeriesCPlusRedeemableConvertiblePreferredSharesMember 2020-10-31 0001815021 us-gaap:SeriesCPreferredStockMember us-gaap:IPOMember 2020-10-31 0001815021 us-gaap:IPOMember us-gaap:CommonClassAMember 2021-02-01 2021-02-28 0001815021 bq:YokenHoldingLimitedMember 2020-10-31 2020-10-31 0001815021 bq:LoanForYokenSeriesAOneWarrantMember 2020-03-31 2020-03-31 0001815021 bq:CMBMember bq:LongTermLoanFromCmbMember 2020-03-31 2020-03-31 0001815021 bq:LoanForYokenSeriesAOneWarrantMember 2020-03-31 0001815021 bq:LongTermLoanFromCmbMember bq:CMBMember 2020-03-31 0001815021 bq:ExtensionOfLoanAgreementMember bq:CMBMember bq:LongTermLoanFromCmbMember 2020-03-31 0001815021 bq:ChongLiMember 2020-03-31 0001815021 bq:SuperbOriginInternationalLimitedMember bq:ChongLiMember bq:EquityOwnerMember 2020-03-31 0001815021 bq:LoanForYokenSeriesAOneWarrantMember 2020-10-23 2020-10-23 0001815021 bq:YokenSeriesAOneWarrantMember bq:InvestorTwoMember 2020-10-23 2020-10-23 0001815021 bq:InvestorOneMember bq:YokenSeriesAOneWarrantMember 2020-10-23 2020-10-23 0001815021 bq:InvestorOneMember bq:YokenSeriesAOneWarrantMember 2020-10-23 0001815021 bq:YokenSeriesAOneWarrantMember bq:InvestorTwoMember 2020-10-23 0001815021 bq:YokenSeriesAOneWarrantMember 2020-10-23 0001815021 bq:LoanForYokenSeriesAOneWarrantMember bq:YokenSeriesAOneWarrantMember 2021-03-31 2021-03-31 0001815021 us-gaap:SubsequentEventMember bq:NanjingAnimalPharmaceuticalMember 2023-04-30 2023-04-30 0001815021 bq:JiangsuNanjingAgriculturalUniversityAnimalPharmaceuticalCoLtdMember bq:EquityMethodInvestmentMember 2019-04-30 0001815021 bq:BeijingPetdogTechnologyDevelopmentCoLtdMember bq:AvailableForSaleDebtInvestmentsMember 2019-10-31 0001815021 bq:NanjingAgriculturalPharmaceuticalMember bq:TwelveMonthInterestFreeLoanAgreementMember 2019-12-31 0001815021 bq:OneYearLoanAgreementMember bq:FeiWangMember 2021-01-31 0001815021 bq:TwoThousandTwelveGlobalSharePlanMember 2012-09-27 0001815021 bq:TwoThousandEighteenGlobalSharePlanMember 2018-08-01 0001815021 bq:TwoThousandEighteenGlobalSharePlanMember 2020-09-01 0001815021 bq:AmendedTwoThousandEighteenGlobalSharePlanMember 2020-09-01 0001815021 bq:ChongLiMember 2020-03-01 0001815021 bq:TwelveMonthInterestFreeLoanAgreementMember bq:NanjingAgriculturalPharmaceuticalMember 2020-06-30 0001815021 bq:EquityMethodInvestmentMember bq:WuhanChunzhijinInformationTechnologyCoLtdMember 2020-04-30 0001815021 bq:CMBMember bq:LongTermLoanFromCmbMember 2020-03-01 2020-03-31 0001815021 bq:TwoThousandEighteenGlobalSharePlanMember 2022-05-31 0001815021 bq:AmendedTwoThousandEighteenGlobalSharePlanMember 2022-05-31 0001815021 us-gaap:CommonStockMember 2020-03-31 0001815021 us-gaap:ReceivablesFromStockholderMember 2020-03-31 0001815021 us-gaap:NoncontrollingInterestMember 2020-03-31 0001815021 us-gaap:RetainedEarningsMember 2020-03-31 0001815021 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001815021 bq:StatutoryReservesMember 2020-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2020-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2021-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember 2020-03-31 0001815021 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-03-31 0001815021 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-03-31 0001815021 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001815021 bq:StatutoryReservesMember 2021-03-31 0001815021 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001815021 us-gaap:RetainedEarningsMember 2021-03-31 0001815021 us-gaap:NoncontrollingInterestMember 2021-03-31 0001815021 us-gaap:ReceivablesFromStockholderMember 2021-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember 2021-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2022-03-31 0001815021 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001815021 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-03-31 0001815021 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001815021 bq:StatutoryReservesMember 2022-03-31 0001815021 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001815021 us-gaap:RetainedEarningsMember 2022-03-31 0001815021 us-gaap:NoncontrollingInterestMember 2022-03-31 0001815021 us-gaap:ReceivablesFromStockholderMember 2022-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember 2022-03-31 0001815021 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-03-31 0001815021 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-03-31 0001815021 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001815021 bq:StatutoryReservesMember 2023-03-31 0001815021 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001815021 us-gaap:RetainedEarningsMember 2023-03-31 0001815021 us-gaap:NoncontrollingInterestMember 2023-03-31 0001815021 us-gaap:ReceivablesFromStockholderMember 2023-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember 2023-03-31 iso4217:USD iso4217:CNY xbrli:shares utr:Year iso4217:HKD iso4217:EUR iso4217:NZD xbrli:pure utr:Month utr:Day iso4217:USD xbrli:shares iso4217:CNY xbrli:shares
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
20-F
 
 
(Mark One)
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
 
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended March 31, 2023.
OR
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
 
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of event requiring this shell company report
                    
For the transition period from
    
    
        
    
to
    
        
    
    
Commission file number:
001-39547
 
 
BOQII HOLDING LIMITED
(Exact name of Registrant as specified in its charter)
 
 
N/A
(Translation of Registrant’s name into English)
Cayman Islands
(Jurisdiction of incorporation or organization)
Building 9, No. 388, Shengrong Road
Pudong New District, Shanghai 201210
People’s Republic of China
(Address of principal executive offices)
Yingzhi (Lisa) Tang
Chief Financial Officer
Tel: +86 180 1851 3366
E-mail:
lisa@boqii.com
Building 9, No. 388, Shengrong Road
Pudong New District, Shanghai 201210
People’s Republic of China
(Name, Telephone,
E-mail
and/or Facsimile number and Address of Company Contact Person)
 
 
Securities registered or to be registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading Symbol
 
Name of each exchange on which registered
American depositary shares, each ADS represents four and one half (4.5) Class A ordinary shares, par value US$0.001 per share
 
BQ
 
The New York Stock Exchange
Class A ordinary shares, par value US$0.001 per share*
 
N/A
 
The New York Stock Exchange
 
*
Not for trading, but only in connection with the listing of the American depositary shares on the New York Stock Exchange.
Securities registered or to be registered pursuant to Section 12(g) of the Act:
None
(Title of Class)
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:
None
(Title of Class)
 
 
Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report.
As of March 31, 2023, there were 70,729,482 ordinary shares outstanding, being the sum of 57,691,753 Class A ordinary shares, including 1,928,662 Class A ordinary shares held by the depositary bank underlying the options granted but not yet exercised under the Amended and Restated 2018 Global Share Plan, and 13,037,729 Class B ordinary shares.
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Yes  ☐            No  ☒
If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Yes  ☐            No  ☒
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes  ☒            No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes  ☒            No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a
non-accelerated
filer, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” and “emerging growth company” in Rule
12b-2
of the Exchange Act.
 
Large Accelerated Filer
 
 
Accelerated Filer
 
  
Non-accelerated Filer
 
 
 
 
  
Emerging growth company
 
If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards † provided pursuant to Section 13(a) of the Exchange Act.  
 
The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.  ☐
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to
§240.10D-1(b).  ☐
Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:
 
 
U.S. GAAP
 
 
International Financial Reporting Standards as issued by the International Accounting Standards Board
 
 
Other
If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow.
☐  Item 17            ☐  Item 18
If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange Act).
Yes  ☐            No  
(APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS)
Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.
Yes  ☐            No  ☐
 
 
 


Table of Contents

TABLE OF CONTENTS

 

INTRODUCTION      1  
FORWARD-LOOKING INFORMATION      2  
PART I      2  
ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS      2  
ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE      3  
ITEM 3. KEY INFORMATION      3  
ITEM 4. INFORMATION ON THE COMPANY      65  
ITEM 4A. UNRESOLVED STAFF COMMENTS      95  
ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS      95  
ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES      107  
ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS      114  
ITEM 8. FINANCIAL INFORMATION      115  
ITEM 9. THE OFFER AND LISTING      116  
ITEM 10. ADDITIONAL INFORMATION      116  
ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK      122  
ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES      123  
PART II      124  
ITEM 13. ITEM DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES      124  
ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS      124  
ITEM 15. CONTROLS AND PROCEDURES      125  
ITEM 16.A. AUDIT COMMITTEE FINANCIAL EXPERT      126  
ITEM 16.B. CODE OF ETHICS      126  
ITEM 16.C. PRINCIPAL ACCOUNTANT FEES AND SERVICES      126  
ITEM 16.D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES      127  
ITEM 16.E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS      127  
ITEM 16.F. CHANGE IN REGISTRANT’S CERTIFYING ACCOUNTANT      127  
ITEM 16.G. CORPORATE GOVERNANCE      127  
ITEM 16.H. MINE SAFETY DISCLOSURE      127  
ITEM 16.I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS      128  
ITEM 16.J. INSIDER TRADING POLICIES      128  
PART III      128  
ITEM 17. FINANCIAL STATEMENTS      128  
ITEM 18. FINANCIAL STATEMENTS      128  
ITEM 19. EXHIBITS      129  


Table of Contents

INTRODUCTION

Except where the context otherwise indicates and for the purpose of this annual report only:

 

   

“ADSs” refers to the American depositary shares, each representing 4.5 Class A ordinary shares;

 

   

“Boqii,” “we,” “us,” “our company,” “the Company,” “the Group” and “our” refer to Boqii Holding Limited, a Cayman Islands exempted company and its subsidiaries and, in the context of describing our operations and consolidated financial information, the VIEs and their respective subsidiaries;

 

   

“brand owner” refers to a company engaging in the production and sale of branded pet goods;

 

   

“brand partner” refers to a specific brand owner whose products are sold via our online sales platforms and offline network;

 

   

“CAGR” refers to compound annual growth rate;

 

   

“Class A ordinary shares” refers to our Class A ordinary shares, par value US$0.001 per share;

 

   

“Class B ordinary shares” refers to our Class B ordinary shares, par value US$0.001 per share;

 

   

“China” or “the PRC” refers to the People’s Republic of China, including Hong Kong and Macau and, only for the purpose of this annual report, excluding Taiwan; the only instances in which “China” or “the PRC” do not include Hong Kong or Macau are when used in the case of laws and regulations, including, among others, tax matters, adopted by the People’s Republic of China; the legal and operational risks associated with operating in China also apply to our operations in Hong Kong;

 

   

“GMV” refers to gross merchandise volume, which is the total value of confirmed orders placed with us and sold through distribution model or drop shipping model where we act as a principal in the transaction regardless of whether the products are delivered or returned, calculated based on the listed prices of the ordered products without taking into consideration any discounts. With respect to products sold by Xingmu, such GMV is calculated based on the suggested retail prices of the ordered products without taking into consideration any discounts and regardless of whether the products are delivered or returned. For the avoidance of doubt, the total GMV amounts disclosed in this annual report (i) includes GMV of products sold by Xingmu, (ii) excludes products sold through consignment model and (iii) excludes the value of services offered by us;

 

   

“KOL” refers to key opinion leaders, or individuals who have the power to engage and impact people within a specific community or field;

 

   

“MAU” refers to monthly active user, or the aggregate number of unique devices that were used to access our online platforms at least once in a given month. Our MAUs are calculated using internal company data, treating each distinguishable device as a separate MAU even though some users may access our platforms using more than one device and multiple users may access our platforms using the same device;

 

   

“online platforms” refers to our online sales platforms and our content platform;

 

   

“online sales platforms” refer to Boqii Mall, our flagship stores on third-party e-commerce platforms and our proprietary SaaS system;

 

   

“Post-IPO MAA” means the twelfth amended and restated memorandum and articles of association of our company currently effective;

 

   

“Meiyizhi WFOE” refers to Shanghai Meiyizhi Supply Chain Co., Ltd.;

 

   

“RMB” or “Renminbi” refers to the legal currency of the People’s Republic of China;

 

   

“Shanghai Guangcheng” refers to Guangcheng (Shanghai) Information Technology Co., Ltd.;

 

   

“Shanghai Xincheng” refers to Xincheng (Shanghai) Information Technology Co., Ltd.;

 

   

“shares” or “ordinary shares” refers to our Class A and Class B ordinary shares, par value US$0.001 per share;

 

   

“Suzhou Taicheng” refers to Suzhou Taicheng Supply Chain Co., Ltd.;

 

   

“Suzhou Xingyun” refers to Suzhou Xingyun Yueming Supply Chain Co., Ltd.;

 

   

“US$,” “dollars” or “U.S. dollars” refers to the legal currency of the United States;

 

   

“variable interest entities,” or “VIEs,” refers to the PRC entities of which we have power to control the management, and financial and operating policies and have the right to recognize and receive substantially all the economic benefits and in which we have an exclusive option to purchase all or part of the equity interests at the minimum price possible to the extent permitted by PRC law;

 

1


Table of Contents
   

“Xingmu” or “Nanjing Xingmu” refers to Nanjing Xingmu Biotechnology Co., Ltd.;

 

   

“Xingmu WFOE” refers to Nanjing Xinmu Information Technology Co., Ltd.; and

 

   

“Yoken WFOE” refers to Chengdu Chongaita Information Technology Co., Ltd.

Unless otherwise noted, all translations from Renminbi to U.S. dollars and from U.S. dollars to Renminbi in this annual report are made at RMB6.8676 to US$1.00, the exchange rate set forth in the H.10 statistical release of the Federal Reserve Board on March 31, 2023. We make no representation that any Renminbi or U.S. dollar amounts could have been, or could be, converted into U.S. dollars or Renminbi, as the case may be, at any particular rate, the rates stated below, or at all.

FORWARD-LOOKING INFORMATION

This annual report contains statements that constitute forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigations Reform Act of 1995. Many of the forward-looking statements contained in this annual report can be identified by the use of forward-looking words such as “anticipate,” “believe,” “could,” “expect,” “should,” “plan,” “intend,” “estimate” and “potential,” among others.

Forward-looking statements appear in a number of places in this annual report and include, but are not limited to, statements regarding our intent, belief or current expectations. Forward-looking statements are based on our management’s beliefs and assumptions and on information currently available to our management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to, those identified under the section entitled “Item 3. Key Information—3.D. Risk Factors” in this annual report. These risks and uncertainties include factors relating to:

 

   

our mission and strategies;

 

   

our future business development, financial conditions and results of operations;

 

   

the expected growth of the online retail and pet industries in China;

 

   

our expectations regarding demand for and market acceptance of our products and services;

 

   

our expectations regarding keeping and strengthening our relationships with customers, users, KOLs, brand partners, manufacturers, strategic partners, offline pet stores and pet hospitals and other stakeholders;

 

   

competition in our industry;

 

   

general economic and business condition in China; and

 

   

relevant government policies and regulations relating to our industry.

This annual report contains certain data and information that we obtained from various government and private publications. Statistical data in these publications also include projections based on a number of assumptions. Our industry may not grow at the rate projected by market data, or at all. Failure of this market to grow at the projected rate may have a material and adverse effect on our business and the market price of our ADSs. In addition, the rapidly changing nature of pet industry results in significant uncertainties for any projections or estimates relating to the growth prospects or future condition of our market. Furthermore, if any one or more of the assumptions underlying the market data are later found to be incorrect, actual results may differ from the projections based on these assumptions. You should not place undue reliance on these forward-looking statements.

Forward-looking statements speak only as of the date they are made, and except to the extent required by applicable laws and regulations, we do not undertake any obligation to update them in light of new information or future developments or to release publicly any revisions to these statements in order to reflect later events or circumstances or to reflect the occurrence of unanticipated events.

PART I

 

ITEM 1.

IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS

Not applicable.

 

2


Table of Contents
ITEM 2.

OFFER STATISTICS AND EXPECTED TIMETABLE

Not applicable.

 

ITEM 3.

KEY INFORMATION

Holding Company Structure

Boqii Holding Limited is a Cayman Islands holding company with no business operations. The Company conducts its operations in China through its PRC subsidiaries and the consolidated variable interest entities, or the VIEs, and the VIEs’ subsidiaries. The Company, its shareholders who are non-PRC residents and its subsidiaries do not and are not legally permitted to have any equity interests in the VIEs as current PRC laws and regulations restrict foreign investment in companies that engage in value-added telecommunication services and certain other restricted services related to our businesses. As a result, the Company operates relevant businesses in China through certain contractual arrangements by and among the WFOEs, the VIEs and the respective shareholders of the VIEs. This structure allows the WFOEs to exercise effective control over the VIEs, and be considered the primary beneficiary of the VIEs, which serves the purpose of consolidating the VIEs’ operating results in the Company’s financial statements under the U.S. GAAP. This structure also provides contractual exposure to foreign investment in such companies. As of the date of this annual report, to the best knowledge of our Company, our directors and management, the VIE agreements have not been tested in a court of law in the PRC. Investors in the Company’s ADSs are purchasing equity securities of a Cayman Islands holding company rather than equity securities issued by the Company’s subsidiaries and the VIEs. Investors who are non-PRC residents may not directly hold equity interests in the VIEs under current PRC laws and regulations.

Our corporate structure involves unique risks to investors in the ADSs. For the fiscal years ended March 31, 2021, 2022 and 2023, the amount of revenues generated by the VIEs accounted for 77.5%, 78.7% and 79.9%, respectively, of our total net revenues. As of March 31, 2021, 2022 and 2023, total assets of the VIEs, excluding amounts due from other companies in our Company, equaled to 24.5%, 34.2% and 43.9% of our consolidated total assets as of the same dates, respectively. If the PRC government deems that our contractual arrangements with the VIEs do not comply with PRC regulatory restrictions on foreign investment in the relevant industries, or if these regulations or the interpretation of existing regulations change in the future, we could be subject to material penalties or be forced to relinquish our interests in those operations or otherwise significantly change our corporate structure. We and our investors face significant uncertainty about potential future actions by the PRC government that could affect the legality and enforceability of the contractual arrangements with the VIEs and, consequently, significantly affect the financial performance of our company as a whole. Our ADSs may decline in value or become worthless, if we are unable to claim our contractual control rights over the assets of the VIEs that conduct substantially all of our operations in China. For detailed discussion, see “Item 3. Key Information—3.D. Risk Factors—Risks Related to Our Corporate Structure and Contractual Arrangements.” The following diagram illustrates our corporate structure, including our principal subsidiaries and VIEs, as of the date of this annual report.

 

LOGO

 

3


Table of Contents

Notes:

 

LOGO   Equity interest
LOGO   Contractual arrangements, including the exclusive technical consulting and service agreement, intellectual property license agreement, equity pledge agreement, exclusive call option agreement, shareholders’ voting rights proxy agreement and loan agreement. See “—Contractual Arrangements with the VIEs and Their Respective Shareholders.”

Contractual Arrangements with the VIEs and Their Respective Shareholders

Current PRC laws and regulations impose certain restrictions or prohibitions on foreign ownership of companies that engage in value-added telecommunication services. We are an exempted company with limited liability incorporated in the Cayman Islands and our wholly owned PRC subsidiaries are currently considered foreign-invested enterprise. Accordingly, our PRC subsidiaries are not eligible to provide value-added telecommunication services in China or import veterinary drugs. To ensure strict compliance with the PRC laws and regulations, we conduct such business activities through the VIEs, Suzhou Taicheng, Shanghai Guangcheng, Nanjing Xingmu and Suzhou Xingyun. Shanghai Xincheng, Xingmu WFOE and Meiyizhi WFOE, our wholly owned subsidiaries in China, have entered into a series of contractual arrangements with the VIEs and their respective shareholders, which enable us to (i) exercise effective control over the VIEs, (ii) receive substantially all of the economic benefits of the VIEs, and (iii) have an exclusive option to purchase all or part of the equity interests in the VIEs when and to the extent permitted by PRC law. These contractual arrangements include the exclusive consultation and technical service agreement, loan agreements, equity pledge agreement, exclusive purchase option agreement, shareholder voting right trust agreement, and spousal consents, as the case may be. As a result of these contractual arrangements, we exert effective control over, and are considered the primary beneficiary of, the VIEs and consolidate its operating results in our financial statements under U.S. GAAP.

The following is a summary of the major terms of the contractual arrangements by and among Shanghai Xincheng, Shanghai Guangcheng and the shareholders of Shanghai Guangcheng. The contractual arrangements by and among Xingmu WFOE, Nanjing Xingmu and the shareholders of Nanjing Xingmu, the contractual arrangements by and among Shanghai Xincheng, Suzhou Taicheng and the shareholders of Suzhou Taicheng, and the contractual arrangements by and among Meiyizhi WFOE, Suzhou Xingyun and the shareholders of Suzhou Xingyun are substantially similar to the corresponding contractual arrangements discussed below, unless otherwise indicated.

Exclusive Technical Consulting and Service Agreement

Pursuant to an exclusive technical consulting and service agreement entered into on August 4, 2020 by and between Shanghai Xincheng and Shanghai Guangcheng, Shanghai Guangcheng agreed to appoint Shanghai Xincheng as its exclusive provider of consulting and services related to, among other things, e-commerce platform design and maintenance, business consulting, internal training, labor support, market research and development, strategic planning and customer support and development. In exchange, Shanghai Guangcheng agrees to pay Shanghai Xincheng an annual service fee, at an amount that is agreed by both parties. This agreement will remain effective unless Shanghai Xincheng and Shanghai Guangcheng terminate this agreement in writing.

Intellectual Property License Agreement

Pursuant to an intellectual property license agreement entered into on August 4, 2020 by and between Shanghai Xincheng and Shanghai Guangcheng, Shanghai Xincheng agreed to grant to Shanghai Guangcheng a nonsublicensable, nontransferable and nonexclusive license of certain intellectual properties solely for Shanghai Guangcheng’s use. In exchange, Shanghai Guangcheng agrees to pay a royalty, at an amount that is agreed by both parties. The term of this agreement is ten years from the date of such agreement and will be automatically extended for another ten-year term unless it is terminated by three months’ written notice by the licensor.

Shareholders’ Voting Rights Proxy Agreement

Pursuant to the shareholders’ voting rights proxy agreement entered into on August 4, 2020, by and among Shanghai Xincheng, Shanghai Guangcheng, and then shareholders of Shanghai Guangcheng, as supplemented from time to time, such shareholders of Shanghai Guangcheng irrevocably authorized the person then designated by Shanghai Xincheng to exercise such shareholders’ rights in Shanghai Guangcheng, including without limitation, the power to participate in and vote at shareholders’ meetings, the power to nominate and appoint the directors, senior management, the power to propose to convene a shareholders’ meeting, and other shareholders’ voting rights permitted by the Articles of Association of Shanghai Guangcheng.

 

4


Table of Contents

Equity Pledge Agreement

Pursuant to an equity pledge agreement entered on October 16, 2019, by and between Shanghai Xincheng, Shanghai Guangcheng, and then shareholders of Shanghai Guangcheng, as supplemented by an equity pledge agreement entered into on August 4, 2020 and an equity pledge agreement entered into on September 25, 2022, by and between Shanghai Xincheng, Shanghai Guangcheng, and Shanghai Chelin Information Technology Center (Limited Partnership), a then shareholder of Shanghai Guangcheng, such shareholders of Shanghai Guangcheng pledged all of their equity interests in Shanghai Guangcheng to Shanghai Xincheng, to guarantee the performance of Shanghai Guangcheng, and, to the extent applicable, such shareholders of Shanghai Guangcheng, or their obligations under the contractual arrangements of the VIEs. If Shanghai Guangcheng or such shareholders fail to perform their obligations under the contractual arrangement of the VIEs, Shanghai Xincheng will be entitled to, among other things, the right to sell the pledged equity interests in Shanghai Guangcheng. The shareholders of Shanghai Guangcheng also undertake that, during the term of the equity pledge agreement, they will not dispose of the pledged equity interests or create or allow any encumbrance on the pledged equity interests without prior written consent of Shanghai Xincheng. As of the date of this annual report, the equity pledges under the share pledge agreements have been registered with the relevant PRC legal authority pursuant to PRC laws and regulations.

As of the date of this annual report, all equity pledges under the share pledge agreements by and between the shareholders of Nanjing Xingmu and Xingmu WFOE, by and between the shareholders of Suzhou Xingyun and Meiyizhi WFOE, as well as by and between the shareholders of Suzhou Taicheng and Shanghai Xincheng have been registered with the relevant PRC legal authority pursuant to PRC laws and regulations.

Exclusive Call Option Agreement

Pursuant to an exclusive call option agreement entered on August 4, 2020, by and between Shanghai Xincheng, Shanghai Guangcheng and then shareholders of Shanghai Guangcheng, as supplemented from time to time, such shareholders of Shanghai Guangcheng irrevocably and unconditionally granted Shanghai Xincheng an exclusive call option to purchase, or have its designated person(s) to purchase, at its discretion, all or part of the equity options in Shanghai Guangcheng. The purchase price shall be the lowest price permitted by applicable PRC laws and regulations. The shareholders of Shanghai Guangcheng undertake that, without the prior written consent of Shanghai Xincheng, they may not increase or decrease the registered capital or conduct any merger, transfer or dispose of their equity options and any other third-party rights thereon, dispose of, or procure the management to dispose of, material assets of Shanghai Guangcheng, terminate or procure the management to terminate any material agreements or enter into any agreements in conflict with any existing material agreement, appoint or dismiss any director, supervisor or any other senior management which should be appointed or dismissed by such shareholders, procure Shanghai Guangcheng to declare or distribute any distributable profits or dividends, procure the winding-up, liquidation or dissolution of Shanghai Guangcheng, amend its articles of association or provide any loans to, or borrow any loans from, third parties or provide security or guarantee, or undertake any substantive obligations beyond the ordinary course of business. The exclusive call option agreement will remain effective until all equity options in Shanghai Guangcheng held by such shareholders are transferred or assigned to Shanghai Xincheng or its designated representatives.

Loan Agreement

Shareholders of Shanghai Guangcheng have entered into a loan agreement, as amended from time to time, with Shanghai Xincheng on August 4, 2020. Pursuant to the loan agreement, Shanghai Xincheng provided such shareholders with a long-term interest-free loan. The proceeds from the loans were used for the investment in or general business development of Shanghai Guangcheng. The loans can be repaid by transferring the shareholders’ respective equity interests in Shanghai Guangcheng to Shanghai Xincheng or its designee.

Spousal Consent Letter

In addition to the contractual arrangements discussed above, each of the respective spouses of the individual shareholders of Nanjing Xingmu has executed an additional spousal consent letter which contains terms as described below. Pursuant to the spousal consent letters dated September 26, 2019, each of the respective spouses of the individual shareholders of Nanjing Xingmu, unconditionally and irrevocably agreed that the equity interest in Nanjing Xingmu held by and registered in the name of his/her spouse will be disposed of pursuant to the equity pledge agreement, the exclusive call option agreement and the shareholders’ voting rights proxy agreement. The spouse agreed not to assert any rights over the equity interest in Nanjing Xingmu held by his/her spouse. In addition, in the event that the spouse obtains any equity interest in Nanjing Xingmu held by his/her spouse for any reason, the spouse agreed to be bound by the contractual arrangements.

These contractual arrangements may not be as effective as direct ownership in providing us with control over the VIEs. If the VIEs or their respective shareholders fail to perform their respective obligations under the contractual arrangements, we could be limited in our ability to enforce the contractual arrangements that give us effective control over our business operations in the PRC and may have to incur substantial costs and expend additional resources to enforce such arrangements. We may also have to rely on legal remedies under PRC law, including seeking specific performance or injunctive relief, and claiming damages, which we cannot assure will be effective under PRC law. As of the date of this annual report, to the best knowledge of our Company, our directors and management, the VIE agreements have not been tested in a court of law in the PRC.

 

5


Table of Contents

In the opinion of Commerce & Finance Law Offices, our PRC counsel:

 

   

the ownership structures of the VIEs do not contravene any PRC laws or regulations currently in effect; and

 

   

the agreements under the contractual arrangements among Shanghai Xincheng, Shanghai Guangcheng and their respective shareholders, among Xingmu WFOE, Nanjing Xingmu and their respective shareholders, among Meiyizhi WFOE, Suzhou Xingyun and their respective shareholders, as well as among Shanghai Xincheng, Suzhou Taicheng and their respective shareholders governed by PRC laws are valid and binding upon each party to such agreements and enforceable against each party thereto in accordance with their terms and applicable PRC laws and regulations currently in effect.

There are substantial uncertainties regarding the interpretation and application of current and future PRC laws, regulations and rules. In particular, in March 2019, the National People’s Congress of the PRC adopted the PRC Foreign Investment Law, which became effective on January 1, 2020. Among other things, the PRC Foreign Investment Law defines the “foreign investment” as investment activities in China by foreign investors in a direct or indirect manner, including those circumstances explicitly listed thereunder as establishing new projects or foreign invested enterprises or acquiring shares of enterprises in China, and other approaches of investment as stipulated by laws, administrative regulations or otherwise regulated by the State Council. The PRC Foreign Investment Law leaves uncertainty as to whether foreign investors’ controlling PRC onshore variable interest entities via contractual arrangements will be recognized as “foreign investment” and thus be subject to the restrictions and/or prohibitions on foreign investments. Accordingly, the PRC regulatory authorities may in the future take a view that is contrary to the above opinion of our PRC counsel. If the PRC government finds that the VIE agreements that establish the structure for operating our podcasts, audio entertainment and other internet related businesses or for importing veterinary drugs do not comply with PRC government restrictions on foreign investment in certain industries, such as value-added telecommunications services business, or if these regulations change or are interpreted differently in the future, our ADSs may decline in value or become worthless, we could be subject to severe penalties, including being prohibited from continuing operations. For detailed discussion, see “Item 3. Key Information—3.D. Risk Factors—Risks Related to Our Corporate Structure and Contractual Arrangements.”

Cash Flows through Our Organization

Transfer of Funds and Other Assets

We currently do not have cash management policies that dictate how funds are transferred between us, our subsidiaries and the VIEs. In practice, we estimate and allocate funds to our WFOE and the VIEs based on their respective available cash balances and forecasted cash requirements. Under relevant PRC laws and regulations, we are permitted to remit funds to the VIEs through loans rather than capital contributions. The following diagram summarizes how funds were transferred among Boqii, our subsidiaries, and the VIEs as of March 31, 2023.

 

LOGO

 

6


Table of Contents

As of March 31, 2023, Boqii Holding Limited had made cumulative capital contributions of RMB1,151.1 million (US$167.6 million) to its PRC subsidiaries through intermediate holding companies, and were accounted as long-term investments of Boqii Holding Limited. Furthermore, funds equivalent to RMB9.8 million, RMB31.4 million and nil were provided to the PRC subsidiaries as loans for the fiscal years ended March 31, 2021, 2022 and 2023, respectively, which were accounted as intra-Group payables due to the Group’s entities. These funds have been used by the Company’s PRC subsidiaries for their operations.

The VIEs may transfer cash to the relevant WFOEs by paying service fees according to the exclusive business cooperation agreements. Pursuant to these agreements between each of the VIEs and its corresponding WFOEs, each of the VIEs agrees to pay the relevant WFOE for services related to design and maintenance of the e-commerce platform, consulting services, technical training, research, planning and development of the market and customer support at an amount based on 100% of the balance of the gross consolidated profits of each VIE after offsetting the accumulated losses for the preceding financial years and deducting the working capital, expenses, taxes and other statutory contributions required for any financial year, or the amount determined by the WFOE in accordance with the terms of the agreements. Considering the future operating and cash flow needs of the VIEs, for the years ended March 31, 2021, 2022 and 2023, no service fees were charged to the VIEs by the WFOEs, and no payments were made by the VIEs under these agreements. If there is any amount payable to relevant WFOEs under the VIE agreements, the VIEs will settle the amount accordingly. For more information, see “—Condensed Consolidating Schedule” and consolidated financial statements included elsewhere in this annual report. For any amounts owed by the VIEs to our PRC subsidiaries under the VIE agreements, unless otherwise required by PRC governmental authorities, we are able to settle such amounts without limitations under the current effective PRC laws and regulations, provided that the VIEs have sufficient funds to do so.

Dividend Distribution to U.S. Investors and Tax Consequences

We have not previously declared or paid any cash dividend, dividend in kind or distributions, and have no plan to declare or pay any dividends or distributions in the near future on our shares or the ADSs representing our ordinary shares. We currently intend to retain most, if not all, of our available funds and any future earnings to operate and expand our business. For more information, see “Item 8. Financial Information—8.A. Consolidated Statements and Other Financial Information—Dividend Policy.”

For purposes of illustration, the following discussion reflects the hypothetical taxes that might be required to be paid within Mainland China, assuming that: (i) we have taxable earnings, and (ii) we determine to pay a dividend in the future:

 

     Taxation Scenario(1)
Statutory Tax and
Standard Rates
 

Hypothetical pre-tax earnings(2)

     100.0

Tax on earnings at statutory rate of 25%(3)

     (25.0 )% 

Net earnings available for distribution

     75.0

Withholding tax at standard rate of 10%(4)

     (7.5 )% 

Net distribution to Boqii Holding Limited /shareholders

     67.5

Notes:

 

(1)

For purposes of this example, the tax calculation has been simplified. The hypothetical book pre-tax earnings amount, not considering timing differences, is assumed to equal taxable income in China.

(2)

Under the terms of VIE agreements, our PRC subsidiaries may charge the VIEs for services provided to VIEs. These fees shall be recognized as expenses of the VIEs, with a corresponding amount as service income by our PRC subsidiaries and eliminate in consolidation. For income tax purposes, our PRC subsidiaries and the VIEs file income tax returns on a separate company basis. The fees paid are recognized as a tax deduction by the VIEs and as income by our PRC subsidiaries and are tax neutral.

(3)

Certain of our subsidiaries and the VIEs qualifies for a 15% preferential income tax rate in China. However, such rate is subject to qualification, is temporary in nature, and may not be available in a future period when distributions are paid. For purposes of this hypothetical example, the table above reflects a maximum tax scenario under which the full statutory rate would be effective.

(4)

The PRC Enterprise Income Tax Law imposes a withholding income tax of 10% on dividends distributed by a foreign invested enterprise, or FIE, to its immediate holding company outside of China. A lower withholding income tax rate of 5% is applied if the FIE’s immediate holding company is registered in Hong Kong or other jurisdictions that have a tax treaty arrangement with China, subject to a qualification review at the time of the distribution. For purposes of this hypothetical example, the table above assumes a maximum tax scenario under which the full withholding tax would be applied.

 

7


Table of Contents

The table above has been prepared under the assumption that all profits of the VIEs will be distributed as fees to our PRC subsidiaries under tax neutral contractual arrangements. If, in the future, the accumulated earnings of the VIEs exceed the fees paid to our PRC subsidiaries (or if the current and contemplated fee structure between the intercompany entities is determined to be non-substantive and disallowed by Chinese tax authorities), the VIEs could, as a matter of last resort, make a nondeductible transfer to our PRC subsidiaries for the amounts of the stranded cash in the VIEs. This would result in such transfer being nondeductible expenses for the VIEs but still taxable income for the PRC subsidiaries. Such a transfer and the related tax burdens would reduce our after-tax income to approximately 50.6% of the pre-tax income. Our management believes that there is only a remote possibility that this scenario would happen.

For PRC and United States federal income tax consideration of an investment in the ADSs, see “Item 10. Additional Information—10.E. Taxation.”

Restrictions on Foreign Exchange and the Ability to Transfer Cash between Entities, Across Borders and to U.S. Investors

Boqii Holding Limited’s ability to pay dividends, if any, to its shareholders and ADS holders and to service any debt it may incur will depend upon dividends paid by our PRC subsidiaries. Under PRC laws and regulations, our PRC subsidiaries are subject to certain restrictions with respect to paying dividends or otherwise transferring any of their net assets offshore to Boqii Holding Limited. In particular, under the current effective PRC laws and regulations, dividends may be paid only out of distributable profits. Distributable profits are the net profit as determined under PRC GAAP, less any recovery of accumulated losses and appropriations to statutory and other reserves required to be made. Each of our PRC subsidiaries is required to set aside at least 10% of its after-tax profits each year, after making up previous years’ accumulated losses, if any, to fund certain statutory reserve funds, until the aggregate amount of such a fund reaches 50% of its registered capital. As a result, our PRC subsidiaries may not have sufficient distributable profits to pay dividends to us in the near future.

Furthermore, if certain procedural requirements are satisfied, the payment of current account items, including profit distributions and trade and service related foreign exchange transactions, can be made in foreign currencies without prior approval from State Administration of Foreign Exchange, or SAFE, or its local branches. However, where RMB is to be converted into foreign currency and remitted out of China to pay capital expenses, such as the repayment of loans denominated in foreign currencies, approval from or registration with competent government authorities or its authorized banks is required. The PRC government may take measures at its discretion from time to time to restrict access to foreign currencies for current account or capital account transactions. If the foreign exchange control system prevents us from obtaining sufficient foreign currencies to satisfy our foreign currency demands, we may not be able to pay dividends in foreign currencies to our offshore intermediary holding companies or ultimate parent company, and therefore, our shareholders or investors in our ADSs. Further, we cannot assure you that new regulations or policies will not be promulgated in the future, which may further restrict the remittance of RMB into or out of the PRC. We cannot assure you, in light of the restrictions in place, or any amendment to be made from time to time, that our current or future PRC subsidiaries will be able to satisfy their respective payment obligations that are denominated in foreign currencies, including the remittance of dividends outside of the PRC. If any of our subsidiaries incurs debt on its own behalf in the future, the instruments governing such debt may restrict its ability to pay dividends to Boqii Holding Limited. In addition, our PRC subsidiaries are required to make appropriations to certain statutory reserve funds, which are not distributable as cash dividends except in the event of a solvent liquidation of the companies.

 

8


Table of Contents

Condensed Consolidating Schedule

The following tables present the condensed consolidating schedules of financial information of Boqii Holding Limited, our subsidiaries that are the primary beneficiaries of VIEs and their subsidiaries, the VIEs and their subsidiaries, and other subsidiaries for the periods and as of the dates indicated.

 

    As of March 31, 2021  
   

Boqii Holding
Limited

   

All
others

   

Primary
Beneficiaries of
VIEs and their
subsidiaries

   

VIEs and their
subsidiaries

   

Eliminating
adjustments

   

Consolidated
totals

 
    (RMB in thousands)  

ASSETS

           

Current assets:

           

Cash and cash equivalents

    18,285       146,671       109,395       17,886       —         292,237  

short-term investments

    —         118,546       50,000       —         —         168,546  

Accounts receivable, net

    —         13,015       5,324       27,393       —         45,732  

Inventories, net

    —         14,411       65,791       11,349       —         91,551  

Prepayments and other current assets

    2,638       42,183       6,995       33,445       —         85,261  

Amounts due from related parties

    —         —         —         11,465       —         11,465  

Intra-Group receivables due from the Group’s entities(1)

    —         44,632       574,610       47,592       (666,834     —    

Non-current assets:

           

Property and equipment, net

    —         14       —         8,372       —         8,386  

Intangible assets

    —         —         28,628       909       —         29,537  

Operating lease right-of-use assets

    —         —         1,498       27,736       —         29,234  

Goodwill

    —         —         39,690       494       —         40,184  

Long-term investments

    —         —         —         74,330       —         74,330  

Other non-current asset

    344       317       1,017       2,433       —         4,111  

Long-term investments to the Group’s entities(2)

    66,868       —         —         —         (66,868     —    
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total assets

    88,135       379,789       882,948       263,404       (733,702     880,574  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS’ EQUITY

           

Current liabilities:

           

Short-term borrowings

    —         32,857       49,225       3,484       —         85,566  

Accounts payable

    —         264       41,644       29,940       —         71,848  

Salary and welfare payable

    —         738       720       4,851       —         6,309  

Accrued liabilities and other current liabilities

    4,055       677       787       24,536       —         30,055  

Amounts due to related parties, current

    —         —         —         910       —         910  

Contract liabilities

    —         —         160       3,706       —         3,866  

Operating lease liabilities, current

    —         —         2,005       6,058       —         8,063  

Derivative liabilities

    444       9,362       190       —         —         9,996  

Intra-Group payables due to the Group’s entities(1)

    962       19,188       35,572       611,112       (666,834     —    

Non-current liabilities:

           

Deferred tax liabilities

    —         —         7,106       1,852       —         8,958  

Operating lease liabilities, non-current

    —         —         —         19,997       —         19,997  

Long-term borrowings

    —         —         67,203       872       —         68,075  

Amounts due to related parties, non-current

    —         —         —         —         —         —    

Other debts, non-current

    —         —         18,170       415,122       —         433,292  

Investments deficit to the Group’s entities(2)

    —         243,889       865,920       —         (1,109,809     —    
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total liabilities

    5,461       306,975       1,088,702       1,122,440       (1,776,643     746,935  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Mezzanine equity:

           

Redeemable non-controlling interests

    —         5,946       —         —         —         5,946  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total mezzanine equity

    —         5,946       —         —         —         5,946  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Shareholders’ equity:

           

Total Boqii Holding Limited shareholders’ equity

    82,674       66,868       (243,889     (865,920     1,042,941       82,674  

Non-controlling interests

    —         —         38,135       6,884       —         45,019  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total shareholders’ equity

    82,674       66,868       (205,754     (859,036     1,042,941       127,693  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total liabilities, mezzanine equity and shareholders’ equity

    88,135       379,789       882,948       263,404       (733,702     880,574  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

9


Table of Contents
     As of March 31, 2022  
    

Boqii Holding
Limited

    

All
others

   

Primary
Beneficiaries of
VIEs and their
subsidiaries

   

VIEs and their
subsidiaries

   

Eliminating
adjustments

   

Consolidated
totals

 
     (RMB in thousands)  

ASSETS

             

Current assets:

             

Cash and cash equivalents

     1,166        112,876       28,246       20,567       —         162,855  

short-term investments

     —          128,084       —         —         —         128,084  

Accounts receivable, net

     —          2,704       15,092       31,435       —         49,231  

Inventories, net

     —          4,777       89,130       16,014       —         109,921  

Prepayments and other current assets

     9,727        13,154       36,750       57,107       —         116,738  

Amounts due from related parties

     —          —         —         11,726       —         11,726  

Intra-Group receivables due from the Group’s entities(1)

     —          80,224       896,341       16,535       (993,100     —    

Non-current assets:

             

Property and equipment, net

     —          61       1,003       6,715       —         7,779  

Intangible assets

     —          —         25,037       507       —         25,544  

Operating lease right-of-use assets

     —          —         2,879       35,688       —         38,567  

Goodwill

     —          —         39,690       994       —         40,684  

Long-term investments

     670        —         —         81,649       —         82,319  

Other non-current asset

     —          306       1,166       3,389       —         4,861  

Long-term investments to the Group’s entities(2)

     189,471        —         —         —         (189,471     —    
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total assets

     201,034        342,186       1,135,334       282,326       (1,182,571     778,309  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS’ EQUITY

             

Current liabilities:

             

Short-term borrowings

     —          31,741       128,513       872       —         161,126  

Accounts payable

     —          39       39,041       55,144       —         94,224  

Salary and welfare payable

     —          827       447       5,597       —         6,871  

Accrued liabilities and other current liabilities

     349        1,189       1,369       24,417       —         27,324  

Amounts due to related parties, current

     —          —         215       4       —         219  

Contract liabilities

     —          —         —         7,007       —         7,007  

Operating lease liabilities, current

     —          —         2,763       7,238       —         10,001  

Derivative liabilities

     —          9,086       —         —         —         9,086  

Intra-Group payables due to the Group’s entities(1)

     1,510        12,123       33,507       945,960       (993,100     —    

Non-current liabilities:

             

Deferred tax liabilities

     —          —         4,847       —         —         4,847  

Operating lease liabilities, non-current

     —          —         —         28,197       —         28,197  

Other debts, non-current

     —          —         23,188       157,874       —         181,062  

Investments deficit to the Group’s entities(2)

     —          91,196       955,158       —         (1,046,354     —    
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total liabilities

     1,859        146,201       1,189,048       1,232,310       (2,039,454     529,964  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Mezzanine equity:

             

Redeemable non-controlling interests

     —          6,522       —         —         —         6,522  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total mezzanine equity

     —          6,522       —         —         —         6,522  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Shareholders’ equity:

             

Total Boqii Holding Limited shareholders’ equity

     199,175        189,471       (91,196     (955,158     856,883       199,175  

Non-controlling interests

     —          (8     37,482       5,174       —         42,648  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total shareholders’ equity

     199,175        189,463       (53,714     (949,984     856,883       241,823  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total liabilities, mezzanine equity and shareholders’ equity

     201,034        342,186       1,135,334       282,326       (1,182,571     778,309  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

10


Table of Contents
    As of March 31, 2023  
   

Boqii Holding
Limited

   

All
others

   

Primary
beneficiaries of
VIEs and their
subsidiaries

   

VIEs and
their
subsidiaries

   

Eliminating
adjustments

   

Consolidated
totals

 
    (RMB in thousands)  

ASSETS

           

Current assets:

           

Cash and cash equivalents

    129       6,420       67,779       15,522       —         89,850  

Short-term investments

    —         69,797       —         —         —         69,797  

Accounts receivable, net

    —         1,763       41,807       33,172       —         76,742  

Inventories, net

    —         1,693       51,465       27,894       —         81,052  

Prepayments and other current assets

    10,507       8,268       12,293       48,291       —         79,359  

Amounts due from related parties

    100       5,497       —         3,782       —         9,379  

Intra-Group receivables due from the Group’s entities(1)

    —         96,497       1,035,667       83,700       (1,215,864     —    

Non-current assets:

           

Property and equipment, net

    —         29       802       4,661       —         5,492  

Intangible assets

    —         50       21,443       101       —         21,594  

Operating lease right-of-use assets

    —         —         49       22,305       —         22,354  

Goodwill

    —         —         —         —         —         —    

Long-term investments

    102       —         —         75,505       —         75,607  

Long-term investments to the Group’s entities

    170,476       —         —         —         (170,476     —    

Amounts due from related parties, non-current

    —         —         —         2,988       —         2,988  

Other non-current asset

    —         262       1,105       5,219       —         6,586  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total assets

    181,314       190,276       1,232,410       323,140       (1,386,340     540,800  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS’ EQUITY

           

Current liabilities:

           

Short-term borrowings

    —         —         85,898       363       —         86,261  

Accounts payable

    —         92       42,471       13,459       —         56,022

Salary and welfare payable

    —         371       946       5,573       —         6,890  

Accrued liabilities and other current liabilities

    350       1,697       3,161       16,896       —         22,104  

Amounts due to related parties, current

    —         —         450       21       —         471  

Intra-Group payables due to the Group’s entities(1)

    2,681       12,112       105,619       1,095,452       (1,215,864     —    

Contract liabilities

    —         —         —         4,471       —         4,471  

Operating lease liabilities, current

    —         —         13       9,207       —         9,220  

Derivative liabilities

    —         7,850       2,851       —         —         10,701  

Non-current liabilities:

           

Deferred tax liabilities

    —         —         5,325       (1,184     —         4,141  

Operating lease liabilities, non-current

    —         —         —         12,741       —         12,741  

Long-term debt

    —         —         27,346       75,481       —         102,827  

Investments deficit to the Group’s entities(2)

    —         (9,510     915,738       —         (906,228     —    
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total liabilities

    3,031       12,612       1,189,818       1,232,480       (2,122,092     315,849  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Mezzanine equity:

           

Redeemable non-controlling interests

    —         7,197       —         —         —         7,197  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total mezzanine equity

    —         7,197       —         —         —         7,197  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Shareholders’ equity:

           

Total Boqii Holding Limited shareholders’ deficit

    178,283       170,476       9,510       (915,738     735,752       178,283  

Non-controlling interests

    —         (9     33,082       6,398       —         39,471  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total shareholders’ equity

    178,283       170,467       42,592       (909,340     735,752       217,754  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total liabilities, mezzanine equity and shareholders’ equity

    181,314       190,276       1,232,410       323,140       (1,386,340     540,800  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Notes:

 

(1)

Represents the elimination of intercompany balances among Boqii Holding Limited, the Primary Beneficiaries of VIEs and their subsidiaries, the Other Subsidiaries, and the VIEs and their subsidiaries that we consolidate.

(2)

Represents the elimination of investments among Boqii Holding Limited, the Primary Beneficiaries of VIEs and their subsidiaries, the Other Subsidiaries, and the VIEs and their subsidiaries that we consolidate.

 

11


Table of Contents
     Year Ended March 31, 2021  
    

Boqii Holding
Limited

   

All
others

   

Primary
Beneficiaries of
VIEs and their
subsidiaries

   

VIEs and their
subsidiaries

   

Eliminating
adjustments

   

Consolidated
totals

 
     (RMB in thousands)  

Net revenues:

            

Third-party revenues

     —         121,190       154,277       735,518       —         1,010,985  

Intra-Group revenues(1)

     —         —         406,049       48,374       (454,423     —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total revenues

     —         121,190       560,326       783,892       (454,423     1,010,985  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cost of revenues:

            

Third-party cost of revenues

     —         (94,519     (356,692     (372,475     —         (823,686

Intra-Group cost of revenues(1)

     —         —         (132,173     (297,844     430,017       —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total cost of revenues

     —         (94,519     (488,865     (670,319     430,017       (823,686
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     —         26,671       71,461       113,573       (24,406     187,299  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating expenses:

            

Third-party operating expenses

     (19,320     (34,391     (85,699     (254,951     —         (394,361

Intra-Group operating expenses(1)

     —         —         (17,149     (7,257     24,406       —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     (19,320     (34,391     (102,848     (262,208     24,406       (394,361
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Other income, net

     —         —         56       1,011       —         1,067  

Loss from operations

     (19,320     (7,720     (31,331     (147,624     —         (205,995
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Equity in loss of the Group’s entities(2)

     (199,065     (196,170     (166,484     —         561,719       —    

Non-operating income/(expense)

     23,941       4,825       2,000       (18,162     —         12,604  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Loss before income tax expenses

     (194,444     (199,065     (195,815     (165,786     561,719       (193,391
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income tax benefits

     —         —         891       (20     —         871  

Share of results of equity investees

     —         —         —         (696     —         (696
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

     (194,444     (199,065     (194,924     (166,502     561,719       (193,216
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Less: Net income attributable to the non-controlling interest shareholders

     —         —         1,246       (18     —         1,228  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net loss attributable to Boqii Holding Limited

     (194,444     (199,065     (196,170     (166,484     561,719       (194,444
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

12


Table of Contents
     Year Ended March 31, 2022  
    

Boqii Holding
Limited

   

All
others

   

Primary
Beneficiaries of
VIEs and their
subsidiaries

   

VIEs and their
subsidiaries

   

Eliminating
adjustments

   

Consolidated
totals

 
     (RMB in thousands)  

Net revenues:

            

Third-party revenues

     —         42,769       266,280       877,380       —         1,186,429  

Intra-Group revenues(1)

     —         —         550,585       56,079       (606,664     —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total revenues

     —         42,769       816,865       933,459       (606,664     1,186,429  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cost of revenues:

            

Third-party cost of revenues

     —         (38,203     (744,834     (160,661     —         (943,698

Intra-Group cost of revenues(1)

     —         (637     (1,761     (550,585     552,983       —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total cost of revenues

     —         (38,840     (746,595     (711,246     552,983       (943,698
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     —         3,929       70,270       222,213       (53,681     242,731  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating expenses:

            

Third-party operating expenses

     (17,058     (21,896     (54,015     (288,291     —         (381,260

Intra-Group operating expenses(1)

     —         —         (53,681     —         53,681       —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     (17,058     (21,896     (107,696     (288,291     53,681       (381,260
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Other income, net

     —         —         182       98       —         280  

Loss from operations

     (17,058     (17,967     (37,244     (65,980     —         (138,249
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Equity in loss of the Group’s entities(2)

     (132,683     (115,665     (81,790     —         330,138       —    

Non-operating income/(expense)

     21,351       941       1,825       (20,680     —         3,437  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Loss before income tax expenses

     (128,390     (132,691     (117,209     (86,660     330,138       (134,812
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income tax benefits

     —         —         890       681       —         1,571  

Share of results of equity investees

     —         —         —         418       —         418  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

     (128,390     (132,691     (116,319     (85,561     330,138       (132,823
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Less: Net income attributable to the non-controlling interest shareholders

     —         (8     (654     (3,771     —         (4,433
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net loss attributable to Boqii Holding Limited

     (128,390     (132,683     (115,665     (81,790     330,138       (128,390
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

13


Table of Contents
     Year Ended March 31, 2023  
    

Boqii Holding
Limited

   

All
others

   

Primary
Beneficiaries of
VIEs and their
subsidiaries

   

VIEs and their
subsidiaries

   

Eliminating
adjustments

   

Consolidated
totals

 
     (RMB in thousands)  

Net revenues:

            

Third-party revenues

     —         8,937       297,005       786,152       —         1,092,094  

Intra-Group revenues(1)

     —         —         534,559       86,463       (621,022     —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total revenues

     —         8,937       831,564       872,615       (621,022     1,092,094  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cost of revenues:

            

Third-party cost of revenues

     —         (8,967     (767,831     (81,810     —         (858,608

Intra-Group cost of revenues(1)

     —         —         (982     (534,518     535,500       —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total cost of revenues

     —         (8,967     (768,813     (616,328     535,500       (858,608
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     —         30       (62,751     (256,287     85,522       (233,486
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating expenses:

            

Third-party operating expenses

     1,076       (10,342     (49,737     (237,852     —         (296,855

Impairment of goodwill

     —         —         (39,690     (994     —         (40,684

Intra-Group operating expenses(1)

     —         —         (85,481     (41     85,522       —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     1,076       (10,372     (174,908     (238,887     85,522       (337,539
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Other income/(expense), net

     —         —         127       158       —         285  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Loss from operations

     1,076       (10,372     (112,030     17,558       —         (103,768
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Equity in loss of the Group’s entities(2)

     (109,424     (101,087     16,245       —         194,266       —    

Non-operating income/(expense)

     5,550       2,033       (10,591     (29     —         (3,037
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Loss before income tax expenses

     (102,798     (109,426     (106,376     17,529       194,266       (106,805
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income tax benefits

     —         —         890       21       —         911  

Share of results of equity investees

     —         —         —         (82     —         (82
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

     (102,798     (109,426     (105,486     17,468       194,266       (105,976
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Less: Net income attributable to the non-controlling interest shareholders

     —         (1     (4,400     1,224       —         (3,177
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net loss attributable to Boqii Holding Limited

     (102,798     (109,425     (101,086     16,244       194,266       (102,799
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Notes:

 

(1)

Represents the elimination of the intercompany transactions at the consolidation level. For the fiscal years ended March 31, 2021, 2022 and 2023, the primary beneficiary of the VIE didn’t charge any service fees according to the exclusive consultation and service agreements.

(2)

Represents the elimination of investments among Boqii Holding Limited, the primary beneficiaries of VIEs and their subsidiaries, the Other Subsidiaries and the VIEs and their subsidiaries that we consolidate.

 

14


Table of Contents
    Year Ended March 31, 2021  
   

Boqii Holding
Limited

   

All
others

   

Primary
Beneficiaries of
VIEs and their
subsidiaries

   

VIEs and their
subsidiaries

   

Eliminating
adjustments

   

Consolidated
totals

 
    (RMB in thousands)  

Cash flows from operating activities:

           

Net cash provided by/(used in) transactions with external parties

    2,193       (161,806     (507,640     419,767       —         (247,486

Net cash provided by/(used in) transactions with the Group’s entities

    34       (6,552     337,582       (331,064     —         —    
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by/(used in) operating activities

    2,227       (168,358     (170,058     88,703       —         (247,486
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from investing activities:

           

Capital contribution to the Group’s entities

    (620,373     (148,624     —         —         768,997       —    

Cash flows of loan funding provided to the Group’s entities, net of repayments received

    —         38,859       (80,577     (5,242     46,960       —    

Other investing activities

    (18,613     (45,942     (87,890     (31,972     —         (184,417
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash used in investing activities

    (638,986     (155,707     (168,467     (37,214     815,957       (184,417
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from financing activities:

           

Proceeds from the initial public offering, net of underwriter discounts and commissions and other offering costs paid

    393,698       —         —         —         —         393,698  

Capital contribution from the Group’s entities

    —         452,553       316,444       —         (768,997     —    

Cash flows of loan funding received from the Group’s entities, net of repayments made

    —         —         5,243       41,717       (46,960     —    

Other financing activities

    266,668       19,845       80,431       (112,151     —         254,793  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by/(used in) financing activities

    660,366       472,398       402,118       (70,434     (815,957     648,491  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

15


Table of Contents
    Year Ended March 31, 2022  
   

Boqii Holding
Limited

   

All
others

   

Primary
Beneficiaries of
VIEs and their
subsidiaries

   

VIEs and their
subsidiaries

   

Eliminating
adjustments

   

Consolidated
totals

 
    (RMB in thousands)  

Cash flows from operating activities:

           

Net cash provided by/(used in) transactions with external parties

    (3,626     16,466       (686,545     526,201       —         (147,504

Net cash provided by/(used in) transactions with the Group’s entities

    563       (29     328,791       (329,325     —         —    
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by/(used in) operating activities

    (3,063     16,437       (357,754     196,876       —         (147,504
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from investing activities:

           

Capital contribution to the Group’s entities

    (242,713     (252,255     —         —         494,968       —    

Cash flows of loan funding provided to the Group’s entities, net of repayments received

    —         (22,616     (91,552     6,294       107,874       —    

Other investing activities

    (34,687     (9,593     83,909       (18,482     —         21,147  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by/(used in) investing activities

    (277,400     (284,464     (7,643     (12,188     602,842       21,147  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from financing activities:

           

Capital contribution from the Group’s entities

    —         242,713       252,255       —         (494,968     —    

Cash flows of loan funding received from the Group’s entities, net of repayments made

    —         (7,167     23,247       91,794       (107,874     —    

Other financing activities

    264,010       —         11,891       (273,906     —         1,995  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by/(used in) financing activities

    264,010       235,546       287,393       (182,112     (602,842     1,995  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

16


Table of Contents
    Year Ended March 31, 2023  
   

Boqii Holding
Limited

   

All
others

   

Primary
Beneficiaries of
VIEs and their
subsidiaries

   

VIEs and their
subsidiaries

   

Eliminating
adjustments

   

Consolidated
totals

 
    (RMB in thousands)  

Cash flows from operating activities:

           

Net cash provided by/(used in) transactions with external parties

    (36,058     (18,677     (471,325     471,991       —         (54,069

Net cash provided by/(used in) transactions with the Group’s entities

    —         —         449,155       (449,155     —         —    
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by/(used in) operating activities

    (36,058     (18,677     (22,170     22,836       —         (54,069
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from investing activities:

           

Capital contribution to the Group’s entities

    (85,947     (215,537     —         —         301,484       —    

Cash flows of loan funding provided to the Group’s entities, net of repayments received

    36,672       (62,075     (107,248     —         132,651       —    

Other investing activities

    (100     58,234       (2,000     (9,638     —         46,496  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by/(used in) investing activities

    (49,375     (219,378     (109,248     (9,638     434,135       46,496  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from financing activities:

           

Capital contribution from the Group’s entities

    —         85,947       215,537       —         (301,484     —    

Cash flows of loan funding received from the Group’s entities, net of repayments made

    —         57,397       6,050       69,204       (132,651     —    

Other financing activities

    87,984       (33,557     (42,614     (88,469     —         (76,656
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by financing activities

    87,984       109,787       178,973       (19,265     (434,135     (76,656
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Permits and Permission Required from the PRC Authorities for Our Operations

As advised by our PRC counsel, Commerce & Finance Law Offices, as of the date of this annual report, our PRC subsidiaries and the VIEs have obtained all licenses and approvals required for conducting our operations in China, except that we are in the process of updating address in the veterinarian drug sales license for one of our subsidiaries, and updating address or legal representative and renewing registrations and filings for certain of our subsidiaries regarding import/export, customs, and dog sales, and we currently do not foresee any impediments for us to complete such update or renewal. Additionally, all of the lease agreements of our leased properties have not been registered with the relevant PRC government authorities as required by PRC law and our certain leased properties are for industrial use, which may expose us to potential fines.

If the interpretation or implementation of existing laws and regulations change, or new regulations come into effect, requiring us or parties on whom we rely to obtain any additional permits, licenses or certificates that were previously not required to operate our business, there can be no assurance that we or parties on whom we rely will successfully obtain such permits, licenses or certificates. If we, our PRC subsidiaries or VIEs are found to be in violation of any existing or future PRC laws or regulations, or fail to obtain or maintain any of the required permits, approvals or filings, the relevant PRC regulatory authorities would have broad discretion to take action in dealing with such violations or failures. In addition, if we had inadvertently concluded that such approvals, permits, registrations or filings were not required, or if applicable laws, regulations or interpretations change in a way that requires us to obtain such approval, permits, registrations or filings in the future, we and the VIEs may be unable to obtain such necessary approvals, permits, registrations or filings in a timely manner, or at all, and such approvals, permits, registrations or filings may be rescinded even if obtained. Any such circumstance may subject us to fines and other regulatory, civil or criminal liabilities, and we may be ordered by the competent government authorities to suspend relevant operations, which will materially and adversely affect our business operation. Furthermore, we may be subject to regular inspections, examinations, inquiries or audits by regulatory authorities, and an adverse outcome of such inspections, examinations, inquiries or audits may result in the loss or non-renewal of the relevant licenses and approvals. Moreover, the criteria used in reviewing applications for, or renewals of licenses and approvals may change from time to time, and there can be no assurance that we will be able to meet new criteria that may be imposed to obtain or renew the necessary licenses and approvals. Many of such licenses and approvals are material to the operation of our business, and if we fail to maintain or renew material licenses and approvals, our ability to conduct our business could be materially impaired. See “—3.D. Risk Factors—Risks Related to Our Business and Industry—If we fail to obtain and maintain the licenses, permits and approvals required or applicable to our business under the complex regulatory environment for our businesses in China, our business, financial condition and results of operations may be materially and adversely affected.”

 

17


Table of Contents

Recent Regulatory Development

Cybersecurity Review Measures

On December 28, 2021, the Cyberspace Administration of China, or the CAC, published the Revised Cybersecurity Review Measures, which became effective on February 15, 2022 and repealed the Cybersecurity Review Measures promulgated on April 13, 2020. The Revised Cybersecurity Review Measures provide that a critical information infrastructure operator purchasing network products and services, and platform operators carrying out data processing activities, which affect or may affect national security, shall apply for cybersecurity review and that a platform operator with more than one million users’ personal information aiming to list abroad must apply for cybersecurity review.

As of the date of this annual report, we have not been informed or involved in any investigations or become subject to a cybersecurity review initiated by the CAC based on the Cybersecurity Review Measures, and we have not received any inquiry, notice, warning, sanctions in such respect or any regulatory objections to our current New York Stock Exchange, or NYSE, listing status from the CAC. However, there remain substantial uncertainties on the interpretation and implementations of the Revised Cybersecurity Review Measures. If the China Securities Regulatory Commission, or the CSRC, the CAC or other regulatory agencies later deem us to be a critical information infrastructures operator and require that we obtain their approvals for any future offshore offerings, we may be unable to obtain such approvals in a timely manner, or at all, and such approvals may be rescinded even if obtained. Any such circumstance could significantly limit or completely hinder our ability to continue to offer securities to investors and cause the value of such securities to significantly decline or be worthless. In addition, implementation of industry-wide regulations affecting our operations could limit our ability to attract new customers and/or users and cause the value of our securities to significantly decline. Therefore, investors of our company and our business face potential uncertainty from actions taken by the PRC government affecting our business.

In the past, we were subject to a fine of RMB100,000 imposed by Shanghai Internet Information Office in December 2021 for the publishing and transmission of illegal information on our Boqii Pet APP and a fine of RMB5,000 imposed by the Shanghai Pudong New Area Market Supervision Administration in May 2023 for the failure to stop sending commercial information to consumers upon receiving their request to unsubscribe. As of the date of this annual report, we have not been involved in any investigations or become subject to a cybersecurity review initiated by the CAC based on the Revised Cybersecurity Review Measures, and we have not received any inquiry, notice, warning, sanctions in such respect or any regulatory objections to our listing status from the CAC. For more information related to risks associated with the cybersecurity review, see “—3.D. Risk Factors—Risks Related to Doing Business in China— PRC laws and regulations regarding data security and cybersecurity are evolving. These laws and regulations are subject to change and substantial uncertainties, and could have material impact on our business operation.”

Permissions or Approvals Required from the PRC Authorities for Offering Securities to Foreign Investors

On February 17, 2023, the CSRC issued the Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Enterprises, or the Trial Measures, which became effective on March 31, 2023. On the same date of the issuance of the Trial Measures, the CSRC circulated No.1 to No.5 Supporting Guidance Rules, the Notes on the Trial Measures, the Notice on Administration Arrangements for the Filing of Overseas Listings by Domestic Enterprises and the relevant CSRC Answers to Reporter Questions on the official website of the CSRC, or collectively, the Guidance Rules and Notice. Under the Trial Measures and the Guidance Rules and Notice, domestic companies conducting overseas securities offering and listing activities, either in direct or indirect form, shall complete filing procedures with the CSRC pursuant to the requirements of the Trial Measures within three working days following its submission of initial public offering or listing application. The companies that have already been listed on overseas stock exchanges are not required to make immediate filings for its listing, yet need to make filings for subsequent offerings in accordance with the Trial Measures. In view of the fact that the Trial Measures have come into effect on March 31, 2023, we shall fulfill the filing procedures with the CSRC for any future offshore offering as per requirements of the Trial Measures. According to CSRC’s Questions and Answers with respect to Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies on February 17, 2023, for the filing of overseas listing of enterprises with VIE structure, the filing procedure will adhere to the principles of market-oriented principle, rule of law, and strengthened regulatory synergy. The CSRC will consult the relevant competent authorities, and the overseas listing of VIE structured enterprises that meet the compliance requirements will be filed. We may not be able to complete the filing if the filing materials are incomplete or do not meet the requirements of the CSRC. Any failure to obtain or delay in obtaining the CSRC permission and approval for any of our offshore offerings, or a rescission of such permission and approval if obtained, may subject us to sanctions imposed by the CSRC or other PRC regulatory authorities, which may materially and adversely affect our business, financial condition, and results of operations. However, as of the date of this annual report, uncertainties exist regarding the interpretation and implementation thereof.

 

18


Table of Contents

As of the date of this annual report, we have not received any formal notice from any PRC authorities that we shall be subject to permission or approval for the filing of this annual report. If we, our subsidiaries and the VIEs inadvertently conclude that such permissions or approvals are not required, and the CSRC, the CAC or any other PRC regulatory body subsequently determines that we, our subsidiaries or the VIEs need to file with such government authorities or obtain their permissions or approvals to maintain our listing status on U.S. exchanges, the CAC or any other PRC government authorities promulgate any interpretation or implements rules that would require us, our subsidiaries or the VIEs to file with or obtain the permissions or approvals from the CSRC, the CAC or other governmental bodies for any such listing status, we, our subsidiaries and the VIEs may face adverse actions that could have a material adverse effect on our business, reputation, financial condition, results of operations, prospects, as well as the trading price of the ADSs, and we cannot assure you that, if ever required, we, our subsidiaries and the VIEs would be able to obtain any such permissions or approvals and fully comply with the relevant new rules on a timely basis, or at all.

3.A. [Reserved]

3.B. Capitalization and Indebtedness

Not applicable.

3.C. Reason for the Offer and Use of Proceeds

Not applicable.

3.D. Risk Factors

Summary of Significant Risk Factors

Below please find a summary of the principal risks we face, organized under relevant headings.

Risks Related to Our Business and Industry

Risks and uncertainties related to our business and industry include, but are not limited to, the following:

 

   

Our limited operating history across our various business initiatives makes it difficult to evaluate our business prospects and future growth rate. For details, see the risk factor with the same heading on page 22 of this annual report.

 

   

We have a history of net losses and may continue to incur losses in the future. For details, see the risk factor with the same heading on page 22 of this annual report.

 

   

We have significant working capital requirements and have historically experienced working capital deficits. If we continue to experience such working capital deficits in the future, our business, liquidity, financial condition and results of operations may be materially and adversely affected. For details, see the risk factor with the same heading on page 22 of this annual report.

 

   

If we are unable to diversify our monetization channels, our business and prospects may be materially and adversely affected. For details, see the risk factor with the same heading on page 22 of this annual report.

 

   

Our business, prospects and financial results may be affected by our relationship with third-party e-commerce platforms. For details, see the risk factor with the same heading on page 23 of this annual report.

 

   

Our business is subject to the changing preferences and needs of our customers and their pets. Any failure by us to timely adapt our offerings according to changes in customer preferences may adversely affect our business and results of operations. For details, see the risk factor with the same heading on page 23 of this annual report.

 

19


Table of Contents
   

If we fail to acquire and retain new customers, or fail to do so in a cost-effective manner, our business, financial condition and results of operations may be materially and adversely affected. For details, see the risk factor with the same heading on page 23 of this annual report.

Risks Related to Our Corporate Structure and Contractual Arrangements

Having a corporate structure being based primarily in China poses risks to investors. Risks and uncertainties related to our corporate structure and the contractual arrangements include, but are not limited to, the following:

 

   

There are substantial uncertainties regarding the interpretation and application of current and future PRC laws, regulations, and rules relating to the agreements that establish the VIE structure for our operations in China, including potential future actions by the PRC government, which could affect the enforceability of our contractual arrangements with the VIEs and, consequently, significantly affect our financial condition and results of operations. If the PRC government finds our contractual arrangements noncompliant with relevant PRC laws, regulations, and rules, or if these laws, regulations, and rules or the interpretation thereof change in the future, we could be subject to severe penalties or be forced to relinquish our interests in the VIEs. For details, see the risk factor with the same heading on page 42 of this annual report.

 

   

Uncertainties exist with respect to the interpretation and implementation of the newly enacted Foreign Investment Law and how it may impact our business, financial condition and results of operations. For details, see the risk factor with the same heading on page 43 of this annual report.

 

   

We rely on contractual arrangements with the VIEs and their respective shareholders for our business operations, which may not be as effective as direct ownership in providing operational control. For details, see the risk factor with the same heading on page 44 of this annual report.

 

   

Any failure by any of the VIEs or their shareholders to perform their respective obligations under our contractual arrangements with them would have a material and adverse effect on our business. For details, see the risk factor with the same heading on page 44 of this annual report.

 

   

Our contractual arrangements are governed by PRC law. Accordingly, these contracts would be interpreted in accordance with PRC law, and any disputes would be resolved in accordance with PRC legal procedures. For details, see the risk factor with the same heading on page 45 of this annual report.

Risks Related to Doing Business in China

Having the majority of our operations in China poses risks to investors. We face risks arising from the legal system in China, including risks and uncertainties regarding the enforcement of laws, rules and regulations in China:

 

   

Uncertainties with respect to the PRC legal system could adversely affect us. For details, see the risk factor with the same heading on page 46 of this annual report.

 

   

PRC laws and regulations regarding data security and cybersecurity are evolving. These laws and regulations are subject to change and substantial uncertainties, and could have material impact on our business operation. For details, see the risk factor with the same heading on page 48 of this annual report.

 

   

Any failure or perceived failure by us to comply with Anti-monopoly Guidelines for Internet Platforms and other Anti-monopoly laws and regulations may result in governmental investigations or enforcement actions, litigation or claims against us and could have an adverse effect on our business, financial condition and results of operations. For details, see the risk factor with the same heading on page 50 of this annual report.

We face risks that the Chinese government may intervene or influence our operations at any time, or may exert more control over offerings conducted overseas and/or foreign investment in China-based issuers, which could result in a material change in our operations, significantly limit or hinder our ability to offer or continue to offer securities to investors, and cause the value of such securities to significantly decline or be worthless:

 

   

Changes in China’s economic, political or social conditions or government policies could have a material adverse effect on our business and operations. For details, see the risk factor with the same heading on page 46 of this annual report.

 

20


Table of Contents
   

The permission and approval from the CSRC or other PRC government authorities may be required in connection with an offshore offering under PRC law, and, if required, we cannot predict whether or for how long we will be able to obtain such permission or approval. For details, see the risk factor with the same heading on page 47 of this annual report.

In addition, we are also subject to other risks and uncertainties related to doing business in China, which include, but are not limited to risks related our business, enforcement of legal procedures and regulatory developments in relation to PCAOB inspection:

 

   

Our business, financial condition and results of operations depend on the level of consumer confidence and spending in China and may be adversely affected by the downturn in the global or Chinese economy. For details, see the risk factor with the same heading on page 46 of this annual report.

 

   

You may experience difficulties in effecting service of legal process, enforcing foreign judgments or bringing actions in China against us or our management named in this annual report based on foreign laws, and the ability of U.S. authorities to bring actions in China may also be limited. For details, see the risk factor with the same heading on page 50 of this annual report.

 

   

It may be difficult for overseas regulators to conduct investigation or collect evidence within China. For details, see the risk factor with the same heading on page 51 of this annual report.

 

   

Trading in our securities will be prohibited under the HFCAA if the PCAOB determines that it is unable to inspect or investigate completely registered public accounting firms headquartered in mainland China and Hong Kong, including our auditor as an independent registered public accounting firm, and as a result, U.S. national securities exchanges, such as the NYSE, may determine to delist our securities. For details, see the risk factor with the same heading on page 56 of this annual report.

Risks Related to Our Class A Ordinary Shares and Our ADSs

In addition to the risks described above, we are subject to risks related to our ADSs, including, but are not limited to, the following:

 

   

We face possible delisting by the NYSE due to non-compliance with the continued listing standards of the NYSE. For details, see the risk factor with the same heading on page 58 of this annual report.

 

   

The trading price of the ADSs is likely to be volatile, which could result in substantial losses to investors. For details, see the risk factor with the same heading on page 59 of this annual report.

 

   

Our dual-class share structure with different voting rights will limit your ability to influence corporate matters and could discourage others from pursuing any change of control transactions that holders of our Class A ordinary shares and the ADSs may view as beneficial. For details, see the risk factor with the same heading on page 60 of this annual report.

 

   

The dual-class structure of our ordinary shares may adversely affect the trading market for our ADSs. For details, see the risk factor with the same heading on page 60 of this annual report.

 

   

If securities or industry analysts do not publish research or reports about our business, or if they adversely change their recommendations regarding the ADSs, the market price for the ADSs and trading volume could decline. For details, see the risk factor with the same heading on page 61 of this annual report.

 

   

The sale or availability for sale of substantial amounts of ADSs could adversely affect their market price. For details, see the risk factor with the same heading on page 61 of this annual report.

 

   

Techniques employed by short sellers may drive down the market price of the ADSs. For details, see the risk factor with the same heading on page 61 of this annual report.

 

   

Due to our ADS’s price fluctuations, our passive foreign investment company, or PFIC, status for the year ended March 31, 2023 is uncertain, and there is a significant risk that we will be a PFIC for the current or any future taxable year, which could result in adverse U.S. federal income tax consequences to U.S. investors in the ADSs or our Class A ordinary shares. For details, see the risk factor with the same heading on page 65 of this annual report.

 

21


Table of Contents

Risks Related to Our Business and Industry

Our limited operating history across our various business initiatives makes it difficult to evaluate our business prospects and future growth rate.

We have a limited operating history across our various business initiatives, such as operating our private label lines, cooperating with KOLs to promote sales on our platform, offering SaaS solution to offline pet stores, engaging in pet healthcare business and other new pet-related product and service offerings. As a result, our historical performance may not be indicative of our future growth or financial results. In addition, we may continue to introduce and implement new business strategies and initiatives as we continue to respond to changing market needs and customer preferences. We cannot assure you that we will be able to successfully implement our business initiatives or achieve our expected growth rate, or at all, as our business model continues to evolve. Our overall business growth may slow down or become negative, and our revenues may decline for a number of possible reasons, some of which are beyond our control, including decreasing customer spending, changes in consumer preferences, increasing competition, declining growth of our overall market or industry, the emergence of alternative business models, changes in rules, regulations, government policies or general economic conditions. Our net revenues were RMB1,011.0 million, RMB1,186.4 million and RMB1,092.1 million (US$159.0 million) in the fiscal years ended March 31, 2021, 2022 and 2023, respectively. If our growth rate declines or if our business initiatives fail to yield positive customer acceptance or economic returns as expected or if such initiatives cause any material disruption to our business model, investors’ perceptions of our business and prospects may be materially and adversely affected and the market price of the ADSs could decline. You should consider our prospects in light of the risks and uncertainties that companies with a limited operating history may encounter.

We have a history of net losses and may continue to incur losses in the future.

We recorded net loss of RMB193.2 million, RMB132.8 million and RMB106.0 million (US$15.4 million) for the fiscal years ended March 31, 2021, 2022 and 2023, respectively. Our net revenues will be impacted by various factors, including customer spending and preference, competitive landscape and macroeconomic and regulatory environment. Hence, our net revenues may not grow at the rate we expect.

Moreover, our net revenues may not increase sufficiently to offset the increase in our expenses as we further increase our brand awareness, expand our customer base, enhance customer experience, and expand our product and service offerings as well as offline distribution network. We will continue to invest in sales, marketing and branding efforts, which is expected to cause our sales and marketing expenses to increase continuously and rapidly. We will also continue to invest in improving our technologies and developing additional products and services. In addition, as we are now a public company, we may incur certain legal, accounting and other expenses that we did not previously incur as a private company. These efforts may be more costly than we expect. We may continue to incur losses in the future and we cannot assure you that we will eventually achieve profitability.

We have significant working capital requirements and have historically experienced working capital deficits. If we continue to experience such working capital deficits in the future, our business, liquidity, financial condition and results of operations may be materially and adversely affected.

We had a positive working capital, representing the difference between total current assets and total current liabilities, of RMB478.2 million, RMB262.7 million and RMB210.0 million (US$30.6 million) as of March 31, 2021, 2022 and 2023, respectively. Although we had a positive working capital as of March 31, 2023 to meet our ongoing working capital needs and fund our continuous growth, there is no assurance that we will generate sufficient net income or operating cash flows to meet our working capital requirements and repay our liabilities as they become due in the future. Working capital constraints have in the past limited, and may continue to limit, our ability to grow revenues, especially with emerging brands that generally require larger inventory investments during their early commercial development. Working capital deficits will restrict our liquidity position and have a negative impact on our ability to repay current liabilities. Our inability to take actions that address our working capital deficit in a timely and efficient manner, including prudently managing our working capital, or raising additional equity or debt financing on terms that are acceptable to us when necessary, could materially adversely affect our liquidity, results of operations, financial condition and ability to operate.

If we are unable to diversify our monetization channels, our business and prospects may be materially and adversely affected.

To promote business growth and enhance our platform, we will diversify our monetization channels, such as expanding our offline presence and monetizing our online community user base. However, we cannot assure you that we will be able to execute any of such strategies for monetization and business expansion successfully.

 

22


Table of Contents

In addition, these monetization strategies will require significant efforts and resources from our management. For instance, we need to continue to manage our relationships with KOLs to ensure that our content appeals to our users and customers in an effort to monetize our online community user base. Content offerings may not achieve broad user acceptance, and may present new and difficult technological or operational challenges and subject us to claims if users and customers are not satisfied with the quality of the content or if customers are not satisfied with the products promoted on our platform. For further information, see “—If we fail to maintain our relationships with content creators, in particular KOLs, or if our KOLs fail to produce popular pet-focused contents, we may not be able to attract or retain users of our online community, and our revenues and results of operations may be harmed.” Also, we will need to gain acceptance from offline pet stores and maintain steady relationship with them to expand our offline distribution network. For further information, see “—Our business, prospects and financial results may be affected by our relationships with offline pet stores.” All of these endeavors involve risks and will require significant management, financial and human resources. We cannot assure you that we will be able to implement our strategies successfully. If we are not able to diversify our monetization channels and achieve growth in our financials effectively, our business and prospects may be materially and adversely affected.

Our business, prospects and financial results may be affected by our relationship with third-party e-commerce platforms.

In addition to our self-operated Boqii Mall, we also operate flagship stores on third-party e-commerce platforms, including Tmall, JD.com and Pinduoduo. We leverage customer traffic of these e-commerce platforms to boost our product sales. Sales through these platforms have significantly contributed to our financial performance. Nevertheless, these e-commerce platforms tend to lack expertise in the pet industry, and may lose appeal to customers who need tailored services and specialized pet products. To the extent that we fail to leverage traffic on these third-party platforms, our flagship store sales may decline and we may experience difficulties in locating customers. At the same time, our cooperation with these third-party platforms may be negatively affected by a number of factors, including but not limited to higher commissions and fees, negative publicity and service outages of these platforms, all of which are beyond our control. In addition, these third-party platforms may deem our business a strong competitor of theirs and terminate their cooperation with us. If our relationships with these third-party platforms deteriorate or are terminated or if we fail to maintain the relationships on commercially viable terms, we may not be able to quickly locate alternative sales channels. Hence, our operations and financial condition will be materially and adversely affected.

Our business is subject to the changing preferences and needs of our customers and their pets. Any failure by us to timely adapt our offerings according to changes in customer preferences may adversely affect our business and results of operations.

Our growth depends, in part, on our ability to successfully introduce new products to meet the evolving requirements of our customers and that of their pets. This, in turn, depends on our ability to foresee and respond to evolving customer trends, demands and preferences. The development and introduction of new products involve considerable costs, and may not generate sufficient customer interest or sales to cover their development or marketing expenses, which may reduce our operating income. In addition, any such unsuccessful effort may adversely affect our brand and reputation. To the extent that we are not able to successfully identify customer preferences, develop or promote new products, we may lose our competitive edge in the market and our business, financial condition and results of operations may be adversely affected.

If we fail to acquire and retain new customers, or fail to do so in a cost-effective manner, our business, financial condition and results of operations may be materially and adversely affected.

Our success depends on our ability to acquire and retain new customers and to do so in a cost-effective manner. We must continue to acquire customers in order to increase sales and achieve profitability. Considered our ability to monetize the user base of our online community is also critical to our business and growth, we have invested heavily in branding, sales and marketing to acquire and retain customers. We operate a pet-focused online community in China’s pet market with approximately 26 million registered users as of March 31, 2023 and approximately 2.9 million average MAUs in 2023. As of March 31, 2023, we managed over 750 pet-focused Weixin/WeChat groups to extend our customer reach and promote our brand. The former U.S. President had announced a ban of the messaging mobile application WeChat, which is used by many of our customers. Although the ban was dropped in 2021, there is no assurance that no bans of a similar nature will be implemented. Any negative publicity in this regard may also adversely affect our communications and interactions with our customers. We also leverage third-party e-commerce platforms and social networks for customer traffic. As social network and e-commerce channels continue to rapidly evolve, we may be unable to develop or maintain a presence within these channels. Furthermore, we utilize online search engines from time to time on an as-needed basis to generate additional traffic to our platforms through search engine optimization and posting sponsored articles. In the fiscal years ended March 31, 2021, 2022 and 2023, we incurred RMB160.2 million, RMB171.0 million and RMB124.0 million (US$18.1 million) in sales and marketing expenses, respectively. We expect to continue to spend significant amounts to acquire additional customers and retain existing ones, which may lead to increased net losses. However, there is no assurance that we will be able to recover the costs of our sales and marketing activities or successfully convert users on our online community into our customers, or that these activities will be effective in attracting new customers or retaining existing customers. If we fail to attract sufficient new customers, increase our sales per customer, generate customer traffic for our online sales platforms, generate repeat purchases or maintain high levels of customer engagement in a cost-effective and timely manner, or at all, our revenues may decrease and our business, financial condition, and results of operations will be materially and adversely affected.

 

23


Table of Contents

We rely on assumptions and estimates to calculate certain key operating metrics, such as GMV, and such measures may not be directly comparable with similarly titled operating metrics adopted by other companies in our industry, which may lead to inaccurate interpretation of our business operations and our market position.

GMV and certain other key operating metrics are calculated using internal company data. While these numbers are based on what we believe to be reasonable calculations for the applicable periods of measurement, there are inherent challenges in measuring those metrics. For example, when calculating GMV, we exclude products sold through the consignment model and the value of services offered by us. Although our management believes that such metrics are defined in a way that it believes best reflects our business operations, our operating metrics may differ from estimates published by third parties or from similarly titled operating metrics used by other companies in our industry due to differences in data availability, sources and methodology. If third parties do not perceive our operating metrics to be accurate representations of our business operations or if we discover material inaccuracies in our operating metrics, our reputation may be harmed, which could adversely affect our business and operating results.

Increasing focus with respect to environmental, social and governance matters may impose additional costs on us or expose us to additional risks. Failure to comply with the laws and regulations on environmental, social and governance matters may subject us to penalties and adversely affect our business, financial condition and results of operations.

The PRC government and public advocacy groups have been increasingly focused on environment, social and governance, or ESG, issues in recent years, making our business more sensitive to ESG issues and changes in governmental policies and laws and regulations associated with environment protection and other ESG-related matters. Investor advocacy groups, certain institutional investors, investment funds, and other influential investors are also increasingly focused on ESG practices and in recent years have placed increasing importance on the implications and social cost of their investments. Regardless of the industry, increased focus from investors and the PRC government on ESG and similar matters may hinder access to capital, as investors may decide to reallocate capital or to not commit capital as a result of their assessment of a company’s ESG practices. Any ESG concern or issue could increase our regulatory compliance costs. If we do not adapt to or comply with the evolving expectations and standards on ESG matters from investors and the PRC government or are perceived to have not responded appropriately to the growing concern for ESG issues, regardless of whether there is a legal requirement to do so, we may suffer from reputational damage and the business, financial condition, and the price of our ADSs could be materially and adversely effected.

We face risks related to natural disasters, health epidemics, civil and social disruption and other outbreaks, which could significantly disrupt our operations.

We are vulnerable to natural disasters, other epidemics and calamities. Fire, floods, typhoons, earthquakes, power loss, telecommunications failures, break-ins, war, riots, terrorist attacks or similar events may give rise to server interruptions, breakdowns, system failures or internet failures, which could cause the loss or corruption of data or malfunctions of software or hardware as well as adversely affect our ability to provide our offerings.

Following the outbreak of Covid-19, certain aspects of our business operations were negatively affected. Reduced transportations and travel restrictions have caused temporary delays in product delivery, which has further resulted in a decrease in number of orders. Moreover, most of the offline pet stores that we cooperate with experienced some temporary decrease in the number of customers. Disruption to manufacturing and logistics networks also affected our brand partners’ and manufacturers’ abilities to produce and supply goods. Deteriorating economic conditions in China and globally caused by the Covid-19, such as increased unemployment, decreased capital spending, declines in consumer confidence, or economic slowdowns or recessions, could cause a decrease in market demand, and thereby harm our business. In addition to Covid-19, our business operations could be disrupted due to the spread of other epidemics, including Ebola virus, H1N1 flu, H7N9 flu, avian flu and SARS. A prolonged or worsened Covid-19 or any other adverse public health developments could lead to a material adverse effect on our business, financial condition and results of operations and cash flows, and the trading price of our ADSs may be adversely affected.

Any harm to our brand or failure to maintain and enhance our brand recognition may materially and adversely affect our business and results of operations.

We believe that the recognition and reputation of our brands among customers and brand partners are crucial to our business and competitiveness. Many factors, some of which are beyond our control, are important to maintaining and enhancing our brands and may negatively impact our brands and reputation if not properly managed. These factors include our ability to:

 

   

maintain superior customer experience;

 

   

maintain a diverse selection of high-quality products;

 

   

maintain and grow our customer base, online community user base and keep our users highly active and engaged;

 

   

maintain and grow our content offerings and ensure access to high-quality content creators, especially KOLs;

 

   

maintain and enhance our reputation and goodwill generally and in the event of any negative publicity on product quality, customer services, internet security, or other issues affecting us or our industry in China;

 

24


Table of Contents
   

maintain our relationships with brand partners, manufacturers, physical pet stores and pet hospitals and oversee the quality of products and services provided by these third parties; and

 

   

maintain our relationships with KOLs and ensure that their behaviors represent our brands and products.

We operate in a relatively new and evolving market.

Our business and prospects primarily depend on the continuing development and growth of China’s pet industry, which is relatively new, evolving and unproven. China’s pet industry is affected by numerous factors, including but not limited to comprehensive consumption upgrade, governmental and regulatory policy and expansion and diversification of pet products and services portfolio. Compared to U.S. pet parents, Chinese pet parents generally have less pet parenting experience. They are generally more price sensitive and less brand loyal. Accordingly, we believe that first-time Chinese pet parents prefer general e-commerce platforms that offer pet products at competitive prices, and we also believe that they have limited demand for specialized, pure-play online retail platforms with high-quality pet-focused product offerings, such as our online sales platforms. If we no longer offer competitive discounts, we may experience a decrease in the number of our customers and their orders, which materially and adversely affects our results of operations and financial condition. Pet products still represent a niche market in China. If China’s pet industry does not grow or grows slower than expected, our business, financial condition and results of operation may be materially and adversely affected.

We face intense competition. If we do not compete successfully against existing or new competitors, we may lose customers and market share.

China’s pet industry is highly competitive and Chinese pet parents are generally price-sensitive. We compete with pet product retail stores, supermarkets, generic e-commerce platforms and other pet-focused online retail platforms. Our competitors may have more financial, technical, marketing and other resources than we do and may be more experienced and able to devote greater resources to the development, promotion and support of their business. Specifically, they may be able to derive greater net sales and profits from their existing large customer base, acquire customers at lower costs or respond more quickly to new or emerging technologies and changes in customer preferences or habits than we can. They may also engage in more extensive research and development efforts, undertake more far-reaching marketing campaigns and adopt more aggressive pricing policies, including but not limited to predatory pricing policies and provision of substantial discounts, which may allow them to build larger customer bases and generate more net sales than we do. Increased competition may reduce our market share and require us to increase our sales and marketing efforts and capital commitment in the future, which could negatively affect our results of operations or force us to incur further losses. Furthermore, any disputes with current or future competitors may lead to negative publicity related to us, which may cause us to incur significant costs to defend against these activities and harm our business.

We expect competition in China’s pet industry, in particular among pet-focused online retail platforms, to continue to increase. We believe that our ability to compete successfully in this market depends on many factors both within and beyond our control, including:

 

   

the size and composition of our customer base;

 

   

the number of brand partners and products that we feature;

 

   

the quality and price of the products that we offer;

 

   

our ability to customize content and product recommendations to customers tailored to their needs;

 

   

the convenient shopping experience that we provide;

 

   

our selling and marketing efforts, including our ability to promote the brands of our brand partners and our private label brands; and

 

   

our reputation and brand strength.

If we fail to compete successfully in this market, our business, financial condition, and results of operations could be materially and adversely affected.

We may be unable to manage and expand the relationships with brand partners, or otherwise fail to cooperate with them at favorable terms, and our business and growth prospects may suffer as a result.

We cooperate with our brand partners to provide a substantial majority of the products offered on our platform. Maintaining strong relationships with our brand partners is important to the growth of our business. If we lose our existing brand partners due to, for example, increased competition, ineffectiveness of our advertisement solutions or fulfillment process, a significant change in the business policy or operation of the relevant brand partners, or any deterioration in our relationship with such brand partners, our business, financial condition and results of operations may be materially and adversely affected.

 

25


Table of Contents

We generally do not maintain long-term exclusive supply contracts with our brand partners. We cannot assure you that our existing brand partners will continue to cooperate with us on commercially attractive terms, or at all, after the term of the current agreements expire. If these brand partners choose to enter into distribution agreements with our competitors or develop and rely on their in-house e-commerce capabilities, our sales could suffer and our business could be adversely affected. The loss of any of our significant brand partners or the discontinuance of any preferential pricing or supply terms they currently offer to us would have a material and negative impact on our business, financial condition, and results of operations. Additionally, there can be no assurance that our current brand partners will be able to accommodate our anticipated growth. An inability of our existing brand partners to provide products in a timely or cost-effective manner could also impair our business and growth prospects. Moreover, our principal brand partners have provided us with certain incentives, such as cash rebates and free products. A reduction or discontinuance of these incentives would increase our costs and prevent us from achieving our profitability. In addition, if one or more of our brand partners were to offer these incentives, including preferential pricing, to our competitors, our competitive advantage would be reduced, which could materially and adversely affect our business, financial condition, and results of operations.

Meanwhile, we are continually seeking to build relationships with other high-quality brand partners. If we are unable to attract or cooperate with new brand partners, or to replace the loss of any of our existing brand partners, in a timely manner, or at all, we may experience a competitive disadvantage, our business may be disrupted and our business, financial condition, and results of operations may be materially and adversely affected.

Our private label products may not always appeal to our customers, and may compete with our brand partners.

We launched our private labels, Yoken and Mocare, in 2015 and 2018, respectively. Our Yoken brand offers high value for money pet food and products, and our Mocare brand focuses on premium freeze-dried cat food. We launched two “D-cat” labels in 2022, under which we offer (i) pet snacks and pet supplies and (ii) pet pharmaceuticals and medical care products, respectively.

However, there is no assurance that our private label product offerings will continue to generate customer interest and cater to their needs. If we are unable to generate sufficient sales of our private label products, we may fail to cover our development, manufacturing and marketing expenses on these products, and our business, results of operations and financial condition may be adversely affected.

Moreover, as we sell both branded products sourced from our brand partners and our private label products on our online sales platforms, we are likely to face competition from our brand partners. Branded products may have an advantage over our private label products primarily due to name recognition, although private label products are typically more competitively priced compared to branded products. In addition, selling private label products may harm our relationship with our brand partners. If we lose our brand partners or if our relationships with our brand partners deteriorate, our business may be adversely affected. See “—We may be unable to manage and expand the relationships with brand partners, or otherwise fail to cooperate with them at favorable terms, and our business and growth prospects may suffer as a result.”

We outsource the manufacturing of our private label products. As a result, our business, results of operations, financial conditions and reputation may be affected by issues relating to our manufacturer.

We outsource the manufacturing of our private label products to pet food manufacturers in China. We may be unable to maintain our relationships with our manufacturing partners or identify or enter into relationships with new manufacturing partners to meet the manufacturing and assembly needs of our private label business in a timely manner, or at all. Additionally, manufacturing at our manufacturing partners may be disrupted or delayed for a variety of reasons, including, but not limited to, natural and man-made disasters, health epidemics, information technology system failures, commercial disputes, labor disputes, and environmental and worker health and safety issues. As a result, we may experience shortage in supply and delay in delivery of our private label products, and our business, financial condition, results of operations and reputation may be materially and adversely affected.

Failure to maintain the quality and safety of our products and significant merchandise returns or refunds resulting could have a material and adverse effect on our reputation, financial condition and results of operations.

The quality and safety of our products are critical to our business. We have implemented stringent quality control systems on our private label products. Yet, due to the scale of our operations and rapid growth of our offline presence, maintaining consistent product quality depends significantly on the effectiveness of our quality control system, which in turn depends on a number of factors, including the design of our quality control system and the implementation of our quality control procedures. We may not be able to fully monitor the manufacturing process of our private label products and the quality control measures taken by our manufacturers may not be effective. There can be no assurance that our quality control system will always prove to be effective.

 

26


Table of Contents

We may be exposed to product recalls and withdrawals and adverse publicity if our products are alleged to be fake or expired, or cause injury or illness or if we are alleged to have mislabeled or misbranded our products or otherwise violated governmental regulations. We may also voluntarily recall or withdraw products that we consider below our standards, whether for taste, appearance or otherwise. Consumer concerns regarding the safety of our products, whether justified or not, could adversely affect our brand reputation and business. A product recall or withdrawal could result in substantial and unexpected expenditures, destruction of product inventory and lost sales, which could reduce our cash flow and prevent us from achieving profitability. In addition, a product recall or withdrawal may have detrimental effects on our brand reputation, leading to increased scrutiny by regulatory agencies and sharp decrease in demand for our products, all of which require significant management attention. These could negatively impact our business and, consequently, adversely affect our results of operations and reputation.

We do not carry product liability insurance and may be subject to product liability claims if consumption and use of our products is alleged to cause injury or illness to our customers and their pets. The real or perceived sale of contaminated food products by us could result in product liability claims against our brand partners or us, expose us or our brand partners to governmental enforcement action or private litigation, or lead to costly recalls and a loss of consumer confidence, any of which could have an adverse effect on our business, financial condition and results of operations. While we may attempt to seek compensation from responsible brand partners or our manufacturers in the event that we become subject to claims due to their misconduct, such compensation may be limited and if we cannot fully recover our damages from them, we will be required to bear such losses at our own costs. Any material product liability claim, litigation or governmental enforcement action could materially and adversely affect our business, financial condition and results of operations. Even unsuccessful claims could result in the use of funds and managerial efforts in defending them and could negatively impact on our reputation.

In addition, we allow our customers to return certain products and offer refunds, subject to our return and refunds policy. If merchandise returns or refunds are significant or higher than anticipated and forecasted, our business, financial condition, and results of operations could be adversely affected. Furthermore, we revise our policies relating to returns or refunds from time to time, and may do so in the future, which may result in customer dissatisfaction and harm to our reputation or brand, or an increase in the number of product returns or the amount of refunds we make.

If we cannot manage the growth of our business or execute our strategies effectively, our business and prospects may be materially and adversely affected.

Business growth will place significant demands on our management, operational and financial resources. We may encounter difficulties as we expand our operations, data and technology, sales and marketing, and general and administrative functions. We expect our expenses to continue to increase in the future as we acquire more users and customers and launch new initiatives. Continued growth could also strain our ability to maintain the quality and reliability of our platform and products and services we offer, develop and improve our operational, financial, legal and management controls, and enhance our reporting systems and procedures. Our expenses may grow faster than our revenues, and our expenses may be greater than we anticipate. Managing our growth will require significant expenditures and allocation of valuable management resources. If we are unable to manage our growth or execute our strategies effectively, our business and prospects may be materially and adversely affected.

Diversifying our product offerings may expose us to more risks.

Since our inception, we have focused on selling pet food, treats and supplies, and have also expanded our product offerings to include veterinary drugs. Diversifying our product offerings involve new risks and challenges different from those of our existing product categories. Our lack of familiarity with and lack of relevant customer data relating to new products may make it more difficult for us to anticipate customer demand and preferences, inspect and control quality and handle and store the products. As we broaden our product offerings, we may also be required to obtain additional licenses or permits for the sales of certain new products and subject to additional regulations by the relevant PRC government authorities. There is no assurance that we will be able to acquire additional requisite licenses or permits or to comply with the relevant legal requirements, which may materially and adversely affect our business. Moreover, as we continue to diversify our product offerings, we will need to continuously enhance and upgrade our technology, optimize our branding, sales and marketing efforts, expand our research and development team and train our customer service staff. All these efforts will require significant managerial, financial and human resources. At the same time, new products may have lower profit margins than our existing offerings, and we may need to price aggressively to gain market share or remain competitive in any new categories, which may further reduce our profit margins.

 

27


Table of Contents

If we fail to maintain our relationships with content creators, in particular KOLs, or if our KOLs fail to produce popular pet-focused contents, we may not be able to attract or retain users of our online community, and our revenues and results of operations may be harmed.

We rely on our content creators, in particular KOLs, to present popular pet-focused content on our online community and promote our products that appeal to existing and potential customers. Hence, if we fail to maintain our relationships with KOLs, our revenues and results of operations may be materially and adversely affected.

We generally enter into customary contracts with our KOLs, under which they are paid a fee for each piece of advertising post or video. We may need to offer higher compensation and incur additional recruitment costs to retain our KOLs due to increased competition for KOLs. Even so, we cannot assure you that we will be able to control, incentivize or retain KOLs to provide popular content and stimulate purchases of our products. If our KOLs cease to contribute content to our online community, or their content fail to attract users and customers, we may experience a decline in user traffic and user engagement of our online community. If we are unable to grow our user base or increase user engagement, our online community will become less attractive to existing and potential customers, which will have a material and adverse effect on our business and results of operations.

Any change, disruption, discontinuity in the features and functions of major social networks could severely limit our ability to continue growing our customer base, and our business may be materially and adversely affected.

We leverage social networks as a tool for customer acquisition and engagement. Through these social networks, such as Wechat/Weixin, our customers may share product information and their purchase experiences with their friends, family and other social contacts, which helps us generate low-cost organic traffic and active interactions among customers. A portion of our customer traffic comes from such user recommendation or product introduction feature on social networks. To the extent that we fail to leverage such social networks, our ability to attract or retain customers may be severely harmed. If any of these social networks changes its features or support, such as charging fees for the current free features, or stops providing us with infrastructure support, we may not be able to locate alternative platforms of similar scale to provide similar features or support on commercially reasonable terms in a timely manner, or at all. Furthermore, we may fail to establish or maintain relationships with social network operators to support the growth of our business on economically viable terms, or at all. Any interruption to or discontinuation of our relationships with major social network operators may severely and negatively impact our ability to continue growing our customer base, and any occurrence of the circumstances mentioned above may have a material adverse effect on our business, financial condition and results of operations.

We may be held liable for any false or misleading statements or advice given by KOLs on our online community.

We may be held liable for any false or misleading statements or advice given by KOLs on our online community. When these KOLs post pet-related content, respond to user inquiries, offer pet parenting advice or recommend products to pet parents, they may make false or misleading statements in relation to pet parenting or the suitability and effectiveness of pet products. These KOLs may be negligent in giving advice or fail to specify that their recommendation is general in nature and may not apply to the circumstances of particular pet parents and their pets. We may not always have appropriate disclaimers in place on our online community for such behavior.

We may be subject to legal and administrative proceedings and claims from time to time where these statements are found to result in harm to our customers or their pets. These claims and proceedings may be expensive and time consuming to investigate and defend and may divert resources and management attention from the operation of our business. Although these claims may not be successful, they may harm our reputation and business.

Negative media coverage could adversely affect our business and reputation.

Negative publicity about us or our business, shareholders, affiliates, directors, officers or other employees, brand partners, manufacturers, content creators, third-party platforms, delivery service providers and other third parties as well as the industry in which we operate, can harm our operations and reputation. Such negative publicity could be related to a variety of matters, including, but not limited to:

 

   

alleged misconduct or other improper activities committed by our shareholders, affiliates, directors, officers and other employees, as well as our brand partners, manufacturers, content creators, third-party platforms, delivery service providers and other third parties;

 

   

allegations or rumors about us or our shareholders, affiliates, directors, officers and other employees, as well as our brand partners, manufacturers, content creators, third-party platforms, delivery service providers and other third parties;

 

   

customer complaints about the quality of products and services provided by us or third parties we cooperate with;

 

   

infringement activities associated with counterfeit goods on our platform;

 

28


Table of Contents
   

security breaches or customer data leakage;

 

   

governmental and regulatory investigations or penalties resulting from our failure to comply with applicable laws and regulations;

 

   

instances of product or service safety issues, even those not involving us or our business partners; and

 

   

other lawsuits and legal proceedings, with or without merits.

In addition to traditional media, there has been an increasing use of social media platforms and similar devices in China, including instant messaging applications, social media websites and other forms of internet-based communications that provide individuals with access to a broad audience of users and other interested persons. The availability of information on instant messaging applications and social media platforms is virtually immediate and may not afford us an opportunity for redress or correction. The opportunity for dissemination of information, including inaccurate information, is seemingly limitless and readily available. Information concerning our company, shareholders, directors, officers and employees as well as our brand partners, manufacturers, content creators, third-party platforms and other third parties may be posted on such platforms at any time. Such negative publicity, whether valid or not, may result in a decrease in customer confidence in us and materially and adversely affect our reputation, business, financial condition and results of operations.

Our reputation, business and result of operations would be adversely impacted by any counterfeit, unauthorized or infringing products sold on our platform that fail to meet the applicable legal requirements sold on our platforms.

Although we have adopted various measures to ensure the authenticity of products sold on our platform, these measures may not always be successful. If we were to negligently participate or assist in infringement activities associated with counterfeit goods or failed to duly verify the qualifications or the licenses of our brand partners, we may be subject to sanctions under PRC law, including injunctions to cease infringing activities, rectification, compensation, administrative penalties and even criminal liability, depending on the gravity of such misconduct. See “Item 4.B. Business Overview—Regulation—Regulations on Consumer Protection” and “Item 4.B. Business Overview—Regulation—Regulations on E-commerce.”

We believe our brand and reputation are extremely important to our success and our competitive position. If counterfeit products were sold on our platform or we were facing any administrative penalties against us due to products that failed to meet the applicable legal requirements, our reputation could be severely damaged and customers may choose not to spend time on our platform. As a result, our business operations and financial results may be negatively affected.

Our business, prospects and financial results may be affected by our relationships with offline pet stores.

We sell selected products to offline pet stores and pet hospitals as a supplement to our online sales. Offline sales to pet stores and pet hospitals are generally steady and help us maintain a healthy inventory levels, increase our brand awareness and expand our customer reach. We intend to cooperate with more offline pet stores and pet hospitals to expand our geographical footprint and further build up our offline network in the future. If our relationships with such businesses deteriorate or are terminated or we fail to maintain such relationships on commercially viable terms, our business, financial condition and results of operations may be materially and adversely affected.

If we do not successfully optimize, operate and manage our fulfillment network, our business, financial condition, and results of operations could be harmed.

Failures to successfully optimize, operate and manage our fulfillment network result in excess or insufficient fulfillment capacity, increased costs, and impairment charges, any of which could materially and adversely affect our business. As of March 31, 2023, we operated four warehouses and utilized one fulfillment center, and as we continue to expand our business with different requirements and add fulfillment capacity, our fulfillment network will become increasingly complex and operating them will become more challenging. We strategically closed our warehouse in Hong Kong in late 2019 and sought to cooperate with additional new warehouses in mainland China to better manage global macro-economic risks. If we grow faster than we anticipate, we may exceed our fulfillment capacity sooner than we anticipate, we may experience difficulties fulfilling orders in a timely manner and our customers may experience delays in receiving their purchases, which could harm customer experience and our reputation. As a result, we would need to increase our capital expenditures on expanding our fulfillment network sooner than we expected. We cannot assure you that we will be able to locate suitable facilities or recruit qualified managerial and operational personnel to support the expansion our fulfillment network. Also, there can be no assurance that we will be able to operate our fulfillment network cost effectively.

In addition, failure to optimize inventory in our fulfillment network may increase our shipping costs and result in delayed shipment. In particular, we maintain inventory of most of our brand partners’ products, which further complicates our inventory management. Our failure to properly handle our inventory may result in us being unable to secure sufficient storage space or optimize the use of our warehouses or cause other unexpected costs and harm to our business and operations.

 

29


Table of Contents

Delivery is a critical part of our business and any changes in, or disruptions to, our delivery arrangements could adversely affect our business, financial condition, and results of operations.

We rely on a limited number of third-party delivery service providers, to fulfill orders to our customers. If we are unable to negotiate acceptable pricing and other terms with these delivery service providers, our results of operations and financial condition will be negatively affected. Our delivery service providers may experience performance problems or other difficulties in processing orders or delivering our products to customers on time, including natural disasters, labor disputes, financial difficulties, system failures or other disruptions to their operations. We are also subject to risks of damage or loss during delivery by our delivery service providers. If the products ordered by our customers are not delivered in a timely fashion or are damaged or lost during the delivery process, our customers could become dissatisfied and cease buying products from us, which would adversely affect our business, financial condition, results of operations and reputation.

Our results of operations are subject to fluctuations due to the seasonality of our business and other events.

We have experienced and expect to continue to experience seasonal fluctuations in our financial performance. These seasonal patterns have caused and will continue to cause fluctuations in our operating results. Historically, we have recorded stronger performance in the fourth quarter of a calendar year, primarily because consumers increase their purchases during e-commerce festivals in China, such as the periods around Double Eleven Shopping Festival (which is an online sales promotion event that falls on November 11 of each year) and Double Twelve (which is another online sales promotion event that falls on December 12 of each year). In addition, we generally experience a lower level of sales activity in the first quarter due to the Chinese New Year holiday, during which the volumes of online purchases and logistical operations drop significantly due to vacations and business closures.

In anticipation of increased sales activity prior to shopping festivals, we increase our inventory levels and incur additional expenses such as procuring additional working capital and increasing the size of our workforce on a temporary basis. If our seasonal sales patterns become more pronounced in the future, this may strain our personnel, customer service operations, fulfillment operations and shipment activities and may cause a shortfall in revenues compared to expenses in a given period. As a result, our financial results may be materially and adversely affected. In addition to increasing our own inventory levels, we also rely on our brand partners to increase their inventory levels to match projected seasonal demand. If we and our brand partners do not increase inventory levels for popular products in sufficient amounts or if we are unable to restock popular products from our brand partners in a timely manner, we may fail to fulfill customer demand. This may harm our reputation and damage the trust that consumers have in our business, which is a key part of our business model. As a result, we may experience a material and adverse effect on our financial conditions and results of operations.

Our SaaS solutions bring additional business and operational risks, and may not be attractive to offline pet stores.

We first introduced our self-developed software-as-a-service, or SaaS, to pet stores in 2015. We currently offer our SaaS solutions for free and there can be no assurance that our SaaS solutions will be well accepted by offline pet stores or that we will be able to monetize our SaaS solutions in the future. In addition, we may find it difficult and costly to support our SaaS solutions, which require professional implementation and technical support services which we could not provide without incurring significant costs. To the extent that our SaaS solutions are defective or there are disruptions to our services, demand for our SaaS solutions could diminish, and we would be subject to substantial liability. Specifically, if we experience security breaches and unauthorized access to our customer’s data or our data, our SaaS solutions may be perceived as not secure. As a result, customers may stop using our SaaS solutions, leading to loss of monetization opportunities, and we may incur significant legal and financial exposure and liabilities. Our reputation and results of operations may be adversely affected.

Our customers use third-party payment service providers to make payments on our platform. If these payment services are restricted or curtailed in any way or become unavailable to us or our customers for any reason, our business may be materially and adversely affected.

Our customers make payments through a variety of methods, including payment through our third-party online payment service partners. We depend on the billing, payment and escrow systems of these service providers to maintain accurate records of payments of sales proceeds and collect such payments. If the quality, utility, convenience or attractiveness of these payment processing and escrow services declines, our platform may become less attractive to our customers. Moreover, certain commercial banks in China impose limits on the amounts that may be transferred by automated payment from customers’ bank accounts to their linked accounts with third-party online payment services. We cannot predict whether these and any additional restrictions that could be put in place would have a material adverse effect on our platform. We may also be subject to various rules, regulations and requirements, regulatory or otherwise, governing electronic fund transfers and online payment, which could change or be reinterpreted to make it difficult or impossible for us to comply with.

 

30


Table of Contents

In addition, we cannot assure you that we will be successful to enter into amicable relationships with additional online payment service providers or maintain our relationship with existing ones. Identifying, negotiating and maintaining relationships with these providers require significant time and resources. They could choose to terminate their relationships with us or propose terms that we cannot accept. For example, increasing costs to these payment service providers, including fees charged by banks to process transactions through online payment channels, would increase our general and administrative expenses. Furthermore, these service providers may not perform as expected under our agreements with them, and we may have disagreements or disputes with such payment service providers, any of which could adversely affect our brand and reputation as well as our business operations. Meanwhile, we may be subject to fraud, customer data leakage and other illegal activities in connection with the various payment methods we offer.

If we fail to obtain and maintain the licenses, permits and approvals required or applicable to our business under the complex regulatory environment for our businesses in China, our business, financial condition and results of operations may be materially and adversely affected.

As the internet industry in China is still at a relatively early stage of development, new laws and regulations may be adopted from time to time to address new issues that come to the authorities’ attention. Considerable uncertainties still exist with respect to the interpretation and implementation of existing and future laws and regulations governing our business activities. We cannot assure you that we will not be found in violation of any future laws and regulations or any of the laws and regulations currently in effect due to changes in or discrepancies with respect to the relevant authorities’ interpretation of these laws and regulations. Additionally, since we are engaged in the sales and distribution of veterinary drugs in China, we may also be required to comply with the relevant PRC laws and regulations or obtain license or approvals, such as Veterinary Drug Distribution License. Any failure to comply with such laws and regulations or obtain such license or approvals may subject us to potential administrative penalties, fine and even suspension of our business. See “Item 4.B. Business Overview—Regulation—Regulations on Veterinary Drugs.” We cannot assure you that we will be able to timely obtain or maintain all the required licenses or approvals or make all the necessary filings in the future.

According to relevant PRC laws and regulations, no entities or individuals may provide internet audio-visual program services, which includes making and editing of audio-visual programs and broadcasting such content to the general public online, without a License for Online Transmission of Audio-Visual Programs issued by the State Administration of Press, Publication, Radio, Film and Television, or the SAPPRFT (currently known as National Radio and Television Administration), or its local bureaus or completing the relevant registration procedures. In general, only state-owned or state-controlled entities are eligible to apply for such license. Shanghai Guangcheng may be required to obtain an Internet audio-visual program transmission license for video interaction or recorded video functions in our Boqii Pet app offered by Shanghai Guangcheng. Shanghai Guangcheng, however, is not eligible to apply for such license since we are not a state-owned or state-controlled entity. See “Item 4.B. Business Overview—Regulation—Regulations on Online Transmission of Audio-Visual Program.” As of the date of this annual report, we have not filed any application for such license, nor have we received any written notice of warning from, or been subject to penalties imposed by, the relevant government authorities for alleged failure by us to comply with the Audio-Visual Program Provisions. In the event that the authorities find us in violation of the relevant laws and regulations, we may be subject to warnings, fines or orders to rectify such non-compliance. In severe cases, we may be ordered to disable the video interaction or recorded video functions in our app and subject to a penalty equal to one to two times our total investment in the affected business, and the devices we used for such operation may be confiscated. Furthermore, the competent authorities may order us to close our platform, revoke the relevant license or filings for the provision of Internet information services and order the relevant network operation entity to stop providing us with signal access services, which could adversely affect our business, financial condition and results of operations.

In addition, as required by the applicable PRC laws and regulations, an entity providing internet surveying and mapping services, such as geographic positioning, the uploading of geographic information or markings and the development of a public map database is required to obtain a Surveying and Mapping Qualification Certificate for Internet Surveying and Mapping, and the service provider may only provide internet surveying and mapping services within the scope of the certificate. With the technical supports offered by a certain map service provider, users have access to the mapping information to locate nearby pet stores and pet hospitals in the Boqii Pet app offered by Shanghai Guangcheng. Therefore, Shanghai Guangcheng may be required by the competent department of Surveying and Mapping and Geographic Information to obtain a Surveying and Mapping Qualification Certificate for such business. However, there are still significant uncertainties relating to the interpretation and implementation of the relevant laws and regulations and we have yet to file any application for the Surveying and Mapping Qualification Certificate as of the date of this annual report. We cannot assure you that we will be able to obtain such license when required. Although we have not received any warning or been subject to any penalties due to lack of the Surveying and Mapping Qualification Certificate, we may be ordered to suspend the mapping function in our Boqii Pet app and the relevant government authorities may impose administrative fines, and confiscate the revenue we derived from such business, if any, our surveying and mapping results, or, in the worst case, our surveying and mapping tools.

Should we be required to obtain additional licenses or approvals, we may not be able to do so in a timely manner or at all. If we fail to obtain or maintain any of the required licenses or approvals or make the necessary filings, or fail to obtain required licenses or approvals in a timely manner, we may be subject to various penalties, such as confiscation of the revenues that were generated through the unlicensed activities, the imposition of fines and the termination or restriction of our operations. Any such penalties may disrupt our business operations or materially and adversely affect our business, financial condition and results of operations.

 

31


Table of Contents

The proper functioning of our online platforms is essential to our business. Any disruption to our IT systems could materially affect our ability to maintain the satisfactory performance of our platform and deliver consistent services to our users and customers.

The proper functioning of our online platforms is essential to our business. The satisfactory performance, reliability and availability of our IT systems are critical to our success, our ability to attract and retain users and customers and our ability to maintain and deliver consistent services to them. However, we may be unable to monitor and ensure high-quality maintenance and upgrade of our IT systems and infrastructure on a real-time basis, and customers may experience service outages or delays in accessing and using our platform to place orders. Specifically, we may experience surges in online traffic and orders associated with promotional activities and generally as we scale, under which our platform may be overloaded and may not be able to function properly. Our technology infrastructure may also fail to keep pace with increased sales and traffic on our online platforms, and as a result, we may be required to incur significant additional costs to upgrade the underlying network infrastructure both in terms of capacity and functionality. We cannot assure you that we will be successful in executing these system upgrades in a timely manner, or at all, and the failure to do so may affect out user experiences and impede our growth.

We currently use third-party cloud services and servers to store our data, to allow us to analyze a large amount of data simultaneously and to update our user and customer database and profiles quickly. Servers may be vulnerable to computer viruses, physical or electronic break-ins and similar disruptions, which could lead to system interruptions, website or mobile app slowdown or unavailability, delays or errors in transaction processing, loss of data or the inability to accept and fulfill customer orders. We also rely on various Internet service providers and mobile networks to deliver and “push” communications to users and customers and allow them to access our online platforms. Any interruption or delay in the functionality of these cloud service providers, servers or networks may materially and adversely affect the operations of our business. Additionally, the costs and complexities involved in expanding and upgrading our systems may prevent us from doing so in a timely manner and may prevent us from adequately meeting the demand placed on our systems. Given that we exercise little control over these third-party service providers, we are vulnerable to issues with the services they provide.

Furthermore, our technology or infrastructure may not function properly at all times, and may be subject to disruptions caused by natural disasters, accidents, power disruptions, telecommunications failures, acts of terrorism or war, computer viruses, physical or electronic break-ins, or other events or disruptions. Any of such occurrences could lead to the unavailability of our online platforms and mobile apps, interruption of our supply chain and delivery, leakage or permanent loss of customer data, interruptions or decreases in connection speed, or other events which would affect our operations. While we have certain disaster recovery arrangements in place, such as back-up servers and data redundancy plans, our precautionary measures may be inadequate, and our business interruption insurance may not be sufficient to cover potential loss. If any IT disruptions were to occur to our business, our reputation or relationships with our customers may be damaged and our customers may switch to our competitors. As a result, our operations could be impaired and our business, financial condition, and results of operations may be materially and adversely affected.

Our business may be adversely affected if we are unable to provide our customers with a cost-effective platform that is able to respond and adapt to rapid changes in technology.

The number of people who access the Internet through devices other than personal computers, such as mobile phones and tablets, has increased dramatically in recent years. The versions of our website, mobile app and mini-program on Weixin developed for these devices may not be compelling to customers. Adapting our services and/or infrastructure to these devices as well as other new Internet, networking or telecommunications technologies could be time consuming and could require us to incur substantial expenditures, which could adversely affect our business, financial condition, and results of operations.

Additionally, as new mobile devices and platforms are released, we may need to devote significant time and resources to the creation, support and maintenance of such applications. If we are unable to attract consumers to our website or mobile app through these devices or are slow to develop a version of our website or mobile app that is more compatible with alternative devices, we may fail to capture a significant share of customers in the pet industry and or lose existing customers, which could materially and adversely affect our business, financial condition, and results of operations.

Further, we regularly upgrade our technologies and business applications, and we will continue to implement new technologies or business applications in the future. Technology upgrades and changes require significant investments. Our financial condition and results of operations may be affected by the timing, effectiveness and costs associated with any of these upgrades or changes to our systems and infrastructure. In the event that it is more difficult for our customers to buy products from us on their mobile devices, or if our customers choose not to buy products from us on their mobile devices or to use mobile products that do not offer access to our website, we may not be able to retain our existing customers or attract new customers. As a result, our customer growth could be harmed and our business, financial condition, and results of operations may be materially and adversely affected.

 

32


Table of Contents

We may be subject to liability for placing advertisements with content that is deemed inappropriate or misleading under PRC laws.

We provide online and offline online marketing and information services to our brand partners, helping them design and implement effective marketing strategies. PRC laws and regulations prohibit advertising companies from producing, distributing or publishing any advertisement with content that violates PRC laws and regulations, impairs the national dignity of the PRC, involves designs of the PRC national flag, national emblem or national anthem or the music of the national anthem, is considered reactionary, obscene, superstitious or absurd, is fraudulent, or disparages similar products. We may also be subject to the administrative penalties incurred by the exaggerating or fraudulent advertisement from time to time. Additionally, we may be subject to claims by customers misled by information on our mobile apps, website or other portals where we place advertisements. We may not be able to recover such losses from brand partners by enforcing the indemnification provisions in the contracts, which may result us in diverting our management’s time and other resources from our business and operations to defend against these infringement claims. As a result, our business, financial condition, results of operations and reputation could be materially and adversely affected.

Our business generates and processes a large amount of data, and the improper collection, storage, use or disclosure of such data could harm our reputation as well as have a material adverse effect on our business and prospects.

Our business generates and processes a large quantity of data. We face risks inherent in handling and possessing large volumes of data and in protecting the security of such data. In particular, we face a number of challenges relating to data from transactions and other activities on our platforms, including without limitation:

 

   

protecting the data in and hosted on our system, including against attacks on our system by outside parties or fraudulent behavior or improper use by our employees;

 

   

addressing concerns related to privacy and sharing, safety, security and other factors; and

 

   

complying with applicable laws, rules and regulations relating to the collection, use, storage, transfer, disclosure or security of personal information, including any requests from regulatory and government authorities relating to such data.

Concerns about our practices with regard to the collection, use or disclosure of personal information or other privacy-related and security matters, even if unfounded, could damage our reputation and operations. On November 28, 2019, the Secretary Bureau of the Cyberspace Administration of China, the General Office of the Ministry of Industry and Information Technology, the General Office of the Ministry of Public Security and the General Office of the State Administration for Market Regulation promulgated the Identification Method of Illegal Collection and Use of Personal Information Through App, which provides guidance for the regulatory authorities to identify the illegal collection and use of personal information through mobile apps, and for the app operators to conduct self-examination and self-correction and for other participants to voluntarily monitor compliance. Moreover, the PRC Constitution, the PRC Criminal Law, the Civil Code of the PRC and the Cybersecurity Law protect individual privacy in general, which require certain authorization or consent from internet users prior to collection, use or disclosure of their personal data and also protection of the security of the personal data of such users. In particular, Amendment 7 to the PRC Criminal Law prohibits institutions, companies and their employees in the telecommunications and other industries from selling or otherwise illegally disclosing a citizen’s personal information obtained during the course of performing duties or providing services. While we strive to comply with all applicable data protection laws and regulations, as well as our own privacy policies, any failure or perceived failure to comply may result in proceedings or actions against us by government entities or private individuals, which could have an adverse effect on our business. See “—Risks Related to Doing Business in China—PRC laws and regulations regarding data security and cybersecurity are evolving. These laws and regulations are subject to change and substantial uncertainties, and could have material impact on our business operation.” Moreover, failure or perceived failure to comply with applicable laws and regulations related to the collection, use, or sharing of personal information or other privacy-related and security matters could result in a loss of confidence in us by customers and users, which could adversely affect our business, financial condition and results of operations.

Furthermore, in August 2021, the Standing Committee of the National People’s Congress, or the SCNPC, officially promulgated the Personal Information Protection Law of the People’s Republic of China, or the Personal Information Protection Law. The Personal Information Protection Law provides a comprehensive personal information protection system, under which in case of any personal information processing, individual prior consent must be obtained except in other circumstances stipulated therein to the contrary. No organization or individual may illegally collect, use, process or transmit the personal information of others, illegally buy or sell, provide or make public the personal information of others, or engage in the processing of personal information that endangers the national security or public interests. The Personal Information Protection Law raises the protection requirements for processing personal information, and many specific requirements of the Personal Information Protection Law remain to be clarified by the CAC, other regulatory authorities, and courts in practice. We may be required to make further adjustments to our business practices to comply with the personal information protection laws and regulations. In addition, if we fail to collect, use, process or transmit the personal information properly, our reputation as well as our business and prospects may be affected adversely.

 

33


Table of Contents

Failure to protect confidential information of our users and customers and network against security breaches could damage our reputation and brand and substantially harm our business and results of operations.

Orders for products we offer are made through our online sales platforms. Online payments for our products are settled through third-party online payment service providers. We also share certain personal information about our customers with third-party delivery service providers, such as their names, addresses, and phone numbers. In such cases, maintaining complete security for the transmission of confidential information on our platform, such as customer names, personal information and billing addresses, is essential to maintaining customer confidence.

We have adopted security policies and measures, including encryption technology, to protect our proprietary data and customer information. We do not maintain insurance against damages incurred by us resulting from customer identity theft and subsequent fraudulent payments. However, advances in technology, the expertise of hackers, new discoveries in the field of cryptography or other events or developments could result in a compromise or breach of the technology that we use to protect confidential information. We may not be able to prevent third parties, especially hackers or other individuals or entities engaging in similar activities, from illegally obtaining such confidential or private information we hold as a result of our customers’ visits on our online platforms. We could therefore be exposed to litigation and regulatory action and possible liability, causing significant legal and financial exposure, adverse publicity and a loss of confidence in our security measures, which could in turn have a material adverse effect on our business, financial condition, and results of operations. Such individuals or entities obtaining our users’ and customers’ confidential or private information may further engage in various other illegal activities using such information. In addition, we have limited control or influence over the security policies or measures adopted by third-party providers of online payment services. Our third-party delivery service providers may also violate their confidentiality obligations and disclose or use information about our customers illegally. Any negative publicity on our platform’s safety or privacy protection mechanism and policy could have a material and adverse effect on our public image and reputation. Any compromise of our information security or third-party service providers’ information security measures could require us to expend significant capital and other resources to alleviate the problems and, despite our best remediation efforts, have a material and adverse effect on our reputation, business, prospects, financial condition and results of operations.

We do not have material tangible assets and may incur goodwill and intangible asset impairment charges. Significant impairment of our goodwill and intangible assets could materially impact our financial position and results of our operations.

We carried a significant goodwill balance on our balance sheet as a result of the acquisitions of Cuida, Xingmu and Chongni Network. We recorded goodwill in connection with the excess of the purchase price over the fair value of the identifiable assets and the liabilities acquired in business combinations. Our goodwill accounted for 4.6% and 5.2% of our total assets as of March 31, 2021 and 2022, respectively, as a result of historical business combinations. We are required to review our goodwill for impairment on an annual basis or more frequently if events or changes in circumstances indicate evidence of impairment. As of March 31, 2023, there was no goodwill recorded. The application of a goodwill impairment test requires significant management judgment. If our estimates and judgment are inaccurate, the fair value determined could be inaccurate and the impairment may not be recognized in a timely manner. If the fair value declines, we may need to recognize goodwill impairment in the future, which could have a material adverse effect on our results of operations. In addition, we perform valuation of the intangible assets arising from business combination to determine the relative fair value to be assigned to each asset acquired. The intangible assets are expensed or amortized using the straight-line approach over the estimated economic useful lives of the assets. There can be no assurance that we will not be required to record impairments on goodwill or intangible assets in the future or that such impairments will not be material. Any significant impairment losses charged against our goodwill or intangible assets could have a material adverse effect on our business, financial condition and results of operations. In addition, our lack of material tangible assets may expose us to certain risks, including decreased ability to obtain debt financings or hedge against fluctuations in value of our intangible assets.

We have and may continue to invest in or acquire complementary assets, technologies and businesses, or enter into strategic alliances. Such efforts may fail and have in the past resulted, and may continue to result, in equity or earnings dilution, which may materially and adversely affect our results of operations and financial condition.

We have in the past invested in or acquired, and may continue to invest in or acquire, assets, technologies and businesses, or enter into strategic alliances, that are complementary to our business. These investments may involve minority stakes in other companies, acquisitions of entire companies or acquisitions of selected assets.

Risks and uncertainties associated with such investments, acquisitions or strategic alliances include:

 

   

acquired businesses or assets may not yield the results we expect;

 

   

acquisitions of assets and businesses have in the past resulted, and may continue to result, in the use of substantial amounts of cash, potentially dilutive issuances of equity securities, significant amortization expenses related to intangible assets and exposure to potential unknown liabilities of the acquired businesses or assets;

 

34


Table of Contents
   

any future strategic alliances, investments or acquisitions and the subsequent integration of the new assets and businesses obtained or developed from such transactions into our own may divert management from their primary responsibilities and subject us to additional liabilities;

 

   

to the extent we fund these investment or acquisition through the issuance of equity or convertible debt securities, the ownership interests of our shareholders could be significantly diluted;

 

   

the cost of identifying and consummating acquisitions, and integrating the acquired businesses or assets into ours, may materially exceed our expectations, and the integration of acquired businesses or assets may be disruptive to our business operations;

 

   

we may not be able to successfully retain the customers and key personnel of acquisitions over the longer term, which could also adversely affect our business;

 

   

we may have to obtain approval from the relevant PRC governmental authorities or counterparts elsewhere in the world for the acquisitions and comply with any applicable PRC rules and regulations, which may be costly; and

 

   

if we fail to integrate successfully such acquisitions, or the business associated with such acquisitions, into our company, the revenues and operating results of the combined company could be adversely affected.

The size and complexity of our business has increased following previous acquisitions, and may continue to increase following additional acquisitions in the future. For example, our acquisition of Xingmu allows us to leverage Xingmu’s extensive pet hospital network to develop our pet healthcare business. However, our future success depends, in part, upon our ability to manage this expanded business, which also poses substantial challenges, including challenges related to the management and monitoring of new operations and sales of medical products that we did not engage in previously. The integration of Xingmu’s business also requires significant time and resources and is associated with increased costs and complexity. We may not successfully evaluate or utilize the acquired business and accurately forecast the financial impact of the acquisition of Xingmu. As such, there can be no assurance that we will realize the expected benefits anticipated from our acquisition of Xingmu. We may not ultimately strengthen our competitive position or achieve our goals from our acquisition of Xingmu, which could be viewed negatively by users, customers, business partners or investors.

We may need additional capital, and financing may be not available on terms acceptable to us, or at all.

We require additional cash resources to fund our business operations, including any marketing initiatives or investments we may decide to pursue. If these resources are insufficient to satisfy our cash requirements, we may seek to obtain additional credit facilities or sell additional equity or debt securities. The issuance and sale of additional equity securities could result in dilution of our existing shareholders. The incurrence of indebtedness would result in increased debt service obligations and could result in operating and financing covenants that would restrict our operations. It is uncertain whether financing will be available in amounts or on terms acceptable to us, if at all. If financing proves to be unavailable or on unacceptable terms, we may be forced to raise funds on undesirable terms, or we may be unable to maintain or grow our business or respond to competitive pressures, any of which could have a material adverse effect on our business, financial condition, and results of operations.

The failure of any bank in which we deposit our funds could have an adverse effect on our business, financial condition and results of operations.

Events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services industry or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems. Most recently, on March 10, 2023, Silicon Valley Bank (“SVB”) was closed by the California Department of Financial Protection and Innovation, which appointed the U.S. Federal Deposit Insurance Corporation (“FDIC”) as receiver. Similarly, on March 12, 2023, Signature Bank was also placed into receivership. A statement by the U.S. Department of the Treasury, the Federal Reserve and the FDIC indicated that all depositors of SVB would have access to all of their money after only one business day of closure, including funds held in uninsured deposit accounts, however, borrowers under credit agreements, letters of credit and certain other financial instruments with SVB, Signature Bank or any other financial institution that is placed into receivership by the FDIC may be unable to access undrawn amounts thereunder.

Although we do not hold funds at the banks described above, we have funds at other banks, including a commercial bank in China jointly held by SVB and Shanghai Pudong Development Bank. As of March 31, 2023, funds we deposited at this bank accounted for approximately 13% of our total assets, and as of the date of this annual report, we have not experienced any difficulty in withdrawing cash from the relevant deposit account. Additionally, we generally seek to diversify our cash and cash equivalents across several financial institutions in an attempt to minimize exposure to any one of these entities. Nevertheless, our cash balance with a financial institution may exceed the amount under the deposit guarantee program in the relevant jurisdiction. To the extent any of the financial institutions in which we have deposited funds ultimately fails, we may lose our deposits to the extent they exceed the amount under the deposit guarantee program in the relevant jurisdiction, and/or we may be required to move our accounts to another financial institution, which could cause operational difficulties, such as delays in making payments to third parties, which could have an adverse effect on our business, financial condition and results of operations.

 

35


Table of Contents

Disruption in the financial markets and economic conditions could affect our ability to raise capital

Global economies could suffer dramatic downturns as the result of a deterioration in the credit markets and related financial crisis as well as a variety of other factors including, extreme volatility in security prices, severely diminished liquidity and credit availability, ratings downgrades of certain investments and declining valuations of others. For example, the Covid-19 has caused significant volatility in financial markets across the world. In the past, governments have taken unprecedented actions in an attempt to address and rectify these extreme market and economic conditions by providing liquidity and stability to the financial markets. If these actions are not successful, the return of adverse economic conditions may cause a significant impact on our ability to raise capital, if needed, on a timely basis and on acceptable terms or at all.

Our business depends substantially on the continuing efforts of our senior management. If we lose their services, we could incur significant costs in finding suitable replacements and our business may be severely disrupted.

Our business operations depend substantially on the continuing efforts of our senior management. If one or more members of our senior management were unable or unwilling to continue their employment with us, we might not be able to replace them in a timely manner, or at all. As qualified individuals are in high demand, we may incur additional expenses to recruit and retain qualified replacements. As a result, our business may be severely disrupted and our financial condition and results of operations may be materially and adversely affected. In addition, our senior management may join a competitor or form a competing company. We can provide no assurance that we will be able to successfully enforce our contractual rights included in the employment agreements we have entered into with our senior management team, particularly in China, where such individuals reside. As a result, our business may be negatively affected due to the loss of one or more members of our senior management.

Employee or other business misconduct could expose us to monetary loss, legal liability, regulatory scrutiny, and reputational harm.

Our employees and outsourced workers may engage in illegal, fraudulent, corrupt or collusive activities that adversely affect our business. For example, if an employee were to engage in illegal or suspicious activities such as fraud, theft, kickback or bribery, we could suffer direct losses, become subject to regulatory sanctions and suffer serious harm to our financial condition and reputation. In addition, any business misconduct in violation of applicable laws and regulatins could also subject us to administrative penalties or fine, or even criminal liability in extreme cases, by the competent authorities. In the past, we were subject to a fine of RMB100,000 imposed by Shanghai Internet Information Office in December 2021 for the publishing and transmission of illegal information on our Boqii Pet APP and a fine of RMB5,000 imposed by the Shanghai Pudong New Area Market Supervision Administration in May 2023 for the failure to update system promptly upon receiving customers’ request to unsubscribe, which resulted in resending commercial information to them. As the date of this annual report, we have rectified these two activities. There can be no assurance that our internal controls and policies will prevent fraud or illegal activity or that similar incidents will not occur in the future. Any of such activities could severely damage our brand and reputation, which could drive customers away from our platform, and materially and adversely affect our business, financial condition and results of operations.

We rely on proper operation and maintenance of our platform and internet infrastructure and telecommunications networks in China. Any deficiencies, malfunction, capacity constraint or operation interruption, any undetected programming errors or flaws or failure to maintain effective customer service could harm our reputation, impair our platform, and may have an adverse impact on our business.

Currently, a majority of our product sales are generated through our online sales platforms. Therefore, the satisfactory performance, reliability and availability of our platform are critical to our success and our ability to attract and retain users and customers. Our business depends on the performance and reliability of the internet infrastructure in China. The reliability and availability of our platform depends on telecommunications carriers and other third-party providers for communications and storage capacity, including bandwidth and server storage. If we are unable to enter into and renew agreements with these providers on acceptable terms, or if any of our existing agreements with such providers are terminated as a result of our breach or otherwise, our ability to provide our services to our users and customers could be adversely affected.

Access to internet in China is maintained through state-owned telecommunications carriers under administrative control, and we obtain access to end-user networks operated by such telecommunications carriers and internet service providers to give customers access to our mobile platform. The failure of telecommunications network operators to provide us with the requisite bandwidth could also interfere with the speed and availability of our platform. Service interruptions prevent customers from accessing our platform and placing orders, and frequent interruptions could frustrate users and customers and discourage them from attempting to place orders or accessing our platform, which could cause us to lose customers and harm our operating results.

 

36


Table of Contents

In addition, our platform and internal systems rely on software that is highly technical and complex, and depend on the ability of such software to store, retrieve, process and manage immense amount of data. The software on which we rely has contained, and may now or in the future contain, undetected programming errors or flaws. Some errors may only be discovered after the code has been released for external or internal use. Errors or other design defects within the software on which we rely may result in a negative experience for customers using our platform, delay introductions of new features or enhancements, result in errors or compromise our ability to support effective customer service and enjoyable customer engagement. Any errors, bugs or defects discovered in the software on which we rely could result in harm to our reputation and loss of users and customers, which could adversely affect our business, results of operations and financial conditions.

We may be subject to intellectual property infringement claims, which may be expensive to defend and may disrupt our business and operations.

We cannot be certain that our operations or any aspects of our business do not or will not infringe upon or otherwise violate trademarks, patents, copyrights, know-how or other intellectual property rights held by third parties. We may be subject to legal proceedings and claims relating to the intellectual property rights of others. In addition, there may be other third-party intellectual property that is infringed upon by our products, services, the content displayed on our platform or other aspects of our business. There could also be existing patents or other intellectual property rights of which we are not aware that our products or content may inadvertently infringe. We cannot assure you that holders of the relevant intellectual property rights purportedly relating to some aspect of our technology platform or business, if any such holders exist, would not seek to enforce such intellectual property rights against us in China, the United States or any other jurisdictions. For example, the use of Microsoft and Adobe software and systems by our employees are not authorized by their respective proprietary intellectual property holder, and therefore it poses to us the risks of potential intellectual property claim by the proprietors or the administrative penalties or fine, or even criminal liability in extreme cases, by the competent authorities. As of the date of this annual report, we have not received from the proprietors or competent authorities any warning, subpoena, administrative penalties or fine as a result of our unauthorized use of such IT software or systems, but we cannot assure you that such actions will not be taken in the future. We strive to closely monitor the products offered on our platforms. However, we cannot be certain that these measures would be effective in completely preventing the infringement of trademarks, patents, copyrights, know-how or other intellectual property rights held by third parties. Further, the application and interpretation of China’s intellectual property right laws and the procedures and standards for granting trademarks, patents, copyrights, know-how or other intellectual property rights in China are still evolving and are uncertain, and we cannot assure you that PRC courts or regulatory authorities would agree with our analysis. If we are found to have violated the intellectual property rights of others, we may be subject to liability for our infringement activities or may be prohibited from using such intellectual property, and we may incur licensing fees or be forced to develop alternatives of our own, but such alternative may not be available on terms acceptable to us or at all. In addition, we may incur significant expenses, and may be forced to divert management’s time and other resources from our business and operations to defend against these third-party infringement claims, regardless of their merits. Successful infringement or licensing claims made against us may result in significant monetary liabilities and may materially disrupt our business and operations by restricting or prohibiting our use of the intellectual property in question. These risks have been amplified by the increase in third parties whose sole or primary business is to assert such claims.

We may not be able to prevent others from unauthorized use of our intellectual property, which could harm our business and competitive position.

We regard our trademarks, copyrights, patents, domain names, know-how, proprietary technologies, and similar intellectual property as critical to our success, and we rely on a combination of intellectual property laws and contractual arrangements, including confidentiality, invention assignment and non-compete agreements with our employees and others, to protect our proprietary rights. Any of our intellectual property rights could be challenged, invalidated, circumvented or misappropriated, or such intellectual property may not be sufficient to provide us with competitive advantages. In addition, there can be no assurance that (i) our application for registration of trademarks, patents, and other intellectual property rights will be approved, (ii) any intellectual property rights will be adequately protected, or (iii) such intellectual property rights will not be challenged by third parties or found by a judicial authority to be invalid or unenforceable. Further, because of the rapid pace of technological change in our industry, parts of our business rely on technologies developed or licensed by third parties, and we may not be able to obtain or continue to obtain licenses and technologies from these third parties at all or on reasonable terms.

 

37


Table of Contents

It is often difficult to register, maintain and enforce intellectual property rights in China. Statutory laws and regulations are subject to judicial interpretation and enforcement and may not be applied consistently due to the lack of clear guidance on statutory interpretation. Confidentiality, invention assignment and non-compete agreements may be breached by counterparties, and there may not be adequate remedies available to us for any such breach. Accordingly, we may not be able to effectively protect our intellectual property rights or to enforce our contractual rights in China. Policing any unauthorized use of our intellectual property is difficult and costly and the steps we take may be inadequate to prevent the infringement or misappropriation of our intellectual property. For example, third parties may register trademarks or domain names or purchase internet search engine keywords that are similar to our trademarks, brands or websites, or misappropriate our intellectual property or data and copy our platform, all of which could cause confusion to our users and customers, divert online customers away from our content and products and harm our reputation. In the event that we resort to litigation to enforce our intellectual property rights, such litigation could result in substantial costs and a diversion of our management and financial resources, and could put our intellectual property at risk of being invalidated or narrowed in scope. We can provide no assurance that we will prevail in such litigation, and even if we do prevail, we may not obtain a meaningful recovery. In addition, our trade secrets may be leaked or otherwise become available to, or be independently discovered by, our competitors. Any failure in maintaining, protecting or enforcing our intellectual property rights could have a material adverse effect on our business, financial condition and results of operations.

We may be held liable for information or content displayed on, retrieved from or linked to our platform, or distributed to our users and customers, and PRC authorities may impose legal sanctions on us, including, in serious cases, suspending or revoking the licenses necessary to operate our platforms.

The PRC government has adopted regulations governing internet access and the distribution of news and other information over the internet. Under these regulations, internet content providers and internet publishers are prohibited from posting or displaying over the internet content that, among other things, violates PRC laws and regulations, impairs the national dignity of China, or is reactionary, obscene, superstitious, fraudulent or defamatory. Failure to comply with these requirements may result in the revocation of licenses to provide internet content and other licenses, and the closure of the concerned websites. The website operator may also be held liable for such censored information displayed on or linked to the websites. Our content creators engage in sales promotion activities through interacting and exchanging information with our users and customers and generating and distributing content. It is possible that our users and customers, including our content creators, may engage in illegal, obscene or incendiary conversations or activities, including displaying or publishing information or content that may be deemed unlawful under PRC laws and regulations on our platform. Our Boqii community also allows users to upload user-generated content on our platform, which exposes us to potential disputes and liabilities in connection with third-party copyrights. When users register on our platform, they agree to our standard agreement, under which they agree not to disseminate any content infringing on third-party copyright on our platform. However, if any information or content on our platform is deemed illegal, obscene or incendiary, or if appropriate licenses and third-party consents have not been obtained, claims may be brought against us for defamation, libel, negligence, copyright, patent or trademark infringement, other unlawful activities or other theories and claims based on the nature and content of the information delivered on or otherwise accessed through our platform. Defending against any such actions could be costly and involve significant time and attention of our management and other resources.

If our platform or content is found to be in violation of any applicable requirements, we may be penalized by relevant authorities, or, if we are not eligible for the safe harbor exemption, or if it is found that we have not adequately managed the information or content on our platform, we may be subject to joint infringement liability and PRC authorities may impose legal sanctions on us, including, in serious cases, suspending or revoking the licenses necessary to operate our platform and our business and reputation may accordingly be adversely affected.

We may from time to time be subject to claims, controversies, lawsuits and other legal and administrative proceedings, which could have a material adverse effect on our business, results of operations, financial condition and reputation.

As of the date of this annual report, we are not party to any material legal or administrative proceedings. However, in light of the nature of our business, we are susceptible to potential claims or controversies. We have been, and may from time to time in the future be, subject to or involved in various claims, controversies, lawsuits and other legal and administrative proceedings. Lawsuits and other administrative or legal proceedings that may arise in the course of our operations can involve substantial costs, including the costs associated with investigation, litigation and possible settlement, judgment, penalty or fine. In addition, lawsuits and other legal and administrative proceedings may be costly and time consuming and may require a commitment of management and personnel resources that will be diverted from our normal business operations, which will materially and adversely affect our business, financial condition, and results of operations.

 

38


Table of Contents

Our grant of share options and other forms of share based incentive awards may result in significant share based compensation expenses.

We adopted share incentive plans in July 2014 and March 2016, respectively, to enhance our ability to attract and retain exceptionally qualified individuals and to encourage them to acquire a proprietary interest in the growth and performance of us. We adopted the 2018 Global Share Plan in August 2018, for the purpose of granting share-based compensation awards to employees, directors and consultants to incentivize their performance and align their interests with ours. The two share incentive plans adopted in July 2014 and March 2016 were canceled concurrently upon the adoption of the 2018 Global Share Plan, and each participant to those two share incentive plans is expected to receive corresponding grants under the 2018 Global Share Plan. The 2018 Global Share Plan was last amended and restated in May 2022, and the total number of Class A ordinary shares reserved for awards to be granted to the eligible participants thereunder was increased by 4,000,000 Class A ordinary shares, in order to retain and attract talent to drive the long-term success of Boqii.

The maximum aggregate number of Class A ordinary shares that may be issued under the amended and restated 2018 Global Share Plan, or the Amended and Restated 2018 Global Share Plan, is 12,987,836. As of March 31, 2023, options to purchase a total of 5,569,125 ordinary shares were outstanding, excluding those that were forfeited or canceled, of which options underlying 1,257,983 ordinary shares had become vested and exercisable. We account for compensation costs for certain share options granted using a fair value-based method and recognize expenses in our consolidated statement of income in accordance with U.S. GAAP. We believe the granting of share-based compensation is of significant importance to our ability to attract and retain key personnel and employees, and we will continue to grant share-based compensation to employees in the future. As a result, our expenses associated with share-based compensation may increase, which may have an adverse effect on our results of operations.

All of the lease agreements of our leased properties have not been registered with the relevant PRC government authorities as required by PRC law and our certain leased properties are for industrial use, which may expose us to potential fines.

Under PRC law, lease agreements of commodity housing tenancy are required to be registered with the local construction (real estate) departments. As of the date of this annual report, all of our lease agreements for our leased properties in China have not been registered with the relevant PRC government authorities, which may expose us to potential fines if we fail to remediate after receiving any notice from the relevant PRC government authorities. Failure to complete the lease registration will not affect the legal effectiveness of the lease agreements according to PRC law, but the real estate administrative authorities may require the parties to the lease agreements to complete lease registration within a prescribed period of time, and the failure to do so may subject the parties to fines from RMB1,000 to RMB10,000 for each of such lease agreements. Furthermore, our lessors are required to comply with various laws and regulations to enable them to lease effective titles of their properties for our use. Certain of our leased properties used for our warehouse are defined as the properties for industrial use only under the PRC law. We may need to seek for an alternative lease, and our operation of business may be accordingly affected.

Failure to make adequate contributions to various employee benefit plans and withhold individual income tax on employees’ salaries as required by PRC regulations may subject us to penalties.

In accordance with the PRC Social Insurance Law and the Regulations on the Administration of Housing Fund and other relevant laws and regulations, China establishes a social insurance system and other employee benefits including basic pension insurance, basic medical insurance, work-related injury insurance, unemployment insurance, maternity insurance, housing fund, and a handicapped employment security fund, or collectively the Employee Benefits. An employer shall pay the Employee Benefits for its employees in accordance with the rates provided under relevant regulations and shall withhold the social insurance and other Employee Benefits that should be assumed by the employees. For example, an employer that has not made social insurance contributions at a rate and based on an amount prescribed by the law, or at all, may be ordered to rectify the noncompliance and pay the required contributions within a stipulated deadline and be subject to a late fee of 0.05% per day. If the employer still fails to rectify the failure to make social insurance contributions within the stipulated deadline, it may be subject to a fine ranging from one to three times of the amount overdue.

Under the PRC Social Insurance Law and the Regulations on the Administration of Housing Fund, PRC subsidiaries shall register with local social insurance agencies and register with applicable housing fund management centers and establish a special housing fund account in an entrusted bank. Both PRC subsidiaries and their employees are required to contribute to the Employee Benefits. Companies operating in China are also required to withhold individual income tax on employees’ salaries based on the actual salary of each employee upon payment. We may be subject to late fees and fines in relation to the underpaid employee benefits and under-withheld individual income tax, our financial condition and results of operations may be adversely affected.

 

39


Table of Contents

Non-compliance with labor-related laws and regulations of the PRC may have an adverse impact on our financial condition and results of operation.

We have been subject to stricter regulatory requirements in terms of entering into labor contracts with our employees and paying various statutory employee benefits, including pensions, housing fund, medical insurance, work-related injury insurance, unemployment insurance and childbearing insurance to designated government agencies for the benefit of our employees. Pursuant to the PRC Labor Contract Law, or the Labor Contract Law, that became effective in January 2008 and was amended in 2012 and its implementing rules that became effective in September 2008, employers are subject to stricter requirements in terms of signing labor contracts, minimum wages, paying remuneration, determining the term of employees’ probation and unilaterally terminating labor contracts. In the event that we decide to terminate some of our employees or otherwise change our employment or labor practices, the Labor Contract Law and its implementation rules may limit our ability to effect those changes in a desirable or cost-effective manner, which could adversely affect our business and results of operations. We believe our current practice complies with the Labor Contract Law and its implementation rules. However, the relevant governmental authorities may take a different view and impose fines on us.

As the interpretation and implementation of labor-related laws and regulations are still evolving, we cannot assure you that our employment practice does not and will not violate labor-related laws and regulations in China, which may subject us to labor disputes or government investigations. If we are deemed to have violated relevant labor laws and regulations, we could be required to provide additional compensation to our employees and our business, financial condition and results of operations could be materially and adversely affected.

If we fail to implement and maintain an effective system of internal control, we may be unable to accurately report our operating results, meet our reporting obligations or prevent fraud.

In preparing our consolidated financial statements for the fiscal year ended March 31, 2019, we and our independent registered public accounting firm identified two material weaknesses in our internal control over financial reporting. As defined in the standards established by the PCAOB, a “material weakness” is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis.

The material weaknesses identified are (i) our company’s lack of sufficient and competent financial reporting and accounting personnel with appropriate knowledge of U.S. GAAP and SEC reporting and compliance requirements, and (ii) lack of sufficient documented financial closing policies and procedures, specifically those related to period end logistics expenses cut-off and accruals and vendor rebate accruals. These material weaknesses, if not timely remedied, may lead to material misstatements in our consolidated financial statements in the future.

Following the identification of the material weaknesses and other control deficiencies, we have taken measures and plan to continue to take measures to remedy these control deficiencies. We are in the process of implementing a number of remedial measures, including: (i) hiring more qualified resources, equipped with relevant U.S. GAAP and SEC reporting experiences and qualifications, (ii) implementing regular and continuous U.S. GAAP accounting and financial reporting training programs for accounting and financial reporting personnel, (iii) establishing effective oversight and clarifying reporting requirements for non-recurring and complex transactions, and (iv) continuing to enhance accounting policies and closing procedures. However, the implementation of these measures may not fully address these deficiencies in our internal control over financial reporting, and we cannot conclude that they have been fully remedied. Our failure to correct these control deficiencies or our failure to discover and address any other control deficiencies could result in inaccuracies in our consolidated financial statements and impair our ability to comply with applicable financial reporting requirements and related regulatory filings on a timely basis.

We are a public company in the United States subject to the Sarbanes-Oxley Act of 2002. The Securities and Exchange Commission, or the SEC, adopted rules pursuant to Section 404 of the Sarbanes-Oxley Act of 2002 requiring every public company to include a management report on such company’s internal control over financial reporting in its annual report, which contains management’s assessment of the effectiveness of our internal control over financial reporting. In addition, when we lose our status as an “emerging growth company” as such term is defined in the JOBS Act, and once we become an “accelerated filer,” as defined in the Securities Exchange Act of 1934, as amended, or Exchange Act, our independent registered public accounting firm must attest to and report on the effectiveness of our internal control over financial reporting.

Due to material weaknesses identified in our internal control over financial reporting, our management has concluded that our internal control over financial reporting is not effective as of March 31, 2023. In the future, even if our management concludes that our internal control over financial reporting is effective, our independent registered public accounting firm, after conducting its own independent testing, may issue a report that is qualified if it is not satisfied with our internal controls or the level at which our controls are documented, designed, operated or reviewed, or if it interprets the relevant requirements differently from us.

 

40


Table of Contents

Furthermore, as we are now a public company, our reporting obligations may place a significant strain on our management, operational and financial resources and systems for the foreseeable future. We may be unable to timely complete our evaluation testing and any required remediation.

During the course of documenting and testing our internal control procedures, in order to satisfy the requirements of Section 404, we may identify weaknesses and deficiencies in our internal control over financial reporting. In addition, if we fail to maintain the adequacy of our internal control over financial reporting, as these standards are modified, supplemented or amended from time to time, we may not be able to conclude on an ongoing basis that we have effective internal control over financial reporting in accordance with Section 404. Generally speaking, if we fail to achieve and maintain an effective internal control environment, we could suffer material misstatements in our consolidated financial statements and fail to meet our reporting obligations, which would likely cause investors to lose confidence in our reported financial information. This could, in turn, limit our access to capital markets, harm our results of operations and lead to a decline in the trading price of our ADSs. Additionally, ineffective internal control over financial reporting could expose us to increased risk of fraud or misuse of corporate assets and subject us to potential delisting from the stock exchange on which we list, regulatory investigations and civil or criminal sanctions.

We are an “emerging growth company” and may take advantage of certain reduced reporting requirements.

We are an “emerging growth company,” as defined in the JOBS Act, and we may take advantage of certain exemptions from various requirements applicable to other public companies that are not emerging growth companies including, most significantly, not being required to comply with the auditor attestation requirements of Section 404 of Sarbanes-Oxley Act of 2002 for so long as we are an emerging growth company. As a result, if we elect not to comply with such auditor attestation requirements, our investors may not have access to certain information they may deem important.

The JOBS Act also provides that an emerging growth company does not need to comply with any new or revised financial accounting standards until such date that a private company is otherwise required to comply with such new or revised accounting standards. We do not plan to “opt out” of such exemptions afforded to an emerging growth company. As a result, our operating results and financial statements may not be comparable to the operating results and financial statements of other companies who have adopted the new or revised accounting standards.

Climate change and greenhouse gas restrictions may adversely impact our operations and markets.

Due to concern over the risk of climate change, a number of countries have adopted, or are considering the adoption of, regulatory frameworks to reduce greenhouse gas emissions. These regulatory measures include, among others, adoption of cap and trade regimes, carbon taxes, increased efficiency standards, and incentives or mandates for renewable energy. Compliance with changes in laws, regulations and obligations relating to climate change could increase our costs related to operating and maintaining our vessels and require us to install new emission controls, acquire allowances or pay taxes related to our greenhouse gas emissions, or administer and manage a greenhouse gas emissions program. Revenue generation and strategic growth opportunities may also be adversely affected.

We have incurred and will continue to incur increased costs as a result of being a public company, particularly after we cease to qualify as an “emerging growth company.”

As a public company, we currently incur and expect to continue to incur significant legal, accounting and other expenses that we did not incur as a private company. The Sarbanes-Oxley Act of 2002, as well as rules subsequently implemented by the SEC and the NYSE, impose various requirements on the corporate governance practices of public companies. Compliance with these rules and regulations has increased and will continue to increase our legal and financial compliance costs and have made and will continue to make some corporate activities more time-consuming and costly. We currently incur and expect to continue to incur significant expenses and devote substantial management effort toward ensuring compliance with the requirements of Section 404 of the Sarbanes-Oxley Act of 2002 and the other rules and regulations of the SEC. For example, as we are now a public company, we have increased the number of independent directors and adopted policies regarding internal controls and disclosure controls and procedures. Operating as a public company has made it more expensive for us to maintain director and officer liability insurance, and we may be required to accept reduced policy limits and coverage or incur substantially higher costs to maintain the same or similar coverage. In addition, we are incurring and expect to continue to incur additional costs associated with our public company reporting requirements. It may also be more difficult for us to find qualified persons to serve on our board of directors or as executive officers. We are currently evaluating and monitoring developments with respect to these rules and regulations, and we cannot predict or estimate with any degree of certainty the amount of additional costs we may incur or the timing of such costs in the future.

 

41


Table of Contents

We have limited insurance coverage which could expose us to significant costs and business disruption.

We believe we have obtained a prudent amount of insurance for the insurable risks relating to our business, including the property insurance for some of our warehouses. However, there is no assurance that the insurance policies we maintain are sufficient to cover our business operations. If we were to incur substantial liabilities that were not covered by our insurance, we could incur costs and losses that could materially and adversely affect our results of operations.

Risks Related to Our Corporate Structure and Contractual Arrangements

There are substantial uncertainties regarding the interpretation and application of current and future PRC laws, regulations, and rules relating to the agreements that establish the VIE structure for our operations in China, including potential future actions by the PRC government, which could affect the enforceability of our contractual arrangements with the VIEs and, consequently, significantly affect our financial condition and results of operations. If the PRC government finds our contractual arrangements noncompliant with relevant PRC laws, regulations, and rules, or if these laws, regulations, and rules or the interpretation thereof change in the future, we could be subject to severe penalties or be forced to relinquish our interests in the VIEs.

PRC laws and regulations impose certain restrictions or prohibitions on foreign ownership of companies that engage in internet and other related businesses, including the provision of internet content. Specifically, foreign ownership is prohibited in industries of online audio program services and internet cultural business (excluding music), foreign ownership of an internet content provider in managing value-added telecommunications business may not exceed 50%. Foreign investment in the value-added telecommunication services industry and certain other businesses is extensively regulated and subject to numerous restrictions. Pursuant to the Special Management Measures (Negative List) for the Access of Foreign Investment (2021), published by the National Development and Reform Commission and the Ministry of Commerce on December 27, 2021 and effective on January 1, 2022, with a few exceptions, foreign investors are not allowed to own more than 50% of the equity interests in a value-added telecommunication service provider.

There are substantial uncertainties regarding the interpretation and application of current and future PRC laws, regulations and rules. In particular, in March 2019, the National People’s Congress of the PRC adopted the PRC Foreign Investment Law, which became effective on January 1, 2020. Among other things, the PRC Foreign Investment Law defines the “foreign investment” as investment activities in China by foreign investors in a direct or indirect manner, including those circumstances explicitly listed thereunder as establishing new projects or foreign invested enterprises or acquiring shares of enterprises in China, and other approaches of investment as stipulated by laws, administrative regulations or otherwise regulated by the State Council. The PRC Foreign Investment Law leaves uncertainty as to whether foreign investors’ controlling PRC onshore variable interest entities via contractual arrangements will be recognized as “foreign investment” and thus be subject to the restrictions and/or prohibitions on foreign investments. If the PRC government finds that the VIE agreements that establish the structure for operating our podcasts, audio entertainment and other internet related businesses or for importing veterinary drugs do not comply with PRC government restrictions on foreign investment in these industries, or if these regulations change or are interpreted differently in the future, our securities may decline in value or become worthless, we could be subject to severe penalties, including being prohibited from continuing operations.

We are an exempted company with limited liability incorporated in the Cayman Islands and our wholly owned PRC subsidiaries are currently considered foreign-invested enterprises. Accordingly, our PRC subsidiaries are not eligible to provide value-added telecommunication services in China or import veterinary drugs. To ensure strict compliance with the PRC laws and regulations, we conduct such business activities through the VIEs, including Shanghai Guangcheng, Nanjing Xingmu, Suzhou Taicheng and Suzhou Xingyun. Shanghai Xincheng, Meiyizhi WFOE and Xingmu WFOE, our wholly owned subsidiaries in China, have entered into a series of contractual arrangements with the VIEs and their respective shareholders, which enable us to (i) exercise effective control over the VIEs, (ii) receive substantially all of the economic benefits of the VIEs, and (iii) have an exclusive option to purchase all or part of the equity interests in the VIEs when and to the extent permitted by PRC law. As a result of these contractual arrangements, we have control over and are the primary beneficiary of the VIEs and hence consolidate their financial results as the VIEs under U.S. GAAP.

Our PRC counsel, Commerce & Finance Law Offices, is of the opinion that (i) the ownership structures of the VIEs do not contravene any PRC laws or regulations currently in effect; and (ii) the agreements under the contractual arrangements among Shanghai Xincheng, Shanghai Guangcheng and their respective shareholders, among Xingmu WFOE, Nanjing Xingmu and their respective shareholders, among Meiyizhi WFOE, Suzhou Xingyun and their respective shareholders, as well as among Shanghai Xincheng, Suzhou Taicheng and their respective shareholders governed by PRC laws are valid and binding upon each party to such agreements and enforceable against each party thereto in accordance with their terms and applicable PRC laws and regulations currently in effect.

However, there can be no assurance that the PRC government authorities will take a view that is not contrary to or otherwise different from the opinion of our PRC counsel stated above. There is also the possibility that the PRC government authorities may adopt new laws, regulations and interpretations that may invalidate the contractual arrangements.

 

42


Table of Contents

If the PRC government finds that our contractual arrangements do not comply with its restrictions on foreign investment in the value-added telecommunication services industry or certain other businesses, or if the PRC government otherwise finds that we, the VIEs, or any of their subsidiaries are in violation of PRC laws or regulations or lack the necessary permits or licenses to operate our business, the relevant PRC regulatory authorities would have broad discretion in dealing with such violation or failures, including, without limitation:

 

   

revoking the business licenses and/or operating licenses of such entities;

 

   

discontinuing or placing restrictions or onerous conditions on our operation through any transactions between our PRC subsidiaries and the VIEs;

 

   

imposing fines on us, placing restrictions on our right to collect revenues, confiscating the income from our PRC subsidiaries or the VIEs, or imposing other requirements with which we or the VIEs may not be able to comply;

 

   

requiring us to restructure our ownership structure or operations, including terminating the contractual arrangements with the VIEs and deregistering the equity pledges of the VIEs, which in turn would affect our ability to consolidate, derive economic interests from, or exert effective control over the VIEs;

 

   

shutting down our servers or blocking our mobile apps and websites;

 

   

requiring us to restructure the operations in such a way as to compel us to establish a new enterprise, reapply for the necessary licenses or relocate our businesses, staff and assets;

 

   

imposing additional conditions or requirements with which we may not be able to comply; or

 

   

taking other regulatory or enforcement actions against us that could be harmful to our business.

The imposition of any of these penalties may result in a material and adverse effect on our ability to conduct our business operations. The PRC government has broad discretion in determining rectifiable or punitive measures for non-compliance with or violations of PRC laws and regulations. The VIE agreements have never been tested in a court of law in China. In addition, new PRC laws, regulations, and rules may be introduced to impose additional requirements, posing additional challenges to our corporate structure and contractual arrangements. If the imposition of any of these penalties causes us to lose the rights to direct the activities of our the VIEs or the right to receive their economic benefits, we would no longer be able to consolidate their financial results and/or claim our contractual control rights over the assets of the VIEs that conduct substantially all of our operations in China, which could materially and adversely affect our financial condition and results of operations and cause our securities to significantly decline in value or become worthless.

Uncertainties exist with respect to the interpretation and implementation of the newly enacted Foreign Investment Law and how it may impact our business, financial condition and results of operations.

On March 15, 2019, the National People’s Congress of the PRC promulgated the Foreign Investment Law of the People’s Republic of China, or the Foreign Investment Law, which came into effect on January 1, 2020 and replace the trio of existing laws regulating foreign investment in China, namely, the Sino-foreign Equity Joint Venture Enterprise Law, the Sino-foreign Cooperative Joint Venture Enterprise Law and the Wholly Foreign-invested Enterprise Law, together with their implementation rules and ancillary regulations. On December 26, 2019, the State Council published the Implementation Rules of Foreign Investment Law, or the Implementation Rules, which came into effect on January 1, 2020. The Foreign Investment Law and its Implementation Rules embody an expected PRC regulatory trend to rationalize its foreign investment regulatory regime in line with prevailing international practice and the legislative efforts to unify the corporate legal requirements for both foreign and domestic investments. The enacted Foreign Investment Law and its Implementation Rules do not mention concepts such as “actual control” and “controlling PRC companies by contracts or trusts” that were included in the previous drafts, nor do they specify regulation on controlling through contractual arrangements, and thus this regulatory topic remains unclear. However, these laws and rules are relatively new, uncertainties still exist in relation to their interpretation and implementation. For instance, though the Foreign Investment Law does not explicitly classify contractual arrangements as a form of foreign investment, it contains a catch-all provision under the definition of “foreign investment,” which includes investments made by foreign investors in China through means stipulated in laws or administrative regulations or other methods prescribed by the State Council. Therefore, it still leaves leeway for future laws, administrative regulations or provisions promulgated by the State Council to provide for contractual arrangements as a form of foreign investment. Furthermore, if future laws, administrative regulations or provisions prescribed by the State Council mandate further actions to be taken by companies with respect to existing contractual arrangements, such as unwinding our existing contractual arrangements and/or disposal of our related business operations, we may face substantial uncertainties as to whether we can complete such actions in a timely manner, or at all. Failure to take timely and appropriate measures to cope with any of these or similar regulatory compliance challenges could materially and adversely affect our current corporate structure, corporate governance and business operations. If any of these occurrences results in our inability to direct the activities of any of the VIEs and/or our failure to receive economic benefits from any of them, we may not be able to consolidate their results into our consolidated financial statements in accordance with U.S. GAAP.

 

43


Table of Contents

We rely on contractual arrangements with the VIEs and their respective shareholders for our business operations, which may not be as effective as direct ownership in providing operational control.

We have relied and expect to continue to rely on contractual arrangements with the VIEs and their respective shareholders to operate our business in China. These contractual arrangements may not be as effective as direct ownership in providing us with control over the VIEs. For example, the VIEs and their respective shareholders could breach their contractual arrangements with us by, among other things, failing to conduct their operations in an acceptable manner or taking other actions that are detrimental to our interests. If we had direct ownership of the VIEs in China, we would be able to exercise our rights as a shareholder to effect changes in the board of directors of the VIEs, which in turn could implement changes, subject to any applicable fiduciary obligations, at the management and operational level. However, under the current contractual arrangements, we rely on the performance by the VIEs and their respective shareholders of their obligations under the contracts to exercise control over the VIEs. The shareholders of the VIEs may not act in the best interests of our company or may not perform their obligations under these contracts. Such risks exist throughout the period in which we intend to operate certain portions of our business through the contractual arrangements with the VIEs. If any dispute relating to these contracts remain unresolved, we will have to enforce our rights under these contracts through the operations of PRC law and arbitration, litigation and other legal proceedings and therefore will be subject to uncertainties in the PRC legal system. In the event that we are unable to enforce these contractual arrangements, or if we suffer significant delays or other obstacles in the process of enforcing these contractual arrangements, we may not be able to exert substantial influence over the VIEs, and our ability to conduct our business may be negatively affected. Therefore, our contractual arrangements with the VIEs may not be as effective in ensuring our control over the relevant portion of our business operations as direct ownership would be.

Any failure by any of the VIEs or their shareholders to perform their respective obligations under our contractual arrangements with them would have a material and adverse effect on our business.

If any of the VIEs or their shareholders fail to perform their respective obligations under the contractual arrangements, we may be limited in our ability to enforce the contractual arrangements that give us effective control over the VIEs, and if we are unable to maintain such control, our ability to consolidate the financial results of the VIEs will be affected. We may also have to rely on legal remedies under PRC law, including seeking specific performance or injunctive relief, and claiming damages, which we cannot assure you will be effective sufficient or effective under PRC law. For example, if the shareholders of any of the VIEs refuse to transfer their equity interests in such VIEs to us or our designee if we exercise the purchase option pursuant to these contractual arrangements, or if they otherwise act in bad faith toward us, then we may have to take legal actions to compel them to perform their contractual obligations. In addition, if any third parties claim any interest in such shareholders’ equity interests in any of the VIEs, our ability to exercise shareholders’ rights or foreclose the share pledge according to the contractual arrangements may be impaired. If these or other disputes between the shareholders of the VIEs and third parties were to impair our control over the VIEs, our ability to consolidate the financial results of the VIEs would be affected, which would in turn result in a material adverse effect on our business, operations and financial condition.

In addition, the individual shareholders of the VIEs may be involved in personal disputes with third parties or other incidents that may have an adverse effect on their respective equity interests in the VIEs and the validity or enforceability of the contractual arrangements. For instance, in the event that such shareholder divorces his or her spouse, the spouse may claim that the equity interest of the VIEs held by such shareholder is part of their marital or community property and should be divided between such shareholder and his or her spouse. If such claim is supported by the competent court, the relevant equity interest may be obtained by the shareholder’s spouse or another third-party who is not bound by our contractual arrangements, which could result in our losing effective control over the VIEs. Even if we receive a consent letter from the spouse of an individual nominee shareholder of the VIEs where such spouse undertakes that he or she would not take any actions to interfere with the contractual arrangements through which we control such VIEs, including by claiming that the equity interest of the VIEs held by such shareholder is part of their marital or community property, we cannot assure you that these undertakings will be complied with or effectively enforced. In the event that any of them is breached or becomes unenforceable and leads to legal proceedings, it could disrupt our business, distract our management’s attention and subject us to substantial uncertainties as to the outcome of any such legal proceedings. Similarly, if any of the equity interests of the VIEs are inherited by a third-party on whom the current contractual arrangements are not binding, we could lose our control over the VIEs or have to maintain such control at unpredictable cost, which could cause significant disruption to our business operations and harm our financial condition and results of operations.

 

44


Table of Contents

Our contractual arrangements are governed by PRC law. Accordingly, these contracts would be interpreted in accordance with PRC law, and any disputes would be resolved in accordance with PRC legal procedures.

The legal system in the PRC is constantly evolving and may involve more uncertainty than in some other jurisdictions, such as the United States. As a result, uncertainties in the PRC legal system could limit our ability to enforce these contractual arrangements. Meanwhile, there are very few precedents and little formal guidance as to how contractual arrangements in the context of a VIE should be interpreted or enforced under PRC law. There remain significant uncertainties regarding the ultimate outcome of such arbitration should legal action become necessary. In addition, under PRC law, rulings by arbitrators are final, parties cannot appeal the arbitration results in courts, and if the losing parties fail to carry out the arbitration awards within a prescribed time limit, the prevailing parties may only enforce the arbitration awards in PRC courts, which would require additional expenses and delay. In the event we are unable to enforce these contractual arrangements, or if we suffer significant delays or other obstacles in the process of enforcing these contractual arrangements, we may not be able to exert effective control over the VIEs, and our ability to conduct our business may be negatively affected.

The shareholders of the VIEs may have actual or potential conflicts of interest with us, which may materially and adversely affect our business and financial condition.

The shareholders of the VIEs may have actual or potential conflicts of interest with us. These shareholders may refuse to sign or breach, or cause the VIEs to breach, or refuse to renew, the existing contractual arrangements we have with them and the VIEs, which would have a material and adverse effect on our ability to effectively control the VIEs and receive economic benefits from them. For example, the shareholders may be able to cause our agreements with the VIEs to be performed in a manner adverse to us by, among other things, failing to remit payments due under the contractual arrangements to us on a timely basis. We cannot assure you that when conflicts of interest arise any or all of these shareholders will act in the best interests of our company or such conflicts will be resolved in our favor. Currently, we do not have any arrangements to address potential conflicts of interest between these shareholders and our company. If we cannot resolve any conflict of interest or dispute between us and these shareholders, we would have to rely on legal proceedings, which could result in disruption of our business and subject us to substantial uncertainty as to the outcome of any such legal proceedings.

Contractual arrangements in relation to the VIEs may be subject to scrutiny by the PRC tax authorities and they may determine that we or our PRC VIEs owe additional taxes, which could negatively affect our financial condition and the value of your investment.

Under applicable PRC laws and regulations, arrangements and transactions among related parties may be subject to audit or challenge by the PRC tax authorities within ten years after the taxable year when the transactions are conducted. We could face material and adverse tax consequences if the PRC tax authorities determine that the VIE contractual arrangements were not entered into on an arm’s-length basis in such a way as to result in an impermissible reduction in taxes under applicable PRC laws, rules and regulations, and adjust income of the VIEs in the form of a transfer pricing adjustment. A transfer pricing adjustment could, among other things, result in a reduction of expense deductions recorded by the VIEs for PRC tax purposes, which could in turn increase the VIEs’ tax liabilities without reducing our PRC subsidiaries’ tax expenses. In addition, the PRC tax authorities may impose late payment fees and other penalties on the VIEs for the adjusted but unpaid taxes according to the applicable regulations. Our financial position could be materially and adversely affected if the VIEs’ tax liabilities increase or if the VIEs are required to pay late payment fees and other penalties.

We may lose the ability to use, or otherwise benefit from, the licenses, approvals and assets held by the VIEs, which could severely disrupt our business, render us unable to conduct some or all of our business operations and constrain our growth.

As part of our contractual arrangements with the VIEs, the VIEs hold certain assets, licenses and permits that are material to our business operations, such as the ICP License and Veterinary Drug Distribution License. The contractual arrangements contain terms that specifically obligate VIEs’ shareholders to ensure the valid existence of the VIEs and restrict the disposal of material assets of the VIEs. However, in the event the VIEs’ shareholders breach the terms of these contractual arrangements and voluntarily liquidate the VIEs, or the VIEs declare bankruptcy and all or part of its assets become subject to liens or rights of third-party creditors, or are otherwise disposed of without our consent, we may be unable to conduct some or all of our business operations or otherwise benefit from the assets held by the VIEs, which could have a material adverse effect on our business, financial condition and results of operations. Furthermore, if any of the VIEs undergoes a voluntary or involuntary liquidation proceeding, its shareholders or unrelated third-party creditors may claim rights to some or all of the assets of such VIEs, thereby hindering our ability to operate our business as well as constrain our growth.

 

45


Table of Contents

Risks Related to Doing Business in China

Changes in China’s economic, political or social conditions or government policies could have a material adverse effect on our business and operations.

Substantially all of our assets and operations are located in China. Accordingly, our business, financial condition, results of operations and prospects may be influenced to a significant degree by political, economic and social conditions in China generally. The Chinese economy differs from the economies of most developed countries in many respects, including the level of government involvement, level of development, growth rate, control of foreign exchange and allocation of resources. Although the Chinese government has implemented measures emphasizing the utilization of market forces for economic reform, the reduction of state ownership of productive assets, and the establishment of improved corporate governance in business enterprises, a substantial portion of productive assets in China is still owned by the government. In addition, the Chinese government continues to play a significant role in regulating industry development by imposing industrial policies. The Chinese government also exercises significant control over China’s economic growth through allocating resources, controlling payment of foreign currency-denominated obligations, setting monetary policy and providing preferential treatment to particular industries or companies. While the Chinese economy has experienced significant growth over past decades, growth has slowed down in recent years and has been uneven, both geographically and among various sectors of the economy. Any adverse changes in economic conditions in China, in the policies of the Chinese government or in the laws and regulations in China could have a material adverse effect on the overall economic growth of China. Such developments could adversely affect our business and operating results, lead to a reduction in demand for our services and adversely affect our competitive position. The Chinese government has implemented various measures to encourage economic growth and guide the allocation of resources. Some of these measures may benefit the overall Chinese economy, but may have a negative effect on us. For example, our financial condition and results of operations may be adversely affected by government control over capital investments or changes in tax regulations. In addition, in the past the Chinese government has implemented certain measures, including interest rate adjustment, to control the pace of economic growth. These measures may cause decreased economic activity in China, which may adversely affect our business and operating results.

PRC government has significant authority in regulating our operations and may influence our operations. It may exert more oversight and control over offerings conducted overseas by, and/or foreign investment in, China-based issuers, which could significantly limit or completely hinder our ability to offer or continue to offer securities to investors. Implementation of industry-wide regulations in this nature may cause the value of such securities to significantly decline.

Our business, financial condition and results of operations depend on the level of consumer confidence and spending in China and may be adversely affected by the downturn in the global or Chinese economy.

Our business, financial condition and results of operations are sensitive to changes in overall economic conditions that affect consumer spending in China. The retail industry, including the online retail sector, is highly sensitive to general economic changes. Online purchases tend to decline significantly during recessionary periods. Many factors outside of our control, including inflation and deflation, interest rates, volatility of equity and debt securities markets, taxation rates, employment and other government policies can adversely affect consumer confidence and spending. While the economy in China has grown significantly over the past decades, growth has been uneven, both geographically and among various sectors of the economy, and the rate of growth has been slowing. The online retail industry is particularly sensitive to economic downturns, and the macroeconomic environment in China may affect our business and prospects. A prolonged slowdown or deterioration in the global or Chinese economy that maybe caused by events in Ukraine, higher interest rates and inflation may lead to a reduced level of online purchasing activities, which could materially and adversely affect our business, financial condition, and results of operations.

In addition, the domestic and international political environments, including military conflicts and political turmoil or social instability, may also adversely affect consumer confidence and reduce spending, which could in turn materially and adversely affect our business, financial condition, and results of operations.

Uncertainties with respect to the PRC legal system could adversely affect us.

The PRC legal system is a civil law system based on written statutes. Unlike common law systems, it is a system in which prior court decisions have limited value as precedents. Our PRC subsidiaries and the VIEs are subject to various PRC laws and regulations generally applicable to companies in China. However, since these laws and regulations are relatively new and the PRC legal system continues to rapidly evolve, their interpretation is not always consistent and their enforcement involves uncertainties.

 

46


Table of Contents

In 1979, the PRC government began to promulgate a comprehensive system of laws and regulations governing economic matters in general. The overall effect of legislation over the past four decades has significantly enhanced the protections afforded to various forms of foreign investments in China. However, China has not developed a fully integrated legal system, and recently enacted laws and regulations may not sufficiently cover all aspects of economic activities in China. In particular, the interpretation and enforcement of these laws and regulations involve uncertainties. Since PRC administrative and court authorities have significant discretion in interpreting and implementing statutory provisions and contractual terms, it may be difficult to evaluate the outcome of administrative and court proceedings and the level of legal protection we enjoy. These uncertainties may affect our judgment on the relevance of legal requirements and our ability to enforce our contractual rights or tort claims. In addition, the regulatory uncertainties may be exploited through unmerited or frivolous legal actions or threats in attempts to extract payments or benefits from us.

The PRC government has significant oversight and discretion over the conduct of our business and may intervene with or influence our operations as the government deems appropriate to further regulatory, political and societal goals. The PRC government has recently published new policies that adversely affected our industry and our business, and we cannot rule out the possibility that it will in the future further release regulations or policies regarding our industry that could further adversely affect our business, financial condition and results of operations. Furthermore, the PRC government has also recently indicated an intent to exert more oversight and control over securities offerings and other capital markets activities that are conducted overseas and foreign investment in China-based companies like us. Any such action, once taken by the PRC government, could significantly limit or completely hinder our ability to offer or continue to offer securities to investors and cause the value of such securities to significantly decline or in extreme cases, become worthless.

However, as there are still regulatory uncertainties in this regard, we cannot assure you that we will be able to comply with new laws and regulations in all respects, and we may be ordered to rectify, suspend or terminate any actions or services that are deemed illegal by the regulatory authorities and become subject to material penalties, which may materially harm our business, financial condition, results of operations and prospects. Furthermore, the PRC legal system is based in part on government policies and internal rules, some of which are not published on a timely basis or at all and may have a retroactive effect. As a result, we may not be aware of our violation of any of these policies and rules until sometime after the violation. In addition, any administrative and court proceedings in China may be protracted, resulting in substantial costs and diversion of resources and management attention.

The permission and approval from the CSRC or other PRC government authorities may be required in connection with an offshore offering under PRC law, and, if required, we cannot predict whether or for how long we will be able to obtain such permission or approval.

On February 17, 2023, the CSRC issued the Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Enterprises, or the Trial Measures, which became effective on March 31, 2023. On the same date of the issuance of the Trial Measures, the CSRC circulated No.1 to No.5 Supporting Guidance Rules, the Notes on the Trial Measures, the Notice on Administration Arrangements for the Filing of Overseas Listings by Domestic Enterprises and the relevant CSRC Answers to Reporter Questions on the official website of the CSRC, or collectively, the Guidance Rules and Notice. Under the Trial Measures and the Guidance Rules and Notice, domestic companies conducting overseas securities offering and listing activities, either in direct or indirect form, shall complete filing procedures with the CSRC pursuant to the requirements of the Trial Measures within three working days following its submission of initial public offering or listing application. The companies that have already been listed on overseas stock exchanges are not required to make immediate filings for its listing, yet need to make filings for subsequent offerings in accordance with the Trial Measures. In view of the fact that the Trial Measures have come into effect on March 31, 2023, we shall fulfill the filing procedures with the CSRC for any future offshore offering as per requirements of the Trial Measures. According to CSRC’s Questions and Answers with respect to Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies on February 17, 2023, for the filing of overseas listing of enterprises with VIE structure, the filing procedure will adhere to the principles of market-oriented principle, rule of law, and strengthened regulatory synergy. The CSRC will consult the relevant competent authorities, and the overseas listing of VIE structured enterprises that meet the compliance requirements will be filed. In addition, on February 24, 2023, the CSRC released the Provisions on Strengthening the Confidentiality and Archives Administration Related to the Overseas Securities Offering and Listing by Domestic Enterprises, or, the Confidentiality Provisions, which came into effect on March 31, 2023. Pursuant to the Confidentiality Provisions, any future inspection or investigation conducted by overseas securities regulator or the relevant competent authorities on our PRC domestic companies with respect to our overseas issuance and listing shall be carried out in the manner in compliance with PRC laws and regulations. As the Trial Measures and Confidentiality Provisions have only been recently published, there are significant uncertainties as to their implementation, interpretation and impact on our current listing and any future offerings or financings. We may not be able to complete the filing described above if the filing materials are incomplete or do not meet the requirements of the CSRC. Any failure to obtain or delay in obtaining the CSRC permission and approval for any of our offshore offerings, or a rescission of such permission and approval if obtained, may subject us to sanctions imposed by the CSRC or other PRC regulatory authorities, which may materially and adversely affect our business, financial condition, and results of operations.

 

47


Table of Contents

PRC laws and regulations regarding data security and cybersecurity are evolving. These laws and regulations are subject to change and substantial uncertainties, and could have material impact on our business operation.

PRC regulators, including the Standing Committee of the National People’s Congress, or the SCNPC, the Ministry of Industry and Information Technology of the PRC, or the MIIT and the CAC, have been increasingly focused on regulation in the areas of data security and cybersecurity. A series of laws and regulations relating to the protection of privacy, date security and cyber security have been enacted. However, such laws and regulations are currently evolving and are likely to remain uncertain for the foreseeable future.

On July 1, 2015, the SCNPC, promulgated the National Security Law, or the New National Security Law, which took effect on the same date and replaced the former National Security Law promulgated in 2009. The New National Security Law covers various types of national security including technology security and information security. According to the New National Security Law, the state shall ensure that the information system and data in important areas are secure and controllable. In addition, according to the New National Security Law, the state shall establish national security review and supervision policies and mechanisms, and conduct national security reviews of key technologies and IT products and services that affect or may affect national security. In particular, we are obligated under the New National Security Law to safeguard national security by, for example, providing evidence related to activities endangering national security, providing convenience and assistance for national security work, and providing necessary support and assistance for national security institutions, public security institutions as well as military institutions. As such, we may have to provide data to PRC government authorities and military institutions for compliance with the New National Security Law, which may result in additional expenses to us and subject us to negative publicity which could harm our reputation with users and negatively affect the trading price of our ADSs.

On November 7, 2016, the SCNPC promulgated the Cybersecurity Law, which took effect on June 1, 2017. The Cybersecurity Law specifies requirements on user information protection applicable to network operators, who are prohibited from collecting or disclosing without permission or selling individual information with limited exceptions. When network operators become aware of any information of which the release or transmission is prohibited by any law or administrative regulation, they are required to immediately cease transmission of such information and take measures such as deletion of relevant information to prevent its dissemination. In addition, according to the Cybersecurity Law and relevant regulations, network operators, are obligated to take technical and other necessary measures to ensure the security and stable operation of network, maintain the integrity, confidentiality and availability of network data, and furthermore provide assistance and support in accordance with the law for public security and national security authorities to protect national security or assist with criminal investigations. In addition, the PRC Cybersecurity Law provides that personal information and important data collected and generated by operators of critical information infrastructure in the course of their operations in the PRC should be stored in the PRC, and the law imposes heightened regulation and additional security obligations on operators of critical information infrastructure. On September 12, 2022, the CAC proposed a series of draft amendments to the Cybersecurity Law, including raising the size of fines for some violations. Such draft amendments are released for soliciting public comments until September 29, 2022, and its final form, interpretation and implementation remain substantially uncertain.

On June 10, 2021, the SCNPC promulgated the PRC Data Security Law, which became effective in September 2021. The PRC Data Security Law imposes data security and privacy obligations on entities and individuals carrying out data activities, and introduces a data classification and hierarchical protection system based on the importance of data in economic and social development, as well as the degree of harm it will cause to national security, public interests, or legitimate rights and interests of individuals or organizations when such data is tampered with, destroyed, leaked, or illegally acquired or used. The PRC Data Security Law also provides for a national security review procedure for data activities that may affect national security and imposes export restrictions on certain data and information. On December 28, 2021, the CAC, together with other authorities, jointly promulgated the Revised Cybersecurity Review Measures, effective on February 15, 2022 and repeal the Cybersecurity Review Measures promulgated on April 13, 2020. The Revised Cybersecurity Review Measures provide that a critical information infrastructure operator purchasing network products and services, and platform operators carrying out data processing activities, which affect or may affect national security, shall apply for cybersecurity review and that a platform operator with more than one million users’ personal information aiming to list abroad must apply for cybersecurity review. Such measures further restate and expand the applicable scope of the cybersecurity review.

On July 30, 2021, the State Council promulgated the Regulations on Protection of Critical Information Infrastructure, which became effective on September 1, 2021. On December 31, 2021, the CAC together with other relevant administrative departments published the Administrative Provisions on Internet Information Service Algorithm Recommendation, which became effective on March 1, 2022. This recommendation provides that, among others, that algorithm recommendation service providers shall (i) establish and improve the management systems and technical measures for algorithm mechanism and principle review, scientific and technological ethics review, user registration, information release review, data security and personal information protection, anti-telecommunications and Internet fraud, security assessment and monitoring, and security incident emergency response, formulate and disclose the relevant rules for algorithm recommendation services, and be equipped with professional staff and technical support appropriate to the scale of the algorithm recommendation service; (ii) regularly review, evaluate and verify the principle, models, data and application results of algorithm mechanisms, (iii) strengthen information security management, establish and improve a feature database for identifying illegal and bad information, and improve entry standards, rules and procedures; (iv) strengthen the management of user models and user labels, and improve the rules on points of interest recorded into user models and user label management, and shall not record illegal and harmful information keywords into the points of interest of users or use them as user labels to push information.

 

48


Table of Contents

On November 14, 2021, the CAC released the Regulations on the Network Data Security (Draft for Comments), or the Draft Regulations. The Draft Regulations provide that data processors refer to individuals or organizations that have autonomy over the purpose and the manner of data processing activities such as data collection, storage, utilization, transmission, publication and deletion. In accordance with the Draft Regulations, data processors shall apply for a cybersecurity review for certain activities, including, among other things, (i) the listing abroad of data processors that process the personal information of more than one million users and (ii) any data processing activity that affects or may affect national security. However, there have been no clarifications from the relevant authorities as of the date of this annual report as to the standards for determining whether an activity is one that “affects or may affect national security.” In addition, the Draft Regulations requires that data processors that process “important data” or are listed overseas must conduct an annual data security assessment by itself or commission a data security service provider to do so, and submit the assessment report of the preceding year to the municipal cybersecurity department by the end of January each year. The Draft Regulations was released for public comments until December 13, 2021, and their respective provisions and anticipated adoption or effective date may be subject to change with substantial uncertainty.

On July 7, 2022, the CAC promulgated the Data Outbound Transfer Security Assessment Measures or the Security Assessment Measures, which came into effect on September 1, 2022. The Security Assessment Measures provides that, among others, data processors shall apply to competent authorities for security assessment when transferring important data abroad or when, in the case of a critical information infrastructure operator, or a personal information processor that has processed personal information of more than one million individuals, transferring personal information abroad.

Furthermore, the Opinions on Strictly Cracking Down on Illegal Securities Activities in Accordance with the Law, or the Opinions on Strictly Cracking Down on Illegal Securities Activities, which were issued by the General Office of the State Council and another authority on July 6, 2021 emphasized the need to strengthen the regulations over illegal securities activities and the supervision on overseas listings by China-based companies, and proposed to take effective measures, such as promoting the establishment of relevant regulatory systems to deal with the risks and incidents faced by China-based overseas listed companies, and provided that the special provisions of the State Council on overseas offering and listing by those companies limited by shares will be revised and therefore the duties of domestic industry competent authorities and regulatory agencies will be clarified. As these opinions were newly issued and there are no further explanations or detailed rules and regulations with respect to such opinions, there are still uncertainties regarding the interpretation and implementation of such opinions. Any new rules or regulations promulgated in the future could impose additional requirements on our future overseas capital raising activities.

We are making efforts to comply with the applicable laws, regulations and standards relating to the protection of privacy, date security and cybersecurity. As there remains high uncertainty in the interpretation and enforcement of relevant laws and regulations (including whether the Draft Regulations will be implemented in the proposed form and when they will be implemented), there can be no assurance that our measures will be effective and sufficient, or we would be able to comply with the requirements therein in a timely manner. Failure to comply with such laws and regulations may lead to fines, suspension of business operation, revocation of business permits or licenses and other sanctions, which may have material impact on our business operation. Newly promulgated laws and regulations reflect PRC government further attempts to strengthen the legal protection for the national network security, data security, the security of critical information infrastructure and the security of personal information protection. For details on regulations over data protection and privacy in the PRC, see “Item 4. Information on the Company—4.B. Business Overview—Regulation—Regulations on Cyber Security and Privacy” for details on regulations over data protection and privacy in the PRC.

In addition, we procure server and system for storage, process and other aspects of business operation from time to time. It remains unclear whether such server and system will fall into the category of the so-called “critical network equipment” or “dedicated network security products” due to lack of specific criteria or standards in the Cybersecurity Law. As such, we cannot assure you that the server and system we have procured or may procure in the future comply with relevant requirements, and we may incur additional costs to comply with such requirements. Also, as the scope of operator of critical information infrastructure is not completely clear, certain parties involved in our business operation (such as, our customers or suppliers) may be deemed as an operator of critical information infrastructure where the cybersecurity review could be required before we enter into relevant business relationships with them which may have a material adverse effect on our business and prospects.

 

49


Table of Contents

Any failure or perceived failure by us to comply with Anti-monopoly Guidelines for Internet Platforms and other Anti-monopoly laws and regulations may result in governmental investigations or enforcement actions, litigation or claims against us and could have an adverse effect on our business, financial condition and results of operations.

In recent years, PRC Anti-monopoly enforcement agencies have strengthened enforcement under the PRC Anti-monopoly Law. In March 2018, the State Administration for Market Regulation, or the SAMR was formed as a new governmental agency to take over, among other things, the anti-monopoly enforcement functions from the relevant departments under the Ministry of Commerce of the People’s Republic of China, or the MOFCOM, the National Development and Reform Commission, or the NDRC and the State Administration for Industry and Commerce, or the SAIC (the predecessor of the SAMR), respectively. Since its inception, the SAMR has continued to strengthen anti-monopoly enforcement. In December 2018, the SAMR issued the Notice on Anti-monopoly Enforcement Authorization, which grants authorities to its province-level branches to conduct anti-monopoly enforcement within their respective jurisdictions. In November 2021, the National Anti-monopoly Bureau was inaugurated by the State Council, which aims to further implement the fair competition policies, and strengthen anti-monopoly supervision in the PRC, especially to strengthen oversight and law enforcement in areas involving platform economy, innovation, science and technology, information security and people’s livelihood.

The PRC anti-monopoly regulators may also issue implementation rules or guidelines from time to time to reinforce their regulation on certain industrial sectors. In February 2021, the Anti-monopoly Committee of the State Council published the Anti-monopoly Guidelines for Internet Platforms. This guideline prohibits monopolistic conduct such as entering into monopoly agreements, abusing market dominance and concentration of undertakings that may have the effect to eliminate or restrict competition in the field of platform economy. More specifically, the Anti-monopoly Guidelines for Internet Platforms outlines certain practices that may, if without justifiable reasons, constitute abuse of a dominant position, including without limitation, discriminating customers in terms of pricing and other transactional conditions using big data and analytics, coercing counterparties into exclusivity arrangements, using technology means to block competitors’ interface, using bundle services to sell services or products, and compulsory collection of users’ unnecessary data. The Anti-monopoly Guidelines for Internet Platforms further expressly states that concentration involving VIE will also be subject to antitrust filing requirements, and therefore will also fall within the scope of the antitrust review. In addition, Anti-monopoly Guidelines for Internet Platforms reinforces antitrust merger review for internet platform related transactions to safeguard market competition. Since the Anti-monopoly Guidelines for Internet Platforms is relatively new and may be subject to interpretation by the regulators in the process of implementing such guidelines, we cannot assure you that our business operations will comply with such regulation in all respects, and any failure or perceived failure by us to comply with such regulation may result in governmental investigations, fines and/or other sanctions on us. Furthermore, on October 23, 2021, the SCNPC issued a discussion draft of the amended Anti-monopoly Law. On June 24, 2022, the Decision of the Standing Committee of the National People’s Congress on Revising the Anti-monopoly Law of the People’s Republic of China, or the Revised Anti- monopoly Law was released, which became effective on August 1, 2022. According to the Revised Anti-monopoly Law, the fines for illegal concentration of business operators have been increased to no more than ten percent of its last year’s sales revenue if the concentration of business operator has or may have an effect of excluding or limiting competitions; or a fine of up to RMB5 million if the concentration of business operator does not have an effect of excluding or limiting competition. The Revised Anti-monopoly Law also stipulates that the relevant authority shall investigate a transaction where there is any evidence that the concentration has or may have the effect of eliminating or restricting competitions, even if such concentration does not reach the filing threshold. And in order to adapt the Revised Anti-monopoly Law, on March 10, 2023, the SAMR issued the Provisions on Prohibition of the Abuse of Market Dominance, which took effect on April 15, 2023. See “Item 4. Information of the Company—4.B. Business Overview—Regulation—Regulations on Anti-Monopoly.”

You may experience difficulties in effecting service of legal process, enforcing foreign judgments or bringing actions in China against us, our directors or our management named in this annual report based on foreign laws, and the ability of U.S. authorities to bring actions in China may also be limited.

We are an exempted company with limited liability incorporated under the laws of the Cayman Islands, we conduct substantially all of our operations in China, and substantially all of our assets are located in China. In addition, all our senior executive officers and directors reside within China for a significant portion of the time and most are PRC nationals. There are also uncertainties regarding the status of the rights of Boqii Holding Limited, our Cayman Islands holding company, with respect to our contractual arrangements with the VIEs, our founders and shareholders. As a result, it may be difficult for our shareholders to effect service of process upon us or those persons inside China.

The recognition and enforcement of foreign judgments are provided for under the PRC Civil Procedures Law. PRC courts may recognize and enforce foreign judgments in accordance with the requirements of the PRC Civil Procedures Law and other applicable laws, regulations and interpretations based either on treaties between China and the country where the judgment is made or on principles of reciprocity between jurisdictions. China does not have any treaties or other forms of reciprocity with the U.S. and many other jurisdictions that provide for the reciprocal recognition and enforcement of judgments from the U.S. and many other jurisdictions. In addition, according to the PRC Civil Procedures Law, the PRC courts will not enforce a foreign judgment against us or our directors and officers if they decide that the judgment violates the basic principles of PRC laws or national sovereignty, security or public interest. As a result, it is uncertain whether and on what basis a PRC court would enforce a judgment rendered by a court in the U.S and many other jurisdictions. Moreover, the SEC, the U.S. Department of Justice and other U.S. authorities and the comparable authorities from many other jurisdictions may also have difficulties in bringing and enforcing actions against us or our directors or officers in the PRC.

 

50


Table of Contents

You may have difficulty enforcing judgments in Hong Kong.

Judgment of United States courts will not be directly enforced in Hong Kong as there are currently no treaties or other arrangements providing for reciprocal enforcement of foreign judgments between Hong Kong and the United States. However, subject to certain conditions, including but not limited to when the judgment is for a fixed sum in a civil matter and not in respect of taxes, fines, penalties or similar charges, the judgment is final and conclusive upon the merits of the claim and has not been stayed or satisfied in full, the proceedings in which the judgment was obtained were not contrary to natural justice, were not procured by fraud and the enforcement of the judgment is not contrary to public policy of Hong Kong, Hong Kong courts may accept such judgment obtained from a United States court as a debt due under the rules of common law enforcement. However, a separate legal action for debt must be commenced in Hong Kong in order to recover such debt from the judgment debtor.

It may be difficult for overseas regulators to conduct investigation or collect evidence within China.

Shareholder claims or regulatory investigation that are common in the United States generally are difficult to pursue as a matter of law or practicality in China. For example, in China, there are significant legal and other obstacles to providing information needed for regulatory investigations or litigation initiated outside China. Although the authorities in China may establish a regulatory cooperation mechanism with the securities regulatory authorities of another country or region to implement cross-border supervision and administration, such cooperation with the securities regulatory authorities in the Unities States may not be efficient in the absence of mutual and practical cooperation mechanism. Furthermore, according to Article 177 of the PRC Securities Law, or Article 177, which became effective in March 2020, no overseas securities regulator is allowed to directly conduct investigation or evidence collection activities within the territory of the PRC. While detailed interpretation of or implementation rules under Article 177 have yet to be promulgated, the inability for an overseas securities regulator to directly conduct investigation or evidence collection activities within China may further increase difficulties faced by you in protecting your interests.

We may rely on dividends and other distributions on equity paid by our PRC subsidiaries to fund any cash and financing requirements we may have, and any limitation on the ability of our PRC subsidiaries to make payments to us could have a material and adverse effect on our ability to conduct our business.

We are a Cayman Islands holding company and we rely principally on dividends and other distributions on equity from our PRC subsidiaries for our cash requirements, including for services of any debt we may incur. The ability of our PRC subsidiaries to pay dividends and other distributions on equity, in turn, depends on the payment they receive from the VIEs as service fees pursuant to certain contractual arrangements among our PRC subsidiaries, the VIEs and the VIEs’ shareholders entered into to comply with certain restrictions under PRC law on foreign investment. For more information about such contractual arrangements, see “Item 3. Key Information—Contractual Arrangements with the VIEs and Their Respective Shareholders.”

Our PRC subsidiaries’ ability to distribute dividends is based upon its distributable earnings. Current PRC regulations permit our PRC subsidiaries to pay dividends to their respective shareholders only out of their accumulated profits, if any, determined in accordance with PRC accounting standards and regulations. In addition, each of our PRC subsidiaries, the VIEs and their subsidiaries are required to set aside at least 10% of its after-tax profits each year, if any, to fund a statutory reserve until such reserve reaches 50% of its registered capital. These reserves are not distributable as cash dividends. If our PRC subsidiaries incur debt on their own behalf in the future, the instruments governing the debt may restrict their ability to pay dividends or make other payments to us. Any limitation on the ability of our PRC subsidiaries to distribute dividends or other payments to their respective shareholders could materially and adversely limit our ability to grow, make investments or acquisitions that could be beneficial to our businesses, pay dividends or otherwise fund and conduct our business. For example, the funds in our PRC subsidiaries or the variable interest entities in the Chinese mainland may not be available to fund operations or for other use outside of the Chinese mainland due to interventions in or the imposition of restrictions and limitations on the ability of our holding company, our subsidiaries, or the variable interest entities by the PRC government on cash transfers. While we are not aware of any similar restrictions under current Hong Kong laws, there is no assurance that such restrictions will not be introduced in the future or that the Hong Kong government will not intervene in or impose restrictions on the ability of a Hong Kong entity to transfer cash or assets out of Hong Kong in the future.

To address the persistent capital outflow and the Renminbi’s depreciation against the U.S. dollar in the fourth quarter of 2016, the People’s Bank of China and the State Administration of Foreign Exchange, or SAFE, have implemented a series of capital control measures in the subsequent months, including stricter vetting procedures for China-based companies to remit foreign currency for overseas acquisitions, dividend payments and shareholder loan repayments. For instance, the Circular on Promoting the Reform of Foreign Exchange Management and Improving Authenticity and Compliance Review, or the SAFE Circular 3, issued on January 26, 2017, provides that the banks shall, when dealing with dividend remittance transactions from domestic enterprise to its offshore shareholders of more than US$50,000, review the relevant board resolutions, original tax filing form and audited financial statements of such domestic enterprise based on the principal of genuine transaction. The PRC government may continue to strengthen its capital controls and our PRC subsidiaries’ dividends and other distributions may be subject to tightened scrutiny in the future. Any limitation on the ability of our PRC subsidiaries to pay dividends or make other distributions to us could materially and adversely limit our ability to grow, make investments or acquisitions that could be beneficial to our business, pay dividends, or otherwise fund and conduct our business.

 

51


Table of Contents

In addition, the Enterprise Income Tax Law and its implementation rules provide that a withholding tax at a rate of 10% will be applicable to dividends payable by Chinese companies to non-PRC-resident enterprises unless reduced under treaties or arrangements between the PRC central government and governments of other countries or regions where the non-PRC resident enterprises are tax resident.

The custodians or authorized users of our controlling nontangible assets, including chops and seals, may fail to fulfill their responsibilities, or misappropriate or misuse these assets.

Under the PRC law, legal documents for corporate transactions, including agreements and contracts are executed using the chop or seal of the signing entity or with the signature of a legal representative whose designation is registered and filed with relevant PRC industry and commerce authorities.

In order to secure the use of our chops and seals, we have established internal control procedures and rules for using these chops and seals. In any event that the chops and seals are intended to be used, the responsible personnel will submit the application which will then be verified and approved by authorized employees in accordance with our internal control procedures and rules. In addition, in order to maintain the physical security of our chops, we generally have them stored in secured locations accessible only to authorized employees. Although we monitor such authorized employees, the procedures may not be sufficient to prevent all instances of abuse or negligence. There is a risk that our employees could abuse their authority, for example, by entering into a contract not approved by us or seeking to gain control of one of our subsidiaries or VIEs. If any employee obtains, misuses or misappropriates our chops and seals or other controlling nontangible assets for whatever reason, we could experience disruption to our normal business operations. We may have to take corporate or legal action, which could involve significant time and resources to resolve and divert management from our operations.

Fluctuations in exchange rates could have a material and adverse effect on our results of operations and the value of your investment.

The value of the Renminbi against the U.S. dollar and other currencies has in the past fluctuated significantly and may in the future continue to do so. Since October 1, 2016, the Renminbi has joined the International Monetary Fund’s basket of currencies that make up the Special Drawing Right, along with the U.S. dollar, the Euro, the Japanese yen and the British pound. With the development of the foreign exchange market and progress towards interest rate liberalization and Renminbi internationalization, the PRC government may in the future announce further changes to the exchange rate system and there is no guarantee that the Renminbi will not appreciate or depreciate significantly in value against the U.S. dollar in the future. It is difficult to predict how market forces or PRC or U.S. government policy may impact the exchange rate between the Renminbi and the U.S. dollar in the future.

A majority of our revenue is denominated in Renminbi. Vast majority of our costs are denominated in Renminbi and a portion of them are denominated in U.S. dollars and Hong Kong dollars as we import certain products from overseas. We are a holding company and we rely on dividends paid by our operating subsidiaries in China for our cash needs. Any significant revaluation of Renminbi may materially and adversely affect our results of operations and financial position reported in Renminbi when translated into U.S. dollars, and the value of, and any dividends payable on, the ADSs in U.S. dollars.

Very limited hedging options are available in China to reduce our exposure to exchange rate fluctuations. As of the date of this annual report, we have entered into two material hedging transactions in an effort to reduce our exposure to foreign currency exchange risk. However, the effectiveness of these hedges may be limited and we may not be able to adequately hedge our exposure or at all. In addition, our currency exchange losses may be magnified by PRC exchange control regulations that restrict our ability to convert Renminbi into foreign currency.

Governmental control of currency conversion may limit our ability to utilize our revenues effectively and affect the value of your investment.

The PRC government imposes controls on the convertibility of the Renminbi into foreign currencies and, in certain cases, the remittance of currency out of China. We receive substantially all of our revenues in Renminbi. Under our current corporate structure, our Cayman Islands holding company primarily relies on dividend payments from our PRC subsidiaries to fund any cash and financing requirements we may have. Under existing PRC foreign exchange regulations, payments of current account items, including profit distributions, interest payments and trade and service-related foreign exchange transactions, can be made in foreign currencies without prior approval of SAFE by complying with certain procedural requirements. Specifically, under the existing exchange restrictions, without prior approval of SAFE, cash generated from the operations of our PRC subsidiaries in China may be used to pay dividends to our company. However, approval from or registration with appropriate government authorities is required where Renminbi is to be converted into foreign currency and remitted out of China to pay capital expenses such as the repayment of loans denominated in foreign currencies. As a result, we need to obtain SAFE approval to use cash generated from the operations of our PRC subsidiaries and the VIEs to pay off their respective debt in a currency other than Renminbi owed to entities outside China, or to make other capital expenditure payments outside China in a currency other than Renminbi.

 

52


Table of Contents

The PRC government has imposed more restrictive foreign exchange policies and scrutiny of major outbound capital movement including overseas direct investment. More restrictions and substantial vetting process are put in place by SAFE to regulate cross-border transactions falling under the capital account. See “Item 4.B. Business Overview—Regulation—Regulations on Foreign Exchange” and “Item 4.B. Business Overview—Regulation—Regulations on Outbound Direct Investment.”

We have notified all PRC entities who directly or indirectly hold shares in our Cayman Islands holding company to complete the overseas direct investment registrations and filings. However, we may not be informed of the identities of all the PRC entities holding direct or indirect interest in our company, nor can we compel our beneficial owners to comply with overseas direct investment registration or filing requirements as required by SAFE, NDRC and MOC regulations. As a result, we cannot assure you that all of our shareholders or beneficial owners which are PRC entities have complied with, and will in the future make, obtain or update any applicable overseas direct investment registrations or approvals. If any of our shareholders regulated by such policies fails to satisfy the applicable overseas direct investment filing or approval requirement timely or at all, it may be subject to penalties from the relevant PRC authorities, and our PRC subsidiaries may be prohibited from distributing their profits and proceeds from any reduction in capital, share transfer or liquidation to us, and we may be further restricted in our ability to contribute additional capital to our PRC subsidiaries. The PRC government may at its discretion further restrict access to foreign currencies for current account transactions in the future. If the foreign exchange control system prevents us from obtaining sufficient foreign currencies to satisfy our foreign currency demands, we may not be able to pay dividends in foreign currencies to our shareholders, including holders of the ADSs. In addition, our shareholders may be required to suspend or stop the investment and complete the registration within a specified time, and may be warned or prosecuted for criminal liability if a crime is constituted. Moreover, failure to comply with the SAFE registration could result in liability under PRC laws for evasion of applicable foreign exchange restrictions.

Certain PRC regulations may make it more difficult for us to pursue growth through acquisitions.

Among other things, the Regulations on Mergers and Acquisitions of Domestic Enterprises by Foreign Investors, or the M&A Rules, adopted by six PRC regulatory agencies in 2006 and amended in 2009, established additional procedures and requirements that could make merger and acquisition activities by foreign investors more time-consuming and complex. Such regulation requires, among other things, that MOFCOM be notified in advance of any change-of-control transaction in which a foreign investor acquires control of a PRC domestic enterprise or a foreign company with substantial PRC operations, if certain thresholds under the Provisions on Thresholds for Prior Notification of Concentrations of Undertakings, issued by the State Council in 2008 and amended in 2018, are triggered. Moreover, the Anti-monopoly Law promulgated by the SCNPC was newly amended on June 24, 2022, which took effect on August 1, 2022. Pursuant to the Revised Anti-monopoly Law, the relevant authority shall investigate a transaction where there is any evidence that the concentration has or may have the effect of eliminating or restricting competitions, even if such concentration does not reach the filing threshold. On February 7, 2021, the Anti-monopoly Commission of the State Council promulgated the Anti-Monopoly Guidelines for the Internet Platform Economy Sector that aims at specifying some of the circumstances under which an activity of internet platforms may be identified as monopolistic act as well as clarifying that concentration of undertakings involving VIE structure shall be subject to anti-monopoly review. In addition, the Rules of the MOFCOM on Implementation of Security Review System of Mergers and Acquisitions of Domestic Enterprises by Foreign Investors issued by MOFCOM, which became effective in September 2011 require acquisitions by foreign investors of PRC companies engaged in military related or certain other industries that are crucial to national security be subject to security review before consummation of any such acquisition. Further, the Measures for the Security Review of Foreign Investments promulgated by the NDRC and MOFCOM which became effective from January 2021 requires that security review by relevant governmental authorities shall be conducted in accordance with the provisions of the Measures for foreign investments that affect or may affect national security. We may pursue potential strategic acquisitions that are complementary to our business and operations. Complying with the requirements of these regulations to complete such transactions could be time-consuming, and any required approval processes, including obtaining approval or clearance from MOFCOM, may delay or inhibit our ability to complete such transactions, which could affect our ability to expand our business or maintain our market share.

PRC regulation of loans to and direct investment in PRC entities by offshore holding companies and governmental control of currency conversion may delay us from making loans or additional capital contributions to our PRC subsidiaries and to make loans to the VIEs, which could materially and adversely affect our liquidity and our ability to fund and expand our business.

We are an offshore holding company conducting our operations in China through our PRC subsidiaries, VIEs and their subsidiaries. We may make loans to our PRC subsidiaries, VIEs and their subsidiaries, or we may make additional capital contributions to our PRC subsidiaries, or we may establish new PRC subsidiaries and make capital contributions to these new PRC subsidiaries, or we may acquire offshore entities with business operations in China in an offshore transaction.

 

53


Table of Contents

Most of these ways are subject to PRC regulations and approvals. For example, loans by us to our wholly owned PRC subsidiaries to finance their activities cannot exceed statutory limits and must be registered with the local counterpart of SAFE. If we decide to finance our wholly owned PRC subsidiaries by means of capital contributions, these capital contributions are subject to the requirement of making necessary filings in the Foreign Investment Comprehensive Management Information System and registration with other governmental authorities in China. Due to the restrictions imposed on loans in foreign currencies extended to any PRC domestic companies, we are not likely to make such loans to our consolidated affiliated entities, which are PRC domestic company. Further, we are not likely to finance the activities of our consolidated affiliated entities by means of capital contributions due to regulatory restrictions relating to foreign investment in PRC domestic enterprises engaged in value-added telecommunication services and certain other businesses.

SAFE promulgated Circular on the Reforming of the Management Method of the Settlement of Foreign Currency Capital of Foreign-invested Enterprises, or SAFE Circular 19, effective on June 1, 2015 and recently amended on March 23, 2023, in replacement of the Circular on the Relevant Issues Concerning the Launch of Reforming Trial of the Administration Model of the Settlement of Foreign Currency Capital of Foreign-Invested Enterprises, the Notice from the State Administration of Foreign Exchange on Relevant Issues Concerning Strengthening the Administration of Foreign Exchange Businesses, and the Circular on Further Clarification and Regulation of the Issues Concerning the Administration of Certain Capital Account Foreign Exchange Businesses. According to SAFE Circular 19, the flow and use of the Renminbi capital converted from foreign currency-denominated registered capital of a foreign-invested company is regulated such that Renminbi capital may not be used for the issuance of Renminbi entrusted loans, the repayment of inter-enterprise loans or the repayment of banks loans that have been transferred to a third party. Although SAFE Circular 19 allows Renminbi capital converted from foreign currency-denominated registered capital of a foreign-invested enterprise to be used for equity investments within China, it also reiterates the principle that Renminbi capital converted from the foreign currency-denominated capital of a foreign-invested company may not be directly or indirectly used for purposes beyond its business scope. Thus, it is unclear whether SAFE will permit such capital to be used for equity investments in China in actual practice. SAFE promulgated the Notice of the State Administration of Foreign Exchange on Reforming and Standardizing the Foreign Exchange Settlement Management Policy of Capital Account, or SAFE Circular 16, effective on June 9, 2016, which reiterates some of the rules set forth in SAFE Circular 19, but changes the prohibition against using Renminbi capital converted from foreign currency-denominated registered capital of a foreign-invested company to issue Renminbi entrusted loans to a prohibition against using such capital to issue loans to nonassociated enterprises. Violations of SAFE Circular 19 and SAFE Circular 16 could result in administrative penalties. SAFE Circular 19 and SAFE Circular 16 may significantly limit our ability to transfer any foreign currency we hold, including the net proceeds from our initial public offering, to our PRC subsidiaries, which may adversely affect our liquidity and our ability to fund and expand our business in China.

On October 23, 2019, SAFE promulgated the Notice of the State Administration of Foreign Exchange on Further Promoting the Convenience of Cross-border Trade and Investment, or SAFE Circular 28, which, among other things, allows all foreign-invested companies to use Renminbi converted from foreign currency-denominated capital for equity investments in China, as long as the equity investment is genuine, does not violate applicable laws, and complies with the negative list on foreign investment. However, since SAFE Circular 28 is newly promulgated, it is unclear how SAFE and competent banks will carry this out in practice.

In light of the various requirements imposed by PRC regulations on loans to and direct investment in PRC entities by offshore holding companies, we cannot assure you that we will be able to complete the necessary government registrations or obtain the necessary government approvals on a timely basis, if at all, with respect to future loans by us to our PRC subsidiaries or with respect to future capital contributions by us to our PRC subsidiaries. If we fail to complete such registrations or obtain such approvals, our ability to use the proceeds we received from our initial public offering and to capitalize or otherwise fund our PRC operations may be negatively affected, which could materially and adversely affect our liquidity and our ability to fund and expand our business.

PRC regulations relating to the establishment of offshore special purpose companies by PRC residents may subject our PRC resident beneficial owners or our PRC subsidiaries to liability or penalties, limit our ability to inject capital into our PRC subsidiaries, limit our PRC subsidiaries’ ability to increase their registered capital or distribute profits to us, or may otherwise adversely affect us.

SAFE promulgated the Circular on Issues Concerning the Foreign Exchange Administration over the Overseas Investment and Financing and Round-trip Investment by Domestic Residents via Special Purpose Vehicles, or SAFE Circular 37, in July 2014. SAFE Circular 37 requires PRC residents or entities to register with SAFE or its local branches in connection with their establishment or control of an offshore entity established for the purpose of overseas investment or financing with such PRC residents or entities’ legally owned assets or equity interests in domestic enterprises or offshore assets or interests. In addition, such PRC residents or entities must update their SAFE registrations when the offshore special purpose vehicle undergoes material events relating to any change of basic information (including change of such PRC citizens or residents, name and operation term), increases or decreases in investment amount, transfers or exchanges of shares, or mergers or divisions. According to the Circular of Further Simplifying and Improving the Policies of Foreign Exchange Administration Applicable to Direct Investment released in February 2015 by SAFE, local banks will examine and handle foreign exchange registration for overseas direct investment, including the initial foreign exchange registration and amendment registration, under SAFE Circular 37 from June 2015. See “Item 4. Information on the Company—4.B. Business Overview—Regulation—Regulations on Foreign Exchange” and “Item 4. Information on the Company—4.B. Business Overview—Regulation—Regulations on Offshore Special Purpose Companies Held by PRC Residents.”

 

54


Table of Contents

If our shareholders who are PRC residents or entities do not complete their registration with the local SAFE, NDRC or MOC branches, our PRC subsidiaries may be prohibited from distributing their profits and proceeds from any reduction in capital, share transfer or liquidation to us, and we may be restricted in our ability to contribute additional capital to our PRC subsidiaries. In addition, our shareholders may be required to suspend or stop the investment and complete the registration within a specified time, and may be warned or prosecuted for criminal liability if a crime is constituted. Moreover, failure to comply with the SAFE registration described above could result in liability under PRC laws for evasion of applicable foreign exchange restrictions.

We have notified all PRC residents or entities who directly or indirectly hold shares in our Cayman Islands holding company and who are known to us as being PRC residents to complete the foreign exchange registrations. However, we may not be informed of the identities of all the PRC residents or entities holding direct or indirect interest in our company, nor can we compel our beneficial owners to comply with SAFE registration requirements. As a result, we cannot assure you that all of our shareholders or beneficial owners who are PRC residents or entities have complied with, and will in the future make, obtain or update any applicable registrations or approvals required by SAFE regulations. Failure by such shareholders or beneficial owners to comply with SAFE regulations, or failure by us to amend the foreign exchange registrations of our PRC subsidiaries, could subject us to fines or legal sanctions, restrict our overseas or cross-border investment activities, limit our PRC subsidiaries’ ability to make distributions or pay dividends to us or affect our ownership structure, which could adversely affect our business and prospects.

Furthermore, as these foreign exchange regulations are still relatively new and their interpretation and implementation has been constantly evolving, it is unclear how these regulations, and any future regulation concerning offshore or cross-border transactions, will be interpreted, amended and implemented by the relevant government authorities. For example, we may be subject to a more stringent review and approval process with respect to our foreign exchange activities, such as remittance of dividends and foreign-currency-denominated borrowings, which may adversely affect our financial condition and results of operations. In addition, if we decide to acquire a PRC domestic company, we cannot assure you that we or the owners of such company, as the case may be, will be able to obtain the necessary approvals or complete the necessary filings and registrations required by the foreign exchange regulations. This may restrict our ability to implement our acquisition strategy and could adversely affect our business and prospects.

Any failure to comply with PRC regulations regarding the registration requirements for employee stock incentive plans may subject the PRC plan participants or us to fines and other legal or administrative sanctions.

In February 2012, SAFE promulgated the Notices on Issues Concerning the Foreign Exchange Administration for Domestic Individuals Participating in Stock Incentive Plan of Overseas Publicly Listed Company, replacing earlier rules promulgated in 2007 and 2008. Pursuant to these rules, PRC citizens and non-PRC citizens who reside in China for a continuous period of not less than one year who participate in any stock incentive plan of an overseas publicly listed company, subject to a few exceptions, are required to register with SAFE through a domestic qualified agent, which could be the PRC subsidiaries of such overseas-listed company, and complete certain other procedures. In addition, an overseas-entrusted institution must be retained to handle matters in connection with the exercise or sale of stock options and the purchase or sale of shares and interests. We and our executive officers and other employees who are PRC citizens or who reside in the PRC for a continuous period of not less than one year and who have been granted options have become subject to these regulations when our company became an overseas-listed company. Failure to complete the SAFE registrations may subject them to fines and legal sanctions, there may be additional restrictions on the ability of them to exercise their stock options or remit proceeds gained from sale of their stock into the PRC. We also face regulatory uncertainties that could restrict our ability to adopt additional incentive plans for our directors, executive officers and employees under PRC law. See “Item 4. Information on the Company—4.B. Business Overview—Regulation—Regulations on Stock Incentive Plans.”

If we are classified as a PRC resident enterprise for PRC enterprise income tax purposes, such classification could result in unfavorable tax consequences to us and our non-PRC shareholders and ADS holders.

Under the PRC Enterprise Income Tax Law and its implementation rules, an enterprise established outside of the PRC with its “de facto management body” within the PRC is considered a “resident enterprise” and will be subject to the enterprise income tax on its global income at the rate of 25%. The implementation rules define the term “de facto management body” as the body that exercises full and substantial control and overall management over the business, productions, personnel, accounts and properties of an enterprise. In 2009, the State Taxation Administration, or STA, issued a circular, known as STA Circular 82, which provides certain specific criteria for determining whether the “de facto management body” of a PRC-controlled enterprise that is incorporated offshore is located in China. Although this circular only applies to offshore enterprises controlled by PRC enterprises or PRC enterprise groups, not those controlled by PRC individuals or foreigners, the criteria set forth in the circular may reflect the STA’s general position on how the “de facto management body” text should be applied in determining the tax resident status of all offshore enterprises. According to STA Circular 82, an offshore incorporated enterprise controlled by a PRC enterprise or a PRC enterprise group will be regarded as a PRC tax resident by virtue of having its “de facto management body” in mainland China, and will be subject to PRC enterprise income tax on its global income only if all of the following conditions are met: (i) the primary location of the day-to-day operational management is in the PRC; (ii) decisions relating to the enterprise’s financial and human resource matters are made or are subject to approval by organizations or personnel in the PRC; (iii) the enterprise’s primary assets, accounting books and records, company seals, and board and shareholder resolutions are located or maintained in the PRC; and (iv) at least 50% of voting board members or senior executives habitually reside in the PRC.

 

55


Table of Contents

We believe our company is not a PRC resident enterprise for PRC tax purposes. However, the tax resident status of an enterprise is subject to determination by the PRC tax authorities and uncertainties remain with respect to the interpretation of the term “de facto management body.” If the PRC tax authorities determine that our company is a PRC resident enterprise for enterprise income tax purposes, we will be subject to PRC enterprise income tax on our worldwide income at the rate of 25%. Furthermore, we will be required to withhold a 10% withholding tax from dividends we pay to our shareholders that are nonresident enterprises, including the holders of the ADSs. In addition, nonresident enterprise shareholders (including our ADS holders) may be subject to PRC tax at a rate of 10% on gains realized on the sale or other disposition of ADSs or ordinary shares, if such gain is treated as derived from a PRC source. Furthermore, if we are deemed a PRC resident enterprise, dividends paid to our non-PRC individual shareholders (including our ADS holders) and any gain realized on the transfer of ADSs or ordinary shares by such shareholders may be subject to PRC tax at a rate of 20% (which, in the case of dividends, may be withheld at source by us). These rates may be reduced by an applicable tax treaty. For example, PRC Enterprise Income Tax Law imposes a withholding income tax of 10% on dividends distributed by a foreign invested enterprise, or an FIE, to its immediate holding company outside of mainland China. A lower withholding income tax rate of 5% is applied if the FIE’s immediate holding company is registered in Hong Kong or other jurisdictions that have a tax treaty arrangement with mainland China, subject to a qualification review at the time of the distribution. But it is unclear whether non-PRC shareholders of our company would, in practice, be able to obtain the benefits of any tax treaties between their country of tax residence and the mainland China in the event that we are treated as a PRC resident enterprise. Any such tax may reduce the returns on your investment in the ADSs or ordinary shares.

We face uncertainty with respect to indirect transfers of equity interests in PRC resident enterprises by their non-PRC holding companies.

On February 3, 2015, the State Tax Administration, or the STA, issued the Public Notice Regarding Certain Corporate Income Tax Matters on Indirect Transfer of Properties by Non-Tax Resident Enterprises, or STA Bulletin 7. STA Bulletin 7 extends its tax jurisdiction to transactions involving the transfer of taxable assets through offshore transfer of a foreign intermediate holding company. In addition, STA Bulletin 7 has introduced safe harbors for internal group restructurings and the purchase and sale of equity through a public securities market. STA Bulletin 7 also brings challenges to both foreign transferor and transferee (or other person who is obligated to pay for the transfer) of taxable assets.

On October 17, 2017, the STA issued the Announcement of the State Administration of Taxation on Issues Concerning the Withholding of Nonresident Enterprise Income Tax at Source, or STA Bulletin 37, which came into effect on December 1, 2017 and amended on June 15, 2018. The STA Bulletin 37 further clarifies the practice and procedure of the withholding of nonresident enterprise income tax.

Where a nonresident enterprise transfers taxable assets indirectly by disposing of the equity interests of an overseas holding company, which is an Indirect Transfer, the nonresident enterprise as either transferor or transferee, or the PRC entity that directly owns the taxable assets, may report such Indirect Transfer to the relevant tax authority. Using a “substance over form” principle, the PRC tax authority may disregard the existence of the overseas holding company if it lacks a reasonable commercial purpose and was established for the purpose of reducing, avoiding or deferring PRC tax. As a result, gains derived from such Indirect Transfer may be subject to PRC enterprise income tax, and the transferee or other person who is obligated to pay for the transfer is obligated to withhold the applicable taxes, currently at a rate of 10% for the transfer of equity interests in a PRC resident enterprise. Both the transferor and the transferee may be subject to penalties under PRC tax laws if the transferee fails to withhold the taxes and the transferor fails to pay the taxes.

We face uncertainties as to the reporting and other implications of certain past and future transactions where PRC taxable assets are involved, such as offshore restructuring, sale of the shares in our offshore subsidiaries and investments. Our company may be subject to filing obligations or taxed if our company is the transferor in such transactions, and may be subject to withholding obligations if our company is the transferee in such transactions, under STA Bulletin 7 and/or STA Bulletin 37. For transfer of shares in our company by investors who are non-PRC resident enterprises, our PRC subsidiaries may be requested to assist in the filing under STA Bulletin 7 and/or STA Bulletin 37. As a result, we may be required to expend valuable resources to comply with STA Bulletin 7 and/or STA Bulletin 37 or to request the relevant transferors from whom we purchase taxable assets to comply with these circulars, or to establish that our company should not be taxed under these circulars, which may have a material adverse effect on our financial condition and results of operations.

Trading in our securities will be prohibited under the HFCAA if the PCAOB determines that it is unable to inspect or investigate completely registered public accounting firms headquartered in mainland China and Hong Kong, including our auditor as an independent registered public accounting firm, and as a result, U.S. national securities exchanges, such as the NYSE, may determine to delist our securities.

U.S. legislators and regulators have in recent years voiced concerns about risks associated with investing in companies that are based in or have substantial operations in emerging markets, including China. In particular, lawmakers have highlighted the increased risks associated with companies whose independent auditors are unable to be inspected or investigated completely by the PCAOB.

 

56


Table of Contents

As part of this continued focus in the United States on access to audit and other information currently protected by national law, in particular China’s, on December 18, 2020, the U.S. president signed the Holding Foreign Companies Accountable Act, or the HFCAA, into law. Among other things, the HFCAA requires the SEC to identify public companies that have retained a registered public accounting firm to issue an audit report where the firm has a branch or office that: (i) is located in a foreign jurisdiction, and (ii) the Public Company Accounting Oversight Board, or the PCAOB, has determined that it is unable to inspect or investigate completely because of a position taken by an authority in the foreign jurisdiction. On December 29, 2022, the U.S. President signed the “Consolidated Appropriations Act, 2023” into law, which, among other things, amended the HFCAA to reduce the number of consecutive years an issuer can be identified as a Commission-Identified Issuer before the SEC must impose an initial trading prohibition on the issuer’s securities from three years to two years. Therefore, if we are identified as a Commission-Identified Issuer for two consecutive years, the SEC is required under the HCFAA to prohibit the trading of our securities on a U.S. national securities exchange and in the over-the-counter market.

On December 16, 2021, the PCAOB issued the HFCAA Determination Report, according to which registered public accounting firms headquartered in mainland China and Hong Kong, including our auditor, are subject to the determinations that the PCAOB is unable to inspect or investigate completely. On August 22, 2022, we were conclusively identified by the SEC under the HFCAA as having filed audit reports issued by a registered public accounting firm that cannot be inspected or investigated completely by the PCAOB in connection with the filing of our annual report on the Form 20-F for the fiscal year ended March 31, 2022. The inability of the PCAOB to conduct inspections in the past also deprived our investors of the benefits of such inspections.

On August 26, 2022, the PCAOB signed a Statement of Protocol with China Securities Regulatory Commission, or the CSRC, and the Ministry of Finance of the People’s Republic of China, taking the first step toward opening access for the PCAOB to inspect and investigate registered public accounting firms headquartered in mainland China and Hong Kong. On December 15, 2022, the PCAOB announced that it was able to conduct inspections and investigations completely of PCAOB-registered public accounting firms headquartered in mainland China and Hong Kong in 2022. The PCAOB vacated its previous 2021 determinations accordingly. While vacating those determinations, each year, the PCAOB will determine whether it can inspect and investigate completely accounting firms headquartered in mainland China and Hong Kong. Whether the PCAOB will be able to continue to conduct inspections of registered public accounting firms headquartered in mainland China and Hong Kong, including our auditor, in the two consecutive years, or at all, are subject to substantial uncertainty and depends on factors out of our control or the control of registered public accounting firms headquartered in mainland China and Hong Kong (including our auditor). Uncertainties exist with respect to the implementation of this framework and there is no assurance that the PCAOB will be able to have continued access for complete inspections and investigations in 2023 and beyond. The delisting of our ADSs, or the threat of their being delisted, may materially and adversely affect the value of your investment. The HFCAA or other efforts to increase U.S. regulatory access to audit information could cause investor uncertainty for affected issuers, including us, and the market price of our ADSs could be adversely affected.

If our ADSs are delisted from the NYSE and are prohibited from trading in the over-the-counter market in the United States, there is no certainty that we will be able to list our securities on a non-U.S. securities exchange or that a market for our securities will develop outside of the United States. Such a delisting would significantly affect our ability to raise capital on terms acceptable to us, or at all, which would have a material adverse impact on our business, financial condition, results of operations and prospects.

 

57


Table of Contents

Changes in U.S. and international policies, particularly with regard to China, may adversely impact our business and operating results.

Recently there have been changes in international trade policies and rising political tensions, particularly between the U.S. and China, but also as a result of the war in Ukraine and sanctions on Russia. For instance, the U.S. government has in the past imposed, additional, new, or higher tariffs on certain products imported from China to penalize China for what it characterizes as unfair trade practices. China has responded by imposing additional, new, or higher tariffs on certain products imported from the United States. Although the United States and China entered into the Economic and Trade Agreement between the United States of America and the People’s Republic of China as a phase one trade deal, effective on February 14, 2020, it is uncertain whether there will be any further material changes to tariff policies. Any unfavorable government policies on international trade, such as capital controls or tariffs, may affect our business, financial condition and results of operations. If any new tariffs, legislation and/or regulations are implemented, or if existing trade agreements are renegotiated or, in particular, if the U.S. government takes retaliatory trade actions due to the recent U.S.-China trade tension, such changes could have an adverse effect on our business, financial condition and results of operations.

In addition to the proposed U.S. legislation and policies relating to Chinese companies’ compliance with applicable U.S. securities laws, our business and prospect may also be negatively affected by other changes in governmental policies including sanctions and export controls administered by U.S. government authorities, including those imposed as a result of a material deterioration of the political or economic relations between China and the United States and other geopolitical challenges. There is no assurance that the governmental authorities in the United States will not take any such actions against us or affiliates in the event the tensions between China and the United States escalate, which could result in a material and adverse impact on our business and prospect.

Risks Related to our Class A Ordinary Shares and our ADSs

We face possible delisting by the NYSE due to non-compliance with the continued listing standards of the NYSE.

We are required to meet certain quantitative tests as well as corporate governance and other qualitative standards to maintain the listing of our ADSs on the NYSE. It is possible that we could fail to satisfy one or more of these requirements.

We received a deficiency letter from the NYSE dated April 5, 2022 notifying us that we were not in compliance with the continued listing standards of the NYSE. The noncompliance arose from our total market capitalization deficiency as our total market capitalization was less than $50 million over a 30 trading-day period and our stockholders’ equity was less than $50 million. Our total market capitalization remains subject to wide fluctuations due to factors beyond our control, such as broad market industry and regulatory factors, and may thus continue to fall. As required by the NYSE Listed Company Manual, we have submitted a detailed plan of compliance to the NYSE, advising the NYSE of the actions we have taken, or plans to take, that would bring us into compliance with the continued listing standards within 18 months of receipt of the deficiency letter. The NYSE has agreed to accept our submission and is currently reviewing our plan. There is no assurance that we will be able to successfully execute our plan within the required 18-month period and regain compliance. If we fail to return to compliance by the end of that period, the NYSE will delist our ADSs. If that occurs, the liquidity of our securities could be significantly impacted, as any trading in our securities would no longer be executed over the NYSE.

 

58


Table of Contents

In addition, pursuant to the NYSE Listed Company Manual, a company is considered to be below compliance standards if the average closing price of a security as reported on the consolidated tape is less than $1.00 over a consecutive 30 trading-day period. We received a letter from the NYSE dated January 26, 2022, notifying us that we were below the foregoing compliance standard. Once notified, a company must bring its share price and average share price back above $1.00 within six months following receipt of the notification. If on the last trading day of any calendar month during the cure period the company has a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month, then the company can regain compliance at any time during the six-month cure period. In the event that at the expiration of the six-month cure period, both a $1.00 closing share price on the last trading day of the cure period and a $1.00 average closing share price over the 30 trading-day period ending on the last trading day of the cure period are not attained, the NYSE will commence suspension and delisting procedures. To address this issue, we have changed the ratio of our ADSs to Class A ordinary shares from one (1) ADS representing three fourths (0.75) Class A ordinary shares to one (1) ADS representing four and a half (4.5) Class A ordinary shares (the “ADS Ratio Change”), which became effective on June 3, 2022. The NYSE issued a letter on July 1, 2022 notifying the Company that it is no longer considered below the $1.00 continued listing criterion.

Furthermore, there can be no assurance that we will be able to maintain compliance with any other continued listing requirements of the NYSE. In the event of deficiency or non-compliance, we could receive notices from the NYSE and suffer loss of investor confidence and trading price decline. If we fail to regain compliance in time, we could face trading suspension or even delisting from the NYSE, which could make it more difficult to obtain accurate quotations of and buy or sell our securities, and the price of our securities could suffer further significant decline. Delisting may also impair our ability to raise capital and harm our reputation.

The trading price of the ADSs is likely to be volatile, which could result in substantial losses to investors.

The trading price of the ADSs is likely to be volatile and could fluctuate widely due to factors beyond our control. This may happen because of broad market and industry factors, including the performance and fluctuation of the market prices of other companies with business operations located mainly in China that have listed their securities in the United States. In addition to market and industry factors, the price and trading volume for the ADSs may be highly volatile for factors specific to our own operations, including the following:

 

   

actual or anticipated fluctuations in our results of operations, e.g., net revenues, earnings and cash flows;

 

   

the financial projections we may provide to the public, any changes in these projections or our failure to meet these projections;

 

   

announcements of significant technical innovations, new investments, acquisitions, strategic partnerships, joint ventures, results of operations or capital commitments by us or our competitors;

 

   

announcements of new offerings, solutions and expansions by us or our competitors;

 

   

failure of securities analysts to initiate or maintain coverage of our company, changes in financial estimates or ratings by any securities analysts who follow our company or our failure to meet these estimates or the expectations of investors;

 

   

detrimental adverse publicity about us, our services or our industry;

 

   

announcements of new regulations, rules or policies relevant to our business;

 

   

additions or departures of key personnel;

 

   

release of lock-up or other transfer restrictions on our outstanding equity securities or sales of additional equity securities;

 

   

potential litigation or regulatory investigations; and

 

   

other events or factors, including those resulting from war, epidemics, incidents of terrorism or responses to these events.

Any of these factors may result in large and sudden changes in the volume and price at which the ADSs will trade.

In addition, the stock market in general, and the performance and fluctuation of the market prices for internet-related companies and other companies with operations mainly in China in particular, may affect the volatility in the prices of and trading volumes for our ADSs. The securities of some China-based companies that have listed their securities in the United States have experienced significant volatility that often has been unrelated to the operating performance of such companies, including, in some cases, substantial declines in the trading prices of their securities. The trading performances of these companies’ securities may affect the attitudes of investors towards Chinese companies listed in the United States in general, which consequently may impact the trading performance of our ADSs, regardless of our actual operating performance. In addition, any negative news or perceptions about inadequate corporate governance practices or fraudulent accounting, corporate structure or other matters of other Chinese companies may also negatively affect the attitudes of investors towards Chinese companies in general, including us, regardless of whether we have engaged in any inappropriate activities. In particular, the global financial crisis, the ensuing economic recessions and deterioration in the credit market in many countries have contributed and may continue to contribute to extreme volatility in the global stock markets. These broad market and industry fluctuations may adversely affect the market price of our ADSs. Volatility or a lack of positive performance in our ADS price may also adversely affect our ability to retain key employees, most of whom have been granted options or other equity incentives.

 

59


Table of Contents

In the past, shareholders of public companies have often brought securities class action suits against those companies following periods of instability in the market price of their securities. If we were involved in a class action suit, it could divert a significant amount of our management’s attention and other resources from our business and operations and require us to incur significant expenses to defend the suit, which could harm our results of operations. Any such class action suit, whether or not successful, could harm our reputation and restrict our ability to raise capital in the future. In addition, if a claim is successfully made against us, we may be required to pay significant damages, which could have a material adverse effect on our financial condition and results of operations.

Our dual-class share structure with different voting rights will limit your ability to influence corporate matters and could discourage others from pursuing any change of control transactions that holders of our Class A ordinary shares and the ADSs may view as beneficial.

We have adopted a dual-class share structure such that our ordinary shares consist of Class A ordinary shares and Class B ordinary shares. In respect of matters requiring the votes of shareholders, each Class A ordinary share is entitled to one vote, and each Class B ordinary share is entitled to 20 votes. Each Class B ordinary share is convertible into one Class A ordinary share at any time by the holder thereof, while Class A ordinary shares are not convertible into Class B ordinary shares under any circumstances. Upon any sale, transfer, assignment or disposition of any Class B ordinary shares by a holder thereof to any person who is not a Founder (as such term is defined under our Post-IPO MAA) or an affiliate of a Founder, or upon a change of ultimate beneficial ownership of any Class B ordinary share to a person who is not a Founder or an affiliate of a Founder, each of such Class B ordinary shares will be automatically and immediately converted into one Class A ordinary share. There is no limit on the circumstances where holders of Class B ordinary shares may transfer or otherwise dispose of their Class B ordinary shares. Mr. Hao (Louis) Liang, Ms. Yingzhi (Lisa) Tang and a former director beneficially owns all of our issued Class B ordinary shares. As of March 31, 2023, they in the aggregate held approximately 18.4% of our total issued and outstanding share capital and 81.9% of the aggregate voting power of our total issued and outstanding share.

As a result of this dual-class share structure, the holders of our Class B ordinary shares will have complete control over the outcome of matters put to a vote of shareholders and have significant influence over our business, including decisions regarding mergers, consolidations, liquidations and the sale of all or substantially all of our assets, election of directors and other significant corporate actions. The holders of Class B ordinary shares control the outcome of a shareholder vote (i) with respect to matters requiring an ordinary resolution which requires the affirmative vote of a simple majority of shareholder votes, to the extent that the Class B ordinary shares represent at least 4.8% of our total issued and outstanding share capital; and (ii) with respect to matters requiring a special resolution which requires the affirmative vote of no less than two-thirds of shareholder votes, to the extent that the Class B ordinary shares represent at least 9.1% of our total issued and outstanding share capital. The holders of Class B ordinary shares may take actions that are not in the best interest of us or our other shareholders or holders of the ADSs. It may discourage, delay or prevent a change in control of our company, which could have the effect of depriving our other shareholders of the opportunity to receive a premium for their shares as part of a sale of our company and may reduce the price of the ADSs. This concentrated control will limit your ability to influence corporate matters and could discourage others from pursuing any potential merger, takeover or other change of control transactions that holders of Class A ordinary shares and ADSs may view as beneficial.

Future issuances of our Class B ordinary shares, which can be approved by our board of directors, could result in dilution to existing holders of our Class A ordinary shares. Such issuances, or the perception that such issuances may occur, could depress the market price of our ADSs. We may issue additional equity securities from time to time, including Class B ordinary shares. As a result, holders of ADSs bear the risk that future issuances of equity securities may reduce the value of their ADSs and dilute their ownership interests. In addition, any conversion of any Class B ordinary shares into Class A ordinary shares, at the option of any holder of Class B ordinary shares, would dilute holders of Class A ordinary shares in terms of voting power and beneficial ownership and as a result, the market price of our ADSs could be adversely affected. Furthermore, the conversion of Class B ordinary shares to Class A ordinary shares, while increasing the absolute voting power of holders of our Class A ordinary shares, may have the effect of increasing the relative voting power of the holders of Class B ordinary shares who retain their shares in the long term. As a result, the relative voting power of holders of Class A ordinary shares may remain limited for a significant period of time.

The dual-class structure of our ordinary shares may adversely affect the trading market for our ADSs.

S&P Dow Jones and FTSE Russell have announced changes to their eligibility criteria for inclusion of shares of public companies on certain indices, including the S&P 500, to exclude companies with multiple classes of shares and companies whose public shareholders hold no more than 5% of total voting power from being added to such indices. In addition, several shareholder advisory firms have announced their opposition to the use of multiple class structures. As a result, the dual class structure of our ordinary shares may prevent the inclusion of our ADSs representing Class A ordinary shares in such indices and may cause shareholder advisory firms to publish negative commentary about our corporate governance practices or otherwise seek to cause us to change our capital structure. Any such exclusion from indices could result in a less active trading market for our ADSs. Any actions or publications by shareholder advisory firms critical of our corporate governance practices or capital structure could also adversely affect the value of our ADSs.

 

60


Table of Contents

If securities or industry analysts do not publish research or reports about our business, or if they adversely change their recommendations regarding the ADSs, the market price for the ADSs and trading volume could decline.

The trading market for the ADSs will be influenced by research or reports that industry or securities analysts publish about our business, our market and our competitors. We do not have any control over these analysts. If one or more analysts who cover us downgrade the ADSs or change their opinion on the ADSs, the market price for the ADSs would likely decline. If one or more of these analysts cease to cover us or fail to regularly publish reports on us, we could lose visibility in the financial markets, which in turn could cause the market price or trading volume for the ADSs to decline.

The sale or availability for sale of substantial amounts of ADSs could adversely affect their market price.

Sales of substantial amounts of ADSs in the public market, or the perception that these sales could occur, could adversely affect the market price of the ADSs and could materially impair our ability to raise capital through equity offerings in the future. We cannot predict what effect, if any, market sales of securities held by our significant shareholders or any other shareholder or the availability of these securities for future sale will have on the market price of the ADSs.

Techniques employed by short sellers may drive down the market price of the ADSs.

Short selling is the practice of selling securities that the seller does not own but rather has borrowed from a third-party with the intention of buying identical securities back at a later date to return to the lender. The short seller hopes to profit from a decline in the value of the securities between the sale of the borrowed securities and the purchase of the replacement shares, as the short seller expects to pay less in that purchase than it received in the sale. As it is in the short seller’s interest for the price of the security to decline, many short sellers publish, or arrange for the publication of, negative opinions regarding the relevant issuer and its business prospects in order to create negative market momentum and generate profits for themselves after selling a security short. These short attacks have, in the past, led to selling of shares in the market.

Public companies that have substantially all of their operations in China have been the subject of short selling. Much of the scrutiny and negative publicity has centered on allegations of a lack of effective internal control over financial reporting resulting in financial and accounting irregularities and mistakes, inadequate corporate governance policies or a lack of adherence thereto and, in many cases, allegations of fraud. As a result, many of these companies are now conducting internal and external investigations into the allegations and, in the interim, are subject to shareholder lawsuits and/or SEC enforcement actions.

It is not clear what effect such negative publicity could have on us. If we were to become the subject of any unfavorable allegations, whether such allegations are proven to be true or untrue, we could have to expend a significant amount of resources to investigate such allegations and/or defend ourselves. While we would strongly defend against any such short seller attacks, we may be constrained in the manner in which we can proceed against the relevant short seller by principles of freedom of speech, applicable state law or issues of commercial confidentiality. Such a situation could be costly and time-consuming, and could distract our management from growing our business. Even if such allegations are ultimately proven to be groundless, allegations against us could severely impact our business operations, and any investment in the ADSs could be greatly reduced or even rendered worthless.

Because we will not pay dividends in the foreseeable future, you must rely on a price appreciation of the ADSs for a return on your investment.

We currently intend to retain most, if not all, of our available funds and any future earnings to fund the development and growth of our business. As a result, we will not pay any cash dividends in the foreseeable future. Therefore, you should not rely on an investment in the ADSs as a source for any future dividend income.

Our Board of Directors has discretion as to whether to distribute dividends, subject to certain requirements of Cayman Islands law. In addition, our shareholders may by ordinary resolution declare a dividend, but no dividend may exceed the amount recommended by our board of directors. In either case, all dividends are subject to certain restrictions under Cayman Islands law, namely that our company may pay a dividend out of either profit or share premium account, and provided always that in no circumstances may a dividend be paid if this would result in the company being unable to pay its debts as they fall due in the ordinary course of business. Even if our Board of Directors decides to declare and pay dividends, the timing, amount and form of future dividends, if any, will depend on our future results of operations and cash flow, our capital requirements and surplus, the amount of distributions, if any, received by us from our subsidiaries, our financial condition, contractual restrictions and other factors deemed relevant by our Board of Directors. Accordingly, the return on your investment in the ADSs will likely depend entirely upon any future price appreciation of the ADSs. There is no guarantee that the ADSs will appreciate in value or even maintain the price at which you purchased the ADSs. You may not realize a return on your investment in our ADSs and you may even lose your entire investment in the ADSs.

 

61


Table of Contents

You may face difficulties in protecting your interests, and your ability to protect your rights through U.S. courts may be limited, because we are incorporated under Cayman Islands law.

We are an exempted company with limited liability incorporated under the laws of the Cayman Islands. Our corporate affairs are governed by our memorandum and articles of association, as amended from time to time, the Companies Act (As Revised), or the Companies Act, of the Cayman Islands and the common law of the Cayman Islands. The rights of shareholders to take action against our directors, actions by our minority shareholders and the fiduciary duties of our directors to us under Cayman Islands law are to a large extent governed by the common law of the Cayman Islands. The common law of the Cayman Islands is derived in part from comparatively limited judicial precedent in the Cayman Islands as well as from the common law of England and Wales, the decisions of whose courts are of persuasive authority, but are not binding, on a court in the Cayman Islands. The rights of our shareholders and the fiduciary duties of our directors under Cayman Islands law are not as clearly established as they would be under statutes or judicial precedent in some jurisdictions in the United States. In particular, the Cayman Islands have a less developed body of securities laws than the United States. Some U.S. states, such as Delaware, have more fully developed and judicially interpreted bodies of corporate law than the Cayman Islands. In addition, Cayman Islands companies may not have standing to initiate a shareholder derivative action in a federal court of the United States.

Shareholders of Cayman Islands exempted companies like us have no general rights under Cayman Islands law to inspect corporate records (other than the memorandum and articles of association, the register of mortgages and charges and any special resolutions passed by shareholders and a list of current directors) or to obtain copies of lists of shareholders of these companies. Our directors have discretion under our twelfth amended and restated memorandum and articles of association currently in effect, or the Post-IPO MAA, to determine whether or not, and under what conditions, our corporate records may be inspected by our shareholders, but are not obliged to make them available to our shareholders. This may make it more difficult for you to obtain the information needed to establish any facts necessary for a shareholder motion or to solicit proxies from other shareholders in connection with a proxy contest.

Certain corporate governance practices in the Cayman Islands, which is our home country, differ significantly from requirements for companies incorporated in other jurisdictions such as the United States. If we choose to follow home country practice, our shareholders may be afforded less protection than they otherwise would under rules and regulations applicable to U.S. domestic issuers.

As a result of all of the above, our public shareholders may have more difficulty in protecting their interests in the face of actions taken by our management or members of the board of directors than they would as public shareholders of a company incorporated in the United States. For a discussion of significant differences between the provisions of the Companies Act of the Cayman Islands and the laws applicable to companies incorporated in the United States and their shareholders, see “Item 10. Additional Information—10.B. Memorandum and Articles of Association.”

Certain judgments obtained against us by our shareholders may not be enforceable.

We are an exempted company limited by shares incorporated under the laws of the Cayman Islands and substantially all of our assets are located outside of the United States. Substantially all of our current operations are conducted in China. In addition, all of our current directors and officers are nationals and residents of countries other than the United States. Substantially all of the assets of these persons are located outside the United States. As a result, it may be difficult or impossible for you to bring an action against us or against these individuals in the United States in the event that you believe that your rights have been infringed under the U.S. federal securities laws or otherwise. Even if you are successful in bringing an action of this kind, the laws of the Cayman Islands and of China may render you unable to enforce a judgment against our assets or the assets of our directors and officers. However, the deposit agreement gives you the right to submit claims against us to binding arbitration, and arbitration awards may be enforceable against us and our assets in China even when court judgments are not.

ADSs holders may not be entitled to a jury trial with respect to claims arising under the deposit agreement, which could result in less favorable outcomes to the plaintiff(s) in any such action.

The deposit agreement governing the ADSs representing our Class A ordinary shares provides that, to the fullest extent permitted by law, ADS holders waive the right to a jury trial for any claim they may have against us or the depositary arising out of or relating to our shares, the ADSs or the deposit agreement, including any claim under the U.S. federal securities laws.

 

62


Table of Contents

If we or the depositary were to oppose a jury trial based on this waiver, the court would have to determine whether the waiver was enforceable based on the facts and circumstances of the case in accordance with applicable state and federal law. To our knowledge, the enforceability of a contractual pre-dispute jury trial waiver in connection with claims arising under the federal securities laws has not been finally adjudicated by the United States Supreme Court. However, we believe that a contractual pre-dispute jury trial waiver provision is generally enforceable, including under the laws of the State of New York, which govern the deposit agreement, or by a federal or state court in the City of New York, which has nonexclusive jurisdiction over matters arising under the deposit agreement. In determining whether to enforce a contractual pre-dispute jury trial waiver, courts will generally consider whether a party knowingly, intelligently and voluntarily waived the right to a jury trial. We believe that this would be the case with respect to the deposit agreement and the ADSs. It is advisable that you consult legal counsel regarding the jury waiver provision before investing in the ADSs.

If you or any other holders or beneficial owners of ADSs, including purchasers of ADSs in secondary market transactions, bring a claim against us or the depositary in connection with matters arising under the deposit agreement or the ADSs, including claims under federal securities laws, you or such other holder or beneficial owner may not be entitled to a jury trial with respect to such claims, which may have the effect of increasing the cost of bringing a claim and limiting and discouraging lawsuits against us or the depositary. If a lawsuit is brought against either or both of us and the depositary under the deposit agreement, it may be heard only by a judge or justice of the applicable trial court, which would be conducted according to different civil procedures and may result in different outcomes than a trial by jury would have, including outcomes that could be less favorable to the plaintiff(s) in any such action.

Nevertheless, if this jury trial waiver is not permitted by applicable law, an action could proceed under the terms of the deposit agreement with a jury trial. No condition, stipulation or provision of the deposit agreement or the ADSs serves as a waiver by any holder or beneficial owner of ADSs or by us or the depositary of compliance with any substantive provision of the U.S. federal securities laws and the rules and regulations promulgated thereunder.

The voting rights of holders of ADSs are limited by the terms of the deposit agreement, and you may not be able to exercise your right to direct the voting of the Class A ordinary shares underlying your ADSs.

As an exempted company with limited liability incorporated in the Cayman Islands, we may, but are not obliged by the Companies Act to call shareholders’ annual general meetings. Our Post-IPO MAA provide that we may (but are not obliged to) each year hold a general meeting as our annual general meeting. As a holder of ADSs, you will not have any direct right to attend general meetings of our shareholders or to cast any votes at such meetings. You will only be able to exercise the voting rights which attach to the Class A ordinary shares underlying your ADSs indirectly by giving voting instructions to the depositary in accordance with the provisions of the deposit agreement. Under the deposit agreement, you may vote only by giving voting instructions to the depositary, as holder of the Class A ordinary shares underlying your ADSs. Upon receipt of your voting instructions, the depositary may try to vote the Class A ordinary shares underlying your ADSs in accordance with your instructions. If we ask for your instructions, then upon receipt of your voting instructions, the depositary will try to vote the underlying Class A ordinary shares in accordance with those instructions. If we do not instruct the depositary to ask for your instructions, the depositary may still vote in accordance with instructions you give, but it is not required to do so. You will not be able to directly exercise any right to vote with respect to the underlying Class A ordinary shares unless you withdraw the shares and become the registered holder of such shares prior to the record date for the general meeting. When a general meeting is convened, you may not receive sufficient advance notice of the meeting to enable you to withdraw the shares underlying your ADSs and become the registered holder of such shares prior to the record date for the general meeting to allow you to attend the general meeting and to vote directly with respect to any specific matter or resolution to be considered and voted upon at the general meeting. In addition, under our Post-IPO MAA, for the purposes of determining those shareholders who are entitled to attend and vote at any general meeting, our directors may close our register of members and/or fix in advance a record date for such meeting, and such closure of our register of members or the setting of such a record date may prevent you from withdrawing the Class A ordinary shares underlying your ADSs and becoming the registered holder of such shares prior to the record date, so that you would not be able to attend the general meeting or to vote directly. Where any matter is to be put to a vote at a general meeting, the depositary will notify you of the upcoming vote and to deliver our voting materials to you, if we ask it to. We cannot assure you that you will receive the voting material in time to ensure you can direct the depositary to vote your shares. In addition, the depositary and its agents are not responsible for failing to carry out voting instructions or for their manner of carrying out your voting instructions. This means that you may not be able to exercise your right to direct how the shares underlying your ADSs are voted and you may have no legal remedy if the shares underlying your ADSs are not voted as you requested.

 

63


Table of Contents

You may experience dilution of your holdings due to the inability to participate in rights offerings.

We may, from time to time, distribute rights to our shareholders, including rights to acquire securities. However, we cannot make such rights available to you in the United States unless we register both the rights and the securities to which the rights relate under the Securities Act of 1933, as amended, or Securities Act, or an exemption from the registration requirements is available. Under the deposit agreement, the depositary will not distribute rights to holders of ADSs unless the distribution and sale of rights and the securities to which these rights relate are either exempt from registration under the Securities Act with respect to all holders of ADSs, or are registered under the provisions of the Securities Act. The depositary may, but is not required to, attempt to sell these undistributed rights to third parties, and may allow the rights to lapse. We may be unable to establish an exemption from registration under the Securities Act, and we are under no obligation to file a registration statement with respect to these rights or underlying securities or to endeavor to have a registration statement declared effective. Accordingly, holders of the ADSs may be unable to participate in our rights offerings and may experience dilution of their holdings as a result.

You may be subject to limitations on the transfer of your ADSs.

Your ADSs are transferable on the books of the depositary. However, the depositary may close its books at any time or from time to time when it deems it expedient in connection with the performance of its duties. The depositary may close its books in emergencies, and on weekends and public holidays. The depositary may refuse to deliver, transfer or register transfers of our ADSs generally when our register of members or the books of the depositary are closed, or at any time if we or the depositary thinks it is advisable to do so because of any requirement of law or of any government or governmental body, or under any provision of the deposit agreement, or for any other reason.

We are an “emerging growth company” within the meaning of the Securities Act and may take advantage of certain reduced reporting requirements.

We are an “emerging growth company,” as defined in the JOBS Act, and we may take advantage of certain exemptions from requirements applicable to other public companies that are not emerging growth companies, including, most significantly, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 for so long as we remain an emerging growth company. As a result, if we elect not to comply with such auditor attestation requirements, our investors may not have access to certain information they may deem important.

We are a foreign private issuer within the meaning of the rules under the Exchange Act, and as such we are exempt from certain provisions applicable to U.S. domestic public companies.

Because we qualify as a foreign private issuer under the Exchange Act, we are exempt from certain provisions of the securities rules and regulations in the United States that are applicable to U.S. domestic issuers, including:

 

   

the rules under the Exchange Act requiring the filing with the SEC of quarterly reports on Form 10-Q or current reports on Form 8-K;

 

   

the sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations in respect of a security registered under the Exchange Act;

 

   

the sections of the Exchange Act requiring insiders to file public reports of their stock ownership and trading activities and liability for insiders who profit from trades made in a short period of time; and

 

   

the selective disclosure rules by issuers of material nonpublic information under Regulation FD.

We will be required to file an annual report on Form 20-F within four months of the end of each fiscal year. In addition, we intend to publish our results on a semi-annual basis as press releases, distributed pursuant to the rules and regulations of the NYSE. Press releases relating to financial results and material events will also be furnished to the SEC on Form 6-K. However, the information we are required to file with or furnish to the SEC will be less extensive and less timely compared to that required to be filed with the SEC by U.S. domestic issuers. As a result, you may not be afforded the same protections or information that would be made available to you were you investing in a U.S. domestic issuer.

As an exempted company with limited liability incorporated in the Cayman Islands, we are permitted to adopt certain home country practices in relation to corporate governance matters that differ significantly from the NYSE corporate governance listing standards. These practices may afford less protection to shareholders than they would enjoy if we complied fully with the NYSE corporate governance listing standards.

 

64


Table of Contents

As an exempted company with limited liability incorporated in the Cayman Islands and listed on the NYSE, we are subject to corporate governance listing standards of the NYSE. However, the NYSE rules permit a foreign private issuer like us to follow the corporate governance practices of its home country. Certain corporate governance practices in the Cayman Islands, which is our home country, may differ significantly from the NYSE corporate governance listing standards. We currently intend to follow Cayman Islands corporate governance practices in lieu of the corporate governance requirements of the NYSE that listed companies must (i) have a majority of independent directors, (ii) have a minimum of three members at its audit committee, (iii) have a nominating committee composed entirely of independent directors, and (iv) have a compensation committee composed entirely of independent directors. In addition, we intend to follow home country practice and be exempt from requirements to obtain shareholder approval prior to an issuance of securities in any transaction or series of related transactions under Section 312.03 of the NYSE Listed Company Manual. For details, see “Item 16.G. Corporate Governance.” To the extent that we choose to follow home country practice in the future, our shareholders may be afforded less protection than they otherwise would enjoy under the NYSE corporate governance listing standards applicable to U.S. domestic issuers.

Due to our ADS’s price fluctuations, our passive foreign investment company, or PFIC, status for the year ended March 31, 2023 is uncertain, and there is a significant risk that we will be a PFIC for the current or any future taxable year, which could result in adverse U.S. federal income tax consequences to U.S. investors in the ADSs or our Class A ordinary shares.

In general, a non-U.S. corporation is a PFIC for U.S. federal income tax purposes for any taxable year in which (i) 50% or more of the average value of its assets (generally determined on a quarterly basis) consists of assets that produce, or are held for the production of, passive income (the “asset test”), or (ii) 75% or more of its gross income consists of passive income. For purposes of the above calculations, a non-U.S. corporation that owns (or is treated as owning for U.S. federal income tax purposes), directly or indirectly, at least 25% by value of the shares of another corporation is treated as if it held its proportionate share of the assets of the other corporation and received directly its proportionate share of the income of the other corporation. Passive income generally includes dividends, interest, rents, royalties and gains from financial investments. Cash is generally a passive asset for these purposes. Goodwill (the value of which may be determined by reference to the excess of the sum of the corporation’s market capitalization and liabilities over the value of its assets) is generally characterized as an active asset to the extent it is associated with business activities that produce active income.

If the value of our goodwill is determined by reference to our market capitalization, then we would have had a negative amount of goodwill for a portion of our most recent taxable year ended on March 31, 2023. There is uncertainty as to how to apply the asset test is that situation. Taking into account the composition of our income and assets for that year, we believe it is reasonable to take the position that we were not a PFIC for our taxable year ended on March 31, 2023. However, due to the uncertainty described above, as well uncertainties regarding the characterization and value of certain of our assets for purposes of the asset test, our PFIC status for our taxable year ended on March 31, 2023 is not entirely clear and the U.S. Internal Revenue Service may assert that we were a PFIC for that year. Furthermore, because of the substantial fluctuations in our market capitalization, there is a significant risk that we will be a PFIC for our current taxable year ending on March 31, 2024, and possibly future taxable years. We hold a substantial amount of cash and financial investments and while this continues to be the case, our PFIC status may depend on the average value of our goodwill. The value of our goodwill may be determined, in large part, by reference to our market capitalization, which has been volatile and generally in decline in recent years. As a result, there is a significant risk that we will be a PFIC for any taxable year because the average value of our goodwill (if any) and other active assets may not be sufficiently large in relation to the average value of our passive assets. Moreover, it is not entirely clear how the contractual arrangements between us, the VIEs and their nominal shareholders will be treated for purposes of the PFIC rules, and we may be or become a PFIC if the VIEs are not treated as owned by us for these purposes.

If we are a PFIC for any taxable year during which a U.S. taxpayer holds ADSs or Class A ordinary shares, the U.S. taxpayer generally will be subject to adverse U.S. federal income tax consequences, including increased tax liability on disposition gains and “excess distributions” and additional reporting requirements. This will generally continue to be the case even if we ceased to be a PFIC in a later taxable year, unless certain elections are made. See “Item 10.E. Taxation—Material U.S. Federal Income Tax Considerations—Passive Foreign Investment Company Rules.”

 

ITEM 4.

INFORMATION ON THE COMPANY

4.A. History and Development of the Company

Corporate History

We commenced operations in 2008 with the establishment of Guangcheng Technology in December 2007. In November 2012, Shanghai Guangcheng was established in the PRC. In November 2012 and March 2013, Guangcheng Technology and Shanghai Guangcheng entered into an asset transfer agreement and a supplemental agreement thereto, respectively, pursuant to which Guangcheng Technology transferred all of its business operations and assets to Shanghai Guangcheng.

We incorporated Boqii Holding Limited, an exempted company with limited liability incorporated in the Cayman Islands, as our offshore holding company in June 2012 to facilitate offshore financing and our initial public offering. In July 2012 and August 2016, Boqii Corporation and Boqii International, two of our wholly owned subsidiaries, were incorporated in Hong Kong. In October 2019, Yoken International, our wholly owned subsidiary, was incorporated in Hong Kong, respectively. In November 2019, we incorporated Yoken Holding as a wholly owned subsidiary under the laws of the Cayman Islands, and in December 2019, we transferred all of our shares in Yoken International to Yoken Holding.

 

65


Table of Contents

In November 2012, Shanghai Xincheng, our wholly owned subsidiary, was established in the PRC. In the same year, due to the restrictions imposed by PRC laws and regulations on foreign ownership of companies engaged in value-added telecommunication services, Shanghai Xincheng entered into a series of contractual arrangements, as supplemented and amended, with Shanghai Guangcheng and then shareholders of Shanghai Guangcheng, by which Shanghai Xincheng may exert control over Shanghai Guangcheng and consolidate Shanghai Guangcheng’s financial statements under U.S. GAAP. In August 2020, Shanghai Xincheng re-entered into another series of similar contractual arrangements, as supplemented and amended, with Shanghai Guangcheng and then shareholders of Shanghai Guangcheng, which substitute for or supplement the above contractual arrangements entered into in 2019. For details, please refer to “Item 3. Key Information—Contractual Arrangements with the VIEs and Their Respective Shareholders.” As of the date of this annual report, share pledge registration of the shareholders of Shanghai Guangcheng have been completed.

In June 2021, Suzhou Taicheng was established in the PRC. In the same month, Shanghai Xincheng entered into a series of contractual arrangements, as supplemented and amended, with Suzhou Taicheng and then shareholders of Suzhou Taicheng, by which Shanghai Xincheng may exert control over Suzhou Taicheng and consolidate Suzhou Taicheng’s financial statements under U.S. GAAP. For details, please refer to “Item 3. Key Information—Contractual Arrangements with the VIEs and Their Respective Shareholders.”

In August 2013, Nanjing Xingmu was established in the PRC. In August 2019, Xingmu Group was established, which in turn established a wholly owned subsidiary, Xingmu Holding. Afterwards, Xingmu Holding established a wholly owned subsidiary, Xingmu International. Xingmu International then established Xingmu HK, which in turn established Xingmu WFOE. In November 2019, Xingmu Holding transferred 49% of its shares of Xingmu International to Xingmu Group, and Boqii Holding Limited acquired the rest 51% of the equity interests in Xingmu International from Xingmu Holding. In September 2019, Xingmu WFOE entered into a series of contractual arrangements, as supplemented and amended, with Nanjing Xingmu and then shareholders of Nanjing Xingmu, by which Xingmu WFOE may exert control over Nanjing Xingmu and consolidate Nanjing Xingmu’s financial statements under U.S. GAAP. For details, please refer to “Item 3. Key Information—Contractual Arrangements with the VIEs and Their Respective Shareholders.”

In February 2013, Shanghai Yiqin, was established in the PRC. In February 2020, Yoken International established Yoken WFOE, in the PRC. Shanghai Yiqin has completed its restructuring. We hold 1,862,142 ordinary shares and 2,887,858 series A ordinary shares, representing 83.6% of equity interest in Yoken Holding on a fully diluted and converted basis, and Shanghai Yiqin is a wholly owned subsidiary of Yoken WFOE. As of the date of this annual report, the Yiqin Restructuring has been completed at the offshore level and PRC level. As such, we refer to each of Shanghai Xincheng, Xingmu WFOE and Yoken WFOE as our wholly foreign owned entity, or WFOE, and to each of Suzhou Taicheng, Shanghai Guangcheng and Nanjing Xingmu as our variable interest entity, or VIE, in this annual report.

In October 2020, we completed an initial public offering in which we offered and sold an aggregate of 5,250,000 Class A ordinary shares in the form of ADSs. On September 30, 2020, the ADSs have been listed on the NYSE under the symbol “BQ.”

In May 2022, we changed the ratio of our ADSs to Class A ordinary shares from one (1) ADS representing three fourths (0.75) Class A ordinary shares to one (1) ADS representing four and a half (4.5) Class A ordinary shares (the “ADS Ratio Change”). The ADS Ratio Change became effective on June 3, 2022.

We are a holding company and do not directly own any substantive business operations in the PRC. We currently focus our business operations within the PRC primarily through the VIEs, Suzhou Taicheng, Shanghai Guangcheng, Nanjing Xingmu and Shanghai Yiqin. See “Item 3. Key Information—3.D. Risk Factors—Risks Related to Our Corporate Structure and Contractual Arrangements—We may lose the ability to use, or otherwise benefit from, the licenses, approvals and assets held by the VIEs, which could severely disrupt our business, render us unable to conduct some or all of our business operations and constrain our growth.”

Corporate Information

Our principal executive offices are located at Building 9, No. 388, Shengrong Road, Pudong New District, Shanghai 201210, People’s Republic of China. Our telephone number at this address is +86-21-6882 6799. Our registered office in the Cayman Islands is located at the offices of Vistra (Cayman) Limited, P.O. Box 31119 Grand Pavilion, Hibiscus Way, 802 West Bay Road, Grand Cayman, KY1-1205, Cayman Islands. Our agent for service of process in the United States is Cogency Global Inc. located at 122 East 42nd Street, 18th Floor New York, NY 10168. Investors should contact us for any inquiries through the address and telephone number of our principal executive office. Our principal website is www.boqii.com. The information contained on our website is not a part of this annual report.

The SEC maintains an internet site at www.sec.gov that contains reports, information statements, and other information regarding issuers that file electronically with the SEC.

 

66


Table of Contents

4.B. Business Overview

Our Vision

Our vision is to connect people and pets.

Our Mission

Boqii was founded for the love of pets. With this belief, we are inspired to empower the pet ecosystem and instill love and trust into pet parenting.

Boqii at a Glance

Boqii is a leading pet-focused platform in China. We offer a truly one-stop destination that pet parents in China may go to get everything they need for their pets and share their passion for pet parenting. They come to Boqii to discover the best pet products for their pets, share their most memorable pet raising stories, and find ways to make their pets healthier and happier. With our purpose-built platform, we are reshaping how pet parents in China engage with their pets—by educating and inspiring them to become better pet parents, helping them find what their pets need, and bringing them a unique shopping experience. We believe you will love Boqii if you love pets. With online sales platforms at its core, we extend our reach offline to connect and empower other participants in the pet value chain, including brand partners, manufacturers of pet products, physical pet stores and pet hospitals, and pet-related content providers.

We operate a leading pet-focused online retail business in China’s pet market in terms of GMV. We seamlessly connected 635 brand partners with pet parents in China since our inception and up to March 31, 2023. We are redefining e-commerce for pet parents by providing an accessible, personalized and enjoyable shopping experience based on a deep understanding of our users and customers and their pets by leveraging extensive user interactions and transactional behaviors we have observed over the years. We create and continue to develop our private brands, including Yoken, Mocare and two “D-cat” labels, with compelling quality and prices. Users and customers come to shop on Boqii because we offer them a high-quality, high-touch experience with access to 26,705 SKUs as of March 31, 2023. Since our inception, we had delivered more than 68.6 million online orders to our users and customers as of March 31, 2023.

We have a large pet-focused online community in China’s pet market. We had approximately 26 million registered users as of March 31, 2023, and approximately 2.2 million average MAUs for the fiscal year ended March 31, 2023. We deeply understand and care about our users and customers and their pets. We engage with our users and customers through shopping, content, social media, and offline events, spurring interactions in a way that traditional retailers do not. On top of extensive interactions and transactional behaviors we have observed, we have developed a profound understanding of who our users and customers are, what they are keen to buy for their pets, how they communicate with other pet parents, and what content they resonate with. Our rich content not only guides users and customers along their shopping journey, but also becomes a trusted source for discovery and inspiration for all pet lovers.

We generate revenues primarily from transactions completed on our online sales platforms and by supplying products to physical pet stores we cooperate with. Our total net revenues were RMB1,011.0 million, RMB1,186.4 million and RMB1,092.1 million (US$159.0 million) in the fiscal years ended March 31, 2021, 2022 and 2023, respectively. Net revenues generated from the sale of products were RMB1,003.2 million, RMB1,137.3 million and RMB1,048.5 million (US$152.7 million), accounting for 99.2%, 95.9% and 96.0% of our total net revenues in the fiscal years ended March 31, 2021, 2022 and 2023, respectively. We recorded net loss of RMB193.2 million, RMB132.8 million and RMB106.0 million (US$15.4 million) in the fiscal years ended March 31, 2021, 2022 and 2023, respectively.

Our Business Model

Focusing on the needs of pet parents and their pets, we have established a large pet ecosystem in China in terms of revenue and the number of customers. Through Boqii, we offer a truly one-stop destination that pet parents in China may go to for everything they need for their pets, from pet products and services to pet knowledge and parenting advice. Our online sales platforms, comprised of Boqii Mall and our flagship stores on third-party e-commerce platforms, provides customers with convenient access to a wide selection of high-quality pet products and an engaging and personalized shopping experience. Our informative and interactive content platform, Boqii Community, allows users to share their pet parenting experience and discover new products and ways to make their pets healthier and happier. We had cooperated with over 15,000 physical pet stores and pet hospitals as of March 31, 2023 to further extend our product and service offerings to connect with users and customers in their neighborhoods.

 

67


Table of Contents

We have a large pet-focused online community in China’s pet market. We had approximately 26 million registered users as of March 31, 2023, and approximately 2.2 million average MAUs for the fiscal year ended March 31, 2023. We take pride in building a vibrant online community where we lead our users through a content and product discovery journey, developing a user-centric content-driven “discover and buy” model.

Our Users

Our dynamic and growing user base consists of pet lovers, pet parents, and KOLs. Our users come from towns and cities all over China, but are primarily concentrated in economically developed provinces and cities. Based on information voluntarily provided by our users, we believe that a majority of our users own pets, mostly cats and dogs. We have acquired our users mainly through third-party e-commerce platforms, social media marketing, word-of-mouth referral and physical pet stores. Our users primarily access our pet-focused platform through our online sales platforms.

Mobile App

When users and customers open our mobile app, they will immediately see the homepage of our vibrant user community with featured pet-related content, and may switch to our self-operated online sales platform, Boqii Mall, and offline pet services homepage with the navigation bar on the bottom. Users and customers can directly browse and search for contents by topics, products by brand and category, and services by location on the respective homepages.

Weixin/WeChat Mini-programs

Mini-program is an innovative platform built into Weixin/WeChat, facilitating discovery and consumption of services and products. Our mini-programs on Weixin/WeChat include Boqii Flagship Store, Mini Boqii Mall, Boqii Group Buy and Mengchong Haowuguan, and they feature similar interfaces and functions as our mobile app. Users and customers can also access our mini-programs through Weixin/WeChat. These mini-programs serve as additional access points to our pet-focused platform and complement our full-function native mobile app.

Monetization Channels

Through diverse product selections, informative content offerings and fun social interactive features, we have engaged a dynamic and growing user base and developed various models of monetization.

 

   

Self-operated online sales platform. Our self-operated online sales platform can be accessed by users through Boqii Mall, our mobile app and Weixin/WeChat mini-programs. We sell both branded products and private label products through our online sales platforms. We acquire branded products from our branded partners and private label products from our manufacturing partners before we sell them to our customers. We typically recognize the sales income as our revenue and product procurement costs as our cost of revenue.

 

   

Flagship stores on third-party e-commerce platforms. We also sell branded products and private label products on our flagship stores on third-party e-commerce platforms, including Tmall, JD.com and Pinduoduo. We typically pay marketing and promotion service fees and annual service fees to these third-party platforms and account for such fees as sales and marketing expenses.

 

   

Offline distribution network. We supply branded products and private label products, mostly in bulk, to physical pet stores and pet hospitals at discounted prices.

 

   

Membership programs. To cultivate customer stickiness, we offer prepaid membership to users of Boqii Mall. Our prepaid membership card, Magic Black Card, requires a deposit of at least RMB500, which can be used for future purchases on Boqii Mall. We do not recognize the deposit payment as revenue, and instead we recognize revenue only upon successful sales to our customers.

 

   

Online marketing and information services. We provide online marketing and information services to pet product brand owners, including helping them place advertisements on our online platforms and third-party platforms and organize marketing campaigns to promote their products and brands. We recognize revenue for provision of online marketing and information services over the service period pursuant to our service contracts with the brand owners. For the fiscal years ended March 31, 2021, 2022 and 2023, we generated net revenues of RMB7.8 million, RMB49.1 million and RMB43.6 million (US$6.3 million) from provision of online marketing and information services.

 

   

Content offerings. We provide users with informative, fun and interactive content. While our content offerings are free of charge, they provide us with a multitude of monetization opportunities. We engage KOLs to recommend products to our users, and integrate our curated content with relevant products to guide users along their shopping journey. Specifically, we place links to products on Boqii Mall within content to capture purchase impulse and meet user demands, delivering a seamless user experience.

 

68


Table of Contents
   

SaaS solution. We have introduced our proprietary SaaS solution, which provides inventory management, membership management, price information and other services, to offline stores. We currently provide the SaaS solution to pet stores for free. Our free SaaS solution serves as our initial contact with physical pet stores and we expect that it will open up more business opportunities with these stores.

Our Online Sales Platforms

We operate a leading online retail business in China in terms of GMV. We seamlessly connected 635 brand partners with pet parents in China since our inception and up to March 31, 2023. We offer branded products and private label products primarily through our self-operated online sales platform, Boqii Mall, as well as major third-party e-commerce platforms, such as Tmall, JD.com and Pinduoduo.

The following tables set forth a breakdown of our GMV by product type and by sales channel during the specified periods.

 

     For the Fiscal Year Ended March 31,  
     2021      2022      2023  
     RMB      %      RMB      %      RMB      US$      %  
                                                  
     (in millions, except for percentages)  

GMV generated from sales of branded products

     2,074.4        85.2        2,490.8        85.7        2,121.7        308.9        82.7  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

GMV generated from sales of our private label products

     360.8        14.8        416.4        14.3        442.3        64.4        17.3  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total

     2,435.2        100.0        2,907.2        100.0        2,564.0        373.3        100.0  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

     For the Fiscal Year Ended March 31,  
     2021      2022      2023  
     RMB      %      RMB      %      RMB      US$      %  
                                                  
     (in millions, except for percentages)  

GMV generated from sales on Boqii Mall

     1,048.5        43.1        1,242.7        42.7        1,229.8        179.1        48.0  

GMV generated from our sales on third-party e-commerce platforms

     1,386.7        56.9        1,664.5        57.3        1,334.3        194.3        52.0  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total

     2,435.2        100.0        2,907.2        100.0        2,564.1        373.4        100.0  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

The following tables set forth a breakdown of our net revenues by product type and by sales channel during the specified periods.

 

     For the Fiscal Year Ended March 31,  
     2021      2022      2023  
     RMB      %      RMB      %      RMB      US$      %  
                                                  
     (in thousands, except for percentages)  

Net revenues generated from sales of branded products

     851,915        84.9        962,215        84.6        839,829        122,288        80.1  

Net revenues generated from sales of our private label products

     151,262        15.1        175,114        15.4        208,662        30,384        19.9  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total

     1,003,197        100.0        1,137,329        100.0        1,048,491        152,672        100.0  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

     For the Fiscal Year Ended March 31,  
     2021      2022      2023  
     RMB      %      RMB      %      RMB      US$      %  
                                                  
     (in thousands, except for percentages)  

Net revenues generated from sales on Boqii Mall

     385,627        38.4        433,573        38.1        433,983        63,193        41.4  

Net revenues generated from our sales on third-party e-commerce platforms

     617,570        61.6        703,756        61.9        614,508        89,479        58.6  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total

     1,003,197        100.0        1,137,329        100.0        1,048,491        152,672        100.0  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Our Pet Product Offerings

We offer our customers, which include both pet parents and small and medium pet businesses, a diverse selection of high-quality pet products at competitive prices, including food, treats, shampoos, cages, toys, apparel, OTC veterinary drugs and many more. As of March 31, 2023, we offered 26,705 SKUs from approximately 681 brands, including 63 international brands. We are committed to offering a comprehensive and relevant selection of product inventory so that pet parents can get everything they need for their pets at one destination.

 

69


Table of Contents

Branded products

Since our inception and up to March 31, 2023, we cooperated with 635 brand partners, such as Royal Canin and Pedigree. Our brand partners together contributed 21,821 SKUs to our online sales platforms, accounting for approximately 81.7% of our total SKUs on March 31, 2023. In addition to branded pet food and other daily supplies, we cooperate with certain brand partners to offer OTC veterinary drugs, such as dermatology drugs and worm medications. We have designated a team with backgrounds in veterinary pharmacy to oversee the procurement of OTC veterinary drugs on our online sales platforms.

We select our brand partners based on their brand reputation, product quality, manufacturing capability and prices. Before engaging a brand partner, we inspect its business licenses, permits and trademarks, perform background checks, sample products, and in certain cases conduct on-site visits.

We normally enter into one-year nonexclusive framework agreements with our brand partners or, in most cases of foreign brand partners, their agents and renew them annually if we are satisfied with their performance. The key terms of our supply contracts are as follows.

 

   

Delivery and acceptance. Our brand partners are responsible for delivering products to our warehouses, and the products delivered shall conform, in form and substance, to the samples we have accepted.

 

   

Quality. The products shall satisfy all applicable quality requirements under relevant laws and regulations, industry standards and our quality standards specified in the agreements. We may reject or return any substandard products.

 

   

Purchase commitment. A few brand partners specify minimum purchase requirements in our supply agreements.

Private label products

Complementary to our extensive selection of branded products, we also offer high-quality private label products at compelling prices. Leveraging our wealth of expertise in the pet industry and deep understanding of customer needs, we have developed our private label brands, Yoken and Mocare in 2015 and 2018, respectively. We launched two “D-cat” label brands in 2022. We achieved significant growth in the sales of private label products. On March 31, 2023, approximately 4,884 SKUs of private label products were offered, accounting for approximately 18.3% of our total SKUs. Moreover, as we introduce our high-quality competitively priced private label products to physical pet stores and pet hospitals, we are able to develop close relationships with them that provide for additional business opportunities.

We had approximately 2,272 SKUs under our Yoken brand for the fiscal year ended March 31, 2023. We operate two business lines under our Yoken brand, Yiqin and Youbeizi. We mainly offer competitively priced cat litter, liners, bath products, dog food, cat food, canned food, pet clothes and pet toys under Yiqin, and value-for-money pet food under Youbeizi. Yoken was awarded 2020 and 2021 Annual Horse Brand, 2020 Consumers’ Favorite Cat Litter Brand and 2021 Annual Cat Litter at the Tmall Golden Cosmetics Festival.

We had approximately 66 SKUs under our Mocare brand for the fiscal year ended March 31, 2023. Mocare focuses on premium freeze-dry cat and dog food, which is made from cooked fresh foods with nearly all of the water content removed through a special process. Freeze-dried cat and dog food is known to preserve more nutritional content compared to conventional dry food, has longer shelf life than wet food, and allows for more convenient transportation and storage than frozen food. Mocare was awarded Annual Top 10 Dark Horse Brand by Shenzhen International Pet Product Fair in 2019.

In 2022, we launched two “D-cat” label brands, under which we offer (i) pet snacks and pet supplies and (ii) pet pharmaceuticals and medical care products, respectively.

We adopt a “customer-to-manufacturer” model in developing our private label products. We identify customer needs by analyzing the massive trove of customer and transactional behaviors we have observed, evaluating the feasibility and profitability of developing the products that satisfy such needs and engaging manufacturing partners to bring the products to market. For example, since 2020, we identified rapidly growing demands for pet supplies and expand our offerings of pet suppliers catering to customer needs, such as cat litter and cat litter boxes, pet beddings, cat scratchers, and airline-compliant crates. These have achieved significant popularity in the pet supplies market.

We have implemented strict quality control procedures on our private label products. Manufacturing factories for our private labels conduct pre-delivery inspection for each batch of products. In the case of newly developed products, our own personnel will conduct on-site inspections at manufacturing factories to ensure the compliance with our stringent quality standards. Meanwhile, we will conduct spot checks when each batch of products are delivered to our own warehouses. Irregular inspections will also be made on site to our cooperated manufacturing factories and products, and we have the right to demand manufacturers to rectify, impose a fine thereon or request a refund or exchange of products if they fail any of such inspections.

 

70


Table of Contents

We carefully select manufacturers based on their ability to ensure timely delivery of quality products at competitive prices. Before engaging a manufacturer, we examine its business licenses, permits and operating history, sample products and evaluate its quality control effectiveness, assess its production capacity and conduct on-site visits. Our manufacturing agreement generally sets out a price cap for each product category will be set out in the agreement. We normally make a lump-sum payment within an agreed timeframe following our acceptance of the products. To strengthen our relationship with Shuangan, a leading pet food manufacturer in China, we made an equity investment in it in 2017. Starting in 2018, we have partnered with Shuangan to carry out the production of a majority of our private label food and treats product line at its two plants. We outsource the manufacturing of the rest of our private label products to various other high-quality manufacturers in China.

Boqii Mall

Boqii Mall, our self-operated online sales platform, has transformed shopping for pet products from a traditional search-based experience to a personalized discovery journey. Users and customers can easily navigate Boqii Mall through our mobile app, website or Weixin/Wechat mini-programs.

Our users and customers may browse through our extensive catalog of pet products by pet species and age, and product type, flavor and brand. For example, users and customers may choose specialty dog food for 15 dog breeds, such as golden retrievers, Labradors, poodles and huskies, and specialty cat food for cat breeds of all ages. Such detailed search categories allow users and customers to quickly identify the most suitable product for their pets.

When registering on our mobile app, pet parents may create their pet profiles, entering the names, species, age and sex of their pets. Pet profiles help us better understand the needs of pet parents and connect them with the right product at the right time throughout their pets’ lives. As we personalize pet parents’ shopping experience, we are able to further enhance customer loyalty.

Through our automated recommendation algorithm, we study and analyze customers’ browsing and purchase history and their pet profiles to identify their needs and preferences and recommend products of interest to them. Furthermore, we integrate our content offerings on our online community with the most relevant products and make customized recommendation, which create a unique and engaging experience for our users and customers. See “—Our Content Platform.” We have been constantly improving our algorithms to more precisely target customers with smart recommendations.

We engage various third parties to provide payment and delivery services for our customers on Boqii Mall. We require our customers to make full payment before we ship out their orders. We collaborate with YeePay, WeChat Pay, Alipay and Union Pay to offer convenient and secure payment options. We have engaged STO Express, Yuantong and Yunda to provide fast and reliable delivery services to our customers. See “—Supply Chain Management.”

Flagship Stores on Third-party E-commerce Platforms

We operate flagship stores on major third-party e-commerce platforms, including Tmall, JD.com and Pinduoduo. These third-party e-commerce platforms expand our customer reach and serve as our initial contact with customers, especially first-time pet parents who have yet to develop brand loyalty. For the fiscal years ended March 31, 2021, 2022 and 2023, we generated revenue of RMB617.6 million, RMB703.8 million and RMB614.5 million (US$89.5 million), respectively, from sales on our flagship stores on third-party e-commerce platforms.

According to our arrangement with third-party e-commerce platforms, we are responsible for product selection and display, product delivery, warehousing and customer support services, while e-commerce platforms provide online marketing and information services, payment processing services and customer relationship management system. We typically pay annual fees for basic store operations on third-party e-commerce platforms, and we also need to pay for additional services, such as technical service surcharges, online marketing and information services, and payment processing services.

Offline Distribution Network

We have developed a proprietary SaaS solution which provides inventory management, membership management, price information and other services to offline pet stores. We first introduced this SaaS solution to pet stores for free in December 2015. Our free SaaS solution serves as our initial contact with physical pet stores.

With our SaaS system, pet store owners may access their inventory status, view real-time analysis of sales status, keep tabs on upcoming re-order needs, and track shipping status anytime and anywhere. They may also easily replenish their stock with our products at competitive prices and manage their business more efficiently. Our SaaS system reminds pet store owners to re-order when their stock level is low and offers them an easy ordering process. Additionally, pet store owners may integrate their membership program with our SaaS system for easy management of their member profiles and interactions.

 

71


Table of Contents

We supply a variety of branded products and private label products to physical pet stores and pet hospitals in bulk at discounted prices, which diversify their store product portfolio. With our valuable data insights, we identify unique needs of local pet stores, and recommend high-quality and value-for-money products to them accordingly. In certain cases, we coordinate with our brand partners to offer free samples to pet stores before they decide to make bulk purchases. We enter into customary supply agreements with physical pet stores and pet hospitals, pursuant to which the physical pet stores or pet hospitals may not sell our products at a price lower than specified in the agreements unless otherwise agreed. For the fiscal years ended March 31, 2021, 2022 and 2023, we generated revenue of RMB91.6 million, RMB142.0 million and RMB190.4 million (US$27.7 million) from sales through our offline distribution network, accounting for 9.1%, 12.5% and 17.4% of our total net revenues during the same periods, respectively.

Our offline distribution network also extends our brand partners’ customer reach to pet parents who frequently visit physical pet stores and pet hospitals. We help our brand partners design tailored offline marketing strategies. For example, we promote their branded products to and display their marketing campaigns at physical pet stores we cooperate with and during trade fairs.

Customer Services

Our professional customer services distinguish us from generic retailers and adds a personal touch to the customer shopping experience. Unlike shopping for personal goods, shopping for pet products can be more challenging and requires professional guidance. We maintain a dedicated team of customer services staff, including our nine employees and other outsourced customer service stuff. Pet parents can reach our knowledgeable customer services staff and our intelligent customer service system every day. Our responsive and experienced customer services team has achieved an average satisfaction rate of 4.87 points out of five points with respect to service attitude in the fiscal year ended March 31, 2023.

Most of the products offered on our platform can be returned with full refund or exchanged for within seven days of receipt of shipment, and we provide full refund to our customers if there is a product quality issue. We normally pay for shipping expenses to facilitate successful return or exchange of defective products. Meanwhile, we cooperate with third-party insurance companies which provide our customers with shipping return and exchange insurance that cover their return or exchange shipping expenses incurred by the orders with our stores at Tmall and JD.com.

Supply Chain Management

We have an integrated supply chain management system covering from inventory management to order fulfillment. Our integrated system aims to ensure that we maintain appropriate inventory levels at our warehouses and that we can optimize order routing, which helps us reduce inventory risks, shipping time and transportation costs.

We have adopted three inventory models—distribution model, consignment model and drop shipping model—and had an average inventory turnover days of 41 days for the fiscal year ended March 31, 2023. Average annual inventory turnover days are calculated by dividing the ending inventory balance by cost of product sales and multiplying by 365.

 

   

Distribution model. Distribution model is the most common inventory model in our operations. Under this model, we purchase products from our brand partners before selling them to customers and take inventory.

 

   

Consignment model. We initially partnered with some emerging brand partners, using a consignment model where ownership of the products remained with such brand partners until the products were sold. We believed this model allowed us to minimize inventory and working capital risks. Since early 2019, we have started to substantially reduce product sales through consignment model as we strategically reduced the sales volume of certain long-tail, less popular products offered by emerging brand partners.

 

   

Drop shipping model. Only a few of our manufacturers have chosen drop shipping model. Under this model, we take inventory although our manufacturers ship the products directly to the customers under this model.

As of March 31, 2023, we operated four warehouses and utilized one fulfillment center across China, and maintained a team of 11 employees and 87 outsourced staff. We store our inventories, and sort, package and ship products to customers from our warehouses. We also utilize fulfillment centers at free trade-zones where certain brand partners we cooperate with ship their products to us or our customers directly. As of March 31, 2023, we also partnered with five delivery service providers to ensure fast and reliable delivery to our customers. Our expansive fulfillment network enables us to reach certain parts of China in 24 hours or less, providing customers with a convenient click-to-door shopping experience.

 

72


Table of Contents

Membership Programs

We have established prepaid and free membership programs to enhance customer loyalty. As of March 31, 2023, we had 41,935 prepaid members. Our prepaid members on average deposited RMB1,979 each year in their membership cards for the fiscal years ended March 31, 2021, 2022 and 2023.

 

   

Prepaid membership. Prepaid membership is only available to users of Boqii Mall. Our prepaid membership card, Magic Black Card, requires a deposit of at least RMB500, which can be used for purchases on Boqii Mall. Our Magic Black Card holders receive discounts on all purchases made on Boqii Mall, access to limited-time offers, birthday coupons, free shipping twice a month, VIP customer service and other value-added services.

 

   

Free membership. Free membership is only available to users of our flagship stores on Tmall, JD.com and Pinduoduo. Users earn points for visiting, making purchases or drawing lotteries on our flagship stores, and points can be then used for deducting the order amounts in future purchases on these stores. Free members enjoy discount offers at our flagship stores from time to time and one-to-one customer service.

Our Content Platform

Boqii Community provides an interactive content platform for users to share their knowledge and love for pets. We strive to provide our users with a variety of high-quality and engaging original content.

When users open the “Community” feature on our mobile app, they will immediately see our recommended content based on their initial indication of interests upon registration and their reading, social and purchase behavior. They may browse posts from other community members they follow, latest updates, videos and news by sliding through the top navigation bar. By clicking on the navigation buttons in the middle of the page, users can explore hot topics, KOLs, Q&As and product reviews. Users may also post questions and share their informative pet parenting experience, memorable pet raising stories, favorite pet photos and short videos on our mobile app.

Content Creation

Our users and customers constantly contribute to our diverse, high-quality and engaging content. Among them, some have attracted a significant number of followers and grown to become KOLs. We have also engaged a number of KOLs, who are particularly active in creating and sharing content on pet parenting and pet products. They encourage social interactions among our users and customers and help shape their purchasing decisions. As of March 31, 2023, we had over 413 KOLs on our platform and approximately 700 KOL accounts on social media platforms. We continuously monitor user activities and original content creation on our platform to discover potential KOLs and encourage them to partner with us.

We offer KOLs access to broad user base, and help them monetize their content offerings. KOLs earn commissions from us for actively promoting branded products and our private label products. At the same time, we depend on KOLs’ content creation capabilities to invigorate Boqii Community, and capitalize on their marketing skills which lead to enhanced product sales on our online sales platforms. We typically pay KOLs a fee for each piece of their advertising post or video on per case basis.

Our diverse, engaging and original content is available in various formats, including articles, photographs, and short videos.

Content Monitoring

We place strong emphasis on content screening and monitoring content posted on our platform to ensure that they do not infringe copyright and other intellectual property rights, and that they fully comply with applicable laws and regulations. Our online content screening and monitoring procedures consist of automated screening performed by an automated filtering system as well as a set of manual review procedures conducted by our editors. We maintain a dedicated team of content editors and hold regular internal trainings on latest compliance requirements and development.

Monetization through Content Offerings

Our rich and informative content provides us with a multitude of monetization opportunities. We recommend relevant content to users and customers based on their pet profiles, initial indication of interests upon registration and their reading, social and purchase behavior. In addition to facilitating users and customers in content discovery, we also leverage our automated recommendation algorithm to integrate our curated content with relevant products and make customized product recommendations. We place links to products on Boqii Mall within content to capture purchase impulse and meet user demands, delivering a seamless user experience. From time to time, our customer service staff mail free samples and make phone calls to our users and customers to provide offer updates and promote our products.

 

73


Table of Contents

Social Media

Through interactive social network platforms, we bring our dynamic community and their diverse and engaging content offerings to life. We distribute content through substantially all major social communications and social media platforms in China, including Weixin/WeChat, Weibo, Red and Tiktok. Our content offerings on these platforms have attracted a large number of loyal fans. As of March 31, 2023, we managed over 1,013 Weixin/WeChat groups, most of which are under our direct management.

We leverage these major social media platforms for viral and interactive marketing. Such platforms enable our users and customers to make purchases as part of their social networking and entertainment, boosting the frequency and value of their purchases.

Our Offline Network

Despite the convenience of online sales platforms, we believe physical pet stores and pet hospitals are still an integral part to the pet industry. Certain services, such as pet care, training and grooming, are only available offline. Offline store settings provide us with an opportunity to interact with pet parents face-to-face and offer more value-added products and services.

We began cooperating with physical pet stores and pet hospitals in 2013. As of March 31, 2023, we had cooperated with over 15,000 physical pet stores and pet hospitals, spanning over 250 cities in China. Our offline network increases our brand awareness and presents a complementary source of user traffic. By making pet products and services more accessible and appealing to pet parents, we are able to drive customer acquisition and customer loyalty in a more cost-effective manner. Through our brand influence and proprietary technology, we have also begun to digitally connect and empower an extensive, growing network of physical pet stores and pet hospitals through our SaaS solutions.

Our mobile app allows users and customers to quickly and accurately locate nearby pet stores and pet hospitals we cooperate with. We host a homepage for each store we cooperate with on our mobile app, where users and customers may view store photos, browse the type of services provided, review staff backgrounds and access and provide store reviews.

Acquisition of Xingmu International

To further our presence in the pet healthcare market, we acquired 51% equity ownership in Xingmu International in November 2019 and have since consolidated results of Xingmu International. As a competitive veterinary drug distributor in China, Xingmu has regional exclusive distribution rights to six veterinary drug brands and close relationships with approximately 1,300 pet hospitals in China as of March 31, 2023. Our acquisition of Xingmu allows us to leverage Xingmu’s extensive pet hospital network to develop our pet healthcare business. We are a leading online UGC audio community, interactive audio entertainment platform and online audio platform in China.

Partnership with PetDog

In an effort to expand our offline presence and enhance pet service offerings, we made a 23.6% equity investment in PetDog in 2019. PetDog offers a variety of courses on pet beauty, pet training, pet store management and pet nutrition management to train and prepare students to become licensed pet professionals, expanding the talent pool in the pet industry. According to Frost & Sullivan, PetDog is the largest pet store franchise in terms of number of pet stores and the largest training center for pet service professionals in terms of training service revenue in China as of 2019. We equip PetDog stores with smart inventory management through our SaaS solution, and diversify its product portfolio with our wide selection of high-quality and value-for-money pet products.

Through our investment in PetDog, we have also successfully expanded the outreach of professional trainings to more offline pet stores to improve the quality of their services. With more licensed pet professionals available, pet stores are able to offer more varieties of high-quality services to pet parents.

Our Marketing Services

We offer our brand partners as well as other brand owners tailored marketing and information services and distribution support to promote their brands and increase product sales. We charge our marketing service clients a service fee for our online marketing and information services, which was settled according to the overall service price in the contracts. Our vibrant online community and extensive offline network give our brand partners and brand owners wide access to targeted and high-quality user traffic.

With valuable data insights on user behavior, we also help our brand partners and brand owners design and implement effective marketing strategies, and guide them in offering more relevant products and optimizing pricing strategies. In 2013, we started to provide online marketing and information services to Chuncui, a new Chinese pet product brand.

 

74


Table of Contents

Sales and Marketing

Our diverse and high-quality product offerings, rich and engaging content, and personalized user experience have contributed to our expanding user base and increasing user engagement, leading to a strong word-of-mouth effect that strengthens our brand awareness.

Additionally, we promote our platform and enhance our brand awareness through a variety of online and offline marketing activities. We cooperate with third-party e-commerce platforms, social media platforms, and popular search engines for online and mobile marketing. We also conduct offline marketing by attending leading trade fairs and exhibits in the industry, such as Chengdu International Pet Fair and China Pet Fair.

Competition

The pet industry is highly competitive in China. We mainly compete with online and physical pet product retail stores, pet product sections in supermarkets, general e-commerce platforms and other pet-focused online retail platforms.

We have a large pet ecosystem in China in terms of revenue and the number of customers. We believe we differentiate ourselves from our competitors by our significant brand awareness, transformative retail model, content-driven marketing approach, diverse and high-quality product offerings, rich and engaging content offerings, smart recommendations, personalized customer service and reliable fulfillment services.

Licenses and Approvals

The following table sets forth a list of material licenses and approvals, subject to further renewal, that our PRC subsidiaries and the VIEs are required to obtain to carry out our operations in China.

 

License

 

Entity Holding the License

 

Type of the Entity

 

Regulatory Authority

ICP License

  Guangcheng Technology  

VIE

  Shanghai Communication Administration

Veterinary Drug Operation Permit

  Guangcheng Technology  

VIE

  Shanghai Pudong Agricultural Committee

Veterinary Drug Operation Permit

  Shanghai Xincheng  

WFOE

  Shanghai Pudong Agricultural Committee

Veterinary Drug Operation Permit

  Guangcheng Technology Wuhu Branch  

Branch of VIE

  Wuhu Economic Technology Development District Social Affair Bureau

Veterinary Drug Operation Permit

  Nanjing Cuida Biotechnology Co., Limited  

Subsidiary of VIE

  Nanjing Agricultural Committee

Veterinary Drug Operation Permit

  Suzhou Taicheng  

VIE

  Suzhou Agriculture and Country Bureau

Veterinary Drug Operation Permit

  Nanjing Xingmu  

VIE

  Nanjing Yuhua District Agricultural Bureau

Veterinary Drug Operation Permit

  Taizhou Xinmu Biotechnology Co., Limited  

Subsidiary of VIE

  Taizhou Hailing District Agriculture and Country Bureau

Veterinary Drug Operation Permit

  Shanghai Chongpan Pet Service Co., Limited Jingan Branch  

Branch of VIE

  Shanghai Pudong Agricultural Committee

Our Technology

Our strong technology and data capabilities enable us to deliver superior user experience and increase our operational efficiency. As of March 31, 2023, we had a five-member research and development team dedicated to the design and development of algorithm and the upgrades and maintenance of our technology infrastructure.

Data Analytics

With access to a massive trove of customer and transaction data, we have built our big data analytics capabilities upon detailed user tagging and third-party computing infrastructure that can efficiently process complex analytical computing tasks. We have created approximately 16 different user purchase behavior tags by studying user interactions and purchase behaviors. With such user and transactional behaviors we have observed, we leverage big data analytics and artificial intelligence technology to enhance the accuracy of user behavior predictions and user profiling, and hence customize our content and product recommendation to optimize user experience.

 

75


Table of Contents

Data Privacy and Security

We believe data security is critical to our business operation. Users must acknowledge the terms and conditions of the user agreement before registering an account with us, pursuant to which they consent to our collection, use and disclosure of their data in compliance with applicable laws and regulations. To protect users’ information, we have internal rules and policies governing how we may use and share personal information, and protocols, technologies and systems guarding against improper access or disclosure of personal information. We collect personal information and data only with users’ prior consent. We have also adopted strict data protection policy to ensure the security of our proprietary data, and back up the important information we gather from our platform. The use of data within our various departments is under our strict supervision and management. We have outsourced some of our data security work, including cloud storage and anti-hacking, to certain third-party technological service providers.

To ensure data security and avoid data leakage, we limit access to our servers that store our user information and internal data on a “need-to-know” basis by establishing stringent internal protocols under which we grant classified access to confidential personal data only to limited employees with strictly defined and layered access authority. We have also adopted a data encryption system intended to ensure secure storage and transmission of data, and to prevent any unauthorized access to use of our data. Furthermore, we implement comprehensive data masking to fend off potential hacking and security attacks.

In addition, we back up our data on a daily basis in various separate secured data back-up systems to minimize the risk of data loss. We also conduct frequent reviews of our back-up systems to ensure that they are well maintained and function properly.

Inventory Management

We have adopted a smart ERP inventory management system that enables real-time inventory tracking and sales analysis, which helps us monitor and administer warehouse operations and forecast demand. In addition, our drop shipping system is able to connect our manufacturers to the third-party delivery service providers to ensure efficient order shipment.

Moreover, we provide our inventory management system to physical pet stores and pet hospitals as a SaaS solution and help them manage their business more efficiently. See “—Our Business Model —Offline Distribution Network.”

Intellectual Property

Our trademarks, copyrights, domain names, trade names, trade secrets, patents and other proprietary rights are critical to our success. As of March 31, 2023, we had two registered patents and one patent application under review, 271 registered trademarks, 35 registered copyrights and 23 registered domain names in China. We rely on trademark, copyright and trade secret protection laws in China and enter into standard confidentiality agreements with all of our employees to protect our intellectual properties.

Seasonality

We experience seasonality in our business, primarily as a result of seasonal fluctuations in personal consumption needs and patterns. We typically record higher net revenues in the fourth calendar quarters, primarily because consumers tend to increase their purchases during e-commerce festivals in China, such as the periods around Double Eleven Shopping Festival (which is an online sales promotion event that falls on November 11 of each year) and Double Twelve (which is another online sales promotion event that falls on December 12 of each year). In addition, we typically experience a lower level of sales activity in the first calendar quarters due to the Chinese New Year holiday, during which the volumes of online purchases and logistical operations may drop significantly due to vacations and business closures. As a result, we generally generate higher net revenues in quarters ended December 31. Similar to the trends in our net revenues, our cost of revenues and to a lesser extent, fulfillment expenses, sales and marketing expenses, and general and administrative expenses generally also experience seasonal fluctuations. Due to our limited operating history, the seasonal trends that we have experienced in the past may not apply to, or be indicative of, our future operating results. See “Item 3. Key Information—Item 3.D. Risk Factors—Risks Related to Our Business and Industry—Our results of operations are subject to fluctuations due to the seasonality of our business and other events.”

Our Environmental, Social and Governance (ESG) Efforts

We believe that strong ESG management is essential to the sustainability of our business. As of the date of this annual report, we had not been subject to any fines or other penalties due to noncompliance in relation to health, work safety or environment regulations and had not had any incident, or received any claim for personal or property damage made by our employees which had materially and adversely affected our financial condition or business operations.

 

76


Table of Contents

Regulations

This section sets forth a summary of the most significant rules and regulations that affect our business activities in China.

Regulations on Foreign Investment

The Foreign Investment Law of the PRC, or the Foreign Investment Law, was formally adopted by the National People’s Congress on March 15, 2019 and became effective on January 1, 2020. The Foreign Investment Law is formulated to further expand opening-up, vigorously promote foreign investment and protect the legitimate rights and interests of foreign investors. According to the Foreign Investment Law, foreign investments are entitled to pre-entry national treatment and are subject to negative list management system. The pre-entry national treatment means that the treatment given to foreign investors and their investments at the stage of investment access is not lower than that of domestic investors and their investments. The negative list management system means that the state implements special administrative procedures for access of foreign investment in specific fields. Foreign investors shall not invest in any forbidden fields stipulated in the negative list and shall meet the conditions stipulated in the negative list before investing in any restricted fields.

Foreign investors’ investment, earnings and other legitimate rights and interests within the territory of China shall be protected in accordance with the law, and all national policies on supporting the development of enterprises shall equally apply to foreign-invested enterprises. The state guarantees that foreign-invested enterprises participate in the formulation of standards in an equal manner. The state guarantees that foreign-invested enterprises participate in government procurement activities through fair competition in accordance with the law. The State shall not expropriate any foreign investment except under special circumstances. In special circumstances, the state may levy or expropriate the investment of foreign investors in accordance with the law for the needs of the public interest. The expropriation and requisition shall be conducted in accordance with legal procedures and timely and reasonable compensation shall be given. In carrying out business activities, foreign-invested enterprises shall comply with relevant provisions on labor protection, social insurance, tax, accounting, foreign exchange and other matters stipulated in laws and regulations.

On December 19, 2020, the NDRC and the MOFCOM jointly promulgated the Measures on the Security Review of Foreign Investment, effective on January 18, 2021, which sets forth provisions concerning the security review mechanism on foreign investment, including the types of investments subject to review, review scopes and procedures, among others. The Office of the Working Mechanism of the Security Review of Foreign Investment, or the Office of the Working Mechanism, will be established under the NDRC, who will carry out routine work of security review on foreign investment. Foreign investor or relevant parties in China must declare the security review to the Office of the Working Mechanism prior to (i) the investments in the military industry, military industrial supporting industry and other fields relating to the security of national defense, and investments in areas surrounding military facilities and military industry facilities; and (ii) investments in important agricultural products, important energy and resources, important equipment manufacturing, important infrastructure, important transport services, important cultural products and services, important information technology and internet products and services, important financial services, key technologies and other important fields relating to national security, and obtain control in the target enterprise. Control exists when the foreign investor (i) holds over 50% equity interests in the target, (ii) has voting rights that can materially impact on the resolutions of the board of directors or shareholders meeting of the target even when it holds less than 50% equity interests in the target, or (iii) has material impact on the target’s business decisions, human resources, accounting and technology, etc.

From January 1, 2020, the Wholly Foreign-Owned Enterprises Law of the PRC, together with the Law of the People’s Republic of China on Sino-Foreign Equity Joint Ventures and the Law of the People’s Republic of China on Sino-Foreign Cooperative Joint Ventures shall be abolished. The organization form, organization and activities of foreign-invested enterprises shall be governed by the laws of the Company Law of the People’s Republic of China and the Partnership Enterprise Law of the People’s Republic of China. Foreign-invested enterprises established before the implementation of the Foreign Investment Law may retain the original business organization and so on within five years after the implementation of the Foreign Investment Law.

On December 26, 2019, the State Council promulgated the Implementation Regulations on the Foreign Investment Law, which came into effect on January 1, 2020, and it further requires that foreign-invested enterprises and domestic enterprises shall be treated equally with respect to policy making and implementation. Pursuant to the Implementation Regulations on the Foreign Investment Law, if the existing foreign-invested enterprises fail to change their original forms as of January 1, 2025, the relevant market regulation departments will not process other registration matters for the enterprises, and may disclose their relevant information to the public.

 

77


Table of Contents

On December 30, 2019, the MOFCOM and the State Administration for Market Regulation jointly issued the Measures for Reporting of Foreign Investment Information, or the Foreign Investment Information Measures, which came into effect on January 1, 2020 and replaced the Interim Administrative Measures for the Record-filing of the Establishment and Modification of Foreign-invested Enterprises. Since January 1, 2020, for foreign investors carrying out investment activities directly or indirectly in the PRC, foreign investors or foreign-invested enterprises shall submit investment information through the Enterprise Registration System and the National Enterprise Credit Information Publicity System operated by the State Administration for Market Regulation. Foreign investors or foreign-invested enterprises shall disclose their investment information by submitting reports for their establishments, modifications and cancelations and their annual reports in accordance with the Foreign Investment Information Measures. If a foreign-invested enterprise investing in the PRC has finished submitting its reports for its establishment, modifications and cancelation and its annual reports, the relevant information will be shared by the competent market regulation department to the competent commercial department, and does not require such foreign-invested enterprise to submit the reports separately.

Foreign Investment Industrial Policy

Investment in the PRC conducted by foreign investors and foreign-owned enterprises shall comply with the Catalog for the Guidance of Foreign Investment Industries, or the Catalog, which was first issued in 1995 and amended from time to time. The most updated Catalog was promulgated by the MOFCOM and the NDRC, on June 28, 2017 and became effective on July 28, 2017, and contains specific provisions guiding market access of foreign capital and stipulates in detail the areas of entry pertaining to the categories of encouraged foreign investment industries, restricted foreign investment industries and prohibited foreign investment industries. On October 26, 2022, the MOFCOM and the NDRC promulgated the Catalog of Industries for Encouraged Foreign Investment (2022 Edition), or the Encouraging Catalog, which became effective on January 1, 2023, to replace the previous Encouraging Catalog. On December 27, 2021, the MOFCOM and the NDRC released the Special Administrative Measures for Access of Foreign Investments (2021 Edition), or the Negative List 2021, which became effective on January 1, 2022, to replace the previous Negative List. According to the current regulation, any industry not listed in the Negative List 2021 is a permitted industry and generally open to foreign investment unless specifically prohibited or restricted by PRC laws and regulations. According to the Negative List 2021, the foreign investment in value-added telecommunications services shall not exceed 50% (excluding e-commerce, domestic multi-party telecommunication, storage and forwarding business, and call center).

Regulations on Value-added Telecommunications Services

Foreign Investment in Value-Added Telecommunications

Foreign direct investment in telecommunications companies in China is regulated by the Administrative Provisions of Foreign-Invested Telecommunications Enterprises, or the FITE Regulation, which was issued by the State Council on December 11, 2001 and recently amended on March 29, 2022 and effective from May 1, 2022, respectively. The FITE Regulation stipulates that a foreign-invested telecommunications enterprise in the PRC, or the FITE, must be established as a sino-foreign equity joint venture for operations in the PRC. Under the FITE Regulation and in accordance with WTO-related agreements, the foreign party investing in a FITE engaging in value-added telecommunications services may hold up to 50% of the ultimate equity interests of the FITE. The FITE must obtain approvals from the MIIT and the MOFCOM or their authorized local counterparts, which retain considerable discretion in granting approvals. Furthermore, the foreign party investing in e-commerce business, as a type of value-added telecommunications services, has been allowed to hold up to 100% of the equity interests of the FITE based on the Circular of the Ministry of Industry and Information Technology on Removing the Restrictions on Shareholding Ratio Held by Foreign Investors in Online Data Processing and Transaction Processing (Operating E-commerce) Business issued on June 19, 2015 and the current effective Catalog of Telecommunications Services, or the Telecom Catalog.

On July 13, 2006, the Ministry of Information Industry of the PRC, or the MII (which is the predecessor of the MIIT) promulgated the Notice of the Ministry of Information Industry on Strengthening the Administration of Foreign Investment in Value-added Telecommunications Services, or the MII Notice, which reiterates certain requirements of the FITE Regulations and strengthens the administration by the MII. Under the MII Notice, if a foreign investor intends to invest in PRC value-added telecommunications business, the FITE must be established to apply for the relevant telecommunications business licenses. In addition, a domestic company that holds a license for the provision of value-added telecommunications services is prohibited from leasing, transferring or selling the license to foreign investors in any form, and from providing any assistance, including providing resources, sites or facilities, to foreign investors to conduct value-added telecommunications businesses illegally in China. Trademarks and domain names that are used in the provision of value-added telecommunications services must be owned by the license holder or its shareholders. The MII Notice also requires that each value-added telecommunications services license holder have appropriate facilities for its approved business operations and to maintain such facilities in the business regions covered by its license. The value-added telecommunications services license holder shall perfect relevant measures for safeguarding the network and information, establish relevant administrative system for information safety, set up the procedures for handling emergencies of network and information safety and implement the liabilities of information safety.

 

78


Table of Contents

Telecommunications Regulations

The Telecommunications Regulations of the People’s Republic of China, or the Telecom Regulations, promulgated on September 25, 2000 and amended on July 29, 2014 and February 6, 2016 respectively, are the primary PRC laws governing telecommunications services, and set out the general framework for the provision of telecommunications services by domestic PRC companies. The Telecom Regulations require that telecommunications service providers shall obtain operating licenses prior to commencing operations. The Telecom Regulations draw a distinction between basic telecommunications services and value-added telecommunications services. The Telecom Catalog, promulgated by MII on February 21, 2003 and issued as an attachment to the Telecom Regulations and amended by the MIIT on December 28, 2015 and June 6, 2019, identifies Internet information services and online data processing and transaction processing as value-added telecommunications services.

On July 3, 2017, the MIIT issued the revised Administrative Measures for the Licensing of Telecommunications Business, or the Telecom License Measures, which became effective on September 1, 2017, to supplement the Telecom Regulations. The Telecom License Measures require that an operator of value-added telecommunications services obtain a value-added telecommunications business operating license from the MIIT or its provincial level counterparts. The term of a value-added telecommunications business license is five years and subject to annual inspection.

Internet Information Services

On September 25, 2000, the State Council promulgated the Measures for the Administration of Internet Information Services, or the ICP Measures, as amended on January 8, 2011. Under the ICP Measures, the internet information service is categorized into commercial internet information services and noncommercial internet services. The operators of noncommercial internet information services must file with relevant governmental authorities and operators of commercial internet information services in China must obtain a license for internet information provision, or the ICP License, from the relevant governmental authorities, and the provision of particular information services, such as news, publishing, education, healthcare, medicine and medical device must also comply with relevant laws and regulations and obtain the approval from competent governmental authorities.

Internet information service providers are required to monitor their websites. They may not post or disseminate any content that falls within prohibited categories provided by laws or administrative regulations and must stop providing any such content on their websites. The PRC government may order ICP License holders that violate the content restrictions to correct those violations and revoke their ICP Licenses under serious conditions.

The MIIT released the Circular on Regulating the Use of Domain Names in Internet Information Services on November 27, 2017, effective from January 1, 2018, which provides that the domain names used by the Internet information service provider in providing Internet information services shall be registered and owned by such Internet information service provider, and if the Internet information service provider is a legal entity, the domain name registrant shall be the legal entity (or any of its shareholders), or its principal or senior manager.

Mobile Internet Applications Information Services

On June 28, 2016, the CAC, promulgated the Administrative Provisions on Mobile Internet Applications Information Services, or the APP Provisions, which was amended on June 14, 2022 and took effect on August 1, 2022. Under the APP Provisions, mobile application providers are prohibited from engaging in any activity that may endanger national security, disturb the social order, or infringe the legal rights of third parties, and may not produce or disseminate through internet mobile applications any content prohibited by laws and regulations. The APP Provisions also require application providers to procure relevant qualifications required by laws and regulations to provide services through such applications and require application distribution platforms to file a record with local branches of the CAC within 30 days after their online operation.

Furthermore, on December 16, 2016, the MIIT promulgated the Interim Measures on the Administration of Pre-Installation and Distribution of Applications for Mobile Smart Terminals, which took effect on July 1, 2017 and requires, among others, that internet information service providers should ensure that a mobile application, as well as its ancillary resource files, configuration files and user data can be uninstalled by a user on a convenient basis, unless it is a basic function software, which refers to a software that supports the normal functioning of hardware and operating system of a mobile smart device.

 

79


Table of Contents

Regulations on Online Transmission of Audio-Visual Program

On December 20, 2007, the State Administration of Radio, Film and Television, or the SARFT (which is the predecessor of State Administration of Press, Publication, Radio, Film and Television, or the SAPPRFT) and the MII, jointly promulgated the Administrative Provisions on Internet Audio-visual Program Service, or the Audio-visual Program Provisions, effective January 31, 2008 and amended on August 28, 2015. The Audio-visual Program Provisions apply to the provision of audio-visual program services to the public via internet (including mobile network) within China. Providers of internet audio-visual program services are required to obtain a License for Online Transmission of Audio-visual Programs issued by the SARFT or complete certain registration procedures with the SARFT. Providers of internet audiovisual program services are generally required to be either state-owned or state-controlled by the PRC government, and the business to be carried out by such providers must satisfy the overall planning and guidance catalog for internet audio-visual program service determined by the SARFT. In a press conference jointly held by the SARFT and MII in 2008, the SARFT and MII clarified that providers of internet audio-visual program services who had engaged in such services prior to the promulgation of the Audio-visual Program Provisions shall be eligible to register their businesses and continue their operations of internet audio-visual program services so long as those providers have not been in violation of the laws and regulations.

On April 8, 2008, the SARFT issued the Notice on Relevant Issues Concerning Application and Approval of License for Online Transmission of Audio-visual Programs, as amended on August 28, 2015, which further sets forth detailed provisions concerning the application and approval process regarding the License for Online Transmission of Audio-visual Programs. The notice also provides that providers of internet audio-visual program services who engaged in such services prior to the promulgation of the Audio-visual Program Provisions shall also be eligible to apply for the license so long as their violation of the laws and regulations is minor and can be rectified timely and they have no records of violation during the latest three months prior to the promulgation of the Audio-visual Program Provisions. The SARFT further issued the Notice on Strengthening the Administration of Television Drama and Films Transmitted via Internet on December 28, 2007 and the Notice on Further Implementing the Administration of Overseas Television Drama and Films Transmitted via Internet on September 2, 2014. According to these notices, the audio-visual programs of film and drama category published to the public through information network shall be television drama under the Permit for Issuance of Television Drama, films under the Permit for Public Projection of Films, cartoons under the Permit for Issuance of Cartoons or academic literature movies and television plays under the Permit for Public Projection of Academic Literature Movies and Television Plays. Providers of such services shall obtain the prior consents from copyright owners of all such audio-visual programs.

The Classified Categories of the Internet Audio-Video Program Services (for Trial Implementation), or the Audio-video Program Categories, promulgated by the SAPPRFT on March 10, 2017, classifies internet audio/video program services into detailed categories.

On October 31, 2018, the National Radio and Television Administration issued the Notice on Further Strengthening the Management of Radio and Television and Network Audiovisual Programs, or the Notice 60. According to Notice 60, all radio and television broadcasting institutes, network audiovisual program service institutes and program production institutes shall stick to the right political direction and strengthen value guidance; pursue people-centered creative orientation to curb bad tendencies such as pursuing celebrities, pan-entertainment and so on; persist in providing high-quality content, constantly innovate programs, and strictly control the remuneration of guests.

Regulations on Feeds and Feed Additives

The State Council promulgated the Administrative Regulations on Feed and Feed Additives on May 29, 1999, as amended on November 29, 2001, November 3, 2011, December 7, 2013, February 6, 2016 and March 1, 2017. Pursuant to the Administrative Regulations on Feed and Feed Additives, the operators of feed and feed additives shall inspect product labels, product quality inspection certificates and the corresponding licensing documents when purchasing such products and no operator of feed or feed additives may unpack or repack any feed or feed additives or reprocess or add any other substance into any feed or feed additives.

On April 27, 2018, the Ministry of Agriculture and Rural Affairs promulgated a series of announcements, including the Administrative Measures for Pet Feed, the Permit Conditions for Pet Feed Manufacturers, the Pet Feed Labeling Regulations, the Pet Feed Hygienic Regulations, the Requirements for Pet Compound Feed Production Licensing Application Materials and the Requirements for Pet Additive Premix Feed Production License Application Materials, which further set forth detailed provisions concerning the production, operation and usage of animal feed and feed additives.

Regulations on Veterinary Drugs

On April 9, 2004, State Council promulgated the Regulation on Veterinary Drug Administration, which was amended on July 29, 2014, February 6, 2016 and March 27, 2020. Pursuant to the Regulation on Veterinary Drug Administration, the distribution of veterinary drug requires a Veterinary Drug Distribution License. The Veterinary Drug Distribution License shall indicate such details as the scope of business, place of business, validity period, name of the legal representative, and domicile. The validity period of a Veterinary Drug Distribution License is five years.

 

80


Table of Contents

The veterinary drug distributors in the PRC shall also comply with the Norms for the Business Operation and Quality Management of Veterinary Drugs, or the GSP, which was promulgated by the Ministry of Agriculture on January 15, 2010 and amended on November 30, 2017. GSP is a set of standards relating to the quality management in the distribution of veterinary drugs in the PRC. It sets standards regulating veterinary drug distributors with respect to distribution sites, equipment, personnel, bylaws, purchases, warehousing, distribution and freight.

On July 31, 2007, the Ministry of Agriculture and the General Administration of Customs promulgated the Administrative Measures for the Import of Veterinary Drugs, or the Veterinary Drugs Import Measures, which was amended on April 25, 2019 and January 7, 2022. Pursuant to the Veterinary Drugs Import Measures, the Customs Clearance Document for Imported Veterinary Drugs shall be obtained for the import of veterinary drugs. The Customs Clearance Document for Imported Veterinary Drugs shall be applied for by a Chinese domestic agent to the veterinary administrative department under the provincial people’s government at the locality of the veterinary drug import port. The Veterinary Drugs Import Measures also stipulates that no overseas enterprise may directly sell veterinary drugs within the territory of China. The imported veterinary biological products shall be sold by a veterinary drug enterprise within the territory of China as an agent; but no wholly foreign-invested enterprise, sino-foreign equity joint venture or sino-foreign contractual joint venture may sell the imported veterinary biological products.

Regulations on E-Commerce

On January 26, 2014, the SAIC (which is the predecessor of the State administration for Market Regulation) promulgated the Administrative Measures for Online Trading, or the Online Trading Measures, which became effective on March 15, 2014, to regulate all operating activities for product sales and services provision via the internet (including mobile internet). It stipulates the obligations of online products operators and services providers and certain special requirements applicable to third-party platform operators. On March 15, 2021, the State Administration for Market Regulation promulgated the Measures for the Supervision and Administration of Online Trading, which became effective on May 1, 2021 and totally replaced the Online Trading Measures. Furthermore, the MOFCOM promulgated the Provisions on the Procedures for Formulating Transaction Rules of Third-Party Online Retail Platforms (Trial) on December 24, 2014, which became effective on April 1, 2015, to guide and regulate the formulation, revision and enforcement of transaction rules by online retail third-party platforms operators. These measures impose more stringent requirements and obligations on third-party platform operators. For example, third-party platform operators are obligated to make public and file their transaction rules with MOFCOM or their respective provincial counterparts, examine and register the legal status of each third-party merchant selling products or services on their platforms and display on a prominent location on a merchant’s webpage the information stated in the merchant’s business license or a link to its business license. Where third-party platform operators also conduct self-operation of products or services on the platform, these third-party platform operators must make a clear distinction between their online direct sales and sales of third-party merchant products on their third-party platforms to avoid misleading the consumers.

On August 31, 2018, the SCNPC promulgated the E-Commerce Law of the People’s Republic of China, or the E-Commerce Law, which became effective on January 1, 2019. The promulgation of the E-Commerce Law established the basic legal framework for the development of China’s E-Commerce business and clarified the obligations of the operators of E-Commerce platforms and the possible legal consequences if operators of E-commerce platforms are found to be in violation of legally prescribed obligations. For example, pursuant to the E-Commerce Law, all e-commerce operators shall (i) register themselves as market subjects according to the law, except for individuals selling self-produced agricultural and sideline products or family handicrafts, applying their own skills in labor activities that are exempted from registration, or engaged in odd small-amount transaction activities that do not require any license under the law; (ii) fulfill their tax obligations and enjoy tax incentives in accordance with the law; (iii) always have information about its own business license, the administrative license issued for its business, and its status as a party that is not required to register itself as a market subject, or the link to a webpage with such information published in a prominent position on its homepage; (iv) bear the likely risks and responsibilities when commodities are in transit, except when consumers select separate express logistics service providers; and (v) provide clear notice to consumers for tie-in sales and shall not set tie-in commodities or services as the default option. Further, e-commerce operators that possess dominant market positions shall not abuse their market dominance to eliminate or restrict competition.

In addition, the E-commerce Law provides that platform operators shall (i) verify and register the identity, address, contact and administrative license of e-commerce operators applying to sell commodities or provide services on its platform, establish registration archives and have them verified and updated regularly; (ii) record and save information released on its platform about commodities and services and deals concluded for a period of three years (unless otherwise stipulated), and ensure the completeness, confidentiality and availability of such information; (iii) use noticeable labels to clearly identify any business that it conducts on its own platform. A platform operator shall not impose unreasonable restrictions over or add unjustified conditions to transactions concluded on its platform by e-commerce operators, nor shall a platform operator charge e-commerce operators on its platform any unreasonable fees.

 

81


Table of Contents

Violation of the provisions of the E-Commerce Law may entail being ordered to make corrections within a prescribed period of time, confiscation of gains illegally obtained, fines, suspension of business, inclusion of such violations in the credit records and possible civil liabilities. If a platform operator knows, or should have known, that an e-commerce operator has conducted acts infringing on the legitimate rights and interests of consumers, but the platform operator fails to take any necessary measure, the platform operator shall be held jointly and severally liable with the e-commerce operator. Where a platform operator fails to examine the qualifications of the e-commerce operators on its platform or fails to protect the safety of its consumers in respect of goods or services that may affect the consumer’s health, the platform operator shall bear corresponding liability to the consumers. Where a platform operator fails to take necessary measures against violations of intellectual property rights by e-commerce operators on its platform, the relevant administrative departments of intellectual property may order the platform operator to make corrections within the required time limit; where it fails to make corrections within the required time limit, the platform operator may face administrative fines of up to RMB2,000,000.

Regulations on Product Quality

According to the Product Quality Law of the People’s Republic of China, which was effective as from September 1, 1993 and amended by the SCNPC on July 8, 2000, August 27, 2009 and December 29, 2018, respectively, products for sale must satisfy relevant safety standards and sellers shall adopt measures to maintain the quality of products for sale. Sellers may not mix impurities or imitations into products, or pass counterfeit goods off as genuine ones, or defective products as good ones or substandard products as standard ones. For sellers, any violation of state or industrial standards for health and safety or other requirements may result in civil liabilities and administrative penalties, such as compensation for damages, fines, confiscation of products illegally manufactured or sold and the proceeds from the sales of such products illegally manufactured or sold and even revoking business license; in addition, severe violations may subject the responsible individual or enterprise to criminal liabilities.

In addition to Product Quality Law of the People’s Republic of China, there are also other PRC laws that apply to the product liability. Under the Civil Code of the People’s Republic of China, which became effective on January 1, 2021, if a substandard product causes property damage or physical injury to others, the producer or seller shall bear civil liability according to Law. If the transporter or storekeeper is responsible for the matter, the producer or seller shall have the right to demand compensation for its losses.

Regulations on Consumer Protection

According to the Consumers Rights and Interests Protection Law of the People’s Republic of China, or the Consumers Rights and Interests Protection Law, which became effective on January 1, 1994 and was amended by the SCNPC on August 27, 2009 and October 25, 2013 respectively, business operators should guarantee that the products and services they provide satisfy the requirements for personal or property safety, and provide consumers with authentic information about the quality, function, usage and term of validity of the products or services. The consumers whose interests have been damaged due to the products or services that they purchase or accept on the internet trading platforms may claim damages to sellers or service providers. Where the operators of the online trading platforms are unable to provide the real names, addresses and valid contact details of the sellers or service providers, the consumers may also claim damages to the operators of the online trading platforms. Operators of online trading platforms that clearly knew or should have known that sellers or service providers use their platforms to infringe upon the legitimate rights and interests of consumers but fail to take necessary measures must bear joint and several liabilities with the sellers or service providers. Moreover, if business operators deceive consumers or knowingly sell substandard or defective products, they should not only compensate consumers for their losses, but also pay additional damages equal to three times the price of the goods or services.

On January 6, 2017, the SAIC issued the Interim Measures for Seven-day Unconditional Return of Online Purchased Goods, which became effective on March 15, 2017 and amended on October 23, 2020, further clarifying the scope of consumers’ rights to make returns without a reason, including exceptions, return procedures and online trading platform operators’ responsibility to formulate seven-day unconditional return rules and related consumer protection systems, and supervise the merchants for compliance with these rules.

Regulations on Pricing

In China, the prices of a small number of products and services are guided or fixed by the government. According to the Pricing Law of the People’s Republic of China, or the Pricing Law, promulgated by the SCNPC on December 29, 1997 and became effective on May 1, 1998, business operators must, as required by the government departments in charge of pricing, mark the prices explicitly and indicate the name, origin of production, specifications and other related particulars clearly. Business operators may not sell products at a premium or charge any fees that are not explicitly indicated. Business operators must not commit the specified unlawful pricing activities, such as colluding with others to manipulate the market price, using false or misleading prices to deceive consumers to transact, or conducting price discrimination against other business operators. Failure to comply with the Pricing Law may subject business operators to administrative sanctions such as warning, ceasing unlawful activities, compensation, confiscating illegal gains and fines. The business operators may be ordered to suspend business for rectification or have their business licenses revoked under severe circumstances.

 

82


Table of Contents

Regulations on Advertising

In 1994, the SCNPC promulgated the Advertising Law of the People’s Republic of China, or the Advertising Law, which was recently revised on April 29, 2021 and became effective on the same date. The Advertising Law regulates commercial advertising activities in the PRC and sets out the obligations of advertisers, advertising operators, advertising publishers and advertisement endorser, and prohibits any advertisement from containing any obscenity, pornography, gambling, superstition, terrorism or violence-related content. Any advertiser in violation of such requirements on advertisement content will be ordered to cease publishing such advertisements and imposed a fine, the business license of such advertiser may be revoked, and the relevant authorities may revoke the approval document for advertisement examination and refuse to accept applications submitted by such advertiser for one year. In addition, any advertising operator or advertising publisher in violation of such requirements will be imposed a fine, and the advertisement fee received will be confiscated; in severe circumstances, the business license of such advertising operator or advertising publisher may be revoked.

The Measures for the Administration of Internet Advertising, or the Internet Advertising Measures, regulating the internet-based advertising activities were promulgated by the SAMR on February 25, 2023 and became effective on May 1, 2023. According to the Internet Advertising Measures, internet advertisers are responsible for the authenticity of the advertisements content and all online advertisements must be marked “Advertisement” so that viewers can easily identify them as such. Publishing and circulating advertisements through the Internet shall not affect the normal use of the Internet by users. It is not allowed to induce users to click on the content of advertisements by any fraudulent means, or to attach advertisements or advertising links in the emails without permission.

Regulations on Cyber Security and Privacy

The PRC Constitution states that the PRC laws protect the freedom and privacy of communications of citizens and prohibit infringement of such rights. PRC government authorities have enacted laws and regulations with respect to internet information security and protection of personal information from any abuse or unauthorized disclosure, and which includes the Decision of the Standing Committee of the National People’s Congress on Internet Security Protection enacted and amended by the SCNPC on December 28, 2000 and August 27, 2009, respectively, the Provisions on the Technical Measures for Internet Security Protection issued by the Ministry of Public Security on December 13, 2005 and took effect on March 1, 2006, the Decision of the Standing Committee of the National People’s Congress on Strengthening Network Information Protection promulgated by the SCNPC on December 28, 2012, the Several Provisions on Regulating the Market Order of Internet Information Services promulgated by the MIIT on December 29, 2011, and the Provisions on Protection of Personal Information of Telecommunication and Internet Users released by the MIIT on July 16, 2013. Internet information in China is regulated and restricted from a national security standpoint.

The Provisions on Protection of Personal Information of Telecommunication and Internet Users regulate the collection and use of users’ personal information in the provision of telecommunications services and Internet information services in the PRC. Telecommunication business operators and Internet service providers are required to institute and disclose their own rules for the collecting and use of users’ information. Telecommunication business operators and Internet service providers must specify the purposes, manners and scopes of information collection and uses, obtain consent of the relevant citizens, and keep the collected personal information confidential. Telecommunication business operators and Internet service providers are prohibited from disclosing, tampering with, damaging, selling or illegally providing others with, collected personal information. Telecommunication business operators and Internet service providers are required to take technical and other measures to prevent the collected personal information from any unauthorized disclosure, damage or loss. Once users terminate the use of telecommunications services or Internet information services, telecommunications business operators and Internet information service providers shall stop the collection and use of the personal information of users and provide the users with services for deregistering their account numbers.

The Provisions on Protecting Personal Information of Telecommunication and Internet Users further define the personal information of user to include user name, birth date, identification number, address, phone number, account number, passcode, and other information that may be used to identify the user independently or in combination with other information and the timing, places, etc. of the use of services by the users. Furthermore, according to the Interpretations on Several Issues Concerning the Application of Law in the Handling of Criminal Cases Involving Infringement of Citizens’ Personal Information, or the Interpretations, issued by the Supreme People’s Court and the Supreme People’s Procuratorate on May 8, 2017 and took effect on June 1, 2017, personal information means various information recorded electronically or through other manners, which may be used to identify individuals or activities of individuals, including but not limited to the name, identification number, contact information, address, user account number and passcode, property ownership and whereabouts.

On November 1, 2015, the Ninth Amendment to the Criminal Law of the People’s Republic of China issued by the SCNPC became effective, pursuant to which, any internet service provider that fails to comply with obligations related to internet information security administration as required by applicable laws and refuses to rectify upon order is subject to criminal penalty for (i) any large-scale dissemination of illegal information; (ii) any severe consequences due to the leakage of the user information; (iii) any serious loss of criminal evidence; or (iv) other severe circumstances. Furthermore, any individual or entity that (i) sells or distributes personal information in a manner which violates relevant regulations, or (ii) steals or illegally obtains any personal information is subject to criminal penalty in severe circumstances.

 

83


Table of Contents

On June 1, 2017, the Cyber Security Law of the People’s Republic of China, or the Cyber Security Law, promulgated by SCNPC took effect, which is formulated to maintain the network security, safeguard the cyberspace sovereignty, national security and public interests, protect the lawful rights and interests of citizens, legal persons and other organizations, and requires that a network operator, which includes, among others, internet information services providers, take technical measures and other necessary measures to safeguard the safe and stable operation of the networks, effectively respond to the network security incidents, prevent illegal and criminal activities, and maintain the integrity, confidentiality and availability of network data. The Cyber Security Law reaffirms the basic principles and requirements set forth in other existing laws and regulations on personal information protections and strengthens the obligations and requirements of internet service providers, which include but are not limited to: (i) keeping all user information collected strictly confidential and setting up a comprehensive user information protection system; (ii) abiding by the principles of legality, rationality and necessity in the collection and use of user information and disclosure of the rules, purposes, methods and scopes of collection and use of user information; and (iii) protecting users’ personal information from being leaked, tampered with, destroyed or provided to third parties. Any violation of the provisions and requirements under the Cyber Security Law and other related regulations and rules may result in administrative liabilities such as warnings, fines, confiscation of illegal gains, revocation of licenses, suspension of business, and shutting down of websites, or, in severe cases, criminal liabilities. After the release of the Cyber Security Law, on April 13, 2020, the CAC together with other relevant administrative departments jointly promulgated Cybersecurity Review Measures, which was subsequently amended on December 28, 2021 and became effective on February 15, 2022.

The recommended national standard, Information Security Technology Personal Information Security Specification, puts forward specific refinement requirements on the collection, preservation, use and commission processing, sharing, transfer, public disclosure, etc. Although it is not mandatory, in the absence of clear implementation rules and standards for the law on Cyber security and other personal information protection, it will be used as the basis for judging and making determinations.

On August 20, 2021, the SCNPC promulgated the Personal Information Protection Law of People’s Republic of China, which became effective on November 1, 2021. It stipulates the scope of personal information and the ways of processing personal information, establishes rules for processing personal information and for transfer offshore, and clarifies the individual’s rights and the processor’s obligations in the processing of personal information.

On June 10, 2021, the SCNPC promulgated the Data Security Law of People’s Republic of China, which became effective on September 1, 2021. It is formulated so as to regulate the handling of data, ensure data security, promote the development and exploitation of data, protect the legitimate rights and interests of citizens and organizations, and preserve state sovereignty, security, and development interests. The law stipulates that the carrying out of data handling activities shall obey laws and regulations, respect social mores and ethics, comply with commercial ethics and professional ethics, be honest and trustworthy, perform obligations to protect data security, and undertake social responsibility; it must not endanger national security, the public interest, or individuals’ and organizations’ lawful rights and interests. Furthermore, the Opinions on Strictly Cracking Down on Illegal Securities Activities in Accordance with the Law, or the Opinions on Strictly Cracking Down on Illegal Securities Activities, which were issued by the General Office of the State Council and another authority on July 6, 2021, require the speedup of the revision of the provisions on strengthening the confidentiality and archives coordination between regulators related to overseas issuance and listing of securities, and improvement to the laws and regulations related to data security, cross-border data flow, and management of confidential information.

On November 14, 2021, the CAC released the Regulations for the Administration of Network Data Security (Draft for comments) for public opinions, pursuant to which, data processors shall adopt backup, encryption, access control or other necessary measures to protect data from leakage, theft, tampering with, damage, loss and illegal use, to respond to data security incidents, and to guard against illegal and criminal activities targeting or using data, in order to maintain the integrity, confidentiality and availability of data. On July 7, 2022, the CAC promulgated the Data Outbound Transfer Security Assessment Measures or the Security Assessment Measures, which took effect on September 1, 2022. The Security Assessment Measures provides that, among others, data processors shall apply to competent authorities for security assessment when transferring important data abroad or when, in the case of a critical information infrastructure operator, or a personal information processor that has processed personal information of more than one million individual, transferring personal information abroad.

Regulations on Intellectual Property

China has adopted comprehensive legislation governing intellectual property rights, including copyrights, trademarks, patents and domain names. China is a signatory to the primary international conventions on intellectual property rights and has been a member of the Agreement on Trade Related Aspects of Intellectual Property Rights since its accession to the World Trade Organization on December 11, 2001.

 

84


Table of Contents

Copyright

On September 7, 1990, the SCNPC promulgated the Copyright Law of the People’s Republic of China, or the Copyright Law, effective on June 1, 1991 and amended on October 27, 2001, February 26, 2010 and November 11, 2020, respectively. The amended Copyright Law extends copyright protection to internet activities, products disseminated over the Internet and software products. In addition, there is a voluntary registration system administered by the Copyright Protection Center of China. According to the Copyright Law, Chinese citizens, legal persons, or other organizations shall, whether published or not, own copyright in their copyrightable works, which include, among others, works of literature, art, natural science, social science, engineering technology and computer software. Copyright owners enjoy certain legal rights, including right of publication, right of authorship and right of reproduction. An infringer of the copyrights shall be subject to various civil liabilities, which include ceasing infringement activities, apologizing to the copyright owners and compensating the loss of copyright owner. Infringers of copyright may also be subject to fines and/or administrative or criminal liabilities in severe situations.

Under the Regulations on the Protection of the Right to Network Dissemination of Information that took effect on July 1, 2006 and was amended on January 30, 2013, it is further provided that an Internet information service provider may be held liable under various situations, including that if it knows or should reasonably have known a copyright infringement through the Internet and the service provider fails to take measures to remove or block or disconnect links to the relevant content, or, although not aware of the infringement, the Internet information service provider fails to take such measures upon receipt of the copyright holder’s notice of such infringement.

In order to further implement the Regulations on Computer Software Protection, promulgated by the State Council on June 4, 1991 and recently amended on January 30, 2013, the National Copyright Administration issued the Measures for the Registration of Computer Software Copyright on February 20, 2002, which specify detailed procedures and requirements with respect to the registration of software copyrights.

Trademark

According to the Trademark Law of the People’s Republic of China promulgated by the SCNPC on August 23, 1982, and amended on February 22, 1993, October 27, 2001, August 30, 2013 and April 23, 2019 respectively, the Trademark Office of the SAIC is responsible for the registration and administration of trademarks in China. The SAIC under the State Council has established a Trademark Review and Adjudication Board for resolving trademark disputes. Registered trademarks are valid for ten years from the date the registration is approved. A registrant may apply to renew a registration within 12 months before the expiration date of the registration. If the registrant fails to apply in a timely manner, a grace period of six additional months may be granted. If the registrant fails to apply before the grace period expires, the registered trademark shall be deregistered. Renewed registrations are valid for ten years. On April 29, 2014, the State Council issued the revised Implementing Regulations of the Trademark Law of the People’s Republic of China, which specified the requirements of applying for trademark registration and renewal.

Patent

According to the Patent Law of the People’s Republic of China, or the Patent Law, promulgated by the SCNPC on March 12, 1984 and amended on September 4, 1992, August 25, 2000, December 27, 2008 and October 17, 2020, respectively, and the Implementation Rules of the Patent Law of the People’s Republic of China, or the Implementation Rules of the Patent Law, promulgated by the State Council on June 15, 2001 and revised on December 28, 2002 and January 9, 2010, the patent administrative department under the State Council is responsible for the administration of patent-related work nationwide and the patent administration departments of provincial or autonomous regions or municipal governments are responsible for administering patents within their respective administrative areas. The Patent Law and Implementation Rules of the Patent Law provide for three types of patents, namely “inventions,” “utility models” and “designs.” Invention patents are valid for twenty years, while utility model patents are valid for ten years, and design patents are valid for fifteen years, in each case from the date of application. The Chinese patent system adopts a “first come, first file” principle, which means that where more than one person files a patent application for the same invention, a patent will be granted to the person who files the application first. An invention or a utility model must possess novelty, inventiveness and practical applicability to be patentable. Third Parties must obtain consent or a proper license from the patent owner to use the patent. Otherwise, the unauthorized use constitutes an infringement on the patent rights.

 

85


Table of Contents

Domain Names

On May 29, 2012, the China Internet Network Information Center, or the CNNIC, issued the Implementing Rules for Domain Name Registration, which took effect on May 29, 2012, setting forth the detailed rules for registration of domain names. On June 18, 2019, the CNNIC promulgated the Implementing Rules for the Registration of National Top-level Domain Names, which became effective on the same day and totally replaced the Implementing Rules for Domain Name Registration. On August 24, 2017, the MIIT promulgated the Administrative Measures for Internet Domain Names, or the Domain Name Measures, which became effective on November 1, 2017. The Domain Name Measures regulate the registration of domain names, such as the China’s national top-level domain name “.CN”. According to the Domain Name Measures, the MIIT is in charge of the administration of PRC internet domain names. The domain name registration follows a first-to-file principle. Applicants for registration of domain names shall provide the true, accurate and complete information of their identities to domain name registration service institutions. The applicants will become the holder of such domain names upon the completion of the registration procedure. According to the Implementing Rules for the Registration of National Top-level Domain Names, if any entity or person considers that a domain name registered by any other person conflicts with its or his lawful rights or interests, it or he may file a complaint with a dispute resolution service provider.

Regulations on Foreign Exchange

The principal regulations governing foreign currency exchange in China are the Administrative Regulations on Foreign Exchange of the People’s Republic of China, or the Foreign Exchange Administrative Regulation, which were promulgated by the State Council on January 29, 1996, became effective on April 1, 1996 and was subsequently amended on January 14, 1997 and August 5, 2008 and the Administrative Regulations on Foreign Exchange Settlement, Sales and Payment which was promulgated by the People’s Bank of China, or the PBOC, on June 20, 1996 and became effective on July 1, 1996. Under these regulations, payments of current account items, such as profit distributions and trade and service-related foreign exchange transactions, can be made in foreign currencies without prior approval from State Foreign Exchange Administration of the People’s Republic of China, or the SAFE, by complying with certain procedural requirements. By contrast, approval from or registration with appropriate government authorities is required where Renminbi is to be converted into foreign currency and remitted out of China to pay capital account items such as the repayment of foreign currency denominated loans, direct investment overseas and investments in securities or derivative products outside of the PRC. FIEs are permitted to convert their after tax dividends into foreign exchange and to remit such foreign exchange out of their foreign exchange bank accounts in the PRC.

On March 30, 2015, SAFE promulgated the Notice on Reforming the Administration of Foreign Exchange Settlement of Capital of Foreign-invested Enterprises, or the SAFE Circular 19, which took effect on June 1, 2015. According to SAFE Circular 19, the foreign currency capital contribution to an FIE in its capital account may be converted into RMB on a discretional basis.

On June 9, 2016, the SAFE promulgated the Circular on Reforming and Regulating Policies on the Management of the Settlement of Foreign Exchange of Capital Accounts, or the SAFE Circular 16. The SAFE Circular 16 unifies the discretional foreign exchange settlement for all the domestic institutions. The Discretional Foreign Exchange Settlement refers to the foreign exchange capital in the capital account which has been confirmed by the relevant policies subject to the discretional foreign exchange settlement (including foreign exchange capital, foreign loans and funds remitted from the proceeds from the overseas listing) can be settled at the banks based on the actual operational needs of the domestic institutions. The proportion of Discretional Foreign Exchange Settlement of the foreign exchange capital is temporarily determined as 100%. Violations of SAFE Circular 19 or SAFE Circular 16 could result in administrative penalties in accordance with the Foreign Exchange Administrative Regulation and relevant provisions.

Furthermore, SAFE Circular 16 stipulates that the use of foreign exchange incomes of capital accounts by FIEs shall follow the principles of authenticity and self-use within the business scope of the enterprises. The foreign exchange incomes of capital accounts and capital in RMB obtained by the FIE from foreign exchange settlement shall not be used for the following purposes: (i) directly or indirectly used for the payment beyond the business scope of the enterprises or the payment prohibited by relevant laws and regulations; (ii) directly or indirectly used for investment in securities or financial schemes other than bank guaranteed products unless otherwise provided by relevant laws and regulations; (iii) used for granting loans to nonaffiliated enterprises, unless otherwise permitted by its business scope; and (iv) used for the construction or purchase of real estate that is not for self-use (except for the real estate enterprises).

On October 23, 2019, the SAFE promulgated the Notice of the State Administration of Foreign Exchange on Further Promoting the Convenience of Cross-border Trade and Investment, or the SAFE Circular 28. The SAFE Circular 28 stipulates that non-investment FIEs may use capital to carry out domestic equity investment in accordance with the law under the premise of not violating the Negative list and the projects invested are true and in compliance with laws and regulations.

 

86


Table of Contents

Regulations on Dividend Distributions

The principal regulations governing distribution of dividends of wholly foreign-owned enterprise, or the WFOE, include the PRC Company Law. Under these regulations, WFOEs in China may pay dividends only out of their accumulated profits, if any, determined in accordance with the PRC accounting standards and regulations. In addition, FIEs in the PRC are required to allocate at least 10% of their accumulated profits each year, if any, to fund certain reserve funds unless these reserves have reached 50% of the registered capital of the enterprises. These reserves are not distributable as cash dividends.

Regulations on Foreign Debts

A loan made by foreign investors as shareholders in a foreign-invested enterprise is considered to be foreign debt in the PRC and is regulated by various laws and regulations, including the Foreign Exchange Administrative Regulation, the Interim Provisions on the Management of Foreign Debts promulgated by SAFE, the NDRC and the Ministry of Finance, or the MOF, and took effect on March 1, 2003 and the Administrative Measures for Registration of Foreign Debts promulgated by SAFE on April 28, 2013 and amended by the Notice of the SAFE on Abolishing and Amending the Normative Documents Related to the Reform of the Registered Capital Registration System on May 4, 2015. Under these rules, a shareholder loan in the form of foreign debt made to a Chinese entity does not require the prior approval of SAFE. However, such foreign debt must be registered with and recorded by local banks. The SAFE Circular 28 provides that a nonfinancial enterprise in the pilot areas may register the permitted amounts of foreign debts, which is as twice of the nonfinancial enterprise’s net assets, at the local foreign exchange bureau. Such nonfinancial enterprise may borrow foreign debts within the permitted amounts and directly handle the relevant procedures in banks without registration of each foreign debt. However, the nonfinancial enterprise shall report its international income and expenditure regularly.

Regulations on Offshore Special Purpose Companies Held by PRC Residents

SAFE promulgated Notice on Issues Relating to Foreign Exchange Administration over the Overseas Investment and Financing and Round-trip Investment by Domestic Residents via Special Purpose Vehicles, or the SAFE Circular 37, on July 4, 2014 that requires PRC residents or entities to register with SAFE or its local branch in connection with their establishment or control of an offshore entity established for the purpose of overseas investment or financing. In addition, such PRC residents or entities must update their SAFE registrations when the offshore special purpose vehicle undergoes material events relating to any change of basic information (including change of such PRC citizens or residents, name and term of operation), capital increase or capital reduction, transfers or exchanges of shares, or mergers or divisions. SAFE Circular 37 was issued to replace the Notice on Relevant Issues Concerning Foreign Exchange Administration for PRC Residents Engaging in Financing and Roundtrip Investments via Overseas Special Purposes Vehicles.

SAFE further enacted the Notice of the State Administration of Foreign Exchange on Further Simplifying and Improving the Foreign Exchange Management Policies for Direct Investment, or the SAFE Circular 13, which allows PRC residents or entities to register with qualified banks in connection with their establishment or control of an offshore entity established for the purpose of overseas investment or financing. However, remedial registration applications made by PRC residents that previously failed to comply with the SAFE Circular 37 continue to fall under the jurisdiction of the relevant local branch of SAFE. In the event that a PRC shareholder holding interests in a special purpose vehicle fails to fulfill the required SAFE registration, the PRC subsidiaries of that special purpose vehicle may be prohibited from distributing profits to the offshore parent and from carrying out subsequent cross-border foreign exchange activities, and the special purpose vehicle may be restricted in its ability to contribute additional capital into its PRC subsidiary.

On January 26, 2017, SAFE issued the Notice on Improving the Check of Authenticity and Compliance to Further Promote Foreign Exchange Control, or the SAFE Circular 3, which stipulates several capital control measures with respect to the outbound remittance of profit from domestic entities to offshore entities, including (i) under the principle of genuine transaction, banks shall check board resolutions regarding profit distribution, the original version of tax filing records and audited financial statements; and (ii) domestic entities shall hold income to account for previous years’ losses before remitting the profits. Moreover, pursuant to SAFE Circular 3, domestic entities shall make detailed explanations of the sources of capital and utilization arrangements, and provide board resolutions, contracts and other proof when completing the registration procedures in connection with an outbound investment.

 

87


Table of Contents

Regulations on Stock Incentive Plans

According to the Notice of the State Administration of Foreign Exchange on Issues Relating to the Foreign Exchange Administration for Domestic Individuals Participating in Stock Incentive Plan of Overseas Listed Company, or the Share Option Rules, which was issued on February 15, 2012 and other regulations, directors, supervisors, senior management and other employees participating in any share incentive plan of an overseas publicly listed company who are PRC citizens or non-PRC citizens residing in China for a continuous period of not less than one year, subject to certain exceptions, are required to register with the SAFE. All such participants need to authorize a qualified PRC agent, such as a PRC subsidiary of the overseas publicly listed company to register with the SAFE and handle foreign exchange matters such as opening accounts, transferring and settlement of the relevant proceeds. The Share Incentive Rules further require an offshore agent to be designated to handle matters in connection with the exercise of share options and sales of proceeds for the participants of the share incentive plans. Failure to complete the said SAFE registrations may subject our participating directors, supervisors, senior management and other employees to fines and legal sanctions.

In addition, the STA, has issued certain circulars concerning employee stock options and restricted shares. Under these circulars, employees working in the PRC who exercise stock options or are granted restricted shares will be subject to PRC individual income tax. The PRC subsidiaries of an overseas listed company are required to file documents related to employee stock options and restricted shares with relevant tax authorities and to withhold individual income taxes of employees who exercise their stock option or purchase restricted shares. If the employees fail to pay or the PRC subsidiaries fail to withhold income tax in accordance with relevant laws and regulations, the PRC subsidiaries may face sanctions imposed by the tax authorities or other PRC governmental authorities.

Regulations on Outbound Direct Investment

On December 26, 2017, the NDRC promulgated the Administrative Measures on Overseas Investments of Enterprises, or NDRC Order No. 11, which took effect on March 1, 2018. According to NDRC Order No. 11, non-sensitive overseas investment projects are required to make record filings with the local branch of the NDRC. On September 6, 2014, MOFCOM promulgated the revised Administrative Measures on Overseas Investments, which took effect on October 6, 2014. According to such regulations, overseas investments of PRC enterprises that involve non-sensitive countries and regions and non-sensitive industries must make record filings with a local branch of MOFCOM. The Notice of the State Administration of Foreign Exchange on Further Improving and Adjusting Foreign Exchange Administration Policies for Direct Investment was issued by SAFE on November 19, 2012 and amended on May 4, 2015, October 10, 2018, and December 30, 2019, respectively, under which PRC enterprises must register for overseas direct investment with local banks. The shareholders or beneficial owners who are PRC entities are required to be in compliance with the related overseas investment regulations. If they fail to complete the filings or registrations required by overseas direct investment regulations, the relevant authority may order them to suspend or cease the implementation of such investment and make corrections within a specified time.

 

88


Table of Contents

Regulations on Taxation

Income tax

According to the Enterprise Income Tax Law of the People’s Republic of China, or the EIT Law, which was promulgated on March 16, 2007, became effective as from January 1, 2008 and was amended on February 24, 2017 and December 29, 2018, an enterprise established outside the PRC with de facto management bodies within the PRC is considered a resident enterprise for PRC enterprise income tax purposes and is generally subject to a uniform 25% enterprise income tax rate on its worldwide income. The Implementing Rules of the Enterprise Income Law of the People’s Republic of China, or the Implementing Rules of the EIT Law, defines a de facto management body as a managing body that in practice exercises “substantial and overall management and control over the production and operations, personnel, accounting, and properties” of the enterprise. Non-PRC resident enterprises without any branches in the PRC pay an enterprise income tax in connection with their income originating from the PRC at the tax rate of 10%.

Enterprises that are recognized as high and new technology enterprises in accordance with the Administrative Measures for the Determination of High and New Tech Enterprises issued by the Ministry of Science, the Ministry of Finance and the STA are entitled to enjoy a preferential enterprise income tax rate of 15%. The validity period of the high and new technology enterprise qualification shall be three years from the date of issuance of the certificate. An enterprise can reapply for such recognition as a high and new technology enterprise before or after the previous certificate expires.

On February 3, 2015, the STA issued the Announcement on Several Issues Concerning the Enterprise Income Tax on Indirect Transfer of Assets by Nonresident Enterprises, or the STA Circular 7. The STA Circular 7 repeals certain provisions in the Notice of the State Administration of Taxation on Strengthening the Administration of Enterprise Income Tax on Income from Equity Transfer by Nonresident Enterprises, or the STA Circular 698, issued by STA on December 10, 2009 and the Announcement on Several Issues Relating to the Administration of Income Tax on Nonresident Enterprises issued by STA on March 28, 2011 and clarifies certain provisions in the STA Circular 698. The STA Circular 7 provides comprehensive guidelines relating to, and heightening the Chinese tax authorities’ scrutiny on, indirect transfers by a nonresident enterprise of assets (including assets of organizations and premises in PRC, immovable property in the PRC, equity investments in PRC resident enterprises) or the PRC Taxable Assets. For instance, when a nonresident enterprise transfers equity interests in an overseas holding company that directly or indirectly holds certain PRC Taxable Assets and if the transfer is believed by the Chinese tax authorities to have no reasonable commercial purpose other than to evade enterprise income tax, the STA Circular 7 allows the Chinese tax authorities to reclassify the indirect transfer of PRC Taxable Assets into a direct transfer and therefore impose a 10% rate of PRC enterprise income tax on the nonresident enterprise. The STA Circular 7 lists several factors to be taken into consideration by tax authorities in determining if an indirect transfer has a reasonable commercial purpose. However, regardless of these factors, the overall arrangements in relation to an indirect transfer satisfying all the following criteria will be deemed to lack a reasonable commercial purpose: (i) 75% or more of the equity value of the intermediary enterprise being transferred is derived directly or indirectly from PRC Taxable Assets; (ii) at any time during the one-year period before the indirect transfer, 90% or more of the asset value of the intermediary enterprise (excluding cash) is composed directly or indirectly of investments in the PRC, or during the one-year period before the indirect transfer, 90% or more of its income is derived directly or indirectly from the PRC; (iii) the functions performed and risks assumed by the intermediary enterprise and any of its subsidiaries and branches that directly or indirectly hold the PRC Taxable Assets are limited and are insufficient to prove their economic substance; and (iv) the foreign tax payable on the gain derived from the indirect transfer of the PRC Taxable Assets is lower than the potential PRC tax on the direct transfer of those assets. On the other hand, indirect transfers falling into the scope of the safe harbors under the STA Circular 7 may not be subject to PRC tax under the STA Circular 7. The safe harbors include qualified group restructurings, public market trades and exemptions under tax treaties or arrangements.

On October 17, 2017, STA issued the Announcement on Issues Relating to Withholding at Source of Income Tax of Nonresident Enterprises, or the STA Circular 37, which took effect on December 1, 2017. Certain provisions of the STA Circular 37 were repealed by the Announcement of the State Administration of Taxation on Revising Certain Taxation Normative Documents. According to the STA Circular 37, the balance after deducting the equity net value from the equity transfer income shall be the taxable income amount for equity transfer income. Equity transfer income shall mean the consideration collected by the equity transferor from the equity transfer, including various income in monetary form and nonmonetary form. Equity net value shall mean the tax computation basis for obtaining the said equity. The tax computation basis for equity shall be: (i) the capital contribution costs actually paid by the equity transferor to a Chinese resident enterprise at the time of investment and equity participation, or (ii) the equity transfer costs actually paid at the time of acquisition of such equity to the original transferor of the said equity. Where there is reduction or appreciation of value during the equity holding period, and the gains or losses may be confirmed pursuant to the rules of the finance and tax authorities of the State Council, the equity net value shall be adjusted accordingly. When an enterprise computes equity transfer income, it shall not deduct the amount in the shareholders’ retained earnings such as undistributed profits etc., of the investee enterprise, which may be distributed in accordance with the said equity. In the event of partial transfer of equity under multiple investments or acquisitions, the enterprise shall determine the costs corresponding to the transferred equity in accordance with the transfer ratio, out of all costs of the equity.

 

89


Table of Contents

Under the STA Circular 7 and the Law of the People’s Republic of China on the Administration of Tax Collection promulgated by the SCNPC on September 4, 1992 and newly amended on April 24, 2015, in the case of an indirect transfer, entities or individuals obligated to pay the transfer price to the transferor shall act as withholding agents. If they fail to make withholding or withhold the full amount of tax payable, the transferor of equity shall declare and pay tax to the relevant tax authorities within seven days from the occurrence of tax payment obligation. Where the withholding agent does not make the withholding, and the transferor of the equity does not pay the tax payable amount, the tax authority may impose late payment interest on the transferor. In addition, the tax authority may also hold the withholding agents liable and impose a penalty of ranging from 50% to 300% of the unpaid tax on them. The penalty imposed on the withholding agents may be reduced or waived if the withholding agents have submitted the relevant materials in connection with the indirect transfer to the PRC tax authorities in accordance with the STA Circular 7.

Withholding tax on dividend distribution

The EIT Law prescribes a standard withholding tax rate of 20% on dividends and other China-sourced income of non-PRC resident enterprises which have no establishment or place of business in the PRC, or if established, the relevant dividends or other China-sourced income are in fact not associated with such establishment or place of business in the PRC. However, the Implementing Rules of the EIT Law reduced the rate from 20% to 10%, effective from January 1, 2008. However, a lower withholding tax rate might be applied if there is a tax treaty between China and the jurisdiction of the foreign holding companies. For example, pursuant to the Arrangement Between the Mainland of China and the Hong Kong Special Administrative Region for the Avoidance of Double Taxation on Income, or the Double Tax Avoidance Arrangement, and other applicable PRC laws, if a Hong Kong resident enterprise is determined by the competent PRC tax authority to have satisfied the relevant conditions and requirements under the Double Tax Avoidance Arrangement and other applicable laws, the 10% withholding tax on the dividends that the Hong Kong resident enterprise receives from a PRC resident enterprise may be reduced to 5% upon receiving approval from the tax authority in charge.

Based on the Notice on Relevant Issues Relating to the Enforcement of Dividend Provisions in Tax Treaties issued on February 20, 2009 by the STA, if the relevant PRC tax authorities determine, at their discretion, that a company benefits from such reduced income tax rate due to a structure or arrangement that is primarily tax-driven, such PRC tax authorities may adjust the preferential tax treatment. The Announcement of the State Administration of Taxation on Issues concerning “Beneficial Owners” in Tax Treaties, which was promulgated by the STA on February 3, 2018 and took effect on April 1, 2018, further clarified the analysis standard when determining one’s qualification for beneficial owner status.

Value-Added Tax

Pursuant to the Interim Regulations on Value-Added Tax of the People’s Republic of China, which was promulgated by the State Council on December 13, 1993 and amended on November 5, 2008, February 6, 2016 and November 19, 2017, and the Implementation Rules for the Interim Regulations on Value-Added Tax of the People’s Republic of China, which was promulgated by the MOF, and STA on December 15, 2008 and became effective on January 1, 2009 and as amended on October 28, 2011, entities or individuals engaging in sale of goods, provision of processing services, repairs and replacement services or importation of goods within the territory of the PRC shall pay value-added tax, or the VAT. Unless provided otherwise, the rate of VAT is 17% on sales and 6% on services. On April 4, 2018, MOF and STA jointly promulgated the Circular of the Ministry of Finance and the State Administration of Taxation on Adjustment of Value-Added Tax Rates, or the Circular 32, according to which (i) for VAT taxable sales acts or import of goods originally subject to VAT rates of 17% and 11% respectively, such tax rates shall be adjusted to 16% and 10%, respectively; (ii) for purchase of agricultural products originally subject to tax rate of 11%, such tax rate shall be adjusted to 10%; (iii) for purchase of agricultural products for the purpose of production and sales or consigned processing of goods subject to tax rate of 16%, such tax shall be calculated at the tax rate of 12%; (iv) for exported goods originally subject to tax rate of 17% and export tax refund rate of 17%, the export tax refund rate shall be adjusted to 16%; and (v) for exported goods and cross-border taxable acts originally subject to tax rate of 11% and export tax refund rate of 11%, the export tax refund rate shall be adjusted to 10%. Circular 32 became effective on May 1, 2018 and shall supersede existing provisions which are inconsistent with Circular 32.

Since November 16, 2011, the MOF and the STA have implemented the Pilot Plan for Imposition of Value-Added Tax to Replace Business Tax, or the VAT Pilot Plan, which imposes VAT in lieu of business tax for certain “modern service industries” in certain regions and eventually expanded to nation-wide application in 2013. According to the Implementation Rules for the Pilot Plan for Imposition of Value-Added Tax to Replace Business Tax released by the MOF and the STA on the VAT Pilot Program, the “modern service industries” include research, development and technology services, information technology services, cultural innovation services, logistics support, lease of corporeal properties, attestation and consulting services. The Notice on Comprehensively promoting the Pilot Plan of the Conversion of Business Tax to Value-Added Tax, which was promulgated on March 23, 2016, became effective on May 1, 2016 and amended on July 11, 2017 and March 20, 2019, sets out that VAT in lieu of business tax be collected in all regions and industries.

 

90


Table of Contents

On March 20, 2019, MOF, STA and the General Administration of Customs jointly promulgated the Announcement on Relevant Policies for Deepening Value-Added Tax Reform, which became effective on April 1, 2019 and provides that (i) with respect to VAT taxable sales acts or import of goods originally subject to VAT rates of 16% and 10% respectively, such tax rates shall be adjusted to 13% and 9%, respectively; (ii) with respect to purchase of agricultural products originally subject to tax rate of 10%, such tax rate shall be adjusted to 9%; (iii) with respect to purchase of agricultural products for the purpose of production or consigned processing of goods subject to tax rate of 13%, such tax shall be calculated at the tax rate of 10%; (iv) with respect to export of goods and services originally subject to tax rate of 16% and export tax refund rate of 16%, the export tax refund rate shall be adjusted to 13%; and (v) with respect to export of goods and cross-border taxable acts originally subject to tax rate of 10% and export tax refund rate of 10%, the export tax refund rate shall be adjusted to 9%.

Regulations on Employment and Social Welfare

According to the Labor Contract Law of the People’s Republic of China, or the Labor Contract Law, promulgated by the SCNPC on June 29, 2007 and amended on December 28, 2012, and the Implementation Rules of the Labor Contract Law of the People’s Republic of China, or the Implementation Rules of the Labor Contract Law, promulgated by the State Council on September 18, 2008, a written employment contract shall be concluded in the establishment of an employment relationship. If an employer fails to enter into a written employment contract with an employee within one year from the date on which the employment relationship is established, the employer must rectify the situation by entering into a written employment contract with the employee and pay the employee twice the employee’s salary for the period from the day following the lapse of one month from the date of establishment of the employment relationship to the day prior to the execution of the written employment contract. The Labor Contract Law and its implementation rules also require compensation to be paid upon certain terminations. In addition, if an employer intends to enforce a non-compete provision in an employment contract or noncompetition agreement with an employee, it has to compensate the employee on a monthly basis during the term of the restriction period after the termination or expiry of the labor contract. Employers in most cases are also required to provide severance payment to their employees after their employment relationships are terminated.

Pursuant to the Social Insurance Law of the People’s Republic of China, which was promulgated by the SCNPC on October 28, 2010, effective on July 1, 2011 and last amended on December 29, 2018, the Interim Regulations on the Collection of Social Insurance Fees, issued by the State Council on January 22, 1999 and last amended on March 24, 2019, and the Regulations on the Administration of Housing Provident Funds, issued by the State Council on April 3, 1999 and last amended on March 24, 2019, enterprises in China are required to participate in certain employee benefit plans, including social insurance funds, namely a pension plan, a medical insurance plan, an unemployment insurance plan, a work-related injury insurance plan and a maternity insurance plan, and a housing provident fund, and contribute to the plans or funds in amounts equal to certain percentages of salaries, including bonuses and allowances, of the employees as specified by the local government from time to time at locations where they operate their businesses or where they are located.

Regulations on Overseas Listing and M&A

On August 8, 2006, six PRC regulatory agencies, including the China Securities Regulatory Commission, or the CSRC, promulgated the Rules on the Merger and Acquisition of Domestic Enterprises by Foreign Investors, or the M&A Rules, which became effective on September 8, 2006 and were amended on June 22, 2009. The M&A Rules, among other things, require offshore special purpose vehicles formed for overseas listing purposes through acquisitions of PRC domestic companies and controlled by PRC domestic enterprises or individuals to obtain the approval of the CSRC prior to the listing and trading of such special purpose vehicle’s securities on an overseas stock exchange. In September 2006, the CSRC published on its official website procedures regarding its approval of overseas listings by special purpose vehicles. The CSRC approval procedures require the filing of a number of documents with the CSRC. Although (i) the CSRC currently has not issued any definitive rule or interpretation concerning whether offerings like ours under this annual report are subject to the M&A Rules, (ii) the company established the WFOEs by means of direct investment and not through a merger or acquisition of the equity or assets of a “PRC domestic company” as such term is defined under the M&A Rules; and (iii) no provision in the M&A Rules classifies the contractual arrangements under the VIE Agreements as a type of acquisition transaction falling under the M&A Rules, the interpretation and application of the regulations remain unclear. The M&A Rules, and other regulations and rules concerning mergers and acquisitions established additional procedures and requirements that could make merger and acquisition activities by foreign investors more time consuming and complex. For example, the M&A Rules require that MOFCOM be notified in advance of any change-of-control transaction in which a foreign investor takes control of a PRC domestic enterprise, if (i) any important industry is concerned, (ii) such transaction involves factors that impact or may impact national economic security, or (iii) such transaction will lead to a change in control of a domestic enterprise which holds a famous trademark or PRC time-honored brand.

 

91


Table of Contents

In addition, according to the Notice on Establishing the Security Review System for Mergers and Acquisitions of Domestic Enterprises by Foreign Investors issued by the General Office of the State Council on February 3, 2011 and which became effective on March 4, 2011, the Rules on Implementation of Security Review System for the Merger and Acquisition of Domestic Enterprises by Foreign Investors issued by the MOFCOM on August 25, 2011 and which became effective on September 1, 2011, mergers and acquisitions by foreign investors that raise “national defense and security” concerns and mergers and acquisitions through which foreign investors may acquire de facto control over domestic enterprises that raise “national security” concerns are subject to strict review by the MOFCOM, and the regulations prohibit any activities attempting to bypass such security review, including by structuring the transaction through a proxy or contractual control arrangement.

On February 17, 2023, the CSRC, as approved by the State Council, released the Trial Measures. According to the Trial Measures, domestic companies in the Chinese mainland that directly or indirectly offer or list their securities in an overseas market, are required to file with the CSRC. Specifically, the securities under the Trial Measures refer to stocks, depositary receipts, convertible corporate bonds, exchangeable bonds and other equity-linked securities to be issued and offered in overseas markets by domestic companies directly or indirectly, while a direct offering and listing refers to the overseas offering and listing of a joint-stock company incorporated in the Chinese mainland, and an indirect offering and listing refers to the overseas offering and listing of a domestic company which conducts its business operations primarily in the Chinese mainland, in the name of an offshore company and based on the underlying equities, assets, earnings or similar interests of the domestic company. In particular, the determination of an indirect offering and listing will be conducted on a “substance over form” basis, and an offering and listing should be considered as an indirect overseas offering and listing by a domestic company if the issuer meets both of the following conditions: (i) any of the revenue, profits, total assets or net assets of such domestic company in the most recent financial year account for more than 50% of the corresponding data in the issuer’s audited consolidated financial statements for the same period; and (ii) the majority of its business operations are conducted in the Chinese mainland or its principal place of business is located in the Chinese mainland, or the majority of senior management in charge of business operations are Chinese citizens or have domicile in the Chinese mainland. According to the Trial Measures, an overseas offering and listing is prohibited under any of the following circumstances: (i) if the intended securities offering and listing is specifically prohibited by the laws, administrative regulations and relevant national provisions; (ii) if the intended securities offering and listing may constitute a threat to or endangers national security as reviewed and determined by competent authorities under the State Council in accordance with law; (iii) the domestic companies or their controlling shareholders or actual controllers have committed corruption, bribery, embezzlement, misappropriation of property, or other criminal offenses disruptive to the order of the socialist market economy in the past three years; (iv) the domestic companies are currently under investigations in connection with suspicion of having committed criminal offenses or material violations of applicable laws and regulations, and there is still no explicit conclusion; (v) there are material ownership disputes over the shareholdings held by the controlling shareholder or the shareholder under the control of the controlling shareholder or the actual controllers. According to the Trial Measures, the issuer or its affiliated domestic company, as the case may be, is required to file with the CSRC (i) with respect to its initial public offering and listing and its subsequent securities offering in an overseas market different from the market where it has listed, within three business days after its submission of listing application documents to the relevant regulator in the place of intended listing, (ii) with respect to its follow-on offering in the same overseas market where it has listed (including issuance of any corporate convertible bonds, exchangeable bonds and other equity-linked securities, but excluding the offering for employees incentive, dividend distribution by shares and share split), within three business days after completion of such follow-on offering, (iii) with respect to listing by means of single or multiple acquisitions, share swap, transfers of shares and similar transactions, within three business days after its initial filing of the listing application or the first public announcement of the transaction, as case may be. Failure to comply with the filing requirements may result in an order of rectification, a warning and fines up to RMB10 million to the non-compliant domestic companies, and the directly responsible persons of the companies will be warned and fined between RMB500,000 and RMB5 million. Furthermore, if the controlling shareholder and the actual controller of the non-compliant companies organizes or instigates the breach, they will be fined between RMB1 million and RMB10 million. In addition to above filing requirements, the Filings Rules also requires an issuer to report to the CSRC within three business days after occurrence of any the following events: (i) its change of control; (ii) its being subject to investigation or sanctions by any overseas securities regulators or overseas authorities; (iii) its change of listing status or listing segment; (iv) voluntary or mandatory delisting; and (v) material change of its principal business operations to the extent that it ceases to be subject to the filing requirements of the Trial Measures.

Furthermore, on February 24, 2023, the CSRC released the Provisions on Strengthening the Confidentiality and Archives Administration Related to the Overseas Securities Offering and Listing by Domestic Enterprises, or, the Confidentiality Provisions, which came into effect on March 31, 2023. Pursuant to the Confidentiality Provisions, any future inspection or investigation conducted by overseas securities regulator or the relevant competent authorities on our PRC domestic companies with respect to our overseas issuance and listing shall be carried out in the manner in compliance with PRC laws and regulations.

 

92


Table of Contents

Regulations on Anti-Monopoly

The Anti-Monopoly Law promulgated by the Standing Committee of the National People’s Congress which became effective on August 1, 2008 and the Provisions on the Review of Concentrations of Undertakings promulgated by the SAMR which became effective on April 15, 2023 require that transactions which are deemed concentrations and involve parties with specified turnover thresholds must be cleared by the SAMR before they can be completed. Where the participation in concentration of undertakings by way of foreign-funded merger and acquisition of domestic enterprises or any other method which involves national security, the examination of concentration of undertakings shall be carried out pursuant to the provisions of this law and examination of national security shall be carried out pursuant to the relevant provisions of the state. Failure to comply with above regulations may result in an order to stop concentration, dispose the shares/assets or transfer the operation within a stipulated period, or adopt other necessary measures to reinstate the preconcentration status, or fines.

On October 23, 2021, the SCNPC issued a draft of the amended Anti-Monopoly Law for public comments. On June 24, 2022, the Decision of the Standing Committee of the National People’s Congress on Revising the Anti-monopoly Law of the People’s Republic of China, or the Revised Anti-monopoly Law was released, which will be effective on August 1, 2022. According to the Revised Anti-monopoly Law, the fines for illegal concentration of business operators have been increased to no more than ten percent of its last year’s sales revenue if the concentration of business operator has or may have an effect of excluding or limiting competitions; or a fine of up to RMB5 million if the concentration of business operator does not have an effect of excluding or limiting competition. The Revised Anti-monopoly Law also stipulates that the relevant authority shall investigate a transaction where there is any evidence that the concentration has or may have the effect of eliminating or restricting competitions, even if such concentration does not reach the filing threshold. And in order to adapt the Revised Anti-monopoly Law, on March 10, 2023, the SAMR issued the Provisions on Prohibition of the Abuse of Market Dominance, which took effect on April 15, 2023.

On February 7, 2021, the Anti-Monopoly Commission of the State Council issued the Anti-Monopoly Guidelines for the Internet Platform Economy Sector that aims to specify some of the circumstances under which an activity of internet platforms may be identified as monopolistic as well as to clarify that concentration of undertakings involving VIE structure shall also be subject to anti-monopoly review.

Regulations on Anti-Long-Arm Jurisdiction

The MOFCOM issued the Provisions on the List of Unreliable Entities, or the MOFCOM Order No. 4 of 2020, on September 19, 2020. Pursuant to the MOFCOM Order No. 4 of 2020, the working mechanism shall, according to the investigation results and by taking the following factors into comprehensive consideration, decide whether or not to include a foreign entity concerned in the list of unreliable entities, and make an announcement on such inclusion: (i) the extent of damage caused to China’s sovereignty, security and development interests; (ii) the extent of the damage to the legitimate rights and interests of Chinese enterprises, other organizations or individuals; (iii) whether or not the international economic and trade rules are followed; (iv) other factors that shall be taken into consideration. If a foreign entity is included in the list of unreliable entities, the working mechanism may decide to take one or more of the following measures: (i) restricting or prohibiting the foreign entity from engaging in import or export activities related to China; (ii) restricting or prohibiting the foreign entity’s investment within the territory of China; (iii) restricting or prohibiting the entry of the foreign entity’s relevant personnel or transport vehicles into the territory of China; (iv) restricting or canceling the work permit, stay or residence qualification of the foreign entity’s relevant personnel in China; (v) imposing a fine corresponding to the seriousness of the case against the foreign entity; and (vi) other necessary measures.

On January 9, 2021, the MOFCOM promulgated the Rules on Counteracting Unjustified Extra-Territorial Application of Foreign Legislation and Other Measures, or the MOFCOM Order No. 1 of 2021. Pursuant to the MOFCOM Order No. 1 of 2021, where a citizen, legal person or other organization of China is prohibited or restricted by foreign legislation and other measures from engaging in normal economic, trade and related activities with a third state (or region) or its citizens, legal persons or other organizations, he/she/it shall truthfully report such matters to the competent department of commerce of the State Council within 30 days. The working mechanism will take the following factors into overall account when assessing whether there exists unjustified extra-territorial application of foreign legislation and other measures: (i) whether international law or the basic principles of international relations are violated; (ii) potential impact on China’s national sovereignty, security and development interests; (iii) potential impact on the legitimate rights and interests of the citizens, legal persons or other organizations of China; (iv) other factors that shall be taken into account. If the working mechanism determines that there exists unjustified extra-territorial application of foreign legislation and other measures, MOFCOM may issue an injunction that the relevant foreign legislation and other measures shall not be accepted, executed or observed. A citizen, legal person or other organization in China may apply for exemption from compliance with an injunction.

 

93


Table of Contents

4.C. Organizational Structure

The following diagram illustrates our corporate structure, including our principal subsidiaries and VIEs, as of the date of this annual report.

 

LOGO

 

94


Table of Contents

Notes:

 

   LOGO    Equity interest
   LOGO    Contractual arrangements, including the exclusive technical consulting and service agreement, intellectual property license agreement, equity pledge agreement, exclusive call option agreement, shareholders’ voting rights proxy agreement and loan agreement. See “Item 3. Key Information—Contractual Arrangements with the VIEs and Their Respective Shareholders.”

4.D. Property, Plant and Equipment

We are headquartered in Shanghai. As of March 31, 2023, we did not have any self-owned properties, and we leased 11 properties with an aggregate gross floor area of approximately 17,147 square meters in China, which are primarily used for office building and warehouses. We believe our existing properties are adequate for current operational needs, but we expect to seek additional space to accommodate our future growth.

 

ITEM 4A.

UNRESOLVED STAFF COMMENTS

None.

 

ITEM 5.

OPERATING AND FINANCIAL REVIEW AND PROSPECTS

You should read the following discussion together with our consolidated financial statements and the related notes included elsewhere in this annual report. This discussion may contain forward-looking statements about our business and operations. Our actual results may differ materially from those we currently anticipate as a result of many factors, including those we describe under “Item 3. Key Information—3.D. Risk Factors” and elsewhere in this annual report. For the impact of foreign currency fluctuations on the company, and the extent to which foreign currency net investments are hedged by currency borrowing and other hedging instruments, please refer to, “Item 11. Quantitative and Qualitative Disclosures about Market Risk—Foreign exchange risk.”

5.A. Operating Results

General Factors Affecting Our Results of Operations

Our business and operating results are affected by a number of general factors in China’s pet industry, including:

 

   

China’s overall economic growth, level of urbanization and level of per capita disposable income;

 

   

China’s demographic shift in terms of rising numbers of no-kid families and aging population;

 

   

Development of China’s online retail market, such as the growing number of online shoppers, improved logistics infrastructure and increasing adoption of mobile payment;

 

   

Seasonality of China’s online retail market with increasing sales during the fourth quarter of each year;

 

   

Growing population of pets and pet parents and demand for quality pet products and services;

 

   

Increase in pet parents’ expenditure on pets, pet products and pet services; and

 

   

Market competition.

Unfavorable changes in any of these general factors could materially and adversely affect our business and our results of operations.

Specific Factors Affecting Our Results of Operations

Our ability to diversify product offerings and promote private label products

We will continue to diversify our product offerings and optimize our product mix catering to customers’ demands and drive profitability. For the fiscal year ended March 31, 2023, our GMV from sales of (i) pet staple food, (ii) snacks and wet food, (iii) supplies and (iv) heath care products accounted for 36.8%, 9.3%, 19.4% and 34.5% of our total GMV, compared to 44.7%, 10.4%, 15.7% and 29.2% for the fiscal year ended March 31, 2022. Through diversifying our product source, we will continue to support the growth of emerging brands with attractive margin profiles, providing them with access to our broad user base and reliable fulfillment infrastructure. At the same time, we tend to have greater pricing power over these emerging brands compared to more established brands. Since our inception and up to March 31, 2023, we cooperated with 635 brand partners, and realized a GMV of RMB2,121.7 million from sales of branded products for the fiscal year ended March 31, 2023.

 

95


Table of Contents

In addition to third-party brands, we will further promote private label products and expand our product portfolio, from which we can realize higher gross margin compared to third-party brands. We have launched a number of private labels, including Yoken, Mocare, and two “D-cat” labels, and will continue to accumulate data insights on customer behavior and tailor our private label product offerings accordingly. On March 31, 2023, approximately 4,884 SKUs of private label products were offered, accounting for approximately 18.3% of our total SKUs, compared to approximately 5,643 private label SKUs, accounting for approximately 17.5% of our total SKUs on March 31, 2022. For the fiscal year ended March 31, 2023, we realized a GMV of RMB442.3 million from sales of our private label products, accounting for 17.3% of our total GMV, compared to a GMV of RMB416.4 million from sales of our private label products, accounting for 14.3% of our total GMV for the fiscal year ended March 31, 2022. Through working closely with our manufacturing partners, we expect to further improve the profitability of our private label products.

Our ability to expand and engage our user base

We will continue to expand our user base and strengthen user engagement to achieve sustainable growth. We aim to attract more users and maintain our vibrant community with rich and informative content offerings, intelligent content recommendation, and superior user experience. For example, we continuously attract more KOLs and produce more professionally generated pet-related content to diversify our content offerings. In addition, our users may interact with one another with the support of our platform’s wide array of innovative and appealing social functions. Such real-time interactions on our platform cultivate a strong sense of belonging, which we believe effectively increases our user stickiness. A large, engaging and loyal user base not only contributes to our diverse content offerings, but also brings us more business opportunities. Through diverse and informative content and interesting social interactions, we are able to incentivize more users to shop on our online sales platforms.

Our ability to use content to drive sales

We focus on developing our user-centric content-driven “discover and buy” model, and our results of operations in part depend on our ability to educate our users and convert users to buyers. With the help of social media tools and advanced data analytics, we are able to identify user preferences, new trends, unmet demands, and emerging brands, and create curated content accordingly. We then make customized product recommendations by linking the curated content to the relevant product page. We believe this content-driven approach will allow us to drive buyer engagement and recurring purchases.

Our ability to diversify our service offerings through strategic acquisitions and investments

We envision fostering a pet ecosystem around online sales platforms and expanding offline network and have made strategic acquisitions and investments to expand our product and service offerings. Through our acquisition of Xingmu, a veterinary drug distributor in China, we have entered into China’s pet healthcare industry. In 2019, we invested in PetDog, a large pet store franchise in China, to expand the outreach of professional pet service trainings to offline stores to improve the quality of their services. The business or financial performance of the companies we have acquired or invested in as well as our ability to successfully integrate these acquired businesses or investments with our existing business would impact our results of operations and financial conditions. See “Item 3. Key Information—3.D. Risk Factors—Risks Related to Our Business and Industry—We have and may continue to invest in or acquire complementary assets, technologies and businesses, or enter into strategic alliances. Such efforts may fail and have in the past resulted, and may continue to result, in equity or earnings dilution, which may materially and adversely affect our results of operations and financial condition.”

 

96


Table of Contents

Key Components of Results of Operations

Net Revenues

The following table sets forth a breakdown of our net revenues, in absolute amounts and as percentages of total net revenues, for the periods indicated.

 

     For the Fiscal Year Ended March 31,  
     2021      2022      2023  
     RMB      %      RMB      %      RMB      US$      %  
     (in thousands, except for percentages)  

Net revenues:

              

Product sales

     1,003,197        99.2        1,137,329        95.9        1,048,491        152,672        96.0  

Online marketing and information services and other revenue

     7,788        0.8        49,100        4.1        43,603        6,349        4.0  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total net revenues

     1,010,985        100.0        1,186,429        100.0        1,092,094        159,021        100.0  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Product Sales. We offer a diverse selection of branded and private label pet food and other pet products. Net revenues from product sales are recognized upon customers’ receipt of the products. We generate a substantial majority of product sales revenues from sales of branded products. We also generate product sales revenues from sales of our private label products, including Yoken, Mocare, Dokete and D-cat. We generated a substantial majority of our product sales revenues from sales to retail customers. As we continued to expand our offline network, we also generated an increasing portion of our total product sales revenues from sales to offline pet stores and pet hospitals.

Online marketing and information services and other revenue. We generate net revenues of online marketing and information and other services through the provision of online marketing and information and other services to brand owners. We help brand owners place advertisements and organize online and offline marketing campaigns featuring KOLs. We primarily charge our brand owners service fees for our online marketing and information services. Net revenues from online marketing and information services are recognized over the service period.

Cost of revenue

Our cost of revenue consists of cost of product sales and cost of services. Cost of product sales comprises the purchase price of products, vendor rebates and inventory write-downs, which together accounted for 99.6%, 98.6% and 98.2% of our total cost of revenue for the fiscal years ended March 31, 2021, 2022 and 2023, respectively. Cost of services consists of the advertising and promotion costs, employee wages and benefits in connection with our provision of marketing and information services including the fees that we paid to third party for advertising and promotion on various online and offline channels.

Gross profit and gross margin

We recorded gross profit of RMB187.3 million, RMB242.7 million RMB233.5 million (US$34.0 million) for the fiscal years ended March 31, 2021, 2022 and 2023, respectively.

In the fiscal years ended March 31, 2021, 2022 and 2023, our overall gross margin was 18.5%, 20.5% and 21.4%, respectively. During the same period, the gross margin of product sales was 18.2%, 18.2% and 19.6%, and the gross margin of online marketing and information services was 56.2%, 72.9% and 63.6%, respectively.

We have endeavored to diversify our product offerings and promote private label products, which we believe generally had higher gross margin compared to that of branded products. Moreover, we plan to further improve the gross margin of private label products as our private label brands become more established. We are gradually making strategic adjustments to our product mix by reducing sales of certain products with high fulfillment expenses, such as the branded ones, to improve our net profit margin, and have offered private label products at discount to promote brand awareness and cultivate customer loyalty. Last but not least, as we continue to expand our pet-based ecosystem by driving sales to small and medium pet businesses, our gross margin may experience a short-term downward pressure as sales to such businesses typically carry a bigger ticket size per order and a lower gross margin profile.

 

97


Table of Contents

Operating expenses

The following table sets forth a breakdown of our operating expenses, in absolute amounts and as percentages of our total operating expenses and as percentages of our total net revenues, for the periods indicated.

 

    For the Fiscal Year Ended March 31,  
    2021     2022     2023  
    RMB     % of total
operating
expenses
    % of total
revenue
    RMB     % of total
operating
expenses
    % of total
revenue
    RMB     US$     % of total
operating
expenses
    % of total
revenue
 
    (in thousands, except for percentages)  

Operating expenses:

                   

Fulfillment expenses

    120,188       30.5       11.9       134,026       35.2       11.3       126,295       18,390       42.5       11.6  

Sales and marketing expenses

    160,201       40.6       15.8       170,986       44.8       14.4       124,007       18,057       41.8       11.4  

General and administrative expenses

    113,972       28.9       11.3       76,248       20.0       6.4       46,554       6,779       15.7       4.3  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

    394,361       100.0       39.0       381,260       100.0       32.1       296,856       43,226       100.0       27.3  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Fulfillment expenses. Our fulfillment expenses consist primarily of warehousing, shipping and handling expenses for dispatching and delivering products to consumers, employee wages and benefits for the relevant personnel, customs clearance expenses and other related transaction costs. We will continue to improve our fulfillment and warehousing capabilities and reduce sales of certain products with high fulfillment expenses to improve our net profit margin. Moreover, with our increasing scale, we are able to gain more bargaining power with our brand partners, warehouses and delivery service providers, which will further improve the cost efficiency of our fulfillment process.

Sales and marketing expenses. Our sales and marketing expenses consist primarily of advertising expenses, third-party platforms commission fee, employee wages, rental expenses and benefits for sales and marketing staff, depreciation expenses and other daily expenses which are related to the sales and marketing functions. We expect to explore and leverage new cost-effective sales and marketing channels with high conversion rate, such as Red and Tiktok.

General and administrative expenses. Our general and administrative expenses consist primarily of employee wages and benefits for corporate employees, research and development expenses and other expenses which are related to the general corporate functions. We are incurring and expect to continue to incur additional costs as a result of operating as a public company.

Taxation

Cayman Islands

The Cayman Islands currently levies no taxes on individuals or corporations based upon profits, income, gains or appreciation and there is no taxation in the nature of inheritance tax or estate duty.

There are no other taxes likely to be material to us levied by the government of the Cayman Islands except for stamp duties which may be applicable on instruments executed in, or after execution brought within the jurisdiction of the Cayman Islands. In addition, the Cayman Islands does not impose withholding tax on dividend payments.

British Virgin Islands

Under the current laws of the British Virgin Islands, entities incorporated in the British Virgin Islands are exempted from income tax on their foreign-derived incomes in the British Virgin Islands. There are no withholding taxes in the British Virgin Islands.

Hong Kong

Under the current Hong Kong Inland Revenue Ordinance, our subsidiaries incorporated in Hong Kong are subject to a two-tiered profits tax rate of 8.25% and 16.5% on its taxable income generated from operations in Hong Kong. Additionally, payments of dividends by the subsidiaries incorporated in Hong Kong to us are not subject to any income tax.

 

98


Table of Contents

PRC

Generally, our PRC subsidiaries, the VIEs and their subsidiaries are subject to enterprise income tax on their taxable income in the PRC at a rate of 25%. The enterprise income tax is calculated based on the entity’s global income as determined under PRC tax laws and accounting standards. Boqii (Shanghai) Information Technology Co., Ltd. obtained High and New Technology Enterprises, or HNTE, status in 2019 and is thus eligible to enjoy a preferential tax rate of 15% from 2019 to 2024, to the extent it has taxable income under the Enterprise Income Tax Law of the PRC, or EIT Law. On July 25, 2018, Boqii (Shanghai) Information Technology Co., Ltd. (“Shanghai Boqii”) was entitled to be “Software Enterprises.” According to the Enterprise Income Tax (“EIT”) Law and relevant regulations in the PRC, from the year of 2018, Shanghai Boqii could enjoy a tax holiday of 2-year EIT exemption and subsequently 3-year 12.5% preferential tax rate. For the years ended March 31, 2021, 2022 and 2023, Boqii (Shanghai) Information Technology Co., Ltd. remains subject to an EIT rate of 12.5%.

Our pet products sales revenues were subject to value-added tax at a rate of 17% before July 1, 2017, 17% from July 1, 2017 to April 30, 2018, and 16% from May 1, 2018 to March 31, 2019. Since April 1, 2019, our pet product sales revenues have been subject to value-added tax at a rate of 13%. Our pet foods sales revenues were subject to value-added tax at a rate of 13% before July 1, 2017, 11% from July 1, 2017 to April 30, 2018, and 10% from May 1, 2018 to March 31, 2019. Since April 1, 2019, our pet foods sales revenues have been subject to value-added tax at a rate of 9%. Our services revenues are subject to value-added tax at a rate of 6%.

Under the EIT Law and its implementation rules, subject to any applicable tax treaty or similar arrangement between the PRC and the jurisdiction where the shareholders of our PRC subsidiaries reside that provides for a different income tax arrangement, PRC withholding tax at the rate of 10% is normally applicable to dividends from PRC sources payable to shareholders that are non-PRC resident enterprises, which do not have an establishment or place of business in the PRC, or which have such establishment or place of business if the relevant income is not effectively connected with the establishment or place of business. Under the PRC Individual Income Tax Law and its implementation rules, dividends from sources within the PRC paid to foreign individual shareholders who are not PRC residents are generally subject to a PRC withholding tax at a rate of 20%, subject to any reduction or exemption set forth in applicable tax treaties and PRC laws. Although majority of our business operations are based in the PRC, it is unclear whether dividends we pay with respect to our ordinary shares or ADSs would be treated as income derived from sources within the PRC and as a result be subject to PRC income tax if we were considered a PRC resident enterprise, as described below. See “Item 3. Key Information—3.D. Risk Factors—Risks Related to Doing Business in China—If we are classified as a PRC resident enterprise for PRC enterprise income tax purposes, such classification could result in unfavorable tax consequences to us and our non-PRC shareholders and ADS holders.”

If we or any of our subsidiaries outside of the PRC was deemed to be a “resident enterprise” under the EIT Law, it would be subject to enterprise income tax on its worldwide income at a rate of 25%. See “Item 3. Key Information—3.D. Risk Factors—Risks Related to Doing Business in China—If we are classified as a PRC resident enterprise for PRC enterprise income tax purposes, such classification could result in unfavorable tax consequences to us and our non-PRC shareholders and ADS holders.”

 

99


Table of Contents

Results of Operations

The following table summarizes our consolidated results of operations both in absolute amounts and as percentages of our total net revenues for the periods presented. The operating results in any historical period are not necessarily indicative of the results that may be expected for any future period.

 

     For the Fiscal Year Ended March 31,  
     2021     2022     2023  
     RMB     % of total
net
revenues
    RMB     % of total
net
revenues
    RMB     US$     % of total
net
revenues
 
     (in thousands, except for share and per share data)  

Net revenues:

              

Product sales

     1,003,197       99.2       1,137,329       95.9       1,048,491       152,672       96.0  

Online marketing and information services and other revenue

     7,788       0.8       49,100       4.1       43,603       6,349       4.0  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total net revenues

     1,010,985       100.0       1,186,429       100.0       1,092,094       159,021       100.0  

Total cost of revenues

     (823,686     (81.5     (943,698     (79.5     (858,608     (125,023     (78.6
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     187,299       18.5       242,731       20.5       233,486       33,998       21.4  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating expenses:

              

Fulfillment expenses

     (120,188     (11.9     (134,026     (11.3     (126,295     (18,390     (11.6

Sales and marketing expenses

     (160,201     (15.8     (170,986     (14.4     (124,007     (18,057     (11.4

General and administrative expenses

     (113,972     (11.3     (76,248     (6.4     (46,554     (6,779     (4.3

Impairment of goodwill

     —         —         —         —         (40,684     (5,924     (3.7

Other income, net

     1,067       0.1       280       0.0       286       42       0.0  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Loss from operations

     (205,995     (20.4     (138,249     (11.7     (103,768     (15,110     (9.5
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Interest income

     17,553       1.7       15,477       1.3       7,420       1,081       0.7  

Interest expense

     (27,650     (2.7     (20,884     (1.8     (13,350     (1,944     (1.2

Other gains, net

     11,332       1.1       6,020       0.5       5,159       751       0.5  

Fair value change of derivative liabilities

     11,369       1.1       2,824       0.2       (2,266     (330     (0.2
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Loss before income tax expenses

     (193,391     (19.1     (134,812     (11.4     (106,805     (15,552     (9.8

Income tax expenses

     871       0.1       1,571       0.1       911       133       0.1  

Share of results of equity investee

     (696     (0.1     418       0.0       (82     (12     0.0  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

     (193,216     (19.1     (132,823     (11.2     (105,976     (15,431     (9.7

Less: Net income attributable to the non-controlling interest shareholders

     1,228       0.1       (4,433     (0.4     (3,177     (462     (0.3
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net loss attributable to Boqii Holding Limited

     (194,444     (19.2     (128,390     (10.8     (102,799     (14,969     (9.4

Accretion on the convertible redeemable preferred shares to redemption value

     120,873       12.0       —         —         —         —         —    

Accretion on redeemable non-controlling interests to redemption value

     (138     (0.0     (575     (0.0     (675     (98     (0.1

Deemed dividend to preferred shareholders

     (12,547     (1.2     —         —         —         —         —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net loss attributable to Boqii Holding Limited’s ordinary shareholders

     (86,256     (8.5     (128,965     (10.9     (103,474     (15,067     (9.5

Net loss per share attributable to Boqii Holding Limited’s ordinary shareholders

              

Basic

     (1.29       (1.90       (1.50     (0.22  

Diluted

     (1.29       (1.90       (1.50     (0.22  

Weighted average number of ordinary shares

              

Basic

     66,953,610         68,006,172         68,858,823      

Diluted

     66,953,610         68,006,172         68,858,823      

 

100


Table of Contents

Fiscal Year Ended March 31, 2023 Compared to Fiscal Year Ended March 31, 2022

Net revenues

Our net revenues decreased by 7.9% from RMB1,186.4 million for the fiscal year ended March 31, 2022 to RMB1,092.1 million (US$159.0 million) for the fiscal year ended March 31, 2023. Net revenues generated from product sales decreased from RMB1,137.3 million for the fiscal year ended March 31, 2022 to RMB1,048.5 million (US$152.7 million) for the fiscal year ended March 31, 2023. Net revenues generated from our online marketing and information services decreased from RMB49.1 million for the fiscal year ended March 31, 2022 to RMB43.6 million (US$6.3 million) for the fiscal year ended March 31, 2023. These decreases were primarily due to the negative impact brought by the outbreak and spread of Covid-19 in China.

Cost of revenue

Our cost of revenue decreased by 9.0% from RMB943.7 million for the fiscal year ended March 31, 2022 to RMB858.6 million (US$125.0 million) for the fiscal year ended March 31, 2023, in line with our decreased revenue.    

Gross profit

Our overall gross profit decreased by 3.8% from RMB242.7 million for the fiscal year ended March 31, 2022 to RMB233.5 million (US$34.0 million) for the fiscal year ended March 31, 2023. Our overall gross margin increased from 20.5% for the fiscal year ended March 31, 2022 to 21.4% for the fiscal year ended March 31, 2023, which was primarily due to the improvement of gross margin of private label products and increased proportion of pet supplies and health care products with higher margins.

Operating expenses

Our operating expenses decreased by 22.1% from RMB381.3 million for the fiscal year ended March 31, 2022 to RMB296.9 million (US$43.2 million) for the fiscal year ended March 31, 2023, for the following reasons:

Fulfillment expenses

Our fulfillment expenses decreased by 5.8% from RMB134.0 million for the fiscal year ended March 31, 2022 to RMB126.3 million (US$18.4 million) for the fiscal year ended March 31, 2023. Fulfillment expenses as a percentage of total revenues increased from 11.3% in the fiscal year ended March 31, 2022 to 11.6% in the fiscal year ended March 31, 2023, primarily due to higher shipping and handling expenses in the first half of fiscal year 2023, resulting from temporary logistics price increases and transportation restrictions following the Covid-19 resurgence in China since April 2022.

Sales and marketing expenses

Our sales and marketing expenses decreased by 27.5% from RMB171.0 million for the fiscal year ended March 31, 2022 to RMB124.0 million (US$18.1 million) for the fiscal year ended March 31, 2023. Our sales and marketing expenses as a percentage of total revenue decreased from 14.4% in the fiscal year ended March 31, 2022 to 11.4% in the fiscal year ended March 31, 2023. The decrease was primarily due to (i) the decrease in personnel expense of RMB7.6 million related to the optimization of our organizational structure; (ii) the decrease in advertising expenses of RMB36.7 million, as a greater proportion of revenues were generated from channels that are more cost-efficient; and (iii) the decrease in third-party platform commission fee of RMB1.8 million, resulting from a reduced proportion of revenues generated from third-party e-commerce platforms.

General and administrative expenses

Our general and administrative expenses decreased by 38.9% from RMB76.2 million for the fiscal year ended March 31, 2022 to RMB46.6 million (US$6.8 million) for the fiscal year ended March 31, 2023. Our general and administrative expenses as a percentage of total revenue decreased from 6.4% in the fiscal year ended March 31, 2022 to 4.3% in the fiscal year ended March 31, 2023. The decrease was primarily due to (i) the decrease in share-based compensation expenses of RMB20.7 million, resulting form the cancellation of options corresponding to employee departures; (ii) the decrease in staff costs of RMB2.5 million related to the optimization of our organizational structure; and (iii) the decrease in professional expenses of RMB3.2 million.

Impairment of goodwill

We had a full impairment charge of goodwill of RMB40.7 million (US$6.0 million) for the fiscal year ended March 31, 2023, caused by the difference between the fair value of the reporting unit of RMB119.8 million (US$17.4 million) and the carrying value of our net assets of RMB217.8 million (US$31.7 million) as of March 31, 2023, based on quantitative goodwill impairment test.

 

101


Table of Contents

Other income, net

We had other income, net of RMB280 thousand and RMB286 thousand (US$42 thousand) for the fiscal year ended March 31, 2022 and 2023, respectively, which was mainly attributable to government subsidies for the period therein.

Loss from operations

As a result of the foregoing, our loss from operations decreased by 24.9% from RMB138.2 million for the fiscal year ended March 31, 2022 to RMB103.8 million (US$15.1 million) for the fiscal year ended March 31, 2023.

Interest income

Our interest income decreased from RMB15.5 million for the fiscal year ended March 31, 2022 to RMB7.4 million (US$1.1 million) for the fiscal year ended March 31, 2023. The decrease was primarily attributable to a lower balance of bank deposits and decreased amount of receivable for issuance of ordinary shares.

Interest expense

Our interest expense decreased from RMB20.9 million for the fiscal year ended March 31, 2022 to RMB13.4 million (US$1.9 million) for the fiscal year ended March 31, 2023. The decrease was primarily attributable to a decrease in the amortization charges on promissory notes of RMB7.4 million.

Other gains, net

We recorded other gains, net of RMB6.0 million for the fiscal year ended March 31, 2022, due to a net gain on foreign exchange of RMB5.3 million and reimbursement from a depositary bank of RMB1.5 million. We recorded other gains, net of RMB5.2 million (US$0.8 million) for the fiscal year ended March 31, 2023, primarily due to a net gain on foreign exchange of RMB2.7 million (US$0.4 million).

Net loss

As a result of the foregoing, our net losses decreased by 20.2% from RMB132.8 million for the fiscal year ended March 31, 2022 to RMB106.0 million (US$15.4 million) for the fiscal year ended March 31, 2023.

Fiscal Year Ended March 31, 2022 Compared to Fiscal Year Ended March 31, 2021

For a detailed description of the comparison of our operating results for the fiscal year ended March 31, 2022 to the fiscal year ended March 31, 2021, see “Item 5. Operating and Financial Review and Prospects—5.A. Operating Results—Fiscal Year Ended March 31, 2022 Compared to Fiscal Year Ended March 31, 2021” beginning on page 107 of our annual report on Form 20-F for the fiscal year ended March 31, 2022 initially filed with the SEC on July 27, 2022 (File No. 001-39547).

5.B Liquidity and Capital Resources

Cash flows and working capital

The following table sets forth a summary of our cash flows for the periods indicated:

 

     For the Fiscal Year Ended March 31,  
     2021      2022      2023  
     RMB      RMB      RMB      US$  
     (in thousands)  

Net cash flows used in operating activities

     (247,486      (147,504      (54,069      (7,873

Net cash flows (used in)/generated from investing activities

     (184,417      21,147        46,496        6,770  

Net cash flows generated from/(used in) financing activities

     648,491        1,995        (76,656      (11,161

Net increase/(decrease) in cash and cash equivalents

     216,588        (124,362      (84,229      (12,264

Cash and cash equivalents at beginning of the year

     88,352        292,237        162,855        23,714  

Effects of foreign exchange rate changes on cash and cash equivalents

     (12,703      (5,020      11,224        1,633  

Cash and cash equivalents at the end of the period

     292,237        162,855        89,850        13,083  

 

102


Table of Contents

Historically, we have not been profitable or generated positive operating cash flows. Our principal source of liquidity has been cash generated from equity financing transactions and short-term and long-term borrowings. As of March 31, 2021, 2022 and 2023, we had RMB292.2 million, RMB162.9 million and RMB89.9 million (US$13.1 million) in cash and cash equivalents, respectively. Our cash and cash equivalents consist primarily of cash on hand and demand deposits placed with banks and third-party payment processors, which are unrestricted as to withdrawal or use, have original maturities of three months or less at the time of purchase and are readily convertible to known amounts of cash. Our cash and cash equivalents are primarily denominated in Renminbi.

We had a positive working capital, representing the difference between total current assets and total current liabilities, of RMB478.2 million, RMB262.7 million and RMB210.0 million (US$30.6 million) as of March 31, 2021, 2022 and 2023, respectively. As of March 31, 2023, our total current liabilities were RMB196.1 million (US$28.6 million), which primarily included short-term borrowings, accounts payable, accrued liabilities and other current liabilities and derivative liabilities. We recorded RMB86.3 million (US$12.6 million) in short-term borrowings as of March 31, 2023. As of the date of this annual report, all the outstanding short-term borrowing as of March 31, 2023 was subsequently settled. We recorded RMB56.0 million (US$8.2 million) in accounts payable as of March 31, 2023. A substantial majority of our accounts payable is due to brand partners, with a credit period between 30 to 60 days. We recorded RMB22.1 million (US$3.2 million) in accrued liabilities and other current liabilities as of March 31, 2023, which primarily included logistics expenses payables, refund obligation of sales returns, advances from customers and payable for investment. We recorded RMB10.7 million (US$1.6 million) in derivative liabilities as of March 31, 2023. We assessed the embedded warrants along with the conversion features of Yoken Series A-1 Warrant, and concluded that this is required to be bifurcated and accounted for separately as derivative liabilities.

Despite the fact that we had a positive working capital as of March 31, 2023, working capital constraints have in the past limited, our ability to grow revenues, especially with emerging brands that generally require larger inventory investments during their early commercial development. If we incur any working capital deficits in the future, our liquidity position will be restricted, and such working capital deficits will have a negative impact on our ability to repay current liabilities. Our inability to take actions that address any working capital deficit in a timely and efficient manner, including prudently managing our working capital, or raising additional equity or debt financing on terms that are acceptable to us when necessary, could materially adversely affect our liquidity, results of operations, financial condition and ability to operate. We will continue to develop our paid membership program, where customers prepay for our services, work closely with our brand partners to optimize our payment terms, and collaborate with certain financial institutions to develop supply chain financing products. We believe that, with the additional financial resources obtained, our current cash, cash equivalents and short-term investments and borrowings will be sufficient to meet our anticipated cash needs, including our cash needs for working capital and capital expenditures, for at least the next 12 months.

We may, however, require additional cash due to changing business conditions or other future developments, including any investments or acquisitions we may decide to pursue. If our existing cash is insufficient to meet our requirements, we may seek to issue debt or equity securities or obtain additional credit facilities. Financing may be unavailable in the amounts we need or on terms acceptable to us, if at all. Issuance of additional equity securities, including convertible debt securities, would dilute our earnings per share. The incurrence of debt would divert cash for working capital and capital expenditures to service debt obligations and could result in operating and financial covenants that restrict our operations and our ability to pay dividends to our shareholders. If we are unable to obtain additional equity or debt financing as required, our business operations and prospects may suffer.

Operating activities

Net cash used in operating activities was RMB54.1 million (US$7.9 million) for the fiscal year ended March 31, 2023. The difference between our net loss of RMB106.0 million (US$15.4 million) and the net cash used in operating activities for the fiscal year ended March 31, 2023 was primarily attributable to (i) a decrease in accounts payable of RMB36.3 million (US$5.3 million), (ii) a decrease in operating lease liabilities of RMB26.4 million (US$3.8 million), and (iii) an increase in accounts receivable of RMB27.5 million (US$4.0 million), partially offset by (i) a decrease in prepayments and other current assets of RMB47.8 million (US$7.0 million), (ii) impairment of goodwill of RMB40.7 million (US$5.9 million) in the fiscal year ended March 31, 2023 and (iii) amortization of right-of-use assets of RMB24.6 million (US$3.6 million) in the fiscal year ended March 31, 2023.

Net cash used in operating activities was RMB147.5 million for the fiscal year ended March 31, 2022. The difference between our net loss of RMB132.8 million and the net cash used in operating activities for the fiscal year ended March 31, 2022 was primarily attributable to (i) an increase in prepayments and other current assets of RMB35.1 million, resulting from the growth of our business, (ii) an increase in inventories of RMB23.2 million, (iii) a decrease in operating lease liabilities of RMB12.8 million, partially offset by (i) one-off shared-based compensation expense of RMB14.4 million in the fiscal year ended March 31, 2022, (ii) interest expense of other debts of RMB17.1 million in the fiscal year ended March 31, 2022 and (iii) an increase in accounts payable of RMB18.1 million in the fiscal year ended March 31, 2022.

 

103


Table of Contents

Net cash used in operating activities was RMB247.5 million for the fiscal year ended March 31, 2021. The difference between our net loss of RMB193.2 million and the net cash used in operating activities for the fiscal year ended March 31, 2021 was primarily attributable to (i) an increase in prepayments and other current assets of RMB48.9 million, resulting from the growth of our business, (ii) an increase in inventories of RMB38.8 million, and (iii) a decrease in accounts payable of RMB22.0 million, partially offset by (i) one-off shared-based compensation expense of RMB55.0 million in the fiscal year ended March 31, 2021, and (ii) interest expense of other debts of RMB21.6 million in the fiscal year ended March 31, 2021.

Investing activities

Net cash generated from investing activities was RMB46.5 million (US$6.8 million) for the fiscal year ended March 31, 2023, which was primarily attributable to an increase in short-term investments of RMB58.3 million (US$8.5 million), partially offset by loan receivables advanced to a third party of RMB7.9 million (US$1.1 million).

Net cash generated from investing activities was RMB21.1 million for the fiscal year ended March 31, 2022, which was primarily attributable to the net impact of decrease in short-term investments of RMB 40.5 million and acquisitions of long-term investments of RMB15.8 million.

Net cash used in investing activities was RMB184.4 million for the fiscal year ended March 31, 2021, which was primarily attributable to short-term investments of RMB168.5 million.

Financing activities

Net cash used in financing activities was RMB76.7 million (US$11.2 million) for the fiscal year ended March 31, 2023, which was primarily attributable to repayments of short-term and long-term borrowings of RMB187.2 million (US$27.3 million), partially offset by proceeds from short-term and long-term borrowings of RMB110.6 million (US$16.1 million).

Net cash generated from financing activities was RMB2.0 million for the fiscal year ended March 31, 2022, which was primarily attributable to (i) the proceeds from borrowing of RMB185.6 million, net of the repayments of borrowings of RMB176.9 million and (ii) the proceeds from issuance of ordinary shares of RMB262.9 million, partially offset by repayments of other debts of RMB270.9 million.

Net cash generated from financing activities was RMB648.5 million for the fiscal year ended March 31, 2021, which was primarily attributable to (i) the proceeds from issuance of convertible redeemable preferred shares, net of issuance costs of RMB354.8 million and (ii) the proceeds from the initial public offering, net of underwriter discounts and commissions and other offering costs paid of RMB393.7 million, partially offset by repayments of other debts of RMB130.8 million.

Material Cash Requirements

Other than the ordinary cash requirements for our operations, our material cash requirements as of March 31, 2023 and any subsequent interim period primarily include our capital expenditures and contractual obligations.

Capital Expenditures

Our capital expenditures are incurred primarily in connection with purchase of fixed assets, including electronic equipment, office equipment and vehicles, and intangible assets. Our capital expenditures were RMB6.5 million, RMB3.1 million and RMB1.9 million (US$0.3 million) for the fiscal years ended March 31, 2021, 2022 and 2023, respectively. We intend to fund our future capital expenditures with our existing cash balance and proceeds from our initial public offering.

Contractual Obligations

As of March 31, 2023, we had borrowings of RMB86.3 million (US$12.6 million), interest payable of RMB1.5 million (US$0.2 million), which are to be paid within one year. The borrowings and interests payable represent our borrowings from commercial banks or other financial institutions for our working capital and the corresponding interests payable.

As of the same date, we also had operating lease commitments of RMB9.9 million (US$1.4 million), RMB14.6 million (US$2.1 million) and RMB0.2 million (US$0.03 million), which are to be paid within one year, between one to three years, and between three to five years, respectively. Our operating lease commitments relate to our leases of offices and warehouses.

We intend to fund our existing and future material cash requirements with our existing cash balance and other financing alternatives. We will continue to make cash commitments, including capital expenditures to support the short-term and/or long-term growth of our business.

 

104


Table of Contents

Holding Company Structure

Boqii Holding Limited is a holding company with no material operations of its own. We conduct our operations primarily through our subsidiaries and the VIEs and their subsidiaries in the PRC. For the fiscal year ended March 31, 2021, 2022 and 2023, the amount of revenues generated by the VIEs accounted for 77.5%, 78.7% and 79.9%, respectively, of our total net revenues.

We are permitted under PRC laws and regulations to provide funding to our PRC subsidiaries in China through capital contributions or loans, subject to the approval of government authorities and limits on the amount of capital contributions and loans. In addition, our subsidiaries in China may provide Renminbi funding to the VIEs only through loans. As a result, there is uncertainty with respect to our ability to provide prompt financial support to our PRC subsidiaries and VIEs when needed. See “Item 3. Key Information—3.D. Risk Factors—Risks Related to Doing Business in China—PRC regulation of loans to and direct investment in PRC entities by offshore holding companies and governmental control of currency conversion may delay us from making loans or additional capital contributions to our PRC subsidiaries and to make loans to the VIEs, which could materially and adversely affect our liquidity and our ability to fund and expand our business.” Notwithstanding the foregoing, our PRC subsidiaries may use their own retained earnings (rather than Renminbi converted from foreign currency-denominated capital) to provide financial support to the VIEs either through loans from our PRC subsidiaries or direct loans to the VIEs’ nominee shareholders, which would be contributed to the VIEs as capital injections. Such direct loans to the nominee shareholders of the VIEs would be eliminated in our consolidated financial statements against such VIEs’ share capital. For more information, see “Item 3. Key Information—Condensed Consolidating Schedule” and consolidated financial statements included elsewhere in this annual report.

Our ability to pay dividends depends upon dividends paid by our subsidiaries which, in turn, depends on the payment of the service fees to our PRC subsidiaries by the VIEs in the PRC pursuant to certain contractual arrangements among our PRC subsidiaries, the VIEs and the VIEs’ shareholders. Considering the future operating and cash flow needs of the VIEs, for the years ended March 31, 2021, 2022 and 2023, no service fees were charged to the VIEs by the WFOEs, and no payments were made by the VIEs. The ability of our subsidiaries in China to make dividends or other cash payments to us is subject to various restrictions under PRC laws and regulations. Our subsidiaries in China are permitted to pay dividends to us only out of their retained earnings, if any, as determined in accordance with the Accounting Standards for Business Enterprise as promulgated by the Ministry of Finance of the PRC, or PRC GAAP. In accordance with PRC company laws and the Foreign Investment Law, the VIEs and subsidiaries in China must make appropriations from their after-tax profit to nondistributable reserve funds including (i) the statutory surplus fund and (ii) the discretionary surplus fund. The appropriation to the statutory surplus fund must be at least 10% of the after-tax profits calculated in accordance with PRC GAAP. Appropriation is not required if the statutory surplus fund has reached 50% of the registered capital of the VIEs. Appropriation to the discretionary surplus fund is made at the discretion of the VIEs. For associated risks, see “Item 3. Key Information—3.D. Risk Factors—Risks Related to Doing Business in China—We may rely on dividends and other distributions on equity paid by our PRC subsidiaries to fund any cash and financing requirements we may have, and any limitation on the ability of our PRC subsidiaries to make payments to us could have a material and adverse effect on our ability to conduct our business.” Additionally, if our subsidiaries or any newly formed subsidiaries incur debt on their own behalf in the future, the instruments governing their debt may restrict their ability to pay dividends to us.

5.C. Research and Development

Our strong technology and data capabilities enable us to deliver superior user experience and increase our operational efficiency. See “Item 4. Information on the Company—4.B. Business Overview—Our Technology.”

5.D. Trend Information

Other than as disclosed elsewhere in this annual report, we are not aware of any trends, uncertainties, demands, commitments or events for the year ended March 31, 2023 that are reasonably likely to have a material and adverse effect on our net revenues, income, profitability, liquidity or capital resources, or that would cause the disclosed financial information to be not necessarily indicative of future results of operations or financial condition.

5.E. Critical Accounting Estimates

Our consolidated financial statements have been prepared in accordance with U.S. GAAP, which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses, and related disclosures of contingent liabilities in the consolidated financial statements and accompanying notes.

Our estimates are based on historical experience and various assumptions that we believe to be reasonable under the circumstances. Given that changes in circumstances, facts and experience may cause us to revise our estimates, actual results could differ materially from those estimates. Our critical accounting estimates are described below.

 

105


Table of Contents

Inventories

Inventories are stated at the lower of cost and net realizable value. Cost elements of our inventories comprise the purchase price of products, vendor rebates, shipping charges to receive products from the suppliers when they are embedded in the purchase price. Cost is determined using the first-in first-out method. Provisions are made for excessive, slow moving, expired and obsolete inventories as well as for inventories with carrying values in excess of market. Certain factors could impact the realizable value of inventory, so we continually evaluate the recoverability based on assumptions about customer demand and market conditions. The evaluation may take into consideration historical usage, inventory aging, expiration date, expected demand, anticipated sales price, new product development schedules, the effect new products might have on the sale of existing products, product obsolescence, customer concentrations, and other factors. The reserve or write-down is equal to the difference between the cost of inventory and the estimated net realizable value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than those projected by management, additional inventory reserves or write-downs may be required that could negatively impact our gross margin and operating results. If actual market conditions are more favorable, we may have higher gross margin when products that have been previously reserved or written down are eventually sold.

Impairment of long-lived assets other than goodwill

Long-lived assets (including property and equipment and amortizable intangible assets) are evaluated for impairment whenever events or changes in circumstances (such as a significant adverse change to market conditions that will impact the future use of the assets) indicate that the carrying amount may not be fully recoverable or that the useful life is shorter than we had originally estimated. When these events occur, we evaluate the impairment by comparing carrying value of the assets to an estimate of future undiscounted cash flows expected to be generated from the use of the assets and their eventual disposition. If the sum of the expected future undiscounted cash flows is less than the carrying value of the assets, we recognize an impairment loss based on the excess of the carrying value of the assets over the fair value of the assets. No impairment charges were recognized for the years ended March 31, 2021, 2022 and 2023.

Goodwill

Goodwill represents the excess of the purchase price over the fair value of the identifiable assets and liabilities acquired in a business combination. Goodwill is not amortized but is tested for impairment on an annual basis, and in between annual tests when an event occurs or circumstances change that could indicate that the asset might be impaired.

In accordance with ASU No. 2017-04, “Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment” (“ASU 2017-04”), which removes the requirement to compare the implied fair value of goodwill with its carrying amount as part of step 2 of the goodwill impairment test. Management conducts the goodwill impairment assessment as of March 31 annually or more frequently if events or changes in circumstances indicate that it may be impaired. We first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill, so as to perform the quantitative goodwill impairment test. If determined to be necessary, the quantitative impairment test is used to identify goodwill impairment by comparing the fair value of a reporting unit with its carrying amount and recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. The loss recognized should not exceed the total amount of goodwill allocated to that reporting unit.

There is only one reporting unit in our company. Therefore, the goodwill assessment was performed for our company on consolidated level as one reporting unit. As of March 31, 2023, there was no goodwill recorded.

Long-term investments

Our investments include equity method investments, equity securities with readily determinable fair values and available-for-sale debt securities.

We apply the equity method of accounting to account for an equity investment, in common stock or in-substance common stock, according to ASC 323 "Investment—Equity Method and Joint Ventures," over which it has significant influence but does not own a majority equity interest or otherwise control. Under the equity method, our share of the post-acquisition profits or losses of the equity investees are recorded in share of results of equity investees in the consolidated statements of comprehensive loss. The excess of the carrying amount of the investment over the underlying equity in net assets of the equity investee, if any, represents goodwill and intangible assets acquired. When our share of losses in the equity investee equals or exceeds its interest in the equity investee, we don’t recognize further losses, unless we have incurred obligations or made payments or guarantees on behalf of the equity investee.

Equity securities with readily determinable fair values are measured and recorded at fair value on a recurring basis with changes in fair value, whether realized or unrealized, recorded through the income statement.

 

106


Table of Contents

Debt securities that we have the intent to hold the security for an indefinite period or may sell the security in response to the changes in economic conditions are classified as available-for-sale debt securities and reported at fair value. Unrealized gains and losses (other than impairment losses) are reported, net of the related tax effect, in other comprehensive income. Upon sale, realized gains and losses are reported in net income.

We continually review our investments to determine whether a decline in fair value to below the carrying value is other-than-temporary. The primary factors we consider in our determination are the duration and severity of the decline in fair value; the financial condition, operating performance and the prospects of the equity investee; and other company specific information such as recent financing rounds. If the decline in fair value is deemed to be other-than-temporary, the carrying value of the investment is written down to fair value.

 

ITEM 6.

DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES

6.A. Directors and Senior Management

The following table sets forth information regarding our executive officers and directors as of the date of this annual report.

 

Directors and Executive Officers

   Age   

Position/Title

Hao (Louis) Liang

   44   

Director, Chairman and Chief Executive Officer

Yingzhi (Lisa) Tang

   42   

Director, co-Chief Executive Officer and Chief Financial Officer

Dong Li

   46   

Independent Director

Su Zhang

   50   

Independent Director

Chao Guo

   39   

Senior Vice President

Hao (Louis) Liang has served as our Director, Chairman and Chief Executive Officer since 2012, and is currently in charge of our overall strategic planning and management. Mr. Liang has 15 years of experience in management and strategy, and deep understanding of internet, pet and media industries. Prior to joining us, Mr. Liang was the chief operational officer of PPLive Inc., director of Tencent Video and one of the earliest product managers of QQ. Mr. Liang obtained his bachelor’s degree in computer science from Guilin Electronic Technology University.

Yingzhi (Lisa) Tang has served as our Director and our co-Chief Executive Officer and Chief Financial Officer since 2012, and is currently in charge of our private labels business, online community, MCN & content marketing, external cooperation and human resources management. Ms. Tang has 14 years of experience in internet, pet, media industries and expertise in financial investment and mergers and acquisitions. Prior to joining us, Ms. Tang was the marketing director of PPLive Inc. and the head of Tencent’s business services department. Ms. Tang obtained her bachelor’s degree in computer science from Tongji University.

 

107


Table of Contents

Dong Li has served as our Independent Director since September 2020. Mr. Li is currently serving as the chief financial officer of Tim Hortons China, a premium coffee chain network in China since September 2021. Mr. Li has also served as an independent director of GreenTree Hospitality Group Ltd. (a leading hospitality management group in China listed on the NYSE, ticker symbol: GHG) since March 2018, as an independent nonexecutive director of Helens International Holdings Company Limited (China’s largest bar chain network listed on the Hong Kong Stock Exchange, ticker symbol: 09869) since August 2021, as an independent non-executive director of Sinosoft Technology Group Limited, a leading government big data and related services provider listed on the Hong Kong Stock Exchange (HKEx: 01297) since February 2023; as an independent non-executive director of Logory Logistics Technology Co., Ltd., a leading end-to-end digital freight transportation services provider in China listed on the Hong Kong Stock Exchange (HKEx: 02482) since March 2023; and as an independent non-executive director of ZJLD Group Inc, a leading baijiu company in China offering premium baijiu products featuring sauce aroma profile and listed on the Hong Kong Stock Exchange (HKEx: 06979) since April 2023. Prior to joining Tim Hortons China, Mr. Li served as the chief financial officer for several companies, including Ximalaya Inc., one of China’s largest online audio platforms from September 2019 to September 2021; OneSmart International Education Group Limited, a diversified premium K through 12 education company in China listed on the New York Stock Exchange (ticker symbol: ONE) from July 2017 to June 2019; Pegasus Media Group Limited, a company focusing on movie and TV show production, investment, licensing, marketing and derivatives from April 2016 to April 2017; and Ecovacs Robotics Holdings Limited, a consumer robotics company in China listed on the Shanghai Stock Exchange (ticker symbol: 603486) from March 2015 to February 2016. From September 2008 to February 2015, Mr. Li worked as an associate and later vice president in investment banking at Bank of America Merrill Lynch and ICBC International in Hong Kong. Prior to that, Mr. Li worked in KPMG’s auditing practice group from August 1999 to April 2006 in its Beijing and Silicon Valley offices, respectively. Mr. Li received a bachelor’s degree in accounting from School of Economics and Management, Tsinghua University in July 1999, as well as a master’s degree in business administration in finance from Kellogg School of Management, Northwestern University in June 2008. Mr. Li is a member of the Chinese Institute of Certified Public Accountants and the Certified General Accountants Association of Canada.

Su Zhang has served as our Independent Director since May 2023. Mr. Zhang, with over 28 years of experience in the technology and internet industry, has worked at international well-known technology enterprises for more than 20 years. Mr. Zhang obtained his bachelor’s degree in automatic control in the Information and Control Engineering from Xi’an Jiaotong University in 1995.

Chao Guo has served as our Senior Vice President since 2019, and is currently in charge of management of Nanjing Xingmu. Mr. Guo has 16 years of experience in pet healthcare industry. Prior to joining us, Mr. Guo served as the technician of Qianyuanhao Nanjing Biopharmaceutical Factory, salesman of Zhongmu Nanjing Animal Pharmaceutical Co., Ltd. Mr. Guo serves as the general manager of Nanjing Xingmu since 2013. Mr. Guo obtained his bachelor’s degree in biotechnology from Jiangsu Ocean University.

6.B. Compensation

For the fiscal year ended March 31, 2023, we paid an aggregate of RMB1.5 million (US$0.2 million) in cash to our executive officers, and we did not pay any cash compensation to our non-executive directors. We have not set aside or accrued any amount to provide pension, retirement or other similar benefits to our directors and executive officers. Our PRC subsidiaries and the VIEs are required by law to make contributions equal to certain percentages of each employee’s salary for his or her pension insurance, medical insurance, unemployment insurance and other statutory benefits and a housing provident fund. For share incentive grants to our directors and executive officers, see “—Share Incentive Plan.”

Employment Agreements and Indemnification Agreements

We have entered into an employment agreement with each of our executive officers. Each of our executive officers is employed for a specified time period. We may terminate employment for cause, at any time, without advance notice or remuneration, for certain acts of the executive officer. We may also terminate an executive officer’s employment without cause upon advance written notice. In such case of termination by us other than for cause, we will pay an additional amount to the executive officer as provided by applicable law. The executive officer may resign at any time with an advance written notice.

Each executive officer has agreed to hold, both during and after the termination or expiry of his or her employment agreement, in strict confidence and not to use all nonpublic information relating to the business, financial condition and other aspects of us and our customers, users and suppliers, and may not disclose such nonpublic information for any purpose other than to fulfill his or her responsibilities in the best interest of the Company except otherwise authorized by us. In addition, each executive officer has agreed to be bound by noncompetition and nonsolicitation restrictions during the term of his or her employment and typically for one year following the last date of employment.

We have also entered into an indemnification agreement with each of our directors and executive officers. Under these agreements, we agree to indemnify our directors and executive officers against certain liabilities and expenses incurred by such persons in connection with claims made by reason of their being a director or officer of our company.

 

108


Table of Contents

Share Incentive Plan

Amended and Restated 2018 Global Share Plan

We adopted the 2018 Global Share Plan in August 2018, for the purpose of granting share-based compensation awards to employees, directors and consultants to incentivize their performance and align their interests with ours. The 2018 Global Share Plan was last amended and restated in May 2022, and the total number of Class A ordinary shares reserved for awards to be granted to the eligible participants thereunder was increased by 4,000,000 Class A ordinary shares, in order to retain and attract talent to drive the long-term success of Boqii. After the increase, the maximum aggregate number of Class A ordinary shares that may be issued under the amended and restated 2018 Global Share Plan, or the Amended and Restated 2018 Global Share Plan, is 12,987,836.

The following paragraphs summarize the key terms of the Amended and Restated 2018 Global Share Plan.

Types of Awards. The Amended and Restated 2018 Global Share Plan permits the awards of options, including incentive stock option and nonstatutory stock option and rights to purchase restricted shares, including Reg S share purchase right and share purchase right other than a Reg S share purchase right.

Plan Administration. The Amended and Restated 2018 Global Share Plan shall be administered by the board or our chief executive officer. Subject to applicable law, the administrator may delegate limited authority to specified officers of our company to execute on behalf of the Company any instrument required to effect an award previously granted by the administrator.

Eligibility. Our employees, directors and consultants (together, as “service providers”) are eligible to participate in the Amended and Restated 2018 Global Share Plan. Generally, only service providers that are not U.S. persons, or trusts established in connection with any of our employee benefit plans for the benefit of such a service provider, shall be eligible for the grant of Reg S options and Reg S share purchase rights. Non-statutory stock options that are not designated as Reg S options and share purchase rights that are not designated as Reg S share purchase rights may be granted to service providers only. Incentive stock options may be granted to employees only. Any awards granted to consultants that are intended to comply with and qualify under Rule 701 promulgated under the Securities Act may only be granted to natural persons who meet the applicable requirements under the Securities Act. A service provider who owns more than 10% of the total combined voting power of all classes of outstanding securities of Boqii Holding Limited or any of its parent or subsidiary shall not be eligible for the grant of an incentive stock option unless otherwise specified under the Amended and Restated 2018 Global Share Plan, and notwithstanding any contrary provision of Amended and Restated 2018 Global Share Plan, a service provider located in California is eligible to receive only awards that comply with certain requirements under the Amended and Restated 2018 Global Share Plan.

Designation of Award. Each award under the Amended and Restated 2018 Global Share Plan is designated in an award agreement, which is a written agreement evidencing the grant of an award executed by our company and the grantee, including any amendments thereto.

Conditions of Award. The board of directors or the chief executive officer shall determine the terms and conditions of each award including, but not limited to, the exercise price, the purchase price, the exercise conditions, the repurchase or redemption rights, vesting acceleration or waiver of forfeiture restrictions, and restriction or limitation regarding any award or shares relating thereto.

Terms of Award. The term of each award is stated in the award agreement between our company and the grantee of such award, and shall not exceed ten years from the date of grant.

Transfer Restrictions. Unless otherwise determined by the administrator and so provided in the applicable award agreement (or be amended to provide), no award shall be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner (whether by operation of law or otherwise) other than by will or applicable laws of descent and distribution or (except in the case of an incentive stock option) pursuant to a domestic relations order, and shall not be subject to execution, attachment, or similar process, and each award may be exercised, during the lifetime of the participant only by the participant.

Change in Control. In the event that our company is a party to a change in control (whether structured as a merger, share purchase, scheme of arrangement or other similar transaction), outstanding awards and shares acquired under the Amended and Restated 2018 Global Share Plan shall be subject to the definitive agreement covering such change in control, which need not treat all outstanding awards in an identical manner.

Amendment or Termination. The administrator of the Amended and Restated 2018 Global Share Plan may at any time amend, alter, suspend, or terminate the Amended and Restated 2018 Global Share Plan.

 

109


Table of Contents

As of March 31, 2023, options to purchase a total of 5,569,125 ordinary shares were outstanding, excluding those that were forfeited or canceled, of which options to purchase 1,257,983 ordinary shares had become vested and exercisable. The following table summarizes the number of ordinary shares underlying outstanding options that we granted to our directors and executive officers but have not been exercised under the Amended and Restated 2018 Global Share Plan as of the same date.

 

    Ordinary Shares
Underlying Options
Granted
    Exercise Price
(US$/Share)
   

Date of Grant

 

Date of Expiration

Hao (Louis) Liang

    791,331       0.10 to 4.13     Various dates from September 27, 2012 to April 12, 2023   Various dates from
September 26, 2022 to
April 11, 2033

Yingzhi (Lisa) Tang

    379,486       0.10 to 4.13     Various dates from September 27, 2012 to April 12, 2023   Various dates from
September 26, 2022 to
April 11, 2033

Dong Li

    —         —       —     —  

Su Zhang

    —         —       —     —  

Chao Guo

    *       4.13     May 17, 2021   May 16, 2031
 

 

 

       

All directors and executive officers as a group

    1,220,817        
 

 

 

       

 

Note:

 

*

Less than 1% of our total outstanding shares.

As of March 31, 2023, there were outstanding options to purchase 4,348,308 ordinary shares, with exercise prices ranging from US$0.0001 per share to US$4.13 per share that were granted to our employees, other than members of our senior management.

6.C. Board Practices

Board of Directors

Our board of directors consist of four directors, including two independent directors. A director is not required to hold any shares in our company to qualify to serve as a director. A director may vote with respect to any contract, proposed contract or arrangement notwithstanding that he may be interested therein, and if he or she does so his or her vote shall be counted and he or she may be counted in the quorum at any meeting of our directors at which any such contract or proposed contract or arrangement is considered, provided that (i) such director declares the nature of his interest at the meeting of the board at which the question of entering into the contract or arrangement is first considered, if he knows his or her interest then exists, or in any other case at the first meeting of the board after he or she knows that he is or has become so interested, and (ii) if such contract or arrangement is a transaction with a related party, such transaction has been approved by the audit committee. The directors may exercise all the powers of the company to borrow money, to mortgage or charge its undertaking, property and uncalled capital, and to issue debentures or other securities whenever money is borrowed or as security for any debt, liability or obligation of the company or of any third party. None of our non-executive directors has a service contract with us that provides for benefits upon termination of service.

Committees of the board of directors

We have established an audit committee, a compensation committee and a nominating and corporate governance committee under our board of directors and have adopted a charter for each of the three committees. Each committee’s members and functions are described below.

Audit Committee. Our audit committee consists of Mr. Dong Li and Mr. Su Zhang. Mr. Dong Li is the chairman of our audit committee. We have determined that each of Mr. Dong Li and Mr. Su Zhang satisfies the “independence” requirements of Section 303A of the Corporate Governance Rules of the NYSE and Rule 10A-3 under the Securities Exchange Act of 1934. We have determined that Mr. Dong Li qualifies as an “audit committee financial expert.” The audit committee oversees our accounting and financial reporting processes and the audits of the consolidated financial statements of our company. The audit committee is responsible for, among other things:

 

   

selecting the independent registered public accounting firm and preapproving all auditing and nonauditing services permitted to be performed by the independent registered public accounting firm;

 

   

reviewing with the independent registered public accounting firm any audit problems or difficulties and management’s response;

 

   

reviewing and approving all proposed related party transactions;

 

   

discussing the annual audited consolidated financial statements with management and the independent registered public accounting firm;

 

   

reviewing major issues as to the adequacy of our internal controls and any special audit steps adopted in light of material control deficiencies;

 

110


Table of Contents
   

annually reviewing and reassessing the adequacy of our audit committee charter;

 

   

meeting separately and periodically with management and the independent registered public accounting firm; and

 

   

reporting regularly to the board of directors.

Compensation Committee. Our compensation committee consists of Mr. Hao (Louis) Liang, Mr. Dong Li and Ms. Yingzhi (Lisa) Tang, and is chaired by Mr. Hao (Louis) Liang. We have determined that Mr. Dong Li satisfies the “independence” requirements of Section 303A of the Corporate Governance Rules of the NYSE. The compensation committee assists the board in reviewing and approving the compensation structure, including all forms of compensation, relating to our executive officers. Our executive officer may not be present at any committee meeting during which such executive officer’s performance or compensation is deliberated upon. The compensation committee is responsible for, among other things:

 

   

reviewing and approving the compensation for our executive officers;

 

   

reviewing and evaluating periodically the management succession plan in consultation with the chief executive officer;

 

   

reviewing any incentive compensation or equity plans, programs or similar arrangements;

 

   

selecting compensation consultant, legal counsel or other adviser only after taking into consideration of all factors relevant to that person’s independence from management; and

 

   

reporting periodically to the board of directors.

Nominating and Corporate Governance Committee. Our nominating and corporate governance committee consists of Mr. Hao (Louis) Liang and Mr. Su Zhang and is chaired by Mr. Hao (Louis) Liang. We have determined that Mr. Su Zhang satisfies the “independence” requirements of Section 303A of the Corporate Governance Rules of the NYSE. The nominating and corporate governance committee assists the board in selecting individuals qualified to become our directors and in determining the composition of the board and its committees. The nominating and corporate governance committee is responsible for, among other things:

 

   

recommending nominees to the board for membership on the board and its committees pursuant to the terms of the Post-IPO MAA effective upon the completion of our initial public offering;

 

   

leading and overseeing self-evaluation of the board at least annually to determine whether it and its committees are functioning effectively;

 

   

recommending criteria for the selection of candidates to the board of directors and its committees;

 

   

selecting and recommending to the board the names of directors to serve as members of the audit committee and the compensation committee, as well as of the nominating and corporate governance committee itself;

 

   

developing and recommending to the board of directors the code of business conduct and ethics; and

 

   

overseeing and setting compensation for our directors.

Duties and Functions of Directors

Under Cayman Islands law, our directors owe fiduciary duties to our company, including a duty of loyalty, a duty to act honestly and a duty to act in what they consider in good faith to be in our best interests. Our directors must also exercise their powers only for a proper purpose. Our directors also owe to our company a duty to exercise the skill they actually possess and such care and diligence that a reasonable prudent person would exercise in comparable circumstances. It was previously considered that a director need not exhibit in the performance of his duties a greater degree of skill than may reasonably be expected from a person of his knowledge and experience. However, English and Commonwealth courts have moved towards an objective standard with regard to the required skill and care and these authorities are likely to be followed in the Cayman Islands. In fulfilling their duty of care to us, our directors must ensure compliance with our memorandum and articles of association, as amended and restated from time to time. Our company has the right to seek damages if a duty owed by our directors is breached. In limited exceptional circumstances, a shareholder may have the right to seek damages in our name if a duty owed by our directors is breached. In accordance with our Post-IPO MAA, the functions and powers of our board of directors include, among others, (i) convening shareholders’ annual general meetings and extraordinary general meetings and reporting its work to shareholders at such meetings, (ii) declaring dividends, (iii) appointing officers and determining their terms of offices and responsibilities, and (iv) approving the transfer of shares of our company, including the registering of such shares in our register of members.

 

111


Table of Contents

Terms of Directors and Officers

Our officers are elected by and serve at the discretion of the board. Each director is not subject to a term of office and holds office until such time as his successor takes office or until the earlier of his death, resignation or removal from office by ordinary resolution or the affirmative vote of a simple majority of the other directors present and voting at a board meeting. In accordance with our Post-IPO MAA, a director will be removed from office automatically if, among other things, the director (i) becomes bankrupt or makes any arrangement or composition with his creditors generally; (ii) dies or is found by our company to be or become of unsound mind; (iii) resigns by notice in writing to our company; (iv) is prohibited by law or NYSE rules from being a director; or (v) is removed from office pursuant to any other provisions of our Post-IPO MAA.

Interested Transactions

A director may, subject to any separate requirement for audit committee approval under applicable law or applicable NYSE rules, vote in respect of any contract or transaction in which he or she is interested, provided that the nature of the interest of any directors in such contract or transaction is disclosed by him or her at or prior to its consideration and any vote in that matter.

6.D. Employees

We had 325, 417 and 256 full-time employees as of March 31, 2021, 2022 and 2023, respectively. The following table sets forth the number of our full-time employees by function as of March 31, 2023, and all of these full-time employees are based in China.

 

Function

   Number of employees  

Fulfillment

     13  

Sales and marketing

     102  

General and administrative

     141  
  

 

 

 

Total

     256  
  

 

 

 

Additionally, we also had 142 outsourced workers as of March 31, 2023, of whom 49 primarily support our customer services and 93 primarily support our fulfillment services.

Our success depends on our ability to attract, motivate, train and retain qualified personnel. We have fostered a friendly and productive work culture that encourages self-development and collaboration. We believe we offer our employees competitive compensation packages consisting of base salary and various performance bonuses. As a result, we have generally been to attract and retain qualified personnel and maintain a stable core management team.

As required by regulations in China, we participate in housing fund and various employee social security plans that are organized by applicable local governments, including medical insurance, childbirth insurance, workplace injury insurance, unemployment benefit plans and pension benefit plans, under which we make contributions at specified percentages of the salaries of our employees.

Some of our employees are represented by labor unions. We maintain a good working relationship with our employees. As of the date of this annual report, we have not experienced any material labor disputes.

6.E. Share Ownership

The following table sets forth information concerning the beneficial ownership of our ordinary shares as of March 31, 2023, by:

 

   

each of our directors and executive officers; and

 

   

each person known to us to beneficially own more than 5% of our ordinary shares.

The calculations in the table below are based on 70,729,482 ordinary shares issued and outstanding as of March 31, 2023, comprising (i) 57,691,753 Class A ordinary shares, including 1,928,662 Class A ordinary shares held by the depositary bank underlying the options granted but not yet exercised under the Amended and Restated 2018 Global Share Plan, and (ii) 13,037,729 Class B ordinary shares.

Beneficial ownership is determined in accordance with the rules and regulations of the SEC. In computing the number of shares beneficially owned by a person and the percentage ownership of that person, we have included shares that the person has the right to acquire within 60 days after March 31, 2023, including through the exercise of any option, warrant, or other right or the conversion of any other security. These shares, however, are not included in the computation of the percentage ownership of any other person.

 

112


Table of Contents
     Ordinary Shares Beneficially Owned as of March 31, 2023  
     Class A ordinary
shares
     Class B
ordinary
shares
     Total ordinary
shares on an as-
converted basis
     % of
beneficial
ownership**
    %
of aggregate
voting
power***
 

Directors and Executive Officers: †

             

Hao (Louis) Liang(1)

     791,331        8,314,160        9,105,491        12.9     52.5

Yingzhi (Lisa) Tang(2)

     379,486        4,345,475        4,724,961        6.7     27.4

Dong Li

     —          —          —          —         —    

Su Zhang

     —          —          —          —         —    

Chao Guo

     *        —          50,000        *       *  

All directors and executive officers as a group

     1,220,817        12,659,635        13,880,452        19.6     79.9

Principal Shareholders:

             

Merchant Tycoon Limited(3)

     —          13,037,729        13,037,729        18.4     81.9

CMB(4)

     7,308,199        —          7,308,199        10.3     2.3

Apsaras Legend Limited(5)

     5,112,641        —          5,112,641        7.2     1.6

Raumier Limited(6)

     4,842,587        —          4,842,587        6.8     1.5

Chong Li’s Entities(7)

     4,591,045        —          4,591,045        6.5     1.4

Notes:

 

*

Less than 1% of our total outstanding shares.

**

For each person and group included in this column, percentage of beneficial ownership is calculated by dividing the number of shares beneficially owned by such person or group by the sum of (i) 70,729,482, being the number of ordinary shares on an as-converted basis issued and outstanding as of March 31, 2023, and (ii) the number of ordinary shares underlying share options held by such person or group that are exercisable within 60 days after March 31, 2023.

***

For each person and group included in this column, percentage of voting power is calculated by dividing the voting power beneficially owned by such person or group by the voting power of all of our ordinary shares as a single class. Each holder of Class A ordinary shares is entitled to one vote per share and each holder of our Class B ordinary shares is entitled to 20 votes per share on all matters submitted to them for a vote. Our Class A ordinary shares and Class B ordinary shares vote together as a single class on all matters submitted to a vote of our shareholders, except as may otherwise be required by law. Our Class B ordinary shares are convertible at any time by the holder thereof into Class A ordinary shares on a one-for-one basis.

Except as otherwise indicated below, the business address of our directors and executive officers is Building 9, No. 388, Shengrong Road, Pudong New District, Shanghai 201210, People’s Republic of China.

(1)

Represents an aggregate of 9,105,491 ordinary shares, consisting of (i) 8,314,160 Class B ordinary shares held by Merchant Tycoon Limited, a limited liability company incorporated under the laws of the British Virgin Islands; and (ii) 791,331 Class A ordinary shares underlying share options held by Hao (Louis) Liang that are exercisable within 60 days after March 31, 2023. Hao (Louis) Liang holds 63.77% of equity interest in Merchant Tycoon Limited. The registered address of Merchant Tycoon Limited is Trinity Chambers, PO Box 4301, Road Town, Tortola, British Virgin Islands. Based on the terms of governing documents of Merchant Tycoon Limited, Hao (Louis) Liang disclaims beneficial ownership of the ordinary shares beneficially owned by Yingzhi (Lisa) Tang and a former director through their respective shareholdings in Merchant Tycoon Limited.

(2)

Represents an aggregate of 4,724,961 ordinary shares, consisting of (i) 4,345,475 Class B ordinary shares held by Merchant Tycoon Limited, a limited liability company incorporated under the laws of the British Virgin Islands; and (ii) 379,486 Class A ordinary shares underlying share options held by Yingzhi (Lisa) Tang that are exercisable within 60 days after March 31, 2023. Yingzhi (Lisa) Tang holds 33.33% of equity interest in Merchant Tycoon Limited. The registered address of Merchant Tycoon Limited is Trinity Chambers, PO Box 4301, Road Town, Tortola, British Virgin Islands. Based on the terms of governing documents of Merchant Tycoon Limited, Yingzhi (Lisa) Tang disclaims beneficial ownership of the ordinary shares beneficially owned by Hao (Louis) Liang and a former director through their respective shareholdings in Merchant Tycoon Limited.

(3)

Represents an aggregate of 13,037,729 Class B ordinary shares held of record by Merchant Tycoon Limited, a limited liability company incorporated under the laws of the British Virgin Islands. Each of Hao (Louis) Liang, Yingzhi (Lisa) Tang and a former director holds 63.77%, 33.33% and 2.9% of the equity interest in Merchant Tycoon Limited, and beneficially owns 8,314,160, 4,345,475 and 378,094 Class B ordinary shares directly held by Merchant Tycoon Limited. The registered address of Merchant Tycoon Limited is Trinity Chambers, PO Box 4301, Road Town, Tortola, British Virgin Islands.

 

113


Table of Contents
(4)

Represents an aggregate of 7,308,199 Class A ordinary shares, based on the Amendment No. 1 to Schedule 13G filed on February 13, 2023 by China Merchants Bank Co., Limited, among other reporting persons. CMBI Private Equity Series SPC acting for and on behalf of Internet Retail Fund I SP (“SPC”), a segregated portfolio company incorporated under the laws of the Cayman Islands, directly holds 670,615 Class A ordinary shares. Shanghai Qiji Technology LLP (“Qiji”), a limited partnership formed under the laws of the People’s Republic of China, directly holds 6,637,584 Class A ordinary shares. CMB International Private Investment Limited (“CMBIPI”), a company incorporated under the laws of the Cayman Islands, owns all the management shares of SPC. CMBIPI is wholly owned by CMB International Investment Management Limited (“CMBIIM”), a company incorporated under the laws of the British Virgin Islands. Pursuant to Section 13(d) of the Exchange Act, and the rules promulgated thereunder, each of CMBIPI and CMBIIM may be deemed to beneficially own all of the ordinary shares held by SPC. CMB International Capital Holdings (Shenzhen) (“CMBICH SZ”) owns the majority of interest in Qiji. Pursuant to Section 13(d) of the Exchange Act, and the rules promulgated thereunder, CMBICH SZ may be deemed to beneficially own all of the Issuer’s shares held by Qiji. Each of CMBICH SZ and CMBIIM is wholly owned by CMB International Capital Corporation Limited (“CMBICC”), a company incorporated in Hong Kong. CMBICC is a majority-owned subsidiary of CMB International Capital Holdings Corporation Limited (“CMBICH”), a company incorporated in Hong Kong. CMBICH is wholly owned by China Merchants Bank Co., Limited (“CMB”), a company incorporated in Hong Kong and listed on the Stock Exchange of Hong Kong. Pursuant to Section 13(d) of the Exchange Act, and the rules promulgated thereunder, each of CMBICC, CMBICH and CMB may be deemed to beneficially own all of the Issuer’s shares held by SPC and Qiji. The registered address of CMBI Private Equity Series SPC is 4th Floor, Harbour Place, 103 South Church Street, P.O. Box 10240, Grand Cayman KYI-1002, Cayman Islands. The registered address of Shanghai Qiji Technology LLP. is 2A, No. 1200, Pudong Avenue, Pilot Free Trade Zone, Shanghai, People’s Republic of China.

(5)

Represents 5,112,641 Class A ordinary shares held by Apsaras Legend Limited, a limited liability company incorporated under the laws of the British Virgin Islands, ultimately controlled by Fengjin Jiang. The registered address of Apsaras Legend Limited is Woodbourne Hall, P.O. Box 3162, Road Town, Tortola, British Virgin Islands.

(6)

Represents 4,842,587 Class A ordinary shares held by Raumier Limited, a limited liability company incorporated under the Companies (Jersey) Laws, based on the Schedule 13G filed on February 16, 2021 by Raumier Limited, among other reporting persons. The shares in Raumier Limited are owned of record 50% by Premier Circle Limited and 50% by Second Circle Limited; however, Premier Circle Limited and Second Circle Limited are the record owners of such shares in Raumier Limited solely as nominee and in trust for Brunei Investment Agency, which is the sole beneficial owner of such shares. The registered address of Raumier Limited is 26 New Street, St Helier, Jersey, JE2 3RA.

(7)

Represents an aggregate of 4,591,045 Class A ordinary shares held by Superb Origin International Limited, a limited liability company incorporated under the laws of the British Virgin Islands, in which Chong Li holds 100.0% equity interest. The registered address of Superb Origin International Limited is Trinity Chambers, PO Box 4301, Road Town, Tortola, British Virgin Islands; and (ii) 250,093 Class A ordinary shares held by DL Capital Holding Limited, a limited liability company incorporated under the laws of the British Virgin Islands, in which Chong Li holds 100.0% equity interest. The registered address of DL Capital Holding Limited is Trinity Chambers, P.O. Box 4301, Road Town, Tortola, British Virgin Island.

To our knowledge, as of March 31, 2023, a total of 2,296,386 Class A ordinary shares were held by one record holder in the United States, which represents approximately 3.2% of our total issued and outstanding shares. The holder is The Bank of New York Mellon, the depositary of our ADS program. The number of beneficial owners of our ADSs in the United States is much larger than the number of record holders of our Class A ordinary shares in the United States. We are not aware of any arrangement that may, at a subsequent date, result in a change of control of our company.

6.F. Disclosure of a Registrant’s Action to Recover Erroneously Awarded Compensation

Not applicable.

 

ITEM 7.

MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS

7.A. Major Shareholders

Please refer to “Item 6. Directors, Senior Management and Employees—6.E. Share Ownership.”

7.B. Related Party Transactions

Contractual Arrangements

See “Item 3. Key Information—Contractual Arrangements with the VIEs and Their Respective Shareholders.”

 

114


Table of Contents

Shareholders Agreement

Our currently effective shareholders agreement was entered into on August 19, 2020 by and among us, our shareholders, and certain other parties named therein. Except for the registration rights described below, all of the preferential rights, including the provisions governing the board of directors, has automatically terminated upon the completion of our initial public offering.

Registration Rights

Pursuant to the current shareholders agreement, prior to the consummation of a qualified initial public offering, the company shall extend to the shareholders registration rights with respect to the shares held by them with terms and conditions customary for a transaction of similar type and size, including demand registration rights, piggyback registration rights and Form F-3 or Form S-3 registration rights. For details regarding such registration rights, see the shareholders agreement filed as an exhibit to this annual report.

Employment Agreements and Indemnification Agreements

See “Item 6. Directors, Senior Management and Employees—6.B. Compensation—Employment Agreements and Indemnification Agreements.”

Share Incentive Plan

See “Item 6. Directors, Senior Management and Employees—6.B. Compensation—Share Incentive Plan.”

7.C. Interests of Experts and Counsel

Not applicable.

 

ITEM 8.

FINANCIAL INFORMATION

8.A. Consolidated Statements and Other Financial Information

We have appended consolidated financial statements filed as part of this annual report.

Legal and Administrative Proceedings

From time to time, we may be subject to legal proceedings and claims arising in the ordinary course of our business. As of the date of this annual report, we were not involved in any litigation, arbitration or administrative proceedings pending or, to our knowledge, threatened against us that could have a material and adverse effect on our business, financial condition or results of operations.

Dividend Policy

We have not previously declared or paid cash dividends and we have no plan to declare or pay any dividends in the near future on our ordinary shares or the ADSs representing our Class A ordinary shares. We currently intend to retain most, if not all, of our available funds and any future earnings to operate and expand our business.

We are an exempted company with limited liability incorporated in the Cayman Islands. We rely principally on dividends from our PRC subsidiaries for our cash requirements, including any payment of dividends to our shareholders. PRC regulations may restrict the ability of our PRC subsidiaries to pay dividends to us. See “Item 4. Information on the Company—4.B. Business Overview—Regulation—Regulations Related to Dividend Distribution.”

Our board of directors has discretion as to whether to distribute dividends, subject to certain requirements of Cayman Islands law. In addition, our shareholders may by ordinary resolution declare a dividend, but no dividend may exceed the amount recommended by our board of directors. Under Cayman Islands law, a Cayman Islands exempted company may pay a dividend out of either profit or share premium account, provided that in no circumstances may a dividend be paid if this would result in the company being unable to pay its debts as they fall due in the ordinary course of business. Even if our board of directors decides to pay dividends, the form, frequency and amount will depend upon our future operations and earnings, capital requirements and surplus, general financial condition, contractual restrictions and other factors that our board of directors may deem relevant. If we pay any dividends on our ordinary shares, we will pay those dividends which are payable in respect of the Class A ordinary shares underlying the ADSs to the depositary, as the registered holder of such Class A ordinary shares, and the depositary then will pay such amounts to the ADS holders in proportion to the Class A ordinary shares underlying the ADSs held by such ADS holders, subject to the terms of the deposit agreement, including the fees and expenses payable thereunder. See “Item 12. Description of Securities Other Than Equity Securities—12.D. American Depositary Shares.”

 

115


Table of Contents

8.B. Significant Changes

Except as otherwise disclosed in this report, we have not experienced any significant changes since the date of our audited consolidated financial statements included herein.

 

ITEM 9.

THE OFFER AND LISTING

9.A. Offering and Listing Details

Our ADSs have been listed on the NYSE since September 30, 2020 under the symbol “BQ.” Each ADS represents four and one half (4.5) Class A ordinary shares.

9.B. Plan of Distribution

Not applicable.

9.C. Markets

Each ADS represents four and one half (4.5) Class A ordinary shares. Our ADSs have been listed on the NYSE since September 30, 2020 under the symbol “BQ.”

9.D. Selling Shareholders

Not applicable.

9.E. Dilution

Not applicable.

9.F. Expenses of the Issue

Not applicable.

 

ITEM 10.

ADDITIONAL INFORMATION

10.A. Share Capital

Not applicable.

10.B. Memorandum and Articles of Association

We are an exempted company with limited liability incorporated under the laws of the Cayman Islands and our affairs are governed by our Post-IPO MAA, as amended and restated from time to time, the Companies Act, and the common law of the Cayman Islands. We incorporate by reference into this annual report our Post-IPO MAA, the form of which was filed as Exhibit 3.2 to our registration statement on Form F-1 (File No. 333-248641) filed with the Securities and Exchange Commission on September 8, 2020, as amended. Our shareholders adopted our Post-IPO MAA by a special resolution in September 2019, which became effective immediately prior to completion of our initial public offering of ADSs representing our ordinary shares.

Registered Office and Objects

Our registered office in the Cayman Islands is at the offices of Vistra (Cayman) Limited, P.O. Box 31119 Grand Pavilion, Hibiscus Way, 802 West Bay Road, Grand Cayman, KY1-1205, Cayman Islands

According to Clause 3 of our Post-IPO MAA, the objects for which the Company is established are unrestricted and the Company shall have full power and authority to carry out any object not prohibited by any law as provided by the Companies Act or as the same may be revised from time to time, or any other law of the Cayman Islands.

Board of Directors

See “Item 6. Directors, Senior Management and Employees.”

 

116


Table of Contents

Ordinary Shares

See Exhibit 2.4 to this annual report.

Differences in Corporate Law

See Exhibit 2.4 to this annual report.

10.C. Material Contracts

We have not entered into any material contracts other than in the ordinary course of business and other than those described elsewhere in this annual report.

10.D. Exchange Controls

The Cayman Islands currently has no exchange control regulations or currency restrictions. See “Item 4. Information of the Company—4.B. Business Overview—Regulation—Regulations Related to Foreign Exchange.”

10.E. Taxation

Cayman Islands Taxation

According to Maples and Calder (Hong Kong) LLP, our Cayman Islands legal counsel, the Cayman Islands currently levies no taxes on individuals or corporations based upon profits, income, gains or appreciation, and there is no taxation in the nature of inheritance tax or estate duty. The Cayman Islands is not party to any double tax treaties that are applicable to any payments made to or by our company. There are no exchange control regulations or currency restrictions in the Cayman Islands.

In terms of material tax consequences in the Cayman Islands, there are no other taxes likely to be material to us or holders of the ADSs or ordinary shares levied by the government of the Cayman Islands, except for stamp duties which may be applicable on instruments executed in, or after execution brought within the jurisdiction of the Cayman Islands. Payments of dividends and capital in respect of the ADSs or ordinary shares will not be subject to taxation in the Cayman Islands and no withholding will be required on the payment of a dividend or capital to any holder of the ADSs or ordinary shares, nor will gains derived from the disposal of the ADSs or ordinary shares be subject to Cayman Islands income or corporate tax.

People’s Republic of China Taxation

Under the PRC EIT Law, which became effective on January 1, 2008 and was most recently amended on December 29, 2018, an enterprise established outside the PRC with “de facto management bodies” within the PRC is considered a “resident enterprise” for PRC enterprise income tax purposes and is generally subject to a uniform 25% enterprise income tax rate on its worldwide income. Under the implementation regulations to the PRC EIT Law, a “de facto management body” is defined as a body that has material and overall management and control over the manufacturing and business operations, personnel and human resources, finances and properties of an enterprise.

In addition, the STA Circular 82 issued by the STA in April 2009 specifies that certain offshore incorporated enterprises controlled by PRC enterprises or PRC enterprise groups will be classified as PRC resident enterprises if the following are located or resident in the PRC: (a) senior management personnel and departments that are responsible for daily production, operation and management; (b) financial and personnel decision making bodies; (c) key properties, accounting books, company seal, minutes of board meetings and shareholders’ meetings; and (d) half or more of the senior management or directors having voting rights. Further to STA Circular 82, the STA issued the STA Bulletin 45, which took effect in September 2011, to provide more guidance on the implementation of STA Circular 82. STA Bulletin 45 provides for procedures and administration details of determination on resident status and administration on post-determination matters. Our company is a company incorporated outside the PRC. As a holding company, its key assets are its ownership interests in its subsidiaries, and its key assets are located outside the PRC. As such, we do not believe that our company meets all of the conditions above or is a PRC resident enterprise for PRC tax purposes. For similar reasons, we believe our other entities outside of China are also not PRC resident enterprises. However, the tax resident status of an enterprise is subject to determination by the PRC tax authorities and uncertainties remain with respect to the interpretation of the term “de facto management body.” There can be no assurance that the PRC government will ultimately take a view that is consistent with us.

 

117


Table of Contents

In terms of material tax consequences to ADS holders, if the PRC tax authorities determine that our Cayman Islands holding company is a PRC resident enterprise for PRC enterprise income tax purposes, a 10% withholding tax would be imposed on dividends we pay to our non-PRC enterprise shareholders (including the ADS holders). In addition, nonresident enterprise shareholders (including the ADS holders) may be subject to PRC tax at a rate of 10% on gains realized on the sale or other disposition of ADSs or ordinary shares, if such gains are treated as derived from a PRC source. Furthermore, if we are deemed a PRC resident enterprise, dividends paid to our non-PRC individual shareholders (including the ADS holders) and any gain realized on the transfer of ADSs or ordinary shares by such shareholders may be subject to PRC individual income tax at a rate of 20% (which, in the case of dividends, may be withheld at source by us). These rates may be reduced by an applicable tax treaty, but it is unclear whether non-PRC shareholders of our company would be able to in practice, obtain the benefits of any tax treaties between their country of tax residence and the PRC in the event that we are treated as a PRC resident enterprise. See “Item 3. Key Information—3.D.Risk Factors—Risks Related to Doing Business in China—If we are classified as a PRC resident enterprise for PRC enterprise income tax purposes, such classification could result in unfavorable tax consequences to us and our non-PRC shareholders and ADS holders.”

Material U.S. Federal Income Tax Considerations

The following are material U.S. federal income tax consequences to the U.S. Holders described below of owning and disposing of the ADSs or Class A ordinary shares, but this discussion does not purport to be a comprehensive description of all of the tax considerations that may be relevant to a particular person’s decision to own ADSs or Class A ordinary shares.

The following applies only to a U.S. Holder that holds the ADSs or Class A ordinary shares as capital assets for U.S. federal income tax purposes. In addition, it does not address all of the tax consequences that may be relevant in light of a U.S. Holder’s particular circumstances, including the alternative minimum tax, the Medicare contribution tax on net investment income and tax consequences applicable to U.S. Holders subject to special rules, such as:

 

   

certain financial institutions;

 

   

insurance companies;

 

   

regulated investment companies;

 

   

dealers or traders in securities that use a mark-to-market method of tax accounting;

 

   

persons holding ADSs or Class A ordinary shares as part of a straddle, integrated or similar transaction;

 

   

persons whose functional currency for U.S. federal income tax purposes is not the U.S. dollar;

 

   

entities classified as partnerships for U.S. federal income tax purposes and their partners;

 

   

tax-exempt entities, “individual retirement accounts” or “Roth IRAs”;

 

   

persons that acquired ADSs or Class A ordinary shares as compensation;

 

   

persons that own or are deemed to own ADSs or Class A ordinary shares representing 10% or more of our voting power or value; or

 

   

persons holding ADSs or Class A ordinary shares in connection with a trade or business outside the United States.

If a partnership (or other entity that is classified as a partnership for U.S. federal income tax purposes) owns ADSs or Class A ordinary shares, the U.S. federal income tax treatment of a partner will depend on the status of the partner and the activities of the partnership. Partnerships owning ADSs or Class A ordinary shares and their partners should consult their tax advisers as to their particular U.S. federal income tax consequences of owning and disposing of ADSs or Class A ordinary shares.

The following is based on the Internal Revenue Code of 1986, as amended, or the Code, administrative pronouncements, judicial decisions, final, temporary and proposed Treasury regulations, and the income tax treaty between the United States and the PRC, or the Treaty, all as of the date hereof, any of which is subject to change, possibly with retroactive effect. The following assumes that each obligation under the deposit agreement and any related agreement will be performed in accordance with its terms.

As used herein, a “U.S. Holder” is a person that is, for U.S. federal income tax purposes, a beneficial owner of the ADSs or Class A ordinary shares and:

 

   

a citizen or individual resident of the United States;

 

   

a corporation, or other entity taxable as a corporation, created or organized in or under the laws of the United States, any state therein or the District of Columbia; or

 

   

an estate or trust the income of which is subject to U.S. federal income taxation regardless of its source.

 

118


Table of Contents

A U.S. Holder that owns ADSs generally will be treated as the owner of the underlying Class A ordinary shares represented by those ADSs for U.S. federal income tax purposes. Accordingly, no gain or loss will be recognized if a U.S. Holder exchanges ADSs for the underlying Class A ordinary shares represented by those ADSs.

U.S. Holders should consult their tax advisers concerning the U.S. federal, state, local and non-U.S. tax consequences of owning and disposing of ADSs or Class A ordinary shares in their particular circumstances.

Passive Foreign Investment Company Rules

In general, a non-U.S. corporation is a PFIC for U.S. federal income tax purposes for any taxable year in which (i) 50% or more of the average value of its assets (generally determined on a quarterly basis) consists of assets that produce, or are held for the production of, passive income (the “asset test”), or (ii) 75% or more of its gross income consists of passive income. For purposes of the above calculations, a non-U.S. corporation that owns (or is treated as owning for U.S. federal income tax purposes), directly or indirectly, at least 25% by value of the shares of another corporation is treated as if it held its proportionate share of the assets of the other corporation and received directly its proportionate share of the income of the other corporation. Passive income generally includes dividends, interest, rents, royalties and gains from financial investments. Cash is generally a passive asset for these purposes. Goodwill (the value of which may be determined by reference to the excess of the sum of the corporation’s market capitalization and liabilities over the value of its assets) is generally characterized as an active asset to the extent it is associated with business activities that produce active income.

If the value of our goodwill is determined by reference to our market capitalization, then we would have had a negative amount of goodwill for a portion of our most recent taxable year ended on March 31, 2023. There is uncertainty as to how to apply the asset test is that situation. Taking into account the composition of our income and assets for that year, we believe it is reasonable to take the position that we were not a PFIC for our taxable year ended on March 31, 2023. However, due to the uncertainty described above, as well uncertainties regarding the characterization and value of certain of our assets for purposes of the asset test, our PFIC status for our taxable year ended on March 31, 2023 is not entirely clear and the Internal Revenue Service may assert that we were a PFIC for that year. Furthermore, because of the substantial fluctuations in our market capitalization, there is a significant risk that we will be a PFIC for our current taxable year ending on March 31, 2024, and possibly future taxable years. We hold a substantial amount of cash and financial investments and while this continues to be the case, our PFIC status may depend on the average value of our goodwill. The value of our goodwill may be determined, in large part, by reference to our market capitalization, which has been volatile and generally in decline in recent years. As a result, there is a significant risk that we will be a PFIC for any taxable year because the average value of our goodwill (if any) and other active assets may not be sufficiently large in relation to the average value of our passive assets. Moreover, it is not entirely clear how the contractual arrangements between us, the VIEs and their nominal shareholders will be treated for purposes of the PFIC rules, and we may be or become a PFIC if the VIEs are not treated as owned by us for these purposes.

If we are a PFIC for any taxable year and any entity in which we own or are deemed to own equity interests (including our subsidiaries and the VIEs) is also a PFIC (any such entity, a “Lower-tier PFIC”), U.S. Holders will be deemed to own a proportionate amount (by value) of the shares of each Lower-tier PFIC and will be subject to U.S. federal income tax according to the rules described in the next paragraph on (i) certain distributions by a Lower-tier PFIC and (ii) dispositions of shares of Lower-tier PFICs, in each case as if the U.S. Holders held such shares directly, even though the U.S. Holder did not receive any proceeds of those distributions or dispositions.

If we are a PFIC for any taxable year during which a U.S. Holder owns ADSs or Class A ordinary shares, and unless the mark-to-market election described in the subsequent paragraph applies, gain recognized by such U.S. Holder on a sale or other disposition (including certain pledges) of its ADSs or Class A ordinary shares will be allocated ratably over its holding period. The amounts allocated to the taxable year of the sale or disposition and to any year before we became a PFIC will be taxed as ordinary income. The amount allocated to each other taxable year will be subject to tax at the highest rate in effect for individuals or corporations, as appropriate, for that taxable year, and an interest charge will be imposed on the resulting tax liability for each such year. Furthermore, to the extent that distributions received by a U.S. Holder in any taxable year on its ADSs or Class A ordinary shares exceed 125% of the average of the annual distributions on the ADSs or Class A ordinary shares received during the preceding three taxable years or the U.S. Holder’s holding period, whichever is shorter, such excess distributions will be subject to taxation in the same manner. If we are a PFIC for any taxable year during which a U.S. Holder owns ADSs or Class A ordinary shares, we will continue to be treated as a PFIC with respect to the U.S. Holder for all succeeding years during which the U.S. Holder owns the ADSs or Class A ordinary shares, even if we cease to meet the threshold requirements for PFIC status, unless the U.S. Holder makes a timely “deemed sale” election, in which case any gain on the deemed sale will be taxed under the PFIC rules described above. U.S. Holders should consult their tax advisers regarding the advisability of making a deemed sale election in the event that we are a PFIC for any taxable year and cease to be a PFIC thereafter.

 

119


Table of Contents

Alternatively, if we are a PFIC and if the ADSs are “regularly traded” on a “qualified exchange,” a U.S. Holder of ADSs may be able to make a mark-to-market election that would result in tax treatment different from the general tax treatment for PFICs described in the preceding paragraph. The ADSs will be treated as regularly traded for any calendar year in which more than a de minimis quantity of the ADSs are traded on a qualified exchange on at least 15 days during each calendar quarter. The NYSE, where the ADSs are listed, is a qualified exchange for this purpose, but there is no assurance that our ADSs will be regularly traded. If a U.S. Holder of ADSs makes the mark-to-market election, the U.S. Holder will recognize as ordinary income any excess of the fair market value of the ADSs at the end of each taxable year over their adjusted tax basis, and will recognize an ordinary loss in respect of any excess of the adjusted tax basis of the ADSs over their fair market value at the end of the taxable year to the extent of the net amount of income previously included as a result of the mark-to-market election. If a U.S. Holder makes the election, the U.S. Holder’s tax basis in the ADSs will be adjusted to reflect the income or loss amounts recognized. Any gain recognized on the sale or other disposition of ADSs in a year in which we are a PFIC will be treated as ordinary income and any loss will be treated as an ordinary loss (but only to the extent of the net amount of income previously included as a result of the mark-to-market election, with any excess treated as capital loss). If a U.S. Holder makes the mark-to-market election, distributions paid on ADSs will be treated as discussed under “—Taxation of Distributions” below. U.S. Holders should consult their tax advisers regarding the availability and advisability of making a mark-to-market election in their particular circumstances. In particular, U.S. Holders should consider carefully the impact of a mark-to-market election with respect to their ADSs given that we may have Lower-tier PFICs, and there is no provision in the Code, Treasury regulations or other official guidance that would permit U.S. Holders to make a mark-to-market election with respect to any Lower-tier PFIC, the shares of which are not regularly traded. Therefore, if we are a PFIC for any taxable year, a U.S. Holder could be subject to the general PFIC rules described in the preceding paragraph with respect to any Lower-tier PFIC, even if the U.S. Holder makes a mark-to-market election with respect to us. A mark-to-market election will not be available for Class A ordinary shares unless they are regularly traded on a qualified exchange. Our Class A ordinary shares currently are not listed on any exchange and therefore, if our ADSs are delisted from trading on the NYSE, a mark-to-market election will not be available.

If we are a PFIC (or with respect to a particular U.S. Holder are treated as a PFIC) for a taxable year of ours in which we pay a dividend or for the prior taxable year, the favorable tax rate described above with respect to dividends paid to certain non-corporate U.S. Holders will not apply.

We do not intend to provide information necessary for U.S. Holders to make qualified electing fund elections which, if available, would result in tax treatment different from the general tax treatment for PFICs described above.

If we are a PFIC for any taxable year during which a U.S. Holder owns any ADSs or Class A ordinary shares, subject to certain limited exceptions set forth in applicable Treasury regulations the U.S. Holder will be required to file annual reports with the Internal Revenue Service. U.S. Holders should consult their tax advisers regarding the determination of whether we are a PFIC for any taxable year and the potential application of the PFIC rules to their ownership of ADSs or Class A ordinary shares.

Taxation of Distributions

The following is subject to the discussion under “—Passive Foreign Investment Company Rules” above.

Distributions paid on the ADSs or Class A ordinary shares, other than certain pro rata distributions of ADSs or Class A ordinary shares, will be treated as dividends to the extent paid out of our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Because we do not maintain calculations of our earnings and profits under U.S. federal income tax principles, it is expected that distributions will be reported by financial intermediaries to U.S. Holders as dividends. Dividends will not be eligible for the dividends-received deduction generally available to U.S. corporations under the Code. Subject to applicable limitations, dividends paid on our ADSs to certain non-corporate U.S. Holders may be taxable at a favorable rate, provided that we are not a PFIC for our taxable year in which the dividend is paid or the preceding taxable year. Furthermore, assuming we are not entitled to the benefits of the Treaty (which is the position we have taken), the favorable tax rate will not apply if our ADSs are delisted from trading on the NYSE. Non-corporate U.S. Holders should consult their tax advisers to determine whether the favorable rate may apply to dividends, if any, and whether they are subject to any special rules that limit their ability to be taxed at this favorable rate.

Dividends will be included in a U.S. Holder’s income on the date of the U.S. Holder’s, or in the case of ADSs, the depositary’s, receipt. The amount of any dividend income paid in non-U.S. currency will be the U.S. dollar amount calculated by reference to the spot rate in effect on the date of receipt, regardless of whether the payment is in fact converted into U.S. dollars. If the dividend is converted into U.S. dollars on the date of receipt, a U.S. Holder should not be required to recognize foreign currency gain or loss in respect of the amount received. A U.S. Holder may have foreign currency gain or loss if the dividend is converted into U.S. dollars after the date of receipt.

 

120


Table of Contents

Dividends will be treated as foreign-source income for foreign tax credit purposes. As described in “—People’s Republic of China Taxation,” dividends paid by us may be subject to PRC withholding tax. For U.S. federal income tax purposes, the amount of the dividend income will include any amounts withheld in respect of PRC withholding tax. Subject to applicable limitations, which vary depending upon the U.S. Holder’s circumstances, and the discussion below regarding certain Treasury regulations, PRC taxes withheld from dividend payments (at a rate not exceeding any applicable Treaty rate) will be creditable against a U.S. Holder’s U.S. federal income tax liability. The rules governing foreign tax credits are complex. For example, Treasury regulations provide that, in the absence of an election to apply the benefits of an applicable income tax treaty, in order for foreign income taxes to the creditable, the relevant foreign income tax rules must be consistent with certain U.S. federal income tax principles, and we have not determined whether the PRC income tax system meets these requirements. U.S. Holders should consult their tax advisers regarding the creditability of foreign taxes in their particular circumstances. In lieu of claiming a credit, a U.S. Holder may elect to deduct creditable PRC taxes in computing its taxable income, subject to applicable limitations. An election to deduct foreign taxes instead of claiming foreign tax credits applies to all creditable foreign taxes paid or accrued in the relevant taxable year.

Sale or Other Taxable Disposition of ADSs or Class A Ordinary Shares

The following is subject to the discussion under “—Passive Foreign Investment Company Rules” above.

A U.S. Holder will recognize capital gain or loss on a sale or other taxable disposition of ADSs or Class A ordinary shares in an amount equal to the difference between the amount realized on the sale or disposition and the U.S. Holder’s tax basis in the ADSs or Class A ordinary shares disposed of, in each case as determined in U.S. dollars. Such gain or loss will be long-term capital gain or loss if at the time of the sale or disposition the U.S. Holder has owned the ADSs or Class A ordinary shares for more than one year. Long-term capital gains recognized by non-corporate U.S. Holders are subject to tax rates that are lower than those applicable to ordinary income. The deductibility of capital losses is subject to limitations.

As described in “—People’s Republic of China Taxation”, gains on the sale of ADSs or Class A ordinary shares may be subject to PRC taxes. Under the Code, capital gains of U.S. persons are generally treated as U.S. source income. However, a U.S. Holder that is eligible for Treaty benefits may be able to elect to treat the gain as foreign-source income under the Treaty and claim foreign tax credit in respect of any PRC tax on dispositions. Under certain Treasury regulations, a U.S. Holder generally will be precluded from claiming a foreign tax credit with respect to PRC income taxes on gains from dispositions of ADSs or Class A ordinary shares if the U.S. Holder unless the U.S. Holder is eligible for Treaty benefits and elects to apply them. However, if a U.S. Holder is so precluded from claiming a foreign tax credit, it is possible that any PRC taxes on disposition gains may either be deductible or reduce the amount realized on the disposition. The rules governing foreign tax credits and deductibility of foreign taxes are complex. U.S. Holders should consult their tax advisers regarding the consequences of the imposition of any PRC tax on disposition gains, including the Treaty’s resourcing rule, the eligibility for the benefits of the Treaty in the U.S. Holders’ circumstances, the obligation to report a Treaty-based return position and any limitation on the creditability or deductibility of any PRC tax on disposition gains in their particular circumstances.

Information Reporting and Backup Withholding

Payments of dividends and sales proceeds that are made within the United States or through certain U.S.-related financial intermediaries may be subject to information reporting and backup withholding, unless (i) the U.S. Holder is a corporation or other “exempt recipient” and (ii) in the case of backup withholding, the U.S. Holder provides a correct taxpayer identification number and certifies that it is not subject to backup withholding. The amount of any backup withholding from a payment to a U.S. Holder will be allowed as a credit against its U.S. federal income tax liability and may entitle it to a refund, provided that the required information is timely furnished to the Internal Revenue Service.

Certain U.S. Holders who are individuals (or certain specified entities) may be required to report information relating to their ownership of Class A ordinary shares or non-U.S. accounts through which ADSs or Class A ordinary shares are held. U.S. Holders should consult their tax advisers regarding their reporting obligations with respect to ADSs and Class A ordinary shares.

10.F. Dividends and Paying Agents

Not applicable.

10.G. Statement by Experts

Not applicable.

10.H. Documents on Display

We previously filed with the SEC a registration statement on Form F-1 (File No. 333-248641), as amended, to register our Class A ordinary shares in relation to our initial public offering, and filed with the SEC a registration statement on Form F-3 (File No. 333-267919) to register certain securities with respect to any follow-on offering. We also filed with the SEC a related registration statement on Form F-6 (File No. 333-248968) to register our ADSs and registration statements on Form S-8 (File Nos. 333-256675 and 333-265313) to register our securities to be issued under our Amended and Restated 2018 Global Share Plan.

 

121


Table of Contents

We are subject to the periodic reporting and other informational requirements of the Exchange Act as applicable to foreign private issuers. Under the Exchange Act, we are required to file reports and other information with the SEC. Specifically, we are required to file annually a Form 20-F within four months after the end of each fiscal year. We have filed this annual report on Form 20-F, including exhibits, with the SEC. As allowed by the SEC, we incorporate by reference certain information we filed with the SEC. This means that we can disclose important information to you by referring you to another document filed separately with the SEC. The information incorporated by reference is considered to be part of this annual report.

All information filed with the SEC can be obtained over the internet at the SEC’s website at www.sec.gov or inspected and copied at the public reference facilities maintained by the SEC at 100 F Street, N.E., Washington, D.C. 20549. You can request copies of documents, upon payment of a duplicating fee, by writing to the SEC.

As a foreign private issuer, we are exempt from the rules of the Exchange Act prescribing the furnishing and content of quarterly reports and proxy statements, and our executive officers, directors and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act. In addition, we are not required under the Exchange Act to file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act. However, we will furnish The Bank of New York Mellon, the depositary of our ADSs, with our annual reports, which will include a review of operations and annual audited consolidated financial statements prepared in conformity with U.S. GAAP, and all notices of shareholders’ meetings and other reports and communications that are made generally available to our shareholders. The depositary will make such notices, reports and communications available to holders of ADSs and, upon our request, will mail to all record holders of ADSs the information contained in any notice of a shareholders’ meeting received by the depositary from us.

10.I Subsidiary information

Not applicable.

 

ITEM 11.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Foreign exchange risk

Foreign currency exchange rate risk

The depreciation of RMB against US$ was approximately 2.3% and 2.3% in 2021 and 2022, respectively. The appreciation of RMB against US$ was approximately 8.5% in 2023. It is difficult to predict how market forces or the PRC or the U.S. government policy may impact the exchange rate between RMB and US$ in the future.

To the extent that we need to convert U.S. dollars into RMB for our operations, appreciation of RMB against the U.S. dollar would reduce the RMB amount we receive from the conversion. Conversely, if we decide to convert RMB into U.S. dollars for the purpose of making payments for dividends on our ordinary shares or ADSs, servicing our outstanding debt, or for other business purposes, appreciation of the U.S. dollar against the RMB would reduce the U.S. dollar amounts available to us.

As of March 31, 2023, we had RMB-denominated cash and cash equivalents of RMB27.1 million (US$3.9 million). A 10% depreciation of RMB against U.S. dollar based on the foreign exchange rate on March 31, 2023 would result in a decrease of US$0.4 million in cash and cash equivalents. A 10% appreciation of RMB against U.S. dollar based on the foreign exchange rate on March 31, 2023 would result in an increase of US$0.4 million in cash and cash equivalents.

Interest rate risk

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. Our interest rate risk arises primarily from long-term borrowings. As of March 31, 2023, we had not obtained long-term bank borrowings. Borrowings issued at variable rates and fixed rates expose us to cash flow interest rate risk and fair value interest rate risk respectively. We have not been exposed to material risks due to changes in interest rates, and we have not used any derivative financial instruments to manage our interest risk exposure.

Concentration of credit risk

Financial instruments that potentially subject us to the concentration of credit risks consist of cash and cash equivalents, short-term investment, accounts receivable and amounts due from related parties. The maximum exposures of such assets to credit risk is their carrying amounts as of the balance sheet dates. We deposit our cash and cash equivalents and short-term investment with financial institutions located in jurisdictions where the subsidiaries are located. We believe that no significant credit risk exists as these financial institutions have high credit quality.

 

122


Table of Contents

Accounts receivable are typically unsecured and are derived from revenue earned through third-party consumers. We conduct credit evaluations of third-party customers and related parties, and generally do not require collateral or other security from its third-party customers and related parties. We establish an allowance for doubtful accounts primarily based upon the age of the receivables and factors surrounding the credit risk of specific third-party customers and related parties.

Concentration of customers and suppliers

Substantially all revenue was derived from customers located in China. There are no customers from whom revenues individually represent greater than 10% of our total revenues in any of the periods presented. Royal Canin China Co., Ltd. contributed to 19%, 17% and 22% of our total purchases as for the fiscal year ended March 31, 2021, 2022 and 2023, respectively.

Inflation risk

Since our inception, inflation in China has not materially impacted our results of operations. According to the National Bureau of Statistics of China, the year-over-year percent changes in the consumer price index for March 2021, 2022 and 2023 were increases of 0.4%, 1.5%, and 0.7% respectively. Although we have not in the past been materially affected by inflation since our inception, we can provide no assurance that we will not be affected in the future by higher rates of inflation in China.

 

ITEM 12.

DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES

12.A. Debt Securities

Not applicable.

12.B. Warrants and Rights

Not applicable.

12.C. Other Securities

Not applicable.

12.D. American Depositary Shares

Fees and Expenses

Pursuant to the terms of the deposit agreement, as an ADS holder, you will be required to pay the following service fees to the depositary bank and certain taxes and governmental charges (in addition to any applicable fees, expenses, taxes and other governmental charges payable on the deposited securities represented by any of your ADSs):

 

Persons depositing or withdrawing shares or ADS holders must pay:

  

For:

$5.00 (or less) per 100 ADSs (or portion of 100 ADSs)    Issuance of ADSs, including issuances resulting from a distribution of shares or rights or other property Cancellation of ADSs for the purpose of withdrawal, including if the deposit agreement terminates
$.05 (or less) per ADS    Any cash distribution to ADS holders
A fee equivalent to the fee that would be payable if securities distributed to you had been shares and the shares had been deposited for issuance of ADSs    Distribution of securities distributed to holders of deposited securities (including rights) that are distributed by the depositary to ADS holders
$.05 (or less) per ADS per calendar year    Depositary services
Registration or transfer fees    Transfer and registration of shares on our share register to or from the name of the depositary or its agent when you deposit or withdraw shares
Expenses of the depositary    Cable (including SWIFT) and facsimile transmissions (when expressly provided in the deposit agreement) Converting foreign currency to U.S. dollars
Taxes and other governmental charges the depositary or the custodian has to pay on any ADSs or shares underlying ADSs, such as stock transfer taxes, stamp duty or withholding taxes    As necessary
Any charges incurred by the depositary or its agents for servicing the deposited securities    As necessary

 

123


Table of Contents

The depositary collects its fees for delivery and surrender of ADSs directly from investors depositing shares or surrendering ADSs for the purpose of withdrawal or from intermediaries acting for them. The depositary collects fees for making distributions to investors by deducting those fees from the amounts distributed or by selling a portion of distributable property to pay the fees. The depositary may collect its annual fee for depositary services by deduction from cash distributions or by directly billing investors or by charging the book-entry system accounts of participants acting for them. The depositary may collect any of its fees by deduction from any cash distribution payable (or by selling a portion of securities or other property distributable) to ADS holders that are obligated to pay those fees. The depositary may generally refuse to provide fee-attracting services until its fees for those services are paid.

From time to time, the depositary may make payments to us to reimburse us for costs and expenses generally arising out of establishment and maintenance of the ADS program, waive fees and expenses for services provided to us by the depositary or share revenue from the fees collected from ADS holders. In performing its duties under the deposit agreement, the depositary may use brokers, dealers, foreign currency dealers or other service providers that are owned by or affiliated with the depositary and that may earn or share fees, spreads or commissions. In the fiscal year ended March 31, 2023, we did not receive any reimbursement from The Bank of New York Mellon for the expenses incurred in connection with our ADR program.

The depositary may convert currency itself or through any of its affiliates, or the custodian or we may convert currency and pay U.S. dollars to the depositary. Where the depositary converts currency itself or through any of its affiliates, the depositary acts as principal for its own account and not as agent, advisor, broker or fiduciary on behalf of any other person and earns revenue, including, without limitation, transaction spreads, that it will retain for its own account. The revenue is based on, among other things, the difference between the exchange rate assigned to the currency conversion made under the deposit agreement and the rate that the depositary or its affiliate receives when buying or selling foreign currency for its own account. The depositary makes no representation that the exchange rate used or obtained by it or its affiliate in any currency conversion under the deposit agreement will be the most favorable rate that could be obtained at the time or that the method by which that rate will be determined will be the most favorable to ADS holders, subject to the depositary’s obligation to act without negligence or bad faith. The methodology used to determine exchange rates used in currency conversions made by the depositary is available upon request. Where the custodian converts currency, the custodian has no obligation to obtain the most favorable rate that could be obtained at the time or to ensure that the method by which that rate will be determined will be the most favorable to ADS holders, and the depositary makes no representation that the rate is the most favorable rate and will not be liable for any direct or indirect losses associated with the rate. In certain instances, the depositary may receive dividends or other distributions from us in U.S. dollars that represent the proceeds of a conversion of foreign currency or translation from foreign currency at a rate that was obtained or determined by us and, in such cases, the depositary will not engage in, or be responsible for, any foreign currency transactions and neither it nor we make any representation that the rate obtained or determined by us is the most favorable rate and neither it nor we will be liable for any direct or indirect losses associated with the rate.

PART II

 

ITEM 13.

ITEM DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES

None.

 

ITEM 14.

MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS

14.A. – 14.D. Material Modifications to the Rights of Security Holders

See “Item 10. Additional Information” for a description of the rights of shareholders, which remain unchanged.

14.E. Use of Proceeds

The following “Use of Proceeds” information relates to the registration statement on Form F-1, as amended (File No. 333-248641), or the F-1 Registration Statement, in relation to our initial public offering of 7,000,000 ADSs representing 5,250,000 Class A ordinary shares, at an initial offering price of US$10.0 per ADS. Roth Capital Partners, LLC was the representative of the underwriters.

The F-1 Registration Statement was declared effective on September 29, 2020. For the period from the effective date of the F-1 Registration Statement to March 31, 2023, the total expenses incurred for our company’s account in connection with our IPO was approximately US$12.8 million, which included US$4.9 million in underwriting discounts and commissions for the IPO and approximately US$7.9 million in other costs and expenses for our initial public offering. None of the transaction expenses included direct or indirect payments to directors or officers of our company or their associates, persons owning more than 10% or more of our equity securities or our affiliates or others.

 

124


Table of Contents

Our initial public offering was closed on October 2, 2020. We received an aggregate net proceeds of approximately US$65.1 million from our initial public offering. For the period from the effective date of the F-1 Registration Statement to March 31, 2023, we have used US$60.7 million to invest in content innovation, membership system development and research and development (including big data technology), develop and market our private label brands, improve our fulfillment and warehousing capabilities and seek for potential merger and acquisition opportunities. We still intend to use the remainder of the proceeds from our initial public offering as disclosed in our registration statements on Form F-1. None of these net proceeds from our initial public offering and the optional offering was paid, directly or indirectly, to any of our directors or officers or their associates, persons owning 10% or more of our equity securities or our affiliates or others.

 

ITEM 15.

CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has performed an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this report, as required by Rule 13a-15(b) under the Exchange Act.

Based upon that evaluation, our management has concluded that, as of March 31, 2023, due to the outstanding material weaknesses described below, our disclosure controls and procedures were not effective. We started to undertake steps to remediate the material weaknesses in our disclosure controls and procedures as set forth below under “Internal Control over Financial Reporting.”

Internal Control Over Financial Reporting

In preparing our consolidated financial statements for the fiscal year ended March 31, 2019, we and our independent registered public accounting firm identified two material weaknesses in our internal control over financial reporting. As defined in the standards established by the PCAOB, a“material weakness” is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis.

The material weaknesses identified are (i) our company’s lack of sufficient and competent financial reporting and accounting personnel with appropriate knowledge of U.S. GAAP and SEC reporting and compliance requirements, and (ii) lack of sufficient documented financial closing policies and procedures, specifically those related to period end logistics expenses cut-off and accruals and vendor rebate accruals.

We are in the process of implementing a number of measures to address these material weaknesses identified, including: (i) hiring more qualified resources, equipped with relevant U.S. GAAP and SEC reporting experiences and qualifications to strengthen the financial reporting function and to set up financial and system control framework, (ii) implementing regular and continuous U.S. GAAP accounting and financial reporting training programs for accounting and financial reporting personnel, (iii) establishing effective oversight and clarifying reporting requirements for non-recurring and complex transactions to ensure consolidated financial statements and related disclosures are accurate, complete and in compliance with U.S. GAAP and SEC reporting requirements, and (iv) continuing to enhance accounting policies and closing procedures to improve the quality and accuracy of our period end financing closing process with respect to the preparation of U.S. GAAP financial statements.

The process of designing and implementing an effective financial reporting system is a continuous effort that requires us to anticipate and react to changes in our business and the economic and regulatory environments and to expend significant resources to maintain a financial reporting system that is adequate to satisfy our reporting obligation. See “Item 3. Key Information—3.D. Risk Factors—Risks Relating to Our Business and Industry—If we fail to implement and maintain an effective system of internal controls to remediate our material weaknesses over financial reporting, we may be unable to accurately report our results of operations, meet our reporting obligations or prevent fraud, and investor confidence and the market price of ADSs may be materially and adversely affected.”

As a company with less than US$1.235 billion in revenue for our last fiscal year, we qualify as an “emerging growth company” pursuant to the JOBS Act. An emerging growth company may take advantage of specified reduced reporting and other requirements that are otherwise applicable generally to public companies. These provisions include exemption from the auditor attestation requirement under Section 404 of the Sarbanes-Oxley Act of 2002 in the assessment of the emerging growth company’s internal control over financial reporting. The JOBS Act also provides that an emerging growth company does not need to comply with any new or revised financial accounting standards until such date that a private company is otherwise required to comply with such new or revised accounting standards. We have elected to take advantage of such exemptions.

 

125


Table of Contents

Management’s Annual Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) and 15d-15(f) under the Exchange Act. Our management evaluated the effectiveness of our internal control over financial reporting, as required by Rule 13a-15(c) of the Exchange Act, based on criteria established in the framework in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, our management has concluded that our internal control over financial reporting was not effective as of March 31, 2023 due to material weaknesses identified in our internal control over financial reporting as described above.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. In addition, projections of any evaluation of effectiveness of our internal control over financial reporting to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies and procedures may deteriorate.

Attestation Report of the Registered Public Accounting Firm

Since we are an “emerging growth company” as defined under the JOBS Act, we are exempt from the requirement to comply with the auditor attestation requirements that our independent registered public accounting firm attest to and report on the effectiveness of our internal control over financial reporting.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the period covered by this annual report on Form 20-F that have materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.

 

ITEM 16.A.

AUDIT COMMITTEE FINANCIAL EXPERT

Our audit committee consists of Mr. Dong Li and Mr. Su Zhang. Mr. Dong Li is the chairman of our audit committee. We have determined that each of Mr. Dong Li and Mr. Su Zhang satisfies the “independence” requirements of Section 303A of the Corporate Governance Rules of the NYSE and Rule 10A-3 under the Exchange Act. We have determined that Mr. Dong Li qualifies as an “audit committee financial expert.”

 

ITEM 16.B.

CODE OF ETHICS

Our board of directors has adopted a code of business conduct and ethics that applies to all of our directors, officers, employees, including certain provisions that specifically apply to our principal executive officer, principal financial officer, principal accounting officer or controller and any other persons who perform similar functions for us. We have filed our code of business conduct and ethics as Exhibit 99.1 of our registration statement on Form F-1, as amended (File No. 333-248641), initially filed with the SEC on September 8, 2020, and posted a copy of our code of business conduct and ethics on our website at www.ir.boqii.com. We hereby undertake to provide to any person without charge, a copy of our code of business conduct and ethics within ten working days after we receive such person’s written request.

 

ITEM 16.C.

PRINCIPAL ACCOUNTANT FEES AND SERVICES

The following table sets forth the aggregate fees by categories specified below in connection with certain professional services rendered by PricewaterhouseCoopers Zhong Tian LLP, our independent registered public accounting firm, for the periods indicated.

 

     Fiscal Year Ended March 31,  
     2022      2023  
    

   RMB   

    

   RMB   

    

   US$   

 
     (in thousands)  

Audit Fees(1)

     5,300        3,800        553  
  

 

 

    

 

 

    

 

 

 

Total

     5,300        3,800        553  
  

 

 

    

 

 

    

 

 

 

 

Notes:

 

(1)

Audit Fees. Audit fees mean the aggregate fees billed in each of the fiscal periods listed for professional services rendered by our principal auditors for the audit of our annual consolidated financial statements and assistance with and review of documents filed with the SEC.

 

126


Table of Contents

The policy of our audit committee is to preapprove all audit and non-audit services provided by PricewaterhouseCoopers Zhong Tian LLP, our independent registered public accounting firm, including audit services and audit-related services as described above, other than those for de minimis services which are approved by the audit committee prior to the completion of the audit.

 

ITEM 16.D.

EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES

Not applicable.

 

ITEM 16.E.

PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS

Not applicable.

 

ITEM 16.F.

CHANGE IN REGISTRANT’S CERTIFYING ACCOUNTANT

Not applicable.

 

ITEM 16.G.

CORPORATE GOVERNANCE

We are a “foreign private issuer” (as such term is defined in Rule 3b-4 under the Exchange Act), and our ADSs, each representing 4.5 Class A ordinary shares, are listed on the NYSE. We are therefore required to comply with certain of the NYSE’s corporate governance listing standards, or the NYSE Standards. As a foreign private issuer, we are permitted to follow home country practice in lieu of NYSE Standards with limited exceptions.

Our corporate governance practices differ in certain significant respects from those that U.S. companies must adopt in order to maintain NYSE listing and, in accordance with Section 303A.11 of the NYSE Listed Company Manual, a brief, general summary of those differences is provided as follows.

Director independence

The NYSE Standards require a majority of the membership of NYSE-listed company boards to be composed of independent directors, which is not required under Cayman Islands law, the law of our country of incorporation. As of the date of this annual report, our board of directors consists of four members, two of whom are independent directors.

Non-management directors’ executive sessions

The NYSE Standards require non-management directors of NYSE-listed companies to meet at regularly scheduled executive sessions without management. We are not subject to this requirement under the Cayman Islands law.

Committee member composition

Nominating/Corporate Governance Committee; Compensation Committee

The NYSE Standards require NYSE-listed companies to have a nominating/corporate governance committee and a compensation committee that are composed entirely of independent directors. Cayman Islands law does not impose similar requirements. As of the date of this annual report, our corporate governance and nominating committee consists of two members, only one of whom is an independent director. As of the same date, our compensation committee consists of three members, only one of whom is an independent director.

Audit Committee

The NYSE Standards require NYSE-listed companies to have an audit committee with a minimum of three members, all of whom are independent. Cayman Islands law does not impose similar requirements. As of the date of this annual report, our audit committee only consists of two members, who are all independent directors.

Shareholder approval

The NYSE Standards require NYSE-listed companies to obtain shareholder approval prior to an issuance of securities in any transaction or series of related transactions under Section 312.03 of the NYSE Listed Company Manual. Cayman Islands law does not require shareholder approval prior to an issuance of securities to the extent the securities are authorized. We intend to rely on the foreign private issuer exemption with respect to the forgoing shareholder approval requirements under the NYSE Listed Company Manual.

 

ITEM 16.H.

MINE SAFETY DISCLOSURE

Not applicable.

 

127


Table of Contents
ITEM 16.I.

DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

On August 22, 2022, we were conclusively identified by the SEC under the HFCAA as having filed audit reports issued by a registered public accounting firm that cannot be inspected or investigated completely by the PCAOB in connection with our filing of our annual report on Form 20-F for the fiscal year ended March 31, 2022.

As of the date of this annual report, we and our consolidated operating entities, including the VIEs, are incorporated or otherwise organized in the Cayman Islands, British Virgin Islands, mainland China and Hong Kong.

To our best knowledge, none of our shares or the shares of our operating entities are owned by governmental entities in the jurisdiction in which we or such operating entities are incorporated or otherwise organized.

To our best knowledge, governmental entities in mainland China do not have any controlling financial interest with respect to us or any of our operating entities.

With respect to the members of the board of directors of our company or any of our consolidated foreign operating entities (each a “board member”), taking into consideration of each board member’s current or prior memberships on, or affiliations, with committees of the Chinese Communist Party, to the extent such information is known to our company, none of such board member is any official of the Chinese Communist Party.

Neither the memorandum and articles of association of our company nor the articles of incorporation (or equivalent organizing document) of our consolidated foreign operating entities contains any charter of the Chinese Communist Party.

On December 15, 2022, the PCAOB announced that it was able to conduct inspections and investigations completely of PCAOB-registered public accounting firms headquartered in mainland China and Hong Kong in 2022. The PCAOB vacated its previous 2021 determinations accordingly. As a result, we do not expect to be identified as a “Commission-Identified Issuer” under the HFCAA for the fiscal year ended March 31, 2023 after we file our annual report on Form 20-F for such fiscal year.

We have not relied upon any legal opinions or third-party certifications, such as affidavits, as the basis for our disclosure under this Item 16.I.

 

ITEM 16.J.

Insider Trading Policies

Not applicable.

PART III

 

ITEM 17.

FINANCIAL STATEMENTS

We have elected to provide financial statements pursuant to Item 18.

 

ITEM 18.

FINANCIAL STATEMENTS

The consolidated financial statements of Boqii Holding Limited are included at the end of this annual report.

 

128


Table of Contents
ITEM 19.

EXHIBITS

 

Exhibit
Number
  

Description of Document

    1.1    Twelfth Amended and Restated Memorandum and Articles of Association of the Registrant (incorporated herein by reference to Exhibit 3.2 to our registration statement on Form F-1 (File No. 333-248641), as amended, initially filed with the SEC on September 8, 2020)
    2.1    Form of Registrant’s Specimen American Depositary Receipt (incorporated by reference to Exhibit 4.3 to our registration statement on Form F-1 (File No. 333-248641), as amended, initially filed with the SEC on September 8, 2020)
    2.2    Registrant’s Specimen Certificate for Class A Ordinary Shares (incorporated by reference to Exhibit 4.2 to our registration statement on Form F-1 (File No. 333-248641), as amended, initially filed with the SEC on September 8, 2020)
    2.3    Form of Deposit Agreement among the Registrant, the depositary and owners of the American Depositary Shares (incorporated by reference to Exhibit 4.3 to our registration statement on Form F-1 (File No. 333-248641), as amended, initially filed with the SEC on September 8, 2020)
    2.4*    Description of Securities registered under Section 12 of the Exchange Act
    4.1    The Amended and Restated 2018 Global Share Plan (incorporated by reference to Exhibit 10.1 to our registration statement on Form S-8 (File No. 333-265313), as amended, initially filed with the SEC on May 31, 2022)
    4.2    Form of Indemnification Agreement with the Registrant’s directors and executive officers (incorporated by reference to Exhibit 10.2 to our registration statement on Form F-1 (File No. 333-248641), as amended, initially filed with the SEC on September 8, 2020)
    4.3    Form of Employment Agreement between the Registrant and a director or executive officer of the Registrant (incorporated by reference to Exhibit 10.3 to our registration statement on Form F-1 (File No. 333-248641), as amended, initially filed with the SEC on September 8, 2020)
    4.4    Tenth Amended and Restated Warrant Holders and Shareholders Agreement by and among the Registrant, its ordinary shareholder, preferred shareholders and other parties named therein dated August 19, 2020 (incorporated by reference to Exhibit 10.4 to our registration statement on Form F-1 (File No. 333-248641), as amended, initially filed with the SEC on September 8, 2020)
    4.5    English translation of Equity Pledge Agreement entered on October 16, 2019, by and between Shanghai Xincheng, Shanghai Guangcheng, and then shareholders of Shanghai Guangcheng (incorporated by reference to Exhibit 10.8 to our registration statement on Form F-1 (File No. 333-248641), as amended, initially filed with the SEC on September 8, 2020)
    4.6    English translation of Equity Pledge Agreement entered on August 4, 2020 by and between Shanghai Xincheng, Shanghai Guangcheng, and Shanghai Chelin Information Technology Center (Limited Partnership), and then shareholders of Shanghai Guangcheng (incorporated by reference to Exhibit 10.9 to our registration statement on Form F-1 (File No. 333-248641), as amended, initially filed with the SEC on September 8, 2020)
    4.7    English translation of Exclusive Call Option Agreement entered on August 4, 2020, by and between Shanghai Xincheng, Shanghai Guangcheng and then shareholders of Shanghai Guangcheng (incorporated by reference to Exhibit 10.10 to our registration statement on Form F-1 (File No. 333-248641), as amended, initially filed with the SEC on September 8, 2020)
    4.8    English translation of Exclusive Technical Consulting and Service Agreement entered into on August 4, 2020 by and between Shanghai Xincheng and Shanghai Guangcheng (incorporated by reference to Exhibit 10.5 to our registration statement on Form F-1 (File No. 333-248641), as amended, initially filed with the SEC on September 8, 2020)
    4.9    English translation of Intellectual Property License Agreement entered into on August 4, 2020 by and between Shanghai Xincheng and Shanghai Guangcheng (incorporated by reference to Exhibit 10.6 to our registration statement on Form F-1 (File No. 333-248641), as amended, initially filed with the SEC on September 8, 2020)
    4.10    English translation of Shareholders’ Voting Rights Proxy Agreement entered into on August 4, 2020, by and among Shanghai Xincheng, Shanghai Guangcheng, and then shareholders of Shanghai Guangcheng (incorporated by reference to Exhibit 10.7 to our registration statement on Form F-1 (File No. 333-248641), as amended, initially filed with the SEC on September 8, 2020)
    4.11    English translation of Shareholders’ Voting Rights Proxy Agreement entered into on September 26, 2019, by and among Xingmu WFOE, Nanjing Xingmu, and certain shareholders of Nanjing Xingmu (incorporated by reference to Exhibit 10.14 to our registration statement on Form F-1, File No. 333-248641), as amended, initially filed with the SEC on September 8, 2020)
    4.12    English translation of Equity Pledge Agreement entered on September 26, 2019, by and between Xingmu WFOE, Nanjing Xingmu, and certain shareholders of Nanjing Xingmu (incorporated by reference to Exhibit 10.15 to our registration statement on Form F-1 (File No. 333-248641), as amended, initially filed with the SEC on September 8, 2020)
    4.13    English translation of Exclusive Call Option Agreement entered on September 26, 2019, by and between Xingmu WFOE, Nanjing Xingmu and certain shareholders of Nanjing Xingmu (incorporated by reference to Exhibit 10.16 to our registration statement on Form F-1 (File No. 333-248641), as amended, initially filed with the SEC on September 8, 2020)

 

129


Table of Contents
Exhibit
Number
  

Description of Document

    4.14    English translation of Exclusive Technical Consulting and Service Agreement entered into on September 26, 2019 by and between Xingmu WFOE and Nanjing Xingmu (incorporated by reference to Exhibit 10.12 to our registration statement on Form F-1 (File No. 333-248641), as amended, initially filed with the SEC on September 8, 2020)
    4.15    English translation of Intellectual Property License Agreement entered into on September 26, 2019 by and between Xingmu WFOE and Nanjing Xingmu (incorporated by reference to Exhibit 10.13 to our registration statement on Form F-1 (File No. 333-248641), as amended, initially filed with the SEC on September 8, 2020)
    4.16    English translation of Shareholders’ Voting Rights Proxy Agreement entered into on September 26, 2019, by and among Xingmu WFOE, Nanjing Xingmu, and certain shareholders of Nanjing Xingmu (incorporated by reference to Exhibit 10.14 to our registration statement on Form F-1 (File No. 333-248641), as amended, initially filed with the SEC on September 8, 2020)
    4.17    English translation of Spousal Consent Letter signed by Ms. Jiajia Chen dated September 26, 2019 (incorporated by reference to Exhibit 10.18 to our registration statement on Form F-1 (File No. 333-248641), as amended, initially filed with the SEC on September 8, 2020)
    4.18    English translation of Spousal Consent Letter signed by Ms. Yan Wang dated September 26, 2019 (incorporated by reference to Exhibit 10.19 to our registration statement on Form F-1 (File No. 333-248641), as amended, initially filed with the SEC on September 8, 2020)
    4.19    English translation of Equity Pledge Agreement entered on June 18, 2021, by and between Shanghai Xincheng, Suzhou Taicheng, and certain shareholders of Suzhou Taicheng (incorporated by reference to Exhibit 4.19 to our annual report on Form 20-F for the fiscal year ended March 31, 2022, as amended, initially filed with the SEC on July 27, 2022)
    4.20    English translation of Exclusive Call Option Agreement entered on June 18, 2021, by and between Shanghai Xincheng, Suzhou Taicheng and certain shareholders of Suzhou Taicheng (incorporated by reference to Exhibit 4.20 to our annual report on Form 20-F for the fiscal year ended March 31, 2022, as amended, initially filed with the SEC on July 27, 2022)
    4.21    English translation of Exclusive Technical Consulting and Service Agreement entered into on June 18, 2021 by and between Shanghai Xincheng and Suzhou Taicheng (incorporated by reference to Exhibit 4.21 to our annual report on Form 20-F for the fiscal year ended March 31, 2022, as amended, initially filed with the SEC on July 27, 2022)
    4.22    English translation of Intellectual Property License Agreement entered into on June 18, 2021 by and between Shanghai Xincheng and Suzhou Taicheng (incorporated by reference to Exhibit 4.22 to our annual report on Form 20-F for the fiscal year ended March 31, 2022, as amended, initially filed with the SEC on July 27, 2022)
    4.23    English translation of Shareholders’ Voting Rights Proxy Agreement entered into on June 18, 2021, by and among Shanghai Xincheng, Suzhou Taicheng, and certain shareholders of Suzhou Taicheng (incorporated by reference to Exhibit 4.23 to our annual report on Form 20-F for the fiscal year ended March 31, 2022, as amended, initially filed with the SEC on July 27, 2022)
    4.24    English translation of Supplement Shareholders’ Voting Rights Proxy Agreement entered into on September 25, 2022, by and among Shanghai Xincheng, Shanghai Guangcheng, and the shareholder of Shanghai Guangcheng (incorporated by reference to Exhibit 4.6 to our registration statement on Form F-3 (File No. 333-267919), as amended, initially filed with the SEC on October 18, 2022)
    4.25*    English translation of Equity Pledge Agreement entered into on September 25, 2022, by and among Shanghai Xincheng, Shanghai Guangcheng, and the shareholder of Shanghai Guangcheng
    4.26    English translation of Supplement Exclusive Option Agreement entered into on September 25, 2022, by and among Shanghai Xincheng, Shanghai Guangcheng, and the shareholder of Shanghai Guangcheng (incorporated by reference to Exhibit 4.8 to our registration statement on Form F-3 (File No. 333-267919), as amended, initially filed with the SEC on October 18, 2022)
    4.27    English translation of Supplement Loan Agreement entered into on September 25, 2022, by and between Shanghai Xincheng and the shareholder of Shanghai Guangcheng (incorporated by reference to Exhibit 4.9 to our registration statement on Form F-3 (File No. 333-267919), as amended, initially filed with the SEC on October 18, 2022)
    8.1*    Principal Subsidiaries and VIEs of the Registrant
  11.1    Code of Business Conduct and Ethics of the Registrant (incorporated by reference to Exhibit 99.1 to our registration statement on Form F-1 (File No. 333-248641), as amended, initially filed with the SEC on September 8, 2020)

 

130


Table of Contents
Exhibit
Number
  

Description of Document

  12.1*    Certification by Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
  12.2*    Certification by Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
  13.1**    Certification by Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
  13.2**    Certification by Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
  15.1*    Consent of Maples and Calder (Hong Kong) LLP
  15.2*    Consent of Commerce & Finance Law Offices
  15.3*    Consent of PricewaterhouseCoopers Zhong Tian LLP
  15.4**    Submission under Item 16I(a) of Form 20-F in relation to the Holding Foreign Companies Accountable Act
101.INS*    Inline XBRL Instance Document- the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH*    Inline XBRL Taxonomy Extension Schema Document
101.CAL*    Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*    Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*    Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*    Inline XBRL Taxonomy Extension Presentation Linkbase Document
104    Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

 

*

Filed herewith

**

Furnished herewith

 

131


Table of Contents

SIGNATURES

The registrant hereby certifies that it meets all of the requirements for filing its annual report on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.

 

BOQII HOLDING LIMITED
By:  

/s/ Yingzhi (Lisa) Tang

Name:   Yingzhi (Lisa) Tang
Title:   Director, co-Chief Executive Officer and Chief Financial Officer

Date: July 25, 2023

 

132


Table of Contents
2012-07-312016-08-312019-08-312019-11-302019-11-302012-11-302013-02-282021-09-302012-11-302019-11-302021-06-302022-04-302014-08-312017-06-302017-04-302019-11-30http://fasb.org/us-gaap/2022#DerivativeLiabilitiesCurrenthttp://Boqii.com/20230331#OtherIncomeNet

Report of Independent Registered Public Accounting Firm
To the
Board of Directors and Shareholders of Boqii Holding Limited
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of Boqii Holding Limited and its subsidiaries (the “Company”) as of March 31, 2023 and 2022, and the related consolidated
statements of loss and comprehensive loss, of changes in shareholders’ equity and of cash flows for each of the three years in the period ended March 31, 2023, including the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of March 31, 2023 and 2022, and the results of its operations and its cash flows for each of the three years in the period ended March 31, 2023 in conformity with accounting principles generally accepted in the United States of America.
Basis for Opinion
These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated
financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits of these consolidated
financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated
financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.
/s/ PricewaterhouseCoopers Zhong Tian LLP
Shanghai, the People’s Republic of China
July 25, 2023
We have served as the Company’s auditor since 2020.
 
F-2

BOQII HOLDING LIMITED
CONSOLIDATED BALANCE SHEETS
AS OF MARCH 31, 2022 AND 2023
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
         
As of March 31,
 
    
Note
  
2022
    
2023
 
         
RMB
    
RMB
    
US$
(Note 2(f))
 
ASSETS
           
Current assets:
           
Cash and cash equivalents
   5      162,855        89,850        13,083  
Short-term investments
        128,084        69,797        10,163  
Accounts receivable, net
   6      49,231        76,742        11,175  
Inventories, net
   7      109,921        81,052        11,802  
Prepayments and other current assets
   8      116,738        79,359        11,556  
Amounts due from related parties
   27      11,726        9,379        1,366  
     
 
 
    
 
 
    
 
 
 
Total current assets
        578,555        406,179        59,145  
     
 
 
    
 
 
    
 
 
 
Non-current
assets:
           
Property and equipment, net
   9      7,779        5,492        800  
Intangible assets
   10      25,544        21,594        3,144  
Operating lease
right-of-use
assets
   15      38,567        22,354        3,255  
Long-term investments
   11      82,319        75,607        11,010  
Goodwill
   12      40,684        —          —    
Amounts due from related parties,
non-current
        —          2,988        435  
Other
non-current
asset
   13      4,861        6,586        959  
     
 
 
    
 
 
    
 
 
 
Total
non-current
assets
        199,754        134,621        19,603  
     
 
 
    
 
 
    
 
 
 
Total assets
        778,309        540,800        78,748  
     
 
 
    
 
 
    
 
 
 
LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS’ EQUITY
           
Current liabilities
           
Short-term borrowings (including amounts of the consolidated VIEs and VIEs’ subsidiaries without recourse to the Company of RMB872 and RMB363 as of March 31, 2022 and 2023, respectively)
   22      161,126        86,261        12,561  
Accounts payable (including accounts payable of the consolidated VIEs and VIEs’ subsidiaries without recourse to the Company of RMB55,144 and RMB13,459 as of March 31, 2022 and 2023, respectively)
        94,224        56,022        8,157  
Salary and welfare payable (including amounts of the consolidated VIEs and VIEs’ subsidiaries without recourse to the Company of RMB5,597 and RMB5,573 as of March 31, 2022 and 2023, respectively)
        6,871        6,890        1,003  
Accrued liabilities and other current liabilities (including amounts of the consolidated VIEs and VIEs’ subsidiaries without recourse to the Company of RMB24,417 and RMB15,712 as of March 31, 2022 and 2023, respectively)
   14      27,324        22,104        3,219  
Amounts due to related parties, current (including amounts of the consolidated VIEs and VIEs’ subsidiaries without recourse to the Company of RMB4 and RMB21 as of March 31, 2022 and 2023, respectively)
   28      219        471        69  
Contract liabilities (including amounts of the consolidated VIEs and VIEs’ subsidiaries without recourse to the Company of RMB7,007 and RMB4,471 as of March 31, 2022 and 2023, respectively)
        7,007        4,471        651  
Operating lease liabilities, current (including amounts of the consolidated VIEs and VIEs’ subsidiaries without recourse to the Company of RMB7,238 and RMB9,207 as of March 31, 2022 and 2023, respectively)
   15      10,001        9,220        1,343  
Derivative liabilities (including amounts of the consolidated VIEs and VIEs’ subsidiaries without recourse to the Company of nil as of March 31, 2022 and 2023, respectively)
   22      9,086        10,701        1,558  
     
 
 
    
 
 
    
 
 
 
Total current liabilities
        315,858        196,140        28,561  
     
 
 
    
 
 
    
 
 
 
 
F-3

BOQII HOLDING LIMITED
CONSOLIDATED BALANCE SHEETS  (CONTINUED)
AS OF MARCH 31, 2022 AND 2023
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
         
As of March 31,
 
    
Note
  
2022
   
2023
 
         
RMB
   
RMB
   
US$

(Note 2(f))
 
LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS’ EQUITY (CONTINUED)
         
Non-current
liabilities
         
Deferred tax liabilities (including amounts of the consolidated VIEs and VIEs’ subsidiaries without recourse to the Company of nil as of March 31, 2022 and 2023, respectively)
   18      4,847       4,141       603  
Operating lease liabilities,
non-current
(including amounts of the consolidated VIEs and VIEs’ subsidiaries without recourse to the Company of RMB28,197 and RMB12,741 as of March 31, 2022 and 2023, respectively)
   15      28,197       12,741       1,855  
Other debts,
non-current
(including amounts of the consolidated VIEs and VIEs’ subsidiaries without recourse to the Company of RMB157,874 and RMB 75,481 as of March 31, 2022 and 2023, respectively)
   22      181,062       102,827       14,973  
     
 
 
   
 
 
   
 
 
 
Total
non-current
liabilities
        214,106       119,709       17,431  
     
 
 
   
 
 
   
 
 
 
Total liabilities
        529,964       315,849       45,992  
     
 
 
   
 
 
   
 
 
 
Commitments and contingencies (Note 28)
         
Mezzanine equity:
         
Redeemable
non-controlling
interests
   21      6,522       7,197       1,048  
     
 
 
   
 
 
   
 
 
 
Total mezzanine equity
        6,522       7,197       1,048  
     
 
 
   
 
 
   
 
 
 
Shareholders’ equity:
         
Class A ordinary shares (US$0.001 par value; 129,500,000 shares authorized, 55,709,591 shares issued and outstanding as of March 31, 2022; 129,500,000 shares authorized, 55,763,079 shares issued and outstanding as of March 31, 2023)
   19      372       373       54  
Class B ordinary shares (US$0.001 par value; 15,000,000 shares authorized, 13,037,729 shares issued and outstanding as of March 31, 2022 and March 31, 2023)
   19      82       82       12  
Additional
paid-in
capital
        3,295,336       3,287,696       478,727  
Statutory reserves
        3,433       3,876       564  
Accumulated other comprehensive loss
        (46,069     (37,189     (5,415
Accumulated deficit
        (2,889,233     (2,993,150     (435,836
Receivable for issuance of ordinary shares
   23      (164,746     (83,405     (12,145
     
 
 
   
 
 
   
 
 
 
Total Boqii Holding Limited shareholders’ equity
        199,175       178,283       25,961  
     
 
 
   
 
 
   
 
 
 
Non-controlling
interests
        42,648       39,471       5,747  
     
 
 
   
 
 
   
 
 
 
Total shareholders’ equity
        241,823       217,754       31,708  
     
 
 
   
 
 
   
 
 
 
Total liabilities, mezzanine equity and shareholders’ equity
        778,309       540,800       78,748  
     
 
 
   
 
 
   
 
 
 
The accompanying notes are an integral part of these consolidated financial statements.
 
F-4
BOQII HOLDING LIMITED
CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS
FOR THE YEARS ENDED MARCH 31, 2021, 2022 AND 2023
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
         
Year Ended March 31,
 
    
Note
  
2021
   
2022
   
2023
 
         
RMB
   
RMB
   
RMB
   
US$
(Note 2(f))
 
Net revenues:
           
Product sales
        1,003,197       1,137,329       1,048,491       152,672  
Online marketing and information services and other revenue
        7,788       49,100       43,603       6,349  
     
 
 
   
 
 
   
 
 
   
 
 
 
Total revenues
        1,010,985       1,186,429       1,092,094       159,021  
Total cost of revenue
        (823,686     (943,698     (858,608     (125,023
     
 
 
   
 
 
   
 
 
   
 
 
 
Gross profit
        187,299       242,731       233,486       33,998  
     
 
 
   
 
 
   
 
 
   
 
 
 
Operating expenses:
           
Fulfillment expenses
        (120,188     (134,026     (126,295     (18,390
Sales and marketing expenses
        (160,201     (170,986     (124,007     (18,057
General and administrative expenses
        (113,972     (76,248     (46,554     (6,779
Impairment of goodwill
   12      —         —         (40,684     (5,924
Other income, net
        1,067       280       286       42  
     
 
 
   
 
 
   
 
 
   
 
 
 
Loss from operations
        (205,995     (138,249     (103,768     (15,110
     
 
 
   
 
 
   
 
 
   
 
 
 
Interest income
        17,553       15,477       7,420       1081  
Interest expense
   16      (27,650     (20,884     (13,350     (1,944
Other gains, net
   17      11,332       6,020       5,159       751  
Fair value change of derivative liabilities
        11,369       2,824       (2,266     (330
     
 
 
   
 
 
   
 
 
   
 
 
 
Loss before income tax expenses
        (193,391     (134,812     (106,805     (15,552
Income tax benefit
   18      871       1,571       911       133  
Share of results of equity investees
        (696     418       (82     (12
     
 
 
   
 
 
   
 
 
   
 
 
 
Net loss
        (193,216     (132,823     (105,976     (15,431
Less: Net income/(loss) attributable to the
non-controlling
interest shareholders
        1,228       (4,433     (3,177     (462
     
 
 
   
 
 
   
 
 
   
 
 
 
Net loss attributable to Boqii Holding Limited
        (194,444     (128,390     (102,799     (14,969
Accretion on convertible redeemable preferred shares to redemption value
        120,873       —         —         —    
Accretion on redeemable
non-controlling
interests to redemption value
   21      (138     (575     (675     (98
Deemed dividend to preferred shareholders
        (12,547     —         —         —    
     
 
 
   
 
 
   
 
 
   
 
 
 
Net loss attributable to Boqii Holding Limited’s ordinary shareholders
        (86,256     (128,965     (103,474     (15,067
     
 
 
   
 
 
   
 
 
   
 
 
 
Net loss
        (193,216     (132,823     (105,976     (15,431
Other comprehensive income (loss):
           
Foreign currency translation adjustment, net of nil tax
        (32,148     (16,529     15,591       2,270  
Unrealized securities holding gains/(losses)
        772       (9,368     (6,711     (977
     
 
 
   
 
 
   
 
 
   
 
 
 
Total comprehensive loss
        (224,592     (158,720     (97,096     (14,138
     
 
 
   
 
 
   
 
 
   
 
 
 
Less: Total comprehensive loss/(income) attributable to
non-controlling
interests shareholders
        1,228       (4,433     (3,177     (462
     
 
 
   
 
 
   
 
 
   
 
 
 
Total comprehensive loss attributable to Boqii Holding Limited
        (225,820     (154,287     (93,919     (13,676
     
 
 
   
 
 
   
 
 
   
 
 
 
Net loss per share attributable to Boqii Holding Limited’s ordinary shareholders
           
— basic
        (1.29     (1.90     (1.50     (0.22
— diluted
        (1.29     (1.90     (1.50     (0.22
Weighted average number of ordinary shares
           
— basic
        66,953,610       68,006,172       68,858,823       68,858,823  
— diluted
        66,953,610       68,006,172       68,858,823       68,858,823  
The accompanying notes are an integral part of these consolidated financial statements.
 
F-5

BOQII HOLDING LIMITED
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY)
FOR THE YEARS ENDED MARCH 31, 2021, 2022 AND 2023
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
   
Ordinary Shares

(US$0.001 per value)
   
Class A

Ordinary Shares

(US$0.001 per value)
   
Class B

Ordinary Shares

(US$0.001 per value)
   
Additional
Paid-in

Capital
   
Statutory

reserves
   
Accumulated
other
comprehensive
income
   
Accumulated
deficit
   
Non-

controlling
interests
   
Receivable
for
issuance of
ordinary
shares
   
Total
Shareholders’
(Deficit)/
Equity
 
   
Number of

Shares
   
Amount
   
Number of

Shares
   
Amount
   
Number of

Shares
   
Amount
 
          RMB           RMB           RMB     RMB     RMB     RMB     RMB     RMB     RMB     RMB  
Balances as of March 31, 2020
    22,238,454       139       —         —         —         —         —         2,627       11,204       (2,016,758     43,741       (9     (1,959,056
Share-based compensation
    —         —         —         —         —         —         55,022       —         —         —         —         9       55,031  
Foreign currency translation adjustment
    —         —         —         —         —         —         —         —         (32,148     —         —         —         (32,148
Appropriations to statutory reserves
    —         —         —         —         —         —         —         420       —         (420     —         —         —    
Deemed dividend to preferred shareholders
    —         —         —         —         —         —         —         —         —         (12,547     —         —         (12,547
Accretion to redemption value of redeemable convertible preferred shares (Note 20)
    —         —         —         —         —         —         —         —         —         120,873       —         —         120,873  
Accretion to redemption value of redeemable non-controlling interests (Note 21)
    —         —         —         —         —         —         —         —         —         (138     —         —         (138
Unrealized securities holding gains, net of tax
    —         —         —         —         —         —         —         —         772       —         —         —         772  
Exercise of CMB Warrant
    —         —         —         —         —         —         —         —         —         (656,448     —         —         (656,448
Capital contribution from
non-controlling
interests
    —         —         —         —         —         —         —         —         —         —         50       —         50  
Receivable for issuance of convertible redeemable preferred shares
    —         —         —         —         —         —         —         —         —         —         —         (413,377     (413,377
Conversion of ordinary shares into Class A and Class B ordinary shares
    (22,238,454     (139     10,033,850       63       12,204,604       76       —         —         —         —         —         —         —    
Issuance of Class A ordinary shares upon initial public offering (“IPO”), net of cost of issuance
    —         —         5,250,000       36       —         —         395,035       —         —         —         —         —         395,071  
 
F-6
BOQII HOLDING LIMITED
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY  (CONTINUED)
FOR THE YEARS ENDED MARCH 31, 2021, 2022 AND 2023
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
   
Ordinary Shares

(US$0.001 per value)
   
Class A

Ordinary Shares

(US$0.001 per value)
   
Class B

Ordinary Shares

(US$0.001 per value)
   
Additional
Paid-in

Capital
   
Statutory

reserves
   
Accumulated
other
comprehensive
income
   
Accumulated
deficit
   
Non-

controlling
interests
   
Receivable
for
issuance of
ordinary
shares
   
Total
Shareholders’
(Deficit)/
Equity
 
   
Number of

Shares
   
Amount
   
Number of

Shares
   
Amount
   
Number of

Shares
   
Amount
 
          RMB           RMB           RMB     RMB     RMB     RMB     RMB     RMB     RMB     RMB  
Conversion of Series A convertible redeemable preferred shares upon completion of the IPO
    —         —         7,844,137       53       —         —         461,392       —         —         —         —         —         461,445  
Conversion of Series B convertible redeemable preferred shares upon completion of the IPO
    —         —         8,557,980       57       —         —         504,280       —         —         —         —         —         504,337  
Conversion of Series C convertible redeemable preferred shares upon completion of the IPO
    —         —         4,684,976       32       833,125       6       331,427       —         —         —         —         —         331,465  
Conversion of Series C+ convertible redeemable preferred shares upon completion of the IPO
    —         —         6,883,520       47       —         —         662,761       —         —         —         —         —         662,808  
Conversion of Series D convertible redeemable preferred shares upon completion of the IPO
    —         —         2,526,026       17       —         —         180,987       —         —         —         —         —         181,004  
Conversion of Series D-1 convertible redeemable preferred shares upon completion of the IPO
    —         —         2,178,530       15       —         —         164,844       —         —         —         —         —         164,859  
Conversion of Series D-2 convertible redeemable preferred shares upon completion of the IPO
    —         —         1,182,803       8       —         —         92,306       —         —         —         —         —         92,314  
Conversion of Series E convertible redeemable preferred shares upon completion of the IPO
    —         —         5,885,210       40       —         —         455,940       —         —         —         —         —         455,980  
Repurchase of Ordinary Shares
    —         —         (521,924     (4     —         —         (31,382     —         —         —         —         —         (31,386
Net loss
    —         —         —         —         —         —         —         —         —         (194,444     1,228       —         (193,216
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balances as of March 31, 2021
    —         —         54,505,108       364       13,037,729       82       3,272,612       3,047       (20,172     (2,759,882     45,019       (413,377     127,693  
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
F-7

BOQII HOLDING LIMITED
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY  (CONTINUED)
FOR THE YEARS ENDED MARCH 31, 2021, 2022 AND 2023
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
   
Class A

Ordinary Shares

(US$0.001 per value)
   
Class B

Ordinary Shares

(US$0.001 per value)
   
Additional
Paid-in

Capital
   
Statutory

reserves
   
Accumulated
other
comprehensive
income
   
Accumulated
deficit
   
Non-

controlling
interests
   
Receivable for
issuance of
ordinary
shares
   
Total
Shareholders’
Equity
 
   
Number of

Shares
   
Amount
   
Number of

Shares
   
Amount
 
          RMB           RMB     RMB     RMB     RMB     RMB     RMB     RMB     RMB  
Balances as of March 31, 2021
    54,505,108       364       13,037,729       82       3,272,612       3,047       (20,172     (2,759,882     45,019       (413,377     127,693  
Foreign currency translation adjustment
    —         —         —         —         —         —         (16,529     —         —         —         (16,529
Accretion on redeemable
non-controlling
interests to redemption value
    —         —         —         —         —         —         —         (575     —         —         (575
Receivable for issuance of ordinary shares (Note 23)
    —         —         —         —         —         —         —         —         —         248,631       248,631  
Unrealized securities holding losses, net of tax
    —         —         —         —         —         —         (9,368     —         —         —         (9,368
Acquisition of a subsidiary
    —         —         —         —         —         —         —         —         1,817       —         1,817  
Issuance of ordinary shares for the exercise of stock options
    1,204,483       8       —         —         8,315       —         —         —         —         —         8,323  
Capital contribution from
non-controlling
interests
    —         —         —         —         —         —         —         —         245       —         245  
Appropriations to statutory reserves
    —         —         —         —         —         386       —         (386     —         —         —    
Share-based compensation
    —         —         —         —         14,409       —         —         —         —         —         14,409  
Net loss
    —         —         —         —         —         —         —         (128,390     (4,433     —         (132,823
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balances as of March 31, 2022
    55,709,591       372       13,037,729       82       3,295,336       3,433       (46,069     (2,889,233     42,648       (164,746     241,823  
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
F-8
BOQII HOLDING LIMITED
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY  (CONTINUED)
FOR THE YEARS ENDED MARCH 31, 2021, 2022 AND 2023
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
   
Class A

Ordinary Shares

(US$0.001 per value)
   
Class B

Ordinary Shares

(US$0.001 per value)
   
Additional
Paid-in

Capital
   
Statutory

reserves
   
Accumulated
other
comprehensive
income
   
Accumulated
deficit
   
Non-

controlling
interests
   
Receivable for
issuance of
ordinary
shares
   
Total
Shareholders’
Equity
 
   
Number of

Shares
   
Amount
   
Number of

Shares
   
Amount
 
          RMB           RMB     RMB     RMB     RMB     RMB     RMB     RMB     RMB  
Balances as of March 31, 2022
    55,709,591       372       13,037,729       82       3,295,336       3,433       (46,069     (2,889,233     42,648       (164,746     241,823  
Foreign currency translation adjustment
    —         —         —         —         —         —         15,591       —         —         —         15,591  
Accretion on redeemable
non-controlling
interests to redemption value
    —         —         —         —         —         —         —         (675     —         —         (675
Receivable for issuance of ordinary shares (Note 23)
    —         —         —         —         —         —         —         —         —         81,341       81,341  
Unrealized securities holding losses, net of tax
    —         —         —         —         —         —         (6,711     —         —         —         (6,711
Issuance of ordinary shares for the exercise of stock options
    53,488       1       —         —         37       —         —         —         —         —         38  
Appropriations to statutory reserves
    —         —         —         —         —         443       —         (443     —         —         —    
Share-based compensation
    —         —         —         —         (7,677     —         —         —         —         —         (7,677
Net loss
    —         —         —         —         —         —         —         (102,799     (3,177     —         (105,976
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balances as of March 31, 2023
    55,763,079       373       13,037,729       82       3,287,696       3,876       (37,189     (2,993,150     39,471       (83,405     217,754  
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
The accompanying notes are an integral part of these consolidated financial statements.
 
F-9

BOQII HOLDING LIMITED
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE YEARS ENDED March 31, 2021, 2022 AND 2023
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
         
Year Ended March 31,
 
    
Note
  
2021
   
2022
   
2023
 
         
RMB
   
RMB
   
RMB
   
US$
(Note 2(f))
 
Cash flows from operating activities:
           
Net loss
        (193,216     (132,823     (105,976     (15,431
Adjustments to reconcile net loss to net cash provided by operating activities:
           
Depreciation and amortization expense
        7,083       7,678       7,844       1,142  
Provision for inventories
        (8     311       35       5  
Provision for doubtful accounts
   6      (107     213       133       19  
Interest expense of other debts
   16      21,611       17,144       9,706       1,413  
Interest receivable for issuance of ordinary shares
        (15,394     (14,239     (6,112     (890
Amortization of
right-of-use
assets
   15      11,687       11,705       24,597       3,582  
Interest of lease liabilities
   15      1,596       1,949       1,777       259  
Investment income
        —         622       178       26  
Share of results of equity investees
        131       (418     82       12  
Loss/(gain) on disposal of property and equipment and intangible assets
        20       (104     (7     (1
Gain on disposal of other debts
        (6,846           —         —    
Gain from the
re-measurement
of the previously held equity interest to the fair value in the business acquisition
   17      —         (127     —         —    
Gain from disposal of a subsidiary
   17      —         —         (3,597     (524
Impairment of goodwill
        —         —         40,684       5,924  
Share-based compensation expense
   24      55,022       14,409       (7,677     (1,118
Fair value change of derivative liabilities
   26      (11,369     (2,824     2,266       330  
Deferred tax expense
        (1,889     (989     (989     (144
Changes in operating assets and liabilities, net of effects of businesses acquired:
           
Accounts receivable
        (880     (6,131     (27,455     (3,998
Inventories
        (38,839     (23,176     30,583       4,453  
Prepayments and other current assets
        (48,853     (35,056     47,754       6,954  
Amounts due from related parties
        (2,663     490       (3,839     (559
Operating lease liabilities
   15      (12,850     (12,849     (26,397     (3,844
Accounts payable
        (22,029     18,106       (36,342     (5,292
Salary and welfare payable
        2,518       293       6       1  
Accrued liabilities and other current liabilities
        667       1,954       2,701       393  
Amounts due to related parties
        1,062       (808     252       37  
Contract liabilities
        (5,229     3,140       (2,536     (369
Other
non-current
assets
        11,289       4,026       (1,740     (253
     
 
 
   
 
 
   
 
 
   
 
 
 
Net cash used in operating activities
        (247,486     (147,504     (54,069     (7,873
     
 
 
   
 
 
   
 
 
   
 
 
 
Cash flows from investing activities:
           
Loan receivables advanced to third parties
        (49,392     (2,376     (7,864     (1,145
Repayments on loan receivables from third parties
        44,840       2,579       1,096       160  
Loan receivables advanced to related parties
        (4,814     (35,995     (4,120     (600
Repayments on loan receivables from related parties
        —         35,245       3,874       564  
Acquisition of subsidiaries
        —         —         (2,938     (428
Increase/(decrease) in short-term investments
        (168,546     40,462       58,287       8,487  
Purchase of intangible assets
        —         (24     (50     (7
Purchase of property and equipment
        (6,509     (3,077     (1,805     (263
Disposal of property and equipment
        4       125       16       2  
Acquisitions of long-term investments
        —         (15,792     —         —    
     
 
 
   
 
 
   
 
 
   
 
 
 
Net cash generated from/ (used in) investing activities
        (184,417     21,147       46,496       6,770  
     
 
 
   
 
 
   
 
 
   
 
 
 
 
F-10
BOQII HOLDING LIMITED
CONSOLIDATED STATEMENTS OF CASH FLOWS  (CONTINUED)
FOR THE YEARS ENDED March 31, 2021, 2022 AND 2023
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
           
Year Ended March 31,
 
    
Note
    
2021
   
2022
   
2023
 
           
RMB
   
RMB
   
RMB
   
US$
(Note 2(f))
 
Cash flows from financing activities:
           
Proceeds from issuance of convertible redeemable preferred shares,
net of issuance costs
        354,825       —               —    
Acquisition of additional interests in subsidiaries from
non-controlling
interests
        —         245             —    
Proceeds from short-term and long-term borrowings
        87,846       185,614       110,553       16,098  
Repayments of short-term and long-term borrowings
        (74,000     (176,897     (187,234     (27,263
Proceeds from issuance of other debts, net of issuance costs
        16,940       —         —         —    
Proceeds from issuance of ordinary shares
        —         262,870       87,959       12,808  
Repayments of other debts
        (130,827     (270,860     (87,959     (12,808
Proceeds from exercise of share option
        9       1,023       25       4  
Proceeds from the initial public offering, net of underwriter discounts and commissions and other offering costs paid
        393,698       —         —         —    
     
 
 
   
 
 
   
 
 
   
 
 
 
Net cash flows generated from/ (used in) financing activities
        648,491       1,995       (76,656     (11,161
     
 
 
   
 
 
   
 
 
   
 
 
 
Net increase (decrease) in cash, cash equivalents and restricted cash
        216,588       (124,362     (84,229     (12,264
     
 
 
   
 
 
   
 
 
   
 
 
 
Cash, cash equivalents and restricted cash at beginning of year
        88,352       292,237       162,855       23,714  
     
 
 
   
 
 
   
 
 
   
 
 
 
Effects of exchange rate changes on cash, cash equivalents and restricted cash
        (12,703     (5,020     11,224       1,633  
     
 
 
   
 
 
   
 
 
   
 
 
 
Cash, cash equivalents and restricted cash at end of year
        292,237       162,855       89,850       13,083  
     
 
 
   
 
 
   
 
 
   
 
 
 
Supplemental schedule of
non-cash
investing and financing activities:
           
Accretion on convertible redeemable preferred shares
        120,873       —         —         —    
Accretion on redeemable
non-controlling
interests
        (138     (575     (675     (98
Deemed dividend to preferred shareholders
        (12,547     —         —         —    
Unpaid cash consideration for business acquisitions
        —         (2,938     —         —    
Additional ASC 842 supplemental disclosure:
           
Cash paid for fixed operating lease costs included in the measurement of lease obligations in operating activities
        12,850       12,849       26,397       3,844  
Right-of-use
assets obtained in exchange for operating lease obligations
        25,970       21,038       8,384       1,221  
The accompanying notes are an integral part of these consolidated financial statements.
 
F-11

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
1.
Organization and principal activities
(a) Principal activities
Boqii Holding Limited (“Boqii Holding”, or the “Company”), was incorporated under the laws of the Cayman Islands in June 2012, as an exempted company with limited liability. In these consolidated financial statements, where appropriate, the term “Company” also refers to its subsidiaries, the VIEs and the VIEs’ subsidiaries as a whole.
The Company operates as an online
one-stop
destination for users to shop for a variety of pet products and interact with other users in its online pet community in the People’s Republic of China (the “PRC”), through its online platforms (Boqii.com and Boqii application, collectively “Boqii Marketplace”), branded stores on third-party online platforms (the “Online Branded Stores”) and its online pet community (“Boqii Community”). In addition to online business, the Company provides pet products to offline pet stores.
The Company’s consolidated financial statements include the financial statements of the Company, its subsidiaries, consolidated VIEs and VIEs’ subsidiaries.
As
of March 31, 2023, the Company’s principal subsidiaries, consolidated VIEs and
major
VIEs’ subsidiaries are as follows:
 
Name of subsidiaries and VIE
 
Place of
incorporation
 
Date of
incorporation
or acquisition
 
Percentage
of direct
or indirect
 
Principal activities
Subsidiaries:
               
Boqii Corporation Limited (“Boqii Corporation”)
  Hong Kong   July 2012   100%  
Investment holding
Boqii International Limited
  Hong Kong   August 2016   100%  
Investment holding
Xingmu International Limited
  British Virgin Islands   August 2019   51%  
Investment holding
Xingmu HK Limited
  Hong Kong   November 2019   51%  
Investment holding
Nanjing Xinmu Information Technology Co., Ltd. (“Xingmu WFOE”)
  Nanjing, the PRC   November 2019   51%  
Technology development and sales of merchandise
Xincheng (Shanghai) Information Technology Co., Ltd. (“Shanghai Xincheng”)
  Shanghai, the PRC   November 2012   100%  
Technology development and sales of merchandise
Shanghai Yiqin Pets Products Co., Ltd.
  Shanghai, the PRC   February 2013   100%  
Technology development and sales of merchandise
Shanghai Every Supply Chain Co., Ltd. (“Shanghai Every”)
  Shanghai, the PRC   September 2021   100%  
Sales of merchandise
         
Consolidated VIEs
               
Guangcheng (Shanghai) Information Technology Co., Ltd. (“Guangcheng”)
  Shanghai, the PRC   November 2012   100%  
Operates the Company’s own online
e-commerce platform
Nanjing Xingmu Biotechnology Co., Ltd. (“Nanjing Xingmu”)
  Nanjing, the PRC   November 2019   51%  
Biotechnology research and development
Suzhou Taicheng Supply Chain Co., Ltd. (“Suzhou Taicheng”)
  Suzhou, the PRC   June 2021   100%   Sales of merchandise
Suzhou Xingyun Yueming Supply Chain Co., Ltd. (“Suzhou Xingyun Yueming”)
  Suzhou, the PRC   April 2022   100%  
Sales of merchandise
         
Subsidiaries of VIEs
               
Boqii (Shanghai) Information Technology Co., Ltd.
  Shanghai, the PRC   August 2014   90%  
Technology development
Tianjing Guangcheng Information Technology Co., Ltd.
  Tianjin, the PRC   June 2017   100%  
Sales of merchandise
Nanjing Cuida Biotechnology Co. Ltd.(“Cuida”)
  Nanjing, the PRC   April 2017   70%  
Biotechnology extension services
Taizhou Xingmu Biotechnology Co., Ltd.
  Taizhou, the PRC   November 2019   80%  
Biotechnology research and development
 
F-12

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
1.
Organization and principal activities (continued)
 
(b) Consolidated variable interest entities
In order to comply with the PRC laws and regulations which prohibit or restrict foreign investments into companies involved in restricted businesses, the Company operates online platforms that provide internet information services and engages in other foreign-ownership-restricted businesses through certain PRC domestic companies (the PRC Domestic Companies, or the “VIEs”). The equity interests of the PRC Domestic Companies are held by certain management members of the Company or onshore nominees of certain investors of the Company (“Nominee Shareholders”), who act as nominee equity holders of the PRC Domestic Companies on behalf of Shanghai Xincheng and Xingmu WFOE, the Company’s wholly owned subsidiaries in the PRC (the “WFOEs”). The WFOEs entered into a series of contractual arrangements with the PRC Domestic Companies and their respective Nominee Shareholders (the “Contractual Arrangements”). These Contractual Agreements cannot be unilaterally terminated by the Nominee Shareholders or the PRC Domestic Companies. Through the Contractual Arrangements, the Nominee Shareholders have granted all their legal rights including voting rights and disposition rights of their equity interests in the PRC Domestic Companies to the WFOEs. The Nominee Shareholders do not have the power to direct the activities of the PRC Domestic Companies that most significantly impact their economic performance. The Nominee Shareholders do not have the obligation to absorb losses of the PRC Domestic Companies that could potentially be significant to them or the right to receive benefits from the PRC Domestic Companies that could potentially be significant to them. Accordingly, the PRC Domestic Companies are considered as variable interest entities of the Company, through the WFOEs.
In accordance with Accounting Standards Codification
(“ASC”) 810-10-25-38A, the
Company, through its WFOEs, has a controlling financial interest in the VIEs because the WFOEs have the power to direct activities of the VIEs that most significantly impact the economic performance of the VIEs. In addition, under the terms of the Contractual Arrangements, the WFOEs have (i) the right to receive economic benefits that could potentially be significant to the VIEs in the form of service fees under the Exclusive Consultation and Service Agreements; (ii) the right to receive all dividends declared by the VIEs and the right to all undistributed earnings of the VIEs; and (iii) the obligation to absorb the substantially expected losses and the right to receive the residual benefits of the VIEs through its exclusive option to acquire 100% of the equity interests in the VIEs, to the extent permitted under PRC law. Thus, the Company, through the WFOEs, has the obligation to absorb the expected losses and the right to receive expected residual return of the VIEs that could potentially be significant to the VIEs.
Based on the above, the Company, through the WFOEs, is the ultimate primary beneficiary of the VIEs. Accordingly, the financial statements of the VIEs and their subsidiaries are consolidated in the Company’s consolidated financial statements.
Loan Agreements
Pursuant to the relevant loan agreements, the WFOEs have granted interest-free loans to the relevant Nominee Shareholders of the relevant VIEs with the sole purpose of providing funds necessary for the capital injection to the relevant VIEs.
The loans can only be repaid by transfer of the equity interests of the relevant VIEs held by the Nominee Shareholders, and shall be repaid upon the occurrence of, among other events, the WFOEs exercise of their options to purchase the relevant VIEs’ equity interests under the Exclusive Option Agreements (refer to following section for further details). Any proceeds received by the Nominee Shareholders from transfer of the equity interests shall also be repaid to the WFOEs as part of the loan repayments.
 
F-13

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
1.
Organization and principal activities (continued)
(b) Consolidated variable interest entities (continued)
Loan Agreements (continued)
 
Other events that will lead to loan repayments include: the Nominee Shareholders receiving a written notice from the relevant PRC subsidiaries requesting loan repayments; the death or loss of capacity for civil conduct of the Nominee Shareholders; the Nominee Shareholders no longer acting as shareholders of the relevant VIEs or employees of the relevant VIEs, PRC subsidiaries or their related parties; the Nominee Shareholders being involved in criminal activities; or, any third party making a claim in an amount over RMB 500,000 against the Nominee Shareholders.
The loans shall be considered fully repaid when the Nominee Shareholders have transferred all equity interests held by them to the WFOEs or a party designated by the WFOEs. The Loan Agreements shall remain valid until the Nominee Shareholders repaid the relevant loans to the WFOEs.
Exclusive Option Agreements
The Nominee Shareholders of the VIEs have granted the WFOEs the exclusive and irrevocable right to purchase or to designate one or more person(s) at their discretion to purchase part or all of the equity interests in the VIEs from the Nominee Shareholders for a purchase price at any time, subject to the lowest price permitted by PRC laws and regulations. The VIEs and their Nominee Shareholders have agreed that without prior written consent of the WFOEs, their respective Nominee Shareholders cannot sell, transfer, pledge or dispose their equity interests, and the VIEs cannot sell, transfer, pledge or dispose, but not limit to, the equity interests, significant assets, significant revenue and significant business. Also as agreed, the VIEs cannot declare any dividend or change capitalization structure of the VIEs and cannot enter into any loan or investment agreements. Furthermore, the Nominee Shareholders have agreed that any proceeds but not limited to the sales of the Nominee Shareholders’ equity interest in relevant VIEs should be gratuitously paid to the WOFEs or one or more person(s) at their discretion. The Exclusive Option Agreement will remain effective until all equity options in VIEs held by such Nominee Shareholders are transferred or assigned to the WFOEs or their designated representatives.
Proxy Agreement and Power of Attorney
Pursuant to the irrevocable power of attorney, each of the Nominee Shareholders appointed the WFOEs as their
attorney-in-fact
to exercise all shareholder rights under PRC law and the relevant articles of association, including but not limited to, attending shareholders meetings, voting on their behalf on all matters requiring shareholder approval, including but not limited to sale, transfer, pledge, or disposition of all or part of the Nominee Shareholders’ equity interests, and designation and appointing the legal representative, directors, supervisors, chief executive officer and other senior management members of the VIEs. Each power of attorney will remain in force during the period when the Nominee Shareholders continues to be shareholders of the VIEs. Each Nominee Shareholder has waived all the rights which have been authorized to the person designated by the WFOEs under each power of attorney.
Exclusive Consultation and Service Agreements
Pursuant to the Exclusive Consultation Service Agreements, the WFOEs have agreed to provide to the VIEs services, including, but not limited to, design and maintenance of the
E-Commerce
platform, consulting services, technical training, research, planning and development of the market and customer support. The VIEs shall pay to the WFOEs service fees determined based on the complexity and difficulty of the services, title of and time consumed by employees, contents and value of the services, operation conditions and market price of the service provided. The Exclusive Consultation and Service Agreements will be in effect permanent unless terminated by the WFOEs. The WFOEs have the exclusive ownership of all the intellectual property rights created as a result of the performance of the agreements.
 
F-14

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
1.
Organization and principal activities (continued)
(b) Consolidated variable interest entities (continued)
 
Intellectual Property License Agreements
Pursuant to the intellectual property license agreements, the WFOEs have granted a
non-exclusive
and
non-transferable
license, without sublicensing rights, to the VIEs to use its intellectual property. The VIEs may only use the licenses in its own business operations. The VIEs agree to pay the WFOEs a quarterly service fee at an amount that is equal to the VIEs’ revenue for the relevant quarter with a certain percentage or an amount adjusted at the WFOEs’ sole discretion for the relevant quarter, which should be paid within 15 business days after the VIEs confirm in writing the amount and breakdown of the service fee for the relevant quarter. The agreement has a term of 10 years and shall automatically renew at the end of each term for a further term of 10 years, unless otherwise terminated by the WFOEs in its sole discretion with 90 days’ prior written notice.
Equity Interest Pledge Agreements
Pursuant to the relevant equity interest pledge agreements, the Nominee Shareholders of the VIEs have pledged 100% equity interests in relevant VIEs to the WFOEs to guarantee performance by the Nominee Shareholders of their obligations under the Exclusive Option Agreements, the Proxy Agreement and Power of Attorney and the Loan Agreements, as well as the performance by the VIEs of their obligations under the Exclusive Option Agreements, the Exclusive Consultation and Service Agreements and Intellectual Property License Agreements. In the event of a breach by the VIEs or any of their Nominee Shareholders of contractual obligations under the Contractual Agreements, as the case may be, the WFOEs, as pledgee, will have the right to dispose of the pledged equity interests in the relevant VIEs and will have priority in receiving the proceeds from such disposal. The Nominee Shareholders of the VIEs also covenant that, without the prior written consent of the WFOEs, they will not dispose of, create or allow any encumbrance on the pledged equity interests. The Equity Interest Pledge Agreements will remain in effect so long as any of the Loan Agreements, the Exclusive Consultation Service Agreements, the Exclusive Option Agreements, the Proxy Agreement and Power of Attorney, or the Intellectual Property License Agreements, as mentioned above, remains in effect or any guaranteed obligations of the VIEs, or, to the extent applicable, its Nominee Shareholders, remains outstanding under the Contractual Agreements. The pledge was registered with the relevant local administration and will remain binding until the VIEs and their Nominee Shareholders discharge all their obligations under the Contractual Arrangements. The registration of the equity pledge enables the WFOEs to enforce the equity pledge against third parties who acquire the equity interests of the VIEs in good faith.
One set of existing Contractual Agreements were initially entered into in September 2012 by Shanghai Xincheng (one of the Company’s WOFEs), Guangcheng (one of the Company’s VIEs) and its nominee shareholders, was subsequently amended and restated on substantially similar terms in September 2017, October 2019 and August 2020, respectively. One set of existing Contractual Agreements were entered into in September 2019 by Xingmu WFOE (one of the Company’s WOFEs), Nanjing Xingmu (one of the Company’s VIEs) and its Nominee Shareholders. One set of Contractual Agreements were entered into in June 2021 by Shanghai Xincheng (one of the Company’s WOFEs), Suzhou Taicheng (one of the Company’s VIEs) and its Nominee Shareholders. A new set of Contractual Agreements were entered into in April 2022 by Shanghai Every (one of the Company’s WOFEs), Suzhou Xingyun Yueming (one of the Company’s VIEs) and its Nominee Shareholders.The Loan Agreements, Exclusive Option Agreements, Proxy Agreement and Power of Attorney, Exclusive Consultation and Service Agreements, Intellectual Property License Agreements and Equity Interest Pledge Agreements were amended to reflect the changes of shareholders’ holding in the VIE in their respective dates. No other material terms or conditions of these agreements were changed or altered. There was no impact to the Company’s control over the VIEs and the Company continues to consolidate the VIEs.
(c) Risks in relations to the VIE structure
Under the Contractual Agreements with the consolidated VIEs, the Company has the power to direct activities of the consolidated VIEs and VIEs’ subsidiaries through the Company’s relevant PRC subsidiaries, and can have assets transferred freely out of the consolidated VIEs and VIEs’ subsidiaries without restrictions. Therefore, the Company considers that there is no asset of the consolidated VIEs that can only be used to settle obligations of the respective consolidated VIEs, except for the registered capital of the consolidated VIEs amounting to RMB52 million and RMB52 million as of March 31, 2022 and 2023. Since the consolidated VIEs and VIEs’ subsidiaries are incorporated as limited liability companies under the PRC Law, creditors of the consolidated VIEs and VIEs’ subsidiaries do not have recourse to the general credit of the Company.
 
F-15

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
1.
Organization and principal activities (continued)
(c) Risks in relations to the VIE structure (continued)
 
The Company believes that the Company’s relevant PRC subsidiaries’ Contractual Arrangements with the consolidated VIEs and the Nominee Shareholders are in compliance with PRC laws and regulations, as applicable, and are legally binding and enforceable. However, uncertainties in the PRC legal system could limit the Company’s ability to enforce these contractual arrangements.
In addition, if the current structure or any of the contractual arrangements were found to be in violation of any existing or future PRC law, the Company may be subject to penalties, which may include but not be limited to, the cancellation or revocation of the Company’s business and operating licenses, being required to restructure the Company’s operations or terminate the Company’s operating activities. The imposition of any of these or other penalties may result in a material and adverse effect on the Company’s ability to conduct its operations. In such case, the Company may not be able to operate or control the VIEs, which may result in deconsolidation of the VIEs.
The following table set forth the assets, liabilities, results of operations and changes in cash, cash equivalents and restricted cash of the consolidated VIEs and their subsidiaries taken as a whole, which were included in the Company’s consolidated financial statements with intercompany transactions eliminated (RMB in thousands):
 
    
As of March 31,
 
    
2022
    
2023
 
    
RMB
    
RMB
 
Cash and cash equivalents
     20,567        15,522  
Accounts receivable, net
     31,435        33,172  
Amounts due from related parties
     11,726        6,770  
Inventories, net
     16,014        27,894  
Prepayments and other current assets
     57,107        48,291  
Inter-company receivables
     16,535        83,700  
Property and equipment, net
     6,715        4,661  
Intangible assets
     507        101  
Operating lease
right-of-use
assets
     35,688        22,305  
Goodwill
     994        —    
Long-term investments
     81,649        75,505  
Other
non-current
asset
     3,389        5,219  
  
 
 
    
 
 
 
Total assets
     282,326        323,140  
  
 
 
    
 
 
 
 
    
As of March 31,
 
    
2022
    
2023
 
    
RMB
    
RMB
 
Short-term borrowings
     872        363  
Accounts payable
     55,144        13,459  
Amounts due to related parties, current
     4        21  
Salary and welfare payable
     5,597        5,573  
Accrued liabilities and other current liabilities
     24,417        15,712  
Contract liabilities
     7,007        4,471  
Operating lease liabilities, current
     7,238        9,207  
Inter-company payables
     945,960        1,095,452  
Operating lease liabilities,
non-current
     28,197        12,741  
Other debts,
non-current
     157,874        75,481  
  
 
 
    
 
 
 
Total liabilities
     1,232,310        1,232,480  
  
 
 
    
 
 
 
 
F-16

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
1.
Organization and principal activities (continued)
(c) Risks in relations to the VIE structure (continued)
 
    
Year Ended March 31,
 
    
2021
    
2022
    
2023
 
    
RMB
    
RMB
    
RMB
 
Net revenues:
        
Third-party revenues
     735,518        877,380        786,152  
Inter-company revenues
     48,374        56,079        86,463  
  
 
 
    
 
 
    
 
 
 
Total revenues
     783,892        933,459        872,615  
Cost of revenues:
        
Third-party cost of revenues
     (372,475      (160,661      (81,810
Inter-company cost of revenues
     (297,844      (550,585      (534,518
  
 
 
    
 
 
    
 
 
 
Total cost of revenues
     (670,319      (711,246      (616,328
  
 
 
    
 
 
    
 
 
 
Gross profit
     113,573        222,213        256,287  
Operating expenses:
        
Third-party operating expenses
     (254,951      (288,291      (237,852
Inter-company operating expenses
     (7,257             (41
  
 
 
    
 
 
    
 
 
 
Total operating expenses
     (262,208      (288,291      (237,893
  
 
 
    
 
 
    
 
 
 
Impairment of goodwill
     —          —          (994
Other income, net
     1,011        98        158  
  
 
 
    
 
 
    
 
 
 
Profit/(Loss) from operations
     (147,624      (65,980      17,558  
Non-operating
expense
     (18,162      (20,680      (29
  
 
 
    
 
 
    
 
 
 
Profit/(Loss) before income tax expenses
     (165,786      (86,660      17,529  
Income tax benefits/(expenses)
     (20      681        21  
Share of results of equity investees
     (696      418        (82
  
 
 
    
 
 
    
 
 
 
Net profit/(loss)
     (166,502      (85,561      17,468  
  
 
 
    
 
 
    
 
 
 
Cash flows from operating activities:
        
Net cash provided by transactions with external parties
     419,767        526,201        471,991  
Net cash used in transactions with the Company’s entities
     (331,064      (329,325      (449,155
  
 
 
    
 
 
    
 
 
 
Net cash generated from/ (used in) operating activities
     88,703        196,876        22,836  
  
 
 
    
 
 
    
 
 
 
Cash flows from investing activities:
        
Other investing activities
     (31,972      (18,482      (9,638
Cash flows of loan funding provided to the Company’s entities, net of repayments received
     (5,242      6,294        —    
  
 
 
    
 
 
    
 
 
 
Net cash used in investing activities
     (37,214      (12,188      (9,638
  
 
 
    
 
 
    
 
 
 
Cash flows from financing activities:
        
Other financing activities
     (112,151      (273,906      (88,469
Cash flows of loan funding received from the Company’s entities, net of repayments made
     41,717        91,794        69,204  
  
 
 
    
 
 
    
 
 
 
Net cash generated from/ (used in) financing activities
     (70,434      (182,112      (19,265 )
  
 
 
    
 
 
    
 
 
 
 
F-17

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
2.
Principal Accounting Policies
(a) Basis of preparation
The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”). Significant accounting policies followed by the Company in the preparation of the accompanying consolidated financial statements are summarized below.
(b) Basis of consolidation
The Company’s consolidated financial statements include the financial statements of the Company, its subsidiaries, the consolidated VIEs and VIEs’ subsidiaries for which the Company is the primary beneficiary.
A subsidiary is an entity in which the Company, directly or indirectly, controls more than one half of the voting power, has the power to appoint or remove the majority of the members of the board of directors, to cast a majority of votes at the meeting of the board of directors or to govern the financial and operating policies of the investee under a statute or agreement among the shareholders or equity holders.
A consolidated VIE is an entity in which the Company, or its subsidiaries, through Contractual Agreements, bears the risks of, and enjoys the rewards normally associated with, ownership of the entity, and therefore the Company or its subsidiaries are the primary beneficiary of the entity.
All transactions and balances among the Company, its subsidiaries, the consolidated VIEs and VIEs’ subsidiaries have been eliminated upon consolidation
.
(c) Business combination and
non-controlling
interests
The Company accounts for its business combinations using the acquisition method of accounting in accordance with Accounting Standards Codification (“ASC”) 805,
Business Combinations
. The cost of an acquisition is measured as the aggregate of the acquisition date fair values of the assets transferred and liabilities incurred by the Company to the sellers and equity instruments issued. Transaction costs directly attributable to the acquisition are expensed as incurred. Identifiable assets and liabilities acquired or assumed are measured separately at their fair values as of the acquisition date, irrespective of the extent of any
non-controlling
interests. The excess of (i) the total costs of acquisition, fair value of the
non-controlling
interests and acquisition date fair value of any previously held equity interest in the acquiree over (ii) the fair value of the identifiable net assets of the acquiree is recorded as goodwill. If the cost of acquisition is less than the fair value of the net assets of the subsidiary acquired, the difference is recognized directly in the consolidated statements of loss and comprehensive loss as a bargain purchase gain. During the measurement period, which can be up to one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill or bargain purchase gain. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the consolidated statements of loss and comprehensive loss.
In a business combination achieved in stages, the Company
re-measures
the previously held equity interest in the acquiree immediately before obtaining control at its acquisition-date fair value and the
re-measurement
gain or loss, if any, is recognized in the consolidated statements of loss and comprehensive loss.
When there is a change in ownership interests or a change in contractual arrangements that results in a loss of control of a subsidiary or consolidated VIE, the Company deconsolidates the subsidiary or consolidated VIE from the date control is lost. Any retained
non-controlling
investment in the former subsidiary or consolidated VIE is measured at fair value and is included in the calculation of the gain or loss upon deconsolidation of the subsidiary or consolidated VIE.
For the Company’s consolidated subsidiaries, VIEs and VIEs’ subsidiaries,
non-controlling
interests are recognized to reflect the portion of their equity that is not attributable, directly or indirectly, to the Company as the controlling shareholder.
Non-controlling
interests are classified as a separate line item in the equity section of the Company’s consolidated balance sheets and have been separately disclosed in the Company’s consolidated statements of loss and comprehensive loss to distinguish the interests from that of the Company.
 
F-18

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
2.
Principal Accounting Policies (continued)
 
(d) Use of estimates
The preparation of the Company’s consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.
The Company believes that assessment for impairment of long-lived assets and valuation of
available-for-sale
debt securities require significant judgments and estimates used in the preparation of its consolidated financial statements.
Management bases the estimates on historical experience and on various other assumptions as discussed elsewhere to the consolidated financial statements that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. On an ongoing basis, management evaluates its estimates based on information that is currently available. Changes in circumstances, facts and experience may cause the Company to revise its estimates. Changes in estimates are recorded in the period in which they become known. Actual results could materially differ from these estimates.
(e) Functional currency and foreign currency translation
The Company’s reporting currency is Renminbi (“RMB”). The functional currency of the Company’s entities incorporated in Cayman Islands, British Virgin Islands and Hong Kong is the United States dollars (“US$”). The Company’s PRC subsidiaries, consolidated VIEs and VIEs’ subsidiaries determined their functional currency to be RMB. The determination of the respective functional currency is based on the criteria of ASC 830,
Foreign Currency Matters
.
Transactions denominated in other than the functional currencies are translated into the functional currency of the entity at the exchange rates prevailing on the transaction dates. Financial assets and liabilities denominated in other than the functional currency are translated at the balance sheet date exchange rate. The resulting exchange differences are included in the consolidated statements of loss and comprehensive loss as other gains, net.
The financial statements of the Company are translated from the functional currency into RMB. Assets and liabilities denominated in foreign currencies are translated into RMB using the applicable exchange rates at the balance sheet date. Equity accounts other than earnings generated in current period are translated into RMB at the appropriate historical rates. Revenues, expenses, gains and losses are translated into RMB using the periodic average exchange rates. The resulting foreign currency translation adjustments are recorded in accumulated other comprehensive loss as a component of shareholders’ equity.
The exchange rates used for translation on March 31, 2022 and 2023 were US$1.00= RMB 6.3482 and RMB 6.8717, respectively, representing the index rates stipulated by the People’s Bank of China.
(f) Convenience translation
Translations of the consolidated balance sheets, the consolidated statements of loss and comprehensive loss and the consolidated statements of cash flows from RMB into US$ as of and for the year ended March 31, 2023 are solely for the convenience of the readers and were calculated at the rate of US$1.00=RMB 6.8676, representing the certificated exchange rate published by the Federal Reserve Board. No representation is made that the RMB amounts could have been, or could be, converted, realized or settled into US$ at that rate on March 31, 2023, or at any other rate.
(g) Fair value of financial instruments
Accounting guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and it considers assumptions that market participants would use when pricing the asset or liability.
 
F-19

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
2.
Principal Accounting Policies (continued)
(g) Fair value of financial instruments (continued)
 
The established fair value hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
The three levels of inputs that may be used to measure fair value:
Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2: Observable, market-based inputs, other than quoted prices, in active markets for identical assets or liabilities.
Level 3: Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.
Accounting guidance also describes three main approaches to measuring the fair value of assets and liabilities: (1) market approach; (2) income approach and (3) cost approach. The market approach uses prices and other relevant information generated from market transactions involving identical or comparable assets or liabilities. The income approach uses valuation techniques to convert future amounts to a single present value amount. The measurement is based on the value indicated by current market expectations about those future amounts. The cost approach is based on the amount that would currently be required to replace an asset.
Financial assets and liabilities of the Company mainly consist of cash and cash equivalents, short-term investments, accounts receivable, amounts due from related parties, prepayments and other current assets,
available-for-sale
debt investments, accounts payable, short-term borrowings, derivative liabilities, accrued liabilities and other current liabilities, amounts due to related parties, and other debts.
As of March 31, 2022 and 2023, except for
available-for-sale
debt investments and derivative liabilities, carrying values of cash and cash equivalents, short-term investments, accounts receivable, amounts due from related parties, certain prepayments and other current assets, accounts payable, short-term borrowings, certain accrued liabilities and other current liabilities, amounts due to related parties and current portion of other debts approximated their fair values reported in the consolidated balance sheets due to the short-term maturities of these instruments. The carrying value of long-term loan receivable, long-term borrowings and
non-current
portion of other debts approximated their fair values as of March 31, 2022 and 2023 as the interest rates and credit risk they bear reflect the current market yield for comparable instruments. The Company reports derivative liabilities at fair value at each balance sheet date and change in fair value is reflected in “Fair value change of derivative liabilities” in the consolidated statements of loss and comprehensive loss. The Company reports
available-for-sale
debt investments at fair value at each balance sheet date with the aggregate unrealized gains and losses, net of tax, reflected in “Accumulated other comprehensive loss” in the consolidated balance sheets.
(h) Cash and cash equivalents
Cash and cash equivalents include cash on hand and time deposits placed with banks and third party payment processors, which are unrestricted as to withdrawal or use, have original maturities of three months or less at the time of purchase and are readily convertible to known amounts of cash.
(i) Short-term investments
Short-term investments comprise primarily of (i) cash deposits at fixed rates with original maturities of greater than three months, but less than 12 months and; (ii) the investments issued by commercial banks or other financial institutions with a variable interest rate indexed to the performance of underlying assets within one year. As of March 31, 2022 and 2023, RMB128 million and RMB70 million short-term investments were used as collateral of RMB111 million and RMB64 million short-term borrowings, respectively.
 
F-20

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
2.
Principal Accounting Policies (continued)
 
(j) Accounts receivable, net
Accounts receivable are presented net of allowance for doubtful accounts. The Company maintains an allowance for doubtful accounts which reflects its best estimate of amounts that potentially will not be collected. The Company determines the allowance for doubtful accounts on general basis taking into consideration various factors including but not limited to historical collection experience and credit-worthiness of the customers as well as the age of the individual receivables balance. Additionally, the Company makes specific bad debt provisions based on any specific knowledge the Company has acquired that might indicate that an account is uncollectible. The facts and circumstances of each account may require the Company to use substantial judgment in assessing its collectability.
(k) Inventories
Inventories are stated at the lower of cost and net realizable value. Cost elements of our inventories comprise the purchase price of products, vendor rebates, shipping charges to receive products from the suppliers when they are embedded in the purchase price. Cost is determined using the
first-in
first-out
method. Provisions are made for excessive, slow moving, expired and obsolete inventories as well as for inventories with carrying values in excess of market. Certain factors could impact the realizable value of inventory, so the Company continually evaluates the recoverability based on assumptions about customer demand and market conditions. The evaluation may take into consideration historical usage, inventory aging, expiration date, expected demand, anticipated sales price, new product development schedules, the effect new products might have on the sale of existing products, product obsolescence, customer concentrations, and other factors. The reserve or write-down is equal to the difference between the cost of inventory and the estimated net realizable value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than those projected by management, additional inventory reserves or write-downs may be required that could negatively impact the Company’s gross margin and operating results. If actual market conditions are more favorable, the Company may have higher gross margin when products that have been previously reserved or written down are eventually sold.
(l) Property and equipment, net
Property and equipment are carried at cost less accumulated depreciation and amortization. Depreciation is calculated on a straight-line basis over the following estimated useful lives.
The estimated useful lives are as follows:
 
    
Useful years
Warehouse equipment    3 - 5 years
Furniture, computer and office equipment    3 - 5 years
Vehicles    5 years
Software    10 years
Leasehold improvements    Over the shorter of the expected life of leasehold improvements or the lease term
Expenditures for maintenance and repairs are expensed as incurred. The gain or loss on the disposal of property and equipment is the difference between the net sales proceeds and the carrying amount of the relevant assets and is recognized in the consolidated statements of loss and comprehensive loss.
 
F-21

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
2.
Principal Accounting Policies (continued)
 
(m) Intangible assets, net
Intangible assets purchased from third parties are initially recorded at cost. The Company performs valuation of the intangible assets arising from business combinations to determine the relative fair value to be assigned to each asset acquired. The intangible assets are amortized using the straight-line method over the estimated useful lives of the assets.
The estimated useful lives of intangible assets are as follows:
 
    
Useful years
Trademark    10 years
Dealership    10 years
License    4.5 years
The estimated life of amortized intangibles is reassessed if circumstances occur that indicate the life has changed.
(n) Goodwill
Goodwill represents the excess of the purchase price over the fair value of the identifiable assets and liabilities acquired in a business combination. Goodwill is not amortized but is tested for impairment on an annual basis as of March 31, and in between annual tests when an event occurs or circumstances change that could indicate that the asset might be impaired.
In accordance with ASU
No. 2017-04,
“Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment” (“ASU
2017-04”),
which removes the requirement to compare the implied fair value of goodwill with its carrying amount as part of step 2 of the goodwill impairment test. Management conducts its goodwill impairment assessment as of March 31 annually or more frequently if events or changes in circumstances indicate that it may be impaired. The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill, so as to perform the quantitative goodwill impairment test. If determined to be necessary, the quantitative impairment test is used to identify goodwill impairment by comparing the fair value of a reporting unit with its carrying amount and recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. The loss recognized should not exceed the total amount of goodwill allocated to that reporting unit.
As there is only one reporting unit in the Company, the goodwill assessment was performed for the Company on consolidated level as one reporting unit.
(o) Long-term investments
The Company’s investments include equity method investments, equity securities with readily determinable fair values and
available-for-sale
debt securities.
The Company applies the equity method of accounting to account for an equity investment, in common stock or
in-substance
common stock, according to ASC 323 “Investment—Equity Method and Joint Ventures”, over which it has significant influence but does not own a majority equity interest or otherwise control. Under the equity method, the Company’s share of the post-acquisition profits or losses of the equity investees are recorded in share of results of equity investees in the consolidated statements of loss and comprehensive loss. The excess of the carrying amount of the investment over the underlying equity in net assets of the equity investee, if any, represents goodwill and intangible assets acquired. When the Company’s share of losses in the equity investee equals or exceeds its interest in the equity investee, the Company does not recognize further losses, unless the Company has incurred obligations or made payments or guarantees on behalf of the equity investee.
Equity securities with readily determinable fair values are measured and recorded at fair value on a recurring basis with changes in fair value, whether realized or unrealized, recorded through the income statement.
 
F-22

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
2.
Principal Accounting Policies (continued)
(o) Long-term investments (continued)
 
Debt securities that the Company has the intent to hold the security for an indefinite period or may sell the security in response to the changes in economic conditions are classified as
available-for-sale
debt securities and reported at fair value. Unrealized gains and losses (other than impairment losses) are reported, net of the related tax effect, in other comprehensive income (loss). Upon sale, realized gains and losses are reported in net income (loss).
The Company continually reviews its investments to determine whether a decline in fair value to below the carrying value is other-than-temporary. The primary factors the Company considers in its determination are the duration and severity of the decline in fair value; the financial condition, operating performance and the prospects of the equity investee; and other company specific information such as recent financing rounds. If the decline in fair value is deemed to be other-than-temporary, the carrying value of the investment is written down to fair value.
(p) Impairment of long-lived assets other than goodwill
Long-lived assets (including property and equipment and amortizable intangible assets) are evaluated for impairment whenever events or changes in circumstances (such as a significant adverse change to market conditions that will impact the future use of the assets) indicate that the carrying amount may not be fully recoverable or that the useful life is shorter than the Company had originally estimated. When these events occur, the Company evaluates the impairment by comparing carrying value of the assets to an estimate of future undiscounted cash flows expected to be generated from the use of the assets and their eventual disposition. If the sum of the expected future undiscounted cash flows is less than the carrying value of the assets, the Company recognizes an impairment loss based on the excess of the carrying value of the assets over the fair value of the assets. No impairment charges were recognized for the years ended March 31, 2021, 2022 and 2023.
(q) Revenue recognition
In May 2014, the FASB issued ASU
No. 2014-09,
“Revenue from Contracts with Customers (Topic 606)” (“ASU
2014-09”)
and subsequently, the FASB issued several amendments which amends certain aspects of the guidance in ASC
2014-09
(ASU
No. 2014-09
and the related amendments are collectively referred to as “ASC 606”). According to ASC 606, revenue is recognized when control of the promised good or service is transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services.
Consistent with the criteria of Topic 606, the Company follows five steps for its revenue recognition: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the entity satisfies a performance obligation. Revenue arrangements with multiple performance obligations are divided into separate distinct goods or services. The Company allocates the transaction price to each performance obligation based on the relative standalone selling price of the goods or services provided. The Company’s revenues are primarily derived from (i) product sales and (ii) online marketing and information services and other revenue.
When either party to a contract has performed, the Company presents the contract in the statement of financial position as a contract asset or a contract liability, depending on the relationship between the entity’s performance and the customer’s payment. A receivable is recorded when the Company has an unconditional right to consideration. A right to consideration is unconditional if only the passage of time is required before payment of that consideration is due. A contract asset is recorded when the Company has transferred products or services to the customer before payment is received or is due, and the Company’s right to consideration is conditional on future performance or other factors in the contract. No contract asset was recorded as of March 31, 2022 and 2023. The Company’s contract liabilities consist of payments received or awards to customers (in the form of Boqii Beans) related to unsatisfied performance obligations at the end of the period. As of April 1, 2021 and 2022, the Company’s total contract liabilities were RMB3.9 million and RMB7.0 million, respectively, of which RMB3.6 million and RMB3.0 million were recognized as revenue for the years ended March 31, 2022 and 2023. The Company’s total unearned revenue was RMB4.5 million as of March 31, 2023.
Revenue is recorded net of value-added tax.
 
F-23

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
2.
Principal Accounting Policies (continued)
(q) Revenue recognition (continued)
 
Revenue recognition policies for each type of revenue steam are as follows:
Sales of merchandise
The Company primarily sells pet products through online stores to individual online customers. Besides online sales, the Company also sells products through offline channels to its business customers and pet stores across the country. The Company recognizes the product revenues from products sales on a gross basis as the Company is acting as a principal in these transactions. The Company has obtained control of the products before they are transferred to customers. The Company is primarily obligated in these transactions, is subject to inventory risk or has the ability to direct the use of inventory, and has latitude in establishing prices and selecting suppliers. Revenue is recognized when consumers physically accept the products after delivery, which is when the control of products is transferred, and is recorded net of return allowances and rebates to pet stores.
The Company also enters into arrangements with its business partners to sell their products on the Company’s online stores. The Company considers the arrangements meet the indicators of consignment arrangement under ASC
606-10-55-80,
because (i) the business partners do not relinquish control of the products, even though the Company has physical possession of the goods. The Company does not control the underlying products, which are considered to be the business partners’ inventory until they are sold to the end consumers; (ii) the business partner retains the right to require the return of the goods held by the Company; (iii) the Company has no obligation to pay for the products that are in its physical possession; and (iv) the Company has no discretion in establishing prices of the products provided by its business partners. Upon successful sales, the Company will charge the business partners a negotiated amount or a fixed rate commission fee based on the sales amount. Commission revenues are recognized on a net basis at the point of consumers’ acceptance of products, net of return allowance.
Online marketing and information services and other revenue
The Company provides online marketing and information services to third-parties on the Company’s various channels and third-party platforms, including but not limited to advertising placements, organizing online and offline marketing campaigns featuring social media influencers and circulating marketing messages to end consumers. With respect to the Company’s marketing services, length of the periods over which services are provided are generally within months or less, revenue from such arrangements is recognized ratably over the service period, as the third-party simultaneously consumes the benefits when the advertisement is displayed or the campaign is ongoing.
The Company also provides warehouse services. The warehouse services include warehousing, packaging, dispatching and other services. Revenue is primarily recognized when the services are rendered.
(r) Sales returns
The Company offers online consumers an unconditional right of return for a period of seven days upon receipt of products. Return allowances, which reduce revenue and cost of sales, are estimated by categories of return policies offered to online customers, based on historical data the Company has maintained, and subject to adjustments to the extent that actual returns differ or are expected to differ.
(s) Sales incentives
The Company adopted a customer reward program, under which the Company grants certain units (“Boqii Bean”) to its customers at its discretion in different situations. Boqii Beans are not redeemable for cash and can be used as a coupon for the customer’s future purchase on the Boqii Marketplace and Boqii.com. The value of ten units of Boqii Bean is equivalent to one RMB yuan before taking into account the impact of breakage.
 
F-24

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
2.
Principal Accounting Policies (continued)
(s) Sales incentives (continued)
 
For the Boqii Beans that are granted with concurrent revenue transactions, the allocated transaction price based on its relative standalone selling price are recognized as reduction of the revenue and accrued for as contract liabilities. As customers redeem awards, the accrued liability is reduced correspondingly. For the Boqii Beans that are granted without concurrent revenue transactions, they are not accounted for when granted and are recognized as a reduction of revenue when they are applied in future sales.
The Company also has a coupon program, through which the Company grants coupons to online customers when they make a successful purchase order, finish first registration on Boqii Marketplace or comment on products. When a coupon is granted concurrent with a revenue transaction, the Company accounts for the estimated cost of future usage of the coupon as reduction of the revenue. When a coupon is not granted concurrent with a revenue transaction, they are not accounted for when they are granted and are recognized as a reduction of revenue when they are applied in future sales.
(t) Cost of revenue
Cost of revenue consist of cost of product sales of RMB820.3 million, RMB930.4 million and RMB842.7 million for the years ended March 31, 2021, 2022 and 2023, respectively, and cost of services of RMB3.4million, RMB13.3million and RMB15.9
 million for the years ended March 31, 2021, 2022 and 2023, respectively. Cost of product sales comprise the purchase price of products, vendor rebates and inventory write-downs. Cost of products does not include other costs such as shipping and handling expense, payroll and benefits of logistic staff, and logistic centers rental expenses. Cost of service consists of the advertising and promotion costs, employee wages and benefits in connection with the Company’s provision of marketing and information services including the fees that the Company paid to third-parties for advertising and promotion on various online and offline channels. 
(u) Vendor rebates
The Company periodically receives consideration from certain vendors, representing rebates for products sold over a period of time. The Company accounts for the rebates received from its vendors as a reduction to the price it pays for the products purchased. Rebates are earned based on reaching minimum purchased thresholds for a specified period. When volume rebates can be reasonably estimated based on the Company’s past experience, current forecasts and purchase volume, a portion of the rebate is recognized as the Company makes progress towards the purchase threshold.
(v) Fulfillment expenses
Fulfillment costs primarily represent warehousing, shipping and handling expenses for dispatching and delivering products to consumers, employee wages and benefits for the relevant personnel, customs clearance expenses and other related transaction costs.
(w) Sales and marketing expenses
Sales and marketing expenses comprise primarily of advertising expenses, third-party platforms commission fee, employee wages, rental expenses and benefits for sales and marketing staff, depreciation expenses and other daily expenses which are related to the sales and marketing functions.
Advertising expenses consist primarily of customer acquisition cost and costs for the promotion of corporate image and product marketing. The Company expenses all advertising costs as incurred and classifies these costs under sales and marketing expenses. For the years ended March 31, 2021, 2022 and 2023, the advertising expenses were RMB83 million, RMB81 million and RMB44 million, respectively.
 
F-25

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
2.
Principal Accounting Policies (continued)
 
(x) General and administrative expenses
General and administrative expenses consist of employee wages and benefits for corporate employees, research and development expenses and other expenses which are related to the general corporate functions, including accounting, finance, tax, legal and human resources, costs associated with use by these functions of facilities and equipment, such as depreciation expenses, rental and other general corporate related expenses. For the years ended March 31, 2021, 2022 and 2023, the research and development were RMB14.1 million, RMB11.3 million and RMB3.7 million, respectively.
(y) Leases
The Company applied ASC 842, “Leases”, by using the optional transition method at the adoption date without recasting comparative periods. The Company determines if an arrangement is a lease at inception. Operating leases are primarily for office and warehouse space and are included in operating lease
right-of-use
(“ROU”) assets, operating lease liabilities, current and operating lease liabilities,
non-current
on its consolidated balance sheets.
ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. When determining the lease term, the Company includes options to extend or terminate the lease when it is reasonably certain that it will exercise that option, if any. As the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate, which it calculates based on the credit quality of the Company and by comparing interest rates available in the market for similar borrowings, and adjusting this amount based on the impact of collateral over the term of each lease. Lease expense for lease payments is recognized on a straight-line basis over the lease term.
For operating leases with a term of one year or less, the Company has elected to not recognize a lease liability or ROU asset on its consolidated balance sheet. Instead, it recognizes the lease payments as expense on a straight-line basis over the lease term. Short-term lease costs are immaterial to its consolidated statements of loss and comprehensive loss and cash flows.
(z) Government grants
The Company’s PRC based subsidiaries received government subsidies from certain local governments. The government subsidies are granted from time to time at the discretion of the relevant government authorities. These subsidies are granted for general corporate purposes and to support the Group’s ongoing operations in the region Cash subsidies are recorded in other income, net on the consolidated statements of loss and comprehensive loss when received and when all conditions for their receipt have been satisfied. The Group recognized government subsidies of RMB1.1 million, RMB0.2 million and RMB0.3 million for the years ended December 31, 2021, 2022 and 2023, respectively.
(aa) Income taxes
Current income taxes are recorded in accordance with the regulations of the relevant tax jurisdiction. The Company accounts for income taxes under the asset and liability method in accordance with ASC 740,
Income Tax
. Under this method, deferred tax assets and liabilities are recognized for the tax consequences attributable to differences between carrying amounts of existing assets and liabilities in the financial statements and their respective tax basis, and operating loss carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred taxes of a change in tax rates is recognized in the consolidated statements of loss and comprehensive loss in the period of change. Valuation allowances are established when necessary to reduce the amount of deferred tax assets if it is considered more likely than not that amount of the deferred tax assets will not be realized.
 
F-26

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
2.
Principal Accounting Policies (continued)
(aa) Income taxes (continued)
 
Uncertain tax positions
The Company recognizes in its consolidated financial statements the benefit of a tax position if the tax position is “more likely than not” to prevail based on the facts and technical merits of the position. Tax positions that meet the “more likely than not” recognition threshold are measured at the largest amount of tax benefit that has a greater than fifty percent likelihood of being realized upon settlement. The Company estimates its liability for unrecognized tax benefits which are periodically assessed and may be affected by changing interpretations of laws, rulings by tax authorities, changes and/or developments with respect to tax audits, and expiration of the statute of limitations. The ultimate outcome for a particular tax position may not be determined with certainty prior to the conclusion of a tax audit and, in some cases, appeal or litigation process. The actual benefits ultimately realized may differ from the Company’s estimates. As each audit is concluded, adjustments, if any, are recorded in the Company’s consolidated financial statements in the period in which the audit is concluded. Additionally, in future periods, changes in facts, circumstances and new information may require the Company to adjust the recognition and measurement estimates with regard to individual tax positions. Changes in recognition and measurement estimates are recognized in the period in which the changes occur. As of March 31, 2022 and 2023, the Company did not have any material unrecognized uncertain tax positions.
(ab) Share-based compensation
The Company follows ASC 718 to determine whether a share option should be classified and accounted for as a liability award or equity award. All grants of share-based awards to employees, management and nonemployees classified as equity awards are recognized in the financial statements based on their grant date fair values which are calculated using an option pricing model.
Employees’ share-based compensation awards are measured at the grant date fair value of the awards and recognized as expenses (a) immediately at the grant date if no vesting conditions are required; or (b) for share-based awards granted with only service conditions, using the graded vesting method, net of estimated forfeitures, over the vesting period; or (c) for share-based awards granted with service conditions and the occurrence of an initial public offering (“IPO”) as performance condition, cumulative share-based compensation expenses for the options that have satisfied the service condition should be recorded upon the completion of the IPO, using the graded vesting method.
Under ASC 718, the Company applies the Binominal option pricing model in determining the fair value of options granted. ASC 718 requires forfeiture rates to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from initial estimates. Share-based compensation expense is recorded net of estimated forfeitures such that expense is recorded only for those share-based awards that are expected to vest.
(ac) Net loss per share
Basic net loss per share is computed by dividing net loss attributable to holders of ordinary shares by the weighted average number of ordinary shares outstanding during the year using the
two-class
method. Using the
two-class
method, net profit/loss is allocated between ordinary shares and other participating securities (i.e. preferred shares) based on their participating rights.
Diluted loss per share is calculated by dividing net loss attributable to ordinary shareholders as adjusted for the effect of dilutive ordinary equivalent shares, if any, by the weighted average number of ordinary and dilutive ordinary equivalents shares outstanding during the year/period. Ordinary share equivalents consist of the ordinary shares issuable in connection with the Company’s convertible redeemable preferred shares using the
if-converted
method, and ordinary shares issuable upon the conversion of the share options, using the treasury stock method. Ordinary equivalent shares are not included in the denominator of the diluted earnings per share calculation when inclusion of such shares would be anti-dilutive.
 
F-27

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
2.
Principal Accounting Policies (continued)
 
(ad) Comprehensive loss
Comprehensive loss is defined as the changes in shareholders’ equity of the Company during a period transactions and other events and circumstances excluding transactions resulting from investments from shareholders, distributions to shareholders, accretions on convertible redeemable preferred shares and modification and extinguishment of convertible redeemable preferred shares. Comprehensive loss for the periods presented includes net loss, foreign currency translation adjustments and unrealized securities holding gains (losses).
(ae) Segment reporting
ASC 280,
Segment Reporting
, establishes standards for companies to report in their financial statements information about operating segments, products, services, geographic areas, and major customers.
Based on the criteria established by ASC 280, the Company’s chief operating decision maker (“CODM”) has been identified as the Chief Executive Officer, who reviews consolidated results when making decisions about allocating resources and assessing performance of the Company. As a whole and hence, the Company has only one reportable segment. The Company does not distinguish between markets or segments for the purpose of internal reporting. As the Company’s long-lived assets are substantially located in the PRC and substantially all the Company’s revenue are derived from within the PRC, no geographical segments are presented.
(af) Recent accounting pronouncements
The Company qualifies as an “emerging growth company”, or EGC, pursuant to the Jumpstart Our Business Startups Act of 2012, as amended, or the JOBS Act. As an EGC, the Company does not need to comply with any new or revised financial accounting standards until such date that a private company is otherwise required to comply with such new or revised accounting standards. The Company adopts the following standards based on extended transition period provided to private companies or early adopts as necessary as permitted by the respective standards.
New and Amended Standards Adopted by the Company:
In August 2020, the FASB issued ASU
2020-06,
“Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic
815-40),”
which removes certain separation models for convertible debt instruments and convertible preferred stock that require the separation of a convertible debt instrument into a debt component and an equity or derivative component. The ASU also expands disclosure requirements for convertible instruments and simplifies areas of the guidance for diluted
earnings-per-share
calculations that are impacted by the amendments. The standard is effective for interim and annual periods beginning after December 15, 2021, with early adoption permitted. The adoption of this standard did not have a material impact on the Company’s disclosures.
New and amended standards not yet adopted by the Company:
In June 2016, the FASB issued ASU
2016-13,
Financial Instruments—Credit Losses (Topic 326), to provide financial statement users with more useful information about expected credit losses. ASU
2016-13
also changes how entities measure credit losses on financial instruments and the timing of when such losses are recorded. The FASB further issued Accounting Standards Update No. 2019-10, “Financial Instruments-Credit Losses (Topic 326): Effective Dates,”. According to ASU 2019-10, for public business entities that are U.S. SEC filers, the amendments in this Update are effective for fiscal years beginning after December 15, 2019. For all other entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company elected to use the extended transition period for complying with any new or revised financial accounting standards. Therefore, the Company elected to adopt this new guidance for the year ended March 31, 2024, including interim periods in the year ended March 31, 2024. The Company is in the process of evaluating the impact of this accounting standard on its consolidated financial statements.
In October 2021, the FASB issued
ASU 2021-08, “Business
Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”, which require that an entity (acquirer) recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. At the acquisition date, an acquirer should account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts. The amendments in this Update also provide certain practical expedients for acquirers when recognizing and measuring acquired contract assets and contract liabilities from revenue contracts in a business combination. The standard is effective for interim and annual periods beginning after December 15, 2022, with early adoption permitted. The Company is evaluating the impact of the adoption of this guidance on its consolidated financial statements.
 
F-28

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
2.
Principal Accounting Policies (continued)
(af) Recent accounting pronouncements (continued)
 
In March 2022, the FASB issued ASU
2022-02,
Troubled Debt Restructurings and Vintage Disclosures. This ASU eliminates the accounting guidance for troubled debt restructurings by creditors that have adopted ASU
2016-13,
Measurement of Credit Losses on Financial Instruments. This ASU also enhances the disclosure requirements for certain loan refinancing and restructurings by creditors when a borrower is experiencing financial difficulty. In addition, the ASU amends the guidance on vintage disclosures to require entities to disclose current period gross write-offs by year of origination for financing receivables and net investments in leases within the scope of ASC
326-20.
The ASU is effective for annual periods beginning after December 15, 2022, including interim periods within those fiscal years. Adoption of the ASU would be applied prospectively. The Company is evaluating the impact of the adoption of this guidance on its consolidated financial statements.
In June 2022, the FASB issued ASU
2022-03
Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. The update clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The update also clarifies that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. The update also requires certain additional disclosures for equity securities subject to contractual sale restrictions. The amendments in this update are effective for the Company beginning January 1, 2024 on a prospective basis. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is in the process of evaluating the impact of the new guidance on its consolidated financial statements.
 
3.
Business combinations
For the year ended March 31, 2022, the Company has completed the below business combination. The results of the acquired entities’ operations have been included in the Company’s consolidated financial statements since their respective dates of acquisition.
(a) Chongni Network Technology (Shanghai) Co., Ltd (“Chongni Network”)
In October 2018, the Company acquired 49% equity interest of Chongni Network, an offline trading company incorporated in the PRC. According to the investment agreement, the Company was entitled to appoint a director to Chongni Network (out of total three board seats). The Company accounted this investment using equity method. In May 2021, the Company entered into an agreement with Chongni to purchase additional equity interest of Chongni Network with total cash consideration of RMB2.9 million.
Upon the acquisition of additional interests in Chongni Network, on June 30, 2021, the date of acquisition, the Company’s equity interests in Chongni network was increased from 49% to 63.65% with the right to appoint 2 out of 3 of Chongni Network’s board of directors, and have obtained control over Chongni Network thereon. The Company accounted for this transaction as a step acquisition with the total purchase consideration of RMB3.2 million, which included the cash consideration of RMB2.9 million, and the fair value of the previously held 49% equity interest of Chongni Network in an amount of RMB0.3 million. A gain of RMB0.1 million in relation to the revaluation of the previously held equity interests was recorded in other gains, net in the consolidated statement of loss and comprehensive loss for the year ended March 31, 2022. The fair value of the previously held equity interests was estimated based on the acquisition price of the additional interests of Chongni Network.
 
F-29

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
3.
Business combinations (continued)
 
On the acquisition date, the allocation of the purchase price of the assets acquired and liabilities assumed based on their fair values was as follows:
 
     As of June 30, 2021  
     RMB  
Total purchase price is comprised of:
  
- fair value of 49% previously held equity interests
     245  
- cash consideration
     2,938  
  
 
 
 
Fair value of total consideration
     3,183  
  
 
 
 
 
     As of June 30, 2021  
     RMB  
Cash and cash equivalents
     2  
Prepayments and other current assets
     4,533  
  
 
 
 
Total assets
     4,535  
  
 
 
 
Accrued liabilities and other current liabilities
     (33
  
 
 
 
Total liabilities
     (33
  
 
 
 
Net assets acquired
     4,502  
  
 
 
 
Goodwill
     499  
Non-controlling
interests
     (1,818
  
 
 
 
Total
     3,183  
  
 
 
 
The acquired business contributed revenues of nil and loss of RMB0.08 million to the Company for the period from June 30, 2021 to March 31, 2022. Pro forma results of operations for the acquisition have not been presented because they are not material to the consolidated statements of loss and comprehensive losses for the year ended March 31, 2021 and 2022.
 
4.
Risks and Concentration
(a) Foreign currency exchange rate risk
The Company may experience economic losses and negative impacts on earnings and equity as a result of fluctuations in the exchange rate between the US$ and the RMB. The depreciation of RMB against US$ was approximately 2.3% in 2021. The appreciation of RMB against US$ was approximately 8.5% in 2022. It is difficult to predict how market forces or the PRC or the U.S. government policy may impact the exchange rate between RMB and US$ in the future.
(b) Interest rate risk
Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company’s interest rate risk arises primarily from long-term borrowings. Borrowings issued at variable rates and fixed rates expose the Company to cash flow interest rate risk and fair value interest rate risk respectively.
(c) Concentration of credit risk
Financial instruments that potentially subject the Company to the concentration of credit risks consist of cash and cash equivalents, short-term investment, accounts receivable and amounts due from related parties. The maximum exposures of such assets to credit risk are their carrying amounts as of the balance sheet dates. The Company deposits its cash and cash equivalents and short-term investment with financial institutions located in jurisdictions where the subsidiaries are located. The Company believes that no significant credit risk exists as these financial institutions have high credit quality.
 
F-30

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
4.
Risks and Concentration (continued)
(c) Concentration of credit risk (continued)
 
Accounts receivable are typically unsecured and are derived from revenue earned through third-party consumers. The Company conducts credit evaluations of third-party customers and related parties, and generally does not require collateral or other security from its third-party customers and related parties. The Company establishes an allowance for doubtful accounts primarily based upon the age of the receivables and factors surrounding the credit risk of specific third-party customers and related parties.
(d) Concentration of customers and suppliers
Substantially all revenue was derived from customers located in China. There are no customers from whom revenues individually represent greater than 10% of the total revenues of the Company in any of the periods presented.
The information of the supplier with greater than 10% of the total purchases of the Company for the years ended March 31, 2021, 2022 and 2023 was as follows:
 
    
Year Ended

March 31, 2021
   
Year Ended

March 31, 2022
   
Year Ended

March 31, 2023
 
     RMB     RMB     RMB  
Royal Canin China Co., Ltd.
     19     17     22
 
5.
Cash and cash equivalents
Cash and cash equivalents represent cash on hand and demand deposits placed with banks and third party-payment processors, which are unrestricted as to withdrawal or use. Cash and cash equivalents balance as of March 31, 2022 and March 31, 2023 primarily consist of the following currencies:
 
    
As of March 31, 2022
    
As of March 31, 2023
 
    
Amount
    
RMB
equivalent
    
Amount
    
RMB
equivalent
 
RMB
     47,321        47,321        62,727        62,727  
Hong Kong
dollars
     39        31        7        6  
US$
     18,133        115,110        3,946        27,114  
EUR
     55        392                  2  
NZD
               1                  1  
     
 
 
       
 
 
 
Total
        162,855           89,850  
     
 
 
       
 
 
 
 
6.
Accounts receivable, net
Accounts receivable consist of the following:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Accounts receivable - Product sales
     42,070        71,471  
Accounts receivable - Online marketing and information service and other service
     7,630        5,873  
Allowance of doubtful accounts
     (469      (602
  
 
 
    
 
 
 
Total
     49,231        76,742  
  
 
 
    
 
 
 
 
F-31

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
6.
Accounts receivable, net (continued)
 
Movement of allowance of doubtful accounts
 
    
As of March 31,
2021
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
    
RMB
 
At beginning of year
     363        256        469  
Addition/(reversal)
     (107      213        133  
  
 
 
    
 
 
    
 
 
 
At end of year
     256        469        602  
  
 
 
    
 
 
    
 
 
 
 
7.
Inventories, net of inventory reserves
Inventories, net of inventory reserves consist of the following:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Products
     109,383        80,431  
Packaging materials and others
     538        621  
  
 
 
    
 
 
 
Total inventories, net of inventory reserves
     109,921        81,052  
  
 
 
    
 
 
 
Movement of inventory provision:
 
    
As of March 31,
2021
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
    
RMB
 
At beginning of year
     273        266        577  
Provision/(reversal)
     (7      311        35  
  
 
 
    
 
 
    
 
 
 
At end of year
     266        577        612  
  
 
 
    
 
 
    
 
 
 
The total amounts charged to the consolidated statements of loss and comprehensive loss for (reversal)/provision of inventory reserves amounted to approximately RMB(0.007) million, RMB0.31 million and RMB0.035 million for the years ended March 31, 2021, 2022 and 2023, respectively.
 
8.
Prepayments and other current assets
The prepayments and other current assets consist of the following:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Prepayments for purchases of products (a)
     52,348        24,216  
Vendor rebate receivables (b)
     24,462        16,160  
Value-added tax (“VAT”) deductible (c)
     18,864        10,512  
Loan receivables (d)
     3,845        9,886  
Sales return assets
     1,264        2,835  
Deposits
     1,312        999  
Others
     14,643        14,751  
  
 
 
    
 
 
 
Total
     116,738        79,359  
  
 
 
    
 
 
 
 
F-32

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
8.
Prepayments and other current assets (continued)
 
(a) Prepayments for purchases of products represent cash prepaid to the Company’s third-party brand partners for the procurement of products.
(b) Vendor rebate receivables represent the rebates to be received by the Company from its suppliers after certain levels of purchases are achieved.
(c) VAT recoverable represents the balances that the Company can utilize to deduct its value-added tax liabilities within the next 12 months.
(d) The balance represents loan receivables due from certain third-party companies and individuals. From July 2020 to March 2023, the Company entered into several loan agreements with aggregate principal amount of RMB11.0 million. The maturity dates of these loans are from October 2023 to March 2024. The interest rates ranged from 0% to 4% per annum. As of March 31, 2022 and 2023, the balances of loan receivables were RMB3.8 million and RMB9.9 million, respectively.
 
9.
Property and equipment, net
Property and equipment consist of the following:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Cost:
     
Warehouse equipment
     2,669        2,879  
Furniture, computer and office equipment
     7,503        7,082  
Vehicles
     3,684        4,740  
Leasehold improvement
     10,209        10,501  
Software
     2,995        3,009  
  
 
 
    
 
 
 
Total cost
     27,060        28,211  
Less: Accumulated depreciation
     (19,281      (22,719
  
 
 
    
 
 
 
Property and equipment, net
     7,779        5,492  
  
 
 
    
 
 
 
The total amounts charged to the consolidated statements of loss and comprehensive loss for depreciation and amortization expenses amounted to approximately RMB3.08 million, RMB3.7 million and RMB3.8 million for the years ended March 31, 2021, 2022 and 2023, respectively.
 
10.
Intangible assets, net
Intangible assets of the Company were mainly as follows:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Cost:
     
Trademark
     437        486  
License
     3,530        3,530  
Dealership
     31,717        31,717  
  
 
 
    
 
 
 
Total cost
     35,684        35,733  
Less: Accumulated amortization
     (10,140      (14,139
  
 
 
    
 
 
 
Intangible assets, net
     25,544        21,594  
  
 
 
    
 
 
 
 
F-33

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
10.
Intangible assets, net (continued)
 
License and dealership resulting from the business combinations completed during the year ended March 31,2021 have been allocated to the single reporting unit of the Company. The total carrying amount of intangible assets resulting from the business combinations were 
RMB 25.5 million and RMB 21.6 million as of March 31, 2022 and 2023, respectively.
The total amortization expenses of the intangible assets charged to the consolidated statements of loss and comprehensive loss amounted to approximately RMB4.0 million, RMB4.0 million and RMB4.0 million for the years ended March 31, 2021, 2022 and 2023, respectively.
The annual estimated amortization expense for intangible assets subject to amortization for the succeeding five years is as follows:
 
    
As of March 31,
 
    
2024
    
2025
    
2026
    
2027
    
2028
 
Amortization expenses
     3,867        3,438        3,207        3,203        3,187  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
11.
Long-term investments
The Company’s long-term investments consist of the following:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Equity method investments
     6,783        7,494  
Available-for-sale
investments
     74,866        68,011  
Equity securities with readily determinable fair values
     670        102  
    
 
 
    
 
 
 
Total
     82,319        75,607  
    
 
 
    
 
 
 
Equity method investments
The Company applies equity method in accounting for its investments in entities in which the Company has the ability to exercise significant influence but does not have control. As of March 31, 2022 and 2023, the carrying value of the equity method investments were RMB6.8 million and RMB7.5
 million respectively, the change of which primarily relates to the equity gain recognized and the following investments which were accounted for as equity method investment: 
In April 2019, the Company invested in Jiangsu Nanjing Agricultural University Animal Pharmaceutical Co., Ltd. (“Nanjing Animal Pharmaceutical”) to purchase 8.42% equity interest with total cash consideration of RMB2.5
 million. As the Company is able to exercise significant influence through its entitlement to appoint one director, the Company therefore accounts for this investment under the equity method of accounting. In December 2022, the Company disposed all of its equity interest in Nanjing Animal Pharmaceutical with a total cash consideration of RMB 
3 million. Accordingly, the Company recognized an investment gain of RMB0.54 million in other gains, net.
The Company had 24.6
% equity interests in Wuhan Chunzhijin Information Technology Co., Ltd. (“Chunzhijin”), which was accounted using equity method. The Company also provided loan to Chunzhijin (Note 28). In March 2023, the Company further invested in Chunzhijin to purchase 
13.3% of the equity interest by waiving a loan receivable of RMB 3.4 million from Chunzhijin. After this transaction, together with the previously held equity interest in Chunzhijin, the total equity interest held by the Company increased to 34.65%. The Company continues to have significant influence over Chunzhijin and accounts for this investment under equity method.
 
F-34

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
11.
Long-term investments (continued)
 
Available-for-sale
debt investments
The following table summarizes the Company’s
available-for-sale
debt investments as of March 31, 2022:
 
     Cost      Gross unrealized gains      Gross unrealized losses    
Disposal of Long-term

investments
     Fair value  
Unlisted debt securities
     76,000                  (1,134               74,866  
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
 
The following table summarizes the Company’s
available-for-sale
debt investments as of March 31, 2023:
 
     Cost      Gross unrealized gains      Gross unrealized losses    
Disposal of Long-term
investments
    Fair value  
Unlisted debt securities
     76,000                  (7,561     (428     68,011  
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
The Company held 6.2% shareholding of Qingdao Shuangan Biotechnology Co., Ltd (“Qingdao Shuangan”). According to the investment agreement, the Company is entitled to redemption right after 48 months from the investment closing date. In April 2022, the Company transferred 0.31% shareholding of Qingdao Shuangan to a third-party investor with a cash consideration of RMB0.8 million. The Company recognized a RMB0.37 million investment gain in other gains, net. After the completion of the transaction, the shareholding of Qingdao Shuangan held by the Company was 5.9%. As of March 31, 2022 and 2023, based on the valuation results, the Company
re-measured
the investment in Qingdao Shuangan at fair value of RMB17.8 million and RMB12.8
 million, respectively. For the years ended March 31, 2021, 2022 and 2023, the unrealized securities holding gains/(losses) (net of tax) of RMB0.02 million, RMB
0.34 million and RMB(1.14) million was recorded as other comprehensive income, respectively.
In October 2019, the Company purchased 23.64% shareholding of Beijing Petdog Technology Development Co., Ltd. (“Beijing Petdog”) with a cash consideration of RMB50 million. According to the investment agreement, the Company is entitled to redemption right after 60
 months from the investment closing date. As of March 31, 2021, 2022 and 2023, based on the valuation results, the Company re-measured the investment at fair value of RMB
40.1 million and RMB33.7
 million, respectively. For year ended March 31, 2022 and 2023, the unrealized securities holding gains/(losses) (net of tax) of RMB0.75 million, RMB(10.4) million and RMB(6.4) million was recorded as other comprehensive income/(loss), respectively. 
In July and November 2021, the Company entered into investment agreements with Nanjing Animal Pharmaceutical. The Company provided Nanjing Animal Pharmaceutical
one-year
loans amounting to RMB16 million carrying a simple interest of 8% per annum. Together with the loan, the Company was also entitled a conversion right to convert all or part of the loan
s
into 3.33% equity interest of Nanjing Animal Pharmaceutical during the loan term
s
. As of March 31, 2022 and 2023, RMB 2 million was unpaid and recorded in accrued liabilities and other current liabilities. The Company recognized the investment under available for sale debt securities. It was measured and recognized at fair value on a recurring basis with changes in fair value recorded in other comprehensive income/(loss). As of March 31, 2022 and 2023, based on the valuation results, the Company
re-measured
the investment at fair value of RMB16.9 million and RMB18.0 million, respectively. For year ended March 31, 2022 and 2023, the unrealized securities holding gains (net of tax) of RMB0.71 million and RMB0.83 million was recorded as other comprehensive income/(loss), respectively.
Equity securities with readily determinable fair values
The following table summarizes the Company’s equity securities with readily determinable fair values as of March 31, 2022:
 
     Cost      Gross unrealized gains      Gross unrealized losses      Fair value  
Listed company
     1,292                  (622      670  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
F-35

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
11.
Long-term investments (continued)
 
Equity securities with readily determinable fair values (continued)
The following table summarizes the Company’s equity securities with readily determinable fair values as of March 31, 2023:
 
     Cost      Gross unrealized gains      Gross unrealized losses      Fair value  
Listed company
     1,292                  (1,190      102  
  
 
 
    
 
 
    
 
 
    
 
 
 
In June 2021, the Company purchased 40,000 ordinary shares of Better Choice Company Inc. (“BTTR”), a company registered on NYSE American and engaging in selling pet products with a total cash consideration of US$200,000. The Company measured and recorded the investment at fair value on a recurring basis with changes in fair value, whether realized or unrealized, recorded through the income statement. The change of fair value is reported in other gains, net.
 
12.
Goodwill
The changes in the carrying amount of goodwill for the years ended March 31, 2022 and 2023 were as follows:
 
     Total  
     RMB  
Balance as of March 31, 2021
  
Goodwill
     40,184  
Accumulated impairment loss
         
  
 
 
 
     40,184  
  
 
 
 
Transaction during the year
  
Addition (Note 3)
     500  
  
 
 
 
Balance as of March 31, 2022
  
Goodwill
     40,684  
Accumulated impairment loss
         
  
 
 
 
     40,684  
  
 
 
 
Transaction during the year
  
Impairment
     (40,684
  
 
 
 
Balance as of March 31, 2023
  
Goodwill
     40,684  
Accumulated impairment loss
     (40,684
  
 
 
 
         
  
 
 
 
In the second half of fiscal year 2023, the Covid-19 resurgence in certain areas of China and the market downturn impact on our operations caused a triggering event for possible impairment of goodwill. Together with other indicators such as history of net losses and low market capitalization of us, as a result, management concluded the existence of the impairment indicator which required the Company to perform a quantitative goodwill impairment test as of March 31, 2023. Since there is only one reporting unit in the Company, management used the market capitalization to determine the reporting unit’s fair value. Based on quantitative goodwill impairment test, the fair value of the reporting unit was RMB119.8 million (US$17.4 million), which was lower than the carrying value of our net assets of RMB213.0 million (US$31.0 million) as of March 31, 2023, hence a full impairment charge of RMB40.7 million (US$5.9 million) was recognized during the year ended March 31, 2023.
 
13.
Other
non-current
Assets
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Deposits (a)
     3,924        3,165  
Long-term loan receivables (b)
     937        3,421  
  
 
 
    
 
 
 
     4,861        6,586  
  
 
 
    
 
 
 
(a) Deposits mainly consisted of rental deposits and deposit for online stores operated on third party platforms, which will be collected after one year.
(b) From May 2021 to May 2022, the Company entered into interest free loan agreements with three third parties for total principal amounts of RMB3.4 million. The repayment terms of the loan agreements were ranged from 24 months to 36 months with due dates from May 2024 to June 2025. As of March 31, 2022 and 2023, the balances of long-term loan receivables were RMB0.9 million and RMB3.4 million, respectively.
 
F-36

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
14.
Accrued liabilities and other current liabilities
Accrued liabilities and other current liabilities consist of the following:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Logistics expenses payables
     14,625        7,663  
Advances from customers
     3,773        3,077  
Payable for investment
     2,563        2,563  
Refund obligation of sales returns
     1,411        3,113  
Professional service fee accruals
     579        1,694  
Accrued advertising expenses
     150        168  
Others
     4,223        3,826  
  
 
 
    
 
 
 
Total
     27,324        22,104  
  
 
 
    
 
 
 
 
15.
Leases
As of March 31, 2022 and 2023, the Company has operating leases recorded on its consolidated balance sheet for certain office spaces and facilities that expire on various dates through 2026. The Company does not plan to cancel the existing lease agreements for its existing facilities prior to their respective expiration dates. When determining the lease term, the Company considers options to extend or terminate the lease when it is reasonably certain that it will exercise or not exercise that option. All of the Company’s leases qualify as operating leases.
 
    
As of March 31,
2022
   
As of March 31,
2023
 
    
RMB
   
RMB
 
Assets
    
Operating lease
right-of-use
assets
     38,567       22,354  
  
 
 
   
 
 
 
Liabilities
    
Operating lease liabilities, current
     10,001       9,220  
Operating lease liabilities,
non-current
     28,197       12,741  
  
 
 
   
 
 
 
Total operating lease liabilities
     38,198       21,961  
  
 
 
   
 
 
 
Weighted average remaining lease term (years)
     3.61       2.77  
Weighted average discount rate
     4.95     5.38
Information related to operating lease activity during the years ended March 31, 2021, 2022 and 2023 are as follows:
 
    
Year ended

March 31, 2021
    
Year ended

March 31, 2022
    
Year ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Operating lease
right-of-use
assets obtained in exchange for lease obligations
     25,970        21,038        8,384  
  
 
 
    
 
 
    
 
 
 
Operating lease related expenses
        
Amortization of
right-of-use
assets
     11,687        11,705        24,597  
Interest of lease liabilities
     1,596        1,949        1,777  
  
 
 
    
 
 
    
 
 
 
     13,283        13,654        26,374  
  
 
 
    
 
 
    
 
 
 
 
F-37
BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
15.
Leases (continued)
 
    
Year ended

March 31, 2021
    
Year ended

March 31, 2022
    
Year ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Operating lease payments (included in measurement of lease liabilities)
     12,850        12,849        26,397  
  
 
 
    
 
 
    
 
 
 
Maturities of lease liabilities were as follows:
 
    
Year ended

March 31, 2023
 
    
RMB
 
For the year ending March 31,
  
2023
     9,902  
2024
     10,287  
2025
     4,263  
2026
     152  
2027
         
  
 
 
 
Total lease payments
     24,604  
Less: imputed interest
     (2,643
  
 
 
 
Total
     21,961  
  
 
 
 
 
16.
Interest expense
 
    
Year ended

March 31, 2021
    
Year ended

March 31, 2022
    
Year ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Amortization charges on promissory notes
     21,611        17,144        9,706  
Interest expense on borrowings
     6,039        3,740        3,644  
  
 
 
    
 
 
    
 
 
 
Total
     27,650        20,884        13,350  
  
 
 
    
 
 
    
 
 
 
 
17.
Other gains, net
 
    
Year ended

March 31, 2021
    
Year ended

March 31, 2022
    
Year ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Gain from the
re-measurement
of the previously held equity interests to the fair value in the step acquisitions (Note 3)
     —          127        —    
Foreign exchange losses, net
     (2,867      5,322        2,679  
Gain on disposal of other debts
     6,846        —          —    
Reimbursement from a depositary bank (a)
     6,556        1,482        —    
Investment loss
               (622      (178
Gain on disposal of a subsidiary (b)
     —          —          3,597  
Others
     797        (289      (939
  
 
 
    
 
 
    
 
 
 
     11,332        6,020        5,159  
  
 
 
    
 
 
    
 
 
 
 
(a)
The Company received a reimbursement of US$1.0M (equivalent to RMB6.6 million), US$0.2M (equivalent to RMB1.5 million) and nil from the depository for the establishment and maintenance of the ADS program for the years ended March 31, 2021, 2022 and 2023.
 
(b)
In August 2022, the Company disposed a subsidiary to a third-party investor and recognized an investment gain of RMB 3.6 million.
 
F-38

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
18.
Income taxes
Cayman Islands
Under the current tax laws of Cayman Islands, the Company and its subsidiaries incorporated in the Cayman Islands are not subject to tax on income or capital gain. Additionally, the Cayman Islands does not impose a withholding tax on payments of dividends to shareholders.
Hong Kong
Under the current Hong Kong Inland Revenue Ordinance, the Company’s subsidiaries incorporated in Hong Kong are subject to a
two-tiered
profits tax rate of 8.25% and 16.5% on its taxable income generated from operations in Hong Kong. Additionally, payments of dividends by the subsidiaries incorporated in Hong Kong to the Company are not subject to income tax.
China
On July 25, 2018, Boqii (Shanghai) Information Technology Co., Ltd. (“Shanghai Boqii”) was entitled to be “Software Enterprises”. According to the Enterprise Income Tax (“EIT”) Law and relevant regulations in the PRC, from the year of 2018, Shanghai Boqii could enjoy a tax holiday of
2-year
EIT exemption and subsequently
3-year
12.5% preferential tax rate.
In addition, Shanghai Boqii was also qualified as a “High and New Technology Enterprise (“HNTE”) on August 29, 2019, and is eligible to enjoy a preferential tax rate of 15% from 2019 to 2024 to the extent it has taxable income under the EIT Law, as long as it maintains the HNTE qualification and duly conducts relevant EIT filing procedures with the relevant tax authority. Shanghai Boqii can
re-apply
for the HNTE certificate when the prior certificate expires. Whilst Shanghai Boqii was entitled to the tax preferential treatments under both “HNTE” and “Software Enterprises”, Shanghai Boqii chose to apply the preferential tax rate of “Software Enterprises”. For the years ended March 31, 2021, 2022 and 2023, Shanghai Boqii was subject to EIT rate at 12.5%, 12.5% and 12.5%, respectively.
The Company’s other subsidiaries, VIEs and VIEs’ subsidiaries established in the PRC are subject to the PRC general income tax rate of 25%.
Reconciliations of the differences between the income tax expenses of the Company and the PRC statutory EIT rate applicable to losses of the consolidated entities are as follows:
 
    
Year ended

March 31, 2021
    
Year ended

March 31, 2022
    
Year ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Loss before income taxes
     (193,391      (134,812      (106,805
Income tax computed at respective applicable tax rates
     (48,348      (33,702      (26,701
Effect of different tax jurisdiction
     14,272        2,341        12,323  
Super deduction for research and development expenses (a)
     (2,632      (1,881      (456
Non-deductible
expenses
     140        97        728  
Change in valuation allowance
     37,439        34,716        15,017  
  
 
 
    
 
 
    
 
 
 
Total
     871        1,571        911  
  
 
 
    
 
 
    
 
 
 
 
  (a)
According to the relevant laws and regulations promulgated by the State Administration of Tax of the PRC, from 2018 onwards, enterprises engaging in research and development activities are entitled to claim 175% of their qualified research and development expenses so incurred as tax deductible expenses. The additional deduction of 75% of qualified research and development expenses (the “Super Deduction”) can be directly claimed in the annual EIT filing. For the years end March 31, 2021, 2022 and 2023, the Super Deduction for research and development expenses available to the Company amounted to RMB2.6 million, RMB1.9 million and RMB0.5 million, respectively.
 
F-39

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
18.
Income taxes (continued)
 
The provisions for income taxes for the years ended March 31, 2021, 2022 and 2023 differ from the amounts computed by applying the EIT primarily due to change in valuation allowance provided and tax differential from certain subsidiaries with preferential tax rates of the Company.
The following table sets forth the effect of tax holiday effect on China operations:
 
    
Year ended

March 31, 2021
    
Year ended

March 31, 2022
    
Year ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Tax holiday effect
     1,074        3,513        1,235  
Basic and diluted net loss per share effect
     0.02        0.05        0.02  
    
 
 
    
 
 
    
 
 
 
Reconciliations between the effective income tax rate and the PRC statutory income tax rates are as follows:
 
    
Year ended

March 31, 2021
   
Year ended

March 31, 2022
   
Year ended

March 31, 2023
 
    
RMB
   
RMB
   
RMB
 
PRC statutory income tax rates
     25     25     25
Tax holiday effect
     1     3     (1 %) 
Difference in tax rates of subsidiaries outside PRC
     (8 %)      (8 %)      (10 %) 
Super deduction for research and development expenses
     1     1     0
Non-deductible
expenses
     0     0     1
Change in valuation allowance
     (19 %)      (20 %)      (14 %) 
    
 
 
   
 
 
   
 
 
 
Effective income tax rate
     0     1     1
    
 
 
   
 
 
   
 
 
 
Composition of income tax expenses
The current and deferred portions of income tax expenses included in the consolidated statements of loss and comprehensive loss are as follows:
 
    
Year ended

March 31, 2021
    
Year ended

March 31, 2022
    
Year ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Current income tax expense/(benefit)
     1,018        (582      78  
Deferred tax benefit
     (1,889      (989      (989
    
 
 
    
 
 
    
 
 
 
Income tax credit, net
     (871      (1,571      (911
    
 
 
    
 
 
    
 
 
 
 
F-40

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
18.
Income taxes (continued)
 
Deferred tax assets and deferred tax liabilities
Deferred taxes were measured using the enacted tax rates for the periods in which they are expected to be reversed. The tax effects of temporary differences that give rise to the deferred tax asset and liabilities balances as of March 31, 2022 and 2023 are as follows:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Deferred tax assets:
                 
Net accumulated loss-carry forward
     172,059        163,526  
Deferred deductible advertising expense
     2,483            
Allowance
     78        238  
Contract liabilities
     419        172  
Accruals
     2,208        842  
Fair Value Change
               1,891  
Less: Valuation allowance
     (177,247      (166,669
    
 
 
    
 
 
 
Net deferred tax assets

 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Deferred tax liabilities:
                 
Recognition of intangible assets arising from asset acquisition and business combination
     (5,130      (4,141
Unrealized fair value change of the
available-for-sale
debt investments
     283            
    
 
 
    
 
 
 
Net deferred tax liabilities
     (4,847      (4,141
    
 
 
    
 
 
 
As of March 31, 2022 and 2023, the PRC entities of the Company had tax loss carryforwards of approximately RMB688 million and RMB654 million respectively, which can be carried forward to offset taxable income. The carryforwards period for net operating losses under the EIT Law is five years. The net operating loss carry forward of the Company will expire in varying amounts between 2024 and 2028. Other than the expiration, there are no other limitations or restrictions upon the Company’s ability to use these operating loss carryforwards.
Valuation allowance is provided against deferred tax assets when the Company determines that it is more likely than not that the deferred tax assets will not be utilized in the future. In making such determination, the Company considered factors including future taxable income exclusive of reversing temporary differences and tax loss carry forwards. If events occur in the future that allow the Company to realize part or all of its deferred income tax, an adjustment to the valuation allowances will result in a decrease in tax expense when those events occur. As of March 31, 2022 and 2023, valuation allowances of RMB177.2 million and RMB166.7 million were provided because it was more likely than not that the Company will not be able to utilize these tax losses carry forwards and other deferred tax assets generated by its subsidiaries and VIEs.
Movement of valuation allowance is as follows:
 
    
Year Ended

March 31, 2021
    
Year Ended

March 31, 2022
    
Year Ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Beginning balance
     112,539        149,978        177,247  
Change of valuation allowance
     37,439        27,269        15,017  
Written-off
for expiration of net operating losses
                         (22,995
Decrease of valuation allowances related to the disposal of a subsidiary
                         (2,600
    
 
 
    
 
 
    
 
 
 
Ending balance
     149,978        177,247        166,669  
    
 
 
    
 
 
    
 
 
 
 
F-41
BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
19.
Ordinary Share
As of March 31, 2022, the Company had 55,709,591 Class A ordinary shares and 13,037,729 Class B ordinary shares issued and outstanding, respectively. As of March 31, 2023, the Company had 55,763,079 Class A ordinary shares and 13,037,729 Class B ordinary shares issued and outstanding, respectively.
Initial public offering
In October 2020, the Company completed its IPO on the New York Stock Exchange of 7,000,000 American Depositary Shares (“ADSs”) (including 1,050,000 ADSs sold upon the full exercise of the underwriters’ over-allotment option) (each representing 0.75 of one Class A ordinary share), for a total ordinary shares offering of 5,250,000 shares at a price of US$10.00 per ADS. The net proceeds raised from the IPO amounted to approximately US$61 million after deducting underwriting discounts and commissions and other offering expenses.
Upon the completion of the IPO, all series of redeemable convertible preferred shares of the Company were converted and designated as Class A ordinary shares with a par value of US$0.001 each on a
one-for-
one basis except for
(i)10,340,000 shares of Series A preferred shares were automatic converted into 7,844,137 ordinary shares on a 1: 0.76 basis, (ii) 9,067,384 shares of Series B preferred shares were automatic converted into 8,557,980 ordinary shares on a 1:0.94 basis, (iii) 6,734,459 shares of Series C+ preferred shares were automatic converted into 6,883,520 ordinary shares on a 1:1.02 basis and (iv) 833,125 shares of Series C preferred shares were converted and designated as Class B ordinary shares with a par value of US$0.001 each on a
one-for-one basis
12,204,604 ordinary shares were designated as Class B ordinary share on a
one-for-one
basis. The remaining ordinary shares were designated as Class A ordinary shares on a
one-for-one
basis.
In respect of all matters subject to shareholders’ vote, each holder of Class A ordinary share is entitled to one and each holder of Class B ordinary share is entitled to twenty votes.
In February 2021, the Company repurchased 521,924 shares of Class A ordinary shares from one of its shareholders with a consideration amounting to US$4.8 million, the repurchased shares were cancelled thereafter.
 
20.
Convertible redeemable preferred shares
The Company issued several series of convertible redeemable preferred shares in previous years. Upon the completion of the IPO, all series of redeemable convertible preferred shares of the Company were converted and designated as Class A ordinary shares (Note 19).
 
F-42

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
20.
Convertible redeemable preferred shares (continued)
 
The Company classified the Preferred Shares in the mezzanine section of the Consolidated Balance Sheets because they were contingently redeemable upon the occurrence of an event outside of the Company’s control (e.g. the Company not achieving a Qualified IPO before the Optional Redemption Date). The Preferred Shares were determined to be mezzanine equity with no embedded feature to be bifurcated and no BCF to be recognized. The Preferred Shares
were
initially recorded at their respective issuance date fair value, net of issuance cost.
Since the Preferred Shares bec
a
me redeemable at the option of the holder at any time after the Optional Redemption Date, for each reporting period, the Company accreted the carrying amount of the Preferred Shares to the higher of (1) the fair market value of the Preferred Shares on the reporting date, or (2) the result of using effective interest rate method to accrete the Preferred Shares to the redemption prices on the Optional Redemption Date that were calculated with
pre-determined
formulas (e.g., for Series A Preferred Shares, such redemption price shall be 180% of the issue price). While all Preferred Shares were automatically converted upon a Qualified IPO, the effectiveness of a Qualified IPO was not within the control of the Company and
was
not deemed probable to occur for accounting purposes until the effective date of the Qualified IPO. As such, the Company continued to recognize accretion of the Preferred Shares until the completion of the IPO on October 2, 2020 when all of the Preferred Shares of the Company were converted to ordinary shares. The accretion of the Preferred Shares was
RMB-121 million
(US$-18million), nil and nil for the years ended March 31, 2021, 2022 and 2023.
 
F-43

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
21.
Redeemable
non-controlling
interests
Yoken Holding Limited (“Yoken”), a wholly owned subsidiary of the Company issued 120,000 redeemable preferred shares amounting to RMB6 million to a third-party investor in October, 2020. The preferred shares are redeemable at the holder’s option if Yoken fails to complete a qualified IPO in a
pre-agreed
period of time since its issuance with a redemption price measured by 10% interest per year. The preferred shares are therefore accounted for as redeemable
non-controlling
interests in mezzanine equity and are accreted to the redemption value over the period starting from the issuance date. The contract terms are the same as the Preferred Shares of the Company.
For the years ended March 31 2021, 2022 and 2023, the Company recognized accretion of RMB0.1 million, RMB0.6 million and RMB0.7 million, respectively, to the respective redemption value of the redeemable non-controlling interest over the period starting from issuance date with a corresponding increase to the accumulated deficit. As of March 31, 2022 and 2023, the redeemable
non-controlling
interests was RMB6.5 million and RMB7.2 million, respectively.
The following tables provides details of the redeemable non-controlling interests activity for the years ended March 31, 2021, 2022 and 2023:
 
    
Year Ended

March 31, 2021
    
Year Ended

March 31, 2022
    
Year Ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Beginning balance
     5,809        5,947        6,522  
Accretion of redeemable non-controlling interests
     138        575        675  
  
 
 
    
 
 
    
 
 
 
Ending balance
     5,947        6,522        7,197  
  
 
 
    
 
 
    
 
 
 
 
22.
Borrowings, other debts and derivative liabilities
Short-term borrowings
The following table presents short-term borrowings from commercial banks, other institutions and individuals as of March 31, 2022 and 2023. Short-term borrowings include borrowings with maturity terms shorter than one year:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Bank borrowings
     134,540        86,261  
Current portion of long-term bank borrowings
     26,586        —    
  
 
 
    
 
 
 
Total
     161,126        86,261  
  
 
 
    
 
 
 
Bank borrowings
As of March 31, 2022 and 2023, the Company obtained short-term bank borrowings of RMB161.1 million and RMB86.3 million in aggregate, of which RMB110.5 million and RMB63.9 million were collateralized by short-term investments, respectively. The weighted average interest rate for the outstanding borrowings were approximately 2.63% and 3.98%, respectively. These short-term bank borrowings did not include any restrictive covenants. As of March 31, 2022 and 2023, the unused facility for the short-term borrowing were RMB170.3 million and RMB
 
213.0 million, respectively.
As of March 31, 2023, the Company has not obtained long-term bank borrowings. As of March 31, 2023, the unused facility for the long-term borrowings was none.
 
F-44

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
22.
Borrowings, other debts and derivative liabilities (continued)
Short-term borrowings (continued)
 
Future principal maturities of short-term borrowings and long-term borrowings as of March 31, 2021 and 2022 are as followings:
 
    
Year ended
March 31, 2022
    
Year ended
March 31, 2023
 
    
RMB
    
RMB
 
For the year ending March 31,
     
- Within 1 year
     161,126        86,261  
  
 
 
    
 
 
 
Total
     161,126        86,261  
  
 
 
    
 
 
 
As of the date of this annual report, all the outstanding short-term borrowing as of March 31, 2023 was subsequently settled.
Other debts
Other debts –
non-current
consist of the following:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Loan from CMB (a)
     86,373        —    
Loan from Chong Li (b)
     70,001        73,981  
Loan for Yoken Series
A-1
Warrant (c)
     23,188        27,346  
Payable for investment
     1,500        1,500  
  
 
 
    
 
 
 
Total
     181,062        102,827  
  
 
 
    
 
 
 
(a) Loan from CMB
Guangcheng signed loan agreement with CMB in March 2020 (“Loan from CMB”). The loan was interest-free with a principal amount of US$46 million. The term is 2 years and can be extended if agreed by both CMB and Guangcheng.
The Company accounts for Loan from CMB as a long-term debt initially recognized in the amount of RMB303 million (which is the present value of the principal amount of US$46 million) and subsequently measured at amortized cost. During the years ended March 31, 2022 and 2023, the Company repaid the principal of Loan from CMB in the amount of RMB235.0 million and RMB87.9 million, respectively. For the years ended March 31, 2022 and 2023, the Company recorded RMB8.9 million and RMB1.5 million interest expenses of Loan from CMB.
The Company issued preferred shares to be settled by CMB after CMB receiving the repayment of the Loan from CMB. The Company recorded a receivable for issuance of preferred shares in the amount of RMB303 million (which is the present value of the principal amount of US$46 million) in mezzanine equity for the consideration of the preferred shares not yet received from the investors. After the completion of the IPO in October 2020, the preferred shares were automatically converted into Class A ordinary shares. The Company accounted for the consideration of such-converted ordinary shares as receivable for issuance of ordinary shares in equity. As of March 31, 2022 and 2023, the receivable for issuance of ordinary shares is RMB86.4 million and nil, respectively (Note 23).
 
F-45

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
22.
Borrowings, other debts and derivative liabilities (continued)
Other debts (continued)
 
(b) Loan from Chong Li
Guangcheng signed loan agreement with Chong Li in March 2020 (“Loan from Chong Li”). The loan was interest-free with a principal amount of RMB128 million. The term is 5 years and can be extended if agreed by both Chong Li and Guangcheng.
 
F-46

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
22.
Borrowings, other debts and derivative liabilities (continued)
Other debts (continued)
(b) Loan from Chong Li (continued)
 
The Company accounted for Loan from Chong Li as a long-term debt initially recognized in the amount of RMB95 million (which is the present value of the principal amount of RMB128 million) and subsequently measured at amortized cost. During the years ended March 31, 2022 and 2023, the Company repaid the principal of Loan from Chong Li of RMB35.9 million and RMB36.4 million, respectively. For the years ended March 31, 2022 and 2023, the Company recorded interest expenses of RMB5.1 million and RMB4.5 million, respectively.
The Company issued preferred shares to be settled by Superb Origin International Limited (“Superb Origin”, Chong Li is the 100% equity owner of Superb Origin) after Guangcheng repaid the Loan from Chong Li. The Company recorded a receivable for issuance of preferred shares in the amount of RMB95 million (which is the present value of the principal amount of RMB128 million) in mezzanine equity for the consideration of the preferred shares not yet received from Superb Origin. After the completion of the IPO in October 2020, preferred shares were automatically converted into Class A ordinary shares. The Company then recorded the unreceived consideration from Superb Origin as receivable for issuance of ordinary shares under shareholders’ equity (Note 23).
 
F-47

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
22.
Borrowings, other debts and derivative liabilities (continued)
Other debts (continued)
 
(c)
Yoken Series
A-1
Warrant
On March 2, 2020, Yoken Holding Limited (“Yoken”), a wholly owned subsidiary of the Company, entered into a share purchase agreement with three investors (“Yoken Series
A-1
SPA”). According to the Yoken Series
A-1
SPA, Yoken will issue each investor a warrant (“Yoken Series
A-1
Warrant”) to purchase certain quantity of Yoken’s Series
A-1
Preferred Shares (“Yoken Series
A-1
Preferred Shares”). As the consideration for each Yoken Series
A-1
Warrant, the respective investor shall provide a loan (“Loan for Yoken Series
A-1
Warrant”) carrying a simple interest of 10% per annum to Chengdu Chongaita Information Technology Co., Ltd. (“Chongaita”), a wholly owned PRC subsidiary of Yoken. Yoken will only issue the Yoken Series
A-1
Warrants after Chongaita has received all loan proceeds. Both the issuance of the Yoken Series
A-1
Warrants and the receipt of the loan proceeds are closing conditions of the transactions in the Yoken Series
A-1
SPA. The Company accounted for the loan as a term loan carrying an annual simple interest of 10%. As of March 31, 2020, the carrying value of the loan proceeds of Yoken Series
A-1
Warrant was RMB18 million.
 
F-48

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
22.
Borrowings, other debts and derivative liabilities (continued)
Other debts (continued)
(c)
Yoken Series
A-1
Warrant (continued)
 
On October 23, 2020, one of the investors terminated and entered into a new share purchase agreement with Yoken, pursuant to which 120,000 Yoken Series
A-1
Preferred Shares were issued on October 23, 2020 for an aggregated consideration of RMB6 million. On the same day, the Company issued the remaining two investors two warrants to purchase up to 360,000 and 200,000 Yoken Series
A-1
Preferred Shares at an exercise price per share of US$ 7.14 in connection with a loan of RMB18 million (equivalent to US$2.5 million) and RMB10 million (equivalent to US$1.4 million) granted to Chongaita (“Loan for Yoken Series
A-1
Warrant”). As a debt modification, the Company reversed RMB1.4 million interest expense as other gains, net (Note 17). The Company recognized the Yoken Series
A-1
Warrant and bifurcated the conversion feature as derivative liability out of the total consideration received. As of March 31, 2022 and 2023, the carrying value of Yoken Series
A-1
Warrant were RMB23.2 million and RMB27.3 million, respectively, and fair value of conversion feature were RMB9.1 million and RMB7.9 million, respectively.
Derivative liabilities
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Conversion feature of Yoken Series
A-1
Warrant (a)
     9,086        7,850  
Forward exchange contracts (b)
     —          2,851  
  
 
 
    
 
 
 
Total
     9,086        10,701  
  
 
 
    
 
 
 
For the initial recognition of each debt instrument that has a bifurcated derivative liability (i.e., embedded warrant or conversion feature), out of the total consideration received, the derivative liability is recognized at fair value and the remaining consideration (net of issuance costs) is then allocated to the host debt instrument. The derivative liability is subsequently carried at fair value with any changes in fair value recognized currently in the income statement. The host debt instrument is subsequently amortized using the effective interest rate method. Upon conversion of the host debt instrument into the Preferred Shares or debt repayment, both the host debt instrument and the respective derivative liability are subject to extinguishment accounting with a gain or loss recognized from the difference between the recoded values of both liabilities and the fair value of consideration given by the Company (i.e., the Preferred Shares or cash).
(a) The warrant issued in connection with Yoken Series
A-1
Warrant is embedded instead of freestanding because it is (1) issued in connection with the instrument and (2) not separately exercisable without terminating the debt instruments. Therefore, each combined instrument (loan with embedded warrant) is substantially similar to a convertible debt where the embedded warrant is similar to a conversion feature able to convert the debt instrument into the Preferred Shares.
The Company assessed the embedded warrant along with the conversion features in Yoken Series
A-1
Warrant and concluded that it is required to be bifurcated and accounted for separately as derivative liabilities. This is because (1) the embedded warrant or conversion feature, as an equity-linked feature, is not considered clearly and closely related to its debt host instrument, and (2) the redemption rights of the convertible Preferred Shares could give rise to net settlement of the conversion feature of the Preferred Shares.
 
F-49

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
22.
Borrowings, other debts and derivative liabilities (continued)
Derivative liabilities (continued)
 
(b) In June and December 2021 and March 2022, the Company entered three new forward exchange contracts with a financial institution. Pursuant to which, the financial institution agreed to purchase US$8 million, US$4 million and US$5 million from the Company in exchange of RMB52.4 million, RMB26.1 million and RMB32.1 million at a fixed foreign exchange rate of 6.5452, 6.5128 and 6.4200 on June 2022, December 2022 and March 2023, respectively. The Company settled in advance with amount of US$11 million and recorded the fair value gain in the amount of RMB1.2 million as fair value change of derivative liabilities. For the year ended March 31, 2022, the fair value gain of the rest forward exchange contracts was RMB0.9 million and was recorded as fair value change of derivative liabilities. The carrying value of the remaining forward exchange contracts was RMB0.7 million and was recorded as prepayments and other current assets.
In December 2022 and March 2023, the forward exchange contracts which signed in December 2021 and March 2022 were renewed to December 2023 and March 2024 respectively. And the Company settled in advance with amount of US$1.5 million and recorded the fair value gain in the amount of RMB0.1 million as fair value change of derivative liabilities. For the year ended March 31, 2023, the fair value loss of the rest forward exchange contracts was RMB(3.6) million and was recorded as fair value change of derivative liabilities. The carrying value of the remaining forward exchange contracts was RMB2.9 million and was recorded as derivative liabilities.
 
23.
Receivable for issuance of ordinary shares
The Company issued preferred shares to investors, which to be settled by the investors after Guangcheng repaid the Loan from CMB and Loan from Chong Li to the investors. The Company recorded a receivable for issuance of preferred shares in mezzanine equity for the consideration of the preferred shares not yet received from the investors. After the completion of the IPO in October 2020, the preferred shares were automatically converted into Class A ordinary shares. The Company accounted for the consideration of such-converted ordinary shares as receivable for issuance of ordinary shares under shareholders’ equity.
During the years ended March 31, 2022 and 2023, the Company received RMB262.9 and RMB87.9 million from the receivable for issuance of ordinary shares. For the years ended March 31, 2022 and 2023, the Company recorded interest income of RMB14.2 million and RMB6.1 million, respectively. As of March 31, 2022 and 2023, the balances of receivable for issuance of ordinary shares were RMB164.7 million and RMB83.4 million, respectively.
 
24.
Share-based compensation
On September 27, 2012, the Company adopted 2012 Global Share Plan (the “2012 Plan”) and reserved 1,061,500 ordinary shares for share options to be granted to certain of the Company’s employees and
non-employees
(the “Participants”). On August 1, 2018, the Company adopted 2018 Global Share Plan (the “2018 Plan”) to replace the 2012 Plan and increased the reserved ordinary shares to 5,987,836 in total for future grants of share options. On September 1, 2020, the Company amended the 2018 Plan and increased the authorized reserved shares from 5,987,836 to 8,987,836.
 
In May 2022, the Company amended the 2018 Plan and increased 4,000,000 authorized reserved shares from 8,987,836 to 12,987,836.
 
F-50

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
24.
Share-based compensation (continued)
 
Except for share options granted to certain senior management personnel during the years ended March 31, 2015 and 2016, which were immediately fully vested and exercisable once granted, other share options granted to employees and
non-employees
under the 2012 and 2018 Plans would generally be exercisable upon the Company’s completion of a Qualified IPO or a defined corporate transactions (i.e. change of control, etc.) and the employees render services to the Company in accordance with the stipulated service schedules. The employee participants are generally subject to a four-year service schedule, under which the employees earn an entitlement to vest in 25% of their option grants at the end of each year of completed service.
For the years ended March 31, 2022 and 2023, 1,282,500 and nil share options were granted to the Participants respectively.
The following table sets forth the share options activity for the years ended March 31, 2022 and 2023:
 
    
Number of
shares
   
Weighted
average
exercise price
    
Weighted average
remaining
contractual term
    
Aggregate
intrinsic
value
    
Weighted average
fair value
 
          
US$
           
US$
    
US$
 
Outstanding as of March 31, 2021
     5,512,222       3.36        6.32        29,360        3.28  
Exercisable as of March 31, 2021
     —         —          —          —          —    
Granted
     1,282,500       2.86                          2.27  
Exercised
     (1,204,483     1.09                          0.73  
Forfeited
     (358,348     2.86                          3.83  
Outstanding as of March 31, 2022
     5,231,891       2.86        5.25        404        2.36  
Exercisable as of March 31, 2022
     —         —          —          —          —    
Exercised
     (53,488     0.60                          2.26  
Forfeited
     (1,233,050     1.31                          0.86  
Outstanding as of March 31, 2023
     3,945,354       2.58        3.45        124        2.06  
Exercisable as of March 31, 2023
     —         —          —          —          —    
The aggregate intrinsic value is calculated as the difference between the exercise price of the options and the estimated fair value of the underlying shares of US$29,359,582, US$404,409 and US$123,594 at March 31, 2021, 2022 and 2023, respectively.
As of March 31, 2022 and 2023, there were US$2,298,328 and US$322,926 of unrecognized share-based compensation expenses related to share options granted by the Company, which were expected to be recognized over a weighted-average period of 5.3 years and 3.4 years, respectively.
Options granted to the Participants were measured at fair value on the dates of grant using the Binomial Option Pricing Model. The assumptions used to value the Company’s option grants for the year ended March 31, 2022 were as follows:
 
    
Year ended March 31, 2022
Expected volatility
  
42.22
% - 
43.71%
Risk-free interest rate
   1.62
% - 
1.86%
Exercise multiple
   2.8/2.2
Expected dividend yield
   0%
Contractual term (in years)
   10
 
F-51

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
24.
Share-based compensation (continued)
 
The expected volatility was estimated based on the historical volatility of comparable peer public companies with a time horizon close to the expected term of the Company’s options. The risk-free interest rate was estimated based on the yield to maturity of U.S. treasury bonds denominated in US$ for a term consistent with the expected term of the Company’s options in effect at the option valuation date. The expected exercise multiple was estimated as the average ratio of the stock price to the exercise price of when employees would decide to voluntarily exercise their vested options. As the Company did not have sufficient information of past employee exercise history, it was estimated by referencing to a widely-accepted academic research publication. The expected dividend yield is zero as the Company has never declared or paid any cash dividends on its shares, and the Company does not anticipate any dividend payments in the foreseeable future. The expected term is the contract life of the option.
For the Company’s share options granted to the Participants, the completion of a Qualified IPO is considered to be a performance condition of the awards. A Qualified IPO is not considered to be probable until it is completed. Under ASC 718, compensation cost should be accrued if it is probable that the performance condition will be achieved. As a result, no compensation expense will be recognized related to these options until the completion of a Qualified IPO, and hence no share-based compensation expense was recognized for the year ended March 31, 2020. For the year ended March 31, 2021, upon the completion of the IPO in October 2020, the Company recorded RMB55 million of share-based compensation expense. For the year ended March 31, 2022 and 2023, RMB14.4 million and RMB-7.7 million of share-based compensation expense was recorded, respectively.
The fair value of options granted to the Participants for the years ended March 31, 2022 and 2023 was amounting to US$2.9 million and nil, respectively.
 
25.
Employee benefits
The full-time employees of the Company’s subsidiaries and VIEs that are incorporated in the PRC are entitled to staff welfare benefits including medical insurance, basic pensions, unemployment insurance, work injury insurance, maternity insurance and housing funds. These companies are required to contribute to these benefits based on certain percentages of the employees’ salaries in accordance with the relevant regulations and charge the amount contributed to these benefits to the consolidated statements of loss and comprehensive loss. The Company has no legal obligation for the benefits beyond the contribution made. The PRC government is responsible for the welfare and medical benefits and ultimate pension liability to these employees. The total amounts charged to the consolidated statements of loss and comprehensive loss for such employee benefits amounted to RMB6 million, RMB7 million and RMB9 million for the years ended March 31, 2021, 2022 and 2023, respectively.
 
26.
Fair value measurements
The Company measured its short-term investments,
available-for-sale
investments, equity securities with readily determinable fair values and derivative liabilities at fair value on a recurring basis. Equity securities classified within Level 1 are valued using quoted market prices that currently available on a securities exchange registered on NYSE American. Short-term investments classified within Level 2 are valued using directly or indirectly observable inputs in the marketplace. As the Company’s
available-for-sale
investments and derivative liabilities are not traded in an active market with readily observable prices, the Company uses significant unobservable inputs to measure the fair value of
available-for-sale
investments and derivative liabilities. These instruments are categorized in the Level 3 valuation hierarchy based on the significance of unobservable factors in the overall fair value measurement. The Company did not transfer any assets or liabilities in or out of level 3 during the years ended March 31, 2021, 2022, and 2023.
 
F-52

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
26.
Fair value measurements (continued)
 
The following table summarizes the Company’s financial assets and liabilities measured and recorded at fair value on recurring basis as of March 31, 2022 and 2023:
 
            Fair value measurement at reporting date using  
Description
   Fair value as of
March 31, 2022
     Quoted price in
active markets
for identical
assets (Level 1)
     Significant other
observable Inputs
(Level 2)
     Significant
unobservable Inputs
(Level 3)
 
     RMB      RMB      RMB      RMB  
Assets:
           
Short-term investments
     128,084        —          128,084        —    
Available-for-sale
debt investments
     74,866        —          —          74,866  
Equity securities with readily determinable fair values
     670        670        —          —    
  
 
 
    
 
 
    
 
 
    
 
 
 
Total assets
     203,620        670        128,084        74,866  
  
 
 
    
 
 
    
 
 
    
 
 
 
Liabilities:
           
Derivative liabilities
     9,086        —          —          9,086  
  
 
 
    
 
 
    
 
 
    
 
 
 
 
            Fair value measurement at reporting date using  
Description
   Fair value as of
March 31, 2023
     Quoted price in
active markets
for identical
assets (Level 1)
     Significant other
observable Inputs
(Level 2)
     Significant
unobservable Inputs
(Level 3)
 
     RMB      RMB      RMB      RMB  
Assets:
           
Short-term investments
     69,797        —          69,797        —    
Available-for-sale
debt investments
     68,011        —          —          68,011  
Equity securities with readily determinable fair values
     102        102        —          —    
  
 
 
    
 
 
    
 
 
    
 
 
 
Total assets
     137,910        102        69,797        68,011  
  
 
 
    
 
 
    
 
 
    
 
 
 
Liabilities:
           
Derivative liabilities
     10,701        —          —          10,701  
  
 
 
    
 
 
    
 
 
    
 
 
 
The roll forward of major Level 3 investments are as following:
 
     Derivative liabilities     
Available-for-sale

debt investments
 
Fair value of Level 3 investments as at March 31, 2020
     14,351        70,328  
New addition
     9,581        —    
Disposal of Series
D-3
Notes
     (2,377      —    
Unrealized fair value change of the derivative liabilities
     (11,559      —    
Unrealized fair value change of the
available-for-sale
debt investments
     —          1,029  
  
 
 
    
 
 
 
Fair value of Level 3 investments as at March 31, 2021
     9,996        71,357  
  
 
 
    
 
 
 
New addition
     —          16,000  
Reclassification of forward exchange contracts
     746        —    
Unrealized fair value change of the derivative liabilities
     (1,656      —    
Unrealized fair value change of the
available-for-sale
debt investments
     —          (12,491
  
 
 
    
 
 
 
Fair value of Level 3 investments as at March 31, 2022
     9,086        74,866  
  
 
 
    
 
 
 
Reclassification of forward exchange contracts
     (651      —    
Unrealized fair value change of the derivative liabilities
     2,266        —    
Unrealized fair value change of the
available-for-sale
debt investments
     —          (6,427
Disposal of
available-for-sale
debt investments
     —          (428
  
 
 
    
 
 
 
Fair value of Level 3 investments as at March 31, 2023
     10,701        68,011  
  
 
 
    
 
 
 
 
F-53

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
26.
Fair value measurements (continued)
 
The Company determined the fair value of their investments by using equity allocation model, market approach and binomial model. The determination of the fair value was based on estimates, judgments and information of other comparable public companies. The significant unobservable inputs adopted in the valuation as of March 31, 2022 and 2023:
 
    
As of March 31,

2022
  
As of March 31,

2023
Implied price to sales after discount
for lack of marketability
   n.a.    1.04x
Weighted average cost of capital
   15
%, 
16.5
%, 
18
%
   n.a.
Lack of marketability discount
   17
%, 
23
%, 
29
%
   20%
Risk-free rate
   1.95
%, 
2.23
%, 
2.34
%, 
2.36
%
   2.60
%, 
2.31
%, 
2.19%
Expected volatility
   39.88
%, 
42.17
%, 
42.48
%, 
47.34
%
   47.19
%, 
43.65
%, 
32.08%
Probability
   Liquidation scenario: 20%
Redemption scenario: 40%
IPO scenario: 40%
   Liquidation scenario: 35
%, 
40%
Redemption scenario: 35
%, 
40%
IPO scenario: 30
%, 
20%
The significant unobservable inputs used in the fair value measurement of the fair value of the investments include weighted average cost of capital, implied price to sales after discount for lack of marketability, lack of marketability discount, risk-free rate, expected volatility and probabilities of different scenarios. Significant increases in lack of marketability discount and risk-free rate would result in a significantly lower fair value measurement. Significant decreases in expected volatility would result in a significantly lower fair value measurement. If the probabilities of redemption and liquidation scenarios are assumed to keep equal, significant increases in the probability of IPO scenario would result in a significantly lower fair value measurement.
The Company determined the fair value of their derivative liabilities by using binominal model. The determination of the fair value was based on estimates, judgments and information of other comparable public companies. The significant unobservable inputs adopted in the valuation as of March 31, 2022 and 2023 are as follows:
 
    
As of March 31,
2022
  
As of March 31,
2023
Spot price (US$)
   0.446.93    5.90
Risk-free rate
   1.25%, 2.5%    3.83%
Expected volatility
   57.95%, 48.15%    61.13%
Expected expiry years (in years)
   0.50, 3.56    2.60
The significant unobservable inputs used in the fair value measurement of the derivative liabilities include spot price, risk-free rate, expected volatility and expected expiry years. Significant decreases in spot price, risk-free rate, expected volatility and expected expiry years would result in a significantly lower fair value measurement.
 
27.
Net loss per share
Basic loss per share and diluted loss per share have been calculated in accordance with ASC 260 on computation of earnings per share for the years ended March 31, 2021, 2022 and 2023, respectively, as follows:
 
   
Year Ended

March 31, 2021
   
Year Ended

March 31, 2022
   
Year Ended

March 31, 2023
 
   
RMB
   
RMB
   
RMB
 
Numerator:
                       
Net loss attributable to Boqii Holding Limited
    (194,444     (128,390     (102,799
Accretion on the Preferred Shares to redemption value (Note 20)
    120,873       —         —    
Accretion on the Redeemable
non-controlling
interests to redemption value (Note 21)
    (138     (575     (675
Deemed dividend to preferred shareholders
    (12,547     —         —    
   
 
 
   
 
 
   
 
 
 
Net loss attributable to ordinary shareholders
    (86,256     (128,965     (103,474
   
 
 
   
 
 
   
 
 
 
Denominator:
                       
Weighted average number of ordinary shares used in computing net loss per share, Basic and diluted (Note (a))
    66,953,610       68,006,172       68,858,823  
   
 
 
   
 
 
   
 
 
 
Net loss per share attributable to ordinary shareholders:
                       
Basic and diluted
    (1.29     (1.90     (1.50
   
 
 
   
 
 
   
 
 
 
 
F-54

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
27.
Net loss per share (continued)
 
Note (a): Options exercisable for a minimal exercise price (the “Penny Stock”) are included in the denominator of basic loss per share calculation once there are no further vesting conditions or contingencies associated with them, as they are considered issuable shares. Basic net loss per share is computed using the weighted average number of ordinary shares outstanding and the Penny Stock during the reporting periods. Diluted net loss per share is computed using the weighted average number of ordinary shares and dilutive potential ordinary shares outstanding and the Penny Stock during the reporting periods.
For the years ended March 31, 2022 and 2023, assumed share options have not been reflected in the dilutive calculations pursuant to ASC 260, “Earnings Per Share,” due to the anti-dilutive effect.
The following ordinary shares equivalent were excluded from the computation of diluted net loss per ordinary share for the periods presented because including them would have had an anti-dilutive effect:
 
    
Year Ended

March 31, 2021
    
Year Ended

March 31, 2022
    
Year Ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Share options - weighted average
     2,585,103        719,437        591,418  
 
28.
Related party transactions
The table below sets forth the major related parties and their relationships with the Company as of March 31, 2021, 2022 and 2023:
 
Name of related parties
  
Relationship with the Company
Nanjing Animal Pharmaceutical    An equity investee of the Company
Wuhan Chunzhijin    An equity investee of the Company
Weishi Network    An equity investee of the Company
Beijing Petdog    An available-for-sale debt investee that the Company has significant influence
Shanghai Guangcheng Information Technology (limited partnership) (“Shanghai Guangcheng Information”)    A company with a common director of the Company
MERCHANT TYCOON LIMITED    A shareholder of the Company
SUPERB ORIGIN INTERNATIONAL LIMITED    A shareholder of the Company
Yingzhi (Lisa) Tang    Senior management of the Company
Yan Jiang    Senior management of the Company
Di (Jackie) Chen    Senior management of the Company until July, 2021
Ying (Christina) Zhang    Senior management of the Company until February, 2022
Fei Wang    Senior management of the Company until April, 2022
Lijun Zhou    Senior management of the Company until April, 2022
 
F-55

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
28.
Related party transactions (continued)
 
Details of related party transactions are as follows:
 
    
Year Ended

March 31, 2021
    
Year Ended

March 31, 2022
    
Year Ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Online marketing and information services
        
Beijing Petdog
     410        —          —    
Weishi Network
     —          19        —    
  
 
 
    
 
 
    
 
 
 
     410        19        —    
  
 
 
    
 
 
    
 
 
 
Purchase of merchandise
        
Weishi Network
     —          1,582        —    
Nanjing Animal Pharmaceutical
     250        1,020        1,402  
  
 
 
    
 
 
    
 
 
 
     250        2,602        1,402  
  
 
 
    
 
 
    
 
 
 
 
    
Year Ended

March 31, 2021
    
Year Ended

March 31, 2022
    
Year Ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Loans granted to related parties
        
Shanghai Guangcheng Information (a)
     —          33,395        —    
Wuhan Chunzhijin (b)
     5,690        2,600        2,720  
MERCHANT TYCOON LIMITED
     —          —          100  
Yingzhi (Lisa) Tang
     —          1,750        —    
Lijun Zhou
     —          300        —    
Yan Jiang
     200        70        —    
Nanjing Animal Pharmaceutical (c)
     500        —          —    
Fei Wang
     500        —          —    
  
 
 
    
 
 
    
 
 
 
     6,890        38,115        2,820  
  
 
 
    
 
 
    
 
 
 
 
F-56

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
28.
Related party transactions (continued)
 
  (a)
In April 2021, the Company granted Shanghai Guangcheng Information a short-term loan with a total principal amount of RMB33.4 million (equivalent to USD5 million), bearing an interest rate of
3.5
% per annum. The loan was fully repaid by March 31, 2022.
  (b)
The Company entered into a loan agreement with Wuhan Chunzhijin to provide Wuhan Chunzhijin with an interest-free loan of up to 10 million, which will be repaid on demand. In March 2023, the company converted RMB3.4 million loan to Wuhan Chunzhijin into equity interest. (Detail refer to Note 11)
  (c)
In December 2019, Nanjing Xingmu, one of the Company’s subsidiaries, entered into a twelve-month interest free loan agreement with Nanjing Agricultural Pharmaceutical for a principal amount of RMB1 million. This loan was early repaid in May 2020. In June 2020, Nanjing Xingmu entered into another twelve-month interest free loan agreement with Nanjing Agricultural Pharmaceutical for a principal amount of RMB0.5 million. The loan was repaid in June 2021.
 
    
Year Ended

March 31, 2021
    
Year Ended

March 31, 2022
    
Year Ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Staff advances
        
Yingzhi (Lisa) Tang
     10                      
  
 
 
       
Advances provided to related parties
        
SUPERB ORIGIN INTERNATIONAL LIMITED
                         5,497  
Nanjing Animal Pharmaceutical
     2,073                  350  
  
 
 
    
 
 
    
 
 
 
     2,073                  5,847  
  
 
 
    
 
 
    
 
 
 
Loans granted from related parties
        
Shanghai Guangcheng Information (a)
               9,961            
  
 
 
    
 
 
    
 
 
 
 
  (a)
In April 2021, the Company obtained a total loan facility up to USD5 million from Shanghai Guangcheng Information. During the year ended March 31, 2022, the Company drew down a total amount of USD1.5 million (equivalent to RMB10.0 million) from the loan facility, with interest bearing at 3.5% per annum. The loan was fully repaid by March 31, 2022.
 
F-57

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
28.
Related party transactions (continued)
 
Details of related party balances are as follows:
Amounts due from related parties
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Prepayments to related parties
                 
SUPERB ORIGIN INTERNATIONAL LIMITED
               5,497  
Nanjing Animal Pharmaceutical
     1,650        2,000  
Weishi Network
     1,582        1,582  
    
 
 
    
 
 
 
       3,232        9,079  
    
 
 
    
 
 
 
Other receivables from related parties
                 
Wuhan Chunzhijin
     7,594        2,988  
    
 
 
    
 
 
 
Loans to related parties
                 
Yan Jiang
     200        200  
Fei Wang (
a
)
     500            
Lijun Zhou
     200            
MERCHANT TYCOON LIMITED
               100  
    
 
 
    
 
 
 
       900        300  
    
 
 
    
 
 
 
 
(
a
)
In January 2021, the Company entered into a one-year loan agreement with Fei Wang, for a principal amount of RMB0.5 million, bearing an interest rate of 4% per annum. This loan was pledged by 515,000 stock options owned by Fei Wang. In December 2022, the loan contract was renewed to December 2023 and was recorded as prepayments and other current assets as of March 31, 2023.
Amounts due to related parties
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Trade payables to related parties
                 
Nanjing Animal Pharmaceutical
     219        471  
    
 
 
    
 
 
 
 
F-58

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
29.
Commitments and contingencies
 
(a)
Capital commitments
The Company’s capital commitments primarily relate to commitments on leasehold improvement and purchase of equipment. As of March 31, 2022 and 2023, no capital commitment was related to leasehold improvement and purchase of equipment.
 
(b)
Contingencies
The Company is subject to legal proceedings and regulatory actions in the ordinary course of business. The results of such proceedings cannot be predicted with certainty, but the Company does not anticipate that the final outcome arising out of any such matter will have a material adverse effect on our consolidated financial position, cash flows or results of operations on an individual basis or in the aggregate. As of March 31, 2022 and 2023, the Company is not a party to any material legal or administrative proceedings.
 
30.
Subsequent events
In April 2023, the Company and Nanjing Animal Pharmaceutical signed the Convertible Debt Release Agreement, in which Nanjing Animal Pharmaceutical would redeem part of the convertible debts from the Company. According to the agreement, Nanjing Animal Pharmaceutical repaid the Company the principal amount of RMB6 million, interest of RMB0.84 million, and an additional compensation of RMB1.06 million in April 2023.
 
31.
Restricted net assets
The Company’s ability to pay dividends may depend on the Company receiving distributions of funds from the Company’s subsidiaries and the VIEs incorporated in the PRC. Relevant PRC statutory laws and regulations permit payments of dividends by the Company’s PRC subsidiaries only out of their retained earnings, if any, as determined in accordance with PRC accounting standards and regulations. The results of operations reflected in the consolidated financial statements prepared in accordance with US GAAP differ from those reflected in the statutory financial statements of the Company’s PRC subsidiary.
In accordance with the Company law of the PRC, a domestic enterprise is required to provide statutory reserves of at least 10% of its annual
after-tax
profit until such reserve has reached 50% of its respective registered capital based on the enterprise’s PRC statutory accounts. A domestic enterprise is also required to provide discretionary surplus reserve, at the discretion of the Board of Directors, from the profits determined in accordance with the enterprise’s PRC statutory accounts. The aforementioned reserves can only be used for specific purposes and are not distributable as cash dividends. The Company’s PRC subsidiaries were established as domestic invested enterprises and therefore are subject to the above mentioned restrictions on distributable profits.
For the years ended March 31, 2021, 2022 and 2023, appropriation to statutory reserves was made because two PRC subsidiaries had generated profits for these periods.
As a result of these PRC laws and regulations subject to the limit discussed above that require annual appropriations of 10% of
after-tax
income to be set aside, prior to payment of dividends, as general reserve fund, the Company’s PRC subsidiaries are restricted in their ability to transfer a portion of their net assets to the Company.
Foreign exchange and other regulations in the PRC further restrict the Company’s PRC subsidiaries from transferring funds to the Company in the form of dividends, loans and advances.
As of March 31, 2023, the total restricted net assets of the Company’s subsidiaries and the VIEs incorporated in the PRC and subjected to restriction amounted to nil.
 
F-59

BOQII HOLDING LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in thousands, except for share and per share data, unless otherwise noted)
 
31.
Restricted net assets (continued)
 
 
Rules
12-04(a)
and
4-08(e)(3)
of Regulation
S-X
require condensed financial information as to the financial position, cash flows and results of operations of a parent company as of and for the same periods for which the audited consolidated financial statements have been presented when the restricted net assets of the consolidated and unconsolidated subsidiaries together exceed 25% of consolidated net assets as of the end of the most recently completed fiscal year. The Company performed a test on the restricted net assets of consolidated subsidiaries in accordance
S-X
Rule4-08
(e)(3) and concluded that it was not applicable for the Company to disclose the financial statements for the parent company since the 25% threshold was not met for the year ended March 31, 2023.
 
F-60
EX-2.4 2 d290954dex24.htm EX-2.4 EX-2.4

Exhibit 2.4

Description of rights of each class of securities

registered under Section 12 of the Securities Exchange Act of 1934 (the “Exchange Act”)

American Depositary Shares (“ADSs”) each representing 4.5 Class A ordinary share of Boqii Holding Limited (“we,” “our,” “our company,” or “us”) are listed and traded on the New York Stock Exchange (“NYSE”) and, in connection therewith, the Class A ordinary shares are registered under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). This exhibit contains a description of the rights of (i) the holders of Class A ordinary shares and (ii) the holders of the ADSs. Class A ordinary shares underlying the ADSs are held by The Bank of New York Mellon, as depositary, and holders of ADSs will not be treated as holders of Class A ordinary shares.

Description of Class A Ordinary Shares

The following is a summary of material provisions of our currently effective twelfth amended and restated memorandum and articles of association (the “Memorandum and Articles of Association”), as well as the Companies Act (As Revised) of the Cayman Islands (the “Companies Act”) insofar as they relate to the material terms of the Class A ordinary shares. Notwithstanding this, because it is a summary, it may not contain all the information that you may otherwise deem important. For more complete information, you should read the entire Memorandum and Articles of Association, which has been initially filed with the Securities and Exchange Commission (the “SEC”) as an exhibit to our Registration Statement on Form F-1 (File No. 333-248641), as amended, on September 8, 2020.

Type and Class of Securities (Item 9.A.5 of Form 20-F)

Each Class A ordinary share has US$0.001 par value. The number of Class A ordinary shares that have been issued as of the last day of the financial year ended March 31, 2023 is provided on the cover of our annual report on Form 20-F (the “Form 20-F”). Our Class A ordinary shares may be held in either certificated or uncertificated form.

Preemptive Rights (Item 9.A.3 of Form 20-F)

Our shareholders do not have preemptive rights.

Limitations or Qualifications (Item 9.A.6 of Form 20-F)

We have adopted a dual-class share structure such that our ordinary shares consist of Class A ordinary shares and Class B ordinary shares. In respect of matters requiring the votes of shareholders, each Class A ordinary share is entitled to one vote, and each Class B ordinary share is entitled to 20 votes. Holders of Class A ordinary shares and Class B ordinary shares shall, at all times, vote together as one class on all matters submitted to a vote by the members. Due to the super voting power of Class B ordinary shareholder, the voting power of the Class A ordinary shares may be materially limited. See also “—Variations of Rights of Shares.”

Rights of Other Types of Securities (Item 9.A.7 of Form 20-F)

Not applicable.


Rights of Class A Ordinary Shares (Item 10.B.3 of Form 20-F)

General

Holders of ordinary shares will have the same rights except for voting and conversion rights. Our ordinary shares are issued in registered form and are issued when registered in our register of members (shareholders). We may not issue share to bearer. Our shareholders who are non-residents of the Cayman Islands may freely hold and transfer their ordinary shares.

Dividends

The holders of our ordinary shares are entitled to such dividends as may be declared by our board of directors subject to our Memorandum and Articles of Association and the Companies Act. In addition, our shareholders may by ordinary resolution declare a dividend, but no dividend may exceed the amount recommended by our directors. Our Memorandum and Articles of Association provide that dividends may be declared and paid out of our profits, realized or unrealized, or out of the share premium account or as otherwise permitted by the Statute, provided that in no circumstances may a dividend be paid if this would result in our company being unable to pay its debts as they fall due in the ordinary course of business.

Classes of Ordinary Shares

Our ordinary shares are divided into Class A ordinary shares and Class B ordinary shares. Holders of Class A ordinary shares and Class B ordinary shares have the same rights except for voting and conversion rights.

Conversion

Each Class B ordinary share is convertible into one Class A ordinary share at any time by the holder thereof. Class A ordinary shares are not convertible into Class B ordinary shares under any circumstances. Upon any sale, transfer, assignment or disposition of any Class B ordinary shares by a holder thereof to any person who is not a founder or an affiliate of a founder, or upon a change of beneficial ownership of any Class B ordinary shares as a result of which any person who is not a founder or an affiliate of a founder becomes a beneficial owner of such Class B ordinary shares, each of such Class B ordinary shares will be automatically and immediately converted into one Class A ordinary share.

Voting Rights

Holders of Class A ordinary shares and Class B ordinary shares shall, at all times, vote together as one class on all matters submitted to a vote by the members. Each Class A ordinary share shall be entitled to one vote on all matters subject to vote at general and special meetings of our company and each Class B ordinary share shall be entitled to 20 votes on all matters subject to vote at general and special meetings of our company.

 

2


A quorum required for a meeting of shareholders consists of one or more shareholders holding a majority of all votes attaching to the issued and outstanding shares entitled to vote at general meetings, which shall include Merchant Tycoon Limited and any other entity that holds shares on behalf of and is jointly controlled by our Founders present in person or by proxy or, if a corporation or other non-natural person, by its duly authorized representative. As an exempted company incorporated in the Cayman Islands, we are not obliged by the Companies Act to call shareholders’ annual general meetings. Our Memorandum and Articles of Association provide that we may (but are not obliged to) in each year hold a general meeting as our annual general meeting in which case we will specify the meeting as such in the notices calling it, and the annual general meeting will be held at such time and place as may be determined by our board of directors. We, however, will hold an annual shareholders’ meeting during each fiscal year, as required by the Listing Rules at the NYSE. Each general meeting, other than an annual general meeting, shall be an extraordinary general meeting. Shareholders’ annual general meetings and any other general meetings of our shareholders may be called by a majority of our board of directors or our chairman or upon a requisition of any one or more of our shareholders who together hold shares which carry in aggregate not less than one-third of all votes attaching to the issued and outstanding shares of our company entitled to vote at general meetings, in which case the directors are obliged to call such meeting and to put the resolutions so requisitioned to a vote at such meeting; however, our Memorandum and Articles of Association do not provide our shareholders with any right to put any proposals before annual general meetings or extraordinary general meetings not called by such shareholders. Advance notice of at least thirty (30) calendar days is required for the convening of our annual general meeting and other general meetings unless such notice is waived in accordance with our articles of association.

An ordinary resolution to be passed at a meeting by the shareholders requires the affirmative vote of a simple majority of the votes attaching to the ordinary shares cast by those shareholders entitled to vote who are present in person or by proxy at a general meeting, while a special resolution also requires the affirmative vote of no less than two-thirds of the votes attaching to the ordinary shares cast by those shareholders entitled to vote who are present in person or by proxy at a general meeting. A special resolution will be required for important matters such as a change of name or making changes to our Memorandum and Articles of Association.

Transfer of Ordinary Shares

Subject to the restrictions in our Memorandum and Articles of Association as set out below, any of our shareholders may transfer all or any of his or her ordinary shares by an instrument of transfer in the usual or common form or any other form approved by our board of directors.

Our board of directors may, in its absolute discretion, decline to register any transfer of any ordinary share which is not fully paid up or on which we have a lien. Our board of directors may also decline to register any transfer of any ordinary share unless:

 

 

the instrument of transfer is lodged with us, accompanied by the certificate for the ordinary shares to which it relates and such other evidence as our board of directors may reasonably require to show the right of the transferor to make the transfer;

 

 

the instrument of transfer is in respect of only one class of shares;

 

 

the instrument of transfer is properly stamped, if required;

 

 

in the case of a transfer to joint holders, the number of joint holders to whom the ordinary share is to be transferred does not exceed four; and

 

 

a fee of such maximum sum as the NYSE may determine to be payable or such lesser sum as our directors may from time to time require is paid to us in respect thereof.

If our directors refuse to register a transfer they shall, within two months after the date on which the instrument of transfer was lodged, send to each of the transferor and the transferee notice of such refusal.

 

3


The registration of transfers may, after compliance with any notice required of the NYSE, be suspended and the register closed at such times and for such periods as our board of directors may, in their absolute discretion, from time to time determine, provided always that the registration of transfers shall not be suspended nor the register closed for more than 30 days in any year.

Liquidation

On a return of capital on winding up or otherwise (other than on conversion, redemption or purchase of ordinary shares), if the assets available for distribution amongst our shareholders shall be more than sufficient to repay the whole of the share capital at the commencement of the winding up, the surplus shall be distributed amongst our shareholders in proportion to the par value of the shares held by them at the commencement of the winding up, subject to a deduction from those shares in respect of which there are monies due, of all monies payable to our company for unpaid calls or otherwise. If our assets available for distribution are insufficient to repay all of the paid up share capital, the assets will be distributed so that the losses are borne by our shareholders in proportion to the par value of the shares held by them. Any distribution of assets or capital to a holder of ordinary share will be the same in any liquidation event.

Calls on Ordinary Shares and Forfeiture of Ordinary Shares

Our board of directors may from time to time make calls upon shareholders for any amounts unpaid on their ordinary shares in a notice served to such shareholders at least 14 calendar days prior to the specified time of payment. The ordinary shares that have been called upon and remain unpaid are subject to forfeiture.

Redemption, Repurchase and Surrender of Ordinary Shares

We may issue shares on terms that such shares are subject to redemption, at our option or at the option of the holders thereof, on such terms and in such manner as may be determined, before the issue of such shares, by our board of directors or by or by an ordinary resolution of our shareholders. Our company may also repurchase any of our shares provided that the manner and terms of such purchase have been approved by our board of directors or by ordinary resolution of our shareholders, or are otherwise authorized by our Memorandum and Articles of Association. Under the Companies Act, the redemption or repurchase of any share may be paid out of our company’s profits or out of the proceeds of a fresh issue of shares made for the purpose of such redemption or repurchase, or out of capital (including share premium account and capital redemption reserve) if the company can, immediately following such payment, pay its debts as they fall due in the ordinary course of business. In addition, under the Companies Act no such share may be redeemed or repurchased (a) unless it is fully paid up, (b) if such redemption or repurchase would result in there being no shares outstanding, or (c) if we have has commenced liquidation. In addition, our company may accept the surrender of any fully paid share for no consideration.

Requirements to Change the Rights of Holders of Class A Ordinary Shares (Item 10.B.4 of Form 20-F)

Variations of Rights of Shares

If at any time our share capital is divided into different classes or series of shares (and as otherwise determined by the directors), the rights attached to any class or series of shares may, subject to any rights or restrictions for the time being attached to any class or series of shares, only be materially adversely varied or abrogated with the consent in writing of the holders of not less than two-thirds of the issued shares of that class or series or with the sanction of a special resolution at a separate meeting of the holders of the shares of the class or series by two-thirds of the votes cast at such a meeting. The rights conferred upon the holders of the shares of any class issued shall not, unless otherwise expressly provided by the terms of issue of the shares of that class, be deemed to be varied by the creation or issue of further shares ranking pari passu with such existing class of shares.

 

4


Limitations on the Rights to Own Class A Ordinary Shares (Item 10.B.6 of Form 20-F)

There are no limitations under the laws of the Cayman Islands or under the Memorandum and Articles of Association that limit the right of non-resident or foreign owners to hold or vote Class A ordinary shares.

Provisions Affecting Any Change of Control (Item 10.B.7 of Form 20-F)

Anti-Takeover Provisions

Some provisions of our Memorandum and Articles of Association may discourage, delay or prevent a change of control of our company or management that shareholders may consider favorable, including provisions that authorize our board of directors to issue preferred shares in one or more series and to designate the price, rights, preferences, privileges and restrictions of such preferred shares without any further vote or action by our shareholders.

Ownership Threshold (Item 10.B.8 of Form 20-F)

There are no provisions under the Memorandum and Articles of Association that require our company to disclose shareholder ownership above any particular ownership threshold.

Differences between the Law of Different Jurisdictions (Item 10.B.9 of Form 20-F)

The Companies Act is derived, to a large extent, from the older Companies Acts of England, but does not follow many recent English law statutory enactments. In addition, the Companies Act differs from laws applicable to United States corporations and their shareholders. Set forth below is a summary of the significant differences between the provisions of the Companies Act applicable to us and the laws applicable to companies incorporated in the State of Delaware.

Mergers and Similar Arrangements

The Companies Act permits mergers and consolidations between Cayman Islands companies and between Cayman Islands companies and non-Cayman Islands companies. For these purposes, (a) “merger” means the merging of two or more constituent companies and the vesting of their undertaking, property and liabilities in one of such companies as the surviving company, and (b) a “consolidation” means the combination of two or more constituent companies into a consolidated company and the vesting of the undertaking, property and liabilities of such companies to the consolidated company. In order to effect such a merger or consolidation, the directors of each constituent company must approve a written plan of merger or consolidation, which must then be authorized by (a) a special resolution of the shareholders of each constituent company, and (b) such other authorization, if any, as may be specified in such constituent company’s articles of association. The written plan of merger or consolidation must be filed with the Registrar of Companies of the Cayman Islands together with a declaration as to the solvency of the consolidated or surviving company, a declaration as to the assets and liabilities of each constituent company and an undertaking that a copy of the certificate of merger or consolidation will be given to the members and creditors of each constituent company and that notification of the merger or consolidation will be published in the Cayman Islands Gazette. Court approval is not required for a merger or consolidation which is effected in compliance with these statutory procedures.

 

5


A merger between a Cayman parent company and its Cayman subsidiary or subsidiaries does not require authorization by a resolution of shareholders of that Cayman subsidiary if a copy of the plan of merger is given to every member of that Cayman subsidiary to be merged unless that member agrees otherwise. For this purpose a company is a “parent” of a subsidiary if it holds issued shares that together represent at least ninety percent (90%) of the votes at a general meeting of the subsidiary.

The consent of each holder of a fixed or floating security interest over a constituent company is required unless this requirement is waived by a court in the Cayman Islands.

Save in certain limited circumstances, a shareholder of a Cayman constituent company who dissents from the merger or consolidation is entitled to payment of the fair value of his shares (which, if not agreed between the parties, will be determined by the Cayman Islands court) upon dissenting to the merger or consolidation, provide the dissenting shareholder complies strictly with the procedures set out in the Companies Act. The exercise of dissenter rights will preclude the exercise by the dissenting shareholder of any other rights to which he or she might otherwise be entitled by virtue of holding shares, save for the right to seek relief on the grounds that the merger or consolidation is void or unlawful.

Separate from the statutory provisions relating to mergers and consolidations, the Companies Act also contains statutory provisions that facilitate the reconstruction and amalgamation of companies by way of schemes of arrangement, provided that the arrangement is approved by (i) 75% in value of the shareholders or class of shareholders, as the case may be, or (ii) a majority in number representing 75% in value of the creditors or each class of shareholders and creditors, as the case may be, with whom the arrangement is to be made, that are, in each case, present and voting either in person or by proxy at a meeting, or meetings, convened for that purpose. The convening of the meetings and subsequently the arrangement must be sanctioned by the Grand Court of the Cayman Islands. While a dissenting shareholder has the right to express to the court the view that the transaction ought not to be approved, the court can be expected to approve the arrangement if it determines that:

 

 

the statutory provisions as to the required majority vote have been met;

 

 

the shareholders have been fairly represented at the meeting in question and the statutory majority are acting bona fide without coercion of the minority to promote interests adverse to those of the class;

 

 

the arrangement is such that may be reasonably approved by an intelligent and honest man of that class acting in respect of his interest; and

 

 

the arrangement is not one that would more properly be sanctioned under some other provision of the Companies Act.

 

6


The Companies Act also contains a statutory power of compulsory acquisition which may facilitate the “squeeze out” of a dissenting minority shareholder upon a tender offer. When a tender offer is made and accepted by holders of 90.0% of the shares affected within four months, the offeror may, within a two-month period commencing on the expiration of such four-month period, require the holders of the remaining shares to transfer such shares to the offeror on the terms of the offer. An objection can be made to the Grand Court of the Cayman Islands but this is unlikely to succeed in the case of an offer which has been so approved unless there is evidence of fraud, bad faith or collusion.

If an arrangement and reconstruction is thus approved, or if a tender offer is made and accepted, a dissenting shareholder would have no rights comparable to appraisal rights, which would otherwise ordinarily be available to dissenting shareholders of Delaware corporations, providing rights to receive payment in cash for the judicially determined value of the shares.

Shareholders’ Suits

In principle, we will normally be the proper plaintiff to sue for a wrong done to us as a company, and as a general rule a derivative action may not be brought by a minority shareholder. However, based on English authorities, which would in all likelihood be of persuasive authority in the Cayman Islands, the Cayman Islands court can be expected to follow and apply the common law principles (namely the rule in Foss v. Harbottle and the exceptions thereto) which permit a minority shareholder to commence a class action against or derivative actions in the name of the company to challenge actions where:

 

 

a company acts or proposes to act illegally or ultra vires;

 

 

the act complained of, although not ultra vires, could only be effected duly if authorized by more than a simple majority vote that has not been obtained; and

 

 

those who control the company are perpetrating a “fraud on the minority.”

Indemnification of Directors and Executive Officers and Limitation of Liability

Cayman Islands law does not limit the extent to which a company’s memorandum and articles of association may provide for indemnification of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against civil fraud or the consequences of committing a crime. Our Memorandum and Articles of Association provides that we shall indemnify our officers and directors against all actions, proceedings, costs, charges, expenses, losses, damages or liabilities incurred or sustained by such directors or officer, other than by reason of such person’s dishonesty, willful default or fraud, in or about the conduct of our company’s business or affairs (including as a result of any mistake of judgment) or in the execution or discharge of his duties, powers, authorities or discretions, including without prejudice to the generality of the foregoing, any costs, expenses, losses or liabilities incurred by such director or officer in defending (whether successfully or otherwise) any civil proceedings concerning our company or its affairs in any court whether in the Cayman Islands or elsewhere. This standard of conduct is generally the same as permitted under the Delaware General Corporation Law for a Delaware corporation.

In addition, we have entered into indemnification agreements with our directors and executive officers that provide such persons with additional indemnification beyond that provided in our Memorandum and Articles of Association.

 

7


Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers or persons controlling us under the foregoing provisions, we have been informed that in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.

Directors’ Fiduciary Duties

Under Delaware corporate law, a director of a Delaware corporation has a fiduciary duty to the corporation and its shareholders. This duty has two components: the duty of care and the duty of loyalty. The duty of care requires that a director act in good faith, with the care that an ordinarily prudent person would exercise under similar circumstances. Under this duty, a director must inform himself of, and disclose to shareholders, all material information reasonably available regarding a significant transaction. The duty of loyalty requires that a director acts in a manner he reasonably believes to be in the best interests of the corporation. He must not use his corporate position for personal gain or advantage. This duty prohibits self-dealing by a director and mandates that the best interest of the corporation and its shareholders take precedence over any interest possessed by a director, officer or controlling shareholder and not shared by the shareholders generally. In general, actions of a director are presumed to have been made on an informed basis, in good faith and in the honest belief that the action taken was in the best interests of the corporation. However, this presumption may be rebutted by evidence of a breach of one of the fiduciary duties. Should such evidence be presented concerning a transaction by a director, the director must prove the procedural fairness of the transaction, and that the transaction was of fair value to the corporation.

As a matter of Cayman Islands law, a director of a Cayman Islands company is in the position of a fiduciary with respect to the company and therefore it is considered that he owes the following duties to the company—a duty to act bona fide in the best interests of the company, a duty not to make a profit based on his position as director (unless the company permits him to do so), a duty not to put himself in a position where the interests of the company conflict with his personal interest or his duty to a third party, and a duty to exercise powers for the purpose for which such powers were intended. A director of a Cayman Islands company owes to the company a duty to act with skill and care. It was previously considered that a director need not exhibit in the performance of his duties a greater degree of skill than may reasonably be expected from a person of his knowledge and experience. However, English and Commonwealth courts have moved towards an objective standard with regard to the required skill and care and these authorities are likely to be followed in the Cayman Islands.

Controlling Shareholders’ Fiduciary Duties

Under Delaware law, controlling shareholders owe fiduciary duties to the companies they control and their minority shareholders. As a matter of Cayman Islands law and in contrast to the position under Delaware law, controlling shareholders of Cayman Islands companies do not owe any such fiduciary duties to the companies they control or to the minority shareholders of such companies under Cayman Islands law. Controlling shareholders of Cayman Islands companies may exercise their powers as shareholders, including the exercise of voting rights in respect of their shares, in such manner as they think fit, subject only to very limited equitable constraints, including that the exercise of voting rights to amend the memorandum or articles of association of a Cayman Islands company must be exercised bona fide for the benefit of the company as a whole.

 

8


Shareholder Action by Written Consent

Under the Delaware General Corporation Law, a corporation may eliminate the right of shareholders to act by written consent by amendment to its certificate of incorporation. The Companies Act and our Memorandum and Articles of Association provide that our shareholders may approve corporate matters by way of a unanimous written resolution signed by or on behalf of each shareholder who would have been entitled to vote on such matter at a general meeting without a meeting being held.

Shareholder Proposals

Under the Delaware General Corporation Law, a shareholder has the right to put any proposal before the annual meeting of shareholders, provided it complies with the notice provisions in the governing documents. A special meeting may be called by the board of directors or any other person authorized to do so in the governing documents, but shareholders may be precluded from calling special meetings.

The Companies Act provide shareholders with only limited rights to requisition a general meeting, and does not provide shareholders with any right to put any proposal before a general meeting. However, these rights may be provided in a company’s articles of association. Our Memorandum and Articles of Association allow our shareholders holding in aggregate not less than one-third of all votes attaching to the issued and outstanding shares of our company entitled to vote at general meetings to requisition an extraordinary general meeting of our shareholders, in which case our board is obliged to convene an extraordinary general meeting and to put the resolutions so requisitioned to a vote at such meeting. Other than this right to requisition a shareholders’ meeting, our Memorandum and Articles of Association do not provide our shareholders with any other right to put proposals before annual general meetings or extraordinary general meetings not called by such shareholders. As an exempted Cayman Islands company, we may, but are not obliged by law to call shareholders’ annual general meetings.

Cumulative Voting

Under the Delaware General Corporation Law, cumulative voting for elections of directors is not permitted unless the corporation’s certificate of incorporation specifically provides for it. Cumulative voting potentially facilitates the representation of minority shareholders on a board of directors since it permits the minority shareholder to cast all the votes to which the shareholder is entitled on a single director, which increases the shareholder’s voting power with respect to electing such director. There are no prohibitions in relation to cumulative voting under the laws of the Cayman Islands but our Memorandum and Articles of Association do not provide for cumulative voting. As a result, our shareholders are not afforded any less protections or rights on this issue than shareholders of a Delaware corporation.

Removal of Directors

Under the Delaware General Corporation Law, a director of a corporation with a classified board may be removed only for cause with the approval of a majority of the outstanding shares entitled to vote, unless the certificate of incorporation provides otherwise. Under our Memorandum and Articles of Association, directors may be removed with or without cause, by an ordinary resolution of our shareholders. A director shall hold office until the expiration of his or her term or his or her successor shall have been elected and qualified, or until his or her office is otherwise vacated. In addition, a director’s office shall be vacated if the director (i) becomes bankrupt or makes any arrangement or composition with his creditors generally; (ii) is found to be or becomes of unsound mind or dies; (iii) resigns his office by notice in writing to the company; (iv) without special leave of absence from our board of directors, is absent from three consecutive meetings of the board and the board resolves that his office be vacated; (v) is prohibited by law or NYSE rules from being a director; or (vi) is removed from office pursuant to any other provisions of our Memorandum and Articles of Association.

 

9


Transactions with Interested Shareholders

The Delaware General Corporation Law contains a business combination statute applicable to Delaware corporations whereby, unless the corporation has specifically elected not to be governed by such statute by amendment to its certificate of incorporation, it is prohibited from engaging in certain business combinations with an “interested shareholder” for three years following the date that such person becomes an interested shareholder. An interested shareholder generally is a person or a group who or which owns or owned 15% or more of the target’s outstanding voting share within the past three years. This has the effect of limiting the ability of a potential acquirer to make a two-tiered bid for the target in which all shareholders would not be treated equally. The statute does not apply if, among other things, prior to the date on which such shareholder becomes an interested shareholder, the board of directors approves either the business combination or the transaction which resulted in the person becoming an interested shareholder. This encourages any potential acquirer of a Delaware corporation to negotiate the terms of any acquisition transaction with the target’s board of directors.

Cayman Islands law has no comparable statute. As a result, we cannot avail ourselves of the types of protections afforded by the Delaware business combination statute. However, although Cayman Islands law does not regulate transactions between a company and its significant shareholders, the directors of our Company are required to comply with fiduciary duties which they owe to our Company under Cayman Islands laws, including the duty to ensure that, in their opinion, any such transactions must be entered into bona fide in the best interests of the Company, and are entered into for a proper corporate purpose and not with the effect of constituting a fraud on the minority shareholders.

Restructuring

A company may present a petition to the Grand Court of the Cayman Islands for the appointment of a restructuring officer on the grounds that the company:

(a) is or is likely to become unable to pay its debts; and

(b) intends to present a compromise or arrangement to its creditors (or classes thereof) either pursuant to the Companies Act, the law of a foreign country or by way of a consensual restructuring.

The Grand Court may, among other things, make an order appointing a restructuring officer upon hearing of such petition, with such powers and to carry out such functions as the court may order. At any time (i) after the presentation of a petition for the appointment of a restructuring officer but before an order for the appointment of a restructuring officer has been made, and (ii) when an order for the appointment of a restructuring officer is made, until such order has been discharged, no suit, action or other proceedings (other than criminal proceedings) shall be proceeded with or commenced against the company, no resolution to wind up the company shall be passed, and no winding up petition may be presented against the company, except with the leave of the court. However, notwithstanding the presentation of a petition for the appointment of a restructuring officer or the appointment of a restructuring officer, a creditor who has security over the whole or part of the assets of the company is entitled to enforce the security without the leave of the court and without reference to the restructuring officer appointed.

 

10


Dissolution; Winding up

Under the Delaware General Corporation Law, unless the board of directors approves the proposal to dissolve, dissolution must be approved by shareholders holding 100% of the total voting power of the corporation. Only if the dissolution is initiated by the board of directors may it be approved by a simple majority of the corporation’s outstanding shares. Delaware law allows a Delaware corporation to include in its certificate of incorporation a supermajority voting requirement in connection with dissolutions initiated by the board.

Under Cayman Islands law, a company may be wound up by either an order of the courts of the Cayman Islands or by a special resolution of its members or, if the company is unable to pay its debts as they fall due, by an ordinary resolution of its members. The court has authority to order winding up in a number of specified circumstances including where it is, in the opinion of the court, just and equitable to do so. Under the Companies Act and our Memorandum and Articles of Association, our company may be dissolved, liquidated or wound up by a special resolution of our shareholders.

Variation of Rights of Shares

Under the Delaware General Corporation Law, a corporation may vary the rights of a class of shares with the approval of a majority of the outstanding shares of such class, unless the certificate of incorporation provides otherwise. Under our Memorandum and Articles of Association, if our share capital is divided into more than one class of shares, we may vary the rights attached to any class with the written consent of the holders representing not less than two-thirds of the issued shares of that class or with the sanction of a special resolution passed at a general meeting of the holders of the shares of that class.

Amendment of Governing Documents

Under the Delaware General Corporation Law, a corporation’s governing documents may be amended with the approval of a majority of the outstanding shares entitled to vote, unless the certificate of incorporation provides otherwise. Under the Companies Act and our Memorandum and Articles of Association, our memorandum and articles of association may only be amended by a special resolution of our shareholders.

Rights of Non-resident or Foreign Shareholders

There are no limitations imposed by our Memorandum and Articles of Association on the rights of non-resident or foreign shareholders to hold or exercise voting rights on our shares. In addition, there are no provisions in our Memorandum and Articles of Association that require our Company to disclose shareholder ownership above particular ownership threshold.

Changes in Capital (Item 10.B.10 of Form 20-F)

The requirements of the Memorandum and Articles of Association regarding changes in capital are not more stringent than the requirements of Cayman Islands law.

 

11


Debt Securities (Item 12.A of Form 20-F)

Not applicable.

Warrants and Rights (Item 12.B of Form 20-F)

Not applicable.

Other Securities (Item 12.C of Form 20-F)

Not applicable.

Description of American Depositary Shares (Items 12.D.1 and 12.D.2 of Form 20-F)

The Bank of New York Mellon, as depositary, issues and delivers American Depositary Shares, also referred to as ADSs. Each ADS represents one Class A ordinary share (or a right to receive one Class A ordinary share) deposited with The Hongkong and Shanghai Banking Corporation Limited, as custodian for the depositary in Hong Kong. Each ADS also represents any other securities, cash or other property which may be held by the depositary. The deposited shares together with any other securities, cash or other property held by the depositary are referred to as the deposited securities. The depositary’s office at which the ADSs will be administered and its principal executive office are located at 240 Greenwich Street, New York, New York 10286.

You may hold ADSs either (A) directly (i) by having an American Depositary Receipt, also referred to as an ADR, which is a certificate evidencing a specific number of ADSs, registered in your name, or (ii) by having uncertificated ADSs registered in your name, or (B) indirectly by holding a security entitlement in ADSs through your broker or other financial institution that is a direct or indirect participant in The Depository Trust Company, also called DTC. If you hold ADSs directly, you are a registered ADS holder, also referred to as an ADS holder. This description assumes you are an ADS holder. If you hold the ADSs indirectly, you must rely on the procedures of your broker or other financial institution to assert the rights of ADS holders described in this section. You should consult with your broker or financial institution to find out what those procedures are.

Registered holders of uncertificated ADSs will receive statements from the depositary confirming their holdings.

As an ADS holder, we will not treat you as one of our shareholders and you will not have shareholder rights. Cayman Islands law governs shareholder rights. The depositary will be the holder of the shares underlying your ADSs. As a registered holder of ADSs, you will have ADS holder rights. A deposit agreement among us, the depositary, ADS holders and all other persons indirectly or beneficially holding ADSs sets out ADS holder rights as well as the rights and obligations of the depositary. New York law governs the deposit agreement and the ADSs.

The following is a summary of the material provisions of the deposit agreement. For more complete information, you should read the entire deposit agreement and the form of ADR. For directions on how to obtain copies of those documents, see “Where You Can Find Additional Information.” The following is a summary of what we believe to be the material terms of the deposit agreement. Notwithstanding this, because it is a summary, it may not contain all the information that you may otherwise deem important. For more complete information, you should read the entire deposit agreement and the form of ADR which contains the terms of your ADSs. The deposit agreement has been filed with the SEC as an exhibit to a Registration Statement on Form F-6 (File No. 333-248968) for our company on September 22, 2020. The form of ADR has been initially filed with the SEC as an exhibit to our Registration Statement on Form F-1 (File No. 333-248641), as amended, on September 8, 2020.

 

12


Dividends and Other Distributions

How will you receive dividends and other distributions on the shares?

The depositary has agreed to pay or distribute to ADS holders the cash dividends or other distributions it or the custodian receives on shares or other deposited securities, upon payment or deduction of its fees and expenses. You will receive these distributions in proportion to the number of shares your ADSs represent.

Cash

The depositary will convert any cash dividend or other cash distribution we pay on the shares into U.S. dollars, if it can do so on a reasonable basis and can transfer the U.S. dollars to the United States. If that is not possible or if any government approval is needed and cannot be obtained, the deposit agreement allows the depositary to distribute the foreign currency only to those ADS holders to whom it is possible to do so. It will hold the foreign currency it cannot convert for the account of the ADS holders who have not been paid. It will not invest the foreign currency and it will not be liable for any interest.

Before making a distribution, any withholding taxes, or other governmental charges that must be paid will be deducted. See “Taxation.” The depositary will distribute only whole U.S. dollars and cents and will round fractional cents to the nearest whole cent. If the exchange rates fluctuate during a time when the depositary cannot convert the foreign currency, you may lose some of the value of the distribution.

Shares

The depositary may distribute additional ADSs representing any shares we distribute as a dividend or free distribution. The depositary will only distribute whole ADSs. It will sell shares which would require it to deliver a fraction of an ADS (or ADSs representing those shares) and distribute the net proceeds in the same way as it does with cash. If the depositary does not distribute additional ADSs, the outstanding ADSs will also represent the new shares. The depositary may sell a portion of the distributed shares (or ADSs representing those shares) sufficient to pay its fees and expenses in connection with that distribution.

Rights to purchase additional shares

If we offer holders of our securities any rights to subscribe for additional shares or any other rights, the depositary may (i) exercise those rights on behalf of ADS holders, (ii) distribute those rights to ADS holders or (iii) sell those rights and distribute the net proceeds to ADS holders, in each case after deduction or upon payment of its fees and expenses. To the extent the depositary does not do any of those things, it will allow the rights to lapse. In that case, you will receive no value for them. The depositary will exercise or distribute rights only if we ask it to and provide satisfactory assurances to the depositary that it is legal to do so. If the depositary will exercise rights, it will purchase the securities to which the rights relate and distribute those securities or, in the case of shares, new ADSs representing the new shares, to subscribing ADS holders, but only if ADS holders have paid the exercise price to the depositary. U.S. securities laws may restrict the ability of the depositary to distribute rights or ADSs or other securities issued on exercise of rights to all or certain ADS holders, and the securities distributed may be subject to restrictions on transfer.

 

13


Other Distributions

The depositary will send to ADS holders anything else we distribute on deposited securities by any means it thinks is legal, fair and practical. If it cannot make the distribution in that way, the depositary has a choice. It may decide to sell what we distributed and distribute the net proceeds, in the same way as it does with cash. Or, it may decide to hold what we distributed, in which case ADSs will also represent the newly distributed property. However, the depositary is not required to distribute any securities (other than ADSs) to ADS holders unless it receives satisfactory evidence from us that it is legal to make that distribution. The depositary may sell a portion of the distributed securities or property sufficient to pay its fees and expenses in connection with that distribution. U.S. securities laws may restrict the ability of the depositary to distribute securities to all or certain ADS holders, and the securities distributed may be subject to restrictions on transfer.

The depositary is not responsible if it decides that it is unlawful or impractical to make a distribution available to any ADS holders. We have no obligation to register ADSs, shares, rights or other securities under the Securities Act. We also have no obligation to take any other action to permit the distribution of ADSs, shares, rights or anything else to ADS holders. This means that you may not receive the distributions we make on our shares or any value for them if it is illegal or impractical for us to make them available to you.

Deposit, Withdrawal and Cancellation

How are ADSs issued?

The depositary will deliver ADSs if you or your broker deposits shares or evidence of rights to receive shares with the custodian. Upon payment of its fees and expenses and of any taxes or charges, such as stamp taxes or stock transfer taxes or fees, the depositary will register the appropriate number of ADSs in the names you request and will deliver the ADSs to or upon the order of the person or persons that made the deposit.

How can ADS holders withdraw the deposited securities?

You may surrender your ADSs to the depositary for the purpose of withdrawal. Upon payment of its fees and expenses and of any taxes or charges, such as stamp taxes or stock transfer taxes or fees, the depositary will deliver the shares and any other deposited securities underlying the ADSs to the ADS holder or a person the ADS holder designates at the office of the custodian. Or, at your request, risk and expense, the depositary will deliver the deposited securities at its office, if feasible. However, the depositary is not required to accept surrender of ADSs to the extent it would require delivery of a fraction of a deposited share or other security. The depositary may charge you a fee and its expenses for instructing the custodian regarding delivery of deposited securities.

How do ADS holders interchange between certificated ADSs and uncertificated ADSs?

You may surrender your ADR to the depositary for the purpose of exchanging your ADR for uncertificated ADSs. The depositary will cancel that ADR and will send to the ADS holder a statement confirming that the ADS holder is the registered holder of uncertificated ADSs. Upon receipt by the depositary of a proper instruction from a registered holder of uncertificated ADSs requesting the exchange of uncertificated ADSs for certificated ADSs, the depositary will execute and deliver to the ADS holder an ADR evidencing those ADSs.

 

14


Voting Rights

How do you vote?

ADS holders may instruct the depositary how to vote the number of deposited shares their ADSs represent. If we request the depositary to solicit your voting instructions (and we are not required to do so), the depositary will notify you of a shareholders’ meeting and send or make voting materials available to you. Those materials will describe the matters to be voted on and explain how ADS holders may instruct the depositary how to vote. For instructions to be valid, they must reach the depositary by a date set by the depositary. The depositary will try, as far as practical, subject to the laws of the Cayman Islands and the provisions of our articles of association or similar documents, to vote or to have its agents vote the shares or other deposited securities as instructed by ADS holders. If we do not request the depositary to solicit your voting instructions, you can still send voting instructions, and, in that case, the depositary may try to vote as you instruct, but it is not required to do so.

Except by instructing the depositary as described above, you won’t be able to exercise voting rights unless you surrender your ADSs and withdraw the shares. However, you may not know about the meeting enough in advance to withdraw the shares. In any event, the depositary will not exercise any discretion in voting deposited securities and it will only vote or attempt to vote as instructed.

We cannot assure you that you will receive the voting materials in time to ensure that you can instruct the depositary to vote your shares. In addition, the depositary and its agents are not responsible for failing to carry out voting instructions or for the manner of carrying out voting instructions. This means that you may not be able to exercise voting rights and there may be nothing you can do if your shares are not voted as you requested.

In order to give you a reasonable opportunity to instruct the depositary as to the exercise of voting rights relating to Deposited Securities, if we request the depositary to act, we agree to give the depositary notice of any such meeting and details concerning the matters to be voted upon at least 45 days in advance of the meeting date.

Tender and Exchange Offers; Redemption, Replacement or Cancelation of Deposited Securities

The depositary will not tender deposited securities in any voluntary tender or exchange offer unless instructed to do so by an ADS holder surrendering ADSs and subject to any conditions or procedures the depositary may establish.

If deposited securities are redeemed for cash in a transaction that is mandatory for the depositary as a holder of deposited securities, the depositary will call for surrender of a corresponding number of ADSs and distribute the net redemption money to the holders of called ADSs upon surrender of those ADSs.

If there is any change in the deposited securities such as a sub-division, combination or other reclassification, or any merger, consolidation, recapitalization or reorganization affecting the issuer of deposited securities in which the depositary receives new securities in exchange for or in lieu of the old deposited securities, the depositary will hold those replacement securities as deposited securities under the deposit agreement. However, if the depositary decides it would not be lawful and practical to hold the replacement securities because those securities could not be distributed to ADS holders or for any other reason, the depositary may instead sell the replacement securities and distribute the net proceeds upon surrender of the ADSs.

 

15


If there is a replacement of the deposited securities and the depositary will continue to hold the replacement securities, the depositary may distribute new ADSs representing the new deposited securities or ask you to surrender your outstanding ADRs in exchange for new ADRs identifying the new deposited securities.

If there are no deposited securities underlying ADSs, including if the deposited securities are canceled, or if the deposited securities underlying ADSs have become apparently worthless, the depositary may call for surrender of those ADSs or cancel those ADSs upon notice to the ADS holders.

Amendment and Termination

How may the deposit agreement be amended?

We may agree with the depositary to amend the deposit agreement and the ADRs without your consent for any reason. If an amendment adds or increases fees or charges, except for taxes and other governmental charges or expenses of the depositary for registration fees, facsimile costs, delivery charges or similar items, or prejudices a substantial right of ADS holders, it will not become effective for outstanding ADSs until 30 days after the depositary notifies ADS holders of the amendment. At the time an amendment becomes effective, you are considered, by continuing to hold your ADSs, to agree to the amendment and to be bound by the ADRs and the deposit agreement as amended.

How may the deposit agreement be terminated?

The depositary will initiate termination of the deposit agreement if we instruct it to do so. The depositary may initiate termination of the deposit agreement if

 

   

60 days have passed since the depositary told us it wants to resign but a successor depositary has not been appointed and accepted its appointment;

 

   

we delist the ADSs from an exchange in the United States on which they were listed and do not list the ADSs on another exchange in the United States or make arrangements for trading of ADSs on the U.S. over-the-counter market;

 

   

we delist our shares from an exchange outside the United States on which they were listed and do not list the shares on another exchange outside the United States;

 

   

the depositary has reason to believe the ADSs have become, or will become, ineligible for registration on Form F-6 under the Securities Act of 1933;

 

   

we appear to be insolvent or enter insolvency proceedings;

 

   

all or substantially all the value of the deposited securities has been distributed either in cash or in the form of securities;

 

16


   

there are no deposited securities underlying the ADSs or the underlying deposited securities have become apparently worthless; or

 

   

there has been a replacement of deposited securities.

If the deposit agreement will terminate, the depositary will notify ADS holders at least 90 days before the termination date. At any time after the termination date, the depositary may sell the deposited securities. After that, the depositary will hold the money it received on the sale, as well as any other cash it is holding under the deposit agreement, unsegregated and without liability for interest, for the pro rata benefit of the ADS holders that have not surrendered their ADSs. Normally, the depositary will sell as soon as practicable after the termination date.

After the termination date and before the depositary sells, ADS holders can still surrender their ADSs and receive delivery of deposited securities, except that the depositary may refuse to accept a surrender for the purpose of withdrawing deposited securities or reverse previously accepted surrenders of that kind that have not settled if it would interfere with the selling process. The depositary may refuse to accept a surrender for the purpose of withdrawing sale proceeds until all the deposited securities have been sold. The depositary will continue to collect distributions on deposited securities, but, after the termination date, the depositary is not required to register any transfer of ADSs or distribute any dividends or other distributions on deposited securities to the ADSs holder (until they surrender their ADSs) or give any notices or perform any other duties under the deposit agreement except as described in this paragraph.

Limitations on Obligations and Liability

Limits on our Obligations and the Obligations of the Depositary; Limits on Liability to Holders of ADSs

The deposit agreement expressly limits our obligations and the obligations of the depositary. It also limits our liability and the liability of the depositary. We and the depositary:

 

   

are only obligated to take the actions specifically set forth in the deposit agreement without negligence or bad faith, and the depositary will not be a fiduciary or have any fiduciary duty to holders of ADSs;

 

   

are not liable if we are or it is prevented or delayed by law or by events or circumstances beyond our or its ability to prevent or counteract with reasonable care or effort from performing our or its obligations under the deposit agreement;

 

   

are not liable if we or it exercises discretion permitted under the deposit agreement;

 

   

are not liable for the inability of any holder of ADSs to benefit from any distribution on deposited securities that is not made available to holders of ADSs under the terms of the deposit agreement, or for any special, consequential or punitive damages for any breach of the terms of the deposit agreement;

 

   

have no obligation to become involved in a lawsuit or other proceeding related to the ADSs or the deposit agreement on your behalf or on behalf of any other person;

 

   

may rely upon any documents we believe or it believes in good faith to be genuine and to have been signed or presented by the proper person;

 

17


   

are not liable for the acts or omissions of any securities depository, clearing agency or settlement system; and

 

   

the depositary has no duty to make any determination or provide any information as to our tax status, or any liability for any tax consequences that may be incurred by ADS holders as a result of owning or holding ADSs or be liable for the inability or failure of an ADS holder to obtain the benefit of a foreign tax credit, reduced rate of withholding or refund of amounts withheld in respect of tax or any other tax benefit.

In the deposit agreement, we and the depositary agree to indemnify each other under certain circumstances.

Requirements for Depositary Actions

Before the depositary will deliver or register a transfer of ADSs, make a distribution on ADSs, or permit withdrawal of shares, the depositary may require:

 

   

payment of stock transfer or other taxes or other governmental charges and transfer or registration fees charged by third parties for the transfer of any shares or other deposited securities;

 

   

satisfactory proof of the identity and genuineness of any signature or other information it deems necessary; and

 

   

compliance with regulations it may establish, from time to time, consistent with the deposit agreement, including presentation of transfer documents.

The depositary may refuse to deliver ADSs or register transfers of ADSs when the transfer books of the depositary or our transfer books are closed or at any time if the depositary or we think it advisable to do so.

Your Right to Receive the Shares Underlying your ADSs

ADS holders have the right to cancel their ADSs and withdraw the underlying shares at any time except:

 

   

when temporary delays arise because: (i) the depositary has closed its transfer books or we have closed our transfer books; (ii) the transfer of shares is blocked to permit voting at a shareholders’ meeting; or (iii) we are paying a dividend on our shares;

 

   

when you owe money to pay fees, taxes and similar charges; or

 

   

when it is necessary to prohibit withdrawals in order to comply with any laws or governmental regulations that apply to ADSs or to the withdrawal of shares or other deposited securities.

This right of withdrawal may not be limited by any other provision of the deposit agreement.

 

18


Direct Registration System

In the deposit agreement, all parties to the deposit agreement acknowledge that the Direct Registration System, also referred to as DRS, and Profile Modification System, also referred to as Profile, will apply to the ADSs. DRS is a system administered by DTC that facilitates interchange between registered holding of uncertificated ADSs and holding of security entitlements in ADSs through DTC and a DTC participant. Profile is a feature of DRS that allows a DTC participant, claiming to act on behalf of a registered holder of uncertificated ADSs, to direct the depositary to register a transfer of those ADSs to DTC or its nominee and to deliver those ADSs to the DTC account of that DTC participant without receipt by the depositary of prior authorization from the ADS holder to register that transfer.

In connection with and in accordance with the arrangements and procedures relating to DRS/Profile, the parties to the deposit agreement understand that the depositary will not determine whether the DTC participant that is claiming to be acting on behalf of an ADS holder in requesting registration of transfer and delivery as described in the paragraph above has the actual authority to act on behalf of the ADS holder (notwithstanding any requirements under the Uniform Commercial Code). In the deposit agreement, the parties agree that the depositary’s reliance on and compliance with instructions received by the depositary through the DRS/Profile system and in accordance with the deposit agreement will not constitute negligence or bad faith on the part of the depositary.

Shareholder communications; inspection of register of holders of ADSs

The depositary will make available for your inspection at its office all communications that it receives from us as a holder of deposited securities that we make generally available to holders of deposited securities. The depositary will send you copies of those communications or otherwise make those communications available to you if we ask it to. You have a right to inspect the register of holders of ADSs, but not for the purpose of contacting those holders about a matter unrelated to our business or the ADSs.

Jury Trial Waiver

The deposit agreement provides that, to the extent permitted by law, ADS holders waive the right to a jury trial of any claim they may have against us or the depositary arising out of or relating to our shares, the ADSs or the deposit agreement, including any claim under the U.S. federal securities laws. If we or the depositary opposed a jury trial demand based on the waiver, the court would determine whether the waiver was enforceable in the facts and circumstances of that case in accordance with applicable case law.

You will not, by agreeing to the terms of the deposit agreement, be deemed to have waived our or the depositary’s compliance with U.S. federal securities laws or the rules and regulations promulgated thereunder.

 

19

EX-4.25 3 d290954dex425.htm EX-4.25 EX-4.25

Exhibit 4.25

Equity Pledge Agreement

on

Guang Cheng (Shanghai) Information Technology Co., Ltd.

between

Shanghai Che Lin Information Technology Center (Limited Partnership)

and

Xin Cheng (Shanghai) Information Technology Co., Ltd.

25 September 2022


Equity Pledge Agreement

This Equity Pledge Agreement (hereinafter referred to as the “Agreement”) was executed by and among the following parties on 25 September 2022:

 

1.

Shanghai Che Lin Information Technology Center (Limited Partnership) (hereinafter referred to as the “Pledgor”)

Principal place of business: Room D1-6112, 58 Fumin Branch Road, Hengsha Township, Chongming District, Shanghai (Shanghai Hengtai Economic Development Zone)

 

2

Xin Cheng (Shanghai) Information Technology Co., Ltd. (hereinafter referred to as the “Pledgee”)

Registered address: 1F, Building 1, No. 977 Shangfeng Road, Pudong New District, Shanghai

 

3

Guang Cheng (Shanghai) Information Technology Co., Ltd. (hereinafter referred to as the “Company”)

Registered address: Room 722, 7F, Building A, No. 977 Shangfeng Road, Tang Town, Pudong New District, Shanghai

(In the Agreement, the aforesaid respective parties are individually referred to as a “Party” and collectively as the “Parties”.)

Whereas:

 

(1)

The Pledgor entered into an equity transfer agreement with Xinrong Zhihui Technology Development Co., Ltd. (新荣智汇科技发展有限公司, formerly known as Xinjiang Xinrong Zhihui Equity Investment Co., Ltd. (新疆新荣智汇股权投资有限公司)) on 9 September 2022, under which it was agreed that Xinrong Zhihui Technology Development Co., Ltd shall transfer its 3.586% equity in the Company, representing RMB1,654,500 in the registered capital of the Company, to the Pledgor.

 

(2)

The Pledgor is a registered shareholder of the Company and holds 85.057% equity in the Company, representing RMB39,239,348in the registered capital of the Company (hereinafter referred to as the “Subject Equity”).

 

(3)

According to the Exclusive Call Option Agreement (including the agreement and any amendment thereto or restatement thereof, hereinafter referred to as the “Call Option Agreement”) executed by the Parties to the Agreement on 4 August 2020, the Pledgor shall, where permitted by PRC Law and as required by the Pledgee, transfer all or part of its equity held in the Company to the Pledgee and/or any other entities or individuals designated by it.

 

(4)

According to the Loan Agreement (including the agreement and any amendment thereto or restatement thereof, hereinafter referred to as the “Loan Agreement”) executed by the Pledgor and the Pledgee on 4 August 2020, the Pledgee agrees to provide loans to the Pledgor in accordance with the terms and conditions of the Loan Agreement.


(5)

Pursuant to the Shareholders’ Voting Rights Proxy Agreement (including the agreement and any amendment thereto or restatement thereof, hereinafter referred to as the “Voting Rights Proxy Agreement”) executed by the parties to the Agreement on 4 August 2020, the Pledgor has irrevocably and fully authorized the person appointed by the Pledgee to exercise on its behalf all of its shareholder’s voting rights in the Company.

 

(6)

According to the Exclusive Technical Consulting and Service Agreement (including the agreement and any amendment thereto or restatement thereof, hereinafter referred to as the “Consulting and Service Agreement”) executed between the Company and the Pledgee on 4 August 2020, the Company has exclusively engaged the Pledgee to provide relevant technical support and Consulting and Services for it and agreed to pay corresponding service fees to the Pledgee for such services.

 

(7)

According to the Intellectual Property License Agreement (including the agreement and any amendment thereto or restatement thereof, hereinafter referred to as the “Intellectual Property License Agreement”) executed between the Company and the Pledgee on 4 August 2020, the Pledgee has granted the Company (including the Pledgee) an exclusive licence to use the intellectual property rights of the Pledgee, and the Company shall pay the Pledgee the corresponding licensing fees for such license.

 

(8)

As security for performance of the Contract Obligations (as defined below) and repayment of the Guaranteed Liabilities (as defined below) by the Pledgor and the Company, the Pledgor agrees to pledge its 85.057% equity in the Company to the Pledgee (the amount of pledged equity is RMB39,239,348, and the secured obligations are approximately RMB50,000,000), and grant the Pledgee the right of payment on first priority.

Therefore, the Parties, upon negotiation, arrive at the following agreement:

Article 1 Definitions

 

1.1

Save as otherwise interpreted pursuant to the context, the following terms shall have the following meanings in the Agreement:

 

“Contract Obligations”:    shall mean all contract obligations of the Pledgor and/or the Company under Loan Agreement, Consultation and Service Agreement, Intellectual Property License Agreement, Call Option Agreement and Voting Rights Proxy Agreement and the Agreement (and any amendment thereto or restatement thereof).
“Guaranteed Liabilities”:    shall include all service fees and interest that the Pledgee shall receive under the Transaction Agreements (as defined below) and loan repayment and interest payment by the Pledgor to the Pledgee; all direct and indirect losses of foreseeable profits suffered due to any Event of Default(as defined below) of the Pledgor and/or the Company; all expenses incurred to the Pledgee for forcing the Pledgor and/or the Company to perform their Contract Obligations, as well as general expenses for the exercise of the pledge (including but not limited to attorney fees, arbitration fees, assessment and auction fees for the pledged equity).


“Transaction Agreements”:    shall mean the Loan Agreement, Call Option Agreement, Voting Rights Proxy Agreement, Consulting and Service Agreement and Intellectual Property License Agreement.
“Event of Default”:    shall mean the Pledgor’s and/or the Company’s violation of any Contract Obligations under the Loan Agreement, Call Option Agreement, Voting Rights Proxy Agreement, Consulting and Service Agreement, Intellectual Property License Agreement, and/or the Agreement (and any amendment thereto or restatement thereof).
“Pledged Equity”:    shall mean all of the Subject Equity that is legally owned by the Pledgor at the time when the Agreement takes effect and will be pledged to the Pledgee according to the provisions of the Agreement as security for the performance of Contract Obligations by the Pledgor, and the increased capital contribution/equity and share dividend as described in Articles 2.6 and 2.7 hereof.
“Pledge”:    shall mean the right entitled to the Pledgee to be repaid in priority with proceeds from discounts, auctions or realization of the equity pledged by the Pledgor to the Pledgee.
“PRC Law”:    shall mean the then-effective laws, administrative regulations, administrative rules, local regulations, judicial interpretations and other binding regulatory documents of the People’s Republic of China (excluding Hong Kong Special Administrative Region, Macau Special Administrative Region and Taiwan for the purpose of the Agreement).

 

1.2

The references to any PRC Law herein shall be deemed (1) simultaneously to include the references to the amendments, changes, supplements and re-enactment of such PRC Law, irrespective of whether they take effect before or after the execution of the Agreement, and (2) simultaneously to include the references to other decisions, notices and regulations enacted in accordance therewith or effective as a result thereof.

 

1.3

Except as otherwise stated in the context herein, all references to an article, clause, item or paragraph herein shall refer to the corresponding part of the Agreement.


Article 2 Equity Pledge

 

2.1

The Pledgor agrees to pledge all equity legally owned by it and at its disposal to the Pledgee as security for performance of the Contract Obligations and payment of the Guaranteed Liabilities by the Pledgor according to the Agreement.

 

2.2

The Pledgor shall, register the equity pledge hereunder with the administration for industry and commerce with jurisdiction over the Company within ten working days after the execution of the Agreement or on other dates agreed by the Parties. The pledge rights hereunder shall be established upon registration of the pledge with the administration for industry and commerce.

 

2.3

The Company shall, and the Pledgor shall cause the Company to record the Pledge of the Pledged Equity as specified in the Agreement on the share register, and agree to submit the only share register to the Pledgee for safekeeping. In addition, the Company shall not set up any other share register.

 

2.4

During the valid term of the Agreement, except for the willful misconduct or gross negligence of the Pledgee which has direct causation with the reduction in value of the Pledged Equity, the Pledgee shall not be liable in any way, nor shall the Pledgor have any right to claim in any way or propose any demands on the Pledgee, in respect of the said reduction in value of the Pledged Equity.

 

2.5

In case of any Event of Default, the Pledgee shall have the right to dispose of the Pledged Equity in the way set out in Article 4 hereof.

 

2.6

With the prior consent of the Pledgee, the Pledgor may increase its capital contribution to the Company, transfer or accept the transfer of any of the Subject Equity.

 

2.7

With the prior consent of the Pledgee, the Pledgor may be able to receive dividends, share profits or receive other profit distributions from the Pledged Equity. The Pledgor agrees that during the existence of the Equity Pledge, the Pledgee shall have the right to receive any dividends or share profits from the Pledged Equity. The Company shall pay the partial amount to the bank account designated by the Pledgee.

 

2.8

The additional equity acquired by the Pledgor under Article 2.6 or 2.7, that is, further capital contribution made by the Pledgor to the registered capital of the Company due to capital increase to the Company, acceptance of equity transfer, or distribution of dividends by the Company or any other reason, shall also be part of the Pledged Equity. The Company shall, and the Pledgor shall cause the Company to record change to the Equity Pledge on the Company’s share register on the date of change to the Pledged Equity (including but not limited to capital increase), and complete the registration of change to the Equity Pledge with the administration for industry and commerce within 15 days after the change.


2.9

To the extent not violating provision of Article 2.4 above, in case of any possibility of obvious reduction in value of the Pledged Equity which is sufficient to jeopardize the Pledgee’s rights, the Pledgee may at any time auction or realize the Pledged Equity on behalf of the Pledgor, and discuss with the Pledgor to use the proceeds from such auction or realization as early repayment of the Guaranteed Liabilities, or may escrow such proceeds with the local notary institution where the Pledgee is domiciled (any resulting fees shall be borne by the Pledgee). In addition, as requested by the Pledgee, the Pledgor should provide other property as security.

Article 3 Release of Pledge

 

3.1

Upon full and complete performance of all the Contract Obligations and upon the full repayment of all the Guaranteed Liabilities by the Pledgor and the Company, or upon termination or invalidation of the Transaction Agreements, or upon termination of Contract Obligations due to legal reasons, the Pledgee shall, at the request of the Pledgor, release the Equity Pledge under the Agreement, and shall cooperate with the Pledgor to go through the formalities to cancel registration of the Equity Pledge at the administration for industry and commerce. The reasonable fees incurred in connection with such release shall be borne by Pledgee.

Article 4 Disposal of the Pledged Equity

 

4.1

The Parties hereby agree that, in case of any Event of Default, the Pledgee shall have the right to exercise, upon giving a written notice to the Pledgor, all of the remedial rights and powers enjoyed by it under PRC Law, Transaction Agreements and the terms hereof, including (but not limited to) being repaid in priority with proceeds from auctions or realisation of the Pledged Equity. The Pledgee shall not be liable for any loss resulting from its legal and reasonable exercise of such rights and powers.

 

4.2

The Pledgee shall have the right to designate in writing its solicitors or other agents to exercise on its behalf any and all rights and powers set out above, to which the Pledgor shall not raise an objection.

 

4.3

For the reasonable costs incurred to the Pledgee in connection with its exercise of any or all rights and powers set out above, the Pledgee shall have the right to deduct the costs actually incurred from the proceeds acquired from the exercise of the rights and powers.

 

4.4

The proceeds that the Pledgee acquires from the exercise of its rights and powers shall be used in the following order:

First, to pay any cost incurred in connection with the disposal of the Pledged Equity and the Pledgee’s exercise of its rights and powers (including remuneration paid to its solicitors and agents);


Second, to pay any taxes and levies payable for the disposal of the Pledged Equity; and

Third, to repay the Pledgee for the Guaranteed Liabilities;

In case of any balance after payment of the above amounts, the Pledgee shall return it to the Pledgor or other persons entitled thereto according to the relevant laws and rules or escrow it with the local notary institution where the Pledgee is domiciled (any resulting fees shall be borne by the Pledgee).

 

4.5

The Pledgee shall have the option to exercise, simultaneously or successively, any of the breach remedies entitled to it. The Pledgee shall not be obliged to exercise any other breach remedies before exercise of the right to the auction or realisation of the Pledged Equity hereunder.

Article 5 Fees and Costs

 

5.1

All costs actually incurred in connection with the establishment of the Equity Pledge hereunder, including (but not limited to) stamp duties, any other taxes and all legal fees, shall be borne by the Parties respectively as required by law.

Article 6 Continuity and No Waiver

 

6.1

The Equity Pledge hereunder is a continuous guarantee, with its validity to continue until the full performance of the Contract Obligations, the termination or invalidation of the Transaction Agreements, the termination of Contract Obligations due to legal reasons or the full repayment of the Guaranteed Liabilities (whichever is earlier). Neither exemption or grace period granted by Pledgee to the Pledgor in respect of any breach of contract, nor delay by the Pledgee in exercising any of its rights under the Transaction Agreements and the Agreement shall affect the rights of the Pledgee under the Agreement, relevant PRC Law and the Transaction Agreements, the rights of the Pledgee to demand at any time thereafter the strict performance of the Transaction Agreements and the Agreement by the Pledgor or the rights entitled to the Pledgee due to subsequent breach of the Transaction Agreements and/or the Agreement by the Pledgor.

Article 7 Representations and Warranties of the Pledgor and the Company

 

7.1

The Pledgor and the Company hereby jointly and severally represent and warrant to the Pledgee as follows:

 

  (1)

They are duly authorized to execute, deliver and perform the Agreement and may act as the subject of litigation independently;

 

  (2)

All reports, documents and information concerning the Pledgor, the Pledged Equity and all matters as required by the Agreement which are provided by the Pledgor and the Company to the Pledgee before the Agreement comes into effect are true and correct in all material aspects at the time when the Agreement comes into effect;


  (3)

All reports, documents and information concerning the Pledgor, the Pledged Equity and all matters as required by the Agreement which are provided by the Pledgor and the Company to the Pledgee after the Agreement comes into effect are true and correct in all material aspects at the time when they are provided;

 

  (4)

At the time when the Agreement comes into effect, the Pledgor is the legal owner of the Pledged Equity, without any existing dispute concerning the ownership of the Pledged Equity. The Pledgor has the right to dispose of the Pledged Equity or any part thereof;

 

  (5)

Except for the security rights on the Pledged Equity hereunder, the rights set under the Transaction Agreements and those disclosed in writing by the Pledgers to the Pledgee, there is no other security rights, third party interest or any other restrictions set on the Pledged Equity. The Pledgor has not transferred or disposed of any Pledged Equity otherwise;

 

  (6)

The Pledged Equity is capable of being pledged or transferred according to the laws, and the Pledgor has the full right and power to pledge the Pledged Equity to the Pledgee according to the Agreement;

 

  (7)

The Agreement constitutes the legal, valid and binding obligations on the Pledgor and the Company when it is duly executed by the Pledgor and the Company;

 

  (8)

Except for the right of first refusal with the same conditions and other rights enjoyed by shareholders of the Company in accordance with the law and the Articles of Association, any consent, permission, waiver or authorization by any third person, or any approval, permission or exemption by any government authority, or any registration (except for registrations required by Article 2.2) or filing formalities (if required by laws) with any government authority to be obtained in respect of the execution and performance hereof and the Equity Pledge hereunder have already been handled or obtained, and will be fully effective during the valid term of the Agreement;

 

  (9)

The execution and performance of the Agreement by the Pledgor and the Company are not in violation of or conflict with any laws in force applicable to them, any agreement to which they are a party or which has binding effect on their assets, any court judgment, any arbitration award, or any decision of administrative authorities;

 

  (10)

The pledge hereunder constitutes the security rights of first order in priority on the Pledged Equity;

 

  (11)

All taxes and fees payable in connection with acquisition of the Pledged Equity have already been paid in full by the Pledgor and/or the Company;


  (12)

There is no pending or, to the knowledge of the Pledgor or the Company, threatened litigation, arbitrations, other legal proceedings or demand by any court or any arbitral tribunal against the Pledged Equity, the Pledgor or its property, or the Company or its assets, nor is there any pending or, to the knowledge of the Pledgor or the Company, threatened administrative procedures, other legal proceedings or demand by any government authority or any administrative authority against the Pledged Equity, the Pledgor or its property, or the Company or its assets, which is of material or detrimental effect on the economic status of the Pledgor or the Company or the Pledgor’s capability to perform the obligations hereunder and the Guaranteed Liabilities;

 

  (13)

The Pledgor and the Company hereby warrant to the Pledgee that the above representations and warranties will remain true and correct at the time of execution of the Agreement, and will be fully complied with.

Article 8 Undertakings by the Pledgor and the Company

 

8.1

The Pledgor and the Company hereby undertake to the Pledgee as follows:

 

  (1)

Without prior written consent of the Pledgee, the Pledgor shall not establish or permit to establish any new pledge or any other security rights or third party rights on the Pledged Equity, and any pledge or any other security rights established or third party rights on all or part of the Pledged Equity without prior written consent of the Pledgee shall be invalid;

 

  (2)

Except for the transfer of the Pledged Equity to the Pledgee or the individual designated by the Pledgee pursuant to the Exclusive Call Option Agreement (including its amendments, supplements or restatements from time to time) executed by the Pledgor and the Pledgee on 4 August 2020, without prior written notice to the Pledgee and having the Pledgee’s prior written consent, the Pledgor shall not transfer or otherwise dispose of all or part of the Pledged Equity, and any attempt or actual transfer or otherwise disposal of the Pledged Equity by the Pledgor shall be null and void. With written consent of the Pledgee, the proceeds from transfer or otherwise disposal of the Pledged Equity by the Pledgor shall be first used to repay to the Pledgee in advance the Guaranteed Liabilities or escrow the same to the third party as agreed with the Pledgee;

 

  (3)

In case of any litigation, arbitration or other legal proceedings or demand which may affect detrimentally the interest or the Pledged Equity of the Pledgor or the Pledgee under the Transaction Agreements and hereunder, the Pledgor undertakes to notify the Pledgee thereof in writing as soon as possible and promptly and shall take, at the reasonable request of the Pledgee, all necessary measures to ensure the pledge interest of the Pledgee in the Pledged Equity, except for disputes, litigations, arbitrations between the Pledgor and the Pledgee;


  (4)

The Pledgor and the Company shall not carry on or permit any act or action which may affect detrimentally the interest or the Pledged Equity of the Pledgee under the Transaction Agreements and hereunder. Each of the Pledgor shall waive the right of first refusal when the Pledgee realizes the pledge rights, except for disputes, litigations, arbitrations between the Pledgor and the Pledgee;

 

  (5)

The Pledgor and the Company guarantee that they shall, at the reasonable request of the Pledgee, take all necessary measures and execute all necessary documents (including but not limited to supplementary agreement hereof) to ensure the pledge interest of the Pledgee in the Pledged Equity and the legal and contractual exercise and realization of the rights thereof;

 

  (6)

In case of transfer of any Pledged Equity caused by the legal and contractual exercise of the right to the pledge hereunder, the Pledgor and the Company guarantee that they will take all necessary measures to realize such transfer;

 

  (7)

The Pledgor and the Company shall ensure that the convening procedures and voting methods and contents of the Company’s shareholders’ meeting or Board meeting (if any) held for the purpose of the conclusion of the Agreement and establishment and exercise of the pledge rights are in compliance with laws, administrative rules or the Articles of Association;

 

  (8)

Unless with the prior written consent of the Pledgee, the Pledgor shall have no right to transfer any rights and obligations thereof under the Agreement;

 

  (9)

Subject to the restrictions in Article 8.1 (2) of the Agreement, the Pledgor and the Company shall guarantee the representations and warranties made by the Pledgor to the Pledgee in Article 7 will remain true and correct at any time and under any circumstance before the Contract Obligations are fully performed or the Guaranteed Liabilities are fully repaid, and will be fully complied with;


  (10)

If the Pledgor fails to perform the representations and warranties made by it to the Pledgee in Article 7.1 (8) and Article 7.1 (9) at any time due to the promulgation or change of any PRC Law, regulations or rules, or changes in the interpretation or application of such laws, regulations or rules, or changes in the relevant registration procedures, the Pledgor agrees to perform in accordance with the provisions of Article 9.1 hereof;

 

  (11)

The Pledgor agrees, upon the occurrence of a breach of contract, to immediately and unconditionally gift any shared profit, bonus, dividend and other distributable profit that they obtain from the Company during the term of the Agreement (after deducting relevant taxes) to the Pledgee or the entity/individual designated by the Pledgee;

 

  (12)

In the event of a breach of contract, if the Company is required to be dissolved or liquidated as per compulsory provisions of applicable laws, any interest distributed to the Pledgor (after deducting relevant taxes) according to law upon completion of legal dissolution or liquidation of the Company shall be gifted to the Pledgee or the entity/individual designated by the Pledgee to the extent not in violation of the PRC Law.

Article 9 Change of Circumstances

 

9.1

As supplement and subject to compliance with other terms of the Transaction Agreements and the Agreement, if at any time the promulgation or change of any PRC Law, regulations or rules, or change in interpretation or application of such laws, regulations and rules, or the change of the relevant registration procedures enables the Pledgee to believe that it will be illegal or in conflict with such laws, regulations or rules to further maintain the effectiveness of the Agreement and/or dispose of the Pledged Equity in the way provided herein, the Pledgor shall, at the written direction of the Pledgee and in accordance with the reasonable request of the Pledgee, promptly take any action and/or execute any agreement or other document, in order to:

 

  (1)

keep the Agreement effective;

 

  (2)

facilitate the disposal of the Pledged Equity in the way provided herein; and/or

 

  (3)

maintain or realize the guarantee established or intentionally established hereunder.


Article 10 Effectiveness and Term of The Agreement

 

10.1

The Agreement shall become effective upon due execution by all the Parties.

 

10.2

The Pledgor shall register the Equity Pledge under the Agreement with the administration for industry and commerce with jurisdiction over the Company, and provide the Pledgee with the registration certificate of the Equity Pledge in a form satisfactory to the Pledgee. The Pledgee shall give full cooperation.

 

10.3

The Agreement shall have its valid term until the full performance of the Contract Obligations, the termination or invalidation of the Transaction Agreements, the termination of Contract Obligations due to legal reasons or the full repayment of the Guaranteed Liabilities (whichever is earlier), unless the parties agree otherwise.

Article 11 Notice

 

11.1

Any notice, request, demand and other correspondences required by the Agreement or made in accordance with the Agreement shall be delivered in writing to the relevant Party.

 

11.2

Any notice hereunder shall be sent to the following addresses (unless changes are notified in writing) by personal delivery, facsimile or registered mail. It shall be deemed as served on the date of receipt recorded on the receipt of the registered mail if posted by registered mail; it shall be deemed as served on the date of transmission if delivered in person or transmitted by facsimile. If it is transmitted by facsimile, the original shall be sent to the following addresses by registered mail or personal delivery.

Pledgee: Xin Cheng (Shanghai) Information Technology Co., Ltd.

Address: 6F, Building 1, Yaxin Technology Park, No. 399 Shengxia Road, Pudong New District, Shanghai

Phone: 021- 61096226

E-mail: nichole@boqii.com

Recipient: Lisa

Pledgor: Shanghai Che Lin Information Technology Center (Limited Partnership)

Address:

Fax:

Phone:

Recipient:

Company: Guang Cheng (Shanghai) Information Technology Co., Ltd.

Address: 6F, Building 1, Yaxin Technology Park, No. 399 Shengxia Road, Pudong New District, Shanghai

Fax: 021- 61096226

Phone: nichole@boqii.com

Recipient: Lisa


Article 12 Miscellaneous

 

12.1

The equity pledge agreement among the Company, the Pledgee, Shanghai Yuji Information Technology Center, Shanghai Yuqiang Information Technology Center, Xinjiang Xinrong Zhihui Equity Investment Co., Ltd., Ningbo Dingfeng Mingde Chengyi Equity Investment Partnership (Limited Partnership), Ningbo Dingfeng Mingde Gewu Equity Investment Partnership (Limited Partnership) and other relevant parties dated 4 August 2020 (hereinafter referred to as the “Original Agreement”) shall continue to be valid. Given that Xinrong Zhihui Technology Development Co., Ltd. (formerly known as Xinjiang Xinrong Zhihui Equity Investment Co., Ltd.) has transferred all of its equity in the Company to the Pledgor, Xinrong Zhihui Technology Development Co., Ltd. (formerly known as Xinjiang Xinrong Zhihui Equity Investment Co., Ltd.) will no longer be treated as a party to the Original Agreement and shall not enjoy any right under the Original Agreement, nor shall it assume any obligation under the Original Agreement. In case of any conflict or inconsistency between the Agreement and the Original Agreement, the provisions in the Agreement shall prevail.

 

12.2

The Pledgor and the Company agree that the Pledgee may, upon notice to the Pledgor and the Company, transfer its rights and/or obligations hereunder to any third party; and that without prior written consent of the Pledgee, neither the Pledgor nor the Company may transfer their respective rights, obligations or liabilities hereunder to any third party. Successors or permitted assignees (if any) of the Pledgor and the Company shall continue to perform the obligations of the Pledgor and the Company under the Agreement.

 

12.3

The Agreement is written in Chinese and executed in counterparts, with one (1) to be retained by each Party hereto, one (1) to be used for registration of the pledge with the relevant administration for industry and commerce, and the rest to be used for relevant procedures. All counterparts shall have the same legal effect.

 

12.4

The conclusion, effectiveness, performance, revision, interpretation and termination of the Agreement shall be governed by the PRC Law.

 

12.5

Any dispute arising out of and in connection with the Agreement shall be resolved through negotiation among the Parties. In case the Parties fail to reach an agreement within thirty (30) days after the dispute arises, such dispute shall be submitted to Shanghai Arbitration Commission for arbitration in Shanghai in accordance with such Commission’s arbitration rules in effect at the time. The language used in arbitration shall be Chinese and the arbitration award shall be final and equally binding on the Parties hereto.

 

12.6

None of the rights, powers or remedies granted to any Party by any provision herein shall preclude any other rights, powers or remedies available to such Party at law and under the other provisions of the Agreement. In addition, a Party’s exercise of any of its rights, powers and remedies shall not exclude such Party from exercising any of its other rights, powers and remedies.


12.7

No failure or delay by any Party in exercising any rights, powers and remedies available to it hereunder or at law (“Such Rights”) shall result in a waiver of Such Rights, nor shall the waiver of any single or part of Such Rights shall exclude such Party from exercising Such Rights in any other way and exercising other Such Rights.

 

12.8

The headings of the provisions herein are for reference only, and in no event shall such headings be used for or affect the interpretation of the provisions hereof.

 

12.9

Each provision contained herein shall be severable and independent from each of the other provisions. If any one or more provisions herein become(s) invalid, illegal or unenforceable at any time, the validity, legality and enforceability of the remaining provisions herein shall not be affected as a result thereof.

 

12.10

Any amendments or supplements to the Agreement shall be made in writing and take effect only when properly signed by the Parties to the Agreement.

 

12.11

The Agreement shall be binding on the legal successors of the Parties.

[The remainder of this page is intentionally left blank]


[Signature Page of Equity Pledge Agreement]

IN WITNESS WHEREOF, the Agreement is signed by the Parties on the first above written date and place hereof.

 

Xin Cheng (Shanghai) Information Technology Co., Ltd.
(Seal)
/s/ Seal of Xin Cheng (Shanghai) Information Technology Co., Ltd.

 

Signature:

 

/s/ Yan Jiang

Name: Yan Jiang

Title:

Guang Cheng (Shanghai) Information Technology Co., Ltd.

(Seal)

/s/ Seal of Guang Cheng (Shanghai) Information Technology Co., Ltd.

 

Signature:  

/s/ Yangyang Lu

Name: Yangyang Lu
Title:

Shanghai Che Lin Information Technology Center (Limited Partnership)

(Seal)

/s/ Seal of Shanghai Che Lin Information Technology Center (Limited Partnership)

 

Signature:  

/s/ Yan Jiang

Name: Yan Jiang
Title:
EX-8.1 4 d290954dex81.htm EX-8.1 EX-8.1

Exhibit 8.1

Principal Subsidiaries and VIEs of the Registrant

 

Principal Subsidiaries    Place of Incorporation
Boqii Corporation Limited    Hong Kong
Boqii International Limited    Hong Kong
Xingmu International Limited    British Virgin Islands
Xingmu HK Limited    Hong Kong
Nanjing Xinmu Information Technology Co., Ltd.    PRC
Xincheng (Shanghai) Information Technology Co., Ltd.    PRC
Shanghai Yiqin Pets Products Co., Ltd.    PRC
VIEs    Place of Incorporation
Guangcheng (Shanghai) Information Technology Co., Ltd.    PRC
Nanjing Xingmu Biotechnology Co., Ltd.    PRC
Suzhou Taicheng Supply Chain Co., Ltd.    PRC
Significant Subsidiaries of VIEs    Place of Incorporation
Boqii (Shanghai) Information Technology Co., Ltd.    PRC
Tianjing Guangcheng Information Technology Co., Ltd.    PRC
Nanjing Cuida Biotechnology Co. Ltd.    PRC
Taizhou Xingmu Biotechnology Co., Ltd.    PRC
EX-12.1 5 d290954dex121.htm EX-12.1 EX-12.1

Exhibit 12.1

Certification by the Principal Executive Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Hao (Louis) Liang, certify that:

 

  1.

I have reviewed this annual report on Form 20-F of Boqii Holding Limited (the “Company”);

 

  2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

  3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;

 

  4.

The Company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have:

 

  (a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c)

Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d)

Disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and

 

  5.

The Company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and the audit committee of the Company’s board of directors:

 

  (a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and

 

  (b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting.

 

Date:   July 25, 2023
By:  

/s/ Hao (Louis) Liang

Name:   Hao (Louis) Liang
Title:   Chief Executive Officer
EX-12.2 6 d290954dex122.htm EX-12.2 EX-12.2

Exhibit 12.2

Certification by the Principal Financial Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Yingzhi (Lisa) Tang, certify that:

 

  1.

I have reviewed this annual report on Form 20-F of Boqii Holding Limited (the “Company”);

 

  2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

  3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;

 

  4.

The Company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have:

 

  (a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c)

Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d)

Disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and

 

  5.

The Company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and the audit committee of the Company’s board of directors:

 

  (a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and

 

  (b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting.

 

Date:   July 25, 2023
By:  

/s/ Yingzhi (Lisa) Tang

Name:   Yingzhi (Lisa) Tang
Title:   Chief Financial Officer
EX-13.1 7 d290954dex131.htm EX-13.1 EX-13.1

Exhibit 13.1

Certification by the Principal Executive Officer

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the annual report of Boqii Holding Limited (the “Company”) on Form 20-F for the fiscal year ended March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Hao (Louis) Liang, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: July 25, 2023

 

By:  

/s/ Hao (Louis) Liang

Name: Hao (Louis) Liang
Title: Chief Executive Officer
EX-13.2 8 d290954dex132.htm EX-13.2 EX-13.2

Exhibit 13.2

Certification by the Principal Financial Officer

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the annual report of Boqii Holding Limited (the “Company”) on Form 20-F for the fiscal year ended March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Yingzhi (Lisa) Tang, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: July 25, 2023

 

By:  

/s/ Yingzhi (Lisa) Tang

Name:   Yingzhi (Lisa) Tang
Title:   Chief Financial Officer
EX-15.1 9 d290954dex151.htm EX-15.1 EX-15.1

Exhibit 15.1

 

LOGO

 

Our  ref

SQG/675098-000007/26653117v2

Boqii Holding Limited

Building 9, No. 388, Shengrong Road

Pudong New District, Shanghai 201210

People’s Republic of China

25 July 2023

Dear Sirs

Boqii Holding Limited

We have acted as Cayman Islands legal advisers to Boqii Holding Limited (the “Company”) in connection with the Company’s annual report on Form 20-F for the fiscal year ended March 31, 2023 (“Form 20-F”), filed with the Securities and Exchange Commission under the U.S. Securities Act of 1933.

We hereby consent to the filing of this opinion as an exhibit to the Form 20-F and to the reference to our name under the heading “Item 10. Additional Information—E. Taxation” included in the Form 20-F, and further consent to the incorporation by reference into the Registration Statements on Form S-8 (No. 333-256675), Form S-8 (No. 333-265313) and Form F-3 (No. 333-267919).

In giving such consent, we do not thereby admit that we come within the category of persons whose consent is required under Section 7 of the U.S. Securities Act of 1933, as amended, or the Rules and Regulations of the Commission thereunder.

Yours faithfully

/s/ Maples and Calder (Hong Kong) LLP

Maples and Calder (Hong Kong) LLP

EX-15.2 10 d290954dex152.htm EX-15.2 EX-15.2

Exhibit 15.2

July 25, 2023

 

To:

Boqii Holding Limited

Building 9, No. 388, Shengrong Road

Pudong New District

Shanghai 201210

People’s Republic of China

Dear Sir/Madam,

We hereby consent to the references to our firm’s name under the headings “Item 3. Key Information—Contractual Arrangements with the VIEs and Their Respective Shareholders” “Item 3. Key Information—Permits and Permission Required from the PRC Authorities for Our Operations” and “Item 3. Key Information—3.D. Risk Factors—Risks Related to Our Corporate Structure and Contractual Arrangements” in the annual report on Form 20-F for the fiscal year ended March 31, 2023 of Boqii Holding Limited (the “Annual Report”), which will be filed with the Securities and Exchange Commission (the “SEC”) on the date hereof. We also consent to the filing of this consent letter with the SEC as an exhibit to the Annual Report, and further consent to the incorporation by reference into the Registration Statement on Form F-3 (File No. 333-267919) of Boqii Holding Limited of the summary of our opinion under the heading “Item 3. Key Information—Contractual Arrangements with the VIEs and Their Respective Shareholders” in the Annual Report.

In giving such consent, we do not thereby admit that we come within the category of persons whose consent is required under Section 7 of the Securities Act of 1933, or under the Securities Exchange Act of 1934, in each case, as amended, or the regulations promulgated thereunder.

Yours sincerely,

 

/s/ Commerce & Finance Law Offices

Commerce & Finance Law Offices
EX-15.3 11 d290954dex153.htm EX-15.3 EX-15.3

Exhibit 15.3

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-267919) and Form S-8 (Nos. 333-256675 and 333-265313) of Boqii Holding Limited of our report dated July 25, 2023 relating to the financial statements, which appears in this Form 20-F.

 

/s/ PricewaterhouseCoopers Zhong Tian LLP
Shanghai, the People’s Republic of China
July 25, 2023
EX-15.4 12 d290954dex154.htm EX-15.4 EX-15.4

Exhibit 15.4

Boqii Holding Limited

Building 9, No. 388, Shengrong Road

Pudong New District, Shanghai 201210

People’s Republic of China

July 25, 2023

VIA EDGAR

Division of Corporation Finance

U.S. Securities & Exchange Commission

100 F Street, NE

Washington, D.C. 20549

 

Re:

Boqii Holding Limited

Submission under the Item 16I(a) of Form 20-F

Dear Sir/Madam,

In compliance with the Holding Foreign Companies Accountable Act, Boqii Holding Limited (the “Company”) is submitting via EDGAR the following information as required under Item 16I(a) of Form 20-F.

In August 2022, the Company was conclusively identified by the SEC as a Commission Identified Issuer pursuant to the HFCAA because it filed an annual report on Form 20-F for the year ended March 31, 2022 with the SEC with an audit report issued by PricewaterhouseCoopers Zhong Tian LLP, a registered public accounting firm retained by the Company, for the preparation of the audit report on the Company’s financial statements included therein. PricewaterhouseCoopers Zhong Tian LLP is a registered public accounting firm headquartered in mainland China, a foreign jurisdiction where the Public Company Accounting Oversight Board (the “PCAOB”) determined that it had been unable to inspect or investigate completely registered public accounting firms headquartered there until December 2022 when the PCAOB vacated its previous determination.

To the Company’s best knowledge and based on an examination of the Company’s register of members and public filings made by the Company’s shareholders, including reports of beneficial ownership on Schedule 13G, and where applicable, the amendments thereto, as well as inquiries to the relevant shareholders by the Company, (i) other than the following entities, no other person beneficially owned 5% or more of the Company’s outstanding shares, as of March 31, 2023; and (ii) except CMB, the Company is not aware of any of the following entities being owned or controlled by a governmental entity in mainland China as of the date of this submission:

 

   

Merchant Tycoon Limited. Merchant Tycoon Limited, a limited liability company incorporated under the laws of the British Virgin Islands, beneficially owned 18.4% of the Company’s total outstanding shares and held 81.9% of the Company’s aggregating voting power as of March 31, 2023. Each of the Company’s co-founders, namely Hao (Louis) Liang and Yingzhi (Lisa) Tang, as well as a former director of the Company, holds 63.77%, 33.33% and 2.9% of the equity interest in Merchant Tycoon Limited, respectively. To the best knowledge of the Company, none of the co-founders or the former director is controlled by or affiliated with any governmental entity in mainland China.


   

CMB. China Merchants Bank Co., Limited, through several affiliates, beneficially owned 10.3% of the Company’s total outstanding shares and held 2.3% of the Company’s aggregating voting power as of March 31, 2023. China Merchants Bank Co., Limited is a company incorporated in Hong Kong and listed on the Hong Kong Stock Exchange. Based on public disclosure of China Merchants Bank Co., Limited, as of December 31, 2022, an aggregate of more than 35% of its shares were held by several state-owned legal persons in China.

 

   

Apsaras Legend Limited. Apsaras Legend Limited, a limited liability company incorporated under the laws of the British Virgin Islands, beneficially owned 7.2% of the Company’s total outstanding shares and held 1.6% of the Company’s aggregating voting power as of March 31, 2023. Apsaras Legend Limited is ultimately controlled by Fengjin Jiang. To the best knowledge of the Company, such individual is not controlled by or affiliated with any governmental entity in mainland China.

 

   

Raumier Limited. Raumier Limited, a limited liability company incorporated under the Companies (Jersey) Laws, beneficially owned 6.8% of the Company’s total outstanding shares and held 1.5% of the Company’s aggregating voting power as of March 31, 2023. The shares in Raumier Limited are owned of record 50% by Premier Circle Limited and 50% by Second Circle Limited; however, Premier Circle Limited and Second Circle Limited are the record owners of such shares in Raumier Limited solely as nominee and in trust for Brunei Investment Agency, which is the sole beneficial owner of such shares. To the best knowledge of the Company, the Brunei Investment Agency is controlled by or affiliated with the government of Brunei.

 

   

Chong Li’s entities. Chong Li’s entities refer to Perfect Deal Global Limited, a limited liability company incorporated under the laws of the British Virgin Islands and DL Capital Holding Limited, a limited liability company incorporated under the laws of the British Virgin Islands. Chong Li’s entities beneficially owned 6.5% of the Company’s total outstanding shares and held 1.4% of the Company’s aggregating voting power as of March 31, 2023. Chong Li holds 100.0% equity interest in each of Chong Li’s entities. To the best knowledge of the Company, such individual is not controlled by or affiliated with any governmental entity in mainland China.

Please refer to “Item 6.E. Directors, Senior Management and Employees—E. Share Ownership” of the Company’s annual report on Form 20-F for the fiscal year ended March 31, 2023 for more details.

Based on the foregoing, the Company is not aware of any governmental entity that is in possession of, direct or indirect, of the power to control the ownership or management of the Company.

The Company has not relied upon any legal opinions or third-party certifications, such as affidavits, as the basis for this submission under the Item 16I(a) of Form 20-F.

Should any member of the Staff have any questions or comments regarding the Company’s submission set forth above, please do not hesitate to contact our outside legal counsel, Li He, Davis Polk & Wardwell, at (852) 2533-3386 and Kevin Zhang, Davis Polk & Wardwell, at (852) 2533-3384.

[Signature Page to Follow]


Very truly yours,

/s/ Hao Liang

Name: Hao Liang
Title: Chief Executive Officer

cc:

Yingzhi (Lisa) Tang, Chief Financial Officer

Li He, Davis Polk & Wardwell LLP

Kevin Zhang, Davis Polk & Wardwell LLP

EX-101.SCH 13 bq-20230331.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - Consolidated Statements of Loss and Comprehensive Loss link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - Consolidated Statements of Changes in Shareholders' Equity link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 1007 - Disclosure - Organization and principal activities link:presentationLink link:definitionLink link:calculationLink 1008 - Disclosure - Principal Accounting Policies link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - Business combinations link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - Risks and Concentration link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - Cash and cash equivalents link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - Accounts receivable, net link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - Inventories, net of inventory reserves link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - Prepayments and other current assets link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - Property and equipment, net link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - Intangible assets, net link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - Long-Term Investments link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - Goodwill link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - Other non-current Assets link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - Accrued liabilities and other current liabilities link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - Leases link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - Interest expense link:presentationLink link:definitionLink link:calculationLink 1023 - Disclosure - Other gains, net link:presentationLink link:definitionLink link:calculationLink 1024 - Disclosure - Income taxes link:presentationLink link:definitionLink link:calculationLink 1025 - Disclosure - Ordinary Share link:presentationLink link:definitionLink link:calculationLink 1026 - Disclosure - Convertible redeemable preferred shares link:presentationLink link:definitionLink link:calculationLink 1027 - Disclosure - Redeemable non-controlling interests link:presentationLink link:definitionLink link:calculationLink 1028 - Disclosure - Borrowings, other debts and derivative liabilities link:presentationLink link:definitionLink link:calculationLink 1029 - Disclosure - Receivable for issuance of ordinary shares link:presentationLink link:definitionLink link:calculationLink 1030 - Disclosure - Share-based compensation link:presentationLink link:definitionLink link:calculationLink 1031 - Disclosure - Employee benefits link:presentationLink link:definitionLink link:calculationLink 1032 - Disclosure - Fair value measurements link:presentationLink link:definitionLink link:calculationLink 1033 - Disclosure - Net loss per share link:presentationLink link:definitionLink link:calculationLink 1034 - Disclosure - Related party transactions link:presentationLink link:definitionLink link:calculationLink 1035 - Disclosure - Commitments and contingencies link:presentationLink link:definitionLink link:calculationLink 1036 - Disclosure - Subsequent events link:presentationLink link:definitionLink link:calculationLink 1037 - Disclosure - Restricted net assets link:presentationLink link:definitionLink link:calculationLink 1038 - Disclosure - Principal Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 1039 - Disclosure - Organization and principal activities (Tables) link:presentationLink link:definitionLink link:calculationLink 1040 - Disclosure - Principal Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 1041 - Disclosure - Business combinations (Tables) link:presentationLink link:definitionLink link:calculationLink 1042 - Disclosure - Risks and Concentration (Tables) link:presentationLink link:definitionLink link:calculationLink 1043 - Disclosure - Cash and cash equivalents (Tables) link:presentationLink link:definitionLink link:calculationLink 1044 - Disclosure - Accounts receivable, net (Tables) link:presentationLink link:definitionLink link:calculationLink 1045 - Disclosure - Inventories, net of inventory reserves (Tables) link:presentationLink link:definitionLink link:calculationLink 1046 - Disclosure - Prepayments and other current assets (Tables) link:presentationLink link:definitionLink link:calculationLink 1047 - Disclosure - Property and equipment, net (Tables) link:presentationLink link:definitionLink link:calculationLink 1048 - Disclosure - Intangible assets, net (Tables) link:presentationLink link:definitionLink link:calculationLink 1049 - Disclosure - Long-Term Investments (Tables) link:presentationLink link:definitionLink link:calculationLink 1050 - Disclosure - Goodwill (Tables) link:presentationLink link:definitionLink link:calculationLink 1051 - Disclosure - Other non-current Assets (Tables) link:presentationLink link:definitionLink link:calculationLink 1052 - Disclosure - Accrued liabilities and other current liabilities (Tables) link:presentationLink link:definitionLink link:calculationLink 1053 - Disclosure - Leases (Tables) link:presentationLink link:definitionLink link:calculationLink 1054 - Disclosure - Interest expense (Tables) link:presentationLink link:definitionLink link:calculationLink 1055 - Disclosure - Other gains, net (Tables) link:presentationLink link:definitionLink link:calculationLink 1056 - Disclosure - Income taxes (Tables) link:presentationLink link:definitionLink link:calculationLink 1057 - Disclosure - Redeemable non-controlling interests (Tables) link:presentationLink link:definitionLink link:calculationLink 1058 - Disclosure - Borrowings, other debts and derivative liabilities (Tables) link:presentationLink link:definitionLink link:calculationLink 1059 - Disclosure - Share-based compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 1060 - Disclosure - Fair value measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 1061 - Disclosure - Net loss per share (Tables) link:presentationLink link:definitionLink link:calculationLink 1062 - Disclosure - Related party transactions (Tables) link:presentationLink link:definitionLink link:calculationLink 1063 - Disclosure - Organization and principal activities - Schedule of Details of the Subsidiaries, VIEs and VIE's Subsidiaries (Detail) link:presentationLink link:definitionLink link:calculationLink 1064 - Disclosure - Organization and principal activities - Schedule of Variable Interest Entities (Detail) link:presentationLink link:definitionLink link:calculationLink 1065 - Disclosure - Organization and principal activities - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1066 - Disclosure - Principal Accounting Policies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1067 - Disclosure - Principal Accounting Policies - Schedule of Property Plant And Equipment Useful Lives (Detail) link:presentationLink link:definitionLink link:calculationLink 1068 - Disclosure - Principal Accounting Policies - Schedule of Finite Lived Intangible Assets Useful Lives (Detail) link:presentationLink link:definitionLink link:calculationLink 1069 - Disclosure - Business combinations - Summary of Identified Assets Acquired and Liabilities Assumed (Detail) link:presentationLink link:definitionLink link:calculationLink 1070 - Disclosure - Business combinations - Summary of Identified Assets Acquired and Liabilities Assumed (Detail) (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1071 - Disclosure - Business combinations - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1072 - Disclosure - Risks and Concentration - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1073 - Disclosure - Risks and Concentration - Schedules of Concentration of Risk, By Risk Factor (Detail) link:presentationLink link:definitionLink link:calculationLink 1074 - Disclosure - Cash and cash equivalents - Schedule of Cash And Cash Equivalents (Detail) link:presentationLink link:definitionLink link:calculationLink 1075 - Disclosure - Accounts receivable, net - Summary of Accounts Receivable Net (Detail) link:presentationLink link:definitionLink link:calculationLink 1076 - Disclosure - Accounts receivable, net - Summary of Movement of Allowance of Doubtful Accounts (Detail) link:presentationLink link:definitionLink link:calculationLink 1077 - Disclosure - Inventories, net of inventory reserves - Summary of Inventories, Net of Inventory Reserves (Detail) link:presentationLink link:definitionLink link:calculationLink 1078 - Disclosure - Inventories, net of inventory reserves - Summary of Movement of Inventory Provision (Detail) link:presentationLink link:definitionLink link:calculationLink 1079 - Disclosure - Inventories, net of inventory reserves - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1080 - Disclosure - Prepayments and other current assets - Summary of Prepayments and Other Current Assets (Detail) link:presentationLink link:definitionLink link:calculationLink 1081 - Disclosure - Prepayments and other current assets - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1082 - Disclosure - Property and equipment, net - Summary of Property, Plant and Equipment's (Detail) link:presentationLink link:definitionLink link:calculationLink 1083 - Disclosure - Property and equipment, net - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1084 - Disclosure - Intangible assets, net - Schedule of Intangible Assets (Detail) link:presentationLink link:definitionLink link:calculationLink 1085 - Disclosure - Intangible assets, net - Schedule of Annual Estimated Amortization Expense for Intangible Assets (Detail) link:presentationLink link:definitionLink link:calculationLink 1086 - Disclosure - Intangible assets, net - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1087 - Disclosure - Long-Term Investments - Summary of Long-Term Investment (Detail) link:presentationLink link:definitionLink link:calculationLink 1088 - Disclosure - Long-Term Investments - Summary of Available-For-Sale Debt Investments (Detail) link:presentationLink link:definitionLink link:calculationLink 1089 - Disclosure - Long-Term Investments - Summary Of Equity Securities With Readily Determinable Fair Values (Detail) link:presentationLink link:definitionLink link:calculationLink 1090 - Disclosure - Long-Term Investments - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1091 - Disclosure - Goodwill - Schedule of Changes in the Carrying Amount of Goodwill (Detail) link:presentationLink link:definitionLink link:calculationLink 1092 - Disclosure - Goodwill - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1093 - Disclosure - Other non-current Assets - Schedule of Other Non-current Assets (Detail) link:presentationLink link:definitionLink link:calculationLink 1094 - Disclosure - Other non-current Assets - Schedule of Other Non-current Assets (Parenthetical) (Detail) link:presentationLink link:definitionLink link:calculationLink 1095 - Disclosure - Accrued liabilities and other current liabilities - Schedule of Accrued Liabilities and Other Current Liabilities (Detail) link:presentationLink link:definitionLink link:calculationLink 1096 - Disclosure - Leases - Summary of Operating Leases (Detail) link:presentationLink link:definitionLink link:calculationLink 1097 - Disclosure - Leases - Summary of Operating Lease Activity (Detail) link:presentationLink link:definitionLink link:calculationLink 1098 - Disclosure - Leases - Summary of Maturities of Lease Liabilities (Detail) link:presentationLink link:definitionLink link:calculationLink 1099 - Disclosure - Interest expense - Summary of Interest Expense (Detail) link:presentationLink link:definitionLink link:calculationLink 1100 - Disclosure - Other gains, net - Summary of Other (Losses), Net (Detail) link:presentationLink link:definitionLink link:calculationLink 1101 - Disclosure - Other gains, net - Summary of Other (Losses), Net (Parenthetical) (Detail) link:presentationLink link:definitionLink link:calculationLink 1102 - Disclosure - Income taxes - Schedule of Effective Income Tax Rate Reconciliation (Detail) link:presentationLink link:definitionLink link:calculationLink 1103 - Disclosure - Income taxes - Schedule of Effective Income Tax Rate Reconciliation (Parenthetical) (Detail) link:presentationLink link:definitionLink link:calculationLink 1104 - Disclosure - Income taxes - Summary of Income Tax Holiday (Detail) link:presentationLink link:definitionLink link:calculationLink 1105 - Disclosure - Income taxes - Schedule of Components of Income Tax Expenses Benefit (Detail) link:presentationLink link:definitionLink link:calculationLink 1106 - Disclosure - Income taxes - Schedule of Deferred Tax Assets And Tax Liabilities (Detail) link:presentationLink link:definitionLink link:calculationLink 1107 - Disclosure - Income taxes - Summary of Valuation Allowance (Detail) link:presentationLink link:definitionLink link:calculationLink 1108 - Disclosure - Income taxes - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1109 - Disclosure - Ordinary Share - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1110 - Disclosure - Convertible redeemable preferred shares - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1111 - Disclosure - Redeemable non-controlling interests - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1112 - Disclosure - Redeemable non-controlling interests - Schedule Of Redeemable Non-Controlling Interests Activity (Detail) link:presentationLink link:definitionLink link:calculationLink 1113 - Disclosure - Borrowings, other debts and derivative liabilities - Summary of Short-term Debt (Detail) link:presentationLink link:definitionLink link:calculationLink 1114 - Disclosure - Borrowings, other debts and derivative liabilities - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1115 - Disclosure - Borrowings, other debts and derivative liabilities - Summary of Maturities of Long-term Debt (Detail) link:presentationLink link:definitionLink link:calculationLink 1116 - Disclosure - Borrowings, other debts and derivative liabilities - Summary of Other Long Term Debt (Detail) link:presentationLink link:definitionLink link:calculationLink 1117 - Disclosure - Borrowings, other debts and derivative liabilities - Summary of Fair Value of Derivative Liabilities (Detail) link:presentationLink link:definitionLink link:calculationLink 1118 - Disclosure - Receivable for issuance of ordinary shares - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1119 - Disclosure - Share-based compensation - Summary of Stock Option Activity (Detail) link:presentationLink link:definitionLink link:calculationLink 1120 - Disclosure - Share-based compensation - Summary of Options Measured At Fair Value, Valuation Assumptions (Detail) link:presentationLink link:definitionLink link:calculationLink 1121 - Disclosure - Share-based compensation - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1122 - Disclosure - Employee benefits - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1123 - Disclosure - Fair value measurements - Summary of Company's Financial Assets and Liabilities (Detail) link:presentationLink link:definitionLink link:calculationLink 1124 - Disclosure - Fair value measurements - Summary of Roll Forward of Major Level 3 Investments (Detail) link:presentationLink link:definitionLink link:calculationLink 1125 - Disclosure - Fair value measurements - Summary of Significant Unobservable Inputs (Detail) link:presentationLink link:definitionLink link:calculationLink 1126 - Disclosure - Fair value measurements - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Detail) link:presentationLink link:definitionLink link:calculationLink 1127 - Disclosure - Net Loss per share - Schedule of Earnings Per Share, Basic and Diluted (Detail) link:presentationLink link:definitionLink link:calculationLink 1128 - Disclosure - Net Loss per share - Schedule of Antidilutive Securities Excluded From Computation of Earnings Per Share (Detail) link:presentationLink link:definitionLink link:calculationLink 1129 - Disclosure - Related party transactions - Summary of Major Related Parties and Their Relationships With The Company (Detail) link:presentationLink link:definitionLink link:calculationLink 1130 - Disclosure - Related party transactions - Summary of Related Party Transactions And Balances (Detail) link:presentationLink link:definitionLink link:calculationLink 1131 - Disclosure - Related party transactions - Summary of Related Party Transactions And Balances (Parenthetical) (Detail) link:presentationLink link:definitionLink link:calculationLink 1132 - Disclosure - Related party transactions - Summary of Related Party Transaction (Detail) link:presentationLink link:definitionLink link:calculationLink 1133 - Disclosure - Related party transactions - Summary of Related Party Transaction (Parenthetical) (Detail) link:presentationLink link:definitionLink link:calculationLink 1134 - Disclosure - Related party transactions - Summary of Transactions Due From Related Parties (Detail) link:presentationLink link:definitionLink link:calculationLink 1135 - Disclosure - Related party transactions - Summary of Transactions Due From Related Parties (Parenthetical) (Detail) link:presentationLink link:definitionLink link:calculationLink 1136 - Disclosure - Related party transactions - Summary of Transactions Due To Related Parties (Detail) link:presentationLink link:definitionLink link:calculationLink 1137 - Disclosure - Commitments and contingencies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1138 - Disclosure - Subsequent events - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1139 - Disclosure - Restricted net assets - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1140 - Statement - Leases - Summary of Maturities of Lease Liabilities (Detail) Alternate 1 link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 14 bq-20230331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 15 bq-20230331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 16 bq-20230331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 17 bq-20230331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 18 g290954g00a01.jpg GRAPHIC begin 644 g290954g00a01.jpg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g290954g0717040154773.jpg GRAPHIC begin 644 g290954g0717040154773.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#W^BBB@ HH MKF?'6M/HOAN5X#BYG/E18Z@GJ?RJZ<'.2BNI%2HJ<'.6R,#QE\2%TR633]'V M27"<23MRJ'T [FO&M2\2ZUJERTMUJMW)D\#SF 'T X%7Y[;;:RR2$L^,FL0< M=*^CI8.%**26O<^Q.#G*SM_+.#7JG@CXK2W M,T>G^(2FYB%2[4;>?]L=/Q%>1E%/44L$;*[$R8)DGDH>E=S7@IW5STL10E0JRI M2W04444S$2BBB@!:*** "N%^)-O]HMK$$D!78CZX%=U6!XOTUM0T9FC&9(#O M ]1WKHPM2-.M&N:YC5M(9YBT*DOZ8ZBOI56IRCS*2MZGR&&]I";I3BT_0Y^M73[;_ $=F MAI:* .*UWPK(LKW-@FY&Y: M+N/I7'7L31$"2-D8=0PQ7LU0RVEO/_K8(W_WE!KR*^4PG+FIOE\NAZN&S25. MRJ1O;[SQ/R?/8*(_,)Z +FNGT#P,UU*EQ?P"*W!R$(^9_P# 5Z)%96L)S%;Q M(?4**GJL/EBIN\Y7\C;$9U4G'EI+E&QQI%&L<:A4484#H!3J**]4\0**** $ MHHHH \Y^'/CNYUNYN-+U=P;L.SV\F,"5 <$?45V/B/7;?P[HEQJ-QSL&(T[N MYZ*/QKR[PUX?GU;X?#4--.S6--U">>T9SPG+E2ZLVOAKK^H^(M N;O4G#3+=.@ M7&T#'%5/'_B/6+.^M-)\/NHOFB>YERN<1J*;\*F5-"U5F("KJ,Q)/8<5SNB^ M+].'B_6MUDTM%T#F]Q)O<]*\+ZRNO^';/4 M01NE0>8!V8=1^=JV?Q:UA])TY+Z8VT89&DV8'KFDJ?+.2\M+@YWBC9 MM-<\0:!XILM%U^:"\M[_ "(+F)=I##L15WPUK=_J'C#Q#87,H:WLW40KMQMS M5.ST#7M<\46>M^(8X+6&Q!-O:1/O.X]R:C\&_P#)0?%O_71/Y4I*+B]KV_4: M;NO4Z[Q#=36/AW4+JW;;-# [H<="!7$:#;^-]=T*SU-/$EO$MRF\(;?)'.*[ M#Q9_R*6K?]>K_P JX7PAI?C*;PEILFGZY9P6C19BC> DJ,G@FII)>S;TWZCG M\=CH]6U?4_!W@F:\U&XCU#4%?;&ZKM4ECA-KUI*SLK2VS0 M_(%/4 ^PKH]3T.+7?#QTK53YGF1J)'3CYQ_$/QYKAK^'Q9\/M.:^AU)-6T>V MQYD,XQ(B9QP:=-J2LKE_P#/*;\J*R]A4[%^TCW+ MG@CP[<>&-!>PN9HY9&N))MT><88Y'6N@@MX+5&2")(U9BY"#&23DG\ZCO[M+ M&REN7Y$:YQZGL*R+;3[_ %.%;J\OI8?,&Y8H3@*.U3*3DW)]1I)*R,?2_"&J MZ5X1UC2X+N 7=]-(\T)28.#^\C/;CO18^&KFU\>:AKS31F"Y@6-8QG<"/6K>GW%U:Z MM+IMS/YZ!/,21AR![U$CWFNW,IBN7MK*)MH*?>TE:WE8.57N=#7GY\*^* M;#Q+JFIZ/J&GQQWSABLZ,Q 'TK?NK*^TF(W=K>RSK'R\4QSD>U.U;4&ETJSN M;:1D$LBYVG\Q1";AMU"23W*<6E>)KS1M3LM9O;&5KF QPF!&4*2.^:R-*\/> M.]'TNWT^UU32?(@7:FZ)B<5Z".@^EUGU6"WU8ON6YMXSMP#D#!_6L*\\,^,/$5NNF:[J=C'II8>?\ M94.^8 YQSTZ5O6&FW%WID-R-3NDE==WWLC-7M"OIKRTD6XP9H)#&S#HV.])5 M91VL#BGN1_\ ",:/_P ^245L45/M)=RN5=C)\30O-H4X09*$,1[ \U>L9TN; M"&6(@JR#'M5@X92" 01R#7*ZE;G1Y]<1G*H[?+^0%='/;Q7-NT$J M!HV&"M+8>Y(C!HU8'*D9!KEH2'@U^1>4)(!]>#5:2*:WN_[/CO;I;.! M]<5T$MA!9Z'/;0J5C\LY.>2?6GL*]S.TR#6)=)MUAN;:*%D^4["7 _EFMG3= B/CTVT$",7))9W/5B>]-TA!'I-L@R0$[U=I,:"BBBD,__V0$! end GRAPHIC 20 g290954g0717053118747.jpg GRAPHIC begin 644 g290954g0717053118747.jpg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end GRAPHIC 21 g290954g0717053118958.jpg GRAPHIC begin 644 g290954g0717053118958.jpg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g290954g0717053119066.jpg GRAPHIC begin 644 g290954g0717053119066.jpg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end XML 23 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover Page
12 Months Ended
Mar. 31, 2023
shares
Document Information [Line Items]  
Document Type 20-F
Amendment Flag false
Document Registration Statement false
Document Annual Report true
Document Transition Report false
Document Shell Company Report false
Document Period End Date Mar. 31, 2023
Document Fiscal Year Focus 2023
Document Fiscal Period Focus FY
Entity File Number 001-39547
Entity Registrant Name Boqii Holding Ltd
Entity Central Index Key 0001815021
Current Fiscal Year End Date --03-31
Entity Well-known Seasoned Issuer No
Entity Current Reporting Status Yes
Entity Filer Category Non-accelerated Filer
Entity Emerging Growth Company true
Entity Ex Transition Period false
Entity Shell Company false
Entity Voluntary Filers No
Entity Interactive Data Current Yes
Entity Address, Country CN
ICFR Auditor Attestation Flag false
Entity Incorporation, State or Country Code E9
Document Accounting Standard U.S. GAAP
Entity Address, Address Line One Building 9, No. 388, Shengrong Road
Entity Address, Address Line Two Pudong New District
Entity Address, City or Town Shanghai
Entity Address, Postal Zip Code 201210
Auditor Name PricewaterhouseCoopers Zhong Tian LLP
Auditor Firm ID 1424
Auditor Location Shanghai, the People’s Republic of China
Business Contact [Member]  
Document Information [Line Items]  
Entity Address, Country CN
Entity Address, Address Line One Building 9, No. 388, Shengrong Road
Entity Address, Address Line Two Pudong New District
Entity Address, City or Town Shanghai
Entity Address, Postal Zip Code 201210
Contact Personnel Name Yingzhi (Lisa) Tang
Contact Personnel Fax Number 180 1851 3366
Ordinary Shares [Member]  
Document Information [Line Items]  
Entity Common Stock, Shares Outstanding 70,729,482
Class A Ordinary Shares [Member]  
Document Information [Line Items]  
Title of 12(b) Security Class A ordinary shares, par value US$0.001 per share
No Trading Symbol Flag true
Security Exchange Name NYSE
Entity Common Stock, Shares Outstanding 57,691,753
Class B Ordinary Shares [Member]  
Document Information [Line Items]  
Entity Common Stock, Shares Outstanding 13,037,729
American Depositary Shares [Member]  
Document Information [Line Items]  
Title of 12(b) Security American depositary shares, each ADS represents four and one half (4.5) Class A ordinary shares, par value US$0.001 per share
Trading Symbol BQ
Security Exchange Name NYSE
Entity Common Stock, Shares Outstanding 1,928,662
XML 24 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Balance Sheets
¥ in Thousands, $ in Thousands
Mar. 31, 2023
CNY (¥)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
CNY (¥)
Current assets:      
Cash and cash equivalents ¥ 89,850 $ 13,083 ¥ 162,855
Short-term investments 69,797 10,163 128,084
Accounts receivable, net 76,742 11,175 49,231
Inventories, net 81,052 11,802 109,921
Prepayments and other current assets 79,359 11,556 116,738
Amounts due from related parties 9,379 1,366 11,726
Total current assets 406,179 59,145 578,555
Non-current assets:      
Property and equipment, net 5,492 800 7,779
Intangible assets 21,594 3,144 25,544
Operating lease right-of-use assets 22,354 3,255 38,567
Long-term investments 75,607 11,010 82,319
Goodwill 0   40,684
Amounts due from related parties, non-current 2,988 435  
Other non-current asset 6,586 959 4,861
Total non-current assets 134,621 19,603 199,754
Total assets 540,800 78,748 778,309
Current liabilities      
Short-term borrowings (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB872 and RMB363 as of March 31, 2022 and 2023, respectively) 86,261 12,561 161,126
Accounts payable (including accounts payable of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB55,144 and RMB13,459 as of March 31, 2022 and 2023, respectively) 56,022 8,157 94,224
Salary and welfare payable (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB5,597 and RMB5,573 as of March 31, 2022 and 2023, respectively) 6,890 1,003 6,871
Accrued liabilities and other current liabilities (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB24,417 and RMB15,712 as of March 31, 2022 and 2023, respectively) 22,104 3,219 27,324
Amounts due to related parties, current (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB4 and RMB21 as of March 31, 2022 and 2023, respectively) 471 69 219
Contract liabilities (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB7,007 and RMB4,471 as of March 31, 2022 and 2023, respectively) 4,471 651 7,007
Operating lease liabilities, current (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB7,238 and RMB9,207 as of March 31, 2022 and 2023, respectively) 9,220 1,343 10,001
Derivative liabilities (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of nil as of March 31, 2022 and 2023, respectively) 10,701 1,558 9,086
Total current liabilities 196,140 28,561 315,858
Non-current liabilities      
Deferred tax liabilities (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of nil as of March 31, 2022 and 2023, respectively) 4,141 603 4,847
Operating lease liabilities, non-current (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB28,197 and RMB12,741 as of March 31, 2022 and 2023, respectively) 12,741 1,855 28,197
Other debts, non-current (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB157,874 and RMB 75,481 as of March 31, 2022 and 2023, respectively) 102,827 14,973 181,062
Total non-current liabilities 119,709 17,431 214,106
Total liabilities 315,849 45,992 529,964
Commitments and contingencies (Note 28)
Mezzanine equity:      
Redeemable non-controlling interests 7,197 1,048 6,522
Total mezzanine equity 7,197 1,048 6,522
Shareholders' equity:      
Additional paid-in capital 3,287,696 478,727 3,295,336
Statutory reserves 3,876 564 3,433
Accumulated other comprehensive loss (37,189) (5,415) (46,069)
Accumulated deficit (2,993,150) (435,836) (2,889,233)
Receivable for issuance of ordinary shares (83,400) (12,145) (164,746)
Total Boqii Holding Limited shareholders' equity 178,283 25,961 199,175
Non-controlling interests 39,471 5,747 42,648
Total shareholders' equity 217,754 31,708 241,823
Total liabilities, mezzanine equity and shareholders' equity 540,800 78,748 778,309
Class A Ordinary Shares [Member]      
Shareholders' equity:      
Common Stock Value 373 54 372
Class B Ordinary Shares [Member]      
Shareholders' equity:      
Common Stock Value ¥ 82 $ 12 ¥ 82
XML 25 R3.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Balance Sheets (Parenthetical)
¥ in Thousands, $ in Thousands
Mar. 31, 2023
CNY (¥)
shares
Mar. 31, 2023
USD ($)
$ / shares
shares
Mar. 31, 2022
CNY (¥)
shares
Short-term borrowings ¥ 86,261 $ 12,561 ¥ 161,126
Accounts payable 56,022 8,157 94,224
Salary and welfare payable 6,890 1,003 6,871
Accrued liabilities and other current liabilities 22,104 3,219 27,324
Amounts due to related parties, current 471 69 219
Contract liabilities 4,471 651 7,007
Operating lease liabilities, current 9,220 1,343 10,001
Derivative liabilities 10,701 1,558 9,086
Operating lease liabilities, non-current 12,741 1,855 28,197
Other debts, non-current 102,827 $ 14,973 181,062
Nonrecourse [Member] | Variable Interest Entity, Primary Beneficiary [Member]      
Short-term borrowings 363   872
Accounts payable 13,459   55,144
Salary and welfare payable 5,573   5,597
Accrued liabilities and other current liabilities 15,712   24,417
Amounts due to related parties, current 21   4
Contract liabilities 4,471   7,007
Operating lease liabilities, current 9,207   7,238
Derivative liabilities 0   0
Deferred tax liabilities 0   0
Operating lease liabilities, non-current 12,741   28,197
Other debts, non-current ¥ 75,481   ¥ 157,874
Class A Ordinary Shares [Member]      
Common Stock, Par or Stated Value Per Share | $ / shares   $ 0.001  
Common Stock, Shares Authorized | shares 129,500,000 129,500,000 129,500,000
Common Stock, Shares, Issued | shares 55,763,079 55,763,079 55,709,591
Common Stock, Shares, Outstanding | shares 55,763,079 55,763,079 55,709,591
Class B Ordinary Shares [Member]      
Common Stock, Par or Stated Value Per Share | $ / shares   $ 0.001  
Common Stock, Shares Authorized | shares 15,000,000 15,000,000 15,000,000
Common Stock, Shares, Issued | shares 13,037,729 13,037,729 13,037,729
Common Stock, Shares, Outstanding | shares 13,037,729 13,037,729 13,037,729
XML 26 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Loss and Comprehensive Loss
¥ in Thousands, $ in Thousands
12 Months Ended
Mar. 31, 2023
CNY (¥)
¥ / shares
shares
Mar. 31, 2023
USD ($)
$ / shares
shares
Mar. 31, 2022
CNY (¥)
¥ / shares
shares
Mar. 31, 2021
CNY (¥)
¥ / shares
shares
Net revenues:        
Total revenues ¥ 1,092,094 $ 159,021 ¥ 1,186,429 ¥ 1,010,985
Total cost of revenue (858,608) (125,023) (943,698) (823,686)
Gross profit 233,486 33,998 242,731 187,299
Operating expenses:        
Fulfillment expenses (126,295) (18,390) (134,026) (120,188)
Sales and marketing expenses (124,007) (18,057) (170,986) (160,201)
General and administrative expenses (46,554) (6,779) (76,248) (113,972)
Impairment of goodwill (40,684) (5,900)    
Other income, net 286 42 280 1,067
Loss from operations (103,768) (15,110) (138,249) (205,995)
Interest income 7,420 1,081 15,477 17,553
Interest expense (13,350) (1,944) (20,884) (27,650)
Other gains, net 5,159 751 6,020 11,332
Fair value change of derivative liabilities (2,266) (330) 2,824 11,369
Loss before income tax expenses (106,805) (15,552) (134,812) (193,391)
Income tax benefit 911 133 1,571 871
Share of results of equity investees (82) (12) 418 (696)
Net loss (105,976) (15,431) (132,823) (193,216)
Less: Net income attributable to the non-controlling interest shareholders (3,177) (462) (4,433) 1,228
Net loss attributable to Boqii Holding Limited (102,799) (14,969) (128,390) (194,444)
Accretion on convertible redeemable preferred shares to redemption value       120,873
Accretion on redeemable non-controlling interests to redemption value (675) (98) (575) (138)
Deemed dividend to preferred shareholders       (12,547)
Net loss attributable to Boqii Holding Limited's ordinary shareholders (103,474) (15,067) (128,965) (86,256)
Net loss (105,976) (15,431) (132,823) (193,216)
Other comprehensive income (loss):        
Foreign currency translation adjustment, net of nil tax 15,591 2,270 (16,529) (32,148)
Unrealized securities holding gains/(losses) (6,711) (977) (9,368) 772
Total comprehensive loss (97,096) (14,138) (158,720) (224,592)
Less: Total comprehensive loss/(income) attributable to non- controlling interests shareholders (3,177) (462) (4,433) 1,228
Total comprehensive loss attributable to Boqii Holding Limited ¥ (93,919) $ (13,676) ¥ (154,287) ¥ (225,820)
Net loss per share attributable to Boqii Holding Limited's ordinary shareholders        
— basic | (per share) ¥ (1.5) $ (0.22) ¥ (1.9) ¥ (1.29)
— diluted | (per share) ¥ (1.5) $ (0.22) ¥ (1.9) ¥ (1.29)
Weighted average number of ordinary shares        
— basic | shares 68,858,823 68,858,823 68,006,172 66,953,610
— diluted | shares 68,858,823 68,858,823 68,006,172 66,953,610
Product Sales [Member]        
Net revenues:        
Total revenues ¥ 1,048,491 $ 152,672 ¥ 1,137,329 ¥ 1,003,197
Total cost of revenue (842,700)   (930,400) (820,300)
Online Marketing And Information Services And Other Revenue [Member]        
Net revenues:        
Total revenues 43,603 $ 6,349 49,100 7,788
Total cost of revenue ¥ (15,900)   ¥ (13,300) ¥ (3,400)
XML 27 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Changes in Shareholders' Equity
¥ in Thousands, $ in Thousands
CNY (¥)
shares
USD ($)
shares
Ordinary Shares [Member]
CNY (¥)
shares
Ordinary Shares [Member]
Common Class A [Member]
CNY (¥)
shares
Ordinary Shares [Member]
Common Class B [Member]
CNY (¥)
shares
Additional Paid-in Capital [Member]
CNY (¥)
Statutory reserves [Member]
CNY (¥)
Accumulated other comprehensive income [Member]
CNY (¥)
Accumulated deficit [Member]
CNY (¥)
Non-controlling interests [Member]
CNY (¥)
Receivable for issuance of ordinary shares [Member]
CNY (¥)
Beginning Balance , Shares at Mar. 31, 2020 | shares     22,238,454                
Beginning Balance at Mar. 31, 2020 ¥ (1,959,056)   ¥ 139       ¥ 2,627 ¥ 11,204 ¥ (2,016,758) ¥ 43,741 ¥ (9)
Share-based compensation 55,031         ¥ 55,022         9
Foreign currency translation adjustment (32,148)             (32,148)      
Appropriations to statutory reserves             420   (420)    
Deemed dividend to preferred shareholders (12,547)               (12,547)    
Accretion to redemption value of redeemable convertible preferred shares (Note 20) 120,873               120,873    
Accretion on redeemable non-controlling interests to redemption value (138)               (138)    
Unrealized securities holding gains (losses), net of tax 772             772      
Exercise of CMB Warrant (656,448)               (656,448)    
Capital contribution from non-controlling interests 50                 50  
Receivable for issuance of convertible redeemable preferred shares (413,377)                   (413,377)
Conversion of ordinary shares into Class A and Class B ordinary shares , Shares | shares     (22,238,454) 10,033,850 12,204,604            
Conversion of ordinary shares into Class A and Class B ordinary shares     ¥ (139) ¥ 63 ¥ 76            
Issuance of Class A ordinary shares upon initial public offering ("IPO"), net of cost of issuance, Shares | shares       5,250,000              
Issuance of Class A ordinary shares upon initial public offering ("IPO"), net of cost of issuance 395,071     ¥ 36   395,035          
Conversion of Series A convertible redeemable preferred shares upon completion of the IPO , Shares | shares       7,844,137              
Conversion of Series A convertible redeemable preferred shares upon completion of the IPO 461,445     ¥ 53   461,392          
Conversion of Series B convertible redeemable preferred shares upon completion of the IPO , Shares | shares       8,557,980              
Conversion of Series B convertible redeemable preferred shares upon completion of the IPO 504,337     ¥ 57   504,280          
Conversion of Series C convertible redeemable preferred shares upon completion of the IPO , Shares | shares       4,684,976 833,125            
Conversion of Series C convertible redeemable preferred shares upon completion of the IPO 331,465     ¥ 32 ¥ 6 331,427          
Conversion of Series C+ convertible redeemable preferred shares upon completion of the IPO , Shares | shares       6,883,520              
Conversion of Series C+ convertible redeemable preferred shares upon completion of the IPO 662,808     ¥ 47   662,761          
Conversion of Series D convertible redeemable preferred shares upon completion of the IPO , Shares | shares       2,526,026              
Conversion of Series D convertible redeemable preferred shares upon completion of the IPO 181,004     ¥ 17   180,987          
Conversion of Series D-1 convertible redeemable preferred shares upon completion of the IPO , Shares | shares       2,178,530              
Conversion of Series D-1 convertible redeemable preferred shares upon completion of the IPO 164,859     ¥ 15   164,844          
Conversion of Series D-2 convertible redeemable preferred shares upon completion of the IPO , Shares | shares       1,182,803              
Conversion of Series D-2 convertible redeemable preferred shares upon completion of the IPO 92,314     ¥ 8   92,306          
Conversion of Series E convertible redeemable preferred shares upon completion of the IPO , Shares | shares       5,885,210              
Conversion of Series E convertible redeemable preferred shares upon completion of the IPO 455,980     ¥ 40   455,940          
Repurchase of Ordinary Shares , Shares | shares       (521,924)              
Repurchase of Ordinary Shares (31,386)     ¥ (4)   (31,382)          
Net loss (193,216)               (194,444) 1,228  
Ending Balance, Shares at Mar. 31, 2021 | shares       54,505,108 13,037,729            
Ending Balance at Mar. 31, 2021 127,693     ¥ 364 ¥ 82 3,272,612 3,047 (20,172) (2,759,882) 45,019 (413,377)
Share-based compensation 14,409         14,409          
Foreign currency translation adjustment (16,529)             (16,529)      
Appropriations to statutory reserves             386   (386)    
Accretion on redeemable non-controlling interests to redemption value (575)               (575)    
Receivable for issuance of ordinary shares (Note 23) 248,631                   248,631
Unrealized securities holding gains (losses), net of tax (9,368)             (9,368)      
Acquisition of a subsidiaries ¥ 1,817                 1,817  
Issuance of ordinary shares for the exercise of stock options, Shares | shares 1,204,483 1,204,483   1,204,483              
Issuance of ordinary shares for the exercise of stock options ¥ 8,323     ¥ 8   8,315          
Capital contribution from non-controlling interests 245                 245  
Net loss (132,823)               (128,390) (4,433)  
Ending Balance, Shares at Mar. 31, 2022 | shares       55,709,591 13,037,729            
Ending Balance at Mar. 31, 2022 241,823     ¥ 372 ¥ 82 3,295,336 3,433 (46,069) (2,889,233) 42,648 (164,746)
Share-based compensation (7,677)         (7,677)          
Foreign currency translation adjustment 15,591             15,591      
Appropriations to statutory reserves             443   (443)    
Accretion on redeemable non-controlling interests to redemption value (675)               (675)    
Receivable for issuance of ordinary shares (Note 23) 81,341                   81,341
Unrealized securities holding gains (losses), net of tax ¥ (6,711)             (6,711)      
Issuance of ordinary shares for the exercise of stock options, Shares | shares 53,488 53,488   53,488              
Issuance of ordinary shares for the exercise of stock options ¥ 38     ¥ 1   37          
Net loss (105,976) $ (15,431)             (102,799) (3,177)  
Ending Balance, Shares at Mar. 31, 2023 | shares       55,763,079 13,037,729            
Ending Balance at Mar. 31, 2023 ¥ 217,754 $ 31,708   ¥ 373 ¥ 82 ¥ 3,287,696 ¥ 3,876 ¥ (37,189) ¥ (2,993,150) ¥ 39,471 ¥ (83,405)
XML 28 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Cash Flows
¥ in Thousands, $ in Thousands
12 Months Ended
Mar. 31, 2023
CNY (¥)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
CNY (¥)
Mar. 31, 2021
CNY (¥)
Cash flows from operating activities:        
Net loss ¥ (105,976) $ (15,431) ¥ (132,823) ¥ (193,216)
Adjustments to reconcile net loss to net cash provided by operating activities:        
Depreciation and amortization expense 7,844 1,142 7,678 7,083
Provision for inventories 35 5 311 (8)
Provision for doubtful accounts 133 19 213 (107)
Interest expense of other debts 9,706 1,413 17,144 21,611
Interest receivable for issuance of ordinary shares (6,112) (890) (14,239) (15,394)
Amortization of right-of-use assets 24,597 3,582 11,705 11,687
Interest of lease liabilities 1,777 259 1,949 1,596
Investment income 178 26 622  
Share of results of equity investees 82 12 (418) 131
Loss/(gain) on disposal of property and equipment and intangible assets (7) (1) (104) 20
Gain on disposal of other debts       (6,846)
Gain from the re-measurement of the previously held equity interest to the fair value in the business acquisition     (127)  
Gain from disposal of a subsidiary (3,597) (524)    
Impairment of goodwill 40,684 5,900    
Share-based compensation expense (7,677) (1,118) 14,409 55,022
Fair value change of derivative liabilities 2,266 330 (2,824) (11,369)
Deferred tax expense (989) (144) (989) (1,889)
Changes in operating assets and liabilities, net of effects of businesses acquired:        
Accounts receivable (27,455) (3,998) (6,131) (880)
Inventories 30,583 4,453 (23,176) (38,839)
Prepayments and other current assets 47,754 6,954 (35,056) (48,853)
Amounts due from related parties (3,839) (559) 490 (2,663)
Operating lease liabilities (26,397) (3,844) (12,849) (12,850)
Accounts payable (36,342) (5,292) 18,106 (22,029)
Salary and welfare payable 6 1 293 2,518
Accrued liabilities and other current liabilities 2,701 393 1,954 667
Amounts due to related parties 252 37 (808) 1,062
Contract liabilities (2,536) (369) 3,140 (5,229)
Other non-current assets (1,740) (253) 4,026 11,289
Net cash used in operating activities (54,069) (7,873) (147,504) (247,486)
Cash flows from investing activities:        
Loan receivables advanced to third parties (7,864) (1,145) (2,376) (49,392)
Repayments on loan receivables from third parties 1,096 160 2,579 44,840
Loan receivables advanced to related parties (4,120) (600) (35,995) (4,814)
Repayments on loan receivables from related parties 3,874 564 35,245  
Acquisition of subsidiaries (2,938) (428)    
Increase/(decrease) in short-term investments 58,287 8,487 40,462 (168,546)
Purchase of intangible assets (50) (7) (24)  
Purchase of property and equipment (1,805) (263) (3,077) (6,509)
Disposal of property and equipment 16 2 125 4
Acquisitions of long-term investments     (15,792)  
Net cash generated from/ (used in) investing activities 46,496 6,770 21,147 (184,417)
Cash flows from financing activities:        
Proceeds from issuance of convertible redeemable preferred shares, net of issuance costs       354,825
Acquisition of additional interests in subsidiaries from non-controlling interests     245  
Proceeds from short-term and long-term borrowings 110,553 16,098 185,614 87,846
Repayments of short-term and long-term borrowings (187,234) (27,263) (176,897) (74,000)
Proceeds from issuance of other debts, net of issuance costs       16,940
Proceeds from issuance of ordinary shares 87,959 12,808 262,870  
Repayments of other debts (87,959) (12,808) (270,860) (130,827)
Proceeds from exercise of share option 25 4 1,023 9
Proceeds from the initial public offering, net of underwriter discounts and commissions and other offering costs paid       393,698
Net cash flows generated from/ (used in) financing activities (76,656) (11,161) 1,995 648,491
Net increase (decrease) in cash, cash equivalents and restricted cash (84,229) (12,264) (124,362) 216,588
Cash, cash equivalents and restricted cash at beginning of year 162,855 23,714 292,237 88,352
Effects of exchange rate changes on cash, cash equivalents and restricted cash 11,224 1,633 (5,020) (12,703)
Cash, cash equivalents and restricted cash at end of year 89,850 13,083 162,855 292,237
Supplemental schedule of non-cash investing and financing activities:        
Accretion on convertible redeemable preferred shares       120,873
Accretion on redeemable non-controlling interests (675) (98) (575) (138)
Deemed dividend to preferred shareholders       (12,547)
Unpaid cash consideration for business acquisitions     (2,938)  
Additional ASC 842 supplemental disclosure:        
Cash paid for fixed operating lease costs included in the measurement of lease obligations in operating activities 26,397 3,844 12,849 12,850
Right-of-use assets obtained in exchange for operating lease obligations ¥ 8,384 $ 1,221 ¥ 21,038 ¥ 25,970
XML 29 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Organization and principal activities
12 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and principal activities
1.
Organization and principal activities
(a) Principal activities
Boqii Holding Limited (“Boqii Holding”, or the “Company”), was incorporated under the laws of the Cayman Islands in June 2012, as an exempted company with limited liability. In these consolidated financial statements, where appropriate, the term “Company” also refers to its subsidiaries, the VIEs and the VIEs’ subsidiaries as a whole.
The Company operates as an online
one-stop
destination for users to shop for a variety of pet products and interact with other users in its online pet community in the People’s Republic of China (the “PRC”), through its online platforms (Boqii.com and Boqii application, collectively “Boqii Marketplace”), branded stores on third-party online platforms (the “Online Branded Stores”) and its online pet community (“Boqii Community”). In addition to online business, the Company provides pet products to offline pet stores.
The Company’s consolidated financial statements include the financial statements of the Company, its subsidiaries, consolidated VIEs and VIEs’ subsidiaries.
As
of March 31, 2023, the Company’s principal subsidiaries, consolidated VIEs and
major
VIEs’ subsidiaries are as follows:
 
Name of subsidiaries and VIE
 
Place of
incorporation
 
Date of
incorporation
or acquisition
 
Percentage
of direct
or indirect
 
Principal activities
Subsidiaries:
               
Boqii Corporation Limited (“Boqii Corporation”)
  Hong Kong   July 2012   100%  
Investment holding
Boqii International Limited
  Hong Kong   August 2016   100%  
Investment holding
Xingmu International Limited
  British Virgin Islands   August 2019   51%  
Investment holding
Xingmu HK Limited
  Hong Kong   November 2019   51%  
Investment holding
Nanjing Xinmu Information Technology Co., Ltd. (“Xingmu WFOE”)
  Nanjing, the PRC   November 2019   51%  
Technology development and sales of merchandise
Xincheng (Shanghai) Information Technology Co., Ltd. (“Shanghai Xincheng”)
  Shanghai, the PRC   November 2012   100%  
Technology development and sales of merchandise
Shanghai Yiqin Pets Products Co., Ltd.
  Shanghai, the PRC   February 2013   100%  
Technology development and sales of merchandise
Shanghai Every Supply Chain Co., Ltd. (“Shanghai Every”)
  Shanghai, the PRC   September 2021   100%  
Sales of merchandise
         
Consolidated VIEs
               
Guangcheng (Shanghai) Information Technology Co., Ltd. (“Guangcheng”)
  Shanghai, the PRC   November 2012   100%  
Operates the Company’s own online
e-commerce platform
Nanjing Xingmu Biotechnology Co., Ltd. (“Nanjing Xingmu”)
  Nanjing, the PRC   November 2019   51%  
Biotechnology research and development
Suzhou Taicheng Supply Chain Co., Ltd. (“Suzhou Taicheng”)
  Suzhou, the PRC   June 2021   100%   Sales of merchandise
Suzhou Xingyun Yueming Supply Chain Co., Ltd. (“Suzhou Xingyun Yueming”)
  Suzhou, the PRC   April 2022   100%  
Sales of merchandise
         
Subsidiaries of VIEs
               
Boqii (Shanghai) Information Technology Co., Ltd.
  Shanghai, the PRC   August 2014   90%  
Technology development
Tianjing Guangcheng Information Technology Co., Ltd.
  Tianjin, the PRC   June 2017   100%  
Sales of merchandise
Nanjing Cuida Biotechnology Co. Ltd.(“Cuida”)
  Nanjing, the PRC   April 2017   70%  
Biotechnology extension services
Taizhou Xingmu Biotechnology Co., Ltd.
  Taizhou, the PRC   November 2019   80%  
Biotechnology research and development
 
(b) Consolidated variable interest entities
In order to comply with the PRC laws and regulations which prohibit or restrict foreign investments into companies involved in restricted businesses, the Company operates online platforms that provide internet information services and engages in other foreign-ownership-restricted businesses through certain PRC domestic companies (the PRC Domestic Companies, or the “VIEs”). The equity interests of the PRC Domestic Companies are held by certain management members of the Company or onshore nominees of certain investors of the Company (“Nominee Shareholders”), who act as nominee equity holders of the PRC Domestic Companies on behalf of Shanghai Xincheng and Xingmu WFOE, the Company’s wholly owned subsidiaries in the PRC (the “WFOEs”). The WFOEs entered into a series of contractual arrangements with the PRC Domestic Companies and their respective Nominee Shareholders (the “Contractual Arrangements”). These Contractual Agreements cannot be unilaterally terminated by the Nominee Shareholders or the PRC Domestic Companies. Through the Contractual Arrangements, the Nominee Shareholders have granted all their legal rights including voting rights and disposition rights of their equity interests in the PRC Domestic Companies to the WFOEs. The Nominee Shareholders do not have the power to direct the activities of the PRC Domestic Companies that most significantly impact their economic performance. The Nominee Shareholders do not have the obligation to absorb losses of the PRC Domestic Companies that could potentially be significant to them or the right to receive benefits from the PRC Domestic Companies that could potentially be significant to them. Accordingly, the PRC Domestic Companies are considered as variable interest entities of the Company, through the WFOEs.
In accordance with Accounting Standards Codification
(“ASC”) 810-10-25-38A, the
Company, through its WFOEs, has a controlling financial interest in the VIEs because the WFOEs have the power to direct activities of the VIEs that most significantly impact the economic performance of the VIEs. In addition, under the terms of the Contractual Arrangements, the WFOEs have (i) the right to receive economic benefits that could potentially be significant to the VIEs in the form of service fees under the Exclusive Consultation and Service Agreements; (ii) the right to receive all dividends declared by the VIEs and the right to all undistributed earnings of the VIEs; and (iii) the obligation to absorb the substantially expected losses and the right to receive the residual benefits of the VIEs through its exclusive option to acquire 100% of the equity interests in the VIEs, to the extent permitted under PRC law. Thus, the Company, through the WFOEs, has the obligation to absorb the expected losses and the right to receive expected residual return of the VIEs that could potentially be significant to the VIEs.
Based on the above, the Company, through the WFOEs, is the ultimate primary beneficiary of the VIEs. Accordingly, the financial statements of the VIEs and their subsidiaries are consolidated in the Company’s consolidated financial statements.
Loan Agreements
Pursuant to the relevant loan agreements, the WFOEs have granted interest-free loans to the relevant Nominee Shareholders of the relevant VIEs with the sole purpose of providing funds necessary for the capital injection to the relevant VIEs.
The loans can only be repaid by transfer of the equity interests of the relevant VIEs held by the Nominee Shareholders, and shall be repaid upon the occurrence of, among other events, the WFOEs exercise of their options to purchase the relevant VIEs’ equity interests under the Exclusive Option Agreements (refer to following section for further details). Any proceeds received by the Nominee Shareholders from transfer of the equity interests shall also be repaid to the WFOEs as part of the loan repayments.
 
Other events that will lead to loan repayments include: the Nominee Shareholders receiving a written notice from the relevant PRC subsidiaries requesting loan repayments; the death or loss of capacity for civil conduct of the Nominee Shareholders; the Nominee Shareholders no longer acting as shareholders of the relevant VIEs or employees of the relevant VIEs, PRC subsidiaries or their related parties; the Nominee Shareholders being involved in criminal activities; or, any third party making a claim in an amount over RMB 500,000 against the Nominee Shareholders.
The loans shall be considered fully repaid when the Nominee Shareholders have transferred all equity interests held by them to the WFOEs or a party designated by the WFOEs. The Loan Agreements shall remain valid until the Nominee Shareholders repaid the relevant loans to the WFOEs.
Exclusive Option Agreements
The Nominee Shareholders of the VIEs have granted the WFOEs the exclusive and irrevocable right to purchase or to designate one or more person(s) at their discretion to purchase part or all of the equity interests in the VIEs from the Nominee Shareholders for a purchase price at any time, subject to the lowest price permitted by PRC laws and regulations. The VIEs and their Nominee Shareholders have agreed that without prior written consent of the WFOEs, their respective Nominee Shareholders cannot sell, transfer, pledge or dispose their equity interests, and the VIEs cannot sell, transfer, pledge or dispose, but not limit to, the equity interests, significant assets, significant revenue and significant business. Also as agreed, the VIEs cannot declare any dividend or change capitalization structure of the VIEs and cannot enter into any loan or investment agreements. Furthermore, the Nominee Shareholders have agreed that any proceeds but not limited to the sales of the Nominee Shareholders’ equity interest in relevant VIEs should be gratuitously paid to the WOFEs or one or more person(s) at their discretion. The Exclusive Option Agreement will remain effective until all equity options in VIEs held by such Nominee Shareholders are transferred or assigned to the WFOEs or their designated representatives.
Proxy Agreement and Power of Attorney
Pursuant to the irrevocable power of attorney, each of the Nominee Shareholders appointed the WFOEs as their
attorney-in-fact
to exercise all shareholder rights under PRC law and the relevant articles of association, including but not limited to, attending shareholders meetings, voting on their behalf on all matters requiring shareholder approval, including but not limited to sale, transfer, pledge, or disposition of all or part of the Nominee Shareholders’ equity interests, and designation and appointing the legal representative, directors, supervisors, chief executive officer and other senior management members of the VIEs. Each power of attorney will remain in force during the period when the Nominee Shareholders continues to be shareholders of the VIEs. Each Nominee Shareholder has waived all the rights which have been authorized to the person designated by the WFOEs under each power of attorney.
Exclusive Consultation and Service Agreements
Pursuant to the Exclusive Consultation Service Agreements, the WFOEs have agreed to provide to the VIEs services, including, but not limited to, design and maintenance of the
E-Commerce
platform, consulting services, technical training, research, planning and development of the market and customer support. The VIEs shall pay to the WFOEs service fees determined based on the complexity and difficulty of the services, title of and time consumed by employees, contents and value of the services, operation conditions and market price of the service provided. The Exclusive Consultation and Service Agreements will be in effect permanent unless terminated by the WFOEs. The WFOEs have the exclusive ownership of all the intellectual property rights created as a result of the performance of the agreements.
 
Intellectual Property License Agreements
Pursuant to the intellectual property license agreements, the WFOEs have granted a
non-exclusive
and
non-transferable
license, without sublicensing rights, to the VIEs to use its intellectual property. The VIEs may only use the licenses in its own business operations. The VIEs agree to pay the WFOEs a quarterly service fee at an amount that is equal to the VIEs’ revenue for the relevant quarter with a certain percentage or an amount adjusted at the WFOEs’ sole discretion for the relevant quarter, which should be paid within 15 business days after the VIEs confirm in writing the amount and breakdown of the service fee for the relevant quarter. The agreement has a term of 10 years and shall automatically renew at the end of each term for a further term of 10 years, unless otherwise terminated by the WFOEs in its sole discretion with 90 days’ prior written notice.
Equity Interest Pledge Agreements
Pursuant to the relevant equity interest pledge agreements, the Nominee Shareholders of the VIEs have pledged 100% equity interests in relevant VIEs to the WFOEs to guarantee performance by the Nominee Shareholders of their obligations under the Exclusive Option Agreements, the Proxy Agreement and Power of Attorney and the Loan Agreements, as well as the performance by the VIEs of their obligations under the Exclusive Option Agreements, the Exclusive Consultation and Service Agreements and Intellectual Property License Agreements. In the event of a breach by the VIEs or any of their Nominee Shareholders of contractual obligations under the Contractual Agreements, as the case may be, the WFOEs, as pledgee, will have the right to dispose of the pledged equity interests in the relevant VIEs and will have priority in receiving the proceeds from such disposal. The Nominee Shareholders of the VIEs also covenant that, without the prior written consent of the WFOEs, they will not dispose of, create or allow any encumbrance on the pledged equity interests. The Equity Interest Pledge Agreements will remain in effect so long as any of the Loan Agreements, the Exclusive Consultation Service Agreements, the Exclusive Option Agreements, the Proxy Agreement and Power of Attorney, or the Intellectual Property License Agreements, as mentioned above, remains in effect or any guaranteed obligations of the VIEs, or, to the extent applicable, its Nominee Shareholders, remains outstanding under the Contractual Agreements. The pledge was registered with the relevant local administration and will remain binding until the VIEs and their Nominee Shareholders discharge all their obligations under the Contractual Arrangements. The registration of the equity pledge enables the WFOEs to enforce the equity pledge against third parties who acquire the equity interests of the VIEs in good faith.
One set of existing Contractual Agreements were initially entered into in September 2012 by Shanghai Xincheng (one of the Company’s WOFEs), Guangcheng (one of the Company’s VIEs) and its nominee shareholders, was subsequently amended and restated on substantially similar terms in September 2017, October 2019 and August 2020, respectively. One set of existing Contractual Agreements were entered into in September 2019 by Xingmu WFOE (one of the Company’s WOFEs), Nanjing Xingmu (one of the Company’s VIEs) and its Nominee Shareholders. One set of Contractual Agreements were entered into in June 2021 by Shanghai Xincheng (one of the Company’s WOFEs), Suzhou Taicheng (one of the Company’s VIEs) and its Nominee Shareholders. A new set of Contractual Agreements were entered into in April 2022 by Shanghai Every (one of the Company’s WOFEs), Suzhou Xingyun Yueming (one of the Company’s VIEs) and its Nominee Shareholders.The Loan Agreements, Exclusive Option Agreements, Proxy Agreement and Power of Attorney, Exclusive Consultation and Service Agreements, Intellectual Property License Agreements and Equity Interest Pledge Agreements were amended to reflect the changes of shareholders’ holding in the VIE in their respective dates. No other material terms or conditions of these agreements were changed or altered. There was no impact to the Company’s control over the VIEs and the Company continues to consolidate the VIEs.
(c) Risks in relations to the VIE structure
Under the Contractual Agreements with the consolidated VIEs, the Company has the power to direct activities of the consolidated VIEs and VIEs’ subsidiaries through the Company’s relevant PRC subsidiaries, and can have assets transferred freely out of the consolidated VIEs and VIEs’ subsidiaries without restrictions. Therefore, the Company considers that there is no asset of the consolidated VIEs that can only be used to settle obligations of the respective consolidated VIEs, except for the registered capital of the consolidated VIEs amounting to RMB52 million and RMB52 million as of March 31, 2022 and 2023. Since the consolidated VIEs and VIEs’ subsidiaries are incorporated as limited liability companies under the PRC Law, creditors of the consolidated VIEs and VIEs’ subsidiaries do not have recourse to the general credit of the Company.
 
The Company believes that the Company’s relevant PRC subsidiaries’ Contractual Arrangements with the consolidated VIEs and the Nominee Shareholders are in compliance with PRC laws and regulations, as applicable, and are legally binding and enforceable. However, uncertainties in the PRC legal system could limit the Company’s ability to enforce these contractual arrangements.
In addition, if the current structure or any of the contractual arrangements were found to be in violation of any existing or future PRC law, the Company may be subject to penalties, which may include but not be limited to, the cancellation or revocation of the Company’s business and operating licenses, being required to restructure the Company’s operations or terminate the Company’s operating activities. The imposition of any of these or other penalties may result in a material and adverse effect on the Company’s ability to conduct its operations. In such case, the Company may not be able to operate or control the VIEs, which may result in deconsolidation of the VIEs.
The following table set forth the assets, liabilities, results of operations and changes in cash, cash equivalents and restricted cash of the consolidated VIEs and their subsidiaries taken as a whole, which were included in the Company’s consolidated financial statements with intercompany transactions eliminated (RMB in thousands):
 
    
As of March 31,
 
    
2022
    
2023
 
    
RMB
    
RMB
 
Cash and cash equivalents
     20,567        15,522  
Accounts receivable, net
     31,435        33,172  
Amounts due from related parties
     11,726        6,770  
Inventories, net
     16,014        27,894  
Prepayments and other current assets
     57,107        48,291  
Inter-company receivables
     16,535        83,700  
Property and equipment, net
     6,715        4,661  
Intangible assets
     507        101  
Operating lease
right-of-use
assets
     35,688        22,305  
Goodwill
     994        —    
Long-term investments
     81,649        75,505  
Other
non-current
asset
     3,389        5,219  
  
 
 
    
 
 
 
Total assets
     282,326        323,140  
  
 
 
    
 
 
 
 
    
As of March 31,
 
    
2022
    
2023
 
    
RMB
    
RMB
 
Short-term borrowings
     872        363  
Accounts payable
     55,144        13,459  
Amounts due to related parties, current
     4        21  
Salary and welfare payable
     5,597        5,573  
Accrued liabilities and other current liabilities
     24,417        15,712  
Contract liabilities
     7,007        4,471  
Operating lease liabilities, current
     7,238        9,207  
Inter-company payables
     945,960        1,095,452  
Operating lease liabilities,
non-current
     28,197        12,741  
Other debts,
non-current
     157,874        75,481  
  
 
 
    
 
 
 
Total liabilities
     1,232,310        1,232,480  
  
 
 
    
 
 
 
 
    
Year Ended March 31,
 
    
2021
    
2022
    
2023
 
    
RMB
    
RMB
    
RMB
 
Net revenues:
        
Third-party revenues
     735,518        877,380        786,152  
Inter-company revenues
     48,374        56,079        86,463  
  
 
 
    
 
 
    
 
 
 
Total revenues
     783,892        933,459        872,615  
Cost of revenues:
        
Third-party cost of revenues
     (372,475      (160,661      (81,810
Inter-company cost of revenues
     (297,844      (550,585      (534,518
  
 
 
    
 
 
    
 
 
 
Total cost of revenues
     (670,319      (711,246      (616,328
  
 
 
    
 
 
    
 
 
 
Gross profit
     113,573        222,213        256,287  
Operating expenses:
        
Third-party operating expenses
     (254,951      (288,291      (237,852
Inter-company operating expenses
     (7,257             (41
  
 
 
    
 
 
    
 
 
 
Total operating expenses
     (262,208      (288,291      (237,893
  
 
 
    
 
 
    
 
 
 
Impairment of goodwill
     —          —          (994
Other income, net
     1,011        98        158  
  
 
 
    
 
 
    
 
 
 
Profit/(Loss) from operations
     (147,624      (65,980      17,558  
Non-operating
expense
     (18,162      (20,680      (29
  
 
 
    
 
 
    
 
 
 
Profit/(Loss) before income tax expenses
     (165,786      (86,660      17,529  
Income tax benefits/(expenses)
     (20      681        21  
Share of results of equity investees
     (696      418        (82
  
 
 
    
 
 
    
 
 
 
Net profit/(loss)
     (166,502      (85,561      17,468  
  
 
 
    
 
 
    
 
 
 
Cash flows from operating activities:
        
Net cash provided by transactions with external parties
     419,767        526,201        471,991  
Net cash used in transactions with the Company’s entities
     (331,064      (329,325      (449,155
  
 
 
    
 
 
    
 
 
 
Net cash generated from/ (used in) operating activities
     88,703        196,876        22,836  
  
 
 
    
 
 
    
 
 
 
Cash flows from investing activities:
        
Other investing activities
     (31,972      (18,482      (9,638
Cash flows of loan funding provided to the Company’s entities, net of repayments received
     (5,242      6,294        —    
  
 
 
    
 
 
    
 
 
 
Net cash used in investing activities
     (37,214      (12,188      (9,638
  
 
 
    
 
 
    
 
 
 
Cash flows from financing activities:
        
Other financing activities
     (112,151      (273,906      (88,469
Cash flows of loan funding received from the Company’s entities, net of repayments made
     41,717        91,794        69,204  
  
 
 
    
 
 
    
 
 
 
Net cash generated from/ (used in) financing activities
     (70,434      (182,112      (19,265 )
  
 
 
    
 
 
    
 
 
 
XML 30 R8.htm IDEA: XBRL DOCUMENT v3.23.2
Principal Accounting Policies
12 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Principal Accounting Policies
2.
Principal Accounting Policies
(a) Basis of preparation
The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”). Significant accounting policies followed by the Company in the preparation of the accompanying consolidated financial statements are summarized below.
(b) Basis of consolidation
The Company’s consolidated financial statements include the financial statements of the Company, its subsidiaries, the consolidated VIEs and VIEs’ subsidiaries for which the Company is the primary beneficiary.
A subsidiary is an entity in which the Company, directly or indirectly, controls more than one half of the voting power, has the power to appoint or remove the majority of the members of the board of directors, to cast a majority of votes at the meeting of the board of directors or to govern the financial and operating policies of the investee under a statute or agreement among the shareholders or equity holders.
A consolidated VIE is an entity in which the Company, or its subsidiaries, through Contractual Agreements, bears the risks of, and enjoys the rewards normally associated with, ownership of the entity, and therefore the Company or its subsidiaries are the primary beneficiary of the entity.
All transactions and balances among the Company, its subsidiaries, the consolidated VIEs and VIEs’ subsidiaries have been eliminated upon consolidation
.
(c) Business combination and
non-controlling
interests
The Company accounts for its business combinations using the acquisition method of accounting in accordance with Accounting Standards Codification (“ASC”) 805,
Business Combinations
. The cost of an acquisition is measured as the aggregate of the acquisition date fair values of the assets transferred and liabilities incurred by the Company to the sellers and equity instruments issued. Transaction costs directly attributable to the acquisition are expensed as incurred. Identifiable assets and liabilities acquired or assumed are measured separately at their fair values as of the acquisition date, irrespective of the extent of any
non-controlling
interests. The excess of (i) the total costs of acquisition, fair value of the
non-controlling
interests and acquisition date fair value of any previously held equity interest in the acquiree over (ii) the fair value of the identifiable net assets of the acquiree is recorded as goodwill. If the cost of acquisition is less than the fair value of the net assets of the subsidiary acquired, the difference is recognized directly in the consolidated statements of loss and comprehensive loss as a bargain purchase gain. During the measurement period, which can be up to one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill or bargain purchase gain. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the consolidated statements of loss and comprehensive loss.
In a business combination achieved in stages, the Company
re-measures
the previously held equity interest in the acquiree immediately before obtaining control at its acquisition-date fair value and the
re-measurement
gain or loss, if any, is recognized in the consolidated statements of loss and comprehensive loss.
When there is a change in ownership interests or a change in contractual arrangements that results in a loss of control of a subsidiary or consolidated VIE, the Company deconsolidates the subsidiary or consolidated VIE from the date control is lost. Any retained
non-controlling
investment in the former subsidiary or consolidated VIE is measured at fair value and is included in the calculation of the gain or loss upon deconsolidation of the subsidiary or consolidated VIE.
For the Company’s consolidated subsidiaries, VIEs and VIEs’ subsidiaries,
non-controlling
interests are recognized to reflect the portion of their equity that is not attributable, directly or indirectly, to the Company as the controlling shareholder.
Non-controlling
interests are classified as a separate line item in the equity section of the Company’s consolidated balance sheets and have been separately disclosed in the Company’s consolidated statements of loss and comprehensive loss to distinguish the interests from that of the Company.
 
 
 
(d) Use of estimates
The preparation of the Company’s consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.
The Company believes that assessment for impairment of long-lived assets and valuation of
available-for-sale
debt securities require significant judgments and estimates used in the preparation of its consolidated financial statements.
Management bases the estimates on historical experience and on various other assumptions as discussed elsewhere to the consolidated financial statements that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. On an ongoing basis, management evaluates its estimates based on information that is currently available. Changes in circumstances, facts and experience may cause the Company to revise its estimates. Changes in estimates are recorded in the period in which they become known. Actual results could materially differ from these estimates.
(e) Functional currency and foreign currency translation
The Company’s reporting currency is Renminbi (“RMB”). The functional currency of the Company’s entities incorporated in Cayman Islands, British Virgin Islands and Hong Kong is the United States dollars (“US$”). The Company’s PRC subsidiaries, consolidated VIEs and VIEs’ subsidiaries determined their functional currency to be RMB. The determination of the respective functional currency is based on the criteria of ASC 830,
Foreign Currency Matters
.
Transactions denominated in other than the functional currencies are translated into the functional currency of the entity at the exchange rates prevailing on the transaction dates. Financial assets and liabilities denominated in other than the functional currency are translated at the balance sheet date exchange rate. The resulting exchange differences are included in the consolidated statements of loss and comprehensive loss as other gains, net.
The financial statements of the Company are translated from the functional currency into RMB. Assets and liabilities denominated in foreign currencies are translated into RMB using the applicable exchange rates at the balance sheet date. Equity accounts other than earnings generated in current period are translated into RMB at the appropriate historical rates. Revenues, expenses, gains and losses are translated into RMB using the periodic average exchange rates. The resulting foreign currency translation adjustments are recorded in accumulated other comprehensive loss as a component of shareholders’ equity.
The exchange rates used for translation on March 31, 2022 and 2023 were US$1.00= RMB 6.3482 and RMB 6.8717, respectively, representing the index rates stipulated by the People’s Bank of China.
(f) Convenience translation
Translations of the consolidated balance sheets, the consolidated statements of loss and comprehensive loss and the consolidated statements of cash flows from RMB into US$ as of and for the year ended March 31, 2023 are solely for the convenience of the readers and were calculated at the rate of US$1.00=RMB 6.8676, representing the certificated exchange rate published by the Federal Reserve Board. No representation is made that the RMB amounts could have been, or could be, converted, realized or settled into US$ at that rate on March 31, 2023, or at any other rate.
(g) Fair value of financial instruments
Accounting guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and it considers assumptions that market participants would use when pricing the asset or liability.
 
 
The established fair value hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
The three levels of inputs that may be used to measure fair value:
Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2: Observable, market-based inputs, other than quoted prices, in active markets for identical assets or liabilities.
Level 3: Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.
Accounting guidance also describes three main approaches to measuring the fair value of assets and liabilities: (1) market approach; (2) income approach and (3) cost approach. The market approach uses prices and other relevant information generated from market transactions involving identical or comparable assets or liabilities. The income approach uses valuation techniques to convert future amounts to a single present value amount. The measurement is based on the value indicated by current market expectations about those future amounts. The cost approach is based on the amount that would currently be required to replace an asset.
Financial assets and liabilities of the Company mainly consist of cash and cash equivalents, short-term investments, accounts receivable, amounts due from related parties, prepayments and other current assets,
available-for-sale
debt investments, accounts payable, short-term borrowings, derivative liabilities, accrued liabilities and other current liabilities, amounts due to related parties, and other debts.
As of March 31, 2022 and 2023, except for
available-for-sale
debt investments and derivative liabilities, carrying values of cash and cash equivalents, short-term investments, accounts receivable, amounts due from related parties, certain prepayments and other current assets, accounts payable, short-term borrowings, certain accrued liabilities and other current liabilities, amounts due to related parties and current portion of other debts approximated their fair values reported in the consolidated balance sheets due to the short-term maturities of these instruments. The carrying value of long-term loan receivable, long-term borrowings and
non-current
portion of other debts approximated their fair values as of March 31, 2022 and 2023 as the interest rates and credit risk they bear reflect the current market yield for comparable instruments. The Company reports derivative liabilities at fair value at each balance sheet date and change in fair value is reflected in “Fair value change of derivative liabilities” in the consolidated statements of loss and comprehensive loss. The Company reports
available-for-sale
debt investments at fair value at each balance sheet date with the aggregate unrealized gains and losses, net of tax, reflected in “Accumulated other comprehensive loss” in the consolidated balance sheets.
(h) Cash and cash equivalents
Cash and cash equivalents include cash on hand and time deposits placed with banks and third party payment processors, which are unrestricted as to withdrawal or use, have original maturities of three months or less at the time of purchase and are readily convertible to known amounts of cash.
(i) Short-term investments
Short-term investments comprise primarily of (i) cash deposits at fixed rates with original maturities of greater than three months, but less than 12 months and; (ii) the investments issued by commercial banks or other financial institutions with a variable interest rate indexed to the performance of underlying assets within one year. As of March 31, 2022 and 2023, RMB128 million and RMB70 million short-term investments were used as collateral of RMB111 million and RMB64 million short-term borrowings, respectively.
 
 
 
(j) Accounts receivable, net
Accounts receivable are presented net of allowance for doubtful accounts. The Company maintains an allowance for doubtful accounts which reflects its best estimate of amounts that potentially will not be collected. The Company determines the allowance for doubtful accounts on general basis taking into consideration various factors including but not limited to historical collection experience and credit-worthiness of the customers as well as the age of the individual receivables balance. Additionally, the Company makes specific bad debt provisions based on any specific knowledge the Company has acquired that might indicate that an account is uncollectible. The facts and circumstances of each account may require the Company to use substantial judgment in assessing its collectability.
(k) Inventories
Inventories are stated at the lower of cost and net realizable value. Cost elements of our inventories comprise the purchase price of products, vendor rebates, shipping charges to receive products from the suppliers when they are embedded in the purchase price. Cost is determined using the
first-in
first-out
method. Provisions are made for excessive, slow moving, expired and obsolete inventories as well as for inventories with carrying values in excess of market. Certain factors could impact the realizable value of inventory, so the Company continually evaluates the recoverability based on assumptions about customer demand and market conditions. The evaluation may take into consideration historical usage, inventory aging, expiration date, expected demand, anticipated sales price, new product development schedules, the effect new products might have on the sale of existing products, product obsolescence, customer concentrations, and other factors. The reserve or write-down is equal to the difference between the cost of inventory and the estimated net realizable value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than those projected by management, additional inventory reserves or write-downs may be required that could negatively impact the Company’s gross margin and operating results. If actual market conditions are more favorable, the Company may have higher gross margin when products that have been previously reserved or written down are eventually sold.
(l) Property and equipment, net
Property and equipment are carried at cost less accumulated depreciation and amortization. Depreciation is calculated on a straight-line basis over the following estimated useful lives.
The estimated useful lives are as follows:
 
    
Useful years
Warehouse equipment    3 - 5 years
Furniture, computer and office equipment    3 - 5 years
Vehicles    5 years
Software    10 years
Leasehold improvements    Over the shorter of the expected life of leasehold improvements or the lease term
Expenditures for maintenance and repairs are expensed as incurred. The gain or loss on the disposal of property and equipment is the difference between the net sales proceeds and the carrying amount of the relevant assets and is recognized in the consolidated statements of loss and comprehensive loss.
 
 
(m) Intangible assets, net
Intangible assets purchased from third parties are initially recorded at cost. The Company performs valuation of the intangible assets arising from business combinations to determine the relative fair value to be assigned to each asset acquired. The intangible assets are amortized using the straight-line method over the estimated useful lives of the assets.
The estimated useful lives of intangible assets are as follows:
 
    
Useful years
Trademark    10 years
Dealership    10 years
License    4.5 years
The estimated life of amortized intangibles is reassessed if circumstances occur that indicate the life has changed.
(n) Goodwill
Goodwill represents the excess of the purchase price over the fair value of the identifiable assets and liabilities acquired in a business combination. Goodwill is not amortized but is tested for impairment on an annual basis as of March 31, and in between annual tests when an event occurs or circumstances change that could indicate that the asset might be impaired.
In accordance with ASU
No. 2017-04,
“Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment” (“ASU
2017-04”),
which removes the requirement to compare the implied fair value of goodwill with its carrying amount as part of step 2 of the goodwill impairment test. Management conducts its goodwill impairment assessment as of March 31 annually or more frequently if events or changes in circumstances indicate that it may be impaired. The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill, so as to perform the quantitative goodwill impairment test. If determined to be necessary, the quantitative impairment test is used to identify goodwill impairment by comparing the fair value of a reporting unit with its carrying amount and recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. The loss recognized should not exceed the total amount of goodwill allocated to that reporting unit.
As there is only one reporting unit in the Company, the goodwill assessment was performed for the Company on consolidated level as one reporting unit.
(o) Long-term investments
The Company’s investments include equity method investments, equity securities with readily determinable fair values and
available-for-sale
debt securities.
The Company applies the equity method of accounting to account for an equity investment, in common stock or
in-substance
common stock, according to ASC 323 “Investment—Equity Method and Joint Ventures”, over which it has significant influence but does not own a majority equity interest or otherwise control. Under the equity method, the Company’s share of the post-acquisition profits or losses of the equity investees are recorded in share of results of equity investees in the consolidated statements of loss and comprehensive loss. The excess of the carrying amount of the investment over the underlying equity in net assets of the equity investee, if any, represents goodwill and intangible assets acquired. When the Company’s share of losses in the equity investee equals or exceeds its interest in the equity investee, the Company does not recognize further losses, unless the Company has incurred obligations or made payments or guarantees on behalf of the equity investee.
Equity securities with readily determinable fair values are measured and recorded at fair value on a recurring basis with changes in fair value, whether realized or unrealized, recorded through the income statement.
 
Debt securities that the Company has the intent to hold the security for an indefinite period or may sell the security in response to the changes in economic conditions are classified as
available-for-sale
debt securities and reported at fair value. Unrealized gains and losses (other than impairment losses) are reported, net of the related tax effect, in other comprehensive income (loss). Upon sale, realized gains and losses are reported in net income (loss).
The Company continually reviews its investments to determine whether a decline in fair value to below the carrying value is other-than-temporary. The primary factors the Company considers in its determination are the duration and severity of the decline in fair value; the financial condition, operating performance and the prospects of the equity investee; and other company specific information such as recent financing rounds. If the decline in fair value is deemed to be other-than-temporary, the carrying value of the investment is written down to fair value.
(p) Impairment of long-lived assets other than goodwill
Long-lived assets (including property and equipment and amortizable intangible assets) are evaluated for impairment whenever events or changes in circumstances (such as a significant adverse change to market conditions that will impact the future use of the assets) indicate that the carrying amount may not be fully recoverable or that the useful life is shorter than the Company had originally estimated. When these events occur, the Company evaluates the impairment by comparing carrying value of the assets to an estimate of future undiscounted cash flows expected to be generated from the use of the assets and their eventual disposition. If the sum of the expected future undiscounted cash flows is less than the carrying value of the assets, the Company recognizes an impairment loss based on the excess of the carrying value of the assets over the fair value of the assets. No impairment charges were recognized for the years ended March 31, 2021, 2022 and 2023.
(q) Revenue recognition
In May 2014, the FASB issued ASU
No. 2014-09,
“Revenue from Contracts with Customers (Topic 606)” (“ASU
2014-09”)
and subsequently, the FASB issued several amendments which amends certain aspects of the guidance in ASC
2014-09
(ASU
No. 2014-09
and the related amendments are collectively referred to as “ASC 606”). According to ASC 606, revenue is recognized when control of the promised good or service is transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services.
Consistent with the criteria of Topic 606, the Company follows five steps for its revenue recognition: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the entity satisfies a performance obligation. Revenue arrangements with multiple performance obligations are divided into separate distinct goods or services. The Company allocates the transaction price to each performance obligation based on the relative standalone selling price of the goods or services provided. The Company’s revenues are primarily derived from (i) product sales and (ii) online marketing and information services and other revenue.
When either party to a contract has performed, the Company presents the contract in the statement of financial position as a contract asset or a contract liability, depending on the relationship between the entity’s performance and the customer’s payment. A receivable is recorded when the Company has an unconditional right to consideration. A right to consideration is unconditional if only the passage of time is required before payment of that consideration is due. A contract asset is recorded when the Company has transferred products or services to the customer before payment is received or is due, and the Company’s right to consideration is conditional on future performance or other factors in the contract. No contract asset was recorded as of March 31, 2022 and 2023. The Company’s contract liabilities consist of payments received or awards to customers (in the form of Boqii Beans) related to unsatisfied performance obligations at the end of the period. As of April 1, 2021 and 2022, the Company’s total contract liabilities were RMB3.9 million and RMB7.0 million, respectively, of which RMB3.6 million and RMB3.0 million were recognized as revenue for the years ended March 31, 2022 and 2023. The Company’s total unearned revenue was RMB4.5 million as of March 31, 2023.
Revenue is recorded net of value-added tax.
 
 
Revenue recognition policies for each type of revenue steam are as follows:
Sales of merchandise
The Company primarily sells pet products through online stores to individual online customers. Besides online sales, the Company also sells products through offline channels to its business customers and pet stores across the country. The Company recognizes the product revenues from products sales on a gross basis as the Company is acting as a principal in these transactions. The Company has obtained control of the products before they are transferred to customers. The Company is primarily obligated in these transactions, is subject to inventory risk or has the ability to direct the use of inventory, and has latitude in establishing prices and selecting suppliers. Revenue is recognized when consumers physically accept the products after delivery, which is when the control of products is transferred, and is recorded net of return allowances and rebates to pet stores.
The Company also enters into arrangements with its business partners to sell their products on the Company’s online stores. The Company considers the arrangements meet the indicators of consignment arrangement under ASC
606-10-55-80,
because (i) the business partners do not relinquish control of the products, even though the Company has physical possession of the goods. The Company does not control the underlying products, which are considered to be the business partners’ inventory until they are sold to the end consumers; (ii) the business partner retains the right to require the return of the goods held by the Company; (iii) the Company has no obligation to pay for the products that are in its physical possession; and (iv) the Company has no discretion in establishing prices of the products provided by its business partners. Upon successful sales, the Company will charge the business partners a negotiated amount or a fixed rate commission fee based on the sales amount. Commission revenues are recognized on a net basis at the point of consumers’ acceptance of products, net of return allowance.
Online marketing and information services and other revenue
The Company provides online marketing and information services to third-parties on the Company’s various channels and third-party platforms, including but not limited to advertising placements, organizing online and offline marketing campaigns featuring social media influencers and circulating marketing messages to end consumers. With respect to the Company’s marketing services, length of the periods over which services are provided are generally within months or less, revenue from such arrangements is recognized ratably over the service period, as the third-party simultaneously consumes the benefits when the advertisement is displayed or the campaign is ongoing.
The Company also provides warehouse services. The warehouse services include warehousing, packaging, dispatching and other services. Revenue is primarily recognized when the services are rendered.
(r) Sales returns
The Company offers online consumers an unconditional right of return for a period of seven days upon receipt of products. Return allowances, which reduce revenue and cost of sales, are estimated by categories of return policies offered to online customers, based on historical data the Company has maintained, and subject to adjustments to the extent that actual returns differ or are expected to differ.
(s) Sales incentives
The Company adopted a customer reward program, under which the Company grants certain units (“Boqii Bean”) to its customers at its discretion in different situations. Boqii Beans are not redeemable for cash and can be used as a coupon for the customer’s future purchase on the Boqii Marketplace and Boqii.com. The value of ten units of Boqii Bean is equivalent to one RMB yuan before taking into account the impact of breakage.
 
 
For the Boqii Beans that are granted with concurrent revenue transactions, the allocated transaction price based on its relative standalone selling price are recognized as reduction of the revenue and accrued for as contract liabilities. As customers redeem awards, the accrued liability is reduced correspondingly. For the Boqii Beans that are granted without concurrent revenue transactions, they are not accounted for when granted and are recognized as a reduction of revenue when they are applied in future sales.
The Company also has a coupon program, through which the Company grants coupons to online customers when they make a successful purchase order, finish first registration on Boqii Marketplace or comment on products. When a coupon is granted concurrent with a revenue transaction, the Company accounts for the estimated cost of future usage of the coupon as reduction of the revenue. When a coupon is not granted concurrent with a revenue transaction, they are not accounted for when they are granted and are recognized as a reduction of revenue when they are applied in future sales.
(t) Cost of revenue
Cost of revenue consist of cost of product sales of RMB820.3 million, RMB930.4 million and RMB842.7 million for the years ended March 31, 2021, 2022 and 2023, respectively, and cost of services of RMB3.4million, RMB13.3million and RMB15.9
 million for the years ended March 31, 2021, 2022 and 2023, respectively. Cost of product sales comprise the purchase price of products, vendor rebates and inventory write-downs. Cost of products does not include other costs such as shipping and handling expense, payroll and benefits of logistic staff, and logistic centers rental expenses. Cost of service consists of the advertising and promotion costs, employee wages and benefits in connection with the Company’s provision of marketing and information services including the fees that the Company paid to third-parties for advertising and promotion on various online and offline channels. 
(u) Vendor rebates
The Company periodically receives consideration from certain vendors, representing rebates for products sold over a period of time. The Company accounts for the rebates received from its vendors as a reduction to the price it pays for the products purchased. Rebates are earned based on reaching minimum purchased thresholds for a specified period. When volume rebates can be reasonably estimated based on the Company’s past experience, current forecasts and purchase volume, a portion of the rebate is recognized as the Company makes progress towards the purchase threshold.
(v) Fulfillment expenses
Fulfillment costs primarily represent warehousing, shipping and handling expenses for dispatching and delivering products to consumers, employee wages and benefits for the relevant personnel, customs clearance expenses and other related transaction costs.
(w) Sales and marketing expenses
Sales and marketing expenses comprise primarily of advertising expenses, third-party platforms commission fee, employee wages, rental expenses and benefits for sales and marketing staff, depreciation expenses and other daily expenses which are related to the sales and marketing functions.
Advertising expenses consist primarily of customer acquisition cost and costs for the promotion of corporate image and product marketing. The Company expenses all advertising costs as incurred and classifies these costs under sales and marketing expenses. For the years ended March 31, 2021, 2022 and 2023, the advertising expenses were RMB83 million, RMB81 million and RMB44 million, respectively.
 
 
(x) General and administrative expenses
General and administrative expenses consist of employee wages and benefits for corporate employees, research and development expenses and other expenses which are related to the general corporate functions, including accounting, finance, tax, legal and human resources, costs associated with use by these functions of facilities and equipment, such as depreciation expenses, rental and other general corporate related expenses. For the years ended March 31, 2021, 2022 and 2023, the research and development were RMB14.1 million, RMB11.3 million and RMB3.7 million, respectively.
(y) Leases
The Company applied ASC 842, “Leases”, by using the optional transition method at the adoption date without recasting comparative periods. The Company determines if an arrangement is a lease at inception. Operating leases are primarily for office and warehouse space and are included in operating lease
right-of-use
(“ROU”) assets, operating lease liabilities, current and operating lease liabilities,
non-current
on its consolidated balance sheets.
ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. When determining the lease term, the Company includes options to extend or terminate the lease when it is reasonably certain that it will exercise that option, if any. As the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate, which it calculates based on the credit quality of the Company and by comparing interest rates available in the market for similar borrowings, and adjusting this amount based on the impact of collateral over the term of each lease. Lease expense for lease payments is recognized on a straight-line basis over the lease term.
For operating leases with a term of one year or less, the Company has elected to not recognize a lease liability or ROU asset on its consolidated balance sheet. Instead, it recognizes the lease payments as expense on a straight-line basis over the lease term. Short-term lease costs are immaterial to its consolidated statements of loss and comprehensive loss and cash flows.
(z) Government grants
The Company’s PRC based subsidiaries received government subsidies from certain local governments. The government subsidies are granted from time to time at the discretion of the relevant government authorities. These subsidies are granted for general corporate purposes and to support the Group’s ongoing operations in the region Cash subsidies are recorded in other income, net on the consolidated statements of loss and comprehensive loss when received and when all conditions for their receipt have been satisfied. The Group recognized government subsidies of RMB1.1 million, RMB0.2 million and RMB0.3 million for the years ended December 31, 2021, 2022 and 2023, respectively.
(aa) Income taxes
Current income taxes are recorded in accordance with the regulations of the relevant tax jurisdiction. The Company accounts for income taxes under the asset and liability method in accordance with ASC 740,
Income Tax
. Under this method, deferred tax assets and liabilities are recognized for the tax consequences attributable to differences between carrying amounts of existing assets and liabilities in the financial statements and their respective tax basis, and operating loss carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred taxes of a change in tax rates is recognized in the consolidated statements of loss and comprehensive loss in the period of change. Valuation allowances are established when necessary to reduce the amount of deferred tax assets if it is considered more likely than not that amount of the deferred tax assets will not be realized.
 
Uncertain tax positions
The Company recognizes in its consolidated financial statements the benefit of a tax position if the tax position is “more likely than not” to prevail based on the facts and technical merits of the position. Tax positions that meet the “more likely than not” recognition threshold are measured at the largest amount of tax benefit that has a greater than fifty percent likelihood of being realized upon settlement. The Company estimates its liability for unrecognized tax benefits which are periodically assessed and may be affected by changing interpretations of laws, rulings by tax authorities, changes and/or developments with respect to tax audits, and expiration of the statute of limitations. The ultimate outcome for a particular tax position may not be determined with certainty prior to the conclusion of a tax audit and, in some cases, appeal or litigation process. The actual benefits ultimately realized may differ from the Company’s estimates. As each audit is concluded, adjustments, if any, are recorded in the Company’s consolidated financial statements in the period in which the audit is concluded. Additionally, in future periods, changes in facts, circumstances and new information may require the Company to adjust the recognition and measurement estimates with regard to individual tax positions. Changes in recognition and measurement estimates are recognized in the period in which the changes occur. As of March 31, 2022 and 2023, the Company did not have any material unrecognized uncertain tax positions.
(ab) Share-based compensation
The Company follows ASC 718 to determine whether a share option should be classified and accounted for as a liability award or equity award. All grants of share-based awards to employees, management and nonemployees classified as equity awards are recognized in the financial statements based on their grant date fair values which are calculated using an option pricing model.
Employees’ share-based compensation awards are measured at the grant date fair value of the awards and recognized as expenses (a) immediately at the grant date if no vesting conditions are required; or (b) for share-based awards granted with only service conditions, using the graded vesting method, net of estimated forfeitures, over the vesting period; or (c) for share-based awards granted with service conditions and the occurrence of an initial public offering (“IPO”) as performance condition, cumulative share-based compensation expenses for the options that have satisfied the service condition should be recorded upon the completion of the IPO, using the graded vesting method.
Under ASC 718, the Company applies the Binominal option pricing model in determining the fair value of options granted. ASC 718 requires forfeiture rates to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from initial estimates. Share-based compensation expense is recorded net of estimated forfeitures such that expense is recorded only for those share-based awards that are expected to vest.
(ac) Net loss per share
Basic net loss per share is computed by dividing net loss attributable to holders of ordinary shares by the weighted average number of ordinary shares outstanding during the year using the
two-class
method. Using the
two-class
method, net profit/loss is allocated between ordinary shares and other participating securities (i.e. preferred shares) based on their participating rights.
Diluted loss per share is calculated by dividing net loss attributable to ordinary shareholders as adjusted for the effect of dilutive ordinary equivalent shares, if any, by the weighted average number of ordinary and dilutive ordinary equivalents shares outstanding during the year/period. Ordinary share equivalents consist of the ordinary shares issuable in connection with the Company’s convertible redeemable preferred shares using the
if-converted
method, and ordinary shares issuable upon the conversion of the share options, using the treasury stock method. Ordinary equivalent shares are not included in the denominator of the diluted earnings per share calculation when inclusion of such shares would be anti-dilutive.
 
 
 
(ad) Comprehensive loss
Comprehensive loss is defined as the changes in shareholders’ equity of the Company during a period transactions and other events and circumstances excluding transactions resulting from investments from shareholders, distributions to shareholders, accretions on convertible redeemable preferred shares and modification and extinguishment of convertible redeemable preferred shares. Comprehensive loss for the periods presented includes net loss, foreign currency translation adjustments and unrealized securities holding gains (losses).
(ae) Segment reporting
ASC 280,
Segment Reporting
, establishes standards for companies to report in their financial statements information about operating segments, products, services, geographic areas, and major customers.
Based on the criteria established by ASC 280, the Company’s chief operating decision maker (“CODM”) has been identified as the Chief Executive Officer, who reviews consolidated results when making decisions about allocating resources and assessing performance of the Company. As a whole and hence, the Company has only one reportable segment. The Company does not distinguish between markets or segments for the purpose of internal reporting. As the Company’s long-lived assets are substantially located in the PRC and substantially all the Company’s revenue are derived from within the PRC, no geographical segments are presented.
(af) Recent accounting pronouncements
The Company qualifies as an “emerging growth company”, or EGC, pursuant to the Jumpstart Our Business Startups Act of 2012, as amended, or the JOBS Act. As an EGC, the Company does not need to comply with any new or revised financial accounting standards until such date that a private company is otherwise required to comply with such new or revised accounting standards. The Company adopts the following standards based on extended transition period provided to private companies or early adopts as necessary as permitted by the respective standards.
New and Amended Standards Adopted by the Company:
In August 2020, the FASB issued ASU
2020-06,
“Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic
815-40),”
which removes certain separation models for convertible debt instruments and convertible preferred stock that require the separation of a convertible debt instrument into a debt component and an equity or derivative component. The ASU also expands disclosure requirements for convertible instruments and simplifies areas of the guidance for diluted
earnings-per-share
calculations that are impacted by the amendments. The standard is effective for interim and annual periods beginning after December 15, 2021, with early adoption permitted. The adoption of this standard did not have a material impact on the Company’s disclosures.
New and amended standards not yet adopted by the Company:
In June 2016, the FASB issued ASU
2016-13,
Financial Instruments—Credit Losses (Topic 326), to provide financial statement users with more useful information about expected credit losses. ASU
2016-13
also changes how entities measure credit losses on financial instruments and the timing of when such losses are recorded. The FASB further issued Accounting Standards Update No. 2019-10, “Financial Instruments-Credit Losses (Topic 326): Effective Dates,”. According to ASU 2019-10, for public business entities that are U.S. SEC filers, the amendments in this Update are effective for fiscal years beginning after December 15, 2019. For all other entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company elected to use the extended transition period for complying with any new or revised financial accounting standards. Therefore, the Company elected to adopt this new guidance for the year ended March 31, 2024, including interim periods in the year ended March 31, 2024. The Company is in the process of evaluating the impact of this accounting standard on its consolidated financial statements.
In October 2021, the FASB issued
ASU 2021-08, “Business
Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”, which require that an entity (acquirer) recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. At the acquisition date, an acquirer should account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts. The amendments in this Update also provide certain practical expedients for acquirers when recognizing and measuring acquired contract assets and contract liabilities from revenue contracts in a business combination. The standard is effective for interim and annual periods beginning after December 15, 2022, with early adoption permitted. The Company is evaluating the impact of the adoption of this guidance on its consolidated financial statements.
 
 
In March 2022, the FASB issued ASU
2022-02,
Troubled Debt Restructurings and Vintage Disclosures. This ASU eliminates the accounting guidance for troubled debt restructurings by creditors that have adopted ASU
2016-13,
Measurement of Credit Losses on Financial Instruments. This ASU also enhances the disclosure requirements for certain loan refinancing and restructurings by creditors when a borrower is experiencing financial difficulty. In addition, the ASU amends the guidance on vintage disclosures to require entities to disclose current period gross write-offs by year of origination for financing receivables and net investments in leases within the scope of ASC
326-20.
The ASU is effective for annual periods beginning after December 15, 2022, including interim periods within those fiscal years. Adoption of the ASU would be applied prospectively. The Company is evaluating the impact of the adoption of this guidance on its consolidated financial statements.
In June 2022, the FASB issued ASU
2022-03
Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. The update clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The update also clarifies that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. The update also requires certain additional disclosures for equity securities subject to contractual sale restrictions. The amendments in this update are effective for the Company beginning January 1, 2024 on a prospective basis. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is in the process of evaluating the impact of the new guidance on its consolidated financial statements.
XML 31 R9.htm IDEA: XBRL DOCUMENT v3.23.2
Business combinations
12 Months Ended
Mar. 31, 2023
Business Combinations [Abstract]  
Business combinations
3.
Business combinations
For the year ended March 31, 2022, the Company has completed the below business combination. The results of the acquired entities’ operations have been included in the Company’s consolidated financial statements since their respective dates of acquisition.
(a) Chongni Network Technology (Shanghai) Co., Ltd (“Chongni Network”)
In October 2018, the Company acquired 49% equity interest of Chongni Network, an offline trading company incorporated in the PRC. According to the investment agreement, the Company was entitled to appoint a director to Chongni Network (out of total three board seats). The Company accounted this investment using equity method. In May 2021, the Company entered into an agreement with Chongni to purchase additional equity interest of Chongni Network with total cash consideration of RMB2.9 million.
Upon the acquisition of additional interests in Chongni Network, on June 30, 2021, the date of acquisition, the Company’s equity interests in Chongni network was increased from 49% to 63.65% with the right to appoint 2 out of 3 of Chongni Network’s board of directors, and have obtained control over Chongni Network thereon. The Company accounted for this transaction as a step acquisition with the total purchase consideration of RMB3.2 million, which included the cash consideration of RMB2.9 million, and the fair value of the previously held 49% equity interest of Chongni Network in an amount of RMB0.3 million. A gain of RMB0.1 million in relation to the revaluation of the previously held equity interests was recorded in other gains, net in the consolidated statement of loss and comprehensive loss for the year ended March 31, 2022. The fair value of the previously held equity interests was estimated based on the acquisition price of the additional interests of Chongni Network.
 
 
On the acquisition date, the allocation of the purchase price of the assets acquired and liabilities assumed based on their fair values was as follows:
 
     As of June 30, 2021  
     RMB  
Total purchase price is comprised of:
  
- fair value of 49% previously held equity interests
     245  
- cash consideration
     2,938  
  
 
 
 
Fair value of total consideration
     3,183  
  
 
 
 
 
     As of June 30, 2021  
     RMB  
Cash and cash equivalents
     2  
Prepayments and other current assets
     4,533  
  
 
 
 
Total assets
     4,535  
  
 
 
 
Accrued liabilities and other current liabilities
     (33
  
 
 
 
Total liabilities
     (33
  
 
 
 
Net assets acquired
     4,502  
  
 
 
 
Goodwill
     499  
Non-controlling
interests
     (1,818
  
 
 
 
Total
     3,183  
  
 
 
 
The acquired business contributed revenues of nil and loss of RMB0.08 million to the Company for the period from June 30, 2021 to March 31, 2022. Pro forma results of operations for the acquisition have not been presented because they are not material to the consolidated statements of loss and comprehensive losses for the year ended March 31, 2021 and 2022.
XML 32 R10.htm IDEA: XBRL DOCUMENT v3.23.2
Risks and Concentration
12 Months Ended
Mar. 31, 2023
Risks and Uncertainties [Abstract]  
Risks and Concentration
4.
Risks and Concentration
(a) Foreign currency exchange rate risk
The Company may experience economic losses and negative impacts on earnings and equity as a result of fluctuations in the exchange rate between the US$ and the RMB. The depreciation of RMB against US$ was approximately 2.3% in 2021. The appreciation of RMB against US$ was approximately 8.5% in 2022. It is difficult to predict how market forces or the PRC or the U.S. government policy may impact the exchange rate between RMB and US$ in the future.
(b) Interest rate risk
Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company’s interest rate risk arises primarily from long-term borrowings. Borrowings issued at variable rates and fixed rates expose the Company to cash flow interest rate risk and fair value interest rate risk respectively.
(c) Concentration of credit risk
Financial instruments that potentially subject the Company to the concentration of credit risks consist of cash and cash equivalents, short-term investment, accounts receivable and amounts due from related parties. The maximum exposures of such assets to credit risk are their carrying amounts as of the balance sheet dates. The Company deposits its cash and cash equivalents and short-term investment with financial institutions located in jurisdictions where the subsidiaries are located. The Company believes that no significant credit risk exists as these financial institutions have high credit quality.
 
 
Accounts receivable are typically unsecured and are derived from revenue earned through third-party consumers. The Company conducts credit evaluations of third-party customers and related parties, and generally does not require collateral or other security from its third-party customers and related parties. The Company establishes an allowance for doubtful accounts primarily based upon the age of the receivables and factors surrounding the credit risk of specific third-party customers and related parties.
(d) Concentration of customers and suppliers
Substantially all revenue was derived from customers located in China. There are no customers from whom revenues individually represent greater than 10% of the total revenues of the Company in any of the periods presented.
The information of the supplier with greater than 10% of the total purchases of the Company for the years ended March 31, 2021, 2022 and 2023 was as follows:
 
    
Year Ended

March 31, 2021
   
Year Ended

March 31, 2022
   
Year Ended

March 31, 2023
 
     RMB     RMB     RMB  
Royal Canin China Co., Ltd.
     19     17     22
XML 33 R11.htm IDEA: XBRL DOCUMENT v3.23.2
Cash and cash equivalents
12 Months Ended
Mar. 31, 2023
Cash and Cash Equivalents [Abstract]  
Cash and cash equivalents
5.
Cash and cash equivalents
Cash and cash equivalents represent cash on hand and demand deposits placed with banks and third party-payment processors, which are unrestricted as to withdrawal or use. Cash and cash equivalents balance as of March 31, 2022 and March 31, 2023 primarily consist of the following currencies:
 
    
As of March 31, 2022
    
As of March 31, 2023
 
    
Amount
    
RMB
equivalent
    
Amount
    
RMB
equivalent
 
RMB
     47,321        47,321        62,727        62,727  
Hong Kong
dollars
     39        31        7        6  
US$
     18,133        115,110        3,946        27,114  
EUR
     55        392        —          2  
NZD
     —          1        —          1  
     
 
 
       
 
 
 
Total
        162,855           89,850  
     
 
 
       
 
 
 
XML 34 R12.htm IDEA: XBRL DOCUMENT v3.23.2
Accounts receivable, net
12 Months Ended
Mar. 31, 2023
Receivables [Abstract]  
Accounts receivable, net
6.
Accounts receivable, net
Accounts receivable consist of the following:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Accounts receivable - Product sales
     42,070        71,471  
Accounts receivable - Online marketing and information service and other service
     7,630        5,873  
Allowance of doubtful accounts
     (469      (602
  
 
 
    
 
 
 
Total
     49,231        76,742  
  
 
 
    
 
 
 
 
 
Movement of allowance of doubtful accounts
 
    
As of March 31,
2021
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
    
RMB
 
At beginning of year
     363        256        469  
Addition/(reversal)
     (107      213        133  
  
 
 
    
 
 
    
 
 
 
At end of year
     256        469        602  
  
 
 
    
 
 
    
 
 
 
XML 35 R13.htm IDEA: XBRL DOCUMENT v3.23.2
Inventories, net of inventory reserves
12 Months Ended
Mar. 31, 2023
Inventory Disclosure [Abstract]  
Inventories, net of inventory reserves
7.
Inventories, net of inventory reserves
Inventories, net of inventory reserves consist of the following:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Products
     109,383        80,431  
Packaging materials and others
     538        621  
  
 
 
    
 
 
 
Total inventories, net of inventory reserves
     109,921        81,052  
  
 
 
    
 
 
 
Movement of inventory provision:
 
    
As of March 31,
2021
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
    
RMB
 
At beginning of year
     273        266        577  
Provision/(reversal)
     (7      311        35  
  
 
 
    
 
 
    
 
 
 
At end of year
     266        577        612  
  
 
 
    
 
 
    
 
 
 
The total amounts charged to the consolidated statements of loss and comprehensive loss for (reversal)/provision of inventory reserves amounted to approximately RMB(0.007) million, RMB0.31 million and RMB0.035 million for the years ended March 31, 2021, 2022 and 2023, respectively.
XML 36 R14.htm IDEA: XBRL DOCUMENT v3.23.2
Prepayments and other current assets
12 Months Ended
Mar. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Prepayments and other current assets
8.
Prepayments and other current assets
The prepayments and other current assets consist of the following:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Prepayments for purchases of products (a)
     52,348        24,216  
Vendor rebate receivables (b)
     24,462        16,160  
Value-added tax (“VAT”) deductible (c)
     18,864        10,512  
Loan receivables (d)
     3,845        9,886  
Sales return assets
     1,264        2,835  
Deposits
     1,312        999  
Others
     14,643        14,751  
  
 
 
    
 
 
 
Total
     116,738        79,359  
  
 
 
    
 
 
 
 
 
(a) Prepayments for purchases of products represent cash prepaid to the Company’s third-party brand partners for the procurement of products.
(b) Vendor rebate receivables represent the rebates to be received by the Company from its suppliers after certain levels of purchases are achieved.
(c) VAT recoverable represents the balances that the Company can utilize to deduct its value-added tax liabilities within the next 12 months.
(d) The balance represents loan receivables due from certain third-party companies and individuals. From July 2020 to March 2023, the Company entered into several loan agreements with aggregate principal amount of RMB11.0 million. The maturity dates of these loans are from October 2023 to March 2024. The interest rates ranged from 0% to 4% per annum. As of March 31, 2022 and 2023, the balances of loan receivables were RMB3.8 million and RMB9.9 million, respectively.
XML 37 R15.htm IDEA: XBRL DOCUMENT v3.23.2
Property and equipment, net
12 Months Ended
Mar. 31, 2023
Property, Plant and Equipment [Abstract]  
Property and equipment, net
9.
Property and equipment, net
Property and equipment consist of the following:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Cost:
     
Warehouse equipment
     2,669        2,879  
Furniture, computer and office equipment
     7,503        7,082  
Vehicles
     3,684        4,740  
Leasehold improvement
     10,209        10,501  
Software
     2,995        3,009  
  
 
 
    
 
 
 
Total cost
     27,060        28,211  
Less: Accumulated depreciation
     (19,281      (22,719
  
 
 
    
 
 
 
Property and equipment, net
     7,779        5,492  
  
 
 
    
 
 
 
The total amounts charged to the consolidated statements of loss and comprehensive loss for depreciation and amortization expenses amounted to approximately RMB3.08 million, RMB3.7 million and RMB3.8 million for the years ended March 31, 2021, 2022 and 2023, respectively.
XML 38 R16.htm IDEA: XBRL DOCUMENT v3.23.2
Intangible assets, net
12 Months Ended
Mar. 31, 2023
Intangible Assets, Net (Excluding Goodwill) [Abstract]  
Intangible assets, net
10.
Intangible assets, net
Intangible assets of the Company were mainly as follows:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Cost:
     
Trademark
     437        486  
License
     3,530        3,530  
Dealership
     31,717        31,717  
  
 
 
    
 
 
 
Total cost
     35,684        35,733  
Less: Accumulated amortization
     (10,140      (14,139
  
 
 
    
 
 
 
Intangible assets, net
     25,544        21,594  
  
 
 
    
 
 
 
 
 
License and dealership resulting from the business combinations completed during the year ended March 31,2021 have been allocated to the single reporting unit of the Company. The total carrying amount of intangible assets resulting from the business combinations were 
RMB 25.5 million and RMB 21.6 million as of March 31, 2022 and 2023, respectively.
The total amortization expenses of the intangible assets charged to the consolidated statements of loss and comprehensive loss amounted to approximately RMB4.0 million, RMB4.0 million and RMB4.0 million for the years ended March 31, 2021, 2022 and 2023, respectively.
The annual estimated amortization expense for intangible assets subject to amortization for the succeeding five years is as follows:
 
    
As of March 31,
 
    
2024
    
2025
    
2026
    
2027
    
2028
 
Amortization expenses
     3,867        3,438        3,207        3,203        3,187  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
XML 39 R17.htm IDEA: XBRL DOCUMENT v3.23.2
Long-Term Investments
12 Months Ended
Mar. 31, 2023
Long-term Investments and Receivables, Net [Abstract]  
Long-term investments
11.
Long-term investments
The Company’s long-term investments consist of the following:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Equity method investments
     6,783        7,494  
Available-for-sale
investments
     74,866        68,011  
Equity securities with readily determinable fair values
     670        102  
    
 
 
    
 
 
 
Total
     82,319        75,607  
    
 
 
    
 
 
 
Equity method investments
The Company applies equity method in accounting for its investments in entities in which the Company has the ability to exercise significant influence but does not have control. As of March 31, 2022 and 2023, the carrying value of the equity method investments were RMB6.8 million and RMB7.5
 million respectively, the change of which primarily relates to the equity gain recognized and the following investments which were accounted for as equity method investment: 
In April 2019, the Company invested in Jiangsu Nanjing Agricultural University Animal Pharmaceutical Co., Ltd. (“Nanjing Animal Pharmaceutical”) to purchase 8.42% equity interest with total cash consideration of RMB2.5
 million. As the Company is able to exercise significant influence through its entitlement to appoint one director, the Company therefore accounts for this investment under the equity method of accounting. In December 2022, the Company disposed all of its equity interest in Nanjing Animal Pharmaceutical with a total cash consideration of RMB 
3 million. Accordingly, the Company recognized an investment gain of RMB0.54 million in other gains, net.
The Company had 24.6
% equity interests in Wuhan Chunzhijin Information Technology Co., Ltd. (“Chunzhijin”), which was accounted using equity method. The Company also provided loan to Chunzhijin (Note 28). In March 2023, the Company further invested in Chunzhijin to purchase 
13.3% of the equity interest by waiving a loan receivable of RMB 3.4 million from Chunzhijin. After this transaction, together with the previously held equity interest in Chunzhijin, the total equity interest held by the Company increased to 34.65%. The Company continues to have significant influence over Chunzhijin and accounts for this investment under equity method.
 
 
Available-for-sale
debt investments
The following table summarizes the Company’s
available-for-sale
debt investments as of March 31, 2022:
 
     Cost      Gross unrealized gains      Gross unrealized losses    
Disposal of Long-term

investments
     Fair value  
Unlisted debt securities
     76,000        —          (1,134     —          74,866  
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
 
The following table summarizes the Company’s
available-for-sale
debt investments as of March 31, 2023:
 
     Cost      Gross unrealized gains      Gross unrealized losses    
Disposal of Long-term
investments
    Fair value  
Unlisted debt securities
     76,000        —          (7,561     (428     68,011  
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
The Company held 6.2% shareholding of Qingdao Shuangan Biotechnology Co., Ltd (“Qingdao Shuangan”). According to the investment agreement, the Company is entitled to redemption right after 48 months from the investment closing date. In April 2022, the Company transferred 0.31% shareholding of Qingdao Shuangan to a third-party investor with a cash consideration of RMB0.8 million. The Company recognized a RMB0.37 million investment gain in other gains, net. After the completion of the transaction, the shareholding of Qingdao Shuangan held by the Company was 5.9%. As of March 31, 2022 and 2023, based on the valuation results, the Company
re-measured
the investment in Qingdao Shuangan at fair value of RMB17.8 million and RMB12.8
 million, respectively. For the years ended March 31, 2021, 2022 and 2023, the unrealized securities holding gains/(losses) (net of tax) of RMB0.02 million, RMB
0.34 million and RMB(1.14) million was recorded as other comprehensive income, respectively.
In October 2019, the Company purchased 23.64% shareholding of Beijing Petdog Technology Development Co., Ltd. (“Beijing Petdog”) with a cash consideration of RMB50 million. According to the investment agreement, the Company is entitled to redemption right after 60
 months from the investment closing date. As of March 31, 2021, 2022 and 2023, based on the valuation results, the Company re-measured the investment at fair value of RMB
40.1 million and RMB33.7
 million, respectively. For year ended March 31, 2022 and 2023, the unrealized securities holding gains/(losses) (net of tax) of RMB0.75 million, RMB(10.4) million and RMB(6.4) million was recorded as other comprehensive income/(loss), respectively. 
In July and November 2021, the Company entered into investment agreements with Nanjing Animal Pharmaceutical. The Company provided Nanjing Animal Pharmaceutical
one-year
loans amounting to RMB16 million carrying a simple interest of 8% per annum. Together with the loan, the Company was also entitled a conversion right to convert all or part of the loan
s
into 3.33% equity interest of Nanjing Animal Pharmaceutical during the loan term
s
. As of March 31, 2022 and 2023, RMB 2 million was unpaid and recorded in accrued liabilities and other current liabilities. The Company recognized the investment under available for sale debt securities. It was measured and recognized at fair value on a recurring basis with changes in fair value recorded in other comprehensive income/(loss). As of March 31, 2022 and 2023, based on the valuation results, the Company
re-measured
the investment at fair value of RMB16.9 million and RMB18.0 million, respectively. For year ended March 31, 2022 and 2023, the unrealized securities holding gains (net of tax) of RMB0.71 million and RMB0.83 million was recorded as other comprehensive income/(loss), respectively.
Equity securities with readily determinable fair values
The following table summarizes the Company’s equity securities with readily determinable fair values as of March 31, 2022:
 
     Cost      Gross unrealized gains      Gross unrealized losses      Fair value  
Listed company
     1,292        —          (622      670  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
The following table summarizes the Company’s equity securities with readily determinable fair values as of March 31, 2023:
 
     Cost      Gross unrealized gains      Gross unrealized losses      Fair value  
Listed company
     1,292        —          (1,190      102  
  
 
 
    
 
 
    
 
 
    
 
 
 
In June 2021, the Company purchased 40,000 ordinary shares of Better Choice Company Inc. (“BTTR”), a company registered on NYSE American and engaging in selling pet products with a total cash consideration of US$200,000. The Company measured and recorded the investment at fair value on a recurring basis with changes in fair value, whether realized or unrealized, recorded through the income statement. The change of fair value is reported in other gains, net.
 
XML 40 R18.htm IDEA: XBRL DOCUMENT v3.23.2
Goodwill
12 Months Ended
Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill
12.
Goodwill
The changes in the carrying amount of goodwill for the years ended March 31, 2022 and 2023 were as follows:
 
     Total  
     RMB  
Balance as of March 31, 2021
  
Goodwill
     40,184  
Accumulated impairment loss
     —    
  
 
 
 
     40,184  
  
 
 
 
Transaction during the year
  
Addition (Note 3)
     500  
  
 
 
 
Balance as of March 31, 2022
  
Goodwill
     40,684  
Accumulated impairment loss
     —    
  
 
 
 
     40,684  
  
 
 
 
Transaction during the year
  
Impairment
     (40,684
  
 
 
 
Balance as of March 31, 2023
  
Goodwill
     40,684  
Accumulated impairment loss
     (40,684
  
 
 
 
     —    
  
 
 
 
In the second half of fiscal year 2023, the Covid-19 resurgence in certain areas of China and the market downturn impact on our operations caused a triggering event for possible impairment of goodwill. Together with other indicators such as history of net losses and low market capitalization of us, as a result, management concluded the existence of the impairment indicator which required the Company to perform a quantitative goodwill impairment test as of March 31, 2023. Since there is only one reporting unit in the Company, management used the market capitalization to determine the reporting unit’s fair value. Based on quantitative goodwill impairment test, the fair value of the reporting unit was RMB119.8 million (US$17.4 million), which was lower than the carrying value of our net assets of RMB213.0 million (US$31.0 million) as of March 31, 2023, hence a full impairment charge of RMB40.7 million (US$5.9 million) was recognized during the year ended March 31, 2023.
XML 41 R19.htm IDEA: XBRL DOCUMENT v3.23.2
Other non-current Assets
12 Months Ended
Mar. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Other non-current Assets
13.
Other
non-current
Assets
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Deposits (a)
     3,924        3,165  
Long-term loan receivables (b)
     937        3,421  
  
 
 
    
 
 
 
     4,861        6,586  
  
 
 
    
 
 
 
(a) Deposits mainly consisted of rental deposits and deposit for online stores operated on third party platforms, which will be collected after one year.
(b) From May 2021 to May 2022, the Company entered into interest free loan agreements with three third parties for total principal amounts of RMB3.4 million. The repayment terms of the loan agreements were ranged from 24 months to 36 months with due dates from May 2024 to June 2025. As of March 31, 2022 and 2023, the balances of long-term loan receivables were RMB0.9 million and RMB3.4 million, respectively.
XML 42 R20.htm IDEA: XBRL DOCUMENT v3.23.2
Accrued liabilities and other current liabilities
12 Months Ended
Mar. 31, 2023
Accrued Liabilities and Other Liabilities [Abstract]  
Accrued liabilities and other current liabilities
14.
Accrued liabilities and other current liabilities
Accrued liabilities and other current liabilities consist of the following:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Logistics expenses payables
     14,625        7,663  
Advances from customers
     3,773        3,077  
Payable for investment
     2,563        2,563  
Refund obligation of sales returns
     1,411        3,113  
Professional service fee accruals
     579        1,694  
Accrued advertising expenses
     150        168  
Others
     4,223        3,826  
  
 
 
    
 
 
 
Total
     27,324        22,104  
  
 
 
    
 
 
 
XML 43 R21.htm IDEA: XBRL DOCUMENT v3.23.2
Leases
12 Months Ended
Mar. 31, 2023
Leases [Abstract]  
Leases
15.
Leases
As of March 31, 2022 and 2023, the Company has operating leases recorded on its consolidated balance sheet for certain office spaces and facilities that expire on various dates through 2026. The Company does not plan to cancel the existing lease agreements for its existing facilities prior to their respective expiration dates. When determining the lease term, the Company considers options to extend or terminate the lease when it is reasonably certain that it will exercise or not exercise that option. All of the Company’s leases qualify as operating leases.
 
    
As of March 31,
2022
   
As of March 31,
2023
 
    
RMB
   
RMB
 
Assets
    
Operating lease
right-of-use
assets
     38,567       22,354  
  
 
 
   
 
 
 
Liabilities
    
Operating lease liabilities, current
     10,001       9,220  
Operating lease liabilities,
non-current
     28,197       12,741  
  
 
 
   
 
 
 
Total operating lease liabilities
     38,198       21,961  
  
 
 
   
 
 
 
Weighted average remaining lease term (years)
     3.61       2.77  
Weighted average discount rate
     4.95     5.38
Information related to operating lease activity during the years ended March 31, 2021, 2022 and 2023 are as follows:
 
    
Year ended

March 31, 2021
    
Year ended

March 31, 2022
    
Year ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Operating lease
right-of-use
assets obtained in exchange for lease obligations
     25,970        21,038        8,384  
  
 
 
    
 
 
    
 
 
 
Operating lease related expenses
        
Amortization of
right-of-use
assets
     11,687        11,705        24,597  
Interest of lease liabilities
     1,596        1,949        1,777  
  
 
 
    
 
 
    
 
 
 
     13,283        13,654        26,374  
  
 
 
    
 
 
    
 
 
 
 
 
 
    
Year ended

March 31, 2021
    
Year ended

March 31, 2022
    
Year ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Operating lease payments (included in measurement of lease liabilities)
     12,850        12,849        26,397  
  
 
 
    
 
 
    
 
 
 
Maturities of lease liabilities were as follows:
 
    
Year ended

March 31, 2023
 
    
RMB
 
For the year ending March 31,
  
2023
     9,902  
2024
     10,287  
2025
     4,263  
2026
     152  
2027
     —    
  
 
 
 
Total lease payments
     24,604  
Less: imputed interest
     (2,643
  
 
 
 
Total
     21,961  
  
 
 
 
XML 44 R22.htm IDEA: XBRL DOCUMENT v3.23.2
Interest expense
12 Months Ended
Mar. 31, 2023
Interest and Debt Expense [Abstract]  
Interest expense
16.
Interest expense
 
    
Year ended

March 31, 2021
    
Year ended

March 31, 2022
    
Year ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Amortization charges on promissory notes
     21,611        17,144        9,706  
Interest expense on borrowings
     6,039        3,740        3,644  
  
 
 
    
 
 
    
 
 
 
Total
     27,650        20,884        13,350  
  
 
 
    
 
 
    
 
 
 
XML 45 R23.htm IDEA: XBRL DOCUMENT v3.23.2
Other gains, net
12 Months Ended
Mar. 31, 2023
Other Income and Expenses [Abstract]  
Other gains, net
17.
Other gains, net
 
    
Year ended

March 31, 2021
    
Year ended

March 31, 2022
    
Year ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Gain from the
re-measurement
of the previously held equity interests to the fair value in the step acquisitions (Note 3)
     —          127        —    
Foreign exchange losses, net
     (2,867      5,322        2,679  
Gain on disposal of other debts
     6,846        —          —    
Reimbursement from a depositary bank (a)
     6,556        1,482        —    
Investment loss
     —          (622      (178
Gain on disposal of a subsidiary (b)
     —          —          3,597  
Others
     797        (289      (939
  
 
 
    
 
 
    
 
 
 
     11,332        6,020        5,159  
  
 
 
    
 
 
    
 
 
 
 
(a)
The Company received a reimbursement of US$1.0M (equivalent to RMB6.6 million), US$0.2M (equivalent to RMB1.5 million) and nil from the depository for the establishment and maintenance of the ADS program for the years ended March 31, 2021, 2022 and 2023.
 
(b)
In August 2022, the Company disposed a subsidiary to a third-party investor and recognized an investment gain of RMB 3.6 million.
XML 46 R24.htm IDEA: XBRL DOCUMENT v3.23.2
Income taxes
12 Months Ended
Mar. 31, 2023
Income Tax Disclosure [Abstract]  
Income taxes
18.
Income taxes
Cayman Islands
Under the current tax laws of Cayman Islands, the Company and its subsidiaries incorporated in the Cayman Islands are not subject to tax on income or capital gain. Additionally, the Cayman Islands does not impose a withholding tax on payments of dividends to shareholders.
Hong Kong
Under the current Hong Kong Inland Revenue Ordinance, the Company’s subsidiaries incorporated in Hong Kong are subject to a
two-tiered
profits tax rate of 8.25% and 16.5% on its taxable income generated from operations in Hong Kong. Additionally, payments of dividends by the subsidiaries incorporated in Hong Kong to the Company are not subject to income tax.
China
On July 25, 2018, Boqii (Shanghai) Information Technology Co., Ltd. (“Shanghai Boqii”) was entitled to be “Software Enterprises”. According to the Enterprise Income Tax (“EIT”) Law and relevant regulations in the PRC, from the year of 2018, Shanghai Boqii could enjoy a tax holiday of
2-year
EIT exemption and subsequently
3-year
12.5% preferential tax rate.
In addition, Shanghai Boqii was also qualified as a “High and New Technology Enterprise (“HNTE”) on August 29, 2019, and is eligible to enjoy a preferential tax rate of 15% from 2019 to 2024 to the extent it has taxable income under the EIT Law, as long as it maintains the HNTE qualification and duly conducts relevant EIT filing procedures with the relevant tax authority. Shanghai Boqii can
re-apply
for the HNTE certificate when the prior certificate expires. Whilst Shanghai Boqii was entitled to the tax preferential treatments under both “HNTE” and “Software Enterprises”, Shanghai Boqii chose to apply the preferential tax rate of “Software Enterprises”. For the years ended March 31, 2021, 2022 and 2023, Shanghai Boqii was subject to EIT rate at 12.5%, 12.5% and 12.5%, respectively.
The Company’s other subsidiaries, VIEs and VIEs’ subsidiaries established in the PRC are subject to the PRC general income tax rate of 25%.
Reconciliations of the differences between the income tax expenses of the Company and the PRC statutory EIT rate applicable to losses of the consolidated entities are as follows:
 
    
Year ended

March 31, 2021
    
Year ended

March 31, 2022
    
Year ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Loss before income taxes
     (193,391      (134,812      (106,805
Income tax computed at respective applicable tax rates
     (48,348      (33,702      (26,701
Effect of different tax jurisdiction
     14,272        2,341        12,323  
Super deduction for research and development expenses (a)
     (2,632      (1,881      (456
Non-deductible
expenses
     140        97        728  
Change in valuation allowance
     37,439        34,716        15,017  
  
 
 
    
 
 
    
 
 
 
Total
     871        1,571        911  
  
 
 
    
 
 
    
 
 
 
 
  (a)
According to the relevant laws and regulations promulgated by the State Administration of Tax of the PRC, from 2018 onwards, enterprises engaging in research and development activities are entitled to claim 175% of their qualified research and development expenses so incurred as tax deductible expenses. The additional deduction of 75% of qualified research and development expenses (the “Super Deduction”) can be directly claimed in the annual EIT filing. For the years end March 31, 2021, 2022 and 2023, the Super Deduction for research and development expenses available to the Company amounted to RMB2.6 million, RMB1.9 million and RMB0.5 million, respectively.
 
 
 
The provisions for income taxes for the years ended March 31, 2021, 2022 and 2023 differ from the amounts computed by applying the EIT primarily due to change in valuation allowance provided and tax differential from certain subsidiaries with preferential tax rates of the Company.
The following table sets forth the effect of tax holiday effect on China operations:
 
    
Year ended

March 31, 2021
    
Year ended

March 31, 2022
    
Year ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Tax holiday effect
     1,074        3,513        1,235  
Basic and diluted net loss per share effect
     0.02        0.05        0.02  
    
 
 
    
 
 
    
 
 
 
Reconciliations between the effective income tax rate and the PRC statutory income tax rates are as follows:
 
    
Year ended

March 31, 2021
   
Year ended

March 31, 2022
   
Year ended

March 31, 2023
 
    
RMB
   
RMB
   
RMB
 
PRC statutory income tax rates
     25     25     25
Tax holiday effect
     1     3     (1 %) 
Difference in tax rates of subsidiaries outside PRC
     (8 %)      (8 %)      (10 %) 
Super deduction for research and development expenses
     1     1     0
Non-deductible
expenses
     0     0     1
Change in valuation allowance
     (19 %)      (20 %)      (14 %) 
    
 
 
   
 
 
   
 
 
 
Effective income tax rate
     0     1     1
    
 
 
   
 
 
   
 
 
 
Composition of income tax expenses
The current and deferred portions of income tax expenses included in the consolidated statements of loss and comprehensive loss are as follows:
 
    
Year ended

March 31, 2021
    
Year ended

March 31, 2022
    
Year ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Current income tax expense/(benefit)
     1,018        (582      78  
Deferred tax benefit
     (1,889      (989      (989
    
 
 
    
 
 
    
 
 
 
Income tax credit, net
     (871      (1,571      (911
    
 
 
    
 
 
    
 
 
 
 
 
 
Deferred tax assets and deferred tax liabilities
Deferred taxes were measured using the enacted tax rates for the periods in which they are expected to be reversed. The tax effects of temporary differences that give rise to the deferred tax asset and liabilities balances as of March 31, 2022 and 2023 are as follows:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Deferred tax assets:
                 
Net accumulated loss-carry forward
     172,059        163,526  
Deferred deductible advertising expense
     2,483        —    
Allowance
     78        238  
Contract liabilities
     419        172  
Accruals
     2,208        842  
Fair Value Change
     —          1,891  
Less: Valuation allowance
     (177,247      (166,669
    
 
 
    
 
 
 
Net deferred tax assets

 
 
—  
 
 
 
—  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Deferred tax liabilities:
                 
Recognition of intangible assets arising from asset acquisition and business combination
     (5,130      (4,141
Unrealized fair value change of the
available-for-sale
debt investments
     283        —    
    
 
 
    
 
 
 
Net deferred tax liabilities
     (4,847      (4,141
    
 
 
    
 
 
 
As of March 31, 2022 and 2023, the PRC entities of the Company had tax loss carryforwards of approximately RMB688 million and RMB654 million respectively, which can be carried forward to offset taxable income. The carryforwards period for net operating losses under the EIT Law is five years. The net operating loss carry forward of the Company will expire in varying amounts between 2024 and 2028. Other than the expiration, there are no other limitations or restrictions upon the Company’s ability to use these operating loss carryforwards.
Valuation allowance is provided against deferred tax assets when the Company determines that it is more likely than not that the deferred tax assets will not be utilized in the future. In making such determination, the Company considered factors including future taxable income exclusive of reversing temporary differences and tax loss carry forwards. If events occur in the future that allow the Company to realize part or all of its deferred income tax, an adjustment to the valuation allowances will result in a decrease in tax expense when those events occur. As of March 31, 2022 and 2023, valuation allowances of RMB177.2 million and RMB166.7 million were provided because it was more likely than not that the Company will not be able to utilize these tax losses carry forwards and other deferred tax assets generated by its subsidiaries and VIEs.
Movement of valuation allowance is as follows:
 
    
Year Ended

March 31, 2021
    
Year Ended

March 31, 2022
    
Year Ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Beginning balance
     112,539        149,978        177,247  
Change of valuation allowance
     37,439        27,269        15,017  
Written-off
for expiration of net operating losses
     —          —          (22,995
Decrease of valuation allowances related to the disposal of a subsidiary
     —          —          (2,600
    
 
 
    
 
 
    
 
 
 
Ending balance
     149,978        177,247        166,669  
    
 
 
    
 
 
    
 
 
 
XML 47 R25.htm IDEA: XBRL DOCUMENT v3.23.2
Ordinary Share
12 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Ordinary Share
 
19.
Ordinary Share
As of March 31, 2022, the Company had 55,709,591 Class A ordinary shares and 13,037,729 Class B ordinary shares issued and outstanding, respectively. As of March 31, 2023, the Company had 55,763,079 Class A ordinary shares and 13,037,729 Class B ordinary shares issued and outstanding, respectively.
Initial public offering
In October 2020, the Company completed its IPO on the New York Stock Exchange of 7,000,000 American Depositary Shares (“ADSs”) (including 1,050,000 ADSs sold upon the full exercise of the underwriters’ over-allotment option) (each representing 0.75 of one Class A ordinary share), for a total ordinary shares offering of 5,250,000 shares at a price of US$10.00 per ADS. The net proceeds raised from the IPO amounted to approximately US$61 million after deducting underwriting discounts and commissions and other offering expenses.
Upon the completion of the IPO, all series of redeemable convertible preferred shares of the Company were converted and designated as Class A ordinary shares with a par value of US$0.001 each on a
one-for-
one basis except for
(i)10,340,000 shares of Series A preferred shares were automatic converted into 7,844,137 ordinary shares on a 1: 0.76 basis, (ii) 9,067,384 shares of Series B preferred shares were automatic converted into 8,557,980 ordinary shares on a 1:0.94 basis, (iii) 6,734,459 shares of Series C+ preferred shares were automatic converted into 6,883,520 ordinary shares on a 1:1.02 basis and (iv) 833,125 shares of Series C preferred shares were converted and designated as Class B ordinary shares with a par value of US$0.001 each on a
one-for-one basis
. 12,204,604 ordinary shares were designated as Class B ordinary share on a
one-for-one
basis. The remaining ordinary shares were designated as Class A ordinary shares on a
one-for-one
basis.
In respect of all matters subject to shareholders’ vote, each holder of Class A ordinary share is entitled to one and each holder of Class B ordinary share is entitled to twenty votes.
In February 2021, the Company repurchased 521,924 shares of Class A ordinary shares from one of its shareholders with a consideration amounting to US$4.8 million, the repurchased shares were cancelled thereafter.
XML 48 R26.htm IDEA: XBRL DOCUMENT v3.23.2
Convertible redeemable preferred shares
12 Months Ended
Mar. 31, 2023
Statement of Stockholders' Equity [Abstract]  
Convertible redeemable preferred shares
20.
Convertible redeemable preferred shares
The Company issued several series of convertible redeemable preferred shares in previous years. Upon the completion of the IPO, all series of redeemable convertible preferred shares of the Company were converted and designated as Class A ordinary shares (Note 19).
 
The Company classified the Preferred Shares in the mezzanine section of the Consolidated Balance Sheets because they were contingently redeemable upon the occurrence of an event outside of the Company’s control (e.g. the Company not achieving a Qualified IPO before the Optional Redemption Date). The Preferred Shares were determined to be mezzanine equity with no embedded feature to be bifurcated and no BCF to be recognized. The Preferred Shares
were
initially recorded at their respective issuance date fair value, net of issuance cost.
Since the Preferred Shares bec
a
me redeemable at the option of the holder at any time after the Optional Redemption Date, for each reporting period, the Company accreted the carrying amount of the Preferred Shares to the higher of (1) the fair market value of the Preferred Shares on the reporting date, or (2) the result of using effective interest rate method to accrete the Preferred Shares to the redemption prices on the Optional Redemption Date that were calculated with
pre-determined
formulas (e.g., for Series A Preferred Shares, such redemption price shall be 180% of the issue price). While all Preferred Shares were automatically converted upon a Qualified IPO, the effectiveness of a Qualified IPO was not within the control of the Company and
was
not deemed probable to occur for accounting purposes until the effective date of the Qualified IPO. As such, the Company continued to recognize accretion of the Preferred Shares until the completion of the IPO on October 2, 2020 when all of the Preferred Shares of the Company were converted to ordinary shares. The accretion of the Preferred Shares was
RMB-121 million
(US$-18million), nil and nil for the years ended March 31, 2021, 2022 and 2023.
XML 49 R27.htm IDEA: XBRL DOCUMENT v3.23.2
Redeemable non-controlling interests
12 Months Ended
Mar. 31, 2023
Noncontrolling Interest [Abstract]  
Redeemable non-controlling interests
21.
Redeemable
non-controlling
interests
Yoken Holding Limited (“Yoken”), a wholly owned subsidiary of the Company issued 120,000 redeemable preferred shares amounting to RMB6 million to a third-party investor in October, 2020. The preferred shares are redeemable at the holder’s option if Yoken fails to complete a qualified IPO in a
pre-agreed
period of time since its issuance with a redemption price measured by 10% interest per year. The preferred shares are therefore accounted for as redeemable
non-controlling
interests in mezzanine equity and are accreted to the redemption value over the period starting from the issuance date. The contract terms are the same as the Preferred Shares of the Company.
For the years ended March 31 2021, 2022 and 2023, the Company recognized accretion of RMB0.1 million, RMB0.6 million and RMB0.7 million, respectively, to the respective redemption value of the redeemable non-controlling interest over the period starting from issuance date with a corresponding increase to the accumulated deficit. As of March 31, 2022 and 2023, the redeemable
non-controlling
interests was RMB6.5 million and RMB7.2 million, respectively.
The following tables provides details of the redeemable non-controlling interests activity for the years ended March 31, 2021, 2022 and 2023:
 
    
Year Ended

March 31, 2021
    
Year Ended

March 31, 2022
    
Year Ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Beginning balance
     5,809        5,947        6,522  
Accretion of redeemable non-controlling interests
     138        575        675  
  
 
 
    
 
 
    
 
 
 
Ending balance
     5,947        6,522        7,197  
  
 
 
    
 
 
    
 
 
 
XML 50 R28.htm IDEA: XBRL DOCUMENT v3.23.2
Borrowings, other debts and derivative liabilities
12 Months Ended
Mar. 31, 2023
Debt Disclosure [Abstract]  
Borrowings, other debts and derivative liabilities
22.
Borrowings, other debts and derivative liabilities
Short-term borrowings
The following table presents short-term borrowings from commercial banks, other institutions and individuals as of March 31, 2022 and 2023. Short-term borrowings include borrowings with maturity terms shorter than one year:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Bank borrowings
     134,540        86,261  
Current portion of long-term bank borrowings
     26,586        —    
  
 
 
    
 
 
 
Total
     161,126        86,261  
  
 
 
    
 
 
 
Bank borrowings
As of March 31, 2022 and 2023, the Company obtained short-term bank borrowings of RMB161.1 million and RMB86.3 million in aggregate, of which RMB110.5 million and RMB63.9 million were collateralized by short-term investments, respectively. The weighted average interest rate for the outstanding borrowings were approximately 2.63% and 3.98%, respectively. These short-term bank borrowings did not include any restrictive covenants. As of March 31, 2022 and 2023, the unused facility for the short-term borrowing were RMB170.3 million and RMB
 
213.0 million, respectively.
As of March 31, 2023, the Company has not obtained long-term bank borrowings. As of March 31, 2023, the unused facility for the long-term borrowings was none.
 
Future principal maturities of short-term borrowings and long-term borrowings as of March 31, 2021 and 2022 are as followings:
 
    
Year ended
March 31, 2022
    
Year ended
March 31, 2023
 
    
RMB
    
RMB
 
For the year ending March 31,
     
- Within 1 year
     161,126        86,261  
  
 
 
    
 
 
 
Total
     161,126        86,261  
  
 
 
    
 
 
 
As of the date of this annual report, all the outstanding short-term borrowing as of March 31, 2023 was subsequently settled.
Other debts
Other debts –
non-current
consist of the following:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Loan from CMB (a)
     86,373        —    
Loan from Chong Li (b)
     70,001        73,981  
Loan for Yoken Series
A-1
Warrant (c)
     23,188        27,346  
Payable for investment
     1,500        1,500  
  
 
 
    
 
 
 
Total
     181,062        102,827  
  
 
 
    
 
 
 
(a) Loan from CMB
Guangcheng signed loan agreement with CMB in March 2020 (“Loan from CMB”). The loan was interest-free with a principal amount of US$46 million. The term is 2 years and can be extended if agreed by both CMB and Guangcheng.
The Company accounts for Loan from CMB as a long-term debt initially recognized in the amount of RMB303 million (which is the present value of the principal amount of US$46 million) and subsequently measured at amortized cost. During the years ended March 31, 2022 and 2023, the Company repaid the principal of Loan from CMB in the amount of RMB235.0 million and RMB87.9 million, respectively. For the years ended March 31, 2022 and 2023, the Company recorded RMB8.9 million and RMB1.5 million interest expenses of Loan from CMB.
The Company issued preferred shares to be settled by CMB after CMB receiving the repayment of the Loan from CMB. The Company recorded a receivable for issuance of preferred shares in the amount of RMB303 million (which is the present value of the principal amount of US$46 million) in mezzanine equity for the consideration of the preferred shares not yet received from the investors. After the completion of the IPO in October 2020, the preferred shares were automatically converted into Class A ordinary shares. The Company accounted for the consideration of such-converted ordinary shares as receivable for issuance of ordinary shares in equity. As of March 31, 2022 and 2023, the receivable for issuance of ordinary shares is RMB86.4 million and nil, respectively (Note 23).
 
(b) Loan from Chong Li
Guangcheng signed loan agreement with Chong Li in March 2020 (“Loan from Chong Li”). The loan was interest-free with a principal amount of RMB128 million. The term is 5 years and can be extended if agreed by both Chong Li and Guangcheng.
 
The Company accounted for Loan from Chong Li as a long-term debt initially recognized in the amount of RMB95 million (which is the present value of the principal amount of RMB128 million) and subsequently measured at amortized cost. During the years ended March 31, 2022 and 2023, the Company repaid the principal of Loan from Chong Li of RMB35.9 million and RMB36.4 million, respectively. For the years ended March 31, 2022 and 2023, the Company recorded interest expenses of RMB5.1 million and RMB4.5 million, respectively.
The Company issued preferred shares to be settled by Superb Origin International Limited (“Superb Origin”, Chong Li is the 100% equity owner of Superb Origin) after Guangcheng repaid the Loan from Chong Li. The Company recorded a receivable for issuance of preferred shares in the amount of RMB95 million (which is the present value of the principal amount of RMB128 million) in mezzanine equity for the consideration of the preferred shares not yet received from Superb Origin. After the completion of the IPO in October 2020, preferred shares were automatically converted into Class A ordinary shares. The Company then recorded the unreceived consideration from Superb Origin as receivable for issuance of ordinary shares under shareholders’ equity (Note 23).
 
(c)
Yoken Series
A-1
Warrant
On March 2, 2020, Yoken Holding Limited (“Yoken”), a wholly owned subsidiary of the Company, entered into a share purchase agreement with three investors (“Yoken Series
A-1
SPA”). According to the Yoken Series
A-1
SPA, Yoken will issue each investor a warrant (“Yoken Series
A-1
Warrant”) to purchase certain quantity of Yoken’s Series
A-1
Preferred Shares (“Yoken Series
A-1
Preferred Shares”). As the consideration for each Yoken Series
A-1
Warrant, the respective investor shall provide a loan (“Loan for Yoken Series
A-1
Warrant”) carrying a simple interest of 10% per annum to Chengdu Chongaita Information Technology Co., Ltd. (“Chongaita”), a wholly owned PRC subsidiary of Yoken. Yoken will only issue the Yoken Series
A-1
Warrants after Chongaita has received all loan proceeds. Both the issuance of the Yoken Series
A-1
Warrants and the receipt of the loan proceeds are closing conditions of the transactions in the Yoken Series
A-1
SPA. The Company accounted for the loan as a term loan carrying an annual simple interest of 10%. As of March 31, 2020, the carrying value of the loan proceeds of Yoken Series
A-1
Warrant was RMB18 million.
 
On October 23, 2020, one of the investors terminated and entered into a new share purchase agreement with Yoken, pursuant to which 120,000 Yoken Series
A-1
Preferred Shares were issued on October 23, 2020 for an aggregated consideration of RMB6 million. On the same day, the Company issued the remaining two investors two warrants to purchase up to 360,000 and 200,000 Yoken Series
A-1
Preferred Shares at an exercise price per share of US$ 7.14 in connection with a loan of RMB18 million (equivalent to US$2.5 million) and RMB10 million (equivalent to US$1.4 million) granted to Chongaita (“Loan for Yoken Series
A-1
Warrant”). As a debt modification, the Company reversed RMB1.4 million interest expense as other gains, net (Note 17). The Company recognized the Yoken Series
A-1
Warrant and bifurcated the conversion feature as derivative liability out of the total consideration received. As of March 31, 2022 and 2023, the carrying value of Yoken Series
A-1
Warrant were RMB23.2 million and RMB27.3 million, respectively, and fair value of conversion feature were RMB9.1 million and RMB7.9 million, respectively.
Derivative liabilities
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Conversion feature of Yoken Series
A-1
Warrant (a)
     9,086        7,850  
Forward exchange contracts (b)
     —          2,851  
  
 
 
    
 
 
 
Total
     9,086        10,701  
  
 
 
    
 
 
 
For the initial recognition of each debt instrument that has a bifurcated derivative liability (i.e., embedded warrant or conversion feature), out of the total consideration received, the derivative liability is recognized at fair value and the remaining consideration (net of issuance costs) is then allocated to the host debt instrument. The derivative liability is subsequently carried at fair value with any changes in fair value recognized currently in the income statement. The host debt instrument is subsequently amortized using the effective interest rate method. Upon conversion of the host debt instrument into the Preferred Shares or debt repayment, both the host debt instrument and the respective derivative liability are subject to extinguishment accounting with a gain or loss recognized from the difference between the recoded values of both liabilities and the fair value of consideration given by the Company (i.e., the Preferred Shares or cash).
(a) The warrant issued in connection with Yoken Series
A-1
Warrant is embedded instead of freestanding because it is (1) issued in connection with the instrument and (2) not separately exercisable without terminating the debt instruments. Therefore, each combined instrument (loan with embedded warrant) is substantially similar to a convertible debt where the embedded warrant is similar to a conversion feature able to convert the debt instrument into the Preferred Shares.
The Company assessed the embedded warrant along with the conversion features in Yoken Series
A-1
Warrant and concluded that it is required to be bifurcated and accounted for separately as derivative liabilities. This is because (1) the embedded warrant or conversion feature, as an equity-linked feature, is not considered clearly and closely related to its debt host instrument, and (2) the redemption rights of the convertible Preferred Shares could give rise to net settlement of the conversion feature of the Preferred Shares.
 
(b) In June and December 2021 and March 2022, the Company entered three new forward exchange contracts with a financial institution. Pursuant to which, the financial institution agreed to purchase US$8 million, US$4 million and US$5 million from the Company in exchange of RMB52.4 million, RMB26.1 million and RMB32.1 million at a fixed foreign exchange rate of 6.5452, 6.5128 and 6.4200 on June 2022, December 2022 and March 2023, respectively. The Company settled in advance with amount of US$11 million and recorded the fair value gain in the amount of RMB1.2 million as fair value change of derivative liabilities. For the year ended March 31, 2022, the fair value gain of the rest forward exchange contracts was RMB0.9 million and was recorded as fair value change of derivative liabilities. The carrying value of the remaining forward exchange contracts was RMB0.7 million and was recorded as prepayments and other current assets.
In December 2022 and March 2023, the forward exchange contracts which signed in December 2021 and March 2022 were renewed to December 2023 and March 2024 respectively. And the Company settled in advance with amount of US$1.5 million and recorded the fair value gain in the amount of RMB0.1 million as fair value change of derivative liabilities. For the year ended March 31, 2023, the fair value loss of the rest forward exchange contracts was RMB(3.6) million and was recorded as fair value change of derivative liabilities. The carrying value of the remaining forward exchange contracts was RMB2.9 million and was recorded as derivative liabilities.
XML 51 R29.htm IDEA: XBRL DOCUMENT v3.23.2
Receivable for issuance of ordinary shares
12 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Receivable for issuance of ordinary shares
23.
Receivable for issuance of ordinary shares
The Company issued preferred shares to investors, which to be settled by the investors after Guangcheng repaid the Loan from CMB and Loan from Chong Li to the investors. The Company recorded a receivable for issuance of preferred shares in mezzanine equity for the consideration of the preferred shares not yet received from the investors. After the completion of the IPO in October 2020, the preferred shares were automatically converted into Class A ordinary shares. The Company accounted for the consideration of such-converted ordinary shares as receivable for issuance of ordinary shares under shareholders’ equity.
During the years ended March 31, 2022 and 2023, the Company received RMB262.9 and RMB87.9 million from the receivable for issuance of ordinary shares. For the years ended March 31, 2022 and 2023, the Company recorded interest income of RMB14.2 million and RMB6.1 million, respectively. As of March 31, 2022 and 2023, the balances of receivable for issuance of ordinary shares were RMB164.7 million and RMB83.4 million, respectively.
XML 52 R30.htm IDEA: XBRL DOCUMENT v3.23.2
Share-based compensation
12 Months Ended
Mar. 31, 2023
Share-based Payment Arrangement [Abstract]  
Share-based compensation
24.
Share-based compensation
On September 27, 2012, the Company adopted 2012 Global Share Plan (the “2012 Plan”) and reserved 1,061,500 ordinary shares for share options to be granted to certain of the Company’s employees and
non-employees
(the “Participants”). On August 1, 2018, the Company adopted 2018 Global Share Plan (the “2018 Plan”) to replace the 2012 Plan and increased the reserved ordinary shares to 5,987,836 in total for future grants of share options. On September 1, 2020, the Company amended the 2018 Plan and increased the authorized reserved shares from 5,987,836 to 8,987,836.
 
In May 2022, the Company amended the 2018 Plan and increased 4,000,000 authorized reserved shares from 8,987,836 to 12,987,836.
 
 
Except for share options granted to certain senior management personnel during the years ended March 31, 2015 and 2016, which were immediately fully vested and exercisable once granted, other share options granted to employees and
non-employees
under the 2012 and 2018 Plans would generally be exercisable upon the Company’s completion of a Qualified IPO or a defined corporate transactions (i.e. change of control, etc.) and the employees render services to the Company in accordance with the stipulated service schedules. The employee participants are generally subject to a four-year service schedule, under which the employees earn an entitlement to vest in 25% of their option grants at the end of each year of completed service.
For the years ended March 31, 2022 and 2023, 1,282,500 and nil share options were granted to the Participants respectively.
The following table sets forth the share options activity for the years ended March 31, 2022 and 2023:
 
    
Number of
shares
   
Weighted
average
exercise price
    
Weighted average
remaining
contractual term
    
Aggregate
intrinsic
value
    
Weighted average
fair value
 
          
US$
           
US$
    
US$
 
Outstanding as of March 31, 2021
     5,512,222       3.36        6.32        29,360        3.28  
Exercisable as of March 31, 2021
     —         —          —          —          —    
Granted
     1,282,500       2.86                          2.27  
Exercised
     (1,204,483     1.09                          0.73  
Forfeited
     (358,348     2.86                          3.83  
Outstanding as of March 31, 2022
     5,231,891       2.86        5.25        404        2.36  
Exercisable as of March 31, 2022
     —         —          —          —          —    
Exercised
     (53,488     0.60                          2.26  
Forfeited
     (1,233,050     1.31                          0.86  
Outstanding as of March 31, 2023
     3,945,354       2.58        3.45        124        2.06  
Exercisable as of March 31, 2023
     —         —          —          —          —    
The aggregate intrinsic value is calculated as the difference between the exercise price of the options and the estimated fair value of the underlying shares of US$29,359,582, US$404,409 and US$123,594 at March 31, 2021, 2022 and 2023, respectively.
As of March 31, 2022 and 2023, there were US$2,298,328 and US$322,926 of unrecognized share-based compensation expenses related to share options granted by the Company, which were expected to be recognized over a weighted-average period of 5.3 years and 3.4 years, respectively.
Options granted to the Participants were measured at fair value on the dates of grant using the Binomial Option Pricing Model. The assumptions used to value the Company’s option grants for the year ended March 31, 2022 were as follows:
 
    
Year ended March 31, 2022
Expected volatility
  
42.22
% - 
43.71%
Risk-free interest rate
   1.62
% - 
1.86%
Exercise multiple
   2.8/2.2
Expected dividend yield
   0%
Contractual term (in years)
   10
 
The expected volatility was estimated based on the historical volatility of comparable peer public companies with a time horizon close to the expected term of the Company’s options. The risk-free interest rate was estimated based on the yield to maturity of U.S. treasury bonds denominated in US$ for a term consistent with the expected term of the Company’s options in effect at the option valuation date. The expected exercise multiple was estimated as the average ratio of the stock price to the exercise price of when employees would decide to voluntarily exercise their vested options. As the Company did not have sufficient information of past employee exercise history, it was estimated by referencing to a widely-accepted academic research publication. The expected dividend yield is zero as the Company has never declared or paid any cash dividends on its shares, and the Company does not anticipate any dividend payments in the foreseeable future. The expected term is the contract life of the option.
For the Company’s share options granted to the Participants, the completion of a Qualified IPO is considered to be a performance condition of the awards. A Qualified IPO is not considered to be probable until it is completed. Under ASC 718, compensation cost should be accrued if it is probable that the performance condition will be achieved. As a result, no compensation expense will be recognized related to these options until the completion of a Qualified IPO, and hence no share-based compensation expense was recognized for the year ended March 31, 2020. For the year ended March 31, 2021, upon the completion of the IPO in October 2020, the Company recorded RMB55 million of share-based compensation expense. For the year ended March 31, 2022 and 2023, RMB14.4 million and RMB-7.7 million of share-based compensation expense was recorded, respectively.
The fair value of options granted to the Participants for the years ended March 31, 2022 and 2023 was amounting to US$2.9 million and nil, respectively.
XML 53 R31.htm IDEA: XBRL DOCUMENT v3.23.2
Employee benefits
12 Months Ended
Mar. 31, 2023
Compensation Related Costs [Abstract]  
Employee benefits
25.
Employee benefits
The full-time employees of the Company’s subsidiaries and VIEs that are incorporated in the PRC are entitled to staff welfare benefits including medical insurance, basic pensions, unemployment insurance, work injury insurance, maternity insurance and housing funds. These companies are required to contribute to these benefits based on certain percentages of the employees’ salaries in accordance with the relevant regulations and charge the amount contributed to these benefits to the consolidated statements of loss and comprehensive loss. The Company has no legal obligation for the benefits beyond the contribution made. The PRC government is responsible for the welfare and medical benefits and ultimate pension liability to these employees. The total amounts charged to the consolidated statements of loss and comprehensive loss for such employee benefits amounted to RMB6 million, RMB7 million and RMB9 million for the years ended March 31, 2021, 2022 and 2023, respectively.
XML 54 R32.htm IDEA: XBRL DOCUMENT v3.23.2
Fair value measurements
12 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Fair value measurements
26.
Fair value measurements
The Company measured its short-term investments,
available-for-sale
investments, equity securities with readily determinable fair values and derivative liabilities at fair value on a recurring basis. Equity securities classified within Level 1 are valued using quoted market prices that currently available on a securities exchange registered on NYSE American. Short-term investments classified within Level 2 are valued using directly or indirectly observable inputs in the marketplace. As the Company’s
available-for-sale
investments and derivative liabilities are not traded in an active market with readily observable prices, the Company uses significant unobservable inputs to measure the fair value of
available-for-sale
investments and derivative liabilities. These instruments are categorized in the Level 3 valuation hierarchy based on the significance of unobservable factors in the overall fair value measurement. The Company did not transfer any assets or liabilities in or out of level 3 during the years ended March 31, 2021, 2022, and 2023.
 
The following table summarizes the Company’s financial assets and liabilities measured and recorded at fair value on recurring basis as of March 31, 2022 and 2023:
 
            Fair value measurement at reporting date using  
Description
   Fair value as of
March 31, 2022
     Quoted price in
active markets
for identical
assets (Level 1)
     Significant other
observable Inputs
(Level 2)
     Significant
unobservable Inputs
(Level 3)
 
     RMB      RMB      RMB      RMB  
Assets:
           
Short-term investments
     128,084        —          128,084        —    
Available-for-sale
debt investments
     74,866        —          —          74,866  
Equity securities with readily determinable fair values
     670        670        —          —    
  
 
 
    
 
 
    
 
 
    
 
 
 
Total assets
     203,620        670        128,084        74,866  
  
 
 
    
 
 
    
 
 
    
 
 
 
Liabilities:
           
Derivative liabilities
     9,086        —          —          9,086  
  
 
 
    
 
 
    
 
 
    
 
 
 
 
            Fair value measurement at reporting date using  
Description
   Fair value as of
March 31, 2023
     Quoted price in
active markets
for identical
assets (Level 1)
     Significant other
observable Inputs
(Level 2)
     Significant
unobservable Inputs
(Level 3)
 
     RMB      RMB      RMB      RMB  
Assets:
           
Short-term investments
     69,797        —          69,797        —    
Available-for-sale
debt investments
     68,011        —          —          68,011  
Equity securities with readily determinable fair values
     102        102        —          —    
  
 
 
    
 
 
    
 
 
    
 
 
 
Total assets
     137,910        102        69,797        68,011  
  
 
 
    
 
 
    
 
 
    
 
 
 
Liabilities:
           
Derivative liabilities
     10,701        —          —          10,701  
  
 
 
    
 
 
    
 
 
    
 
 
 
The roll forward of major Level 3 investments are as following:
 
     Derivative liabilities     
Available-for-sale

debt investments
 
Fair value of Level 3 investments as at March 31, 2020
     14,351        70,328  
New addition
     9,581        —    
Disposal of Series
D-3
Notes
     (2,377      —    
Unrealized fair value change of the derivative liabilities
     (11,559      —    
Unrealized fair value change of the
available-for-sale
debt investments
     —          1,029  
  
 
 
    
 
 
 
Fair value of Level 3 investments as at March 31, 2021
     9,996        71,357  
  
 
 
    
 
 
 
New addition
     —          16,000  
Reclassification of forward exchange contracts
     746        —    
Unrealized fair value change of the derivative liabilities
     (1,656      —    
Unrealized fair value change of the
available-for-sale
debt investments
     —          (12,491
  
 
 
    
 
 
 
Fair value of Level 3 investments as at March 31, 2022
     9,086        74,866  
  
 
 
    
 
 
 
Reclassification of forward exchange contracts
     (651      —    
Unrealized fair value change of the derivative liabilities
     2,266        —    
Unrealized fair value change of the
available-for-sale
debt investments
     —          (6,427
Disposal of
available-for-sale
debt investments
     —          (428
  
 
 
    
 
 
 
Fair value of Level 3 investments as at March 31, 2023
     10,701        68,011  
  
 
 
    
 
 
 
 
 
 
The Company determined the fair value of their investments by using equity allocation model, market approach and binomial model. The determination of the fair value was based on estimates, judgments and information of other comparable public companies. The significant unobservable inputs adopted in the valuation as of March 31, 2022 and 2023:
 
    
As of March 31,

2022
  
As of March 31,

2023
Implied price to sales after discount
for lack of marketability
   n.a.    1.04x
Weighted average cost of capital
   15
%, 
16.5
%, 
18
%
   n.a.
Lack of marketability discount
   17
%, 
23
%, 
29
%
   20%
Risk-free rate
   1.95
%, 
2.23
%, 
2.34
%, 
2.36
%
   2.60
%, 
2.31
%, 
2.19%
Expected volatility
   39.88
%, 
42.17
%, 
42.48
%, 
47.34
%
   47.19
%, 
43.65
%, 
32.08%
Probability
   Liquidation scenario: 20%
Redemption scenario: 40%
IPO scenario: 40%
   Liquidation scenario: 35
%, 
40%
Redemption scenario: 35
%, 
40%
IPO scenario: 30
%, 
20%
The significant unobservable inputs used in the fair value measurement of the fair value of the investments include weighted average cost of capital, implied price to sales after discount for lack of marketability, lack of marketability discount, risk-free rate, expected volatility and probabilities of different scenarios. Significant increases in lack of marketability discount and risk-free rate would result in a significantly lower fair value measurement. Significant decreases in expected volatility would result in a significantly lower fair value measurement. If the probabilities of redemption and liquidation scenarios are assumed to keep equal, significant increases in the probability of IPO scenario would result in a significantly lower fair value measurement.
The Company determined the fair value of their derivative liabilities by using binominal model. The determination of the fair value was based on estimates, judgments and information of other comparable public companies. The significant unobservable inputs adopted in the valuation as of March 31, 2022 and 2023 are as follows:
 
    
As of March 31,
2022
  
As of March 31,
2023
Spot price (US$)
   0.44, 6.93    5.90
Risk-free rate
   1.25%, 2.5%    3.83%
Expected volatility
   57.95%, 48.15%    61.13%
Expected expiry years (in years)
   0.50, 3.56    2.60
The significant unobservable inputs used in the fair value measurement of the derivative liabilities include spot price, risk-free rate, expected volatility and expected expiry years. Significant decreases in spot price, risk-free rate, expected volatility and expected expiry years would result in a significantly lower fair value measurement.
XML 55 R33.htm IDEA: XBRL DOCUMENT v3.23.2
Net loss per share
12 Months Ended
Mar. 31, 2023
Earnings Per Share [Abstract]  
Net Loss per share
27.
Net loss per share
Basic loss per share and diluted loss per share have been calculated in accordance with ASC 260 on computation of earnings per share for the years ended March 31, 2021, 2022 and 2023, respectively, as follows:
 
   
Year Ended

March 31, 2021
   
Year Ended

March 31, 2022
   
Year Ended

March 31, 2023
 
   
RMB
   
RMB
   
RMB
 
Numerator:
                       
Net loss attributable to Boqii Holding Limited
    (194,444     (128,390     (102,799
Accretion on the Preferred Shares to redemption value (Note 20)
    120,873       —         —    
Accretion on the Redeemable
non-controlling
interests to redemption value (Note 21)
    (138     (575     (675
Deemed dividend to preferred shareholders
    (12,547     —         —    
   
 
 
   
 
 
   
 
 
 
Net loss attributable to ordinary shareholders
    (86,256     (128,965     (103,474
   
 
 
   
 
 
   
 
 
 
Denominator:
                       
Weighted average number of ordinary shares used in computing net loss per share, Basic and diluted (Note (a))
    66,953,610       68,006,172       68,858,823  
   
 
 
   
 
 
   
 
 
 
Net loss per share attributable to ordinary shareholders:
                       
Basic and diluted
    (1.29     (1.90     (1.50
   
 
 
   
 
 
   
 
 
 
 
 
Note (a): Options exercisable for a minimal exercise price (the “Penny Stock”) are included in the denominator of basic loss per share calculation once there are no further vesting conditions or contingencies associated with them, as they are considered issuable shares. Basic net loss per share is computed using the weighted average number of ordinary shares outstanding and the Penny Stock during the reporting periods. Diluted net loss per share is computed using the weighted average number of ordinary shares and dilutive potential ordinary shares outstanding and the Penny Stock during the reporting periods.
For the years ended March 31, 2022 and 2023, assumed share options have not been reflected in the dilutive calculations pursuant to ASC 260, “Earnings Per Share,” due to the anti-dilutive effect.
The following ordinary shares equivalent were excluded from the computation of diluted net loss per ordinary share for the periods presented because including them would have had an anti-dilutive effect:
 
    
Year Ended

March 31, 2021
    
Year Ended

March 31, 2022
    
Year Ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Share options - weighted average
     2,585,103        719,437        591,418  
XML 56 R34.htm IDEA: XBRL DOCUMENT v3.23.2
Related party transactions
12 Months Ended
Mar. 31, 2023
Related Party Transactions [Abstract]  
Related party transactions
28.
Related party transactions
The table below sets forth the major related parties and their relationships with the Company as of March 31, 2021, 2022 and 2023:
 
Name of related parties
  
Relationship with the Company
Nanjing Animal Pharmaceutical    An equity investee of the Company
Wuhan Chunzhijin    An equity investee of the Company
Weishi Network    An equity investee of the Company
Beijing Petdog    An available-for-sale debt investee that the Company has significant influence
Shanghai Guangcheng Information Technology (limited partnership) (“Shanghai Guangcheng Information”)    A company with a common director of the Company
MERCHANT TYCOON LIMITED    A shareholder of the Company
SUPERB ORIGIN INTERNATIONAL LIMITED    A shareholder of the Company
Yingzhi (Lisa) Tang    Senior management of the Company
Yan Jiang    Senior management of the Company
Di (Jackie) Chen    Senior management of the Company until July, 2021
Ying (Christina) Zhang    Senior management of the Company until February, 2022
Fei Wang    Senior management of the Company until April, 2022
Lijun Zhou    Senior management of the Company until April, 2022
 
 
Details of related party transactions are as follows:
 
    
Year Ended

March 31, 2021
    
Year Ended

March 31, 2022
    
Year Ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Online marketing and information services
        
Beijing Petdog
     410        —          —    
Weishi Network
     —          19        —    
  
 
 
    
 
 
    
 
 
 
     410        19        —    
  
 
 
    
 
 
    
 
 
 
Purchase of merchandise
        
Weishi Network
     —          1,582        —    
Nanjing Animal Pharmaceutical
     250        1,020        1,402  
  
 
 
    
 
 
    
 
 
 
     250        2,602        1,402  
  
 
 
    
 
 
    
 
 
 
 
    
Year Ended

March 31, 2021
    
Year Ended

March 31, 2022
    
Year Ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Loans granted to related parties
        
Shanghai Guangcheng Information (a)
     —          33,395        —    
Wuhan Chunzhijin (b)
     5,690        2,600        2,720  
MERCHANT TYCOON LIMITED
     —          —          100  
Yingzhi (Lisa) Tang
     —          1,750        —    
Lijun Zhou
     —          300        —    
Yan Jiang
     200        70        —    
Nanjing Animal Pharmaceutical (c)
     500        —          —    
Fei Wang
     500        —          —    
  
 
 
    
 
 
    
 
 
 
     6,890        38,115        2,820  
  
 
 
    
 
 
    
 
 
 
 
 
  (a)
In April 2021, the Company granted Shanghai Guangcheng Information a short-term loan with a total principal amount of RMB33.4 million (equivalent to USD5 million), bearing an interest rate of
3.5
% per annum. The loan was fully repaid by March 31, 2022.
  (b)
The Company entered into a loan agreement with Wuhan Chunzhijin to provide Wuhan Chunzhijin with an interest-free loan of up to 10 million, which will be repaid on demand. In March 2023, the company converted RMB3.4 million loan to Wuhan Chunzhijin into equity interest. (Detail refer to Note 11)
  (c)
In December 2019, Nanjing Xingmu, one of the Company’s subsidiaries, entered into a twelve-month interest free loan agreement with Nanjing Agricultural Pharmaceutical for a principal amount of RMB1 million. This loan was early repaid in May 2020. In June 2020, Nanjing Xingmu entered into another twelve-month interest free loan agreement with Nanjing Agricultural Pharmaceutical for a principal amount of RMB0.5 million. The loan was repaid in June 2021.
 
    
Year Ended

March 31, 2021
    
Year Ended

March 31, 2022
    
Year Ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Staff advances
        
Yingzhi (Lisa) Tang
     10        —          —    
  
 
 
       
Advances provided to related parties
        
SUPERB ORIGIN INTERNATIONAL LIMITED
     —          —          5,497  
Nanjing Animal Pharmaceutical
     2,073        —          350  
  
 
 
    
 
 
    
 
 
 
     2,073        —          5,847  
  
 
 
    
 
 
    
 
 
 
Loans granted from related parties
        
Shanghai Guangcheng Information (a)
     —          9,961        —    
  
 
 
    
 
 
    
 
 
 
 
  (a)
In April 2021, the Company obtained a total loan facility up to USD5 million from Shanghai Guangcheng Information. During the year ended March 31, 2022, the Company drew down a total amount of USD1.5 million (equivalent to RMB10.0 million) from the loan facility, with interest bearing at 3.5% per annum. The loan was fully repaid by March 31, 2022.
 
 
Details of related party balances are as follows:
Amounts due from related parties
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Prepayments to related parties
                 
SUPERB ORIGIN INTERNATIONAL LIMITED
     —          5,497  
Nanjing Animal Pharmaceutical
     1,650        2,000  
Weishi Network
     1,582        1,582  
    
 
 
    
 
 
 
       3,232        9,079  
    
 
 
    
 
 
 
Other receivables from related parties
                 
Wuhan Chunzhijin
     7,594        2,988  
    
 
 
    
 
 
 
Loans to related parties
                 
Yan Jiang
     200        200  
Fei Wang (
a
)
     500        —    
Lijun Zhou
     200        —    
MERCHANT TYCOON LIMITED
     —          100  
    
 
 
    
 
 
 
       900        300  
    
 
 
    
 
 
 
 
(
a
)
In January 2021, the Company entered into a one-year loan agreement with Fei Wang, for a principal amount of RMB0.5 million, bearing an interest rate of 4% per annum. This loan was pledged by 515,000 stock options owned by Fei Wang. In December 2022, the loan contract was renewed to December 2023 and was recorded as prepayments and other current assets as of March 31, 2023.
Amounts due to related parties
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Trade payables to related parties
                 
Nanjing Animal Pharmaceutical
     219        471  
    
 
 
    
 
 
 
XML 57 R35.htm IDEA: XBRL DOCUMENT v3.23.2
Commitments and contingencies
12 Months Ended
Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
 
29.
Commitments and contingencies
 
(a)
Capital commitments
The Company’s capital commitments primarily relate to commitments on leasehold improvement and purchase of equipment. As of March 31, 2022 and 2023, no capital commitment was related to leasehold improvement and purchase of equipment.
 
(b)
Contingencies
The Company is subject to legal proceedings and regulatory actions in the ordinary course of business. The results of such proceedings cannot be predicted with certainty, but the Company does not anticipate that the final outcome arising out of any such matter will have a material adverse effect on our consolidated financial position, cash flows or results of operations on an individual basis or in the aggregate. As of March 31, 2022 and 2023, the Company is not a party to any material legal or administrative proceedings.
XML 58 R36.htm IDEA: XBRL DOCUMENT v3.23.2
Subsequent events
12 Months Ended
Mar. 31, 2023
Subsequent Events [Abstract]  
Subsequent events
 
30.
Subsequent events
In April 2023, the Company and Nanjing Animal Pharmaceutical signed the Convertible Debt Release Agreement, in which Nanjing Animal Pharmaceutical would redeem part of the convertible debts from the Company. According to the agreement, Nanjing Animal Pharmaceutical repaid the Company the principal amount of RMB6 million, interest of RMB0.84 million, and an additional compensation of RMB1.06 million in April 2023.
XML 59 R37.htm IDEA: XBRL DOCUMENT v3.23.2
Restricted net assets
12 Months Ended
Mar. 31, 2023
Receivables [Abstract]  
Restricted net assets
 
31.
Restricted net assets
The Company’s ability to pay dividends may depend on the Company receiving distributions of funds from the Company’s subsidiaries and the VIEs incorporated in the PRC. Relevant PRC statutory laws and regulations permit payments of dividends by the Company’s PRC subsidiaries only out of their retained earnings, if any, as determined in accordance with PRC accounting standards and regulations. The results of operations reflected in the consolidated financial statements prepared in accordance with US GAAP differ from those reflected in the statutory financial statements of the Company’s PRC subsidiary.
In accordance with the Company law of the PRC, a domestic enterprise is required to provide statutory reserves of at least 10% of its annual
after-tax
profit until such reserve has reached 50% of its respective registered capital based on the enterprise’s PRC statutory accounts. A domestic enterprise is also required to provide discretionary surplus reserve, at the discretion of the Board of Directors, from the profits determined in accordance with the enterprise’s PRC statutory accounts. The aforementioned reserves can only be used for specific purposes and are not distributable as cash dividends. The Company’s PRC subsidiaries were established as domestic invested enterprises and therefore are subject to the above mentioned restrictions on distributable profits.
For the years ended March 31, 2021, 2022 and 2023, appropriation to statutory reserves was made because two PRC subsidiaries had generated profits for these periods.
As a result of these PRC laws and regulations subject to the limit discussed above that require annual appropriations of 10% of
after-tax
income to be set aside, prior to payment of dividends, as general reserve fund, the Company’s PRC subsidiaries are restricted in their ability to transfer a portion of their net assets to the Company.
Foreign exchange and other regulations in the PRC further restrict the Company’s PRC subsidiaries from transferring funds to the Company in the form of dividends, loans and advances.
As of March 31, 2023, the total restricted net assets of the Company’s subsidiaries and the VIEs incorporated in the PRC and subjected to restriction amounted to nil.
 
 
 
Rules
12-04(a)
and
4-08(e)(3)
of Regulation
S-X
require condensed financial information as to the financial position, cash flows and results of operations of a parent company as of and for the same periods for which the audited consolidated financial statements have been presented when the restricted net assets of the consolidated and unconsolidated subsidiaries together exceed 25% of consolidated net assets as of the end of the most recently completed fiscal year. The Company performed a test on the restricted net assets of consolidated subsidiaries in accordance
S-X
Rule4-08
(e)(3) and concluded that it was not applicable for the Company to disclose the financial statements for the parent company since the 25% threshold was not met for the year ended March 31, 2023.
XML 60 R38.htm IDEA: XBRL DOCUMENT v3.23.2
Principal Accounting Policies (Policies)
12 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Basis of preparation
(a) Basis of preparation
The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”). Significant accounting policies followed by the Company in the preparation of the accompanying consolidated financial statements are summarized below.
Basis of consolidation
(b) Basis of consolidation
The Company’s consolidated financial statements include the financial statements of the Company, its subsidiaries, the consolidated VIEs and VIEs’ subsidiaries for which the Company is the primary beneficiary.
A subsidiary is an entity in which the Company, directly or indirectly, controls more than one half of the voting power, has the power to appoint or remove the majority of the members of the board of directors, to cast a majority of votes at the meeting of the board of directors or to govern the financial and operating policies of the investee under a statute or agreement among the shareholders or equity holders.
A consolidated VIE is an entity in which the Company, or its subsidiaries, through Contractual Agreements, bears the risks of, and enjoys the rewards normally associated with, ownership of the entity, and therefore the Company or its subsidiaries are the primary beneficiary of the entity.
All transactions and balances among the Company, its subsidiaries, the consolidated VIEs and VIEs’ subsidiaries have been eliminated upon consolidation
.
Business combination and non-controlling interests
(c) Business combination and
non-controlling
interests
The Company accounts for its business combinations using the acquisition method of accounting in accordance with Accounting Standards Codification (“ASC”) 805,
Business Combinations
. The cost of an acquisition is measured as the aggregate of the acquisition date fair values of the assets transferred and liabilities incurred by the Company to the sellers and equity instruments issued. Transaction costs directly attributable to the acquisition are expensed as incurred. Identifiable assets and liabilities acquired or assumed are measured separately at their fair values as of the acquisition date, irrespective of the extent of any
non-controlling
interests. The excess of (i) the total costs of acquisition, fair value of the
non-controlling
interests and acquisition date fair value of any previously held equity interest in the acquiree over (ii) the fair value of the identifiable net assets of the acquiree is recorded as goodwill. If the cost of acquisition is less than the fair value of the net assets of the subsidiary acquired, the difference is recognized directly in the consolidated statements of loss and comprehensive loss as a bargain purchase gain. During the measurement period, which can be up to one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill or bargain purchase gain. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the consolidated statements of loss and comprehensive loss.
In a business combination achieved in stages, the Company
re-measures
the previously held equity interest in the acquiree immediately before obtaining control at its acquisition-date fair value and the
re-measurement
gain or loss, if any, is recognized in the consolidated statements of loss and comprehensive loss.
When there is a change in ownership interests or a change in contractual arrangements that results in a loss of control of a subsidiary or consolidated VIE, the Company deconsolidates the subsidiary or consolidated VIE from the date control is lost. Any retained
non-controlling
investment in the former subsidiary or consolidated VIE is measured at fair value and is included in the calculation of the gain or loss upon deconsolidation of the subsidiary or consolidated VIE.
For the Company’s consolidated subsidiaries, VIEs and VIEs’ subsidiaries,
non-controlling
interests are recognized to reflect the portion of their equity that is not attributable, directly or indirectly, to the Company as the controlling shareholder.
Non-controlling
interests are classified as a separate line item in the equity section of the Company’s consolidated balance sheets and have been separately disclosed in the Company’s consolidated statements of loss and comprehensive loss to distinguish the interests from that of the Company.
Use of estimates
(d) Use of estimates
The preparation of the Company’s consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.
The Company believes that assessment for impairment of long-lived assets and valuation of
available-for-sale
debt securities require significant judgments and estimates used in the preparation of its consolidated financial statements.
Management bases the estimates on historical experience and on various other assumptions as discussed elsewhere to the consolidated financial statements that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. On an ongoing basis, management evaluates its estimates based on information that is currently available. Changes in circumstances, facts and experience may cause the Company to revise its estimates. Changes in estimates are recorded in the period in which they become known. Actual results could materially differ from these estimates.
Functional currency and foreign currency translation
(e) Functional currency and foreign currency translation
The Company’s reporting currency is Renminbi (“RMB”). The functional currency of the Company’s entities incorporated in Cayman Islands, British Virgin Islands and Hong Kong is the United States dollars (“US$”). The Company’s PRC subsidiaries, consolidated VIEs and VIEs’ subsidiaries determined their functional currency to be RMB. The determination of the respective functional currency is based on the criteria of ASC 830,
Foreign Currency Matters
.
Transactions denominated in other than the functional currencies are translated into the functional currency of the entity at the exchange rates prevailing on the transaction dates. Financial assets and liabilities denominated in other than the functional currency are translated at the balance sheet date exchange rate. The resulting exchange differences are included in the consolidated statements of loss and comprehensive loss as other gains, net.
The financial statements of the Company are translated from the functional currency into RMB. Assets and liabilities denominated in foreign currencies are translated into RMB using the applicable exchange rates at the balance sheet date. Equity accounts other than earnings generated in current period are translated into RMB at the appropriate historical rates. Revenues, expenses, gains and losses are translated into RMB using the periodic average exchange rates. The resulting foreign currency translation adjustments are recorded in accumulated other comprehensive loss as a component of shareholders’ equity.
The exchange rates used for translation on March 31, 2022 and 2023 were US$1.00= RMB 6.3482 and RMB 6.8717, respectively, representing the index rates stipulated by the People’s Bank of China.
Convenience translation
(f) Convenience translation
Translations of the consolidated balance sheets, the consolidated statements of loss and comprehensive loss and the consolidated statements of cash flows from RMB into US$ as of and for the year ended March 31, 2023 are solely for the convenience of the readers and were calculated at the rate of US$1.00=RMB 6.8676, representing the certificated exchange rate published by the Federal Reserve Board. No representation is made that the RMB amounts could have been, or could be, converted, realized or settled into US$ at that rate on March 31, 2023, or at any other rate.
Fair value of financial instruments
(g) Fair value of financial instruments
Accounting guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and it considers assumptions that market participants would use when pricing the asset or liability.
 
 
The established fair value hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
The three levels of inputs that may be used to measure fair value:
Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2: Observable, market-based inputs, other than quoted prices, in active markets for identical assets or liabilities.
Level 3: Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.
Accounting guidance also describes three main approaches to measuring the fair value of assets and liabilities: (1) market approach; (2) income approach and (3) cost approach. The market approach uses prices and other relevant information generated from market transactions involving identical or comparable assets or liabilities. The income approach uses valuation techniques to convert future amounts to a single present value amount. The measurement is based on the value indicated by current market expectations about those future amounts. The cost approach is based on the amount that would currently be required to replace an asset.
Financial assets and liabilities of the Company mainly consist of cash and cash equivalents, short-term investments, accounts receivable, amounts due from related parties, prepayments and other current assets,
available-for-sale
debt investments, accounts payable, short-term borrowings, derivative liabilities, accrued liabilities and other current liabilities, amounts due to related parties, and other debts.
As of March 31, 2022 and 2023, except for
available-for-sale
debt investments and derivative liabilities, carrying values of cash and cash equivalents, short-term investments, accounts receivable, amounts due from related parties, certain prepayments and other current assets, accounts payable, short-term borrowings, certain accrued liabilities and other current liabilities, amounts due to related parties and current portion of other debts approximated their fair values reported in the consolidated balance sheets due to the short-term maturities of these instruments. The carrying value of long-term loan receivable, long-term borrowings and
non-current
portion of other debts approximated their fair values as of March 31, 2022 and 2023 as the interest rates and credit risk they bear reflect the current market yield for comparable instruments. The Company reports derivative liabilities at fair value at each balance sheet date and change in fair value is reflected in “Fair value change of derivative liabilities” in the consolidated statements of loss and comprehensive loss. The Company reports
available-for-sale
debt investments at fair value at each balance sheet date with the aggregate unrealized gains and losses, net of tax, reflected in “Accumulated other comprehensive loss” in the consolidated balance sheets.
Cash and cash equivalents
(h) Cash and cash equivalents
Cash and cash equivalents include cash on hand and time deposits placed with banks and third party payment processors, which are unrestricted as to withdrawal or use, have original maturities of three months or less at the time of purchase and are readily convertible to known amounts of cash.
Short-term investments
(i) Short-term investments
Short-term investments comprise primarily of (i) cash deposits at fixed rates with original maturities of greater than three months, but less than 12 months and; (ii) the investments issued by commercial banks or other financial institutions with a variable interest rate indexed to the performance of underlying assets within one year. As of March 31, 2022 and 2023, RMB128 million and RMB70 million short-term investments were used as collateral of RMB111 million and RMB64 million short-term borrowings, respectively.
Accounts receivable, net
(j) Accounts receivable, net
Accounts receivable are presented net of allowance for doubtful accounts. The Company maintains an allowance for doubtful accounts which reflects its best estimate of amounts that potentially will not be collected. The Company determines the allowance for doubtful accounts on general basis taking into consideration various factors including but not limited to historical collection experience and credit-worthiness of the customers as well as the age of the individual receivables balance. Additionally, the Company makes specific bad debt provisions based on any specific knowledge the Company has acquired that might indicate that an account is uncollectible. The facts and circumstances of each account may require the Company to use substantial judgment in assessing its collectability.
Inventories
(k) Inventories
Inventories are stated at the lower of cost and net realizable value. Cost elements of our inventories comprise the purchase price of products, vendor rebates, shipping charges to receive products from the suppliers when they are embedded in the purchase price. Cost is determined using the
first-in
first-out
method. Provisions are made for excessive, slow moving, expired and obsolete inventories as well as for inventories with carrying values in excess of market. Certain factors could impact the realizable value of inventory, so the Company continually evaluates the recoverability based on assumptions about customer demand and market conditions. The evaluation may take into consideration historical usage, inventory aging, expiration date, expected demand, anticipated sales price, new product development schedules, the effect new products might have on the sale of existing products, product obsolescence, customer concentrations, and other factors. The reserve or write-down is equal to the difference between the cost of inventory and the estimated net realizable value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than those projected by management, additional inventory reserves or write-downs may be required that could negatively impact the Company’s gross margin and operating results. If actual market conditions are more favorable, the Company may have higher gross margin when products that have been previously reserved or written down are eventually sold.
Property and equipment, net
(l) Property and equipment, net
Property and equipment are carried at cost less accumulated depreciation and amortization. Depreciation is calculated on a straight-line basis over the following estimated useful lives.
The estimated useful lives are as follows:
 
    
Useful years
Warehouse equipment    3 - 5 years
Furniture, computer and office equipment    3 - 5 years
Vehicles    5 years
Software    10 years
Leasehold improvements    Over the shorter of the expected life of leasehold improvements or the lease term
Expenditures for maintenance and repairs are expensed as incurred. The gain or loss on the disposal of property and equipment is the difference between the net sales proceeds and the carrying amount of the relevant assets and is recognized in the consolidated statements of loss and comprehensive loss.
Intangible assets, net
 
(m) Intangible assets, net
Intangible assets purchased from third parties are initially recorded at cost. The Company performs valuation of the intangible assets arising from business combinations to determine the relative fair value to be assigned to each asset acquired. The intangible assets are amortized using the straight-line method over the estimated useful lives of the assets.
The estimated useful lives of intangible assets are as follows:
 
    
Useful years
Trademark    10 years
Dealership    10 years
License    4.5 years
The estimated life of amortized intangibles is reassessed if circumstances occur that indicate the life has changed.
Goodwill
(n) Goodwill
Goodwill represents the excess of the purchase price over the fair value of the identifiable assets and liabilities acquired in a business combination. Goodwill is not amortized but is tested for impairment on an annual basis as of March 31, and in between annual tests when an event occurs or circumstances change that could indicate that the asset might be impaired.
In accordance with ASU
No. 2017-04,
“Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment” (“ASU
2017-04”),
which removes the requirement to compare the implied fair value of goodwill with its carrying amount as part of step 2 of the goodwill impairment test. Management conducts its goodwill impairment assessment as of March 31 annually or more frequently if events or changes in circumstances indicate that it may be impaired. The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill, so as to perform the quantitative goodwill impairment test. If determined to be necessary, the quantitative impairment test is used to identify goodwill impairment by comparing the fair value of a reporting unit with its carrying amount and recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. The loss recognized should not exceed the total amount of goodwill allocated to that reporting unit.
As there is only one reporting unit in the Company, the goodwill assessment was performed for the Company on consolidated level as one reporting unit.
Long-term investments
(o) Long-term investments
The Company’s investments include equity method investments, equity securities with readily determinable fair values and
available-for-sale
debt securities.
The Company applies the equity method of accounting to account for an equity investment, in common stock or
in-substance
common stock, according to ASC 323 “Investment—Equity Method and Joint Ventures”, over which it has significant influence but does not own a majority equity interest or otherwise control. Under the equity method, the Company’s share of the post-acquisition profits or losses of the equity investees are recorded in share of results of equity investees in the consolidated statements of loss and comprehensive loss. The excess of the carrying amount of the investment over the underlying equity in net assets of the equity investee, if any, represents goodwill and intangible assets acquired. When the Company’s share of losses in the equity investee equals or exceeds its interest in the equity investee, the Company does not recognize further losses, unless the Company has incurred obligations or made payments or guarantees on behalf of the equity investee.
Equity securities with readily determinable fair values are measured and recorded at fair value on a recurring basis with changes in fair value, whether realized or unrealized, recorded through the income statement.
 
Debt securities that the Company has the intent to hold the security for an indefinite period or may sell the security in response to the changes in economic conditions are classified as
available-for-sale
debt securities and reported at fair value. Unrealized gains and losses (other than impairment losses) are reported, net of the related tax effect, in other comprehensive income (loss). Upon sale, realized gains and losses are reported in net income (loss).
The Company continually reviews its investments to determine whether a decline in fair value to below the carrying value is other-than-temporary. The primary factors the Company considers in its determination are the duration and severity of the decline in fair value; the financial condition, operating performance and the prospects of the equity investee; and other company specific information such as recent financing rounds. If the decline in fair value is deemed to be other-than-temporary, the carrying value of the investment is written down to fair value.
Impairment of long-lived assets other than goodwill
(p) Impairment of long-lived assets other than goodwill
Long-lived assets (including property and equipment and amortizable intangible assets) are evaluated for impairment whenever events or changes in circumstances (such as a significant adverse change to market conditions that will impact the future use of the assets) indicate that the carrying amount may not be fully recoverable or that the useful life is shorter than the Company had originally estimated. When these events occur, the Company evaluates the impairment by comparing carrying value of the assets to an estimate of future undiscounted cash flows expected to be generated from the use of the assets and their eventual disposition. If the sum of the expected future undiscounted cash flows is less than the carrying value of the assets, the Company recognizes an impairment loss based on the excess of the carrying value of the assets over the fair value of the assets. No impairment charges were recognized for the years ended March 31, 2021, 2022 and 2023.
Revenue recognition
(q) Revenue recognition
In May 2014, the FASB issued ASU
No. 2014-09,
“Revenue from Contracts with Customers (Topic 606)” (“ASU
2014-09”)
and subsequently, the FASB issued several amendments which amends certain aspects of the guidance in ASC
2014-09
(ASU
No. 2014-09
and the related amendments are collectively referred to as “ASC 606”). According to ASC 606, revenue is recognized when control of the promised good or service is transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services.
Consistent with the criteria of Topic 606, the Company follows five steps for its revenue recognition: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the entity satisfies a performance obligation. Revenue arrangements with multiple performance obligations are divided into separate distinct goods or services. The Company allocates the transaction price to each performance obligation based on the relative standalone selling price of the goods or services provided. The Company’s revenues are primarily derived from (i) product sales and (ii) online marketing and information services and other revenue.
When either party to a contract has performed, the Company presents the contract in the statement of financial position as a contract asset or a contract liability, depending on the relationship between the entity’s performance and the customer’s payment. A receivable is recorded when the Company has an unconditional right to consideration. A right to consideration is unconditional if only the passage of time is required before payment of that consideration is due. A contract asset is recorded when the Company has transferred products or services to the customer before payment is received or is due, and the Company’s right to consideration is conditional on future performance or other factors in the contract. No contract asset was recorded as of March 31, 2022 and 2023. The Company’s contract liabilities consist of payments received or awards to customers (in the form of Boqii Beans) related to unsatisfied performance obligations at the end of the period. As of April 1, 2021 and 2022, the Company’s total contract liabilities were RMB3.9 million and RMB7.0 million, respectively, of which RMB3.6 million and RMB3.0 million were recognized as revenue for the years ended March 31, 2022 and 2023. The Company’s total unearned revenue was RMB4.5 million as of March 31, 2023.
Revenue is recorded net of value-added tax.
 
 
Revenue recognition policies for each type of revenue steam are as follows:
Sales of merchandise
The Company primarily sells pet products through online stores to individual online customers. Besides online sales, the Company also sells products through offline channels to its business customers and pet stores across the country. The Company recognizes the product revenues from products sales on a gross basis as the Company is acting as a principal in these transactions. The Company has obtained control of the products before they are transferred to customers. The Company is primarily obligated in these transactions, is subject to inventory risk or has the ability to direct the use of inventory, and has latitude in establishing prices and selecting suppliers. Revenue is recognized when consumers physically accept the products after delivery, which is when the control of products is transferred, and is recorded net of return allowances and rebates to pet stores.
The Company also enters into arrangements with its business partners to sell their products on the Company’s online stores. The Company considers the arrangements meet the indicators of consignment arrangement under ASC
606-10-55-80,
because (i) the business partners do not relinquish control of the products, even though the Company has physical possession of the goods. The Company does not control the underlying products, which are considered to be the business partners’ inventory until they are sold to the end consumers; (ii) the business partner retains the right to require the return of the goods held by the Company; (iii) the Company has no obligation to pay for the products that are in its physical possession; and (iv) the Company has no discretion in establishing prices of the products provided by its business partners. Upon successful sales, the Company will charge the business partners a negotiated amount or a fixed rate commission fee based on the sales amount. Commission revenues are recognized on a net basis at the point of consumers’ acceptance of products, net of return allowance.
Online marketing and information services and other revenue
The Company provides online marketing and information services to third-parties on the Company’s various channels and third-party platforms, including but not limited to advertising placements, organizing online and offline marketing campaigns featuring social media influencers and circulating marketing messages to end consumers. With respect to the Company’s marketing services, length of the periods over which services are provided are generally within months or less, revenue from such arrangements is recognized ratably over the service period, as the third-party simultaneously consumes the benefits when the advertisement is displayed or the campaign is ongoing.
The Company also provides warehouse services. The warehouse services include warehousing, packaging, dispatching and other services. Revenue is primarily recognized when the services are rendered.
Sales returns
(r) Sales returns
The Company offers online consumers an unconditional right of return for a period of seven days upon receipt of products. Return allowances, which reduce revenue and cost of sales, are estimated by categories of return policies offered to online customers, based on historical data the Company has maintained, and subject to adjustments to the extent that actual returns differ or are expected to differ.
Sales incentives
(s) Sales incentives
The Company adopted a customer reward program, under which the Company grants certain units (“Boqii Bean”) to its customers at its discretion in different situations. Boqii Beans are not redeemable for cash and can be used as a coupon for the customer’s future purchase on the Boqii Marketplace and Boqii.com. The value of ten units of Boqii Bean is equivalent to one RMB yuan before taking into account the impact of breakage.
 
 
For the Boqii Beans that are granted with concurrent revenue transactions, the allocated transaction price based on its relative standalone selling price are recognized as reduction of the revenue and accrued for as contract liabilities. As customers redeem awards, the accrued liability is reduced correspondingly. For the Boqii Beans that are granted without concurrent revenue transactions, they are not accounted for when granted and are recognized as a reduction of revenue when they are applied in future sales.
The Company also has a coupon program, through which the Company grants coupons to online customers when they make a successful purchase order, finish first registration on Boqii Marketplace or comment on products. When a coupon is granted concurrent with a revenue transaction, the Company accounts for the estimated cost of future usage of the coupon as reduction of the revenue. When a coupon is not granted concurrent with a revenue transaction, they are not accounted for when they are granted and are recognized as a reduction of revenue when they are applied in future sales.
Cost of revenue
(t) Cost of revenue
Cost of revenue consist of cost of product sales of RMB820.3 million, RMB930.4 million and RMB842.7 million for the years ended March 31, 2021, 2022 and 2023, respectively, and cost of services of RMB3.4million, RMB13.3million and RMB15.9
 million for the years ended March 31, 2021, 2022 and 2023, respectively. Cost of product sales comprise the purchase price of products, vendor rebates and inventory write-downs. Cost of products does not include other costs such as shipping and handling expense, payroll and benefits of logistic staff, and logistic centers rental expenses. Cost of service consists of the advertising and promotion costs, employee wages and benefits in connection with the Company’s provision of marketing and information services including the fees that the Company paid to third-parties for advertising and promotion on various online and offline channels. 
Vendor rebates
(u) Vendor rebates
The Company periodically receives consideration from certain vendors, representing rebates for products sold over a period of time. The Company accounts for the rebates received from its vendors as a reduction to the price it pays for the products purchased. Rebates are earned based on reaching minimum purchased thresholds for a specified period. When volume rebates can be reasonably estimated based on the Company’s past experience, current forecasts and purchase volume, a portion of the rebate is recognized as the Company makes progress towards the purchase threshold.
Fulfillment expenses
(v) Fulfillment expenses
Fulfillment costs primarily represent warehousing, shipping and handling expenses for dispatching and delivering products to consumers, employee wages and benefits for the relevant personnel, customs clearance expenses and other related transaction costs.
Sales and marketing expenses
(w) Sales and marketing expenses
Sales and marketing expenses comprise primarily of advertising expenses, third-party platforms commission fee, employee wages, rental expenses and benefits for sales and marketing staff, depreciation expenses and other daily expenses which are related to the sales and marketing functions.
Advertising expenses consist primarily of customer acquisition cost and costs for the promotion of corporate image and product marketing. The Company expenses all advertising costs as incurred and classifies these costs under sales and marketing expenses. For the years ended March 31, 2021, 2022 and 2023, the advertising expenses were RMB83 million, RMB81 million and RMB44 million, respectively.
General and administrative expenses
(x) General and administrative expenses
General and administrative expenses consist of employee wages and benefits for corporate employees, research and development expenses and other expenses which are related to the general corporate functions, including accounting, finance, tax, legal and human resources, costs associated with use by these functions of facilities and equipment, such as depreciation expenses, rental and other general corporate related expenses. For the years ended March 31, 2021, 2022 and 2023, the research and development were RMB14.1 million, RMB11.3 million and RMB3.7 million, respectively.
Leases
(y) Leases
The Company applied ASC 842, “Leases”, by using the optional transition method at the adoption date without recasting comparative periods. The Company determines if an arrangement is a lease at inception. Operating leases are primarily for office and warehouse space and are included in operating lease
right-of-use
(“ROU”) assets, operating lease liabilities, current and operating lease liabilities,
non-current
on its consolidated balance sheets.
ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. When determining the lease term, the Company includes options to extend or terminate the lease when it is reasonably certain that it will exercise that option, if any. As the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate, which it calculates based on the credit quality of the Company and by comparing interest rates available in the market for similar borrowings, and adjusting this amount based on the impact of collateral over the term of each lease. Lease expense for lease payments is recognized on a straight-line basis over the lease term.
For operating leases with a term of one year or less, the Company has elected to not recognize a lease liability or ROU asset on its consolidated balance sheet. Instead, it recognizes the lease payments as expense on a straight-line basis over the lease term. Short-term lease costs are immaterial to its consolidated statements of loss and comprehensive loss and cash flows.
Government grants
(z) Government grants
The Company’s PRC based subsidiaries received government subsidies from certain local governments. The government subsidies are granted from time to time at the discretion of the relevant government authorities. These subsidies are granted for general corporate purposes and to support the Group’s ongoing operations in the region Cash subsidies are recorded in other income, net on the consolidated statements of loss and comprehensive loss when received and when all conditions for their receipt have been satisfied. The Group recognized government subsidies of RMB1.1 million, RMB0.2 million and RMB0.3 million for the years ended December 31, 2021, 2022 and 2023, respectively.
Income taxes
(aa) Income taxes
Current income taxes are recorded in accordance with the regulations of the relevant tax jurisdiction. The Company accounts for income taxes under the asset and liability method in accordance with ASC 740,
Income Tax
. Under this method, deferred tax assets and liabilities are recognized for the tax consequences attributable to differences between carrying amounts of existing assets and liabilities in the financial statements and their respective tax basis, and operating loss carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred taxes of a change in tax rates is recognized in the consolidated statements of loss and comprehensive loss in the period of change. Valuation allowances are established when necessary to reduce the amount of deferred tax assets if it is considered more likely than not that amount of the deferred tax assets will not be realized.
 
Uncertain tax positions
The Company recognizes in its consolidated financial statements the benefit of a tax position if the tax position is “more likely than not” to prevail based on the facts and technical merits of the position. Tax positions that meet the “more likely than not” recognition threshold are measured at the largest amount of tax benefit that has a greater than fifty percent likelihood of being realized upon settlement. The Company estimates its liability for unrecognized tax benefits which are periodically assessed and may be affected by changing interpretations of laws, rulings by tax authorities, changes and/or developments with respect to tax audits, and expiration of the statute of limitations. The ultimate outcome for a particular tax position may not be determined with certainty prior to the conclusion of a tax audit and, in some cases, appeal or litigation process. The actual benefits ultimately realized may differ from the Company’s estimates. As each audit is concluded, adjustments, if any, are recorded in the Company’s consolidated financial statements in the period in which the audit is concluded. Additionally, in future periods, changes in facts, circumstances and new information may require the Company to adjust the recognition and measurement estimates with regard to individual tax positions. Changes in recognition and measurement estimates are recognized in the period in which the changes occur. As of March 31, 2022 and 2023, the Company did not have any material unrecognized uncertain tax positions.
Share-based compensation
(ab) Share-based compensation
The Company follows ASC 718 to determine whether a share option should be classified and accounted for as a liability award or equity award. All grants of share-based awards to employees, management and nonemployees classified as equity awards are recognized in the financial statements based on their grant date fair values which are calculated using an option pricing model.
Employees’ share-based compensation awards are measured at the grant date fair value of the awards and recognized as expenses (a) immediately at the grant date if no vesting conditions are required; or (b) for share-based awards granted with only service conditions, using the graded vesting method, net of estimated forfeitures, over the vesting period; or (c) for share-based awards granted with service conditions and the occurrence of an initial public offering (“IPO”) as performance condition, cumulative share-based compensation expenses for the options that have satisfied the service condition should be recorded upon the completion of the IPO, using the graded vesting method.
Under ASC 718, the Company applies the Binominal option pricing model in determining the fair value of options granted. ASC 718 requires forfeiture rates to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from initial estimates. Share-based compensation expense is recorded net of estimated forfeitures such that expense is recorded only for those share-based awards that are expected to vest.
Net loss per share
(ac) Net loss per share
Basic net loss per share is computed by dividing net loss attributable to holders of ordinary shares by the weighted average number of ordinary shares outstanding during the year using the
two-class
method. Using the
two-class
method, net profit/loss is allocated between ordinary shares and other participating securities (i.e. preferred shares) based on their participating rights.
Diluted loss per share is calculated by dividing net loss attributable to ordinary shareholders as adjusted for the effect of dilutive ordinary equivalent shares, if any, by the weighted average number of ordinary and dilutive ordinary equivalents shares outstanding during the year/period. Ordinary share equivalents consist of the ordinary shares issuable in connection with the Company’s convertible redeemable preferred shares using the
if-converted
method, and ordinary shares issuable upon the conversion of the share options, using the treasury stock method. Ordinary equivalent shares are not included in the denominator of the diluted earnings per share calculation when inclusion of such shares would be anti-dilutive.
Comprehensive loss
(ad) Comprehensive loss
Comprehensive loss is defined as the changes in shareholders’ equity of the Company during a period transactions and other events and circumstances excluding transactions resulting from investments from shareholders, distributions to shareholders, accretions on convertible redeemable preferred shares and modification and extinguishment of convertible redeemable preferred shares. Comprehensive loss for the periods presented includes net loss, foreign currency translation adjustments and unrealized securities holding gains (losses).
Segment reporting
(ae) Segment reporting
ASC 280,
Segment Reporting
, establishes standards for companies to report in their financial statements information about operating segments, products, services, geographic areas, and major customers.
Based on the criteria established by ASC 280, the Company’s chief operating decision maker (“CODM”) has been identified as the Chief Executive Officer, who reviews consolidated results when making decisions about allocating resources and assessing performance of the Company. As a whole and hence, the Company has only one reportable segment. The Company does not distinguish between markets or segments for the purpose of internal reporting. As the Company’s long-lived assets are substantially located in the PRC and substantially all the Company’s revenue are derived from within the PRC, no geographical segments are presented.
Recent accounting pronouncements
(af) Recent accounting pronouncements
The Company qualifies as an “emerging growth company”, or EGC, pursuant to the Jumpstart Our Business Startups Act of 2012, as amended, or the JOBS Act. As an EGC, the Company does not need to comply with any new or revised financial accounting standards until such date that a private company is otherwise required to comply with such new or revised accounting standards. The Company adopts the following standards based on extended transition period provided to private companies or early adopts as necessary as permitted by the respective standards.
New and Amended Standards Adopted by the Company:
In August 2020, the FASB issued ASU
2020-06,
“Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic
815-40),”
which removes certain separation models for convertible debt instruments and convertible preferred stock that require the separation of a convertible debt instrument into a debt component and an equity or derivative component. The ASU also expands disclosure requirements for convertible instruments and simplifies areas of the guidance for diluted
earnings-per-share
calculations that are impacted by the amendments. The standard is effective for interim and annual periods beginning after December 15, 2021, with early adoption permitted. The adoption of this standard did not have a material impact on the Company’s disclosures.
New and amended standards not yet adopted by the Company:
In June 2016, the FASB issued ASU
2016-13,
Financial Instruments—Credit Losses (Topic 326), to provide financial statement users with more useful information about expected credit losses. ASU
2016-13
also changes how entities measure credit losses on financial instruments and the timing of when such losses are recorded. The FASB further issued Accounting Standards Update No. 2019-10, “Financial Instruments-Credit Losses (Topic 326): Effective Dates,”. According to ASU 2019-10, for public business entities that are U.S. SEC filers, the amendments in this Update are effective for fiscal years beginning after December 15, 2019. For all other entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company elected to use the extended transition period for complying with any new or revised financial accounting standards. Therefore, the Company elected to adopt this new guidance for the year ended March 31, 2024, including interim periods in the year ended March 31, 2024. The Company is in the process of evaluating the impact of this accounting standard on its consolidated financial statements.
In October 2021, the FASB issued
ASU 2021-08, “Business
Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”, which require that an entity (acquirer) recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. At the acquisition date, an acquirer should account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts. The amendments in this Update also provide certain practical expedients for acquirers when recognizing and measuring acquired contract assets and contract liabilities from revenue contracts in a business combination. The standard is effective for interim and annual periods beginning after December 15, 2022, with early adoption permitted. The Company is evaluating the impact of the adoption of this guidance on its consolidated financial statements.
 
 
In March 2022, the FASB issued ASU
2022-02,
Troubled Debt Restructurings and Vintage Disclosures. This ASU eliminates the accounting guidance for troubled debt restructurings by creditors that have adopted ASU
2016-13,
Measurement of Credit Losses on Financial Instruments. This ASU also enhances the disclosure requirements for certain loan refinancing and restructurings by creditors when a borrower is experiencing financial difficulty. In addition, the ASU amends the guidance on vintage disclosures to require entities to disclose current period gross write-offs by year of origination for financing receivables and net investments in leases within the scope of ASC
326-20.
The ASU is effective for annual periods beginning after December 15, 2022, including interim periods within those fiscal years. Adoption of the ASU would be applied prospectively. The Company is evaluating the impact of the adoption of this guidance on its consolidated financial statements.
In June 2022, the FASB issued ASU
2022-03
Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. The update clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The update also clarifies that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. The update also requires certain additional disclosures for equity securities subject to contractual sale restrictions. The amendments in this update are effective for the Company beginning January 1, 2024 on a prospective basis. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is in the process of evaluating the impact of the new guidance on its consolidated financial statements.
XML 61 R39.htm IDEA: XBRL DOCUMENT v3.23.2
Organization and principal activities (Tables)
12 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Details of the Subsidiaries, VIEs and VIE's Subsidiaries
As
of March 31, 2023, the Company’s principal subsidiaries, consolidated VIEs and
major
VIEs’ subsidiaries are as follows:
 
Name of subsidiaries and VIE
 
Place of
incorporation
 
Date of
incorporation
or acquisition
 
Percentage
of direct
or indirect
 
Principal activities
Subsidiaries:
               
Boqii Corporation Limited (“Boqii Corporation”)
  Hong Kong   July 2012   100%  
Investment holding
Boqii International Limited
  Hong Kong   August 2016   100%  
Investment holding
Xingmu International Limited
  British Virgin Islands   August 2019   51%  
Investment holding
Xingmu HK Limited
  Hong Kong   November 2019   51%  
Investment holding
Nanjing Xinmu Information Technology Co., Ltd. (“Xingmu WFOE”)
  Nanjing, the PRC   November 2019   51%  
Technology development and sales of merchandise
Xincheng (Shanghai) Information Technology Co., Ltd. (“Shanghai Xincheng”)
  Shanghai, the PRC   November 2012   100%  
Technology development and sales of merchandise
Shanghai Yiqin Pets Products Co., Ltd.
  Shanghai, the PRC   February 2013   100%  
Technology development and sales of merchandise
Shanghai Every Supply Chain Co., Ltd. (“Shanghai Every”)
  Shanghai, the PRC   September 2021   100%  
Sales of merchandise
         
Consolidated VIEs
               
Guangcheng (Shanghai) Information Technology Co., Ltd. (“Guangcheng”)
  Shanghai, the PRC   November 2012   100%  
Operates the Company’s own online
e-commerce platform
Nanjing Xingmu Biotechnology Co., Ltd. (“Nanjing Xingmu”)
  Nanjing, the PRC   November 2019   51%  
Biotechnology research and development
Suzhou Taicheng Supply Chain Co., Ltd. (“Suzhou Taicheng”)
  Suzhou, the PRC   June 2021   100%   Sales of merchandise
Suzhou Xingyun Yueming Supply Chain Co., Ltd. (“Suzhou Xingyun Yueming”)
  Suzhou, the PRC   April 2022   100%  
Sales of merchandise
         
Subsidiaries of VIEs
               
Boqii (Shanghai) Information Technology Co., Ltd.
  Shanghai, the PRC   August 2014   90%  
Technology development
Tianjing Guangcheng Information Technology Co., Ltd.
  Tianjin, the PRC   June 2017   100%  
Sales of merchandise
Nanjing Cuida Biotechnology Co. Ltd.(“Cuida”)
  Nanjing, the PRC   April 2017   70%  
Biotechnology extension services
Taizhou Xingmu Biotechnology Co., Ltd.
  Taizhou, the PRC   November 2019   80%  
Biotechnology research and development
Schedule of Variable Interest Entities
The following table set forth the assets, liabilities, results of operations and changes in cash, cash equivalents and restricted cash of the consolidated VIEs and their subsidiaries taken as a whole, which were included in the Company’s consolidated financial statements with intercompany transactions eliminated (RMB in thousands):
 
    
As of March 31,
 
    
2022
    
2023
 
    
RMB
    
RMB
 
Cash and cash equivalents
     20,567        15,522  
Accounts receivable, net
     31,435        33,172  
Amounts due from related parties
     11,726        6,770  
Inventories, net
     16,014        27,894  
Prepayments and other current assets
     57,107        48,291  
Inter-company receivables
     16,535        83,700  
Property and equipment, net
     6,715        4,661  
Intangible assets
     507        101  
Operating lease
right-of-use
assets
     35,688        22,305  
Goodwill
     994        —    
Long-term investments
     81,649        75,505  
Other
non-current
asset
     3,389        5,219  
  
 
 
    
 
 
 
Total assets
     282,326        323,140  
  
 
 
    
 
 
 
 
    
As of March 31,
 
    
2022
    
2023
 
    
RMB
    
RMB
 
Short-term borrowings
     872        363  
Accounts payable
     55,144        13,459  
Amounts due to related parties, current
     4        21  
Salary and welfare payable
     5,597        5,573  
Accrued liabilities and other current liabilities
     24,417        15,712  
Contract liabilities
     7,007        4,471  
Operating lease liabilities, current
     7,238        9,207  
Inter-company payables
     945,960        1,095,452  
Operating lease liabilities,
non-current
     28,197        12,741  
Other debts,
non-current
     157,874        75,481  
  
 
 
    
 
 
 
Total liabilities
     1,232,310        1,232,480  
  
 
 
    
 
 
 
 
    
Year Ended March 31,
 
    
2021
    
2022
    
2023
 
    
RMB
    
RMB
    
RMB
 
Net revenues:
        
Third-party revenues
     735,518        877,380        786,152  
Inter-company revenues
     48,374        56,079        86,463  
  
 
 
    
 
 
    
 
 
 
Total revenues
     783,892        933,459        872,615  
Cost of revenues:
        
Third-party cost of revenues
     (372,475      (160,661      (81,810
Inter-company cost of revenues
     (297,844      (550,585      (534,518
  
 
 
    
 
 
    
 
 
 
Total cost of revenues
     (670,319      (711,246      (616,328
  
 
 
    
 
 
    
 
 
 
Gross profit
     113,573        222,213        256,287  
Operating expenses:
        
Third-party operating expenses
     (254,951      (288,291      (237,852
Inter-company operating expenses
     (7,257             (41
  
 
 
    
 
 
    
 
 
 
Total operating expenses
     (262,208      (288,291      (237,893
  
 
 
    
 
 
    
 
 
 
Impairment of goodwill
     —          —          (994
Other income, net
     1,011        98        158  
  
 
 
    
 
 
    
 
 
 
Profit/(Loss) from operations
     (147,624      (65,980      17,558  
Non-operating
expense
     (18,162      (20,680      (29
  
 
 
    
 
 
    
 
 
 
Profit/(Loss) before income tax expenses
     (165,786      (86,660      17,529  
Income tax benefits/(expenses)
     (20      681        21  
Share of results of equity investees
     (696      418        (82
  
 
 
    
 
 
    
 
 
 
Net profit/(loss)
     (166,502      (85,561      17,468  
  
 
 
    
 
 
    
 
 
 
Cash flows from operating activities:
        
Net cash provided by transactions with external parties
     419,767        526,201        471,991  
Net cash used in transactions with the Company’s entities
     (331,064      (329,325      (449,155
  
 
 
    
 
 
    
 
 
 
Net cash generated from/ (used in) operating activities
     88,703        196,876        22,836  
  
 
 
    
 
 
    
 
 
 
Cash flows from investing activities:
        
Other investing activities
     (31,972      (18,482      (9,638
Cash flows of loan funding provided to the Company’s entities, net of repayments received
     (5,242      6,294        —    
  
 
 
    
 
 
    
 
 
 
Net cash used in investing activities
     (37,214      (12,188      (9,638
  
 
 
    
 
 
    
 
 
 
Cash flows from financing activities:
        
Other financing activities
     (112,151      (273,906      (88,469
Cash flows of loan funding received from the Company’s entities, net of repayments made
     41,717        91,794        69,204  
  
 
 
    
 
 
    
 
 
 
Net cash generated from/ (used in) financing activities
     (70,434      (182,112      (19,265 )
  
 
 
    
 
 
    
 
 
 
XML 62 R40.htm IDEA: XBRL DOCUMENT v3.23.2
Principal Accounting Policies (Tables)
12 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Schedule of Property Plant and Equipment & Useful Lives
The estimated useful lives are as follows:
 
    
Useful years
Warehouse equipment    3 - 5 years
Furniture, computer and office equipment    3 - 5 years
Vehicles    5 years
Software    10 years
Leasehold improvements    Over the shorter of the expected life of leasehold improvements or the lease term
Schedule of Finite Lived Intangible Assets Useful Lives
The estimated useful lives of intangible assets are as follows:
 
    
Useful years
Trademark    10 years
Dealership    10 years
License    4.5 years
XML 63 R41.htm IDEA: XBRL DOCUMENT v3.23.2
Business combinations (Tables)
12 Months Ended
Mar. 31, 2023
Chongni network technology Co Ltd [Member]  
Business Acquisition [Line Items]  
Summary of Identified Assets Acquired and Liabilities Assumed
On the acquisition date, the allocation of the purchase price of the assets acquired and liabilities assumed based on their fair values was as follows:
 
     As of June 30, 2021  
     RMB  
Total purchase price is comprised of:
  
- fair value of 49% previously held equity interests
     245  
- cash consideration
     2,938  
  
 
 
 
Fair value of total consideration
     3,183  
  
 
 
 
 
     As of June 30, 2021  
     RMB  
Cash and cash equivalents
     2  
Prepayments and other current assets
     4,533  
  
 
 
 
Total assets
     4,535  
  
 
 
 
Accrued liabilities and other current liabilities
     (33
  
 
 
 
Total liabilities
     (33
  
 
 
 
Net assets acquired
     4,502  
  
 
 
 
Goodwill
     499  
Non-controlling
interests
     (1,818
  
 
 
 
Total
     3,183  
  
 
 
 
XML 64 R42.htm IDEA: XBRL DOCUMENT v3.23.2
Risks and Concentration (Tables)
12 Months Ended
Mar. 31, 2023
Risks and Uncertainties [Abstract]  
Schedules of Concentration of Risk, By Risk Factor
The information of the supplier with greater than 10% of the total purchases of the Company for the years ended March 31, 2021, 2022 and 2023 was as follows:
 
    
Year Ended

March 31, 2021
   
Year Ended

March 31, 2022
   
Year Ended

March 31, 2023
 
     RMB     RMB     RMB  
Royal Canin China Co., Ltd.
     19     17     22
XML 65 R43.htm IDEA: XBRL DOCUMENT v3.23.2
Cash and cash equivalents (Tables)
12 Months Ended
Mar. 31, 2023
Cash and Cash Equivalents [Abstract]  
Schedule of Cash and Cash Equivalents
Cash and cash equivalents represent cash on hand and demand deposits placed with banks and third party-payment processors, which are unrestricted as to withdrawal or use. Cash and cash equivalents balance as of March 31, 2022 and March 31, 2023 primarily consist of the following currencies:
 
    
As of March 31, 2022
    
As of March 31, 2023
 
    
Amount
    
RMB
equivalent
    
Amount
    
RMB
equivalent
 
RMB
     47,321        47,321        62,727        62,727  
Hong Kong
dollars
     39        31        7        6  
US$
     18,133        115,110        3,946        27,114  
EUR
     55        392        —          2  
NZD
     —          1        —          1  
     
 
 
       
 
 
 
Total
        162,855           89,850  
     
 
 
       
 
 
 
XML 66 R44.htm IDEA: XBRL DOCUMENT v3.23.2
Accounts receivable, net (Tables)
12 Months Ended
Mar. 31, 2023
Receivables [Abstract]  
Summary of Accounts Receivable Net
Accounts receivable consist of the following:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Accounts receivable - Product sales
     42,070        71,471  
Accounts receivable - Online marketing and information service and other service
     7,630        5,873  
Allowance of doubtful accounts
     (469      (602
  
 
 
    
 
 
 
Total
     49,231        76,742  
  
 
 
    
 
 
 
Summary of Movement of Allowance of Doubtful Accounts
Movement of allowance of doubtful accounts
 
    
As of March 31,
2021
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
    
RMB
 
At beginning of year
     363        256        469  
Addition/(reversal)
     (107      213        133  
  
 
 
    
 
 
    
 
 
 
At end of year
     256        469        602  
  
 
 
    
 
 
    
 
 
 
XML 67 R45.htm IDEA: XBRL DOCUMENT v3.23.2
Inventories, net of inventory reserves (Tables)
12 Months Ended
Mar. 31, 2023
Inventory Disclosure [Abstract]  
Summary of Inventories, Net of Inventory Reserves
Inventories, net of inventory reserves consist of the following:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Products
     109,383        80,431  
Packaging materials and others
     538        621  
  
 
 
    
 
 
 
Total inventories, net of inventory reserves
     109,921        81,052  
  
 
 
    
 
 
 
Summary of Movement of inventory provision
Movement of inventory provision:
 
    
As of March 31,
2021
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
    
RMB
 
At beginning of year
     273        266        577  
Provision/(reversal)
     (7      311        35  
  
 
 
    
 
 
    
 
 
 
At end of year
     266        577        612  
  
 
 
    
 
 
    
 
 
 
XML 68 R46.htm IDEA: XBRL DOCUMENT v3.23.2
Prepayments and other current assets (Tables)
12 Months Ended
Mar. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Summary of Prepayments and Other Current Assets
The prepayments and other current assets consist of the following:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Prepayments for purchases of products (a)
     52,348        24,216  
Vendor rebate receivables (b)
     24,462        16,160  
Value-added tax (“VAT”) deductible (c)
     18,864        10,512  
Loan receivables (d)
     3,845        9,886  
Sales return assets
     1,264        2,835  
Deposits
     1,312        999  
Others
     14,643        14,751  
  
 
 
    
 
 
 
Total
     116,738        79,359  
  
 
 
    
 
 
 
 
 
(a) Prepayments for purchases of products represent cash prepaid to the Company’s third-party brand partners for the procurement of products.
(b) Vendor rebate receivables represent the rebates to be received by the Company from its suppliers after certain levels of purchases are achieved.
(c) VAT recoverable represents the balances that the Company can utilize to deduct its value-added tax liabilities within the next 12 months.
(d) The balance represents loan receivables due from certain third-party companies and individuals. From July 2020 to March 2023, the Company entered into several loan agreements with aggregate principal amount of RMB11.0 million. The maturity dates of these loans are from October 2023 to March 2024. The interest rates ranged from 0% to 4% per annum. As of March 31, 2022 and 2023, the balances of loan receivables were RMB3.8 million and RMB9.9 million, respectively.
XML 69 R47.htm IDEA: XBRL DOCUMENT v3.23.2
Property and equipment, net (Tables)
12 Months Ended
Mar. 31, 2023
Property, Plant and Equipment [Abstract]  
Summary of Property, Plant and Equipment's
Property and equipment consist of the following:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Cost:
     
Warehouse equipment
     2,669        2,879  
Furniture, computer and office equipment
     7,503        7,082  
Vehicles
     3,684        4,740  
Leasehold improvement
     10,209        10,501  
Software
     2,995        3,009  
  
 
 
    
 
 
 
Total cost
     27,060        28,211  
Less: Accumulated depreciation
     (19,281      (22,719
  
 
 
    
 
 
 
Property and equipment, net
     7,779        5,492  
  
 
 
    
 
 
 
XML 70 R48.htm IDEA: XBRL DOCUMENT v3.23.2
Intangible assets, net (Tables)
12 Months Ended
Mar. 31, 2023
Intangible Assets, Net (Excluding Goodwill) [Abstract]  
Schedule of Intangible Assets
Intangible assets of the Company were mainly as follows:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Cost:
     
Trademark
     437        486  
License
     3,530        3,530  
Dealership
     31,717        31,717  
  
 
 
    
 
 
 
Total cost
     35,684        35,733  
Less: Accumulated amortization
     (10,140      (14,139
  
 
 
    
 
 
 
Intangible assets, net
     25,544        21,594  
  
 
 
    
 
 
 
Schedule of Annual Estimated Amortization Expense for Intangible Assets
The annual estimated amortization expense for intangible assets subject to amortization for the succeeding five years is as follows:
 
    
As of March 31,
 
    
2024
    
2025
    
2026
    
2027
    
2028
 
Amortization expenses
     3,867        3,438        3,207        3,203        3,187  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
XML 71 R49.htm IDEA: XBRL DOCUMENT v3.23.2
Long-Term Investments (Tables)
12 Months Ended
Mar. 31, 2023
Long-term Investments and Receivables, Net [Abstract]  
Summary of Long-Term Investment
The Company’s long-term investments consist of the following:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Equity method investments
     6,783        7,494  
Available-for-sale
investments
     74,866        68,011  
Equity securities with readily determinable fair values
     670        102  
    
 
 
    
 
 
 
Total
     82,319        75,607  
    
 
 
    
 
 
 
Summary of Available-For-Sale Debt Investments
Available-for-sale
debt investments
The following table summarizes the Company’s
available-for-sale
debt investments as of March 31, 2022:
 
     Cost      Gross unrealized gains      Gross unrealized losses    
Disposal of Long-term

investments
     Fair value  
Unlisted debt securities
     76,000        —          (1,134     —          74,866  
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
 
The following table summarizes the Company’s
available-for-sale
debt investments as of March 31, 2023:
 
     Cost      Gross unrealized gains      Gross unrealized losses    
Disposal of Long-term
investments
    Fair value  
Unlisted debt securities
     76,000        —          (7,561     (428     68,011  
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
Summary of Equity Securities With Readily Determinable Fair Values
Equity securities with readily determinable fair values
The following table summarizes the Company’s equity securities with readily determinable fair values as of March 31, 2022:
 
     Cost      Gross unrealized gains      Gross unrealized losses      Fair value  
Listed company
     1,292        —          (622      670  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
The following table summarizes the Company’s equity securities with readily determinable fair values as of March 31, 2023:
 
     Cost      Gross unrealized gains      Gross unrealized losses      Fair value  
Listed company
     1,292        —          (1,190      102  
  
 
 
    
 
 
    
 
 
    
 
 
 
XML 72 R50.htm IDEA: XBRL DOCUMENT v3.23.2
Goodwill (Tables)
12 Months Ended
Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Changes in the Carrying Amount of Goodwill
The changes in the carrying amount of goodwill for the years ended March 31, 2022 and 2023 were as follows:
 
     Total  
     RMB  
Balance as of March 31, 2021
  
Goodwill
     40,184  
Accumulated impairment loss
     —    
  
 
 
 
     40,184  
  
 
 
 
Transaction during the year
  
Addition (Note 3)
     500  
  
 
 
 
Balance as of March 31, 2022
  
Goodwill
     40,684  
Accumulated impairment loss
     —    
  
 
 
 
     40,684  
  
 
 
 
Transaction during the year
  
Impairment
     (40,684
  
 
 
 
Balance as of March 31, 2023
  
Goodwill
     40,684  
Accumulated impairment loss
     (40,684
  
 
 
 
     —    
  
 
 
 
XML 73 R51.htm IDEA: XBRL DOCUMENT v3.23.2
Other non-current Assets (Tables)
12 Months Ended
Mar. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Schedule of Other Non-current Assets
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Deposits (a)
     3,924        3,165  
Long-term loan receivables (b)
     937        3,421  
  
 
 
    
 
 
 
     4,861        6,586  
  
 
 
    
 
 
 
(a) Deposits mainly consisted of rental deposits and deposit for online stores operated on third party platforms, which will be collected after one year.
(b) From May 2021 to May 2022, the Company entered into interest free loan agreements with three third parties for total principal amounts of RMB3.4 million. The repayment terms of the loan agreements were ranged from 24 months to 36 months with due dates from May 2024 to June 2025. As of March 31, 2022 and 2023, the balances of long-term loan receivables were RMB0.9 million and RMB3.4 million, respectively.
XML 74 R52.htm IDEA: XBRL DOCUMENT v3.23.2
Accrued liabilities and other current liabilities (Tables)
12 Months Ended
Mar. 31, 2023
Accrued Liabilities and Other Liabilities [Abstract]  
Schedule of Accrued Liabilities and Other Current Liabilities
Accrued liabilities and other current liabilities consist of the following:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Logistics expenses payables
     14,625        7,663  
Advances from customers
     3,773        3,077  
Payable for investment
     2,563        2,563  
Refund obligation of sales returns
     1,411        3,113  
Professional service fee accruals
     579        1,694  
Accrued advertising expenses
     150        168  
Others
     4,223        3,826  
  
 
 
    
 
 
 
Total
     27,324        22,104  
  
 
 
    
 
 
 
XML 75 R53.htm IDEA: XBRL DOCUMENT v3.23.2
Leases (Tables)
12 Months Ended
Mar. 31, 2023
Leases [Abstract]  
Summary of Operating Leases
    
As of March 31,
2022
   
As of March 31,
2023
 
    
RMB
   
RMB
 
Assets
    
Operating lease
right-of-use
assets
     38,567       22,354  
  
 
 
   
 
 
 
Liabilities
    
Operating lease liabilities, current
     10,001       9,220  
Operating lease liabilities,
non-current
     28,197       12,741  
  
 
 
   
 
 
 
Total operating lease liabilities
     38,198       21,961  
  
 
 
   
 
 
 
Weighted average remaining lease term (years)
     3.61       2.77  
Weighted average discount rate
     4.95     5.38
Summary of Operating Lease Activity
Information related to operating lease activity during the years ended March 31, 2021, 2022 and 2023 are as follows:
 
    
Year ended

March 31, 2021
    
Year ended

March 31, 2022
    
Year ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Operating lease
right-of-use
assets obtained in exchange for lease obligations
     25,970        21,038        8,384  
  
 
 
    
 
 
    
 
 
 
Operating lease related expenses
        
Amortization of
right-of-use
assets
     11,687        11,705        24,597  
Interest of lease liabilities
     1,596        1,949        1,777  
  
 
 
    
 
 
    
 
 
 
     13,283        13,654        26,374  
  
 
 
    
 
 
    
 
 
 
 
 
 
    
Year ended

March 31, 2021
    
Year ended

March 31, 2022
    
Year ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Operating lease payments (included in measurement of lease liabilities)
     12,850        12,849        26,397  
  
 
 
    
 
 
    
 
 
 
Summary of Maturities of Lease Liabilities
Maturities of lease liabilities were as follows:
 
    
Year ended

March 31, 2023
 
    
RMB
 
For the year ending March 31,
  
2023
     9,902  
2024
     10,287  
2025
     4,263  
2026
     152  
2027
     —    
  
 
 
 
Total lease payments
     24,604  
Less: imputed interest
     (2,643
  
 
 
 
Total
     21,961  
  
 
 
 
XML 76 R54.htm IDEA: XBRL DOCUMENT v3.23.2
Interest expense (Tables)
12 Months Ended
Mar. 31, 2023
Interest and Debt Expense [Abstract]  
Summary of Interest Expense
    
Year ended

March 31, 2021
    
Year ended

March 31, 2022
    
Year ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Amortization charges on promissory notes
     21,611        17,144        9,706  
Interest expense on borrowings
     6,039        3,740        3,644  
  
 
 
    
 
 
    
 
 
 
Total
     27,650        20,884        13,350  
  
 
 
    
 
 
    
 
 
 
XML 77 R55.htm IDEA: XBRL DOCUMENT v3.23.2
Other gains, net (Tables)
12 Months Ended
Mar. 31, 2023
Other Income and Expenses [Abstract]  
Summary of Other (Losses), Net
    
Year ended

March 31, 2021
    
Year ended

March 31, 2022
    
Year ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Gain from the
re-measurement
of the previously held equity interests to the fair value in the step acquisitions (Note 3)
     —          127        —    
Foreign exchange losses, net
     (2,867      5,322        2,679  
Gain on disposal of other debts
     6,846        —          —    
Reimbursement from a depositary bank (a)
     6,556        1,482        —    
Investment loss
     —          (622      (178
Gain on disposal of a subsidiary (b)
     —          —          3,597  
Others
     797        (289      (939
  
 
 
    
 
 
    
 
 
 
     11,332        6,020        5,159  
  
 
 
    
 
 
    
 
 
 
 
(a)
The Company received a reimbursement of US$1.0M (equivalent to RMB6.6 million), US$0.2M (equivalent to RMB1.5 million) and nil from the depository for the establishment and maintenance of the ADS program for the years ended March 31, 2021, 2022 and 2023.
 
(b)
In August 2022, the Company disposed a subsidiary to a third-party investor and recognized an investment gain of RMB 3.6 million.
XML 78 R56.htm IDEA: XBRL DOCUMENT v3.23.2
Income taxes (Tables)
12 Months Ended
Mar. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of Effective Income Tax Rate Reconciliation
Reconciliations of the differences between the income tax expenses of the Company and the PRC statutory EIT rate applicable to losses of the consolidated entities are as follows:
 
    
Year ended

March 31, 2021
    
Year ended

March 31, 2022
    
Year ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Loss before income taxes
     (193,391      (134,812      (106,805
Income tax computed at respective applicable tax rates
     (48,348      (33,702      (26,701
Effect of different tax jurisdiction
     14,272        2,341        12,323  
Super deduction for research and development expenses (a)
     (2,632      (1,881      (456
Non-deductible
expenses
     140        97        728  
Change in valuation allowance
     37,439        34,716        15,017  
  
 
 
    
 
 
    
 
 
 
Total
     871        1,571        911  
  
 
 
    
 
 
    
 
 
 
 
  (a)
According to the relevant laws and regulations promulgated by the State Administration of Tax of the PRC, from 2018 onwards, enterprises engaging in research and development activities are entitled to claim 175% of their qualified research and development expenses so incurred as tax deductible expenses. The additional deduction of 75% of qualified research and development expenses (the “Super Deduction”) can be directly claimed in the annual EIT filing. For the years end March 31, 2021, 2022 and 2023, the Super Deduction for research and development expenses available to the Company amounted to RMB2.6 million, RMB1.9 million and RMB0.5 million, respectively.
Reconciliations between the effective income tax rate and the PRC statutory income tax rates are as follows:
 
    
Year ended

March 31, 2021
   
Year ended

March 31, 2022
   
Year ended

March 31, 2023
 
    
RMB
   
RMB
   
RMB
 
PRC statutory income tax rates
     25     25     25
Tax holiday effect
     1     3     (1 %) 
Difference in tax rates of subsidiaries outside PRC
     (8 %)      (8 %)      (10 %) 
Super deduction for research and development expenses
     1     1     0
Non-deductible
expenses
     0     0     1
Change in valuation allowance
     (19 %)      (20 %)      (14 %) 
    
 
 
   
 
 
   
 
 
 
Effective income tax rate
     0     1     1
    
 
 
   
 
 
   
 
 
 
Summary of Income Tax Holiday
The provisions for income taxes for the years ended March 31, 2021, 2022 and 2023 differ from the amounts computed by applying the EIT primarily due to change in valuation allowance provided and tax differential from certain subsidiaries with preferential tax rates of the Company.
The following table sets forth the effect of tax holiday effect on China operations:
 
    
Year ended

March 31, 2021
    
Year ended

March 31, 2022
    
Year ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Tax holiday effect
     1,074        3,513        1,235  
Basic and diluted net loss per share effect
     0.02        0.05        0.02  
    
 
 
    
 
 
    
 
 
 
Schedule of Components of Income Tax Expense (Benefit)
The current and deferred portions of income tax expenses included in the consolidated statements of loss and comprehensive loss are as follows:
 
    
Year ended

March 31, 2021
    
Year ended

March 31, 2022
    
Year ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Current income tax expense/(benefit)
     1,018        (582      78  
Deferred tax benefit
     (1,889      (989      (989
    
 
 
    
 
 
    
 
 
 
Income tax credit, net
     (871      (1,571      (911
    
 
 
    
 
 
    
 
 
 
Schedule of Deferred Tax Assets And Tax Liabilities
Deferred taxes were measured using the enacted tax rates for the periods in which they are expected to be reversed. The tax effects of temporary differences that give rise to the deferred tax asset and liabilities balances as of March 31, 2022 and 2023 are as follows:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Deferred tax assets:
                 
Net accumulated loss-carry forward
     172,059        163,526  
Deferred deductible advertising expense
     2,483        —    
Allowance
     78        238  
Contract liabilities
     419        172  
Accruals
     2,208        842  
Fair Value Change
     —          1,891  
Less: Valuation allowance
     (177,247      (166,669
    
 
 
    
 
 
 
Net deferred tax assets

 
 
—  
 
 
 
—  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Deferred tax liabilities:
                 
Recognition of intangible assets arising from asset acquisition and business combination
     (5,130      (4,141
Unrealized fair value change of the
available-for-sale
debt investments
     283        —    
    
 
 
    
 
 
 
Net deferred tax liabilities
     (4,847      (4,141
    
 
 
    
 
 
 
Summary of Valuation Allowance
Movement of valuation allowance is as follows:
 
    
Year Ended

March 31, 2021
    
Year Ended

March 31, 2022
    
Year Ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Beginning balance
     112,539        149,978        177,247  
Change of valuation allowance
     37,439        27,269        15,017  
Written-off
for expiration of net operating losses
     —          —          (22,995
Decrease of valuation allowances related to the disposal of a subsidiary
     —          —          (2,600
    
 
 
    
 
 
    
 
 
 
Ending balance
     149,978        177,247        166,669  
    
 
 
    
 
 
    
 
 
 
XML 79 R57.htm IDEA: XBRL DOCUMENT v3.23.2
Redeemable non-controlling interests (Tables)
12 Months Ended
Mar. 31, 2023
Noncontrolling Interest [Abstract]  
Schedule Of Redeemable Non-Controlling Interests Activity
The following tables provides details of the redeemable non-controlling interests activity for the years ended March 31, 2021, 2022 and 2023:
 
    
Year Ended

March 31, 2021
    
Year Ended

March 31, 2022
    
Year Ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Beginning balance
     5,809        5,947        6,522  
Accretion of redeemable non-controlling interests
     138        575        675  
  
 
 
    
 
 
    
 
 
 
Ending balance
     5,947        6,522        7,197  
  
 
 
    
 
 
    
 
 
 
XML 80 R58.htm IDEA: XBRL DOCUMENT v3.23.2
Borrowings, other debts and derivative liabilities (Tables)
12 Months Ended
Mar. 31, 2023
Debt Disclosure [Abstract]  
Summary of Short-term Debt
The following table presents short-term borrowings from commercial banks, other institutions and individuals as of March 31, 2022 and 2023. Short-term borrowings include borrowings with maturity terms shorter than one year:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Bank borrowings
     134,540        86,261  
Current portion of long-term bank borrowings
     26,586        —    
  
 
 
    
 
 
 
Total
     161,126        86,261  
  
 
 
    
 
 
 
Summary of Maturities of Long-term Debt
Future principal maturities of short-term borrowings and long-term borrowings as of March 31, 2021 and 2022 are as followings:
 
    
Year ended
March 31, 2022
    
Year ended
March 31, 2023
 
    
RMB
    
RMB
 
For the year ending March 31,
     
- Within 1 year
     161,126        86,261  
  
 
 
    
 
 
 
Total
     161,126        86,261  
  
 
 
    
 
 
 
Summary of Other Long Term Debt
Other debts –
non-current
consist of the following:
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Loan from CMB (a)
     86,373        —    
Loan from Chong Li (b)
     70,001        73,981  
Loan for Yoken Series
A-1
Warrant (c)
     23,188        27,346  
Payable for investment
     1,500        1,500  
  
 
 
    
 
 
 
Total
     181,062        102,827  
  
 
 
    
 
 
 
Summary of Fair Value of Derivative Liabilities
Derivative liabilities
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Conversion feature of Yoken Series
A-1
Warrant (a)
     9,086        7,850  
Forward exchange contracts (b)
     —          2,851  
  
 
 
    
 
 
 
Total
     9,086        10,701  
  
 
 
    
 
 
 
XML 81 R59.htm IDEA: XBRL DOCUMENT v3.23.2
Share-based compensation (Tables)
12 Months Ended
Mar. 31, 2023
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]  
Summary of Stock Option Activity
The following table sets forth the share options activity for the years ended March 31, 2022 and 2023:
 
    
Number of
shares
   
Weighted
average
exercise price
    
Weighted average
remaining
contractual term
    
Aggregate
intrinsic
value
    
Weighted average
fair value
 
          
US$
           
US$
    
US$
 
Outstanding as of March 31, 2021
     5,512,222       3.36        6.32        29,360        3.28  
Exercisable as of March 31, 2021
     —         —          —          —          —    
Granted
     1,282,500       2.86                          2.27  
Exercised
     (1,204,483     1.09                          0.73  
Forfeited
     (358,348     2.86                          3.83  
Outstanding as of March 31, 2022
     5,231,891       2.86        5.25        404        2.36  
Exercisable as of March 31, 2022
     —         —          —          —          —    
Exercised
     (53,488     0.60                          2.26  
Forfeited
     (1,233,050     1.31                          0.86  
Outstanding as of March 31, 2023
     3,945,354       2.58        3.45        124        2.06  
Exercisable as of March 31, 2023
     —         —          —          —          —    
Summary of Options Measured At Fair Value, Valuation Assumptions The significant unobservable inputs adopted in the valuation as of March 31, 2022 and 2023 are as follows:
 
    
As of March 31,
2022
  
As of March 31,
2023
Spot price (US$)
   0.44, 6.93    5.90
Risk-free rate
   1.25%, 2.5%    3.83%
Expected volatility
   57.95%, 48.15%    61.13%
Expected expiry years (in years)
   0.50, 3.56    2.60
Employees and Non Employees [Member]  
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]  
Summary of Options Measured At Fair Value, Valuation Assumptions
    
Year ended March 31, 2022
Expected volatility
  
42.22
% - 
43.71%
Risk-free interest rate
   1.62
% - 
1.86%
Exercise multiple
   2.8/2.2
Expected dividend yield
   0%
Contractual term (in years)
   10
XML 82 R60.htm IDEA: XBRL DOCUMENT v3.23.2
Fair value measurements (Tables)
12 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Summary of Company's Financial Assets and Liabilities
The following table summarizes the Company’s financial assets and liabilities measured and recorded at fair value on recurring basis as of March 31, 2022 and 2023:
 
            Fair value measurement at reporting date using  
Description
   Fair value as of
March 31, 2022
     Quoted price in
active markets
for identical
assets (Level 1)
     Significant other
observable Inputs
(Level 2)
     Significant
unobservable Inputs
(Level 3)
 
     RMB      RMB      RMB      RMB  
Assets:
           
Short-term investments
     128,084        —          128,084        —    
Available-for-sale
debt investments
     74,866        —          —          74,866  
Equity securities with readily determinable fair values
     670        670        —          —    
  
 
 
    
 
 
    
 
 
    
 
 
 
Total assets
     203,620        670        128,084        74,866  
  
 
 
    
 
 
    
 
 
    
 
 
 
Liabilities:
           
Derivative liabilities
     9,086        —          —          9,086  
  
 
 
    
 
 
    
 
 
    
 
 
 
 
            Fair value measurement at reporting date using  
Description
   Fair value as of
March 31, 2023
     Quoted price in
active markets
for identical
assets (Level 1)
     Significant other
observable Inputs
(Level 2)
     Significant
unobservable Inputs
(Level 3)
 
     RMB      RMB      RMB      RMB  
Assets:
           
Short-term investments
     69,797        —          69,797        —    
Available-for-sale
debt investments
     68,011        —          —          68,011  
Equity securities with readily determinable fair values
     102        102        —          —    
  
 
 
    
 
 
    
 
 
    
 
 
 
Total assets
     137,910        102        69,797        68,011  
  
 
 
    
 
 
    
 
 
    
 
 
 
Liabilities:
           
Derivative liabilities
     10,701        —          —          10,701  
  
 
 
    
 
 
    
 
 
    
 
 
 
Summary of Roll Forward of Major Level 3 Investments
The roll forward of major Level 3 investments are as following:
 
     Derivative liabilities     
Available-for-sale

debt investments
 
Fair value of Level 3 investments as at March 31, 2020
     14,351        70,328  
New addition
     9,581        —    
Disposal of Series
D-3
Notes
     (2,377      —    
Unrealized fair value change of the derivative liabilities
     (11,559      —    
Unrealized fair value change of the
available-for-sale
debt investments
     —          1,029  
  
 
 
    
 
 
 
Fair value of Level 3 investments as at March 31, 2021
     9,996        71,357  
  
 
 
    
 
 
 
New addition
     —          16,000  
Reclassification of forward exchange contracts
     746        —    
Unrealized fair value change of the derivative liabilities
     (1,656      —    
Unrealized fair value change of the
available-for-sale
debt investments
     —          (12,491
  
 
 
    
 
 
 
Fair value of Level 3 investments as at March 31, 2022
     9,086        74,866  
  
 
 
    
 
 
 
Reclassification of forward exchange contracts
     (651      —    
Unrealized fair value change of the derivative liabilities
     2,266        —    
Unrealized fair value change of the
available-for-sale
debt investments
     —          (6,427
Disposal of
available-for-sale
debt investments
     —          (428
  
 
 
    
 
 
 
Fair value of Level 3 investments as at March 31, 2023
     10,701        68,011  
  
 
 
    
 
 
 
Summary of Significant Unobservable Inputs
The Company determined the fair value of their investments by using equity allocation model, market approach and binomial model. The determination of the fair value was based on estimates, judgments and information of other comparable public companies. The significant unobservable inputs adopted in the valuation as of March 31, 2022 and 2023:
 
    
As of March 31,

2022
  
As of March 31,

2023
Implied price to sales after discount
for lack of marketability
   n.a.    1.04x
Weighted average cost of capital
   15
%, 
16.5
%, 
18
%
   n.a.
Lack of marketability discount
   17
%, 
23
%, 
29
%
   20%
Risk-free rate
   1.95
%, 
2.23
%, 
2.34
%, 
2.36
%
   2.60
%, 
2.31
%, 
2.19%
Expected volatility
   39.88
%, 
42.17
%, 
42.48
%, 
47.34
%
   47.19
%, 
43.65
%, 
32.08%
Probability
   Liquidation scenario: 20%
Redemption scenario: 40%
IPO scenario: 40%
   Liquidation scenario: 35
%, 
40%
Redemption scenario: 35
%, 
40%
IPO scenario: 30
%, 
20%
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The significant unobservable inputs adopted in the valuation as of March 31, 2022 and 2023 are as follows:
 
    
As of March 31,
2022
  
As of March 31,
2023
Spot price (US$)
   0.44, 6.93    5.90
Risk-free rate
   1.25%, 2.5%    3.83%
Expected volatility
   57.95%, 48.15%    61.13%
Expected expiry years (in years)
   0.50, 3.56    2.60
XML 83 R61.htm IDEA: XBRL DOCUMENT v3.23.2
Net loss per share (Tables)
12 Months Ended
Mar. 31, 2023
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
Basic loss per share and diluted loss per share have been calculated in accordance with ASC 260 on computation of earnings per share for the years ended March 31, 2021, 2022 and 2023, respectively, as follows:
 
   
Year Ended

March 31, 2021
   
Year Ended

March 31, 2022
   
Year Ended

March 31, 2023
 
   
RMB
   
RMB
   
RMB
 
Numerator:
                       
Net loss attributable to Boqii Holding Limited
    (194,444     (128,390     (102,799
Accretion on the Preferred Shares to redemption value (Note 20)
    120,873       —         —    
Accretion on the Redeemable
non-controlling
interests to redemption value (Note 21)
    (138     (575     (675
Deemed dividend to preferred shareholders
    (12,547     —         —    
   
 
 
   
 
 
   
 
 
 
Net loss attributable to ordinary shareholders
    (86,256     (128,965     (103,474
   
 
 
   
 
 
   
 
 
 
Denominator:
                       
Weighted average number of ordinary shares used in computing net loss per share, Basic and diluted (Note (a))
    66,953,610       68,006,172       68,858,823  
   
 
 
   
 
 
   
 
 
 
Net loss per share attributable to ordinary shareholders:
                       
Basic and diluted
    (1.29     (1.90     (1.50
   
 
 
   
 
 
   
 
 
 
Schedule of Antidilutive Securities Excluded From Computation Of Earnings Per Share
The following ordinary shares equivalent were excluded from the computation of diluted net loss per ordinary share for the periods presented because including them would have had an anti-dilutive effect:
 
    
Year Ended

March 31, 2021
    
Year Ended

March 31, 2022
    
Year Ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Share options - weighted average
     2,585,103        719,437        591,418  
XML 84 R62.htm IDEA: XBRL DOCUMENT v3.23.2
Related party transactions (Tables)
12 Months Ended
Mar. 31, 2023
Related Party Transactions [Abstract]  
Summary of Major Related Parties And Their Relationships With The Company
The table below sets forth the major related parties and their relationships with the Company as of March 31, 2021, 2022 and 2023:
 
Name of related parties
  
Relationship with the Company
Nanjing Animal Pharmaceutical    An equity investee of the Company
Wuhan Chunzhijin    An equity investee of the Company
Weishi Network    An equity investee of the Company
Beijing Petdog    An available-for-sale debt investee that the Company has significant influence
Shanghai Guangcheng Information Technology (limited partnership) (“Shanghai Guangcheng Information”)    A company with a common director of the Company
MERCHANT TYCOON LIMITED    A shareholder of the Company
SUPERB ORIGIN INTERNATIONAL LIMITED    A shareholder of the Company
Yingzhi (Lisa) Tang    Senior management of the Company
Yan Jiang    Senior management of the Company
Di (Jackie) Chen    Senior management of the Company until July, 2021
Ying (Christina) Zhang    Senior management of the Company until February, 2022
Fei Wang    Senior management of the Company until April, 2022
Lijun Zhou    Senior management of the Company until April, 2022
Summary of Related Party Transactions And Balances
    
Year Ended

March 31, 2021
    
Year Ended

March 31, 2022
    
Year Ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Online marketing and information services
        
Beijing Petdog
     410        —          —    
Weishi Network
     —          19        —    
  
 
 
    
 
 
    
 
 
 
     410        19        —    
  
 
 
    
 
 
    
 
 
 
Purchase of merchandise
        
Weishi Network
     —          1,582        —    
Nanjing Animal Pharmaceutical
     250        1,020        1,402  
  
 
 
    
 
 
    
 
 
 
     250        2,602        1,402  
  
 
 
    
 
 
    
 
 
 
 
    
Year Ended

March 31, 2021
    
Year Ended

March 31, 2022
    
Year Ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Loans granted to related parties
        
Shanghai Guangcheng Information (a)
     —          33,395        —    
Wuhan Chunzhijin (b)
     5,690        2,600        2,720  
MERCHANT TYCOON LIMITED
     —          —          100  
Yingzhi (Lisa) Tang
     —          1,750        —    
Lijun Zhou
     —          300        —    
Yan Jiang
     200        70        —    
Nanjing Animal Pharmaceutical (c)
     500        —          —    
Fei Wang
     500        —          —    
  
 
 
    
 
 
    
 
 
 
     6,890        38,115        2,820  
  
 
 
    
 
 
    
 
 
 
 
 
  (a)
In April 2021, the Company granted Shanghai Guangcheng Information a short-term loan with a total principal amount of RMB33.4 million (equivalent to USD5 million), bearing an interest rate of
3.5
% per annum. The loan was fully repaid by March 31, 2022.
  (b)
The Company entered into a loan agreement with Wuhan Chunzhijin to provide Wuhan Chunzhijin with an interest-free loan of up to 10 million, which will be repaid on demand. In March 2023, the company converted RMB3.4 million loan to Wuhan Chunzhijin into equity interest. (Detail refer to Note 11)
  (c)
In December 2019, Nanjing Xingmu, one of the Company’s subsidiaries, entered into a twelve-month interest free loan agreement with Nanjing Agricultural Pharmaceutical for a principal amount of RMB1 million. This loan was early repaid in May 2020. In June 2020, Nanjing Xingmu entered into another twelve-month interest free loan agreement with Nanjing Agricultural Pharmaceutical for a principal amount of RMB0.5 million. The loan was repaid in June 2021.
Summary of Related Party Transactions
    
Year Ended

March 31, 2021
    
Year Ended

March 31, 2022
    
Year Ended

March 31, 2023
 
    
RMB
    
RMB
    
RMB
 
Staff advances
        
Yingzhi (Lisa) Tang
     10        —          —    
  
 
 
       
Advances provided to related parties
        
SUPERB ORIGIN INTERNATIONAL LIMITED
     —          —          5,497  
Nanjing Animal Pharmaceutical
     2,073        —          350  
  
 
 
    
 
 
    
 
 
 
     2,073        —          5,847  
  
 
 
    
 
 
    
 
 
 
Loans granted from related parties
        
Shanghai Guangcheng Information (a)
     —          9,961        —    
  
 
 
    
 
 
    
 
 
 
 
  (a)
In April 2021, the Company obtained a total loan facility up to USD5 million from Shanghai Guangcheng Information. During the year ended March 31, 2022, the Company drew down a total amount of USD1.5 million (equivalent to RMB10.0 million) from the loan facility, with interest bearing at 3.5% per annum. The loan was fully repaid by March 31, 2022.
Summary of Transactions Due From Related Parties
Amounts due from related parties
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Prepayments to related parties
                 
SUPERB ORIGIN INTERNATIONAL LIMITED
     —          5,497  
Nanjing Animal Pharmaceutical
     1,650        2,000  
Weishi Network
     1,582        1,582  
    
 
 
    
 
 
 
       3,232        9,079  
    
 
 
    
 
 
 
Other receivables from related parties
                 
Wuhan Chunzhijin
     7,594        2,988  
    
 
 
    
 
 
 
Loans to related parties
                 
Yan Jiang
     200        200  
Fei Wang (
a
)
     500        —    
Lijun Zhou
     200        —    
MERCHANT TYCOON LIMITED
     —          100  
    
 
 
    
 
 
 
       900        300  
    
 
 
    
 
 
 
 
(
a
)
In January 2021, the Company entered into a one-year loan agreement with Fei Wang, for a principal amount of RMB0.5 million, bearing an interest rate of 4% per annum. This loan was pledged by 515,000 stock options owned by Fei Wang. In December 2022, the loan contract was renewed to December 2023 and was recorded as prepayments and other current assets as of March 31, 2023.
Summary of Transactions Due To related parties
Amounts due to related parties
 
    
As of March 31,
2022
    
As of March 31,
2023
 
    
RMB
    
RMB
 
Trade payables to related parties
                 
Nanjing Animal Pharmaceutical
     219        471  
    
 
 
    
 
 
 
XML 85 R63.htm IDEA: XBRL DOCUMENT v3.23.2
Organization and principal activities - Schedule of Details of the Subsidiaries, VIEs and VIE's Subsidiaries (Detail)
12 Months Ended
Mar. 31, 2023
Guangcheng (Shanghai) Information Technology Co., Ltd. ("Guangcheng") [Member]  
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]  
Place of incorporation Shanghai, the PRC
Date of incorporation or acquisition Nov. 30, 2012
Percentage of direct or indirect 100.00%
Principal activities Operates the Company’s own online e-commerce platform
Nanjing Xingmu Biotechnology Co., Ltd. ("Nanjing Xingmu") [Member]  
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]  
Place of incorporation Nanjing, the PRC
Date of incorporation or acquisition Nov. 30, 2019
Percentage of direct or indirect 51.00%
Principal activities Biotechnology research and development
Suzhou Taicheng Supply Chain Co Ltd Suzhou Taicheng [Member]  
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]  
Place of incorporation Suzhou, the PRC
Date of incorporation or acquisition Jun. 30, 2021
Percentage of direct or indirect 100.00%
Principal activities Sales of merchandise
Suzhou Xingyun Yueming Supply Chain Co., Ltd. ("Suzhou Xingyun Yueming") [Member]  
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]  
Place of incorporation Suzhou, the PRC
Date of incorporation or acquisition Apr. 30, 2022
Percentage of direct or indirect 100.00%
Principal activities Sales of merchandise
Boqii (Shanghai) Information Technology Co., Ltd. [Member]  
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]  
Place of incorporation Shanghai, the PRC
Date of incorporation or acquisition Aug. 31, 2014
Percentage of direct or indirect 90.00%
Principal activities Technology development
Tianjing Guangcheng Information Technology Co., Ltd. [Member]  
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]  
Place of incorporation Tianjin, the PRC
Date of incorporation or acquisition Jun. 30, 2017
Percentage of direct or indirect 100.00%
Principal activities Sales of merchandise
Nanjing Cuida Biotechnology Co. Ltd.("Cuida") [Member]  
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]  
Place of incorporation Nanjing, the PRC
Date of incorporation or acquisition Apr. 30, 2017
Percentage of direct or indirect 70.00%
Principal activities Biotechnology extension services
Taizhou Xingmu Biotechnology Co., Ltd. [Member]  
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]  
Place of incorporation Taizhou, the PRC
Date of incorporation or acquisition Nov. 30, 2019
Percentage of direct or indirect 80.00%
Principal activities Biotechnology research and development
Boqii Corporation Limited ("Boqii Corporation") [Member]  
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]  
Place of incorporation Hong Kong
Date of incorporation or acquisition Jul. 31, 2012
Percentage of direct or indirect 100.00%
Principal activities Investment holding
Boqii International Limited [Member]  
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]  
Place of incorporation Hong Kong
Date of incorporation or acquisition Aug. 31, 2016
Percentage of direct or indirect 100.00%
Principal activities Investment holding
Xingmu International Limited [Member]  
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]  
Place of incorporation British Virgin Islands
Date of incorporation or acquisition Aug. 31, 2019
Percentage of direct or indirect 51.00%
Principal activities Investment holding
Xingmu HK Limited [Member]  
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]  
Place of incorporation Hong Kong
Date of incorporation or acquisition Nov. 30, 2019
Percentage of direct or indirect 51.00%
Principal activities Investment holding
Nanjing Xinmu Information Technology Co., Ltd. ("Xinmu WFOE") [Member]  
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]  
Place of incorporation Nanjing, the PRC
Date of incorporation or acquisition Nov. 30, 2019
Percentage of direct or indirect 51.00%
Principal activities Technology development and sales of merchandise
Xincheng (Shanghai) Information Technology Co., Ltd. ("Shanghai Xincheng") [Member]  
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]  
Place of incorporation Shanghai, the PRC
Date of incorporation or acquisition Nov. 30, 2012
Percentage of direct or indirect 100.00%
Principal activities Technology development and sales of merchandise
Shanghai Yiqin Pets Products Co., Ltd. [Member]  
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]  
Place of incorporation Shanghai, the PRC
Date of incorporation or acquisition Feb. 28, 2013
Percentage of direct or indirect 100.00%
Principal activities Technology development and sales of merchandise
Shanghai Every Supply Chain Co., Ltd. ("Shanghai Every") [Member]  
Schedule Of Subsidiaries And Variable Interest Entities [Line Items]  
Place of incorporation Shanghai, the PRC
Date of incorporation or acquisition Sep. 30, 2021
Percentage of direct or indirect 100.00%
Principal activities Sales of merchandise
XML 86 R64.htm IDEA: XBRL DOCUMENT v3.23.2
Organization and principal activities - Schedule of Variable Interest Entities (Detail)
¥ in Thousands, $ in Thousands
12 Months Ended
Mar. 31, 2023
CNY (¥)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
CNY (¥)
Mar. 31, 2021
CNY (¥)
Mar. 31, 2023
USD ($)
Variable Interest Entity [Line Items]          
Cash and cash equivalents ¥ 89,850   ¥ 162,855   $ 13,083
Accounts receivable, net 76,742   49,231   11,175
Amounts due from related parties 9,379   11,726   1,366
Inventories, net 81,052   109,921   11,802
Prepayments and other current assets 79,359   116,738   11,556
Property and equipment, net 5,492   7,779   800
Intangible assets 21,594   25,544   3,144
Operating lease right-of-use assets 22,354   38,567   3,255
Goodwill 0   40,684 ¥ 40,184  
Long-term investments 75,607   82,319   11,010
Other non-current asset 6,586   4,861   959
Total assets 540,800   778,309   78,748
Short-term borrowings 86,261   161,126   12,561
Accounts payable 56,022   94,224   8,157
Amounts due to related parties, current 471   219   69
Salary and welfare payable 6,890   6,871   1,003
Accrued liabilities and other current liabilities 22,104   27,324   3,219
Contract liabilities 4,471   7,007   651
Operating lease liabilities, current 9,220   10,001   1,343
Operating lease liabilities, non-current 12,741   28,197   1,855
Other debts, non-current 102,827   181,062   14,973
Total liabilities 315,849   529,964   $ 45,992
Net revenues:          
Total revenues 1,092,094 $ 159,021 1,186,429 1,010,985  
Cost of revenues:          
Total cost of revenue (858,608) (125,023) (943,698) (823,686)  
Gross profit 233,486 33,998 242,731 187,299  
Operating expenses:          
Impairment of goodwill (40,684) (5,900)      
Other income, net 286 42 280 1,067  
Profit/(Loss) from operations (103,768) (15,110) (138,249) (205,995)  
Income tax benefits/(expenses) (911) (133) (1,571) (871)  
Share of results of equity investees (82) (12) 418 (696)  
Net profit/(loss) (105,976) (15,431) (132,823) (193,216)  
Cash flows from operating activities:          
Net cash generated from/ (used in) operating activities (54,069) (7,873) (147,504) (247,486)  
Cash flows from investing activities:          
Net cash used in investing activities 46,496 6,770 21,147 (184,417)  
Cash flows from financing activities:          
Net cash generated from/ (used in) financing activities (76,656) $ (11,161) 1,995 648,491  
Variable Interest Entity, Primary Beneficiary [Member] | Nonrecourse [Member]          
Variable Interest Entity [Line Items]          
Cash and cash equivalents 15,522   20,567    
Accounts receivable, net 33,172   31,435    
Amounts due from related parties 6,770   11,726    
Inventories, net 27,894   16,014    
Prepayments and other current assets 48,291   57,107    
Inter-company receivables 83,700   16,535    
Property and equipment, net 4,661   6,715    
Intangible assets 101   507    
Operating lease right-of-use assets 22,305   35,688    
Goodwill     994    
Long-term investments 75,505   81,649    
Other non-current asset 5,219   3,389    
Total assets 323,140   282,326    
Short-term borrowings 363   872    
Accounts payable 13,459   55,144    
Amounts due to related parties, current 21   4    
Salary and welfare payable 5,573   5,597    
Accrued liabilities and other current liabilities 15,712   24,417    
Contract liabilities 4,471   7,007    
Operating lease liabilities, current 9,207   7,238    
Inter-company payables 1,095,452   945,960    
Operating lease liabilities, non-current 12,741   28,197    
Other debts, non-current 75,481   157,874    
Total liabilities 1,232,480   1,232,310    
Net revenues:          
Total revenues 872,615   933,459 783,892  
Cost of revenues:          
Total cost of revenue (616,328)   (711,246) (670,319)  
Gross profit 256,287   222,213 113,573  
Operating expenses:          
Total operating expenses (237,893)   (288,291) (262,208)  
Impairment of goodwill (994)        
Other income, net 158   98 1,011  
Profit/(Loss) from operations 17,558   (65,980) (147,624)  
Non-operating expense (29)   (20,680) (18,162)  
Profit/(Loss) before income tax expenses 17,529   (86,660) (165,786)  
Income tax benefits/(expenses) 21   681 (20)  
Share of results of equity investees (82)   418 (696)  
Net profit/(loss) 17,468   (85,561) (166,502)  
Cash flows from operating activities:          
Net cash provided by transactions with external parties 471,991   526,201 419,767  
Net cash used in transactions with the Company's entities (449,155)   (329,325) (331,064)  
Net cash generated from/ (used in) operating activities 22,836   196,876 88,703  
Cash flows from investing activities:          
Other investing activities (9,638)   (18,482) (31,972)  
Cash flows of loan funding provided to the Company's entities, net of repayments received     6,294 (5,242)  
Net cash used in investing activities (9,638)   (12,188) (37,214)  
Cash flows from financing activities:          
Other financing activities (88,469)   (273,906) (112,151)  
Cash flows of loan funding received from the Company's entities, net of repayments made 69,204   91,794 41,717  
Net cash generated from/ (used in) financing activities (19,265)   (182,112) (70,434)  
Variable Interest Entity, Primary Beneficiary [Member] | Nonrecourse [Member] | Third-party [Member]          
Net revenues:          
Total revenues 786,152   877,380 735,518  
Cost of revenues:          
Total cost of revenue (81,810)   (160,661) (372,475)  
Operating expenses:          
Third-party operating expenses (237,852)   (288,291) (254,951)  
Variable Interest Entity, Primary Beneficiary [Member] | Nonrecourse [Member] | Inter-company [Member]          
Net revenues:          
Total revenues 86,463   56,079 48,374  
Cost of revenues:          
Total cost of revenue (534,518)   ¥ (550,585) (297,844)  
Operating expenses:          
Inter-company operating expenses ¥ (41)     ¥ (7,257)  
XML 87 R65.htm IDEA: XBRL DOCUMENT v3.23.2
Organization and principal activities - Additional Information (Detail) - CNY (¥)
Mar. 31, 2023
Mar. 31, 2022
Variable Interest Entity, Primary Beneficiary [Member] | Nonrecourse [Member]    
Organization And Principal Activities [Line Items]    
Total registered capital ¥ 52,000,000 ¥ 52,000,000
Contractual Arrangements [Member]    
Organization And Principal Activities [Line Items]    
Percentage of Maximum entity interests acquirable In variable Interest Entity Under PRC law 100.00%  
Loan Agreements [Member] | Repayment of Loan [Member]    
Organization And Principal Activities [Line Items]    
Third party claim against nominee shareholders ¥ 500,000  
Intellectual Property License Agreements [Member]    
Organization And Principal Activities [Line Items]    
Number of Business days in which agreement amount is to paid from relevant quarter 15 days  
Term of agreement 10 years  
Extended term 10 years  
Period of prior written notice required to terminate the agreement 90 days  
Equity Interest Pledge Agreements [Member]    
Organization And Principal Activities [Line Items]    
Percentage of equity interest pledged by nominal shareholders 100.00%  
XML 88 R66.htm IDEA: XBRL DOCUMENT v3.23.2
Principal Accounting Policies - Additional Information (Detail)
¥ in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
CNY (¥)
Mar. 31, 2023
CNY (¥)
Mar. 31, 2023
USD ($)
Dec. 31, 2022
CNY (¥)
Mar. 31, 2022
CNY (¥)
Dec. 31, 2021
CNY (¥)
Mar. 31, 2021
CNY (¥)
Apr. 01, 2022
CNY (¥)
Apr. 01, 2021
CNY (¥)
Principal Accounting Policies [Line Items]                  
Contract with Customer, Asset   ¥ 0     ¥ 0        
Contract with Customer, Liability               ¥ 7,000 ¥ 3,900
Contract with Customer, Liability, Revenue Recognized   3,000     3,600        
Unearned Revenue   4,500              
Cost of Revenue   858,608 $ 125,023   943,698   ¥ 823,686    
Advertising Expense   ¥ 44,000     81,000   83,000    
Government subsidies recognized ¥ 300     ¥ 200   ¥ 1,100      
Government Assistance, Statement of Income or Comprehensive Income [Extensible Enumeration]   Other Income Net Other Income Net            
Other Research and Development Expense   ¥ 3,700     11,300   14,100    
Impairment of finitely lived intangible assets   0     0   0    
Impairment of tangible assets amount   0     0   0    
Short-term Investments [Member]                  
Principal Accounting Policies [Line Items]                  
Short-term investments used as collateral   70,000     128,000        
Short Term Borrowings Collateralized by Short Term Investments   64,000     111,000        
Cost of product sales [Member]                  
Principal Accounting Policies [Line Items]                  
Cost of Revenue   842,700     930,400   820,300    
Cost of services [Member]                  
Principal Accounting Policies [Line Items]                  
Cost of Revenue   ¥ 15,900     ¥ 13,300   ¥ 3,400    
CNY [Member]                  
Principal Accounting Policies [Line Items]                  
Foreign Currency Exchange Rate   6.8717     6.3482        
Convenience translation exchange rate   6.8676              
XML 89 R67.htm IDEA: XBRL DOCUMENT v3.23.2
Principal Accounting Policies - Schedule of Property Plant And Equipment Useful Lives (Detail)
12 Months Ended
Mar. 31, 2023
Vehicles [Member]  
Property, Plant and Equipment [Line Items]  
Property, Plant and Equipment, Useful Life 5 years
Software [Member]  
Property, Plant and Equipment [Line Items]  
Property, Plant and Equipment, Useful Life 10 years
Leasehold Improvements [Member]  
Property, Plant and Equipment [Line Items]  
Property, Plant and Equipment, Estimated Useful Lives Over the shorter of the expected life of leasehold improvements or the lease term
Maximum [Member] | Warehouse Equipment [Member]  
Property, Plant and Equipment [Line Items]  
Property, Plant and Equipment, Useful Life 5 years
Maximum [Member] | Furniture, Computer And Office Equipment [Member]  
Property, Plant and Equipment [Line Items]  
Property, Plant and Equipment, Useful Life 5 years
Minimum [Member] | Warehouse Equipment [Member]  
Property, Plant and Equipment [Line Items]  
Property, Plant and Equipment, Useful Life 3 years
Minimum [Member] | Furniture, Computer And Office Equipment [Member]  
Property, Plant and Equipment [Line Items]  
Property, Plant and Equipment, Useful Life 3 years
XML 90 R68.htm IDEA: XBRL DOCUMENT v3.23.2
Principal Accounting Policies - Schedule of Finite Lived Intangible Assets Useful Lives (Detail)
12 Months Ended
Mar. 31, 2023
Trademark [Member]  
Finite-Lived Intangible Assets [Line Items]  
Finite-Lived Intangible Asset, Useful Life 10 years
Dealership [Member]  
Finite-Lived Intangible Assets [Line Items]  
Finite-Lived Intangible Asset, Useful Life 10 years
License [Member]  
Finite-Lived Intangible Assets [Line Items]  
Finite-Lived Intangible Asset, Useful Life 4 years 6 months
XML 91 R69.htm IDEA: XBRL DOCUMENT v3.23.2
Business combinations - Summary of Identified Assets Acquired and Liabilities Assumed (Detail) - Chongni network technology Co Ltd [Member] - CNY (¥)
¥ in Thousands
12 Months Ended
Jun. 30, 2021
Mar. 31, 2023
Total purchase price is comprised of:    
- fair value of 49% previously held equity interests ¥ 245  
- cash consideration 2,938 ¥ 2,900
Fair value of total consideration 3,183  
Cash and cash equivalents 2  
Prepayments and other current assets 4,533  
Total assets 4,535  
Accrued liabilities and other current liabilities (33)  
Total liabilities (33)  
Net assets acquired 4,502  
Goodwill 499  
Non-controlling interests (1,818)  
Total ¥ 3,183  
XML 92 R70.htm IDEA: XBRL DOCUMENT v3.23.2
Business combinations - Summary of Identified Assets Acquired and Liabilities Assumed (Detail) (Parenthetical)
Jun. 30, 2021
Xingmu Group [Member]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Line Items]  
Business Combination, Step Acquisition, Equity Interest in Acquire, Percentage 49.00%
XML 93 R71.htm IDEA: XBRL DOCUMENT v3.23.2
Business combinations - Additional Information (Detail) - CNY (¥)
¥ in Thousands
9 Months Ended 12 Months Ended
Jun. 30, 2021
Mar. 31, 2022
Mar. 31, 2023
Oct. 31, 2018
Nanjing Cuida Biotechnology Co Ltd [Member]        
Business Combination, Pro Forma Information, Earnings or Loss of Acquire since Acquisition Date   ¥ (80)    
Chongni network technology Co Ltd [Member]        
Business Acquisition, Percentage of Voting Interests Acquired 63.65%     49.00%
Payments to Acquire Businesses, Gross ¥ 2,938   ¥ 2,900  
Business Combination, Step Acquisition, Equity Interest in Acquire, Percentage       49.00%
Business Combination, Consideration Transferred 3,183      
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned 2,900      
Business Combination Purchase Price Information On Acquisition Date 300      
Business Combination, Step Acquisition, Equity Interest in Acquire, Re-measurement Gain (Loss), Net ¥ 100      
XML 94 R72.htm IDEA: XBRL DOCUMENT v3.23.2
Risks and Concentration - Additional Information (Detail)
12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenue Benchmark [Member]    
Concentration Risk [Line Items]    
Number of Customers   0
Revenue Benchmark [Member] | Royal Canin China Co., Ltd [Member] | Supplier Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration Risk, Percentage   10.00%
CNY [Member]    
Concentration Risk [Line Items]    
Foreign currency increase (decrease) percentage 8.50% (2.30%)
XML 95 R73.htm IDEA: XBRL DOCUMENT v3.23.2
Risks and Concentration - Schedules of Concentration of Risk, By Risk Factor (Detail)
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Royal Canin China Co., Ltd [Member] | Supplier Concentration Risk [Member] | Purchases [Member]      
Concentration Risk [Line Items]      
Concentration Risk, Percentage 22.00% 17.00% 19.00%
XML 96 R74.htm IDEA: XBRL DOCUMENT v3.23.2
Cash and cash equivalents - Schedule of Cash And Cash Equivalents (Detail)
€ in Thousands, ¥ in Thousands, $ in Thousands, $ in Thousands, $ in Thousands
Mar. 31, 2023
CNY (¥)
Mar. 31, 2023
USD ($)
Mar. 31, 2023
HKD ($)
Mar. 31, 2023
EUR (€)
Mar. 31, 2023
NZD ($)
Mar. 31, 2022
CNY (¥)
Mar. 31, 2022
USD ($)
Mar. 31, 2022
HKD ($)
Mar. 31, 2022
EUR (€)
Mar. 31, 2022
NZD ($)
RMB                    
Cash and cash equivalents ¥ 89,850 $ 13,083       ¥ 162,855        
Cash Equivalents [Member]                    
RMB                    
Cash and cash equivalents | ¥ 89,850         162,855        
CNY [Member] | Cash [Member]                    
RMB                    
Cash and cash equivalents | ¥ 62,727         47,321        
CNY [Member] | Cash Equivalents [Member]                    
RMB                    
Cash and cash equivalents | ¥ ¥ 62,727         ¥ 47,321        
Hong Kong dollars [Member] | Cash [Member]                    
RMB                    
Cash and cash equivalents     $ 7         $ 39    
Hong Kong dollars [Member] | Cash Equivalents [Member]                    
RMB                    
Cash and cash equivalents     $ 6         $ 31    
USD [Member] | Cash [Member]                    
RMB                    
Cash and cash equivalents   3,946         $ 18,133      
USD [Member] | Cash Equivalents [Member]                    
RMB                    
Cash and cash equivalents   $ 27,114         $ 115,110      
EUR [Member] | Cash [Member]                    
RMB                    
Cash and cash equivalents | €       € 0         € 55  
EUR [Member] | Cash Equivalents [Member]                    
RMB                    
Cash and cash equivalents | €       € 2         € 392  
NZD | Cash [Member]                    
RMB                    
Cash and cash equivalents         $ 0         $ 0
NZD | Cash Equivalents [Member]                    
RMB                    
Cash and cash equivalents         $ 1         $ 1
XML 97 R75.htm IDEA: XBRL DOCUMENT v3.23.2
Accounts receivable, net - Summary of Accounts Receivable Net (Detail)
¥ in Thousands, $ in Thousands
Mar. 31, 2023
CNY (¥)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
CNY (¥)
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Allowance of doubtful accounts ¥ (602)   ¥ (469)
Total 76,742 $ 11,175 49,231
Product Sales [Member]      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Accounts receivable 71,471   42,070
Online Marketing And Information Services And Other Revenue [Member]      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Accounts receivable ¥ 5,873   ¥ 7,630
XML 98 R76.htm IDEA: XBRL DOCUMENT v3.23.2
Accounts receivable, net - Summary of Movement of Allowance of Doubtful Accounts (Detail)
¥ in Thousands, $ in Thousands
12 Months Ended
Mar. 31, 2023
CNY (¥)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
CNY (¥)
Mar. 31, 2021
CNY (¥)
Accounts, Notes, Loans and Financing Receivable [Line Items]        
At beginning of year ¥ 469   ¥ 256 ¥ 363
Addition/(reversal) 133 $ 19 213 (107)
At end of year ¥ 602   ¥ 469 ¥ 256
XML 99 R77.htm IDEA: XBRL DOCUMENT v3.23.2
Inventories, net of inventory reserves - Summary of Inventories, Net of Inventory Reserves (Detail)
¥ in Thousands, $ in Thousands
Mar. 31, 2023
CNY (¥)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
CNY (¥)
Inventory [Line Items]      
Inventory, Net ¥ 81,052 $ 11,802 ¥ 109,921
Products [Member]      
Inventory [Line Items]      
Inventory, Net 80,431   109,383
Packaging materials and others [Member]      
Inventory [Line Items]      
Inventory, Net ¥ 621   ¥ 538
XML 100 R78.htm IDEA: XBRL DOCUMENT v3.23.2
Inventories, net of inventory reserves - Summary of Movement of Inventory Provision (Detail) - CNY (¥)
¥ in Thousands
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Inventory Disclosure [Abstract]      
At beginning of year ¥ 577 ¥ 266 ¥ 273
Provision/(reversal) 35 311 (7)
At end of year ¥ 612 ¥ 577 ¥ 266
XML 101 R79.htm IDEA: XBRL DOCUMENT v3.23.2
Inventories, net of inventory reserves - Additional Information (Detail) - CNY (¥)
¥ in Thousands
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Inventory Disclosure [Abstract]      
(Reversal) Provision of inventory reserves ¥ 35 ¥ 310 ¥ (7)
XML 102 R80.htm IDEA: XBRL DOCUMENT v3.23.2
Prepayments and other current assets - Summary of Prepayments and Other Current Assets (Detail)
¥ in Thousands, $ in Thousands
Mar. 31, 2023
CNY (¥)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
CNY (¥)
Prepaid Expense and Other Assets, Current [Abstract]      
Prepayments for purchases of products ¥ 24,216   ¥ 52,348
Vendor rebate receivables 16,160   24,462
Value-added tax ("VAT") deductible 10,512   18,864
Loan receivables 9,886   3,845
Sales return assets 2,835   1,264
Deposits 999   1,312
Others 14,751   14,643
Total ¥ 79,359 $ 11,556 ¥ 116,738
XML 103 R81.htm IDEA: XBRL DOCUMENT v3.23.2
Prepayments and other current assets - Additional Information (Detail) - CNY (¥)
¥ in Thousands
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Notes and loans receivable net current    
Financing receivable, after allowance for credit loss, current ¥ 9,886 ¥ 3,845
Loans Receivable Period Ranging From 12 To 24 Months [Member] | Maximum [Member]    
Notes and loans receivable net current    
Loan receivable fixed rate of interest percentage 4.00%  
Loans Receivable Period Ranging From 12 To 24 Months [Member] | Minimum [Member]    
Notes and loans receivable net current    
Loan receivable fixed rate of interest percentage 0.00%  
Loans Receivable Period Ranging From 12 To 24 Months [Member] | From October 2023 to March 2024 [Member]    
Notes and loans receivable net current    
Loan receivable face or par amount ¥ 11,000  
Loans Receivable Period Ranging From 12 To 24 Months [Member] | From October 2023 to March 2024 [Member] | Maximum [Member]    
Notes and loans receivable net current    
Loans receivable month of maturity 2024-03  
Loans Receivable Period Ranging From 12 To 24 Months [Member] | From October 2023 to March 2024 [Member] | Minimum [Member]    
Notes and loans receivable net current    
Loans receivable month of maturity 2023-10  
XML 104 R82.htm IDEA: XBRL DOCUMENT v3.23.2
Property and equipment, net - Summary of Property, Plant and Equipment's (Detail)
¥ in Thousands, $ in Thousands
Mar. 31, 2023
CNY (¥)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
CNY (¥)
Property, Plant and Equipment [Line Items]      
Property, Plant and Equipment, Gross ¥ 28,211   ¥ 27,060
Less: Accumulated depreciation (22,719)   (19,281)
Property and equipment, net 5,492 $ 800 7,779
Warehouse Equipment [Member]      
Property, Plant and Equipment [Line Items]      
Property, Plant and Equipment, Gross 2,879   2,669
Furniture, Computer And Office Equipment [Member]      
Property, Plant and Equipment [Line Items]      
Property, Plant and Equipment, Gross 7,082   7,503
Vehicles [Member]      
Property, Plant and Equipment [Line Items]      
Property, Plant and Equipment, Gross 4,740   3,684
Leasehold Improvements [Member]      
Property, Plant and Equipment [Line Items]      
Property, Plant and Equipment, Gross 10,501   10,209
Software [Member]      
Property, Plant and Equipment [Line Items]      
Property, Plant and Equipment, Gross ¥ 3,009   ¥ 2,995
XML 105 R83.htm IDEA: XBRL DOCUMENT v3.23.2
Property and equipment, net - Additional Information (Detail) - CNY (¥)
¥ in Thousands
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Property, Plant and Equipment [Abstract]      
Depreciation ¥ 3,800 ¥ 3,700 ¥ 3,080
XML 106 R84.htm IDEA: XBRL DOCUMENT v3.23.2
Intangible assets, net - Schedule of Intangible Assets (Detail)
¥ in Thousands, $ in Thousands
Mar. 31, 2023
CNY (¥)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
CNY (¥)
Finite-Lived Intangible Assets [Line Items]      
Finite-Lived Intangible Assets, Gross ¥ 35,733   ¥ 35,684
Less: Accumulated amortization (14,139)   (10,140)
Intangible assets 21,594 $ 3,144 25,544
Trademark [Member]      
Finite-Lived Intangible Assets [Line Items]      
Finite-Lived Intangible Assets, Gross 486   437
License [Member]      
Finite-Lived Intangible Assets [Line Items]      
Finite-Lived Intangible Assets, Gross 3,530   3,530
Dealership [Member]      
Finite-Lived Intangible Assets [Line Items]      
Finite-Lived Intangible Assets, Gross ¥ 31,717   ¥ 31,717
XML 107 R85.htm IDEA: XBRL DOCUMENT v3.23.2
Intangible assets, net - Schedule of Annual Estimated Amortization Expense for Intangible Assets (Detail)
¥ in Thousands
Mar. 31, 2023
CNY (¥)
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]  
2024 ¥ 3,867
2025 3,438
2026 3,207
2027 3,203
2028 ¥ 3,187
XML 108 R86.htm IDEA: XBRL DOCUMENT v3.23.2
Intangible assets, net - Additional Information (Detail) - CNY (¥)
¥ in Millions
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Intangible Assets, Net (Excluding Goodwill) [Abstract]      
Intangible assets resulting from the business combinations ¥ 21.6 ¥ 25.5  
Amortization expenses of the intangible assets ¥ 4.0 ¥ 4.0 ¥ 4.0
XML 109 R87.htm IDEA: XBRL DOCUMENT v3.23.2
Long-Term Investments - Summary of Long-Term Investment (Detail)
¥ in Thousands, $ in Thousands
Mar. 31, 2023
CNY (¥)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
CNY (¥)
Long-term Investments [Abstract]      
Equity method investments ¥ 7,494   ¥ 6,783
Available-for-sale investments 68,011   74,866
Equity securities with readily determinable fair values 102   670
Total ¥ 75,607 $ 11,010 ¥ 82,319
XML 110 R88.htm IDEA: XBRL DOCUMENT v3.23.2
Long-Term Investments - Summary of Available-For-Sale Debt Investments (Detail) - CNY (¥)
¥ in Thousands
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Debt Securities, Available-for-sale [Abstract]    
Cost ¥ 76,000 ¥ 76,000
Gross unrealized gains 0 0
Gross unrealized losses (7,561) (1,134)
Disposal of Long-term investments (428) 0
Fair value ¥ 68,011 ¥ 74,866
XML 111 R89.htm IDEA: XBRL DOCUMENT v3.23.2
Long-Term Investments - Summary Of Equity Securities With Readily Determinable Fair Values (Detail) - CNY (¥)
¥ in Thousands
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Equity Securities With Readily Determinable Fair Value [Line Items]    
Cost ¥ 1,292 ¥ 1,292
Gross unrealized gains 0 0
Gross unrealized losses (1,190) (622)
Fair value ¥ 102 ¥ 670
XML 112 R90.htm IDEA: XBRL DOCUMENT v3.23.2
Long-Term Investments - Additional Information (Detail)
¥ in Thousands
1 Months Ended 12 Months Ended
Jul. 31, 2021
CNY (¥)
Jun. 30, 2021
USD ($)
shares
Oct. 31, 2019
CNY (¥)
Apr. 30, 2019
CNY (¥)
Mar. 31, 2023
CNY (¥)
Dec. 31, 2022
CNY (¥)
Mar. 31, 2022
CNY (¥)
Mar. 31, 2021
CNY (¥)
Apr. 30, 2020
Long term Investments and Receivables Net [Line Items]                  
Carrying value of equity method investments         ¥ 7,494   ¥ 6,783    
Cash consideration             15,792    
Stock Issued During Period, Value, New Issues               ¥ 395,071  
Proceeds from Sale of Equity Method Investments           ¥ 3,000      
Other Nonoperating Gains (Losses)         (939)   (289) 797  
Wuhan Chunzhijin [Member]                  
Long term Investments and Receivables Net [Line Items]                  
Loans receivable waived and converted into shares         3,400        
Discontinued Operations, Disposed of by Sale [Member]                  
Long term Investments and Receivables Net [Line Items]                  
Other Nonoperating Gains (Losses)         540        
Nanjing Animal Pharmaceutical [Member]                  
Long term Investments and Receivables Net [Line Items]                  
Investment re-measured at fair value         18,000   16,900    
Unrealized Securities holding gain, Net of tax         ¥ 830   710    
Long-term Line of Credit ¥ 16,000                
Line of Credit Facility, Interest Rate During Period 8.00%                
Debt Instrument, Convertible, Conversion Ratio 3.33                
Accrued Liabilities And Other Current Liabilities [Member] | Nanjing Animal Pharmaceutical [Member]                  
Long term Investments and Receivables Net [Line Items]                  
Long-term Debt, Gross ¥ 2,000                
Qingdao Shuangan Biotechnology Co Ltd [Member]                  
Long term Investments and Receivables Net [Line Items]                  
Redemption of investment period         48 months        
Investment re-measured at fair value         ¥ 17,800   12,800    
Unrealized Securities holding gain, Net of tax         ¥ (1,140)   340 20  
Qingdao Shuangan Biotechnology Co Ltd [Member] | Available For Sale Debt Investments [Member]                  
Long term Investments and Receivables Net [Line Items]                  
Equity method investment ownership percentage         6.20%        
Beijing Petdog Technology Development Co Ltd [Member]                  
Long term Investments and Receivables Net [Line Items]                  
Cash consideration     ¥ 50,000            
Redemption of investment period     60 months            
Investment re-measured at fair value         ¥ 33,700   40,100    
Unrealized Securities holding gain, Net of tax         ¥ (6,400)   ¥ (10,400) ¥ 750  
Beijing Petdog Technology Development Co Ltd [Member] | Available For Sale Debt Investments [Member]                  
Long term Investments and Receivables Net [Line Items]                  
Equity method investment ownership percentage     23.64%            
Better Choice Company Inc [Member]                  
Long term Investments and Receivables Net [Line Items]                  
Stock Issued During Period, Shares, New Issues | shares   40,000              
Stock Issued During Period, Value, New Issues | $   $ 200,000              
Jiangsu Nanjing Agricultural University Animal Pharmaceutical Co Ltd [Member]                  
Long term Investments and Receivables Net [Line Items]                  
Cash consideration       ¥ 2,500          
Jiangsu Nanjing Agricultural University Animal Pharmaceutical Co Ltd [Member] | Equity Method Investment [Member]                  
Long term Investments and Receivables Net [Line Items]                  
Equity method investment ownership percentage       8.42%          
Wuhan Chunzhijin Information Technology Co Ltd [Member] | Equity Method Investment [Member]                  
Long term Investments and Receivables Net [Line Items]                  
Equity method investment ownership percentage         13.30%       24.60%
Wuhan Chunzhijin Information Technology Co Ltd [Member] | Maximum [Member] | Equity Method Investment [Member]                  
Long term Investments and Receivables Net [Line Items]                  
Equity method investment ownership percentage         34.65%        
Qingdao Shuangan [Member]                  
Long term Investments and Receivables Net [Line Items]                  
Proceeds from Sale of Equity Method Investments         ¥ 800        
Other Nonoperating Gains (Losses)         ¥ 370        
Percentage Of Equity Interests Transferred         0.31%        
Qingdao Shuangan [Member] | Available For Sale Debt Investments [Member]                  
Long term Investments and Receivables Net [Line Items]                  
Equity method investment ownership percentage             5.90%    
XML 113 R91.htm IDEA: XBRL DOCUMENT v3.23.2
Goodwill - Schedule of Changes in the Carrying Amount of Goodwill (Detail)
¥ in Thousands, $ in Thousands
12 Months Ended
Mar. 31, 2023
CNY (¥)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
CNY (¥)
Mar. 31, 2021
CNY (¥)
Goodwill and Intangible Assets Disclosure [Abstract]        
Goodwill ¥ 40,684   ¥ 40,684 ¥ 40,184
Accumulated impairment loss (40,684)   0 0
Impairment (40,684) $ (5,900)    
Total ¥ 0   40,684 ¥ 40,184
Additions     ¥ 500  
XML 114 R92.htm IDEA: XBRL DOCUMENT v3.23.2
Goodwill - Additional Information (Detail) - 12 months ended Mar. 31, 2023
¥ in Thousands, $ in Thousands
CNY (¥)
USD ($)
USD ($)
Indefinite-lived Intangible Assets [Line Items]      
Reporting Unit, Amount of Fair Value Less Than Carrying Amount ¥ 119,800   $ 17,400
Net Assets Of The Group 213,000   $ 31,000
Impairment of goodwill ¥ 40,684 $ 5,900  
XML 115 R93.htm IDEA: XBRL DOCUMENT v3.23.2
Other non-current Assets - Schedule of Other Non-current Assets (Detail)
¥ in Thousands, $ in Thousands
Mar. 31, 2023
CNY (¥)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
CNY (¥)
Other Assets, Noncurrent Disclosure [Abstract]      
Deposits ¥ 3,165   ¥ 3,924
Long-term loans receivable 3,421   937
Total ¥ 6,586 $ 959 ¥ 4,861
XML 116 R94.htm IDEA: XBRL DOCUMENT v3.23.2
Other non-current Assets - Schedule of Other Non-current Assets (Parenthetical) (Detail) - CNY (¥)
¥ in Thousands
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Other Assets Noncurrent Disclosure [Line Items]    
Long-term loans receivable ¥ 3,421 ¥ 937
Loan Receivable for the Period 24 to 36 Months [Member]    
Other Assets Noncurrent Disclosure [Line Items]    
Loan receivable face or par amount ¥ 3,400  
Loan Receivable for the Period 24 to 36 Months [Member] | From May 2021 To May 2022 [Member] | Maximum [Member]    
Other Assets Noncurrent Disclosure [Line Items]    
Loans Receivable Term 36 months  
Loans receivable month of maturity 2025-06  
Loan Receivable for the Period 24 to 36 Months [Member] | From May 2021 To May 2022 [Member] | Minimum [Member]    
Other Assets Noncurrent Disclosure [Line Items]    
Loans Receivable Term 24 months  
Loans receivable month of maturity 2024-05  
XML 117 R95.htm IDEA: XBRL DOCUMENT v3.23.2
Accrued liabilities and other current liabilities - Schedule of Accrued Liabilities and Other Current Liabilities (Detail)
¥ in Thousands, $ in Thousands
Mar. 31, 2023
CNY (¥)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
CNY (¥)
Accrued Liabilities and Other Liabilities [Abstract]      
Logistics expenses payables ¥ 7,663   ¥ 14,625
Advances from customers 3,077   3,773
Payable for investment 2,563   2,563
Refund obligation of sales returns 3,113   1,411
Professional service fee accruals 1,694   579
Accrued advertising expenses 168   150
Others 3,826   4,223
Total ¥ 22,104 $ 3,219 ¥ 27,324
XML 118 R96.htm IDEA: XBRL DOCUMENT v3.23.2
Leases - Summary of Operating Leases (Detail)
¥ in Thousands, $ in Thousands
Mar. 31, 2023
CNY (¥)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
CNY (¥)
Assets      
Operating lease right-of-use assets ¥ 22,354 $ 3,255 ¥ 38,567
Liabilities      
Operating lease liabilities, current 9,220 1,343 10,001
Operating lease liabilities, non-current 12,741 $ 1,855 28,197
Total operating lease liabilities ¥ 21,961   ¥ 38,198
Weighted average remaining lease term (years) 2 years 9 months 7 days 2 years 9 months 7 days 3 years 7 months 9 days
Weighted average discount rate 5.38% 5.38% 4.95%
XML 119 R97.htm IDEA: XBRL DOCUMENT v3.23.2
Leases - Summary of Operating Lease Activity (Detail)
¥ in Thousands, $ in Thousands
12 Months Ended
Mar. 31, 2023
CNY (¥)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
CNY (¥)
Mar. 31, 2021
CNY (¥)
Leases [Abstract]        
Operating lease right-of-use assets obtained in exchange for lease obligations ¥ 8,384 $ 1,221 ¥ 21,038 ¥ 25,970
Amortization of right-of-use assets 24,597   11,705 11,687
Interest of lease liabilities 1,777   1,949 1,596
Operating lease payments (included in measurement of lease liabilities) 26,397   12,849 12,850
Operating lease, expense ¥ 26,374   ¥ 13,654 ¥ 13,283
XML 120 R98.htm IDEA: XBRL DOCUMENT v3.23.2
Leases - Summary of Maturities of Lease Liabilities (Detail) - CNY (¥)
¥ in Thousands
Mar. 31, 2023
Mar. 31, 2022
Leases [Abstract]    
2023 ¥ 9,902  
2024 10,287  
2025 4,263  
2026 152  
2027 0  
Total lease payments 24,604  
Less: imputed interest (2,643)  
Total ¥ 21,961 ¥ 38,198
XML 121 R99.htm IDEA: XBRL DOCUMENT v3.23.2
Interest expense - Summary of Interest Expense (Detail)
¥ in Thousands, $ in Thousands
12 Months Ended
Mar. 31, 2023
CNY (¥)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
CNY (¥)
Mar. 31, 2021
CNY (¥)
Interest and Debt Expense [Abstract]        
Amortization charges on promissory notes ¥ 9,706   ¥ 17,144 ¥ 21,611
Interest expense on borrowings 3,644   3,740 6,039
Total ¥ 13,350 $ 1,944 ¥ 20,884 ¥ 27,650
XML 122 R100.htm IDEA: XBRL DOCUMENT v3.23.2
Other gains, net - Summary of Other (Losses), Net (Detail)
¥ in Thousands, $ in Thousands
1 Months Ended 12 Months Ended
Aug. 31, 2022
CNY (¥)
Mar. 31, 2023
CNY (¥)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
CNY (¥)
Mar. 31, 2021
CNY (¥)
Other gains (losses), net [Abstract]          
Gain from the re-measurement of the previously held equity interests to the fair value in the step acquisitions       ¥ 127  
Foreign exchange losses, net   ¥ 2,679   5,322 ¥ (2,867)
Gain on disposal of other debts         6,846
Reimbursement from a depositary bank       1,482 6,556
Investment loss   (178)   (622) 0
Gain on disposal of a subsidiary ¥ 3,600 3,597 $ 524    
Others   (939)   (289) 797
Total   ¥ 5,159   ¥ 6,020 ¥ 11,332
XML 123 R101.htm IDEA: XBRL DOCUMENT v3.23.2
Other gains, net - Summary of Other (Losses), Net (Parenthetical) (Detail)
¥ in Thousands, $ in Thousands
1 Months Ended 12 Months Ended
Aug. 31, 2022
CNY (¥)
Mar. 31, 2023
CNY (¥)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
CNY (¥)
Mar. 31, 2022
USD ($)
Mar. 31, 2021
CNY (¥)
Mar. 31, 2021
USD ($)
Other gains (losses), net [Abstract]              
Reimbursement depositary received   ¥ 0   ¥ 1,500 $ 200 ¥ 6,600 $ 1,000
Investment gain on disposal of a subsidiary ¥ 3,600 ¥ 3,597 $ 524        
XML 124 R102.htm IDEA: XBRL DOCUMENT v3.23.2
Income taxes - Schedule of Effective Income Tax Rate Reconciliation (Detail)
¥ in Thousands, $ in Thousands
12 Months Ended
Mar. 31, 2023
CNY (¥)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
CNY (¥)
Mar. 31, 2021
CNY (¥)
Income Tax Disclosure [Abstract]        
Loss before income taxes ¥ (106,805) $ (15,552) ¥ (134,812) ¥ (193,391)
Income tax computed at respective applicable tax rates (26,701)   (33,702) (48,348)
Effect of different tax jurisdiction 12,323   2,341 14,272
Super deduction for research and development expenses (456)   (1,881) (2,632)
Non-deductible expenses 728   97 140
Change in valuation allowance 15,017   34,716 37,439
Total ¥ 911 $ 133 ¥ 1,571 ¥ 871
PRC statutory income tax rates 25.00% 25.00% 25.00% 25.00%
Tax holiday effect (1.00%) (1.00%) 3.00% 1.00%
Difference in tax rates of subsidiaries outside PRC (10.00%) (10.00%) (8.00%) (8.00%)
Super deduction for research and development expenses 0.00% 0.00% 1.00% 1.00%
Non-deductible expenses 1.00% 1.00% 0.00% 0.00%
Change in valuation allowance (14.00%) (14.00%) (20.00%) (19.00%)
Effective income tax rate 1.00% 1.00% 1.00% 0.00%
XML 125 R103.htm IDEA: XBRL DOCUMENT v3.23.2
Income taxes - Schedule of Effective Income Tax Rate Reconciliation (Parenthetical) (Detail) - CNY (¥)
¥ in Thousands
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Super deduction for research and development expenses ¥ 456 ¥ 1,881 ¥ 2,632
Tax Year 2018 [Member]      
Effective income tax rate reconciliation non-deductible expense research and development percentage 175.00%    
Effective income tax rate reconciliation non-deductible expense research and development additional deduction percentage 75.00%    
XML 126 R104.htm IDEA: XBRL DOCUMENT v3.23.2
Income taxes - Summary of Income Tax Holiday (Detail) - CNY (¥)
¥ / shares in Units, ¥ in Thousands
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Income Tax Disclosure [Abstract]      
Tax holiday effect ¥ 1,235 ¥ 3,513 ¥ 1,074
Basic and diluted net loss per share effect ¥ 0.02 ¥ 0.05 ¥ 0.02
XML 127 R105.htm IDEA: XBRL DOCUMENT v3.23.2
Income taxes - Schedule of Components of Income Tax Expenses Benefit (Detail)
¥ in Thousands, $ in Thousands
12 Months Ended
Mar. 31, 2023
CNY (¥)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
CNY (¥)
Mar. 31, 2021
CNY (¥)
Income Tax Disclosure [Abstract]        
Current income tax expense/(benefit) ¥ 78   ¥ (582) ¥ 1,018
Deferred tax benefit (989) $ (144) (989) (1,889)
Income tax Credit, net ¥ (911) $ (133) ¥ (1,571) ¥ (871)
XML 128 R106.htm IDEA: XBRL DOCUMENT v3.23.2
Income taxes - Schedule of Deferred Tax Assets And Tax Liabilities (Detail) - CNY (¥)
¥ in Thousands
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2020
Deferred tax assets:        
Net accumulated loss-carry forward ¥ 163,526 ¥ 172,059    
Deferred deductible advertising expense 0 2,483    
Allowance 238 78    
Contract liabilities 172 419    
Accruals 842 2,208    
Fair Value Change 1,891 0    
Less: Valuation allowance (166,669) (177,247) ¥ (149,978) ¥ (112,539)
Net deferred tax assets 0 0    
Deferred tax liabilities:        
Recognition of intangible assets arising from asset acquisition and business combination (4,141) (5,130)    
Unrealized fair value change of the available-for-sale debt investments 0 283    
Net deferred tax liabilities ¥ (4,141) ¥ (4,847)    
XML 129 R107.htm IDEA: XBRL DOCUMENT v3.23.2
Income taxes - Summary of Valuation Allowance (Detail) - CNY (¥)
¥ in Thousands
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Income Tax Disclosure [Abstract]      
Beginning balance ¥ 177,247 ¥ 149,978 ¥ 112,539
Change of valuation allowance 15,017 27,269 37,439
 Written-off for expiration of net operating losses (22,995) 0 0
Decrease of valuation allowances related to the disposal of a subsidiary (2,600) 0 0
Ending balance ¥ 166,669 ¥ 177,247 ¥ 149,978
XML 130 R108.htm IDEA: XBRL DOCUMENT v3.23.2
Income taxes - Additional Information (Detail) - CNY (¥)
¥ in Millions
12 Months Ended
Jul. 25, 2018
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Income tax rate   25.00% 25.00% 25.00%
Income tax holiday, description Shanghai Boqii could enjoy a tax holiday of 2-year EIT exemption and subsequently 3-year 12.5% preferential tax rate.      
Change of valuation allowance   ¥ 166.7 ¥ 177.2  
Operating loss carry forwards   ¥ 654.0 ¥ 688.0  
Preferential tax rate   12.50% 12.50% 12.50%
HK [Member] | Maximum [Member]        
Income tax rate   16.50%    
HK [Member] | Minimum [Member]        
Income tax rate   8.25%    
CHINA [Member]        
Income tax rate   25.00%    
Preferential tax rate   15.00%    
XML 131 R109.htm IDEA: XBRL DOCUMENT v3.23.2
Ordinary Share - Additional Information (Detail)
$ / shares in Units, ¥ in Thousands, $ in Millions
1 Months Ended 12 Months Ended
Feb. 28, 2021
USD ($)
shares
Oct. 31, 2020
USD ($)
shares
$ / shares
Mar. 31, 2023
$ / shares
shares
Mar. 31, 2021
CNY (¥)
Mar. 31, 2022
$ / shares
shares
Number of shares per ADS   0.75      
Proceeds from IPO   $ 61.0   ¥ 393,698  
Common Class A [Member]          
Common Stock, Shares, Issued     55,763,079   55,709,591
Common Stock, Shares, Outstanding     55,763,079   55,709,591
Stock issued during period   5,250,000      
Common Stock, Par or Stated Value Per Share | $ / shares     $ 0.001   $ 0.001
Common Class B [Member]          
Common Stock, Shares, Issued     13,037,729   13,037,729
Common Stock, Shares, Outstanding     13,037,729   13,037,729
Common Stock, Par or Stated Value Per Share | $ / shares   $ 0.001 $ 0.001   $ 0.001
Preferred Stock, Conversion Basis     one basis except for    
ADS [Member]          
Share price | $ / shares   10      
Series C Redeemable Convertible Preferred Shares [Member]          
Preferred Stock, Conversion Basis     one-for-one basis    
IPO [Member] | Common Class A [Member]          
Common Stock, Par or Stated Value Per Share | $ / shares   $ 0.001      
Stock Repurchased and Retired During Period, Shares 521,924        
Stock Repurchased and Retired During Period, Value | $ $ 4.8        
IPO [Member] | Common Class B [Member]          
Stock Issued During Period, Shares, Conversion of Convertible Securities   12,204,604      
IPO [Member] | ADS [Member]          
Sale of Stock, Number of Shares Issued in Transaction   7,000,000      
IPO [Member] | Series A Redeemable Convertible Preferred Shares [Member]          
Convertible Preferred Shares, Outstanding   10,340,000      
Stock Issued During Period, Shares, Conversion of Convertible Securities   7,844,137      
Preferred Stock, Conversion Basis   1: 0.76      
IPO [Member] | Series B Redeemable Convertible Preferred Shares [Member]          
Convertible Preferred Shares, Outstanding   9,067,384      
Stock Issued During Period, Shares, Conversion of Convertible Securities   8,557,980      
Preferred Stock, Conversion Basis   1:0.94      
IPO [Member] | Series C Plus Redeemable Convertible Preferred Shares [Member]          
Convertible Preferred Shares, Outstanding   6,734,459      
Stock Issued During Period, Shares, Conversion of Convertible Securities   6,883,520      
Preferred Stock, Conversion Basis   1:1.02      
IPO [Member] | Series C Preferred Stock [Member]          
Convertible Preferred Shares, Outstanding   833,125      
Over-Allotment Option [Member] | ADS [Member]          
Sale of Stock, Number of Shares Issued in Transaction   1,050,000      
XML 132 R110.htm IDEA: XBRL DOCUMENT v3.23.2
Convertible redeemable preferred shares - Additional Information (Detail)
¥ in Thousands, $ in Millions
12 Months Ended
Mar. 31, 2023
CNY (¥)
Mar. 31, 2022
CNY (¥)
Mar. 31, 2021
CNY (¥)
Mar. 31, 2021
USD ($)
Accretion on the Preferred Shares to redemption value ¥ 0 ¥ 0 ¥ 121,000 $ 18
XML 133 R111.htm IDEA: XBRL DOCUMENT v3.23.2
Redeemable non-controlling interests - Additional Information (Detail) - CNY (¥)
¥ in Thousands
12 Months Ended
Oct. 31, 2020
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2020
Equity, shares issued 120,000        
Redeemable preferred shares issued amount       ¥ 413,377  
Accretion of redemption value of the redeemable non-controlling interest   ¥ (675) ¥ (575) (138)  
Redeemable non controlling interest equity carrying amount total   ¥ 7,197 ¥ 6,522 ¥ 5,947 ¥ 5,809
Yoken Holding Limited [Member]          
Redeemable preferred shares issued amount ¥ 6,000        
Percentage of preferred shares redeemable at redemption price measured by Interest per year Since Issuance of shares 10.00%        
XML 134 R112.htm IDEA: XBRL DOCUMENT v3.23.2
Redeemable non-controlling interests - Schedule Of Redeemable Non-Controlling Interests Activity (Detail) - CNY (¥)
¥ in Thousands
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Noncontrolling Interest [Abstract]      
Beginning balance ¥ 6,522 ¥ 5,947 ¥ 5,809
Accretion of redeemable non-controlling interests 675 575 138
Ending balance ¥ 7,197 ¥ 6,522 ¥ 5,947
XML 135 R113.htm IDEA: XBRL DOCUMENT v3.23.2
Borrowings, other debts and derivative liabilities - Summary of Short-term Debt (Detail)
¥ in Thousands, $ in Thousands
Mar. 31, 2023
CNY (¥)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
CNY (¥)
Debt Disclosure [Abstract]      
Bank borrowings ¥ 86,261   ¥ 134,540
Current portion of long-term bank borrowings     26,586
Total ¥ 86,261 $ 12,561 ¥ 161,126
XML 136 R114.htm IDEA: XBRL DOCUMENT v3.23.2
Borrowings, other debts and derivative liabilities - Additional Information (Detail)
$ / shares in Units, ¥ in Thousands, $ in Thousands
1 Months Ended 12 Months Ended
Mar. 31, 2021
CNY (¥)
Oct. 23, 2020
CNY (¥)
shares
Oct. 23, 2020
USD ($)
$ / shares
shares
Mar. 31, 2020
CNY (¥)
Mar. 31, 2020
USD ($)
Mar. 31, 2023
CNY (¥)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
CNY (¥)
Mar. 31, 2022
USD ($)
Mar. 31, 2021
CNY (¥)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
USD ($)
Mar. 31, 2020
USD ($)
Mar. 01, 2020
CNY (¥)
Borrowings Other Debts And Other Liabilities [Line Items]                            
Short term bank borrowings outstanding           ¥ 86,261   ¥ 161,126     $ 12,561      
Receivable for the issuance of ordinary shares           83,400   164,746     12,145      
Proceeds from Issuance of Debt           110,553 $ 16,098 185,614   ¥ 87,846        
Repayments of other debts           87,959 12,808 270,860   130,827        
Interest expense           13,350 1,944 20,884   27,650        
Derivative Liability, Current           10,701   9,086     $ 1,558      
Stock issued during period, value, new issues                   ¥ 395,071        
New Foreign Exchange Swap Contract [Member]                            
Borrowings Other Debts And Other Liabilities [Line Items]                            
Payment towards advance settlement of foreign exchange swaps | $             $ 1,500   $ 11,000          
Currency Swap [Member] | New Foreign Exchange Swap Contract [Member]                            
Borrowings Other Debts And Other Liabilities [Line Items]                            
Gain (Loss) on Derivative, Net           100   1,200            
Deferred fair value gain loss on foreign swap contract one           (3,600)   900            
Derivative assets current               ¥ 700            
Derivative Liability, Current           2,900                
Currency Swap [Member] | New Foreign Exchange Swap Contract [Member] | New Foreign Exchange Swap Contract One [Member]                            
Borrowings Other Debts And Other Liabilities [Line Items]                            
Currency to be exchanged | $                       $ 8,000    
Derivative forward exchange rate               6.5452       6.5452    
Currency to be received               ¥ 52,400            
Currency Swap [Member] | New Foreign Exchange Swap Contract [Member] | New Foreign Exchange Swap Contract Two [Member]                            
Borrowings Other Debts And Other Liabilities [Line Items]                            
Currency to be exchanged | $                       $ 4,000    
Derivative forward exchange rate               6.5128       6.5128    
Currency to be received               ¥ 26,100            
Currency Swap [Member] | New Foreign Exchange Swap Contract [Member] | New Foreign Exchange Swap Contract Three [Member]                            
Borrowings Other Debts And Other Liabilities [Line Items]                            
Currency to be exchanged | $                       $ 5,000    
Derivative forward exchange rate               6.42       6.42    
Currency to be received               ¥ 32,100            
Yoken Series A One Warrant [Member]                            
Borrowings Other Debts And Other Liabilities [Line Items]                            
Class of warrants or rights exercise price | $ / shares     $ 7.14                      
Class of warrants or rights outstanding value           27,300   23,200            
Chong Li [Member]                            
Borrowings Other Debts And Other Liabilities [Line Items]                            
Debt instrument face value       ¥ 128,000                    
Long-term Debt, Term       5 years                 5 years  
Long term loan due to the related party non current       ¥ 95,000                   ¥ 95,000
Receivable for the issuance of temporary equity           36,400   35,900            
Interest expense           4,500   5,100            
Chong Li [Member] | Superb Origin International Limited [Member] | Equity Owner [Member]                            
Borrowings Other Debts And Other Liabilities [Line Items]                            
Equity method investment ownership interest       100.00%                 100.00%  
Investor One [Member] | Yoken Series A One Warrant [Member]                            
Borrowings Other Debts And Other Liabilities [Line Items]                            
Class of warrants or rights number of securities called by the warrants or rights | shares     360,000                      
Debt instrument convertible carrying value at the time of conversion   ¥ 18,000 $ 2,500                      
Investor Two [Member] | Yoken Series A One Warrant [Member]                            
Borrowings Other Debts And Other Liabilities [Line Items]                            
Class of warrants or rights number of securities called by the warrants or rights | shares     200,000                      
Debt instrument convertible carrying value at the time of conversion   ¥ 10,000 $ 1,400                      
Loan for Yoken Series A-1 Warrant [Member]                            
Borrowings Other Debts And Other Liabilities [Line Items]                            
Long term borrowings fixed rate of interest rate percentage       10.00%                 10.00%  
Debt instrument converted shares issued | shares   120,000 120,000                      
Proceeds from Issuance of Debt       ¥ 18,000                    
Loan for Yoken Series A-1 Warrant [Member] | Yoken Series A One Warrant [Member]                            
Borrowings Other Debts And Other Liabilities [Line Items]                            
Class of warrants or rights outstanding value           7,900   9,100            
Interest Expense Reversed ¥ 1,400                          
Loan from CMB [Member] | CMB [Member]                            
Borrowings Other Debts And Other Liabilities [Line Items]                            
Debt instrument face value | $                         $ 46,000  
Long-term Debt, Term       2 years                 2 years  
Receivable for the issuance of ordinary shares           0   86,400            
Stock issued during period, value, new issues       ¥ 303,000 $ 46,000                  
Loan from CMB [Member] | CMB [Member] | Extension of Loan Agreement [Member]                            
Borrowings Other Debts And Other Liabilities [Line Items]                            
Debt instrument face value       ¥ 303,000                 $ 46,000  
Repayments of other debts           87,900   235,000            
Interest expense           1,500   ¥ 8,900            
Short-term Investments [Member] | Long Term Bank Loan [Member]                            
Borrowings Other Debts And Other Liabilities [Line Items]                            
Debt instrument unused borrowing capacity           ¥ 0                
Short Term Bank Loan [Member]                            
Borrowings Other Debts And Other Liabilities [Line Items]                            
Short term borrowings weighted average interest rate at a point in time           3.98%   2.63%     3.98% 2.63%    
Debt instrument unused borrowing capacity           ¥ 213,000   ¥ 170,300            
Short Term Bank Loan [Member] | Short-term Investments [Member]                            
Borrowings Other Debts And Other Liabilities [Line Items]                            
Collateralized by short-term investments           ¥ 63,900   ¥ 110,500            
XML 137 R115.htm IDEA: XBRL DOCUMENT v3.23.2
Borrowings, other debts and derivative liabilities - Summary of Maturities of Long-term Debt (Detail) - CNY (¥)
¥ in Thousands
Mar. 31, 2023
Mar. 31, 2022
Debt Disclosure [Abstract]    
Within 1 year ¥ 86,261 ¥ 161,126
Total ¥ 86,261 ¥ 161,126
XML 138 R116.htm IDEA: XBRL DOCUMENT v3.23.2
Borrowings, other debts and derivative liabilities - Summary of Other Long Term Debt (Detail)
¥ in Thousands, $ in Thousands
Mar. 31, 2023
CNY (¥)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
CNY (¥)
Debt Instrument [Line Items]      
Other debts, non-current ¥ 102,827 $ 14,973 ¥ 181,062
Payable for investment 1,500   1,500
Loan from CMB [Member]      
Debt Instrument [Line Items]      
Other debts, non-current     86,373
Loan from Chong Li [Member]      
Debt Instrument [Line Items]      
Other debts, non-current 73,981   70,001
Loan for Yoken Series A-1 Warrant [Member]      
Debt Instrument [Line Items]      
Other debts, non-current ¥ 27,346   ¥ 23,188
XML 139 R117.htm IDEA: XBRL DOCUMENT v3.23.2
Borrowings, other debts and derivative liabilities - Summary of Fair Value of Derivative Liabilities (Detail) - CNY (¥)
¥ in Thousands
Mar. 31, 2023
Mar. 31, 2022
Schedule Of Derivative Liabilities At Fair Value [Line Items]    
Derivative Liability ¥ 10,701 ¥ 9,086
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Derivative Liability, Current  
Conversion feature of Yoken Series A-1 Warrant [Member]    
Schedule Of Derivative Liabilities At Fair Value [Line Items]    
Derivative Liability ¥ 7,850 ¥ 9,086
Forward exchange swap [Member]    
Schedule Of Derivative Liabilities At Fair Value [Line Items]    
Derivative Liability ¥ 2,851  
XML 140 R118.htm IDEA: XBRL DOCUMENT v3.23.2
Receivable for issuance of ordinary shares - Additional Information (Detail)
¥ in Thousands, $ in Thousands
12 Months Ended
Mar. 31, 2023
CNY (¥)
Mar. 31, 2022
CNY (¥)
Mar. 31, 2023
USD ($)
Receivable For The Issuance Of Ordinary Shares [Line Items]      
Proceeds from contributed capital ¥ 87,900 ¥ 262,900  
Interest income on subscription receivable from shareholders 6,100 14,200  
Receivable for the issuance of ordinary shares ¥ 83,400 ¥ 164,746 $ 12,145
XML 141 R119.htm IDEA: XBRL DOCUMENT v3.23.2
Share-based compensation - Summary of Stock Option Activity (Detail) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Share-based Payment Arrangement, Disclosure [Abstract]      
Number of shares, Outstanding, beginning 5,231,891 5,512,222  
Number of shares, Granted   1,282,500  
Number of shares, Exercised (53,488) (1,204,483)  
Number of shares, Forfeited (1,233,050) (358,348)  
Number of shares, Outstanding, ending 3,945,354 5,231,891 5,512,222
Weighted average exercise price, Outstanding, beginning $ 2.86 $ 3.36  
Weighted average exercise price, Granted   2.86  
Weighted average exercise price, Exercised 0.6 1.09  
Weighted average exercise price, Forfeited 1.31 2.86  
Weighted average exercise price, Outstanding, ending $ 2.58 $ 2.86 $ 3.36
Weighted average remaining contractual term, Outstanding 3 years 5 months 12 days 5 years 3 months 6 years 3 months 25 days
Aggregate intrinsic value, Outstanding, beginning $ 404 $ 29,360  
Aggregate intrinsic value, Outstanding, ending $ 124 $ 404 $ 29,360
Weighted average fair value, Outstanding, beginning $ 2.36 $ 3.28  
Weighted average fair value, Granted   2.27  
Weighted average fair value, Exercised 2.26 0.73  
Weighted average fair value, Forfeited 0.86 3.83  
Weighted average fair value, Outstanding, ending $ 2.06 $ 2.36 $ 3.28
XML 142 R120.htm IDEA: XBRL DOCUMENT v3.23.2
Share-based compensation - Summary of Options Measured At Fair Value, Valuation Assumptions (Detail) - Share-based Payment Arrangement, Option [Member]
12 Months Ended
Mar. 31, 2022
$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Expected volatility , Minimum 42.22%
Expected volatility , Maximum 43.71%
Risk-free rate , Minimum 1.62%
Risk-free rate , Maximum 1.86%
Expected dividend yield 0.00%
Contractual term (in years) 10 years
Maximum [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Exercise multiple $ 2.8
Minimum [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Exercise multiple $ 2.2
XML 143 R121.htm IDEA: XBRL DOCUMENT v3.23.2
Share-based compensation - Additional Information (Detail)
¥ in Millions
12 Months Ended
Mar. 31, 2020
USD ($)
Mar. 31, 2023
USD ($)
shares
Mar. 31, 2023
CNY (¥)
shares
Mar. 31, 2022
USD ($)
shares
Mar. 31, 2022
CNY (¥)
shares
Mar. 31, 2021
CNY (¥)
May 31, 2022
shares
Mar. 31, 2021
USD ($)
Sep. 01, 2020
shares
Aug. 01, 2018
shares
Sep. 27, 2012
shares
Share Based Payment Arrangement [Line Items]                      
Percentage of entitlement to vest earn by employees   25.00% 25.00%                
Share based compensation arrangement by share based payment award options granted       1,282,500 1,282,500            
Share based compensation arrangement by share based payment award options outstanding intrinsic value | $   $ 123,594,000   $ 404,409,000       $ 29,359,582,000      
Unrecognised share based compensation expenses | $   $ 322,926,000   $ 2,298,328,000              
Weighted average vesting period   3 years 4 months 24 days 3 years 4 months 24 days 5 years 3 months 18 days 5 years 3 months 18 days            
Share based compensation expense recognized until the completion of a qualified IPO | $   $ 0                  
Share based compensation expense $ 0   ¥ (7.7)   ¥ 14.4 ¥ 55.0          
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized             4,000,000        
Employees and Non Employees [Member]                      
Share Based Payment Arrangement [Line Items]                      
Share based compensation arrangement by share based payment award options granted   0 0 1,282,500 1,282,500            
Fair value of options granted amount | $   $ 0   $ 2,900,000              
2012 Global Share Plan [Member]                      
Share Based Payment Arrangement [Line Items]                      
Shares reserved for future issuances                     1,061,500
2018 Global Share Plan [Member]                      
Share Based Payment Arrangement [Line Items]                      
Shares reserved for future issuances             8,987,836   5,987,836 5,987,836  
Amended 2018 Global Share Plan [Member]                      
Share Based Payment Arrangement [Line Items]                      
Shares reserved for future issuances             12,987,836   8,987,836    
XML 144 R122.htm IDEA: XBRL DOCUMENT v3.23.2
Employee benefits - Additional Information (Detail) - CNY (¥)
¥ in Millions
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Compensation Related Costs [Abstract]      
Employee benefits costs ¥ 9 ¥ 7 ¥ 6
XML 145 R123.htm IDEA: XBRL DOCUMENT v3.23.2
Fair value measurements - Summary of Company's Financial Assets and Liabilities (Detail) - CNY (¥)
¥ in Thousands
Mar. 31, 2023
Mar. 31, 2022
Assets:    
Available-for-sale debt investments ¥ 68,011 ¥ 74,866
Equity securities with readily determinable fair values 102 670
Fair Value, Recurring [Member]    
Assets:    
Short-term investments 69,797 128,084
Available-for-sale debt investments 68,011 74,866
Equity securities with readily determinable fair values 102 670
Total assets 137,910 203,620
Liabilities:    
Derivative liabilities 10,701 9,086
Fair Value, Recurring [Member] | Significant unobservable Inputs (Level 1) [Member]    
Assets:    
Equity securities with readily determinable fair values 102 670
Total assets 102 670
Fair Value, Recurring [Member] | Significant other observable Inputs (Level 2) [Member]    
Assets:    
Short-term investments 69,797 128,084
Total assets 69,797 128,084
Fair Value, Recurring [Member] | Significant unobservable Inputs (Level 3) [Member]    
Assets:    
Available-for-sale debt investments 68,011 74,866
Total assets 68,011 74,866
Liabilities:    
Derivative liabilities ¥ 10,701 ¥ 9,086
XML 146 R124.htm IDEA: XBRL DOCUMENT v3.23.2
Fair value measurements - Summary of Roll Forward of Major Level 3 Investments (Detail) - CNY (¥)
¥ in Thousands
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Available-for-sale Securities [Member]      
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Disposal of Series D-3 Notes ¥ (428)    
Fair value of Level 3 investments , Beginning Balance 74,866 ¥ 71,357 ¥ 70,328
New addition   16,000  
Unrealized fair value change of the available-for-sale debt investments (6,427) (12,491) 1,029
Fair value of Level 3 investments , Ending Balance 68,011 74,866 71,357
Derivative Financial Instruments, Liabilities [Member]      
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Fair value of Level 3 investments, Beginning Balance 9,086 9,996 14,351
New addition     9,581
Disposal of Series D-3 Notes     (2,377)
Reclassification of forward exchange contracts (651) 746  
Unrealized fair value change of the derivative liabilities 2,266 (1,656) (11,559)
Fair value of Level 3 investments , Ending Balance ¥ 10,701 ¥ 9,086 ¥ 9,996
XML 147 R125.htm IDEA: XBRL DOCUMENT v3.23.2
Fair value measurements - Summary of Significant Unobservable Inputs (Detail) - Available-for-sale Securities [Member]
Mar. 31, 2023
Mar. 31, 2022
Implied price to sales after discount for lack of marketability [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Debt Securities, Available-for-sale, Measurement Input 1.04  
Weighted average cost of capital [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Debt Securities, Available-for-sale, Measurement Input   15
Weighted average cost of capital [Member] | Median [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Debt Securities, Available-for-sale, Measurement Input   16.5
Weighted average cost of capital [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Debt Securities, Available-for-sale, Measurement Input   18
Lack of marketability discount [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Debt Securities, Available-for-sale, Measurement Input 20  
Lack of marketability discount [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Debt Securities, Available-for-sale, Measurement Input   17
Lack of marketability discount [Member] | Median [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Debt Securities, Available-for-sale, Measurement Input   23
Lack of marketability discount [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Debt Securities, Available-for-sale, Measurement Input   29
Risk-free rate [Member] | Minimum One [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Debt Securities, Available-for-sale, Measurement Input   2.23
Risk-free rate [Member] | Minimum Two [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Debt Securities, Available-for-sale, Measurement Input   2.34
Risk-free rate [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Debt Securities, Available-for-sale, Measurement Input 2.6 1.95
Risk-free rate [Member] | Median [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Debt Securities, Available-for-sale, Measurement Input 2.31  
Risk-free rate [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Debt Securities, Available-for-sale, Measurement Input 2.19 2.36
Expected volatility [Member] | Minimum One [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Debt Securities, Available-for-sale, Measurement Input   42.17
Expected volatility [Member] | Minimum Two [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Debt Securities, Available-for-sale, Measurement Input   42.48
Expected volatility [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Debt Securities, Available-for-sale, Measurement Input 47.19 39.88
Expected volatility [Member] | Median [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Debt Securities, Available-for-sale, Measurement Input 43.65  
Expected volatility [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Debt Securities, Available-for-sale, Measurement Input 32.08 47.34
Probability Liquidation scenario [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Debt Securities, Available-for-sale, Measurement Input   20
Probability Liquidation scenario [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Debt Securities, Available-for-sale, Measurement Input 35  
Probability Liquidation scenario [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Debt Securities, Available-for-sale, Measurement Input 40  
Probability Redemption scenario [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Debt Securities, Available-for-sale, Measurement Input   40
Probability Redemption scenario [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Debt Securities, Available-for-sale, Measurement Input 35  
Probability Redemption scenario [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Debt Securities, Available-for-sale, Measurement Input 40  
Probability IPO scenario [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Debt Securities, Available-for-sale, Measurement Input   40
Probability IPO scenario [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Debt Securities, Available-for-sale, Measurement Input 30  
Probability IPO scenario [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Debt Securities, Available-for-sale, Measurement Input 20  
XML 148 R126.htm IDEA: XBRL DOCUMENT v3.23.2
Fair value measurements - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Detail) - Derivative Financial Instruments, Liabilities [Member] - $ / shares
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Spot price $ 5.9  
Risk-free rate 3.83%  
Risk-free rate , Minimum   1.25%
Risk-free rate , Maximum   2.50%
Expected volatility 61.13%  
Expected volatility , Minimum   57.95%
Expected volatility , Maximum   48.15%
Expected expiry years (in years) 2 years 7 months 6 days  
Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Spot price   $ 0.44
Expected expiry years (in years)   6 months
Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Spot price   $ 6.93
Expected expiry years (in years)   3 years 6 months 21 days
XML 149 R127.htm IDEA: XBRL DOCUMENT v3.23.2
Net Loss per share - Schedule of Earnings Per Share, Basic and Diluted (Detail)
¥ / shares in Units, ¥ in Thousands
12 Months Ended
Mar. 31, 2023
$ / shares
Mar. 31, 2023
CNY (¥)
¥ / shares
shares
Mar. 31, 2022
CNY (¥)
¥ / shares
shares
Mar. 31, 2021
CNY (¥)
¥ / shares
shares
Numerator:        
Net loss attributable to Boqii Holding Limited   ¥ (102,799) ¥ (128,390) ¥ (194,444)
Accretion on the Preferred Shares to redemption value (Note 20)       120,873
Accretion on the Redeemable non-controlling interests to redemption value (Note 21)   (675) (575) (138)
Deemed dividend to preferred shareholders       (12,547)
Net loss attributable to ordinary shareholders   ¥ (103,474) ¥ (128,965) ¥ (86,256)
Denominator:        
Weighted average number of ordinary shares used in computing net loss per share, Basic (Note (a)) | shares   68,858,823 68,006,172 66,953,610
Weighted average number of ordinary shares used in computing net loss per share, Diluted (Note (a)) | shares   68,858,823 68,006,172 66,953,610
Net loss per share attributable to ordinary shareholders:        
Basic | (per share) $ (0.22) ¥ (1.5) ¥ (1.9) ¥ (1.29)
Diluted | (per share) $ (0.22) ¥ (1.5) ¥ (1.9) ¥ (1.29)
XML 150 R128.htm IDEA: XBRL DOCUMENT v3.23.2
Net Loss per share - Schedule of Antidilutive Securities Excluded From Computation of Earnings Per Share (Detail) - shares
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Employee Stock Option [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount 591,418 719,437 2,585,103
XML 151 R129.htm IDEA: XBRL DOCUMENT v3.23.2
Related party transactions - Summary of Major Related Parties and Their Relationships With The Company (Detail)
12 Months Ended
Mar. 31, 2023
Nanjing Animal Pharmaceutical [Member]  
Schedule Of Transactions Between Related Parties [Line Items]  
Name of related parties Nanjing Animal Pharmaceutical
Relationship with the company An equity investee of the Company
Wuhan Chunzhijin [Member]  
Schedule Of Transactions Between Related Parties [Line Items]  
Name of related parties Wuhan Chunzhijin
Relationship with the company An equity investee of the Company
Weishi Network [Member]  
Schedule Of Transactions Between Related Parties [Line Items]  
Name of related parties Weishi Network
Relationship with the company An equity investee of the Company
Beijing Petdog [Member]  
Schedule Of Transactions Between Related Parties [Line Items]  
Name of related parties Beijing Petdog
Relationship with the company An available-for-sale debt investee that the Company has significant influence
Shanghai Guangcheng Information Technology (limited partnership) (Shanghai Guangcheng Information) [Member]  
Schedule Of Transactions Between Related Parties [Line Items]  
Name of related parties Shanghai Guangcheng Information Technology (limited partnership) (“Shanghai Guangcheng Information”)
Relationship with the company A company with a common director of the Company
Yingzhi (Lisa) Tang [Member]  
Schedule Of Transactions Between Related Parties [Line Items]  
Name of related parties Yingzhi (Lisa) Tang
Relationship with the company Senior management of the Company
Lijun Zhou [Member]  
Schedule Of Transactions Between Related Parties [Line Items]  
Name of related parties Lijun Zhou
Relationship with the company Senior management of the Company until April, 2022
Di (Jackie) Chen [Member]  
Schedule Of Transactions Between Related Parties [Line Items]  
Name of related parties Di (Jackie) Chen
Relationship with the company Senior management of the Company until July, 2021
Ying (Christina) Zhang [Member]  
Schedule Of Transactions Between Related Parties [Line Items]  
Name of related parties Ying (Christina) Zhang
Relationship with the company Senior management of the Company until February, 2022
Fei Wang [Member]  
Schedule Of Transactions Between Related Parties [Line Items]  
Name of related parties Fei Wang
Relationship with the company Senior management of the Company until April, 2022
Yan Jiang [Member]  
Schedule Of Transactions Between Related Parties [Line Items]  
Name of related parties Yan Jiang
Relationship with the company Senior management of the Company
MERCHANT TYCOON LIMITED [Member]  
Schedule Of Transactions Between Related Parties [Line Items]  
Name of related parties MERCHANT TYCOON LIMITED
Relationship with the company A shareholder of the Company
Superb Origin International Limited [Member]  
Schedule Of Transactions Between Related Parties [Line Items]  
Name of related parties SUPERB ORIGIN INTERNATIONAL LIMITED
Relationship with the company A shareholder of the Company
XML 152 R130.htm IDEA: XBRL DOCUMENT v3.23.2
Related party transactions - Summary of Related Party Transactions And Balances (Detail) - CNY (¥)
¥ in Thousands
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Related Party Transaction [Line Items]      
Online marketing and information services ¥ 19 ¥ 410
Purchase of merchandise 1,402 2,602 250
Loans granted to related parties 2,820 38,115 6,890
Beijing Petdog [Member]      
Related Party Transaction [Line Items]      
Online marketing and information services 410
Nanjing Animal Pharmaceutical [Member]      
Related Party Transaction [Line Items]      
Purchase of merchandise 1,402 1,020 250
Loans granted to related parties 500
Wuhan Chunzhijin [Member]      
Related Party Transaction [Line Items]      
Loans granted to related parties 2,720 2,600 5,690
Yan Jiang [Member]      
Related Party Transaction [Line Items]      
Loans granted to related parties 70 200
Fei Wang [Member]      
Related Party Transaction [Line Items]      
Loans granted to related parties 500
Weishi Network [Member]      
Related Party Transaction [Line Items]      
Online marketing and information services 19
Purchase of merchandise 1,582
Shanghai Guangcheng Information [Member]      
Related Party Transaction [Line Items]      
Loans granted to related parties 33,395
Yingzhi Lisa Tang [Member]      
Related Party Transaction [Line Items]      
Loans granted to related parties 1,750
Lijun Zhou [Member]      
Related Party Transaction [Line Items]      
Loans granted to related parties 300
Merchant Tycoon Limited [Member]      
Related Party Transaction [Line Items]      
Loans granted to related parties ¥ 100
XML 153 R131.htm IDEA: XBRL DOCUMENT v3.23.2
Related party transactions - Summary of Related Party Transactions And Balances (Parenthetical) (Detail)
¥ in Millions, $ in Millions
12 Months Ended
Mar. 31, 2023
CNY (¥)
Mar. 31, 2022
Apr. 01, 2021
USD ($)
Apr. 01, 2021
CNY (¥)
Jun. 30, 2020
CNY (¥)
Dec. 31, 2019
CNY (¥)
Nanjing Agricultural Pharmaceutical [Member] | Twelve Month Interest Free Loan Agreement [Member]            
Related Party Transaction [Line Items]            
Debt Instrument, Face Amount         ¥ 0.5 ¥ 1.0
Wuhan Chunzhijin [Member]            
Related Party Transaction [Line Items]            
Debt Instrument, Face Amount ¥ 10.0          
Debt instrument converted value ¥ 3.4          
Shanghai Guangcheng Information [Member]            
Related Party Transaction [Line Items]            
Debt Instrument, Face Amount | $     $ 5      
Debt Instrument, Interest Rate, Stated Percentage   3.50%        
Loan Agreement [Member] | Shanghai Guangcheng Information [Member]            
Related Party Transaction [Line Items]            
Debt Instrument, Face Amount     $ 5 ¥ 33.4    
Debt Instrument, Interest Rate, Stated Percentage     3.50% 3.50%    
XML 154 R132.htm IDEA: XBRL DOCUMENT v3.23.2
Related party transactions - Summary of Related Party Transaction (Detail) - CNY (¥)
¥ in Thousands
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Related Party Transaction [Line Items]      
Advances provided to related parties ¥ 5,847 ¥ 0 ¥ 2,073
Yingzhi (Lisa) Tang [Member]      
Related Party Transaction [Line Items]      
Staff advances 0 0 10
Nanjing Animal Pharmaceutical [Member]      
Related Party Transaction [Line Items]      
Advances provided to related parties 350 0 2,073
Shanghai Guangcheng Information [Member]      
Related Party Transaction [Line Items]      
Loans granted from related parties 0 9,961 0
Superb Origin International Limited [Member]      
Related Party Transaction [Line Items]      
Advances provided to related parties ¥ 5,497 ¥ 0 ¥ 0
XML 155 R133.htm IDEA: XBRL DOCUMENT v3.23.2
Related party transactions - Summary of Related Party Transaction (Parenthetical) (Detail) - Shanghai Guangcheng Information [Member]
¥ in Millions, $ in Millions
12 Months Ended
Mar. 31, 2022
USD ($)
Mar. 31, 2022
CNY (¥)
Apr. 01, 2021
USD ($)
Related Party Transaction [Line Items]      
Debt Instrument, Face Amount     $ 5.0
Debt Instrument, Interest Rate, Stated Percentage 3.50% 3.50%  
Loan amount obtained from related party $ 1.5 ¥ 10.0  
XML 156 R134.htm IDEA: XBRL DOCUMENT v3.23.2
Related party transactions - Summary of Transactions Due From Related Parties (Detail) - CNY (¥)
¥ in Thousands
Mar. 31, 2023
Mar. 31, 2022
Schedule Of Transactions Due From Related Parties [Line Items]    
Prepayments to related parties ¥ 9,079 ¥ 3,232
Loans to related parties 300 900
Nanjing Animal Pharmaceutical [Member]    
Schedule Of Transactions Due From Related Parties [Line Items]    
Prepayments to related parties 2,000 1,650
Wuhan Chunzhijin [Member]    
Schedule Of Transactions Due From Related Parties [Line Items]    
Other receivables from related parties 2,988 7,594
Yan Jiang [Member]    
Schedule Of Transactions Due From Related Parties [Line Items]    
Loans to related parties 200 200
Fei Wang [Member]    
Schedule Of Transactions Due From Related Parties [Line Items]    
Loans to related parties 0 500
Lijun Zhou [Member]    
Schedule Of Transactions Due From Related Parties [Line Items]    
Loans to related parties 0 200
Weishi Network [Member]    
Schedule Of Transactions Due From Related Parties [Line Items]    
Prepayments to related parties 1,582 1,582
Merchant Tycoon Limited [Member]    
Schedule Of Transactions Due From Related Parties [Line Items]    
Loans to related parties 100 0
Superb Origin International Limited [Member]    
Schedule Of Transactions Due From Related Parties [Line Items]    
Prepayments to related parties ¥ 5,497 ¥ 0
XML 157 R135.htm IDEA: XBRL DOCUMENT v3.23.2
Related party transactions - Summary of Transactions Due From Related Parties (Parenthetical) (Detail) - Fei Wang [Member] - One Year Loan Agreement [Member]
¥ in Millions
Jan. 31, 2021
CNY (¥)
shares
Schedule Of Transactions Due From Related Parties [Line Items]  
Debt Instrument, Face Amount | ¥ ¥ 0.5
Debt Instrument, Interest Rate, Stated Percentage 4.00%
Debt Instrument, Number of Stock Options Collateralized | shares 515,000
XML 158 R136.htm IDEA: XBRL DOCUMENT v3.23.2
Related party transactions - Summary of Transactions Due To Related Parties (Detail) - CNY (¥)
¥ in Thousands
Mar. 31, 2023
Mar. 31, 2022
Nanjing Animal Pharmaceutical [Member]    
Schedule Of Transactions Due To Related Parties [Line Items]    
Trade payables to related parties ¥ 471 ¥ 219
XML 159 R137.htm IDEA: XBRL DOCUMENT v3.23.2
Commitments and contingencies - Additional Information (Detail) - CNY (¥)
¥ in Thousands
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]    
Capital commitment amount ¥ 0 ¥ 0
XML 160 R138.htm IDEA: XBRL DOCUMENT v3.23.2
Subsequent events - Additional Information (Detail) - Subsequent Event [Member] - Nanjing Animal Pharmaceutical [Member]
¥ in Thousands
Apr. 30, 2023
CNY (¥)
Subsequent Events [Line Items]  
Line of Credit Facility, Periodic Payment, Principal ¥ 6,000
Line of Credit Facility, Periodic Payment, Interest 840
Additional compensation of line of credit ¥ 1,060
XML 161 R139.htm IDEA: XBRL DOCUMENT v3.23.2
Restricted net assets - Additional Information (Detail)
¥ in Thousands
12 Months Ended
Mar. 31, 2023
CNY (¥)
Restricted net assets of the Company's subsidiaries and the VIEs. ¥ 0
Threshold maximum percentage of restricted net assets of consolidated and unconsolidated subsidiaries to the consolidated net assets 25.00%
Threshold maximum percentage of restricted net assets not met by the consolidated subsidiaries to disclose the financial statements for the parent company 25.00%
PRC [Member]  
Required minimum percentage of annual appropriations to general reserve fund or statutory surplus fund 10
PRC [Member] | Statutory Surplus Reserve [Member] | Domestic Enterprise [Member]  
Required minimum percentage of annual appropriations to general reserve fund 10
Maximum percentage of statutory surplus reserve related to entity's registered capital 50
XML 162 d290954d20f_htm.xml IDEA: XBRL DOCUMENT 0001815021 2020-04-01 2021-03-31 0001815021 2021-04-01 2022-03-31 0001815021 2022-04-01 2023-03-31 0001815021 2022-03-31 0001815021 2023-03-31 0001815021 2021-03-31 0001815021 2021-04-01 0001815021 2022-04-01 0001815021 2020-03-31 2020-03-31 0001815021 2018-07-25 2018-07-25 0001815021 2020-10-01 2020-10-31 0001815021 2020-10-31 0001815021 2022-01-01 2022-12-31 0001815021 2022-08-01 2022-08-31 0001815021 2021-01-01 2021-12-31 0001815021 2023-01-01 2023-12-31 0001815021 2022-05-31 0001815021 2020-03-31 0001815021 us-gaap:CommonClassAMember 2022-03-31 0001815021 us-gaap:CommonClassBMember 2022-03-31 0001815021 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:NonrecourseMember 2022-03-31 0001815021 bq:ShanghaiGuangchengInformationMember 2022-03-31 0001815021 bq:WuhanChunzhijinMember 2022-03-31 0001815021 bq:MerchantTycoonLimitedMember 2022-03-31 0001815021 bq:YingzhilisaTangMember 2022-03-31 0001815021 bq:LijunZhouMember 2022-03-31 0001815021 bq:YanJiangMember 2022-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2022-03-31 0001815021 bq:FeiWangMember 2022-03-31 0001815021 bq:ProductSalesMember 2022-03-31 0001815021 bq:OnlineMarketingAndInformationServicesAndOtherRevenueMember 2022-03-31 0001815021 bq:SuperbOriginInternationalLimitedMember 2022-03-31 0001815021 bq:WeishiNetworkMember 2022-03-31 0001815021 bq:SoftwareMember 2022-03-31 0001815021 us-gaap:LeaseholdImprovementsMember 2022-03-31 0001815021 us-gaap:VehiclesMember 2022-03-31 0001815021 us-gaap:FurnitureAndFixturesMember 2022-03-31 0001815021 bq:WarehouseEquipmentMember 2022-03-31 0001815021 us-gaap:DistributionRightsMember 2022-03-31 0001815021 us-gaap:LicenseMember 2022-03-31 0001815021 us-gaap:TrademarksMember 2022-03-31 0001815021 currency:CNY us-gaap:CashMember 2022-03-31 0001815021 currency:CNY us-gaap:CashEquivalentsMember 2022-03-31 0001815021 currency:HKD us-gaap:CashMember 2022-03-31 0001815021 currency:HKD us-gaap:CashEquivalentsMember 2022-03-31 0001815021 currency:USD us-gaap:CashMember 2022-03-31 0001815021 currency:USD us-gaap:CashEquivalentsMember 2022-03-31 0001815021 currency:EUR us-gaap:CashMember 2022-03-31 0001815021 currency:EUR us-gaap:CashEquivalentsMember 2022-03-31 0001815021 currency:NZD us-gaap:CashMember 2022-03-31 0001815021 currency:NZD us-gaap:CashEquivalentsMember 2022-03-31 0001815021 us-gaap:CashEquivalentsMember 2022-03-31 0001815021 us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001815021 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001815021 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001815021 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001815021 srt:MinimumMember us-gaap:AvailableforsaleSecuritiesMember bq:WeightedAverageCostOfCapitalMember 2022-03-31 0001815021 srt:MedianMember us-gaap:AvailableforsaleSecuritiesMember bq:WeightedAverageCostOfCapitalMember 2022-03-31 0001815021 srt:MaximumMember us-gaap:AvailableforsaleSecuritiesMember bq:WeightedAverageCostOfCapitalMember 2022-03-31 0001815021 srt:MinimumMember us-gaap:AvailableforsaleSecuritiesMember us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember 2022-03-31 0001815021 srt:MedianMember us-gaap:AvailableforsaleSecuritiesMember us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember 2022-03-31 0001815021 srt:MaximumMember us-gaap:AvailableforsaleSecuritiesMember us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember 2022-03-31 0001815021 srt:MinimumMember us-gaap:AvailableforsaleSecuritiesMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember us-gaap:MeasurementInputRiskFreeInterestRateMember bq:MinimumOneMember 2022-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember us-gaap:MeasurementInputRiskFreeInterestRateMember bq:MinimumTwoMember 2022-03-31 0001815021 srt:MaximumMember us-gaap:AvailableforsaleSecuritiesMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-03-31 0001815021 srt:MinimumMember us-gaap:AvailableforsaleSecuritiesMember us-gaap:MeasurementInputPriceVolatilityMember 2022-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember us-gaap:MeasurementInputPriceVolatilityMember bq:MinimumOneMember 2022-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember us-gaap:MeasurementInputPriceVolatilityMember bq:MinimumTwoMember 2022-03-31 0001815021 srt:MaximumMember us-gaap:AvailableforsaleSecuritiesMember us-gaap:MeasurementInputPriceVolatilityMember 2022-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember bq:ProbabilityLiquidationScenarioMember 2022-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember bq:ProbabilityRedemptionScenarioMember 2022-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember bq:ProbabilityIpoScenarioMember 2022-03-31 0001815021 srt:MinimumMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2022-03-31 0001815021 srt:MaximumMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2022-03-31 0001815021 bq:QingdaoShuanganMember bq:AvailableForSaleDebtInvestmentsMember 2022-03-31 0001815021 bq:QingdaoShuanganBiotechnologyCoLtdMember 2022-03-31 0001815021 bq:BeijingPetdogTechnologyDevelopmentCoLtdMember 2022-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2022-03-31 0001815021 currency:CNY 2022-03-31 0001815021 us-gaap:ShortTermInvestmentsMember 2022-03-31 0001815021 us-gaap:ShortTermInvestmentsMember bq:ShortTermBankLoanMember 2022-03-31 0001815021 bq:ShortTermBankLoanMember 2022-03-31 0001815021 bq:LongTermLoanFromCmbMember 2022-03-31 0001815021 bq:LoanFromChongLiMember 2022-03-31 0001815021 bq:LoanForYokenSeriesAOneWarrantMember 2022-03-31 0001815021 bq:ConversionFeatureOfYokenSeriesAOneWarrantMember 2022-03-31 0001815021 bq:YokenSeriesAOneWarrantMember bq:LoanForYokenSeriesAOneWarrantMember 2022-03-31 0001815021 bq:YokenSeriesAOneWarrantMember 2022-03-31 0001815021 bq:ChongLiMember 2022-03-31 0001815021 bq:LongTermLoanFromCmbMember bq:CMBMember 2022-03-31 0001815021 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2022-03-31 0001815021 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2022-03-31 0001815021 bq:NewForeignExchangeSwapContractMember bq:NewForeignExchangeSwapContractThreeMember us-gaap:CurrencySwapMember 2022-03-31 0001815021 bq:NewForeignExchangeSwapContractMember bq:NewForeignExchangeSwapContractTwoMember us-gaap:CurrencySwapMember 2022-03-31 0001815021 bq:NewForeignExchangeSwapContractMember bq:NewForeignExchangeSwapContractOneMember us-gaap:CurrencySwapMember 2022-03-31 0001815021 bq:NewForeignExchangeSwapContractMember us-gaap:CurrencySwapMember 2022-03-31 0001815021 us-gaap:CommonClassAMember 2023-03-31 0001815021 us-gaap:CommonClassBMember 2023-03-31 0001815021 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:NonrecourseMember 2023-03-31 0001815021 bq:ShanghaiGuangchengInformationMember 2023-03-31 0001815021 bq:WuhanChunzhijinMember 2023-03-31 0001815021 bq:MerchantTycoonLimitedMember 2023-03-31 0001815021 bq:YingzhilisaTangMember 2023-03-31 0001815021 bq:LijunZhouMember 2023-03-31 0001815021 bq:YanJiangMember 2023-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2023-03-31 0001815021 bq:FeiWangMember 2023-03-31 0001815021 bq:ProductSalesMember 2023-03-31 0001815021 bq:OnlineMarketingAndInformationServicesAndOtherRevenueMember 2023-03-31 0001815021 bq:SuperbOriginInternationalLimitedMember 2023-03-31 0001815021 bq:WeishiNetworkMember 2023-03-31 0001815021 bq:SoftwareMember 2023-03-31 0001815021 us-gaap:LeaseholdImprovementsMember 2023-03-31 0001815021 us-gaap:VehiclesMember 2023-03-31 0001815021 us-gaap:FurnitureAndFixturesMember 2023-03-31 0001815021 bq:WarehouseEquipmentMember 2023-03-31 0001815021 us-gaap:DistributionRightsMember 2023-03-31 0001815021 us-gaap:LicenseMember 2023-03-31 0001815021 us-gaap:TrademarksMember 2023-03-31 0001815021 currency:CNY us-gaap:CashMember 2023-03-31 0001815021 currency:CNY us-gaap:CashEquivalentsMember 2023-03-31 0001815021 currency:HKD us-gaap:CashMember 2023-03-31 0001815021 currency:HKD us-gaap:CashEquivalentsMember 2023-03-31 0001815021 currency:USD us-gaap:CashMember 2023-03-31 0001815021 currency:USD us-gaap:CashEquivalentsMember 2023-03-31 0001815021 currency:EUR us-gaap:CashMember 2023-03-31 0001815021 currency:EUR us-gaap:CashEquivalentsMember 2023-03-31 0001815021 currency:NZD us-gaap:CashMember 2023-03-31 0001815021 currency:NZD us-gaap:CashEquivalentsMember 2023-03-31 0001815021 us-gaap:CashEquivalentsMember 2023-03-31 0001815021 us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001815021 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001815021 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001815021 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001815021 bq:BoqiiCorporationLimitedMember 2023-03-31 0001815021 bq:BoqiiInternationalLimitedMember 2023-03-31 0001815021 bq:XingmuInternationalLimitedMember 2023-03-31 0001815021 bq:XingmuHkLimitedMember 2023-03-31 0001815021 bq:NanjingXinmuInformationTechnologyCoLtdMember 2023-03-31 0001815021 bq:XinchengshanghaiInformationTechnologyCoLtdMember 2023-03-31 0001815021 bq:ShanghaiYiqinPetsProductsCoLtdMember 2023-03-31 0001815021 bq:ShanghaiEverySupplyChainCoLtdMember 2023-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember bq:ImpliedPriceToSalesAfterDiscountForLackOfMarketabilityMember 2023-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember 2023-03-31 0001815021 srt:MinimumMember us-gaap:AvailableforsaleSecuritiesMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-03-31 0001815021 srt:MedianMember us-gaap:AvailableforsaleSecuritiesMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-03-31 0001815021 srt:MaximumMember us-gaap:AvailableforsaleSecuritiesMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-03-31 0001815021 srt:MinimumMember us-gaap:AvailableforsaleSecuritiesMember us-gaap:MeasurementInputPriceVolatilityMember 2023-03-31 0001815021 srt:MedianMember us-gaap:AvailableforsaleSecuritiesMember us-gaap:MeasurementInputPriceVolatilityMember 2023-03-31 0001815021 srt:MaximumMember us-gaap:AvailableforsaleSecuritiesMember us-gaap:MeasurementInputPriceVolatilityMember 2023-03-31 0001815021 srt:MinimumMember us-gaap:AvailableforsaleSecuritiesMember bq:ProbabilityLiquidationScenarioMember 2023-03-31 0001815021 srt:MaximumMember us-gaap:AvailableforsaleSecuritiesMember bq:ProbabilityLiquidationScenarioMember 2023-03-31 0001815021 srt:MinimumMember us-gaap:AvailableforsaleSecuritiesMember bq:ProbabilityRedemptionScenarioMember 2023-03-31 0001815021 srt:MaximumMember us-gaap:AvailableforsaleSecuritiesMember bq:ProbabilityRedemptionScenarioMember 2023-03-31 0001815021 srt:MinimumMember us-gaap:AvailableforsaleSecuritiesMember bq:ProbabilityIpoScenarioMember 2023-03-31 0001815021 srt:MaximumMember us-gaap:AvailableforsaleSecuritiesMember bq:ProbabilityIpoScenarioMember 2023-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2023-03-31 0001815021 bq:QingdaoShuanganBiotechnologyCoLtdMember bq:AvailableForSaleDebtInvestmentsMember 2023-03-31 0001815021 bq:WuhanChunzhijinInformationTechnologyCoLtdMember bq:EquityMethodInvestmentMember 2023-03-31 0001815021 bq:WuhanChunzhijinInformationTechnologyCoLtdMember srt:MaximumMember bq:EquityMethodInvestmentMember 2023-03-31 0001815021 bq:QingdaoShuanganBiotechnologyCoLtdMember 2023-03-31 0001815021 bq:BeijingPetdogTechnologyDevelopmentCoLtdMember 2023-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2023-03-31 0001815021 bq:ContractualArrangementsMember 2023-03-31 0001815021 bq:RepaymentOfLoanMember bq:LoanAgreementsMember 2023-03-31 0001815021 bq:EquityInterestPledgeAgreementsMember 2023-03-31 0001815021 currency:CNY 2023-03-31 0001815021 us-gaap:ShortTermInvestmentsMember 2023-03-31 0001815021 us-gaap:ShortTermInvestmentsMember bq:ShortTermBankLoanMember 2023-03-31 0001815021 bq:ShortTermBankLoanMember 2023-03-31 0001815021 us-gaap:ShortTermInvestmentsMember bq:LongTermBankLoanMember 2023-03-31 0001815021 us-gaap:CommonStockMember 2023-03-31 0001815021 dei:AdrMember 2023-03-31 0001815021 bq:LoanFromChongLiMember 2023-03-31 0001815021 bq:LoanForYokenSeriesAOneWarrantMember 2023-03-31 0001815021 bq:ConversionFeatureOfYokenSeriesAOneWarrantMember 2023-03-31 0001815021 us-gaap:SwapMember 2023-03-31 0001815021 bq:YokenSeriesAOneWarrantMember bq:LoanForYokenSeriesAOneWarrantMember 2023-03-31 0001815021 bq:YokenSeriesAOneWarrantMember 2023-03-31 0001815021 bq:ChongLiMember 2023-03-31 0001815021 bq:LongTermLoanFromCmbMember bq:CMBMember 2023-03-31 0001815021 country:CN 2023-03-31 0001815021 bq:LoansReceivablePeriodRangingFromTwelveToTwentyFourMonthsMember bq:FromOctoberTwoThousandAndTwentyThreeToMarchTwoThousandAndTwentyFourMember 2023-03-31 0001815021 bq:NewForeignExchangeSwapContractMember us-gaap:CurrencySwapMember 2023-03-31 0001815021 bq:LoanReceivableForThePeriodTwentyFourToThirtySixMonthsMember 2023-03-31 0001815021 bq:ProductSalesMember 2020-04-01 2021-03-31 0001815021 bq:OnlineMarketingAndInformationServicesAndOtherRevenueMember 2020-04-01 2021-03-31 0001815021 bq:BeijingPetdogMember 2020-04-01 2021-03-31 0001815021 bq:WeishiNetworkMember 2020-04-01 2021-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2020-04-01 2021-03-31 0001815021 us-gaap:ReceivablesFromStockholderMember 2020-04-01 2021-03-31 0001815021 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2021-03-31 0001815021 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2021-03-31 0001815021 bq:StatutoryReservesMember 2020-04-01 2021-03-31 0001815021 us-gaap:RetainedEarningsMember 2020-04-01 2021-03-31 0001815021 us-gaap:NoncontrollingInterestMember 2020-04-01 2021-03-31 0001815021 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-04-01 2021-03-31 0001815021 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-04-01 2021-03-31 0001815021 us-gaap:CommonStockMember 2020-04-01 2021-03-31 0001815021 us-gaap:EmployeeStockOptionMember 2020-04-01 2021-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2020-04-01 2021-03-31 0001815021 currency:CNY 2020-04-01 2021-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember 2020-04-01 2021-03-31 0001815021 bq:RoyalCaninChinaCoLtdMember us-gaap:SalesRevenueNetMember us-gaap:SupplierConcentrationRiskMember 2020-04-01 2021-03-31 0001815021 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember bq:ThirdPartyMember us-gaap:NonrecourseMember 2020-04-01 2021-03-31 0001815021 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:NonrecourseMember 2020-04-01 2021-03-31 0001815021 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember bq:InterCompanyMember us-gaap:NonrecourseMember 2020-04-01 2021-03-31 0001815021 bq:QingdaoShuanganBiotechnologyCoLtdMember 2020-04-01 2021-03-31 0001815021 bq:BeijingPetdogTechnologyDevelopmentCoLtdMember 2020-04-01 2021-03-31 0001815021 bq:RoyalCaninChinaCoLtdMember bq:PurchasesMember us-gaap:SupplierConcentrationRiskMember 2020-04-01 2021-03-31 0001815021 us-gaap:SalesRevenueNetMember 2020-04-01 2021-03-31 0001815021 bq:ProductSalesMember 2021-04-01 2022-03-31 0001815021 bq:OnlineMarketingAndInformationServicesAndOtherRevenueMember 2021-04-01 2022-03-31 0001815021 bq:BeijingPetdogMember 2021-04-01 2022-03-31 0001815021 bq:WeishiNetworkMember 2021-04-01 2022-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2021-04-01 2022-03-31 0001815021 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2022-03-31 0001815021 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2022-03-31 0001815021 bq:StatutoryReservesMember 2021-04-01 2022-03-31 0001815021 us-gaap:RetainedEarningsMember 2021-04-01 2022-03-31 0001815021 us-gaap:ReceivablesFromStockholderMember 2021-04-01 2022-03-31 0001815021 us-gaap:NoncontrollingInterestMember 2021-04-01 2022-03-31 0001815021 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-04-01 2022-03-31 0001815021 us-gaap:EmployeeStockOptionMember 2021-04-01 2022-03-31 0001815021 currency:CNY 2021-04-01 2022-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2021-04-01 2022-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember 2021-04-01 2022-03-31 0001815021 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember bq:ThirdPartyMember us-gaap:NonrecourseMember 2021-04-01 2022-03-31 0001815021 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:NonrecourseMember 2021-04-01 2022-03-31 0001815021 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember bq:InterCompanyMember us-gaap:NonrecourseMember 2021-04-01 2022-03-31 0001815021 srt:MinimumMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2021-04-01 2022-03-31 0001815021 srt:MaximumMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2021-04-01 2022-03-31 0001815021 bq:QingdaoShuanganBiotechnologyCoLtdMember 2021-04-01 2022-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2021-04-01 2022-03-31 0001815021 bq:BeijingPetdogTechnologyDevelopmentCoLtdMember 2021-04-01 2022-03-31 0001815021 us-gaap:EmployeeStockOptionMember 2021-04-01 2022-03-31 0001815021 bq:EmployeesAndNonEmployeesMember 2021-04-01 2022-03-31 0001815021 bq:NewForeignExchangeSwapContractMember us-gaap:CurrencySwapMember 2021-04-01 2022-03-31 0001815021 bq:ExtensionOfLoanAgreementMember bq:LongTermLoanFromCmbMember bq:CMBMember 2021-04-01 2022-03-31 0001815021 bq:NewForeignExchangeSwapContractMember 2021-04-01 2022-03-31 0001815021 bq:ShanghaiGuangchengInformationMember 2021-04-01 2022-03-31 0001815021 bq:RoyalCaninChinaCoLtdMember bq:PurchasesMember us-gaap:SupplierConcentrationRiskMember 2021-04-01 2022-03-31 0001815021 bq:ChongLiMember 2021-04-01 2022-03-31 0001815021 bq:ProductSalesMember 2022-04-01 2023-03-31 0001815021 bq:OnlineMarketingAndInformationServicesAndOtherRevenueMember 2022-04-01 2023-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2022-04-01 2023-03-31 0001815021 bq:WuhanChunzhijinMember 2022-04-01 2023-03-31 0001815021 bq:WeishiNetworkMember 2022-04-01 2023-03-31 0001815021 bq:BeijingPetdogMember 2022-04-01 2023-03-31 0001815021 bq:ShanghaiGuangchengInformationTechnologyLimitedPartnershipshanghaiGuangchengInformationMember 2022-04-01 2023-03-31 0001815021 bq:MerchantTycoonLimitedMember 2022-04-01 2023-03-31 0001815021 bq:SuperbOriginInternationalLimitedMember 2022-04-01 2023-03-31 0001815021 bq:YingzhilisaTangMember 2022-04-01 2023-03-31 0001815021 bq:YanJiangMember 2022-04-01 2023-03-31 0001815021 bq:DijackieChenMember 2022-04-01 2023-03-31 0001815021 bq:YingchristinaZhangMember 2022-04-01 2023-03-31 0001815021 bq:FeiWangMember 2022-04-01 2023-03-31 0001815021 bq:LijunZhouMember 2022-04-01 2023-03-31 0001815021 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2023-03-31 0001815021 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2023-03-31 0001815021 bq:StatutoryReservesMember 2022-04-01 2023-03-31 0001815021 us-gaap:RetainedEarningsMember 2022-04-01 2023-03-31 0001815021 us-gaap:ReceivablesFromStockholderMember 2022-04-01 2023-03-31 0001815021 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-04-01 2023-03-31 0001815021 us-gaap:EmployeeStockOptionMember 2022-04-01 2023-03-31 0001815021 bq:ShanghaiEverySupplyChainCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:ShanghaiYiqinPetsProductsCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:XinchengshanghaiInformationTechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:NanjingXinmuInformationTechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:XingmuHkLimitedMember 2022-04-01 2023-03-31 0001815021 bq:XingmuInternationalLimitedMember 2022-04-01 2023-03-31 0001815021 bq:BoqiiInternationalLimitedMember 2022-04-01 2023-03-31 0001815021 bq:BoqiiCorporationLimitedMember 2022-04-01 2023-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember 2022-04-01 2023-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2022-04-01 2023-03-31 0001815021 bq:NanjingXingmuBiotechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:SuzhouXingyunYuemingSupplyChainCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:BoqiiShanghaiInformationTechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:TianjingGuangchengInformationTechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:NanjingCuidaBiotechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:TaizhouXingmuBiotechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:GuangchengShanghaiInformationTechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:SuzhouTaichengSupplyChainCoLtdSuzhouTaichengMember 2022-04-01 2023-03-31 0001815021 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember bq:ThirdPartyMember us-gaap:NonrecourseMember 2022-04-01 2023-03-31 0001815021 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:NonrecourseMember 2022-04-01 2023-03-31 0001815021 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember bq:InterCompanyMember us-gaap:NonrecourseMember 2022-04-01 2023-03-31 0001815021 bq:QingdaoShuanganBiotechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2022-04-01 2023-03-31 0001815021 bq:BeijingPetdogTechnologyDevelopmentCoLtdMember 2022-04-01 2023-03-31 0001815021 srt:MinimumMember bq:WarehouseEquipmentMember 2022-04-01 2023-03-31 0001815021 srt:MaximumMember bq:WarehouseEquipmentMember 2022-04-01 2023-03-31 0001815021 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2022-04-01 2023-03-31 0001815021 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2022-04-01 2023-03-31 0001815021 us-gaap:VehiclesMember 2022-04-01 2023-03-31 0001815021 bq:SoftwareMember 2022-04-01 2023-03-31 0001815021 us-gaap:LeaseholdImprovementsMember 2022-04-01 2023-03-31 0001815021 us-gaap:TrademarksMember 2022-04-01 2023-03-31 0001815021 us-gaap:DistributionRightsMember 2022-04-01 2023-03-31 0001815021 us-gaap:LicenseMember 2022-04-01 2023-03-31 0001815021 bq:EmployeesAndNonEmployeesMember 2022-04-01 2023-03-31 0001815021 srt:MinimumMember country:HK 2022-04-01 2023-03-31 0001815021 srt:MaximumMember country:HK 2022-04-01 2023-03-31 0001815021 country:CN 2022-04-01 2023-03-31 0001815021 dei:BusinessContactMember 2022-04-01 2023-03-31 0001815021 dei:AdrMember 2022-04-01 2023-03-31 0001815021 us-gaap:CommonClassAMember 2022-04-01 2023-03-31 0001815021 bq:ChongniNetworkTechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 us-gaap:CommonClassBMember 2022-04-01 2023-03-31 0001815021 bq:SeriesCRedeemableConvertiblePreferredSharesMember 2022-04-01 2023-03-31 0001815021 bq:NewForeignExchangeSwapContractMember us-gaap:CurrencySwapMember 2022-04-01 2023-03-31 0001815021 us-gaap:TaxYear2018Member 2022-04-01 2023-03-31 0001815021 us-gaap:NoncontrollingInterestMember 2022-04-01 2023-03-31 0001815021 bq:ExtensionOfLoanAgreementMember bq:LongTermLoanFromCmbMember bq:CMBMember 2022-04-01 2023-03-31 0001815021 bq:NewForeignExchangeSwapContractMember 2022-04-01 2023-03-31 0001815021 bq:RoyalCaninChinaCoLtdMember bq:PurchasesMember us-gaap:SupplierConcentrationRiskMember 2022-04-01 2023-03-31 0001815021 bq:LoansReceivablePeriodRangingFromTwelveToTwentyFourMonthsMember bq:FromOctoberTwoThousandAndTwentyThreeToMarchTwoThousandAndTwentyFourMember srt:MaximumMember 2022-04-01 2023-03-31 0001815021 bq:LoansReceivablePeriodRangingFromTwelveToTwentyFourMonthsMember bq:FromOctoberTwoThousandAndTwentyThreeToMarchTwoThousandAndTwentyFourMember srt:MinimumMember 2022-04-01 2023-03-31 0001815021 bq:LoansReceivablePeriodRangingFromTwelveToTwentyFourMonthsMember srt:MinimumMember 2022-04-01 2023-03-31 0001815021 bq:LoansReceivablePeriodRangingFromTwelveToTwentyFourMonthsMember srt:MaximumMember 2022-04-01 2023-03-31 0001815021 bq:LoanReceivableForThePeriodTwentyFourToThirtySixMonthsMember bq:FromMayTwoThousandAndTwentyOneToMayTwoThousandAndTwentyTwoMember srt:MinimumMember 2022-04-01 2023-03-31 0001815021 bq:LoanReceivableForThePeriodTwentyFourToThirtySixMonthsMember bq:FromMayTwoThousandAndTwentyOneToMayTwoThousandAndTwentyTwoMember srt:MaximumMember 2022-04-01 2023-03-31 0001815021 bq:ChongLiMember 2022-04-01 2023-03-31 0001815021 bq:StatutorySurplusReserveMember country:CN bq:DomesticEnterpriseMember 2022-04-01 2023-03-31 0001815021 country:CN 2022-04-01 2023-03-31 0001815021 bq:QingdaoShuanganMember 2022-04-01 2023-03-31 0001815021 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2022-04-01 2023-03-31 0001815021 bq:IntellectualPropertyLicenseAgreementsMember 2023-03-31 2023-03-31 0001815021 bq:LoanAgreementMember bq:ShanghaiGuangchengInformationMember 2021-04-01 0001815021 bq:ShanghaiGuangchengInformationMember 2021-04-01 0001815021 bq:ChongniNetworkTechnologyCoLtdMember 2018-10-31 0001815021 bq:ChongniNetworkTechnologyCoLtdMember 2021-06-30 2021-06-30 0001815021 bq:BetterChoiceCompanyIncMember 2021-06-30 2021-06-30 0001815021 bq:ChongniNetworkTechnologyCoLtdMember 2021-06-30 0001815021 bq:XingmuGroupMember 2021-06-30 0001815021 bq:NanjingCuidaBiotechnologyCoLtdMember 2021-06-30 2022-03-31 0001815021 bq:JiangsuNanjingAgriculturalUniversityAnimalPharmaceuticalCoLtdMember 2019-04-01 2019-04-30 0001815021 bq:BeijingPetdogTechnologyDevelopmentCoLtdMember 2019-10-01 2019-10-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2021-07-31 2021-07-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2021-07-31 0001815021 bq:AccruedLiabilitiesAndOtherCurrentLiabilitiesMember bq:NanjingAnimalPharmaceuticalMember 2021-07-31 0001815021 bq:WuhanChunzhijinMember 2021-03-31 0001815021 bq:MerchantTycoonLimitedMember 2021-03-31 0001815021 bq:YingzhilisaTangMember 2021-03-31 0001815021 bq:LijunZhouMember 2021-03-31 0001815021 bq:YanJiangMember 2021-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2021-03-31 0001815021 bq:FeiWangMember 2021-03-31 0001815021 bq:ShanghaiGuangchengInformationMember 2021-03-31 0001815021 bq:SuperbOriginInternationalLimitedMember 2021-03-31 0001815021 bq:AdsMember us-gaap:IPOMember 2020-10-01 2020-10-31 0001815021 bq:AdsMember us-gaap:OverAllotmentOptionMember 2020-10-01 2020-10-31 0001815021 us-gaap:CommonClassAMember 2020-10-01 2020-10-31 0001815021 bq:SeriesARedeemableConvertiblePreferredSharesMember us-gaap:IPOMember 2020-10-01 2020-10-31 0001815021 bq:SeriesBRedeemableConvertiblePreferredSharesMember us-gaap:IPOMember 2020-10-01 2020-10-31 0001815021 bq:SeriesCPlusRedeemableConvertiblePreferredSharesMember us-gaap:IPOMember 2020-10-01 2020-10-31 0001815021 us-gaap:CommonClassBMember us-gaap:IPOMember 2020-10-01 2020-10-31 0001815021 bq:AdsMember 2020-10-31 0001815021 us-gaap:CommonClassAMember us-gaap:IPOMember 2020-10-31 0001815021 us-gaap:CommonClassBMember 2020-10-31 0001815021 bq:SeriesARedeemableConvertiblePreferredSharesMember us-gaap:IPOMember 2020-10-31 0001815021 bq:SeriesBRedeemableConvertiblePreferredSharesMember us-gaap:IPOMember 2020-10-31 0001815021 bq:SeriesCPlusRedeemableConvertiblePreferredSharesMember us-gaap:IPOMember 2020-10-31 0001815021 us-gaap:SeriesCPreferredStockMember us-gaap:IPOMember 2020-10-31 0001815021 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-02-01 2021-02-28 0001815021 bq:YokenHoldingLimitedMember 2020-10-31 2020-10-31 0001815021 bq:LoanForYokenSeriesAOneWarrantMember 2020-03-31 2020-03-31 0001815021 bq:LongTermLoanFromCmbMember bq:CMBMember 2020-03-31 2020-03-31 0001815021 bq:LoanForYokenSeriesAOneWarrantMember 2020-03-31 0001815021 bq:LongTermLoanFromCmbMember bq:CMBMember 2020-03-31 0001815021 bq:ExtensionOfLoanAgreementMember bq:LongTermLoanFromCmbMember bq:CMBMember 2020-03-31 0001815021 bq:ChongLiMember 2020-03-31 0001815021 bq:EquityOwnerMember bq:ChongLiMember bq:SuperbOriginInternationalLimitedMember 2020-03-31 0001815021 bq:LoanForYokenSeriesAOneWarrantMember 2020-10-23 2020-10-23 0001815021 bq:YokenSeriesAOneWarrantMember bq:InvestorTwoMember 2020-10-23 2020-10-23 0001815021 bq:YokenSeriesAOneWarrantMember bq:InvestorOneMember 2020-10-23 2020-10-23 0001815021 bq:YokenSeriesAOneWarrantMember bq:InvestorOneMember 2020-10-23 0001815021 bq:YokenSeriesAOneWarrantMember bq:InvestorTwoMember 2020-10-23 0001815021 bq:YokenSeriesAOneWarrantMember 2020-10-23 0001815021 bq:YokenSeriesAOneWarrantMember bq:LoanForYokenSeriesAOneWarrantMember 2021-03-31 2021-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember us-gaap:SubsequentEventMember 2023-04-30 2023-04-30 0001815021 bq:JiangsuNanjingAgriculturalUniversityAnimalPharmaceuticalCoLtdMember bq:EquityMethodInvestmentMember 2019-04-30 0001815021 bq:BeijingPetdogTechnologyDevelopmentCoLtdMember bq:AvailableForSaleDebtInvestmentsMember 2019-10-31 0001815021 bq:TwelveMonthInterestFreeLoanAgreementMember bq:NanjingAgriculturalPharmaceuticalMember 2019-12-31 0001815021 bq:OneYearLoanAgreementMember bq:FeiWangMember 2021-01-31 0001815021 bq:TwoThousandTwelveGlobalSharePlanMember 2012-09-27 0001815021 bq:TwoThousandEighteenGlobalSharePlanMember 2018-08-01 0001815021 bq:TwoThousandEighteenGlobalSharePlanMember 2020-09-01 0001815021 bq:AmendedTwoThousandEighteenGlobalSharePlanMember 2020-09-01 0001815021 bq:ChongLiMember 2020-03-01 0001815021 bq:TwelveMonthInterestFreeLoanAgreementMember bq:NanjingAgriculturalPharmaceuticalMember 2020-06-30 0001815021 bq:WuhanChunzhijinInformationTechnologyCoLtdMember bq:EquityMethodInvestmentMember 2020-04-30 0001815021 bq:LongTermLoanFromCmbMember bq:CMBMember 2020-03-01 2020-03-31 0001815021 bq:TwoThousandEighteenGlobalSharePlanMember 2022-05-31 0001815021 bq:AmendedTwoThousandEighteenGlobalSharePlanMember 2022-05-31 0001815021 us-gaap:CommonStockMember 2020-03-31 0001815021 us-gaap:ReceivablesFromStockholderMember 2020-03-31 0001815021 us-gaap:NoncontrollingInterestMember 2020-03-31 0001815021 us-gaap:RetainedEarningsMember 2020-03-31 0001815021 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001815021 bq:StatutoryReservesMember 2020-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2020-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2021-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember 2020-03-31 0001815021 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-03-31 0001815021 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-03-31 0001815021 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001815021 bq:StatutoryReservesMember 2021-03-31 0001815021 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001815021 us-gaap:RetainedEarningsMember 2021-03-31 0001815021 us-gaap:NoncontrollingInterestMember 2021-03-31 0001815021 us-gaap:ReceivablesFromStockholderMember 2021-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember 2021-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2022-03-31 0001815021 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001815021 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-03-31 0001815021 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001815021 bq:StatutoryReservesMember 2022-03-31 0001815021 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001815021 us-gaap:RetainedEarningsMember 2022-03-31 0001815021 us-gaap:NoncontrollingInterestMember 2022-03-31 0001815021 us-gaap:ReceivablesFromStockholderMember 2022-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember 2022-03-31 0001815021 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-03-31 0001815021 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-03-31 0001815021 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001815021 bq:StatutoryReservesMember 2023-03-31 0001815021 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001815021 us-gaap:RetainedEarningsMember 2023-03-31 0001815021 us-gaap:NoncontrollingInterestMember 2023-03-31 0001815021 us-gaap:ReceivablesFromStockholderMember 2023-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember 2023-03-31 iso4217:USD iso4217:CNY shares utr:Year iso4217:HKD iso4217:EUR iso4217:NZD pure utr:Month utr:Day iso4217:USD shares iso4217:CNY shares false FY Boqii Holding Ltd 0001815021 true 20-F false true 2023-03-31 --03-31 2023 false false 001-39547 E9 Building 9, No. 388, Shengrong Road Pudong New District Shanghai 201210 CN Yingzhi (Lisa) Tang 180 1851 3366 Building 9, No. 388, Shengrong Road Pudong New District Shanghai 201210 CN American depositary shares, each ADS represents four and one half (4.5) Class A ordinary shares, par value US$0.001 per share BQ NYSE Class A ordinary shares, par value US$0.001 per share NYSE 70729482 57691753 1928662 13037729 No No Yes Yes Non-accelerated Filer true false false U.S. GAAP false 2012-07-31 2016-08-31 2019-08-31 2019-11-30 2019-11-30 2012-11-30 2013-02-28 2021-09-30 2012-11-30 2019-11-30 2021-06-30 2022-04-30 2014-08-31 2017-06-30 2017-04-30 2019-11-30 http://fasb.org/us-gaap/2022#DerivativeLiabilitiesCurrent http://Boqii.com/20230331#OtherIncomeNet 1424 PricewaterhouseCoopers Zhong Tian LLP Shanghai, the People’s Republic of China 162855000 89850000 13083000 128084000 69797000 10163000 49231000 76742000 11175000 109921000 81052000 11802000 116738000 79359000 11556000 11726000 9379000 1366000 578555000 406179000 59145000 7779000 5492000 800000 25544000 21594000 3144000 38567000 22354000 3255000 82319000 75607000 11010000 40684000 2988000 435000 4861000 6586000 959000 199754000 134621000 19603000 778309000 540800000 78748000 872000 363000 161126000 86261000 12561000 55144000 13459000 94224000 56022000 8157000 5597000 5573000 6871000 6890000 1003000 24417000 15712000 27324000 22104000 3219000 4000 21000 219000 471000 69000 7007000 4471000 7007000 4471000 651000 7238000 9207000 10001000 9220000 1343000 0 0 9086000 10701000 1558000 315858000 196140000 28561000 0 0 4847000 4141000 603000 28197000 12741000 28197000 12741000 1855000 157874000 75481000 181062000 102827000 14973000 214106000 119709000 17431000 529964000 315849000 45992000 6522000 7197000 1048000 6522000 7197000 1048000 0.001 0.001 129500000 55709591 55709591 129500000 55763079 55763079 372000 373000 54000 0.001 0.001 15000000 15000000 13037729 13037729 13037729 13037729 82000 82000 12000 3295336000 3287696000 478727000 3433000 3876000 564000 -46069000 -37189000 -5415000 -2889233000 -2993150000 -435836000 164746000 83405000 12145000 199175000 178283000 25961000 42648000 39471000 5747000 241823000 217754000 31708000 778309000 540800000 78748000 1003197000 1137329000 1048491000 152672000 7788000 49100000 43603000 6349000 1010985000 1186429000 1092094000 159021000 823686000 943698000 858608000 125023000 187299000 242731000 233486000 33998000 120188000 134026000 126295000 18390000 160201000 170986000 124007000 18057000 113972000 76248000 46554000 6779000 40684000 5924000 1067000 280000 286000 42000 -205995000 -138249000 -103768000 -15110000 17553000 15477000 7420000 1081000 27650000 20884000 13350000 1944000 11332000 6020000 5159000 751000 -11369000 -2824000 2266000 330000 -193391000 -134812000 -106805000 -15552000 -871000 -1571000 -911000 -133000 -696000 418000 -82000 -12000 -193216000 -132823000 -105976000 -15431000 1228000 -4433000 -3177000 -462000 -194444000 -128390000 -102799000 -14969000 -120873000 138000 575000 675000 98000 12547000 -86256000 -128965000 -103474000 -15067000 -193216000 -132823000 -105976000 -15431000 32148000 16529000 -15591000 -2270000 -772000 9368000 6711000 977000 -224592000 -158720000 -97096000 -14138000 1228000 -4433000 -3177000 -462000 -225820000 -154287000 -93919000 -13676000 -1.29 -1.9 -1.5 -0.22 -1.29 -1.9 -1.5 -0.22 66953610 68006172 68858823 68858823 66953610 68006172 68858823 68858823 22238454 139000 2627000 11204000 -2016758000 43741000 -9000 -1959056000 55022000 9000 55031000 -32148000 -32148000 420000 -420000 12547000 12547000 120873000 120873000 -138000 -138000 772000 772000 656448000 656448000 50000 50000 413377000 413377000 -22238454 -139000 10033850 63000 12204604 76000 5250000 36000 395035000 395071000 7844137 53000 461392000 461445000 8557980 57000 504280000 504337000 4684976 32000 833125 6000 331427000 331465000 6883520 47000 662761000 662808000 2526026 17000 180987000 181004000 2178530 15000 164844000 164859000 1182803 8000 92306000 92314000 5885210 40000 455940000 455980000 -521924 4000 31382000 31386000 -194444000 1228000 -193216000 54505108 364000 13037729 82000 3272612000 3047000 -20172000 -2759882000 45019000 -413377000 127693000 54505108 364000 13037729 82000 3272612000 3047000 -20172000 -2759882000 45019000 -413377000 127693000 -16529000 -16529000 -575000 -575000 248631000 248631000 -9368000 -9368000 1817000 1817000 1204483 8000 8315000 8323000 245000 245000 386000 -386000 14409000 14409000 -128390000 -4433000 -132823000 55709591 372000 13037729 82000 3295336000 3433000 -46069000 -2889233000 42648000 -164746000 241823000 55709591 372000 13037729 82000 3295336000 3433000 -46069000 -2889233000 42648000 -164746000 241823000 15591000 15591000 -675000 -675000 81341000 81341000 -6711000 -6711000 53488 1000 37000 38000 443000 -443000 -7677000 -7677000 -102799000 -3177000 -105976000 55763079 373000 13037729 82000 3287696000 3876000 -37189000 -2993150000 39471000 -83405000 217754000 -193216000 -132823000 -105976000 -15431000 7083000 7678000 7844000 1142000 -8000 311000 35000 5000 -107000 213000 133000 19000 21611000 17144000 9706000 1413000 15394000 14239000 6112000 890000 11687000 11705000 24597000 3582000 1596000 1949000 1777000 259000 622000 178000 26000 -131000 418000 -82000 -12000 -20000 104000 7000 1000 6846000 127000 3597000 524000 40684000 5924000 55022000 14409000 -7677000 -1118000 11369000 2824000 -2266000 -330000 -1889000 -989000 -989000 -144000 880000 6131000 27455000 3998000 38839000 23176000 -30583000 -4453000 48853000 35056000 -47754000 -6954000 2663000 -490000 3839000 559000 -12850000 -12849000 -26397000 -3844000 -22029000 18106000 -36342000 -5292000 2518000 293000 6000 1000 667000 1954000 2701000 393000 1062000 -808000 252000 37000 -5229000 3140000 -2536000 -369000 -11289000 -4026000 1740000 253000 -247486000 -147504000 -54069000 -7873000 49392000 2376000 7864000 1145000 44840000 2579000 1096000 160000 4814000 35995000 4120000 600000 35245000 3874000 564000 2938000 428000 168546000 -40462000 -58287000 -8487000 24000 50000 7000 6509000 3077000 1805000 263000 4000 125000 16000 2000 15792000 -184417000 21147000 46496000 6770000 354825000 245000 87846000 185614000 110553000 16098000 74000000 176897000 187234000 27263000 16940000 262870000 87959000 12808000 130827000 270860000 87959000 12808000 9000 1023000 25000 4000 393698000 648491000 1995000 -76656000 -11161000 216588000 -124362000 -84229000 -12264000 88352000 292237000 162855000 23714000 -12703000 -5020000 11224000 1633000 292237000 162855000 89850000 13083000 120873000 -138000 -575000 -675000 -98000 12547000 -2938000 12850000 12849000 26397000 3844000 25970000 21038000 8384000 1221000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1.</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Organization and principal activities </div></div></td></tr></table> <div style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(a) Principal activities </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">Boqii Holding Limited (“Boqii Holding”, or the “Company”), was incorporated under the laws of the Cayman Islands in June 2012, as an exempted company with limited liability. In these consolidated financial statements, where appropriate, the term “Company” also refers to its subsidiaries, the VIEs and the VIEs’ subsidiaries as a whole. </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">The Company operates as an online </div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">one-stop</div></div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> destination for users to shop for a variety of pet products and interact with other users in its online pet community in the People’s Republic of China (the “PRC”), through its online platforms (Boqii.com and Boqii application, collectively “Boqii Marketplace”), branded stores on third-party online platforms (the “Online Branded Stores”) and its online pet community (“Boqii Community”). In addition to online business, the Company provides pet products to offline pet stores. </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company’s consolidated financial statements include the financial statements of the Company, its subsidiaries, consolidated VIEs and VIEs’ subsidiaries. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;">As </div>of March 31, 2023, the Company’s principal subsidiaries, consolidated VIEs and <div style="letter-spacing: 0px; top: 0px;;display:inline;">major </div>VIEs’ subsidiaries are as follows: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:29%"></td> <td style="vertical-align:bottom"></td> <td style="width:15%"></td> <td style="vertical-align:bottom"></td> <td style="width:15%"></td> <td style="vertical-align:bottom"></td> <td style="width:9%"></td> <td style="vertical-align:bottom;width:1%"></td> <td style="width:28%"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Name of subsidiaries and VIE</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Place of</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">incorporation</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Date of<br/> incorporation</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">or acquisition</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Percentage</div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">of direct</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">or indirect</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Principal activities</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Subsidiaries:</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Boqii Corporation Limited (“Boqii Corporation”)</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Hong Kong</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115513">July 2012</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">100%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Investment holding</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Boqii International Limited</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Hong Kong</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115514">August 2016</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">100%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Investment holding</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Xingmu International Limited</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">British Virgin Islands</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115515">August 2019</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">51%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Investment holding</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Xingmu HK Limited</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Hong Kong</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115516">November 2019</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">51%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Investment holding</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Nanjing Xinmu Information Technology Co., Ltd. (“Xingmu WFOE”)</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Nanjing, the PRC</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115517">November 2019</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">51%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Technology development and sales of merchandise</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Xincheng (Shanghai) Information Technology Co., Ltd. (“Shanghai Xincheng”)</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Shanghai, the PRC</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115518">November 2012</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">100%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Technology development and sales of merchandise</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shanghai Yiqin Pets Products Co., Ltd.</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Shanghai, the PRC</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115519">February 2013</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">100%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Technology development and sales of merchandise</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shanghai Every Supply Chain Co., Ltd. (“Shanghai Every”)</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Shanghai, the PRC</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115520">September 2021</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">100%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales of merchandise</div></td></tr> <tr style="font-size:1pt"> <td style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Consolidated VIEs</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Guangcheng (Shanghai) Information Technology Co., Ltd. (“Guangcheng”)</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Shanghai, the PRC</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115439">November 2012</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">100%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: top; text-indent: -1em;"><div style="margin-left: 0.13in; line-height: normal;">Operates the Company’s own online <br/>e-commerce platform</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Nanjing Xingmu Biotechnology Co., Ltd. (“Nanjing Xingmu”)</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Nanjing, the PRC</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115440">November 2019</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">51%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt;margin-bottom: 0pt;margin-left: 1em;text-indent: -1em;font-size: 10pt;font-family: &quot;Times New Roman&quot;;line-height: normal;">Biotechnology research and development</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Suzhou Taicheng Supply Chain Co., Ltd. (“Suzhou Taicheng”)</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Suzhou, the PRC</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115441">June 2021</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">100%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Sales of merchandise</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Suzhou Xingyun Yueming Supply Chain Co., Ltd. (“Suzhou Xingyun Yueming”)</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Suzhou, the PRC</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115442">April 2022</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">100%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales of merchandise</div></td></tr> <tr style="font-size:1pt"> <td style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Subsidiaries of VIEs</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Boqii (Shanghai) Information Technology Co., Ltd.</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Shanghai, the PRC</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115443">August 2014</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">90%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Technology development</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Tianjing Guangcheng Information Technology Co., Ltd.</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Tianjin, the PRC</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115444">June 2017</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">100%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales of merchandise</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Nanjing Cuida Biotechnology Co. Ltd.(“Cuida”)</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Nanjing, the PRC</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115445">April 2017</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">70%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Biotechnology extension services</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Taizhou Xingmu Biotechnology Co., Ltd.</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Taizhou, the PRC</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115446">November 2019</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">80%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Biotechnology research and development</div></td></tr></table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"></div> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(b) Consolidated variable interest entities </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In order to comply with the PRC laws and regulations which prohibit or restrict foreign investments into companies involved in restricted businesses, the Company operates online platforms that provide internet information services and engages in other foreign-ownership-restricted businesses through certain PRC domestic companies (the PRC Domestic Companies, or the “VIEs”). The equity interests of the PRC Domestic Companies are held by certain management members of the Company or onshore nominees of certain investors of the Company (“Nominee Shareholders”), who act as nominee equity holders of the PRC Domestic Companies on behalf of Shanghai Xincheng and Xingmu WFOE, the Company’s wholly owned subsidiaries in the PRC (the “WFOEs”). The WFOEs entered into a series of contractual arrangements with the PRC Domestic Companies and their respective Nominee Shareholders (the “Contractual Arrangements”). These Contractual Agreements cannot be unilaterally terminated by the Nominee Shareholders or the PRC Domestic Companies. Through the Contractual Arrangements, the Nominee Shareholders have granted all their legal rights including voting rights and disposition rights of their equity interests in the PRC Domestic Companies to the WFOEs. The Nominee Shareholders do not have the power to direct the activities of the PRC Domestic Companies that most significantly impact their economic performance. The Nominee Shareholders do not have the obligation to absorb losses of the PRC Domestic Companies that could potentially be significant to them or the right to receive benefits from the PRC Domestic Companies that could potentially be significant to them. Accordingly, the PRC Domestic Companies are considered as variable interest entities of the Company, through the WFOEs. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In accordance with Accounting Standards Codification <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(“ASC”) 810-10-25-38A, the</div></div></div> Company, through its WFOEs, has a controlling financial interest in the VIEs because the WFOEs have the power to direct activities of the VIEs that most significantly impact the economic performance of the VIEs. In addition, under the terms of the Contractual Arrangements, the WFOEs have (i) the right to receive economic benefits that could potentially be significant to the VIEs in the form of service fees under the Exclusive Consultation and Service Agreements; (ii) the right to receive all dividends declared by the VIEs and the right to all undistributed earnings of the VIEs; and (iii) the obligation to absorb the substantially expected losses and the right to receive the residual benefits of the VIEs through its exclusive option to acquire 100% of the equity interests in the VIEs, to the extent permitted under PRC law. Thus, the Company, through the WFOEs, has the obligation to absorb the expected losses and the right to receive expected residual return of the VIEs that could potentially be significant to the VIEs. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Based on the above, the Company, through the WFOEs, is the ultimate primary beneficiary of the VIEs. Accordingly, the financial statements of the VIEs and their subsidiaries are consolidated in the Company’s consolidated financial statements. </div> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Loan Agreements </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the relevant loan agreements, the WFOEs have granted interest-free loans to the relevant Nominee Shareholders of the relevant VIEs with the sole purpose of providing funds necessary for the capital injection to the relevant VIEs. </div> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The loans can only be repaid by transfer of the equity interests of the relevant VIEs held by the Nominee Shareholders, and shall be repaid upon the occurrence of, among other events, the WFOEs exercise of their options to purchase the relevant VIEs’ equity interests under the Exclusive Option Agreements (refer to following section for further details). Any proceeds received by the Nominee Shareholders from transfer of the equity interests shall also be repaid to the WFOEs as part of the loan repayments. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"></div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"></div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Other events that will lead to loan repayments include: the Nominee Shareholders receiving a written notice from the relevant PRC subsidiaries requesting loan repayments; the death or loss of capacity for civil conduct of the Nominee Shareholders; the Nominee Shareholders no longer acting as shareholders of the relevant VIEs or employees of the relevant VIEs, PRC subsidiaries or their related parties; the Nominee Shareholders being involved in criminal activities; or, any third party making a claim in an amount over RMB 500,000 against the Nominee Shareholders. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The loans shall be considered fully repaid when the Nominee Shareholders have transferred all equity interests held by them to the WFOEs or a party designated by the WFOEs. The Loan Agreements shall remain valid until the Nominee Shareholders repaid the relevant loans to the WFOEs. </div> <div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Exclusive Option Agreements </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Nominee Shareholders of the VIEs have granted the WFOEs the exclusive and irrevocable right to purchase or to designate one or more person(s) at their discretion to purchase part or all of the equity interests in the VIEs from the Nominee Shareholders for a purchase price at any time, subject to the lowest price permitted by PRC laws and regulations. The VIEs and their Nominee Shareholders have agreed that without prior written consent of the WFOEs, their respective Nominee Shareholders cannot sell, transfer, pledge or dispose their equity interests, and the VIEs cannot sell, transfer, pledge or dispose, but not limit to, the equity interests, significant assets, significant revenue and significant business. Also as agreed, the VIEs cannot declare any dividend or change capitalization structure of the VIEs and cannot enter into any loan or investment agreements. Furthermore, the Nominee Shareholders have agreed that any proceeds but not limited to the sales of the Nominee Shareholders’ equity interest in relevant VIEs should be gratuitously paid to the WOFEs or one or more person(s) at their discretion. The Exclusive Option Agreement will remain effective until all equity options in VIEs held by such Nominee Shareholders are transferred or assigned to the WFOEs or their designated representatives. </div> <div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Proxy Agreement and Power of Attorney </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the irrevocable power of attorney, each of the Nominee Shareholders appointed the WFOEs as their <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">attorney-in-fact</div></div> to exercise all shareholder rights under PRC law and the relevant articles of association, including but not limited to, attending shareholders meetings, voting on their behalf on all matters requiring shareholder approval, including but not limited to sale, transfer, pledge, or disposition of all or part of the Nominee Shareholders’ equity interests, and designation and appointing the legal representative, directors, supervisors, chief executive officer and other senior management members of the VIEs. Each power of attorney will remain in force during the period when the Nominee Shareholders continues to be shareholders of the VIEs. Each Nominee Shareholder has waived all the rights which have been authorized to the person designated by the WFOEs under each power of attorney. </div> <div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Exclusive Consultation and Service Agreements </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Exclusive Consultation Service Agreements, the WFOEs have agreed to provide to the VIEs services, including, but not limited to, design and maintenance of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">E-Commerce</div> platform, consulting services, technical training, research, planning and development of the market and customer support. The VIEs shall pay to the WFOEs service fees determined based on the complexity and difficulty of the services, title of and time consumed by employees, contents and value of the services, operation conditions and market price of the service provided. The Exclusive Consultation and Service Agreements will be in effect permanent unless terminated by the WFOEs. The WFOEs have the exclusive ownership of all the intellectual property rights created as a result of the performance of the agreements. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"></div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Intellectual Property License Agreements </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the intellectual property license agreements, the WFOEs have granted a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-exclusive</div> and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-transferable</div> license, without sublicensing rights, to the VIEs to use its intellectual property. The VIEs may only use the licenses in its own business operations. The VIEs agree to pay the WFOEs a quarterly service fee at an amount that is equal to the VIEs’ revenue for the relevant quarter with a certain percentage or an amount adjusted at the WFOEs’ sole discretion for the relevant quarter, which should be paid within 15 business days after the VIEs confirm in writing the amount and breakdown of the service fee for the relevant quarter. The agreement has a term of 10 years and shall automatically renew at the end of each term for a further term of 10 years, unless otherwise terminated by the WFOEs in its sole discretion with 90 days’ prior written notice. </div> <div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Equity Interest Pledge Agreements </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the relevant equity interest pledge agreements, the Nominee Shareholders of the VIEs have pledged 100% equity interests in relevant VIEs to the WFOEs to guarantee performance by the Nominee Shareholders of their obligations under the Exclusive Option Agreements, the Proxy Agreement and Power of Attorney and the Loan Agreements, as well as the performance by the VIEs of their obligations under the Exclusive Option Agreements, the Exclusive Consultation and Service Agreements and Intellectual Property License Agreements. In the event of a breach by the VIEs or any of their Nominee Shareholders of contractual obligations under the Contractual Agreements, as the case may be, the WFOEs, as pledgee, will have the right to dispose of the pledged equity interests in the relevant VIEs and will have priority in receiving the proceeds from such disposal. The Nominee Shareholders of the VIEs also covenant that, without the prior written consent of the WFOEs, they will not dispose of, create or allow any encumbrance on the pledged equity interests. The Equity Interest Pledge Agreements will remain in effect so long as any of the Loan Agreements, the Exclusive Consultation Service Agreements, the Exclusive Option Agreements, the Proxy Agreement and Power of Attorney, or the Intellectual Property License Agreements, as mentioned above, remains in effect or any guaranteed obligations of the VIEs, or, to the extent applicable, its Nominee Shareholders, remains outstanding under the Contractual Agreements. The pledge was registered with the relevant local administration and will remain binding until the VIEs and their Nominee Shareholders discharge all their obligations under the Contractual Arrangements. The registration of the equity pledge enables the WFOEs to enforce the equity pledge against third parties who acquire the equity interests of the VIEs in good faith. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">One set of existing Contractual Agreements were initially entered into in September 2012 by Shanghai Xincheng (one of the Company’s WOFEs), Guangcheng (one of the Company’s VIEs) and its nominee shareholders, was subsequently amended and restated on substantially similar terms in September 2017, October 2019 and August 2020, respectively. One set of existing Contractual Agreements were entered into in September 2019 by Xingmu WFOE (one of the Company’s WOFEs), Nanjing Xingmu (one of the Company’s VIEs) and its Nominee Shareholders. One set of Contractual Agreements were entered into in June 2021 by Shanghai Xincheng (one of the Company’s WOFEs), Suzhou Taicheng (one of the Company’s VIEs) and its Nominee Shareholders. A new set of Contractual Agreements were entered into in April 2022 by Shanghai Every (one of the Company’s WOFEs), Suzhou Xingyun Yueming (one of the Company’s VIEs) and its Nominee Shareholders.The Loan Agreements, Exclusive Option Agreements, Proxy Agreement and Power of Attorney, Exclusive Consultation and Service Agreements, Intellectual Property License Agreements and Equity Interest Pledge Agreements were amended to reflect the changes of shareholders’ holding in the VIE in their respective dates. No other material terms or conditions of these agreements were changed or altered. There was no impact to the Company’s control over the VIEs and the Company continues to consolidate the VIEs. </div></div></div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(c) Risks in relations to the VIE structure </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Under the Contractual Agreements with the consolidated VIEs, the Company has the power to direct activities of the consolidated VIEs and VIEs’ subsidiaries through the Company’s relevant PRC subsidiaries, and can have assets transferred freely out of the consolidated VIEs and VIEs’ subsidiaries without restrictions. Therefore, the Company considers that there is no asset of the consolidated VIEs that can only be used to settle obligations of the respective consolidated VIEs, except for the registered capital of the consolidated VIEs amounting to RMB52 million and RMB52 million as of March 31, 2022 and 2023. Since the consolidated VIEs and VIEs’ subsidiaries are incorporated as limited liability companies under the PRC Law, creditors of the consolidated VIEs and VIEs’ subsidiaries do not have recourse to the general credit of the Company. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"></div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company believes that the Company’s relevant PRC subsidiaries’ Contractual Arrangements with the consolidated VIEs and the Nominee Shareholders are in compliance with PRC laws and regulations, as applicable, and are legally binding and enforceable. However, uncertainties in the PRC legal system could limit the Company’s ability to enforce these contractual arrangements. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In addition, if the current structure or any of the contractual arrangements were found to be in violation of any existing or future PRC law, the Company may be subject to penalties, which may include but not be limited to, the cancellation or revocation of the Company’s business and operating licenses, being required to restructure the Company’s operations or terminate the Company’s operating activities. The imposition of any of these or other penalties may result in a material and adverse effect on the Company’s ability to conduct its operations. In such case, the Company may not be able to operate or control the VIEs, which may result in deconsolidation of the VIEs. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table set forth the assets, liabilities, results of operations and changes in cash, cash equivalents and restricted cash of the consolidated VIEs and their subsidiaries taken as a whole, which were included in the Company’s consolidated financial statements with intercompany transactions eliminated (RMB in thousands): </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash and cash equivalents</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,567</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15,522</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounts receivable, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">31,435</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">33,172</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amounts due from related parties</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,726</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,770</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inventories, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16,014</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27,894</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Prepayments and other current assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">57,107</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">48,291</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inter-company receivables</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16,535</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">83,700</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Property and equipment, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,715</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,661</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Intangible assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">507</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">101</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">35,688</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22,305</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Goodwill</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">994</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Long-term investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">81,649</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,505</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> asset</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,389</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,219</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">282,326</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">323,140</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:76%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Short-term borrowings</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">872</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">363</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounts payable</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">55,144</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,459</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amounts due to related parties, current</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Salary and welfare payable</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,597</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,573</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued liabilities and other current liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24,417</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15,712</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Contract liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,007</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,471</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liabilities, current</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,238</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,207</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inter-company payables</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">945,960</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,095,452</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liabilities, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28,197</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,741</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other debts, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">157,874</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total liabilities</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,232,310</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,232,480</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div></div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"></div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:72%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="10" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended March 31,</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net revenues:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Third-party revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">735,518</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">877,380</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">786,152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inter-company revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">48,374</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">56,079</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">86,463</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">783,892</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">933,459</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">872,615</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1pt"> <td style="height:6pt"></td> <td colspan="4" style="height:6pt"></td> <td colspan="4" style="height:6pt"></td> <td colspan="4" style="height:6pt"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cost of revenues:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Third-party cost of revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(372,475</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(160,661</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(81,810</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inter-company cost of revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(297,844</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(550,585</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(534,518</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total cost of revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(670,319</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(711,246</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(616,328</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross profit</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">113,573</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">222,213</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">256,287</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1pt"> <td style="height:6pt"></td> <td colspan="4" style="height:6pt"></td> <td colspan="4" style="height:6pt"></td> <td colspan="4" style="height:6pt"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating expenses:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Third-party operating expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(254,951</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(288,291</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(237,852</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inter-company operating expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(7,257</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(41</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total operating expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(262,208</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(288,291</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(237,893</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Impairment of goodwill</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(994</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other income, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,011</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">98</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">158</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Profit/(Loss) from operations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(147,624</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(65,980</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,558</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-operating</div> expense</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(18,162</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(20,680</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(29</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Profit/(Loss) before income tax expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(165,786</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(86,660</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,529</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Income tax benefits/(expenses)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(20</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">681</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Share of results of equity investees</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(696</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">418</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(82</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net profit/(loss)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(166,502</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(85,561</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,468</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash flows from operating activities:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net cash provided by transactions with external parties</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">419,767</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">526,201</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">471,991</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net cash used in transactions with the Company’s entities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(331,064</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(329,325</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(449,155</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net cash generated from/ (used in) operating activities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">88,703</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">196,876</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22,836</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash flows from investing activities:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other investing activities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(31,972</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(18,482</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(9,638</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash flows of loan funding provided to the Company’s entities, net of repayments received</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,242</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,294</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net cash used in investing activities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(37,214</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(12,188</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(9,638</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash flows from financing activities:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other financing activities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(112,151</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(273,906</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(88,469</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash flows of loan funding received from the Company’s entities, net of repayments made</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">41,717</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">91,794</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">69,204</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net cash generated from/ (used in) financing activities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(70,434</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(182,112</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(19,265</td> <td style="white-space:nowrap;vertical-align:bottom">)</td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;">As </div>of March 31, 2023, the Company’s principal subsidiaries, consolidated VIEs and <div style="letter-spacing: 0px; top: 0px;;display:inline;">major </div>VIEs’ subsidiaries are as follows: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:29%"></td> <td style="vertical-align:bottom"></td> <td style="width:15%"></td> <td style="vertical-align:bottom"></td> <td style="width:15%"></td> <td style="vertical-align:bottom"></td> <td style="width:9%"></td> <td style="vertical-align:bottom;width:1%"></td> <td style="width:28%"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Name of subsidiaries and VIE</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Place of</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">incorporation</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Date of<br/> incorporation</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">or acquisition</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Percentage</div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">of direct</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">or indirect</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Principal activities</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Subsidiaries:</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Boqii Corporation Limited (“Boqii Corporation”)</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Hong Kong</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115513">July 2012</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">100%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Investment holding</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Boqii International Limited</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Hong Kong</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115514">August 2016</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">100%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Investment holding</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Xingmu International Limited</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">British Virgin Islands</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115515">August 2019</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">51%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Investment holding</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Xingmu HK Limited</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Hong Kong</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115516">November 2019</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">51%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Investment holding</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Nanjing Xinmu Information Technology Co., Ltd. (“Xingmu WFOE”)</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Nanjing, the PRC</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115517">November 2019</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">51%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Technology development and sales of merchandise</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Xincheng (Shanghai) Information Technology Co., Ltd. (“Shanghai Xincheng”)</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Shanghai, the PRC</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115518">November 2012</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">100%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Technology development and sales of merchandise</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shanghai Yiqin Pets Products Co., Ltd.</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Shanghai, the PRC</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115519">February 2013</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">100%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Technology development and sales of merchandise</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shanghai Every Supply Chain Co., Ltd. (“Shanghai Every”)</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Shanghai, the PRC</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115520">September 2021</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">100%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales of merchandise</div></td></tr> <tr style="font-size:1pt"> <td style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Consolidated VIEs</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Guangcheng (Shanghai) Information Technology Co., Ltd. (“Guangcheng”)</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Shanghai, the PRC</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115439">November 2012</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">100%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: top; text-indent: -1em;"><div style="margin-left: 0.13in; line-height: normal;">Operates the Company’s own online <br/>e-commerce platform</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Nanjing Xingmu Biotechnology Co., Ltd. (“Nanjing Xingmu”)</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Nanjing, the PRC</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115440">November 2019</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">51%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt;margin-bottom: 0pt;margin-left: 1em;text-indent: -1em;font-size: 10pt;font-family: &quot;Times New Roman&quot;;line-height: normal;">Biotechnology research and development</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Suzhou Taicheng Supply Chain Co., Ltd. (“Suzhou Taicheng”)</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Suzhou, the PRC</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115441">June 2021</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">100%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Sales of merchandise</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Suzhou Xingyun Yueming Supply Chain Co., Ltd. (“Suzhou Xingyun Yueming”)</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Suzhou, the PRC</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115442">April 2022</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">100%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales of merchandise</div></td></tr> <tr style="font-size:1pt"> <td style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Subsidiaries of VIEs</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Boqii (Shanghai) Information Technology Co., Ltd.</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Shanghai, the PRC</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115443">August 2014</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">90%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Technology development</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Tianjing Guangcheng Information Technology Co., Ltd.</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Tianjin, the PRC</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115444">June 2017</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">100%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales of merchandise</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Nanjing Cuida Biotechnology Co. Ltd.(“Cuida”)</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Nanjing, the PRC</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115445">April 2017</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">70%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Biotechnology extension services</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Taizhou Xingmu Biotechnology Co., Ltd.</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Taizhou, the PRC</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><span style="-sec-ix-hidden:hidden84115446">November 2019</span></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:right;">80%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Biotechnology research and development</div></td></tr></table> Hong Kong 1 Investment holding Hong Kong 1 Investment holding British Virgin Islands 0.51 Investment holding Hong Kong 0.51 Investment holding Nanjing, the PRC 0.51 Technology development and sales of merchandise Shanghai, the PRC 1 Technology development and sales of merchandise Shanghai, the PRC 1 Technology development and sales of merchandise Shanghai, the PRC 1 Sales of merchandise Shanghai, the PRC 1 Operates the Company’s own online e-commerce platform Nanjing, the PRC 0.51 Biotechnology research and development Suzhou, the PRC 1 Sales of merchandise Suzhou, the PRC 1 Sales of merchandise Shanghai, the PRC 0.90 Technology development Tianjin, the PRC 1 Sales of merchandise Nanjing, the PRC 0.70 Biotechnology extension services Taizhou, the PRC 0.80 Biotechnology research and development 1 500000 P15D P10Y P10Y P90D 1 52000000 52000000 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table set forth the assets, liabilities, results of operations and changes in cash, cash equivalents and restricted cash of the consolidated VIEs and their subsidiaries taken as a whole, which were included in the Company’s consolidated financial statements with intercompany transactions eliminated (RMB in thousands): </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash and cash equivalents</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,567</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15,522</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounts receivable, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">31,435</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">33,172</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amounts due from related parties</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,726</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,770</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inventories, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16,014</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27,894</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Prepayments and other current assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">57,107</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">48,291</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inter-company receivables</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16,535</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">83,700</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Property and equipment, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,715</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,661</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Intangible assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">507</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">101</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">35,688</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22,305</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Goodwill</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">994</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Long-term investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">81,649</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,505</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> asset</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,389</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,219</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">282,326</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">323,140</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:76%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Short-term borrowings</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">872</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">363</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounts payable</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">55,144</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,459</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amounts due to related parties, current</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Salary and welfare payable</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,597</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,573</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued liabilities and other current liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24,417</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15,712</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Contract liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,007</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,471</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liabilities, current</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,238</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,207</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inter-company payables</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">945,960</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,095,452</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liabilities, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28,197</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,741</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other debts, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">157,874</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total liabilities</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,232,310</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,232,480</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div></div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"></div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:72%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="10" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended March 31,</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net revenues:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Third-party revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">735,518</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">877,380</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">786,152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inter-company revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">48,374</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">56,079</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">86,463</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">783,892</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">933,459</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">872,615</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1pt"> <td style="height:6pt"></td> <td colspan="4" style="height:6pt"></td> <td colspan="4" style="height:6pt"></td> <td colspan="4" style="height:6pt"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cost of revenues:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Third-party cost of revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(372,475</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(160,661</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(81,810</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inter-company cost of revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(297,844</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(550,585</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(534,518</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total cost of revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(670,319</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(711,246</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(616,328</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross profit</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">113,573</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">222,213</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">256,287</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1pt"> <td style="height:6pt"></td> <td colspan="4" style="height:6pt"></td> <td colspan="4" style="height:6pt"></td> <td colspan="4" style="height:6pt"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating expenses:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Third-party operating expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(254,951</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(288,291</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(237,852</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inter-company operating expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(7,257</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(41</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total operating expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(262,208</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(288,291</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(237,893</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Impairment of goodwill</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(994</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other income, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,011</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">98</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">158</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Profit/(Loss) from operations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(147,624</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(65,980</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,558</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-operating</div> expense</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(18,162</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(20,680</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(29</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Profit/(Loss) before income tax expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(165,786</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(86,660</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,529</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Income tax benefits/(expenses)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(20</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">681</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Share of results of equity investees</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(696</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">418</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(82</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net profit/(loss)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(166,502</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(85,561</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,468</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash flows from operating activities:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net cash provided by transactions with external parties</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">419,767</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">526,201</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">471,991</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net cash used in transactions with the Company’s entities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(331,064</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(329,325</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(449,155</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net cash generated from/ (used in) operating activities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">88,703</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">196,876</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22,836</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash flows from investing activities:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other investing activities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(31,972</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(18,482</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(9,638</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash flows of loan funding provided to the Company’s entities, net of repayments received</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,242</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,294</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net cash used in investing activities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(37,214</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(12,188</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(9,638</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash flows from financing activities:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other financing activities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(112,151</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(273,906</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(88,469</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash flows of loan funding received from the Company’s entities, net of repayments made</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">41,717</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">91,794</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">69,204</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net cash generated from/ (used in) financing activities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(70,434</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(182,112</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(19,265</td> <td style="white-space:nowrap;vertical-align:bottom">)</td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 20567000 15522000 31435000 33172000 11726000 6770000 16014000 27894000 57107000 48291000 16535000 83700000 6715000 4661000 507000 101000 35688000 22305000 994000 81649000 75505000 3389000 5219000 282326000 323140000 872000 363000 55144000 13459000 4000 21000 5597000 5573000 24417000 15712000 7007000 4471000 7238000 9207000 945960000 1095452000 28197000 12741000 157874000 75481000 1232310000 1232480000 735518000 877380000 786152000 48374000 56079000 86463000 783892000 933459000 872615000 372475000 160661000 81810000 297844000 550585000 534518000 670319000 711246000 616328000 113573000 222213000 256287000 -254951000 -288291000 -237852000 -7257000 -41000 -262208000 -288291000 -237893000 994000 1011000 98000 158000 -147624000 -65980000 17558000 -18162000 -20680000 -29000 -165786000 -86660000 17529000 -20000 681000 21000 -696000 418000 -82000 -166502000 -85561000 17468000 419767000 526201000 471991000 -331064000 -329325000 -449155000 88703000 196876000 22836000 -31972000 -18482000 -9638000 -5242000 6294000 -37214000 -12188000 -9638000 -112151000 -273906000 -88469000 41717000 91794000 69204000 -70434000 -182112000 -19265000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2.</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Principal Accounting Policies </div></div></td></tr></table><div style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(a) Basis of preparation </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”). Significant accounting policies followed by the Company in the preparation of the accompanying consolidated financial statements are summarized below. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(b) Basis of consolidation </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company’s consolidated financial statements include the financial statements of the Company, its subsidiaries, the consolidated VIEs and VIEs’ subsidiaries for which the Company is the primary beneficiary. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">A subsidiary is an entity in which the Company, directly or indirectly, controls more than one half of the voting power, has the power to appoint or remove the majority of the members of the board of directors, to cast a majority of votes at the meeting of the board of directors or to govern the financial and operating policies of the investee under a statute or agreement among the shareholders or equity holders. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">A consolidated VIE is an entity in which the Company, or its subsidiaries, through Contractual Agreements, bears the risks of, and enjoys the rewards normally associated with, ownership of the entity, and therefore the Company or its subsidiaries are the primary beneficiary of the entity. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">All transactions and balances among the Company, its subsidiaries, the consolidated VIEs and VIEs’ subsidiaries have been eliminated upon consolidation<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">.</div></div> </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(c) Business combination and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-controlling</div> interests </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company accounts for its business combinations using the acquisition method of accounting in accordance with Accounting Standards Codification (“ASC”) 805, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Business Combinations</div></div>. The cost of an acquisition is measured as the aggregate of the acquisition date fair values of the assets transferred and liabilities incurred by the Company to the sellers and equity instruments issued. Transaction costs directly attributable to the acquisition are expensed as incurred. Identifiable assets and liabilities acquired or assumed are measured separately at their fair values as of the acquisition date, irrespective of the extent of any <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-controlling</div> interests. The excess of (i) the total costs of acquisition, fair value of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-controlling</div> interests and acquisition date fair value of any previously held equity interest in the acquiree over (ii) the fair value of the identifiable net assets of the acquiree is recorded as goodwill. If the cost of acquisition is less than the fair value of the net assets of the subsidiary acquired, the difference is recognized directly in the consolidated statements of loss and comprehensive loss as a bargain purchase gain. During the measurement period, which can be up to one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill or bargain purchase gain. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the consolidated statements of loss and comprehensive loss. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In a business combination achieved in stages, the Company <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measures</div> the previously held equity interest in the acquiree immediately before obtaining control at its acquisition-date fair value and the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measurement</div> gain or loss, if any, is recognized in the consolidated statements of loss and comprehensive loss. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">When there is a change in ownership interests or a change in contractual arrangements that results in a loss of control of a subsidiary or consolidated VIE, the Company deconsolidates the subsidiary or consolidated VIE from the date control is lost. Any retained <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-controlling</div> investment in the former subsidiary or consolidated VIE is measured at fair value and is included in the calculation of the gain or loss upon deconsolidation of the subsidiary or consolidated VIE. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the Company’s consolidated subsidiaries, VIEs and VIEs’ subsidiaries, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-controlling</div> interests are recognized to reflect the portion of their equity that is not attributable, directly or indirectly, to the Company as the controlling shareholder. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-controlling</div> interests are classified as a separate line item in the equity section of the Company’s consolidated balance sheets and have been separately disclosed in the Company’s consolidated statements of loss and comprehensive loss to distinguish the interests from that of the Company. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(d) Use of estimates </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The preparation of the Company’s consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company believes that assessment for impairment of long-lived assets and valuation of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt securities require significant judgments and estimates used in the preparation of its consolidated financial statements. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Management bases the estimates on historical experience and on various other assumptions as discussed elsewhere to the consolidated financial statements that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. On an ongoing basis, management evaluates its estimates based on information that is currently available. Changes in circumstances, facts and experience may cause the Company to revise its estimates. Changes in estimates are recorded in the period in which they become known. Actual results could materially differ from these estimates. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(e) Functional currency and foreign currency translation </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company’s reporting currency is Renminbi (“RMB”). The functional currency of the Company’s entities incorporated in Cayman Islands, British Virgin Islands and Hong Kong is the United States dollars (“US$”). The Company’s PRC subsidiaries, consolidated VIEs and VIEs’ subsidiaries determined their functional currency to be RMB. The determination of the respective functional currency is based on the criteria of ASC 830, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Foreign Currency Matters</div></div>. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Transactions denominated in other than the functional currencies are translated into the functional currency of the entity at the exchange rates prevailing on the transaction dates. Financial assets and liabilities denominated in other than the functional currency are translated at the balance sheet date exchange rate. The resulting exchange differences are included in the consolidated statements of loss and comprehensive loss as other gains, net. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The financial statements of the Company are translated from the functional currency into RMB. Assets and liabilities denominated in foreign currencies are translated into RMB using the applicable exchange rates at the balance sheet date. Equity accounts other than earnings generated in current period are translated into RMB at the appropriate historical rates. Revenues, expenses, gains and losses are translated into RMB using the periodic average exchange rates. The resulting foreign currency translation adjustments are recorded in accumulated other comprehensive loss as a component of shareholders’ equity. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The exchange rates used for translation on March 31, 2022 and 2023 were US$1.00= RMB 6.3482 and RMB 6.8717, respectively, representing the index rates stipulated by the People’s Bank of China. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(f) Convenience translation </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Translations of the consolidated balance sheets, the consolidated statements of loss and comprehensive loss and the consolidated statements of cash flows from RMB into US$ as of and for the year ended March 31, 2023 are solely for the convenience of the readers and were calculated at the rate of US$1.00=RMB 6.8676, representing the certificated exchange rate published by the Federal Reserve Board. No representation is made that the RMB amounts could have been, or could be, converted, realized or settled into US$ at that rate on March 31, 2023, or at any other rate. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(g) Fair value of financial instruments </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Accounting guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and it considers assumptions that market participants would use when pricing the asset or liability. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The established fair value hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The three levels of inputs that may be used to measure fair value: </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Level 2: Observable, market-based inputs, other than quoted prices, in active markets for identical assets or liabilities. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Level 3: Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Accounting guidance also describes three main approaches to measuring the fair value of assets and liabilities: (1) market approach; (2) income approach and (3) cost approach. The market approach uses prices and other relevant information generated from market transactions involving identical or comparable assets or liabilities. The income approach uses valuation techniques to convert future amounts to a single present value amount. The measurement is based on the value indicated by current market expectations about those future amounts. The cost approach is based on the amount that would currently be required to replace an asset. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Financial assets and liabilities of the Company mainly consist of cash and cash equivalents, short-term investments, accounts receivable, amounts due from related parties, prepayments and other current assets, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt investments, accounts payable, short-term borrowings, derivative liabilities, accrued liabilities and other current liabilities, amounts due to related parties, and other debts. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of March 31, 2022 and 2023, except for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt investments and derivative liabilities, carrying values of cash and cash equivalents, short-term investments, accounts receivable, amounts due from related parties, certain prepayments and other current assets, accounts payable, short-term borrowings, certain accrued liabilities and other current liabilities, amounts due to related parties and current portion of other debts approximated their fair values reported in the consolidated balance sheets due to the short-term maturities of these instruments. The carrying value of long-term loan receivable, long-term borrowings and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> portion of other debts approximated their fair values as of March 31, 2022 and 2023 as the interest rates and credit risk they bear reflect the current market yield for comparable instruments. The Company reports derivative liabilities at fair value at each balance sheet date and change in fair value is reflected in “Fair value change of derivative liabilities” in the consolidated statements of loss and comprehensive loss. The Company reports <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt investments at fair value at each balance sheet date with the aggregate unrealized gains and losses, net of tax, reflected in “Accumulated other comprehensive loss” in the consolidated balance sheets. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(h) Cash and cash equivalents </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents include cash on hand and time deposits placed with banks and third party payment processors, which are unrestricted as to withdrawal or use, have original maturities of three months or less at the time of purchase and are readily convertible to known amounts of cash. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(i) Short-term investments </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Short-term investments comprise primarily of (i) cash deposits at fixed rates with original maturities of greater than three months, but less than 12 months and; (ii) the investments issued by commercial banks or other financial institutions with a variable interest rate indexed to the performance of underlying assets within one year. As of March 31, 2022 and 2023, RMB128 million and RMB70 million short-term investments were used as collateral of RMB111 million and RMB64 million short-term borrowings, respectively. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(j) Accounts receivable, net </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Accounts receivable are presented net of allowance for doubtful accounts. The Company maintains an allowance for doubtful accounts which reflects its best estimate of amounts that potentially will not be collected. The Company determines the allowance for doubtful accounts on general basis taking into consideration various factors including but not limited to historical collection experience and credit-worthiness of the customers as well as the age of the individual receivables balance. Additionally, the Company makes specific bad debt provisions based on any specific knowledge the Company has acquired that might indicate that an account is uncollectible. The facts and circumstances of each account may require the Company to use substantial judgment in assessing its collectability. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(k) Inventories </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Inventories are stated at the lower of cost and net realizable value. Cost elements of our inventories comprise the purchase price of products, vendor rebates, shipping charges to receive products from the suppliers when they are embedded in the purchase price. Cost is determined using the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">first-in</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">first-out</div> method. Provisions are made for excessive, slow moving, expired and obsolete inventories as well as for inventories with carrying values in excess of market. Certain factors could impact the realizable value of inventory, so the Company continually evaluates the recoverability based on assumptions about customer demand and market conditions. The evaluation may take into consideration historical usage, inventory aging, expiration date, expected demand, anticipated sales price, new product development schedules, the effect new products might have on the sale of existing products, product obsolescence, customer concentrations, and other factors. The reserve or write-down is equal to the difference between the cost of inventory and the estimated net realizable value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than those projected by management, additional inventory reserves or write-downs may be required that could negatively impact the Company’s gross margin and operating results. If actual market conditions are more favorable, the Company may have higher gross margin when products that have been previously reserved or written down are eventually sold. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(l) Property and equipment, net </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Property and equipment are carried at cost less accumulated depreciation and amortization. Depreciation is calculated on a straight-line basis over the following estimated useful lives. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The estimated useful lives are as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div><div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:96%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:51%"></td> <td style="vertical-align:bottom;width:1%"></td> <td style="width:48%"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Useful years</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">Warehouse equipment</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top">3 - 5 years</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">Furniture, computer and office equipment</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top">3 - 5 years</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">Vehicles</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top">5 years</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">Software</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top">10 years</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">Leasehold improvements</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top">Over the shorter of the expected life of leasehold improvements or the lease term</td></tr></table></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Expenditures for maintenance and repairs are expensed as incurred. The gain or loss on the disposal of property and equipment is the difference between the net sales proceeds and the carrying amount of the relevant assets and is recognized in the consolidated statements of loss and comprehensive loss. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(m) Intangible assets, net </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Intangible assets purchased from third parties are initially recorded at cost. The Company performs valuation of the intangible assets arising from business combinations to determine the relative fair value to be assigned to each asset acquired. The intangible assets are amortized using the straight-line method over the estimated useful lives of the assets. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The estimated useful lives of intangible assets are as follows: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div><div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:96%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:51%"></td> <td style="vertical-align:bottom;width:1%"></td> <td style="width:48%"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Useful years</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">Trademark</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top;text-align:center;">10 years</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">Dealership</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top;text-align:center;">10 years</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">License</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top;text-align:center;">4.5 years</td></tr></table> </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The estimated life of amortized intangibles is reassessed if circumstances occur that indicate the life has changed. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(n) Goodwill </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill represents the excess of the purchase price over the fair value of the identifiable assets and liabilities acquired in a business combination. Goodwill is not amortized but is tested for impairment on an annual basis as of March 31, and in between annual tests when an event occurs or circumstances change that could indicate that the asset might be impaired. </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In accordance with ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2017-04,</div> “Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment” (“ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2017-04”),</div> which removes the requirement to compare the implied fair value of goodwill with its carrying amount as part of step 2 of the goodwill impairment test. Management conducts its goodwill impairment assessment as of March 31 annually or more frequently if events or changes in circumstances indicate that it may be impaired. The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill, so as to perform the quantitative goodwill impairment test. If determined to be necessary, the quantitative impairment test is used to identify goodwill impairment by comparing the fair value of a reporting unit with its carrying amount and recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. The loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As there is only one reporting unit in the Company, the goodwill assessment was performed for the Company on consolidated level as one reporting unit. </div></div></div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(o) Long-term investments </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company’s investments include equity method investments, equity securities with readily determinable fair values and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt securities. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company applies the equity method of accounting to account for an equity investment, in common stock or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">in-substance</div> common stock, according to ASC 323 “Investment—Equity Method and Joint Ventures”, over which it has significant influence but does not own a majority equity interest or otherwise control. Under the equity method, the Company’s share of the post-acquisition profits or losses of the equity investees are recorded in share of results of equity investees in the consolidated statements of loss and comprehensive loss. The excess of the carrying amount of the investment over the underlying equity in net assets of the equity investee, if any, represents goodwill and intangible assets acquired. When the Company’s share of losses in the equity investee equals or exceeds its interest in the equity investee, the Company does not recognize further losses, unless the Company has incurred obligations or made payments or guarantees on behalf of the equity investee. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Equity securities with readily determinable fair values are measured and recorded at fair value on a recurring basis with changes in fair value, whether realized or unrealized, recorded through the income statement. </div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Debt securities that the Company has the intent to hold the security for an indefinite period or may sell the security in response to the changes in economic conditions are classified as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt securities and reported at fair value. Unrealized gains and losses (other than impairment losses) are reported, net of the related tax effect, in other comprehensive income (loss). Upon sale, realized gains and losses are reported in net income (loss). </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company continually reviews its investments to determine whether a decline in fair value to below the carrying value is other-than-temporary. The primary factors the Company considers in its determination are the duration and severity of the decline in fair value; the financial condition, operating performance and the prospects of the equity investee; and other company specific information such as recent financing rounds. If the decline in fair value is deemed to be other-than-temporary, the carrying value of the investment is written down to fair value. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(p) Impairment of long-lived assets other than goodwill </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Long-lived assets (including property and equipment and amortizable intangible assets) are evaluated for impairment whenever events or changes in circumstances (such as a significant adverse change to market conditions that will impact the future use of the assets) indicate that the carrying amount may not be fully recoverable or that the useful life is shorter than the Company had originally estimated. When these events occur, the Company evaluates the impairment by comparing carrying value of the assets to an estimate of future undiscounted cash flows expected to be generated from the use of the assets and their eventual disposition. If the sum of the expected future undiscounted cash flows is less than the carrying value of the assets, the Company recognizes an impairment loss based on the excess of the carrying value of the assets over the fair value of the assets. No impairment charges were recognized for the years ended March 31, 2021, 2022 and 2023. </div></div></div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(q) Revenue recognition </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In May 2014, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2014-09,</div> “Revenue from Contracts with Customers (Topic 606)” (“ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2014-09”)</div> and subsequently, the FASB issued several amendments which amends certain aspects of the guidance in ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2014-09</div> (ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2014-09</div> and the related amendments are collectively referred to as “ASC 606”). According to ASC 606, revenue is recognized when control of the promised good or service is transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Consistent with the criteria of Topic 606, the Company follows five steps for its revenue recognition: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the entity satisfies a performance obligation. Revenue arrangements with multiple performance obligations are divided into separate distinct goods or services. The Company allocates the transaction price to each performance obligation based on the relative standalone selling price of the goods or services provided. The Company’s revenues are primarily derived from (i) product sales and (ii) online marketing and information services and other revenue. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">When either party to a contract has performed, the Company presents the contract in the statement of financial position as a contract asset or a contract liability, depending on the relationship between the entity’s performance and the customer’s payment. A receivable is recorded when the Company has an unconditional right to consideration. A right to consideration is unconditional if only the passage of time is required before payment of that consideration is due. A contract asset is recorded when the Company has transferred products or services to the customer before payment is received or is due, and the Company’s right to consideration is conditional on future performance or other factors in the contract. No contract asset was recorded as of March 31, 2022 and 2023. The Company’s contract liabilities consist of payments received or awards to customers (in the form of Boqii Beans) related to unsatisfied performance obligations at the end of the period. As of April 1, 2021 and 2022, the Company’s total contract liabilities were RMB3.9 million and RMB7.0 million, respectively, of which RMB3.6 million and RMB3.0 million were recognized as revenue for the years ended March 31, 2022 and 2023. The Company’s total unearned revenue was RMB4.5 million as of March 31, 2023. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Revenue is recorded net of value-added tax. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div></div></div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Revenue recognition policies for each type of revenue steam are as follows: </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Sales of merchandise</div> </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company primarily sells pet products through online stores to individual online customers. Besides online sales, the Company also sells products through offline channels to its business customers and pet stores across the country. The Company recognizes the product revenues from products sales on a gross basis as the Company is acting as a principal in these transactions. The Company has obtained control of the products before they are transferred to customers. The Company is primarily obligated in these transactions, is subject to inventory risk or has the ability to direct the use of inventory, and has latitude in establishing prices and selecting suppliers. Revenue is recognized when consumers physically accept the products after delivery, which is when the control of products is transferred, and is recorded net of return allowances and rebates to pet stores. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company also enters into arrangements with its business partners to sell their products on the Company’s online stores. The Company considers the arrangements meet the indicators of consignment arrangement under ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">606-10-55-80,</div></div></div> because (i) the business partners do not relinquish control of the products, even though the Company has physical possession of the goods. The Company does not control the underlying products, which are considered to be the business partners’ inventory until they are sold to the end consumers; (ii) the business partner retains the right to require the return of the goods held by the Company; (iii) the Company has no obligation to pay for the products that are in its physical possession; and (iv) the Company has no discretion in establishing prices of the products provided by its business partners. Upon successful sales, the Company will charge the business partners a negotiated amount or a fixed rate commission fee based on the sales amount. Commission revenues are recognized on a net basis at the point of consumers’ acceptance of products, net of return allowance. </div> <div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Online marketing and information services and other revenue</div> </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company provides online marketing and information services to third-parties on the Company’s various channels and third-party platforms, including but not limited to advertising placements, organizing online and offline marketing campaigns featuring social media influencers and circulating marketing messages to end consumers. With respect to the Company’s marketing services, length of the periods over which services are provided are generally within months or less, revenue from such arrangements is recognized ratably over the service period, as the third-party simultaneously consumes the benefits when the advertisement is displayed or the campaign is ongoing. </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company also provides warehouse services. The warehouse services include warehousing, packaging, dispatching and other services. Revenue is primarily recognized when the services are rendered. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(r) Sales returns </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company offers online consumers an unconditional right of return for a period of seven days upon receipt of products. Return allowances, which reduce revenue and cost of sales, are estimated by categories of return policies offered to online customers, based on historical data the Company has maintained, and subject to adjustments to the extent that actual returns differ or are expected to differ. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(s) Sales incentives </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company adopted a customer reward program, under which the Company grants certain units (“Boqii Bean”) to its customers at its discretion in different situations. Boqii Beans are not redeemable for cash and can be used as a coupon for the customer’s future purchase on the Boqii Marketplace and Boqii.com. The value of ten units of Boqii Bean is equivalent to one RMB yuan before taking into account the impact of breakage. </div> <div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;;text-indent: 0px;"> </div> <div style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div></div></div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">For the Boqii Beans that are granted with concurrent revenue transactions, the allocated transaction price based on its relative standalone selling price are recognized as reduction of the revenue and accrued for as contract liabilities. As customers redeem awards, the accrued liability is reduced correspondingly. For the Boqii Beans that are granted without concurrent revenue transactions, they are not accounted for when granted and are recognized as a reduction of revenue when they are applied in future sales. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Company also has a coupon program, through which the Company grants coupons to online customers when they make a successful purchase order, finish first registration on Boqii Marketplace or comment on products. When a coupon is granted concurrent with a revenue transaction, the Company accounts for the estimated cost of future usage of the coupon as reduction of the revenue. When a coupon is not granted concurrent with a revenue transaction, they are not accounted for when they are granted and are recognized as a reduction of revenue when they are applied in future sales. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(t) Cost of revenue </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">Cost of revenue consist of cost of product sales of RMB820.3 million, RMB930.4 million and RMB842.7 million for the years ended March 31, 2021, 2022 and 2023, respectively, and cost of services of RMB3.4million, RMB13.3million and RMB15.9<div style="letter-spacing: 0px; top: 0px;;display:inline;"> million for the years ended March 31, 2021, 2022 and 2023, respectively. Cost of product sales comprise the purchase price of products, vendor rebates and inventory write-downs. Cost of products does not include other costs such as shipping and handling expense, payroll and benefits of logistic staff, and logistic centers rental expenses. Cost of service consists of the advertising and promotion costs, employee wages and benefits in connection with the Company’s provision of marketing and information services including the fees that the Company paid to third-parties for advertising and promotion on various online and offline channels. </div> </div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(u) Vendor rebates </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Company periodically receives consideration from certain vendors, representing rebates for products sold over a period of time. The Company accounts for the rebates received from its vendors as a reduction to the price it pays for the products purchased. Rebates are earned based on reaching minimum purchased thresholds for a specified period. When volume rebates can be reasonably estimated based on the Company’s past experience, current forecasts and purchase volume, a portion of the rebate is recognized as the Company makes progress towards the purchase threshold. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(v) Fulfillment expenses </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">Fulfillment costs primarily represent warehousing, shipping and handling expenses for dispatching and delivering products to consumers, employee wages and benefits for the relevant personnel, customs clearance expenses and other related transaction costs. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(w) Sales and marketing expenses </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">Sales and marketing expenses comprise primarily of advertising expenses, third-party platforms commission fee, employee wages, rental expenses and benefits for sales and marketing staff, depreciation expenses and other daily expenses which are related to the sales and marketing functions. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">Advertising expenses consist primarily of customer acquisition cost and costs for the promotion of corporate image and product marketing. The Company expenses all advertising costs as incurred and classifies these costs under sales and marketing expenses. For the years ended March 31, 2021, 2022 and 2023, the advertising expenses were RMB83 million, RMB81 million and RMB44 million, respectively. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;;text-indent: 0px;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center;text-indent: 0px;"> </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(x) General and administrative expenses </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">General and administrative expenses consist of employee wages and benefits for corporate employees, research and development expenses and other expenses which are related to the general corporate functions, including accounting, finance, tax, legal and human resources, costs associated with use by these functions of facilities and equipment, such as depreciation expenses, rental and other general corporate related expenses. For the years ended March 31, 2021, 2022 and 2023, the research and development were RMB14.1 million, RMB11.3 million and RMB3.7 million, respectively. </div></div></div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(y) Leases </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company applied ASC 842, “Leases”, by using the optional transition method at the adoption date without recasting comparative periods. The Company determines if an arrangement is a lease at inception. Operating leases are primarily for office and warehouse space and are included in operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> (“ROU”) assets, operating lease liabilities, current and operating lease liabilities, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> on its consolidated balance sheets. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. When determining the lease term, the Company includes options to extend or terminate the lease when it is reasonably certain that it will exercise that option, if any. As the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate, which it calculates based on the credit quality of the Company and by comparing interest rates available in the market for similar borrowings, and adjusting this amount based on the impact of collateral over the term of each lease. Lease expense for lease payments is recognized on a straight-line basis over the lease term. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For operating leases with a term of one year or less, the Company has elected to not recognize a lease liability or ROU asset on its consolidated balance sheet. Instead, it recognizes the lease payments as expense on a straight-line basis over the lease term. Short-term lease costs are immaterial to its consolidated statements of loss and comprehensive loss and cash flows. </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(z) Government grants </div></div></div></div><div style="display:inline;"></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company’s PRC based subsidiaries received government subsidies from certain local governments. The government subsidies are granted from time to time at the discretion of the relevant government authorities. These subsidies are granted for general corporate purposes and to support the Group’s ongoing operations in the region Cash subsidies are recorded in other income, net on the consolidated statements of loss and comprehensive loss when received and when all conditions for their receipt have been satisfied. The <span style="-sec-ix-hidden:hidden84116514">Group recognized government subsidies</span> of RMB1.1 million, RMB0.2 million and RMB0.3 million for the years ended December 31, 2021, 2022 and 2023, respectively. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(aa) Income taxes </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Current income taxes are recorded in accordance with the regulations of the relevant tax jurisdiction. The Company accounts for income taxes under the asset and liability method in accordance with ASC 740, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Tax</div></div>. Under this method, deferred tax assets and liabilities are recognized for the tax consequences attributable to differences between carrying amounts of existing assets and liabilities in the financial statements and their respective tax basis, and operating loss carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred taxes of a change in tax rates is recognized in the consolidated statements of loss and comprehensive loss in the period of change. Valuation allowances are established when necessary to reduce the amount of deferred tax assets if it is considered more likely than not that amount of the deferred tax assets will not be realized. </div><div style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div></div></div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Uncertain tax positions </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company recognizes in its consolidated financial statements the benefit of a tax position if the tax position is “more likely than not” to prevail based on the facts and technical merits of the position. Tax positions that meet the “more likely than not” recognition threshold are measured at the largest amount of tax benefit that has a greater than fifty percent likelihood of being realized upon settlement. The Company estimates its liability for unrecognized tax benefits which are periodically assessed and may be affected by changing interpretations of laws, rulings by tax authorities, changes and/or developments with respect to tax audits, and expiration of the statute of limitations. The ultimate outcome for a particular tax position may not be determined with certainty prior to the conclusion of a tax audit and, in some cases, appeal or litigation process. The actual benefits ultimately realized may differ from the Company’s estimates. As each audit is concluded, adjustments, if any, are recorded in the Company’s consolidated financial statements in the period in which the audit is concluded. Additionally, in future periods, changes in facts, circumstances and new information may require the Company to adjust the recognition and measurement estimates with regard to individual tax positions. Changes in recognition and measurement estimates are recognized in the period in which the changes occur. As of March 31, 2022 and 2023, the Company did not have any material unrecognized uncertain tax positions. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(ab) Share-based compensation </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company follows ASC 718 to determine whether a share option should be classified and accounted for as a liability award or equity award. All grants of share-based awards to employees, management and nonemployees classified as equity awards are recognized in the financial statements based on their grant date fair values which are calculated using an option pricing model. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Employees’ share-based compensation awards are measured at the grant date fair value of the awards and recognized as expenses (a) immediately at the grant date if no vesting conditions are required; or (b) for share-based awards granted with only service conditions, using the graded vesting method, net of estimated forfeitures, over the vesting period; or (c) for share-based awards granted with service conditions and the occurrence of an initial public offering (“IPO”) as performance condition, cumulative share-based compensation expenses for the options that have satisfied the service condition should be recorded upon the completion of the IPO, using the graded vesting method. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Under ASC 718, the Company applies the Binominal option pricing model in determining the fair value of options granted. ASC 718 requires forfeiture rates to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from initial estimates. Share-based compensation expense is recorded net of estimated forfeitures such that expense is recorded only for those share-based awards that are expected to vest. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(ac) Net loss per share </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Basic net loss per share is computed by dividing net loss attributable to holders of ordinary shares by the weighted average number of ordinary shares outstanding during the year using the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method. Using the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method, net profit/loss is allocated between ordinary shares and other participating securities (i.e. preferred shares) based on their participating rights. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Diluted loss per share is calculated by dividing net loss attributable to ordinary shareholders as adjusted for the effect of dilutive ordinary equivalent shares, if any, by the weighted average number of ordinary and dilutive ordinary equivalents shares outstanding during the year/period. Ordinary share equivalents consist of the ordinary shares issuable in connection with the Company’s convertible redeemable preferred shares using the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">if-converted</div> method, and ordinary shares issuable upon the conversion of the share options, using the treasury stock method. Ordinary equivalent shares are not included in the denominator of the diluted earnings per share calculation when inclusion of such shares would be anti-dilutive. </div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(ad) Comprehensive loss </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Comprehensive loss is defined as the changes in shareholders’ equity of the Company during a period transactions and other events and circumstances excluding transactions resulting from investments from shareholders, distributions to shareholders, accretions on convertible redeemable preferred shares and modification and extinguishment of convertible redeemable preferred shares. Comprehensive loss for the periods presented includes net loss, foreign currency translation adjustments and unrealized securities holding gains (losses). </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(ae) Segment reporting </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">ASC 280, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Segment Reporting</div></div>, establishes standards for companies to report in their financial statements information about operating segments, products, services, geographic areas, and major customers. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Based on the criteria established by ASC 280, the Company’s chief operating decision maker (“CODM”) has been identified as the Chief Executive Officer, who reviews consolidated results when making decisions about allocating resources and assessing performance of the Company. As a whole and hence, the Company has only one reportable segment. The Company does not distinguish between markets or segments for the purpose of internal reporting. As the Company’s long-lived assets are substantially located in the PRC and substantially all the Company’s revenue are derived from within the PRC, no geographical segments are presented. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(af) Recent accounting pronouncements </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company qualifies as an “emerging growth company”, or EGC, pursuant to the Jumpstart Our Business Startups Act of 2012, as amended, or the JOBS Act. As an EGC, the Company does not need to comply with any new or revised financial accounting standards until such date that a private company is otherwise required to comply with such new or revised accounting standards. The Company adopts the following standards based on extended transition period provided to private companies or early adopts as necessary as permitted by the respective standards. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">New and Amended Standards Adopted by the Company:</div> </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In August 2020, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06,</div> “Debt with Conversion and Other Options (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-20)</div> and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40),”</div> which removes certain separation models for convertible debt instruments and convertible preferred stock that require the separation of a convertible debt instrument into a debt component and an equity or derivative component. The ASU also expands disclosure requirements for convertible instruments and simplifies areas of the guidance for diluted <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">earnings-per-share</div></div> calculations that are impacted by the amendments. The standard is effective for interim and annual periods beginning after December 15, 2021, with early adoption permitted. The adoption of this standard did not have a material impact on the Company’s disclosures. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">New and amended standards not yet adopted by the Company:</div> </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In June 2016, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13,</div> Financial Instruments—Credit Losses (Topic 326), to provide financial statement users with more useful information about expected credit losses. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13</div> also changes how entities measure credit losses on financial instruments and the timing of when such losses are recorded. The FASB further issued Accounting Standards Update No. 2019-10, “Financial Instruments-Credit Losses (Topic 326): Effective Dates,”. According to ASU 2019-10, for public business entities that are U.S. SEC filers, the amendments in this Update are effective for fiscal years beginning after December 15, 2019. For all other entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company elected to use the extended transition period for complying with any new or revised financial accounting standards. Therefore, the Company elected to adopt this new guidance for the year ended March 31, 2024, including interim periods in the year ended March 31, 2024. The Company is in the process of evaluating the impact of this accounting standard on its consolidated financial statements. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In October 2021, the FASB issued <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASU 2021-08, “Business</div> Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”, which require that an entity (acquirer) recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. At the acquisition date, an acquirer should account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts. The amendments in this Update also provide certain practical expedients for acquirers when recognizing and measuring acquired contract assets and contract liabilities from revenue contracts in a business combination. The standard is effective for interim and annual periods beginning after December 15, 2022, with early adoption permitted. The Company is evaluating the impact of the adoption of this guidance on its consolidated financial statements. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In March 2022, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2022-02,</div> Troubled Debt Restructurings and Vintage Disclosures. This ASU eliminates the accounting guidance for troubled debt restructurings by creditors that have adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13,</div> Measurement of Credit Losses on Financial Instruments. This ASU also enhances the disclosure requirements for certain loan refinancing and restructurings by creditors when a borrower is experiencing financial difficulty. In addition, the ASU amends the guidance on vintage disclosures to require entities to disclose current period gross write-offs by year of origination for financing receivables and net investments in leases within the scope of ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">326-20.</div> The ASU is effective for annual periods beginning after December 15, 2022, including interim periods within those fiscal years. Adoption of the ASU would be applied prospectively. The Company is evaluating the impact of the adoption of this guidance on its consolidated financial statements. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In June 2022, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2022-03</div> Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. The update clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The update also clarifies that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. The update also requires certain additional disclosures for equity securities subject to contractual sale restrictions. The amendments in this update are effective for the Company beginning January 1, 2024 on a prospective basis. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is in the process of evaluating the impact of the new guidance on its consolidated financial statements. </div> <div style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(a) Basis of preparation </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”). Significant accounting policies followed by the Company in the preparation of the accompanying consolidated financial statements are summarized below. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(b) Basis of consolidation </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company’s consolidated financial statements include the financial statements of the Company, its subsidiaries, the consolidated VIEs and VIEs’ subsidiaries for which the Company is the primary beneficiary. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">A subsidiary is an entity in which the Company, directly or indirectly, controls more than one half of the voting power, has the power to appoint or remove the majority of the members of the board of directors, to cast a majority of votes at the meeting of the board of directors or to govern the financial and operating policies of the investee under a statute or agreement among the shareholders or equity holders. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">A consolidated VIE is an entity in which the Company, or its subsidiaries, through Contractual Agreements, bears the risks of, and enjoys the rewards normally associated with, ownership of the entity, and therefore the Company or its subsidiaries are the primary beneficiary of the entity. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">All transactions and balances among the Company, its subsidiaries, the consolidated VIEs and VIEs’ subsidiaries have been eliminated upon consolidation<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">.</div></div> </div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(c) Business combination and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-controlling</div> interests </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company accounts for its business combinations using the acquisition method of accounting in accordance with Accounting Standards Codification (“ASC”) 805, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Business Combinations</div></div>. The cost of an acquisition is measured as the aggregate of the acquisition date fair values of the assets transferred and liabilities incurred by the Company to the sellers and equity instruments issued. Transaction costs directly attributable to the acquisition are expensed as incurred. Identifiable assets and liabilities acquired or assumed are measured separately at their fair values as of the acquisition date, irrespective of the extent of any <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-controlling</div> interests. The excess of (i) the total costs of acquisition, fair value of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-controlling</div> interests and acquisition date fair value of any previously held equity interest in the acquiree over (ii) the fair value of the identifiable net assets of the acquiree is recorded as goodwill. If the cost of acquisition is less than the fair value of the net assets of the subsidiary acquired, the difference is recognized directly in the consolidated statements of loss and comprehensive loss as a bargain purchase gain. During the measurement period, which can be up to one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill or bargain purchase gain. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the consolidated statements of loss and comprehensive loss. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In a business combination achieved in stages, the Company <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measures</div> the previously held equity interest in the acquiree immediately before obtaining control at its acquisition-date fair value and the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measurement</div> gain or loss, if any, is recognized in the consolidated statements of loss and comprehensive loss. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">When there is a change in ownership interests or a change in contractual arrangements that results in a loss of control of a subsidiary or consolidated VIE, the Company deconsolidates the subsidiary or consolidated VIE from the date control is lost. Any retained <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-controlling</div> investment in the former subsidiary or consolidated VIE is measured at fair value and is included in the calculation of the gain or loss upon deconsolidation of the subsidiary or consolidated VIE. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the Company’s consolidated subsidiaries, VIEs and VIEs’ subsidiaries, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-controlling</div> interests are recognized to reflect the portion of their equity that is not attributable, directly or indirectly, to the Company as the controlling shareholder. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-controlling</div> interests are classified as a separate line item in the equity section of the Company’s consolidated balance sheets and have been separately disclosed in the Company’s consolidated statements of loss and comprehensive loss to distinguish the interests from that of the Company. </div> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(d) Use of estimates </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The preparation of the Company’s consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company believes that assessment for impairment of long-lived assets and valuation of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt securities require significant judgments and estimates used in the preparation of its consolidated financial statements. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Management bases the estimates on historical experience and on various other assumptions as discussed elsewhere to the consolidated financial statements that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. On an ongoing basis, management evaluates its estimates based on information that is currently available. Changes in circumstances, facts and experience may cause the Company to revise its estimates. Changes in estimates are recorded in the period in which they become known. Actual results could materially differ from these estimates. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(e) Functional currency and foreign currency translation </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company’s reporting currency is Renminbi (“RMB”). The functional currency of the Company’s entities incorporated in Cayman Islands, British Virgin Islands and Hong Kong is the United States dollars (“US$”). The Company’s PRC subsidiaries, consolidated VIEs and VIEs’ subsidiaries determined their functional currency to be RMB. The determination of the respective functional currency is based on the criteria of ASC 830, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Foreign Currency Matters</div></div>. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Transactions denominated in other than the functional currencies are translated into the functional currency of the entity at the exchange rates prevailing on the transaction dates. Financial assets and liabilities denominated in other than the functional currency are translated at the balance sheet date exchange rate. The resulting exchange differences are included in the consolidated statements of loss and comprehensive loss as other gains, net. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The financial statements of the Company are translated from the functional currency into RMB. Assets and liabilities denominated in foreign currencies are translated into RMB using the applicable exchange rates at the balance sheet date. Equity accounts other than earnings generated in current period are translated into RMB at the appropriate historical rates. Revenues, expenses, gains and losses are translated into RMB using the periodic average exchange rates. The resulting foreign currency translation adjustments are recorded in accumulated other comprehensive loss as a component of shareholders’ equity. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The exchange rates used for translation on March 31, 2022 and 2023 were US$1.00= RMB 6.3482 and RMB 6.8717, respectively, representing the index rates stipulated by the People’s Bank of China. </div> 6.3482 6.8717 <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(f) Convenience translation </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Translations of the consolidated balance sheets, the consolidated statements of loss and comprehensive loss and the consolidated statements of cash flows from RMB into US$ as of and for the year ended March 31, 2023 are solely for the convenience of the readers and were calculated at the rate of US$1.00=RMB 6.8676, representing the certificated exchange rate published by the Federal Reserve Board. No representation is made that the RMB amounts could have been, or could be, converted, realized or settled into US$ at that rate on March 31, 2023, or at any other rate. </div> 6.8676 <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(g) Fair value of financial instruments </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Accounting guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and it considers assumptions that market participants would use when pricing the asset or liability. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The established fair value hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The three levels of inputs that may be used to measure fair value: </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Level 2: Observable, market-based inputs, other than quoted prices, in active markets for identical assets or liabilities. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Level 3: Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Accounting guidance also describes three main approaches to measuring the fair value of assets and liabilities: (1) market approach; (2) income approach and (3) cost approach. The market approach uses prices and other relevant information generated from market transactions involving identical or comparable assets or liabilities. The income approach uses valuation techniques to convert future amounts to a single present value amount. The measurement is based on the value indicated by current market expectations about those future amounts. The cost approach is based on the amount that would currently be required to replace an asset. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Financial assets and liabilities of the Company mainly consist of cash and cash equivalents, short-term investments, accounts receivable, amounts due from related parties, prepayments and other current assets, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt investments, accounts payable, short-term borrowings, derivative liabilities, accrued liabilities and other current liabilities, amounts due to related parties, and other debts. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of March 31, 2022 and 2023, except for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt investments and derivative liabilities, carrying values of cash and cash equivalents, short-term investments, accounts receivable, amounts due from related parties, certain prepayments and other current assets, accounts payable, short-term borrowings, certain accrued liabilities and other current liabilities, amounts due to related parties and current portion of other debts approximated their fair values reported in the consolidated balance sheets due to the short-term maturities of these instruments. The carrying value of long-term loan receivable, long-term borrowings and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> portion of other debts approximated their fair values as of March 31, 2022 and 2023 as the interest rates and credit risk they bear reflect the current market yield for comparable instruments. The Company reports derivative liabilities at fair value at each balance sheet date and change in fair value is reflected in “Fair value change of derivative liabilities” in the consolidated statements of loss and comprehensive loss. The Company reports <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt investments at fair value at each balance sheet date with the aggregate unrealized gains and losses, net of tax, reflected in “Accumulated other comprehensive loss” in the consolidated balance sheets. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(h) Cash and cash equivalents </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents include cash on hand and time deposits placed with banks and third party payment processors, which are unrestricted as to withdrawal or use, have original maturities of three months or less at the time of purchase and are readily convertible to known amounts of cash. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(i) Short-term investments </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Short-term investments comprise primarily of (i) cash deposits at fixed rates with original maturities of greater than three months, but less than 12 months and; (ii) the investments issued by commercial banks or other financial institutions with a variable interest rate indexed to the performance of underlying assets within one year. As of March 31, 2022 and 2023, RMB128 million and RMB70 million short-term investments were used as collateral of RMB111 million and RMB64 million short-term borrowings, respectively. </div> 128000000 70000000 111000000 64000000 <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(j) Accounts receivable, net </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Accounts receivable are presented net of allowance for doubtful accounts. The Company maintains an allowance for doubtful accounts which reflects its best estimate of amounts that potentially will not be collected. The Company determines the allowance for doubtful accounts on general basis taking into consideration various factors including but not limited to historical collection experience and credit-worthiness of the customers as well as the age of the individual receivables balance. Additionally, the Company makes specific bad debt provisions based on any specific knowledge the Company has acquired that might indicate that an account is uncollectible. The facts and circumstances of each account may require the Company to use substantial judgment in assessing its collectability. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(k) Inventories </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Inventories are stated at the lower of cost and net realizable value. Cost elements of our inventories comprise the purchase price of products, vendor rebates, shipping charges to receive products from the suppliers when they are embedded in the purchase price. Cost is determined using the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">first-in</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">first-out</div> method. Provisions are made for excessive, slow moving, expired and obsolete inventories as well as for inventories with carrying values in excess of market. Certain factors could impact the realizable value of inventory, so the Company continually evaluates the recoverability based on assumptions about customer demand and market conditions. The evaluation may take into consideration historical usage, inventory aging, expiration date, expected demand, anticipated sales price, new product development schedules, the effect new products might have on the sale of existing products, product obsolescence, customer concentrations, and other factors. The reserve or write-down is equal to the difference between the cost of inventory and the estimated net realizable value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than those projected by management, additional inventory reserves or write-downs may be required that could negatively impact the Company’s gross margin and operating results. If actual market conditions are more favorable, the Company may have higher gross margin when products that have been previously reserved or written down are eventually sold. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(l) Property and equipment, net </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Property and equipment are carried at cost less accumulated depreciation and amortization. Depreciation is calculated on a straight-line basis over the following estimated useful lives. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The estimated useful lives are as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div><div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:96%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:51%"></td> <td style="vertical-align:bottom;width:1%"></td> <td style="width:48%"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Useful years</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">Warehouse equipment</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top">3 - 5 years</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">Furniture, computer and office equipment</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top">3 - 5 years</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">Vehicles</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top">5 years</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">Software</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top">10 years</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">Leasehold improvements</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top">Over the shorter of the expected life of leasehold improvements or the lease term</td></tr></table></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Expenditures for maintenance and repairs are expensed as incurred. The gain or loss on the disposal of property and equipment is the difference between the net sales proceeds and the carrying amount of the relevant assets and is recognized in the consolidated statements of loss and comprehensive loss. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The estimated useful lives are as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:96%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:51%"></td> <td style="vertical-align:bottom;width:1%"></td> <td style="width:48%"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Useful years</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">Warehouse equipment</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top">3 - 5 years</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">Furniture, computer and office equipment</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top">3 - 5 years</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">Vehicles</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top">5 years</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">Software</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top">10 years</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">Leasehold improvements</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top">Over the shorter of the expected life of leasehold improvements or the lease term</td></tr></table> P3Y P5Y P3Y P5Y P5Y P10Y Over the shorter of the expected life of leasehold improvements or the lease term <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(m) Intangible assets, net </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Intangible assets purchased from third parties are initially recorded at cost. The Company performs valuation of the intangible assets arising from business combinations to determine the relative fair value to be assigned to each asset acquired. The intangible assets are amortized using the straight-line method over the estimated useful lives of the assets. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The estimated useful lives of intangible assets are as follows: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div><div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:96%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:51%"></td> <td style="vertical-align:bottom;width:1%"></td> <td style="width:48%"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Useful years</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">Trademark</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top;text-align:center;">10 years</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">Dealership</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top;text-align:center;">10 years</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">License</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top;text-align:center;">4.5 years</td></tr></table> </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The estimated life of amortized intangibles is reassessed if circumstances occur that indicate the life has changed. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The estimated useful lives of intangible assets are as follows: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:96%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:51%"></td> <td style="vertical-align:bottom;width:1%"></td> <td style="width:48%"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Useful years</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">Trademark</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top;text-align:center;">10 years</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">Dealership</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top;text-align:center;">10 years</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">License</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top;text-align:center;">4.5 years</td></tr></table> P10Y P10Y P4Y6M <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(n) Goodwill </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill represents the excess of the purchase price over the fair value of the identifiable assets and liabilities acquired in a business combination. Goodwill is not amortized but is tested for impairment on an annual basis as of March 31, and in between annual tests when an event occurs or circumstances change that could indicate that the asset might be impaired. </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In accordance with ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2017-04,</div> “Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment” (“ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2017-04”),</div> which removes the requirement to compare the implied fair value of goodwill with its carrying amount as part of step 2 of the goodwill impairment test. Management conducts its goodwill impairment assessment as of March 31 annually or more frequently if events or changes in circumstances indicate that it may be impaired. The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill, so as to perform the quantitative goodwill impairment test. If determined to be necessary, the quantitative impairment test is used to identify goodwill impairment by comparing the fair value of a reporting unit with its carrying amount and recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. The loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As there is only one reporting unit in the Company, the goodwill assessment was performed for the Company on consolidated level as one reporting unit. </div></div></div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(o) Long-term investments </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company’s investments include equity method investments, equity securities with readily determinable fair values and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt securities. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company applies the equity method of accounting to account for an equity investment, in common stock or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">in-substance</div> common stock, according to ASC 323 “Investment—Equity Method and Joint Ventures”, over which it has significant influence but does not own a majority equity interest or otherwise control. Under the equity method, the Company’s share of the post-acquisition profits or losses of the equity investees are recorded in share of results of equity investees in the consolidated statements of loss and comprehensive loss. The excess of the carrying amount of the investment over the underlying equity in net assets of the equity investee, if any, represents goodwill and intangible assets acquired. When the Company’s share of losses in the equity investee equals or exceeds its interest in the equity investee, the Company does not recognize further losses, unless the Company has incurred obligations or made payments or guarantees on behalf of the equity investee. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Equity securities with readily determinable fair values are measured and recorded at fair value on a recurring basis with changes in fair value, whether realized or unrealized, recorded through the income statement. </div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Debt securities that the Company has the intent to hold the security for an indefinite period or may sell the security in response to the changes in economic conditions are classified as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt securities and reported at fair value. Unrealized gains and losses (other than impairment losses) are reported, net of the related tax effect, in other comprehensive income (loss). Upon sale, realized gains and losses are reported in net income (loss). </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company continually reviews its investments to determine whether a decline in fair value to below the carrying value is other-than-temporary. The primary factors the Company considers in its determination are the duration and severity of the decline in fair value; the financial condition, operating performance and the prospects of the equity investee; and other company specific information such as recent financing rounds. If the decline in fair value is deemed to be other-than-temporary, the carrying value of the investment is written down to fair value. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(p) Impairment of long-lived assets other than goodwill </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Long-lived assets (including property and equipment and amortizable intangible assets) are evaluated for impairment whenever events or changes in circumstances (such as a significant adverse change to market conditions that will impact the future use of the assets) indicate that the carrying amount may not be fully recoverable or that the useful life is shorter than the Company had originally estimated. When these events occur, the Company evaluates the impairment by comparing carrying value of the assets to an estimate of future undiscounted cash flows expected to be generated from the use of the assets and their eventual disposition. If the sum of the expected future undiscounted cash flows is less than the carrying value of the assets, the Company recognizes an impairment loss based on the excess of the carrying value of the assets over the fair value of the assets. No impairment charges were recognized for the years ended March 31, 2021, 2022 and 2023. </div></div></div> 0 0 0 0 0 0 <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(q) Revenue recognition </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In May 2014, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2014-09,</div> “Revenue from Contracts with Customers (Topic 606)” (“ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2014-09”)</div> and subsequently, the FASB issued several amendments which amends certain aspects of the guidance in ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2014-09</div> (ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2014-09</div> and the related amendments are collectively referred to as “ASC 606”). According to ASC 606, revenue is recognized when control of the promised good or service is transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Consistent with the criteria of Topic 606, the Company follows five steps for its revenue recognition: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the entity satisfies a performance obligation. Revenue arrangements with multiple performance obligations are divided into separate distinct goods or services. The Company allocates the transaction price to each performance obligation based on the relative standalone selling price of the goods or services provided. The Company’s revenues are primarily derived from (i) product sales and (ii) online marketing and information services and other revenue. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">When either party to a contract has performed, the Company presents the contract in the statement of financial position as a contract asset or a contract liability, depending on the relationship between the entity’s performance and the customer’s payment. A receivable is recorded when the Company has an unconditional right to consideration. A right to consideration is unconditional if only the passage of time is required before payment of that consideration is due. A contract asset is recorded when the Company has transferred products or services to the customer before payment is received or is due, and the Company’s right to consideration is conditional on future performance or other factors in the contract. No contract asset was recorded as of March 31, 2022 and 2023. The Company’s contract liabilities consist of payments received or awards to customers (in the form of Boqii Beans) related to unsatisfied performance obligations at the end of the period. As of April 1, 2021 and 2022, the Company’s total contract liabilities were RMB3.9 million and RMB7.0 million, respectively, of which RMB3.6 million and RMB3.0 million were recognized as revenue for the years ended March 31, 2022 and 2023. The Company’s total unearned revenue was RMB4.5 million as of March 31, 2023. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Revenue is recorded net of value-added tax. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div></div></div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Revenue recognition policies for each type of revenue steam are as follows: </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Sales of merchandise</div> </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company primarily sells pet products through online stores to individual online customers. Besides online sales, the Company also sells products through offline channels to its business customers and pet stores across the country. The Company recognizes the product revenues from products sales on a gross basis as the Company is acting as a principal in these transactions. The Company has obtained control of the products before they are transferred to customers. The Company is primarily obligated in these transactions, is subject to inventory risk or has the ability to direct the use of inventory, and has latitude in establishing prices and selecting suppliers. Revenue is recognized when consumers physically accept the products after delivery, which is when the control of products is transferred, and is recorded net of return allowances and rebates to pet stores. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company also enters into arrangements with its business partners to sell their products on the Company’s online stores. The Company considers the arrangements meet the indicators of consignment arrangement under ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">606-10-55-80,</div></div></div> because (i) the business partners do not relinquish control of the products, even though the Company has physical possession of the goods. The Company does not control the underlying products, which are considered to be the business partners’ inventory until they are sold to the end consumers; (ii) the business partner retains the right to require the return of the goods held by the Company; (iii) the Company has no obligation to pay for the products that are in its physical possession; and (iv) the Company has no discretion in establishing prices of the products provided by its business partners. Upon successful sales, the Company will charge the business partners a negotiated amount or a fixed rate commission fee based on the sales amount. Commission revenues are recognized on a net basis at the point of consumers’ acceptance of products, net of return allowance. </div> <div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Online marketing and information services and other revenue</div> </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company provides online marketing and information services to third-parties on the Company’s various channels and third-party platforms, including but not limited to advertising placements, organizing online and offline marketing campaigns featuring social media influencers and circulating marketing messages to end consumers. With respect to the Company’s marketing services, length of the periods over which services are provided are generally within months or less, revenue from such arrangements is recognized ratably over the service period, as the third-party simultaneously consumes the benefits when the advertisement is displayed or the campaign is ongoing. </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company also provides warehouse services. The warehouse services include warehousing, packaging, dispatching and other services. Revenue is primarily recognized when the services are rendered. </div> 0 0 3900000 7000000 3600000 3000000 4500000 <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(r) Sales returns </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company offers online consumers an unconditional right of return for a period of seven days upon receipt of products. Return allowances, which reduce revenue and cost of sales, are estimated by categories of return policies offered to online customers, based on historical data the Company has maintained, and subject to adjustments to the extent that actual returns differ or are expected to differ. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(s) Sales incentives </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company adopted a customer reward program, under which the Company grants certain units (“Boqii Bean”) to its customers at its discretion in different situations. Boqii Beans are not redeemable for cash and can be used as a coupon for the customer’s future purchase on the Boqii Marketplace and Boqii.com. The value of ten units of Boqii Bean is equivalent to one RMB yuan before taking into account the impact of breakage. </div> <div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;;text-indent: 0px;"> </div> <div style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div></div></div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">For the Boqii Beans that are granted with concurrent revenue transactions, the allocated transaction price based on its relative standalone selling price are recognized as reduction of the revenue and accrued for as contract liabilities. As customers redeem awards, the accrued liability is reduced correspondingly. For the Boqii Beans that are granted without concurrent revenue transactions, they are not accounted for when granted and are recognized as a reduction of revenue when they are applied in future sales. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Company also has a coupon program, through which the Company grants coupons to online customers when they make a successful purchase order, finish first registration on Boqii Marketplace or comment on products. When a coupon is granted concurrent with a revenue transaction, the Company accounts for the estimated cost of future usage of the coupon as reduction of the revenue. When a coupon is not granted concurrent with a revenue transaction, they are not accounted for when they are granted and are recognized as a reduction of revenue when they are applied in future sales. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(t) Cost of revenue </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">Cost of revenue consist of cost of product sales of RMB820.3 million, RMB930.4 million and RMB842.7 million for the years ended March 31, 2021, 2022 and 2023, respectively, and cost of services of RMB3.4million, RMB13.3million and RMB15.9<div style="letter-spacing: 0px; top: 0px;;display:inline;"> million for the years ended March 31, 2021, 2022 and 2023, respectively. Cost of product sales comprise the purchase price of products, vendor rebates and inventory write-downs. Cost of products does not include other costs such as shipping and handling expense, payroll and benefits of logistic staff, and logistic centers rental expenses. Cost of service consists of the advertising and promotion costs, employee wages and benefits in connection with the Company’s provision of marketing and information services including the fees that the Company paid to third-parties for advertising and promotion on various online and offline channels. </div> </div> 820300000 930400000 842700000 3400000 13300000 15900000 <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(u) Vendor rebates </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Company periodically receives consideration from certain vendors, representing rebates for products sold over a period of time. The Company accounts for the rebates received from its vendors as a reduction to the price it pays for the products purchased. Rebates are earned based on reaching minimum purchased thresholds for a specified period. When volume rebates can be reasonably estimated based on the Company’s past experience, current forecasts and purchase volume, a portion of the rebate is recognized as the Company makes progress towards the purchase threshold. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(v) Fulfillment expenses </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">Fulfillment costs primarily represent warehousing, shipping and handling expenses for dispatching and delivering products to consumers, employee wages and benefits for the relevant personnel, customs clearance expenses and other related transaction costs. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(w) Sales and marketing expenses </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">Sales and marketing expenses comprise primarily of advertising expenses, third-party platforms commission fee, employee wages, rental expenses and benefits for sales and marketing staff, depreciation expenses and other daily expenses which are related to the sales and marketing functions. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">Advertising expenses consist primarily of customer acquisition cost and costs for the promotion of corporate image and product marketing. The Company expenses all advertising costs as incurred and classifies these costs under sales and marketing expenses. For the years ended March 31, 2021, 2022 and 2023, the advertising expenses were RMB83 million, RMB81 million and RMB44 million, respectively. </div> 83000000 81000000 44000000 <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(x) General and administrative expenses </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">General and administrative expenses consist of employee wages and benefits for corporate employees, research and development expenses and other expenses which are related to the general corporate functions, including accounting, finance, tax, legal and human resources, costs associated with use by these functions of facilities and equipment, such as depreciation expenses, rental and other general corporate related expenses. For the years ended March 31, 2021, 2022 and 2023, the research and development were RMB14.1 million, RMB11.3 million and RMB3.7 million, respectively. </div></div></div> 14100000 11300000 3700000 <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(y) Leases </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company applied ASC 842, “Leases”, by using the optional transition method at the adoption date without recasting comparative periods. The Company determines if an arrangement is a lease at inception. Operating leases are primarily for office and warehouse space and are included in operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> (“ROU”) assets, operating lease liabilities, current and operating lease liabilities, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> on its consolidated balance sheets. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. When determining the lease term, the Company includes options to extend or terminate the lease when it is reasonably certain that it will exercise that option, if any. As the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate, which it calculates based on the credit quality of the Company and by comparing interest rates available in the market for similar borrowings, and adjusting this amount based on the impact of collateral over the term of each lease. Lease expense for lease payments is recognized on a straight-line basis over the lease term. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For operating leases with a term of one year or less, the Company has elected to not recognize a lease liability or ROU asset on its consolidated balance sheet. Instead, it recognizes the lease payments as expense on a straight-line basis over the lease term. Short-term lease costs are immaterial to its consolidated statements of loss and comprehensive loss and cash flows. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(z) Government grants </div></div></div></div><div style="display:inline;"></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company’s PRC based subsidiaries received government subsidies from certain local governments. The government subsidies are granted from time to time at the discretion of the relevant government authorities. These subsidies are granted for general corporate purposes and to support the Group’s ongoing operations in the region Cash subsidies are recorded in other income, net on the consolidated statements of loss and comprehensive loss when received and when all conditions for their receipt have been satisfied. The <span style="-sec-ix-hidden:hidden84116514">Group recognized government subsidies</span> of RMB1.1 million, RMB0.2 million and RMB0.3 million for the years ended December 31, 2021, 2022 and 2023, respectively. </div> 1100000 200000 300000 <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(aa) Income taxes </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Current income taxes are recorded in accordance with the regulations of the relevant tax jurisdiction. The Company accounts for income taxes under the asset and liability method in accordance with ASC 740, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Tax</div></div>. Under this method, deferred tax assets and liabilities are recognized for the tax consequences attributable to differences between carrying amounts of existing assets and liabilities in the financial statements and their respective tax basis, and operating loss carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred taxes of a change in tax rates is recognized in the consolidated statements of loss and comprehensive loss in the period of change. Valuation allowances are established when necessary to reduce the amount of deferred tax assets if it is considered more likely than not that amount of the deferred tax assets will not be realized. </div><div style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div></div></div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Uncertain tax positions </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company recognizes in its consolidated financial statements the benefit of a tax position if the tax position is “more likely than not” to prevail based on the facts and technical merits of the position. Tax positions that meet the “more likely than not” recognition threshold are measured at the largest amount of tax benefit that has a greater than fifty percent likelihood of being realized upon settlement. The Company estimates its liability for unrecognized tax benefits which are periodically assessed and may be affected by changing interpretations of laws, rulings by tax authorities, changes and/or developments with respect to tax audits, and expiration of the statute of limitations. The ultimate outcome for a particular tax position may not be determined with certainty prior to the conclusion of a tax audit and, in some cases, appeal or litigation process. The actual benefits ultimately realized may differ from the Company’s estimates. As each audit is concluded, adjustments, if any, are recorded in the Company’s consolidated financial statements in the period in which the audit is concluded. Additionally, in future periods, changes in facts, circumstances and new information may require the Company to adjust the recognition and measurement estimates with regard to individual tax positions. Changes in recognition and measurement estimates are recognized in the period in which the changes occur. As of March 31, 2022 and 2023, the Company did not have any material unrecognized uncertain tax positions. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(ab) Share-based compensation </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company follows ASC 718 to determine whether a share option should be classified and accounted for as a liability award or equity award. All grants of share-based awards to employees, management and nonemployees classified as equity awards are recognized in the financial statements based on their grant date fair values which are calculated using an option pricing model. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Employees’ share-based compensation awards are measured at the grant date fair value of the awards and recognized as expenses (a) immediately at the grant date if no vesting conditions are required; or (b) for share-based awards granted with only service conditions, using the graded vesting method, net of estimated forfeitures, over the vesting period; or (c) for share-based awards granted with service conditions and the occurrence of an initial public offering (“IPO”) as performance condition, cumulative share-based compensation expenses for the options that have satisfied the service condition should be recorded upon the completion of the IPO, using the graded vesting method. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Under ASC 718, the Company applies the Binominal option pricing model in determining the fair value of options granted. ASC 718 requires forfeiture rates to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from initial estimates. Share-based compensation expense is recorded net of estimated forfeitures such that expense is recorded only for those share-based awards that are expected to vest. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(ac) Net loss per share </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Basic net loss per share is computed by dividing net loss attributable to holders of ordinary shares by the weighted average number of ordinary shares outstanding during the year using the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method. Using the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method, net profit/loss is allocated between ordinary shares and other participating securities (i.e. preferred shares) based on their participating rights. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Diluted loss per share is calculated by dividing net loss attributable to ordinary shareholders as adjusted for the effect of dilutive ordinary equivalent shares, if any, by the weighted average number of ordinary and dilutive ordinary equivalents shares outstanding during the year/period. Ordinary share equivalents consist of the ordinary shares issuable in connection with the Company’s convertible redeemable preferred shares using the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">if-converted</div> method, and ordinary shares issuable upon the conversion of the share options, using the treasury stock method. Ordinary equivalent shares are not included in the denominator of the diluted earnings per share calculation when inclusion of such shares would be anti-dilutive. </div> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(ad) Comprehensive loss </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Comprehensive loss is defined as the changes in shareholders’ equity of the Company during a period transactions and other events and circumstances excluding transactions resulting from investments from shareholders, distributions to shareholders, accretions on convertible redeemable preferred shares and modification and extinguishment of convertible redeemable preferred shares. Comprehensive loss for the periods presented includes net loss, foreign currency translation adjustments and unrealized securities holding gains (losses). </div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(ae) Segment reporting </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">ASC 280, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Segment Reporting</div></div>, establishes standards for companies to report in their financial statements information about operating segments, products, services, geographic areas, and major customers. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Based on the criteria established by ASC 280, the Company’s chief operating decision maker (“CODM”) has been identified as the Chief Executive Officer, who reviews consolidated results when making decisions about allocating resources and assessing performance of the Company. As a whole and hence, the Company has only one reportable segment. The Company does not distinguish between markets or segments for the purpose of internal reporting. As the Company’s long-lived assets are substantially located in the PRC and substantially all the Company’s revenue are derived from within the PRC, no geographical segments are presented. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(af) Recent accounting pronouncements </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company qualifies as an “emerging growth company”, or EGC, pursuant to the Jumpstart Our Business Startups Act of 2012, as amended, or the JOBS Act. As an EGC, the Company does not need to comply with any new or revised financial accounting standards until such date that a private company is otherwise required to comply with such new or revised accounting standards. The Company adopts the following standards based on extended transition period provided to private companies or early adopts as necessary as permitted by the respective standards. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">New and Amended Standards Adopted by the Company:</div> </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In August 2020, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06,</div> “Debt with Conversion and Other Options (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-20)</div> and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40),”</div> which removes certain separation models for convertible debt instruments and convertible preferred stock that require the separation of a convertible debt instrument into a debt component and an equity or derivative component. The ASU also expands disclosure requirements for convertible instruments and simplifies areas of the guidance for diluted <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">earnings-per-share</div></div> calculations that are impacted by the amendments. The standard is effective for interim and annual periods beginning after December 15, 2021, with early adoption permitted. The adoption of this standard did not have a material impact on the Company’s disclosures. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">New and amended standards not yet adopted by the Company:</div> </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In June 2016, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13,</div> Financial Instruments—Credit Losses (Topic 326), to provide financial statement users with more useful information about expected credit losses. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13</div> also changes how entities measure credit losses on financial instruments and the timing of when such losses are recorded. The FASB further issued Accounting Standards Update No. 2019-10, “Financial Instruments-Credit Losses (Topic 326): Effective Dates,”. According to ASU 2019-10, for public business entities that are U.S. SEC filers, the amendments in this Update are effective for fiscal years beginning after December 15, 2019. For all other entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company elected to use the extended transition period for complying with any new or revised financial accounting standards. Therefore, the Company elected to adopt this new guidance for the year ended March 31, 2024, including interim periods in the year ended March 31, 2024. The Company is in the process of evaluating the impact of this accounting standard on its consolidated financial statements. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In October 2021, the FASB issued <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASU 2021-08, “Business</div> Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”, which require that an entity (acquirer) recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. At the acquisition date, an acquirer should account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts. The amendments in this Update also provide certain practical expedients for acquirers when recognizing and measuring acquired contract assets and contract liabilities from revenue contracts in a business combination. The standard is effective for interim and annual periods beginning after December 15, 2022, with early adoption permitted. The Company is evaluating the impact of the adoption of this guidance on its consolidated financial statements. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In March 2022, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2022-02,</div> Troubled Debt Restructurings and Vintage Disclosures. This ASU eliminates the accounting guidance for troubled debt restructurings by creditors that have adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13,</div> Measurement of Credit Losses on Financial Instruments. This ASU also enhances the disclosure requirements for certain loan refinancing and restructurings by creditors when a borrower is experiencing financial difficulty. In addition, the ASU amends the guidance on vintage disclosures to require entities to disclose current period gross write-offs by year of origination for financing receivables and net investments in leases within the scope of ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">326-20.</div> The ASU is effective for annual periods beginning after December 15, 2022, including interim periods within those fiscal years. Adoption of the ASU would be applied prospectively. The Company is evaluating the impact of the adoption of this guidance on its consolidated financial statements. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In June 2022, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2022-03</div> Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. The update clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The update also clarifies that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. The update also requires certain additional disclosures for equity securities subject to contractual sale restrictions. The amendments in this update are effective for the Company beginning January 1, 2024 on a prospective basis. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is in the process of evaluating the impact of the new guidance on its consolidated financial statements. </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3.</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Business combinations </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the year ended March 31, 2022, the Company has completed the below business combination. The results of the acquired entities’ operations have been included in the Company’s consolidated financial statements since their respective dates of acquisition. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(a) Chongni Network Technology (Shanghai) Co., Ltd (“Chongni Network”) </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In October 2018, the Company acquired 49% equity interest of Chongni Network, an offline trading company incorporated in the PRC. According to the investment agreement, the Company was entitled to appoint a director to Chongni Network (out of total three board seats). The Company accounted this investment using equity method. In May 2021, the Company entered into an agreement with Chongni to purchase additional equity interest of Chongni Network with total cash consideration of RMB2.9 million. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Upon the acquisition of additional interests in Chongni Network, on June 30, 2021, the date of acquisition, the Company’s equity interests in Chongni network was increased from 49% to 63.65% with the right to appoint 2 out of 3 of Chongni Network’s board of directors, and have obtained control over Chongni Network thereon. The Company accounted for this transaction as a step acquisition with the total purchase consideration of RMB3.2 million, which included the cash consideration of RMB2.9 million, and the fair value of the previously held 49% equity interest of Chongni Network in an amount of RMB0.3 million. A gain of RMB0.1 million in relation to the revaluation of the previously held equity interests was recorded in other gains, net in the consolidated statement of loss and comprehensive loss for the year ended March 31, 2022. The fair value of the previously held equity interests was estimated based on the acquisition price of the additional interests of Chongni Network. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On the acquisition date, the allocation of the purchase price of the assets acquired and liabilities assumed based on their fair values was as follows: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:14%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">As of June 30, 2021</td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">RMB</td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total purchase price is comprised of:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">- fair value of 49% previously held equity interests</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">245</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">- cash consideration</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,938</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value of total consideration</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,183</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:13%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">As of June 30, 2021</td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">RMB</td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash and cash equivalents</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Prepayments and other current assets</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,533</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total assets</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,535</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued liabilities and other current liabilities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(33</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total liabilities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(33</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net assets acquired</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,502</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Goodwill</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">499</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-controlling</div> interests</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,818</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,183</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The acquired business contributed revenues of nil and loss of RMB0.08 million to the Company for the period from June 30, 2021 to March 31, 2022. Pro forma results of operations for the acquisition have not been presented because they are not material to the consolidated statements of loss and comprehensive losses for the year ended March 31, 2021 and 2022. </div> 2900000 0.49 0.6365 3200000 2900000 0.49 300000 100000 <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On the acquisition date, the allocation of the purchase price of the assets acquired and liabilities assumed based on their fair values was as follows: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:14%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">As of June 30, 2021</td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">RMB</td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total purchase price is comprised of:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">- fair value of 49% previously held equity interests</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">245</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">- cash consideration</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,938</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value of total consideration</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,183</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:13%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">As of June 30, 2021</td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">RMB</td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash and cash equivalents</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Prepayments and other current assets</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,533</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total assets</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,535</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued liabilities and other current liabilities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(33</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total liabilities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(33</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net assets acquired</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,502</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Goodwill</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">499</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-controlling</div> interests</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,818</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,183</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 0.49 245000 2938000 3183000 2000 4533000 4535000 33000 33000 4502000 499000 1818000 3183000 -80000.00 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">4.</div></div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Risks and Concentration </div></div> </td> </tr> </table> <div style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(a) Foreign currency exchange rate risk </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company may experience economic losses and negative impacts on earnings and equity as a result of fluctuations in the exchange rate between the US$ and the RMB. The depreciation of RMB against US$ was approximately 2.3% in 2021. The appreciation of RMB against US$ was approximately 8.5% in 2022. It is difficult to predict how market forces or the PRC or the U.S. government policy may impact the exchange rate between RMB and US$ in the future. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(b) Interest rate risk </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company’s interest rate risk arises primarily from long-term borrowings. Borrowings issued at variable rates and fixed rates expose the Company to cash flow interest rate risk and fair value interest rate risk respectively. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(c) Concentration of credit risk </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to the concentration of credit risks consist of cash and cash equivalents, short-term investment, accounts receivable and amounts due from related parties. The maximum exposures of such assets to credit risk are their carrying amounts as of the balance sheet dates. The Company deposits its cash and cash equivalents and short-term investment with financial institutions located in jurisdictions where the subsidiaries are located. The Company believes that no significant credit risk exists as these financial institutions have high credit quality. </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Accounts receivable are typically unsecured and are derived from revenue earned through third-party consumers. The Company conducts credit evaluations of third-party customers and related parties, and generally does not require collateral or other security from its third-party customers and related parties. The Company establishes an allowance for doubtful accounts primarily based upon the age of the receivables and factors surrounding the credit risk of specific third-party customers and related parties. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(d) Concentration of customers and suppliers </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Substantially all revenue was derived from customers located in China. There are no customers from whom revenues individually represent greater than 10% of the total revenues of the Company in any of the periods presented. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The information of the supplier with greater than 10% of the total purchases of the Company for the years ended March 31, 2021, 2022 and 2023 was as follows: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:63%"></td> <td style="vertical-align:bottom;width:12%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">RMB</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">RMB</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">RMB</td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Royal Canin China Co., Ltd.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> </table> -0.023 0.085 0 0.10 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The information of the supplier with greater than 10% of the total purchases of the Company for the years ended March 31, 2021, 2022 and 2023 was as follows: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:63%"></td> <td style="vertical-align:bottom;width:12%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">RMB</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">RMB</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">RMB</td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Royal Canin China Co., Ltd.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> </table> 0.19 0.17 0.22 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5.</div></div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Cash and cash equivalents </div></div> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents represent cash on hand and demand deposits placed with banks and third party-payment processors, which are unrestricted as to withdrawal or use. Cash and cash equivalents balance as of March 31, 2022 and March 31, 2023 primarily consist of the following currencies: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:67%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB<br/> equivalent</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB<br/> equivalent</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">RMB</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">47,321</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">47,321</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">62,727</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">62,727</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Hong Kong <div style="letter-spacing: 0px; top: 0px;;display:inline;">dollars</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">39</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">31</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">US$</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,133</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">115,110</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,946</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27,114</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">EUR</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">55</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">392</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NZD</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">162,855</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">89,850</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents represent cash on hand and demand deposits placed with banks and third party-payment processors, which are unrestricted as to withdrawal or use. Cash and cash equivalents balance as of March 31, 2022 and March 31, 2023 primarily consist of the following currencies: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:67%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB<br/> equivalent</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB<br/> equivalent</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">RMB</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">47,321</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">47,321</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">62,727</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">62,727</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Hong Kong <div style="letter-spacing: 0px; top: 0px;;display:inline;">dollars</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">39</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">31</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">US$</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,133</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">115,110</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,946</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27,114</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">EUR</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">55</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">392</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NZD</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">162,855</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">89,850</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 47321000 47321000 62727000 62727000 39000 31000 7000 6000 18133000 115110000 3946000 27114000 55000 392000 0 2000 0 1000 0 1000 162855000 89850000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">6.</div></div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Accounts receivable, net </div></div> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Accounts receivable consist of the following: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounts receivable - Product sales</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,070</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">71,471</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounts receivable - Online marketing and information service and other service</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,630</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,873</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Allowance of doubtful accounts</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(469</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(602</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">49,231</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">76,742</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Movement of allowance of doubtful accounts </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:58%"></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">At beginning of year</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">363</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">256</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">469</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Addition/(reversal)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(107</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">213</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">133</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">At end of year</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">256</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">469</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">602</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Accounts receivable consist of the following: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounts receivable - Product sales</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,070</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">71,471</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounts receivable - Online marketing and information service and other service</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,630</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,873</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Allowance of doubtful accounts</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(469</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(602</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">49,231</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">76,742</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 42070000 71471000 7630000 5873000 469000 602000 49231000 76742000 <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Movement of allowance of doubtful accounts </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:58%"></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">At beginning of year</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">363</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">256</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">469</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Addition/(reversal)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(107</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">213</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">133</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">At end of year</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">256</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">469</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">602</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 363000 256000 469000 -107000 213000 133000 256000 469000 602000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">7.</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Inventories, net of inventory reserves </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Inventories, net of inventory reserves consist of the following: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:69%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">109,383</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">80,431</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Packaging materials and others</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">538</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">621</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total inventories, net of inventory reserves</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">109,921</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">81,052</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Movement of inventory provision: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:58%"></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">At beginning of year</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">273</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">266</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">577</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Provision/(reversal)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(7</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">311</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">35</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">At end of year</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">266</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">577</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">612</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The total amounts charged to the consolidated statements of loss and comprehensive loss for (reversal)/provision of inventory reserves amounted to approximately RMB(0.007) million, RMB0.31 million and RMB0.035 million for the years ended March 31, 2021, 2022 and 2023, respectively. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Inventories, net of inventory reserves consist of the following: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:69%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">109,383</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">80,431</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Packaging materials and others</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">538</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">621</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total inventories, net of inventory reserves</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">109,921</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">81,052</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 109383000 80431000 538000 621000 109921000 81052000 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Movement of inventory provision: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:58%"></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">At beginning of year</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">273</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">266</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">577</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Provision/(reversal)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(7</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">311</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">35</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">At end of year</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">266</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">577</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">612</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 273000 266000 577000 -7000 311000 35000 266000 577000 612000 -7000.000 310000 35000.000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">8.</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Prepayments and other current assets </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The prepayments and other current assets consist of the following: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:69%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Prepayments for purchases of products (a)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">52,348</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24,216</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vendor rebate receivables (b)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24,462</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16,160</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Value-added tax (“VAT”) deductible (c)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,864</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,512</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loan receivables (d)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,845</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,886</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales return assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,264</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,835</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deposits</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,312</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">999</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Others</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,643</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,751</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">116,738</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">79,359</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div></div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a) Prepayments for purchases of products represent cash prepaid to the Company’s third-party brand partners for the procurement of products. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b) Vendor rebate receivables represent the rebates to be received by the Company from its suppliers after certain levels of purchases are achieved. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c) VAT recoverable represents the balances that the Company can utilize to deduct its value-added tax liabilities within the next 12 months. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(d) The balance represents loan receivables due from certain third-party companies and individuals. From July 2020 to March 2023, the Company entered into several loan agreements with aggregate principal amount of RMB11.0 million. The maturity dates of these loans are from October 2023 to March 2024. The interest rates ranged from 0% to 4% per annum. As of March 31, 2022 and 2023, the balances of loan receivables were RMB3.8 million and RMB9.9 million, respectively. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The prepayments and other current assets consist of the following: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:69%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Prepayments for purchases of products (a)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">52,348</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24,216</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vendor rebate receivables (b)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24,462</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16,160</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Value-added tax (“VAT”) deductible (c)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,864</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,512</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loan receivables (d)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,845</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,886</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales return assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,264</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,835</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deposits</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,312</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">999</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Others</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,643</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,751</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">116,738</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">79,359</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div></div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a) Prepayments for purchases of products represent cash prepaid to the Company’s third-party brand partners for the procurement of products. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b) Vendor rebate receivables represent the rebates to be received by the Company from its suppliers after certain levels of purchases are achieved. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c) VAT recoverable represents the balances that the Company can utilize to deduct its value-added tax liabilities within the next 12 months. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(d) The balance represents loan receivables due from certain third-party companies and individuals. From July 2020 to March 2023, the Company entered into several loan agreements with aggregate principal amount of RMB11.0 million. The maturity dates of these loans are from October 2023 to March 2024. The interest rates ranged from 0% to 4% per annum. As of March 31, 2022 and 2023, the balances of loan receivables were RMB3.8 million and RMB9.9 million, respectively. </div> 52348000 24216000 24462000 16160000 18864000 10512000 3845000 9886000 1264000 2835000 1312000 999000 14643000 14751000 116738000 79359000 11000000 2023-10 2024-03 0 0.04 3800000 9900000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">9.</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Property and equipment, net </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Property and equipment consist of the following: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:69%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cost:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warehouse equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,669</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,879</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Furniture, computer and office equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,503</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,082</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vehicles</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,684</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,740</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Leasehold improvement</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,209</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,501</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Software</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,995</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,009</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total cost</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27,060</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28,211</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Accumulated depreciation</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(19,281</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(22,719</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Property and equipment, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,492</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The total amounts charged to the consolidated statements of loss and comprehensive loss for depreciation and amortization expenses amounted to approximately RMB3.08 million, RMB3.7 million and RMB3.8 million for the years ended March 31, 2021, 2022 and 2023, respectively. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Property and equipment consist of the following: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:69%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cost:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warehouse equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,669</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,879</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Furniture, computer and office equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,503</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,082</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vehicles</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,684</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,740</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Leasehold improvement</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,209</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,501</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Software</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,995</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,009</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total cost</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27,060</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28,211</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Accumulated depreciation</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(19,281</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(22,719</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Property and equipment, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,492</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 2669000 2879000 7503000 7082000 3684000 4740000 10209000 10501000 2995000 3009000 27060000 28211000 19281000 22719000 7779000 5492000 3080000.00 3700000 3800000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">10.</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Intangible assets, net </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Intangible assets of the Company were mainly as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:69%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cost:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trademark</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">437</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">486</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">License</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,530</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,530</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Dealership</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">31,717</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">31,717</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total cost</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">35,684</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">35,733</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Accumulated amortization</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,140</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(14,139</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Intangible assets, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25,544</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,594</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"><div style="display:inline;">License and dealership resulting from the business combinations completed during the year ended March 31,2021 have been allocated to the single reporting unit of the Company. The total carrying amount of intangible assets resulting from the business combinations were </div>RMB 25.5 million and RMB 21.6 million as of March 31, 2022 and 2023, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The total amortization expenses of the intangible assets charged to the consolidated statements of loss and comprehensive loss amounted to approximately RMB4.0 million, RMB4.0 million and RMB4.0 million for the years ended March 31, 2021, 2022 and 2023, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The annual estimated amortization expense for intangible assets subject to amortization for the succeeding five years is as follows: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:70%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="18" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2024</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2025</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2026</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2027</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2028</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amortization expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,867</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,438</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,207</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,203</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,187</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Intangible assets of the Company were mainly as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:69%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cost:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trademark</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">437</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">486</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">License</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,530</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,530</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Dealership</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">31,717</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">31,717</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total cost</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">35,684</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">35,733</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Accumulated amortization</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,140</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(14,139</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Intangible assets, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25,544</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,594</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 437000 486000 3530000 3530000 31717000 31717000 35684000 35733000 -10140000 -14139000 25544000 21594000 25500000 21600000 4000000 4000000 4000000 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The annual estimated amortization expense for intangible assets subject to amortization for the succeeding five years is as follows: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:70%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="18" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2024</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2025</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2026</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2027</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2028</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amortization expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,867</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,438</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,207</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,203</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,187</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 3867000 3438000 3207000 3203000 3187000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%;text-indent: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11.</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Long-term investments </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Company’s long-term investments consist of the following: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:70%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equity method investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,783</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Available-for-sale</div></div> investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,866</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68,011</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equity securities with readily determinable fair values</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">670</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">102</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">82,319</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,607</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">Equity method investments </div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Company applies equity method in accounting for its investments in entities in which the Company has the ability to exercise significant influence but does not have control. As of March 31, 2022 and 2023, the carrying value of the equity method investments were RMB6.8 million and RMB7.5<div style="display:inline;"> million respectively, the change of which primarily relates to the equity gain recognized and the following investments which were accounted for as equity method investment: </div> </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">In April 2019, the Company invested in Jiangsu Nanjing Agricultural University Animal Pharmaceutical Co., Ltd. (“Nanjing Animal Pharmaceutical”) to purchase 8.42% equity interest with total cash consideration of RMB2.5<div style="display:inline;"> million. As the Company is able to exercise significant influence through its entitlement to appoint one director, the Company therefore accounts for this investment under the equity method of accounting. In December 2022, the Company disposed all of its equity interest in Nanjing Animal Pharmaceutical with a total cash consideration of RMB </div>3 million. Accordingly, the Company recognized an investment gain of RMB0.54 million in other gains, net. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Company had 24.6<div style="display:inline;">% equity interests in Wuhan Chunzhijin Information Technology Co., Ltd. (“Chunzhijin”), which was accounted using equity method. The Company also provided loan to Chunzhijin (Note 28). In March 2023, the Company further invested in Chunzhijin to purchase </div>13.3% of the equity interest by waiving a loan receivable of RMB 3.4 million from Chunzhijin. After this transaction, together with the previously held equity interest in Chunzhijin, the total equity interest held by the Company increased to 34.65%. The Company continues to have significant influence over Chunzhijin and accounts for this investment under equity method. </div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;;text-indent: 0px;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center;text-indent: 0px;"> </div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Available-for-sale</div></div> debt investments </div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The following table summarizes the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt investments as of March 31, 2022: </div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:44%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Cost</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Gross unrealized gains</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Gross unrealized losses</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Disposal of Long-term</div><br/> investments</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Fair value</td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unlisted debt securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">76,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,134</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,866</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The following table summarizes the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt investments as of March 31, 2023: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:48%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Cost</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Gross unrealized gains</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Gross unrealized losses</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Disposal of Long-term</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">investments</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Fair value</td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unlisted debt securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">76,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(7,561</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(428</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68,011</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Company held 6.2% shareholding of Qingdao Shuangan Biotechnology Co., Ltd (“Qingdao Shuangan”). According to the investment agreement, the Company is entitled to redemption right after 48 months from the investment closing date. In April 2022, the Company transferred 0.31% shareholding of Qingdao Shuangan to a third-party investor with a cash consideration of RMB0.8 million. The Company recognized a RMB0.37 million investment gain in other gains, net. After the completion of the transaction, the shareholding of Qingdao Shuangan held by the Company was 5.9%. As of March 31, 2022 and 2023, based on the valuation results, the Company <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">re-measured</div> the investment in Qingdao Shuangan at fair value of RMB17.8 million and RMB12.8<div style="null;text-indent: 0px;;display:inline;"> million, respectively. For the years ended March 31, 2021, 2022 and 2023, the unrealized securities holding gains/(losses) (net of tax) of RMB0.02 million, RMB</div>0.34 million and RMB(1.14) million was recorded as other comprehensive income, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">In October 2019, the Company purchased 23.64% shareholding of Beijing Petdog Technology Development Co., Ltd. (“Beijing Petdog”) with a cash consideration of RMB50 million. According to the investment agreement, the Company is entitled to redemption right after 60<div style="null;text-indent: 0px;;display:inline;"> months from the investment closing date. As of March 31, 2021, 2022 and 2023, based on the valuation results, the Company re-measured the investment at fair value of RMB</div>40.1 million and RMB33.7<div style="display:inline;"> million, respectively. For year ended March 31, 2022 and 2023, the unrealized securities holding gains/(losses) (net of tax) of RMB0.75 million, RMB(10.4) million and RMB(6.4) million was recorded as other comprehensive income/(loss), respectively. </div> </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">In July and November 2021, the Company entered into investment agreements with Nanjing Animal Pharmaceutical. The Company provided Nanjing Animal Pharmaceutical <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-year</div> loans amounting to RMB16 million carrying a simple interest of 8% per annum. Together with the loan, the Company was also entitled a conversion right to convert all or part of the loan<div style="display:inline;">s</div> into 3.33% equity interest of Nanjing Animal Pharmaceutical during the loan term<div style="display:inline;">s</div>. As of March 31, 2022 and 2023, RMB 2 million was unpaid and recorded in accrued liabilities and other current liabilities. The Company recognized the investment under available for sale debt securities. It was measured and recognized at fair value on a recurring basis with changes in fair value recorded in other comprehensive income/(loss). As of March 31, 2022 and 2023, based on the valuation results, the Company <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measured</div> the investment at fair value of RMB16.9 million and RMB18.0 million, respectively. For year ended March 31, 2022 and 2023, the unrealized securities holding gains (net of tax) of RMB0.71 million and RMB0.83 million was recorded as other comprehensive income/(loss), respectively. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">Equity securities with readily determinable fair values </div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The following table summarizes the Company’s equity securities with readily determinable fair values as of March 31, 2022: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:55%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Cost</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Gross unrealized gains</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Gross unrealized losses</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Fair value</td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Listed company</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,292</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(622</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">670</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;;text-indent: 0px;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center;text-indent: 0px;"> </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the Company’s equity securities with readily determinable fair values as of March 31, 2023: </div><div style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:54%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Cost</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Gross unrealized gains</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Gross unrealized losses</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Fair value</td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Listed company</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,292</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,190</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">102</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In June 2021, the Company purchased 40,000 ordinary shares of Better Choice Company Inc. (“BTTR”), a company registered on NYSE American and engaging in selling pet products with a total cash consideration of US$200,000. The Company measured and recorded the investment at fair value on a recurring basis with changes in fair value, whether realized or unrealized, recorded through the income statement. The change of fair value is reported in other gains, net. </div><div style="font-size:14pt;margin-top:0pt;margin-bottom:0pt"> </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Company’s long-term investments consist of the following: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:70%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equity method investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,783</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Available-for-sale</div></div> investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,866</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68,011</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equity securities with readily determinable fair values</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">670</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">102</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">82,319</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,607</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 6783000 7494000 74866000 68011000 670000 102000 82319000 75607000 6800000 7500000 0.0842 2500000 3000000 540000 0.246 0.133 3400000 0.3465 <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Available-for-sale</div></div> debt investments </div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The following table summarizes the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt investments as of March 31, 2022: </div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:44%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Cost</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Gross unrealized gains</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Gross unrealized losses</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Disposal of Long-term</div><br/> investments</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Fair value</td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unlisted debt securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">76,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,134</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,866</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The following table summarizes the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt investments as of March 31, 2023: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:48%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Cost</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Gross unrealized gains</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Gross unrealized losses</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Disposal of Long-term</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">investments</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Fair value</td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unlisted debt securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">76,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(7,561</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(428</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68,011</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 76000000 0 1134000 0 74866000 76000000 0 7561000 -428000 68011000 0.062 P48M 0.0031 800000 370000 0.059 17800000 12800000 20000.00 340000 -1140000 0.2364 50000000 P60M 40100000 33700000 750000 -10400000 -6400000 16000000 0.08 3.33 2000000 16900000 18000000 710000 830000 <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">Equity securities with readily determinable fair values </div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The following table summarizes the Company’s equity securities with readily determinable fair values as of March 31, 2022: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:55%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Cost</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Gross unrealized gains</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Gross unrealized losses</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Fair value</td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Listed company</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,292</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(622</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">670</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;;text-indent: 0px;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center;text-indent: 0px;"> </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the Company’s equity securities with readily determinable fair values as of March 31, 2023: </div><div style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:54%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Cost</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Gross unrealized gains</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Gross unrealized losses</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Fair value</td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Listed company</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,292</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,190</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">102</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 1292000 0 622000 670000 1292000 0 1190000 102000 40000 200000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">12.</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Goodwill </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The changes in the carrying amount of goodwill for the years ended March 31, 2022 and 2023 were as follows: </div><div style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:89%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">Total</td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">RMB</td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance as of March 31, 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Goodwill</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">40,184</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accumulated impairment loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">40,184</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transaction during the year</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Addition (Note 3)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance as of March 31, 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Goodwill</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">40,684</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accumulated impairment loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">40,684</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transaction during the year</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Impairment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(40,684</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance as of March 31, 2023</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Goodwill</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">40,684</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accumulated impairment loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(40,684</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; margin-right:1%; font-size:10pt; font-family:Times New Roman">In the second half of fiscal year 2023, the Covid-19 resurgence in certain areas of China and the market downturn impact on our operations caused a triggering event for possible impairment of goodwill. Together with other indicators such as history of net losses and low market capitalization of us, as a result, management concluded the existence of the impairment indicator which required the Company to perform a quantitative goodwill impairment test as of March 31, 2023. Since there is only one reporting unit in the Company, management used the market capitalization to determine the reporting unit’s fair value. Based on quantitative goodwill impairment test, the fair value of the reporting unit was RMB119.8 million (US$17.4 million), which was lower than the carrying value of our net assets of RMB213.0 million (US$31.0 million) as of March 31, 2023, hence a full impairment charge of RMB40.7 million (US$5.9 million) was recognized during the year ended March 31, 2023. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The changes in the carrying amount of goodwill for the years ended March 31, 2022 and 2023 were as follows: </div><div style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:89%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">Total</td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">RMB</td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance as of March 31, 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Goodwill</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">40,184</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accumulated impairment loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">40,184</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transaction during the year</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Addition (Note 3)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance as of March 31, 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Goodwill</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">40,684</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accumulated impairment loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">40,684</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transaction during the year</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Impairment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(40,684</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance as of March 31, 2023</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Goodwill</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">40,684</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accumulated impairment loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(40,684</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 40184000 0 40184000 500000 40684000 0 40684000 40684000 40684000 40684000 0 119800000 17400000 213000000 31000000 40700000 5900000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">13.</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> Assets </div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:70%"></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deposits (a)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,924</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,165</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Long-term loan receivables (b)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">937</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,421</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,861</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,586</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a) Deposits mainly consisted of rental deposits and deposit for online stores operated on third party platforms, which will be collected after one year. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b) From May 2021 to May 2022, the Company entered into interest free loan agreements with three third parties for total principal amounts of RMB3.4 million. The repayment terms of the loan agreements were ranged from 24 months to 36 months with due dates from May 2024 to June 2025. As of March 31, 2022 and 2023, the balances of long-term loan receivables were RMB0.9 million and RMB3.4 million, respectively. </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:70%"></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deposits (a)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,924</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,165</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Long-term loan receivables (b)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">937</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,421</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,861</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,586</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a) Deposits mainly consisted of rental deposits and deposit for online stores operated on third party platforms, which will be collected after one year. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b) From May 2021 to May 2022, the Company entered into interest free loan agreements with three third parties for total principal amounts of RMB3.4 million. The repayment terms of the loan agreements were ranged from 24 months to 36 months with due dates from May 2024 to June 2025. As of March 31, 2022 and 2023, the balances of long-term loan receivables were RMB0.9 million and RMB3.4 million, respectively. </div> 3924000 3165000 937000 3421000 4861000 6586000 3400000 P24M P36M 2024-05 2025-06 900000 3400000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">14.</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Accrued liabilities and other current liabilities </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Accrued liabilities and other current liabilities consist of the following: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:70%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Logistics expenses payables</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,663</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Advances from customers</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,773</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,077</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Payable for investment </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,563</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,563</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Refund obligation of sales returns</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,411</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,113</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Professional service fee accruals</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">579</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,694</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued advertising expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">168</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Others</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,223</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,826</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27,324</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22,104</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Accrued liabilities and other current liabilities consist of the following: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:70%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Logistics expenses payables</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,663</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Advances from customers</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,773</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,077</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Payable for investment </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,563</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,563</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Refund obligation of sales returns</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,411</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,113</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Professional service fee accruals</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">579</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,694</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued advertising expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">168</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Others</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,223</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,826</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27,324</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22,104</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 14625000 7663000 3773000 3077000 2563000 2563000 1411000 3113000 579000 1694000 150000 168000 4223000 3826000 27324000 22104000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">15.</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Leases </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of March 31, 2022 and 2023, the Company has operating leases recorded on its consolidated balance sheet for certain office spaces and facilities that expire on various dates through 2026. The Company does not plan to cancel the existing lease agreements for its existing facilities prior to their respective expiration dates. When determining the lease term, the Company considers options to extend or terminate the lease when it is reasonably certain that it will exercise or not exercise that option. All of the Company’s leases qualify as operating leases. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:69%"></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">38,567</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22,354</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Liabilities</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liabilities, current</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,001</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,220</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liabilities, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28,197</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,741</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total operating lease liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">38,198</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,961</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average remaining lease term (years)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.61</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.77</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average discount rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.95</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.38</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Information related to operating lease activity during the years ended March 31, 2021, 2022 and 2023 are as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets obtained in exchange for lease obligations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25,970</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,038</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,384</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease related expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amortization of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,687</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,705</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24,597</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest of lease liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,596</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,949</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,777</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,283</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,654</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26,374</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div></div><div><div style="background-color:white;display: inline;"></div></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease payments (included in measurement of lease liabilities)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,850</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,849</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26,397</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Maturities of lease liabilities were as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:83%"></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">For the year ending March 31,</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,902</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,287</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,263</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total lease payments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24,604</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: imputed interest</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,643</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,961</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:69%"></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">38,567</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22,354</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Liabilities</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liabilities, current</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,001</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,220</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liabilities, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28,197</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,741</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total operating lease liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">38,198</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,961</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average remaining lease term (years)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.61</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.77</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average discount rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.95</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.38</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table> 38567000 22354000 10001000 9220000 28197000 12741000 38198000 21961000 P3Y7M9D P2Y9M7D 0.0495 0.0538 <div style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Information related to operating lease activity during the years ended March 31, 2021, 2022 and 2023 are as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets obtained in exchange for lease obligations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25,970</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,038</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,384</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease related expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amortization of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,687</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,705</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24,597</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest of lease liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,596</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,949</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,777</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,283</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,654</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26,374</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div></div><div><div style="background-color:white;display: inline;"></div></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease payments (included in measurement of lease liabilities)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,850</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,849</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26,397</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 25970000 21038000 8384000 11687000 11705000 24597000 1596000 1949000 1777000 13283000 13654000 26374000 12850000 12849000 26397000 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Maturities of lease liabilities were as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:83%"></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">For the year ending March 31,</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,902</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,287</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,263</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total lease payments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24,604</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: imputed interest</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,643</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,961</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 9902000 10287000 4263000 152000 0 24604000 2643000 21961000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">16.</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Interest expense </div></div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amortization charges on promissory notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,611</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,144</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,706</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest expense on borrowings</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,039</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,740</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,644</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27,650</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,884</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,350</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amortization charges on promissory notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,611</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,144</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,706</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest expense on borrowings</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,039</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,740</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,644</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27,650</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,884</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,350</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 21611000 17144000 9706000 6039000 3740000 3644000 27650000 20884000 13350000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">17.</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Other gains, net </div></div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:59%"></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gain from the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measurement</div> of the previously held equity interests to the fair value in the step acquisitions (Note 3)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">127</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign exchange losses, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,867</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,322</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,679</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gain on disposal of other debts </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,846</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Reimbursement from a depositary bank (a)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,556</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,482</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Investment loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(622</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(178</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gain on disposal of a subsidiary (b)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,597</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Others</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">797</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(289</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(939</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,332</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,020</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,159</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(a)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company received a reimbursement of US$1.0M (equivalent to RMB6.6 million), US$0.2M (equivalent to RMB1.5 million) and nil from the depository for the establishment and maintenance of the ADS program for the years ended March 31, 2021, 2022 and 2023. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(b)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">In August 2022, the Company disposed a subsidiary to a third-party investor and recognized an investment gain of RMB 3.6 million. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:59%"></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gain from the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measurement</div> of the previously held equity interests to the fair value in the step acquisitions (Note 3)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">127</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign exchange losses, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,867</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,322</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,679</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gain on disposal of other debts </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,846</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Reimbursement from a depositary bank (a)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,556</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,482</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Investment loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(622</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(178</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gain on disposal of a subsidiary (b)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,597</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Others</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">797</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(289</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(939</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,332</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,020</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,159</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(a)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company received a reimbursement of US$1.0M (equivalent to RMB6.6 million), US$0.2M (equivalent to RMB1.5 million) and nil from the depository for the establishment and maintenance of the ADS program for the years ended March 31, 2021, 2022 and 2023. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(b)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">In August 2022, the Company disposed a subsidiary to a third-party investor and recognized an investment gain of RMB 3.6 million. </div></td></tr></table> 127000 -2867000 5322000 2679000 6846000 6556000 1482000 0 -622000 -178000 3597000 797000 -289000 -939000 11332000 6020000 5159000 1000000 6600000 200000 1500000 0 3600000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">18.</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Income taxes </div></div></td></tr></table><div style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Cayman Islands </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Under the current tax laws of Cayman Islands, the Company and its subsidiaries incorporated in the Cayman Islands are not subject to tax on income or capital gain. Additionally, the Cayman Islands does not impose a withholding tax on payments of dividends to shareholders. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Hong Kong </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Under the current Hong Kong Inland Revenue Ordinance, the Company’s subsidiaries incorporated in Hong Kong are subject to a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-tiered</div> profits tax rate of 8.25% and 16.5% on its taxable income generated from operations in Hong Kong. Additionally, payments of dividends by the subsidiaries incorporated in Hong Kong to the Company are not subject to income tax. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">China </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On July 25, 2018, Boqii (Shanghai) Information Technology Co., Ltd. (“Shanghai Boqii”) was entitled to be “Software Enterprises”. According to the Enterprise Income Tax (“EIT”) Law and relevant regulations in the PRC, from the year of 2018, Shanghai Boqii could enjoy a tax holiday of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2-year</div> EIT exemption and subsequently <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">3-year</div> 12.5% preferential tax rate. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In addition, Shanghai Boqii was also qualified as a “High and New Technology Enterprise (“HNTE”) on August 29, 2019, and is eligible to enjoy a preferential tax rate of 15% from 2019 to 2024 to the extent it has taxable income under the EIT Law, as long as it maintains the HNTE qualification and duly conducts relevant EIT filing procedures with the relevant tax authority. Shanghai Boqii can <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-apply</div> for the HNTE certificate when the prior certificate expires. Whilst Shanghai Boqii was entitled to the tax preferential treatments under both “HNTE” and “Software Enterprises”, Shanghai Boqii chose to apply the preferential tax rate of “Software Enterprises”. For the years ended March 31, 2021, 2022 and 2023, Shanghai Boqii was subject to EIT rate at 12.5%, 12.5% and 12.5%, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company’s other subsidiaries, VIEs and VIEs’ subsidiaries established in the PRC are subject to the PRC general income tax rate of 25%. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Reconciliations of the differences between the income tax expenses of the Company and the PRC statutory EIT rate applicable to losses of the consolidated entities are as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:60%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loss before income taxes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(193,391</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(134,812</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(106,805</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Income tax computed at respective applicable tax rates</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(48,348</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(33,702</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(26,701</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Effect of different tax jurisdiction</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,272</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,341</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,323</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Super deduction for research and development expenses (a)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,632</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,881</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(456</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-deductible</div> expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">140</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">97</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">728</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in valuation allowance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">37,439</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,716</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15,017</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">871</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,571</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">911</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(a)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">According to the relevant laws and regulations promulgated by the State Administration of Tax of the PRC, from 2018 onwards, enterprises engaging in research and development activities are entitled to claim 175% of their qualified research and development expenses so incurred as tax deductible expenses. The additional deduction of 75% of qualified research and development expenses (the “Super Deduction”) can be directly claimed in the annual EIT filing. For the years end March 31, 2021, 2022 and 2023, the Super Deduction for research and development expenses available to the Company amounted to RMB2.6 million, RMB1.9 million and RMB0.5 million, respectively. </div></td></tr></table> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The provisions for income taxes for the years ended March 31, 2021, 2022 and 2023 differ from the amounts computed by applying the EIT primarily due to change in valuation allowance provided and tax differential from certain subsidiaries with preferential tax rates of the Company. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the effect of tax holiday effect on China operations: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Tax holiday effect</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,074</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,513</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,235</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net loss per share effect</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.02</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.05</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.02</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Reconciliations between the effective income tax rate and the PRC statutory income tax rates are as follows: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:60%"></td> <td style="vertical-align:bottom;width:13%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:12%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:12%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PRC statutory income tax rates</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Tax holiday effect</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1</td> <td style="white-space:nowrap;vertical-align:bottom">%) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Difference in tax rates of subsidiaries outside PRC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8</td> <td style="white-space:nowrap;vertical-align:bottom">%) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8</td> <td style="white-space:nowrap;vertical-align:bottom">%) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10</td> <td style="white-space:nowrap;vertical-align:bottom">%) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Super deduction for research and development expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-deductible</div> expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in valuation allowance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(19</td> <td style="white-space:nowrap;vertical-align:bottom">%) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(20</td> <td style="white-space:nowrap;vertical-align:bottom">%) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(14</td> <td style="white-space:nowrap;vertical-align:bottom">%) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Effective income tax rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Composition of income tax expenses </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The current and deferred portions of income tax expenses included in the consolidated statements of loss and comprehensive loss are as follows: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:59%"></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Current income tax expense/(benefit)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,018</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(582</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">78</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax benefit</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,889</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(989</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(989</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Income tax credit, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(871</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,571</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(911</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Deferred tax assets and deferred tax liabilities </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Deferred taxes were measured using the enacted tax rates for the periods in which they are expected to be reversed. The tax effects of temporary differences that give rise to the deferred tax asset and liabilities balances as of March 31, 2022 and 2023 are as follows: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:69%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax assets:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net accumulated loss-carry forward</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">172,059</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">163,526</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred deductible advertising expense</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,483</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Allowance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">78</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">238</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Contract liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">419</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">172</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accruals</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,208</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">842</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair Value Change</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,891</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Valuation allowance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(177,247</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(166,669</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr> <td style="vertical-align: top; background-color: rgb(204, 238, 255); padding-bottom: 0.375pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Net deferred tax assets</div><br/></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); padding-bottom: 0.375pt;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid black; background-color: rgb(204, 238, 255);"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 0.75pt solid black; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); padding-bottom: 0.375pt;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); padding-bottom: 0.375pt;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid black; background-color: rgb(204, 238, 255);"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid black; background-color: rgb(204, 238, 255);"><div style="margin-bottom: 0px; margin-top: 0px; text-indent: 0px; text-align: right; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); padding-bottom: 0.375pt;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div></td></tr> <tr> <td style="vertical-align: top; line-height: 1pt; font-size: 1pt; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 1pt; font-family: &quot;Times New Roman&quot;; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"><div style="margin-bottom: 0px; margin-top: 0px; font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt; background-color: rgba(255, 255, 255, 0);"><div style="margin-bottom: 0px; margin-top: 0px; font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt; background-color: rgba(255, 255, 255, 0);;text-align:right;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"><div style="margin-bottom: 0px; margin-top: 0px; font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"><div style="margin-bottom: 0px; margin-top: 0px; font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt; background-color: rgba(255, 255, 255, 0);"><div style="margin-bottom: 0px; margin-top: 0px; font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt; background-color: rgba(255, 255, 255, 0);"><div style="margin-bottom: 0px; margin-top: 0px; text-indent: 0px; text-align: right; font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"><div style="margin-bottom: 0px; margin-top: 0px; font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr> <tr> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); line-height: 6pt; font-size: 6pt;"><div style="margin-top: 0px; margin-bottom: 0px; margin-left: 1em; text-indent: -1em; font-size: 6pt; font-family: &quot;Times New Roman&quot;; line-height: 6pt;"><div style="font-size:6pt;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 6pt; font-size: 6pt;"><div style="margin-bottom: 0px; margin-top: 0px; font-size: 6pt; line-height: 6pt;"><div style="font-size:6pt;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 6pt; font-size: 6pt;"><div style="margin-bottom: 0px; margin-top: 0px; font-size: 6pt; line-height: 6pt;"><div style="font-size:6pt;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 6pt; font-size: 6pt;"><div style="margin-bottom: 0px; margin-top: 0px; font-size: 6pt; line-height: 6pt;"><div style="font-size:6pt;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 6pt; font-size: 6pt;"><div style="margin-bottom: 0px; margin-top: 0px; font-size: 6pt; line-height: 6pt;"><div style="font-size:6pt;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 6pt; font-size: 6pt;"><div style="margin-bottom: 0px; margin-top: 0px; font-size: 6pt; line-height: 6pt;"><div style="font-size:6pt;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 6pt; font-size: 6pt;"><div style="margin-bottom: 0px; margin-top: 0px; font-size: 6pt; line-height: 6pt;"><div style="font-size:6pt;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 6pt; font-size: 6pt;"><div style="margin-bottom: 0px; margin-top: 0px; font-size: 6pt; line-height: 6pt;"><div style="font-size:6pt;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 6pt; font-size: 6pt;"><div style="margin-bottom: 0px; margin-top: 0px; font-size: 6pt; line-height: 6pt;"><div style="font-size:6pt;;display:inline;"> </div></div></td></tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax liabilities:</div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Recognition of intangible assets arising from asset acquisition and business combination</div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(5,130</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">) </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(4,141</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">) </td></tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized fair value change of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt investments</div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">283</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net deferred tax liabilities</div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(4,847</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">) </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(4,141</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; margin-right:1%; font-size:10pt; font-family:Times New Roman">As of March 31, 2022 and 2023, the PRC entities of the Company had tax loss carryforwards of approximately RMB688 million and RMB654 million respectively, which can be carried forward to offset taxable income. The carryforwards period for net operating losses under the EIT Law is five years. The net operating loss carry forward of the Company will expire in varying amounts between 2024 and 2028. Other than the expiration, there are no other limitations or restrictions upon the Company’s ability to use these operating loss carryforwards. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Valuation allowance is provided against deferred tax assets when the Company determines that it is more likely than not that the deferred tax assets will not be utilized in the future. In making such determination, the Company considered factors including future taxable income exclusive of reversing temporary differences and tax loss carry forwards. If events occur in the future that allow the Company to realize part or all of its deferred income tax, an adjustment to the valuation allowances will result in a decrease in tax expense when those events occur. As of March 31, 2022 and 2023, valuation allowances of RMB177.2 million and RMB166.7 million were provided because it was more likely than not that the Company will not be able to utilize these tax losses carry forwards and other deferred tax assets generated by its subsidiaries and VIEs. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Movement of valuation allowance is as follows: </div></div></div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:55%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Beginning balance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">112,539</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">149,978</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">177,247</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change of valuation allowance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">37,439</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15,017</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Written-off</div> for expiration of net operating losses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(22,995</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Decrease of valuation allowances related to the disposal of a subsidiary</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,600</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ending balance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">149,978</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">177,247</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">166,669</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 0.0825 0.165 Shanghai Boqii could enjoy a tax holiday of 2-year EIT exemption and subsequently 3-year 12.5% preferential tax rate. 0.15 0.125 0.125 0.125 0.25 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Reconciliations of the differences between the income tax expenses of the Company and the PRC statutory EIT rate applicable to losses of the consolidated entities are as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:60%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loss before income taxes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(193,391</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(134,812</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(106,805</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Income tax computed at respective applicable tax rates</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(48,348</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(33,702</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(26,701</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Effect of different tax jurisdiction</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,272</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,341</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,323</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Super deduction for research and development expenses (a)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,632</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,881</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(456</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-deductible</div> expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">140</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">97</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">728</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in valuation allowance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">37,439</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,716</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15,017</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">871</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,571</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">911</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(a)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">According to the relevant laws and regulations promulgated by the State Administration of Tax of the PRC, from 2018 onwards, enterprises engaging in research and development activities are entitled to claim 175% of their qualified research and development expenses so incurred as tax deductible expenses. The additional deduction of 75% of qualified research and development expenses (the “Super Deduction”) can be directly claimed in the annual EIT filing. For the years end March 31, 2021, 2022 and 2023, the Super Deduction for research and development expenses available to the Company amounted to RMB2.6 million, RMB1.9 million and RMB0.5 million, respectively. </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Reconciliations between the effective income tax rate and the PRC statutory income tax rates are as follows: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:60%"></td> <td style="vertical-align:bottom;width:13%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:12%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:12%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PRC statutory income tax rates</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Tax holiday effect</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1</td> <td style="white-space:nowrap;vertical-align:bottom">%) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Difference in tax rates of subsidiaries outside PRC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8</td> <td style="white-space:nowrap;vertical-align:bottom">%) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8</td> <td style="white-space:nowrap;vertical-align:bottom">%) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10</td> <td style="white-space:nowrap;vertical-align:bottom">%) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Super deduction for research and development expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-deductible</div> expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in valuation allowance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(19</td> <td style="white-space:nowrap;vertical-align:bottom">%) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(20</td> <td style="white-space:nowrap;vertical-align:bottom">%) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(14</td> <td style="white-space:nowrap;vertical-align:bottom">%) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Effective income tax rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> -193391000 -134812000 -106805000 48348000 33702000 26701000 -14272000 -2341000 -12323000 2632000 1881000 456000 -140000 -97000 -728000 -37439000 -34716000 -15017000 -871000 -1571000 -911000 1.75 0.75 2600000 1900000 500000 <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The provisions for income taxes for the years ended March 31, 2021, 2022 and 2023 differ from the amounts computed by applying the EIT primarily due to change in valuation allowance provided and tax differential from certain subsidiaries with preferential tax rates of the Company. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the effect of tax holiday effect on China operations: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Tax holiday effect</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,074</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,513</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,235</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net loss per share effect</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.02</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.05</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.02</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 1074000 3513000 1235000 0.02 0.05 0.02 0.25 0.25 0.25 0.01 0.03 -0.01 -0.08 -0.08 -0.10 0.01 0.01 0 0 0 0.01 -0.19 -0.20 -0.14 0 0.01 0.01 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The current and deferred portions of income tax expenses included in the consolidated statements of loss and comprehensive loss are as follows: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:59%"></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Current income tax expense/(benefit)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,018</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(582</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">78</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax benefit</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,889</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(989</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(989</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Income tax credit, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(871</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,571</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(911</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 1018000 -582000 78000 -1889000 -989000 -989000 -871000 -1571000 -911000 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Deferred taxes were measured using the enacted tax rates for the periods in which they are expected to be reversed. The tax effects of temporary differences that give rise to the deferred tax asset and liabilities balances as of March 31, 2022 and 2023 are as follows: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:69%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax assets:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net accumulated loss-carry forward</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">172,059</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">163,526</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred deductible advertising expense</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,483</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Allowance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">78</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">238</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Contract liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">419</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">172</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accruals</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,208</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">842</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair Value Change</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,891</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Valuation allowance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(177,247</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(166,669</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr> <td style="vertical-align: top; background-color: rgb(204, 238, 255); padding-bottom: 0.375pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Net deferred tax assets</div><br/></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); padding-bottom: 0.375pt;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid black; background-color: rgb(204, 238, 255);"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 0.75pt solid black; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); padding-bottom: 0.375pt;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); padding-bottom: 0.375pt;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid black; background-color: rgb(204, 238, 255);"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid black; background-color: rgb(204, 238, 255);"><div style="margin-bottom: 0px; margin-top: 0px; text-indent: 0px; text-align: right; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); padding-bottom: 0.375pt;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div></td></tr> <tr> <td style="vertical-align: top; line-height: 1pt; font-size: 1pt; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 1pt; font-family: &quot;Times New Roman&quot;; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"><div style="margin-bottom: 0px; margin-top: 0px; font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt; background-color: rgba(255, 255, 255, 0);"><div style="margin-bottom: 0px; margin-top: 0px; font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt; background-color: rgba(255, 255, 255, 0);;text-align:right;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"><div style="margin-bottom: 0px; margin-top: 0px; font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"><div style="margin-bottom: 0px; margin-top: 0px; font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt; background-color: rgba(255, 255, 255, 0);"><div style="margin-bottom: 0px; margin-top: 0px; font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt; background-color: rgba(255, 255, 255, 0);"><div style="margin-bottom: 0px; margin-top: 0px; text-indent: 0px; text-align: right; font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"><div style="margin-bottom: 0px; margin-top: 0px; font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr> <tr> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); line-height: 6pt; font-size: 6pt;"><div style="margin-top: 0px; margin-bottom: 0px; margin-left: 1em; text-indent: -1em; font-size: 6pt; font-family: &quot;Times New Roman&quot;; line-height: 6pt;"><div style="font-size:6pt;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 6pt; font-size: 6pt;"><div style="margin-bottom: 0px; margin-top: 0px; font-size: 6pt; line-height: 6pt;"><div style="font-size:6pt;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 6pt; font-size: 6pt;"><div style="margin-bottom: 0px; margin-top: 0px; font-size: 6pt; line-height: 6pt;"><div style="font-size:6pt;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 6pt; font-size: 6pt;"><div style="margin-bottom: 0px; margin-top: 0px; font-size: 6pt; line-height: 6pt;"><div style="font-size:6pt;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 6pt; font-size: 6pt;"><div style="margin-bottom: 0px; margin-top: 0px; font-size: 6pt; line-height: 6pt;"><div style="font-size:6pt;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 6pt; font-size: 6pt;"><div style="margin-bottom: 0px; margin-top: 0px; font-size: 6pt; line-height: 6pt;"><div style="font-size:6pt;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 6pt; font-size: 6pt;"><div style="margin-bottom: 0px; margin-top: 0px; font-size: 6pt; line-height: 6pt;"><div style="font-size:6pt;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 6pt; font-size: 6pt;"><div style="margin-bottom: 0px; margin-top: 0px; font-size: 6pt; line-height: 6pt;"><div style="font-size:6pt;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 6pt; font-size: 6pt;"><div style="margin-bottom: 0px; margin-top: 0px; font-size: 6pt; line-height: 6pt;"><div style="font-size:6pt;;display:inline;"> </div></div></td></tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax liabilities:</div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Recognition of intangible assets arising from asset acquisition and business combination</div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(5,130</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">) </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(4,141</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">) </td></tr> <tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized fair value change of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt investments</div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">283</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net deferred tax liabilities</div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(4,847</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">) </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(4,141</td> <td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td></tr></table> 172059000 163526000 2483000 0 78000 238000 419000 172000 2208000 842000 0 1891000 177247000 166669000 0 0 5130000 4141000 -283000 0 4847000 4141000 688000000 654000000 177200000 166700000 <div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Movement of valuation allowance is as follows: </div></div></div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:55%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Beginning balance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">112,539</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">149,978</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">177,247</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change of valuation allowance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">37,439</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15,017</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Written-off</div> for expiration of net operating losses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(22,995</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Decrease of valuation allowances related to the disposal of a subsidiary</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,600</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ending balance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">149,978</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">177,247</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">166,669</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 112539000 149978000 177247000 37439000 27269000 15017000 0 0 -22995000 0 0 -2600000 149978000 177247000 166669000 <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">19.</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Ordinary Share </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of March 31, 2022, the Company had 55,709,591 Class A ordinary shares and 13,037,729 Class B ordinary shares issued and outstanding, respectively. As of March 31, 2023, the Company had 55,763,079 Class A ordinary shares and 13,037,729 Class B ordinary shares issued and outstanding, respectively. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Initial public offering </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In October 2020, the Company completed its IPO on the New York Stock Exchange of 7,000,000 American Depositary Shares (“ADSs”) (including 1,050,000 ADSs sold upon the full exercise of the underwriters’ over-allotment option) (each representing 0.75 of one Class A ordinary share), for a total ordinary shares offering of 5,250,000 shares at a price of US$10.00 per ADS. The net proceeds raised from the IPO amounted to approximately US$61 million after deducting underwriting discounts and commissions and other offering expenses. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Upon the completion of the IPO, all series of redeemable convertible preferred shares of the Company were converted and designated as Class A ordinary shares with a par value of US$0.001 each on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-</div></div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one basis except for</div> (i)10,340,000 shares of Series A preferred shares were automatic converted into 7,844,137 ordinary shares on a 1: 0.76 basis, (ii) 9,067,384 shares of Series B preferred shares were automatic converted into 8,557,980 ordinary shares on a 1:0.94 basis, (iii) 6,734,459 shares of Series C+ preferred shares were automatic converted into 6,883,520 ordinary shares on a 1:1.02 basis and (iv) 833,125 shares of Series C preferred shares were converted and designated as Class B ordinary shares with a par value of US$0.001 each on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one basis</div>. 12,204,604 ordinary shares were designated as Class B ordinary share on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis. The remaining ordinary shares were designated as Class A ordinary shares on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In respect of all matters subject to shareholders’ vote, each holder of Class A ordinary share is entitled to one and each holder of Class B ordinary share is entitled to twenty votes. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In February 2021, the Company repurchased 521,924 shares of Class A ordinary shares from one of its shareholders with a consideration amounting to US$4.8 million, the repurchased shares were cancelled thereafter. </div> 55709591 55709591 13037729 13037729 55763079 55763079 13037729 13037729 7000000 1050000 0.75 5250000 10 61000000 0.001 one basis except for 10340000 7844137 1: 0.76 9067384 8557980 1:0.94 6734459 6883520 1:1.02 833125 0.001 one-for-one basis 12204604 521924 4800000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">20.</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Convertible redeemable preferred shares </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company issued several series of convertible redeemable preferred shares in previous years. Upon the completion of the IPO, all series of redeemable convertible preferred shares of the Company were converted and designated as Class A ordinary shares (Note 19). </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company classified the Preferred Shares in the mezzanine section of the Consolidated Balance Sheets because they were contingently redeemable upon the occurrence of an event outside of the Company’s control (e.g. the Company not achieving a Qualified IPO before the Optional Redemption Date). The Preferred Shares were determined to be mezzanine equity with no embedded feature to be bifurcated and no BCF to be recognized. The Preferred Shares <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">were</div> initially recorded at their respective issuance date fair value, net of issuance cost. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Since the Preferred Shares bec<div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">a</div>me redeemable at the option of the holder at any time after the Optional Redemption Date, for each reporting period, the Company accreted the carrying amount of the Preferred Shares to the higher of (1) the fair market value of the Preferred Shares on the reporting date, or (2) the result of using effective interest rate method to accrete the Preferred Shares to the redemption prices on the Optional Redemption Date that were calculated with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">pre-determined</div> formulas (e.g., for Series A Preferred Shares, such redemption price shall be 180% of the issue price). While all Preferred Shares were automatically converted upon a Qualified IPO, the effectiveness of a Qualified IPO was not within the control of the Company and <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">was</div> not deemed probable to occur for accounting purposes until the effective date of the Qualified IPO. As such, the Company continued to recognize accretion of the Preferred Shares until the completion of the IPO on October 2, 2020 when all of the Preferred Shares of the Company were converted to ordinary shares. The accretion of the Preferred Shares was <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">RMB-121 million</div> (US$-18million), nil and nil for the years ended March 31, 2021, 2022 and 2023. </div> 121000000 18000000 0 0 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">21.</div></div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Redeemable <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-controlling</div> interests </div></div> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Yoken Holding Limited (“Yoken”), a wholly owned subsidiary of the Company issued 120,000 redeemable preferred shares amounting to RMB6 million to a third-party investor in October, 2020. The preferred shares are redeemable at the holder’s option if Yoken fails to complete a qualified IPO in a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-agreed</div> period of time since its issuance with a redemption price measured by 10% interest per year. The preferred shares are therefore accounted for as redeemable <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-controlling</div> interests in mezzanine equity and are accreted to the redemption value over the period starting from the issuance date. The contract terms are the same as the Preferred Shares of the Company. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the years ended March 31 2021, 2022 and 2023, the Company recognized accretion of RMB0.1 million, RMB0.6 million and RMB0.7 million, respectively, to the respective redemption value of the redeemable non-controlling interest over the period starting from issuance date with a corresponding increase to the accumulated deficit. As of March 31, 2022 and 2023, the redeemable <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-controlling</div> interests was RMB6.5 million and RMB7.2 million, respectively. </div> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following tables provides details of the redeemable non-controlling interests activity for the years ended March 31, 2021, 2022 and 2023: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Beginning balance</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,809</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,947</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,522</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accretion of redeemable non-controlling interests</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">138</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">575</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">675</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ending balance</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,947</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,522</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,197</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 120000 6000000 0.10 -100000 -600000 -700000 6500000 7200000 <div style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following tables provides details of the redeemable non-controlling interests activity for the years ended March 31, 2021, 2022 and 2023: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Beginning balance</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,809</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,947</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,522</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accretion of redeemable non-controlling interests</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">138</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">575</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">675</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ending balance</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,947</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,522</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,197</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 5809000 5947000 6522000 -138000 -575000 -675000 5947000 6522000 7197000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">22.</div></div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Borrowings, other debts and derivative liabilities </div></div> </td> </tr> </table> <div style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Short-term borrowings </div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table presents short-term borrowings from commercial banks, other institutions and individuals as of March 31, 2022 and 2023. Short-term borrowings include borrowings with maturity terms shorter than one year: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:69%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Bank borrowings</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">134,540</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">86,261</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Current portion of long-term bank borrowings</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26,586</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">161,126</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">86,261</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Bank borrowings </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of March 31, 2022 and 2023, the Company obtained short-term bank borrowings of RMB161.1 million and RMB86.3 million in aggregate, of which RMB110.5 million and RMB63.9 million were collateralized by short-term investments, respectively. The weighted average interest rate for the outstanding borrowings were approximately 2.63% and 3.98%, respectively. These short-term bank borrowings did not include any restrictive covenants. As of March 31, 2022 and 2023, the unused facility for the short-term borrowing were RMB170.3 million and RMB<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>213.0 million, respectively. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of March 31, 2023, the Company has not obtained long-term bank borrowings. As of March 31, 2023, the unused facility for the long-term borrowings was none. </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Future principal maturities of short-term borrowings and long-term borrowings as of March 31, 2021 and 2022 are as followings: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:71%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Year ended</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Year ended</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">For the year ending March 31,</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">- Within 1 year</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">161,126</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">86,261</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">161,126</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">86,261</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of the date of this annual report, all the outstanding short-term borrowing as of March 31, 2023 was subsequently settled. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Other debts </div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Other debts – <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> consist of the following: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:70%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loan from CMB (a)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">86,373</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loan from Chong Li (b)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">70,001</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">73,981</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loan for Yoken Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> Warrant (c)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,188</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27,346</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Payable for investment</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">181,062</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">102,827</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(a) Loan from CMB </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Guangcheng signed loan agreement with CMB in March 2020 (“Loan from CMB”). The loan was interest-free with a principal amount of US$46 million. The term is 2 years and can be extended if agreed by both CMB and Guangcheng. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company accounts for Loan from CMB as a long-term debt initially recognized in the amount of RMB303 million (which is the present value of the principal amount of US$46 million) and subsequently measured at amortized cost. During the years ended March 31, 2022 and 2023, the Company repaid the principal of Loan from CMB in the amount of RMB235.0 million and RMB87.9 million, respectively. For the years ended March 31, 2022 and 2023, the Company recorded RMB8.9 million and RMB1.5 million interest expenses of Loan from CMB. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company issued preferred shares to be settled by CMB after CMB receiving the repayment of the Loan from CMB. The Company recorded a receivable for issuance of preferred shares in the amount of RMB303 million (which is the present value of the principal amount of US$46 million) in mezzanine equity for the consideration of the preferred shares not yet received from the investors. After the completion of the IPO in October 2020, the preferred shares were automatically converted into Class A ordinary shares. The Company accounted for the consideration of such-converted ordinary shares as receivable for issuance of ordinary shares in equity. As of March 31, 2022 and 2023, the receivable for issuance of ordinary shares is RMB86.4 million and nil, respectively (Note 23). </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(b) Loan from Chong Li </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Guangcheng signed loan agreement with Chong Li in March 2020 (“Loan from Chong Li”). The loan was interest-free with a principal amount of RMB128 million. The term is 5 years and can be extended if agreed by both Chong Li and Guangcheng. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company accounted for Loan from Chong Li as a long-term debt initially recognized in the amount of RMB95 million (which is the present value of the principal amount of RMB128 million) and subsequently measured at amortized cost. During the years ended March 31, 2022 and 2023, the Company repaid the principal of Loan from Chong Li of RMB35.9 million and RMB36.4 million, respectively. For the years ended March 31, 2022 and 2023, the Company recorded interest expenses of RMB5.1 million and RMB4.5 million, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company issued preferred shares to be settled by Superb Origin International Limited (“Superb Origin”, Chong Li is the 100% equity owner of Superb Origin) after Guangcheng repaid the Loan from Chong Li. The Company recorded a receivable for issuance of preferred shares in the amount of RMB95 million (which is the present value of the principal amount of RMB128 million) in mezzanine equity for the consideration of the preferred shares not yet received from Superb Origin. After the completion of the IPO in October 2020, preferred shares were automatically converted into Class A ordinary shares. The Company then recorded the unreceived consideration from Superb Origin as receivable for issuance of ordinary shares under shareholders’ equity (Note 23). </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(c) <div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Yoken Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> Warrant</div> </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On March 2, 2020, Yoken Holding Limited (“Yoken”), a wholly owned subsidiary of the Company, entered into a share purchase agreement with three investors (“Yoken Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> SPA”). According to the Yoken Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> SPA, Yoken will issue each investor a warrant (“Yoken Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> Warrant”) to purchase certain quantity of Yoken’s Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> Preferred Shares (“Yoken Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> Preferred Shares”). As the consideration for each Yoken Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> Warrant, the respective investor shall provide a loan (“Loan for Yoken Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> Warrant”) carrying a simple interest of 10% per annum to Chengdu Chongaita Information Technology Co., Ltd. (“Chongaita”), a wholly owned PRC subsidiary of Yoken. Yoken will only issue the Yoken Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> Warrants after Chongaita has received all loan proceeds. Both the issuance of the Yoken Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> Warrants and the receipt of the loan proceeds are closing conditions of the transactions in the Yoken Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> SPA. The Company accounted for the loan as a term loan carrying an annual simple interest of 10%. As of March 31, 2020, the carrying value of the loan proceeds of Yoken Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> Warrant was RMB18 million. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On October 23, 2020, one of the investors terminated and entered into a new share purchase agreement with Yoken, pursuant to which 120,000 Yoken Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> Preferred Shares were issued on October 23, 2020 for an aggregated consideration of RMB6 million. On the same day, the Company issued the remaining two investors two warrants to purchase up to 360,000 and 200,000 Yoken Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> Preferred Shares at an exercise price per share of US$ 7.14 in connection with a loan of RMB18 million (equivalent to US$2.5 million) and RMB10 million (equivalent to US$1.4 million) granted to Chongaita (“Loan for Yoken Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> Warrant”). As a debt modification, the Company reversed RMB1.4 million interest expense as other gains, net (Note 17). The Company recognized the Yoken Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> Warrant and bifurcated the conversion feature as derivative liability out of the total consideration received. As of March 31, 2022 and 2023, the carrying value of Yoken Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> Warrant were RMB23.2 million and RMB27.3 million, respectively, and fair value of conversion feature were RMB9.1 million and RMB7.9 million, respectively. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Derivative liabilities </div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:70%"></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><span style="-sec-ix-hidden:hidden84116483">Conversion</span> feature of Yoken Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> Warrant (a)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,086</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,850</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forward exchange contracts (b)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,851</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,086</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,701</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the initial recognition of each debt instrument that has a bifurcated derivative liability (i.e., embedded warrant or conversion feature), out of the total consideration received, the derivative liability is recognized at fair value and the remaining consideration (net of issuance costs) is then allocated to the host debt instrument. The derivative liability is subsequently carried at fair value with any changes in fair value recognized currently in the income statement. The host debt instrument is subsequently amortized using the effective interest rate method. Upon conversion of the host debt instrument into the Preferred Shares or debt repayment, both the host debt instrument and the respective derivative liability are subject to extinguishment accounting with a gain or loss recognized from the difference between the recoded values of both liabilities and the fair value of consideration given by the Company (i.e., the Preferred Shares or cash). </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a) The warrant issued in connection with Yoken Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> Warrant is embedded instead of freestanding because it is (1) issued in connection with the instrument and (2) not separately exercisable without terminating the debt instruments. Therefore, each combined instrument (loan with embedded warrant) is substantially similar to a convertible debt where the embedded warrant is similar to a conversion feature able to convert the debt instrument into the Preferred Shares. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company assessed the embedded warrant along with the conversion features in Yoken Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> Warrant and concluded that it is required to be bifurcated and accounted for separately as derivative liabilities. This is because (1) the embedded warrant or conversion feature, as an equity-linked feature, is not considered clearly and closely related to its debt host instrument, and (2) the redemption rights of the convertible Preferred Shares could give rise to net settlement of the conversion feature of the Preferred Shares. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">(b) In June and December 2021 and March 2022, the Company entered three new forward exchange contracts with a financial institution. Pursuant to which, the financial institution agreed to purchase US$8 million, US$4 million and US$5 million from the Company in exchange of RMB52.4 million, RMB26.1 million and RMB32.1 million at a fixed foreign exchange rate of 6.5452, 6.5128 and 6.4200 on June 2022, December 2022 and March 2023, respectively. The Company settled in advance with amount of US$11 million and recorded the fair value gain in the amount of RMB1.2 million as fair value change of derivative liabilities. For the year ended March 31, 2022, the fair value gain of the rest forward exchange contracts was RMB0.9 million and was recorded as fair value change of derivative liabilities. The carrying value of the remaining forward exchange contracts was RMB0.7 million and was recorded as prepayments and other current assets. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">In December 2022 and March 2023, the forward exchange contracts which signed in December 2021 and March 2022 were renewed to December 2023 and March 2024 respectively. And the Company settled in advance with amount of US$1.5 million and recorded the fair value gain in the amount of RMB0.1 million as fair value change of derivative liabilities. For the year ended March 31, 2023, the fair value loss of the rest forward exchange contracts was RMB(3.6) million and was recorded as fair value change of derivative liabilities. The carrying value of the remaining forward exchange contracts was RMB2.9 million and was recorded as derivative liabilities. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table presents short-term borrowings from commercial banks, other institutions and individuals as of March 31, 2022 and 2023. Short-term borrowings include borrowings with maturity terms shorter than one year: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:69%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Bank borrowings</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">134,540</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">86,261</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Current portion of long-term bank borrowings</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26,586</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">161,126</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">86,261</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 134540000 86261000 26586000 161126000 86261000 161100000 86300000 110500000 63900000 0.0263 0.0398 170300000 213000000 0 <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Future principal maturities of short-term borrowings and long-term borrowings as of March 31, 2021 and 2022 are as followings: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:71%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Year ended</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Year ended</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">For the year ending March 31,</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">- Within 1 year</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">161,126</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">86,261</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">161,126</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">86,261</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 161126000 86261000 161126000 86261000 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Other debts – <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> consist of the following: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:70%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loan from CMB (a)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">86,373</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loan from Chong Li (b)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">70,001</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">73,981</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loan for Yoken Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> Warrant (c)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,188</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27,346</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Payable for investment</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">181,062</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">102,827</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 86373000 70001000 73981000 23188000 27346000 1500000 1500000 181062000 102827000 46000000 P2Y 303000000 46000000 235000000 87900000 8900000 1500000 303000000 46000000 86400000 0 128000000 P5Y 95000000 128000000 35900000 36400000 5100000 4500000 1 95000000 128000000 0.10 0.10 18000000 120000 360000 200000 7.14 18000000 2500000 10000000 1400000 1400000 23200000 27300000 9100000 7900000 <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Derivative liabilities </div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:70%"></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><span style="-sec-ix-hidden:hidden84116483">Conversion</span> feature of Yoken Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> Warrant (a)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,086</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,850</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forward exchange contracts (b)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,851</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,086</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,701</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 9086000 7850000 2851000 9086000 10701000 8000000 4000000 5000000 52400000 26100000 32100000 6.5452 6.5128 6.42 11000000 1200000 900000 700000 1500000 100000 -3600000 2900000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%;text-indent: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">23.</div></div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Receivable for issuance of ordinary shares </div></div> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Company issued preferred shares to investors, which to be settled by the investors after Guangcheng repaid the Loan from CMB and Loan from Chong Li to the investors. The Company recorded a receivable for issuance of preferred shares in mezzanine equity for the consideration of the preferred shares not yet received from the investors. After the completion of the IPO in October 2020, the preferred shares were automatically converted into Class A ordinary shares. The Company accounted for the consideration of such-converted ordinary shares as receivable for issuance of ordinary shares under shareholders’ equity. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">During the years ended March 31, 2022 and 2023, the Company received RMB262.9 and RMB87.9 million from the receivable for issuance of ordinary shares. For the years ended March 31, 2022 and 2023, the Company recorded interest income of RMB14.2 million and RMB6.1 million, respectively. As of March 31, 2022 and 2023, the balances of receivable for issuance of ordinary shares were RMB164.7 million and RMB83.4 million, respectively. </div> 262900000 87900000 14200000 6100000 164700000 83400000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%;text-indent: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">24.</div></div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Share-based compensation </div></div> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">On September 27, 2012, the Company adopted 2012 Global Share Plan (the “2012 Plan”) and reserved 1,061,500 ordinary shares for share options to be granted to certain of the Company’s employees and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-employees</div> (the “Participants”). On August 1, 2018, the Company adopted 2018 Global Share Plan (the “2018 Plan”) to replace the 2012 Plan and increased the reserved ordinary shares to 5,987,836 in total for future grants of share options. On September 1, 2020, the Company amended the 2018 Plan and increased the authorized reserved shares from 5,987,836 to 8,987,836.<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In May 2022, the Company amended the 2018 Plan and increased 4,000,000 authorized reserved shares from 8,987,836 to 12,987,836. </div></div> </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;;text-indent: 0px;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center;text-indent: 0px;"> </div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"> </div></div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"></div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Except for share options granted to certain senior management personnel during the years ended March 31, 2015 and 2016, which were immediately fully vested and exercisable once granted, other share options granted to employees and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-employees</div> under the 2012 and 2018 Plans would generally be exercisable upon the Company’s completion of a Qualified IPO or a defined corporate transactions (i.e. change of control, etc.) and the employees render services to the Company in accordance with the stipulated service schedules. The employee participants are generally subject to a four-year service schedule, under which the employees earn an entitlement to vest in 25% of their option grants at the end of each year of completed service. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the years ended March 31, 2022 and 2023, 1,282,500 and nil share options were granted to the Participants respectively. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the share options activity for the years ended March 31, 2022 and 2023: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:53%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Number of</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">shares</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Weighted<br/> average</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">exercise price</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Weighted average</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">remaining</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">contractual term</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Aggregate</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">intrinsic</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">value</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Weighted average</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">fair value</div></div> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">US$</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">US$</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">US$</div></div></td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of March 31, 2021</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,512,222</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.36</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.32</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29,360</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.28</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercisable as of March 31, 2021</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Granted</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,282,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.86</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercised</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,204,483</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.09</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.73</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forfeited</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(358,348</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.86</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.83</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of March 31, 2022</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,231,891</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.86</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.25</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">404</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.36</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercisable as of March 31, 2022</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercised</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(53,488</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.60</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forfeited</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,233,050</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.31</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.86</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of March 31, 2023</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,945,354</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.58</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.45</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">124</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.06</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercisable as of March 31, 2023</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The aggregate intrinsic value is calculated as the difference between the exercise price of the options and the estimated fair value of the underlying shares of US$29,359,582, US$404,409 and US$123,594 at March 31, 2021, 2022 and 2023, respectively. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of March 31, 2022 and 2023, there were US$2,298,328 and US$322,926 of unrecognized share-based compensation expenses related to share options granted by the Company, which were expected to be recognized over a weighted-average period of 5.3 years and 3.4 years, respectively. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Options granted to the Participants were measured at fair value on the dates of grant using the Binomial Option Pricing Model. The assumptions used to value the Company’s option grants for the year ended March 31, 2022 were as follows: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:72%"></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended March 31, 2022</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align: bottom; white-space: nowrap; text-indent: 0px;;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">42.22<div style="display:inline;">% - </div>43.71%</div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top;text-indent: 0px;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div> </td> <td style="vertical-align:bottom;text-indent: 0px;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-indent: 0px;;text-align:center;">1.62<div style="display:inline;">% - </div>1.86%</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercise multiple</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">2.8/2.2</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">0%</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Contractual term (in years)</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">10</td> </tr> </table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"> </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"> </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"> </div></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"></div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"></div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The expected volatility was estimated based on the historical volatility of comparable peer public companies with a time horizon close to the expected term of the Company’s options. The risk-free interest rate was estimated based on the yield to maturity of U.S. treasury bonds denominated in US$ for a term consistent with the expected term of the Company’s options in effect at the option valuation date. The expected exercise multiple was estimated as the average ratio of the stock price to the exercise price of when employees would decide to voluntarily exercise their vested options. As the Company did not have sufficient information of past employee exercise history, it was estimated by referencing to a widely-accepted academic research publication. The expected dividend yield is zero as the Company has never declared or paid any cash dividends on its shares, and the Company does not anticipate any dividend payments in the foreseeable future. The expected term is the contract life of the option. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the Company’s share options granted to the Participants, the completion of a Qualified IPO is considered to be a performance condition of the awards. A Qualified IPO is not considered to be probable until it is completed. Under ASC 718, compensation cost should be accrued if it is probable that the performance condition will be achieved. As a result, no compensation expense will be recognized related to these options until the completion of a Qualified IPO, and hence no share-based compensation expense was recognized for the year ended March 31, 2020. For the year ended March 31, 2021, upon the completion of the IPO in October 2020, the Company recorded RMB55 million of share-based compensation expense. For the year ended March 31, 2022 and 2023, RMB14.4 million and RMB-7.7 million of share-based compensation expense was recorded, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The fair value of options granted to the Participants for the years ended March 31, 2022 and 2023 was amounting to US$2.9 million and nil, respectively. </div> 1061500 5987836 5987836 8987836 4000000 8987836 12987836 0.25 1282500 0 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the share options activity for the years ended March 31, 2022 and 2023: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:53%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Number of</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">shares</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Weighted<br/> average</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">exercise price</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Weighted average</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">remaining</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">contractual term</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Aggregate</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">intrinsic</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">value</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Weighted average</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">fair value</div></div> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">US$</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">US$</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">US$</div></div></td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of March 31, 2021</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,512,222</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.36</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.32</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29,360</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.28</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercisable as of March 31, 2021</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Granted</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,282,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.86</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercised</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,204,483</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.09</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.73</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forfeited</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(358,348</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.86</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.83</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of March 31, 2022</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,231,891</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.86</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.25</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">404</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.36</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercisable as of March 31, 2022</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercised</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(53,488</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.60</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forfeited</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,233,050</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.31</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.86</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of March 31, 2023</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,945,354</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.58</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.45</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">124</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.06</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercisable as of March 31, 2023</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> 5512222 3.36 P6Y3M25D 29360000 3.28 1282500 2.86 2.27 1204483 1.09 0.73 358348 2.86 3.83 5231891 2.86 P5Y3M 404000 2.36 53488 0.6 2.26 1233050 1.31 0.86 3945354 2.58 P3Y5M12D 124000 2.06 29359582000 404409000 123594000 2298328000 322926000 P5Y3M18D P3Y4M24D <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:72%"></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended March 31, 2022</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align: bottom; white-space: nowrap; text-indent: 0px;;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">42.22<div style="display:inline;">% - </div>43.71%</div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top;text-indent: 0px;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div> </td> <td style="vertical-align:bottom;text-indent: 0px;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-indent: 0px;;text-align:center;">1.62<div style="display:inline;">% - </div>1.86%</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercise multiple</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">2.8/2.2</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">0%</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Contractual term (in years)</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">10</td> </tr> </table> 0.4222 0.4371 0.0162 0.0186 2.8 2.2 0 P10Y 0 0 55000000 14400000 -7700000 2900000 0 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">25.</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Employee benefits </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The full-time employees of the Company’s subsidiaries and VIEs that are incorporated in the PRC are entitled to staff welfare benefits including medical insurance, basic pensions, unemployment insurance, work injury insurance, maternity insurance and housing funds. These companies are required to contribute to these benefits based on certain percentages of the employees’ salaries in accordance with the relevant regulations and charge the amount contributed to these benefits to the consolidated statements of loss and comprehensive loss. The Company has no legal obligation for the benefits beyond the contribution made. The PRC government is responsible for the welfare and medical benefits and ultimate pension liability to these employees. The total amounts charged to the consolidated statements of loss and comprehensive loss for such employee benefits amounted to RMB6 million, RMB7 million and RMB9 million for the years ended March 31, 2021, 2022 and 2023, respectively. </div> 6000000 7000000 9000000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">26.</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Fair value measurements </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company measured its short-term investments, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> investments, equity securities with readily determinable fair values and derivative liabilities at fair value on a recurring basis. Equity securities classified within Level 1 are valued using quoted market prices that currently available on a securities exchange registered on NYSE American. Short-term investments classified within Level 2 are valued using directly or indirectly observable inputs in the marketplace. As the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> investments and derivative liabilities are not traded in an active market with readily observable prices, the Company uses significant unobservable inputs to measure the fair value of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> investments and derivative liabilities. These instruments are categorized in the Level 3 valuation hierarchy based on the significance of unobservable factors in the overall fair value measurement. The Company did not transfer any assets or liabilities in or out of level 3 during the years ended March 31, 2021, 2022, and 2023. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"></div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"></div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the Company’s financial assets and liabilities measured and recorded at fair value on recurring basis as of March 31, 2022 and 2023: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:48%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">Fair value measurement at reporting date using</td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Description</div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">Fair value as of<br/> March 31, 2022</td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">Quoted price in<br/> active markets<br/> for identical<br/> assets (Level 1)</td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">Significant other<br/> observable Inputs<br/> (Level 2)</td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">Significant<br/> unobservable Inputs<br/> (Level 3)</td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">RMB</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">RMB</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">RMB</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">RMB</td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Assets:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Short-term investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">128,084</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">128,084</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Available-for-sale</div></div> debt investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,866</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,866</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equity securities with readily determinable fair values</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">670</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">670</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">203,620</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">670</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">128,084</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,866</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Liabilities:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Derivative liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,086</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,086</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:49%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">Fair value measurement at reporting date using</td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Description</div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">Fair value as of<br/> March 31, 2023</td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">Quoted price in<br/> active markets<br/> for identical<br/> assets (Level 1)</td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">Significant other<br/> observable Inputs<br/> (Level 2)</td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">Significant<br/> unobservable Inputs<br/> (Level 3)</td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">RMB</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">RMB</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">RMB</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">RMB</td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Assets:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Short-term investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">69,797</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">69,797</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Available-for-sale</div></div> debt investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68,011</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68,011</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equity securities with readily determinable fair values</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">102</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">102</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">137,910</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">102</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">69,797</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68,011</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Liabilities:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Derivative liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,701</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,701</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The roll forward of major Level 3 investments are as following: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:71%"></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Derivative liabilities</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Available-for-sale</div></div><br/> debt investments</td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value of Level 3 investments as at March 31, 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,351</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">70,328</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">New addition</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,581</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Disposal of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-3</div> Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,377</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized fair value change of the derivative liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(11,559</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized fair value change of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,029</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value of Level 3 investments as at March 31, 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,996</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">71,357</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">New addition</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Reclassification of forward exchange contracts</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">746</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized fair value change of the derivative liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,656</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized fair value change of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(12,491</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value of Level 3 investments as at March 31, 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,086</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,866</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Reclassification of forward exchange contracts</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(651</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized fair value change of the derivative liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,266</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized fair value change of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,427</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Disposal of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(428</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value of Level 3 investments as at March 31, 2023</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,701</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68,011</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company determined the fair value of their investments by using equity allocation model, market approach and binomial model. The determination of the fair value was based on estimates, judgments and information of other comparable public companies. The significant unobservable inputs adopted in the valuation as of March 31, 2022 and 2023: </div> <div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 32%;"></td> <td style="width: 2%; vertical-align: bottom;"></td> <td></td> <td style="width: 2%; vertical-align: bottom;"></td> <td></td> </tr> <tr style="font-size: 0px;"> <td style="width: 32%;"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 32%;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 2%;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 2%;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; width: 32%;"> <div style="text-indent: -1em; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em;">Implied price to sales after discount <br/>for lack of marketability</div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">n.a.</td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">1.04x</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; text-indent: 0px; width: 32%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average cost of capital</div> </td> <td style="vertical-align: bottom; text-indent: 0px; width: 2%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-indent: 0px;;text-align:center;">15<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>16.5<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>18<div style="letter-spacing: 0px; top: 0px;;display:inline;">%</div></td> <td style="vertical-align: bottom; text-indent: 0px; width: 2%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-indent: 0px;;text-align:center;">n.a.</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; text-indent: 0px; width: 32%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Lack of marketability discount</div> </td> <td style="vertical-align: bottom; text-indent: 0px; width: 2%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-indent: 0px;;text-align:center;">17<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>23<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>29<div style="letter-spacing: 0px; top: 0px;;display:inline;">%</div></td> <td style="vertical-align: bottom; text-indent: 0px; width: 2%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-indent: 0px;;text-align:center;">20%</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; text-indent: 0px; width: 32%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free rate</div> </td> <td style="vertical-align: bottom; text-indent: 0px; width: 2%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-indent: 0px;;text-align:center;">1.95<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>2.23<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>2.34<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>2.36<div style="letter-spacing: 0px; top: 0px;;display:inline;">%</div></td> <td style="vertical-align: bottom; text-indent: 0px; width: 2%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-indent: 0px;;text-align:center;">2.60<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>2.31<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>2.19%</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; text-indent: 0px; width: 32%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div> </td> <td style="vertical-align: bottom; text-indent: 0px; width: 2%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-indent: 0px;;text-align:center;">39.88<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>42.17<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>42.48<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>47.34<div style="letter-spacing: 0px; top: 0px;;display:inline;">%</div></td> <td style="vertical-align: bottom; text-indent: 0px; width: 2%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-indent: 0px;;text-align:center;">47.19<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>43.65<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>32.08%</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; text-indent: 0px; width: 32%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Probability</div> </td> <td style="vertical-align: bottom; text-indent: 0px; width: 2%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-indent: 0px;;text-align:center;">Liquidation scenario: 20% <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Redemption scenario: 40%</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">IPO scenario: 40%</div> </td> <td style="vertical-align: bottom; text-indent: 0px; width: 2%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-indent: 0px;;text-align:center;">Liquidation scenario: 35<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>40% <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;;text-indent: 0px;">Redemption scenario: 35<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>40%</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;;text-indent: 0px;">IPO scenario: 30<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>20%</div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The significant unobservable inputs used in the fair value measurement of the fair value of the investments include weighted average cost of capital, implied price to sales after discount for lack of marketability, lack of marketability discount, risk-free rate, expected volatility and probabilities of different scenarios. Significant increases in lack of marketability discount and risk-free rate would result in a significantly lower fair value measurement. Significant decreases in expected volatility would result in a significantly lower fair value measurement. If the probabilities of redemption and liquidation scenarios are assumed to keep equal, significant increases in the probability of IPO scenario would result in a significantly lower fair value measurement. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company determined the fair value of their derivative liabilities by using binominal model. The determination of the fair value was based on estimates, judgments and information of other comparable public companies. The significant unobservable inputs adopted in the valuation as of March 31, 2022 and 2023 are as follows: </div> <div style="font-size: 10pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:67%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Spot price (US$)</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">0.44, 6.93</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">5.90</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free rate</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">1.25%, 2.5%</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">3.83%</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">57.95%, 48.15%</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">61.13%</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected expiry years (in years)</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">0.50, 3.56</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">2.60</td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The significant unobservable inputs used in the fair value measurement of the derivative liabilities include spot price, risk-free rate, expected volatility and expected expiry years. Significant decreases in spot price, risk-free rate, expected volatility and expected expiry years would result in a significantly lower fair value measurement. </div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the Company’s financial assets and liabilities measured and recorded at fair value on recurring basis as of March 31, 2022 and 2023: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:48%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">Fair value measurement at reporting date using</td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Description</div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">Fair value as of<br/> March 31, 2022</td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">Quoted price in<br/> active markets<br/> for identical<br/> assets (Level 1)</td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">Significant other<br/> observable Inputs<br/> (Level 2)</td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">Significant<br/> unobservable Inputs<br/> (Level 3)</td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">RMB</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">RMB</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">RMB</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">RMB</td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Assets:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Short-term investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">128,084</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">128,084</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Available-for-sale</div></div> debt investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,866</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,866</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equity securities with readily determinable fair values</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">670</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">670</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">203,620</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">670</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">128,084</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,866</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Liabilities:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Derivative liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,086</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,086</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:49%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">Fair value measurement at reporting date using</td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Description</div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">Fair value as of<br/> March 31, 2023</td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">Quoted price in<br/> active markets<br/> for identical<br/> assets (Level 1)</td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">Significant other<br/> observable Inputs<br/> (Level 2)</td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">Significant<br/> unobservable Inputs<br/> (Level 3)</td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">RMB</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">RMB</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">RMB</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">RMB</td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Assets:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Short-term investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">69,797</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">69,797</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Available-for-sale</div></div> debt investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68,011</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68,011</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equity securities with readily determinable fair values</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">102</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">102</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">137,910</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">102</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">69,797</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68,011</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Liabilities:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Derivative liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,701</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,701</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 128084000 128084000 74866000 74866000 670000 670000 203620000 670000 128084000 74866000 9086000 9086000 69797000 69797000 68011000 68011000 102000 102000 137910000 102000 69797000 68011000 10701000 10701000 <div style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The roll forward of major Level 3 investments are as following: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:71%"></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;">Derivative liabilities</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Available-for-sale</div></div><br/> debt investments</td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value of Level 3 investments as at March 31, 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,351</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">70,328</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">New addition</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,581</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Disposal of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-3</div> Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,377</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized fair value change of the derivative liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(11,559</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized fair value change of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,029</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value of Level 3 investments as at March 31, 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,996</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">71,357</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">New addition</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Reclassification of forward exchange contracts</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">746</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized fair value change of the derivative liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,656</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized fair value change of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(12,491</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value of Level 3 investments as at March 31, 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,086</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,866</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Reclassification of forward exchange contracts</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(651</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized fair value change of the derivative liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,266</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized fair value change of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,427</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Disposal of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(428</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value of Level 3 investments as at March 31, 2023</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,701</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68,011</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 14351000 70328000 9581000 2377000 -11559000 1029000 9996000 71357000 16000000 746000 -1656000 -12491000 9086000 74866000 -651000 2266000 -6427000 428000 10701000 68011000 <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company determined the fair value of their investments by using equity allocation model, market approach and binomial model. The determination of the fair value was based on estimates, judgments and information of other comparable public companies. The significant unobservable inputs adopted in the valuation as of March 31, 2022 and 2023: </div> <div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 32%;"></td> <td style="width: 2%; vertical-align: bottom;"></td> <td></td> <td style="width: 2%; vertical-align: bottom;"></td> <td></td> </tr> <tr style="font-size: 0px;"> <td style="width: 32%;"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 32%;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 2%;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 2%;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; width: 32%;"> <div style="text-indent: -1em; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em;">Implied price to sales after discount <br/>for lack of marketability</div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">n.a.</td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">1.04x</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; text-indent: 0px; width: 32%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average cost of capital</div> </td> <td style="vertical-align: bottom; text-indent: 0px; width: 2%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-indent: 0px;;text-align:center;">15<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>16.5<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>18<div style="letter-spacing: 0px; top: 0px;;display:inline;">%</div></td> <td style="vertical-align: bottom; text-indent: 0px; width: 2%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-indent: 0px;;text-align:center;">n.a.</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; text-indent: 0px; width: 32%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Lack of marketability discount</div> </td> <td style="vertical-align: bottom; text-indent: 0px; width: 2%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-indent: 0px;;text-align:center;">17<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>23<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>29<div style="letter-spacing: 0px; top: 0px;;display:inline;">%</div></td> <td style="vertical-align: bottom; text-indent: 0px; width: 2%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-indent: 0px;;text-align:center;">20%</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; text-indent: 0px; width: 32%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free rate</div> </td> <td style="vertical-align: bottom; text-indent: 0px; width: 2%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-indent: 0px;;text-align:center;">1.95<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>2.23<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>2.34<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>2.36<div style="letter-spacing: 0px; top: 0px;;display:inline;">%</div></td> <td style="vertical-align: bottom; text-indent: 0px; width: 2%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-indent: 0px;;text-align:center;">2.60<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>2.31<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>2.19%</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; text-indent: 0px; width: 32%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div> </td> <td style="vertical-align: bottom; text-indent: 0px; width: 2%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-indent: 0px;;text-align:center;">39.88<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>42.17<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>42.48<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>47.34<div style="letter-spacing: 0px; top: 0px;;display:inline;">%</div></td> <td style="vertical-align: bottom; text-indent: 0px; width: 2%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-indent: 0px;;text-align:center;">47.19<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>43.65<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>32.08%</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; text-indent: 0px; width: 32%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Probability</div> </td> <td style="vertical-align: bottom; text-indent: 0px; width: 2%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-indent: 0px;;text-align:center;">Liquidation scenario: 20% <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Redemption scenario: 40%</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">IPO scenario: 40%</div> </td> <td style="vertical-align: bottom; text-indent: 0px; width: 2%;">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-indent: 0px;;text-align:center;">Liquidation scenario: 35<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>40% <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;;text-indent: 0px;">Redemption scenario: 35<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>40%</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;;text-indent: 0px;">IPO scenario: 30<div style="letter-spacing: 0px; top: 0px;;display:inline;">%, </div>20%</div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> 1.04 15 16.5 18 17 23 29 20 1.95 2.23 2.34 2.36 2.6 2.31 2.19 39.88 42.17 42.48 47.34 47.19 43.65 32.08 20 40 40 35 40 35 40 30 20 The significant unobservable inputs adopted in the valuation as of March 31, 2022 and 2023 are as follows: <div style="font-size: 10pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:67%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Spot price (US$)</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">0.44, 6.93</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">5.90</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free rate</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">1.25%, 2.5%</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">3.83%</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">57.95%, 48.15%</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">61.13%</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected expiry years (in years)</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">0.50, 3.56</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">2.60</td> </tr> </table> 0.44 6.93 5.9 0.0125 0.025 0.0383 0.5795 0.4815 0.6113 P0Y6M P3Y6M21D P2Y7M6D <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">27.</div></div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Net loss per share </div></div> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Basic loss per share and diluted loss per share have been calculated in accordance with ASC 260 on computation of earnings per share for the years ended March 31, 2021, 2022 and 2023, respectively, as follows: </div> <div style="font-size: 10pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:67%"></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Numerator:</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net loss attributable to Boqii Holding Limited</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(194,444</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(128,390</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(102,799</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accretion on the Preferred Shares to redemption value (Note 20)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">120,873</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accretion on the Redeemable <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-controlling</div> interests to redemption value (Note 21)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(138</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(575</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(675</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deemed dividend to preferred shareholders</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(12,547</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net loss attributable to ordinary shareholders</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(86,256</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(128,965</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(103,474</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Denominator:</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average number of ordinary shares used in computing net loss per share, Basic and diluted (Note (a))</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">66,953,610</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68,006,172</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68,858,823</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net loss per share attributable to ordinary shareholders:</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.29</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.90</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.50</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Note (a): Options exercisable for a minimal exercise price (the “Penny Stock”) are included in the denominator of basic loss per share calculation once there are no further vesting conditions or contingencies associated with them, as they are considered issuable shares. Basic net loss per share is computed using the weighted average number of ordinary shares outstanding and the Penny Stock during the reporting periods. Diluted net loss per share is computed using the weighted average number of ordinary shares and dilutive potential ordinary shares outstanding and the Penny Stock during the reporting periods. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the years ended March 31, 2022 and 2023, assumed share options have not been reflected in the dilutive calculations pursuant to ASC 260, “Earnings Per Share,” due to the anti-dilutive effect. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following ordinary shares equivalent were excluded from the computation of diluted net loss per ordinary share for the periods presented because including them would have had an anti-dilutive effect: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:59%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; padding-bottom: 0.375pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Share options - weighted average</div> </td> <td style="vertical-align: bottom; padding-bottom: 0.375pt;">  </td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;"> </td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;">2,585,103</td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.375pt;">  </td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;"> </td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;">719,437</td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.375pt;">  </td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;"> </td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;">591,418</td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Basic loss per share and diluted loss per share have been calculated in accordance with ASC 260 on computation of earnings per share for the years ended March 31, 2021, 2022 and 2023, respectively, as follows: </div> <div style="font-size: 10pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:67%"></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Numerator:</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net loss attributable to Boqii Holding Limited</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(194,444</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(128,390</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(102,799</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accretion on the Preferred Shares to redemption value (Note 20)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">120,873</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accretion on the Redeemable <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-controlling</div> interests to redemption value (Note 21)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(138</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(575</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(675</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deemed dividend to preferred shareholders</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(12,547</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net loss attributable to ordinary shareholders</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(86,256</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(128,965</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(103,474</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Denominator:</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average number of ordinary shares used in computing net loss per share, Basic and diluted (Note (a))</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">66,953,610</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68,006,172</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68,858,823</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net loss per share attributable to ordinary shareholders:</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.29</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.90</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.50</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> -194444000 -128390000 -102799000 120873000 -138000 -575000 -675000 -12547000 -86256000 -128965000 -103474000 66953610 66953610 68006172 68006172 68858823 68858823 -1.29 -1.29 -1.9 -1.9 -1.5 -1.5 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following ordinary shares equivalent were excluded from the computation of diluted net loss per ordinary share for the periods presented because including them would have had an anti-dilutive effect: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:59%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; padding-bottom: 0.375pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Share options - weighted average</div> </td> <td style="vertical-align: bottom; padding-bottom: 0.375pt;">  </td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;"> </td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;">2,585,103</td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.375pt;">  </td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;"> </td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;">719,437</td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.375pt;">  </td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;"> </td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;">591,418</td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"> </td> </tr> </table> 2585103 719437 591418 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">28.</div></div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Related party transactions </div></div> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The table below sets forth the major related parties and their relationships with the Company as of March 31, 2021, 2022 and 2023: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:37%"></td> <td style="vertical-align:bottom;width:2%"></td> <td style="width:61%"></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Name of related parties</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Relationship with the Company</div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom">Nanjing Animal Pharmaceutical</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">An equity investee of the Company</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom">Wuhan Chunzhijin</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">An equity investee of the Company</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom">Weishi Network</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">An equity investee of the Company</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom">Beijing Petdog</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">An available-for-sale debt investee that the Company has significant influence</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; padding-left: 0.13in; text-indent: -0.13in;">Shanghai Guangcheng Information Technology (limited partnership) (“Shanghai Guangcheng Information”)</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top;white-space:nowrap">A company with a common director of the Company</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom">MERCHANT TYCOON LIMITED</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">A shareholder of the Company</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom">SUPERB ORIGIN INTERNATIONAL LIMITED</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">A shareholder of the Company</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom">Yingzhi (Lisa) Tang</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">Senior management of the Company</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom">Yan Jiang</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">Senior management of the Company</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom">Di (Jackie) Chen</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">Senior management of the Company until July, 2021</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom">Ying (Christina) Zhang</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">Senior management of the Company until February, 2022</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom">Fei Wang</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">Senior management of the Company until April, 2022</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom">Lijun Zhou</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">Senior management of the Company until April, 2022</td> </tr> </table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Details of related party transactions are as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:60%"></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Online marketing and information services</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Beijing Petdog</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">410</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weishi Network</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">410</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Purchase of merchandise</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weishi Network</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,582</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Nanjing Animal Pharmaceutical</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,020</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,402</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,602</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,402</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:60%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Loans granted to related parties</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shanghai Guangcheng Information (a)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">33,395</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Wuhan Chunzhijin (b)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,690</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,720</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">MERCHANT TYCOON LIMITED</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Yingzhi (Lisa) Tang</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Lijun Zhou</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">300</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Yan Jiang</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">70</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Nanjing Animal Pharmaceutical (c)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fei Wang</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,890</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">38,115</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,820</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div></div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(a)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">In April 2021, the Company granted Shanghai Guangcheng Information a short-term loan with a total principal amount of RMB33.4 million (equivalent to USD5 million), bearing an interest rate of <div style="display:inline;">3.5</div>% per annum. The loan was fully repaid by March 31, 2022. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(b)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company entered into a loan agreement with Wuhan Chunzhijin to provide Wuhan Chunzhijin with an interest-free loan of up to 10 million, which will be repaid on demand. In March 2023, the company converted RMB3.4 million loan to Wuhan Chunzhijin into equity interest. (Detail refer to Note 11) </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(c)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">In December 2019, Nanjing Xingmu, one of the Company’s subsidiaries, entered into a twelve-month interest free loan agreement with Nanjing Agricultural Pharmaceutical for a principal amount of RMB1 million. This loan was early repaid in May 2020. In June 2020, Nanjing Xingmu entered into another twelve-month interest free loan agreement with Nanjing Agricultural Pharmaceutical for a principal amount of RMB0.5 million. The loan was repaid in June 2021. </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Staff advances</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Yingzhi (Lisa) Tang</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Advances provided to related parties</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="font-size:1pt"> <td style="height:6pt"></td> <td colspan="4" style="height:6pt"></td> <td colspan="4" style="height:6pt"></td> <td colspan="4" style="height:6pt"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SUPERB ORIGIN INTERNATIONAL LIMITED</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,497</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Nanjing Animal Pharmaceutical</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,073</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">350</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,073</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,847</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Loans granted from related parties</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shanghai Guangcheng Information (a)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,961</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(a)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">In April 2021, the Company obtained a total loan facility up to USD5 million from Shanghai Guangcheng Information. During the year ended March 31, 2022, the Company drew down a total amount of USD1.5 million (equivalent to RMB10.0 million) from the loan facility, with interest bearing at 3.5% per annum. The loan was fully repaid by March 31, 2022. </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Details of related party balances are as follows: </div> <div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Amounts due from related parties </div></div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:70%"></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Prepayments to related parties</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SUPERB ORIGIN INTERNATIONAL LIMITED</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,497</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Nanjing Animal Pharmaceutical</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,650</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weishi Network</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,582</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,582</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,232</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,079</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Other receivables from related parties</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Wuhan Chunzhijin</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,594</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,988</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Loans to related parties</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Yan Jiang</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fei Wang (<div style="display:inline;">a</div>)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Lijun Zhou</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">MERCHANT TYCOON LIMITED</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">900</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">300</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(<div style="display:inline;">a</div>)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">In January 2021, the Company entered into a one-year loan agreement with Fei Wang, for a principal amount of RMB0.5 million, bearing an interest rate of 4% per annum. This loan was pledged by 515,000 stock options owned by Fei Wang. In December 2022, the loan contract was renewed to December 2023 and was recorded as prepayments and other current assets as of March 31, 2023. </div></td></tr></table> <div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Amounts due to related parties </div></div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:70%"></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Trade payables to related parties</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Nanjing Animal Pharmaceutical</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">219</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">471</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:70%"></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> <td></td> <td></td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The table below sets forth the major related parties and their relationships with the Company as of March 31, 2021, 2022 and 2023: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:37%"></td> <td style="vertical-align:bottom;width:2%"></td> <td style="width:61%"></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Name of related parties</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Relationship with the Company</div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom">Nanjing Animal Pharmaceutical</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">An equity investee of the Company</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom">Wuhan Chunzhijin</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">An equity investee of the Company</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom">Weishi Network</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">An equity investee of the Company</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom">Beijing Petdog</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">An available-for-sale debt investee that the Company has significant influence</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; padding-left: 0.13in; text-indent: -0.13in;">Shanghai Guangcheng Information Technology (limited partnership) (“Shanghai Guangcheng Information”)</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top;white-space:nowrap">A company with a common director of the Company</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom">MERCHANT TYCOON LIMITED</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">A shareholder of the Company</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom">SUPERB ORIGIN INTERNATIONAL LIMITED</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">A shareholder of the Company</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom">Yingzhi (Lisa) Tang</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">Senior management of the Company</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom">Yan Jiang</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">Senior management of the Company</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom">Di (Jackie) Chen</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">Senior management of the Company until July, 2021</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom">Ying (Christina) Zhang</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">Senior management of the Company until February, 2022</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom">Fei Wang</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">Senior management of the Company until April, 2022</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom">Lijun Zhou</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">Senior management of the Company until April, 2022</td> </tr> </table> Nanjing Animal Pharmaceutical An equity investee of the Company Wuhan Chunzhijin An equity investee of the Company Weishi Network An equity investee of the Company Beijing Petdog An available-for-sale debt investee that the Company has significant influence Shanghai Guangcheng Information Technology (limited partnership) (“Shanghai Guangcheng Information”) A company with a common director of the Company MERCHANT TYCOON LIMITED A shareholder of the Company SUPERB ORIGIN INTERNATIONAL LIMITED A shareholder of the Company Yingzhi (Lisa) Tang Senior management of the Company Yan Jiang Senior management of the Company Di (Jackie) Chen Senior management of the Company until July, 2021 Ying (Christina) Zhang Senior management of the Company until February, 2022 Fei Wang Senior management of the Company until April, 2022 Lijun Zhou Senior management of the Company until April, 2022 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:60%"></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Online marketing and information services</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Beijing Petdog</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">410</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weishi Network</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">410</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Purchase of merchandise</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weishi Network</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,582</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Nanjing Animal Pharmaceutical</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,020</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,402</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,602</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,402</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:60%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Loans granted to related parties</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shanghai Guangcheng Information (a)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">33,395</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Wuhan Chunzhijin (b)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,690</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,720</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">MERCHANT TYCOON LIMITED</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Yingzhi (Lisa) Tang</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Lijun Zhou</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">300</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Yan Jiang</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">70</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Nanjing Animal Pharmaceutical (c)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fei Wang</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,890</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">38,115</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,820</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div></div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(a)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">In April 2021, the Company granted Shanghai Guangcheng Information a short-term loan with a total principal amount of RMB33.4 million (equivalent to USD5 million), bearing an interest rate of <div style="display:inline;">3.5</div>% per annum. The loan was fully repaid by March 31, 2022. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(b)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company entered into a loan agreement with Wuhan Chunzhijin to provide Wuhan Chunzhijin with an interest-free loan of up to 10 million, which will be repaid on demand. In March 2023, the company converted RMB3.4 million loan to Wuhan Chunzhijin into equity interest. (Detail refer to Note 11) </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(c)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">In December 2019, Nanjing Xingmu, one of the Company’s subsidiaries, entered into a twelve-month interest free loan agreement with Nanjing Agricultural Pharmaceutical for a principal amount of RMB1 million. This loan was early repaid in May 2020. In June 2020, Nanjing Xingmu entered into another twelve-month interest free loan agreement with Nanjing Agricultural Pharmaceutical for a principal amount of RMB0.5 million. The loan was repaid in June 2021. </div></td></tr></table> 410000 19000 410000 19000 1582000 250000 1020000 1402000 250000 2602000 1402000 33395000 5690000 2600000 2720000 100000 1750000 300000 200000 70000 500000 500000 6890000 38115000 2820000 33400000 5000000 0.035 10000000 3400000 1000000 500000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Staff advances</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Yingzhi (Lisa) Tang</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Advances provided to related parties</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="font-size:1pt"> <td style="height:6pt"></td> <td colspan="4" style="height:6pt"></td> <td colspan="4" style="height:6pt"></td> <td colspan="4" style="height:6pt"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SUPERB ORIGIN INTERNATIONAL LIMITED</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,497</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Nanjing Animal Pharmaceutical</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,073</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">350</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,073</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,847</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Loans granted from related parties</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shanghai Guangcheng Information (a)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,961</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(a)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">In April 2021, the Company obtained a total loan facility up to USD5 million from Shanghai Guangcheng Information. During the year ended March 31, 2022, the Company drew down a total amount of USD1.5 million (equivalent to RMB10.0 million) from the loan facility, with interest bearing at 3.5% per annum. The loan was fully repaid by March 31, 2022. </div></td></tr></table> 10000 0 0 0 0 5497000 2073000 0 350000 2073000 0 5847000 0 9961000 0 5000000 1500000 10000000 0.035 <div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Amounts due from related parties </div></div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:70%"></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Prepayments to related parties</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SUPERB ORIGIN INTERNATIONAL LIMITED</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,497</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Nanjing Animal Pharmaceutical</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,650</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weishi Network</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,582</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,582</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,232</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,079</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Other receivables from related parties</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Wuhan Chunzhijin</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,594</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,988</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Loans to related parties</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Yan Jiang</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fei Wang (<div style="display:inline;">a</div>)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Lijun Zhou</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">MERCHANT TYCOON LIMITED</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">900</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">300</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(<div style="display:inline;">a</div>)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">In January 2021, the Company entered into a one-year loan agreement with Fei Wang, for a principal amount of RMB0.5 million, bearing an interest rate of 4% per annum. This loan was pledged by 515,000 stock options owned by Fei Wang. In December 2022, the loan contract was renewed to December 2023 and was recorded as prepayments and other current assets as of March 31, 2023. </div></td></tr></table> 0 5497000 1650000 2000000 1582000 1582000 3232000 9079000 7594000 2988000 200000 200000 500000 0 200000 0 0 100000 900000 300000 500000 0.04 515000 <div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Amounts due to related parties </div></div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:70%"></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RMB</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Trade payables to related parties</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Nanjing Animal Pharmaceutical</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">219</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">471</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 219000 471000 <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">29.</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Commitments and contingencies </div></div></td></tr></table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(a)</div></div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Capital commitments</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company’s capital commitments primarily relate to commitments on leasehold improvement and purchase of equipment. As of March 31, 2022 and 2023, no capital commitment was related to leasehold improvement and purchase of equipment. </div> <div style="font-size: 18pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(b)</div></div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Contingencies</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company is subject to legal proceedings and regulatory actions in the ordinary course of business. The results of such proceedings cannot be predicted with certainty, but the Company does not anticipate that the final outcome arising out of any such matter will have a material adverse effect on our consolidated financial position, cash flows or results of operations on an individual basis or in the aggregate. As of March 31, 2022 and 2023, the Company is not a party to any material legal or administrative proceedings. </div> 0 0 <div style="font-size: 18pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">30.</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Subsequent events </div></div></td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In April 2023, the Company and Nanjing Animal Pharmaceutical signed the Convertible Debt Release Agreement, in which Nanjing Animal Pharmaceutical would redeem part of the convertible debts from the Company. According to the agreement, Nanjing Animal Pharmaceutical repaid the Company the principal amount of RMB6 million, interest of RMB0.84 million, and an additional compensation of RMB1.06 million in April 2023. </div> 6000000 840000 1060000.00 <div style="font-size: 18pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">31.</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Restricted net assets </div></div></td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company’s ability to pay dividends may depend on the Company receiving distributions of funds from the Company’s subsidiaries and the VIEs incorporated in the PRC. Relevant PRC statutory laws and regulations permit payments of dividends by the Company’s PRC subsidiaries only out of their retained earnings, if any, as determined in accordance with PRC accounting standards and regulations. The results of operations reflected in the consolidated financial statements prepared in accordance with US GAAP differ from those reflected in the statutory financial statements of the Company’s PRC subsidiary. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In accordance with the Company law of the PRC, a domestic enterprise is required to provide statutory reserves of at least 10% of its annual <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">after-tax</div> profit until such reserve has reached 50% of its respective registered capital based on the enterprise’s PRC statutory accounts. A domestic enterprise is also required to provide discretionary surplus reserve, at the discretion of the Board of Directors, from the profits determined in accordance with the enterprise’s PRC statutory accounts. The aforementioned reserves can only be used for specific purposes and are not distributable as cash dividends. The Company’s PRC subsidiaries were established as domestic invested enterprises and therefore are subject to the above mentioned restrictions on distributable profits. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the years ended March 31, 2021, 2022 and 2023, appropriation to statutory reserves was made because two PRC subsidiaries had generated profits for these periods. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As a result of these PRC laws and regulations subject to the limit discussed above that require annual appropriations of 10% of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">after-tax</div> income to be set aside, prior to payment of dividends, as general reserve fund, the Company’s PRC subsidiaries are restricted in their ability to transfer a portion of their net assets to the Company. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Foreign exchange and other regulations in the PRC further restrict the Company’s PRC subsidiaries from transferring funds to the Company in the form of dividends, loans and advances. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of March 31, 2023, the total restricted net assets of the Company’s subsidiaries and the VIEs incorporated in the PRC and subjected to restriction amounted to nil. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Rules <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">12-04(a)</div> and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">4-08(e)(3)</div> of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X</div> require condensed financial information as to the financial position, cash flows and results of operations of a parent company as of and for the same periods for which the audited consolidated financial statements have been presented when the restricted net assets of the consolidated and unconsolidated subsidiaries together exceed 25% of consolidated net assets as of the end of the most recently completed fiscal year. The Company performed a test on the restricted net assets of consolidated subsidiaries in accordance <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Rule4-08</div> (e)(3) and concluded that it was not applicable for the Company to disclose the financial statements for the parent company since the 25% threshold was not met for the year ended March 31, 2023. </div> 10 50 10 0 0.25 0.25 EXCEL 163 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

O*7>)!Y%6J+0D6=1/3'T:!_(>"S<3Q" MO4>]>-RY-]06)V,H' WQ>Q'''5K] 'Z;2N-6[N%UBZJHS665SSE;IAN>\,51 MCEUE8)2:F!!K P<2:H ][\JKIL(?"/0P' 1OY1OV:\IJ"WG%\/ZS*JR(97M"*.57_PQ26#U+G-;;L@-+25(7SP4&E)]T1-AUYSBT3]W'WHKYGX7C4 MZPZW0[9UG&^\UY%[#]IR&I)J.V@QVS?X *GV3 [UO:4&7EV[Q1*D-_<1KHW0 M])"KV&]JQ""KV.#TV4IDC4D5!FC*J!I4J"OSTJDJJ67N]AMN>T<[^#[T>\]X MG/:4E2)AE6.7A.:I&E!KDYKZ:1$H(C;GOGC_KWA_?ZA!'/7& ]&/AG$?UTE_ MV+F65J<^Y73.P2B4X\8E*$69=]>S>UU .'Z&?-79;Z[M3NIG4&?8;\W'&^C> MJ#^S+?Y D60H?M[^''4JWO7Q=XJ+%YVW#;=@T&@GTT[BF@/(O9[6L\_IM<_:&J@ ZQ(TO/Z#$B?VR<#&H1ZP88V=[H&Z6-\ MZKZU5_-VP%W4";#=:DC:L8EXEE?9%HMWZ!0%4#5;1TY?$DX(@WTCG49!<__X M3TNLFV#EH3'GIU,0UYEV+Z@BT:9/AQ.B)>-)YVWM#AH>1GFZ6 M88IV$1?O*5$/YCA#?P$"@M$[DJ5EX-H) !\J:#E%17/;;T\@I$16BZ62=!23 MB2V1RZ55F8=8=A2G MFX=@M:2=.&JS3=O= @1T3E'E?5QHB-F!C6QBVZJIS"5+D"Q]+[)-S]I/DZN] MT7OW=>"/>?FR\Y'T2--J2>0.[R@1SU)9PB;XBA@:V%02]887(AX!G9/15DZK MA&4&-SG-G@^9!&8\F/29U<3)R\Y54\3CB4CZH*^FX!.S'1<,4.!8KP-"6H+. M ..BI#<1DT'2^46"R_T.4$#;\R 11"-1)Q=QY[VR]I(''*+&>!PE@S%GWF@4 MC4:4HF3Y85!L([56_.T327C)769>M"#%02WOCI##I?<(]_@0\_1[I0,,442G ME*W0G/!@B@;,+TZ'4=SO\1X@B@=4(;\5I0*=_!?4F)$?'M@/@7<$,M!PL#-$ M[LQ*Z)&T G!@;]OO6&CB'52ON)]51Z@B]8=FL[BW&5W(L @!&^=32"<>"4I5 MFD>P* =>1\DYFDSV>>!H.&@>M6E@%"HV\&&2322[SE:4FYG-R-6[!Q>^@'9-6RB&M%E:',ED\N: M>=94A0]D@K\G7?$K'UD 6@*)H?G2GSS1&Q7.1FWK3!J M98JCQXP^&S;DP8IP:X&>?M2RVG_=H]6F;8OQT@FL/5YGZX7:T0.#L ]<4C5X M"$5W@:PEG0GD^ALE"IM/![7\_CBJ6N]@&H7LJ)SV51,Z\ZQRZ!%TIBV6\AN9 M92OD4KWTUJ.-5M3+84O)E9>"B-7MG@N;Q>T?D:E'O.>VCM#[!L(=Z6BWJ#<% MAXD#_][-!!T14[[5G@OL.-W-$;\ EB(E2P=)0 &,4)!4..Q;>^G(T0@ M^-?*.N9LH6,=(6#!N.D\O6U"=[\][0/+T54Q M@3:+XW$WV8<) 'IWW#QD)M"DWU2EDE(9F43GL<^GTDY]AO2I=[0AC4)-U.%2 M^P%CG7P%'DM,?R08=I4'WS[JL\>N^& >F#"2V<=8L+:'-/'V29IXY$WRY)M= MFGBMYKHH*'<#-1%QG$3#/GKTX"*Z0",/G;6F[4\H',ZB$HQ%ZPUG47^4VCE5 MG &M]WLN"'X275P,F1J&]#HNFL^.9:!K_OS4@N9+3G>Y=?#FR!+1J->CP[XB MV[%PUS(1",.Q+W'GK:^D2U7.^5LP=7( N?]@VCQM/C=?^:^LV^'^6S6",*&PO=V]R:W-H965T%]=3(: MN:S 4KBAJ5#3S=K84GC:VLW(519%'I1*-4KC^'!4"JD'\[-P=FOG9Z;V2FJ\ MM>#JLA3VZ0*5V9X/DD%W\%UN"L\'H_E9)3:X1']7W5K:C7J47):HG30:+*[/ M!XODY&+"\D'@-XE;M[,&]F1ES#UOKO/S0HE(,1#1^M)B# MWB0K[JX[]*_!=_)E)1Q>&O6[S'UQ/C@:0(YK42O_W6Q_QM:?*>-E1KGP'[:- M;$+"6>V\*5ME8E!*W?R*QS8..PI'\1L*::N0!MZ-H<#R2G@Q/[-F"Y:E"8T7 MP=6@3>2DYJ0LO:5;27I^?F-SJ2D;L"R$Q;.1)TR^&66M_D6CG[ZAGZ3PS6A? M./BB<\Q? HR(3,\H[1A=I.\B?A-V".,D@C1.Q^_@C7L/QP%O_ ;>EQ^U]$_P MYV+EO*4B^&N?DPW$9#\$/XP35XD,SP=4^0[M P[F'S\DA_'I.P0G/<')>^C_ M(07OZN]GEQP/X24P+!R8-5!XLZ*+;QJ!+Q N35D)_02%R&$ZC6;Q<30]3N!2 M">=@ :;#<8SC0.@%U)N(GK*K,#Q& M]33;S)L56B8:OR2:T:]" M3^C2.[B^O0%J.RSP"S6G/Z@YP=*;[!Z^/&:%T!MDQV=1',?\!XN23&1"PQ56 MQDG?)\[!IX\?CM(T/EU<+5U8)J>?X9/4F:J9/"11/&U!2 *<43G456M\72L% M^(@VDRZ8Y,.:'JO=6NG1!L1D=@KF >V!4,IX:KH>3,5MD^R@H-18#+6E/=N+ MA[,I(QF-;Z3CW=\J5&:6G,JO %1D>BCI!9.N67 MPX1:J5+AJ["F$% ;S^LLN-8'AC>Y=!G#-,5%Z2VI>DBKV1NR99]=P4?Z4#IT M0[CK0M\6!-MIXT[4(J 8 SU3&0)!D:P<&X/*(4'(WSY>[)[OI:=T^+#;'KE V9G%Z\P2JIFKC A2LB;# MHZZ"&T*[1+H\AP(1.J.)ASVC8L50[4/8]]$:[B0*UZ3*S6( MIF.FHTW59A(5L;3?!.6!0V4:%F [M>& M@M]NV$ _HL[_ 5!+ P04 " !-./E67.: ?GH# -" &0 'AL+W=O MY3MP3V<>'"=26*M8P?;V=#]ZV_LI"$+NQ42+XU_S'SSS3?VN(M6FVM;(CKX M5DEEEU'I7'T>QY:76#$[T34JVLFUJ9BCJ2EB6QMD67"J9)Q.IR_CB@D5K19A M;6M6"]TX*11N#=BFJI@YK%'J=ADET7'A2A2E\POQ:E&S G?H/M5;0[-X0,E$ MA MU]*&7V@[V_F+"'ACG:YZ9V)0"=5]V;=>AY'#V?0!A[1W2 /O+E!@^1=S;+4P MN@7CK0G-#T*JP9O(">6+LG.&=@7YN=5&JQLT3NPEDL894LG]D JQHV#>)>8]\+H#3A\ 3E*XU,J5%MZH#+.[ #&Q'*BF1ZKK]"3B)3,3F"7/ M()VFLQ-XLR'U6<";/8"W<\PAG2\'.H>=T_RZU#)#8Y_ FZ^-< ?X[V)OG:&# M\^6^_#OT^?WH_C*=VYIQ7$8DID5S@]'J\:/DY?3U">[S@?O\%/KOE.TT<#J= MP"^"PS\EDFU5,W4 86WC=Y \F:2O$61!PO)?!!/*K]T(W5@X(#-V I]JNK:. M@G *(C'<8D+T*^^W'YX!D^- (_!QS)\"]0A'XBV:P8&,F,KH4EM1*!:F%C:2 M60L7H$TF%/6M(\[3O[5#2/[\8W)'".[-12[(V8?9#N%W0YY^O<+;6Z9(?,J MCS,C\:V6(@OAUTPRQ9%\Z7Y;V"-GC45O]YVX$ZJ@0RP/8P6:HW2:\X;">Q * MP!10@?R);YP5&?X@QN-'9VGRZK4-L(9ZT5.<%),[/$UH(YFPNY*M M<"61 *SVF%%?@1R9:WS,8+\7>6,X.U:2#->;M_V>0:X+)6XQ.T5A)[Q6]Y:. MY*>,Z4 ]'_%LZ8A<7:Z?)VE"_5E*RO.^^QV/6G2%I@@/D1>Z4:[KUL/J\-9= M="W^NWGW4%(?+(2R(#$GU^GD%3TMIGM\NHG3=6CX>^WH^0C#DMYK--Z ]G-- M)[>?^ ##/X#5_U!+ P04 " !-./E6?!>XV>$# H"0 &0 'AL+W=O M"8K$/M#2RB%"D2E)VO5_?(67+;F![^Q"'EYDSY\P,24TV2K^8 M'" MMU)(,PT*:ZO;,#1I@24S756AI)U,RF$W\ MVI.>351M!9?XI,'49WB[ZS]P9_<=R8HS$X)4NE7MSD(9L&D2.$ E/K$!C]6^,] M"N& B,;7'6;0AG2.Q^,]^GNOG;0LF<%[)?[FF2VFP3B #'-6"_NL-A]PIV?@ M\%(EC/^%36/;&P60UL:J*G>F\AQZ8KRV6K:Y>1G9\^8(95Y*1"DDM>IDE8K058KX-*B M1F/-)+04R=F'Z0YUT: F9U#C!!X)J3#P3F:8_0@0$L669[+GN4@N(CXRW85> MW($D2GH7\'JM[I['ZYW!^ZCDL=:'G5;X9[XT5E.O_'M*=8/9/XWISL^MJ5B* MTX .B$&]QF#V]DT\C.XN,.ZWC/N7T(\JU4"^*E>S>+%FE_&3N L7NN&+>D$) M'Y3(W.QW7G*+&?SR]LTX2:([O^O'\=VO'6"P*5 ZV M0+A79<7D%K@Q-1G$2=2)HHA.>1N?,IBCULZ[8"0)6*EJ:5UPJ^#Y<3&DXT#4 MZ&33G!$JU]EUQ;0E5+FF'"A- _B46K5$[1LGZL(?Q2EHC<>AF?4<24&&VHF* M1W<&5.6O$9[O4I$S+HR+G9(6@9;\X&O-!,\Y(3\\?7+1F0MVS58::>UU2NE: M\8&VR+0!="<%J,_3@AK=T6VZ/0$F,]_VG1]2IS%5*\G_(R>6IAH].THOI2;J MQOOD=)KY(5D.S"^-#B:4@PK]]2BV'2?)Q3DL^MR4C?PU$S7NJZC___( M<9& M986:*TJYI1(YBURKTM>?R10A8Y3 #;<%I2Q5V@57,FN02!S=NWM>)+8N:\%< M^]'URU-NNS WCM,^>2?S=H&L:XJ3;JR]DVMR;KRSAW$YR=J=W1;6&W=_5 E=<2L=TR81/^Z SCF[H M]Z8_@F%GD"17\^->^BFM<6\,@]$ AJ/!U;NF9@?X%AA&G?AF=.H>#(]>KQ+U MRK_1AKJ CGOSD+6K[6? O'G]#N;--P1I)X4&!.;D2CT^"$ W[W(SL:KR;^%2 M67I9_;"@3QG4SH#V&ULS5IM;]LX$OZ>7T%X MKXL$4!R]Q([;O !YN=[VT%Z"9GN+Q>$^T#)M\2J17I**D_[ZFR&I-UMVDVM[ MV ]I)9F<>68X\\R0TME*JL\Z8\R0QR(7^GR0&;-\7T9NK8QQO M!_R3LY5N71.T9"KE9[QY-SL?A B(Y2PU*('"?P_LFN4Y"@(8?WB9@UHE3FQ? M5]+?6MO!EBG5[%KFO_&9RT4690WU-"+,R571.%HD(87UE0[ M&\!Q@8MR;Q3\RF&>N;B2"F9PL= !D29C"DR:&DVHF,&5X@\4O49R3J<\YX8S M?79D0"_./DJ]CBNG(]ZB(XK)!RE,ILE?Q8S-N@*.0'V-.JY07\4[)7Z@:DB2 M*"!Q&"<[Y"6U%Q(K+]DB[P9L)C=$D.G.2-6E0!ING?*7,F"I+(HF$HYS2$5Q><:!A?: M<%-BGCLT7,SX Y^5-(=[3>2<0,BD614SL1V$P3/<@I"+-"]GK/UHQ4T&J6=* MQ*P P&15$"D:>&%5O]B[75*[=[WW\<$7@;^\*C&BKB)+C8'0+!K<^-Q,)J,R<\_3>(H/MW[51KP4C2.@B@> M5P+7]:WC[+@F *L8N9;%DHHG(J<&*)[-.LNS)@YD@56@+%0;$$-"W#6*N. .=&X7"T/G><#%_7SU8,\A-8+X>YBN;\"T": M/K51G9KM\MJ,SXB0I@XY]#;B M4=S* &,?F*!@S? YZU6*4H-QYB;0#FOII!&WKE=O# M$E'E6O QKKIN.$N_V?L=,ITP+&CK"[+MEZ3.^[?>PB<_$M>B88=#\AM0#21) MY :L)7%O9COOHLP91K&]YFBN Z$<$(*"0C-\XW@[@V,'F\DUO6ZG&KV1PG) M!9&OF3$YFPW);:L8M*\M&46GN&"'J2.S9W/C>PF4:EG_&I[LTP,T-3E):H9K M#(HQ*]06$AP)2^SL!O>&9!\-B\/3CC3[+#H]<-QE!>$R5)QU. >A M3B!M90(M9 F*P*^?[O]R/*XRVPEQ) D%PT:72XD4Y$X988_&Q2V?.[R66Z?2 MX\61C75.6D4%-$U1I[8>[#H$\-)6TF%H@ &0J!".2'6I7 C+X^ /C,X&/<1! M$C;$M._J!&#'8;YA( \T+UD5_5_UP8&UHA/&!:/8]4%%,#@+:BV"2:4V0W(# MC((MBD]6W9_Q_243LHX"MW=A 9ZN=_J,CI/1,-PHH2=-&5PO,FU">2'&5"H< MC0I:9=;KC%K5N*Z3[!&VA-JQ;,>6;D1PK4L0#,LT9TK9S@%H%-9.8JAY[L#X MLC$RQS8*KP 1@][-.QU]^&2SQB_P#H6U+=0+:3(:H%"1VBC9P//_B3K04K O M7ZB .DD@]-J%+H6VE4,#3:LNSROJXL1"^P3;=&<;%DST @YUA"455MFY:T=1 M:+',65OBN[M;A'&;&CF%04@Z0;\JU^64L/D$2*E-4\ (_9*Q60HK>)U3#3Q* MP.%S^SE!(2ZS5)=IMEA(WM-'%+'CJ5<'PW&.<\^JU-ZB6#M>]CC3H(( MGG<3D>S_0T+UC1/@:ZQ%/27JF=6A&O[5$N$'?FN=P%R/)_V%8O2R0E%!?T:U M\)'1XZ9OJAFO1]^:O%UW_+EJ1N4BSU2C3=9.6H'Z_2M%;QT K:/-7=]Q4S[Z MMF(OKA3WY9*I*;E5? 'K_@Z!"$LEX*3WO. 84%6.=,;Z] A:B>4B(@K#5Q4= MRY4 6@1C.E,/?&UJ)6YKD3;7Y8?5I.\?U3^J)G7\]S_4I!]5CT"A:%;$;3UK MY%V#-^UX82TJ(;.4N\ED#M?:[EM.3BM'MTM%>K"Y/[FMF3_P;G%#?@%IW$9: M-][MKU49@*T>68'>W$6U(R\^XPC0>]X[)0 .P'SV?J0.,EF6H)IJMEZ83(:% MI&XXNMK;\)_[=]M:_*2R%$_2/,Q&%18"<+$]N@%Z68,MV.HKT"W$ '_&53/( M+BZ-HABWC.'F$JS_W?2><3Y[1WMM0]:^SD!IKX-P,B8GP604XH' BBHPZA&@ MBX5-/WL K6T?X;>\$ J3474 X*9'87 21O6!@B^158&L,HU1@.)KJ#:JM$XQ M&=2NS!;:*9^#TZQK>\YQ(5;YD TA4HHIFV'J %:%+@2M:6/4G.$!#(/@DV7= MKQL+MIM<5MVD0>@<\J59SAE%2ETU(6P^=W5W[:BS8":3LR'YM 2GM=;1KUR_ M/N%]=E=S]+TC/.D.?9H=6^#ZP:VBFF6L^H)^=V-.@XW_@3&X8-!Z@F$EUYF3 MXCI)>YKIVML%! 6BR:7N!%&]79IQ< AX'")CRLR*,5'M!R0&MUT?F\(6?_MM M1@6YM8XPK!M]"T OL%EI-T\^@;8Y+J4ZPSI #]P1M4\OWQ=QNSK"O\=LN*Q- M59WF6D-3IGV%V\A9BEUU1>:L)W]MI&XH0!IZ)\C?2^$2\ 9RN/ EVQV4UON4 MN-LX5D3M2@?R]'P[V_DUG /1"_N>I_5J9TCNUKG;:>H=7>U+8&A=$6!//FD: M4MRA=SI6>-#T6'6XU%VJ: #[CC=N]]EX;C/>[(&3N/W,6.,>W<:'P0:PD:G\ MP>UX.#H>@0_A?^S64 ST\S$4*.G][WS<7H&XNP+)KFZ[ZJ>QI9D]6()T7F\? M741=.SI-4ROZ;:[U-:O1,&X$Z/:4QH/]KPR[6Y3>'4K0"\/3EN6W71%&[68^ M7-LVK5Q[YYOU%R)&]V(5>$(:ZK3A38UZ#J23G9"6-;4Z)G+O/GWUL%F/[X@@ M27='AO7=#C"V)_)G$USL3'37F(-ZMG*9UAZ<= ?2EX7EVMO!%\=E MV$[&[QR7R49#AJ?:Q2,+6PG^1H8JNX M^VZE?EI_]7/I/G9IAKM/AL#[L#'3)&=SF KI,QH0Y3[#<3=&+NVG+U#(8>]H M+S-& 2T.@-_G$O9@_@85U-]"7?P74$L#!!0 ( $TX^5;;GDO[B@, !P) M 9 >&PO=V]R:W-H965T5=8V=TEB\@IK9F+5H*0GI=(ULW34F\0T&EGAG6J1 MI(/!)*D9E]%BYG4/>C%3K15;0&&K>32-H,"2 MM<(^JMWOV.7SPN'E2AC_"[M@.QY%D+?&JKIS)@8UE^&??>WJ<.0P'5QP2#N' MU/,.@3S+5\RRQ4RK'6AG36A.\*EZ;R+'I6O*!ZOI*2<_NWC$'/F690*!.@S< MF);)'$&5H'3!)34*3,4TFEEB*9[S2O(.>Q6PTPO8PQ3NE;25@=>RP.(I0$)$ M>[;I@>TJO8IXSW0,H^$-I(-T= 5OU&<_\GBC"WBOO[3<[N&O96:LI@'Y^UR2 M 6)\'L*]-'>F83G.(WHK#.HM1HOGSX:3P=XQO.G*\U\XA6&DIE#/C"6!&N^C M$+/A.$Y[9AW;23P\J&[(WS3H[S9!U5D:YWR 3]KX?+JM?W5OPPWWG?S\-U N6ZX-""P)-=! M?/LB AWNXG"PJO'W7Z8LO0U>K.CS!;4SH.>E4O9P< 'Z#Z+%/U!+ P04 M" !-./E6O9]V;'X( ".%@ &0 'AL+W=O;!,$$#WZ>[3W0 OETI_-X40EKU496VN>H6UB_-^WV2% MJ+@)U4+4F)DI77&+H9[WS4(+GKM-5=F/HVC4K[BL>]>7[MVCOKY4C2UE+1XU M,TU5<;VZ%:5:7O4&O?6+KW)>6'K1O[Y<\+EX$O;;XE%CU.^DY+(2M9&J9EK, MKGHW@_/;(:UW"_XEQ=)L/3.R9*K4=QI\R:]Z$0$2I<@L2>#X]RSN1%F2(,#X M7RNSUZFDC=O/:^E_=;;#EBDWXDZ5?\C<%E>]<8_E8L:;TGY5R[^)UIZ4Y&6J M-.Z7+?W:8=)C66.LJMK-0%#)VO_G+ZT?MC:,HS;(:LQ+[[/53P;4X);MREJD*L3:#)?P]9[V4/#\NFW#DW"YZ)JQZ2 MPPC]+'K7O_PT&$47[R ?=LB'[TG_H2B]*^DPSG@8LK=4L(>:/8F%%=54:!:? M430&<6QQY+7[!.M_>6G<1Q'%VX)O77C MP<6OC--D1'#AQ784LL\O M&7Q\P,@#YAE12ZRK>,U;XBZ$-JJN1.&4Z0+/=T.ANV%)/@1ZZMS"0":0T%9"%<#RA7 M(?LGIF>J1$]R_G*&&6$=SVSA=N_*=^U#VI6+T0=1GY_\O7%I T:V-/C#M0G1 M>52PA9;P9_>>/PN-N (NM50"EZ&J4E5JD%56Z(K=S.=:S!$I<- BWD9F[)F7 MS0$I,RZUGSOY]O07UOZ=/#366* D\=P0O!T+!BP-4M SABU)"+:.PB1F\21( M1A%>Q..3SUM\."C 95U\<>S_R>]MQ#;AC'3,BH0EP628!DE* MN-,Q3!^FJ"TTBHY:D7S4"I\]MJW>59[8LM:H^LG+0-A]=K&R2=+E?DD3:M, %>$T/329""230<$F7 M%1*)X0!E))T,&;=[9'U5:W9+Q@(GQ>*TU04>9Q",2 MT=1:9&I>N_Y@WNJWXH6>!14L[TT4L\/E=;K:;E4[Q9R$9.WF*1633J]"96 < MJWRE.%U7"O00J7*"F89)6]S(!-#)C_;=\O"ZV+^JN0Y+A2[9:**%W8FE9T,. M&YV#G1S6F'7_NI6UJB1JGE?$'L$6FKM7N2A] ><&=XD61F,\!B_\4/_W[O-Z MS$X9/US%'7ANVC9ASD_^_=929%GK[F>%F,F2^L00Z1VSG]GIR5=IOI_.M'!I M Z'&,DU)- A'?L&Z0K *=PFY0*JB'O6Q?R,X1_/)H9NMI"AS%OU\H1.?^( ["6L&B36YY_;2@*B>L&O R!6QL0&N(GUZZ&+ 3HLVBF)5+? MO:XEPK>4Z)F<02JDT $($K-2P:*6%1L^$M(W#F@MOWUL]1M.>P>_=PTT8@[G M((_]6_@4,JL=!U=LJNK-*A>DF[']L5W?I= W$U05'9 MIR=BPI%ZGZ1OGM3WBW?0ZD#$Q#J&G/T#Y4;. M)+9\>7QP;9^R!>VXZS6<6HF+/#5^3.=RO=T1>,EU3B1Z+8H<]4K<0N,Z2>X M.W'H!TN<4H=*Y"'[1FQM(=V[;Y^^H%5"_?%<:JL595[+ 0* MM:8%F)\I9=<#4M!]@K[^/U!+ P04 " !-./E6H\W:EL # "D" &0 M 'AL+W=OY^FKJBAX6YJ6M"T4QK;<*2EK5+76N B!#4JS6:SF[3A M4B?K9; ]V_72=*BDAF?+7-D*Z7+:_@(^"G]MG2 M*AU1A&Q .VDTLU"NDH?Y_>;*^P>'SQ(.[N0W\Y7DQGSSBP]BE<.MD;]+076J^0N80)*WBGA.9_A%)#-)&3VA_*1[2T*RD.UX]-J\P1@.6@H93HEBD2K-], MBQYB$R&R5R#F&7LR&FO''K4 \5^ E/B,I+*!U":[B/C$[90MYA.6S;+%!;S% M6.0BX"U>P=N:AIK8\= '.U <0;"M<>C8/P^Y0TN]\>5D M*\>@WW?,E QIRRO(]?'MF[ML?OO>T1W.G1226TD^7 OV^<.C(T^.C%M@4A?& MML8&H:4.$,^[;=@#C1(5V=$PA[PLV0%4Z7=&,A2N.B%UQ1H0LN"*+*ZS7!

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end XML 164 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 165 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 166 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 432 632 1 false 155 0 false 12 false false R1.htm 1001 - Document - Cover Page Sheet http://Boqii.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - Consolidated Balance Sheets Sheet http://Boqii.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 1003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - Consolidated Statements of Loss and Comprehensive Loss Sheet http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss Consolidated Statements of Loss and Comprehensive Loss Statements 4 false false R5.htm 1005 - Statement - Consolidated Statements of Changes in Shareholders' Equity Sheet http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity Consolidated Statements of Changes in Shareholders' Equity Statements 5 false false R6.htm 1006 - Statement - Consolidated Statements of Cash Flows Sheet http://Boqii.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 1007 - Disclosure - Organization and principal activities Sheet http://Boqii.com/role/OrganizationAndPrincipalActivities Organization and principal activities Notes 7 false false R8.htm 1008 - Disclosure - Principal Accounting Policies Sheet http://Boqii.com/role/PrincipalAccountingPolicies Principal Accounting Policies Notes 8 false false R9.htm 1009 - Disclosure - Business combinations Sheet http://Boqii.com/role/BusinessCombinations Business combinations Notes 9 false false R10.htm 1010 - Disclosure - Risks and Concentration Sheet http://Boqii.com/role/RisksAndConcentration Risks and Concentration Notes 10 false false R11.htm 1011 - Disclosure - Cash and cash equivalents Sheet http://Boqii.com/role/CashAndCashEquivalents Cash and cash equivalents Notes 11 false false R12.htm 1012 - Disclosure - Accounts receivable, net Sheet http://Boqii.com/role/AccountsReceivableNet Accounts receivable, net Notes 12 false false R13.htm 1013 - Disclosure - Inventories, net of inventory reserves Sheet http://Boqii.com/role/InventoriesNetOfInventoryReserves Inventories, net of inventory reserves Notes 13 false false R14.htm 1014 - Disclosure - Prepayments and other current assets Sheet http://Boqii.com/role/PrepaymentsAndOtherCurrentAssets Prepayments and other current assets Notes 14 false false R15.htm 1015 - Disclosure - Property and equipment, net Sheet http://Boqii.com/role/PropertyAndEquipmentNet Property and equipment, net Notes 15 false false R16.htm 1016 - Disclosure - Intangible assets, net Sheet http://Boqii.com/role/IntangibleAssetsNet Intangible assets, net Notes 16 false false R17.htm 1017 - Disclosure - Long-Term Investments Sheet http://Boqii.com/role/LongTermInvestments Long-Term Investments Notes 17 false false R18.htm 1018 - Disclosure - Goodwill Sheet http://Boqii.com/role/Goodwill Goodwill Notes 18 false false R19.htm 1019 - Disclosure - Other non-current Assets Sheet http://Boqii.com/role/OtherNonCurrentAssets Other non-current Assets Notes 19 false false R20.htm 1020 - Disclosure - Accrued liabilities and other current liabilities Sheet http://Boqii.com/role/AccruedLiabilitiesAndOtherCurrentLiabilities Accrued liabilities and other current liabilities Notes 20 false false R21.htm 1021 - Disclosure - Leases Sheet http://Boqii.com/role/Leases Leases Notes 21 false false R22.htm 1022 - Disclosure - Interest expense Sheet http://Boqii.com/role/InterestExpense Interest expense Notes 22 false false R23.htm 1023 - Disclosure - Other gains, net Sheet http://Boqii.com/role/OtherGainsNet Other gains, net Notes 23 false false R24.htm 1024 - Disclosure - Income taxes Sheet http://Boqii.com/role/IncomeTaxes Income taxes Notes 24 false false R25.htm 1025 - Disclosure - Ordinary Share Sheet http://Boqii.com/role/OrdinaryShare Ordinary Share Notes 25 false false R26.htm 1026 - Disclosure - Convertible redeemable preferred shares Sheet http://Boqii.com/role/ConvertibleRedeemablePreferredShares Convertible redeemable preferred shares Notes 26 false false R27.htm 1027 - Disclosure - Redeemable non-controlling interests Sheet http://Boqii.com/role/RedeemableNonControllingInterests Redeemable non-controlling interests Notes 27 false false R28.htm 1028 - Disclosure - Borrowings, other debts and derivative liabilities Sheet http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilities Borrowings, other debts and derivative liabilities Notes 28 false false R29.htm 1029 - Disclosure - Receivable for issuance of ordinary shares Sheet http://Boqii.com/role/ReceivableForIssuanceOfOrdinaryShares Receivable for issuance of ordinary shares Notes 29 false false R30.htm 1030 - Disclosure - Share-based compensation Sheet http://Boqii.com/role/ShareBasedCompensation Share-based compensation Notes 30 false false R31.htm 1031 - Disclosure - Employee benefits Sheet http://Boqii.com/role/EmployeeBenefits Employee benefits Notes 31 false false R32.htm 1032 - Disclosure - Fair value measurements Sheet http://Boqii.com/role/FairValueMeasurements Fair value measurements Notes 32 false false R33.htm 1033 - Disclosure - Net loss per share Sheet http://Boqii.com/role/NetLossPerShare Net loss per share Notes 33 false false R34.htm 1034 - Disclosure - Related party transactions Sheet http://Boqii.com/role/RelatedPartyTransactions Related party transactions Notes 34 false false R35.htm 1035 - Disclosure - Commitments and contingencies Sheet http://Boqii.com/role/CommitmentsAndContingencies Commitments and contingencies Notes 35 false false R36.htm 1036 - Disclosure - Subsequent events Sheet http://Boqii.com/role/SubsequentEvents Subsequent events Notes 36 false false R37.htm 1037 - Disclosure - Restricted net assets Sheet http://Boqii.com/role/RestrictedNetAssets Restricted net assets Notes 37 false false R38.htm 1038 - Disclosure - Principal Accounting Policies (Policies) Sheet http://Boqii.com/role/PrincipalAccountingPoliciesPolicies Principal Accounting Policies (Policies) Policies http://Boqii.com/role/PrincipalAccountingPolicies 38 false false R39.htm 1039 - Disclosure - Organization and principal activities (Tables) Sheet http://Boqii.com/role/OrganizationAndPrincipalActivitiesTables Organization and principal activities (Tables) Tables http://Boqii.com/role/OrganizationAndPrincipalActivities 39 false false R40.htm 1040 - Disclosure - Principal Accounting Policies (Tables) Sheet http://Boqii.com/role/PrincipalAccountingPoliciesTables Principal Accounting Policies (Tables) Tables http://Boqii.com/role/PrincipalAccountingPolicies 40 false false R41.htm 1041 - Disclosure - Business combinations (Tables) Sheet http://Boqii.com/role/BusinessCombinationsTables Business combinations (Tables) Tables http://Boqii.com/role/BusinessCombinations 41 false false R42.htm 1042 - Disclosure - Risks and Concentration (Tables) Sheet http://Boqii.com/role/RisksAndConcentrationTables Risks and Concentration (Tables) Tables http://Boqii.com/role/RisksAndConcentration 42 false false R43.htm 1043 - Disclosure - Cash and cash equivalents (Tables) Sheet http://Boqii.com/role/CashAndCashEquivalentsTables Cash and cash equivalents (Tables) Tables http://Boqii.com/role/CashAndCashEquivalents 43 false false R44.htm 1044 - Disclosure - Accounts receivable, net (Tables) Sheet http://Boqii.com/role/AccountsReceivableNetTables Accounts receivable, net (Tables) Tables http://Boqii.com/role/AccountsReceivableNet 44 false false R45.htm 1045 - Disclosure - Inventories, net of inventory reserves (Tables) Sheet http://Boqii.com/role/InventoriesNetOfInventoryReservesTables Inventories, net of inventory reserves (Tables) Tables http://Boqii.com/role/InventoriesNetOfInventoryReserves 45 false false R46.htm 1046 - Disclosure - Prepayments and other current assets (Tables) Sheet http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsTables Prepayments and other current assets (Tables) Tables http://Boqii.com/role/PrepaymentsAndOtherCurrentAssets 46 false false R47.htm 1047 - Disclosure - Property and equipment, net (Tables) Sheet http://Boqii.com/role/PropertyAndEquipmentNetTables Property and equipment, net (Tables) Tables http://Boqii.com/role/PropertyAndEquipmentNet 47 false false R48.htm 1048 - Disclosure - Intangible assets, net (Tables) Sheet http://Boqii.com/role/IntangibleAssetsNetTables Intangible assets, net (Tables) Tables http://Boqii.com/role/IntangibleAssetsNet 48 false false R49.htm 1049 - Disclosure - Long-Term Investments (Tables) Sheet http://Boqii.com/role/LongTermInvestmentsTables Long-Term Investments (Tables) Tables http://Boqii.com/role/LongTermInvestments 49 false false R50.htm 1050 - Disclosure - Goodwill (Tables) Sheet http://Boqii.com/role/GoodwillTables Goodwill (Tables) Tables http://Boqii.com/role/Goodwill 50 false false R51.htm 1051 - Disclosure - Other non-current Assets (Tables) Sheet http://Boqii.com/role/OtherNonCurrentAssetsTables Other non-current Assets (Tables) Tables http://Boqii.com/role/OtherNonCurrentAssets 51 false false R52.htm 1052 - Disclosure - Accrued liabilities and other current liabilities (Tables) Sheet http://Boqii.com/role/AccruedLiabilitiesAndOtherCurrentLiabilitiesTables Accrued liabilities and other current liabilities (Tables) Tables http://Boqii.com/role/AccruedLiabilitiesAndOtherCurrentLiabilities 52 false false R53.htm 1053 - Disclosure - Leases (Tables) Sheet http://Boqii.com/role/LeasesTables Leases (Tables) Tables http://Boqii.com/role/Leases 53 false false R54.htm 1054 - Disclosure - Interest expense (Tables) Sheet http://Boqii.com/role/InterestExpenseTables Interest expense (Tables) Tables http://Boqii.com/role/InterestExpense 54 false false R55.htm 1055 - Disclosure - Other gains, net (Tables) Sheet http://Boqii.com/role/OtherGainsNetTables Other gains, net (Tables) Tables http://Boqii.com/role/OtherGainsNet 55 false false R56.htm 1056 - Disclosure - Income taxes (Tables) Sheet http://Boqii.com/role/IncomeTaxesTables Income taxes (Tables) Tables http://Boqii.com/role/IncomeTaxes 56 false false R57.htm 1057 - Disclosure - Redeemable non-controlling interests (Tables) Sheet http://Boqii.com/role/RedeemableNonControllingInterestsTables Redeemable non-controlling interests (Tables) Tables http://Boqii.com/role/RedeemableNonControllingInterests 57 false false R58.htm 1058 - Disclosure - Borrowings, other debts and derivative liabilities (Tables) Sheet http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesTables Borrowings, other debts and derivative liabilities (Tables) Tables http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilities 58 false false R59.htm 1059 - Disclosure - Share-based compensation (Tables) Sheet http://Boqii.com/role/ShareBasedCompensationTables Share-based compensation (Tables) Tables http://Boqii.com/role/ShareBasedCompensation 59 false false R60.htm 1060 - Disclosure - Fair value measurements (Tables) Sheet http://Boqii.com/role/FairValueMeasurementsTables Fair value measurements (Tables) Tables http://Boqii.com/role/FairValueMeasurements 60 false false R61.htm 1061 - Disclosure - Net loss per share (Tables) Sheet http://Boqii.com/role/NetLossPerShareTables Net loss per share (Tables) Tables http://Boqii.com/role/NetLossPerShare 61 false false R62.htm 1062 - Disclosure - Related party transactions (Tables) Sheet http://Boqii.com/role/RelatedPartyTransactionsTables Related party transactions (Tables) Tables http://Boqii.com/role/RelatedPartyTransactions 62 false false R63.htm 1063 - Disclosure - Organization and principal activities - Schedule of Details of the Subsidiaries, VIEs and VIE's Subsidiaries (Detail) Sheet http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail Organization and principal activities - Schedule of Details of the Subsidiaries, VIEs and VIE's Subsidiaries (Detail) Details 63 false false R64.htm 1064 - Disclosure - Organization and principal activities - Schedule of Variable Interest Entities (Detail) Sheet http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail Organization and principal activities - Schedule of Variable Interest Entities (Detail) Details 64 false false R65.htm 1065 - Disclosure - Organization and principal activities - Additional Information (Detail) Sheet http://Boqii.com/role/OrganizationAndPrincipalActivitiesAdditionalInformationDetail Organization and principal activities - Additional Information (Detail) Details 65 false false R66.htm 1066 - Disclosure - Principal Accounting Policies - Additional Information (Detail) Sheet http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail Principal Accounting Policies - Additional Information (Detail) Details 66 false false R67.htm 1067 - Disclosure - Principal Accounting Policies - Schedule of Property Plant And Equipment Useful Lives (Detail) Sheet http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfPropertyPlantAndEquipmentUsefulLivesDetail Principal Accounting Policies - Schedule of Property Plant And Equipment Useful Lives (Detail) Details 67 false false R68.htm 1068 - Disclosure - Principal Accounting Policies - Schedule of Finite Lived Intangible Assets Useful Lives (Detail) Sheet http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfFiniteLivedIntangibleAssetsUsefulLivesDetail Principal Accounting Policies - Schedule of Finite Lived Intangible Assets Useful Lives (Detail) Details 68 false false R69.htm 1069 - Disclosure - Business combinations - Summary of Identified Assets Acquired and Liabilities Assumed (Detail) Sheet http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail Business combinations - Summary of Identified Assets Acquired and Liabilities Assumed (Detail) Details 69 false false R70.htm 1070 - Disclosure - Business combinations - Summary of Identified Assets Acquired and Liabilities Assumed (Detail) (Parenthetical) Sheet http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetailParenthetical Business combinations - Summary of Identified Assets Acquired and Liabilities Assumed (Detail) (Parenthetical) Details 70 false false R71.htm 1071 - Disclosure - Business combinations - Additional Information (Detail) Sheet http://Boqii.com/role/BusinessCombinationsAdditionalInformationDetail Business combinations - Additional Information (Detail) Details 71 false false R72.htm 1072 - Disclosure - Risks and Concentration - Additional Information (Detail) Sheet http://Boqii.com/role/RisksAndConcentrationAdditionalInformationDetail Risks and Concentration - Additional Information (Detail) Details 72 false false R73.htm 1073 - Disclosure - Risks and Concentration - Schedules of Concentration of Risk, By Risk Factor (Detail) Sheet http://Boqii.com/role/RisksAndConcentrationSchedulesOfConcentrationOfRiskByRiskFactorDetail Risks and Concentration - Schedules of Concentration of Risk, By Risk Factor (Detail) Details 73 false false R74.htm 1074 - Disclosure - Cash and cash equivalents - Schedule of Cash And Cash Equivalents (Detail) Sheet http://Boqii.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetail Cash and cash equivalents - Schedule of Cash And Cash Equivalents (Detail) Details 74 false false R75.htm 1075 - Disclosure - Accounts receivable, net - Summary of Accounts Receivable Net (Detail) Sheet http://Boqii.com/role/AccountsReceivableNetSummaryOfAccountsReceivableNetDetail Accounts receivable, net - Summary of Accounts Receivable Net (Detail) Details 75 false false R76.htm 1076 - Disclosure - Accounts receivable, net - Summary of Movement of Allowance of Doubtful Accounts (Detail) Sheet http://Boqii.com/role/AccountsReceivableNetSummaryOfMovementOfAllowanceOfDoubtfulAccountsDetail Accounts receivable, net - Summary of Movement of Allowance of Doubtful Accounts (Detail) Details 76 false false R77.htm 1077 - Disclosure - Inventories, net of inventory reserves - Summary of Inventories, Net of Inventory Reserves (Detail) Sheet http://Boqii.com/role/InventoriesNetOfInventoryReservesSummaryOfInventoriesNetOfInventoryReservesDetail Inventories, net of inventory reserves - Summary of Inventories, Net of Inventory Reserves (Detail) Details 77 false false R78.htm 1078 - Disclosure - Inventories, net of inventory reserves - Summary of Movement of Inventory Provision (Detail) Sheet http://Boqii.com/role/InventoriesNetOfInventoryReservesSummaryOfMovementOfInventoryProvisionDetail Inventories, net of inventory reserves - Summary of Movement of Inventory Provision (Detail) Details 78 false false R79.htm 1079 - Disclosure - Inventories, net of inventory reserves - Additional Information (Detail) Sheet http://Boqii.com/role/InventoriesNetOfInventoryReservesAdditionalInformationDetail Inventories, net of inventory reserves - Additional Information (Detail) Details 79 false false R80.htm 1080 - Disclosure - Prepayments and other current assets - Summary of Prepayments and Other Current Assets (Detail) Sheet http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsSummaryOfPrepaymentsAndOtherCurrentAssetsDetail Prepayments and other current assets - Summary of Prepayments and Other Current Assets (Detail) Details 80 false false R81.htm 1081 - Disclosure - Prepayments and other current assets - Additional Information (Detail) Sheet http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsAdditionalInformationDetail Prepayments and other current assets - Additional Information (Detail) Details 81 false false R82.htm 1082 - Disclosure - Property and equipment, net - Summary of Property, Plant and Equipment's (Detail) Sheet http://Boqii.com/role/PropertyAndEquipmentNetSummaryOfPropertyPlantAndEquipmentsDetail Property and equipment, net - Summary of Property, Plant and Equipment's (Detail) Details 82 false false R83.htm 1083 - Disclosure - Property and equipment, net - Additional Information (Detail) Sheet http://Boqii.com/role/PropertyAndEquipmentNetAdditionalInformationDetail Property and equipment, net - Additional Information (Detail) Details 83 false false R84.htm 1084 - Disclosure - Intangible assets, net - Schedule of Intangible Assets (Detail) Sheet http://Boqii.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsDetail Intangible assets, net - Schedule of Intangible Assets (Detail) Details 84 false false R85.htm 1085 - Disclosure - Intangible assets, net - Schedule of Annual Estimated Amortization Expense for Intangible Assets (Detail) Sheet http://Boqii.com/role/IntangibleAssetsNetScheduleOfAnnualEstimatedAmortizationExpenseForIntangibleAssetsDetail Intangible assets, net - Schedule of Annual Estimated Amortization Expense for Intangible Assets (Detail) Details 85 false false R86.htm 1086 - Disclosure - Intangible assets, net - Additional Information (Detail) Sheet http://Boqii.com/role/IntangibleAssetsNetAdditionalInformationDetail Intangible assets, net - Additional Information (Detail) Details 86 false false R87.htm 1087 - Disclosure - Long-Term Investments - Summary of Long-Term Investment (Detail) Sheet http://Boqii.com/role/LongTermInvestmentsSummaryOfLongTermInvestmentDetail Long-Term Investments - Summary of Long-Term Investment (Detail) Details 87 false false R88.htm 1088 - Disclosure - Long-Term Investments - Summary of Available-For-Sale Debt Investments (Detail) Sheet http://Boqii.com/role/LongTermInvestmentsSummaryOfAvailableForSaleDebtInvestmentsDetail Long-Term Investments - Summary of Available-For-Sale Debt Investments (Detail) Details 88 false false R89.htm 1089 - Disclosure - Long-Term Investments - Summary Of Equity Securities With Readily Determinable Fair Values (Detail) Sheet http://Boqii.com/role/LongTermInvestmentsSummaryOfEquitySecuritiesWithReadilyDeterminableFairValuesDetail Long-Term Investments - Summary Of Equity Securities With Readily Determinable Fair Values (Detail) Details 89 false false R90.htm 1090 - Disclosure - Long-Term Investments - Additional Information (Detail) Sheet http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail Long-Term Investments - Additional Information (Detail) Details 90 false false R91.htm 1091 - Disclosure - Goodwill - Schedule of Changes in the Carrying Amount of Goodwill (Detail) Sheet http://Boqii.com/role/GoodwillScheduleOfChangesInTheCarryingAmountOfGoodwillDetail Goodwill - Schedule of Changes in the Carrying Amount of Goodwill (Detail) Details 91 false false R92.htm 1092 - Disclosure - Goodwill - Additional Information (Detail) Sheet http://Boqii.com/role/GoodwillAdditionalInformationDetail Goodwill - Additional Information (Detail) Details 92 false false R93.htm 1093 - Disclosure - Other non-current Assets - Schedule of Other Non-current Assets (Detail) Sheet http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsDetail Other non-current Assets - Schedule of Other Non-current Assets (Detail) Details 93 false false R94.htm 1094 - Disclosure - Other non-current Assets - Schedule of Other Non-current Assets (Parenthetical) (Detail) Sheet http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsParentheticalDetail Other non-current Assets - Schedule of Other Non-current Assets (Parenthetical) (Detail) Details 94 false false R95.htm 1095 - Disclosure - Accrued liabilities and other current liabilities - Schedule of Accrued Liabilities and Other Current Liabilities (Detail) Sheet http://Boqii.com/role/AccruedLiabilitiesAndOtherCurrentLiabilitiesScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesDetail Accrued liabilities and other current liabilities - Schedule of Accrued Liabilities and Other Current Liabilities (Detail) Details 95 false false R96.htm 1096 - Disclosure - Leases - Summary of Operating Leases (Detail) Sheet http://Boqii.com/role/LeasesSummaryOfOperatingLeasesDetail Leases - Summary of Operating Leases (Detail) Details 96 false false R97.htm 1097 - Disclosure - Leases - Summary of Operating Lease Activity (Detail) Sheet http://Boqii.com/role/LeasesSummaryOfOperatingLeaseActivityDetail Leases - Summary of Operating Lease Activity (Detail) Details 97 false false R98.htm 1098 - Disclosure - Leases - Summary of Maturities of Lease Liabilities (Detail) Sheet http://Boqii.com/role/LeasesSummaryOfMaturitiesOfLeaseLiabilitiesDetail Leases - Summary of Maturities of Lease Liabilities (Detail) Details 98 false false R99.htm 1099 - Disclosure - Interest expense - Summary of Interest Expense (Detail) Sheet http://Boqii.com/role/InterestExpenseSummaryOfInterestExpenseDetail Interest expense - Summary of Interest Expense (Detail) Details 99 false false R100.htm 1100 - Disclosure - Other gains, net - Summary of Other (Losses), Net (Detail) Sheet http://Boqii.com/role/OtherGainsNetSummaryOfOtherLossesNetDetail Other gains, net - Summary of Other (Losses), Net (Detail) Details 100 false false R101.htm 1101 - Disclosure - Other gains, net - Summary of Other (Losses), Net (Parenthetical) (Detail) Sheet http://Boqii.com/role/OtherGainsNetSummaryOfOtherLossesNetParentheticalDetail Other gains, net - Summary of Other (Losses), Net (Parenthetical) (Detail) Details 101 false false R102.htm 1102 - Disclosure - Income taxes - Schedule of Effective Income Tax Rate Reconciliation (Detail) Sheet http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail Income taxes - Schedule of Effective Income Tax Rate Reconciliation (Detail) Details 102 false false R103.htm 1103 - Disclosure - Income taxes - Schedule of Effective Income Tax Rate Reconciliation (Parenthetical) (Detail) Sheet http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationParentheticalDetail Income taxes - Schedule of Effective Income Tax Rate Reconciliation (Parenthetical) (Detail) Details 103 false false R104.htm 1104 - Disclosure - Income taxes - Summary of Income Tax Holiday (Detail) Sheet http://Boqii.com/role/IncomeTaxesSummaryOfIncomeTaxHolidayDetail Income taxes - Summary of Income Tax Holiday (Detail) Details 104 false false R105.htm 1105 - Disclosure - Income taxes - Schedule of Components of Income Tax Expenses Benefit (Detail) Sheet http://Boqii.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpensesBenefitDetail Income taxes - Schedule of Components of Income Tax Expenses Benefit (Detail) Details 105 false false R106.htm 1106 - Disclosure - Income taxes - Schedule of Deferred Tax Assets And Tax Liabilities (Detail) Sheet http://Boqii.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndTaxLiabilitiesDetail Income taxes - Schedule of Deferred Tax Assets And Tax Liabilities (Detail) Details 106 false false R107.htm 1107 - Disclosure - Income taxes - Summary of Valuation Allowance (Detail) Sheet http://Boqii.com/role/IncomeTaxesSummaryOfValuationAllowanceDetail Income taxes - Summary of Valuation Allowance (Detail) Details 107 false false R108.htm 1108 - Disclosure - Income taxes - Additional Information (Detail) Sheet http://Boqii.com/role/IncomeTaxesAdditionalInformationDetail Income taxes - Additional Information (Detail) Details 108 false false R109.htm 1109 - Disclosure - Ordinary Share - Additional Information (Detail) Sheet http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail Ordinary Share - Additional Information (Detail) Details 109 false false R110.htm 1110 - Disclosure - Convertible redeemable preferred shares - Additional Information (Detail) Sheet http://Boqii.com/role/ConvertibleRedeemablePreferredSharesAdditionalInformationDetail Convertible redeemable preferred shares - Additional Information (Detail) Details 110 false false R111.htm 1111 - Disclosure - Redeemable non-controlling interests - Additional Information (Detail) Sheet http://Boqii.com/role/RedeemableNonControllingInterestsAdditionalInformationDetail Redeemable non-controlling interests - Additional Information (Detail) Details 111 false false R112.htm 1112 - Disclosure - Redeemable non-controlling interests - Schedule Of Redeemable Non-Controlling Interests Activity (Detail) Sheet http://Boqii.com/role/RedeemableNonControllingInterestsScheduleOfRedeemableNonControllingInterestsActivityDetail Redeemable non-controlling interests - Schedule Of Redeemable Non-Controlling Interests Activity (Detail) Details 112 false false R113.htm 1113 - Disclosure - Borrowings, other debts and derivative liabilities - Summary of Short-term Debt (Detail) Sheet http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfShortTermDebtDetail Borrowings, other debts and derivative liabilities - Summary of Short-term Debt (Detail) Details 113 false false R114.htm 1114 - Disclosure - Borrowings, other debts and derivative liabilities - Additional Information (Detail) Sheet http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail Borrowings, other debts and derivative liabilities - Additional Information (Detail) Details 114 false false R115.htm 1115 - Disclosure - Borrowings, other debts and derivative liabilities - Summary of Maturities of Long-term Debt (Detail) Sheet http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfMaturitiesOfLongTermDebtDetail Borrowings, other debts and derivative liabilities - Summary of Maturities of Long-term Debt (Detail) Details 115 false false R116.htm 1116 - Disclosure - Borrowings, other debts and derivative liabilities - Summary of Other Long Term Debt (Detail) Sheet http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfOtherLongTermDebtDetail Borrowings, other debts and derivative liabilities - Summary of Other Long Term Debt (Detail) Details 116 false false R117.htm 1117 - Disclosure - Borrowings, other debts and derivative liabilities - Summary of Fair Value of Derivative Liabilities (Detail) Sheet http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfFairValueOfDerivativeLiabilitiesDetail Borrowings, other debts and derivative liabilities - Summary of Fair Value of Derivative Liabilities (Detail) Details 117 false false R118.htm 1118 - Disclosure - Receivable for issuance of ordinary shares - Additional Information (Detail) Sheet http://Boqii.com/role/ReceivableForIssuanceOfOrdinarySharesAdditionalInformationDetail Receivable for issuance of ordinary shares - Additional Information (Detail) Details 118 false false R119.htm 1119 - Disclosure - Share-based compensation - Summary of Stock Option Activity (Detail) Sheet http://Boqii.com/role/ShareBasedCompensationSummaryOfStockOptionActivityDetail Share-based compensation - Summary of Stock Option Activity (Detail) Details 119 false false R120.htm 1120 - Disclosure - Share-based compensation - Summary of Options Measured At Fair Value, Valuation Assumptions (Detail) Sheet http://Boqii.com/role/ShareBasedCompensationSummaryOfOptionsMeasuredAtFairValueValuationAssumptionsDetail Share-based compensation - Summary of Options Measured At Fair Value, Valuation Assumptions (Detail) Details 120 false false R121.htm 1121 - Disclosure - Share-based compensation - Additional Information (Detail) Sheet http://Boqii.com/role/ShareBasedCompensationAdditionalInformationDetail Share-based compensation - Additional Information (Detail) Details 121 false false R122.htm 1122 - Disclosure - Employee benefits - Additional Information (Detail) Sheet http://Boqii.com/role/EmployeeBenefitsAdditionalInformationDetail Employee benefits - Additional Information (Detail) Details 122 false false R123.htm 1123 - Disclosure - Fair value measurements - Summary of Company's Financial Assets and Liabilities (Detail) Sheet http://Boqii.com/role/FairValueMeasurementsSummaryOfCompanySFinancialAssetsAndLiabilitiesDetail Fair value measurements - Summary of Company's Financial Assets and Liabilities (Detail) Details 123 false false R124.htm 1124 - Disclosure - Fair value measurements - Summary of Roll Forward of Major Level 3 Investments (Detail) Sheet http://Boqii.com/role/FairValueMeasurementsSummaryOfRollForwardOfMajorLevel3InvestmentsDetail Fair value measurements - Summary of Roll Forward of Major Level 3 Investments (Detail) Details 124 false false R125.htm 1125 - Disclosure - Fair value measurements - Summary of Significant Unobservable Inputs (Detail) Sheet http://Boqii.com/role/FairValueMeasurementsSummaryOfSignificantUnobservableInputsDetail Fair value measurements - Summary of Significant Unobservable Inputs (Detail) Details 125 false false R126.htm 1126 - Disclosure - Fair value measurements - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Detail) Sheet http://Boqii.com/role/FairValueMeasurementsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail Fair value measurements - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Detail) Details 126 false false R127.htm 1127 - Disclosure - Net Loss per share - Schedule of Earnings Per Share, Basic and Diluted (Detail) Sheet http://Boqii.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail Net Loss per share - Schedule of Earnings Per Share, Basic and Diluted (Detail) Details 127 false false R128.htm 1128 - Disclosure - Net Loss per share - Schedule of Antidilutive Securities Excluded From Computation of Earnings Per Share (Detail) Sheet http://Boqii.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail Net Loss per share - Schedule of Antidilutive Securities Excluded From Computation of Earnings Per Share (Detail) Details 128 false false R129.htm 1129 - Disclosure - Related party transactions - Summary of Major Related Parties and Their Relationships With The Company (Detail) Sheet http://Boqii.com/role/RelatedPartyTransactionsSummaryOfMajorRelatedPartiesAndTheirRelationshipsWithTheCompanyDetail Related party transactions - Summary of Major Related Parties and Their Relationships With The Company (Detail) Details 129 false false R130.htm 1130 - Disclosure - Related party transactions - Summary of Related Party Transactions And Balances (Detail) Sheet http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesDetail Related party transactions - Summary of Related Party Transactions And Balances (Detail) Details 130 false false R131.htm 1131 - Disclosure - Related party transactions - Summary of Related Party Transactions And Balances (Parenthetical) (Detail) Sheet http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesParentheticalDetail Related party transactions - Summary of Related Party Transactions And Balances (Parenthetical) (Detail) Details 131 false false R132.htm 1132 - Disclosure - Related party transactions - Summary of Related Party Transaction (Detail) Sheet http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionDetail Related party transactions - Summary of Related Party Transaction (Detail) Details 132 false false R133.htm 1133 - Disclosure - Related party transactions - Summary of Related Party Transaction (Parenthetical) (Detail) Sheet http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionParentheticalDetail Related party transactions - Summary of Related Party Transaction (Parenthetical) (Detail) Details 133 false false R134.htm 1134 - Disclosure - Related party transactions - Summary of Transactions Due From Related Parties (Detail) Sheet http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesDetail Related party transactions - Summary of Transactions Due From Related Parties (Detail) Details 134 false false R135.htm 1135 - Disclosure - Related party transactions - Summary of Transactions Due From Related Parties (Parenthetical) (Detail) Sheet http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesParentheticalDetail Related party transactions - Summary of Transactions Due From Related Parties (Parenthetical) (Detail) Details 135 false false R136.htm 1136 - Disclosure - Related party transactions - Summary of Transactions Due To Related Parties (Detail) Sheet http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueToRelatedPartiesDetail Related party transactions - Summary of Transactions Due To Related Parties (Detail) Details 136 false false R137.htm 1137 - Disclosure - Commitments and contingencies - Additional Information (Detail) Sheet http://Boqii.com/role/CommitmentsAndContingenciesAdditionalInformationDetail Commitments and contingencies - Additional Information (Detail) Details 137 false false R138.htm 1138 - Disclosure - Subsequent events - Additional Information (Detail) Sheet http://Boqii.com/role/SubsequentEventsAdditionalInformationDetail Subsequent events - Additional Information (Detail) Details 138 false false R139.htm 1139 - Disclosure - Restricted net assets - Additional Information (Detail) Sheet http://Boqii.com/role/RestrictedNetAssetsAdditionalInformationDetail Restricted net assets - Additional Information (Detail) Details 139 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept DueFromRelatedPartiesCurrent in us-gaap/2022 used in 5 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. d290954d20f.htm 17670, 17674, 17678, 25038, 25042 [dq-0542-Deprecated-Concept] Concept DueFromRelatedPartiesNoncurrent in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. d290954d20f.htm 17834, 17838 [dq-0542-Deprecated-Concept] Concept DueToRelatedPartiesCurrent in us-gaap/2022 used in 7 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. d290954d20f.htm 18033, 18038, 18042, 18046, 25220, 25224 [dq-0542-Deprecated-Concept] Concept PropertyPlantAndEquipmentEstimatedUsefulLives in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. d290954d20f.htm 26098 [dq-0542-Deprecated-Concept] Concept DueToOfficersOrStockholdersNoncurrent in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. d290954d20f.htm 30264 [dq-0542-Deprecated-Concept] Concept AccountsPayableRelatedPartiesCurrent in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. d290954d20f.htm 32776, 32780 [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 9 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName, us-gaap:VariableInterestEntityQualitativeOrQuantitativeInformationDateInvolvementBegan1 - d290954d20f.htm 9, 17461 d290954d20f.htm bq-20230331.xsd bq-20230331_cal.xml bq-20230331_def.xml bq-20230331_lab.xml bq-20230331_pre.xml d290954dex121.htm d290954dex122.htm d290954dex131.htm d290954dex132.htm d290954dex151.htm d290954dex152.htm d290954dex153.htm d290954dex154.htm d290954dex24.htm d290954dex425.htm d290954dex81.htm g290954g00a01.jpg g290954g0717053118747.jpg g290954g0717053118958.jpg g290954g0717053119066.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 169 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d290954d20f.htm": { "axisCustom": 10, "axisStandard": 40, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 1486, "http://xbrl.sec.gov/dei/2022": 57 }, "contextCount": 432, "dts": { "calculationLink": { "local": [ "bq-20230331_cal.xml" ] }, "definitionLink": { "local": [ "bq-20230331_def.xml" ] }, "inline": { "local": [ "d290954d20f.htm" ] }, "labelLink": { "local": [ "bq-20230331_lab.xml" ] }, "presentationLink": { "local": [ "bq-20230331_pre.xml" ] }, "schema": { "local": [ "bq-20230331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 1033, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 10, "http://xbrl.sec.gov/dei/2022": 13, "total": 23 }, "keyCustom": 163, "keyStandard": 469, "memberCustom": 99, "memberStandard": 51, "nsprefix": "bq", "nsuri": "http://Boqii.com/20230331", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "1001 - Document - Cover Page", "menuCat": "Cover", "order": "1", "role": "http://Boqii.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1010 - Disclosure - Risks and Concentration", "menuCat": "Notes", "order": "10", "role": "http://Boqii.com/role/RisksAndConcentration", "shortName": "Risks and Concentration", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R100": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1100 - Disclosure - Other gains, net - Summary of Other (Losses), Net (Detail)", "menuCat": "Details", "order": "100", "role": "http://Boqii.com/role/OtherGainsNetSummaryOfOtherLossesNetDetail", "shortName": "Other gains, net - Summary of Other (Losses), Net (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2021To03_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R101": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-6", "first": true, "lang": null, "name": "bq:ReimbursementDepositaryReceived", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1101 - Disclosure - Other gains, net - Summary of Other (Losses), Net (Parenthetical) (Detail)", "menuCat": "Details", "order": "101", "role": "http://Boqii.com/role/OtherGainsNetSummaryOfOtherLossesNetParentheticalDetail", "shortName": "Other gains, net - Summary of Other (Losses), Net (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-6", "first": true, "lang": null, "name": "bq:ReimbursementDepositaryReceived", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R102": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "reportCount": 1, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1102 - Disclosure - Income taxes - Schedule of Effective Income Tax Rate Reconciliation (Detail)", "menuCat": "Details", "order": "102", "role": "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail", "shortName": "Income taxes - Schedule of Effective Income Tax Rate Reconciliation (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-3", "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R103": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment", "reportCount": 1, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1103 - Disclosure - Income taxes - Schedule of Effective Income Tax Rate Reconciliation (Parenthetical) (Detail)", "menuCat": "Details", "order": "103", "role": "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationParentheticalDetail", "shortName": "Income taxes - Schedule of Effective Income Tax Rate Reconciliation (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023_TaxYear2018MemberusgaapTaxPeriodAxis", "decimals": "2", "lang": null, "name": "bq:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentPercentage", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R104": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:SummaryOfIncomeTaxHolidayTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "bq:EffectiveOfIncomeTaxHolidayAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1104 - Disclosure - Income taxes - Summary of Income Tax Holiday (Detail)", "menuCat": "Details", "order": "104", "role": "http://Boqii.com/role/IncomeTaxesSummaryOfIncomeTaxHolidayDetail", "shortName": "Income taxes - Summary of Income Tax Holiday (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:SummaryOfIncomeTaxHolidayTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "bq:EffectiveOfIncomeTaxHolidayAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R105": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CurrentIncomeTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1105 - Disclosure - Income taxes - Schedule of Components of Income Tax Expenses Benefit (Detail)", "menuCat": "Details", "order": "105", "role": "http://Boqii.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpensesBenefitDetail", "shortName": "Income taxes - Schedule of Components of Income Tax Expenses Benefit (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CurrentIncomeTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R106": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1106 - Disclosure - Income taxes - Schedule of Deferred Tax Assets And Tax Liabilities (Detail)", "menuCat": "Details", "order": "106", "role": "http://Boqii.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndTaxLiabilitiesDetail", "shortName": "Income taxes - Schedule of Deferred Tax Assets And Tax Liabilities (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R107": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsValuationAllowance", "reportCount": 1, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1107 - Disclosure - Income taxes - Summary of Valuation Allowance (Detail)", "menuCat": "Details", "order": "107", "role": "http://Boqii.com/role/IncomeTaxesSummaryOfValuationAllowanceDetail", "shortName": "Income taxes - Summary of Valuation Allowance (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:SummaryOfValuationAllowanceTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-3", "lang": null, "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R108": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1108 - Disclosure - Income taxes - Additional Information (Detail)", "menuCat": "Details", "order": "108", "role": "http://Boqii.com/role/IncomeTaxesAdditionalInformationDetail", "shortName": "Income taxes - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P07_25_2018To07_25_2018", "decimals": null, "lang": "en-US", "name": "us-gaap:IncomeTaxHolidayDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R109": { "firstAnchor": { "ancestors": [ "div", "bq:OrdinaryShareTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P10_01_2020To10_31_2020", "decimals": "2", "first": true, "lang": null, "name": "bq:NumberOfSharesPerAds", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1109 - Disclosure - Ordinary Share - Additional Information (Detail)", "menuCat": "Details", "order": "109", "role": "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail", "shortName": "Ordinary Share - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "bq:OrdinaryShareTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P10_01_2020To10_31_2020", "decimals": "2", "first": true, "lang": null, "name": "bq:NumberOfSharesPerAds", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1011 - Disclosure - Cash and cash equivalents", "menuCat": "Notes", "order": "11", "role": "http://Boqii.com/role/CashAndCashEquivalents", "shortName": "Cash and cash equivalents", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R110": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "bq:AccretionOnThePreferredSharesToRedemptionValue", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1110 - Disclosure - Convertible redeemable preferred shares - Additional Information (Detail)", "menuCat": "Details", "order": "110", "role": "http://Boqii.com/role/ConvertibleRedeemablePreferredSharesAdditionalInformationDetail", "shortName": "Convertible redeemable preferred shares - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "bq:AccretionOnThePreferredSharesToRedemptionValue", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R111": { "firstAnchor": { "ancestors": [ "div", "bq:RedeemableNoncontrollingInterestTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn10_31_2020", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:TemporaryEquitySharesIssued", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1111 - Disclosure - Redeemable non-controlling interests - Additional Information (Detail)", "menuCat": "Details", "order": "111", "role": "http://Boqii.com/role/RedeemableNonControllingInterestsAdditionalInformationDetail", "shortName": "Redeemable non-controlling interests - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "bq:RedeemableNoncontrollingInterestTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn10_31_2020", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:TemporaryEquitySharesIssued", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R112": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:RedeemableNoncontrollingInterestTableTextBlock", "bq:RedeemableNoncontrollingInterestTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount", "reportCount": 1, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1112 - Disclosure - Redeemable non-controlling interests - Schedule Of Redeemable Non-Controlling Interests Activity (Detail)", "menuCat": "Details", "order": "112", "role": "http://Boqii.com/role/RedeemableNonControllingInterestsScheduleOfRedeemableNonControllingInterestsActivityDetail", "shortName": "Redeemable non-controlling interests - Schedule Of Redeemable Non-Controlling Interests Activity (Detail)", "subGroupType": "details", "uniqueAnchor": null }, "R113": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShortTermDebtTextBlock", "bq:BorrowingsOtherDebtsAndDerivativeLiabilitiesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShortTermBankLoansAndNotesPayable", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1113 - Disclosure - Borrowings, other debts and derivative liabilities - Summary of Short-term Debt (Detail)", "menuCat": "Details", "order": "113", "role": "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfShortTermDebtDetail", "shortName": "Borrowings, other debts and derivative liabilities - Summary of Short-term Debt (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShortTermDebtTextBlock", "bq:BorrowingsOtherDebtsAndDerivativeLiabilitiesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShortTermBankLoansAndNotesPayable", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R114": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShortTermDebtTextBlock", "bq:BorrowingsOtherDebtsAndDerivativeLiabilitiesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShortTermBorrowings", "reportCount": 1, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1114 - Disclosure - Borrowings, other debts and derivative liabilities - Additional Information (Detail)", "menuCat": "Details", "order": "114", "role": "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "shortName": "Borrowings, other debts and derivative liabilities - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023_NewForeignExchangeSwapContractMemberBQForeignExchangeSwapAxis", "decimals": "-5", "lang": null, "name": "bq:PaymentTowardsAdvanceSettlementOfForeignExchangeSwaps", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R115": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1115 - Disclosure - Borrowings, other debts and derivative liabilities - Summary of Maturities of Long-term Debt (Detail)", "menuCat": "Details", "order": "115", "role": "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfMaturitiesOfLongTermDebtDetail", "shortName": "Borrowings, other debts and derivative liabilities - Summary of Maturities of Long-term Debt (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R116": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "bq:DisclosureOfOtherLongTermDebtTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "bq:OtherDebtNoncurrent", "reportCount": 1, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1116 - Disclosure - Borrowings, other debts and derivative liabilities - Summary of Other Long Term Debt (Detail)", "menuCat": "Details", "order": "116", "role": "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfOtherLongTermDebtDetail", "shortName": "Borrowings, other debts and derivative liabilities - Summary of Other Long Term Debt (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "bq:DisclosureOfOtherLongTermDebtTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "lang": null, "name": "bq:PayableForInvestmentNonCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R117": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilities", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1117 - Disclosure - Borrowings, other debts and derivative liabilities - Summary of Fair Value of Derivative Liabilities (Detail)", "menuCat": "Details", "order": "117", "role": "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfFairValueOfDerivativeLiabilitiesDetail", "shortName": "Borrowings, other debts and derivative liabilities - Summary of Fair Value of Derivative Liabilities (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilities", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R118": { "firstAnchor": { "ancestors": [ "div", "bq:ReceivableForTheIssuanceOfOrdinarySharesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProceedsFromContributedCapital", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1118 - Disclosure - Receivable for issuance of ordinary shares - Additional Information (Detail)", "menuCat": "Details", "order": "118", "role": "http://Boqii.com/role/ReceivableForIssuanceOfOrdinarySharesAdditionalInformationDetail", "shortName": "Receivable for issuance of ordinary shares - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "bq:ReceivableForTheIssuanceOfOrdinarySharesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProceedsFromContributedCapital", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R119": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1119 - Disclosure - Share-based compensation - Summary of Stock Option Activity (Detail)", "menuCat": "Details", "order": "119", "role": "http://Boqii.com/role/ShareBasedCompensationSummaryOfStockOptionActivityDetail", "shortName": "Share-based compensation - Summary of Stock Option Activity (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "0", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsAndNontradeReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1012 - Disclosure - Accounts receivable, net", "menuCat": "Notes", "order": "12", "role": "http://Boqii.com/role/AccountsReceivableNet", "shortName": "Accounts receivable, net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsAndNontradeReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R120": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2021To03_31_2022_EmployeeStockOptionMemberusgaapAwardTypeAxis", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1120 - Disclosure - Share-based compensation - Summary of Options Measured At Fair Value, Valuation Assumptions (Detail)", "menuCat": "Details", "order": "120", "role": "http://Boqii.com/role/ShareBasedCompensationSummaryOfOptionsMeasuredAtFairValueValuationAssumptionsDetail", "shortName": "Share-based compensation - Summary of Options Measured At Fair Value, Valuation Assumptions (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2021To03_31_2022_EmployeeStockOptionMemberusgaapAwardTypeAxis", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R121": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "reportCount": 1, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1121 - Disclosure - Share-based compensation - Additional Information (Detail)", "menuCat": "Details", "order": "121", "role": "http://Boqii.com/role/ShareBasedCompensationAdditionalInformationDetail", "shortName": "Share-based compensation - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "lang": null, "name": "bq:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R122": { "firstAnchor": { "ancestors": [ "div", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:CompensationExpenseExcludingCostOfGoodAndServiceSold", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1122 - Disclosure - Employee benefits - Additional Information (Detail)", "menuCat": "Details", "order": "122", "role": "http://Boqii.com/role/EmployeeBenefitsAdditionalInformationDetail", "shortName": "Employee benefits - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:CompensationExpenseExcludingCostOfGoodAndServiceSold", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R123": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "bq:ScheduleOfLongTermInvestmentsTableTextBlock", "bq:LongTermInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities", "reportCount": 1, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1123 - Disclosure - Fair value measurements - Summary of Company's Financial Assets and Liabilities (Detail)", "menuCat": "Details", "order": "123", "role": "http://Boqii.com/role/FairValueMeasurementsSummaryOfCompanySFinancialAssetsAndLiabilitiesDetail", "shortName": "Fair value measurements - Summary of Company's Financial Assets and Liabilities (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis", "decimals": "-3", "lang": null, "name": "us-gaap:OtherShortTermInvestments", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R124": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023_AvailableforsaleSecuritiesMemberusgaapFairValueByAssetClassAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1124 - Disclosure - Fair value measurements - Summary of Roll Forward of Major Level 3 Investments (Detail)", "menuCat": "Details", "order": "124", "role": "http://Boqii.com/role/FairValueMeasurementsSummaryOfRollForwardOfMajorLevel3InvestmentsDetail", "shortName": "Fair value measurements - Summary of Roll Forward of Major Level 3 Investments (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023_AvailableforsaleSecuritiesMemberusgaapFairValueByAssetClassAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R125": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023_AvailableforsaleSecuritiesMemberusgaapFairValueByAssetClassAxis_ImpliedPriceToSalesAfterDiscountForLackOfMarketabilityMemberusgaapMeasurementInputTypeAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1125 - Disclosure - Fair value measurements - Summary of Significant Unobservable Inputs (Detail)", "menuCat": "Details", "order": "125", "role": "http://Boqii.com/role/FairValueMeasurementsSummaryOfSignificantUnobservableInputsDetail", "shortName": "Fair value measurements - Summary of Significant Unobservable Inputs (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023_AvailableforsaleSecuritiesMemberusgaapFairValueByAssetClassAxis_ImpliedPriceToSalesAfterDiscountForLackOfMarketabilityMemberusgaapMeasurementInputTypeAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R126": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023_DerivativeFinancialInstrumentsLiabilitiesMemberusgaapFairValueByLiabilityClassAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:SharePrice", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1126 - Disclosure - Fair value measurements - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Detail)", "menuCat": "Details", "order": "126", "role": "http://Boqii.com/role/FairValueMeasurementsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail", "shortName": "Fair value measurements - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023_DerivativeFinancialInstrumentsLiabilitiesMemberusgaapFairValueByLiabilityClassAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:SharePrice", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R127": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "bq:NetIncomeLossAttributableToBeforeRedemptionAndDividend", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1127 - Disclosure - Net Loss per share - Schedule of Earnings Per Share, Basic and Diluted (Detail)", "menuCat": "Details", "order": "127", "role": "http://Boqii.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail", "shortName": "Net Loss per share - Schedule of Earnings Per Share, Basic and Diluted (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "bq:NetIncomeLossAttributableToBeforeRedemptionAndDividend", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R128": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023_EmployeeStockOptionMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1128 - Disclosure - Net Loss per share - Schedule of Antidilutive Securities Excluded From Computation of Earnings Per Share (Detail)", "menuCat": "Details", "order": "128", "role": "http://Boqii.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail", "shortName": "Net Loss per share - Schedule of Antidilutive Securities Excluded From Computation of Earnings Per Share (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023_EmployeeStockOptionMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R129": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "bq:ScheduleOfTransactionsBetweenRelatedPartiesTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023_NanjingAnimalPharmaceuticalMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis", "decimals": null, "first": true, "lang": "en-US", "name": "bq:DescriptionOfTransactionsWithRelatedParty", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1129 - Disclosure - Related party transactions - Summary of Major Related Parties and Their Relationships With The Company (Detail)", "menuCat": "Details", "order": "129", "role": "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfMajorRelatedPartiesAndTheirRelationshipsWithTheCompanyDetail", "shortName": "Related party transactions - Summary of Major Related Parties and Their Relationships With The Company (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "bq:ScheduleOfTransactionsBetweenRelatedPartiesTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023_NanjingAnimalPharmaceuticalMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis", "decimals": null, "first": true, "lang": "en-US", "name": "bq:DescriptionOfTransactionsWithRelatedParty", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1013 - Disclosure - Inventories, net of inventory reserves", "menuCat": "Notes", "order": "13", "role": "http://Boqii.com/role/InventoriesNetOfInventoryReserves", "shortName": "Inventories, net of inventory reserves", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R130": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": null, "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "true" }, "groupType": "disclosure", "isDefault": "false", "longName": "1130 - Disclosure - Related party transactions - Summary of Related Party Transactions And Balances (Detail)", "menuCat": "Details", "order": "130", "role": "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesDetail", "shortName": "Related party transactions - Summary of Related Party Transactions And Balances (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": null, "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "true" } }, "R131": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn06_30_2020_NanjingAgriculturalPharmaceuticalMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_TwelveMonthInterestFreeLoanAgreementMemberusgaapLongtermDebtTypeAxis", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1131 - Disclosure - Related party transactions - Summary of Related Party Transactions And Balances (Parenthetical) (Detail)", "menuCat": "Details", "order": "131", "role": "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesParentheticalDetail", "shortName": "Related party transactions - Summary of Related Party Transactions And Balances (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn06_30_2020_NanjingAgriculturalPharmaceuticalMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_TwelveMonthInterestFreeLoanAgreementMemberusgaapLongtermDebtTypeAxis", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R132": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "bq:ScheduleOfRelatedPartyTransactionsByRelatedPartyTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "bq:AdvancesProvidedToRelatedParties", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1132 - Disclosure - Related party transactions - Summary of Related Party Transaction (Detail)", "menuCat": "Details", "order": "132", "role": "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionDetail", "shortName": "Related party transactions - Summary of Related Party Transaction (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "bq:ScheduleOfRelatedPartyTransactionsByRelatedPartyTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "bq:AdvancesProvidedToRelatedParties", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R133": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "bq:ScheduleOfRelatedPartyTransactionsByRelatedPartyTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn04_01_2021_ShanghaiGuangchengInformationMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1133 - Disclosure - Related party transactions - Summary of Related Party Transaction (Parenthetical) (Detail)", "menuCat": "Details", "order": "133", "role": "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionParentheticalDetail", "shortName": "Related party transactions - Summary of Related Party Transaction (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "bq:ScheduleOfRelatedPartyTransactionsByRelatedPartyTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2021To03_31_2022_ShanghaiGuangchengInformationMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis", "decimals": "-5", "lang": null, "name": "us-gaap:ProceedsFromRelatedPartyDebt", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R134": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "bq:ScheduleOfTransactionsDueFromRelatedPartiesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "bq:PrepaymentsToRelatedParties", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1134 - Disclosure - Related party transactions - Summary of Transactions Due From Related Parties (Detail)", "menuCat": "Details", "order": "134", "role": "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesDetail", "shortName": "Related party transactions - Summary of Transactions Due From Related Parties (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "bq:ScheduleOfTransactionsDueFromRelatedPartiesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "bq:PrepaymentsToRelatedParties", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R135": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "bq:ScheduleOfTransactionsDueFromRelatedPartiesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn01_31_2021_FeiWangMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OneYearLoanAgreementMemberusgaapLongtermDebtTypeAxis", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1135 - Disclosure - Related party transactions - Summary of Transactions Due From Related Parties (Parenthetical) (Detail)", "menuCat": "Details", "order": "135", "role": "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesParentheticalDetail", "shortName": "Related party transactions - Summary of Transactions Due From Related Parties (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "bq:ScheduleOfTransactionsDueFromRelatedPartiesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn01_31_2021_FeiWangMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OneYearLoanAgreementMemberusgaapLongtermDebtTypeAxis", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R136": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "bq:ScheduleOfTransactionsDueToRelatedPartiesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023_NanjingAnimalPharmaceuticalMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccountsPayableRelatedPartiesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1136 - Disclosure - Related party transactions - Summary of Transactions Due To Related Parties (Detail)", "menuCat": "Details", "order": "136", "role": "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueToRelatedPartiesDetail", "shortName": "Related party transactions - Summary of Transactions Due To Related Parties (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "bq:ScheduleOfTransactionsDueToRelatedPartiesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023_NanjingAnimalPharmaceuticalMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccountsPayableRelatedPartiesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R137": { "firstAnchor": { "ancestors": [ "us-gaap:LongTermPurchaseCommitmentAmount", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermPurchaseCommitmentAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1137 - Disclosure - Commitments and contingencies - Additional Information (Detail)", "menuCat": "Details", "order": "137", "role": "http://Boqii.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "shortName": "Commitments and contingencies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:LongTermPurchaseCommitmentAmount", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermPurchaseCommitmentAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R138": { "firstAnchor": { "ancestors": [ "div", "us-gaap:SubsequentEventsTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_30_2023To04_30_2023_NanjingAnimalPharmaceuticalMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:LineOfCreditFacilityPeriodicPaymentPrincipal", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1138 - Disclosure - Subsequent events - Additional Information (Detail)", "menuCat": "Details", "order": "138", "role": "http://Boqii.com/role/SubsequentEventsAdditionalInformationDetail", "shortName": "Subsequent events - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:SubsequentEventsTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_30_2023To04_30_2023_NanjingAnimalPharmaceuticalMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:LineOfCreditFacilityPeriodicPaymentPrincipal", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R139": { "firstAnchor": { "ancestors": [ "div", "us-gaap:RestrictedAssetsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "bq:RestrictedNetAssetsOfCompanysSubsidiariesAndVIEs", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1139 - Disclosure - Restricted net assets - Additional Information (Detail)", "menuCat": "Details", "order": "139", "role": "http://Boqii.com/role/RestrictedNetAssetsAdditionalInformationDetail", "shortName": "Restricted net assets - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:RestrictedAssetsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "bq:RestrictedNetAssetsOfCompanysSubsidiariesAndVIEs", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "bq:PrepaymentsAndOtherCurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1014 - Disclosure - Prepayments and other current assets", "menuCat": "Notes", "order": "14", "role": "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssets", "shortName": "Prepayments and other current assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "bq:PrepaymentsAndOtherCurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1015 - Disclosure - Property and equipment, net", "menuCat": "Notes", "order": "15", "role": "http://Boqii.com/role/PropertyAndEquipmentNet", "shortName": "Property and equipment, net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1016 - Disclosure - Intangible assets, net", "menuCat": "Notes", "order": "16", "role": "http://Boqii.com/role/IntangibleAssetsNet", "shortName": "Intangible assets, net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "bq:LongTermInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1017 - Disclosure - Long-Term Investments", "menuCat": "Notes", "order": "17", "role": "http://Boqii.com/role/LongTermInvestments", "shortName": "Long-Term Investments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "bq:LongTermInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1018 - Disclosure - Goodwill", "menuCat": "Notes", "order": "18", "role": "http://Boqii.com/role/Goodwill", "shortName": "Goodwill", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "bq:OtherNoncurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1019 - Disclosure - Other non-current Assets", "menuCat": "Notes", "order": "19", "role": "http://Boqii.com/role/OtherNonCurrentAssets", "shortName": "Other non-current Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "bq:OtherNoncurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002 - Statement - Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://Boqii.com/role/ConsolidatedBalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "lang": null, "name": "us-gaap:ShortTermInvestments", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1020 - Disclosure - Accrued liabilities and other current liabilities", "menuCat": "Notes", "order": "20", "role": "http://Boqii.com/role/AccruedLiabilitiesAndOtherCurrentLiabilities", "shortName": "Accrued liabilities and other current liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1021 - Disclosure - Leases", "menuCat": "Notes", "order": "21", "role": "http://Boqii.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InterestIncomeAndInterestExpenseDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1022 - Disclosure - Interest expense", "menuCat": "Notes", "order": "22", "role": "http://Boqii.com/role/InterestExpense", "shortName": "Interest expense", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InterestIncomeAndInterestExpenseDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1023 - Disclosure - Other gains, net", "menuCat": "Notes", "order": "23", "role": "http://Boqii.com/role/OtherGainsNet", "shortName": "Other gains, net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1024 - Disclosure - Income taxes", "menuCat": "Notes", "order": "24", "role": "http://Boqii.com/role/IncomeTaxes", "shortName": "Income taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "bq:OrdinaryShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1025 - Disclosure - Ordinary Share", "menuCat": "Notes", "order": "25", "role": "http://Boqii.com/role/OrdinaryShare", "shortName": "Ordinary Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "bq:OrdinaryShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "bq:ConvertiblePedeemablePreferredSharesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1026 - Disclosure - Convertible redeemable preferred shares", "menuCat": "Notes", "order": "26", "role": "http://Boqii.com/role/ConvertibleRedeemablePreferredShares", "shortName": "Convertible redeemable preferred shares", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "bq:ConvertiblePedeemablePreferredSharesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "bq:RedeemableNoncontrollingInterestTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1027 - Disclosure - Redeemable non-controlling interests", "menuCat": "Notes", "order": "27", "role": "http://Boqii.com/role/RedeemableNonControllingInterests", "shortName": "Redeemable non-controlling interests", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "bq:RedeemableNoncontrollingInterestTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "bq:BorrowingsOtherDebtsAndDerivativeLiabilitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1028 - Disclosure - Borrowings, other debts and derivative liabilities", "menuCat": "Notes", "order": "28", "role": "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilities", "shortName": "Borrowings, other debts and derivative liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "bq:BorrowingsOtherDebtsAndDerivativeLiabilitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "bq:ReceivableForTheIssuanceOfOrdinarySharesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1029 - Disclosure - Receivable for issuance of ordinary shares", "menuCat": "Notes", "order": "29", "role": "http://Boqii.com/role/ReceivableForIssuanceOfOrdinaryShares", "shortName": "Receivable for issuance of ordinary shares", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "bq:ReceivableForTheIssuanceOfOrdinarySharesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShortTermDebtTextBlock", "bq:BorrowingsOtherDebtsAndDerivativeLiabilitiesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShortTermBorrowings", "reportCount": 1, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003 - Statement - Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023_NonrecourseMemberusgaapRecourseStatusAxis_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis", "decimals": "-3", "lang": null, "name": "us-gaap:DerivativeLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1030 - Disclosure - Share-based compensation", "menuCat": "Notes", "order": "30", "role": "http://Boqii.com/role/ShareBasedCompensation", "shortName": "Share-based compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1031 - Disclosure - Employee benefits", "menuCat": "Notes", "order": "31", "role": "http://Boqii.com/role/EmployeeBenefits", "shortName": "Employee benefits", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1032 - Disclosure - Fair value measurements", "menuCat": "Notes", "order": "32", "role": "http://Boqii.com/role/FairValueMeasurements", "shortName": "Fair value measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1033 - Disclosure - Net loss per share", "menuCat": "Notes", "order": "33", "role": "http://Boqii.com/role/NetLossPerShare", "shortName": "Net loss per share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1034 - Disclosure - Related party transactions", "menuCat": "Notes", "order": "34", "role": "http://Boqii.com/role/RelatedPartyTransactions", "shortName": "Related party transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1035 - Disclosure - Commitments and contingencies", "menuCat": "Notes", "order": "35", "role": "http://Boqii.com/role/CommitmentsAndContingencies", "shortName": "Commitments and contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1036 - Disclosure - Subsequent events", "menuCat": "Notes", "order": "36", "role": "http://Boqii.com/role/SubsequentEvents", "shortName": "Subsequent events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestrictedAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1037 - Disclosure - Restricted net assets", "menuCat": "Notes", "order": "37", "role": "http://Boqii.com/role/RestrictedNetAssets", "shortName": "Restricted net assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestrictedAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1038 - Disclosure - Principal Accounting Policies (Policies)", "menuCat": "Policies", "order": "38", "role": "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies", "shortName": "Principal Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "bq:ScheduleOfSubsidiariesAndVariableInterestEntitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1039 - Disclosure - Organization and principal activities (Tables)", "menuCat": "Tables", "order": "39", "role": "http://Boqii.com/role/OrganizationAndPrincipalActivitiesTables", "shortName": "Organization and principal activities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "bq:ScheduleOfSubsidiariesAndVariableInterestEntitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004 - Statement - Consolidated Statements of Loss and Comprehensive Loss", "menuCat": "Statements", "order": "4", "role": "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "shortName": "Consolidated Statements of Loss and Comprehensive Loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-3", "lang": null, "name": "bq:FulfilmentExpenses", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "bq:ScheduleOfPropertyPlantAndEquipmentUsefulLivesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1040 - Disclosure - Principal Accounting Policies (Tables)", "menuCat": "Tables", "order": "40", "role": "http://Boqii.com/role/PrincipalAccountingPoliciesTables", "shortName": "Principal Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "bq:ScheduleOfPropertyPlantAndEquipmentUsefulLivesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023_ChongniNetworkTechnologyCoLtdMemberusgaapBusinessAcquisitionAxis", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1041 - Disclosure - Business combinations (Tables)", "menuCat": "Tables", "order": "41", "role": "http://Boqii.com/role/BusinessCombinationsTables", "shortName": "Business combinations (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023_ChongniNetworkTechnologyCoLtdMemberusgaapBusinessAcquisitionAxis", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1042 - Disclosure - Risks and Concentration (Tables)", "menuCat": "Tables", "order": "42", "role": "http://Boqii.com/role/RisksAndConcentrationTables", "shortName": "Risks and Concentration (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1043 - Disclosure - Cash and cash equivalents (Tables)", "menuCat": "Tables", "order": "43", "role": "http://Boqii.com/role/CashAndCashEquivalentsTables", "shortName": "Cash and cash equivalents (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsAndNontradeReceivableTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1044 - Disclosure - Accounts receivable, net (Tables)", "menuCat": "Tables", "order": "44", "role": "http://Boqii.com/role/AccountsReceivableNetTables", "shortName": "Accounts receivable, net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsAndNontradeReceivableTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1045 - Disclosure - Inventories, net of inventory reserves (Tables)", "menuCat": "Tables", "order": "45", "role": "http://Boqii.com/role/InventoriesNetOfInventoryReservesTables", "shortName": "Inventories, net of inventory reserves (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "bq:PrepaymentsAndOtherCurrentAssetsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1046 - Disclosure - Prepayments and other current assets (Tables)", "menuCat": "Tables", "order": "46", "role": "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsTables", "shortName": "Prepayments and other current assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "bq:PrepaymentsAndOtherCurrentAssetsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1047 - Disclosure - Property and equipment, net (Tables)", "menuCat": "Tables", "order": "47", "role": "http://Boqii.com/role/PropertyAndEquipmentNetTables", "shortName": "Property and equipment, net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1048 - Disclosure - Intangible assets, net (Tables)", "menuCat": "Tables", "order": "48", "role": "http://Boqii.com/role/IntangibleAssetsNetTables", "shortName": "Intangible assets, net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "bq:LongTermInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "bq:ScheduleOfLongTermInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1049 - Disclosure - Long-Term Investments (Tables)", "menuCat": "Tables", "order": "49", "role": "http://Boqii.com/role/LongTermInvestmentsTables", "shortName": "Long-Term Investments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "bq:LongTermInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "bq:ScheduleOfLongTermInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2020_CommonStockMemberusgaapStatementEquityComponentsAxis", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005 - Statement - Consolidated Statements of Changes in Shareholders' Equity", "menuCat": "Statements", "order": "5", "role": "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "shortName": "Consolidated Statements of Changes in Shareholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2020_CommonStockMemberusgaapStatementEquityComponentsAxis", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "us-gaap:GoodwillDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1050 - Disclosure - Goodwill (Tables)", "menuCat": "Tables", "order": "50", "role": "http://Boqii.com/role/GoodwillTables", "shortName": "Goodwill (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:GoodwillDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "bq:OtherNoncurrentAssetsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1051 - Disclosure - Other non-current Assets (Tables)", "menuCat": "Tables", "order": "51", "role": "http://Boqii.com/role/OtherNonCurrentAssetsTables", "shortName": "Other non-current Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "bq:OtherNoncurrentAssetsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "bq:ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1052 - Disclosure - Accrued liabilities and other current liabilities (Tables)", "menuCat": "Tables", "order": "52", "role": "http://Boqii.com/role/AccruedLiabilitiesAndOtherCurrentLiabilitiesTables", "shortName": "Accrued liabilities and other current liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "bq:ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "us-gaap:LeasesOfLesseeDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1053 - Disclosure - Leases (Tables)", "menuCat": "Tables", "order": "53", "role": "http://Boqii.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LeasesOfLesseeDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "us-gaap:InterestIncomeAndInterestExpenseDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1054 - Disclosure - Interest expense (Tables)", "menuCat": "Tables", "order": "54", "role": "http://Boqii.com/role/InterestExpenseTables", "shortName": "Interest expense (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InterestIncomeAndInterestExpenseDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1055 - Disclosure - Other gains, net (Tables)", "menuCat": "Tables", "order": "55", "role": "http://Boqii.com/role/OtherGainsNetTables", "shortName": "Other gains, net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1056 - Disclosure - Income taxes (Tables)", "menuCat": "Tables", "order": "56", "role": "http://Boqii.com/role/IncomeTaxesTables", "shortName": "Income taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "bq:RedeemableNoncontrollingInterestTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1057 - Disclosure - Redeemable non-controlling interests (Tables)", "menuCat": "Tables", "order": "57", "role": "http://Boqii.com/role/RedeemableNonControllingInterestsTables", "shortName": "Redeemable non-controlling interests (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "bq:RedeemableNoncontrollingInterestTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "bq:BorrowingsOtherDebtsAndDerivativeLiabilitiesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1058 - Disclosure - Borrowings, other debts and derivative liabilities (Tables)", "menuCat": "Tables", "order": "58", "role": "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesTables", "shortName": "Borrowings, other debts and derivative liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "bq:BorrowingsOtherDebtsAndDerivativeLiabilitiesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1059 - Disclosure - Share-based compensation (Tables)", "menuCat": "Tables", "order": "59", "role": "http://Boqii.com/role/ShareBasedCompensationTables", "shortName": "Share-based compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "6", "role": "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-3", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1060 - Disclosure - Fair value measurements (Tables)", "menuCat": "Tables", "order": "60", "role": "http://Boqii.com/role/FairValueMeasurementsTables", "shortName": "Fair value measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1061 - Disclosure - Net loss per share (Tables)", "menuCat": "Tables", "order": "61", "role": "http://Boqii.com/role/NetLossPerShareTables", "shortName": "Net loss per share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "bq:ScheduleOfTransactionsBetweenRelatedPartiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1062 - Disclosure - Related party transactions (Tables)", "menuCat": "Tables", "order": "62", "role": "http://Boqii.com/role/RelatedPartyTransactionsTables", "shortName": "Related party transactions (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "bq:ScheduleOfTransactionsBetweenRelatedPartiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "bq:ScheduleOfSubsidiariesAndVariableInterestEntitiesTableTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023_GuangchengShanghaiInformationTechnologyCoLtdMembersrtConsolidatedEntitiesAxis", "decimals": null, "first": true, "lang": "en-US", "name": "bq:VariableInterestEntityPlaceOfIncorporation", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1063 - Disclosure - Organization and principal activities - Schedule of Details of the Subsidiaries, VIEs and VIE's Subsidiaries (Detail)", "menuCat": "Details", "order": "63", "role": "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail", "shortName": "Organization and principal activities - Schedule of Details of the Subsidiaries, VIEs and VIE's Subsidiaries (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "bq:ScheduleOfSubsidiariesAndVariableInterestEntitiesTableTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023_GuangchengShanghaiInformationTechnologyCoLtdMembersrtConsolidatedEntitiesAxis", "decimals": null, "first": true, "lang": "en-US", "name": "bq:VariableInterestEntityPlaceOfIncorporation", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1064 - Disclosure - Organization and principal activities - Schedule of Variable Interest Entities (Detail)", "menuCat": "Details", "order": "64", "role": "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail", "shortName": "Organization and principal activities - Schedule of Variable Interest Entities (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023_NonrecourseMemberusgaapRecourseStatusAxis_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis", "decimals": "-3", "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023_NonrecourseMemberusgaapRecourseStatusAxis_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis", "decimals": "-6", "first": true, "lang": null, "name": "bq:CommonStockValueAuthorized", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1065 - Disclosure - Organization and principal activities - Additional Information (Detail)", "menuCat": "Details", "order": "65", "role": "http://Boqii.com/role/OrganizationAndPrincipalActivitiesAdditionalInformationDetail", "shortName": "Organization and principal activities - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023_NonrecourseMemberusgaapRecourseStatusAxis_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis", "decimals": "-6", "first": true, "lang": null, "name": "bq:CommonStockValueAuthorized", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "us-gaap:ContractWithCustomerAssetNet", "div", "us-gaap:RevenueRecognitionPolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerAssetNet", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1066 - Disclosure - Principal Accounting Policies - Additional Information (Detail)", "menuCat": "Details", "order": "66", "role": "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail", "shortName": "Principal Accounting Policies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:ContractWithCustomerAssetNet", "div", "us-gaap:RevenueRecognitionPolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerAssetNet", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "div", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023_VehiclesMemberusgaapPropertyPlantAndEquipmentByTypeAxis", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1067 - Disclosure - Principal Accounting Policies - Schedule of Property Plant And Equipment Useful Lives (Detail)", "menuCat": "Details", "order": "67", "role": "http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfPropertyPlantAndEquipmentUsefulLivesDetail", "shortName": "Principal Accounting Policies - Schedule of Property Plant And Equipment Useful Lives (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "div", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023_VehiclesMemberusgaapPropertyPlantAndEquipmentByTypeAxis", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "div", "us-gaap:IntangibleAssetsFiniteLivedPolicy", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023_TrademarksMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1068 - Disclosure - Principal Accounting Policies - Schedule of Finite Lived Intangible Assets Useful Lives (Detail)", "menuCat": "Details", "order": "68", "role": "http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfFiniteLivedIntangibleAssetsUsefulLivesDetail", "shortName": "Principal Accounting Policies - Schedule of Finite Lived Intangible Assets Useful Lives (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "div", "us-gaap:IntangibleAssetsFiniteLivedPolicy", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023_TrademarksMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P06_30_2021To06_30_2021_ChongniNetworkTechnologyCoLtdMemberusgaapBusinessAcquisitionAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1069 - Disclosure - Business combinations - Summary of Identified Assets Acquired and Liabilities Assumed (Detail)", "menuCat": "Details", "order": "69", "role": "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail", "shortName": "Business combinations - Summary of Identified Assets Acquired and Liabilities Assumed (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P06_30_2021To06_30_2021_ChongniNetworkTechnologyCoLtdMemberusgaapBusinessAcquisitionAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1007 - Disclosure - Organization and principal activities", "menuCat": "Notes", "order": "7", "role": "http://Boqii.com/role/OrganizationAndPrincipalActivities", "shortName": "Organization and principal activities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn06_30_2021_XingmuGroupMemberusgaapBusinessAcquisitionAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1070 - Disclosure - Business combinations - Summary of Identified Assets Acquired and Liabilities Assumed (Detail) (Parenthetical)", "menuCat": "Details", "order": "70", "role": "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetailParenthetical", "shortName": "Business combinations - Summary of Identified Assets Acquired and Liabilities Assumed (Detail) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn06_30_2021_XingmuGroupMemberusgaapBusinessAcquisitionAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P06_30_2021To03_31_2022_NanjingCuidaBiotechnologyCoLtdMemberusgaapBusinessAcquisitionAxis", "decimals": "-4", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1071 - Disclosure - Business combinations - Additional Information (Detail)", "menuCat": "Details", "order": "71", "role": "http://Boqii.com/role/BusinessCombinationsAdditionalInformationDetail", "shortName": "Business combinations - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P06_30_2021To03_31_2022_NanjingCuidaBiotechnologyCoLtdMemberusgaapBusinessAcquisitionAxis", "decimals": "-4", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2020To03_31_2021_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis", "decimals": "0", "first": true, "lang": null, "name": "bq:NumberOfCustomers", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1072 - Disclosure - Risks and Concentration - Additional Information (Detail)", "menuCat": "Details", "order": "72", "role": "http://Boqii.com/role/RisksAndConcentrationAdditionalInformationDetail", "shortName": "Risks and Concentration - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2020To03_31_2021_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis", "decimals": "0", "first": true, "lang": null, "name": "bq:NumberOfCustomers", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023_PurchasesMemberusgaapConcentrationRiskByBenchmarkAxis_RoyalCaninChinaCoLtdMembersrtMajorCustomersAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1073 - Disclosure - Risks and Concentration - Schedules of Concentration of Risk, By Risk Factor (Detail)", "menuCat": "Details", "order": "73", "role": "http://Boqii.com/role/RisksAndConcentrationSchedulesOfConcentrationOfRiskByRiskFactorDetail", "shortName": "Risks and Concentration - Schedules of Concentration of Risk, By Risk Factor (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023_PurchasesMemberusgaapConcentrationRiskByBenchmarkAxis_RoyalCaninChinaCoLtdMembersrtMajorCustomersAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1074 - Disclosure - Cash and cash equivalents - Schedule of Cash And Cash Equivalents (Detail)", "menuCat": "Details", "order": "74", "role": "http://Boqii.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetail", "shortName": "Cash and cash equivalents - Schedule of Cash And Cash Equivalents (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023_CashEquivalentsMemberusgaapFairValueByAssetClassAxis", "decimals": "-3", "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:AccountsAndNontradeReceivableTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1075 - Disclosure - Accounts receivable, net - Summary of Accounts Receivable Net (Detail)", "menuCat": "Details", "order": "75", "role": "http://Boqii.com/role/AccountsReceivableNetSummaryOfAccountsReceivableNetDetail", "shortName": "Accounts receivable, net - Summary of Accounts Receivable Net (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:AccountsAndNontradeReceivableTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1076 - Disclosure - Accounts receivable, net - Summary of Movement of Allowance of Doubtful Accounts (Detail)", "menuCat": "Details", "order": "76", "role": "http://Boqii.com/role/AccountsReceivableNetSummaryOfMovementOfAllowanceOfDoubtfulAccountsDetail", "shortName": "Accounts receivable, net - Summary of Movement of Allowance of Doubtful Accounts (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2020", "decimals": "-3", "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryNet", "reportCount": 1, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1077 - Disclosure - Inventories, net of inventory reserves - Summary of Inventories, Net of Inventory Reserves (Detail)", "menuCat": "Details", "order": "77", "role": "http://Boqii.com/role/InventoriesNetOfInventoryReservesSummaryOfInventoriesNetOfInventoryReservesDetail", "shortName": "Inventories, net of inventory reserves - Summary of Inventories, Net of Inventory Reserves (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023_ProductSalesMembersrtProductOrServiceAxis", "decimals": "-3", "lang": null, "name": "us-gaap:InventoryNet", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "bq:ScheduleOfMovementOfInventoryProvisionTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryAdjustments", "reportCount": 1, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1078 - Disclosure - Inventories, net of inventory reserves - Summary of Movement of Inventory Provision (Detail)", "menuCat": "Details", "order": "78", "role": "http://Boqii.com/role/InventoriesNetOfInventoryReservesSummaryOfMovementOfInventoryProvisionDetail", "shortName": "Inventories, net of inventory reserves - Summary of Movement of Inventory Provision (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "bq:ScheduleOfMovementOfInventoryProvisionTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2020", "decimals": "-3", "lang": null, "name": "us-gaap:InventoryAdjustments", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "div", "us-gaap:InventoryDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "bq:ReversalProvisionOfInventoryReserve", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1079 - Disclosure - Inventories, net of inventory reserves - Additional Information (Detail)", "menuCat": "Details", "order": "79", "role": "http://Boqii.com/role/InventoriesNetOfInventoryReservesAdditionalInformationDetail", "shortName": "Inventories, net of inventory reserves - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:InventoryDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "bq:ReversalProvisionOfInventoryReserve", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1008 - Disclosure - Principal Accounting Policies", "menuCat": "Notes", "order": "8", "role": "http://Boqii.com/role/PrincipalAccountingPolicies", "shortName": "Principal Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "bq:PrepaymentsAndOtherCurrentAssetsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "bq:PrepaymentsForPurchasesOfProducts", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1080 - Disclosure - Prepayments and other current assets - Summary of Prepayments and Other Current Assets (Detail)", "menuCat": "Details", "order": "80", "role": "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsSummaryOfPrepaymentsAndOtherCurrentAssetsDetail", "shortName": "Prepayments and other current assets - Summary of Prepayments and Other Current Assets (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "bq:PrepaymentsAndOtherCurrentAssetsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "bq:PrepaymentsForPurchasesOfProducts", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "bq:PrepaymentsAndOtherCurrentAssetsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NotesAndLoansReceivableNetCurrent", "reportCount": 1, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1081 - Disclosure - Prepayments and other current assets - Additional Information (Detail)", "menuCat": "Details", "order": "81", "role": "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsAdditionalInformationDetail", "shortName": "Prepayments and other current assets - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023_LoansReceivablePeriodRangingFromTwelveToTwentyFourMonthsMemberBQAgreementAxis_MaximumMembersrtRangeAxis", "decimals": "2", "lang": null, "name": "bq:LoanReceivableFixedRateOfInterestPercentage", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1082 - Disclosure - Property and equipment, net - Summary of Property, Plant and Equipment's (Detail)", "menuCat": "Details", "order": "82", "role": "http://Boqii.com/role/PropertyAndEquipmentNetSummaryOfPropertyPlantAndEquipmentsDetail", "shortName": "Property and equipment, net - Summary of Property, Plant and Equipment's (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "div", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1083 - Disclosure - Property and equipment, net - Additional Information (Detail)", "menuCat": "Details", "order": "83", "role": "http://Boqii.com/role/PropertyAndEquipmentNetAdditionalInformationDetail", "shortName": "Property and equipment, net - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1084 - Disclosure - Intangible assets, net - Schedule of Intangible Assets (Detail)", "menuCat": "Details", "order": "84", "role": "http://Boqii.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsDetail", "shortName": "Intangible assets, net - Schedule of Intangible Assets (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1085 - Disclosure - Intangible assets, net - Schedule of Annual Estimated Amortization Expense for Intangible Assets (Detail)", "menuCat": "Details", "order": "85", "role": "http://Boqii.com/role/IntangibleAssetsNetScheduleOfAnnualEstimatedAmortizationExpenseForIntangibleAssetsDetail", "shortName": "Intangible assets, net - Schedule of Annual Estimated Amortization Expense for Intangible Assets (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1086 - Disclosure - Intangible assets, net - Additional Information (Detail)", "menuCat": "Details", "order": "86", "role": "http://Boqii.com/role/IntangibleAssetsNetAdditionalInformationDetail", "shortName": "Intangible assets, net - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "bq:ScheduleOfLongTermInvestmentsTableTextBlock", "bq:LongTermInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestments", "reportCount": 1, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1087 - Disclosure - Long-Term Investments - Summary of Long-Term Investment (Detail)", "menuCat": "Details", "order": "87", "role": "http://Boqii.com/role/LongTermInvestmentsSummaryOfLongTermInvestmentDetail", "shortName": "Long-Term Investments - Summary of Long-Term Investment (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "bq:ScheduleOfLongTermInvestmentsTableTextBlock", "bq:LongTermInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "lang": null, "name": "bq:EquitySecuritiesWithReadilyDeterminableFairValues", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1088 - Disclosure - Long-Term Investments - Summary of Available-For-Sale Debt Investments (Detail)", "menuCat": "Details", "order": "88", "role": "http://Boqii.com/role/LongTermInvestmentsSummaryOfAvailableForSaleDebtInvestmentsDetail", "shortName": "Long-Term Investments - Summary of Available-For-Sale Debt Investments (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:EquitySecuritiesFvNiCost", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1089 - Disclosure - Long-Term Investments - Summary Of Equity Securities With Readily Determinable Fair Values (Detail)", "menuCat": "Details", "order": "89", "role": "http://Boqii.com/role/LongTermInvestmentsSummaryOfEquitySecuritiesWithReadilyDeterminableFairValuesDetail", "shortName": "Long-Term Investments - Summary Of Equity Securities With Readily Determinable Fair Values (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:EquitySecuritiesFvNiCost", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1009 - Disclosure - Business combinations", "menuCat": "Notes", "order": "9", "role": "http://Boqii.com/role/BusinessCombinations", "shortName": "Business combinations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R90": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "bq:ScheduleOfLongTermInvestmentsTableTextBlock", "bq:LongTermInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestments", "reportCount": 1, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1090 - Disclosure - Long-Term Investments - Additional Information (Detail)", "menuCat": "Details", "order": "90", "role": "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail", "shortName": "Long-Term Investments - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "bq:LongTermInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-6", "lang": null, "name": "us-gaap:ProceedsFromSaleOfEquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfGoodwillTextBlock", "us-gaap:GoodwillDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GoodwillGross", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1091 - Disclosure - Goodwill - Schedule of Changes in the Carrying Amount of Goodwill (Detail)", "menuCat": "Details", "order": "91", "role": "http://Boqii.com/role/GoodwillScheduleOfChangesInTheCarryingAmountOfGoodwillDetail", "shortName": "Goodwill - Schedule of Changes in the Carrying Amount of Goodwill (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfGoodwillTextBlock", "us-gaap:GoodwillDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GoodwillGross", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "div", "us-gaap:GoodwillDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-5", "first": true, "lang": null, "name": "bq:ReportingUnitAmountOfFairValueLessThanCarryingAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1092 - Disclosure - Goodwill - Additional Information (Detail)", "menuCat": "Details", "order": "92", "role": "http://Boqii.com/role/GoodwillAdditionalInformationDetail", "shortName": "Goodwill - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:GoodwillDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-5", "first": true, "lang": null, "name": "bq:ReportingUnitAmountOfFairValueLessThanCarryingAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock", "bq:OtherNoncurrentAssetsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DepositsAssetsNoncurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1093 - Disclosure - Other non-current Assets - Schedule of Other Non-current Assets (Detail)", "menuCat": "Details", "order": "93", "role": "http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsDetail", "shortName": "Other non-current Assets - Schedule of Other Non-current Assets (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock", "bq:OtherNoncurrentAssetsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DepositsAssetsNoncurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R94": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock", "bq:OtherNoncurrentAssetsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermInvestmentsAndReceivablesNet", "reportCount": 1, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1094 - Disclosure - Other non-current Assets - Schedule of Other Non-current Assets (Parenthetical) (Detail)", "menuCat": "Details", "order": "94", "role": "http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsParentheticalDetail", "shortName": "Other non-current Assets - Schedule of Other Non-current Assets (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock", "bq:OtherNoncurrentAssetsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023_LoanReceivableForThePeriodTwentyFourToThirtySixMonthsMemberBQAgreementAxis", "decimals": "-5", "lang": null, "name": "us-gaap:ReceivableWithImputedInterestFaceAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R95": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "bq:ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "bq:LogisticsExpensesPayables", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1095 - Disclosure - Accrued liabilities and other current liabilities - Schedule of Accrued Liabilities and Other Current Liabilities (Detail)", "menuCat": "Details", "order": "95", "role": "http://Boqii.com/role/AccruedLiabilitiesAndOtherCurrentLiabilitiesScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesDetail", "shortName": "Accrued liabilities and other current liabilities - Schedule of Accrued Liabilities and Other Current Liabilities (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "bq:ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "bq:LogisticsExpensesPayables", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R96": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1096 - Disclosure - Leases - Summary of Operating Leases (Detail)", "menuCat": "Details", "order": "96", "role": "http://Boqii.com/role/LeasesSummaryOfOperatingLeasesDetail", "shortName": "Leases - Summary of Operating Leases (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2022", "decimals": null, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R97": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "reportCount": 1, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1097 - Disclosure - Leases - Summary of Operating Lease Activity (Detail)", "menuCat": "Details", "order": "97", "role": "http://Boqii.com/role/LeasesSummaryOfOperatingLeaseActivityDetail", "shortName": "Leases - Summary of Operating Lease Activity (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-3", "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R98": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1098 - Disclosure - Leases - Summary of Maturities of Lease Liabilities (Detail)", "menuCat": "Details", "order": "98", "role": "http://Boqii.com/role/LeasesSummaryOfMaturitiesOfLeaseLiabilitiesDetail", "shortName": "Leases - Summary of Maturities of Lease Liabilities (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } }, "R99": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "us-gaap:InterestIncomeAndInterestExpenseDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AmortizationOfFinancingCosts", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1099 - Disclosure - Interest expense - Summary of Interest Expense (Detail)", "menuCat": "Details", "order": "99", "role": "http://Boqii.com/role/InterestExpenseSummaryOfInterestExpenseDetail", "shortName": "Interest expense - Summary of Interest Expense (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "us-gaap:InterestIncomeAndInterestExpenseDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d290954d20f.htm", "contextRef": "P04_01_2022To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AmortizationOfFinancingCosts", "reportCount": 1, "unique": true, "unitRef": "Unit_CNY", "xsiNil": "false" } } }, "segmentCount": 155, "tag": { "bq_AccretionOnConvertibleRedeemablePreferredShares": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accretion on convertible redeemable preferred shares.", "label": "Accretion On Convertible Redeemable Preferred Shares", "terseLabel": "Accretion on convertible redeemable preferred shares", "verboseLabel": "Accretion on the Preferred Shares to redemption value (Note 20)" } } }, "localname": "AccretionOnConvertibleRedeemablePreferredShares", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows", "http://Boqii.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "monetaryItemType" }, "bq_AccretionOnConvertibleRedeemablePreferredSharesToRedemptionValue": { "auth_ref": [], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 25.0, "parentTag": "bq_NetIncomeLossAttributableToAfterRedemptionAndDividendForOrdinaryShareholders", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accretion on convertible redeemable preferred shares to redemption value.", "label": "Accretion On Convertible Redeemable Preferred Shares To Redemption Value", "negatedLabel": "Accretion on convertible redeemable preferred shares to redemption value" } } }, "localname": "AccretionOnConvertibleRedeemablePreferredSharesToRedemptionValue", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "bq_AccretionOnRedeemableNonControllingInterests": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accretion on redeemable\u00a0non-controlling\u00a0interests.", "label": "Accretion On Redeemable Non controlling Interests", "terseLabel": "Accretion on redeemable non-controlling interests" } } }, "localname": "AccretionOnRedeemableNonControllingInterests", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "bq_AccretionOnRedeemableNonControllingInterestsToRedemptionValue": { "auth_ref": [], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 26.0, "parentTag": "bq_NetIncomeLossAttributableToAfterRedemptionAndDividendForOrdinaryShareholders", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accretion on redeemable non controlling interests to redemption value.", "label": "Accretion On Redeemable Non Controlling Interests To Redemption Value", "negatedLabel": "Accretion on redeemable\u00a0non-controlling\u00a0interests to redemption value" } } }, "localname": "AccretionOnRedeemableNonControllingInterestsToRedemptionValue", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "bq_AccretionOnThePreferredSharesToRedemptionValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accretion on the Preferred Shares to redemption value", "label": "Accretion on the Preferred Shares to redemption value", "verboseLabel": "Accretion on the Preferred Shares to redemption value" } } }, "localname": "AccretionOnThePreferredSharesToRedemptionValue", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConvertibleRedeemablePreferredSharesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "bq_AccruedLiabilitiesAndOtherCurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accrued Liabilities And Other Current Liabilities [Member]" } } }, "localname": "AccruedLiabilitiesAndOtherCurrentLiabilitiesMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_AcquisitionOfAdditionalInterestsInSubsidiariesFromNonControllingInterests": { "auth_ref": [], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Acquisition of additional interests in subsidiaries from non-controlling interests.", "label": "Acquisition Of Additional Interests In Subsidiaries From Non Controlling Interests", "terseLabel": "Acquisition of additional interests in subsidiaries from non-controlling interests" } } }, "localname": "AcquisitionOfAdditionalInterestsInSubsidiariesFromNonControllingInterests", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "bq_AdditionalCompensationOfLineOfCredit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Additional compensation of line of credit.", "label": "Additional compensation of line of credit", "terseLabel": "Additional compensation of line of credit" } } }, "localname": "AdditionalCompensationOfLineOfCredit", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "bq_AdsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ADS [Member]" } } }, "localname": "AdsMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_AdvancesFromCustomers": { "auth_ref": [], "calculation": { "http://Boqii.com/role/AccruedLiabilitiesAndOtherCurrentLiabilitiesScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesDetail": { "order": 5.0, "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Advances from customers.", "label": "Advances From Customers", "terseLabel": "Advances from customers" } } }, "localname": "AdvancesFromCustomers", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/AccruedLiabilitiesAndOtherCurrentLiabilitiesScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "bq_AdvancesProvidedToRelatedParties": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Advances provided to related parties.", "label": "Advances Provided To Related Parties", "terseLabel": "Advances provided to related parties" } } }, "localname": "AdvancesProvidedToRelatedParties", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionDetail" ], "xbrltype": "monetaryItemType" }, "bq_AgreeementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreeement.", "label": "Agreeement [Axis]" } } }, "localname": "AgreeementAxis", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/ConvertibleRedeemablePreferredSharesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "bq_AgreeementDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreeement.", "label": "Agreeement [Domain]" } } }, "localname": "AgreeementDomain", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/ConvertibleRedeemablePreferredSharesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_AgreementAdditionalExtendedPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement additional extended period.", "label": "Agreement Additional Extended Period", "terseLabel": "Extended term" } } }, "localname": "AgreementAdditionalExtendedPeriod", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "bq_AgreementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Agreement [Axis]" } } }, "localname": "AgreementAxis", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsParentheticalDetail", "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsAdditionalInformationDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesParentheticalDetail" ], "xbrltype": "stringItemType" }, "bq_AgreementDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Agreement [Domain]" } } }, "localname": "AgreementDomain", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsParentheticalDetail", "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsAdditionalInformationDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesParentheticalDetail" ], "xbrltype": "domainItemType" }, "bq_AgreementTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term of agreement.", "label": "Agreement Term", "terseLabel": "Term of agreement" } } }, "localname": "AgreementTerm", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "bq_AmendedTwoThousandEighteenGlobalSharePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Amended Two Thousand Eighteen Global Share Plan [Member]", "terseLabel": "Amended 2018 Global Share Plan [Member]" } } }, "localname": "AmendedTwoThousandEighteenGlobalSharePlanMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_AmortizationExpensesOfIntangibleAsset": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortization expenses of intangible asset.", "label": "Amortization Expenses Of Intangible Asset", "verboseLabel": "Amortization expenses of the intangible assets" } } }, "localname": "AmortizationExpensesOfIntangibleAsset", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/IntangibleAssetsNetAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "bq_AppropriationsForStatutorySurplusFund": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Appropriations for statutory surplus fund.", "label": "Appropriations For Statutory Surplus Fund", "terseLabel": "Appropriations to statutory reserves" } } }, "localname": "AppropriationsForStatutorySurplusFund", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "bq_AvailableForSaleDebtInvestmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Available for sale debt investments.", "label": "Available For Sale Debt Investments [Member]" } } }, "localname": "AvailableForSaleDebtInvestmentsMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_BeijingPetdogMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Beijing Petdog [Member]", "terseLabel": "Beijing Petdog [Member]" } } }, "localname": "BeijingPetdogMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfMajorRelatedPartiesAndTheirRelationshipsWithTheCompanyDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesDetail" ], "xbrltype": "domainItemType" }, "bq_BeijingPetdogTechnologyDevelopmentCoLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Beijing petdog technology development co ltd.", "label": "Beijing Petdog Technology Development Co Ltd [Member]", "terseLabel": "Beijing Petdog Technology Development Co Ltd [Member]" } } }, "localname": "BeijingPetdogTechnologyDevelopmentCoLtdMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_BetterChoiceCompanyIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Better Choice Company Inc [Member]" } } }, "localname": "BetterChoiceCompanyIncMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_BoqiiCorporationLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Boqii Corporation Limited [Member]", "terseLabel": "Boqii Corporation Limited (\"Boqii Corporation\") [Member]" } } }, "localname": "BoqiiCorporationLimitedMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail" ], "xbrltype": "domainItemType" }, "bq_BoqiiInternationalLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Boqii International Limited [Member]", "terseLabel": "Boqii International Limited [Member]" } } }, "localname": "BoqiiInternationalLimitedMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail" ], "xbrltype": "domainItemType" }, "bq_BoqiiShanghaiInformationTechnologyCoLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Boqii Shanghai Information Technology Co Ltd [Member]", "terseLabel": "Boqii (Shanghai) Information Technology Co., Ltd. [Member]" } } }, "localname": "BoqiiShanghaiInformationTechnologyCoLtdMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail" ], "xbrltype": "domainItemType" }, "bq_BorrowingsOtherDebtsAndDerivativeLiabilitiesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Borrowings other debts and derivative liabilities.", "label": "Borrowings Other Debts And Derivative Liabilities [Text Block]", "terseLabel": "Borrowings, other debts and derivative liabilities" } } }, "localname": "BorrowingsOtherDebtsAndDerivativeLiabilitiesTextBlock", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilities" ], "xbrltype": "textBlockItemType" }, "bq_BorrowingsOtherDebtsAndOtherLiabilitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Borrowings Other Debts And Other Liabilities [Line Items]" } } }, "localname": "BorrowingsOtherDebtsAndOtherLiabilitiesLineItems", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "bq_BorrowingsOtherDebtsAndOtherLiabilitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Borrowings Other Debts And Other Liabilities [Table]" } } }, "localname": "BorrowingsOtherDebtsAndOtherLiabilitiesTable", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "bq_BusinessAcquisitionFairValueAdjustmentsOfEquityInterestIssued": { "auth_ref": [], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 33.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain from the\u00a0re-measurement\u00a0of the previously held equity interest to the fair value in the business acquisition.", "label": "Business Acquisition Fair Value Adjustments Of Equity Interest Issued", "negatedLabel": "Gain from the re-measurement of the previously held equity interest to the fair value in the business acquisition" } } }, "localname": "BusinessAcquisitionFairValueAdjustmentsOfEquityInterestIssued", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "bq_BusinessCombinationPurchasePriceInformationOnAcquisitionDate": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business combination purchase price information on acquisition date.", "label": "Business Combination Purchase Price Information On Acquisition Date" } } }, "localname": "BusinessCombinationPurchasePriceInformationOnAcquisitionDate", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BusinessCombinationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "bq_CMBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CMB.", "label": "CMB [Member]" } } }, "localname": "CMBMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_CashPaidForFixedOperatingLeaseCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash paid for fixed operating lease costs.", "label": "Cash Paid For Fixed Operating Lease Costs", "verboseLabel": "Cash paid for fixed operating lease costs included in the measurement of lease obligations in operating activities" } } }, "localname": "CashPaidForFixedOperatingLeaseCosts", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "bq_ChangeOfValuationAllowance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Change of valuation allowance.", "label": "Change Of Valuation Allowance", "verboseLabel": "Change of valuation allowance" } } }, "localname": "ChangeOfValuationAllowance", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "bq_ChongLiMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Chong Li.", "label": "Chong Li [Member]" } } }, "localname": "ChongLiMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_ChongniNetworkTechnologyCoLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Chongni network technologyCo Ltd [Member].", "label": "Chongni network technology Co Ltd [Member]" } } }, "localname": "ChongniNetworkTechnologyCoLtdMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BusinessCombinationsAdditionalInformationDetail", "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail", "http://Boqii.com/role/BusinessCombinationsTables" ], "xbrltype": "domainItemType" }, "bq_CollateralizedByShortTermInvestments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Collateralized by short-term investments.", "label": "Collateralized by short term investments", "terseLabel": "Collateralized by short-term investments" } } }, "localname": "CollateralizedByShortTermInvestments", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "bq_CommonStockValueAuthorized": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total Authorized Share Capital.", "label": "Common Stock Value Authorized", "terseLabel": "Total registered capital" } } }, "localname": "CommonStockValueAuthorized", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "bq_ComponentOfDerivativeLiabilitiesAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Component of derivative liabilities.", "label": "Component Of Derivative Liabilities [Axis]" } } }, "localname": "ComponentOfDerivativeLiabilitiesAxis", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfFairValueOfDerivativeLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "bq_ComponentOfDerivativeLiabilitiesDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Component of derivative liabilities.", "label": "Component Of Derivative Liabilities [Domain]" } } }, "localname": "ComponentOfDerivativeLiabilitiesDomain", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfFairValueOfDerivativeLiabilitiesDetail" ], "xbrltype": "domainItemType" }, "bq_ContractualArrangementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contractual Arrangements [Member]", "terseLabel": "Contractual Arrangements [Member]" } } }, "localname": "ContractualArrangementsMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_ConvenienceTranslationExchangeRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convenience translation exchange rate.", "label": "Convenience Translation Exchange Rate", "terseLabel": "Convenience translation exchange rate" } } }, "localname": "ConvenienceTranslationExchangeRate", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "pureItemType" }, "bq_ConvenienceTranslationPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convenience translation policy text block.", "label": "Convenience translation [Policy Text Block]", "terseLabel": "Convenience translation" } } }, "localname": "ConvenienceTranslationPolicyTextBlock", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "bq_ConversionFeatureOfYokenSeriesAOneWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion feature of yoken series\u00a0A one\u00a0warrant", "label": "Conversion Feature Of Yoken Series A One Warrant [Member]", "terseLabel": "Conversion feature of Yoken Series A-1 Warrant [Member]" } } }, "localname": "ConversionFeatureOfYokenSeriesAOneWarrantMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfFairValueOfDerivativeLiabilitiesDetail" ], "xbrltype": "domainItemType" }, "bq_ConversionOfSeriesAConvertibleRedeemablePreferredSharesToOrdinaryShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion of series A convertible redeemable preferred shares to ordinary shares.", "label": "Conversion Of Series A Convertible Redeemable Preferred Shares To Ordinary Shares", "terseLabel": "Conversion of Series A convertible redeemable preferred shares upon completion of the IPO , Shares" } } }, "localname": "ConversionOfSeriesAConvertibleRedeemablePreferredSharesToOrdinaryShares", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "bq_ConversionOfSeriesAConvertibleRedeemablePreferredSharesToOrdinarySharesValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Conversion of series A convertible redeemable preferred shares to ordinary shares value.", "label": "Conversion Of Series A Convertible Redeemable Preferred Shares To Ordinary Shares Value", "terseLabel": "Conversion of Series A convertible redeemable preferred shares upon completion of the IPO" } } }, "localname": "ConversionOfSeriesAConvertibleRedeemablePreferredSharesToOrdinarySharesValue", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "bq_ConversionOfSeriesBConvertibleRedeemablePreferredSharesToOrdinaryShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion of series B convertible redeemable preferred shares to ordinary shares.", "label": "Conversion Of Series B Convertible Redeemable Preferred Shares To Ordinary Shares", "terseLabel": "Conversion of Series B convertible redeemable preferred shares upon completion of the IPO , Shares" } } }, "localname": "ConversionOfSeriesBConvertibleRedeemablePreferredSharesToOrdinaryShares", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "bq_ConversionOfSeriesBConvertibleRedeemablePreferredSharesToOrdinarySharesValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Conversion of series B convertible redeemable preferred shares to ordinary shares value.", "label": "Conversion Of Series B Convertible Redeemable Preferred Shares To Ordinary Shares Value", "terseLabel": "Conversion of Series B convertible redeemable preferred shares upon completion of the IPO" } } }, "localname": "ConversionOfSeriesBConvertibleRedeemablePreferredSharesToOrdinarySharesValue", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "bq_ConversionOfSeriesCConvertibleRedeemablePreferredSharesToOrdinaryShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion of series C convertible redeemable preferred shares to ordinary shares.", "label": "Conversion Of Series C Convertible Redeemable Preferred Shares To Ordinary Shares", "terseLabel": "Conversion of Series C convertible redeemable preferred shares upon completion of the IPO , Shares" } } }, "localname": "ConversionOfSeriesCConvertibleRedeemablePreferredSharesToOrdinaryShares", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "bq_ConversionOfSeriesCConvertibleRedeemablePreferredSharesToOrdinarySharesValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Conversion of series C convertible redeemable preferred shares to ordinary shares value.", "label": "Conversion Of Series C Convertible Redeemable Preferred Shares To Ordinary Shares Value", "terseLabel": "Conversion of Series C convertible redeemable preferred shares upon completion of the IPO" } } }, "localname": "ConversionOfSeriesCConvertibleRedeemablePreferredSharesToOrdinarySharesValue", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "bq_ConversionOfSeriesCPlusConvertibleRedeemablePreferredSharesToOrdinaryShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion of series C plus convertible redeemable preferred shares to ordinary shares.", "label": "Conversion Of Series C Plus Convertible Redeemable Preferred Shares To Ordinary Shares", "terseLabel": "Conversion of Series C+ convertible redeemable preferred shares upon completion of the IPO , Shares" } } }, "localname": "ConversionOfSeriesCPlusConvertibleRedeemablePreferredSharesToOrdinaryShares", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "bq_ConversionOfSeriesCPlusConvertibleRedeemablePreferredSharesToOrdinarySharesValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Conversion of series C plus convertible redeemable preferred shares to ordinary shares value.", "label": "Conversion Of Series C Plus Convertible Redeemable Preferred Shares To Ordinary Shares Value", "terseLabel": "Conversion of Series C+ convertible redeemable preferred shares upon completion of the IPO" } } }, "localname": "ConversionOfSeriesCPlusConvertibleRedeemablePreferredSharesToOrdinarySharesValue", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "bq_ConversionOfSeriesDConvertibleRedeemablePreferredSharesToOrdinaryShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion of series D convertible redeemable preferred shares to ordinary shares.", "label": "Conversion Of Series D Convertible Redeemable Preferred Shares To Ordinary Shares", "terseLabel": "Conversion of Series D convertible redeemable preferred shares upon completion of the IPO , Shares" } } }, "localname": "ConversionOfSeriesDConvertibleRedeemablePreferredSharesToOrdinaryShares", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "bq_ConversionOfSeriesDConvertibleRedeemablePreferredSharesToOrdinarySharesValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Conversion of series D convertible redeemable preferred shares to ordinary shares value.", "label": "Conversion Of Series D Convertible Redeemable Preferred Shares To Ordinary Shares Value", "terseLabel": "Conversion of Series D convertible redeemable preferred shares upon completion of the IPO" } } }, "localname": "ConversionOfSeriesDConvertibleRedeemablePreferredSharesToOrdinarySharesValue", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "bq_ConversionOfSeriesDOneConvertibleRedeemablePreferredSharesToOrdinaryShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion of series D one convertible redeemable preferred shares to ordinary shares.", "label": "Conversion Of Series D One Convertible Redeemable Preferred Shares To Ordinary Shares", "terseLabel": "Conversion of Series D-1 convertible redeemable preferred shares upon completion of the IPO , Shares" } } }, "localname": "ConversionOfSeriesDOneConvertibleRedeemablePreferredSharesToOrdinaryShares", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "bq_ConversionOfSeriesDOneConvertibleRedeemablePreferredSharesToOrdinarySharesValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Conversion of series D one convertible redeemable preferred shares to ordinary shares value.", "label": "Conversion Of Series D One Convertible Redeemable Preferred Shares To Ordinary Shares Value", "terseLabel": "Conversion of Series D-1 convertible redeemable preferred shares upon completion of the IPO" } } }, "localname": "ConversionOfSeriesDOneConvertibleRedeemablePreferredSharesToOrdinarySharesValue", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "bq_ConversionOfSeriesDTwoConvertibleRedeemablePreferredSharesToOrdinaryShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion of series D two convertible redeemable preferred shares to ordinary shares.", "label": "Conversion Of Series D Two Convertible Redeemable Preferred Shares To Ordinary Shares", "terseLabel": "Conversion of Series D-2 convertible redeemable preferred shares upon completion of the IPO , Shares" } } }, "localname": "ConversionOfSeriesDTwoConvertibleRedeemablePreferredSharesToOrdinaryShares", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "bq_ConversionOfSeriesDTwoConvertibleRedeemablePreferredSharesToOrdinarySharesValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Conversion of series D two convertible redeemable preferred shares to ordinary shares value.", "label": "Conversion Of Series D Two Convertible Redeemable Preferred Shares To Ordinary Shares Value", "terseLabel": "Conversion of Series D-2 convertible redeemable preferred shares upon completion of the IPO" } } }, "localname": "ConversionOfSeriesDTwoConvertibleRedeemablePreferredSharesToOrdinarySharesValue", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "bq_ConversionOfSeriesEConvertibleRedeemablePreferredSharesToOrdinaryShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion of series E convertible redeemable preferred shares to ordinary shares.", "label": "Conversion Of Series E Convertible Redeemable Preferred Shares To Ordinary Shares", "terseLabel": "Conversion of Series E convertible redeemable preferred shares upon completion of the IPO , Shares" } } }, "localname": "ConversionOfSeriesEConvertibleRedeemablePreferredSharesToOrdinaryShares", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "bq_ConversionOfSeriesEConvertibleRedeemablePreferredSharesToOrdinarySharesValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Conversion of series E convertible redeemable preferred shares to ordinary shares value.", "label": "Conversion Of Series E Convertible Redeemable Preferred Shares To Ordinary Shares Value", "terseLabel": "Conversion of Series E convertible redeemable preferred shares upon completion of the IPO" } } }, "localname": "ConversionOfSeriesEConvertibleRedeemablePreferredSharesToOrdinarySharesValue", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "bq_ConvertiblePedeemablePreferredSharesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible redeemable preferred shares.", "label": "Convertible Pedeemable Preferred Shares [Text Block]", "terseLabel": "Convertible redeemable preferred shares" } } }, "localname": "ConvertiblePedeemablePreferredSharesTextBlock", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConvertibleRedeemablePreferredShares" ], "xbrltype": "textBlockItemType" }, "bq_CurrencyToBeExchanged": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Currency to be exchanged.", "label": "Currency To Be Exchanged", "terseLabel": "Currency to be exchanged" } } }, "localname": "CurrencyToBeExchanged", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "bq_CurrencyToBeReceived": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Currency to be received.", "label": "Currency To Be Received", "terseLabel": "Currency to be received" } } }, "localname": "CurrencyToBeReceived", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "bq_DebtInstrumentNumberOfStockOptionsCollateralized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt instrument number of stock options collateralized.", "label": "Debt Instrument Number Of Stock Options Collateralized", "terseLabel": "Debt Instrument, Number of Stock Options Collateralized" } } }, "localname": "DebtInstrumentNumberOfStockOptionsCollateralized", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesParentheticalDetail" ], "xbrltype": "sharesItemType" }, "bq_DecreaseOfValuationAllowancesRelatedToTheDisposalOfASubsidiary": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Decrease of valuation allowances related to the disposal of a subsidiary.", "label": "Decrease of valuation allowances related to the disposal of a subsidiary", "terseLabel": "Decrease of valuation allowances related to the disposal of a subsidiary" } } }, "localname": "DecreaseOfValuationAllowancesRelatedToTheDisposalOfASubsidiary", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/IncomeTaxesSummaryOfValuationAllowanceDetail" ], "xbrltype": "monetaryItemType" }, "bq_DeemedDividendToPreferredShareholders": { "auth_ref": [], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 27.0, "parentTag": "bq_NetIncomeLossAttributableToAfterRedemptionAndDividendForOrdinaryShareholders", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deemed dividend to preferred shareholders.", "label": "Deemed Dividend To Preferred Shareholders", "negatedLabel": "Deemed dividend to preferred shareholders" } } }, "localname": "DeemedDividendToPreferredShareholders", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "bq_DeferredFairValueOfForeignSwapContractOne": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred fair value of foreign swap contract one.", "label": "Deferred Fair Value Of Foreign Swap Contract One", "terseLabel": "Deferred fair value gain loss on foreign swap contract one" } } }, "localname": "DeferredFairValueOfForeignSwapContractOne", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "bq_DeferredIncomeTaxLiabilityNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred Income Tax Liability Net.", "label": "Deferred Income Tax Liability Net", "verboseLabel": "Deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilityNet", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "bq_DeferredTaxAssetsChangesInFairValue": { "auth_ref": [], "calculation": { "http://Boqii.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndTaxLiabilitiesDetail": { "order": 9.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets changes in fair value.", "label": "Deferred Tax Assets Changes In Fair Value", "terseLabel": "Fair Value Change" } } }, "localname": "DeferredTaxAssetsChangesInFairValue", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndTaxLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "bq_DeferredTaxAssetsContractLiabilities": { "auth_ref": [], "calculation": { "http://Boqii.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndTaxLiabilitiesDetail": { "order": 6.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets contract liabilities.", "label": "Deferred Tax Assets Contract Liabilities", "verboseLabel": "Contract liabilities" } } }, "localname": "DeferredTaxAssetsContractLiabilities", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndTaxLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "bq_DeferredTaxAssetsDeferredDeductibleAdvertisingExpense": { "auth_ref": [], "calculation": { "http://Boqii.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndTaxLiabilitiesDetail": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets deferred deductible advertising expense.", "label": "Deferred Tax Assets Deferred Deductible Advertising Expense", "verboseLabel": "Deferred deductible advertising expense" } } }, "localname": "DeferredTaxAssetsDeferredDeductibleAdvertisingExpense", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndTaxLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "bq_DeferredTaxAssetsLiabilitiesInvestments": { "auth_ref": [], "calculation": { "http://Boqii.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndTaxLiabilitiesDetail": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets (Liabilities), Investments.", "label": "Deferred Tax Assets Liabilities, Investments", "negatedLabel": "Unrealized fair value change of the\u00a0available-for-sale\u00a0debt investments" } } }, "localname": "DeferredTaxAssetsLiabilitiesInvestments", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndTaxLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "bq_DescriptionOfNatureOfRelatedPartyRelationship": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of nature of related party relationships.", "label": "Description Of Nature Of Related Party Relationship", "terseLabel": "Relationship with the company" } } }, "localname": "DescriptionOfNatureOfRelatedPartyRelationship", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfMajorRelatedPartiesAndTheirRelationshipsWithTheCompanyDetail" ], "xbrltype": "stringItemType" }, "bq_DescriptionOfTransactionsWithRelatedParty": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of transactions with related party.", "label": "Description Of Transactions With Related Party", "terseLabel": "Name of related parties" } } }, "localname": "DescriptionOfTransactionsWithRelatedParty", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfMajorRelatedPartiesAndTheirRelationshipsWithTheCompanyDetail" ], "xbrltype": "stringItemType" }, "bq_DijackieChenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Di Jackie Chen [Member]", "terseLabel": "Di (Jackie) Chen [Member]" } } }, "localname": "DijackieChenMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfMajorRelatedPartiesAndTheirRelationshipsWithTheCompanyDetail" ], "xbrltype": "domainItemType" }, "bq_DisclosureOfOtherLongTermDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of other long term debt [Table text block].", "label": "Disclosure Of Other Long Term Debt [Table Text Block]", "terseLabel": "Summary of Other Long Term Debt" } } }, "localname": "DisclosureOfOtherLongTermDebtTableTextBlock", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "bq_DisposalOfLongTermInvestments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Disposal of long term investments.", "label": "Disposal Of Long Term Investments", "terseLabel": "Disposal of Long-term investments" } } }, "localname": "DisposalOfLongTermInvestments", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsSummaryOfAvailableForSaleDebtInvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "bq_DomesticEnterpriseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Domestic Enterprise.", "label": "Domestic Enterprise [Member]" } } }, "localname": "DomesticEnterpriseMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RestrictedNetAssetsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_EarningPerShareBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earning Per Share Basic And Diluted [Abstract]", "terseLabel": "Net loss per share attributable to ordinary shareholders:" } } }, "localname": "EarningPerShareBasicAndDilutedAbstract", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "stringItemType" }, "bq_EarningsPerShareBasicAndDilutedOtherDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share Basic And Diluted Other Disclosure [Abstract]", "terseLabel": "Denominator:" } } }, "localname": "EarningsPerShareBasicAndDilutedOtherDisclosureAbstract", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "stringItemType" }, "bq_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAdditionalDeductionPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Effective income tax rate reconciliation non-deductible expense research and development additional deduction percentage.", "label": "Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development Additional Deduction Percentage", "terseLabel": "Effective income tax rate reconciliation non-deductible expense research and development additional deduction percentage" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAdditionalDeductionPercentage", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationParentheticalDetail" ], "xbrltype": "percentItemType" }, "bq_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Effective income tax rate reconciliation non-deductible expense research and development percentage.", "label": "Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development Percentage", "terseLabel": "Effective income tax rate reconciliation non-deductible expense research and development percentage" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentPercentage", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationParentheticalDetail" ], "xbrltype": "percentItemType" }, "bq_EffectiveOfIncomeTaxHolidayAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Effective of income tax holiday amount.", "label": "Effective Of Income Tax Holiday Amount", "terseLabel": "Tax holiday effect" } } }, "localname": "EffectiveOfIncomeTaxHolidayAmount", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/IncomeTaxesSummaryOfIncomeTaxHolidayDetail" ], "xbrltype": "monetaryItemType" }, "bq_EffectiveOfIncomeTaxHolidayNetIncomeLossPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Effective of income tax holiday net income loss per share.", "label": "Effective Of Income Tax Holiday Net Income Loss Per Share", "terseLabel": "Basic and diluted net loss per share effect" } } }, "localname": "EffectiveOfIncomeTaxHolidayNetIncomeLossPerShare", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/IncomeTaxesSummaryOfIncomeTaxHolidayDetail" ], "xbrltype": "perShareItemType" }, "bq_EmployeesAndNonEmployeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Employees and Non Employees [Member]", "terseLabel": "Employees and Non Employees [Member]" } } }, "localname": "EmployeesAndNonEmployeesMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationAdditionalInformationDetail", "http://Boqii.com/role/ShareBasedCompensationTables" ], "xbrltype": "domainItemType" }, "bq_EntityDescriptionOfPrincipalActivities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Entity description of principal activities.", "label": "Entity Description Of Principal Activities", "terseLabel": "Principal activities" } } }, "localname": "EntityDescriptionOfPrincipalActivities", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail" ], "xbrltype": "stringItemType" }, "bq_EquityInterestPledgeAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Interest Pledge Agreements [Member]", "terseLabel": "Equity Interest Pledge Agreements [Member]" } } }, "localname": "EquityInterestPledgeAgreementsMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_EquityMethodInvestmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity method investment.", "label": "Equity Method Investment [Member]" } } }, "localname": "EquityMethodInvestmentMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_EquityOwnerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity owner.", "label": "Equity Owner [Member]" } } }, "localname": "EquityOwnerMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_EquitySecuritiesWithReadilyDeterminableFairValueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Securities With Readily Determinable Fair Value [Line Items]" } } }, "localname": "EquitySecuritiesWithReadilyDeterminableFairValueLineItems", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsSummaryOfEquitySecuritiesWithReadilyDeterminableFairValuesDetail" ], "xbrltype": "stringItemType" }, "bq_EquitySecuritiesWithReadilyDeterminableFairValueTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Securities With Readily Determinable Fair Value [Table]" } } }, "localname": "EquitySecuritiesWithReadilyDeterminableFairValueTable", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsSummaryOfEquitySecuritiesWithReadilyDeterminableFairValuesDetail" ], "xbrltype": "stringItemType" }, "bq_EquitySecuritiesWithReadilyDeterminableFairValues": { "auth_ref": [], "calculation": { "http://Boqii.com/role/LongTermInvestmentsSummaryOfLongTermInvestmentDetail": { "order": 3.0, "parentTag": "us-gaap_LongTermInvestments", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity securities with readily determinable fair values.", "label": "Equity Securities With Readily Determinable Fair Values", "terseLabel": "Equity securities with readily determinable fair values" } } }, "localname": "EquitySecuritiesWithReadilyDeterminableFairValues", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsSummaryOfLongTermInvestmentDetail" ], "xbrltype": "monetaryItemType" }, "bq_EquitySecuritiesWithReadilyDeterminableFairValuesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity securities with readily determinable fair values.", "label": "Equity Securities With Readily Determinable Fair Values [Table Text Block]", "terseLabel": "Summary of Equity Securities With Readily Determinable Fair Values" } } }, "localname": "EquitySecuritiesWithReadilyDeterminableFairValuesTableTextBlock", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsTables" ], "xbrltype": "textBlockItemType" }, "bq_EventAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Event [Axis]" } } }, "localname": "EventAxis", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "bq_EventDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Event [Domain]" } } }, "localname": "EventDomain", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_ExtensionOfLoanAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension Of Loan Agreement.", "label": "Extension Of Loan Agreement [Member]", "terseLabel": "Extension of Loan Agreement [Member]" } } }, "localname": "ExtensionOfLoanAgreementMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_FairValueChangeOfDerivativeLiabilities": { "auth_ref": [], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 23.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value change of derivative liabilities.", "label": "Fair Value Change Of Derivative Liabilities", "negatedLabel": "Fair value change of derivative liabilities" } } }, "localname": "FairValueChangeOfDerivativeLiabilities", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "bq_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationOfForwardExchangeContracts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value measurement with unobservable inputs reconciliation recurring basis liability reclassification of forward exchange contracts.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Reclassification of Forward Exchange Contracts", "terseLabel": "Reclassification of forward exchange contracts" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationOfForwardExchangeContracts", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfRollForwardOfMajorLevel3InvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "bq_FeiWangMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fei Wang [Member]", "terseLabel": "Fei Wang [Member]" } } }, "localname": "FeiWangMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfMajorRelatedPartiesAndTheirRelationshipsWithTheCompanyDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesParentheticalDetail" ], "xbrltype": "domainItemType" }, "bq_ForeignCurrencyIncreaseDecreasePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign currency increase (decrease) percentage.", "label": "Foreign Currency Increase Decrease Percentage", "terseLabel": "Foreign currency increase (decrease) percentage" } } }, "localname": "ForeignCurrencyIncreaseDecreasePercentage", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RisksAndConcentrationAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "bq_ForeignExchangeSwapAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign exchange swap.", "label": "Foreign Exchange Swap [Axis]" } } }, "localname": "ForeignExchangeSwapAxis", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "bq_ForeignExchangeSwapDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign exchange swap.", "label": "Foreign Exchange Swap [Domain]" } } }, "localname": "ForeignExchangeSwapDomain", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_ForeignExchangeSwapOneAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign exchange swap one.", "label": "Foreign Exchange Swap One [Axis]" } } }, "localname": "ForeignExchangeSwapOneAxis", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "bq_ForeignExchangeSwapOneDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign exchange swap one.", "label": "Foreign Exchange Swap One [Domain]" } } }, "localname": "ForeignExchangeSwapOneDomain", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_FromMayTwoThousandAndTwentyOneToMayTwoThousandAndTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "From may two thousand and twenty one to may two thousand and twenty two.", "label": "From May Two Thousand And Twenty One To May Two Thousand And Twenty Two [Member]", "terseLabel": "From May 2021 To May 2022 [Member]" } } }, "localname": "FromMayTwoThousandAndTwentyOneToMayTwoThousandAndTwentyTwoMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsParentheticalDetail" ], "xbrltype": "domainItemType" }, "bq_FromOctoberTwoThousandAndTwentyThreeToMarchTwoThousandAndTwentyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "From october two thousand and twenty three to march two thousand and twenty four.", "label": "From October Two Thousand And Twenty Three To March Two Thousand And Twenty Four [Member]", "terseLabel": "From October 2023 to March 2024 [Member]" } } }, "localname": "FromOctoberTwoThousandAndTwentyThreeToMarchTwoThousandAndTwentyFourMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_FulfilmentExpenses": { "auth_ref": [], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 15.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fulfilment expenses.", "label": "Fulfilment Expenses", "negatedLabel": "Fulfillment expenses" } } }, "localname": "FulfilmentExpenses", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "bq_FulfilmentExpensesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fulfilment expenses policy text block.", "label": "Fulfilment expenses [Policy Text Block]", "terseLabel": "Fulfillment expenses" } } }, "localname": "FulfilmentExpensesPolicyTextBlock", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "bq_GeneralAndAdministrativeExpensesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "General and administrative expenses policy text block.", "label": "General and administrative expenses [Policy Text Block]", "terseLabel": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpensesPolicyTextBlock", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "bq_GoodwillAdditionsTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Goodwill additions transaction.", "label": "Goodwill Additions Transaction", "terseLabel": "Additions" } } }, "localname": "GoodwillAdditionsTransaction", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/GoodwillScheduleOfChangesInTheCarryingAmountOfGoodwillDetail" ], "xbrltype": "monetaryItemType" }, "bq_GovernmentGrantPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Government grant policy text block.", "label": "Government grant [Policy Text Block]", "terseLabel": "Government grants" } } }, "localname": "GovernmentGrantPolicyTextBlock", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "bq_GuangchengShanghaiInformationTechnologyCoLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Guangcheng (Shanghai) Information Technology Co Ltd.", "label": "Guangcheng Shanghai Information Technology Co Ltd [Member]", "terseLabel": "Guangcheng (Shanghai) Information Technology Co., Ltd. (\"Guangcheng\") [Member]" } } }, "localname": "GuangchengShanghaiInformationTechnologyCoLtdMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail" ], "xbrltype": "domainItemType" }, "bq_ImpliedPriceToSalesAfterDiscountForLackOfMarketabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Implied price to sales after discount for lack of marketability.", "label": "Implied Price To Sales After Discount For Lack Of Marketability [Member]", "terseLabel": "Implied price to sales after discount for lack of marketability [Member]" } } }, "localname": "ImpliedPriceToSalesAfterDiscountForLackOfMarketabilityMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfSignificantUnobservableInputsDetail" ], "xbrltype": "domainItemType" }, "bq_IncreaseDecreaseInOperatingLeaseLiabilities": { "auth_ref": [], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 45.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in operating lease liabilities.", "label": "Increase Decrease In Operating Lease Liabilities", "terseLabel": "Operating lease liabilities" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiabilities", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "bq_IntellectualPropertyLicenseAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Intellectual Property License Agreements [Member]", "terseLabel": "Intellectual Property License Agreements [Member]" } } }, "localname": "IntellectualPropertyLicenseAgreementsMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_InterCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Inter company.", "label": "Inter Company [Member]", "terseLabel": "Inter-company [Member]" } } }, "localname": "InterCompanyMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "domainItemType" }, "bq_InterestExpenseReversed": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest expense reversed.", "label": "Interest Expense Reversed", "terseLabel": "Interest Expense Reversed" } } }, "localname": "InterestExpenseReversed", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "bq_InterestIncomeOnSubscriptionReceivableFromShareholders": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest income on subscription receivable from shareholders.", "label": "Interest Income On Subscription Receivable From Shareholders", "terseLabel": "Interest income on subscription receivable from shareholders" } } }, "localname": "InterestIncomeOnSubscriptionReceivableFromShareholders", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ReceivableForIssuanceOfOrdinarySharesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "bq_InterestOfLeaseLiabilities": { "auth_ref": [], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 30.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest of lease liabilities.", "label": "Interest Of Lease Liabilities", "terseLabel": "Interest of lease liabilities" } } }, "localname": "InterestOfLeaseLiabilities", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "bq_InterestReceivableForIssuanceOfOrdinaryShares": { "auth_ref": [], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 28.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest receivable for issuance of ordinary shares.", "label": "Interest Receivable For Issuance Of Ordinary Shares", "negatedLabel": "Interest receivable for issuance of ordinary shares" } } }, "localname": "InterestReceivableForIssuanceOfOrdinaryShares", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "bq_IntraGroupOperatingExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intra Group Operating Expenses.", "label": "Intra Group Operating Expenses", "terseLabel": "Inter-company operating expenses" } } }, "localname": "IntraGroupOperatingExpenses", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "bq_IntraGroupPayablesDueToSubsidiariesCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Intra group payables due to subsidiaries current.", "label": "Intra Group Payables Due To Subsidiaries Current", "verboseLabel": "Inter-company payables" } } }, "localname": "IntraGroupPayablesDueToSubsidiariesCurrent", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "bq_IntraGroupReceivablesDueFromTheCompanySubsidiaries": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intra Group Receivables due from the Company Subsidiaries.", "label": "Intra Group Receivables Due From The Company Subsidiaries", "verboseLabel": "Inter-company receivables" } } }, "localname": "IntraGroupReceivablesDueFromTheCompanySubsidiaries", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "bq_InvestmentInEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment in entity.", "label": "Investment In Entity [Axis]", "terseLabel": "Investment In Entity [Axis]" } } }, "localname": "InvestmentInEntityAxis", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "bq_InvestmentInEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment in entity.", "label": "Investment In Entity [Domain]", "terseLabel": "Investment In Entity [Domain]" } } }, "localname": "InvestmentInEntityDomain", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_InvestmentIncome": { "auth_ref": [], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 37.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investment income.", "label": "Investment Income", "terseLabel": "Investment income" } } }, "localname": "InvestmentIncome", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "bq_InvestorOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investor One [Member].", "label": "Investor One [Member]" } } }, "localname": "InvestorOneMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_InvestorTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investor two [Member].", "label": "Investor Two [Member]" } } }, "localname": "InvestorTwoMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_JiangsuNanjingAgriculturalUniversityAnimalPharmaceuticalCoLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Jiangsu nanjing agricultural university animal pharmaceutical\u00a0Co\u00a0Ltd", "label": "Jiangsu Nanjing Agricultural University Animal Pharmaceutical Co Ltd [Member]", "terseLabel": "Jiangsu Nanjing Agricultural University Animal Pharmaceutical Co Ltd [Member]" } } }, "localname": "JiangsuNanjingAgriculturalUniversityAnimalPharmaceuticalCoLtdMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_LijunZhouMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lijun Zhou [Member]" } } }, "localname": "LijunZhouMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfMajorRelatedPartiesAndTheirRelationshipsWithTheCompanyDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesDetail" ], "xbrltype": "domainItemType" }, "bq_LoanAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loan Agreement [Member]" } } }, "localname": "LoanAgreementMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesParentheticalDetail" ], "xbrltype": "domainItemType" }, "bq_LoanAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loan Agreements [Member]", "terseLabel": "Loan Agreements [Member]" } } }, "localname": "LoanAgreementsMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_LoanForYokenSeriesAOneWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loan for yoken series A one warrant.", "label": "Loan For Yoken Series A One Warrant [Member]", "terseLabel": "Loan for Yoken Series A-1 Warrant [Member]" } } }, "localname": "LoanForYokenSeriesAOneWarrantMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfOtherLongTermDebtDetail" ], "xbrltype": "domainItemType" }, "bq_LoanFromChongLiMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loan from chong Li.", "label": "Loan From Chong Li [Member]", "terseLabel": "Loan from Chong Li [Member]" } } }, "localname": "LoanFromChongLiMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfOtherLongTermDebtDetail" ], "xbrltype": "domainItemType" }, "bq_LoanReceivableFixedRateOfInterestPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loan receivable fixed rate of interest percentage.", "label": "Loan Receivable Fixed Rate Of Interest Percentage", "terseLabel": "Loan receivable fixed rate of interest percentage" } } }, "localname": "LoanReceivableFixedRateOfInterestPercentage", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "bq_LoanReceivableForThePeriodTwentyFourToThirtySixMonthsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loan receivable for the period twenty four to thirty six months.", "label": "Loan Receivable For The Period Twenty Four To Thirty Six Months [Member]", "terseLabel": "Loan Receivable for the Period 24 to 36 Months [Member]" } } }, "localname": "LoanReceivableForThePeriodTwentyFourToThirtySixMonthsMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsParentheticalDetail" ], "xbrltype": "domainItemType" }, "bq_LoansGrantedFromRelatedParties": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Loans granted from related parties.", "label": "Loans Granted From Related Parties", "verboseLabel": "Loans granted from related parties" } } }, "localname": "LoansGrantedFromRelatedParties", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionDetail" ], "xbrltype": "monetaryItemType" }, "bq_LoansReceivableMonthOfMaturity": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loans receivable month of maturity.", "label": "Loans Receivable Month Of Maturity", "terseLabel": "Loans receivable month of maturity" } } }, "localname": "LoansReceivableMonthOfMaturity", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsParentheticalDetail", "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsAdditionalInformationDetail" ], "xbrltype": "gYearMonthItemType" }, "bq_LoansReceivablePeriodRangingFromTwelveToTwentyFourMonthsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loans receivable period ranging from twelve to twenty four months.", "label": "Loans Receivable Period Ranging From Twelve To Twenty Four Months [Member]", "terseLabel": "Loans Receivable Period Ranging From 12 To 24 Months [Member]" } } }, "localname": "LoansReceivablePeriodRangingFromTwelveToTwentyFourMonthsMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_LoansReceivableTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loans receivable term.", "label": "Loans Receivable Term" } } }, "localname": "LoansReceivableTerm", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsParentheticalDetail" ], "xbrltype": "durationItemType" }, "bq_LoansReceivableWaivedAndConvertedIntoShares": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Loans receivable waived and converted into shares.", "label": "Loans Receivable Waived And Converted Into Shares", "terseLabel": "Loans receivable waived and converted into shares" } } }, "localname": "LoansReceivableWaivedAndConvertedIntoShares", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "bq_LoansReceivablesAdvancedToARelatedParty": { "auth_ref": [], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Loans receivables advanced to a related party.", "label": "Loans Receivables Advanced To A Related Party", "negatedLabel": "Loan receivables advanced to related parties" } } }, "localname": "LoansReceivablesAdvancedToARelatedParty", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "bq_LoansReceivablesAdvancedToThirdParty": { "auth_ref": [], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Loans receivables advanced to a third party.", "label": "Loans Receivables Advanced To Third Party", "negatedLabel": "Loan receivables advanced to third parties" } } }, "localname": "LoansReceivablesAdvancedToThirdParty", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "bq_LoansToRelatedParties": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Loans to related parties", "documentation": "Loans to related parties.", "label": "Loans To Related Parties" } } }, "localname": "LoansToRelatedParties", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesDetail" ], "xbrltype": "monetaryItemType" }, "bq_LogisticsExpensesPayables": { "auth_ref": [], "calculation": { "http://Boqii.com/role/AccruedLiabilitiesAndOtherCurrentLiabilitiesScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesDetail": { "order": 6.0, "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Logistics expenses payables.", "label": "Logistics Expenses Payables", "terseLabel": "Logistics expenses payables" } } }, "localname": "LogisticsExpensesPayables", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/AccruedLiabilitiesAndOtherCurrentLiabilitiesScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "bq_LongTermBankLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long Term Bank Loan [Member]", "terseLabel": "Long Term Bank Loan [Member]" } } }, "localname": "LongTermBankLoanMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_LongTermInvestmentsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long term investments.", "label": "Long Term Investments [Text Block]", "terseLabel": "Long-term investments" } } }, "localname": "LongTermInvestmentsTextBlock", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/LongTermInvestments" ], "xbrltype": "textBlockItemType" }, "bq_LongTermLoanFromCmbMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long term loan from CMB.", "label": "Long Term Loan From CMB [Member]", "terseLabel": "Loan from CMB [Member]" } } }, "localname": "LongTermLoanFromCmbMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfOtherLongTermDebtDetail" ], "xbrltype": "domainItemType" }, "bq_LongtermInvestmentsAndReceivablesNetLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long-term investments and receivables, net.", "label": "Longterm Investments and Receivables Net [Line Items]", "terseLabel": "Long term Investments and Receivables Net [Line Items]" } } }, "localname": "LongtermInvestmentsAndReceivablesNetLineItems", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "bq_LongtermInvestmentsAndReceivablesNetTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long-term investments and receivables, net.", "label": "Longterm Investments and Receivables Net [Table]", "terseLabel": "Long term Investments and Receivables Net [Table]" } } }, "localname": "LongtermInvestmentsAndReceivablesNetTable", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "bq_LossGainOnDisposalOfPropertyAndEquipmentAndIntangibleAssets": { "auth_ref": [], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 40.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Loss/(gain) on disposal of property and equipment and intangible assets.", "label": "Loss(Gain) On Disposal Of Property And Equipment And Intangible Assets", "negatedLabel": "Loss/(gain) on disposal of property and equipment and intangible assets" } } }, "localname": "LossGainOnDisposalOfPropertyAndEquipmentAndIntangibleAssets", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "bq_MaximumPercentageOfEntityInterestsAcquirableInVariableInterestEntityUnderPrcLaw": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Maximum entity interests acquirable In variable Interest Entity Under PRC law.", "label": "Maximum Percentage of Entity Interests Acquirable In Variable Interest Entity Under Prc law", "terseLabel": "Percentage of Maximum entity interests acquirable In variable Interest Entity Under PRC law" } } }, "localname": "MaximumPercentageOfEntityInterestsAcquirableInVariableInterestEntityUnderPrcLaw", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "bq_MerchantTycoonLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "MERCHANT TYCOON LIMITED [Member]", "terseLabel": "Merchant Tycoon Limited [Member]" } } }, "localname": "MerchantTycoonLimitedMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfMajorRelatedPartiesAndTheirRelationshipsWithTheCompanyDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesDetail" ], "xbrltype": "domainItemType" }, "bq_MinimumOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum One [Member]", "label": "Minimum One [Member]", "terseLabel": "Minimum One [Member]" } } }, "localname": "MinimumOneMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfSignificantUnobservableInputsDetail" ], "xbrltype": "domainItemType" }, "bq_MinimumPortionOfAfterTaxProfitToBeAllocatedToStatutorySurplusUnderPRCLaw": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum portion of after tax profit to be allocated to statutory surplus under PRC law.", "label": "Minimum Portion Of After Tax Profit To Be Allocated To Statutory Surplus Under P R C Law", "terseLabel": "Required minimum percentage of annual appropriations to general reserve fund" } } }, "localname": "MinimumPortionOfAfterTaxProfitToBeAllocatedToStatutorySurplusUnderPRCLaw", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RestrictedNetAssetsAdditionalInformationDetail" ], "xbrltype": "pureItemType" }, "bq_MinimumThresholdThirdPartyClaimAgainstNomineeShareholders": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Third party claim against nominee shareholders.", "label": "Minimum Threshold Third Party Claim Against Nominee Shareholders", "terseLabel": "Third party claim against nominee shareholders" } } }, "localname": "MinimumThresholdThirdPartyClaimAgainstNomineeShareholders", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "bq_MinimumTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum Two [Member]", "label": "Minimum Two [Member]", "terseLabel": "Minimum Two [Member]" } } }, "localname": "MinimumTwoMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfSignificantUnobservableInputsDetail" ], "xbrltype": "domainItemType" }, "bq_NanjingAgriculturalPharmaceuticalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nanjing Agricultural Pharmaceutical [Member].", "label": "Nanjing Agricultural Pharmaceutical [Member]" } } }, "localname": "NanjingAgriculturalPharmaceuticalMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesParentheticalDetail" ], "xbrltype": "domainItemType" }, "bq_NanjingAnimalPharmaceuticalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nanjing Animal Pharmaceutical [Member]", "terseLabel": "Nanjing Animal Pharmaceutical [Member]" } } }, "localname": "NanjingAnimalPharmaceuticalMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfMajorRelatedPartiesAndTheirRelationshipsWithTheCompanyDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueToRelatedPartiesDetail", "http://Boqii.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_NanjingCuidaBiotechnologyCoLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nanjing Cuida Biotechnology Co Ltd [Member]", "terseLabel": "Nanjing Cuida Biotechnology Co. Ltd.(\"Cuida\") [Member]" } } }, "localname": "NanjingCuidaBiotechnologyCoLtdMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BusinessCombinationsAdditionalInformationDetail", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail" ], "xbrltype": "domainItemType" }, "bq_NanjingXingmuBiotechnologyCoLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nanjing Xingmu Biotechnology Co Ltd [Member]", "terseLabel": "Nanjing Xingmu Biotechnology Co., Ltd. (\"Nanjing Xingmu\") [Member]" } } }, "localname": "NanjingXingmuBiotechnologyCoLtdMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail" ], "xbrltype": "domainItemType" }, "bq_NanjingXinmuInformationTechnologyCoLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nanjing Xinmu Information Technology Co Ltd [Member]", "terseLabel": "Nanjing Xinmu Information Technology Co., Ltd. (\"Xinmu WFOE\") [Member]" } } }, "localname": "NanjingXinmuInformationTechnologyCoLtdMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail" ], "xbrltype": "domainItemType" }, "bq_NetCashProvidedByTransactionsWithExternalPartiesOperatingActivities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net Cash Provided by Transactions with External Parties Operating Activities.", "label": "Net Cash Provided by Transactions with External Parties Operating Activities", "terseLabel": "Net cash provided by transactions with external parties" } } }, "localname": "NetCashProvidedByTransactionsWithExternalPartiesOperatingActivities", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "bq_NetCashUsedInTransactionsWithIntraCompanyEntitiesOperatingActivities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net cash used in transactions with intra company entities operating activities.", "label": "Net Cash Used In Transactions With Intra Company Entities Operating Activities", "terseLabel": "Net cash used in transactions with the Company's entities" } } }, "localname": "NetCashUsedInTransactionsWithIntraCompanyEntitiesOperatingActivities", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "bq_NetIncomeLossAttributableToAfterRedemptionAndDividendForOrdinaryShareholders": { "auth_ref": [], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net income loss attributable to after redemption and dividend for ordinary shareholders.", "label": "Net Income Loss Attributable To After Redemption And Dividend For Ordinary Shareholders", "totalLabel": "Net loss attributable to Boqii Holding Limited's ordinary shareholders" } } }, "localname": "NetIncomeLossAttributableToAfterRedemptionAndDividendForOrdinaryShareholders", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "bq_NetIncomeLossAttributableToBeforeRedemptionAndDividend": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net income loss attributable to before redemption and dividend.", "label": "Net Income Loss Attributable To Before Redemption And Dividend", "terseLabel": "Net loss attributable to\u00a0Boqii Holding Limited" } } }, "localname": "NetIncomeLossAttributableToBeforeRedemptionAndDividend", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "monetaryItemType" }, "bq_NewForeignExchangeSwapContractMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New foreign exchange swap contract.", "label": "New Foreign Exchange Swap Contract [Member]" } } }, "localname": "NewForeignExchangeSwapContractMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_NewForeignExchangeSwapContractOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New foreign exchange swap contract one.", "label": "New Foreign Exchange Swap Contract One [Member]" } } }, "localname": "NewForeignExchangeSwapContractOneMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_NewForeignExchangeSwapContractThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New foreign exchange swap contract three.", "label": "New Foreign Exchange Swap Contract Three [Member]" } } }, "localname": "NewForeignExchangeSwapContractThreeMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_NewForeignExchangeSwapContractTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New foreign exchange swap contract two.", "label": "New Foreign Exchange Swap Contract Two [Member]" } } }, "localname": "NewForeignExchangeSwapContractTwoMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_NumberOfBusinessDaysInWhichAgreementAmountIsToPaidFromRelevantQuarter": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Business days in which agreement amount is to paid from relevant quarter.", "label": "Number of Business Days in which Agreement Amount is to Paid from Relevant Quarter", "terseLabel": "Number of Business days in which agreement amount is to paid from relevant quarter" } } }, "localname": "NumberOfBusinessDaysInWhichAgreementAmountIsToPaidFromRelevantQuarter", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "bq_NumberOfCustomers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of customers.", "label": "Number of Customers", "terseLabel": "Number of Customers" } } }, "localname": "NumberOfCustomers", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RisksAndConcentrationAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "bq_NumberOfSharesPerAds": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares per ADS.", "label": "Number of Shares Per ADS", "terseLabel": "Number of shares per ADS" } } }, "localname": "NumberOfSharesPerAds", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail" ], "xbrltype": "decimalItemType" }, "bq_OneYearLoanAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "One Year Loan Agreement [Member]", "terseLabel": "One Year Loan Agreement [Member]" } } }, "localname": "OneYearLoanAgreementMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesParentheticalDetail" ], "xbrltype": "domainItemType" }, "bq_OnlineMarketingAndInformationServicesAndOtherRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "definitionGuidance": "Cost of services [Member]", "label": "Online Marketing And Information Services And Other Revenue [Member]", "terseLabel": "Online Marketing And Information Services And Other Revenue [Member]", "verboseLabel": "Packaging materials and others [Member]" } } }, "localname": "OnlineMarketingAndInformationServicesAndOtherRevenueMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/AccountsReceivableNetSummaryOfAccountsReceivableNetDetail", "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://Boqii.com/role/InventoriesNetOfInventoryReservesSummaryOfInventoriesNetOfInventoryReservesDetail", "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_OrdinaryShareTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ordinary share.", "label": "Ordinary Share [Text Block]", "terseLabel": "Ordinary Share" } } }, "localname": "OrdinaryShareTextBlock", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrdinaryShare" ], "xbrltype": "textBlockItemType" }, "bq_OrganizationAndPrincipalActivitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization And Principal Activities [Line Items]" } } }, "localname": "OrganizationAndPrincipalActivitiesLineItems", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "bq_OrganizationAndPrincipalActivitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization And Principal Activities [Table]" } } }, "localname": "OrganizationAndPrincipalActivitiesTable", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "bq_OtherAssetsNonCurrentDisclosureTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other assets non current disclosure.", "label": "Other Assets Non Current Disclosure [Table]", "terseLabel": "Other Assets Non Current Disclosure [Table]" } } }, "localname": "OtherAssetsNonCurrentDisclosureTable", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsParentheticalDetail" ], "xbrltype": "stringItemType" }, "bq_OtherAssetsNoncurrentDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other assets noncurrent disclosure.", "label": "Other Assets Noncurrent Disclosure [Line Items]", "terseLabel": "Other Assets Noncurrent Disclosure [Line Items]" } } }, "localname": "OtherAssetsNoncurrentDisclosureLineItems", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsParentheticalDetail" ], "xbrltype": "stringItemType" }, "bq_OtherDebtNoncurrent": { "auth_ref": [], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 29.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other debt, noncurrent.", "label": "Other Debt Noncurrent", "terseLabel": "Other debts, non-current (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB157,874 and RMB 75,481 as of March 31, 2022 and 2023, respectively)", "verboseLabel": "Other debts,\u00a0non-current" } } }, "localname": "OtherDebtNoncurrent", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfOtherLongTermDebtDetail", "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "bq_OtherIncomeNet": { "auth_ref": [], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 18.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other income, net.", "label": "Other Income Net", "terseLabel": "Other income, net" } } }, "localname": "OtherIncomeNet", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "bq_OtherNoncurrentAssetsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other noncurrent assets.", "label": "Other Noncurrent Assets [Text Block]", "terseLabel": "Other\u00a0non-current\u00a0Assets" } } }, "localname": "OtherNoncurrentAssetsTextBlock", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OtherNonCurrentAssets" ], "xbrltype": "textBlockItemType" }, "bq_PayableForInvestment": { "auth_ref": [], "calculation": { "http://Boqii.com/role/AccruedLiabilitiesAndOtherCurrentLiabilitiesScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesDetail": { "order": 7.0, "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payable for Investment.", "label": "Payable For Investment", "terseLabel": "Payable for investment" } } }, "localname": "PayableForInvestment", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/AccruedLiabilitiesAndOtherCurrentLiabilitiesScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "bq_PayableForInvestmentNonCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payable for investment non current.", "label": "Payable For Investment Non Current", "verboseLabel": "Payable for investment" } } }, "localname": "PayableForInvestmentNonCurrent", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfOtherLongTermDebtDetail" ], "xbrltype": "monetaryItemType" }, "bq_PaymentTowardsAdvanceSettlementOfForeignExchangeSwaps": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment towards advance settlement of foreign exchange swaps.", "label": "Payment Towards Advance Settlement Of Foreign Exchange Swaps", "terseLabel": "Payment towards advance settlement of foreign exchange swaps" } } }, "localname": "PaymentTowardsAdvanceSettlementOfForeignExchangeSwaps", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "bq_PaymentsForProceedsFromSaleOfPropertyPlantAndEquipment": { "auth_ref": [], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Payments for (Proceeds from) Sale of Property, Plant, and Equipment.", "label": "Payments for (Proceeds from) Sale of Property, Plant, and Equipment", "terseLabel": "Disposal of property and equipment" } } }, "localname": "PaymentsForProceedsFromSaleOfPropertyPlantAndEquipment", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "bq_PercentageOfEquityInterestPledgedByNominalShareholders": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of equity interest pledged by nominal shareholders.", "label": "Percentage of Equity Interest Pledged By Nominal Shareholders", "terseLabel": "Percentage of equity interest pledged by nominal shareholders" } } }, "localname": "PercentageOfEquityInterestPledgedByNominalShareholders", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "bq_PercentageOfEquityInterestsTransferred": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of equity interests transferred.", "label": "Percentage Of Equity Interests Transferred", "terseLabel": "Percentage Of Equity Interests Transferred" } } }, "localname": "PercentageOfEquityInterestsTransferred", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "bq_PercentageOfNetAfterTaxProfitsToBeSetAsidePriorToPaymentOfDividendsAsGeneralReserveFundOrStatutorySurplusFund": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of net after tax profits to be set aside prior to payment of dividends as general reserve fund or statutory surplus fund.", "label": "Percentage Of Net After Tax Profits To Be Set Aside Prior To Payment Of Dividends As General Reserve Fund Or Statutory Surplus Fund", "terseLabel": "Required minimum percentage of annual appropriations to general reserve fund or statutory surplus fund" } } }, "localname": "PercentageOfNetAfterTaxProfitsToBeSetAsidePriorToPaymentOfDividendsAsGeneralReserveFundOrStatutorySurplusFund", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RestrictedNetAssetsAdditionalInformationDetail" ], "xbrltype": "pureItemType" }, "bq_PercentageOfPreferredSharesRedeemableAtRedemptionPriceMeasuredByInterestPerYearSinceIssuanceOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of preferred shares redeemable at redemption price measured by interest per year since issuance of shares.", "label": "Percentage of Preferred Shares Redeemable at Redemption Price Measured by Interest Per Year Since Issuance of Shares", "terseLabel": "Percentage of preferred shares redeemable at redemption price measured by Interest per year Since Issuance of shares" } } }, "localname": "PercentageOfPreferredSharesRedeemableAtRedemptionPriceMeasuredByInterestPerYearSinceIssuanceOfShares", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RedeemableNonControllingInterestsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "bq_PeriodOfAgreementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of agreement.", "label": "Period Of Agreement [Axis]" } } }, "localname": "PeriodOfAgreementAxis", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsParentheticalDetail", "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "bq_PeriodOfAgreementDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of agreement.", "label": "Period Of Agreement [Domain]" } } }, "localname": "PeriodOfAgreementDomain", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsParentheticalDetail", "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_PeriodOfPriorWrittenNoticeRequiredToTerminateAgreement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of prior written notice required to terminate agreement.", "label": "Period Of Prior Written Notice Required To Terminate Agreement", "terseLabel": "Period of prior written notice required to terminate the agreement" } } }, "localname": "PeriodOfPriorWrittenNoticeRequiredToTerminateAgreement", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "bq_PlaceOfIncorporation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Place of incorporation.", "label": "Place Of Incorporation", "terseLabel": "Place of incorporation" } } }, "localname": "PlaceOfIncorporation", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail" ], "xbrltype": "stringItemType" }, "bq_PreferentialTaxRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferential tax rate.", "label": "Preferential Tax Rate", "terseLabel": "Preferential tax rate" } } }, "localname": "PreferentialTaxRate", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "bq_PrepaymentsAndOtherCurrentAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prepayments and other current assets.", "label": "Prepayments And Other Current Assets [Line Items]", "terseLabel": "Notes and loans receivable net current" } } }, "localname": "PrepaymentsAndOtherCurrentAssetsLineItems", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "bq_PrepaymentsAndOtherCurrentAssetsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prepayments and other current assets\n\n.", "label": "Prepayments And Other Current Assets [Table]" } } }, "localname": "PrepaymentsAndOtherCurrentAssetsTable", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "bq_PrepaymentsAndOtherCurrentAssetsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prepayments and other current assets.", "label": "Prepayments And Other Current Assets [Text Block]", "terseLabel": "Prepayments and other current assets" } } }, "localname": "PrepaymentsAndOtherCurrentAssetsTextBlock", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssets" ], "xbrltype": "textBlockItemType" }, "bq_PrepaymentsForPurchasesOfProducts": { "auth_ref": [], "calculation": { "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsSummaryOfPrepaymentsAndOtherCurrentAssetsDetail": { "order": 2.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepayments for purchases of products .", "label": "Prepayments For Purchases Of Products", "terseLabel": "Prepayments for purchases of products" } } }, "localname": "PrepaymentsForPurchasesOfProducts", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsSummaryOfPrepaymentsAndOtherCurrentAssetsDetail" ], "xbrltype": "monetaryItemType" }, "bq_PrepaymentsToRelatedParties": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepayments to related parties.", "label": "Prepayments To Related Parties", "terseLabel": "Prepayments to related parties" } } }, "localname": "PrepaymentsToRelatedParties", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesDetail" ], "xbrltype": "monetaryItemType" }, "bq_PrincipalAccountingPoliciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Principal accounting policies line items.", "label": "Principal Accounting Policies [Line Items]", "terseLabel": "Principal Accounting Policies [Line Items]" } } }, "localname": "PrincipalAccountingPoliciesLineItems", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "bq_PrincipalAccountingPoliciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Principal accounting policies table.", "label": "Principal Accounting Policies [Table]", "terseLabel": "Principal Accounting Policies [Table]" } } }, "localname": "PrincipalAccountingPoliciesTable", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "bq_ProbabilityIpoScenarioMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Probability IPO scenario.", "label": "Probability IPO Scenario [Member]", "terseLabel": "Probability IPO scenario [Member]" } } }, "localname": "ProbabilityIpoScenarioMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfSignificantUnobservableInputsDetail" ], "xbrltype": "domainItemType" }, "bq_ProbabilityLiquidationScenarioMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Probability liquidation scenario.", "label": "Probability Liquidation Scenario [Member]", "terseLabel": "Probability Liquidation scenario [Member]" } } }, "localname": "ProbabilityLiquidationScenarioMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfSignificantUnobservableInputsDetail" ], "xbrltype": "domainItemType" }, "bq_ProbabilityRedemptionScenarioMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Probability redemption scenario.", "label": "Probability Redemption Scenario [Member]", "terseLabel": "Probability Redemption scenario [Member]" } } }, "localname": "ProbabilityRedemptionScenarioMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfSignificantUnobservableInputsDetail" ], "xbrltype": "domainItemType" }, "bq_ProductSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "definitionGuidance": "Cost of product sales [Member]", "label": "Product Sales [Member]", "terseLabel": "Product Sales [Member]", "verboseLabel": "Products [Member]" } } }, "localname": "ProductSalesMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/AccountsReceivableNetSummaryOfAccountsReceivableNetDetail", "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://Boqii.com/role/InventoriesNetOfInventoryReservesSummaryOfInventoriesNetOfInventoryReservesDetail", "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_ProvisionReversalOfInventoryReserve": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Provision reversal of inventory reserve.", "label": "Provision Reversal Of Inventory Reserve", "terseLabel": "Provision/(reversal)" } } }, "localname": "ProvisionReversalOfInventoryReserve", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/InventoriesNetOfInventoryReservesSummaryOfMovementOfInventoryProvisionDetail" ], "xbrltype": "monetaryItemType" }, "bq_PurchasesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchases.", "label": "Purchases [Member]" } } }, "localname": "PurchasesMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RisksAndConcentrationSchedulesOfConcentrationOfRiskByRiskFactorDetail" ], "xbrltype": "domainItemType" }, "bq_QingdaoShuanganBiotechnologyCoLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Qingdao shuangan botechnology co ltd.", "label": "Qingdao Shuangan Biotechnology Co Ltd [Member]", "terseLabel": "Qingdao Shuangan Biotechnology Co Ltd [Member]" } } }, "localname": "QingdaoShuanganBiotechnologyCoLtdMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_QingdaoShuanganMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Qingdao shuangan.", "label": "Qingdao Shuangan [Member]", "terseLabel": "Qingdao Shuangan [Member]" } } }, "localname": "QingdaoShuanganMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_ReceivableForTheIssuanceOfOrdinarySharesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Receivable for the issuance of ordinary shares.", "label": "Receivable For The Issuance Of Ordinary Shares [Line Items]" } } }, "localname": "ReceivableForTheIssuanceOfOrdinarySharesLineItems", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ReceivableForIssuanceOfOrdinarySharesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "bq_ReceivableForTheIssuanceOfOrdinarySharesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Receivable for the issuance of ordinary shares.", "label": "Receivable For The Issuance Of Ordinary Shares [Table]" } } }, "localname": "ReceivableForTheIssuanceOfOrdinarySharesTable", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ReceivableForIssuanceOfOrdinarySharesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "bq_ReceivableForTheIssuanceOfOrdinarySharesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Receivable for the issuance of ordinary shares.", "label": "Receivable For The Issuance Of Ordinary Shares [Text Block]", "terseLabel": "Receivable for issuance of ordinary shares" } } }, "localname": "ReceivableForTheIssuanceOfOrdinarySharesTextBlock", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ReceivableForIssuanceOfOrdinaryShares" ], "xbrltype": "textBlockItemType" }, "bq_RedeemableNonControllingInterests": { "auth_ref": [], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 31.0, "parentTag": "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Redeemable\u00a0non-controlling\u00a0interests.", "label": "Redeemable Non Controlling Interests", "verboseLabel": "Redeemable\u00a0non-controlling\u00a0interests" } } }, "localname": "RedeemableNonControllingInterests", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "bq_RedeemableNoncontrollingInterestTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redeemable non-controlling interest.", "label": "Redeemable Noncontrolling Interest [Text Block]", "terseLabel": "Redeemable\u00a0non-controlling\u00a0interests" } } }, "localname": "RedeemableNoncontrollingInterestTextBlock", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RedeemableNonControllingInterests" ], "xbrltype": "textBlockItemType" }, "bq_RedemptionOfInvestmentPeriodFromTheTransactionClosingDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption of investment period from the transaction closing date.", "label": "Redemption Of Investment Period From The Transaction Closing Date", "terseLabel": "Redemption of investment period" } } }, "localname": "RedemptionOfInvestmentPeriodFromTheTransactionClosingDate", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "bq_ReimbursementDepositaryReceived": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reimbursement depositary received.", "label": "Reimbursement Depositary Received", "terseLabel": "Reimbursement depositary received" } } }, "localname": "ReimbursementDepositaryReceived", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OtherGainsNetSummaryOfOtherLossesNetParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "bq_ReimbursementsFromADepositaryBank": { "auth_ref": [], "calculation": { "http://Boqii.com/role/OtherGainsNetSummaryOfOtherLossesNetDetail": { "order": 5.0, "parentTag": "us-gaap_NonoperatingGainsLosses", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reimbursement from a depositary bank.", "label": "Reimbursements From A Depositary Bank", "terseLabel": "Reimbursement from a depositary bank" } } }, "localname": "ReimbursementsFromADepositaryBank", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OtherGainsNetSummaryOfOtherLossesNetDetail" ], "xbrltype": "monetaryItemType" }, "bq_RelatedPartyTransactionsLoansGrantedToRelatedParties": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Related party transactions loans granted to related parties.", "label": "Related Party Transactions Loans Granted to Related Parties", "presentationGuidance": "Loans granted to related parties" } } }, "localname": "RelatedPartyTransactionsLoansGrantedToRelatedParties", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesDetail" ], "xbrltype": "monetaryItemType" }, "bq_RepaymentOfLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Repayment of Loan [Member]", "terseLabel": "Repayment of Loan [Member]" } } }, "localname": "RepaymentOfLoanMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_ReportingUnitAmountOfFairValueLessThanCarryingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reporting unit amount of fair value less than carrying amount.", "label": "Reporting Unit Amount Of Fair Value Less Than Carrying Amount", "terseLabel": "Reporting Unit, Amount of Fair Value Less Than Carrying Amount" } } }, "localname": "ReportingUnitAmountOfFairValueLessThanCarryingAmount", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/GoodwillAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "bq_RequiredStatutorySurplusRegisteredCapitalRatioToDeforceCompulsoryNetProfitAllocationToStatutorySurplus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Required statutory surplus registered capital ratio to deforce compulsory net profit allocation to statutory surplus.", "label": "Required Statutory Surplus Registered Capital Ratio To Deforce Compulsory Net Profit Allocation To Statutory Surplus", "terseLabel": "Maximum percentage of statutory surplus reserve related to entity's registered capital" } } }, "localname": "RequiredStatutorySurplusRegisteredCapitalRatioToDeforceCompulsoryNetProfitAllocationToStatutorySurplus", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RestrictedNetAssetsAdditionalInformationDetail" ], "xbrltype": "pureItemType" }, "bq_RestrictedNetAssetsOfCompanysSubsidiariesAndVIEs": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Restricted net assets of the Company's subsidiaries and the VIEs.", "label": "Restricted Net Assets Of Companys Subsidiaries And V I Es", "terseLabel": "Restricted net assets of the Company's subsidiaries and the VIEs." } } }, "localname": "RestrictedNetAssetsOfCompanysSubsidiariesAndVIEs", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RestrictedNetAssetsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "bq_ReversalProvisionOfInventoryReserve": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reversal provision of inventory reserve.", "label": "Reversal Provision Of Inventory Reserve", "terseLabel": "(Reversal) Provision of inventory reserves" } } }, "localname": "ReversalProvisionOfInventoryReserve", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/InventoriesNetOfInventoryReservesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "bq_RoyalCaninChinaCoLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Royal canin china co., ltd member.", "label": "Royal Canin China Co Ltd [Member]", "terseLabel": "Royal Canin China Co., Ltd [Member]" } } }, "localname": "RoyalCaninChinaCoLtdMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RisksAndConcentrationAdditionalInformationDetail", "http://Boqii.com/role/RisksAndConcentrationSchedulesOfConcentrationOfRiskByRiskFactorDetail" ], "xbrltype": "domainItemType" }, "bq_SalesIncentivesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sales incentives policy text block.", "label": "Sales incentives [Policy Text Block]", "terseLabel": "Sales incentives" } } }, "localname": "SalesIncentivesPolicyTextBlock", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "bq_SalesReturnAssets": { "auth_ref": [], "calculation": { "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsSummaryOfPrepaymentsAndOtherCurrentAssetsDetail": { "order": 5.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sales return assets.", "label": "Sales Return Assets", "terseLabel": "Sales return assets" } } }, "localname": "SalesReturnAssets", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsSummaryOfPrepaymentsAndOtherCurrentAssetsDetail" ], "xbrltype": "monetaryItemType" }, "bq_ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of accrued liabilities and other current liabilities.", "label": "Schedule Of Accrued Liabilities And Other Current Liabilities [Table Text Block]", "terseLabel": "Schedule of Accrued Liabilities and Other Current Liabilities" } } }, "localname": "ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/AccruedLiabilitiesAndOtherCurrentLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "bq_ScheduleOfDerivativeLiabilitiesAtFairValueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of derivative liabilities at fair value.", "label": "Schedule Of Derivative Liabilities At Fair Value [Line Items]" } } }, "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueLineItems", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfFairValueOfDerivativeLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "bq_ScheduleOfDerivativeLiabilitiesAtFairValueTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of derivative liabilities at fair value.", "label": "Schedule Of Derivative Liabilities At Fair Value [Table]" } } }, "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueTable", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfFairValueOfDerivativeLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "bq_ScheduleOfFiniteLivedIntangibleAssetsUsefulLivesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of finite lived intangible assets useful lives table text block.", "label": "Schedule of Finite Lived Intangible Assets Useful Lives [Table Text Block]", "terseLabel": "Schedule of Finite Lived Intangible Assets Useful Lives" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsUsefulLivesTableTextBlock", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "bq_ScheduleOfLongTermInvestmentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of long term investments.", "label": "Schedule Of Long Term Investments [Table Text Block]", "terseLabel": "Summary of Long-Term Investment" } } }, "localname": "ScheduleOfLongTermInvestmentsTableTextBlock", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsTables" ], "xbrltype": "textBlockItemType" }, "bq_ScheduleOfMovementOfInventoryProvisionTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of movement of inventory provision.", "label": "Schedule Of Movement Of Inventory Provision [Table Text Block]", "terseLabel": "Summary of Movement of inventory provision" } } }, "localname": "ScheduleOfMovementOfInventoryProvisionTableTextBlock", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/InventoriesNetOfInventoryReservesTables" ], "xbrltype": "textBlockItemType" }, "bq_ScheduleOfPropertyPlantAndEquipmentUsefulLivesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of property plant and equipment useful lives table text block.", "label": "Schedule Of Property Plant And Equipment Useful Lives [Table Text Block]", "terseLabel": "Schedule of Property Plant and Equipment & Useful Lives" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentUsefulLivesTableTextBlock", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "bq_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Line Items]" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedLineItems", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail", "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetailParenthetical" ], "xbrltype": "stringItemType" }, "bq_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table]" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTable", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail", "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetailParenthetical" ], "xbrltype": "stringItemType" }, "bq_ScheduleOfRelatedPartyTransactionsByRelatedPartyTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of related party transactions by related party.", "label": "Schedule Of Related Party Transactions By Related Party [Table Text Block]", "terseLabel": "Summary of Related Party Transactions" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTableTextBlock", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsTables" ], "xbrltype": "textBlockItemType" }, "bq_ScheduleOfSubsidiariesAndVariableInterestEntitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Subsidiaries And Variable Interest Entities [Line Items]" } } }, "localname": "ScheduleOfSubsidiariesAndVariableInterestEntitiesLineItems", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail" ], "xbrltype": "stringItemType" }, "bq_ScheduleOfSubsidiariesAndVariableInterestEntitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Subsidiaries And Variable Interest Entities [Table]" } } }, "localname": "ScheduleOfSubsidiariesAndVariableInterestEntitiesTable", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail" ], "xbrltype": "stringItemType" }, "bq_ScheduleOfSubsidiariesAndVariableInterestEntitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the\u00a0 Company's principal subsidiaries, consolidated VIEs and major VIEs' subsidiaries.", "label": "Schedule Of Subsidiaries And Variable Interest Entities [Table Text Block]", "terseLabel": "Schedule of Details of the Subsidiaries, VIEs and VIE's Subsidiaries" } } }, "localname": "ScheduleOfSubsidiariesAndVariableInterestEntitiesTableTextBlock", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesTables" ], "xbrltype": "textBlockItemType" }, "bq_ScheduleOfTransactionsBetweenRelatedPartiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Transactions Between Related Parties [Line Items]" } } }, "localname": "ScheduleOfTransactionsBetweenRelatedPartiesLineItems", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfMajorRelatedPartiesAndTheirRelationshipsWithTheCompanyDetail" ], "xbrltype": "stringItemType" }, "bq_ScheduleOfTransactionsBetweenRelatedPartiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Transactions Between Related Parties [Table]" } } }, "localname": "ScheduleOfTransactionsBetweenRelatedPartiesTable", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfMajorRelatedPartiesAndTheirRelationshipsWithTheCompanyDetail" ], "xbrltype": "stringItemType" }, "bq_ScheduleOfTransactionsBetweenRelatedPartiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of transactions between related parties.", "label": "Schedule Of Transactions Between Related Parties [Table Text Block]", "terseLabel": "Summary of Major Related Parties And Their Relationships With The Company" } } }, "localname": "ScheduleOfTransactionsBetweenRelatedPartiesTableTextBlock", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsTables" ], "xbrltype": "textBlockItemType" }, "bq_ScheduleOfTransactionsDueFromRelatedPartiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Transactions Due From Related Parties [Line Items]" } } }, "localname": "ScheduleOfTransactionsDueFromRelatedPartiesLineItems", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesParentheticalDetail" ], "xbrltype": "stringItemType" }, "bq_ScheduleOfTransactionsDueFromRelatedPartiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Transactions Due From Related Parties [Table]" } } }, "localname": "ScheduleOfTransactionsDueFromRelatedPartiesTable", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesParentheticalDetail" ], "xbrltype": "stringItemType" }, "bq_ScheduleOfTransactionsDueFromRelatedPartiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of transactions due from related parties.", "label": "Schedule Of Transactions Due From Related Parties [Table Text Block]", "terseLabel": "Summary of Transactions Due From Related Parties" } } }, "localname": "ScheduleOfTransactionsDueFromRelatedPartiesTableTextBlock", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsTables" ], "xbrltype": "textBlockItemType" }, "bq_ScheduleOfTransactionsDueToRelatedPartiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Transactions Due To Related Parties [Line Items]" } } }, "localname": "ScheduleOfTransactionsDueToRelatedPartiesLineItems", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueToRelatedPartiesDetail" ], "xbrltype": "stringItemType" }, "bq_ScheduleOfTransactionsDueToRelatedPartiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Transactions Due To Related Parties [Table]" } } }, "localname": "ScheduleOfTransactionsDueToRelatedPartiesTable", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueToRelatedPartiesDetail" ], "xbrltype": "stringItemType" }, "bq_ScheduleOfTransactionsDueToRelatedPartiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of transactions due to related parties.", "label": "Schedule Of Transactions Due To Related Parties [Table Text Block]", "terseLabel": "Summary of Transactions Due To related parties" } } }, "localname": "ScheduleOfTransactionsDueToRelatedPartiesTableTextBlock", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsTables" ], "xbrltype": "textBlockItemType" }, "bq_SeriesARedeemableConvertiblePreferredSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series A Redeemable Convertible Preferred Shares [Member]" } } }, "localname": "SeriesARedeemableConvertiblePreferredSharesMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_SeriesBRedeemableConvertiblePreferredSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series B Redeemable Convertible Preferred Shares [Member]" } } }, "localname": "SeriesBRedeemableConvertiblePreferredSharesMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_SeriesCPlusRedeemableConvertiblePreferredSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series C Plus Redeemable Convertible Preferred Shares [Member]" } } }, "localname": "SeriesCPlusRedeemableConvertiblePreferredSharesMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_SeriesCRedeemableConvertiblePreferredSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series C Redeemable Convertible Preferred Shares [Member]" } } }, "localname": "SeriesCRedeemableConvertiblePreferredSharesMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_ShanghaiEverySupplyChainCoLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shanghai Every Supply Chain Co., Ltd.", "label": "Shanghai Every Supply Chain Co Ltd [Member]", "verboseLabel": "Shanghai Every Supply Chain Co., Ltd. (\"Shanghai Every\") [Member]" } } }, "localname": "ShanghaiEverySupplyChainCoLtdMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail" ], "xbrltype": "domainItemType" }, "bq_ShanghaiGuangchengInformationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shanghai Guangcheng Information [Member]" } } }, "localname": "ShanghaiGuangchengInformationMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionParentheticalDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesParentheticalDetail" ], "xbrltype": "domainItemType" }, "bq_ShanghaiGuangchengInformationTechnologyLimitedPartnershipshanghaiGuangchengInformationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shanghai Guangcheng Information Technology (limited partnership) (Shanghai Guangcheng Information) [Member]" } } }, "localname": "ShanghaiGuangchengInformationTechnologyLimitedPartnershipshanghaiGuangchengInformationMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfMajorRelatedPartiesAndTheirRelationshipsWithTheCompanyDetail" ], "xbrltype": "domainItemType" }, "bq_ShanghaiYiqinPetsProductsCoLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shanghai Yiqin Pets Products Co Ltd [Member]", "terseLabel": "Shanghai Yiqin Pets Products Co., Ltd. [Member]" } } }, "localname": "ShanghaiYiqinPetsProductsCoLtdMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail" ], "xbrltype": "domainItemType" }, "bq_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options aggregate intrinsic value.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value", "terseLabel": "Share based compensation arrangement by share based payment award options outstanding intrinsic value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValue", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "bq_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options granted in period fair value.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Fair Value", "terseLabel": "Fair value of options granted amount" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "bq_ShareBasedCompensationByShareBasedPaymentAwardOptionExcercisedDuringThePeriodWeightedAverageFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation by share based payment award option excercised during the period weighted average fair value.", "label": "Share Based Compensation By Share Based Payment Award Option Excercised During The Period Weighted Average Fair Value", "terseLabel": "Weighted average fair value, Exercised" } } }, "localname": "ShareBasedCompensationByShareBasedPaymentAwardOptionExcercisedDuringThePeriodWeightedAverageFairValue", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationSummaryOfStockOptionActivityDetail" ], "xbrltype": "perShareItemType" }, "bq_ShareBasedCompensationExpenseRecognizedUntilTheCompletionOfAQualifiedIpo": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share based compensation expense recognized until the completion of a qualified IPO.", "label": "Share Based Compensation Expense Recognized Until The Completion Of A Qualified IPO", "terseLabel": "Share based compensation expense recognized until the completion of a qualified IPO" } } }, "localname": "ShareBasedCompensationExpenseRecognizedUntilTheCompletionOfAQualifiedIpo", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "bq_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based compensation arrangement by share-based payment award, options, forfeited, weighted average grant date fair value.", "label": "Sharebased Compensation Arrangement by Sharebased Payment Award Options Forfeited Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average fair value, Forfeited" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageGrantDateFairValue", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationSummaryOfStockOptionActivityDetail" ], "xbrltype": "perShareItemType" }, "bq_SharebasedPaymentArrangementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement.", "label": "ShareBased Payment Arrangement [Line Items]", "terseLabel": "Share Based Payment Arrangement [Line Items]" } } }, "localname": "SharebasedPaymentArrangementLineItems", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "bq_SharebasedPaymentArrangementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement.", "label": "Sharebased Payment Arrangement [Table]", "terseLabel": "Share based Payment Arrangement [Table]" } } }, "localname": "SharebasedPaymentArrangementTable", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "bq_ShortTermBankLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Short Term Bank Loan [Member]", "terseLabel": "Short Term Bank Loan [Member]" } } }, "localname": "ShortTermBankLoanMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_ShortTermBorrowingsCollateralizedByShortTermInvestments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Short Term Borrowings Collateralized by Short Term Investments.", "label": "Short Term Borrowings Collateralized by Short Term Investments" } } }, "localname": "ShortTermBorrowingsCollateralizedByShortTermInvestments", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "bq_ShortTermInvestmentsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Short-term investments policy text block.", "label": "Short term investments [Policy Text Block]", "terseLabel": "Short-term investments" } } }, "localname": "ShortTermInvestmentsPolicyTextBlock", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "bq_ShortTermInvestmentsUsedAsCollateral": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Short-term investments used as collateral.", "label": "Short Term Investments Used As Collateral", "terseLabel": "Short-term investments used as collateral" } } }, "localname": "ShortTermInvestmentsUsedAsCollateral", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "bq_SoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Software [Member]", "terseLabel": "Software [Member]" } } }, "localname": "SoftwareMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfPropertyPlantAndEquipmentUsefulLivesDetail", "http://Boqii.com/role/PropertyAndEquipmentNetSummaryOfPropertyPlantAndEquipmentsDetail" ], "xbrltype": "domainItemType" }, "bq_StaffAdvanceCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Staff advance current.", "label": "Staff Advance Current", "terseLabel": "Staff advances" } } }, "localname": "StaffAdvanceCurrent", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionDetail" ], "xbrltype": "monetaryItemType" }, "bq_StatutoryReserves": { "auth_ref": [], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 38.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Statutory reserves.", "label": "Statutory Reserves", "terseLabel": "Statutory reserves" } } }, "localname": "StatutoryReserves", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "bq_StatutoryReservesAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Statutory reserves.", "label": "Statutory Reserves [Axis]" } } }, "localname": "StatutoryReservesAxis", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RestrictedNetAssetsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "bq_StatutoryReservesByRegulatoryCountryAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Statutory reserves by regulatory country.", "label": "Statutory Reserves By Regulatory Country [Axis]" } } }, "localname": "StatutoryReservesByRegulatoryCountryAxis", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RestrictedNetAssetsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "bq_StatutoryReservesByRegulatoryCountryDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Statutory reserves by regulatory country.", "label": "Statutory Reserves By Regulatory Country [Domain]" } } }, "localname": "StatutoryReservesByRegulatoryCountryDomain", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RestrictedNetAssetsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_StatutoryReservesDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Statutory reserves.", "label": "Statutory Reserves [Domain]" } } }, "localname": "StatutoryReservesDomain", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RestrictedNetAssetsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_StatutoryReservesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Statutory reserves.", "label": "Statutory Reserves [Member]", "terseLabel": "Statutory reserves [Member]" } } }, "localname": "StatutoryReservesMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "bq_StatutorySurplusReserveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Statutory surplus reserve.", "label": "Statutory Surplus Reserve [Member]" } } }, "localname": "StatutorySurplusReserveMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RestrictedNetAssetsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_StockIssuedDuringPeriodValueStockBasedCompensation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value stock based compensation.", "label": "Stock Issued During Period Value Stock Based Compensation", "terseLabel": "Share-based compensation" } } }, "localname": "StockIssuedDuringPeriodValueStockBasedCompensation", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "bq_SubsequentEventsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Subsequent events.", "label": "Subsequent Events [Line Items]" } } }, "localname": "SubsequentEventsLineItems", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "bq_SubsequentEventsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Subsequent events.", "label": "Subsequent Events [Table]", "terseLabel": "Subsequent Events [Table]" } } }, "localname": "SubsequentEventsTable", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "bq_SuperbOriginInternationalLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Superb origin international limited.", "label": "Superb Origin International Limited [Member]" } } }, "localname": "SuperbOriginInternationalLimitedMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfMajorRelatedPartiesAndTheirRelationshipsWithTheCompanyDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesDetail" ], "xbrltype": "domainItemType" }, "bq_SuzhouTaichengSupplyChainCoLtdSuzhouTaichengMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Suzhou Taicheng Supply Chain Co Ltd Suzhou Taicheng [Member].", "label": "Suzhou Taicheng Supply Chain Co Ltd Suzhou Taicheng [Member]" } } }, "localname": "SuzhouTaichengSupplyChainCoLtdSuzhouTaichengMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail" ], "xbrltype": "domainItemType" }, "bq_SuzhouXingyunYuemingSupplyChainCoLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Suzhou Xingyun Yueming Supply Chain Co., Ltd.", "label": "Suzhou Xingyun Yueming Supply Chain Co Ltd [Member]", "verboseLabel": "Suzhou Xingyun Yueming Supply Chain Co., Ltd. (\"Suzhou Xingyun Yueming\") [Member]" } } }, "localname": "SuzhouXingyunYuemingSupplyChainCoLtdMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail" ], "xbrltype": "domainItemType" }, "bq_TaizhouXingmuBiotechnologyCoLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Taizhou Xingmu Biotechnology Co Ltd [Member]", "terseLabel": "Taizhou Xingmu Biotechnology Co., Ltd. [Member]" } } }, "localname": "TaizhouXingmuBiotechnologyCoLtdMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail" ], "xbrltype": "domainItemType" }, "bq_ThirdPartyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Third Party [Member].", "label": "Third Party [Member]", "terseLabel": "Third-party [Member]" } } }, "localname": "ThirdPartyMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "domainItemType" }, "bq_ThirdPartyOperatingExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Third Party Operating Expenses.", "label": "Third Party Operating Expenses", "terseLabel": "Third-party operating expenses" } } }, "localname": "ThirdPartyOperatingExpenses", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "bq_ThresholdMaximumPercentageOfRestrictedNetAssetsNotMetByTheConsolidatedSubsidiariesToDiscloseTheFinancialStatementsForTheParentCompany": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold maximum percentage of restricted net assets not met by the consolidated subsidiaries to disclose the financial statements for the parent company.", "label": "Threshold Maximum Percentage of Restricted Net Assets not met by the Consolidated Subsidiaries to disclose the Financial Statements for the Parent Company", "terseLabel": "Threshold maximum percentage of restricted net assets not met by the consolidated subsidiaries to disclose the financial statements for the parent company" } } }, "localname": "ThresholdMaximumPercentageOfRestrictedNetAssetsNotMetByTheConsolidatedSubsidiariesToDiscloseTheFinancialStatementsForTheParentCompany", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RestrictedNetAssetsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "bq_ThresholdMaximumPercentageOfRestrictedNetAssetsOfConsolidatedAndUnconsolidatedSubsidiariesToTheConsolidatedNetAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold maximum percentage of restricted net assets of consolidated and unconsolidated subsidiaries to the consolidated net assets.", "label": "Threshold Maximum Percentage of Restricted Net Assets of Consolidated and Unconsolidated Subsidiaries to the Consolidated Net Assets", "terseLabel": "Threshold maximum percentage of restricted net assets of consolidated and unconsolidated subsidiaries to the consolidated net assets" } } }, "localname": "ThresholdMaximumPercentageOfRestrictedNetAssetsOfConsolidatedAndUnconsolidatedSubsidiariesToTheConsolidatedNetAssets", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RestrictedNetAssetsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "bq_TianjingGuangchengInformationTechnologyCoLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tianjing Guangcheng Information Technology Co Ltd [Member]", "terseLabel": "Tianjing Guangcheng Information Technology Co., Ltd. [Member]" } } }, "localname": "TianjingGuangchengInformationTechnologyCoLtdMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail" ], "xbrltype": "domainItemType" }, "bq_TwelveMonthInterestFreeLoanAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Twelve Month Interest Free Loan Agreement [Member]" } } }, "localname": "TwelveMonthInterestFreeLoanAgreementMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesParentheticalDetail" ], "xbrltype": "domainItemType" }, "bq_TwoThousandEighteenGlobalSharePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Two Thousand Eighteen Global Share Plan [Member]", "terseLabel": "2018 Global Share Plan [Member]" } } }, "localname": "TwoThousandEighteenGlobalSharePlanMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_TwoThousandTwelveGlobalSharePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Two Thousand Twelve Global Share Plan [Member]", "terseLabel": "2012 Global Share Plan [Member]" } } }, "localname": "TwoThousandTwelveGlobalSharePlanMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_UnearnedRevenue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Unearned revenue.", "label": "Unearned Revenue" } } }, "localname": "UnearnedRevenue", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "bq_UnpaidCashConsiderationForBusinessAcquisitions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Unpaid cash consideration for business acquisitions.", "label": "Unpaid Cash Consideration for Business Acquisitions", "terseLabel": "Unpaid cash consideration for business acquisitions" } } }, "localname": "UnpaidCashConsiderationForBusinessAcquisitions", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "bq_UnrealizedSecuritiesHoldingGainsLossesNetOfTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Unrealized securities holding gains (losses), net of tax.", "label": "Unrealized Securities Holding Gains (Losses), Net Of Tax", "terseLabel": "Unrealized securities holding gains (losses), net of tax" } } }, "localname": "UnrealizedSecuritiesHoldingGainsLossesNetOfTax", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "bq_ValueAddedTax": { "auth_ref": [], "calculation": { "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsSummaryOfPrepaymentsAndOtherCurrentAssetsDetail": { "order": 4.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Value-added tax .", "label": "Value Added Tax", "terseLabel": "Value-added tax (\"VAT\") deductible" } } }, "localname": "ValueAddedTax", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsSummaryOfPrepaymentsAndOtherCurrentAssetsDetail" ], "xbrltype": "monetaryItemType" }, "bq_VariableInterestEntityPlaceOfIncorporation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Variable interest entity place of incorporation.", "label": "Variable Interest Entity Place Of Incorporation", "terseLabel": "Place of incorporation" } } }, "localname": "VariableInterestEntityPlaceOfIncorporation", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail" ], "xbrltype": "normalizedStringItemType" }, "bq_VendorRebateReceivables": { "auth_ref": [], "calculation": { "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsSummaryOfPrepaymentsAndOtherCurrentAssetsDetail": { "order": 3.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Vendor rebate receivables.", "label": "Vendor Rebate Receivables", "terseLabel": "Vendor rebate receivables" } } }, "localname": "VendorRebateReceivables", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsSummaryOfPrepaymentsAndOtherCurrentAssetsDetail" ], "xbrltype": "monetaryItemType" }, "bq_VendorRebatesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vendor rebates policy text block.", "label": "Vendor rebates [Policy Text Block]", "terseLabel": "Vendor rebates" } } }, "localname": "VendorRebatesPolicyTextBlock", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "bq_WarehouseEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warehouse Equipment [Member]", "terseLabel": "Warehouse Equipment [Member]" } } }, "localname": "WarehouseEquipmentMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfPropertyPlantAndEquipmentUsefulLivesDetail", "http://Boqii.com/role/PropertyAndEquipmentNetSummaryOfPropertyPlantAndEquipmentsDetail" ], "xbrltype": "domainItemType" }, "bq_WeightedAverageCostOfCapitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average cost of capital.", "label": "Weighted Average Cost Of Capital [Member]", "terseLabel": "Weighted average cost of capital [Member]" } } }, "localname": "WeightedAverageCostOfCapitalMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfSignificantUnobservableInputsDetail" ], "xbrltype": "domainItemType" }, "bq_WeishiNetworkMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weishi Network [Member]" } } }, "localname": "WeishiNetworkMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfMajorRelatedPartiesAndTheirRelationshipsWithTheCompanyDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesDetail" ], "xbrltype": "domainItemType" }, "bq_WrittenoffforExpirationOfNetOperatingLosses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Written-off\u00a0for expiration of net operating losses.", "label": "Writtenofffor expiration of net operating losses", "terseLabel": "Written-off\u00a0for expiration of net operating losses" } } }, "localname": "WrittenoffforExpirationOfNetOperatingLosses", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/IncomeTaxesSummaryOfValuationAllowanceDetail" ], "xbrltype": "monetaryItemType" }, "bq_WuhanChunzhijinInformationTechnologyCoLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Wuhan chunzhijin information technology Co Ltd.", "label": "Wuhan Chunzhijin Information Technology Co Ltd [Member]" } } }, "localname": "WuhanChunzhijinInformationTechnologyCoLtdMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_WuhanChunzhijinMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Wuhan Chunzhijin [Member]", "terseLabel": "Wuhan Chunzhijin [Member]" } } }, "localname": "WuhanChunzhijinMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfMajorRelatedPartiesAndTheirRelationshipsWithTheCompanyDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesParentheticalDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesDetail" ], "xbrltype": "domainItemType" }, "bq_XinchengshanghaiInformationTechnologyCoLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Xincheng Shanghai Information Technology Co Ltd [Member]", "terseLabel": "Xincheng (Shanghai) Information Technology Co., Ltd. (\"Shanghai Xincheng\") [Member]" } } }, "localname": "XinchengshanghaiInformationTechnologyCoLtdMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail" ], "xbrltype": "domainItemType" }, "bq_XingmuGroupMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Xingmu Group [Member]" } } }, "localname": "XingmuGroupMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetailParenthetical" ], "xbrltype": "domainItemType" }, "bq_XingmuHkLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Xingmu HK Limited [Member]", "terseLabel": "Xingmu HK Limited [Member]" } } }, "localname": "XingmuHkLimitedMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail" ], "xbrltype": "domainItemType" }, "bq_XingmuInternationalLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Xingmu International Limited [Member]", "terseLabel": "Xingmu International Limited [Member]" } } }, "localname": "XingmuInternationalLimitedMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail" ], "xbrltype": "domainItemType" }, "bq_YanJiangMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Yan Jiang [Member]", "terseLabel": "Yan Jiang [Member]" } } }, "localname": "YanJiangMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfMajorRelatedPartiesAndTheirRelationshipsWithTheCompanyDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesDetail" ], "xbrltype": "domainItemType" }, "bq_YingchristinaZhangMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ying Christina Zhang [Member]", "terseLabel": "Ying (Christina) Zhang [Member]" } } }, "localname": "YingchristinaZhangMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfMajorRelatedPartiesAndTheirRelationshipsWithTheCompanyDetail" ], "xbrltype": "domainItemType" }, "bq_YingzhilisaTangMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Yingzhi Lisa Tang [Member]", "terseLabel": "Yingzhi (Lisa) Tang [Member]" } } }, "localname": "YingzhilisaTangMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfMajorRelatedPartiesAndTheirRelationshipsWithTheCompanyDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesDetail" ], "xbrltype": "domainItemType" }, "bq_YokenHoldingLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Yoken Holding Limited [Member]", "terseLabel": "Yoken Holding Limited [Member]" } } }, "localname": "YokenHoldingLimitedMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/RedeemableNonControllingInterestsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "bq_YokenSeriesAOneWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Yoken series a one warrant [Member].", "label": "Yoken Series A One Warrant [Member]" } } }, "localname": "YokenSeriesAOneWarrantMember", "nsuri": "http://Boqii.com/20230331", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "country_CN": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CHINA", "terseLabel": "CHINA [Member]", "verboseLabel": "PRC [Member]" } } }, "localname": "CN", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesAdditionalInformationDetail", "http://Boqii.com/role/RestrictedNetAssetsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "country_HK": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "HONG KONG", "verboseLabel": "HK [Member]" } } }, "localname": "HK", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "currency_AllCurrenciesDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "All Currencies [Domain]", "terseLabel": "All Currencies [Domain]" } } }, "localname": "AllCurrenciesDomain", "nsuri": "http://xbrl.sec.gov/currency/2022", "presentation": [ "http://Boqii.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetail", "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail", "http://Boqii.com/role/RisksAndConcentrationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "currency_CNY": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "China, Yuan Renminbi", "terseLabel": "CNY [Member]" } } }, "localname": "CNY", "nsuri": "http://xbrl.sec.gov/currency/2022", "presentation": [ "http://Boqii.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetail", "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail", "http://Boqii.com/role/RisksAndConcentrationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "currency_EUR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Euro Member Countries, Euro", "terseLabel": "EUR [Member]" } } }, "localname": "EUR", "nsuri": "http://xbrl.sec.gov/currency/2022", "presentation": [ "http://Boqii.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetail" ], "xbrltype": "domainItemType" }, "currency_HKD": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Hong Kong, Dollars", "terseLabel": "Hong Kong dollars [Member]" } } }, "localname": "HKD", "nsuri": "http://xbrl.sec.gov/currency/2022", "presentation": [ "http://Boqii.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetail" ], "xbrltype": "domainItemType" }, "currency_NZD": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "New Zealand, Dollars", "terseLabel": "NZD" } } }, "localname": "NZD", "nsuri": "http://xbrl.sec.gov/currency/2022", "presentation": [ "http://Boqii.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetail" ], "xbrltype": "domainItemType" }, "currency_USD": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "United States of America, Dollars", "terseLabel": "USD [Member]" } } }, "localname": "USD", "nsuri": "http://xbrl.sec.gov/currency/2022", "presentation": [ "http://Boqii.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetail" ], "xbrltype": "domainItemType" }, "dei_AddressTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.", "label": "Address Type [Domain]" } } }, "localname": "AddressTypeDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "dei_AdrMember": { "auth_ref": [ "r772" ], "lang": { "en-us": { "role": { "documentation": "American Depositary Receipt (or American Depositary Share, ADS).", "label": "ADR [Member]", "terseLabel": "American Depositary Shares [Member]" } } }, "localname": "AdrMember", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r773", "r774", "r775" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r773", "r774", "r775" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r773", "r774", "r775" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "internationalNameItemType" }, "dei_BusinessContactMember": { "auth_ref": [ "r774", "r775" ], "lang": { "en-us": { "role": { "documentation": "Business contact for the entity", "label": "Business Contact [Member]" } } }, "localname": "BusinessContactMember", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "dei_ContactPersonnelFaxNumber": { "auth_ref": [ "r774" ], "lang": { "en-us": { "role": { "documentation": "Fax Number of contact personnel.", "label": "Contact Personnel Fax Number" } } }, "localname": "ContactPersonnelFaxNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_ContactPersonnelName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of contact personnel", "label": "Contact Personnel Name" } } }, "localname": "ContactPersonnelName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r774" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r773", "r774", "r775" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r768" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r774" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r776" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressesAddressTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Entity Addresses, Address Type [Axis]" } } }, "localname": "EntityAddressesAddressTypeAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r770" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/FairValueMeasurementsSummaryOfSignificantUnobservableInputsDetail", "http://Boqii.com/role/RestrictedNetAssetsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r770" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r779" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r770" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationDateOfIncorporation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date when an entity was incorporated", "label": "Entity Incorporation, Date of Incorporation", "terseLabel": "Date of incorporation or acquisition" } } }, "localname": "EntityIncorporationDateOfIncorporation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail" ], "xbrltype": "dateItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r777" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r770" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r770" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r778" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r773", "r774", "r775" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/FairValueMeasurementsSummaryOfSignificantUnobservableInputsDetail", "http://Boqii.com/role/RestrictedNetAssetsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "trueItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r769" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r771" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://Boqii.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r343", "r582", "r583", "r586", "r587", "r642", "r725", "r838", "r841", "r842" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesAdditionalInformationDetail", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail", "http://Boqii.com/role/RedeemableNonControllingInterestsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r343", "r582", "r583", "r586", "r587", "r642", "r725", "r838", "r841", "r842" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesAdditionalInformationDetail", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail", "http://Boqii.com/role/RedeemableNonControllingInterestsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_CurrencyAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Currency [Axis]", "terseLabel": "Currency [Axis]" } } }, "localname": "CurrencyAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://Boqii.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetail", "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail", "http://Boqii.com/role/RisksAndConcentrationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/ConvertibleRedeemablePreferredSharesAdditionalInformationDetail", "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r406", "r751", "r845", "r904" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]", "terseLabel": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://Boqii.com/role/RisksAndConcentrationAdditionalInformationDetail", "http://Boqii.com/role/RisksAndConcentrationSchedulesOfConcentrationOfRiskByRiskFactorDetail" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r451", "r452", "r453", "r454", "r506", "r653", "r687", "r726", "r727", "r748", "r757", "r766", "r843", "r894", "r895", "r896", "r897", "r898", "r899" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum [Member]", "verboseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail", "http://Boqii.com/role/FairValueMeasurementsSummaryOfSignificantUnobservableInputsDetail", "http://Boqii.com/role/IncomeTaxesAdditionalInformationDetail", "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail", "http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsParentheticalDetail", "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsAdditionalInformationDetail", "http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfPropertyPlantAndEquipmentUsefulLivesDetail", "http://Boqii.com/role/ShareBasedCompensationSummaryOfOptionsMeasuredAtFairValueValuationAssumptionsDetail" ], "xbrltype": "domainItemType" }, "srt_MedianMember": { "auth_ref": [ "r597" ], "lang": { "en-us": { "role": { "label": "Median [Member]" } } }, "localname": "MedianMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfSignificantUnobservableInputsDetail" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r451", "r452", "r453", "r454", "r506", "r653", "r687", "r726", "r727", "r748", "r757", "r766", "r843", "r894", "r895", "r896", "r897", "r898", "r899" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "verboseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail", "http://Boqii.com/role/FairValueMeasurementsSummaryOfSignificantUnobservableInputsDetail", "http://Boqii.com/role/IncomeTaxesAdditionalInformationDetail", "http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsParentheticalDetail", "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsAdditionalInformationDetail", "http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfPropertyPlantAndEquipmentUsefulLivesDetail", "http://Boqii.com/role/ShareBasedCompensationSummaryOfOptionsMeasuredAtFairValueValuationAssumptionsDetail" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r406", "r751", "r845", "r904" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]", "terseLabel": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://Boqii.com/role/RisksAndConcentrationAdditionalInformationDetail", "http://Boqii.com/role/RisksAndConcentrationSchedulesOfConcentrationOfRiskByRiskFactorDetail" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Domain]" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r403", "r659", "r749", "r764", "r835", "r836", "r845", "r903" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://Boqii.com/role/AccountsReceivableNetSummaryOfAccountsReceivableNetDetail", "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://Boqii.com/role/InventoriesNetOfInventoryReservesSummaryOfInventoriesNetOfInventoryReservesDetail", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail", "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r403", "r659", "r749", "r764", "r835", "r836", "r845", "r903" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://Boqii.com/role/AccountsReceivableNetSummaryOfAccountsReceivableNetDetail", "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://Boqii.com/role/InventoriesNetOfInventoryReservesSummaryOfInventoriesNetOfInventoryReservesDetail", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail", "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r451", "r452", "r453", "r454", "r498", "r506", "r535", "r536", "r537", "r649", "r653", "r687", "r726", "r727", "r748", "r757", "r766", "r834", "r843", "r895", "r896", "r897", "r898", "r899" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]", "verboseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsAdditionalInformationDetail", "http://Boqii.com/role/ConvertibleRedeemablePreferredSharesAdditionalInformationDetail", "http://Boqii.com/role/FairValueMeasurementsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail", "http://Boqii.com/role/FairValueMeasurementsSummaryOfSignificantUnobservableInputsDetail", "http://Boqii.com/role/IncomeTaxesAdditionalInformationDetail", "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail", "http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsParentheticalDetail", "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsAdditionalInformationDetail", "http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfFiniteLivedIntangibleAssetsUsefulLivesDetail", "http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfPropertyPlantAndEquipmentUsefulLivesDetail", "http://Boqii.com/role/RestrictedNetAssetsAdditionalInformationDetail", "http://Boqii.com/role/ShareBasedCompensationAdditionalInformationDetail", "http://Boqii.com/role/ShareBasedCompensationSummaryOfOptionsMeasuredAtFairValueValuationAssumptionsDetail" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r451", "r452", "r453", "r454", "r498", "r506", "r535", "r536", "r537", "r649", "r653", "r687", "r726", "r727", "r748", "r757", "r766", "r834", "r843", "r895", "r896", "r897", "r898", "r899" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]", "verboseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsAdditionalInformationDetail", "http://Boqii.com/role/ConvertibleRedeemablePreferredSharesAdditionalInformationDetail", "http://Boqii.com/role/FairValueMeasurementsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail", "http://Boqii.com/role/FairValueMeasurementsSummaryOfSignificantUnobservableInputsDetail", "http://Boqii.com/role/IncomeTaxesAdditionalInformationDetail", "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail", "http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsParentheticalDetail", "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsAdditionalInformationDetail", "http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfFiniteLivedIntangibleAssetsUsefulLivesDetail", "http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfPropertyPlantAndEquipmentUsefulLivesDetail", "http://Boqii.com/role/RestrictedNetAssetsAdditionalInformationDetail", "http://Boqii.com/role/ShareBasedCompensationAdditionalInformationDetail", "http://Boqii.com/role/ShareBasedCompensationSummaryOfOptionsMeasuredAtFairValueValuationAssumptionsDetail" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r418" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/ConvertibleRedeemablePreferredSharesAdditionalInformationDetail", "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r404", "r405", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r750", "r765", "r845" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "verboseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r404", "r405", "r710", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r750", "r765", "r845" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "verboseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r818", "r890" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationAdditionalInformationDetail", "http://Boqii.com/role/ShareBasedCompensationTables" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationAdditionalInformationDetail", "http://Boqii.com/role/ShareBasedCompensationTables" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsAndNontradeReceivableTextBlock": { "auth_ref": [ "r413", "r427" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts receivable, contract receivable, receivable held-for-sale, and nontrade receivable.", "label": "Accounts and Nontrade Receivable [Text Block]", "terseLabel": "Accounts receivable, net" } } }, "localname": "AccountsAndNontradeReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/AccountsReceivableNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsNotesAndLoansReceivableLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]" } } }, "localname": "AccountsNotesAndLoansReceivableLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/AccountsReceivableNetSummaryOfAccountsReceivableNetDetail", "http://Boqii.com/role/AccountsReceivableNetSummaryOfMovementOfAllowanceOfDoubtfulAccountsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.", "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]", "terseLabel": "Accrued liabilities and other current liabilities" } } }, "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/AccruedLiabilitiesAndOtherCurrentLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://Boqii.com/role/AccruedLiabilitiesAndOtherCurrentLiabilitiesScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 21.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Accrued liabilities and other current liabilities (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB24,417 and RMB15,712 as of March 31, 2022 and 2023, respectively)", "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Accounts Payable and Other Accrued Liabilities, Current", "totalLabel": "Total", "verboseLabel": "Accrued liabilities and other current liabilities" } } }, "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/AccruedLiabilitiesAndOtherCurrentLiabilitiesScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesDetail", "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r25", "r763" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 19.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable (including accounts payable of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB55,144 and RMB13,459 as of March 31, 2022 and 2023, respectively)", "verboseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableRelatedPartiesCurrent": { "auth_ref": [ "r25", "r236", "r237", "r811" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Related Parties, Current", "terseLabel": "Trade payables to related parties" } } }, "localname": "AccountsPayableRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueToRelatedPartiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": { "auth_ref": [ "r821" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]", "terseLabel": "Summary of Movement of Allowance of Doubtful Accounts" } } }, "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/AccountsReceivableNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsReceivableGrossCurrent": { "auth_ref": [ "r307", "r407", "r408", "r731" ], "calculation": { "http://Boqii.com/role/AccountsReceivableNetSummaryOfAccountsReceivableNetDetail": { "order": 1.0, "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, before Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable" } } }, "localname": "AccountsReceivableGrossCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/AccountsReceivableNetSummaryOfAccountsReceivableNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r407", "r408" ], "calculation": { "http://Boqii.com/role/AccountsReceivableNetSummaryOfAccountsReceivableNetDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, net", "totalLabel": "Total" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/AccountsReceivableNetSummaryOfAccountsReceivableNetDetail", "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounts Receivable, after Allowance for Credit Loss, Current [Abstract]" } } }, "localname": "AccountsReceivableNetCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccruedAdvertisingCurrent": { "auth_ref": [ "r30" ], "calculation": { "http://Boqii.com/role/AccruedLiabilitiesAndOtherCurrentLiabilitiesScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesDetail": { "order": 4.0, "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for advertising of the entity's goods and services. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Advertising, Current", "terseLabel": "Accrued advertising expenses" } } }, "localname": "AccruedAdvertisingCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/AccruedLiabilitiesAndOtherCurrentLiabilitiesScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accrued Liabilities and Other Liabilities [Abstract]" } } }, "localname": "AccruedLiabilitiesAndOtherLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r30" ], "calculation": { "http://Boqii.com/role/AccruedLiabilitiesAndOtherCurrentLiabilitiesScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesDetail": { "order": 2.0, "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Professional Fees, Current", "terseLabel": "Professional service fee accruals" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/AccruedLiabilitiesAndOtherCurrentLiabilitiesScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r117", "r298" ], "calculation": { "http://Boqii.com/role/PropertyAndEquipmentNetSummaryOfPropertyPlantAndEquipmentsDetail": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PropertyAndEquipmentNetSummaryOfPropertyPlantAndEquipmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r46", "r48", "r49", "r310", "r682", "r692", "r693" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 37.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r45", "r49", "r195", "r635", "r688", "r689", "r790", "r791", "r792", "r812", "r813", "r814" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated other comprehensive income [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r16", "r763" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 39.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r544", "r545", "r546", "r812", "r813", "r814", "r881" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingExpense": { "auth_ref": [ "r549" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.", "label": "Advertising Expense", "terseLabel": "Advertising Expense" } } }, "localname": "AdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r539" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Share based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r311", "r411", "r422", "r423", "r425" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss", "periodEndLabel": "At end of year", "periodStartLabel": "At beginning of year" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/AccountsReceivableNetSummaryOfMovementOfAllowanceOfDoubtfulAccountsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r311", "r411", "r422" ], "calculation": { "http://Boqii.com/role/AccountsReceivableNetSummaryOfAccountsReceivableNetDetail": { "order": 2.0, "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "negatedLabel": "Allowance of doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/AccountsReceivableNetSummaryOfAccountsReceivableNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r54", "r481", "r622", "r805" ], "calculation": { "http://Boqii.com/role/InterestExpenseSummaryOfInterestExpenseDetail": { "order": 1.0, "parentTag": "us-gaap_InterestExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of Debt Issuance Costs", "terseLabel": "Amortization charges on promissory notes" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/InterestExpenseSummaryOfInterestExpenseDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r75", "r105", "r110" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 29.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization of right-of-use assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r367" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r85" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r85" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesAdditionalInformationDetail", "http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r239", "r260", "r302", "r340", "r387", "r397", "r401", "r420", "r455", "r456", "r458", "r459", "r460", "r461", "r462", "r464", "r465", "r582", "r586", "r604", "r763", "r839", "r840", "r892" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "definitionGuidance": "Assets:", "label": "Assets [Abstract]", "terseLabel": "ASSETS", "verboseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/FairValueMeasurementsSummaryOfCompanySFinancialAssetsAndLiabilitiesDetail", "http://Boqii.com/role/LeasesSummaryOfOperatingLeasesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r291", "r315", "r340", "r420", "r455", "r456", "r458", "r459", "r460", "r461", "r462", "r464", "r465", "r582", "r586", "r604", "r763", "r839", "r840", "r892" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r216" ], "calculation": { "http://Boqii.com/role/FairValueMeasurementsSummaryOfCompanySFinancialAssetsAndLiabilitiesDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "totalLabel": "Total assets" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfCompanySFinancialAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNet": { "auth_ref": [ "r2", "r273", "r275", "r276", "r277" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net assets (liabilities).", "label": "Net Assets Of The Group", "terseLabel": "Net Assets Of The Group" } } }, "localname": "AssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/GoodwillAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r340", "r420", "r455", "r456", "r458", "r459", "r460", "r461", "r462", "r464", "r465", "r582", "r586", "r604", "r839", "r840", "r892" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Assets, Noncurrent", "totalLabel": "Total non-current assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Noncurrent [Abstract]", "terseLabel": "Non-current assets:" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": { "auth_ref": [ "r415", "r426" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale, Amortized Cost", "terseLabel": "Cost" } } }, "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsSummaryOfAvailableForSaleDebtInvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedGain": { "auth_ref": [ "r99" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale, Unrealized Gain", "terseLabel": "Gross\u00a0unrealized\u00a0gains" } } }, "localname": "AvailableForSaleDebtSecuritiesGrossUnrealizedGain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsSummaryOfAvailableForSaleDebtInvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss": { "auth_ref": [ "r100" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale, Unrealized Loss", "negatedLabel": "Gross\u00a0unrealized\u00a0losses" } } }, "localname": "AvailableForSaleDebtSecuritiesGrossUnrealizedLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsSummaryOfAvailableForSaleDebtInvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Available-for-sale [Abstract]" } } }, "localname": "AvailableForSaleSecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecurities": { "auth_ref": [ "r98", "r414", "r426", "r675" ], "calculation": { "http://Boqii.com/role/FairValueMeasurementsSummaryOfCompanySFinancialAssetsAndLiabilitiesDetail": { "order": 2.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 }, "http://Boqii.com/role/LongTermInvestmentsSummaryOfLongTermInvestmentDetail": { "order": 2.0, "parentTag": "us-gaap_LongTermInvestments", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "disclosureGuidance": "Available-for-sale\u00a0investments", "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale", "terseLabel": "Available-for-sale debt investments", "verboseLabel": "Fair value" } } }, "localname": "AvailableForSaleSecuritiesDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfCompanySFinancialAssetsAndLiabilitiesDetail", "http://Boqii.com/role/LongTermInvestmentsSummaryOfAvailableForSaleDebtInvestmentsDetail", "http://Boqii.com/role/LongTermInvestmentsSummaryOfLongTermInvestmentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableforsaleSecuritiesMember": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "Investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Available-for-sale Securities [Member]" } } }, "localname": "AvailableforsaleSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfRollForwardOfMajorLevel3InvestmentsDetail", "http://Boqii.com/role/FairValueMeasurementsSummaryOfSignificantUnobservableInputsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r510", "r511", "r512", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r534", "r535", "r536", "r537", "r538" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationSummaryOfOptionsMeasuredAtFairValueValuationAssumptionsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail", "http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsParentheticalDetail", "http://Boqii.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r210", "r213" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail", "http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsParentheticalDetail", "http://Boqii.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of preparation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r578", "r755", "r756" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsAdditionalInformationDetail", "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail", "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetailParenthetical", "http://Boqii.com/role/BusinessCombinationsTables", "http://Boqii.com/role/ConvertibleRedeemablePreferredSharesAdditionalInformationDetail", "http://Boqii.com/role/GoodwillAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r172", "r173", "r578", "r755", "r756" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsAdditionalInformationDetail", "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail", "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetailParenthetical", "http://Boqii.com/role/BusinessCombinationsTables", "http://Boqii.com/role/ConvertibleRedeemablePreferredSharesAdditionalInformationDetail", "http://Boqii.com/role/GoodwillAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": { "auth_ref": [ "r182" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned", "verboseLabel": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned" } } }, "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsTables" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r168" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "terseLabel": "Business Acquisition, Percentage of Voting Interests Acquired" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": { "auth_ref": [ "r176" ], "calculation": { "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.", "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value", "negatedLabel": "Non-controlling interests" } } }, "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r179", "r180", "r181" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Fair value of total consideration", "verboseLabel": "Business Combination, Consideration Transferred" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsAdditionalInformationDetail", "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination, Consideration Transferred [Abstract]", "terseLabel": "Total purchase price is comprised of:" } } }, "localname": "BusinessCombinationConsiderationTransferredAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r183", "r579" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "Business combinations" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinations" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual": { "auth_ref": [ "r171" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.", "label": "Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual", "terseLabel": "Business Combination, Pro Forma Information, Earnings or Loss of Acquire since Acquisition Date" } } }, "localname": "BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [ "r175" ], "calculation": { "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets", "totalLabel": "Total assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r175" ], "calculation": { "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "terseLabel": "Cash and cash equivalents" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": { "auth_ref": [ "r175" ], "calculation": { "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other", "terseLabel": "Prepayments and other current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": { "auth_ref": [ "r175" ], "calculation": { "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other", "negatedLabel": "Accrued liabilities and other current liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r175" ], "calculation": { "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "negatedTotalLabel": "Total liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r174", "r175" ], "calculation": { "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "terseLabel": "Net assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest": { "auth_ref": [ "r175" ], "calculation": { "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest", "totalLabel": "Total" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "auth_ref": [ "r175" ], "calculation": { "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "terseLabel": "Goodwill" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1": { "auth_ref": [ "r169" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages.", "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value", "terseLabel": "- fair value of 49% previously held equity interests" } } }, "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.", "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage", "terseLabel": "Business Combination, Step Acquisition, Equity Interest in Acquire, Percentage", "verboseLabel": "Business Combination, Step Acquisition, Equity Interest in Acquire, Percentage" } } }, "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsAdditionalInformationDetail", "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetailParenthetical" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain": { "auth_ref": [ "r170" ], "calculation": { "http://Boqii.com/role/OtherGainsNetSummaryOfOtherLossesNetDetail": { "order": 1.0, "parentTag": "us-gaap_NonoperatingGainsLosses", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.", "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain", "terseLabel": "Gain from the re-measurement of the previously held equity interests to the fair value in the step acquisitions" } } }, "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OtherGainsNetSummaryOfOtherLossesNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss": { "auth_ref": [ "r170" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "In a business combination achieved in stages, this element represents the amount of net gain (loss) recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.", "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net", "terseLabel": "Business Combination, Step Acquisition, Equity Interest in Acquire, Re-measurement Gain (Loss), Net" } } }, "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationsPolicy": { "auth_ref": [ "r167" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.", "label": "Business Combinations Policy [Policy Text Block]", "terseLabel": "Business combination and non-controlling interests" } } }, "localname": "BusinessCombinationsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents [Abstract]" } } }, "localname": "CashAndCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r77", "r294", "r729" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetail", "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, at Carrying Value [Abstract]", "terseLabel": "RMB" } } }, "localname": "CashAndCashEquivalentsAtCarryingValueAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsDisclosureTextBlock": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for cash and cash equivalent footnotes, which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.", "label": "Cash and Cash Equivalents Disclosure [Text Block]", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/CashAndCashEquivalents" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Cash and Cash Equivalents [Line Items]", "terseLabel": "Cash and Cash Equivalents [Line Items]" } } }, "localname": "CashAndCashEquivalentsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r78" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r72", "r77", "r82" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents and restricted cash at end of year", "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r72", "r230" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsMember": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "Short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Equivalents [Member]" } } }, "localname": "CashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "Supplemental schedule of non-cash investing and financing activities:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_CashMember": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits.", "label": "Cash [Member]" } } }, "localname": "CashMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r304", "r305", "r306", "r340", "r360", "r361", "r364", "r366", "r374", "r375", "r420", "r455", "r458", "r459", "r460", "r464", "r465", "r486", "r487", "r488", "r489", "r490", "r604", "r728", "r781", "r807", "r815" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]", "verboseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/BusinessCombinationsAdditionalInformationDetail", "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://Boqii.com/role/ConvertibleRedeemablePreferredSharesAdditionalInformationDetail", "http://Boqii.com/role/CoverPage", "http://Boqii.com/role/IncomeTaxesAdditionalInformationDetail", "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail", "http://Boqii.com/role/ReceivableForIssuanceOfOrdinarySharesAdditionalInformationDetail", "http://Boqii.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r139", "r146" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/ConvertibleRedeemablePreferredSharesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/ConvertibleRedeemablePreferredSharesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r491" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Class of warrants or rights exercise price" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r491" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "terseLabel": "Class of warrants or rights number of securities called by the warrants or rights" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r36", "r247", "r267" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 41.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Note 28)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r121", "r449", "r450", "r712", "r837" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common Class A [Member]", "terseLabel": "Class A Ordinary Shares [Member]" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "http://Boqii.com/role/CoverPage", "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common Class B [Member]", "terseLabel": "Class B Ordinary Shares [Member]" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "http://Boqii.com/role/CoverPage", "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r38" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock, Capital Shares Reserved for Future Issuance", "terseLabel": "Shares reserved for future issuances" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r812", "r813", "r881" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Ordinary Shares [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "http://Boqii.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common Stock, Par or Stated Value Per Share", "verboseLabel": "Common Stock, Par or Stated Value Per Share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common Stock, Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common Stock, Shares, Issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r15", "r131" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common Stock, Shares, Outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r15", "r763" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 40.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common Stock Value" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": { "auth_ref": [ "r143", "r144", "r145", "r154" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.", "label": "Compensation and Employee Benefit Plans [Text Block]", "terseLabel": "Employee benefits" } } }, "localname": "CompensationAndEmployeeBenefitPlansTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/EmployeeBenefits" ], "xbrltype": "textBlockItemType" }, "us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold": { "auth_ref": [ "r793" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Other employee benefit expense includes, but is not limited to, service component of net periodic benefit cost for defined benefit plan. Excludes compensation cost in cost of good and service sold.", "label": "Compensation Expense, Excluding Cost of Good and Service Sold", "terseLabel": "Employee benefits costs" } } }, "localname": "CompensationExpenseExcludingCostOfGoodAndServiceSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/EmployeeBenefitsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationRelatedCostsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Compensation Related Costs [Abstract]", "verboseLabel": "Compensation Related Costs [Abstract]" } } }, "localname": "CompensationRelatedCostsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r50", "r324", "r326", "r334", "r678", "r684" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Total comprehensive loss attributable to Boqii Holding Limited" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r187", "r188", "r207", "r324", "r326", "r333", "r677", "r683" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 5.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "terseLabel": "Less: Total comprehensive loss/(income)\u00a0attributable to\u00a0non-\u00a0controlling\u00a0interests shareholders" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive Income, Policy [Policy Text Block]", "terseLabel": "Comprehensive loss" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r89", "r90", "r227", "r228", "r406", "r711" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/RisksAndConcentrationAdditionalInformationDetail", "http://Boqii.com/role/RisksAndConcentrationSchedulesOfConcentrationOfRiskByRiskFactorDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r89", "r90", "r227", "r228", "r406", "r694", "r711" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/RisksAndConcentrationAdditionalInformationDetail", "http://Boqii.com/role/RisksAndConcentrationSchedulesOfConcentrationOfRiskByRiskFactorDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r89", "r90", "r227", "r228", "r406", "r711", "r905" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/RisksAndConcentrationAdditionalInformationDetail", "http://Boqii.com/role/RisksAndConcentrationSchedulesOfConcentrationOfRiskByRiskFactorDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r95" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Concentration Risk Disclosure [Text Block]", "terseLabel": "Risks and Concentration" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/RisksAndConcentration" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]", "terseLabel": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/RisksAndConcentrationAdditionalInformationDetail", "http://Boqii.com/role/RisksAndConcentrationSchedulesOfConcentrationOfRiskByRiskFactorDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r89", "r90", "r227", "r228", "r406" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration Risk, Percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/RisksAndConcentrationAdditionalInformationDetail", "http://Boqii.com/role/RisksAndConcentrationSchedulesOfConcentrationOfRiskByRiskFactorDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r87", "r89", "r90", "r91", "r227", "r229", "r711" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]", "terseLabel": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/RisksAndConcentrationAdditionalInformationDetail", "http://Boqii.com/role/RisksAndConcentrationSchedulesOfConcentrationOfRiskByRiskFactorDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r89", "r90", "r227", "r228", "r406", "r711" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/RisksAndConcentrationAdditionalInformationDetail", "http://Boqii.com/role/RisksAndConcentrationSchedulesOfConcentrationOfRiskByRiskFactorDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r190", "r734" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Basis of consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetNet": { "auth_ref": [ "r493", "r495", "r496" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "Contract with Customer, Asset, after Allowance for Credit Loss", "terseLabel": "Contract with Customer, Asset" } } }, "localname": "ContractWithCustomerAssetNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r493", "r494", "r496" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "terseLabel": "Contract with Customer, Liability" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r493", "r494", "r496" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 23.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "terseLabel": "Contract liabilities (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB7,007 and RMB4,471 as of March 31, 2022 and 2023, respectively)", "verboseLabel": "Contract liabilities" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r497" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "terseLabel": "Contract with Customer, Liability, Revenue Recognized" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConversionOfStockAmountConverted1": { "auth_ref": [ "r79", "r80", "r81" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of Stock, Amount Converted", "terseLabel": "Conversion\u00a0of ordinary shares into Class\u00a0A and Class\u00a0B ordinary shares" } } }, "localname": "ConversionOfStockAmountConverted1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConversionOfStockSharesIssued1": { "auth_ref": [ "r79", "r80", "r81" ], "lang": { "en-us": { "role": { "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of Stock, Shares Issued", "terseLabel": "Conversion\u00a0of ordinary shares into Class\u00a0A and Class\u00a0B ordinary shares , Shares" } } }, "localname": "ConversionOfStockSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r56", "r340", "r420", "r455", "r456", "r458", "r459", "r460", "r461", "r462", "r464", "r465", "r604", "r839" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 14.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "negatedLabel": "Total cost of revenue" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail", "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cost of Revenue [Abstract]", "terseLabel": "Cost of revenues:" } } }, "localname": "CostOfRevenueAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CostOfSalesVendorAllowancesPolicy": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for allowances received from a vendor. The disclosure differentiates between those allowances that are recorded as a reduction in the price of the vendors' products or services (that is, the entity's inventory) and which ultimately will be recorded as a reduction in the entity's cost of sales and those that are not.", "label": "Cost of Sales, Vendor Allowances, Policy [Policy Text Block]", "terseLabel": "Cost of revenue" } } }, "localname": "CostOfSalesVendorAllowancesPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CurrencySwapMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.", "label": "Currency Swap [Member]" } } }, "localname": "CurrencySwapMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r165", "r563", "r571", "r810" ], "calculation": { "http://Boqii.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpensesBenefitDetail": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense (Benefit)", "terseLabel": "Current income tax expense/(benefit)" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpensesBenefitDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerRefundLiabilityCurrent": { "auth_ref": [], "calculation": { "http://Boqii.com/role/AccruedLiabilitiesAndOtherCurrentLiabilitiesScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesDetail": { "order": 3.0, "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Current regulatory liabilities generally represent obligations to make refunds to customers for various reasons including overpayment.", "label": "Customer Refund Liability, Current", "terseLabel": "Refund obligation of sales returns" } } }, "localname": "CustomerRefundLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/AccruedLiabilitiesAndOtherCurrentLiabilitiesScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "auth_ref": [ "r79", "r81" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion, Converted Instrument, Amount", "terseLabel": "Debt instrument converted value" } } }, "localname": "DebtConversionConvertedInstrumentAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "auth_ref": [ "r79", "r81" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.", "label": "Debt Conversion, Converted Instrument, Shares Issued", "terseLabel": "Debt instrument converted shares issued" } } }, "localname": "DebtConversionConvertedInstrumentSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtConversionOriginalDebtAmount1": { "auth_ref": [ "r79", "r81" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion, Original Debt, Amount", "terseLabel": "Debt instrument convertible carrying value at the time of conversion" } } }, "localname": "DebtConversionOriginalDebtAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r9", "r10", "r11", "r240", "r241", "r257", "r343", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r623", "r743", "r744", "r745", "r746", "r747", "r808" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail", "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsAdditionalInformationDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionParentheticalDetail", "http://Boqii.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r11", "r241", "r257", "r483" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-term Debt, Gross" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionRatio1": { "auth_ref": [ "r33", "r132", "r133", "r135", "r468" ], "lang": { "en-us": { "role": { "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.", "label": "Debt Instrument, Convertible, Conversion Ratio" } } }, "localname": "DebtInstrumentConvertibleConversionRatio1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "pureItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r232", "r234", "r466", "r623", "r744", "r745" ], "crdr": "credit", "lang": { "en-us": { "role": { "disclosureGuidance": "Debt instrument face value", "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Debt Instrument, Face Amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionParentheticalDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesParentheticalDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r32", "r467" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionParentheticalDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesParentheticalDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesParentheticalDetail" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfOtherLongTermDebtDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r35", "r343", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r623", "r743", "r744", "r745", "r746", "r747", "r808" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail", "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsAdditionalInformationDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionParentheticalDetail", "http://Boqii.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r35", "r132", "r134", "r135", "r136", "r231", "r232", "r234", "r256", "r343", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r623", "r743", "r744", "r745", "r746", "r747", "r808" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfOtherLongTermDebtDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount": { "auth_ref": [ "r34" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date.", "label": "Debt Instrument, Unused Borrowing Capacity, Amount", "terseLabel": "Debt instrument unused borrowing capacity" } } }, "localname": "DebtInstrumentUnusedBorrowingCapacityAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleMeasurementInput": { "auth_ref": [ "r596" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale, Measurement Input" } } }, "localname": "DebtSecuritiesAvailableForSaleMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfSignificantUnobservableInputsDetail" ], "xbrltype": "decimalItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": { "auth_ref": [ "r819" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale [Table Text Block]", "terseLabel": "Summary of Available-For-Sale Debt Investments" } } }, "localname": "DebtSecuritiesAvailableForSaleTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]" } } }, "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationTables" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]" } } }, "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.", "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]", "terseLabel": "Summary of Prepayments and Other Current Assets" } } }, "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r75", "r165", "r564", "r570", "r571", "r810" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 36.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://Boqii.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpensesBenefitDetail": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "terseLabel": "Deferred tax expense", "verboseLabel": "Deferred tax benefit" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows", "http://Boqii.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpensesBenefitDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r552", "r553" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 27.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Deferred tax liabilities (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of nil as of March 31, 2022 and 2023, respectively)" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r876" ], "calculation": { "http://Boqii.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndTaxLiabilitiesDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "totalLabel": "Net deferred tax assets" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndTaxLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net [Abstract]", "verboseLabel": "Deferred tax assets:" } } }, "localname": "DeferredTaxAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndTaxLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r163", "r877" ], "calculation": { "http://Boqii.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndTaxLiabilitiesDetail": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "verboseLabel": "Net accumulated loss-carry forward" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndTaxLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": { "auth_ref": [ "r163", "r877" ], "calculation": { "http://Boqii.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndTaxLiabilitiesDetail": { "order": 7.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities", "verboseLabel": "Accruals" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndTaxLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": { "auth_ref": [ "r163", "r877" ], "calculation": { "http://Boqii.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndTaxLiabilitiesDetail": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts", "verboseLabel": "Allowance" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndTaxLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r559" ], "calculation": { "http://Boqii.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndTaxLiabilitiesDetail": { "order": 8.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Less: Valuation allowance", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndTaxLiabilitiesDetail", "http://Boqii.com/role/IncomeTaxesSummaryOfValuationAllowanceDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r158", "r876" ], "calculation": { "http://Boqii.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndTaxLiabilitiesDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities, Net", "negatedTotalLabel": "Net deferred tax liabilities" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndTaxLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Net [Abstract]", "verboseLabel": "Deferred tax liabilities:" } } }, "localname": "DeferredTaxLiabilitiesNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndTaxLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets": { "auth_ref": [ "r163", "r877" ], "calculation": { "http://Boqii.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndTaxLiabilitiesDetail": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from long-lived assets other than property, plant, and equipment.", "label": "Deferred Tax Liabilities, Other Finite-Lived Assets", "negatedLabel": "Recognition of intangible assets arising from asset acquisition and business combination" } } }, "localname": "DeferredTaxLiabilitiesOtherFiniteLivedAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndTaxLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositsAssetsCurrent": { "auth_ref": [ "r788" ], "calculation": { "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsSummaryOfPrepaymentsAndOtherCurrentAssetsDetail": { "order": 6.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.", "label": "Deposits Assets, Current", "terseLabel": "Deposits" } } }, "localname": "DepositsAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsSummaryOfPrepaymentsAndOtherCurrentAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositsAssetsNoncurrent": { "auth_ref": [ "r783" ], "calculation": { "http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsDetail": { "order": 1.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.", "label": "Deposits Assets, Noncurrent", "terseLabel": "Deposits" } } }, "localname": "DepositsAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r75", "r115" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PropertyAndEquipmentNetAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r75", "r384" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 24.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "verboseLabel": "Depreciation and amortization expense" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetsCurrent": { "auth_ref": [ "r316" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset, Current", "terseLabel": "Derivative assets current" } } }, "localname": "DerivativeAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This item represents derivative instrument obligations meeting the definition of a liability which are reported as of the balance sheet date. Derivative instrument obligations are generally measured at fair value, and adjustments to the carrying amount of hedged items reflect changes in their fair value (that is, losses) that are attributable to the risk being hedged and that arise while the hedge is in effect.", "label": "Derivative Financial Instruments, Liabilities [Member]" } } }, "localname": "DerivativeFinancialInstrumentsLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail", "http://Boqii.com/role/FairValueMeasurementsSummaryOfRollForwardOfMajorLevel3InvestmentsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeForwardExchangeRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractual rate at which a foreign currency can be purchased or sold.", "label": "Derivative, Forward Exchange Rate", "terseLabel": "Derivative forward exchange rate" } } }, "localname": "DerivativeForwardExchangeRate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "pureItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r880" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Gain (Loss) on Derivative, Net", "terseLabel": "Gain (Loss) on Derivative, Net" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r211", "r212", "r214", "r215", "r733" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r316", "r317", "r603", "r733" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfFairValueOfDerivativeLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r316" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 25.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Current", "terseLabel": "Derivative liabilities (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of nil as of March 31, 2022 and 2023, respectively)", "verboseLabel": "Derivative liabilities" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration": { "auth_ref": [ "r588" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes derivative liability.", "label": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfFairValueOfDerivativeLiabilitiesDetail" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r509", "r540", "r541", "r543", "r548", "r758" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "terseLabel": "Share-based compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DiscontinuedOperationsDisposedOfBySaleMember": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of by sale and representing a strategic shift that has or will have a major effect on operations and financial results.", "label": "Discontinued Operations, Disposed of by Sale [Member]", "terseLabel": "Discontinued Operations, Disposed of by Sale [Member]" } } }, "localname": "DiscontinuedOperationsDisposedOfBySaleMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupClassificationAxis": { "auth_ref": [ "r289" ], "lang": { "en-us": { "role": { "documentation": "Information by disposal group classification.", "label": "Disposal Group Classification [Axis]" } } }, "localname": "DisposalGroupClassificationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupClassificationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.", "label": "Disposal Group Classification [Domain]" } } }, "localname": "DisposalGroupClassificationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DistributionRightsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Legal rights, generally of a limited duration, to distribute a product or products, often within specific geographic areas or supply channels.", "label": "Distribution Rights [Member]", "terseLabel": "Dealership [Member]" } } }, "localname": "DistributionRightsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsDetail", "http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfFiniteLivedIntangibleAssetsUsefulLivesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DividendsPreferredStockCash": { "auth_ref": [ "r137", "r255" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.", "label": "Dividends, Preferred Stock, Cash", "negatedLabel": "Deemed dividend to preferred shareholders" } } }, "localname": "DividendsPreferredStockCash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueFromRelatedPartiesCurrent": { "auth_ref": [ "r308", "r457", "r458", "r459", "r463", "r464", "r465", "r639", "r732", "r811" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).", "label": "Due from Related Parties, Current", "terseLabel": "Amounts due from related parties" } } }, "localname": "DueFromRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueFromRelatedPartiesNoncurrent": { "auth_ref": [ "r295", "r457", "r458", "r459", "r463", "r464", "r465", "r639", "r811" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 15.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date, which are usually due after one year (or one business cycle).", "label": "Due from Related Parties, Noncurrent", "terseLabel": "Amounts due from related parties, non-current" } } }, "localname": "DueFromRelatedPartiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToOfficersOrStockholdersNoncurrent": { "auth_ref": [ "r12", "r235", "r258", "r274" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amounts due to recorded owners or owners with a beneficial interest of more than 10 percent of the voting interests or officers of the company, which are due after one year (or one business cycle).", "label": "Due to Officers or Stockholders, Noncurrent", "terseLabel": "Long term loan due to the related party non current" } } }, "localname": "DueToOfficersOrStockholdersNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r25", "r457", "r458", "r459", "r463", "r464", "r465", "r639", "r811" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 22.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to Related Parties, Current", "terseLabel": "Amounts due to related parties, current (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB4 and RMB21 as of March 31, 2022 and 2023, respectively)", "verboseLabel": "Amounts due to related parties, current" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Net loss per share attributable to Boqii Holding Limited's ordinary shareholders" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r335", "r349", "r350", "r351", "r352", "r353", "r357", "r360", "r364", "r365", "r366", "r370", "r590", "r591", "r679", "r685", "r739" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "\u2014 basic", "verboseLabel": "Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://Boqii.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r335", "r349", "r350", "r351", "r352", "r353", "r360", "r364", "r365", "r366", "r370", "r590", "r591", "r679", "r685", "r739" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "\u2014 diluted", "verboseLabel": "Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://Boqii.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r85", "r86" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net loss per share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r367", "r368", "r369", "r371" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Net Loss per share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/NetLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r885" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "terseLabel": "Effects of exchange rate changes on cash, cash equivalents and restricted cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r555" ], "calculation": { "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "totalLabel": "Effective income tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r341", "r555", "r572" ], "calculation": { "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail": { "order": 6.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "PRC statutory income tax rates", "verboseLabel": "Income tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesAdditionalInformationDetail", "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r874", "r878" ], "calculation": { "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail": { "order": 10.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent", "terseLabel": "Change in valuation allowance" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r874", "r878" ], "calculation": { "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail": { "order": 7.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.", "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent", "terseLabel": "Difference in tax rates of subsidiaries outside PRC" } } }, "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": { "auth_ref": [ "r874", "r878" ], "calculation": { "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail": { "order": 9.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent", "terseLabel": "Non-deductible\u00a0expenses" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment": { "auth_ref": [ "r874", "r878" ], "calculation": { "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail": { "order": 8.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research and development expense.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent", "terseLabel": "Super deduction for research and development expenses" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxHolidays": { "auth_ref": [ "r874", "r878" ], "calculation": { "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail": { "order": 11.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income exempt from income tax because of a tax holiday.", "label": "Effective Income Tax Rate Reconciliation, Tax Holiday, Percent", "terseLabel": "Tax holiday effect" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxHolidays", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r30" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 20.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Salary and welfare payable (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB5,597 and RMB5,573 as of March 31, 2022 and 2023, respectively)", "verboseLabel": "Salary and welfare payable" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r542" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Weighted average vesting period" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r873" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognised share based compensation expenses" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-based Payment Arrangement, Option [Member]", "terseLabel": "Employee Stock Option [Member]" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail", "http://Boqii.com/role/ShareBasedCompensationSummaryOfOptionsMeasuredAtFairValueValuationAssumptionsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r131", "r287", "r328", "r329", "r330", "r344", "r345", "r346", "r348", "r354", "r356", "r373", "r421", "r492", "r544", "r545", "r546", "r566", "r567", "r589", "r610", "r611", "r612", "r613", "r614", "r616", "r635", "r688", "r689", "r690" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "http://Boqii.com/role/ConvertibleRedeemablePreferredSharesAdditionalInformationDetail", "http://Boqii.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r102" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Equity method investment ownership percentage", "verboseLabel": "Equity method investment ownership interest" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r101", "r388", "r782" ], "calculation": { "http://Boqii.com/role/LongTermInvestmentsSummaryOfLongTermInvestmentDetail": { "order": 1.0, "parentTag": "us-gaap_LongTermInvestments", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Equity method investments", "verboseLabel": "Carrying value of equity method investments" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail", "http://Boqii.com/role/LongTermInvestmentsSummaryOfLongTermInvestmentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesFvNiCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value.", "label": "Equity Securities, FV-NI, Cost", "terseLabel": "Cost" } } }, "localname": "EquitySecuritiesFvNiCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsSummaryOfEquitySecuritiesWithReadilyDeterminableFairValuesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent": { "auth_ref": [ "r303", "r602" ], "calculation": { "http://Boqii.com/role/FairValueMeasurementsSummaryOfCompanySFinancialAssetsAndLiabilitiesDetail": { "order": 3.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Equity Securities, FV-NI", "terseLabel": "Fair\u00a0value", "verboseLabel": "Equity securities with readily determinable fair values" } } }, "localname": "EquitySecuritiesFvNiCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfCompanySFinancialAssetsAndLiabilitiesDetail", "http://Boqii.com/role/LongTermInvestmentsSummaryOfEquitySecuritiesWithReadilyDeterminableFairValuesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesFvNiUnrealizedGain": { "auth_ref": [ "r417" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Equity Securities, FV-NI, Unrealized Gain", "terseLabel": "Gross\u00a0unrealized\u00a0gains" } } }, "localname": "EquitySecuritiesFvNiUnrealizedGain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsSummaryOfEquitySecuritiesWithReadilyDeterminableFairValuesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesFvNiUnrealizedLoss": { "auth_ref": [ "r417" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized loss on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Equity Securities, FV-NI, Unrealized Loss", "negatedLabel": "Gross\u00a0unrealized\u00a0losses" } } }, "localname": "EquitySecuritiesFvNiUnrealizedLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsSummaryOfEquitySecuritiesWithReadilyDeterminableFairValuesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfCompanySFinancialAssetsAndLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r592", "r593", "r600" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfCompanySFinancialAssetsAndLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "auth_ref": [ "r216", "r217", "r218", "r223", "r224" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.", "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]", "terseLabel": "Summary of Company's Financial Assets and Liabilities" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail", "http://Boqii.com/role/FairValueMeasurementsSummaryOfSignificantUnobservableInputsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "auth_ref": [ "r219" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail", "http://Boqii.com/role/FairValueMeasurementsSummaryOfSignificantUnobservableInputsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r219" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "terseLabel": "Summary of Significant Unobservable Inputs" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "Class of asset.", "label": "Asset Class [Domain]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetail", "http://Boqii.com/role/FairValueMeasurementsSummaryOfRollForwardOfMajorLevel3InvestmentsDetail", "http://Boqii.com/role/FairValueMeasurementsSummaryOfSignificantUnobservableInputsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfRollForwardOfMajorLevel3InvestmentsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByAssetClassAxis": { "auth_ref": [ "r216", "r224" ], "lang": { "en-us": { "role": { "documentation": "Information by class of asset.", "label": "Asset Class [Axis]" } } }, "localname": "FairValueByAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetail", "http://Boqii.com/role/FairValueMeasurementsSummaryOfRollForwardOfMajorLevel3InvestmentsDetail", "http://Boqii.com/role/FairValueMeasurementsSummaryOfSignificantUnobservableInputsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r474", "r499", "r500", "r501", "r502", "r503", "r504", "r593", "r646", "r647", "r648", "r744", "r745", "r752", "r753", "r754" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfCompanySFinancialAssetsAndLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r222", "r224" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail", "http://Boqii.com/role/FairValueMeasurementsSummaryOfRollForwardOfMajorLevel3InvestmentsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r592", "r593", "r595", "r596", "r601" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfCompanySFinancialAssetsAndLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r599" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair value measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r474", "r499", "r504", "r593", "r646", "r752", "r753", "r754" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Significant unobservable Inputs (Level 1) [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfCompanySFinancialAssetsAndLiabilitiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r474", "r499", "r504", "r593", "r647", "r744", "r745", "r752", "r753", "r754" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Significant other observable Inputs (Level 2) [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfCompanySFinancialAssetsAndLiabilitiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r474", "r499", "r500", "r501", "r502", "r503", "r504", "r593", "r648", "r744", "r745", "r752", "r753", "r754" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Significant unobservable Inputs (Level 3) [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfCompanySFinancialAssetsAndLiabilitiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail", "http://Boqii.com/role/FairValueMeasurementsSummaryOfRollForwardOfMajorLevel3InvestmentsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r220", "r224" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfRollForwardOfMajorLevel3InvestmentsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r220", "r224" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Summary of Roll Forward of Major Level 3 Investments" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfCompanySFinancialAssetsAndLiabilitiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": { "auth_ref": [ "r598" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings", "terseLabel": "Unrealized fair value change of the\u00a0available-for-sale\u00a0debt investments" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfRollForwardOfMajorLevel3InvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues": { "auth_ref": [ "r221" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of issuances of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances", "terseLabel": "New addition" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfRollForwardOfMajorLevel3InvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": { "auth_ref": [ "r220" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value", "periodEndLabel": "Fair value of Level 3 investments , Ending Balance", "periodStartLabel": "Fair value of Level 3 investments , Beginning Balance" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfRollForwardOfMajorLevel3InvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [ "r598" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "terseLabel": "Unrealized fair value change of the derivative liabilities" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfRollForwardOfMajorLevel3InvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": { "auth_ref": [ "r221" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances", "terseLabel": "New addition" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfRollForwardOfMajorLevel3InvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales": { "auth_ref": [ "r221" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of sales of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Sales", "negatedLabel": "Disposal of Series D-3 Notes" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfRollForwardOfMajorLevel3InvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r220" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Fair value of Level 3 investments , Ending Balance", "periodStartLabel": "Fair value of Level 3 investments, Beginning Balance" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfRollForwardOfMajorLevel3InvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r474", "r499", "r500", "r501", "r502", "r503", "r504", "r646", "r647", "r648", "r744", "r745", "r752", "r753", "r754" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfCompanySFinancialAssetsAndLiabilitiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r599", "r601" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfCompanySFinancialAssetsAndLiabilitiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r225", "r226" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair value of financial instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinanceLeaseInterestExpense": { "auth_ref": [ "r626", "r629", "r762" ], "calculation": { "http://Boqii.com/role/LeasesSummaryOfOperatingLeaseActivityDetail": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense on finance lease liability.", "label": "Finance Lease, Interest Expense", "terseLabel": "Interest of lease liabilities" } } }, "localname": "FinanceLeaseInterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LeasesSummaryOfOperatingLeaseActivityDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancialLiabilitiesFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.", "label": "Financial Liabilities Fair Value Disclosure", "terseLabel": "Derivative liabilities" } } }, "localname": "FinancialLiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfCompanySFinancialAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Finite-Lived Intangible Asset, Useful Life" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfFiniteLivedIntangibleAssetsUsefulLivesDetail" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r300", "r444" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "terseLabel": "Less: Accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r111" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IntangibleAssetsNetScheduleOfAnnualEstimatedAmortizationExpenseForIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r111" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "2028" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IntangibleAssetsNetScheduleOfAnnualEstimatedAmortizationExpenseForIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r111" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IntangibleAssetsNetScheduleOfAnnualEstimatedAmortizationExpenseForIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r111" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IntangibleAssetsNetScheduleOfAnnualEstimatedAmortizationExpenseForIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r111" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IntangibleAssetsNetScheduleOfAnnualEstimatedAmortizationExpenseForIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r441", "r443", "r444", "r445", "r660", "r661" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsAdditionalInformationDetail", "http://Boqii.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsDetail", "http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfFiniteLivedIntangibleAssetsUsefulLivesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]" } } }, "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r109", "r661" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Finite-Lived Intangible Assets, Gross" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsDetail", "http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfFiniteLivedIntangibleAssetsUsefulLivesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r106", "r108" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsAdditionalInformationDetail", "http://Boqii.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsDetail", "http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfFiniteLivedIntangibleAssetsUsefulLivesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net [Abstract]" } } }, "localname": "FiniteLivedIntangibleAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FinitelivedIntangibleAssetsAcquired1": { "auth_ref": [ "r442" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.", "label": "Finite-lived Intangible Assets Acquired", "terseLabel": "Intangible assets resulting from the business combinations" } } }, "localname": "FinitelivedIntangibleAssetsAcquired1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IntangibleAssetsNetAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyExchangeRateTranslation1": { "auth_ref": [ "r617", "r618" ], "lang": { "en-us": { "role": { "documentation": "Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency.", "label": "Foreign Currency Exchange Rate, Translation", "terseLabel": "Foreign Currency Exchange Rate" } } }, "localname": "ForeignCurrencyExchangeRateTranslation1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "pureItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r605", "r606", "r607", "r609" ], "calculation": { "http://Boqii.com/role/OtherGainsNetSummaryOfOtherLossesNetDetail": { "order": 2.0, "parentTag": "us-gaap_NonoperatingGainsLosses", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), before Tax", "terseLabel": "Foreign exchange losses, net" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OtherGainsNetSummaryOfOtherLossesNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r619" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Functional currency and foreign currency translation" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]", "verboseLabel": "Furniture, Computer And Office Equipment [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfPropertyPlantAndEquipmentUsefulLivesDetail", "http://Boqii.com/role/PropertyAndEquipmentNetSummaryOfPropertyPlantAndEquipmentsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDispositionOfAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other gains (losses), net [Abstract]" } } }, "localname": "GainLossOnDispositionOfAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GainLossOnInvestments": { "auth_ref": [ "r59", "r97", "r780" ], "calculation": { "http://Boqii.com/role/OtherGainsNetSummaryOfOtherLossesNetDetail": { "order": 6.0, "parentTag": "us-gaap_NonoperatingGainsLosses", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized and unrealized gain (loss) on investment.", "label": "Gain (Loss) on Investments", "terseLabel": "Investment loss" } } }, "localname": "GainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OtherGainsNetSummaryOfOtherLossesNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfOtherAssets": { "auth_ref": [ "r805" ], "calculation": { "http://Boqii.com/role/OtherGainsNetSummaryOfOtherLossesNetDetail": { "order": 3.0, "parentTag": "us-gaap_NonoperatingGainsLosses", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of other assets.", "label": "Gain (Loss) on Disposition of Other Assets", "terseLabel": "Gain on disposal of other debts" } } }, "localname": "GainLossOnSaleOfOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OtherGainsNetSummaryOfOtherLossesNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainOrLossOnSaleOfStockInSubsidiary": { "auth_ref": [ "r794", "r795", "r805", "r900", "r901" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 38.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://Boqii.com/role/OtherGainsNetSummaryOfOtherLossesNetDetail": { "order": 7.0, "parentTag": "us-gaap_NonoperatingGainsLosses", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Investment gain on disposal of a subsidiary", "documentation": "Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries.", "label": "Gain (Loss) on Disposition of Stock in Subsidiary", "negatedLabel": "Gain from disposal of a subsidiary", "verboseLabel": "Gain on disposal of a subsidiary" } } }, "localname": "GainOrLossOnSaleOfStockInSubsidiary", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows", "http://Boqii.com/role/OtherGainsNetSummaryOfOtherLossesNetDetail", "http://Boqii.com/role/OtherGainsNetSummaryOfOtherLossesNetParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r75", "r124", "r125" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 32.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "negatedLabel": "Gain on disposal of other debts" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r57" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 17.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "negatedLabel": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r299", "r432", "r674", "r742", "r763", "r822", "r829" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill", "totalLabel": "Total" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/GoodwillScheduleOfChangesInTheCarryingAmountOfGoodwillDetail", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "auth_ref": [ "r439", "r440", "r742" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.", "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]", "terseLabel": "Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillDisclosureTextBlock": { "auth_ref": [ "r437", "r438", "r440", "r742" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill.", "label": "Goodwill Disclosure [Text Block]", "terseLabel": "Goodwill" } } }, "localname": "GoodwillDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/Goodwill" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillGross": { "auth_ref": [ "r434", "r436", "r742" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Gross", "terseLabel": "Goodwill" } } }, "localname": "GoodwillGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/GoodwillScheduleOfChangesInTheCarryingAmountOfGoodwillDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": { "auth_ref": [ "r434", "r436", "r742" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impaired, Accumulated Impairment Loss", "negatedLabel": "Accumulated impairment loss" } } }, "localname": "GoodwillImpairedAccumulatedImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/GoodwillScheduleOfChangesInTheCarryingAmountOfGoodwillDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r75", "r433", "r435", "r439", "r742" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 39.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 19.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impairment Loss", "negatedLabel": "Impairment of goodwill", "negatedTerseLabel": "Impairment", "terseLabel": "Impairment of goodwill" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows", "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://Boqii.com/role/GoodwillAdditionalInformationDetail", "http://Boqii.com/role/GoodwillScheduleOfChangesInTheCarryingAmountOfGoodwillDetail", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_GovernmentAssistanceAmount": { "auth_ref": [ "r620" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of government assistance recognized.", "label": "Government Assistance, Amount", "terseLabel": "Government subsidies recognized" } } }, "localname": "GovernmentAssistanceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": { "auth_ref": [ "r620" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of income or comprehensive income that includes government assistance.", "label": "Government Assistance, Statement of Income or Comprehensive Income [Extensible Enumeration]" } } }, "localname": "GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r55", "r340", "r387", "r396", "r400", "r402", "r420", "r455", "r456", "r458", "r459", "r460", "r461", "r462", "r464", "r465", "r604", "r741", "r839" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 12.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": { "auth_ref": [ "r805", "r833" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.", "label": "Impairment of Intangible Assets, Finite-Lived", "terseLabel": "Impairment of finitely lived intangible assets" } } }, "localname": "ImpairmentOfIntangibleAssetsFinitelived", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.", "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Impairment of long-lived assets other than goodwill" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r51", "r238", "r250", "r272", "r387", "r396", "r400", "r402", "r680", "r741" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 10.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss before income tax expenses", "verboseLabel": "Loss before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r387", "r396", "r400", "r402", "r741" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "totalLabel": "Profit/(Loss) before income tax expenses" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r52", "r75", "r101", "r249", "r270", "r385" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 9.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "terseLabel": "Share of results of equity investees" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": { "auth_ref": [ "r75" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 31.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.", "label": "Income (Loss) from Equity Method Investments, Net of Dividends or Distributions", "negatedTerseLabel": "Share of results of equity investees" } } }, "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r447", "r448" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r448" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "verboseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r341", "r556", "r557", "r562", "r568", "r573", "r575", "r576", "r577" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r342", "r355", "r356", "r386", "r554", "r569", "r574", "r686" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 8.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 }, "http://Boqii.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpensesBenefitDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Income tax benefit", "negatedTotalLabel": "Total", "terseLabel": "Income tax benefits/(expenses)", "totalLabel": "Income tax Credit, net" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://Boqii.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpensesBenefitDetail", "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxHolidayDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A description of the factual circumstances giving rise to an income tax exemption or special reduction received from a taxing jurisdiction.", "label": "Income Tax Holiday, Description", "verboseLabel": "Income tax holiday, description" } } }, "localname": "IncomeTaxHolidayDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r327", "r550", "r551", "r557", "r558", "r561", "r565" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r874" ], "calculation": { "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail": { "order": 5.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount", "negatedLabel": "Change in valuation allowance" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r874" ], "calculation": { "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount", "negatedLabel": "Effect of different tax jurisdiction" } } }, "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r555" ], "calculation": { "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount", "negatedLabel": "Income tax computed at respective applicable tax rates" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationNondeductibleExpense": { "auth_ref": [ "r874" ], "calculation": { "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail": { "order": 4.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount", "negatedLabel": "Non-deductible\u00a0expenses" } } }, "localname": "IncomeTaxReconciliationNondeductibleExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment": { "auth_ref": [ "r874" ], "calculation": { "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail": { "order": 3.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible research and development expense.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount", "negatedLabel": "Super deduction for research and development expenses", "terseLabel": "Super deduction for research and development expenses" } } }, "localname": "IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetail", "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r74" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 46.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r74" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 41.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": { "auth_ref": [ "r804" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 48.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.", "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities", "terseLabel": "Accrued liabilities and other current liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r654", "r804" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 50.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "terseLabel": "Contract liabilities" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent": { "auth_ref": [ "r74" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 44.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate increase (decrease) during the reporting period in the amount due from the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.", "label": "Increase (Decrease) in Due from Related Parties, Current", "negatedLabel": "Amounts due from related parties" } } }, "localname": "IncreaseDecreaseInDueFromRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDueToRelatedParties": { "auth_ref": [ "r74" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 49.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.", "label": "Increase (Decrease) in Due to Related Parties", "terseLabel": "Amounts due to related parties" } } }, "localname": "IncreaseDecreaseInDueToRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": { "auth_ref": [ "r74" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 47.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Increase (Decrease) in Employee Related Liabilities", "terseLabel": "Salary and welfare payable" } } }, "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r74" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 42.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities, net of effects of businesses acquired:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": { "auth_ref": [ "r804" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 51.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.", "label": "Increase (Decrease) in Other Noncurrent Assets", "negatedLabel": "Other non-current assets" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r74" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 43.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepayments and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Indefinite-lived Intangible Assets [Line Items]", "terseLabel": "Indefinite-lived Intangible Assets [Line Items]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/GoodwillAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r446" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "Intangible Assets Disclosure [Text Block]", "terseLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IntangibleAssetsNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "auth_ref": [ "r108", "r656", "r657", "r658", "r660", "r735" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.", "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]", "terseLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsFiniteLivedPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r104", "r107" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsDetail", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Intangible Assets, Net (Excluding Goodwill) [Abstract]" } } }, "localname": "IntangibleAssetsNetExcludingGoodwillAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InterestAndDebtExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Interest and Debt Expense [Abstract]", "verboseLabel": "Interest and Debt Expense [Abstract]" } } }, "localname": "InterestAndDebtExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r233", "r254", "r331", "r383", "r621" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 21.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 }, "http://Boqii.com/role/InterestExpenseSummaryOfInterestExpenseDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense", "terseLabel": "Interest expense", "totalLabel": "Total" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://Boqii.com/role/InterestExpenseSummaryOfInterestExpenseDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseBorrowings": { "auth_ref": [ "r253" ], "calculation": { "http://Boqii.com/role/InterestExpenseSummaryOfInterestExpenseDetail": { "order": 2.0, "parentTag": "us-gaap_InterestExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate amount of interest expense on all borrowings.", "label": "Interest Expense, Borrowings", "terseLabel": "Interest expense on borrowings" } } }, "localname": "InterestExpenseBorrowings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/InterestExpenseSummaryOfInterestExpenseDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r62", "r479", "r485", "r746", "r747" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 27.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense, Debt", "terseLabel": "Interest expense of other debts" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.", "label": "Interest Income and Interest Expense Disclosure [Table Text Block]", "verboseLabel": "Summary of Interest Expense" } } }, "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/InterestExpenseTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InterestIncomeAndInterestExpenseDisclosureTextBlock": { "auth_ref": [ "r252" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for interest income and interest expense for enterprises that derive a significant portion of their revenue from interest collected on investments, loans, and securities.", "label": "Interest Income and Interest Expense Disclosure [Text Block]", "terseLabel": "Interest expense" } } }, "localname": "InterestIncomeAndInterestExpenseDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/InterestExpense" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryAdjustments": { "auth_ref": [ "r103", "r787" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of inventory reserves for last-in first-out (LIFO) and other inventory valuation methods.", "label": "Inventory Adjustments", "periodEndLabel": "At end of year", "periodStartLabel": "At beginning of year" } } }, "localname": "InventoryAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/InventoriesNetOfInventoryReservesSummaryOfMovementOfInventoryProvisionDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryCurrentTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer.", "label": "Inventory, Current [Table]" } } }, "localname": "InventoryCurrentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/InventoriesNetOfInventoryReservesSummaryOfInventoriesNetOfInventoryReservesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r431" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventories, net of inventory reserves" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/InventoriesNetOfInventoryReserves" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Inventory [Line Items]" } } }, "localname": "InventoryLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/InventoriesNetOfInventoryReservesSummaryOfInventoriesNetOfInventoryReservesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r313", "r730", "r763" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories, net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/InventoriesNetOfInventoryReservesSummaryOfInventoriesNetOfInventoryReservesDetail", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r293", "r312", "r372", "r428", "r430", "r431", "r655", "r736" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r429" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 25.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "Inventory Write-down", "terseLabel": "Provision for inventories" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r58", "r382" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 20.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "terseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentPolicyTextBlock": { "auth_ref": [ "r419", "r902" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment in financial asset.", "label": "Investment, Policy [Policy Text Block]", "terseLabel": "Long-term investments" } } }, "localname": "InvestmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r705", "r706", "r707", "r708", "r709" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r705", "r706", "r707", "r708", "r709" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investments [Domain]" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, Debt and Equity Securities [Abstract]" } } }, "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r592" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Investments, Fair Value Disclosure", "terseLabel": "Investment re-measured at fair value" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r887" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Summary of Operating Lease Activity" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r116" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfPropertyPlantAndEquipmentUsefulLivesDetail", "http://Boqii.com/role/PropertyAndEquipmentNetSummaryOfPropertyPlantAndEquipmentsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]", "verboseLabel": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LeasesOfLesseeDisclosureTextBlock": { "auth_ref": [ "r286" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.", "label": "Leases of Lessee Disclosure [Text Block]", "terseLabel": "Leases" } } }, "localname": "LeasesOfLesseeDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r628" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r888" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Summary of Maturities of Lease Liabilities" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r634" ], "calculation": { "http://Boqii.com/role/LeasesSummaryOfMaturitiesOfLeaseLiabilitiesDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://Boqii.com/role/LeasesSummaryOfMaturitiesOfLeaseLiabilitiesDetailAlternate1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LeasesSummaryOfMaturitiesOfLeaseLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r634" ], "calculation": { "http://Boqii.com/role/LeasesSummaryOfMaturitiesOfLeaseLiabilitiesDetail": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "terseLabel": "2027" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LeasesSummaryOfMaturitiesOfLeaseLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r634" ], "calculation": { "http://Boqii.com/role/LeasesSummaryOfMaturitiesOfLeaseLiabilitiesDetail": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LeasesSummaryOfMaturitiesOfLeaseLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r634" ], "calculation": { "http://Boqii.com/role/LeasesSummaryOfMaturitiesOfLeaseLiabilitiesDetail": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LeasesSummaryOfMaturitiesOfLeaseLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r634" ], "calculation": { "http://Boqii.com/role/LeasesSummaryOfMaturitiesOfLeaseLiabilitiesDetail": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LeasesSummaryOfMaturitiesOfLeaseLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r634" ], "calculation": { "http://Boqii.com/role/LeasesSummaryOfMaturitiesOfLeaseLiabilitiesDetail": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LeasesSummaryOfMaturitiesOfLeaseLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r634" ], "calculation": { "http://Boqii.com/role/LeasesSummaryOfMaturitiesOfLeaseLiabilitiesDetailAlternate1": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LeasesSummaryOfMaturitiesOfLeaseLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r29", "r340", "r420", "r455", "r456", "r458", "r459", "r460", "r461", "r462", "r464", "r465", "r583", "r586", "r587", "r604", "r740", "r839", "r892", "r893" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 16.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities:" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/FairValueMeasurementsSummaryOfCompanySFinancialAssetsAndLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r20", "r243", "r265", "r763", "r809", "r820", "r884" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities, mezzanine equity and shareholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS' EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r31", "r292", "r340", "r420", "r455", "r456", "r458", "r459", "r460", "r461", "r462", "r464", "r465", "r583", "r586", "r587", "r604", "r763", "r839", "r892", "r893" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 17.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r5", "r6", "r7", "r11", "r12", "r340", "r420", "r455", "r456", "r458", "r459", "r460", "r461", "r462", "r464", "r465", "r583", "r586", "r587", "r604", "r839", "r892", "r893" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 26.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total non-current liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Noncurrent [Abstract]", "terseLabel": "Non-current liabilities" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LicenseMember": { "auth_ref": [ "r846" ], "lang": { "en-us": { "role": { "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark.", "label": "License [Member]", "terseLabel": "License [Member]" } } }, "localname": "LicenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsDetail", "http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfFiniteLivedIntangibleAssetsUsefulLivesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r11", "r241", "r257" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-term Line of Credit" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityAxis": { "auth_ref": [ "r27", "r808" ], "lang": { "en-us": { "role": { "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.", "label": "Lender Name [Axis]" } } }, "localname": "LineOfCreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConvertibleRedeemablePreferredSharesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "The effective interest rate during the reporting period.", "label": "Line of Credit Facility, Interest Rate During Period" } } }, "localname": "LineOfCreditFacilityInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityLenderDomain": { "auth_ref": [ "r27", "r808" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.", "label": "Line of Credit Facility, Lender [Domain]" } } }, "localname": "LineOfCreditFacilityLenderDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConvertibleRedeemablePreferredSharesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityPeriodicPaymentInterest": { "auth_ref": [ "r27" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payment applied to interest.", "label": "Line of Credit Facility, Periodic Payment, Interest", "terseLabel": "Line of Credit Facility, Periodic Payment, Interest" } } }, "localname": "LineOfCreditFacilityPeriodicPaymentInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal": { "auth_ref": [ "r27" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payment applied to principal.", "label": "Line of Credit Facility, Periodic Payment, Principal", "terseLabel": "Line of Credit Facility, Periodic Payment, Principal" } } }, "localname": "LineOfCreditFacilityPeriodicPaymentPrincipal", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansPayableToBankCurrent": { "auth_ref": [ "r9" ], "calculation": { "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfShortTermDebtDetail": { "order": 2.0, "parentTag": "us-gaap_ShortTermBorrowings", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of current portion of long-term loans payable to bank due within one year or the operating cycle if longer.", "label": "Loans Payable to Bank, Current", "terseLabel": "Current portion of long-term bank borrowings" } } }, "localname": "LoansPayableToBankCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfShortTermDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r11", "r241", "r262", "r473", "r484", "r744", "r745" ], "calculation": { "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfMaturitiesOfLongTermDebtDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Long-term Debt", "totalLabel": "Total" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfMaturitiesOfLongTermDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r122", "r343", "r477" ], "calculation": { "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfMaturitiesOfLongTermDebtDetail": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year One", "terseLabel": "Within 1 year" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfMaturitiesOfLongTermDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtPercentageBearingFixedInterestRate": { "auth_ref": [ "r32" ], "lang": { "en-us": { "role": { "documentation": "The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.", "label": "Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate", "terseLabel": "Long term borrowings fixed rate of interest rate percentage" } } }, "localname": "LongTermDebtPercentageBearingFixedInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_LongTermDebtTerm": { "auth_ref": [ "r883" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Long-term Debt, Term" } } }, "localname": "LongTermDebtTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_LongTermInvestments": { "auth_ref": [ "r296" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 }, "http://Boqii.com/role/LongTermInvestmentsSummaryOfLongTermInvestmentDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).", "label": "Long-term Investments", "terseLabel": "Long-term investments", "totalLabel": "Total" } } }, "localname": "LongTermInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/LongTermInvestmentsSummaryOfLongTermInvestmentDetail", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long-term Investments [Abstract]" } } }, "localname": "LongTermInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LongTermInvestmentsAndReceivablesNet": { "auth_ref": [ "r784" ], "calculation": { "http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsDetail": { "order": 2.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle) and amount due to the Entity from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such investments and receivables to an amount that approximates their net realizable value.", "label": "Long-term Investments and Receivables, Net", "terseLabel": "Long-term loans receivable" } } }, "localname": "LongTermInvestmentsAndReceivablesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsDetail", "http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermInvestmentsAndReceivablesNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long-term Investments and Receivables, Net [Abstract]" } } }, "localname": "LongTermInvestmentsAndReceivablesNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LongTermPurchaseCommitmentAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The minimum amount the entity agreed to spend under the long-term purchase commitment.", "label": "Long-term Purchase Commitment, Amount", "terseLabel": "Capital commitment amount" } } }, "localname": "LongTermPurchaseCommitmentAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r35" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfOtherLongTermDebtDetail", "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsAdditionalInformationDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionParentheticalDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesParentheticalDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r35", "r123" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfOtherLongTermDebtDetail", "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsAdditionalInformationDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionParentheticalDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesParentheticalDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember": { "auth_ref": [ "r882" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using amount by which value of business ownership interest is reduced to reflect lack of ability to convert business interest into cash quickly.", "label": "Measurement Input, Discount for Lack of Marketability [Member]", "terseLabel": "Lack of marketability discount [Member]" } } }, "localname": "MeasurementInputDiscountForLackOfMarketabilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfSignificantUnobservableInputsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputPriceVolatilityMember": { "auth_ref": [ "r882" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.", "label": "Measurement Input, Price Volatility [Member]", "terseLabel": "Expected volatility [Member]" } } }, "localname": "MeasurementInputPriceVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfSignificantUnobservableInputsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "auth_ref": [ "r882" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.", "label": "Measurement Input, Risk Free Interest Rate [Member]", "terseLabel": "Risk-free rate [Member]" } } }, "localname": "MeasurementInputRiskFreeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfSignificantUnobservableInputsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r594" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfSignificantUnobservableInputsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfSignificantUnobservableInputsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r43", "r242", "r264", "r340", "r420", "r455", "r458", "r459", "r460", "r464", "r465", "r604" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 33.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Non-controlling interests" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestChangeInRedemptionValue": { "auth_ref": [ "r128", "r129", "r130", "r138" ], "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Accretion on the Redeemable non-controlling interests to redemption value (Note 21)", "documentation": "Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.", "label": "Noncontrolling Interest, Change in Redemption Value", "negatedLabel": "Accretion of redeemable non-controlling interests", "positiveLabel": "Accretion of redemption value of the redeemable non-controlling interest", "terseLabel": "Accretion on redeemable non-controlling interests to redemption value" } } }, "localname": "MinorityInterestChangeInRedemptionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "http://Boqii.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail", "http://Boqii.com/role/RedeemableNonControllingInterestsAdditionalInformationDetail", "http://Boqii.com/role/RedeemableNonControllingInterestsScheduleOfRedeemableNonControllingInterestsActivityDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.", "label": "Noncontrolling Interest, Ownership Percentage by Parent", "terseLabel": "Percentage of direct or indirect" } } }, "localname": "MinorityInterestOwnershipPercentageByParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail" ], "xbrltype": "percentItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r338" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "terseLabel": "Net cash generated from/ (used in) financing activities", "totalLabel": "Net cash flows generated from/ (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r338" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash generated from/ (used in) investing activities", "verboseLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r72", "r73", "r76" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 22.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities", "verboseLabel": "Net cash generated from/ (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r53", "r76", "r251", "r271", "r290", "r322", "r325", "r330", "r340", "r347", "r349", "r350", "r351", "r352", "r355", "r356", "r362", "r387", "r396", "r400", "r402", "r420", "r455", "r456", "r458", "r459", "r460", "r461", "r462", "r464", "r465", "r591", "r604", "r741", "r839" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 6.0, "parentTag": "bq_NetIncomeLossAttributableToAfterRedemptionAndDividendForOrdinaryShareholders", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net loss attributable to\u00a0Boqii Holding Limited" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Parent [Abstract]", "terseLabel": "Numerator:" } } }, "localname": "NetIncomeLossAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r192", "r206", "r322", "r325", "r355", "r356", "r792" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 24.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "terseLabel": "Less: Net income attributable to the\u00a0non-controlling\u00a0interest shareholders" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r349", "r350", "r351", "r352", "r357", "r358", "r363", "r366", "r387", "r396", "r400", "r402", "r741" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "terseLabel": "Net loss attributable to ordinary shareholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent accounting pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest [Abstract]" } } }, "localname": "NoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest": { "auth_ref": [ "r138", "r189", "r193" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.", "label": "Noncontrolling Interest, Increase from Sale of Parent Equity Interest", "terseLabel": "Capital contribution from non-controlling interests" } } }, "localname": "NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": { "auth_ref": [ "r138", "r189", "r193" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.", "label": "Noncontrolling Interest, Increase from Subsidiary Equity Issuance", "terseLabel": "Acquisition of a subsidiaries" } } }, "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r184", "r492", "r812", "r813", "r814" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Non-controlling interests [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingGainsLosses": { "auth_ref": [ "r61" ], "calculation": { "http://Boqii.com/role/OtherGainsNetSummaryOfOtherLossesNetDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of gains or losses resulting from nonoperating activities (for example, interest and dividend revenue, property, plant and equipment impairment loss, and so forth).", "label": "Nonoperating Gains (Losses)", "totalLabel": "Total" } } }, "localname": "NonoperatingGainsLosses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OtherGainsNetSummaryOfOtherLossesNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r60" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "terseLabel": "Non-operating expense" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonrecourseMember": { "auth_ref": [ "r583", "r587" ], "lang": { "en-us": { "role": { "documentation": "Liability for which creditor does not have recourse to debtor but rather has recourse only to property used for collateral in transaction or other specific property.", "label": "Nonrecourse [Member]", "terseLabel": "Nonrecourse [Member]" } } }, "localname": "NonrecourseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesAdditionalInformationDetail", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_NotesAndLoansReceivableNetCurrent": { "auth_ref": [ "r407", "r408", "r676" ], "calculation": { "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsSummaryOfPrepaymentsAndOtherCurrentAssetsDetail": { "order": 1.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Loan receivables", "documentation": "Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease.", "label": "Financing Receivable, after Allowance for Credit Loss, Current", "verboseLabel": "Financing receivable, after allowance for credit loss, current" } } }, "localname": "NotesAndLoansReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsAdditionalInformationDetail", "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsSummaryOfPrepaymentsAndOtherCurrentAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "verboseLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r387", "r396", "r400", "r402", "r741" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 11.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "terseLabel": "Profit/(Loss) from operations", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r886" ], "calculation": { "http://Boqii.com/role/LeasesSummaryOfOperatingLeaseActivityDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease, Expense", "totalLabel": "Operating lease, expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LeasesSummaryOfOperatingLeaseActivityDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r625" ], "calculation": { "http://Boqii.com/role/LeasesSummaryOfMaturitiesOfLeaseLiabilitiesDetailAlternate1": { "order": 7.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 }, "http://Boqii.com/role/LeasesSummaryOfOperatingLeasesDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Total", "totalLabel": "Total operating lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LeasesSummaryOfMaturitiesOfLeaseLiabilitiesDetail", "http://Boqii.com/role/LeasesSummaryOfOperatingLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability [Abstract]", "verboseLabel": "Liabilities" } } }, "localname": "OperatingLeaseLiabilityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LeasesSummaryOfOperatingLeasesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r625" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 24.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://Boqii.com/role/LeasesSummaryOfOperatingLeasesDetail": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "presentationGuidance": "Operating lease liabilities, current", "terseLabel": "Operating lease liabilities, current (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB7,238 and RMB9,207 as of March 31, 2022 and 2023, respectively)", "verboseLabel": "Operating lease liabilities, current" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "http://Boqii.com/role/LeasesSummaryOfOperatingLeasesDetail", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r625" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 28.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 }, "http://Boqii.com/role/LeasesSummaryOfOperatingLeasesDetail": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liabilities, non-current (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB28,197 and RMB12,741 as of March 31, 2022 and 2023, respectively)", "verboseLabel": "Operating lease liabilities,\u00a0non-current" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "http://Boqii.com/role/LeasesSummaryOfOperatingLeasesDetail", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r627", "r630" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Operating lease payments (included in measurement of lease liabilities)" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LeasesSummaryOfOperatingLeaseActivityDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r624" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets", "verboseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/LeasesSummaryOfOperatingLeasesDetail", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r805" ], "calculation": { "http://Boqii.com/role/LeasesSummaryOfOperatingLeaseActivityDetail": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for right-of-use asset from operating lease.", "label": "Operating Lease, Right-of-Use Asset, Amortization Expense", "terseLabel": "Amortization of right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LeasesSummaryOfOperatingLeaseActivityDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r633", "r762" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted average discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LeasesSummaryOfOperatingLeasesDetail" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r632", "r762" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted average remaining lease term (years)" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LeasesSummaryOfOperatingLeasesDetail" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock": { "auth_ref": [ "r281", "r282", "r283", "r284", "r285" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for lessee's operating leases. Includes, but is not limited to, description of lessee's operating lease, existence and terms of renewal or purchase options and escalation clauses, restrictions imposed by lease, such as those concerning dividends, additional debt, and further leasing, rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions.", "label": "Lessee, Operating Lease, Disclosure [Table Text Block]", "terseLabel": "Summary of Operating Leases" } } }, "localname": "OperatingLeasesOfLesseeDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r162" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards", "terseLabel": "Operating loss carry forwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r3", "r208" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "Organization and principal activities" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivities" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r314", "r763" ], "calculation": { "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsSummaryOfPrepaymentsAndOtherCurrentAssetsDetail": { "order": 7.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Others" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsSummaryOfPrepaymentsAndOtherCurrentAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r301" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 }, "http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other non-current asset", "totalLabel": "Total" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail", "http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrentDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Assets, Noncurrent Disclosure [Abstract]" } } }, "localname": "OtherAssetsNoncurrentDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": { "auth_ref": [ "r318", "r319", "r320" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax", "terseLabel": "Unrealized Securities holding gain, Net of tax" } } }, "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax": { "auth_ref": [ "r318", "r319", "r321" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after adjustment, of tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax", "negatedLabel": "Unrealized securities holding gains/(losses)" } } }, "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r44" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": { "auth_ref": [ "r44", "r47", "r608", "r615" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax", "negatedLabel": "Foreign currency translation adjustment, net of nil tax" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r186", "r187", "r194", "r323", "r326" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "totalLabel": "Total comprehensive loss" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]", "terseLabel": "Other comprehensive income (loss):" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherIncomeAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Income and Expenses [Abstract]" } } }, "localname": "OtherIncomeAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": { "auth_ref": [ "r140", "r156" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.", "label": "Other Income and Other Expense Disclosure [Text Block]", "terseLabel": "Other gains, net" } } }, "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OtherGainsNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherLiabilities": { "auth_ref": [ "r246" ], "calculation": { "http://Boqii.com/role/AccruedLiabilitiesAndOtherCurrentLiabilitiesScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesDetail": { "order": 1.0, "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other.", "label": "Other Liabilities", "terseLabel": "Others" } } }, "localname": "OtherLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/AccruedLiabilitiesAndOtherCurrentLiabilitiesScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingGainsLosses": { "auth_ref": [ "r61" ], "calculation": { "http://Boqii.com/role/OtherGainsNetSummaryOfOtherLossesNetDetail": { "order": 4.0, "parentTag": "us-gaap_NonoperatingGainsLosses", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Gains (Losses)", "terseLabel": "Others", "verboseLabel": "Other Nonoperating Gains (Losses)" } } }, "localname": "OtherNonoperatingGainsLosses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail", "http://Boqii.com/role/OtherGainsNetSummaryOfOtherLossesNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r63" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 22.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Other gains, net", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivables": { "auth_ref": [ "r309" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from parties in nontrade transactions, classified as other.", "label": "Other Receivables", "terseLabel": "Other receivables from related parties" } } }, "localname": "OtherReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherResearchAndDevelopmentExpense": { "auth_ref": [ "r157" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other research and development expense.", "label": "Other Research and Development Expense", "terseLabel": "Other Research and Development Expense" } } }, "localname": "OtherResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherShortTermInvestments": { "auth_ref": [ "r248", "r268", "r788" ], "calculation": { "http://Boqii.com/role/FairValueMeasurementsSummaryOfCompanySFinancialAssetsAndLiabilitiesDetail": { "order": 1.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term investments classified as other.", "label": "Other Short-term Investments", "terseLabel": "Short-term investments" } } }, "localname": "OtherShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsSummaryOfCompanySFinancialAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "auth_ref": [ "r797", "r799" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.", "label": "Payments for (Proceeds from) Other Investing Activities", "terseLabel": "Other investing activities" } } }, "localname": "PaymentsForProceedsFromOtherInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForProceedsFromShortTermInvestments": { "auth_ref": [ "r796", "r798", "r806" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount paid (received) by the reporting entity through acquisition or sale and maturities of short-term investments with an original maturity that is three months or less which qualify for treatment as an investing activity based on management's intention and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.", "label": "Payments for (Proceeds from) Short-term Investments", "negatedLabel": "Increase/(decrease) in short-term investments" } } }, "localname": "PaymentsForProceedsFromShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r66", "r580" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "terseLabel": "- cash consideration", "verboseLabel": "Payments to Acquire Businesses, Gross" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsAdditionalInformationDetail", "http://Boqii.com/role/BusinessCombinationsSummaryOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r66" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 21.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedLabel": "Acquisition of subsidiaries" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r67" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Purchase of intangible assets" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInvestments": { "auth_ref": [ "r68" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.", "label": "Payments to Acquire Investments", "negatedLabel": "Acquisitions of long-term investments", "verboseLabel": "Cash consideration" } } }, "localname": "PaymentsToAcquireInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows", "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r67" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863", "r864", "r865", "r866", "r867", "r868", "r869", "r870", "r871", "r872" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863", "r864", "r865", "r866", "r867", "r868", "r869", "r870", "r871", "r872" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockConversionBasis": { "auth_ref": [ "r14", "r132" ], "lang": { "en-us": { "role": { "documentation": "Describe the conversion features of preferred stock if preferred stock is convertible. That is, shares of preferred stock into which another convertible security was converted, or shares of preferred stock into which another class of preferred stock was converted.", "label": "Preferred Stock, Conversion Basis", "terseLabel": "Preferred Stock, Conversion Basis" } } }, "localname": "PreferredStockConversionBasis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r789" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsSummaryOfPrepaymentsAndOtherCurrentAssetsDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepayments and other current assets", "totalLabel": "Total" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail", "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsSummaryOfPrepaymentsAndOtherCurrentAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Prepaid Expense and Other Assets, Current [Abstract]" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ProceedsFromCollectionOfLoansReceivable": { "auth_ref": [ "r64" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the collection, including prepayments, of loans receivable issued for financing of goods and services.", "label": "Proceeds from Collection of Loans Receivable", "terseLabel": "Repayments on loan receivables from third parties" } } }, "localname": "ProceedsFromCollectionOfLoansReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties": { "auth_ref": [ "r796", "r889" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with collection, whether partial or full, of long-term loans to a related party. Alternate caption: Proceeds from Advances to Affiliates.", "label": "Proceeds from Collection of Long-term Loans to Related Parties", "terseLabel": "Repayments on loan receivables from related parties" } } }, "localname": "ProceedsFromCollectionOfLongtermLoansToRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromContributedCapital": { "auth_ref": [ "r69" ], "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Proceeds from contributed capital", "documentation": "The cash inflow associated with the amount received by a corporation from a shareholder during the period.", "label": "Proceeds from Contributed Capital" } } }, "localname": "ProceedsFromContributedCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ReceivableForIssuanceOfOrdinarySharesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r69" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from Issuance Initial Public Offering", "terseLabel": "Proceeds from the initial public offering, net of underwriter discounts and commissions and other offering costs paid", "verboseLabel": "Proceeds from IPO" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows", "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r69" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from issuance of ordinary shares" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfDebt": { "auth_ref": [ "r800" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.", "label": "Proceeds from Issuance of Debt", "terseLabel": "Proceeds from short-term and long-term borrowings", "verboseLabel": "Proceeds from Issuance of Debt" } } }, "localname": "ProceedsFromIssuanceOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock": { "auth_ref": [ "r69" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.", "label": "Proceeds from Issuance of Redeemable Convertible Preferred Stock", "terseLabel": "Proceeds from issuance of convertible redeemable preferred shares, net of issuance costs" } } }, "localname": "ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromOtherDebt": { "auth_ref": [ "r70" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from debt classified as other.", "label": "Proceeds from Other Debt", "terseLabel": "Proceeds from issuance of other debts, net of issuance costs" } } }, "localname": "ProceedsFromOtherDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForLongTermLoansForRelatedParties": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow or outflow associated with long-term loans for related parties where one party can exercise control or significant influence over another party, including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from (Payments for) Advances to Affiliates.", "label": "Proceeds from Collection of (Payments to Fund) Long-term Loans to Related Parties", "terseLabel": "Cash flows of loan funding provided to the Company's entities, net of repayments received" } } }, "localname": "ProceedsFromPaymentsForLongTermLoansForRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r801", "r803" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Proceeds from (Payments for) Other Financing Activities", "terseLabel": "Other financing activities" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRelatedPartyDebt": { "auth_ref": [ "r70" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.", "label": "Proceeds from Related Party Debt", "terseLabel": "Loan amount obtained from related party" } } }, "localname": "ProceedsFromRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.", "label": "Proceeds from (Repayments of) Related Party Debt", "terseLabel": "Cash flows of loan funding received from the Company's entities, net of repayments made" } } }, "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfEquityMethodInvestments": { "auth_ref": [ "r65" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.", "label": "Proceeds from Sale of Equity Method Investments", "verboseLabel": "Proceeds from Sale of Equity Method Investments" } } }, "localname": "ProceedsFromSaleOfEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r69", "r153" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from exercise of share option" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r290", "r322", "r325", "r337", "r340", "r347", "r355", "r356", "r387", "r396", "r400", "r402", "r420", "r455", "r456", "r458", "r459", "r460", "r461", "r462", "r464", "r465", "r581", "r584", "r585", "r591", "r604", "r680", "r741", "r760", "r761", "r792", "r839" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 23.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 7.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Net profit/(loss)", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net loss", "totalLabel": "Net loss", "verboseLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows", "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r118" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfPropertyPlantAndEquipmentUsefulLivesDetail", "http://Boqii.com/role/PropertyAndEquipmentNetSummaryOfPropertyPlantAndEquipmentsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r120", "r713", "r714", "r715" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PropertyAndEquipmentNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": { "auth_ref": [ "r114" ], "lang": { "en-us": { "role": { "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).", "label": "Property, Plant and Equipment, Estimated Useful Lives", "terseLabel": "Property, Plant and Equipment, Estimated Useful Lives" } } }, "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfPropertyPlantAndEquipmentUsefulLivesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r116", "r297" ], "calculation": { "http://Boqii.com/role/PropertyAndEquipmentNetSummaryOfPropertyPlantAndEquipmentsDetail": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Property, Plant and Equipment, Gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PropertyAndEquipmentNetSummaryOfPropertyPlantAndEquipmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfPropertyPlantAndEquipmentUsefulLivesDetail", "http://Boqii.com/role/PropertyAndEquipmentNetSummaryOfPropertyPlantAndEquipmentsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r118", "r266", "r681", "r763" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 }, "http://Boqii.com/role/PropertyAndEquipmentNetSummaryOfPropertyPlantAndEquipmentsDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net", "totalLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail", "http://Boqii.com/role/PropertyAndEquipmentNetSummaryOfPropertyPlantAndEquipmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Net [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r118", "r713", "r714" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r118" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Summary of Property, Plant and Equipment's" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PropertyAndEquipmentNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r116" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfPropertyPlantAndEquipmentUsefulLivesDetail", "http://Boqii.com/role/PropertyAndEquipmentNetSummaryOfPropertyPlantAndEquipmentsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Property, Plant and Equipment, Useful Life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfPropertyPlantAndEquipmentUsefulLivesDetail" ], "xbrltype": "durationItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r336", "r424" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 26.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "terseLabel": "Addition/(reversal)", "verboseLabel": "Provision for doubtful accounts" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/AccountsReceivableNetSummaryOfMovementOfAllowanceOfDoubtfulAccountsDetail", "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock": { "auth_ref": [ "r39" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 35.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from owner or affiliate of reporting entity for issuance of shares. Includes, but is not limited to, amount due for award under share-based payment arrangement. Excludes amount due from officer or director.", "label": "Receivable from Shareholders or Affiliates for Issuance of Capital Stock", "negatedLabel": "Receivable for issuance of ordinary shares", "verboseLabel": "Receivable for the issuance of ordinary shares" } } }, "localname": "ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/ReceivableForIssuanceOfOrdinarySharesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivableWithImputedInterestFaceAmount": { "auth_ref": [ "r232", "r623" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The principal amount of the receivable or note before consideration of the discount or premium.", "label": "Receivable with Imputed Interest, Face Amount", "terseLabel": "Loan receivable face or par amount" } } }, "localname": "ReceivableWithImputedInterestFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsParentheticalDetail", "http://Boqii.com/role/PrepaymentsAndOtherCurrentAssetsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Receivables [Abstract]" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ReceivablesFromStockholderMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Category of equity that is due from owners or affiliates of the reporting entity (including due from officers or directors) resulting from the sale of stock before the cash payment is received.", "label": "Receivables from Stockholder [Member]", "terseLabel": "Receivable for issuance of ordinary shares [Member]" } } }, "localname": "ReceivablesFromStockholderMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RecourseStatusAxis": { "auth_ref": [ "r583", "r587" ], "lang": { "en-us": { "role": { "documentation": "Information by recourse or nonrecourse status of liability.", "label": "Recourse Status [Axis]" } } }, "localname": "RecourseStatusAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesAdditionalInformationDetail", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RecourseStatusDomain": { "auth_ref": [ "r583", "r587" ], "lang": { "en-us": { "role": { "documentation": "Recourse or nonrecourse status of liability.", "label": "Recourse Status [Domain]" } } }, "localname": "RecourseStatusDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesAdditionalInformationDetail", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": { "auth_ref": [ "r126", "r127", "r128", "r129" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.", "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "verboseLabel": "Redeemable non controlling interest equity carrying amount total" } } }, "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/RedeemableNonControllingInterestsAdditionalInformationDetail", "http://Boqii.com/role/RedeemableNonControllingInterestsScheduleOfRedeemableNonControllingInterestsActivityDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RedeemableNoncontrollingInterestTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.", "label": "Redeemable Noncontrolling Interest [Table Text Block]", "terseLabel": "Schedule Of Redeemable Non-Controlling Interests Activity" } } }, "localname": "RedeemableNoncontrollingInterestTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/RedeemableNonControllingInterestsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RedeemablePreferredStockDividends": { "auth_ref": [ "r84", "r131", "r137" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Dividends paid to preferred stock holders that is redeemable solely at the option of the issuer.", "label": "Redeemable Preferred Stock Dividends", "negatedLabel": "Deemed dividend to preferred shareholders" } } }, "localname": "RedeemablePreferredStockDividends", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r505", "r638", "r639" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfMajorRelatedPartiesAndTheirRelationshipsWithTheCompanyDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionParentheticalDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesParentheticalDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesParentheticalDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueToRelatedPartiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "auth_ref": [ "r237", "r638" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transactions with related party during the financial reporting period.", "label": "Related Party Transaction, Amounts of Transaction", "terseLabel": "Online marketing and information services" } } }, "localname": "RelatedPartyTransactionAmountsOfTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionDueFromToRelatedPartyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transaction, Due from (to) Related Party [Abstract]" } } }, "localname": "RelatedPartyTransactionDueFromToRelatedPartyAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionParentheticalDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Related Party Transaction, Purchases from Related Party", "terseLabel": "Purchase of merchandise" } } }, "localname": "RelatedPartyTransactionPurchasesFromRelatedParty", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r505", "r638", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r891" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfMajorRelatedPartiesAndTheirRelationshipsWithTheCompanyDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionParentheticalDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesParentheticalDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueFromRelatedPartiesParentheticalDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfTransactionsDueToRelatedPartiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r636", "r637", "r639", "r640", "r641" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related party transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r802" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.", "label": "Repayments of Debt", "negatedLabel": "Repayments of short-term and long-term borrowings" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfOtherDebt": { "auth_ref": [ "r71" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for the payment of debt classified as other.", "label": "Repayments of Other Debt", "negatedLabel": "Repayments of other debts", "terseLabel": "Repayments of other debts" } } }, "localname": "RepaymentsOfOtherDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedAssetsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for assets that are restricted in their use, generally by contractual agreements or regulatory requirements. This would include, but not limited to, a description of the restricted assets and the terms of the restriction.", "label": "Restricted Assets Disclosure [Text Block]", "terseLabel": "Restricted net assets" } } }, "localname": "RestrictedAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/RestrictedNetAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r17", "r137", "r263", "r691", "r693", "r763" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 36.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r287", "r344", "r345", "r346", "r348", "r354", "r356", "r421", "r544", "r545", "r546", "r566", "r567", "r589", "r688", "r690" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated deficit [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r737", "r738" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue [Policy Text Block]", "terseLabel": "Revenue recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionRevenueReductions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy of sales arrangements for goods or services that reduce the amount of revenue recognized for example sales returns, allowances, incentives, rebates, discounts and loyalty programs.", "label": "Revenue Recognition, Revenue Reductions [Policy Text Block]", "terseLabel": "Sales returns" } } }, "localname": "RevenueRecognitionRevenueReductions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r332", "r340", "r380", "r381", "r395", "r398", "r399", "r403", "r404", "r406", "r420", "r455", "r456", "r458", "r459", "r460", "r461", "r462", "r464", "r465", "r604", "r680", "r839" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 13.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Total revenues", "verboseLabel": "Total revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Net revenues:", "verboseLabel": "Net revenues:" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r631", "r762" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Operating lease right-of-use assets obtained in exchange for lease obligations", "verboseLabel": "Right-of-use assets obtained in exchange for operating lease obligations" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows", "http://Boqii.com/role/LeasesSummaryOfOperatingLeaseActivityDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConvertibleRedeemablePreferredSharesAdditionalInformationDetail", "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of Stock, Number of Shares Issued in Transaction", "terseLabel": "Sale of Stock, Number of Shares Issued in Transaction" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r406", "r817" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/RisksAndConcentrationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": { "auth_ref": [ "r42" ], "lang": { "en-us": { "role": { "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/AccountsReceivableNetSummaryOfAccountsReceivableNetDetail", "http://Boqii.com/role/AccountsReceivableNetSummaryOfMovementOfAllowanceOfDoubtfulAccountsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "auth_ref": [ "r42" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]", "terseLabel": "Summary of Accounts Receivable Net" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/AccountsReceivableNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r85" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r85" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of Antidilutive Securities Excluded From Computation Of Earnings Per Share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/NetLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r172", "r173", "r578" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsTables" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCashAndCashEquivalentsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of cash and cash equivalent balances. This table excludes restricted cash balances.", "label": "Schedule of Cash and Cash Equivalents [Table]", "terseLabel": "Schedule of Cash and Cash Equivalents [Table]" } } }, "localname": "ScheduleOfCashAndCashEquivalentsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of cash and cash equivalents.", "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Schedule of Cash and Cash Equivalents" } } }, "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/CashAndCashEquivalentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r164" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Schedule of Components of Income Tax Expense (Benefit)" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": { "auth_ref": [ "r141", "r142" ], "lang": { "en-us": { "role": { "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.", "label": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]" } } }, "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationTables" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r161" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Schedule of Deferred Tax Assets And Tax Liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative liabilities at fair value.", "label": "Schedule of Derivative Liabilities at Fair Value [Table Text Block]", "terseLabel": "Summary of Fair Value of Derivative Liabilities" } } }, "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r816" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/NetLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r159" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r106", "r108", "r660" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsDetail", "http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfFiniteLivedIntangibleAssetsUsefulLivesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r106", "r108" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Intangible Assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IntangibleAssetsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r742", "r822", "r823", "r824", "r825", "r826", "r827", "r828", "r829", "r830", "r831", "r832" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Schedule of Changes in the Carrying Amount of Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/GoodwillTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r112", "r113" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.", "label": "Schedule of Indefinite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/GoodwillAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r4", "r21", "r22", "r23" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Summary of Inventories, Net of Inventory Reserves" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/InventoriesNetOfInventoryReservesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r122" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "Schedule of Maturities of Long-term Debt [Table Text Block]", "terseLabel": "Summary of Maturities of Long-term Debt" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": { "auth_ref": [ "r783" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of noncurrent assets.", "label": "Schedule of Other Assets, Noncurrent [Table Text Block]", "terseLabel": "Schedule of Other Non-current Assets" } } }, "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OtherNonCurrentAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.", "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]", "terseLabel": "Summary of Other (Losses), Net" } } }, "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OtherGainsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r118" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfPropertyPlantAndEquipmentUsefulLivesDetail", "http://Boqii.com/role/PropertyAndEquipmentNetSummaryOfPropertyPlantAndEquipmentsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r177" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Summary of Identified Assets Acquired and Liabilities Assumed" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r236", "r237" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionParentheticalDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesDetail", "http://Boqii.com/role/RelatedPartyTransactionsSummaryOfRelatedPartyTransactionsAndBalancesParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.", "label": "Schedule of Related Party Transactions [Table Text Block]", "terseLabel": "Summary of Related Party Transactions And Balances" } } }, "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/RelatedPartyTransactionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r507", "r508", "r510", "r511", "r512", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r534", "r535", "r536", "r537", "r538" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationSummaryOfOptionsMeasuredAtFairValueValuationAssumptionsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r147", "r148", "r149" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Summary of Stock Option Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r151" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions", "verboseLabel": "Summary of Options Measured At Fair Value, Valuation Assumptions" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsTables", "http://Boqii.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShortTermDebtTextBlock": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-term Debt [Table Text Block]", "terseLabel": "Summary of Short-term Debt" } } }, "localname": "ScheduleOfShortTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfVariableInterestEntitiesTable": { "auth_ref": [ "r196", "r198", "r200", "r203", "r204", "r582", "r583", "r586", "r587", "r650", "r651", "r652" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.", "label": "Schedule of Variable Interest Entities [Table]" } } }, "localname": "ScheduleOfVariableInterestEntitiesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": { "auth_ref": [ "r196", "r198", "r200", "r203", "r204" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.", "label": "Schedule of Variable Interest Entities [Table Text Block]", "terseLabel": "Schedule of Variable Interest Entities" } } }, "localname": "ScheduleOfVariableInterestEntitiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r108" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of Annual Estimated Amortization Expense for Intangible Assets" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IntangibleAssetsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": { "auth_ref": [ "r87", "r89", "r90", "r91", "r227", "r229" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]", "terseLabel": "Schedules of Concentration of Risk, By Risk Factor" } } }, "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/RisksAndConcentrationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r389", "r390", "r391", "r392", "r393", "r394", "r404" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Reporting, Policy [Policy Text Block]", "terseLabel": "Segment reporting" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 16.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and Marketing Expense", "negatedLabel": "Sales and marketing expenses" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": { "auth_ref": [ "r155" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.", "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]", "terseLabel": "Sales and marketing expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SeriesCPreferredStockMember": { "auth_ref": [ "r785", "r786", "r844" ], "lang": { "en-us": { "role": { "documentation": "Series C preferred stock.", "label": "Series C Preferred Stock [Member]" } } }, "localname": "SeriesCPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement, Disclosure [Abstract]" } } }, "localname": "ShareBasedArrangementsToObtainGoodsAndServicesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r74" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 34.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Share-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price", "terseLabel": "Exercise multiple" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationSummaryOfOptionsMeasuredAtFairValueValuationAssumptionsDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r536" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Expected dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationSummaryOfOptionsMeasuredAtFairValueValuationAssumptionsDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r535" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum", "terseLabel": "Expected volatility , Maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail", "http://Boqii.com/role/ShareBasedCompensationSummaryOfOptionsMeasuredAtFairValueValuationAssumptionsDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum", "terseLabel": "Expected volatility , Minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail", "http://Boqii.com/role/ShareBasedCompensationSummaryOfOptionsMeasuredAtFairValueValuationAssumptionsDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r537" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum", "terseLabel": "Risk-free rate , Maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail", "http://Boqii.com/role/ShareBasedCompensationSummaryOfOptionsMeasuredAtFairValueValuationAssumptionsDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum", "terseLabel": "Risk-free rate , Minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail", "http://Boqii.com/role/ShareBasedCompensationSummaryOfOptionsMeasuredAtFairValueValuationAssumptionsDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationSummaryOfOptionsMeasuredAtFairValueValuationAssumptionsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r759" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r520" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Number of shares, Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationSummaryOfStockOptionActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Number of shares, Granted", "verboseLabel": "Share based compensation arrangement by share based payment award options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationAdditionalInformationDetail", "http://Boqii.com/role/ShareBasedCompensationSummaryOfStockOptionActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r528" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average fair value, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationSummaryOfStockOptionActivityDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r152" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value", "periodEndLabel": "Aggregate intrinsic value, Outstanding, ending", "periodStartLabel": "Aggregate intrinsic value, Outstanding, beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationSummaryOfStockOptionActivityDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r514", "r515" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Number of shares, Outstanding, ending", "periodStartLabel": "Number of shares, Outstanding, beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationSummaryOfStockOptionActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r514", "r515" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted average exercise price, Outstanding, ending", "periodStartLabel": "Weighted average exercise price, Outstanding, beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationSummaryOfStockOptionActivityDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r510", "r511", "r512", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r534", "r535", "r536", "r537", "r538" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationSummaryOfOptionsMeasuredAtFairValueValuationAssumptionsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r519" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price, Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationSummaryOfStockOptionActivityDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r520" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price, Forfeited" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationSummaryOfStockOptionActivityDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price, Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationSummaryOfStockOptionActivityDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r513", "r532", "r533", "r534", "r535", "r538", "r547", "r548" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-based Payment Arrangement [Policy Text Block]", "terseLabel": "Share-based compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by supplier.", "label": "Supplier [Axis]" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/RisksAndConcentrationSchedulesOfConcentrationOfRiskByRiskFactorDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Specific identification or general nature of (for example, a construction contractor, a consulting firm) the party from whom the goods or services were or are to be received.", "label": "Supplier [Domain]" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/RisksAndConcentrationSchedulesOfConcentrationOfRiskByRiskFactorDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Share price", "verboseLabel": "Spot price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail", "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "auth_ref": [ "r847" ], "lang": { "en-us": { "role": { "documentation": "Percentage of vesting of award under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage", "terseLabel": "Percentage of entitlement to vest earn by employees" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r534" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected expiry years (in years)", "verboseLabel": "Contractual term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/FairValueMeasurementsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail", "http://Boqii.com/role/ShareBasedCompensationSummaryOfOptionsMeasuredAtFairValueValuationAssumptionsDetail" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "periodEndLabel": "Weighted average fair value, Outstanding, ending", "periodStartLabel": "Weighted average fair value, Outstanding, beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationSummaryOfStockOptionActivityDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r150" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted average remaining contractual term, Outstanding" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ShareBasedCompensationSummaryOfStockOptionActivityDetail" ], "xbrltype": "durationItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending Balance, Shares", "periodStartLabel": "Beginning Balance , Shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermBankLoansAndNotesPayable": { "auth_ref": [ "r24", "r269" ], "calculation": { "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfShortTermDebtDetail": { "order": 1.0, "parentTag": "us-gaap_ShortTermBorrowings", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer.", "label": "Short-term Bank Loans and Notes Payable", "terseLabel": "Bank borrowings" } } }, "localname": "ShortTermBankLoansAndNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfShortTermDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermBorrowings": { "auth_ref": [ "r8", "r240", "r261", "r763" ], "calculation": { "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfShortTermDebtDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 18.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Short term bank borrowings outstanding", "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.", "label": "Short-term Debt", "terseLabel": "Short-term borrowings (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the Company of RMB872 and RMB363 as of March 31, 2022 and 2023, respectively)", "totalLabel": "Total", "verboseLabel": "Short-term borrowings" } } }, "localname": "ShortTermBorrowings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfShortTermDebtDetail", "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r25" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.", "label": "Short-term Debt, Type [Domain]" } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermDebtWeightedAverageInterestRate": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of short-term debt outstanding calculated at point in time.", "label": "Short-term Debt, Weighted Average Interest Rate, at Point in Time", "terseLabel": "Short term borrowings weighted average interest rate at a point in time" } } }, "localname": "ShortTermDebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShortTermInvestments": { "auth_ref": [ "r244", "r245", "r259", "r788" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.", "label": "Short-term Investments", "terseLabel": "Short-term investments" } } }, "localname": "ShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermInvestmentsMember": { "auth_ref": [ "r707", "r708", "r709", "r767" ], "lang": { "en-us": { "role": { "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.", "label": "Short-term Investments [Member]", "terseLabel": "Short-term Investments [Member]" } } }, "localname": "ShortTermInvestmentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r83", "r339" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Principal Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r304", "r305", "r306", "r340", "r360", "r361", "r364", "r366", "r374", "r375", "r420", "r455", "r458", "r459", "r460", "r464", "r465", "r486", "r487", "r488", "r489", "r490", "r604", "r728", "r781", "r807", "r815" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]", "verboseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/BusinessCombinationsAdditionalInformationDetail", "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://Boqii.com/role/ConvertibleRedeemablePreferredSharesAdditionalInformationDetail", "http://Boqii.com/role/CoverPage", "http://Boqii.com/role/IncomeTaxesAdditionalInformationDetail", "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail", "http://Boqii.com/role/ReceivableForIssuanceOfOrdinarySharesAdditionalInformationDetail", "http://Boqii.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r41", "r131", "r287", "r328", "r329", "r330", "r344", "r345", "r346", "r348", "r354", "r356", "r373", "r421", "r492", "r544", "r545", "r546", "r566", "r567", "r589", "r610", "r611", "r612", "r613", "r614", "r616", "r635", "r688", "r689", "r690" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "http://Boqii.com/role/ConvertibleRedeemablePreferredSharesAdditionalInformationDetail", "http://Boqii.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "verboseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsAdditionalInformationDetail", "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://Boqii.com/role/ConvertibleRedeemablePreferredSharesAdditionalInformationDetail", "http://Boqii.com/role/IncomeTaxesAdditionalInformationDetail", "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationParentheticalDetail", "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail", "http://Boqii.com/role/RedeemableNonControllingInterestsAdditionalInformationDetail", "http://Boqii.com/role/RestrictedNetAssetsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r344", "r345", "r346", "r373", "r659" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "verboseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BusinessCombinationsAdditionalInformationDetail", "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://Boqii.com/role/ConvertibleRedeemablePreferredSharesAdditionalInformationDetail", "http://Boqii.com/role/IncomeTaxesAdditionalInformationDetail", "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationParentheticalDetail", "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail", "http://Boqii.com/role/RedeemableNonControllingInterestsAdditionalInformationDetail", "http://Boqii.com/role/RestrictedNetAssetsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of preferred stock and warrants for common stock issued.", "label": "Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants", "negatedLabel": "Exercise of CMB Warrant" } } }, "localname": "StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r40", "r131", "r132", "r137", "r476" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "terseLabel": "Stock Issued During Period, Shares, Conversion of Convertible Securities" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r14", "r15", "r131", "r137" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuance of Class\u00a0A ordinary shares upon initial public offering (\"IPO\"), net of cost of issuance, Shares", "verboseLabel": "Stock issued during period" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail", "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r14", "r15", "r131", "r137", "r519" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "negatedLabel": "Number of shares, Exercised", "terseLabel": "Issuance of ordinary shares for the exercise of stock options, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "http://Boqii.com/role/ShareBasedCompensationSummaryOfStockOptionActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r14", "r15", "r131", "r137" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of Class\u00a0A ordinary shares upon initial public offering (\"IPO\"), net of cost of issuance", "verboseLabel": "Stock issued during period, value, new issues" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail", "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "http://Boqii.com/role/LongTermInvestmentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r41", "r131", "r137" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Issuance of ordinary shares for the exercise of stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "auth_ref": [ "r14", "r15", "r131", "r137" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased and retired during the period.", "label": "Stock Repurchased and Retired During Period, Shares", "terseLabel": "Stock Repurchased and Retired During Period, Shares" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": { "auth_ref": [ "r14", "r15", "r131", "r137" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).", "label": "Stock Repurchased and Retired During Period, Value" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r14", "r15", "r131", "r137" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares", "terseLabel": "Repurchase of Ordinary Shares , Shares" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r14", "r15", "r131", "r137" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "negatedLabel": "Repurchase of Ordinary Shares" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r15", "r18", "r19", "r96", "r763", "r809", "r820", "r884" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 34.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total Boqii Holding Limited shareholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r184", "r185", "r205", "r287", "r288", "r329", "r344", "r345", "r346", "r348", "r354", "r421", "r492", "r544", "r545", "r546", "r566", "r567", "r589", "r610", "r611", "r616", "r635", "r689", "r690", "r809", "r820", "r884" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 32.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "totalLabel": "Total shareholders' equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets", "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Shareholders' equity:" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityPeriodIncreaseDecrease": { "auth_ref": [ "r131", "r137" ], "lang": { "en-us": { "role": { "documentation": "The increase (decrease) in stockholders' equity during the period.", "label": "Stockholders' Equity, Period Increase (Decrease)", "terseLabel": "Receivable for issuance of ordinary shares (Note 23)" } } }, "localname": "StockholdersEquityPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r617", "r644" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r617", "r644" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r617", "r644" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]", "terseLabel": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r643", "r645" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConvertibleRedeemablePreferredSharesAdditionalInformationDetail", "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SummaryOfIncomeTaxHolidayTextBlock": { "auth_ref": [ "r166" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the income tax exemptions and reductions which have been granted by taxing authorities for a specified period, applicable term of the exemptions and reductions, estimated dollar value of tax benefits, and per share benefits.", "label": "Summary of Income Tax Holiday [Table Text Block]", "terseLabel": "Summary of Income Tax Holiday" } } }, "localname": "SummaryOfIncomeTaxHolidayTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SummaryOfValuationAllowanceTextBlock": { "auth_ref": [ "r160" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.", "label": "Summary of Valuation Allowance [Table Text Block]", "terseLabel": "Summary of Valuation Allowance" } } }, "localname": "SummaryOfValuationAllowanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Additional ASC 842 supplemental disclosure:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplierConcentrationRiskMember": { "auth_ref": [ "r88" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.", "label": "Supplier Concentration Risk [Member]" } } }, "localname": "SupplierConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/RisksAndConcentrationAdditionalInformationDetail", "http://Boqii.com/role/RisksAndConcentrationSchedulesOfConcentrationOfRiskByRiskFactorDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SwapMember": { "auth_ref": [ "r209" ], "lang": { "en-us": { "role": { "documentation": "A forward-based contract in which two parties agree to swap streams of payments over a specified period. The payment streams are based on an agreed-upon (or notional) principal amount. The term notional is used because swap contracts generally involve no exchange of principal at either inception or maturity. Rather, the notional amount serves as a basis for calculation of the payment streams to be exchanged.", "label": "Swap [Member]", "terseLabel": "Forward exchange swap [Member]" } } }, "localname": "SwapMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesSummaryOfFairValueOfDerivativeLiabilitiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_TangibleAssetImpairmentCharges": { "auth_ref": [ "r1", "r119" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.", "label": "Tangible Asset Impairment Charges", "terseLabel": "Impairment of tangible assets amount" } } }, "localname": "TangibleAssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxPeriodAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information about the period subject to enacted tax laws.", "label": "Tax Period [Axis]", "verboseLabel": "Tax Period [Axis]" } } }, "localname": "TaxPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesAdditionalInformationDetail", "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_TaxPeriodDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identified tax period.", "label": "Tax Period [Domain]", "verboseLabel": "Tax Period [Domain]" } } }, "localname": "TaxPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesAdditionalInformationDetail", "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_TaxYear2018Member": { "auth_ref": [ "r875" ], "lang": { "en-us": { "role": { "documentation": "Identified as tax year 2018.", "label": "Tax Year 2018 [Member]" } } }, "localname": "TaxYear2018Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_TemporaryEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Temporary Equity [Abstract]", "terseLabel": "Mezzanine equity:" } } }, "localname": "TemporaryEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.", "label": "Temporary Equity, Accretion to Redemption Value, Adjustment", "verboseLabel": "Accretion to redemption value of redeemable convertible preferred shares (Note 20)" } } }, "localname": "TemporaryEquityAccretionToRedemptionValueAdjustment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": { "auth_ref": [ "r37", "r340", "r420", "r604" ], "calculation": { "http://Boqii.com/role/ConsolidatedBalanceSheets": { "order": 30.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests", "totalLabel": "Total mezzanine equity" } } }, "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityDividendsAdjustment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accretion of temporary equity during the period due to cash, stock, and in-kind dividends. This item is an adjustment to net income necessary to derive net income apportioned to common stockholders and is to be distinguished from Temporary Equity, Accretion of Dividends (Temporary Equity, Accretion of Dividends).", "label": "Temporary Equity, Dividends, Adjustment", "terseLabel": "Deemed dividend to preferred shareholders" } } }, "localname": "TemporaryEquityDividendsAdjustment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquitySharesIssued": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Issued", "verboseLabel": "Equity, shares issued" } } }, "localname": "TemporaryEquitySharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/RedeemableNonControllingInterestsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Outstanding", "verboseLabel": "Convertible Preferred Shares, Outstanding" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OrdinaryShareAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesSubscribedButUnissuedSubscriptionsReceivable": { "auth_ref": [ "r13" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate monetary value of a new issue of securities which have been allocated to investors to buy. When security is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the security to the investor until it receives the entire proceeds. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Subscribed but Unissued, Subscriptions Receivable", "terseLabel": "Receivable for the issuance of temporary equity" } } }, "localname": "TemporaryEquitySharesSubscribedButUnissuedSubscriptionsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of new stock classified as temporary equity issued during the period.", "label": "Temporary Equity, Stock Issued During Period, Value, New Issues", "negatedLabel": "Receivable for issuance of convertible redeemable preferred shares", "verboseLabel": "Redeemable preferred shares issued amount" } } }, "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "http://Boqii.com/role/RedeemableNonControllingInterestsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "auth_ref": [ "r278", "r279", "r280", "r409", "r410", "r412" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for accounts receivable.", "label": "Accounts Receivable [Policy Text Block]", "terseLabel": "Accounts receivable, net" } } }, "localname": "TradeAndOtherAccountsReceivablePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_TrademarksMember": { "auth_ref": [ "r178" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.", "label": "Trademarks [Member]", "terseLabel": "Trademark [Member]" } } }, "localname": "TrademarksMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IntangibleAssetsNetScheduleOfIntangibleAssetsDetail", "http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfFiniteLivedIntangibleAssetsUsefulLivesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r879" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesAdditionalInformationDetail", "http://Boqii.com/role/OtherNonCurrentAssetsScheduleOfOtherNonCurrentAssetsParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_UnrealizedGainLossOnDerivatives": { "auth_ref": [ "r75" ], "calculation": { "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows": { "order": 35.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.", "label": "Unrealized Gain (Loss) on Derivatives", "negatedLabel": "Fair value change of derivative liabilities" } } }, "localname": "UnrealizedGainLossOnDerivatives", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r92", "r93", "r94", "r376", "r377", "r378", "r379" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r560" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "verboseLabel": "Change of valuation allowance" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/IncomeTaxesSummaryOfValuationAllowanceDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableInterestEntityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Variable Interest Entity [Line Items]" } } }, "localname": "VariableInterestEntityLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_VariableInterestEntityOwnershipPercentage": { "auth_ref": [ "r199" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).", "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage", "terseLabel": "Percentage of direct or indirect" } } }, "localname": "VariableInterestEntityOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail" ], "xbrltype": "percentItemType" }, "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": { "auth_ref": [ "r196", "r582", "r583", "r586", "r587" ], "lang": { "en-us": { "role": { "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.", "label": "Variable Interest Entity, Primary Beneficiary [Member]", "terseLabel": "Variable Interest Entity, Primary Beneficiary [Member]" } } }, "localname": "VariableInterestEntityPrimaryBeneficiaryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedBalanceSheetsParenthetical", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesAdditionalInformationDetail", "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfVariableInterestEntitiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_VariableInterestEntityQualitativeOrQuantitativeInformationDateInvolvementBegan1": { "auth_ref": [ "r199", "r202" ], "lang": { "en-us": { "role": { "documentation": "Date the relationship between reporting entity and the Variable Interest Entity (VIE) began, in YYYY-MM-DD format.", "label": "Variable Interest Entity, Qualitative or Quantitative Information, Date Involvement Began", "terseLabel": "Date of incorporation or acquisition" } } }, "localname": "VariableInterestEntityQualitativeOrQuantitativeInformationDateInvolvementBegan1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail" ], "xbrltype": "dateItemType" }, "us-gaap_VariableInterestEntityVIEActivitiesOfVIE": { "auth_ref": [ "r191", "r197", "r199", "r201" ], "lang": { "en-us": { "role": { "documentation": "Description of the transactions or business conducted by the Variable Interest Entity (VIE), including how the VIE is financed.", "label": "Variable Interest Entity, Qualitative or Quantitative Information, Activities of VIE", "terseLabel": "Principal activities" } } }, "localname": "VariableInterestEntityVIEActivitiesOfVIE", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/OrganizationAndPrincipalActivitiesScheduleOfDetailsOfTheSubsidiariesViesAndViesSubsidiariesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_VehiclesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment used primarily for road transportation.", "label": "Vehicles [Member]", "terseLabel": "Vehicles [Member]" } } }, "localname": "VehiclesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/PrincipalAccountingPoliciesScheduleOfPropertyPlantAndEquipmentUsefulLivesDetail", "http://Boqii.com/role/PropertyAndEquipmentNetSummaryOfPropertyPlantAndEquipmentsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.", "label": "Warrants and Rights Outstanding", "terseLabel": "Class of warrants or rights outstanding value" } } }, "localname": "WarrantsAndRightsOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/BorrowingsOtherDebtsAndDerivativeLiabilitiesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r359", "r366" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "\u2014 diluted", "verboseLabel": "Weighted average number of ordinary shares used in computing net loss per share, Diluted (Note (a))" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://Boqii.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r357", "r366" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "\u2014 basic", "verboseLabel": "Weighted average number of ordinary shares used in computing net loss per share, Basic (Note (a))" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://Boqii.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]", "terseLabel": "Weighted average number of ordinary shares" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://Boqii.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "stringItemType" } }, "unitCount": 12 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b),(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905813&loc=d3e1205-110223", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(12)(c)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(16)(c)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "14", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "15", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "16(c)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "610", "URI": "https://asc.fasb.org/topic&trid=49130413", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409733&loc=d3e19524-108361", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "710", "URI": "https://asc.fasb.org/topic&trid=2127225", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "712", "URI": "https://asc.fasb.org/topic&trid=2197446", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "https://asc.fasb.org/topic&trid=2235017", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "720", "URI": "https://asc.fasb.org/topic&trid=2122503", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r183": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org/topic&trid=2303972", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569655-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c,d)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6228967-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=77885760&loc=SL35686385-199418", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "b", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6228884-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r208": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "83", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126929950&loc=d3e34841-113949", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL7498348-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(4))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.5)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.1-12)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.7,8)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(17))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(g))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(g))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.16)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604008-122996", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123389372&loc=d3e36991-112694", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 3)", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41499-112717", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r286": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "840", "URI": "https://asc.fasb.org/topic&trid=2208923", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(11))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(12))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.27(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "310", "URI": "https://asc.fasb.org/topic&trid=2196771", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "8B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL6284393-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "326", "URI": "https://asc.fasb.org/topic&trid=82887179", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144471", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(b)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(c),9(a))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)(i)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28228-110885", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7,9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6897108&loc=SL6897125-166521", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r619": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "https://asc.fasb.org/topic&trid=2175825", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342832&loc=SL128342943-244231", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r641": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r645": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(b)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(6))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(7))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r728": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r768": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r769": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r770": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r771": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r772": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d-3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r773": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r774": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r775": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r776": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r777": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r778": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r779": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r780": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r781": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r782": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r783": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r784": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r785": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r786": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r787": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r788": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r789": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r790": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r791": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r792": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r793": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r794": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(7)(c))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r795": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(9)(a))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r796": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r797": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r798": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r799": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r800": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r801": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r802": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r803": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r804": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r805": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r806": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3098-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r807": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r808": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r809": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r810": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r811": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r812": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r813": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r814": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r815": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r816": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r817": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r818": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r819": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org/topic&trid=2196928", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r820": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r821": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r822": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r823": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r824": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r825": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r826": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r827": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r828": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r829": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r83": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r830": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r831": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r832": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r833": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r834": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r835": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r836": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r837": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r838": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r839": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r840": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r841": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r842": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r843": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r844": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r845": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r846": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r847": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r848": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r849": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r850": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r851": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r852": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r853": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r854": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r855": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r856": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r857": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r858": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r859": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r860": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r861": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r862": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r863": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r864": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r865": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r866": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r867": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r868": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r869": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r870": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r871": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r872": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r873": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r874": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r875": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r876": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r877": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r878": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r879": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r880": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r881": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r882": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r883": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r884": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r885": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r886": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r887": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r888": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r889": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r890": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r891": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r892": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r893": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r894": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r895": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r896": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r897": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r898": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r899": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r900": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(g))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r901": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r902": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(b))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r903": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r904": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r905": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27405-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 170 0001193125-23-192729-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-192729-xbrl.zip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